Citrus Sinensis ID: 018263

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------36
Protein Sequence
MKSIFSCFSFPSRVSAENTIGGEQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNIDGXDVEISQPGLIGDIMDVKVGQRSSSKSMTENGS
Secondary Structure (PSIPRED)
cccEEEEEcccccccccccccccccccccccccHHHHHHHHcccccccccccccccccEEEEcccccEEEEEEccccccccHHHHHHHHHHHHHHcccccccccEEEEEcccccEEEEEEccccccccHHccccccccccccHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccEEEccEEcccccccHHHHcccccccccccccHHHHHHHHHccccccccccccccccHHHHHHHHHHcccccccccccccccccHHHHHHHHHHHHHcccccccccccHHHHHHHHccccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccEEEEEEEEccccccHHHccccccccccccEcHHHHHHHHccccHHccccccccccEEEEEcccccEEEEEEEcccccccHHHHHHHHHHHHHHHEHcHcHHEEEEEEEccccEEEEEEEcccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHHHHcHcccccccccHHHEEEcHHHcEEEccccccccccccccEEEccEEEcHHHccHHHHHHccccHHHHHHHHHHHHHHHHccccccccccccccHHHHHHHHHHHHcccHHHHccHHHcccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHccccccccccccccccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
mksifscfsfpsrvsaentiggEQILKNINAFSYnqlkiatngfrwsnkigeggfgsvykgrlqdgtIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVklhggcidgpcrilvydympnnslsqtlLGEEKRRAKFGWKARREIIMGIGRGLAYiheeiqphvvhrdiktsnilldqnfnpkisdfglsklfpentthistrvagtlgylapeyaisgrltrksdvYSFGVLLLEIVSgrtavdfdvqLGEYHLVDkawgmynskelmnlvdpmlygnfpenEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMngetnidgxdveisqpgligdimdvkvgqrsssksmtengS
Flexible Loop (DISEMBL)
mksifscfsfpsrvsaENTIGGEQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIstrvagtlgyLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNIDGXDVEISQPGLIGDImdvkvgqrsssksmtengS
Low Complexity Region (SEG)
MKSIFSCFSFPSRVSAENTIGGEQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNIDGxDVEISQPGLIGDIMDVKVGQRSSSKSMTENGS
Disordered region (IsUnstruct)
***IFSCFSFPSRVSAENTIGGEQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVE*******FMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQE*******************************GLIGDIM******************
Disordered Region (DISOPRED)
*KSIFS*F*********************NAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNI****VEISQPGLI**********************
Disordered Region (DISEMBL)
MKSIFSCFSFPSRVSAENTIGGEQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNIDGXDVEISQPGLIGDIMDVK**************S
Disordered Region (DISPRO)
MKSIFSCFSFPSRVS******GEQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE*NI***********************************
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MKSIFSCFSFPSRVSAENTIGGEQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNIDGXDVEISQPGLIGDIMDVKVGQRSSSKSMTENGS
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	358	2.2.26 [Sep-21-2011]
C0LGH2	1032	Probable LRR receptor-lik	no	no	0.835	0.289	0.495	2e-81
C0LGG9	1035	Probable LRR receptor-lik	no	no	0.812	0.281	0.501	5e-81
C0LGG8	1038	Probable LRR receptor-lik	no	no	0.812	0.280	0.501	9e-81
C0LGH3	1033	Probable LRR receptor-lik	no	no	0.837	0.290	0.490	4e-80
Q9ASQ6	1019	Probable LRR receptor-lik	no	no	0.888	0.312	0.462	4e-80
C0LGG7	953	Probable LRR receptor-lik	no	no	0.835	0.313	0.475	4e-80
C0LGN2	1020	Probable leucine-rich rep	no	no	0.821	0.288	0.476	6e-80
P85193	242	Putative serine/threonine	N/A	no	0.653	0.966	0.591	9e-80
C0LGE0	1014	Probable LRR receptor-lik	no	no	0.807	0.285	0.489	1e-78
Q8GYA4	669	Cysteine-rich receptor-li	no	no	0.801	0.428	0.467	5e-73

>sp|C0LGH2|Y1561_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56130 OS=Arabidopsis thaliana GN=At1g56130 PE=1 SV=2

 Score =  302 bits (774), Expect = 2e-81,   Method: Compositional matrix adjust.
 Identities = 152/307 (49%), Positives = 210/307 (68%), Gaps = 8/307 (2%)

Query: 32  FSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVAS 91
           F+Y++LK AT  F  SNK+GEGGFG VYKG L DG +VAVK+LSV S+QG+ +F++E+ +
Sbjct: 682 FTYSELKSATQDFDPSNKLGEGGFGPVYKGNLNDGRVVAVKLLSVGSRQGKGQFVAEIVA 741

Query: 92  MANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
           +++V   H NLVKL+G C +G  R+LVY+Y+PN SL Q L G+  +     W  R EI +
Sbjct: 742 ISSV--LHRNLVKLYGCCFEGEHRMLVYEYLPNGSLDQALFGD--KTLHLDWSTRYEICL 797

Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT 211
           G+ RGL Y+HEE    +VHRD+K SNILLD    P+ISDFGL+KL+ +  THISTRVAGT
Sbjct: 798 GVARGLVYLHEEASVRIVHRDVKASNILLDSRLVPQISDFGLAKLYDDKKTHISTRVAGT 857

Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKE 271
           +GYLAPEYA+ G LT K+DVY+FGV+ LE+VSGR   D +++  + +L++ AW ++    
Sbjct: 858 IGYLAPEYAMRGHLTEKTDVYAFGVVALELVSGRPNSDENLEEEKKYLLEWAWNLHEKSR 917

Query: 272 LMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNIDGXDVEIS 331
            + L+D  L  +F   EA R + + LLC Q    LRP MS  + M++G+  I   DV  S
Sbjct: 918 DIELIDDKLT-DFNMEEAKRMIGIALLCTQTSHALRPPMSRVVAMLSGDVEI--GDV-TS 973

Query: 332 QPGLIGD 338
           +PG + D
Sbjct: 974 KPGYVSD 980

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGG9|Y5344_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53440 OS=Arabidopsis thaliana GN=At1g53440 PE=1 SV=2

 Score =  301 bits (771), Expect = 5e-81,   Method: Compositional matrix adjust.
 Identities = 147/293 (50%), Positives = 203/293 (69%), Gaps = 2/293 (0%)

Query: 31  AFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVA 90
           +F+  Q+K ATN F   NKIGEGGFG VYKG L DG  +AVK LS +SKQG +EF++E+ 
Sbjct: 654 SFTLKQIKRATNNFDPENKIGEGGFGPVYKGVLADGMTIAVKQLSSKSKQGNREFVTEIG 713

Query: 91  SMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 150
            ++ +   H NLVKL+G CI+G   +LVY+Y+ NNSL++ L G EK+R    W  R ++ 
Sbjct: 714 MISALQ--HPNLVKLYGCCIEGKELLLVYEYLENNSLARALFGTEKQRLHLDWSTRNKVC 771

Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG 210
           +GI +GLAY+HEE +  +VHRDIK +N+LLD + N KISDFGL+KL  E  THISTR+AG
Sbjct: 772 IGIAKGLAYLHEESRLKIVHRDIKATNVLLDLSLNAKISDFGLAKLDEEENTHISTRIAG 831

Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSK 270
           T+GY+APEYA+ G LT K+DVYSFGV+ LEIVSG++  ++  +    +L+D A+ +    
Sbjct: 832 TIGYMAPEYAMRGYLTDKADVYSFGVVCLEIVSGKSNTNYRPKEEFIYLLDWAYVLQEQG 891

Query: 271 ELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNI 323
            L+ LVDP L  +F + EA+R L + LLC      LRP MS+ + M+ G+  +
Sbjct: 892 SLLELVDPDLGTSFSKKEAMRMLNIALLCTNPSPTLRPPMSSVVSMLQGKIKV 944

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGG8|Y5343_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53430 OS=Arabidopsis thaliana GN=At1g53430 PE=1 SV=1

 Score =  300 bits (769), Expect = 9e-81,   Method: Compositional matrix adjust.
 Identities = 147/293 (50%), Positives = 203/293 (69%), Gaps = 2/293 (0%)

Query: 31  AFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVA 90
           +F+  Q+K ATN F   NKIGEGGFG VYKG L DG  +AVK LS +SKQG +EF++E+ 
Sbjct: 656 SFTLKQIKRATNNFDPENKIGEGGFGPVYKGVLADGMTIAVKQLSSKSKQGNREFVTEIG 715

Query: 91  SMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 150
            ++ +   H NLVKL+G CI+G   +LVY+Y+ NNSL++ L G EK+R    W  R +I 
Sbjct: 716 MISALQ--HPNLVKLYGCCIEGKELLLVYEYLENNSLARALFGTEKQRLHLDWSTRNKIC 773

Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG 210
           +GI +GLAY+HEE +  +VHRDIK +N+LLD + N KISDFGL+KL  +  THISTR+AG
Sbjct: 774 IGIAKGLAYLHEESRLKIVHRDIKATNVLLDLSLNAKISDFGLAKLNDDENTHISTRIAG 833

Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSK 270
           T+GY+APEYA+ G LT K+DVYSFGV+ LEIVSG++  ++  +    +L+D A+ +    
Sbjct: 834 TIGYMAPEYAMRGYLTDKADVYSFGVVCLEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQG 893

Query: 271 ELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNI 323
            L+ LVDP L  +F + EA+R L + LLC      LRP MS+ + M+ G+  +
Sbjct: 894 SLLELVDPDLGTSFSKKEAMRMLNIALLCTNPSPTLRPPMSSVVSMLEGKIKV 946

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGH3|Y5614_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56140 OS=Arabidopsis thaliana GN=At1g56140 PE=1 SV=2

 Score =  298 bits (763), Expect = 4e-80,   Method: Compositional matrix adjust.
 Identities = 151/308 (49%), Positives = 208/308 (67%), Gaps = 8/308 (2%)

Query: 31  AFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVA 90
            F+Y++LK AT  F  SNK+GEGGFG VYKG+L DG  VAVK+LSV S+QG+ +F++E+ 
Sbjct: 680 TFTYSELKSATQDFDPSNKLGEGGFGPVYKGKLNDGREVAVKLLSVGSRQGKGQFVAEIV 739

Query: 91  SMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 150
           +++ V   H NLVKL+G C +G  R+LVY+Y+PN SL Q L GE  +     W  R EI 
Sbjct: 740 AISAVQ--HRNLVKLYGCCYEGEHRLLVYEYLPNGSLDQALFGE--KTLHLDWSTRYEIC 795

Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG 210
           +G+ RGL Y+HEE +  +VHRD+K SNILLD    PK+SDFGL+KL+ +  THISTRVAG
Sbjct: 796 LGVARGLVYLHEEARLRIVHRDVKASNILLDSKLVPKVSDFGLAKLYDDKKTHISTRVAG 855

Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSK 270
           T+GYLAPEYA+ G LT K+DVY+FGV+ LE+VSGR   D +++  + +L++ AW ++   
Sbjct: 856 TIGYLAPEYAMRGHLTEKTDVYAFGVVALELVSGRPNSDENLEDEKRYLLEWAWNLHEKG 915

Query: 271 ELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNIDGXDVEI 330
             + L+D  L   F   E  R + + LLC Q    LRP MS  + M++G+  +   DV  
Sbjct: 916 REVELIDHQLT-EFNMEEGKRMIGIALLCTQTSHALRPPMSRVVAMLSGDVEVS--DV-T 971

Query: 331 SQPGLIGD 338
           S+PG + D
Sbjct: 972 SKPGYLTD 979

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ASQ6|Y1972_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g29720 OS=Arabidopsis thaliana GN=RFK1 PE=2 SV=3

 Score =  298 bits (763), Expect = 4e-80,   Method: Compositional matrix adjust.
 Identities = 153/331 (46%), Positives = 217/331 (65%), Gaps = 13/331 (3%)

Query: 31  AFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVA 90
            FS+ QL+ ATN F  +NK+GEGGFGSV+KG L DGTI+AVK LS +S QG +EF++E+ 
Sbjct: 660 CFSWRQLQTATNNFDQANKLGEGGFGSVFKGELSDGTIIAVKQLSSKSSQGNREFVNEIG 719

Query: 91  SMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 150
            ++ +N  H NLVKL+G C++    +LVY+YM NNSL+  L G+     K  W AR++I 
Sbjct: 720 MISGLN--HPNLVKLYGCCVERDQLLLVYEYMENNSLALALFGQNS--LKLDWAARQKIC 775

Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG 210
           +GI RGL ++H+     +VHRDIKT+N+LLD + N KISDFGL++L     THIST+VAG
Sbjct: 776 VGIARGLEFLHDGSAMRMVHRDIKTTNVLLDTDLNAKISDFGLARLHEAEHTHISTKVAG 835

Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSK 270
           T+GY+APEYA+ G+LT K+DVYSFGV+ +EIVSG++            L++ A  +  + 
Sbjct: 836 TIGYMAPEYALWGQLTEKADVYSFGVVAMEIVSGKSNTKQQGNADSVSLINWALTLQQTG 895

Query: 271 ELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNIDGXDVEI 330
           +++ +VD ML G F  +EA+R +KV L+C      LRP MS A+KM+ GE  I      +
Sbjct: 896 DILEIVDRMLEGEFNRSEAVRMIKVALVCTNSSPSLRPTMSEAVKMLEGEIEITQV---M 952

Query: 331 SQPGLIG------DIMDVKVGQRSSSKSMTE 355
           S PG+ G       + D+     SS+  +T+
Sbjct: 953 SDPGIYGHDWSISKLRDIDTHSSSSTSGVTD 983

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGG7|Y1534_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53420 OS=Arabidopsis thaliana GN=At1g53420 PE=2 SV=2

 Score =  298 bits (763), Expect = 4e-80,   Method: Compositional matrix adjust.
 Identities = 143/301 (47%), Positives = 209/301 (69%), Gaps = 2/301 (0%)

Query: 29  INAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSE 88
           I +FS  Q+KIATN F  +N+IGEGGFG VYKG+L DGTI+AVK LS  SKQG +EF++E
Sbjct: 609 IASFSLRQIKIATNNFDSANRIGEGGFGPVYKGKLFDGTIIAVKQLSTGSKQGNREFLNE 668

Query: 89  VASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARRE 148
           +  ++ ++  H NLVKL+G C++G   +LVY+++ NNSL++ L G ++ + +  W  RR+
Sbjct: 669 IGMISALH--HPNLVKLYGCCVEGGQLLLVYEFVENNSLARALFGPQETQLRLDWPTRRK 726

Query: 149 IIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRV 208
           I +G+ RGLAY+HEE +  +VHRDIK +N+LLD+  NPKISDFGL+KL  E++THISTR+
Sbjct: 727 ICIGVARGLAYLHEESRLKIVHRDIKATNVLLDKQLNPKISDFGLAKLDEEDSTHISTRI 786

Query: 209 AGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYN 268
           AGT GY+APEYA+ G LT K+DVYSFG++ LEIV GR+      +   ++L+D    +  
Sbjct: 787 AGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVHGRSNKIERSKNNTFYLIDWVEVLRE 846

Query: 269 SKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNIDGXDV 328
              L+ LVDP L   +   EA+  +++ ++C   +   RP MS  +KM+ G+  ++   +
Sbjct: 847 KNNLLELVDPRLGSEYNREEAMTMIQIAIMCTSSEPCERPSMSEVVKMLEGKKMVEVEKL 906

Query: 329 E 329
           E
Sbjct: 907 E 907

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGN2|Y3148_ARATH Probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840 OS=Arabidopsis thaliana GN=LRR-RLK PE=1 SV=1

 Score =  298 bits (762), Expect = 6e-80,   Method: Compositional matrix adjust.
 Identities = 141/296 (47%), Positives = 207/296 (69%), Gaps = 2/296 (0%)

Query: 29  INAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSE 88
           I++FS  Q+K+AT+ F  +NKIGEGGFG V+KG + DGT++AVK LS +SKQG +EF++E
Sbjct: 657 ISSFSLRQIKVATDNFDPANKIGEGGFGPVHKGIMTDGTVIAVKQLSAKSKQGNREFLNE 716

Query: 89  VASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARRE 148
           +A ++ +   H +LVKL+G C++G   +LVY+Y+ NNSL++ L G ++ +    W  R++
Sbjct: 717 IAMISALQ--HPHLVKLYGCCVEGDQLLLVYEYLENNSLARALFGPQETQIPLNWPMRQK 774

Query: 149 IIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRV 208
           I +GI RGLAY+HEE +  +VHRDIK +N+LLD+  NPKISDFGL+KL  E  THISTRV
Sbjct: 775 ICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKELNPKISDFGLAKLDEEENTHISTRV 834

Query: 209 AGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYN 268
           AGT GY+APEYA+ G LT K+DVYSFGV+ LEIV G++      +   ++L+D    +  
Sbjct: 835 AGTYGYMAPEYAMRGHLTDKADVYSFGVVALEIVHGKSNTSSRSKADTFYLLDWVHVLRE 894

Query: 269 SKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNID 324
              L+ +VDP L  ++ + EA+  +++G+LC       RP MST + M+ G + ++
Sbjct: 895 QNTLLEVVDPRLGTDYNKQEALMMIQIGMLCTSPAPGDRPSMSTVVSMLEGHSTVN 950

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P85193|PK01_HELAN Putative serine/threonine-protein kinase (Fragment) OS=Helianthus annuus PE=1 SV=1

 Score =  297 bits (760), Expect = 9e-80,   Method: Compositional matrix adjust.
 Identities = 145/245 (59%), Positives = 183/245 (74%), Gaps = 11/245 (4%)

Query: 1   MKSIFSCF-SFPSR-----VSAENTIGGEQILKNINAFSYNQLKIATNGFRWSNKIGEGG 54
           MK  F C   F S      V ++N  GGE   K    FSY++LK+A +GF   NK+GEGG
Sbjct: 1   MKMCFPCLQCFCSTSDDKVVVSKNDKGGESG-KKFRLFSYHELKVACDGFSSKNKVGEGG 59

Query: 55  FGSVYKGRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG 112
            G+VYKGRL DGT+VA+KVLSVE  S +GE+EF+SE+A++++    HENLV LHG C++ 
Sbjct: 60  CGAVYKGRLTDGTMVAIKVLSVELESMRGEREFISEIAALSDAQ--HENLVNLHGCCVEE 117

Query: 113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRD 172
             R LVYDYM NNSL+   LG E+ R  F W  R+ +++G+ + LAY+HEEI PH+VHRD
Sbjct: 118 ATRCLVYDYMENNSLAYQFLGREQNRNSFDWTKRKNVLLGVAKALAYLHEEINPHIVHRD 177

Query: 173 IKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVY 232
           IK SN+LLD NFNPK++DFGL++LF E T+HISTRVAGTLGYL+PEYA+S RLTRKSDVY
Sbjct: 178 IKASNVLLDHNFNPKVADFGLARLFQEGTSHISTRVAGTLGYLSPEYAVSERLTRKSDVY 237

Query: 233 SFGVL 237
           SFGVL
Sbjct: 238 SFGVL 242

Helianthus annuus (taxid: 4232)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGE0|Y1765_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g07650 OS=Arabidopsis thaliana GN=At1g07650 PE=1 SV=1

 Score =  293 bits (750), Expect = 1e-78,   Method: Compositional matrix adjust.
 Identities = 143/292 (48%), Positives = 201/292 (68%), Gaps = 3/292 (1%)

Query: 31  AFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVA 90
            F+  Q+K AT+ F  + KIGEGGFGSVYKG L +G ++AVK LS +S+QG +EF++E+ 
Sbjct: 665 TFTLRQIKAATDNFDVTRKIGEGGFGSVYKGELSEGKLIAVKQLSAKSRQGNREFVNEIG 724

Query: 91  SMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLG-EEKRRAKFGWKARREI 149
            ++ +   H NLVKL+G C++G   ILVY+Y+ NN LS+ L G +E  R K  W  R++I
Sbjct: 725 MISALQ--HPNLVKLYGCCVEGNQLILVYEYLENNCLSRALFGKDESSRLKLDWSTRKKI 782

Query: 150 IMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVA 209
            +GI +GL ++HEE +  +VHRDIK SN+LLD++ N KISDFGL+KL  +  THISTR+A
Sbjct: 783 FLGIAKGLTFLHEESRIKIVHRDIKASNVLLDKDLNAKISDFGLAKLNDDGNTHISTRIA 842

Query: 210 GTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNS 269
           GT+GY+APEYA+ G LT K+DVYSFGV+ LEIVSG++  +F       +L+D A+ +   
Sbjct: 843 GTIGYMAPEYAMRGYLTEKADVYSFGVVALEIVSGKSNTNFRPTEDFVYLLDWAYVLQER 902

Query: 270 KELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGET 321
             L+ LVDP L  ++ E EA+  L V L+C      LRP MS  + ++ G+T
Sbjct: 903 GSLLELVDPTLASDYSEEEAMLMLNVALMCTNASPTLRPTMSQVVSLIEGKT 954

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8GYA4|CRK10_ARATH Cysteine-rich receptor-like protein kinase 10 OS=Arabidopsis thaliana GN=CRK10 PE=1 SV=3

 Score =  275 bits (702), Expect = 5e-73,   Method: Compositional matrix adjust.
 Identities = 136/291 (46%), Positives = 193/291 (66%), Gaps = 4/291 (1%)

Query: 32  FSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVAS 91
             Y  ++ AT+ F  SNKIG+GGFG VYKG L DGT VAVK LS  S QGE EF +EV  
Sbjct: 336 LDYRTIQTATDDFVESNKIGQGGFGEVYKGTLSDGTEVAVKRLSKSSGQGEVEFKNEVVL 395

Query: 92  MANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
           +A +   H NLV+L G C+DG  R+LVY+Y+PN SL   L  +  ++ +  W  R +II 
Sbjct: 396 VAKLQ--HRNLVRLLGFCLDGEERVLVYEYVPNKSLDYFLF-DPAKKGQLDWTRRYKIIG 452

Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP-ENTTHISTRVAG 210
           G+ RG+ Y+H++ +  ++HRD+K SNILLD + NPKI+DFG++++F  + T   ++R+ G
Sbjct: 453 GVARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGLDQTEENTSRIVG 512

Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSK 270
           T GY++PEYA+ G+ + KSDVYSFGVL+LEI+SG+    F    G + LV  AWG++++ 
Sbjct: 513 TYGYMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNSSFYQTDGAHDLVSYAWGLWSNG 572

Query: 271 ELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGET 321
             + LVDP +  N   NE +R + +GLLCVQE    RP +ST + M+   T
Sbjct: 573 RPLELVDPAIVENCQRNEVVRCVHIGLLCVQEDPAERPTLSTIVLMLTSNT 623

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	358
224113013	345	predicted protein [Populus trichocarpa]	0.927	0.962	0.715	1e-138
224097961	340	predicted protein [Populus trichocarpa]	0.902	0.95	0.712	1e-136
255577375	392	ATP binding protein, putative [Ricinus c	0.910	0.831	0.707	1e-134
225449074	449	PREDICTED: probable LRR receptor-like se	0.930	0.741	0.696	1e-134
225439972	399	PREDICTED: putative serine/threonine-pro	0.927	0.832	0.637	1e-122
297741595	433	unnamed protein product [Vitis vinifera]	0.927	0.766	0.637	1e-122
255557018	378	ATP binding protein, putative [Ricinus c	0.944	0.894	0.62	1e-120
449450984	364	PREDICTED: putative serine/threonine-pro	0.955	0.939	0.570	1e-113
356536930	378	PREDICTED: putative serine/threonine-pro	0.944	0.894	0.561	1e-107
449526092	397	PREDICTED: probable LRR receptor-like se	0.930	0.838	0.533	1e-106

>gi|224113013|ref|XP_002316361.1| predicted protein [Populus trichocarpa] gi|222865401|gb|EEF02532.1| predicted protein [Populus trichocarpa]

 Score =  497 bits (1279), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 242/338 (71%), Positives = 285/338 (84%), Gaps = 6/338 (1%)

Query: 19  TIGGEQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVES 78
            I G QIL+N++AFS+++LK+ATNGFR SNKIGEGGFGSVYKG LQDG IVA+K+LS ES
Sbjct: 2   VITGLQILQNVHAFSFDELKVATNGFRSSNKIGEGGFGSVYKGVLQDGRIVAIKMLSAES 61

Query: 79  KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRR 138
           KQG +EFMSE+AS++N+N  HENLV LHGGCIDGPC+ILVYDYM N SL+QTLLG E+ R
Sbjct: 62  KQGHREFMSEIASVSNIN--HENLVNLHGGCIDGPCKILVYDYMENGSLAQTLLGGEENR 119

Query: 139 AKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198
           A+FGW+ RR I +GI +GLAYIHEEI+PH+VHRDIK SNILLD+N  PK+SDFGLSKLFP
Sbjct: 120 ARFGWETRRGISLGIAQGLAYIHEEIKPHIVHRDIKASNILLDKNLCPKVSDFGLSKLFP 179

Query: 199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYH 258
           EN TH+STRVAGTLGYLAPEYAISGRLTRK+DVYSFGVLLLEIVSGR A DFD +LGE++
Sbjct: 180 ENFTHVSTRVAGTLGYLAPEYAISGRLTRKTDVYSFGVLLLEIVSGRKATDFDPELGEHY 239

Query: 259 LVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN 318
           LV+KAW MY +  L+ LVDPML GNF   EA+ F+KV LLCVQEK  LRP MS AIKMM 
Sbjct: 240 LVEKAWEMYKADNLLKLVDPMLDGNFLGTEAVGFVKVALLCVQEKCGLRPSMSKAIKMMR 299

Query: 319 GETNIDGXDVEISQPGLIGDIMDVKVGQR--SSSKSMT 354
           GE  ID  + +I+QPG I D MDVK+G++  SS +S+T
Sbjct: 300 GE--IDIHNTQITQPGFIIDFMDVKIGRKPQSSVRSIT 335

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224097961|ref|XP_002311099.1| predicted protein [Populus trichocarpa] gi|222850919|gb|EEE88466.1| predicted protein [Populus trichocarpa]

 Score =  490 bits (1262), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 233/327 (71%), Positives = 281/327 (85%), Gaps = 4/327 (1%)

Query: 24  QILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEK 83
           Q+L+N++AFS+N+LK+ATNGFR SNKIGEGGFGSVYKG LQDG +VAVK+LS  SKQG++
Sbjct: 2   QVLQNVHAFSFNELKVATNGFRSSNKIGEGGFGSVYKGILQDGRMVAVKMLSAGSKQGDR 61

Query: 84  EFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGW 143
           EF+SE+AS++N+N  HENLVKLHGGCIDGP +ILVYDYM N SL+QTLLG E++RAKF W
Sbjct: 62  EFISEIASVSNIN--HENLVKLHGGCIDGPYKILVYDYMENGSLAQTLLGSEEKRAKFRW 119

Query: 144 KARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 203
           + RREI +GI +GLAYIHEEI+P +VHRDIK SNILLDQN  PK+SDFGLSKLFPE+ TH
Sbjct: 120 ETRREISLGIAQGLAYIHEEIKPRIVHRDIKASNILLDQNLCPKVSDFGLSKLFPEDFTH 179

Query: 204 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKA 263
           +STRVAGTLGYLAPEYAISGRLTRK+DVYSFGVLLL+I+ GR AVDFD +LGE++LV+KA
Sbjct: 180 VSTRVAGTLGYLAPEYAISGRLTRKTDVYSFGVLLLQIICGRKAVDFDPELGEHYLVEKA 239

Query: 264 WGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNI 323
           W MY +  L+ LVDPML  +F E EA+ F+K+ LLCVQEK  LRP MS AIKMM GE  I
Sbjct: 240 WQMYKTDNLLKLVDPMLNADFLETEAVGFVKIALLCVQEKCGLRPSMSMAIKMMRGE--I 297

Query: 324 DGXDVEISQPGLIGDIMDVKVGQRSSS 350
           D  +++I+QPG I DIMDVK+G++S S
Sbjct: 298 DVSNMQITQPGFIIDIMDVKIGRKSQS 324

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255577375|ref|XP_002529567.1| ATP binding protein, putative [Ricinus communis] gi|223530943|gb|EEF32801.1| ATP binding protein, putative [Ricinus communis]

 Score =  484 bits (1247), Expect = e-134,   Method: Compositional matrix adjust.
 Identities = 235/332 (70%), Positives = 280/332 (84%), Gaps = 6/332 (1%)

Query: 25  ILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKE 84
           IL+N++AFSY +LK+ATN F  SNKIGEGGFGSVYKG L++G  VAVKVLS ES+QG+KE
Sbjct: 54  ILQNVHAFSYRELKVATNSFHLSNKIGEGGFGSVYKGMLENGKFVAVKVLSAESRQGDKE 113

Query: 85  FMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWK 144
           F+SE+AS+++++  HENLV LHG CIDGPCRILVYDYM N +L+Q LLG +K + KF W+
Sbjct: 114 FLSEIASLSSIS--HENLVILHGACIDGPCRILVYDYMENGNLAQILLGGDKIKRKFCWR 171

Query: 145 ARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 204
            RREI +GI  GLA+IHEEI+PH+VHRDIK SNILLDQNF PK+SDFGLSKLF +N THI
Sbjct: 172 VRREISLGIAEGLAHIHEEIKPHIVHRDIKASNILLDQNFAPKVSDFGLSKLFADNITHI 231

Query: 205 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAW 264
           STRVAGTLGYLAPEYAISG LTRKSD+YSFGVLLLEIVSGRTAVDFD++LGE+ LV+KAW
Sbjct: 232 STRVAGTLGYLAPEYAISGHLTRKSDIYSFGVLLLEIVSGRTAVDFDLELGEHFLVEKAW 291

Query: 265 GMYNSKELMNLVDPMLYG-NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNI 323
            MY   +L++LVDPML G N  E EAIRFLKV LLCVQEK  LRP++S A+KMM GE NI
Sbjct: 292 EMYKENKLVHLVDPMLNGNNLIEEEAIRFLKVALLCVQEKCGLRPKLSKAVKMMRGEINI 351

Query: 324 DGXDVEISQPGLIGDIMDVKVGQ-RSSSKSMT 354
               +EIS+PGLI D M+VK+G+ R SS+S+T
Sbjct: 352 S--SIEISKPGLINDFMNVKIGERRQSSQSIT 381

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225449074|ref|XP_002274408.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g56130-like [Vitis vinifera]

 Score =  483 bits (1242), Expect = e-134,   Method: Compositional matrix adjust.
 Identities = 236/339 (69%), Positives = 283/339 (83%), Gaps = 6/339 (1%)

Query: 22  GEQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQG 81
           G   L+N +AF+YN++KIAT GFR S+KIG+GGFGSVYKGRLQDGT+VAVKVLS ESKQG
Sbjct: 109 GLPTLQNAHAFTYNEIKIATGGFRSSDKIGQGGFGSVYKGRLQDGTVVAVKVLSAESKQG 168

Query: 82  EKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKF 141
           ++EFMSE+AS++N+N  HENLVKLHGGC+ G  R+LVYDYM NNSLS TLL  EKRRAKF
Sbjct: 169 DREFMSEMASISNIN--HENLVKLHGGCVHGARRMLVYDYMQNNSLSHTLLRGEKRRAKF 226

Query: 142 GWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 201
            WK RREI +GI RGLAYIHE+I PHVVHRDIK SNILLD +F PKISDFGLSKLF  N 
Sbjct: 227 SWKTRREICLGIARGLAYIHEDITPHVVHRDIKASNILLDGDFTPKISDFGLSKLFYTNI 286

Query: 202 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVD 261
           THI+TRVAGTLGYLAPEYA+SG LTRKSDVYSFGVL+LEIVSGRTA+DFD+ LGE++LV 
Sbjct: 287 THITTRVAGTLGYLAPEYALSGHLTRKSDVYSFGVLILEIVSGRTAIDFDLDLGEHYLVQ 346

Query: 262 KAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMM-NGE 320
           KAW +Y +K+L  LVDP++ G+    EA+RFL+VGLLCVQEK   RP++S A+ +M + E
Sbjct: 347 KAWELYKTKKLDQLVDPVMRGDITAKEAVRFLRVGLLCVQEKCDRRPKISKAMSLMSDDE 406

Query: 321 TNIDGXDVEISQPGLIGDIMDVKVG-QRSSSKSMTENGS 358
            N+D  D+ ISQPG+I DIMDVK+G +RS+S+ +T   S
Sbjct: 407 INLD--DLLISQPGIITDIMDVKLGRRRSTSQGITSTPS 443

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225439972|ref|XP_002281059.1| PREDICTED: putative serine/threonine-protein kinase [Vitis vinifera] gi|147770086|emb|CAN69887.1| hypothetical protein VITISV_005073 [Vitis vinifera]

 Score =  445 bits (1144), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 216/339 (63%), Positives = 270/339 (79%), Gaps = 7/339 (2%)

Query: 13  RVSAENTIGGEQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVK 72
           R S+     G    +    FSY +LKIAT+ F  SNKIGEGGFGSVYKG+L+DGT VAVK
Sbjct: 21  RSSSSGQETGGNTSEKFQVFSYKELKIATDSFHPSNKIGEGGFGSVYKGQLRDGTTVAVK 80

Query: 73  VLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQT 130
           VLSVE  S +GE+EF+SE++++ ++   HENLV L G C++G  R LVYDYM NNSL+QT
Sbjct: 81  VLSVEIESMRGEREFVSELSALTDIK--HENLVTLQGCCVEGASRFLVYDYMENNSLAQT 138

Query: 131 LLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD 190
           LLG ++ R +FGW+ARR I +G+GRGLAY+HEE+QPH++HRDIK +NILLDQN  PKISD
Sbjct: 139 LLGAKQNRMEFGWEARRGISLGVGRGLAYLHEEVQPHIIHRDIKAANILLDQNLAPKISD 198

Query: 191 FGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDF 250
           FGLSKLF ++ +HISTRVAGTLGYLAPEYA+SGRLTRKSDVYSFGVLLLEI+SG + V++
Sbjct: 199 FGLSKLFVDSRSHISTRVAGTLGYLAPEYALSGRLTRKSDVYSFGVLLLEIISGHSVVEY 258

Query: 251 DVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQM 310
           D++ GE++LV+KAW MY   +L+ LVDP L  +FPE EAI+FLKVGLLCVQE S LRP+M
Sbjct: 259 DLEHGEHYLVEKAWEMYTDNKLLQLVDPTL-KDFPEEEAIQFLKVGLLCVQEISGLRPRM 317

Query: 311 STAIKMMNGETNIDGXDVEISQPGLIGDIMDVKVGQRSS 349
           S A+KM+  E N++  DV ISQPGL+ D+  VK+G R S
Sbjct: 318 SAAVKMLTNEINVN--DVHISQPGLLSDLTAVKIGHRRS 354

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297741595|emb|CBI32727.3| unnamed protein product [Vitis vinifera]

 Score =  444 bits (1143), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 216/339 (63%), Positives = 270/339 (79%), Gaps = 7/339 (2%)

Query: 13  RVSAENTIGGEQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVK 72
           R S+     G    +    FSY +LKIAT+ F  SNKIGEGGFGSVYKG+L+DGT VAVK
Sbjct: 55  RSSSSGQETGGNTSEKFQVFSYKELKIATDSFHPSNKIGEGGFGSVYKGQLRDGTTVAVK 114

Query: 73  VLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQT 130
           VLSVE  S +GE+EF+SE++++ ++   HENLV L G C++G  R LVYDYM NNSL+QT
Sbjct: 115 VLSVEIESMRGEREFVSELSALTDIK--HENLVTLQGCCVEGASRFLVYDYMENNSLAQT 172

Query: 131 LLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD 190
           LLG ++ R +FGW+ARR I +G+GRGLAY+HEE+QPH++HRDIK +NILLDQN  PKISD
Sbjct: 173 LLGAKQNRMEFGWEARRGISLGVGRGLAYLHEEVQPHIIHRDIKAANILLDQNLAPKISD 232

Query: 191 FGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDF 250
           FGLSKLF ++ +HISTRVAGTLGYLAPEYA+SGRLTRKSDVYSFGVLLLEI+SG + V++
Sbjct: 233 FGLSKLFVDSRSHISTRVAGTLGYLAPEYALSGRLTRKSDVYSFGVLLLEIISGHSVVEY 292

Query: 251 DVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQM 310
           D++ GE++LV+KAW MY   +L+ LVDP L  +FPE EAI+FLKVGLLCVQE S LRP+M
Sbjct: 293 DLEHGEHYLVEKAWEMYTDNKLLQLVDPTL-KDFPEEEAIQFLKVGLLCVQEISGLRPRM 351

Query: 311 STAIKMMNGETNIDGXDVEISQPGLIGDIMDVKVGQRSS 349
           S A+KM+  E N++  DV ISQPGL+ D+  VK+G R S
Sbjct: 352 SAAVKMLTNEINVN--DVHISQPGLLSDLTAVKIGHRRS 388

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255557018|ref|XP_002519542.1| ATP binding protein, putative [Ricinus communis] gi|223541405|gb|EEF42956.1| ATP binding protein, putative [Ricinus communis]

 Score =  437 bits (1125), Expect = e-120,   Method: Compositional matrix adjust.
 Identities = 217/350 (62%), Positives = 278/350 (79%), Gaps = 12/350 (3%)

Query: 3   SIFS-CFSFPSRVSAENTIG-GEQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYK 60
           S FS C SFP+   A +TI  GEQ   N+  FS  +L+IAT+ F  SNK+GEG FGSVY 
Sbjct: 5   SCFSFCSSFPNSRPAISTISTGEQKHGNLQIFSSRELEIATHDFSSSNKVGEGAFGSVYM 64

Query: 61  GRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118
           G+L++G+IVAVKVLSVE  S +GE+EF+SE+A++++++  HENLVKL G C+DG  R LV
Sbjct: 65  GQLKNGSIVAVKVLSVELESMRGEREFISELAALSDIS--HENLVKLQGCCVDGANRYLV 122

Query: 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNI 178
           YDYM NNSL+QTLLG+E+ R KF W+ARR I  G+ RGLAYIHEE++PH++HRDIK SNI
Sbjct: 123 YDYMENNSLTQTLLGKEQNRMKFSWEARRNISFGVARGLAYIHEEVKPHILHRDIKASNI 182

Query: 179 LLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLL 238
           LLD++F PK++DFGLS++  +NT+H+STRVAGTLGYLAPEYA+SG LTRKSDVYSFGVLL
Sbjct: 183 LLDKDFTPKVADFGLSRILRDNTSHVSTRVAGTLGYLAPEYALSGHLTRKSDVYSFGVLL 242

Query: 239 LEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNF----PENEAIRFLK 294
           LEI+SGR+AVDFD++LGE+ LV KAW  YN  +L+ ++DP+L  NF     E +A+RFL 
Sbjct: 243 LEIISGRSAVDFDLELGEHFLVQKAWEAYNENKLLQIIDPILIMNFLEEEEEEDALRFLI 302

Query: 295 VGLLCVQEKSKLRPQMSTAIKMMNGETNIDGXDVEISQPGLIGDIMDVKV 344
           VGLLCVQE +KLRPQMST +KMM  E  ID  D++I QPG + ++M VK+
Sbjct: 303 VGLLCVQEIAKLRPQMSTCVKMMVNE--IDIKDIQICQPGCVSNLMGVKL 350

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449450984|ref|XP_004143242.1| PREDICTED: putative serine/threonine-protein kinase-like [Cucumis sativus] gi|449482501|ref|XP_004156301.1| PREDICTED: putative serine/threonine-protein kinase-like [Cucumis sativus]

 Score =  414 bits (1063), Expect = e-113,   Method: Compositional matrix adjust.
 Identities = 199/349 (57%), Positives = 266/349 (76%), Gaps = 7/349 (2%)

Query: 7   CFSFPSRVSAENTIGGEQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDG 66
           C+S PS  + E++    Q  ++   +SYN+LK+ATNGF  +NK+GEGGFG+VYKG L+D 
Sbjct: 11  CYS-PSSTAMESSRHDRQDSESFRVYSYNELKLATNGFSGANKVGEGGFGTVYKGWLRDD 69

Query: 67  TIVAVKVLS--VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 124
             +AVKVLS  VES +GE+EF++E+ S++N+   HENLV+L G  +DG  R LVYDYM N
Sbjct: 70  RKIAVKVLSIEVESMRGEREFIAELTSLSNIR--HENLVELKGFYVDGSNRYLVYDYMEN 127

Query: 125 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF 184
           NSL+  L G  + R +  W AR+EI++G+ RGLAY+HEE++PH+VHRDIK SNILLD NF
Sbjct: 128 NSLAYVLQGVRENRMRLRWIARKEILIGVARGLAYLHEEVEPHIVHRDIKASNILLDHNF 187

Query: 185 NPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
            PK++DFGL+KL  EN++H+STRVAGT+GYLAPEYA+SG LTRKSDVYSFGVLLLEIVSG
Sbjct: 188 KPKVADFGLAKLLRENSSHVSTRVAGTIGYLAPEYAVSGHLTRKSDVYSFGVLLLEIVSG 247

Query: 245 RTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKS 304
           R  VDFD++ GE+HLV + W  Y + EL+ L+DP+L  +F + EA+RF+K+GLLCVQE  
Sbjct: 248 RATVDFDLEHGEHHLVQRVWEHYKANELVKLIDPVLDIDFRKEEAVRFMKIGLLCVQENP 307

Query: 305 KLRPQMSTAIKMMNGETNIDGXDVEISQPGLIGDIMDVKVGQRSSSKSM 353
             RP+MS A+ M+  ET+++  +  ISQP  I D MD+K+G+ +SS S 
Sbjct: 308 TKRPRMSLAVSMLIKETDLNEHN--ISQPAHIIDFMDIKMGKGNSSTSF 354

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356536930|ref|XP_003536985.1| PREDICTED: putative serine/threonine-protein kinase-like [Glycine max]

 Score =  394 bits (1012), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 196/349 (56%), Positives = 260/349 (74%), Gaps = 11/349 (3%)

Query: 5   FSCFSFPSRVSAENT--IGGEQILK-NINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKG 61
           FSCFS PS     N      E+I   +   F++ QLK+AT  F  S K+GEGGFGSV+KG
Sbjct: 6   FSCFS-PSTTEKNNNNDYPDEEINDGSFRLFTHKQLKLATRNFHSSEKVGEGGFGSVFKG 64

Query: 62  RLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119
           +L DG+ VAVKVLSVE  S +GE+EF++E+A++AN+   H+NLV L G C++G  R LVY
Sbjct: 65  KLVDGSFVAVKVLSVEVESMRGEREFVAELATLANIK--HQNLVSLKGCCVEGAYRYLVY 122

Query: 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL 179
           DYM NNSL  T LG E+RR +F W+ R+++ +G+ RGL ++HEE++PH+VHRDIK  NIL
Sbjct: 123 DYMENNSLYNTFLGSEERRMRFNWEIRKDVSIGVARGLDFLHEELKPHIVHRDIKAKNIL 182

Query: 180 LDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLL 239
           LD+NF PK+SDFGL+KL  + T++ISTRVAGTLGYLAPEYA SG+++RKSDVYSFGVLLL
Sbjct: 183 LDRNFIPKVSDFGLAKLLRDETSYISTRVAGTLGYLAPEYANSGQVSRKSDVYSFGVLLL 242

Query: 240 EIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLC 299
           +IVSG   VD   Q  E  +V+KAW  Y S +L+ LVDPML  NFPE EA++FLKVGLLC
Sbjct: 243 QIVSGLAVVD-AYQDIERFIVEKAWAAYQSNDLLKLVDPMLNMNFPEEEALKFLKVGLLC 301

Query: 300 VQEKSKLRPQMSTAIKMMNGETNIDGXDVEISQPGLIGDIMDVKVGQRS 348
           VQE +KLRP+MS  ++ +    +ID  DV IS+PG + D+ ++++ Q++
Sbjct: 302 VQETAKLRPRMSEVVEKLT--KDIDMRDVHISKPGFVADLRNIRIKQQN 348

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449526092|ref|XP_004170048.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g56140-like [Cucumis sativus]

 Score =  392 bits (1006), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 185/347 (53%), Positives = 255/347 (73%), Gaps = 14/347 (4%)

Query: 6   SCFSF--------PSRVSAENTIGGEQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGS 57
           +CF F        P+R S +        ++N+  ++Y QLK+AT  F  +NKIGEGGFGS
Sbjct: 2   TCFPFLFSKRGKGPTRSSVDEEDFSS--MQNVKFYTYKQLKVATEDFSLANKIGEGGFGS 59

Query: 58  VYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117
           VYKG+L+DG + A+KVLS ES+QG +EF++E+  ++ +   HENLV+L+G C+D   RIL
Sbjct: 60  VYKGKLKDGKLAAIKVLSAESRQGLREFLTEINVISKIE--HENLVQLYGCCVDDNHRIL 117

Query: 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSN 177
           VY+Y+ NNSL+QTLLG      +F W+ R +I +GI RGLA++HE++QPH++HRDIK SN
Sbjct: 118 VYNYLENNSLAQTLLGRGYSSIQFNWRTRSKICIGIARGLAFLHEDVQPHIIHRDIKASN 177

Query: 178 ILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVL 237
           ILLD + +PKISDFGL+KL P + TH+STRVAGT+GYLAPEYAI G++TRKSD+YSFGVL
Sbjct: 178 ILLDHDLSPKISDFGLAKLIPASMTHVSTRVAGTIGYLAPEYAIRGQVTRKSDIYSFGVL 237

Query: 238 LLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGL 297
           L+EIVSGR   +  + +GE +L+++ W +Y   EL+ LVD  L G+F    A ++LK+GL
Sbjct: 238 LVEIVSGRWNTNTQLPIGEQYLLERTWNLYEQGELVLLVDTSLNGDFDAEMACKYLKIGL 297

Query: 298 LCVQEKSKLRPQMSTAIKMMNGETNIDGXDVEISQPGLIGDIMDVKV 344
           LC Q+  KLRP MST +KM+ GE +++  D +IS+PGLI D MD+KV
Sbjct: 298 LCTQDSPKLRPSMSTVVKMLTGEMSVE--DRKISKPGLISDFMDLKV 342

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	358
TAIR|locus:2017923	390	AT1G16670 [Arabidopsis thalian	0.930	0.853	0.520	7e-93
TAIR|locus:2095334	393	AT3G09010 [Arabidopsis thalian	0.949	0.865	0.475	1.7e-82
TAIR|locus:2205250	1032	AT1G56130 [Arabidopsis thalian	0.835	0.289	0.495	3.9e-76
TAIR|locus:2205260	1047	AT1G56120 [Arabidopsis thalian	0.891	0.304	0.458	3.5e-75
TAIR|locus:2019317	969	AT1G29730 [Arabidopsis thalian	0.871	0.321	0.489	1.5e-74
TAIR|locus:2009630	953	AT1G53420 [Arabidopsis thalian	0.835	0.313	0.475	1.5e-74
TAIR|locus:2203718	1035	AT1G53440 [Arabidopsis thalian	0.812	0.281	0.501	1.9e-74
TAIR|locus:2019367	1078	AT1G29740 [Arabidopsis thalian	0.879	0.292	0.476	1.4e-72
TAIR|locus:2200151	830	SD1-13 "S-domain-1 13" [Arabid	0.849	0.366	0.479	2.1e-68
TAIR|locus:2121676	669	CRK10 "cysteine-rich RLK (RECE	0.796	0.426	0.477	5.6e-68

TAIR|locus:2017923 AT1G16670 [Arabidopsis thaliana (taxid:3702)]

 Score = 925 (330.7 bits), Expect = 7.0e-93, P = 7.0e-93
 Identities = 177/340 (52%), Positives = 249/340 (73%)

Query:    20 IGGE-QILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVES 78
             + GE   + N+  + Y +++ AT+ F   NKIGEGGFGSVYKG L+DG + A+KVLS ES
Sbjct:    16 VDGEIAAIDNVKIYKYREIRQATDDFSAENKIGEGGFGSVYKGCLKDGKLAAIKVLSAES 75

Query:    79 KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLL--GEEK 136
             +QG KEF++E+  ++ +   HENLVKL+G C++G  RILVY+++ NNSL +TLL  G  +
Sbjct:    76 RQGVKEFLTEINVISEIQ--HENLVKLYGCCVEGNHRILVYNFLENNSLDKTLLAGGYTR 133

Query:   137 RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196
                +F W +R  I +G+ +GLA++HEE++PH++HRDIK SNILLD+  +PKISDFGL++L
Sbjct:   134 SGIQFDWSSRANICVGVAKGLAFLHEEVRPHIIHRDIKASNILLDKYLSPKISDFGLARL 193

Query:   197 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE 256
              P N TH+STRVAGT+GYLAPEYA+ G+LTRK+D+YSFGVLL+EIVSGR+  +  +    
Sbjct:   194 MPPNMTHVSTRVAGTIGYLAPEYAVRGQLTRKADIYSFGVLLMEIVSGRSNKNTRLPTEY 253

Query:   257 YHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKM 316
              +L+++AW +Y   EL++LVD  L G F   EA R+LK+GLLC Q+  KLRP MST +++
Sbjct:   254 QYLLERAWELYERNELVDLVDSGLNGVFDAEEACRYLKIGLLCTQDSPKLRPSMSTVVRL 313

Query:   317 MNGETNIDGXDVEISQPGLIGDIMDVKVGQRSSSKSMTEN 356
             + GE +ID    +IS+PGLI D MD+KV    ++K+   N
Sbjct:   314 LTGEKDIDYK--KISRPGLISDFMDLKVRGPVATKTEQVN 351

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

TAIR|locus:2095334 AT3G09010 [Arabidopsis thaliana (taxid:3702)]

 Score = 827 (296.2 bits), Expect = 1.7e-82, P = 1.7e-82
 Identities = 172/362 (47%), Positives = 240/362 (66%)

Query:     5 FSCFSFPSRVSAENTIG---GEQIL-KNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYK 60
             ++CF      +  + +G    E+I   N+  FSYN L+ AT+ F  +N+IG GG+G V+K
Sbjct:     3 YNCFGLLDMCNGSDRLGQREAEEICTNNVRVFSYNSLRSATDSFHPTNRIGGGGYGVVFK 62

Query:    61 GRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 120
             G L+DGT VAVK LS ESKQG +EF++E+  ++N++  H NLVKL G CI+G  RILVY+
Sbjct:    63 GVLRDGTQVAVKSLSAESKQGTREFLTEINLISNIH--HPNLVKLIGCCIEGNNRILVYE 120

Query:   121 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 180
             Y+ NNSL+  LLG   R     W  R  I +G   GLA++HEE++PHVVHRDIK SNILL
Sbjct:   121 YLENNSLASVLLGSRSRYVPLDWSKRAAICVGTASGLAFLHEEVEPHVVHRDIKASNILL 180

Query:   181 DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLE 240
             D NF+PKI DFGL+KLFP+N TH+STRVAGT+GYLAPEYA+ G+LT+K+DVYSFG+L+LE
Sbjct:   181 DSNFSPKIGDFGLAKLFPDNVTHVSTRVAGTVGYLAPEYALLGQLTKKADVYSFGILVLE 240

Query:   241 IVSGRTAVDFDVQLG-EYH-LVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLL 298
             ++SG ++       G EY  LV+  W +   + L+  VDP L   FP +E  RF+KV L 
Sbjct:   241 VISGNSSTR--AAFGDEYMVLVEWVWKLREERRLLECVDPELT-KFPADEVTRFIKVALF 297

Query:   299 CVQEKSKLRPQMSTAIKMMNG-ETNIDGXDVEISQPGLIGDI--------MDVKVGQRSS 349
             C Q  ++ RP M   ++M+   E N++  D  +++PG+   +        + ++VGQ  S
Sbjct:   298 CTQAAAQKRPNMKQVMEMLRRKELNLN-EDA-LTEPGVYRGVNRGRNHRGIGLRVGQGGS 355

Query:   350 SK 351
             S+
Sbjct:   356 SQ 357

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

TAIR|locus:2205250 AT1G56130 [Arabidopsis thaliana (taxid:3702)]

 Score = 767 (275.1 bits), Expect = 3.9e-76, P = 3.9e-76
 Identities = 152/307 (49%), Positives = 210/307 (68%)

Query:    32 FSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVAS 91
             F+Y++LK AT  F  SNK+GEGGFG VYKG L DG +VAVK+LSV S+QG+ +F++E+ +
Sbjct:   682 FTYSELKSATQDFDPSNKLGEGGFGPVYKGNLNDGRVVAVKLLSVGSRQGKGQFVAEIVA 741

Query:    92 MANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
             +++V   H NLVKL+G C +G  R+LVY+Y+PN SL Q L G+  +     W  R EI +
Sbjct:   742 ISSV--LHRNLVKLYGCCFEGEHRMLVYEYLPNGSLDQALFGD--KTLHLDWSTRYEICL 797

Query:   152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT 211
             G+ RGL Y+HEE    +VHRD+K SNILLD    P+ISDFGL+KL+ +  THISTRVAGT
Sbjct:   798 GVARGLVYLHEEASVRIVHRDVKASNILLDSRLVPQISDFGLAKLYDDKKTHISTRVAGT 857

Query:   212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKE 271
             +GYLAPEYA+ G LT K+DVY+FGV+ LE+VSGR   D +++  + +L++ AW ++    
Sbjct:   858 IGYLAPEYAMRGHLTEKTDVYAFGVVALELVSGRPNSDENLEEEKKYLLEWAWNLHEKSR 917

Query:   272 LMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNIDGXDVEIS 331
              + L+D  L  +F   EA R + + LLC Q    LRP MS  + M++G+  I   DV  S
Sbjct:   918 DIELIDDKLT-DFNMEEAKRMIGIALLCTQTSHALRPPMSRVVAMLSGDVEIG--DVT-S 973

Query:   332 QPGLIGD 338
             +PG + D
Sbjct:   974 KPGYVSD 980

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016020 "membrane" evidence=ISS

TAIR|locus:2205260 AT1G56120 [Arabidopsis thaliana (taxid:3702)]

 Score = 758 (271.9 bits), Expect = 3.5e-75, P = 3.5e-75
 Identities = 150/327 (45%), Positives = 213/327 (65%)

Query:    32 FSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVAS 91
             F+Y++LK AT  F  SNK+GEGGFG+VYKG L DG  VAVK LS+ S+QG+ +F++E+ +
Sbjct:   698 FTYSELKNATQDFDLSNKLGEGGFGAVYKGNLNDGREVAVKQLSIGSRQGKGQFVAEIIA 757

Query:    92 MANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
             +++V   H NLVKL+G C +G  R+LVY+Y+PN SL Q L G++       W  R EI +
Sbjct:   758 ISSV--LHRNLVKLYGCCFEGDHRLLVYEYLPNGSLDQALFGDKSLH--LDWSTRYEICL 813

Query:   152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT 211
             G+ RGL Y+HEE    ++HRD+K SNILLD    PK+SDFGL+KL+ +  THISTRVAGT
Sbjct:   814 GVARGLVYLHEEASVRIIHRDVKASNILLDSELVPKVSDFGLAKLYDDKKTHISTRVAGT 873

Query:   212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKE 271
             +GYLAPEYA+ G LT K+DVY+FGV+ LE+VSGR   D +++ G+ +L++ AW ++    
Sbjct:   874 IGYLAPEYAMRGHLTEKTDVYAFGVVALELVSGRKNSDENLEEGKKYLLEWAWNLHEKNR 933

Query:   272 LMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNIDGXDVEIS 331
              + L+D  L   +   E  R + + LLC Q    LRP MS  + M++G+  ++      S
Sbjct:   934 DVELIDDEL-SEYNMEEVKRMIGIALLCTQSSYALRPPMSRVVAMLSGDAEVNDAT---S 989

Query:   332 QPGLIGDIMDVKVGQRSSSKSMTENGS 358
             +PG + D         S S   T++ S
Sbjct:   990 KPGYLTDCTFDDTTSSSFSNFQTKDTS 1016

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2019317 AT1G29730 [Arabidopsis thaliana (taxid:3702)]

 Score = 752 (269.8 bits), Expect = 1.5e-74, P = 1.5e-74
 Identities = 157/321 (48%), Positives = 213/321 (66%)

Query:    31 AFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVA 90
             +FS  QLK+ATN F   NKIGEGGFGSVYKGRL DGT++AVK LS +S QG KEF++E+ 
Sbjct:   627 SFSLRQLKVATNDFDPLNKIGEGGFGSVYKGRLPDGTLIAVKKLSSKSHQGNKEFVNEIG 686

Query:    91 SMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 150
              +A +   H NLVKL+G C++    +LVY+Y+ NN LS  L    +   K  W  R +I 
Sbjct:   687 MIACLQ--HPNLVKLYGCCVEKNQLLLVYEYLENNCLSDALFAG-RSCLKLEWGTRHKIC 743

Query:   151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG 210
             +GI RGLA++HE+    ++HRDIK +N+LLD++ N KISDFGL++L  +N +HI+TRVAG
Sbjct:   744 LGIARGLAFLHEDSAVKIIHRDIKGTNVLLDKDLNSKISDFGLARLHEDNQSHITTRVAG 803

Query:   211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE--YHLVDKAWGMYN 268
             T+GY+APEYA+ G LT K+DVYSFGV+ +EIVSG++   +     E    L+D A+ +  
Sbjct:   804 TIGYMAPEYAMRGHLTEKADVYSFGVVAMEIVSGKSNAKYTPD-DECCVGLLDWAFVLQK 862

Query:   269 SKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNIDGXDV 328
               ++  ++DP L G F   EA R +KV LLC  + S LRP MS  +KM+ GET I+    
Sbjct:   863 KGDIAEILDPRLEGMFDVMEAERMIKVSLLCANKSSTLRPNMSQVVKMLEGETEIEQI-- 920

Query:   329 EISQPGLIGDIMDVKVGQRSS 349
              IS PG+  D +  K    SS
Sbjct:   921 -ISDPGVYSDNLHFKPSSLSS 940

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2009630 AT1G53420 [Arabidopsis thaliana (taxid:3702)]

 Score = 752 (269.8 bits), Expect = 1.5e-74, P = 1.5e-74
 Identities = 143/301 (47%), Positives = 209/301 (69%)

Query:    29 INAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSE 88
             I +FS  Q+KIATN F  +N+IGEGGFG VYKG+L DGTI+AVK LS  SKQG +EF++E
Sbjct:   609 IASFSLRQIKIATNNFDSANRIGEGGFGPVYKGKLFDGTIIAVKQLSTGSKQGNREFLNE 668

Query:    89 VASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARRE 148
             +  ++ ++  H NLVKL+G C++G   +LVY+++ NNSL++ L G ++ + +  W  RR+
Sbjct:   669 IGMISALH--HPNLVKLYGCCVEGGQLLLVYEFVENNSLARALFGPQETQLRLDWPTRRK 726

Query:   149 IIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRV 208
             I +G+ RGLAY+HEE +  +VHRDIK +N+LLD+  NPKISDFGL+KL  E++THISTR+
Sbjct:   727 ICIGVARGLAYLHEESRLKIVHRDIKATNVLLDKQLNPKISDFGLAKLDEEDSTHISTRI 786

Query:   209 AGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYN 268
             AGT GY+APEYA+ G LT K+DVYSFG++ LEIV GR+      +   ++L+D    +  
Sbjct:   787 AGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVHGRSNKIERSKNNTFYLIDWVEVLRE 846

Query:   269 SKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNIDGXDV 328
                L+ LVDP L   +   EA+  +++ ++C   +   RP MS  +KM+ G+  ++   +
Sbjct:   847 KNNLLELVDPRLGSEYNREEAMTMIQIAIMCTSSEPCERPSMSEVVKMLEGKKMVEVEKL 906

Query:   329 E 329
             E
Sbjct:   907 E 907

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

TAIR|locus:2203718 AT1G53440 [Arabidopsis thaliana (taxid:3702)]

 Score = 751 (269.4 bits), Expect = 1.9e-74, P = 1.9e-74
 Identities = 147/293 (50%), Positives = 203/293 (69%)

Query:    31 AFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVA 90
             +F+  Q+K ATN F   NKIGEGGFG VYKG L DG  +AVK LS +SKQG +EF++E+ 
Sbjct:   654 SFTLKQIKRATNNFDPENKIGEGGFGPVYKGVLADGMTIAVKQLSSKSKQGNREFVTEIG 713

Query:    91 SMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 150
              ++ +   H NLVKL+G CI+G   +LVY+Y+ NNSL++ L G EK+R    W  R ++ 
Sbjct:   714 MISALQ--HPNLVKLYGCCIEGKELLLVYEYLENNSLARALFGTEKQRLHLDWSTRNKVC 771

Query:   151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG 210
             +GI +GLAY+HEE +  +VHRDIK +N+LLD + N KISDFGL+KL  E  THISTR+AG
Sbjct:   772 IGIAKGLAYLHEESRLKIVHRDIKATNVLLDLSLNAKISDFGLAKLDEEENTHISTRIAG 831

Query:   211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSK 270
             T+GY+APEYA+ G LT K+DVYSFGV+ LEIVSG++  ++  +    +L+D A+ +    
Sbjct:   832 TIGYMAPEYAMRGYLTDKADVYSFGVVCLEIVSGKSNTNYRPKEEFIYLLDWAYVLQEQG 891

Query:   271 ELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNI 323
              L+ LVDP L  +F + EA+R L + LLC      LRP MS+ + M+ G+  +
Sbjct:   892 SLLELVDPDLGTSFSKKEAMRMLNIALLCTNPSPTLRPPMSSVVSMLQGKIKV 944

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2019367 AT1G29740 [Arabidopsis thaliana (taxid:3702)]

 Score = 737 (264.5 bits), Expect = 1.4e-72, P = 1.4e-72
 Identities = 155/325 (47%), Positives = 216/325 (66%)

Query:    31 AFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVA 90
             +FS  QLK+AT+ F   NKIGEGGFGSVYKGRL +GT++AVK LS +S QG KEF++E+ 
Sbjct:   664 SFSLRQLKVATDDFNPLNKIGEGGFGSVYKGRLPNGTLIAVKKLSSKSCQGNKEFINEIG 723

Query:    91 SMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 150
              +A +   H NLVKL+G C++    +LVY+Y+ NN L+  L G  +   K  W+ R +I 
Sbjct:   724 IIACLQ--HPNLVKLYGCCVEKTQLLLVYEYLENNCLADALFG--RSGLKLDWRTRHKIC 779

Query:   151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG 210
             +GI RGLA++HE+    ++HRDIK +NILLD++ N KISDFGL++L  ++ +HI+TRVAG
Sbjct:   780 LGIARGLAFLHEDSAVKIIHRDIKGTNILLDKDLNSKISDFGLARLHEDDQSHITTRVAG 839

Query:   211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE--YHLVDKAWGMYN 268
             T+GY+APEYA+ G LT K+DVYSFGV+ +EIVSG++  ++     E    L+D A+ +  
Sbjct:   840 TIGYMAPEYAMRGHLTEKADVYSFGVVAMEIVSGKSNANYTPD-NECCVGLLDWAFVLQK 898

Query:   269 SKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNIDGXDV 328
                   ++DP L G F   EA R +KV LLC  +   LRP MS  +KM+ GET I+  ++
Sbjct:   899 KGAFDEILDPKLEGVFDVMEAERMIKVSLLCSSKSPTLRPTMSEVVKMLEGETEIE--EI 956

Query:   329 EISQPGLIGDIMDVKVGQRSSSKSM 353
              IS PG  GD +  K      S S+
Sbjct:   957 -ISDPGAYGDELRFKKTAEIGSSSL 980

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)]

 Score = 694 (249.4 bits), Expect = 2.1e-68, P = 2.1e-68
 Identities = 150/313 (47%), Positives = 204/313 (65%)

Query:    26 LKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEF 85
             LK +  F +  L +ATN F  +NK+G+GGFG+VYKGRLQ+G  +AVK LS  S QG +EF
Sbjct:   494 LKELPLFEFQVLAVATNNFSITNKLGQGGFGAVYKGRLQEGLDIAVKRLSRTSGQGVEEF 553

Query:    86 MSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKA 145
             ++EV  ++ +   H NLV+L G CI+G  R+LVY++MP N L   L    K+R    WK 
Sbjct:   554 VNEVVVISKLQ--HRNLVRLLGFCIEGEERMLVYEFMPENCLDAYLFDPVKQRL-LDWKT 610

Query:   146 RREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS 205
             R  II GI RGL Y+H + +  ++HRD+K SNILLD+N NPKISDFGL+++F  N   +S
Sbjct:   611 RFNIIDGICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFQGNEDEVS 670

Query:   206 T-RVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAW 264
             T RV GT GY+APEYA+ G  + KSDV+S GV+LLEIVSGR    F       +L   AW
Sbjct:   671 TVRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIVSGRRNSSFYNDGQNPNLSAYAW 730

Query:   265 GMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE-TNI 323
              ++N+ E + LVDP+++    ENE  R + VGLLCVQ+ +  RP ++T I M++ E +N+
Sbjct:   731 KLWNTGEDIALVDPVIFEECFENEIRRCVHVGLLCVQDHANDRPSVATVIWMLSSENSNL 790

Query:   324 DGXDVEISQPGLI 336
                  E  QP  I
Sbjct:   791 P----EPKQPAFI 799

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=RCA;IDA

GO:0009637 "response to blue light" evidence=RCA

GO:0010155 "regulation of proton transport" evidence=RCA

GO:0016556 "mRNA modification" evidence=RCA

TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 690 (248.0 bits), Expect = 5.6e-68, P = 5.6e-68
 Identities = 138/289 (47%), Positives = 192/289 (66%)

Query:    34 YNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMA 93
             Y  ++ AT+ F  SNKIG+GGFG VYKG L DGT VAVK LS  S QGE EF +EV  +A
Sbjct:   338 YRTIQTATDDFVESNKIGQGGFGEVYKGTLSDGTEVAVKRLSKSSGQGEVEFKNEVVLVA 397

Query:    94 NVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGI 153
              +   H NLV+L G C+DG  R+LVY+Y+PN SL   L    K+  +  W  R +II G+
Sbjct:   398 KLQ--HRNLVRLLGFCLDGEERVLVYEYVPNKSLDYFLFDPAKK-GQLDWTRRYKIIGGV 454

Query:   154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIST-RVAGTL 212
              RG+ Y+H++ +  ++HRD+K SNILLD + NPKI+DFG++++F  + T  +T R+ GT 
Sbjct:   455 ARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGLDQTEENTSRIVGTY 514

Query:   213 GYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKEL 272
             GY++PEYA+ G+ + KSDVYSFGVL+LEI+SG+    F    G + LV  AWG++++   
Sbjct:   515 GYMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNSSFYQTDGAHDLVSYAWGLWSNGRP 574

Query:   273 MNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGET 321
             + LVDP +  N   NE +R + +GLLCVQE    RP +ST + M+   T
Sbjct:   575 LELVDPAIVENCQRNEVVRCVHIGLLCVQEDPAERPTLSTIVLMLTSNT 623

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	358
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	6e-52
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	5e-51
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-48
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-48
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-47
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	6e-45
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-43
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	8e-39
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-35
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	8e-35
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-34
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-33
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	4e-32
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-31
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-30
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-30
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-29
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-28
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-27
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-27
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-27
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-27
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	4e-27
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	4e-27
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-26
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	6e-26
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	8e-26
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-25
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-25
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-25
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	7e-25
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-24
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-24
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-24
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-24
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-24
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	4e-24
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	6e-24
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	6e-24
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	7e-24
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-23
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-23
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-23
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-23
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-23
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-23
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	6e-23
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-22
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-22
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-22
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-22
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-22
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	5e-22
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	8e-22
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-21
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-21
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-21
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-21
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-21
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-21
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	5e-21
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	8e-21
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-20
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-20
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-20
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-20
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-20
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-20
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-20
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-20
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	6e-20
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	8e-20
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-19
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-19
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-19
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-19
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-19
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-19
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-19
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-19
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-19
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	4e-19
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	5e-19
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	5e-19
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	5e-19
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	9e-19
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-18
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-18
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-18
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-18
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-18
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-18
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-18
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-18
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	7e-18
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	8e-18
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-17
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-17
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-17
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-17
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-17
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-17
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	5e-17
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	5e-17
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	5e-17
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	6e-17
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	7e-17
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	8e-17
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-16
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-16
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-16
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-16
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-16
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-16
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-16
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-16
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-16
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-16
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-16
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-16
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-16
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	5e-16
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	6e-16
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	7e-16
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	7e-16
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	7e-16
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	9e-16
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	9e-16
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-15
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-15
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-15
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-15
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-15
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-15
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-15
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-15
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-15
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-15
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-15
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-15
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	4e-15
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	6e-15
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	7e-15
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	8e-15
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	8e-15
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	8e-15
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	9e-15
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-14
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-14
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-14
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-14
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-14
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-14
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-14
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-14
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-14
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-14
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-14
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-14
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	4e-14
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-14
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	4e-14
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	5e-14
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	6e-14
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	6e-14
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	7e-14
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	8e-14
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	8e-14
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	9e-14
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	9e-14
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-13
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-13
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-13
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-13
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-13
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-13
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-13
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-13
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-13
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-13
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-13
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-13
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	4e-13
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	4e-13
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	4e-13
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	4e-13
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	6e-13
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	7e-13
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	8e-13
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	9e-13
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-12
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-12
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-12
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-12
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-12
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-12
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-12
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-12
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-12
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-12
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-12
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-12
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-12
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-12
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-12
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	6e-12
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	6e-12
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	8e-12
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	9e-12
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-11
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-11
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-11
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-11
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-11
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-11
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-11
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-11
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-11
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	4e-11
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	4e-11
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-11
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	5e-11
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	6e-11
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	7e-11
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	7e-11
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	7e-11
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	9e-11
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-10
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-10
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-10
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-10
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-10
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-10
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-10
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-10
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-10
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-10
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-10
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	4e-10
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-10
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	4e-10
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	6e-10
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	8e-10
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	8e-10
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	8e-10
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	9e-10
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-09
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-09
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-09
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-09
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-09
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-09
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-09
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-09
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-09
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-09
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-09
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-09
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	4e-09
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	4e-09
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	5e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	5e-09
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	7e-09
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	7e-09
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	8e-09
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	9e-09
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-08
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-08
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-08
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-08
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-08
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-08
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-08
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	3e-08
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	5e-08
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	9e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-07
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-07
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-07
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-07
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	5e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	5e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	7e-07
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	8e-07
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	8e-07
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	5e-06
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	5e-06
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	7e-06
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	8e-06
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-05
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-05
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-05
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-05
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	3e-05
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	6e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	7e-05
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	8e-05
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	1e-04
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	3e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	4e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	0.002
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	0.004
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  171 bits (435), Expect = 6e-52
 Identities = 73/196 (37%), Positives = 106/196 (54%), Gaps = 13/196 (6%)

Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKE-FMSEVASMANVNVCHENLVKLHG 107
           +GEGGFG+VY  R  + G  VA+K++  E      E  + E+  +  +N  H N+VKL+G
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLN--HPNIVKLYG 58

Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
              D     LV +Y    SL   LL  ++   K        I++ I  GL Y+H      
Sbjct: 59  VFEDENHLYLVMEYCEGGSLKD-LL--KENEGKLSEDEILRILLQILEGLEYLHSN---G 112

Query: 168 VVHRDIKTSNILLDQ-NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS-GRL 225
           ++HRD+K  NILLD  N   K++DFGLSKL   + + + T V GT  Y+APE  +  G  
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYY 171

Query: 226 TRKSDVYSFGVLLLEI 241
           + KSD++S GV+L E+
Sbjct: 172 SEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  170 bits (433), Expect = 5e-51
 Identities = 72/218 (33%), Positives = 115/218 (52%), Gaps = 14/218 (6%)

Query: 49  KIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKL 105
           K+G G FG+VYK + +  G IVAVK+L   S   + ++    E+  +  ++  H N+V+L
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLS--HPNIVRL 63

Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
                D     LV +Y     L   L     R         ++I + I RGL Y+H    
Sbjct: 64  IDAFEDKDHLYLVMEYCEGGDLFDYLS----RGGPLSEDEAKKIALQILRGLEYLHSN-- 117

Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL 225
             ++HRD+K  NILLD+N   KI+DFGL+K   ++++ ++T V GT  Y+APE  + G  
Sbjct: 118 -GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNG 175

Query: 226 -TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDK 262
              K DV+S GV+L E+++G+     +  L +  L+ +
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRR 213

Length = 260

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  163 bits (416), Expect = 1e-48
 Identities = 89/280 (31%), Positives = 131/280 (46%), Gaps = 39/280 (13%)

Query: 49  KIGEGGFGSVYKGRL----QDGTI-VAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENL 102
           K+GEG FG VYKG+L        + VAVK L  + S+Q  +EF+ E   M  ++  H N+
Sbjct: 6   KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLD--HPNV 63

Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE 162
           VKL G C +     +V +YM    L   L    K R K          + I RG+ Y+  
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLSYL---RKNRPKLSLSDLLSFALQIARGMEYLES 120

Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS 222
           +   + +HRD+   N L+ +N   KISDFGLS+   ++  +        + ++APE    
Sbjct: 121 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKE 177

Query: 223 GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE--YHLVDKAWGMYNSKELMNLVDPML 280
           G+ T KSDV+SFGVLL EI +          LGE  Y       GM N +E++  +    
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFT----------LGEQPY------PGMSN-EEVLEYLK--- 217

Query: 281 YGNF---PENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMM 317
            G     P N       + L C  E  + RP  S  ++++
Sbjct: 218 NGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  163 bits (414), Expect = 3e-48
 Identities = 71/244 (29%), Positives = 120/244 (49%), Gaps = 24/244 (9%)

Query: 48  NKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKE-FMSEVASMANVNVCHENLVKL 105
            K+GEG FG VY  R  + G +VA+KV+  +  + ++E  + E+  +  +   H N+V+L
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLK--HPNIVRL 62

Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
           +    D     LV +Y     L   L    K+R +      R  +  I   L Y+H +  
Sbjct: 63  YDVFEDEDKLYLVMEYCEGGDLFDLL----KKRGRLSEDEARFYLRQILSALEYLHSK-- 116

Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL 225
             +VHRD+K  NILLD++ + K++DFGL++   +    ++T V GT  Y+APE  +    
Sbjct: 117 -GIVHRDLKPENILLDEDGHVKLADFGLARQL-DPGEKLTTFV-GTPEYMAPEVLLGKGY 173

Query: 226 TRKSDVYSFGVLLLEIVSGRTAVDFDVQL---------GEYHLVDKAWGMYNSKELMNLV 276
            +  D++S GV+L E+++G+     D QL          +       W +  S E  +L+
Sbjct: 174 GKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDI--SPEAKDLI 231

Query: 277 DPML 280
             +L
Sbjct: 232 RKLL 235

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  161 bits (409), Expect = 1e-47
 Identities = 89/280 (31%), Positives = 132/280 (47%), Gaps = 38/280 (13%)

Query: 49  KIGEGGFGSVYKGRLQDG-----TIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENL 102
           K+GEG FG VYKG L+         VAVK L  + S+Q  +EF+ E   M  ++  H N+
Sbjct: 6   KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLD--HPNI 63

Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE 162
           VKL G C +    ++V +YMP   L   L   + R  +          + I RG+ Y+  
Sbjct: 64  VKLLGVCTEEEPLMIVMEYMPGGDLLDYL--RKNRPKELSLSDLLSFALQIARGMEYLES 121

Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS 222
           +   + +HRD+   N L+ +N   KISDFGLS+   ++  +        + ++APE    
Sbjct: 122 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKE 178

Query: 223 GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE--YHLVDKAWGMYNSKELMNLVDPML 280
           G+ T KSDV+SFGVLL EI +          LGE  Y       GM N  E++  +    
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFT----------LGEEPY------PGMSN-AEVLEYLK--- 218

Query: 281 YGNF---PENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMM 317
            G     P N      K+ L C  E  + RP  S  ++++
Sbjct: 219 KGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  154 bits (392), Expect = 6e-45
 Identities = 75/207 (36%), Positives = 102/207 (49%), Gaps = 23/207 (11%)

Query: 49  KIGEGGFGSVYKGRL-----QDGTIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENL 102
           K+GEG FG VYKG L        T VAVK L   + + E+ EF+ E + M  ++  H N+
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLS--HPNI 63

Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE 162
           V+L G C  G    +V +YMP   L   L    K   K   K   ++ + I +G+ Y+  
Sbjct: 64  VRLLGVCTQGEPLYIVTEYMPGGDLLDFL---RKHGEKLTLKDLLQMALQIAKGMEYLES 120

Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL-----AP 217
           +   + VHRD+   N L+ +N   KISDFGLS+                 G L     AP
Sbjct: 121 K---NFVHRDLAARNCLVTENLVVKISDFGLSRD----IYEDDYYRKRGGGKLPIKWMAP 173

Query: 218 EYAISGRLTRKSDVYSFGVLLLEIVSG 244
           E    G+ T KSDV+SFGVLL EI + 
Sbjct: 174 ESLKDGKFTSKSDVWSFGVLLWEIFTL 200

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  151 bits (383), Expect = 2e-43
 Identities = 85/287 (29%), Positives = 128/287 (44%), Gaps = 43/287 (14%)

Query: 48  NKIGEGGFGSVYKGRLQDG----TIVAVKVL-SVESKQGEKEFMSEVASMANVNVCHENL 102
            K+GEG FG VYKG+L+      T VAVK L    S++  K+F+ E   M  +   H N+
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG--HPNV 58

Query: 103 VKLHGGCIDGPCRILVYDYMPNNSL-----SQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
           V+L G C +     LV +YM    L         +     ++    K      + I +G+
Sbjct: 59  VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118

Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL--GYL 215
            Y+  +     VHRD+   N L+ ++   KISDFGLS+    +  +   +  G L   ++
Sbjct: 119 EYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSR-DVYDDDYYRKKTGGKLPIRWM 174

Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE--YHLVDKAWGMYNSKELM 273
           APE    G  T KSDV+SFGVLL EI +          LG   Y       G+ N +E++
Sbjct: 175 APESLKDGIFTSKSDVWSFGVLLWEIFT----------LGATPY------PGLSN-EEVL 217

Query: 274 NLVDPMLYGN---FPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMM 317
             +     G     PE       ++ L C Q   + RP  S  ++ +
Sbjct: 218 EYL---RKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  138 bits (350), Expect = 8e-39
 Identities = 62/213 (29%), Positives = 105/213 (49%), Gaps = 25/213 (11%)

Query: 44  FRWSNKIGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGE--KEFMSEVASMANVNVCHE 100
           +     +G G FGSVY    +D G ++AVK + +     E  +    E+  ++++   H 
Sbjct: 2   WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQ--HP 59

Query: 101 NLVKLHGGCIDGPCR-ILVY-DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG-----I 153
           N+V+ +G   D     + ++ +Y+   SLS  L    K+  K       E ++      I
Sbjct: 60  NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLL----KKFGKL-----PEPVIRKYTRQI 110

Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR-VAGTL 212
             GLAY+H      +VHRDIK +NIL+D +   K++DFG +K   +  T   T  V GT 
Sbjct: 111 LEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTP 167

Query: 213 GYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
            ++APE        R +D++S G  ++E+ +G+
Sbjct: 168 YWMAPEVIRGEEYGRAADIWSLGCTVIEMATGK 200

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  128 bits (325), Expect = 4e-35
 Identities = 73/252 (28%), Positives = 117/252 (46%), Gaps = 29/252 (11%)

Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSV-ESKQGEKEF-MSEVASMANVNVCHE 100
           +    +IG+G FG VY  R   DG +  +K + +    + E+E  ++EV  +  +N  H 
Sbjct: 2   YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLN--HP 59

Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG----IGRG 156
           N++K +    +     +V +Y     LSQ +    K++ K G     E I+     +   
Sbjct: 60  NIIKYYESFEEKGKLCIVMEYADGGDLSQKI----KKQKKEGKPFPEEQILDWFVQLCLA 115

Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLA 216
           L Y+H      ++HRDIK  NI L  N   K+ DFG+SK+   +T  ++  V GT  YL+
Sbjct: 116 LKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVL-SSTVDLAKTVVGTPYYLS 171

Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAW--------GMYN 268
           PE   +     KSD++S G +L E+ + +   + +  L    L  K            Y 
Sbjct: 172 PELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE---LALKILKGQYPPIPSQY- 227

Query: 269 SKELMNLVDPML 280
           S EL NLV  +L
Sbjct: 228 SSELRNLVSSLL 239

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  127 bits (322), Expect = 8e-35
 Identities = 64/205 (31%), Positives = 104/205 (50%), Gaps = 15/205 (7%)

Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENL 102
           F    KIG+GGFG VYK R  + G  VA+KV+ +ESK+ +++ ++E+  +      H N+
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCK--HPNI 59

Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKAR--REIIMGIGRGLAYI 160
           VK +G  +      +V ++    SL   LL    +       A   +E++ G    L Y+
Sbjct: 60  VKYYGSYLKKDELWIVMEFCSGGSLKD-LLKSTNQTLTESQIAYVCKELLKG----LEYL 114

Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
           H      ++HRDIK +NILL  +   K+ DFGLS     + T     + GT  ++APE  
Sbjct: 115 HSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQL--SDTKARNTMVGTPYWMAPEVI 169

Query: 221 ISGRLTRKSDVYSFGVLLLEIVSGR 245
                  K+D++S G+  +E+  G+
Sbjct: 170 NGKPYDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  130 bits (326), Expect = 2e-34
 Identities = 79/285 (27%), Positives = 129/285 (45%), Gaps = 23/285 (8%)

Query: 43  GFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCH 99
            +R   K+GEG FG VY  R  D  +VA+KVL+ +     +  + F+ E+  +A++N   
Sbjct: 1   SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLN-HP 57

Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
            N+VKL+    D     LV +Y+   SL   LL +  R+          I+  I   L Y
Sbjct: 58  PNIVKLYDFFQDEGSLYLVMEYVDGGSLED-LLKKIGRKGPLSESEALFILAQILSALEY 116

Query: 160 IHEEIQPHVVHRDIKTSNILLDQN-FNPKISDFGLSKLFPENTTHISTR-----VAGTLG 213
           +H +    ++HRDIK  NILLD++    K+ DFGL+KL P+  +  S         GT G
Sbjct: 117 LHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPG 173

Query: 214 YLAPEYAISGRL---TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSK 270
           Y+APE  +   L   +  SD++S G+ L E+++G    + +          K       +
Sbjct: 174 YMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK----IILE 229

Query: 271 ELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK 315
                +   L  + PE  +     +    + +  K R   S+ + 
Sbjct: 230 LPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274

Length = 384

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  123 bits (311), Expect = 3e-33
 Identities = 72/216 (33%), Positives = 107/216 (49%), Gaps = 23/216 (10%)

Query: 39  IATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGE---KEFMSEVASMANV 95
           I     +   K+G G FG V+ G     T VAVK L    K G    + F+ E   M  +
Sbjct: 3   IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTL----KPGTMSPEAFLQEAQIMKKL 58

Query: 96  NVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG--I 153
              H+ LV+L+  C +     +V +YM   SL   L   E ++ +      + + M   I
Sbjct: 59  R--HDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRL----PQLVDMAAQI 112

Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN--TTHISTRVAGT 211
             G+AY+      + +HRD+   NIL+ +N   KI+DFGL++L  ++  T     +    
Sbjct: 113 AEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFP-- 167

Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRT 246
           + + APE A  GR T KSDV+SFG+LL EIV+ GR 
Sbjct: 168 IKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRV 203

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  121 bits (305), Expect = 4e-32
 Identities = 68/216 (31%), Positives = 101/216 (46%), Gaps = 31/216 (14%)

Query: 50  IGEGGFGSVYKGRL------QDGTIVAVKVLS-VESKQGEKEFMSEVASMANVNVCHENL 102
           +GEG FG V+ G         D  +VAVK L    S    K+F  E   + N    HEN+
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQ--HENI 70

Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARRE-----------IIM 151
           VK +G C +G   I+V++YM +  L++  L      A F                  I +
Sbjct: 71  VKFYGVCTEGDPPIMVFEYMEHGDLNK-FLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129

Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT 211
            I  G+ Y+  +   H VHRD+ T N L+  +   KI DFG+S+       +   RV G 
Sbjct: 130 QIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY---RVGGH 183

Query: 212 ----LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
               + ++ PE  +  + T +SDV+SFGV+L EI +
Sbjct: 184 TMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  119 bits (300), Expect = 2e-31
 Identities = 65/203 (32%), Positives = 107/203 (52%), Gaps = 15/203 (7%)

Query: 47  SNKIGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGE--KEFMSEVASMANVNVCHENLV 103
            + IG G FG VYKG  L+ G  VA+K +S+E  + E  K  M E+  + N+   H N+V
Sbjct: 5   GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK--HPNIV 62

Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
           K  G         ++ +Y  N SL Q +    K+   F        +  + +GLAY+HE+
Sbjct: 63  KYIGSIETSDSLYIILEYAENGSLRQII----KKFGPFPESLVAVYVYQVLQGLAYLHEQ 118

Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG 223
               V+HRDIK +NIL  ++   K++DFG++    + +   ++ V GT  ++APE  I  
Sbjct: 119 ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS-VVGTPYWMAPE-VIEM 173

Query: 224 R-LTRKSDVYSFGVLLLEIVSGR 245
              +  SD++S G  ++E+++G 
Sbjct: 174 SGASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  116 bits (293), Expect = 2e-30
 Identities = 66/207 (31%), Positives = 103/207 (49%), Gaps = 18/207 (8%)

Query: 47  SNKIGEGGFGSVYKGR---LQDGT--IVAVKVLSVES-KQGEKEFMSEVASMANVNVCHE 100
             ++GEG FG V   R   L D T   VAVK L+    +Q   +F  E+  +  ++  HE
Sbjct: 9   IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLD--HE 66

Query: 101 NLVKLHGGCIDGPCRI--LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
           N+VK  G C     R   L+ +Y+P+ SL   L   ++ R +   K        I +G+ 
Sbjct: 67  NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL---QRHRDQINLKRLLLFSSQICKGMD 123

Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG--YLA 216
           Y+  +     +HRD+   NIL++     KISDFGL+K+ PE+  +   +  G     + A
Sbjct: 124 YLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYA 180

Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVS 243
           PE   + + +  SDV+SFGV L E+ +
Sbjct: 181 PECLRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  115 bits (291), Expect = 3e-30
 Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 24/208 (11%)

Query: 44  FRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLV 103
           F    K+G G FG V++G  ++   VA+K+L  +    +++F  EV ++  +   H++L+
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLR--HKHLI 65

Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAK------FGWKARREIIMGIGRGL 157
            L   C  G    ++ + M   SL   L   E +            +        +  G+
Sbjct: 66  SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQ--------VAEGM 117

Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN--TTHISTRVAGTLGYL 215
           AY+ E+   + +HRD+   NIL+ ++   K++DFGL++L  E+   +    ++     + 
Sbjct: 118 AYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSS-DKKIP--YKWT 171

Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVS 243
           APE A  G  + KSDV+SFG+LL E+ +
Sbjct: 172 APEAASHGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  112 bits (284), Expect = 2e-29
 Identities = 64/205 (31%), Positives = 105/205 (51%), Gaps = 22/205 (10%)

Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCHENLVKL 105
           +G+G FG V   R    G + A+KVL    +  ++  +  ++E   ++ +N  H  +VKL
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN--HPFIVKL 58

Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKR----RAKFGWKARREIIMGIGRGLAYIH 161
           H          LV +Y P   L  + L +E R    RA+F + A  EI++ +     Y+H
Sbjct: 59  HYAFQTEEKLYLVLEYAPGGELF-SHLSKEGRFSEERARF-YAA--EIVLALE----YLH 110

Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI 221
                 +++RD+K  NILLD + + K++DFGL+K      +  +T   GT  YLAPE  +
Sbjct: 111 SL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEVLL 166

Query: 222 SGRLTRKSDVYSFGVLLLEIVSGRT 246
                +  D +S GVLL E+++G+ 
Sbjct: 167 GKGYGKAVDWWSLGVLLYEMLTGKP 191

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  110 bits (278), Expect = 2e-28
 Identities = 63/198 (31%), Positives = 103/198 (52%), Gaps = 9/198 (4%)

Query: 49  KIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG 108
           K+G G FG V++G   + T VAVK L   +    K+F++E   M  +   H  L++L+  
Sbjct: 13  KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLR--HPKLIQLYAV 69

Query: 109 CIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHV 168
           C       +V + M   SL + L G   R  K       ++   +  G+AY+  +   + 
Sbjct: 70  CTLEEPIYIVTELMKYGSLLEYLQGGAGRALKL--PQLIDMAAQVASGMAYLEAQ---NY 124

Query: 169 VHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRK 228
           +HRD+   N+L+ +N   K++DFGL+++  E+           + + APE A+  R + K
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIK 184

Query: 229 SDVYSFGVLLLEIVS-GR 245
           SDV+SFG+LL EIV+ GR
Sbjct: 185 SDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  108 bits (272), Expect = 2e-27
 Identities = 62/205 (30%), Positives = 104/205 (50%), Gaps = 23/205 (11%)

Query: 49  KIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLVKLH 106
            +G+G  G VYK R +  G I A+K + V+   +  K+ + E+ ++ +       +VK +
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCE--SPYVVKCY 65

Query: 107 GGCIDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG-----IGRGLAYI 160
           G        I +V +YM   SL+  L    K+  K       E ++      I +GL Y+
Sbjct: 66  GAFYK-EGEISIVLEYMDGGSLADLL----KKVGKIP-----EPVLAYIARQILKGLDYL 115

Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
           H +   H++HRDIK SN+L++     KI+DFG+SK+        +T V GT+ Y++PE  
Sbjct: 116 HTKR--HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERI 172

Query: 221 ISGRLTRKSDVYSFGVLLLEIVSGR 245
                +  +D++S G+ LLE   G+
Sbjct: 173 QGESYSYAADIWSLGLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  108 bits (271), Expect = 2e-27
 Identities = 62/204 (30%), Positives = 107/204 (52%), Gaps = 10/204 (4%)

Query: 47  SNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLH 106
             +IG G FG V+ G   +   VA+K +  E    E++F+ E   M  + + H  LV+L+
Sbjct: 9   VQEIGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVM--MKLSHPKLVQLY 65

Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
           G C +     LV+++M +  LS  L     +R KF  +    + + +  G+AY+      
Sbjct: 66  GVCTERSPICLVFEFMEHGCLSDYL---RAQRGKFSQETLLGMCLDVCEGMAYLESS--- 119

Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLT 226
           +V+HRD+   N L+ +N   K+SDFG+++   ++    ST     + + +PE     + +
Sbjct: 120 NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYS 179

Query: 227 RKSDVYSFGVLLLEIVS-GRTAVD 249
            KSDV+SFGVL+ E+ S G+T  +
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKTPYE 203

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  107 bits (270), Expect = 2e-27
 Identities = 71/203 (34%), Positives = 104/203 (51%), Gaps = 17/203 (8%)

Query: 48  NKIGEGGFGSVYKG--RLQDGTI--VAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENL 102
            ++G G FGSV KG   ++ G    VAVK L  E    G+KEF+ E + MA ++  H  +
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLD--HPCI 58

Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE 162
           V+L G C  G   +LV +  P   L + L    K+R +      +E+   +  G+AY+  
Sbjct: 59  VRLIGVCK-GEPLMLVMELAPLGPLLKYL----KKRREIPVSDLKELAHQVAMGMAYLES 113

Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT--LGYLAPEYA 220
           +   H VHRD+   N+LL      KISDFG+S+     + +     AG   L + APE  
Sbjct: 114 K---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECI 170

Query: 221 ISGRLTRKSDVYSFGVLLLEIVS 243
             G+ + KSDV+S+GV L E  S
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  107 bits (270), Expect = 3e-27
 Identities = 80/249 (32%), Positives = 128/249 (51%), Gaps = 23/249 (9%)

Query: 43  GFRWSNKIGEGGFGSVYK-GRLQDGTIVAVKVLSVES-KQGEKE-FMSEVASMANVNVCH 99
            F+   K+G+G +GSVYK  RL D    A+K + + S  Q E+E  ++E+  +A+VN  H
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVN--H 58

Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
            N++      +DG    +V +Y P   LS+ +   +K+R     +    I + + RGL  
Sbjct: 59  PNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQA 118

Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEY 219
           +HE+    ++HRD+K++NILL  N   KI D G+SK+  +N         GT  Y+APE 
Sbjct: 119 LHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI---GTPHYMAPEV 172

Query: 220 AISGRLTRKSDVYSFGVLLLEIVS------GRTAVD--FDVQLGEYHLVDKAWGMYNSKE 271
                 + KSD++S G LL E+ +       R+  D  + VQ G+Y  +        S++
Sbjct: 173 WKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPI----YSQD 228

Query: 272 LMNLVDPML 280
           L N +  ML
Sbjct: 229 LQNFIRSML 237

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  107 bits (269), Expect = 4e-27
 Identities = 68/213 (31%), Positives = 101/213 (47%), Gaps = 20/213 (9%)

Query: 45  RW--SNKIGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGE--KEFMSEVASMANVNVCH 99
           RW   NKIG G FG VY    L  G ++AVK + ++    +  KE   E+  +  +   H
Sbjct: 1   RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLK--H 58

Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
            NLVK +G  +      +  +Y    +L + L  E  R         R   + +  GLAY
Sbjct: 59  PNLVKYYGVEVHREKVYIFMEYCSGGTLEELL--EHGRILDE--HVIRVYTLQLLEGLAY 114

Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG---YLA 216
           +H      +VHRDIK +NI LD N   K+ DFG +     NTT +   V    G   Y+A
Sbjct: 115 LHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMA 171

Query: 217 PEYAISGRLT---RKSDVYSFGVLLLEIVSGRT 246
           PE    G+     R +D++S G ++LE+ +G+ 
Sbjct: 172 PEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  107 bits (268), Expect = 4e-27
 Identities = 66/197 (33%), Positives = 102/197 (51%), Gaps = 14/197 (7%)

Query: 50  IGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGC 109
           IG+G FG V  G  + G  VAVK L  +S   +  F++E + M  +   H NLV+L G  
Sbjct: 14  IGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQA-FLAEASVMTTLR--HPNLVQLLGVV 69

Query: 110 IDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVV 169
           + G    +V +YM   SL   L    + RA      +    + +  G+ Y+ E+   + V
Sbjct: 70  LQGNPLYIVTEYMAKGSLVDYL--RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFV 124

Query: 170 HRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKS 229
           HRD+   N+L+ ++   K+SDFGL+K    +    S ++   + + APE     + + KS
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAK--EASQGQDSGKLP--VKWTAPEALREKKFSTKS 180

Query: 230 DVYSFGVLLLEIVS-GR 245
           DV+SFG+LL EI S GR
Sbjct: 181 DVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score =  106 bits (266), Expect = 2e-26
 Identities = 72/228 (31%), Positives = 108/228 (47%), Gaps = 31/228 (13%)

Query: 42  NGFRWSNKIGEGGFGSVYKGRL------QDGTIVAVKVLSVE-SKQGEKEFMSEVASMAN 94
           N   +   IG+G FG V++ R       +  T+VAVK+L  E S   + +F  E A MA 
Sbjct: 5   NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64

Query: 95  VNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRR----AKFGWKARRE-- 148
            +  H N+VKL G C  G    L+++YM    L++ L     R     +     AR+   
Sbjct: 65  FD--HPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGL 122

Query: 149 ------------IIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS-K 195
                       I   +  G+AY+ E      VHRD+ T N L+ +N   KI+DFGLS  
Sbjct: 123 NPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 179

Query: 196 LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
           ++  +    S   A  + ++ PE     R T +SDV+++GV+L EI S
Sbjct: 180 IYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  104 bits (262), Expect = 6e-26
 Identities = 62/208 (29%), Positives = 108/208 (51%), Gaps = 23/208 (11%)

Query: 48  NKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC----HENL 102
            +IGEG +G VYK R  + G +VA+K + +E+   EKE    + ++  + +     H N+
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRMEN---EKEGFP-ITAIREIKLLQKLRHPNI 60

Query: 103 VKLHG---GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
           V+L         G    +V++YM ++ L+  L   +    KF     +  +  +  GL Y
Sbjct: 61  VRLKEIVTSKGKGSI-YMVFEYMDHD-LTGLL---DSPEVKFTESQIKCYMKQLLEGLQY 115

Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLAPE 218
           +H      ++HRDIK SNIL++ +   K++DFGL++ +   N+   + RV  TL Y  PE
Sbjct: 116 LH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPE 171

Query: 219 YAI-SGRLTRKSDVYSFGVLLLEIVSGR 245
             + + R   + D++S G +L E+  G+
Sbjct: 172 LLLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  103 bits (259), Expect = 8e-26
 Identities = 71/209 (33%), Positives = 108/209 (51%), Gaps = 10/209 (4%)

Query: 38  KIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNV 97
           +I     R   K+G+G FG V+ G     T VA+K L   +   E  F+ E   M  +  
Sbjct: 2   EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLR- 59

Query: 98  CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
            HE LV+L+    + P  I V +YM   SL   L GE  +  +       ++   I  G+
Sbjct: 60  -HEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRL--PQLVDMAAQIASGM 115

Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
           AY+    + + VHRD++ +NIL+ +N   K++DFGL++L  +N           + + AP
Sbjct: 116 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 172

Query: 218 EYAISGRLTRKSDVYSFGVLLLEIVS-GR 245
           E A+ GR T KSDV+SFG+LL E+ + GR
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  103 bits (258), Expect = 1e-25
 Identities = 68/203 (33%), Positives = 98/203 (48%), Gaps = 20/203 (9%)

Query: 49  KIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKE-FMSEVASMANVNVCHENLVKLHG 107
           KIG+G FG VYKG L+  T VAVK          K  F+ E   +   +  H N+VKL G
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYD--HPNIVKLIG 59

Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGI--GRGLAYIHEEIQ 165
            C+      +V + +P  SL   L     R+ K     ++ + M +    G+ Y+     
Sbjct: 60  VCVQKQPIYIVMELVPGGSLLTFL-----RKKKNRLTVKKLLQMSLDAAAGMEYLE---S 111

Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT----LGYLAPEYAI 221
            + +HRD+   N L+ +N   KISDFG+S+   E    I T   G     + + APE   
Sbjct: 112 KNCIHRDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALN 168

Query: 222 SGRLTRKSDVYSFGVLLLEIVSG 244
            GR T +SDV+S+G+LL E  S 
Sbjct: 169 YGRYTSESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  103 bits (260), Expect = 1e-25
 Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 23/203 (11%)

Query: 49  KIGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           KIGEG  G VYK      G  VA+K + +  +  E     E+  M +    H N+V  + 
Sbjct: 26  KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN-EILIMKDCK--HPNIVDYYD 82

Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKAR--REIIMGIGRGLAYIHEEIQ 165
             + G    +V +YM   SL+  ++ +   R      A   RE++    +GL Y+H    
Sbjct: 83  SYLVGDELWVVMEYMDGGSLTD-IITQNFVRMNEPQIAYVCREVL----QGLEYLH---S 134

Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFG----LSKLFPENTTHISTRVAGTLGYLAPEYAI 221
            +V+HRDIK+ NILL ++ + K++DFG    L+K   +  +     V GT  ++APE   
Sbjct: 135 QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS-----VVGTPYWMAPEVIK 189

Query: 222 SGRLTRKSDVYSFGVLLLEIVSG 244
                 K D++S G++ +E+  G
Sbjct: 190 RKDYGPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  102 bits (257), Expect = 2e-25
 Identities = 68/207 (32%), Positives = 105/207 (50%), Gaps = 28/207 (13%)

Query: 50  IGEGGFGSVYKGRLQ----DGTIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLVK 104
           IG G FG V +GRL+        VA+K L   S   ++ +F++E + M   +  H N+++
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD--HPNIIR 69

Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L G        +++ +YM N SL + L    +   KF       ++ GI  G+ Y+ E  
Sbjct: 70  LEGVVTKSRPVMIITEYMENGSLDKFL---RENDGKFTVGQLVGMLRGIASGMKYLSEM- 125

Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF----PENTTH---ISTRVAGTLGYLAP 217
             + VHRD+   NIL++ N   K+SDFGLS+         TT    I  R      + AP
Sbjct: 126 --NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIR------WTAP 177

Query: 218 EYAISGR-LTRKSDVYSFGVLLLEIVS 243
           E AI+ R  T  SDV+SFG+++ E++S
Sbjct: 178 E-AIAYRKFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  101 bits (255), Expect = 7e-25
 Identities = 54/220 (24%), Positives = 97/220 (44%), Gaps = 31/220 (14%)

Query: 50  IGEGGFGSVYKGRLQ-DGTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCHENLVKL 105
           IGEG F +V   + +      A+K+L    +  ++  K    E   +  +N  H  ++KL
Sbjct: 9   IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG-HPGIIKL 67

Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
           +    D      V +Y PN  L Q +    ++      K  R     I   L Y+H    
Sbjct: 68  YYTFQDEENLYFVLEYAPNGELLQYI----RKYGSLDEKCTRFYAAEILLALEYLH---S 120

Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVA---------------- 209
             ++HRD+K  NILLD++ + KI+DFG +K+   N++  S +                  
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFA 180

Query: 210 ---GTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT 246
              GT  Y++PE        + SD+++ G ++ ++++G+ 
Sbjct: 181 SFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKP 220

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  101 bits (253), Expect = 1e-24
 Identities = 67/204 (32%), Positives = 105/204 (51%), Gaps = 19/204 (9%)

Query: 50  IGEGGFGSVYKGR---LQDGT--IVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G+G FGSV   R   LQD T  +VAVK L   + +  ++F  E+  + ++   H+N+VK
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQ--HDNIVK 69

Query: 105 LHGGCIDGPCRI---LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
             G C     R    LV +Y+P  SL   L   +K R +   +        I +G+ Y+ 
Sbjct: 70  YKGVCY-SAGRRNLRLVMEYLPYGSLRDYL---QKHRERLDHRKLLLYASQICKGMEYLG 125

Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT--LGYLAPEY 219
            +     VHRD+ T NIL++     KI DFGL+K+ P++  +   R  G   + + APE 
Sbjct: 126 SK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPES 182

Query: 220 AISGRLTRKSDVYSFGVLLLEIVS 243
               + +  SDV+SFGV+L E+ +
Sbjct: 183 LTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  100 bits (250), Expect = 2e-24
 Identities = 61/198 (30%), Positives = 100/198 (50%), Gaps = 15/198 (7%)

Query: 50  IGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGC 109
           +G G FG V+ G+ +    VA+K++  E    E +F+ E   M  ++  H NLV+L+G C
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIR-EGAMSEDDFIEEAKVMMKLS--HPNLVQLYGVC 68

Query: 110 ID-GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHV 168
               P  I V +YM N  L   L    +R+ K G +   ++   +   + Y+        
Sbjct: 69  TKQRPIFI-VTEYMANGCLLNYL---RERKGKLGTEWLLDMCSDVCEAMEYLESN---GF 121

Query: 169 VHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLGYLAPEYAISGRLT 226
           +HRD+   N L+ ++   K+SDFGL++  L  + T+   T+    + +  PE     R +
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFP--VKWAPPEVFDYSRFS 179

Query: 227 RKSDVYSFGVLLLEIVSG 244
            KSDV+SFGVL+ E+ S 
Sbjct: 180 SKSDVWSFGVLMWEVFSE 197

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 99.8 bits (249), Expect = 2e-24
 Identities = 80/279 (28%), Positives = 132/279 (47%), Gaps = 42/279 (15%)

Query: 50  IGEGGFGSVYKG-RLQDGTIVAVKVLSV-----ESKQGEKEFMSEVASMANVNVCHENLV 103
           +G G FGSVY+G  L DG   AVK +S+       ++  K+   E+A ++ +   H N+V
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL--QHPNIV 65

Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM---GIGRGLAYI 160
           +  G   +     +  + +P  SL++ L        K+G      I +    I  GL Y+
Sbjct: 66  QYLGTEREEDNLYIFLELVPGGSLAKLL-------KKYGSFPEPVIRLYTRQILLGLEYL 118

Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
           H+    + VHRDIK +NIL+D N   K++DFG++K   E +   S    G+  ++APE  
Sbjct: 119 HDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS--FKGSPYWMAPEVI 173

Query: 221 IS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPM 279
              G     +D++S G  +LE+ +G+          +   V   + +  SKEL  + D +
Sbjct: 174 AQQGGYGLAADIWSLGCTVLEMATGKPP------WSQLEGVAAVFKIGRSKELPPIPDHL 227

Query: 280 LYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN 318
                  +EA  F+   L C+Q    LRP   TA +++ 
Sbjct: 228 ------SDEAKDFI---LKCLQRDPSLRP---TAAELLE 254

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =   99 bits (249), Expect = 2e-24
 Identities = 70/203 (34%), Positives = 101/203 (49%), Gaps = 20/203 (9%)

Query: 49  KIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKE---FMSEVASMANVNVCHENLVKL 105
           K+G G FG V+ G     T VA+K L    KQG      F++E   M  +   H  LV+L
Sbjct: 13  KLGAGQFGEVWMGYYNGHTKVAIKSL----KQGSMSPEAFLAEANLMKQLQ--HPRLVRL 66

Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG--IGRGLAYIHEE 163
           +      P  I + +YM N SL   L   E  +        + I M   I  G+A+I  +
Sbjct: 67  YAVVTQEPIYI-ITEYMENGSLVDFLKTPEGIKLTI----NKLIDMAAQIAEGMAFIERK 121

Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG 223
              + +HRD++ +NIL+ +    KI+DFGL++L  +N           + + APE    G
Sbjct: 122 ---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 178

Query: 224 RLTRKSDVYSFGVLLLEIVS-GR 245
             T KSDV+SFG+LL EIV+ GR
Sbjct: 179 TFTIKSDVWSFGILLTEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score =  100 bits (249), Expect = 3e-24
 Identities = 65/211 (30%), Positives = 106/211 (50%), Gaps = 21/211 (9%)

Query: 49  KIGEGGFGSVYKGRL------QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENL 102
           ++GEG FG V+          QD  +VAVK L   S    K+F  E   + N+   HE++
Sbjct: 12  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ--HEHI 69

Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQ---------TLLGEEKRRAKFGWKARREIIMGI 153
           VK +G C++G   I+V++YM +  L++          L+ E  R A+        I   I
Sbjct: 70  VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129

Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTHISTRVAGTL 212
             G+ Y+  +   H VHRD+ T N L+ +N   KI DFG+S+ ++  +   +       +
Sbjct: 130 AAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186

Query: 213 GYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
            ++ PE  +  + T +SDV+S GV+L EI +
Sbjct: 187 RWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 99.2 bits (247), Expect = 4e-24
 Identities = 69/224 (30%), Positives = 111/224 (49%), Gaps = 16/224 (7%)

Query: 48  NKIGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLH 106
           +K+G G +G VY+G  +     VAVK L  E     +EF+ E A M  +   H NLV+L 
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIK--HPNLVQLL 68

Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
           G C   P   ++ ++M   +L   L   E  R +        +   I   + Y+ ++   
Sbjct: 69  GVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK--- 123

Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT---LGYLAPEYAISG 223
           + +HRD+   N L+ +N   K++DFGLS+L   +T    T  AG    + + APE     
Sbjct: 124 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYN 180

Query: 224 RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE-YHLVDKAWGM 266
           + + KSDV++FGVLL EI +   +    + L + Y L++K + M
Sbjct: 181 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRM 224

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 98.9 bits (246), Expect = 6e-24
 Identities = 71/209 (33%), Positives = 106/209 (50%), Gaps = 10/209 (4%)

Query: 38  KIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNV 97
           +I     +   K+G G FG V+ G     T VAVK L   +   E  F+ E   M  +  
Sbjct: 2   EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES-FLEEAQIMKKLR- 59

Query: 98  CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
            H+ LV+L+    + P  I V +YM   SL   L   E R  K       ++   +  G+
Sbjct: 60  -HDKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKDGEGRALKL--PNLVDMAAQVAAGM 115

Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
           AYI    + + +HRD++++NIL+      KI+DFGL++L  +N           + + AP
Sbjct: 116 AYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAP 172

Query: 218 EYAISGRLTRKSDVYSFGVLLLEIVS-GR 245
           E A+ GR T KSDV+SFG+LL E+V+ GR
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 99.1 bits (248), Expect = 6e-24
 Identities = 62/210 (29%), Positives = 106/210 (50%), Gaps = 32/210 (15%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKE-----FMSEVASMANVNVCHENL 102
           K+GEG +G VYK R  + G IVA+K + +++   E+E      + E++ +  +   H N+
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKIRLDN---EEEGIPSTALREISLLKELK--HPNI 60

Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE 162
           VKL           LV++Y   + L + L   +KR         + I+  + RGLAY H 
Sbjct: 61  VKLLDVIHTERKLYLVFEYCDMD-LKKYL---DKRPGPLSPNLIKSIMYQLLRGLAYCH- 115

Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE---- 218
                ++HRD+K  NIL++++   K++DFGL++ F       +  V  TL Y APE    
Sbjct: 116 --SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEILLG 172

Query: 219 ---YAISGRLTRKSDVYSFGVLLLEIVSGR 245
              Y+ +       D++S G +  E+++G+
Sbjct: 173 SKHYSTA------VDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 99.0 bits (247), Expect = 7e-24
 Identities = 64/209 (30%), Positives = 99/209 (47%), Gaps = 14/209 (6%)

Query: 42  NGFRWSNKIGEGGFGSVYKGRL-QDGTIVAVKVLSVESKQG-EKEFMSEVASMANVNVC- 98
                 +++GEG  GSV K RL   G I A+K ++ +     +K+ + E+        C 
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEIN---KSCK 57

Query: 99  HENLVKLHGGCID-GPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRG 156
              +VK +G  +D     I +  +Y    SL       +KR  + G K   +I   + +G
Sbjct: 58  SPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKG 117

Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLA 216
           L+Y+H      ++HRDIK SNILL +    K+ DFG+S    E    ++    GT  Y+A
Sbjct: 118 LSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSG---ELVNSLAGTFTGTSFYMA 171

Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
           PE       +  SDV+S G+ LLE+   R
Sbjct: 172 PERIQGKPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 98.0 bits (244), Expect = 1e-23
 Identities = 66/215 (30%), Positives = 111/215 (51%), Gaps = 15/215 (6%)

Query: 44  FRWSNKIGEGGFGSVYKG-RLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHE 100
           F   NKIG+G FG V+K  R  D  + A+K + +   +++  +E + E   +A ++    
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLD--SS 59

Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRR--AKFGWKARREIIMGIGRGLA 158
            +++ +   +D     +V +Y  N  L + L  +  R       W+   +I++G    LA
Sbjct: 60  YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----LA 115

Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE 218
           ++H +    ++HRDIK+ N+ LD   N KI D G++KL  +NT   +T V GT  YL+PE
Sbjct: 116 HLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GTPYYLSPE 171

Query: 219 YAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253
                    KSDV++ GV+L E  +G+   D + Q
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ 206

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 98.9 bits (246), Expect = 1e-23
 Identities = 66/214 (30%), Positives = 107/214 (50%), Gaps = 24/214 (11%)

Query: 49  KIGEGGFGSVYKGR------LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENL 102
           ++GEG FG V+          +D  +VAVK L   +    K+F  E   + N+   HE++
Sbjct: 12  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQ--HEHI 69

Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQ----------TLLGEEKRRAK--FGWKARREII 150
           VK +G C DG   I+V++YM +  L++           L+  + R+AK   G      I 
Sbjct: 70  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129

Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTHISTRVA 209
             I  G+ Y+  +   H VHRD+ T N L+  N   KI DFG+S+ ++  +   +     
Sbjct: 130 SQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186

Query: 210 GTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
             + ++ PE  +  + T +SDV+SFGV+L EI +
Sbjct: 187 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 97.9 bits (244), Expect = 2e-23
 Identities = 61/199 (30%), Positives = 112/199 (56%), Gaps = 13/199 (6%)

Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCH-ENLVKLH 106
           IG G +G+VY+G+ +  G +VA+K++++++   +  +   EVA ++ +      N+ K +
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
           G  + GP   ++ +Y    S+ +TL+       K+     RE+++     L YIH+    
Sbjct: 69  GSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVA----LKYIHKV--- 120

Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL- 225
            V+HRDIK +NIL+    N K+ DFG++ L  +N++  ST V GT  ++APE    G+  
Sbjct: 121 GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKYY 179

Query: 226 TRKSDVYSFGVLLLEIVSG 244
             K+D++S G+ + E+ +G
Sbjct: 180 DTKADIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 97.3 bits (243), Expect = 2e-23
 Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 18/210 (8%)

Query: 48  NKIGEGGFGSVYK-GRLQDGTIVAVKVLSVES-KQGEKEFM-SEVASMANVNVCHENLVK 104
             IG+G FG+V K  R  DG I+  K +   +  + EK+ + SEV  +  +   H N+V+
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELK--HPNIVR 63

Query: 105 LHGGCIDGPCRIL--VYDYMPNNSLSQTL--LGEEKRRA--KFGWKARREIIMGIGRGLA 158
            +   ID   + L  V +Y     L+Q +    +E++    +F W+    I+  +   L 
Sbjct: 64  YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWR----ILTQLLLALY 119

Query: 159 YIHEEIQPH--VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLA 216
             H    P   V+HRD+K +NI LD N N K+ DFGL+K+   +++   T V GT  Y++
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMS 178

Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVSGRT 246
           PE         KSD++S G L+ E+ +   
Sbjct: 179 PEQLNHMSYDEKSDIWSLGCLIYELCALSP 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 96.6 bits (241), Expect = 3e-23
 Identities = 56/206 (27%), Positives = 101/206 (49%), Gaps = 12/206 (5%)

Query: 42  NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCH 99
           +   +  ++G G  G V K   +  G I+AVK + +E  +   K+ + E+  +   N   
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCN--S 58

Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
             +V  +G   +     +  +YM   SL + L   + R      +   +I + + +GL Y
Sbjct: 59  PYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGR---IPERILGKIAVAVLKGLTY 115

Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEY 219
           +HE  +  ++HRD+K SNIL++     K+ DFG+S    +    ++    GT  Y+APE 
Sbjct: 116 LHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSG---QLVNSLAKTFVGTSSYMAPER 170

Query: 220 AISGRLTRKSDVYSFGVLLLEIVSGR 245
                 + KSD++S G+ L+E+ +GR
Sbjct: 171 IQGNDYSVKSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 96.3 bits (240), Expect = 4e-23
 Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 27/208 (12%)

Query: 49  KIGEGGFGSVYKG--------RLQDGTIVAVKVLSVESKQG-EKEFMSEVASMANVNVCH 99
           K+G+G FG V +G         +     VAVK L  +       +F+ E A M +++  H
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIP----VAVKCLKSDKLSDIMDDFLKEAAIMHSLD--H 55

Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
           ENL++L+G  +  P   +V +  P  SL   L   +     F      +  + I  G+ Y
Sbjct: 56  ENLIRLYGVVLTHPLM-MVTELAPLGSLLDRL--RKDALGHFLISTLCDYAVQIANGMRY 112

Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIST----RVAGTLGYL 215
           +        +HRD+   NILL  +   KI DFGL +  P+N  H       +V     + 
Sbjct: 113 LE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVP--FAWC 167

Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVS 243
           APE   +   +  SDV+ FGV L E+ +
Sbjct: 168 APESLRTRTFSHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 96.6 bits (241), Expect = 6e-23
 Identities = 54/176 (30%), Positives = 95/176 (53%), Gaps = 18/176 (10%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQG--EKEFMSEVASMANVNVCHENLVKL 105
           +IGEG  G V+K +  + G  VA+K +++   +G    + + E+ ++      H  +VKL
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQ--HPYVVKL 64

Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKR---RAKFGWKARREIIMGIGRGLAYIHE 162
                 G   +LV +YMP+  LS+ +L +E+R    A+     +  + M + +G+AY+H 
Sbjct: 65  LDVFPHGSGFVLVMEYMPS-DLSE-VLRDEERPLPEAQ----VKSYMRM-LLKGVAYMHA 117

Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE 218
                ++HRD+K +N+L+  +   KI+DFGL++LF E    + +    T  Y APE
Sbjct: 118 N---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPE 170

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 95.5 bits (237), Expect = 1e-22
 Identities = 70/209 (33%), Positives = 106/209 (50%), Gaps = 10/209 (4%)

Query: 38  KIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNV 97
           +I     R   K+G+G FG V+ G     T VA+K L   +   E  F+ E   M  +  
Sbjct: 2   EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA-FLQEAQIMKKLR- 59

Query: 98  CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
            H+ LV L+    + P  I V ++M   SL   L   + +  K       ++   I  G+
Sbjct: 60  -HDKLVPLYAVVSEEPIYI-VTEFMGKGSLLDFLKEGDGKYLKL--PQLVDMAAQIADGM 115

Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
           AYI    + + +HRD++ +NIL+  N   KI+DFGL++L  +N           + + AP
Sbjct: 116 AYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAP 172

Query: 218 EYAISGRLTRKSDVYSFGVLLLEIVS-GR 245
           E A+ GR T KSDV+SFG+LL E+V+ GR
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 95.6 bits (238), Expect = 1e-22
 Identities = 60/203 (29%), Positives = 102/203 (50%), Gaps = 20/203 (9%)

Query: 50  IGEGGFGSVYKG--RLQDGTI---VAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLV 103
           +G G FG+VYKG    +   +   VA+KVL  E+  +  KE + E   MA+V+  H ++V
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVD--HPHVV 72

Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
           +L G C+      L+   MP   L   +      +   G +      + I +G++Y+ E+
Sbjct: 73  RLLGICL-SSQVQLITQLMPLGCLLDYV---RNHKDNIGSQYLLNWCVQIAKGMSYLEEK 128

Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG---TLGYLAPEYA 220
               +VHRD+   N+L+    + KI+DFGL+KL   +         G    + ++A E  
Sbjct: 129 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEY--HAEGGKVPIKWMALESI 183

Query: 221 ISGRLTRKSDVYSFGVLLLEIVS 243
           +    T KSDV+S+GV + E+++
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 95.4 bits (237), Expect = 1e-22
 Identities = 61/218 (27%), Positives = 106/218 (48%), Gaps = 25/218 (11%)

Query: 44  FRWSNKIGEGGFGSVYKGRL------QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNV 97
            +W  ++GEG FG V+          QD  +VAVK L   S+   ++F  E   +  +  
Sbjct: 9   LKW--ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQ- 65

Query: 98  CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLL-----------GEEKRRAKFGWKAR 146
            H+++V+ +G C +G   ++V++YM +  L++ L            GE+    +      
Sbjct: 66  -HQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQM 124

Query: 147 REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTHIS 205
             I   I  G+ Y+      H VHRD+ T N L+ Q    KI DFG+S+ ++  +   + 
Sbjct: 125 LAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 181

Query: 206 TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
            R    + ++ PE  +  + T +SD++SFGV+L EI +
Sbjct: 182 GRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 95.2 bits (237), Expect = 2e-22
 Identities = 65/222 (29%), Positives = 102/222 (45%), Gaps = 31/222 (13%)

Query: 45  RWSNKIGEGGFGSVYKGRL------QDGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNV 97
           R+  ++GEG FG VYKG L         T VA+K L      + ++EF  E   M+++  
Sbjct: 8   RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQ- 66

Query: 98  CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLL----------GEEKRRAKFGWKARR 147
            H N+V L G C       ++++Y+ +  L + L+                 K       
Sbjct: 67  -HPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSD 125

Query: 148 --EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS 205
              I + I  G+ Y+      H VHRD+   N L+ +    KISDFGLS+   +  +   
Sbjct: 126 FLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSR---DIYSADY 179

Query: 206 TRVAGT----LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
            RV       + ++ PE  + G+ T +SD++SFGV+L EI S
Sbjct: 180 YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 95.1 bits (237), Expect = 2e-22
 Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 32/210 (15%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSV--ESKQGEKEFMSEVASMANVNVCHENLVKL 105
           KIGEG +G VYK R    G IVA+K + +  ES+   K  + E+  +  +N  H N++KL
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELN--HPNIIKL 63

Query: 106 HGGCIDGPCRILVYDYMPNNSL-----SQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
                      LV+++M  +        Q  L E   ++          +  + +GLA+ 
Sbjct: 64  LDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKS---------YLYQLLQGLAFC 114

Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PEN---TTHISTRVAGTLGYLA 216
           H      ++HRD+K  N+L++     K++DFGL++ F       T ++ TR      Y A
Sbjct: 115 H---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRA 166

Query: 217 PEYAI-SGRLTRKSDVYSFGVLLLEIVSGR 245
           PE  +     +   D++S G +  E++S R
Sbjct: 167 PELLLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 93.6 bits (233), Expect = 5e-22
 Identities = 75/275 (27%), Positives = 129/275 (46%), Gaps = 38/275 (13%)

Query: 50  IGEGGFGSVYKGRLQD------GTIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENL 102
           +G+G FG VY+G  +        T VA+K ++  +   E+ EF++E + M   N CH ++
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFN-CH-HV 71

Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLG---EEKRRAKFGWKARREII---MGIGRG 156
           V+L G    G   ++V + M    L   L     E +     G    ++ I     I  G
Sbjct: 72  VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131

Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTHISTRVAGTLGYL 215
           +AY+  +     VHRD+   N ++ ++   KI DFG+++ ++  +      +    + ++
Sbjct: 132 MAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188

Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE--YHLVDKAWGMYNSKELM 273
           APE    G  T KSDV+SFGV+L E+ +          L E  Y       G+ N +E++
Sbjct: 189 APESLKDGVFTTKSDVWSFGVVLWEMAT----------LAEQPYQ------GLSN-EEVL 231

Query: 274 NLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRP 308
             V    + + PEN   + L++  +C Q   K+RP
Sbjct: 232 KFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRP 266

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 93.2 bits (232), Expect = 8e-22
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 22/209 (10%)

Query: 48  NKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMS-EVASMANVNVCHENLVKL 105
             IG G    VY    L +   VA+K + +E  Q   + +  EV +M+  N  H N+VK 
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCN--HPNVVKY 64

Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM-----GIGRGLAYI 160
           +   + G    LV  Y+   SL   +      ++ +      E I+      + +GL Y+
Sbjct: 65  YTSFVVGDELWLVMPYLSGGSLLDIM------KSSYPRGGLDEAIIATVLKEVLKGLEYL 118

Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR---VAGTLGYLAP 217
           H   Q   +HRDIK  NILL ++ + KI+DFG+S    +             GT  ++AP
Sbjct: 119 HSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAP 175

Query: 218 EYAISGR-LTRKSDVYSFGVLLLEIVSGR 245
           E          K+D++SFG+  +E+ +G 
Sbjct: 176 EVMEQVHGYDFKADIWSFGITAIELATGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 96.5 bits (240), Expect = 1e-21
 Identities = 71/273 (26%), Positives = 125/273 (45%), Gaps = 23/273 (8%)

Query: 48  NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           N I  G  G+ YKG+        ++ +  E         SE+A M  +   H N+VKL G
Sbjct: 696 NVISRGKKGASYKGKSIKN---GMQFVVKEINDVNSIPSSEIADMGKLQ--HPNIVKLIG 750

Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
            C       L+++Y+   +LS+ L           W+ RR+I +GI + L ++H    P 
Sbjct: 751 LCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPA 803

Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLAPEYAISGRLT 226
           VV  ++    I++D    P +    L  L   +    IS+       Y+APE   +  +T
Sbjct: 804 VVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS------AYVAPETRETKDIT 856

Query: 227 RKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFP- 285
            KSD+Y FG++L+E+++G++  D +  +    +V+ A   Y+   L   +DP + G+   
Sbjct: 857 EKSDIYGFGLILIELLTGKSPADAEFGVHG-SIVEWARYCYSDCHLDMWIDPSIRGDVSV 915

Query: 286 -ENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMM 317
            +NE +  + + L C       RP  +  +K +
Sbjct: 916 NQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948

Length = 968

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 92.6 bits (230), Expect = 1e-21
 Identities = 68/209 (32%), Positives = 104/209 (49%), Gaps = 20/209 (9%)

Query: 50  IGEGGFGSVYKG-RLQDGTIVAVK--VLSVESKQGEKEFMSEVASMAN-----VNVCHEN 101
           IG G FGSVY G     G ++AVK   L   S   +    S + ++A        + HEN
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
           +V+  G  +D     +  +Y+P  S+   LL        F     R  +  I +GL Y+H
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSV-AALL---NNYGAFEETLVRNFVRQILKGLNYLH 123

Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVA-----GTLGYLA 216
                 ++HRDIK +NIL+D     KISDFG+SK    N+    T  A     G++ ++A
Sbjct: 124 NR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180

Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
           PE       TRK+D++S G L++E+++G+
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 92.6 bits (231), Expect = 2e-21
 Identities = 66/204 (32%), Positives = 104/204 (50%), Gaps = 20/204 (9%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMS--EVASMANVNVCHENLVKL 105
           ++G+G FGSVY  R  + G +VA+K +  +    E E M+  EV S+  +N  H N+VKL
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNE-HPNIVKL 63

Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
                +      V++YM  N L Q +   + +   F     R II  I +GLA+IH+   
Sbjct: 64  KEVFRENDELYFVFEYMEGN-LYQLMKDRKGK--PFSESVIRSIIYQILQGLAHIHKH-- 118

Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLF---PENTTHISTRVAGTLGYLAPEYAI- 221
               HRD+K  N+L+      KI+DFGL++     P  T ++STR      Y APE  + 
Sbjct: 119 -GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR-----WYRAPEILLR 172

Query: 222 SGRLTRKSDVYSFGVLLLEIVSGR 245
           S   +   D+++ G ++ E+ + R
Sbjct: 173 STSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 91.8 bits (228), Expect = 2e-21
 Identities = 71/216 (32%), Positives = 107/216 (49%), Gaps = 32/216 (14%)

Query: 50  IGEGGFGSVYKGRLQD------GTI-VAVKVLSVESKQGEK-EFMSEVASMANVNVCHEN 101
           +G G FG VY+G   D      G I VAVK L   +   EK EF+ E   M+N N  H N
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFN--HPN 60

Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFG-----WKARREIIMGIGRG 156
           +VKL G C+    + ++ + M    L   L     R  +FG      K   +I + + +G
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRD--ARVERFGPPLLTLKELLDICLDVAKG 118

Query: 157 LAYIHEEIQPHVVHRDIKTSNILL-----DQNFNPKISDFGLSKLFPENTTHISTRVAGT 211
             Y+    Q H +HRD+   N L+     D +   KI DFGL++   ++  +   R  G 
Sbjct: 119 CVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY---RKEGE 172

Query: 212 ----LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
               + ++APE  + G+ T +SDV+SFGVL+ EI++
Sbjct: 173 GLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 91.5 bits (227), Expect = 3e-21
 Identities = 75/281 (26%), Positives = 134/281 (47%), Gaps = 38/281 (13%)

Query: 50  IGEGGFGSVYKGRLQ----DGTIVAVKVLSV-ESKQGEKEFMSEVASMANVNVCHENLVK 104
           IG G FG V +GRL+        VA+K L    +++  ++F+SE + M   +  H N++ 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD--HPNIIH 69

Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L G        +++ ++M N +L   L    +   +F       ++ GI  G+ Y+ E  
Sbjct: 70  LEGVVTKSRPVMIITEFMENGALDSFL---RQNDGQFTVIQLVGMLRGIAAGMKYLSEM- 125

Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG------YLAPE 218
             + VHRD+   NIL++ N   K+SDFGLS+   ++T+  +     +LG      + APE
Sbjct: 126 --NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT--YTSSLGGKIPIRWTAPE 181

Query: 219 YAISGR-LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD 277
            AI+ R  T  SDV+S+G+++ E++S           GE       W M N ++++N ++
Sbjct: 182 -AIAYRKFTSASDVWSYGIVMWEVMS----------YGE----RPYWDMSN-QDVINAIE 225

Query: 278 PMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN 318
                  P +      ++ L C Q+    RP+    +  ++
Sbjct: 226 QDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLD 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 91.2 bits (226), Expect = 3e-21
 Identities = 67/210 (31%), Positives = 102/210 (48%), Gaps = 10/210 (4%)

Query: 38  KIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNV 97
           +I     +   K+G G FG V+       T VAVK +   S   E  F++E   M  +  
Sbjct: 2   EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQ- 59

Query: 98  CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
            H+ LVKLH      P  I+  ++M   SL   L  +E  +         +    I  G+
Sbjct: 60  -HDKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGM 115

Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
           A+I    Q + +HRD++ +NIL+  +   KI+DFGL+++  +N           + + AP
Sbjct: 116 AFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAP 172

Query: 218 EYAISGRLTRKSDVYSFGVLLLEIVS-GRT 246
           E    G  T KSDV+SFG+LL+EIV+ GR 
Sbjct: 173 EAINFGSFTIKSDVWSFGILLMEIVTYGRI 202

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 90.8 bits (226), Expect = 5e-21
 Identities = 63/210 (30%), Positives = 101/210 (48%), Gaps = 26/210 (12%)

Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENL 102
           F    K+GEG +GSVYK    + G +VA+KV+ VE     +E + E++ +   +     +
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCD--SPYI 60

Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLS------QTLLGEEKRRAKFGWKARREIIMGIGRG 156
           VK +G         +V +Y    S+S         L EE+  A         I+    +G
Sbjct: 61  VKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAA---------ILYQTLKG 111

Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS-KLFPENTTHISTRVAGTLGYL 215
           L Y+H       +HRDIK  NILL++    K++DFG+S +L   +T      V GT  ++
Sbjct: 112 LEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQL--TDTMAKRNTVIGTPFWM 166

Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
           APE         K+D++S G+  +E+  G+
Sbjct: 167 APEVIQEIGYNNKADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 90.2 bits (224), Expect = 8e-21
 Identities = 58/200 (29%), Positives = 91/200 (45%), Gaps = 14/200 (7%)

Query: 49  KIGEGGFGSVYKG---RLQDGTI-VAVKVLSVESKQGEKE-FMSEVASMANVNVCHENLV 103
            IGEG FG VY+G     ++  I VAVK     +    +E F+ E   M   +  H ++V
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD--HPHIV 70

Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
           KL G   + P  I V +  P   L   L   +  +      +       +   LAY+  +
Sbjct: 71  KLIGVITENPVWI-VMELAPLGELRSYL---QVNKYSLDLASLILYSYQLSTALAYLESK 126

Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG 223
                VHRDI   N+L+      K+ DFGLS+   + + + +++    + ++APE     
Sbjct: 127 ---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFR 183

Query: 224 RLTRKSDVYSFGVLLLEIVS 243
           R T  SDV+ FGV + EI+ 
Sbjct: 184 RFTSASDVWMFGVCMWEILM 203

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 90.0 bits (223), Expect = 1e-20
 Identities = 62/201 (30%), Positives = 101/201 (50%), Gaps = 15/201 (7%)

Query: 50  IGEGGFGSVYKGRLQ----DGTIVAVKVLSV-ESKQGEKEFMSEVASMANVNVCHENLVK 104
           IG G FG V  GRL+        VA+K L    +++  ++F+SE + M   +  H N++ 
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFD--HPNIIH 69

Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L G        ++V +YM N SL   L    K   +F       ++ GI  G+ Y+ +  
Sbjct: 70  LEGVVTKSKPVMIVTEYMENGSLDAFL---RKHDGQFTVIQLVGMLRGIASGMKYLSDM- 125

Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG--YLAPEYAIS 222
               VHRD+   NIL++ N   K+SDFGLS++  ++     T   G +   + APE    
Sbjct: 126 --GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 183

Query: 223 GRLTRKSDVYSFGVLLLEIVS 243
            + T  SDV+S+G+++ E++S
Sbjct: 184 RKFTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 89.6 bits (222), Expect = 1e-20
 Identities = 62/202 (30%), Positives = 106/202 (52%), Gaps = 17/202 (8%)

Query: 50  IGEGGFGSVYKGRLQ----DGTIVAVKVLSV-ESKQGEKEFMSEVASMANVNVCHENLVK 104
           IG G FG V++G L+        VA+K L    +++  ++F+SE + M      H N+++
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQF--SHHNIIR 70

Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L G        +++ +YM N +L + L        +F       ++ GI  G+ Y+ +  
Sbjct: 71  LEGVVTKFKPAMIITEYMENGALDKYL---RDHDGEFSSYQLVGMLRGIAAGMKYLSDM- 126

Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG--YLAPEYAIS 222
             + VHRD+   NIL++ N   K+SDFGLS++  ++     T   G +   + APE AI+
Sbjct: 127 --NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPE-AIA 183

Query: 223 GR-LTRKSDVYSFGVLLLEIVS 243
            R  T  SDV+SFG+++ E++S
Sbjct: 184 YRKFTSASDVWSFGIVMWEVMS 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 89.7 bits (223), Expect = 1e-20
 Identities = 63/204 (30%), Positives = 99/204 (48%), Gaps = 27/204 (13%)

Query: 48  NKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLH 106
            +IG G +G VYK R +  G +VA+KV+ +E     +    E++ +      H N+V   
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECR--HPNIVAYF 66

Query: 107 GGCIDGPCRILVYDYMPNNSLS---QTLLG--EEKRRAKFGWKARREIIMGIGRGLAYIH 161
           G  +      +V +Y    SL    Q   G   E + A       RE +    +GLAY+H
Sbjct: 67  GSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVC----RETL----KGLAYLH 118

Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVA--GTLGYLAPEY 219
           E      +HRDIK +NILL ++ + K++DFG+S      T  I+ R +  GT  ++APE 
Sbjct: 119 ET---GKIHRDIKGANILLTEDGDVKLADFGVSAQL---TATIAKRKSFIGTPYWMAPEV 172

Query: 220 A---ISGRLTRKSDVYSFGVLLLE 240
           A     G    K D+++ G+  +E
Sbjct: 173 AAVERKGGYDGKCDIWALGITAIE 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 89.3 bits (221), Expect = 2e-20
 Identities = 74/272 (27%), Positives = 122/272 (44%), Gaps = 25/272 (9%)

Query: 38  KIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNV 97
           +I     +   K+G G FG V+ G   + T VAVK L   +   +  F+ E   M  +  
Sbjct: 2   EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQ- 59

Query: 98  CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
            H+ LV+L+          ++ +YM   SL   L  +E  +         +    I  G+
Sbjct: 60  -HDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGM 116

Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
           AYI  +   + +HRD++ +N+L+ ++   KI+DFGL+++  +N           + + AP
Sbjct: 117 AYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAP 173

Query: 218 EYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV 276
           E    G  T KSDV+SFG+LL EIV+ G+                   GM NS ++M+ +
Sbjct: 174 EAINFGSFTIKSDVWSFGILLYEIVTYGKIPYP---------------GMSNS-DVMSAL 217

Query: 277 DPMLYGNFPENEAIRFLKVGLLCVQEKSKLRP 308
                    EN       +   C +EK++ RP
Sbjct: 218 QRGYRMPRMENCPDELYDIMKTCWKEKAEERP 249

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 88.9 bits (221), Expect = 2e-20
 Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 15/208 (7%)

Query: 43  GFRWSNKIGEGGFGSVYKGRLQD-GTIVAVKVLS---VESKQGEKEFMSEVASMANVNVC 98
            F     IG+G FG V   + +D   + A+K ++      K   +  ++E   +  +N  
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN-- 58

Query: 99  HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
           H  LV L     D     LV D +    L   L     ++ KF  +  +  I  I   L 
Sbjct: 59  HPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLS----QKVKFSEEQVKFWICEIVLALE 114

Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE 218
           Y+H +    ++HRDIK  NILLD+  +  I+DF ++     +T  ++T  +GT GY+APE
Sbjct: 115 YLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPE 169

Query: 219 YAISGRLTRKSDVYSFGVLLLEIVSGRT 246
                  +   D +S GV   E + G+ 
Sbjct: 170 VLCRQGYSVAVDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 89.6 bits (222), Expect = 2e-20
 Identities = 67/215 (31%), Positives = 101/215 (46%), Gaps = 42/215 (19%)

Query: 50  IGEGGFGSVYKGRL---QDGT--IVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLV 103
           +GEG FG V         DGT  +VAVK L  E  +Q    +  E+  +  +   HEN+V
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLY--HENIV 69

Query: 104 KLHGGCIDGPCRIL-----------VYDYMPNN--SLSQTLLGEEKRRAKFGWKARREII 150
           K  G C +   + L           + DY+P +  +L+Q LL  ++              
Sbjct: 70  KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQ-------------- 115

Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG 210
             I  G+AY+H +   H +HRD+   N+LLD +   KI DFGL+K  PE   +   R  G
Sbjct: 116 --ICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG 170

Query: 211 T--LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
              + + A E     + +  SDV+SFGV L E+++
Sbjct: 171 DSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 88.8 bits (220), Expect = 2e-20
 Identities = 63/197 (31%), Positives = 101/197 (51%), Gaps = 13/197 (6%)

Query: 49  KIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG 108
           ++G G FG V  G+ +    VA+K++  E    E EF+ E   M  ++  HE LV+L+G 
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLS--HEKLVQLYGV 67

Query: 109 CIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHV 168
           C       +V +YM N  L    L E  +R  F      E+   +  G+AY+  +     
Sbjct: 68  CTKQRPIYIVTEYMSNGCL-LNYLREHGKR--FQPSQLLEMCKDVCEGMAYLESK---QF 121

Query: 169 VHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLGYLAPEYAISGRLT 226
           +HRD+   N L+D     K+SDFGLS+  L  E T+ + ++    + +  PE  +  + +
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFP--VRWSPPEVLLYSKFS 179

Query: 227 RKSDVYSFGVLLLEIVS 243
            KSDV++FGVL+ E+ S
Sbjct: 180 SKSDVWAFGVLMWEVYS 196

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 89.0 bits (221), Expect = 2e-20
 Identities = 66/211 (31%), Positives = 102/211 (48%), Gaps = 21/211 (9%)

Query: 48  NKIGEGGFGSVYKG--RLQDGTI----VAVKVL-SVESKQGEKEFMSEVASMANVNVCHE 100
             +G G FG VY+G  R +DG      VAVK L    S+Q E +F+ E   M+  N  H+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFN--HQ 69

Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM---GIGRGL 157
           N+V+L G   +   R ++ + M    L   L     R  +      ++++     + +G 
Sbjct: 70  NIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129

Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNP----KISDFGLSK-LFPENTTHISTRVAGTL 212
            Y+ E    H +HRDI   N LL     P    KI+DFG+++ ++  +      R    +
Sbjct: 130 KYLEEN---HFIHRDIAARNCLLTCK-GPGRVAKIADFGMARDIYRASYYRKGGRAMLPI 185

Query: 213 GYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
            ++ PE  + G  T K+DV+SFGVLL EI S
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 89.5 bits (222), Expect = 6e-20
 Identities = 69/208 (33%), Positives = 111/208 (53%), Gaps = 27/208 (12%)

Query: 48  NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQG-EKEFMSEVASMANVNVCHENLVKL 105
           N+IG G  G+VYK   +  G + A+KV+    +    ++   E+  + +VN  H N+VK 
Sbjct: 80  NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVN--HPNVVKC 137

Query: 106 HGGCID--GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
           H    D  G  ++L+ ++M   SL  T + +E+  A       R+I+ GI    AY+H  
Sbjct: 138 HD-MFDHNGEIQVLL-EFMDGGSLEGTHIADEQFLADVA----RQILSGI----AYLHRR 187

Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG 223
              H+VHRDIK SN+L++   N KI+DFG+S++  +     ++ V GT+ Y++PE  I+ 
Sbjct: 188 ---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPE-RINT 242

Query: 224 RLTR------KSDVYSFGVLLLEIVSGR 245
            L          D++S GV +LE   GR
Sbjct: 243 DLNHGAYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 88.0 bits (219), Expect = 8e-20
 Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 37/209 (17%)

Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLS----VESKQ-----GEKEFMSEVASMANVNVCH 99
           +G G FG V   R +  G   A+K+LS    V+ KQ      EK  +  +         H
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI--------RH 60

Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARR----EIIMGIGR 155
             LV L+G   D     LV +Y+P   L   L    ++  +F     R    ++++    
Sbjct: 61  PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL----RKSGRFPEPVARFYAAQVVLA--- 113

Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
            L Y+H      +V+RD+K  N+LLD +   KI+DFG +K     T  +     GT  YL
Sbjct: 114 -LEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC----GTPEYL 165

Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVSG 244
           APE  +S    +  D ++ G+L+ E+++G
Sbjct: 166 APEIILSKGYGKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 87.3 bits (217), Expect = 1e-19
 Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 15/204 (7%)

Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMS-EVASMANVNVCH-E 100
           F     IG+G FG VYK    +   +VA+KV+ +E  + E E +  E+  ++    C   
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQ---CRSP 59

Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
            + K +G  + G    ++ +Y    S    L     +  K        I+  +  GL Y+
Sbjct: 60  YITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-----KPGKLDETYIAFILREVLLGLEYL 114

Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
           HEE     +HRDIK +NILL +  + K++DFG+S       +  +T V GT  ++APE  
Sbjct: 115 HEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVI 170

Query: 221 ISGRLTRKSDVYSFGVLLLEIVSG 244
                  K+D++S G+  +E+  G
Sbjct: 171 KQSGYDEKADIWSLGITAIELAKG 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 87.0 bits (215), Expect = 1e-19
 Identities = 62/195 (31%), Positives = 98/195 (50%), Gaps = 9/195 (4%)

Query: 50  IGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLVKLHGG 108
           +G+G FG V+KG L+D T VAVK    +  Q  K +F+SE   +   +  H N+VKL G 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYD--HPNIVKLIGV 60

Query: 109 CIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHV 168
           C       +V + +P       L    K++ +   K   +  +    G+AY+  +   + 
Sbjct: 61  CTQRQPIYIVMELVPGGDFLSFL---RKKKDELKTKQLVKFALDAAAGMAYLESK---NC 114

Query: 169 VHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRK 228
           +HRD+   N L+ +N   KISDFG+S+   +     S      + + APE    GR + +
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSE 174

Query: 229 SDVYSFGVLLLEIVS 243
           SDV+S+G+LL E  S
Sbjct: 175 SDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 87.1 bits (216), Expect = 1e-19
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 12/206 (5%)

Query: 41  TNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSV----ESKQGEKEFMSEVASMANV 95
              F+   KIG+G F  VYK   L DG +VA+K + +    ++K  +   + E+  +  +
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQD-CLKEIDLLKQL 59

Query: 96  NVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR 155
           +  H N++K     I+     +V +      LS+ +   +K++     +   +  + +  
Sbjct: 60  D--HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS 117

Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
            L ++H +    ++HRDIK +N+ +      K+ D GL + F   TT   + V GT  Y+
Sbjct: 118 ALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYM 173

Query: 216 APEYAISGRLTRKSDVYSFGVLLLEI 241
           +PE         KSD++S G LL E+
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 87.2 bits (216), Expect = 1e-19
 Identities = 61/209 (29%), Positives = 104/209 (49%), Gaps = 20/209 (9%)

Query: 50  IGEGGFGSVYKGRL--QDGTI--VAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLV 103
           +GEG FGSV +G+L   DG+   VAVK + ++  +    +EF+SE A M + +  H N++
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFD--HPNVM 64

Query: 104 KLHGGCIDG------PCRILVYDYMPNNSLSQTLLGE--EKRRAKFGWKARREIIMGIGR 155
           KL G C +       P  +++  +M +  L   LL         K   +   + ++ I  
Sbjct: 65  KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124

Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT-LGY 214
           G+ Y+      + +HRD+   N +L ++    ++DFGLSK       +   R+A   + +
Sbjct: 125 GMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 181

Query: 215 LAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
           +A E       T KSDV++FGV + EI +
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIAT 210

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 87.0 bits (216), Expect = 2e-19
 Identities = 56/203 (27%), Positives = 89/203 (43%), Gaps = 17/203 (8%)

Query: 49  KIGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVC----HENLV 103
            +GEG +G V K R +  G IVA+K    + K+ E +   +  ++  V V     HEN+V
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIK----KFKESEDDEDVKKTALREVKVLRQLRHENIV 63

Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
            L           LV++Y+    L       E         A R  I  + + +AY H  
Sbjct: 64  NLKEAFRRKGRLYLVFEYVERTLLELL----EASPGGLPPDAVRSYIWQLLQAIAYCH-- 117

Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG 223
              +++HRDIK  NIL+ ++   K+ DFG ++          T    T  Y APE  +  
Sbjct: 118 -SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGD 176

Query: 224 RLTRKS-DVYSFGVLLLEIVSGR 245
               K  DV++ G ++ E++ G 
Sbjct: 177 TNYGKPVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 86.0 bits (213), Expect = 2e-19
 Identities = 64/227 (28%), Positives = 102/227 (44%), Gaps = 24/227 (10%)

Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG 108
           +G+G +G VY  R L     +A+K +     +  +    E+A   +  + H N+V+  G 
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIA--LHSYLKHRNIVQYLGS 73

Query: 109 CIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG-----IGRGLAYIHEE 163
             +     +  + +P  SLS  L      R+K+G     E  +      I  GL Y+H+ 
Sbjct: 74  DSENGFFKIFMEQVPGGSLSALL------RSKWGPLKDNEQTIIFYTKQILEGLKYLHDN 127

Query: 164 IQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS 222
               +VHRDIK  N+L++      KISDFG SK          T   GTL Y+APE    
Sbjct: 128 ---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET-FTGTLQYMAPEVIDK 183

Query: 223 GR--LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMY 267
           G       +D++S G  ++E+ +G+      ++LGE        GM+
Sbjct: 184 GPRGYGAPADIWSLGCTIVEMATGKPPF---IELGEPQAAMFKVGMF 227

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 86.6 bits (214), Expect = 3e-19
 Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 32/228 (14%)

Query: 42  NGFRWSNKIGEGGFGSVY----KGRL---------QDG--TIVAVKVLSVE-SKQGEKEF 85
              R   K+GEG FG V+    +G            DG   +VAVK+L  + +K    +F
Sbjct: 5   QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDF 64

Query: 86  MSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKA 145
           + E+  M+ +   + N+++L G C+      ++ +YM N  L+Q  L + +  + F    
Sbjct: 65  LKEIKIMSRLK--NPNIIRLLGVCVSDDPLCMITEYMENGDLNQ-FLSQREIESTF---T 118

Query: 146 RREIIMGIGRG-LAYIHEEIQP--------HVVHRDIKTSNILLDQNFNPKISDFGLSK- 195
               I  +    L Y+  +I          + VHRD+ T N L+  ++  KI+DFG+S+ 
Sbjct: 119 HANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRN 178

Query: 196 LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
           L+  +   I  R    + ++A E  + G+ T  SDV++FGV L E+ +
Sbjct: 179 LYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 86.6 bits (214), Expect = 3e-19
 Identities = 69/222 (31%), Positives = 104/222 (46%), Gaps = 33/222 (14%)

Query: 50  IGEGGFGSVYKGR------LQDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHENL 102
           +GEG FG V K            T VAVK+L   +   E ++ +SE   +  VN  H ++
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVN--HPHV 65

Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTL----------LGEEKRRAKFGWKA--RREII 150
           +KL+G C      +L+ +Y    SL   L          LG +  R          R + 
Sbjct: 66  IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125

Query: 151 MG--------IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 202
           MG        I RG+ Y+ E     +VHRD+   N+L+ +    KISDFGLS+   E  +
Sbjct: 126 MGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182

Query: 203 HIS-TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
           ++  ++    + ++A E       T +SDV+SFGVLL EIV+
Sbjct: 183 YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 85.8 bits (213), Expect = 3e-19
 Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 42/217 (19%)

Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLS---------VESKQGEKEFMSEVASMANVNVCH 99
           I +G +G V+  +    G I A+KV+          V+    E++ +S+  S        
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQS-------- 52

Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTL-----LGEEKRRAKFGWKARREIIMGIG 154
             +VKL+          LV +Y+P   L+  L     L E+  R         EI++   
Sbjct: 53  PYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIA-----EIVLA-- 105

Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-------LFPENTTHISTR 207
             L Y+H      ++HRD+K  NIL+D N + K++DFGLSK       +   +      R
Sbjct: 106 --LEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160

Query: 208 VAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
           + GT  Y+APE  +    ++  D +S G +L E + G
Sbjct: 161 IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 85.6 bits (212), Expect = 4e-19
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 15/199 (7%)

Query: 50  IGEGGFGSVYK-GRLQDGTIVAVKVLSVESKQG-EKEFMSEVASMANVNVCH-ENLVKLH 106
           +G G  GSV K   +  GT++A KV+ + +K    K+ + E+  M     C    +V  +
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHE---CRSPYIVSFY 69

Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
           G  ++     +  ++M   SL +      K+      +   +I + +  GL Y++     
Sbjct: 70  GAFLNENNICMCMEFMDCGSLDRIY----KKGGPIPVEILGKIAVAVVEGLTYLYNVH-- 123

Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLT 226
            ++HRDIK SNIL++     K+ DFG+S    E    I+    GT  Y++PE    G+ T
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKLCDFGVSG---ELINSIADTFVGTSTYMSPERIQGGKYT 180

Query: 227 RKSDVYSFGVLLLEIVSGR 245
            KSDV+S G+ ++E+  G+
Sbjct: 181 VKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 85.0 bits (210), Expect = 5e-19
 Identities = 63/198 (31%), Positives = 98/198 (49%), Gaps = 16/198 (8%)

Query: 49  KIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG 108
            IGEG FG+V +G    G  VAVK +  +     + F+ E A M  ++  H+NLV+L G 
Sbjct: 13  IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTA--QAFLEETAVMTKLH--HKNLVRLLGV 67

Query: 109 CIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHV 168
            +     I V + M   +L   L    + RA        +  + +  G+ Y+  +    +
Sbjct: 68  ILHNGLYI-VMELMSKGNLVNFL--RTRGRALVSVIQLLQFSLDVAEGMEYLESK---KL 121

Query: 169 VHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRK 228
           VHRD+   NIL+ ++   K+SDFGL+++      +    V  T    APE     + + K
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEALKHKKFSSK 177

Query: 229 SDVYSFGVLLLEIVS-GR 245
           SDV+S+GVLL E+ S GR
Sbjct: 178 SDVWSYGVLLWEVFSYGR 195

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 87.6 bits (217), Expect = 5e-19
 Identities = 95/332 (28%), Positives = 144/332 (43%), Gaps = 48/332 (14%)

Query: 50  IGEGGFGSV-YKGRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNV-----CHEN 101
           +G G  G+V    R+ DG   AVKV+ +E  S+  +    +EV  + N +      CHE+
Sbjct: 40  LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHED 99

Query: 102 LVKLHGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIG--RGLA 158
             K      +    I LV DY     L Q    E K RAK   +  RE   G+   + L 
Sbjct: 100 FAKKDPRNPENVLMIALVLDYANAGDLRQ----EIKSRAKTN-RTFREHEAGLLFIQVLL 154

Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAP 217
            +H     H++HRDIK++NILL  N   K+ DFG SK++    +  +     GT  Y+AP
Sbjct: 155 AVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAP 214

Query: 218 EYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD 277
           E       ++K+D++S GVLL E+++ +   D     GE           N +E+M+   
Sbjct: 215 EIWRRKPYSKKADMFSLGVLLYELLTLKRPFD-----GE-----------NMEEVMHKTL 258

Query: 278 PMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNIDGXDVEI--SQPGL 335
              Y   P + +    ++    +    K RP  S  + M   +  I G  +EI  +QPG 
Sbjct: 259 AGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFISGL-LEIVQTQPGF 317

Query: 336 IG--------DIMDVK----VGQRSSSKSMTE 355
            G         I   K    V +R   + M E
Sbjct: 318 SGPLRDTISRQIQQTKQLLQVERRRIVRQMEE 349

Length = 496

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 85.9 bits (213), Expect = 5e-19
 Identities = 62/223 (27%), Positives = 105/223 (47%), Gaps = 35/223 (15%)

Query: 49  KIGEGGFGSVY------------KGRLQDG-----TIVAVKVLSV-ESKQGEKEFMSEVA 90
           K+GEG FG V+            K   ++       +VAVKVL    S    ++F+ EV 
Sbjct: 12  KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71

Query: 91  SMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 150
            ++ ++    N+ +L G C   P   ++ +YM N  L+Q L     ++            
Sbjct: 72  ILSRLS--DPNIARLLGVCTVDPPLCMIMEYMENGDLNQFL-----QKHVAETSGLACNS 124

Query: 151 MGIGRG-LAYIHEEI--------QPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPEN 200
             +    L Y+  +I          + VHRD+ T N L+ +N+  KI+DFG+S+ L+  +
Sbjct: 125 KSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSD 184

Query: 201 TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
              +  R    + ++A E  + G+ T KSDV++FGV L EI++
Sbjct: 185 YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 85.1 bits (211), Expect = 9e-19
 Identities = 61/208 (29%), Positives = 110/208 (52%), Gaps = 24/208 (11%)

Query: 48  NKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANV----NVCHENL 102
           N+IGEG +G VY+ R    G IVA+K + +++   E++ +  ++S+  +    N+ H N+
Sbjct: 13  NRIGEGTYGIVYRARDTTSGEIVALKKVRMDN---ERDGIP-ISSLREITLLLNLRHPNI 68

Query: 103 VKLH----GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
           V+L     G  +D     LV +Y   + L+  L   +     F     + +++ + RGL 
Sbjct: 69  VELKEVVVGKHLDSI--FLVMEYCEQD-LASLL---DNMPTPFSESQVKCLMLQLLRGLQ 122

Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE 218
           Y+HE     ++HRD+K SN+LL      KI+DFGL++ +      ++ +V  TL Y APE
Sbjct: 123 YLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAPE 178

Query: 219 YAI-SGRLTRKSDVYSFGVLLLEIVSGR 245
             +     T   D+++ G +L E+++ +
Sbjct: 179 LLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 84.8 bits (210), Expect = 1e-18
 Identities = 66/209 (31%), Positives = 114/209 (54%), Gaps = 29/209 (13%)

Query: 49  KIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEF-MSEVASMANVNVCHENLVKLH 106
           K+GEG + +VYKGR +  G IVA+K + +++++G     + E++ M  +   HEN+V+LH
Sbjct: 7   KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELK--HENIVRLH 64

Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRA-------KFGWKARREIIMGIGRGLAY 159
                    +LV++YM +  L + +     R A        F ++        + +G+A+
Sbjct: 65  DVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQ--------LLKGIAF 115

Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PENTTHISTRVAGTLGYLAP 217
            HE     V+HRD+K  N+L+++    K++DFGL++ F  P NT   S  V  TL Y AP
Sbjct: 116 CHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT--FSNEVV-TLWYRAP 169

Query: 218 EYAISGRLTRKS-DVYSFGVLLLEIVSGR 245
           +  +  R    S D++S G ++ E+++GR
Sbjct: 170 DVLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 84.5 bits (210), Expect = 1e-18
 Identities = 55/217 (25%), Positives = 98/217 (45%), Gaps = 41/217 (18%)

Query: 48  NKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKE-----------FMSEVASMANV 95
            K+GEG +  VYK R  + G IVA+K + +  ++  K+            + E+      
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK----- 60

Query: 96  NVCHENLVKL-----HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 150
              H N++ L     H   I+     LV+++M  + L + +    K ++     A  +  
Sbjct: 61  ---HPNIIGLLDVFGHKSNIN-----LVFEFMETD-LEKVI----KDKSIVLTPADIKSY 107

Query: 151 MG-IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVA 209
           M    RGL Y+H      ++HRD+K +N+L+  +   K++DFGL++ F      ++ +V 
Sbjct: 108 MLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV 164

Query: 210 GTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGR 245
            T  Y APE     R      D++S G +  E++   
Sbjct: 165 -TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 84.6 bits (209), Expect = 2e-18
 Identities = 63/237 (26%), Positives = 107/237 (45%), Gaps = 45/237 (18%)

Query: 44  FRWSNKIGEGGFGSVY--------------------KGRLQDGTIVAVKVLSVE-SKQGE 82
             +  K+GEG FG V+                    KGR     +VAVK+L  + +K   
Sbjct: 7   LLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGR---PLLVAVKILRPDANKNAR 63

Query: 83  KEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTL----------- 131
            +F+ EV  ++ +     N+++L G C+D     ++ +YM N  L+Q L           
Sbjct: 64  NDFLKEVKILSRLK--DPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEEN 121

Query: 132 ----LGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPK 187
               +          + +   + + I  G+ Y+      + VHRD+ T N L+ +N   K
Sbjct: 122 GNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVHRDLATRNCLVGENLTIK 178

Query: 188 ISDFGLSK-LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
           I+DFG+S+ L+  +   I  R    + ++A E  + G+ T  SDV++FGV L EI+ 
Sbjct: 179 IADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 83.4 bits (206), Expect = 2e-18
 Identities = 57/208 (27%), Positives = 104/208 (50%), Gaps = 22/208 (10%)

Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLS-VESKQGEKE-----FMSEVASMANVNVCHENL 102
           +G G F S Y+ R ++ GT++AVK ++ V +   E+E        E+  MA +N  H ++
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN--HPHI 65

Query: 103 VKLHGG-CIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
           +++ G  C D    + V ++M   S+S  L     +   F           + RGL+Y+H
Sbjct: 66  IRMLGATCEDSHFNLFV-EWMAGGSVSHLL----SKYGAFKEAVIINYTEQLLRGLSYLH 120

Query: 162 EEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLFPENTT---HISTRVAGTLGYLAP 217
           E     ++HRD+K +N+L+D      +I+DFG +       T       ++ GT+ ++AP
Sbjct: 121 EN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAP 177

Query: 218 EYAISGRLTRKSDVYSFGVLLLEIVSGR 245
           E     +  R  DV+S G +++E+ + +
Sbjct: 178 EVLRGEQYGRSCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 83.4 bits (206), Expect = 2e-18
 Identities = 60/209 (28%), Positives = 102/209 (48%), Gaps = 20/209 (9%)

Query: 48  NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQ---GEKEF---MSEVASMANVNVCHEN 101
             +G+G +G+VY G    G ++AVK + +++      EKE+     EV  + ++   H N
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK--HVN 63

Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
           +V+  G C+D     +  +++P  S+S  L     R          +    I  G+AY+H
Sbjct: 64  IVQYLGTCLDDNTISIFMEFVPGGSISSIL----NRFGPLPEPVFCKYTKQILDGVAYLH 119

Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK---LFPENTTH--ISTRVAGTLGYLA 216
                 VVHRDIK +N++L  N   K+ DFG ++       + TH  +   + GT  ++A
Sbjct: 120 NN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176

Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
           PE        RKSD++S G  + E+ +G+
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 83.6 bits (207), Expect = 3e-18
 Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 40/216 (18%)

Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHENLVKLHG 107
           IG G FG+V K   +  GTI+AVK +     + E K  + ++  +   + C   +VK +G
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDC-PYIVKFYG 70

Query: 108 GCI-DGPCRI--------------LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG 152
               +G C I               VY+ +  + + + +LG+              I + 
Sbjct: 71  ALFREGDCWICMELMDISLDKFYKYVYEVL-KSVIPEEILGK--------------IAVA 115

Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL 212
             + L Y+ EE+   ++HRD+K SNILLD+N N K+ DFG+S    ++     TR AG  
Sbjct: 116 TVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA--KTRDAGCR 171

Query: 213 GYLAPEYAISGRLTR---KSDVYSFGVLLLEIVSGR 245
            Y+APE            +SDV+S G+ L E+ +G+
Sbjct: 172 PYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 82.9 bits (205), Expect = 3e-18
 Identities = 68/210 (32%), Positives = 103/210 (49%), Gaps = 33/210 (15%)

Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMAN-----VNVCHENLV 103
           +G+G FG VY     D G  +AVK   V       E   EV ++        N+ HE +V
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVK--QVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67

Query: 104 KLHGGCIDGPCRILVY-DYMPNNSLSQTL-----LGEEKRRAKFGWKARREIIMGIGRGL 157
           + +G C+     + ++ +YMP  S+   L     L E   R     K  R+I+     G+
Sbjct: 68  QYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTR-----KYTRQIL----EGV 117

Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE---NTTHISTRVAGTLGY 214
            Y+H      +VHRDIK +NIL D   N K+ DFG SK       + T + + V GT  +
Sbjct: 118 EYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-VTGTPYW 173

Query: 215 LAPEYAISGR-LTRKSDVYSFGVLLLEIVS 243
           ++PE  ISG    RK+DV+S G  ++E+++
Sbjct: 174 MSPE-VISGEGYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 83.1 bits (206), Expect = 4e-18
 Identities = 65/218 (29%), Positives = 102/218 (46%), Gaps = 47/218 (21%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKE-----FMSEVASMANVNVCHENL 102
           KIGEG +G VYK R    G IVA+K + +E+   E E      + E++ +  +N  H N+
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLET---EDEGVPSTAIREISLLKELN--HPNI 60

Query: 103 VKLHGGCIDGPCRILVYDYM-----------PNNSLSQTLLGEEKRRAKFGWKARREIIM 151
           V+L           LV++++           P   L   L+              +  + 
Sbjct: 61  VRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLI--------------KSYLY 106

Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PENT-THISTRV 208
            + +G+AY H      V+HRD+K  N+L+D+    K++DFGL++ F  P  T TH    V
Sbjct: 107 QLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH---EV 160

Query: 209 AGTLGYLAPEYAISGRLTRKS-DVYSFGVLLLEIVSGR 245
             TL Y APE  +  R      D++S G +  E+V+ R
Sbjct: 161 V-TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 82.5 bits (204), Expect = 7e-18
 Identities = 68/236 (28%), Positives = 113/236 (47%), Gaps = 31/236 (13%)

Query: 48  NKIGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKE-----FMSEVASMANVNVCHEN 101
            +IGEG +G VYK R +D G +VA+K + +++   EKE      + E+  +  +N  H N
Sbjct: 13  GQIGEGTYGQVYKARDKDTGELVALKKVRLDN---EKEGFPITAIREIKILRQLN--HRN 67

Query: 102 LVKLHGGCIDGPCRI----------LVYDYMPNNSLSQTLLG-EEKRRAKFGWKARREII 150
           +V L     D    +          LV++YM ++     L+G  E     F     +  +
Sbjct: 68  IVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHD-----LMGLLESGLVHFSEDHIKSFM 122

Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG 210
             +  GL Y H++   + +HRDIK SNILL+     K++DFGL++L+    +   T    
Sbjct: 123 KQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI 179

Query: 211 TLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG 265
           TL Y  PE  +   R     DV+S G +L E+ + +     + +L +  L+ +  G
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCG 235

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 82.0 bits (202), Expect = 8e-18
 Identities = 64/217 (29%), Positives = 109/217 (50%), Gaps = 30/217 (13%)

Query: 50  IGEGGFGSVYKGRL-QDGTI--VAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVK 104
           +GEG FGSV +G+L QD +I  VAVK + +   ++   ++F+SE   M   +  H N+++
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFD--HPNVMR 64

Query: 105 LHGGCIDG------PCRILVYDYMPNNSLSQTLLGEEKRRAKFG-------WKARREIIM 151
           L G C+        P  +++  +M +  L   LL      ++ G        +   + + 
Sbjct: 65  LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLL-----YSRLGDCPQYLPTQMLVKFMT 119

Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT 211
            I  G+ Y+  +     +HRD+   N +L++N N  ++DFGLSK       +   R+A  
Sbjct: 120 DIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM 176

Query: 212 -LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRT 246
            + ++A E       T KSDV+SFGV + EI + G+T
Sbjct: 177 PVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQT 213

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 81.7 bits (202), Expect = 1e-17
 Identities = 54/212 (25%), Positives = 89/212 (41%), Gaps = 29/212 (13%)

Query: 50  IGEGGFGSVYKGRLQ------DGTIVAVKVL-SVESKQGEKEFMSEVASMANVNVCHENL 102
           +G G FG V+  + +        T+V VK L   + +  + EF  E+     ++  H+N+
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLS--HKNV 70

Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGW-----KARREIIMGIGRGL 157
           V+L G C +     ++ +Y     L Q L   + +  K        K +  +   I  G+
Sbjct: 71  VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130

Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK------LFPENTTHISTRVAGT 211
            ++        VHRD+   N L+      K+S   LSK       +      I  R    
Sbjct: 131 DHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLR---- 183

Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
             +LAPE       + KSDV+SFGVL+ E+ +
Sbjct: 184 --WLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 80.7 bits (200), Expect = 2e-17
 Identities = 62/207 (29%), Positives = 93/207 (44%), Gaps = 29/207 (14%)

Query: 50  IGEGGFGSVYKGRLQ-DGTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G GGFG V   +++      A+K +     VE+ Q ++   SE   +   N  H  +VK
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQ-QEHIFSEKEILEECN--HPFIVK 57

Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEE-----KRRAKFGWKARREIIMGIGRGLAY 159
           L+    D       Y YM    L +  LG E     + R  F     R  I  +     Y
Sbjct: 58  LYRTFKDKK-----YIYM----LMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEY 108

Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTHISTRVAGTLGYLAPE 218
           +H      +++RD+K  N+LLD N   K+ DFG +K L     T   T   GT  Y+APE
Sbjct: 109 LHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW--TFC-GTPEYVAPE 162

Query: 219 YAISGRLTRKSDVYSFGVLLLEIVSGR 245
             ++       D +S G+LL E+++GR
Sbjct: 163 IILNKGYDFSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 80.2 bits (198), Expect = 3e-17
 Identities = 51/205 (24%), Positives = 103/205 (50%), Gaps = 15/205 (7%)

Query: 50  IGEGGFGSVYKGRLQDG--TIVAVKVLSV---ESKQGEKEFMSEVASMAN-VNVC----- 98
           +G G FG VYK R ++    ++A+K ++V      + ++E    +  + + V +      
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 99  HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
           H N+V+ +   ++     +V D +    L +     ++++ +F  +    I + +   L 
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127

Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE 218
           Y+H+E +  +VHRD+  +NI+L ++    I+DFGL+K     +    T V GT+ Y  PE
Sbjct: 128 YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK--LTSVVGTILYSCPE 183

Query: 219 YAISGRLTRKSDVYSFGVLLLEIVS 243
              +     K+DV++FG +L ++ +
Sbjct: 184 IVKNEPYGEKADVWAFGCILYQMCT 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 80.4 bits (199), Expect = 3e-17
 Identities = 68/218 (31%), Positives = 102/218 (46%), Gaps = 40/218 (18%)

Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC-----HENLV 103
           IGEG +G VYK R  + G +VA+K++ +   + E+E   E       N+      H N+ 
Sbjct: 14  IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEY------NILRKYSNHPNIA 66

Query: 104 KLHGGCIDGPCRI------LVYDYMPNNS---LSQTLLGEEKRRAKFGWKARREIIMGIG 154
             +G  I            LV +     S   L + L  ++ +R K  W A   I+    
Sbjct: 67  TFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLR-KKGKRLKEEWIAY--ILRETL 123

Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR--VAGTL 212
           RGLAY+HE     V+HRDIK  NILL +N   K+ DFG+S    +  + +  R    GT 
Sbjct: 124 RGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA---QLDSTLGRRNTFIGTP 177

Query: 213 GYLAPEYAISGRLTR------KSDVYSFGVLLLEIVSG 244
            ++APE  I+           +SDV+S G+  +E+  G
Sbjct: 178 YWMAPE-VIACDEQPDASYDARSDVWSLGITAIELADG 214

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 80.4 bits (198), Expect = 3e-17
 Identities = 76/284 (26%), Positives = 131/284 (46%), Gaps = 36/284 (12%)

Query: 49  KIGEGGFGSVYKGRLQD------GTIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHEN 101
           ++G+G FG VY+G  +D       T VAVK ++  +   E+ EF++E + M     CH +
Sbjct: 13  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFT-CH-H 70

Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLG----EEKRRAKFGWKARREIIMG--IGR 155
           +V+L G    G   ++V + M +  L   L       E    +     +  I M   I  
Sbjct: 71  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 130

Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL--G 213
           G+AY++ +     VHRD+   N ++  +F  KI DFG+++   E T +      G L   
Sbjct: 131 GMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE-TDYYRKGGKGLLPVR 186

Query: 214 YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELM 273
           ++APE    G  T  SD++SFGV+L EI S               L ++ +   ++++++
Sbjct: 187 WMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVL 231

Query: 274 NLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMM 317
             V    Y + P+N   R   +  +C Q   K+RP     + ++
Sbjct: 232 KFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 80.4 bits (198), Expect = 3e-17
 Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 18/204 (8%)

Query: 50  IGEGGFGSVYKGRL-----QDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHENLV 103
           +GEG FG V   R        G  VAVK L  ES      +   E+  + N+   HEN+V
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY--HENIV 69

Query: 104 KLHGGCIDGPCR--ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
           K  G C +       L+ +++P+ SL + L    + + K   K + +  + I +G+ Y+ 
Sbjct: 70  KYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PRNKNKINLKQQLKYAVQICKGMDYLG 126

Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR--VAGTLGYLAPEY 219
                  VHRD+   N+L++     KI DFGL+K    +  + + +  +   + + APE 
Sbjct: 127 SR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPEC 183

Query: 220 AISGRLTRKSDVYSFGVLLLEIVS 243
            I  +    SDV+SFGV L E+++
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 79.6 bits (196), Expect = 5e-17
 Identities = 61/198 (30%), Positives = 103/198 (52%), Gaps = 16/198 (8%)

Query: 50  IGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGC 109
           IG+G FG V  G  + G  VAVK   +++    + F++E + M  +   H NLV+L G  
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLR--HSNLVQLLGVI 68

Query: 110 IDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHV 168
           ++    + +V +YM   SL   L    + R+  G     +  + +   + Y+      + 
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NF 123

Query: 169 VHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRK 228
           VHRD+   N+L+ ++   K+SDFGL+K    ++T  + ++   + + APE     + + K
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKKFSTK 179

Query: 229 SDVYSFGVLLLEIVS-GR 245
           SDV+SFG+LL EI S GR
Sbjct: 180 SDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 79.9 bits (197), Expect = 5e-17
 Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 39/214 (18%)

Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLS---VESKQGEKEFMSEVASMANVN----VC--- 98
           +G+GGFG V   +++  G + A K L    ++ ++GE+  ++E   +  V+    V    
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 99  -HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTL-----LGEEKRRAKFGWKARREIIMG 152
             E    L        C  LV   M    L   +      G  + RA F + A  +II G
Sbjct: 61  AFETKDDL--------C--LVMTLMNGGDLKYHIYNVGEPGFPEARAIF-YAA--QIICG 107

Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL 212
               L ++H+     +V+RD+K  N+LLD + N +ISD GL+              AGT 
Sbjct: 108 ----LEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTP 158

Query: 213 GYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT 246
           GY+APE           D ++ G  L E+++GR+
Sbjct: 159 GYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRS 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 79.6 bits (196), Expect = 5e-17
 Identities = 54/199 (27%), Positives = 101/199 (50%), Gaps = 12/199 (6%)

Query: 50  IGEGGFGSVYKG-RLQDGTIVAVKVL--SVESKQGEKEFMSEVASMANV-NVCHENLVKL 105
           +G G FG+V+KG  + +G  + + V   +++ + G + F      M  + ++ H  +V+L
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
            G C  G    LV    P  SL   +    + R     +      + I +G+ Y+ E   
Sbjct: 75  LGIC-PGASLQLVTQLSPLGSLLDHV---RQHRDSLDPQRLLNWCVQIAKGMYYLEEH-- 128

Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKL-FPENTTHISTRVAGTLGYLAPEYAISGR 224
             +VHR++   NILL  +   +I+DFG++ L +P++  +  +     + ++A E  + GR
Sbjct: 129 -RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGR 187

Query: 225 LTRKSDVYSFGVLLLEIVS 243
            T +SDV+S+GV + E++S
Sbjct: 188 YTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 79.1 bits (195), Expect = 6e-17
 Identities = 63/261 (24%), Positives = 116/261 (44%), Gaps = 26/261 (9%)

Query: 49  KIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG 108
           ++G G FG V+ G+ +    VA+K ++ E    E++F+ E   M  + + H  LV+L+G 
Sbjct: 11  ELGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVM--MKLSHPKLVQLYGV 67

Query: 109 CIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHV 168
           C       +V ++M N  L   L    +R+ K        +   +  G+ Y+    +   
Sbjct: 68  CTQQKPLYIVTEFMENGCLLNYL---RQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSF 121

Query: 169 VHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRK 228
           +HRD+   N L+      K+SDFG+++   ++    S+     + +  PE     + + K
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181

Query: 229 SDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPEN 287
           SDV+SFGVL+ E+ + G+   +         ++ + + +Y  K    L    +Y      
Sbjct: 182 SDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPK----LASMTVY------ 231

Query: 288 EAIRFLKVGLLCVQEKSKLRP 308
                 +V   C  EK + RP
Sbjct: 232 ------EVMYSCWHEKPEGRP 246

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 79.2 bits (196), Expect = 7e-17
 Identities = 64/215 (29%), Positives = 108/215 (50%), Gaps = 39/215 (18%)

Query: 47  SNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVE-SKQGEKEFM-SEVASMANVNVC-HENL 102
             +IGEG +G+VYK R L  G  VA+K + V  S++G       E+A +  +    H N+
Sbjct: 4   LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNI 63

Query: 103 VKL----HGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFG---WKARREIIMGIG 154
           V+L    HG   D   ++ LV++++ +  L+  L     +  K G      +  ++  + 
Sbjct: 64  VRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYL----SKCPKPGLPPETIKD-LMRQLL 117

Query: 155 RGLAYIHEEIQPH-VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS-TRVAGTL 212
           RG+ ++H     H +VHRD+K  NIL+  +   KI+DFGL++++   +  ++ T V  TL
Sbjct: 118 RGVDFLHS----HRIVHRDLKPQNILVTSDGQVKIADFGLARIY---SFEMALTSVVVTL 170

Query: 213 GYLAPE------YAISGRLTRKSDVYSFGVLLLEI 241
            Y APE      YA         D++S G +  E+
Sbjct: 171 WYRAPEVLLQSSYATP------VDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 78.7 bits (194), Expect = 8e-17
 Identities = 53/204 (25%), Positives = 103/204 (50%), Gaps = 13/204 (6%)

Query: 50  IGEGGFGSVYK-GRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLH 106
           +G G FG V+   R  D  +V +K + VE  +K       +E   +  ++  H N+++ +
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLS--HPNIIEYY 65

Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
              ++    ++V +Y P  +L++ +  +++  +           + I   L ++H     
Sbjct: 66  ENFLEDKALMIVMEYAPGGTLAEYI--QKRCNSLLDEDTILHFFVQILLALHHVH---TK 120

Query: 167 HVVHRDIKTSNILLDQNFNP-KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL 225
            ++HRD+KT NILLD++    KI DFG+SK+   ++   +  V GT  Y++PE       
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKIL--SSKSKAYTVVGTPCYISPELCEGKPY 178

Query: 226 TRKSDVYSFGVLLLEIVSGRTAVD 249
            +KSD+++ G +L E+ S + A +
Sbjct: 179 NQKSDIWALGCVLYELASLKRAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 78.5 bits (193), Expect = 1e-16
 Identities = 59/201 (29%), Positives = 103/201 (51%), Gaps = 15/201 (7%)

Query: 49  KIGEGGFGSVYKG--RLQDGTI-VAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLVK 104
           ++G G FG V KG  +++   I VA+KVL  E+++  + E M E   M  ++  +  +V+
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLD--NPYIVR 59

Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           + G C +    +LV +      L++ L G   ++ +       E++  +  G+ Y+  + 
Sbjct: 60  MIGVC-EAEALMLVMEMASGGPLNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGK- 114

Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT--LGYLAPEYAIS 222
             + VHRD+   N+LL      KISDFGLSK    + ++   R AG   L + APE    
Sbjct: 115 --NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF 172

Query: 223 GRLTRKSDVYSFGVLLLEIVS 243
            + + +SDV+S+G+ + E  S
Sbjct: 173 RKFSSRSDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 78.5 bits (193), Expect = 1e-16
 Identities = 68/213 (31%), Positives = 104/213 (48%), Gaps = 21/213 (9%)

Query: 44  FRWSNKIGEGGFGSVYKGRLQD-GTIVAVKVLSV--ESKQGEKEFMS-EVASMANVNVCH 99
           +R    +G+G FG VY     D G  +AVK +    ES +  KE  + E       N+ H
Sbjct: 4   WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63

Query: 100 ENLVKLHGGCIDGPCRIL--VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
           E +V+ +G   D   R L    ++MP  S+   L            K  R+I+     G+
Sbjct: 64  ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL----EGV 119

Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS----TRVAGTLG 213
           +Y+H  +   +VHRDIK +NIL D   N K+ DFG SK     T  +S      V GT  
Sbjct: 120 SYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRL--QTICLSGTGMKSVTGTPY 174

Query: 214 YLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGR 245
           +++PE  ISG    RK+D++S G  ++E+++ +
Sbjct: 175 WMSPE-VISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 79.2 bits (195), Expect = 1e-16
 Identities = 61/221 (27%), Positives = 105/221 (47%), Gaps = 31/221 (14%)

Query: 49  KIGEGGFGSVY----KGRLQ-------------DGTIVAVKVLSVES-KQGEKEFMSEVA 90
           K+GEG FG V+    +G  +                +VAVK+L  ++ K    +F+ E+ 
Sbjct: 12  KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71

Query: 91  SMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKAR---- 146
            M+ +     N+++L   CI      ++ +YM N  L+Q L   E + A           
Sbjct: 72  IMSRLK--DPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISY 129

Query: 147 ---REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTT 202
                +   I  G+ Y+      + VHRD+ T N L+ +N+  KI+DFG+S+ L+  +  
Sbjct: 130 STLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYY 186

Query: 203 HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
            I  R    + +++ E  + G+ T  SDV++FGV L EI++
Sbjct: 187 RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 79.0 bits (195), Expect = 1e-16
 Identities = 62/205 (30%), Positives = 105/205 (51%), Gaps = 18/205 (8%)

Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVL--SVESKQGEKEFMSEVASMANVNVCHENLVKLH 106
           +G G +G V K R +  GTI+AVK +  +V S++ ++  M    SM +V       V  +
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSV--DCPYTVTFY 66

Query: 107 GGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
           G    +G   I + + M + SL +       +          +I + I + L Y+H ++ 
Sbjct: 67  GALFREGDVWICM-EVM-DTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL- 123

Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL 225
             V+HRD+K SN+L+++N   K+ DFG+S    ++     T  AG   Y+APE  I+  L
Sbjct: 124 -SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA--KTIDAGCKPYMAPE-RINPEL 179

Query: 226 TR-----KSDVYSFGVLLLEIVSGR 245
            +     KSDV+S G+ ++E+ +GR
Sbjct: 180 NQKGYDVKSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 78.7 bits (194), Expect = 1e-16
 Identities = 59/221 (26%), Positives = 112/221 (50%), Gaps = 31/221 (14%)

Query: 44  FRW--SNKIGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGEKE----------FMSEVA 90
           F+W     IG+G +G VY    +  G ++AVK + + +    +             SE+ 
Sbjct: 1   FKWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIE 60

Query: 91  SMANVNVCHENLVKLHGGCIDGPCRILVY-DYMPNNSLSQTLLGEEKRRAKFGWKARREI 149
           ++ +++  H N+V+ + G       + ++ +Y+P  S+   L    +   +F  +  R  
Sbjct: 61  TLKDLD--HLNIVQ-YLGFETTEEYLSIFLEYVPGGSIGSCL----RTYGRFEEQLVRFF 113

Query: 150 IMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE---NTTHIST 206
              +  GLAY+H +    ++HRD+K  N+L+D +   KISDFG+SK   +   N  ++S 
Sbjct: 114 TEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSM 170

Query: 207 RVAGTLGYLAPEYAISGR--LTRKSDVYSFGVLLLEIVSGR 245
           +  G++ ++APE   S     + K D++S G ++LE+ +GR
Sbjct: 171 Q--GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 78.5 bits (193), Expect = 1e-16
 Identities = 69/286 (24%), Positives = 125/286 (43%), Gaps = 42/286 (14%)

Query: 45  RWSNKIGEGGFGSVYKGRL-----QDGTIVAVKVLS-VESKQGEKEFMSEVASMANVNVC 98
           R+  ++GE  FG +YKG L         +VA+K L  + + Q   EF  E + MA ++  
Sbjct: 8   RFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELH-- 65

Query: 99  HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARRE---------- 148
           H N+V L G         ++++Y+    L + L+      +  G  +  +          
Sbjct: 66  HPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPH-SDVGCSSDEDGTVKSSLDHG 124

Query: 149 ----IIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTH 203
               I + I  G+ Y+        VH+D+   NIL+ +  + KISD GLS+ ++  +   
Sbjct: 125 DFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYR 181

Query: 204 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKA 263
           +  +    + ++ PE  + G+ +  SD++SFGV+L EI        F   L  Y+     
Sbjct: 182 VQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEI--------FSFGLQPYY----- 228

Query: 264 WGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQ 309
              ++++E++ +V         E+   R   +   C QE    RP+
Sbjct: 229 --GFSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPR 272

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 78.5 bits (193), Expect = 1e-16
 Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 10/204 (4%)

Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVK---VLSVESKQGEKEFMSEVASMANVNVCH 99
           FR   KIG G F  VY+   L DG  VA+K   +  +   +   + + E+  +  +N  H
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN--H 61

Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
            N++K +   I+     +V +      LS+ +   +K++     K   +  + +   L +
Sbjct: 62  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121

Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEY 219
           +H      V+HRDIK +N+ +      K+ D GL + F   TT   + V GT  Y++PE 
Sbjct: 122 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 177

Query: 220 AISGRLTRKSDVYSFGVLLLEIVS 243
                   KSD++S G LL E+ +
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAA 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 77.9 bits (192), Expect = 2e-16
 Identities = 62/210 (29%), Positives = 103/210 (49%), Gaps = 31/210 (14%)

Query: 50  IGEGGFGSVYKGRLQDG----TIVAVKVLS-VESKQGEKEFMSEVASMANVNVCHENLVK 104
           IG+G FG VY G L D        AVK L+ +   +  ++F+ E   M + +  H N++ 
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFS--HPNVLS 60

Query: 105 LHGGCID---GPCRILVYDYMPNNSLSQTLLGEE-----KRRAKFGWKARREIIMGIGRG 156
           L G C+     P  ++V  YM +  L   +  E      K    FG        + + +G
Sbjct: 61  LLGICLPSEGSP--LVVLPYMKHGDLRNFIRSETHNPTVKDLIGFG--------LQVAKG 110

Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN---TTHISTRVAGTLG 213
           + Y+  +     VHRD+   N +LD++F  K++DFGL++   +    + H  T     + 
Sbjct: 111 MEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK 167

Query: 214 YLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
           ++A E   + + T KSDV+SFGVLL E+++
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 78.7 bits (194), Expect = 2e-16
 Identities = 67/204 (32%), Positives = 95/204 (46%), Gaps = 23/204 (11%)

Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKL 105
           IG+G FG V   +   DG   AVKVL  ++   K+ +K  M+E   +   NV H  LV L
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLK-NVKHPFLVGL 61

Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEE---KRRAKFGWKARREIIMGIGRGLAYIHE 162
           H           V DY+    L   L  E    + RA+F + A  EI   +G    Y+H 
Sbjct: 62  HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAA--EIASALG----YLHS 114

Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLGYLAPEYA 220
               ++++RD+K  NILLD   +  ++DFGL K  +    TT   +   GT  YLAPE  
Sbjct: 115 L---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTT---STFCGTPEYLAPEVL 168

Query: 221 ISGRLTRKSDVYSFGVLLLEIVSG 244
                 R  D +  G +L E++ G
Sbjct: 169 RKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 77.7 bits (191), Expect = 2e-16
 Identities = 64/204 (31%), Positives = 96/204 (47%), Gaps = 23/204 (11%)

Query: 49  KIGEGGFGSVYKGRLQ-DGTIVAVK----VLSVESKQGEKEFMSEVASMANVNVCHENLV 103
           +IG G FG V+ GRL+ D T VAVK     L  + K    +F+ E   +   +  H N+V
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKA---KFLQEARILKQYS--HPNIV 56

Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
           +L G C       +V + +       T L  E  R K   K   +++     G+ Y+  +
Sbjct: 57  RLIGVCTQKQPIYIVMELVQGGDF-LTFLRTEGPRLKV--KELIQMVENAAAGMEYLESK 113

Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT----LGYLAPEY 219
              H +HRD+   N L+ +    KISDFG+S+   E    +     G     + + APE 
Sbjct: 114 ---HCIHRDLAARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIPVKWTAPEA 167

Query: 220 AISGRLTRKSDVYSFGVLLLEIVS 243
              GR + +SDV+SFG+LL E  S
Sbjct: 168 LNYGRYSSESDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 77.9 bits (192), Expect = 3e-16
 Identities = 58/204 (28%), Positives = 101/204 (49%), Gaps = 18/204 (8%)

Query: 50  IGEGGFGSVYK------GRLQDGTIVAVKVLSVESKQGEKE-FMSEVASMANVNVCHENL 102
           +G G FG V +       +      VAVK+L   +   E+E  MSE+  M+++   HEN+
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGN-HENI 101

Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE 162
           V L G C  G   +++ +Y     L   L    KR +    +        + +G+A++  
Sbjct: 102 VNLLGACTIGGPILVITEYCCYGDLLNFL--RRKRESFLTLEDLLSFSYQVAKGMAFLAS 159

Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI---STRVAGTLGYLAPEY 219
           +   + +HRD+   N+LL      KI DFGL++    ++ ++   + R+   + ++APE 
Sbjct: 160 K---NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLP--VKWMAPES 214

Query: 220 AISGRLTRKSDVYSFGVLLLEIVS 243
             +   T +SDV+S+G+LL EI S
Sbjct: 215 IFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 78.2 bits (193), Expect = 3e-16
 Identities = 68/219 (31%), Positives = 93/219 (42%), Gaps = 40/219 (18%)

Query: 44  FRWSNKIGEGGFGSV----YKGRLQDGTIVAVKVL---------SVESKQGEKEFMSEVA 90
           FR    +G G FG V    YK     G + A+K L          VES   EK       
Sbjct: 1   FRCLAVLGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETAN 57

Query: 91  SMANVNVCHENLVKLHGGCIDGPCRI-LVYDYMPNNSLSQTLLGE--EKRRAKFGWKARR 147
           S       H  LV L   C      +  V +Y     L   +  +   + RA F + A  
Sbjct: 58  SER-----HPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVF-YAA-- 108

Query: 148 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHIS 205
            +++G    L Y+HE     +V+RD+K  N+LLD     KI+DFGL K  +   + T  S
Sbjct: 109 CVVLG----LQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT--S 159

Query: 206 TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
           T   GT  +LAPE       TR  D +  GVL+ E++ G
Sbjct: 160 T-FCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 77.5 bits (191), Expect = 4e-16
 Identities = 63/224 (28%), Positives = 103/224 (45%), Gaps = 44/224 (19%)

Query: 50  IGEGGFGSVYKGRL-----QDGTI-VAVKVLSVESKQGE-KEFMSEVASMANVNVCHENL 102
           +GEG FG V K         + T  VAVK+L  ++ + +  + +SE+  M  +   H+N+
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK-HKNI 78

Query: 103 VKLHGGCI-DGPCRILV--------YDY-------MPNNSLSQTLLGEEKRRAK----FG 142
           + L G C  +GP  ++V         D+           S       EE    K    F 
Sbjct: 79  INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138

Query: 143 WKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 202
           ++        + RG+ ++        +HRD+   N+L+ ++   KI+DFGL++       
Sbjct: 139 YQ--------VARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDY 187

Query: 203 HISTRVAGTLGY--LAPEYAISGRL-TRKSDVYSFGVLLLEIVS 243
           +  T   G L    +APE A+  R+ T +SDV+SFGVLL EI +
Sbjct: 188 YRKT-TNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 77.0 bits (189), Expect = 5e-16
 Identities = 56/201 (27%), Positives = 101/201 (50%), Gaps = 17/201 (8%)

Query: 48  NKIGEGGFGSVYKG---RLQDGTIVAVKVLSVESKQGEKE-FMSEVASMANVNVCHENLV 103
            +IG+G FG V+KG   R Q   +VA+K++ +E  + E E    E+  ++  +  +  + 
Sbjct: 10  ERIGKGSFGEVFKGIDNRTQ--QVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY--VT 65

Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
           K +G  + G    ++ +Y+   S    L     R   F       ++  I +GL Y+H E
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSALDLL-----RAGPFDEFQIATMLKEILKGLDYLHSE 120

Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG 223
            +   +HRDIK +N+LL +  + K++DFG++    +     +T V GT  ++APE     
Sbjct: 121 KK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQS 176

Query: 224 RLTRKSDVYSFGVLLLEIVSG 244
               K+D++S G+  +E+  G
Sbjct: 177 AYDSKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 76.9 bits (190), Expect = 6e-16
 Identities = 61/214 (28%), Positives = 114/214 (53%), Gaps = 28/214 (13%)

Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKE-FMSEVASMANVNVC--- 98
           +   N+I EG +G VY+ R  + G IVA+K L +E    EKE F   + S+  +N+    
Sbjct: 7   YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEK---EKEGF--PITSLREINILLKL 61

Query: 99  -HENLVKLH----GGCIDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG 152
            H N+V +     G  +D   +I +V +Y+ ++   ++L+   K+   F     + +++ 
Sbjct: 62  QHPNIVTVKEVVVGSNLD---KIYMVMEYVEHDL--KSLMETMKQP--FLQSEVKCLMLQ 114

Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL 212
           +  G+A++H+     ++HRD+KTSN+LL+     KI DFGL++ +        T++  TL
Sbjct: 115 LLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY-TQLVVTL 170

Query: 213 GYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGR 245
            Y APE  +  +  +   D++S G +  E+++ +
Sbjct: 171 WYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 76.6 bits (188), Expect = 7e-16
 Identities = 63/221 (28%), Positives = 111/221 (50%), Gaps = 13/221 (5%)

Query: 48  NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLVKL 105
           +K+GEG + +V+KGR +    +VA+K + +E ++G     + EV+ + N+   H N+V L
Sbjct: 11  DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLK--HANIVTL 68

Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
           H       C  LV++Y+ ++ L Q L       +    K     +  + RGL+Y H+   
Sbjct: 69  HDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKI---FMFQLLRGLSYCHKR-- 122

Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI-SGR 224
             ++HRD+K  N+L+++    K++DFGL++     T   S  V  TL Y  P+  + S  
Sbjct: 123 -KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTE 180

Query: 225 LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG 265
            +   D++  G +L E+ +GR          E HL+ +  G
Sbjct: 181 YSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLG 221

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 76.6 bits (188), Expect = 7e-16
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 24/209 (11%)

Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG 108
           +G G +G VYKGR ++ G + A+KV+ V   + E+E   E+ +M      H N+   +G 
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEI-NMLKKYSHHRNIATYYGA 81

Query: 109 CID-GPC-----RILVYDYMPNNSLSQTLLGEEKRRAKFGWKAR--REIIMGIGRGLAYI 160
            I   P        LV ++    S++  +   +    K  W A   REI+    RGLA++
Sbjct: 82  FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREIL----RGLAHL 137

Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
           H      V+HRDIK  N+LL +N   K+ DFG+S          +T + GT  ++APE  
Sbjct: 138 HAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVI 193

Query: 221 I-----SGRLTRKSDVYSFGVLLLEIVSG 244
                       +SD++S G+  +E+  G
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 76.6 bits (188), Expect = 7e-16
 Identities = 59/201 (29%), Positives = 103/201 (51%), Gaps = 16/201 (7%)

Query: 50  IGEGGFGSVYKG-RLQDGTIV----AVKVLS-VESKQGEKEFMSEVASMANVNVCHENLV 103
           +G G FG+VYKG  + +G  V    A+K+L+     +   EFM E   MA+++  H +LV
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD--HPHLV 72

Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
           +L G C+  P   LV   MP+  L   +    + +   G +      + I +G+ Y+ E 
Sbjct: 73  RLLGVCLS-PTIQLVTQLMPHGCLLDYV---HEHKDNIGSQLLLNWCVQIAKGMMYLEER 128

Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT-LGYLAPEYAIS 222
               +VHRD+   N+L+    + KI+DFGL++L   +    +       + ++A E    
Sbjct: 129 ---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY 185

Query: 223 GRLTRKSDVYSFGVLLLEIVS 243
            + T +SDV+S+GV + E+++
Sbjct: 186 RKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 76.7 bits (188), Expect = 9e-16
 Identities = 70/271 (25%), Positives = 126/271 (46%), Gaps = 34/271 (12%)

Query: 49  KIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           K+GEG + +VYKG+ + +G +VA+KV+ ++ ++G        AS+    + H N+V LH 
Sbjct: 12  KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLK-GLKHANIVLLHD 70

Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
                    LV++Y+ +  L Q +   +K       +  +  +  + RGL+YIH   Q +
Sbjct: 71  IIHTKETLTLVFEYV-HTDLCQYM---DKHPGGLHPENVKLFLFQLLRGLSYIH---QRY 123

Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI-SGRLT 226
           ++HRD+K  N+L+      K++DFGL++      +H  +    TL Y  P+  + S   +
Sbjct: 124 ILHRDLKPQNLLISDTGELKLADFGLARA-KSVPSHTYSNEVVTLWYRPPDVLLGSTEYS 182

Query: 227 RKSDVYSFGVLLLEIVSGRTAV----DFDVQLGEYHLV-----DKAW------------- 264
              D++  G + +E++ G  A     D   QL    LV     +  W             
Sbjct: 183 TCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPER 242

Query: 265 -GMYNSKELMNLVDPMLYGNFPENEAIRFLK 294
             +Y+ K L    + + Y N  E+ A + L+
Sbjct: 243 FTLYSPKNLRQAWNKLSYVNHAEDLASKLLQ 273

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 76.2 bits (187), Expect = 9e-16
 Identities = 78/287 (27%), Positives = 137/287 (47%), Gaps = 38/287 (13%)

Query: 38  KIATNGFRWSNKIGEGGFGSVY----KGRLQDG--TIVAVKVLSVESKQGEK-EFMSEVA 90
           ++A      S ++G+G FG VY    KG ++D   T VA+K ++  +   E+ EF++E +
Sbjct: 2   EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61

Query: 91  SMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLS---QTLLGEEKRRAKFGWKARR 147
            M   N CH ++V+L G    G   +++ + M    L    ++L  E +        + +
Sbjct: 62  VMKEFN-CH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLK 119

Query: 148 EIIMGIGR---GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 204
           ++I   G    G+AY++       VHRD+   N ++ ++F  KI DFG+++   E T + 
Sbjct: 120 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE-TDYY 175

Query: 205 STRVAGTLG--YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDK 262
                G L   +++PE    G  T  SDV+SFGV+L EI +               L ++
Sbjct: 176 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQ 220

Query: 263 AW-GMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRP 308
            + GM N + L  +++  L    P+N      ++  +C Q   K+RP
Sbjct: 221 PYQGMSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRP 266

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 75.9 bits (186), Expect = 1e-15
 Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 24/209 (11%)

Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG 108
           +G G +G VYKGR ++ G + A+KV+ V   + E+E   E+ +M      H N+   +G 
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEI-NMLKKYSHHRNIATYYGA 71

Query: 109 CID-GPCRI-----LVYDYMPNNSLSQTLLGEEKRRAKFGWKAR--REIIMGIGRGLAYI 160
            I   P  +     LV ++    S++  +   +    K  W A   REI+    RGL+++
Sbjct: 72  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL----RGLSHL 127

Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
           H   Q  V+HRDIK  N+LL +N   K+ DFG+S          +T + GT  ++APE  
Sbjct: 128 H---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVI 183

Query: 221 I-----SGRLTRKSDVYSFGVLLLEIVSG 244
                       KSD++S G+  +E+  G
Sbjct: 184 ACDENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 75.8 bits (186), Expect = 1e-15
 Identities = 55/202 (27%), Positives = 107/202 (52%), Gaps = 21/202 (10%)

Query: 49  KIGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           ++G+G FG VYK + ++ G + A KV+  +S++  +++M E+  +A  N  H  +VKL G
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCN--HPYIVKLLG 76

Query: 108 GCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
               DG   I++ ++ P  ++   +L  ++   +      + I   +   L Y+H     
Sbjct: 77  AFYWDGKLWIMI-EFCPGGAVDAIMLELDRGLTE---PQIQVICRQMLEALQYLHSM--- 129

Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVA--GTLGYLAPEYAISGR 224
            ++HRD+K  N+LL  + + K++DFG+S    +N   +  R +  GT  ++APE  +   
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVSA---KNVKTLQRRDSFIGTPYWMAPEVVMCET 186

Query: 225 LTR-----KSDVYSFGVLLLEI 241
           +       K+D++S G+ L+E+
Sbjct: 187 MKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 75.2 bits (185), Expect = 1e-15
 Identities = 64/250 (25%), Positives = 116/250 (46%), Gaps = 39/250 (15%)

Query: 50  IGEGGFGS--VYKGRLQDGTIVAVKV--LSVESKQGEKEFMSEVASMANVNVCHENLVKL 105
           +G+G FG   +Y+ R +D ++V  K   L+  S++  ++ ++E+  ++ +   H N++  
Sbjct: 8   LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQ--HPNIIAY 64

Query: 106 HGGCIDGPCRILVYDYMPNNSLSQ-------TLLGEEKRRAKFGWKARREIIMGIGRGLA 158
           +   +D    ++  +Y    +L          L  EE       W      +  I   ++
Sbjct: 65  YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEM----VLW-----YLFQIVSAVS 115

Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE 218
           YIH+     ++HRDIKT NI L +    K+ DFG+SK+     +   T V GT  Y++PE
Sbjct: 116 YIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPE 171

Query: 219 YAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL--------GEYHLVDKAWGMYNSK 270
                +   KSD+++ G +L E+++ +   D    L        G Y  V   +    S 
Sbjct: 172 LCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVY----SS 227

Query: 271 ELMNLVDPML 280
           EL++LV  +L
Sbjct: 228 ELISLVHSLL 237

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 75.5 bits (185), Expect = 2e-15
 Identities = 59/205 (28%), Positives = 104/205 (50%), Gaps = 28/205 (13%)

Query: 49  KIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           KIGEG  G V   R +  G  VAVK++ +  +Q  +   +EV  M +    H+N+V+++ 
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ--HQNVVEMYK 85

Query: 108 GCIDGPCRILVYDYMPNNSL----SQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
             + G    ++ +++   +L    SQT L EE+            +   + + L Y+H +
Sbjct: 86  SYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIAT---------VCESVLQALCYLHSQ 136

Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFG----LSKLFPENTTHISTRVAGTLGYLAPEY 219
               V+HRDIK+ +ILL  +   K+SDFG    +SK  P+  +     + GT  ++APE 
Sbjct: 137 ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS-----LVGTPYWMAPEV 188

Query: 220 AISGRLTRKSDVYSFGVLLLEIVSG 244
                   + D++S G++++E+V G
Sbjct: 189 ISRTPYGTEVDIWSLGIMVIEMVDG 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 75.2 bits (185), Expect = 2e-15
 Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 32/208 (15%)

Query: 48  NKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLH 106
            KIGEG  G V        G  VAVK + +  +Q  +   +EV  M +    H N+V+++
Sbjct: 25  VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQ--HPNIVEMY 82

Query: 107 GGCIDGPCRILVYDYMPNNSL----SQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE 162
              + G    +V +++   +L    + T + EE+            + + + + L+++H 
Sbjct: 83  SSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT---------VCLAVLKALSFLHA 133

Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFG----LSKLFPENTTHISTRVAGTLGYLAPE 218
           +    V+HRDIK+ +ILL  +   K+SDFG    +SK  P   +     + GT  ++APE
Sbjct: 134 Q---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS-----LVGTPYWMAPE 185

Query: 219 YAISGRLTRKS--DVYSFGVLLLEIVSG 244
             IS RL   +  D++S G++++E+V G
Sbjct: 186 -VIS-RLPYGTEVDIWSLGIMVIEMVDG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 75.4 bits (186), Expect = 2e-15
 Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 37/222 (16%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEF-----MSEVASMANVNVCHENL 102
           K+GEG FG VYK R ++ G +VA+K + + +   EK+      + E+  +  +   H N+
Sbjct: 15  KLGEGTFGEVYKARQIKTGRVVALKKILMHN---EKDGFPITALREIKILKKLK--HPNV 69

Query: 103 VKLHGGCIDGP--------CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIG 154
           V L    ++ P           +V  YM ++ LS  L   E    K      +  ++ + 
Sbjct: 70  VPLIDMAVERPDKSKRKRGSVYMVTPYM-DHDLSGLL---ENPSVKLTESQIKCYMLQLL 125

Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN----------TTHI 204
            G+ Y+HE    H++HRDIK +NIL+D     KI+DFGL++ +              T  
Sbjct: 126 EGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRK 182

Query: 205 STRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGR 245
            T +  T  Y  PE  +  R  T   D++  G +  E+ + R
Sbjct: 183 YTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 74.7 bits (183), Expect = 3e-15
 Identities = 55/199 (27%), Positives = 102/199 (51%), Gaps = 13/199 (6%)

Query: 48  NKIGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGEKE-FMSEVASMANVNVCHENLVKL 105
            +IG+G FG VYKG   +   +VA+K++ +E  + E E    E+  ++  +  +  + + 
Sbjct: 10  ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY--ITRY 67

Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
           +G  + G    ++ +Y+   S +  LL        +     REI+    +GL Y+H E +
Sbjct: 68  YGSYLKGTKLWIIMEYLGGGS-ALDLLKPGPLEETYIATILREIL----KGLDYLHSERK 122

Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL 225
              +HRDIK +N+LL +  + K++DFG++    +     +T V GT  ++APE       
Sbjct: 123 ---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAY 178

Query: 226 TRKSDVYSFGVLLLEIVSG 244
             K+D++S G+  +E+  G
Sbjct: 179 DFKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 75.1 bits (184), Expect = 3e-15
 Identities = 72/218 (33%), Positives = 111/218 (50%), Gaps = 35/218 (16%)

Query: 44  FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLS---VESKQGE------KEFMSEVASMA 93
           FR    +G+GGFG V   +++  G + A K L    ++ ++GE      K+ + +V S  
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 94  NVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTL--LGE---EKRRAKFGWKARRE 148
            V++ +    K      D  C  LV   M    L   +  +GE   E+ RA F + A   
Sbjct: 62  VVSLAYAYETK------DALC--LVLTLMNGGDLKFHIYHMGEAGFEEGRAVF-YAAE-- 110

Query: 149 IIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRV 208
               I  GL  +H+E    +V+RD+K  NILLD + + +ISD GL+   PE  T I  RV
Sbjct: 111 ----ICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV 162

Query: 209 AGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT 246
            GT+GY+APE   + R T   D ++ G LL E+++G++
Sbjct: 163 -GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 74.4 bits (183), Expect = 3e-15
 Identities = 60/202 (29%), Positives = 95/202 (47%), Gaps = 23/202 (11%)

Query: 50  IGEGGFGSVYKGRLQ-DGTIVAVKVL---SVESKQGEKEFMSEVASMANVNVCHENLVKL 105
           I +G FGSVY  + +  G   A+KVL    + +K       +E A M         + KL
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMI-QGESPYVAKL 62

Query: 106 HGGCIDGPCRILVYDYMPNN---SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE 162
           +          LV +Y+      SL +TL G  +  AK   +   E+++G+      +H 
Sbjct: 63  YYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK---QYIAEVVLGVE----DLH- 114

Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS 222
             Q  ++HRDIK  N+L+DQ  + K++DFGLS+         + +  GT  YLAPE  + 
Sbjct: 115 --QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRN-----GLENKKFVGTPDYLAPETILG 167

Query: 223 GRLTRKSDVYSFGVLLLEIVSG 244
               + SD +S G ++ E + G
Sbjct: 168 VGDDKMSDWWSLGCVIFEFLFG 189

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 74.7 bits (184), Expect = 3e-15
 Identities = 58/201 (28%), Positives = 98/201 (48%), Gaps = 16/201 (7%)

Query: 49  KIGEGGFGSVYKGRLQD-GTIVAVKVL--SVESKQGEKEFMSEVASMANVNVCHENLVKL 105
            +GEG +G V K + ++ G IVA+K    S + K  +K  M E+  +  +   HENLV L
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR--HENLVNL 65

Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGE-EKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
                      LV++++ +     T+L + EK          R+ +  I RG+ + H   
Sbjct: 66  IEVFRRKKRLYLVFEFVDH-----TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH- 119

Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG- 223
             +++HRDIK  NIL+ Q+   K+ DFG ++        + T    T  Y APE  +   
Sbjct: 120 --NIIHRDIKPENILVSQSGVVKLCDFGFAR-TLAAPGEVYTDYVATRWYRAPELLVGDT 176

Query: 224 RLTRKSDVYSFGVLLLEIVSG 244
           +  R  D+++ G L+ E+++G
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 74.4 bits (183), Expect = 3e-15
 Identities = 51/202 (25%), Positives = 94/202 (46%), Gaps = 15/202 (7%)

Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG 108
           +G+G FG VYK +  + G   A K++ +ES++  ++FM E+  ++     H N+V L+  
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECK--HPNIVGLYEA 70

Query: 109 CIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHV 168
                   ++ ++    +L   +L  E+          R +   +   L ++H      V
Sbjct: 71  YFYENKLWILIEFCDGGALDSIMLELER---GLTEPQIRYVCRQMLEALNFLHSH---KV 124

Query: 169 VHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI-----SG 223
           +HRD+K  NILL  + + K++DFG+S           T + GT  ++APE          
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETFKDN 183

Query: 224 RLTRKSDVYSFGVLLLEIVSGR 245
               K+D++S G+ L+E+    
Sbjct: 184 PYDYKADIWSLGITLIELAQME 205

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 74.6 bits (183), Expect = 3e-15
 Identities = 67/225 (29%), Positives = 111/225 (49%), Gaps = 31/225 (13%)

Query: 30  NAFSYNQLKIATNGFRWSNKIGEGGFGSVYKG--RLQDGTIVAVKVLSVESKQGEKEFMS 87
            A SY  L+          K+GEG + +VYKG  R+ +G +VA+KV+S+++++G      
Sbjct: 3   AATSYLNLE----------KLGEGSYATVYKGISRI-NGQLVALKVISMKTEEGVPFTAI 51

Query: 88  EVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKAR- 146
             AS+    + H N+V LH           V++YM       T L +   +   G     
Sbjct: 52  REASLLK-GLKHANIVLLHDIIHTKETLTFVFEYM------HTDLAQYMIQHPGGLHPYN 104

Query: 147 -REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL--SKLFPENTTH 203
            R  +  + RGLAYIH +   H++HRD+K  N+L+      K++DFGL  +K  P  T  
Sbjct: 105 VRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT-- 159

Query: 204 ISTRVAGTLGYLAPEYAI-SGRLTRKSDVYSFGVLLLEIVSGRTA 247
            S+ V  TL Y  P+  + +   +   D++  G + +E++ G+ A
Sbjct: 160 YSSEVV-TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPA 203

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 74.7 bits (183), Expect = 4e-15
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 30/218 (13%)

Query: 50  IGEGGFGSVY--------KGRLQDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHE 100
           +GEG FG V         K + ++   VAVK+L  ++ + +  + +SE+  M  +   H+
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK-HK 81

Query: 101 NLVKLHGGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARR------------ 147
           N++ L G C  DGP  ++V +Y    +L + L        ++ +   R            
Sbjct: 82  NIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140

Query: 148 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 207
                + RG+ Y+  +     +HRD+   N+L+ +N   KI+DFGL++    N  +    
Sbjct: 141 SCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDV-NNIDYYKKT 196

Query: 208 VAGTL--GYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
             G L   ++APE       T +SDV+SFGVL+ EI +
Sbjct: 197 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 73.9 bits (181), Expect = 6e-15
 Identities = 64/203 (31%), Positives = 96/203 (47%), Gaps = 16/203 (7%)

Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCHENLVKL 105
           IG GGFG VY  R  D G + A+K L    ++ KQGE   ++E   ++ V+      +  
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 106 HGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
                  P ++  + D M    L   L     +   F  K  R     I  GL ++H   
Sbjct: 62  MTYAFHTPDKLCFILDLMNGGDLHYHL----SQHGVFSEKEMRFYATEIILGLEHMHNRF 117

Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              VV+RD+K +NILLD++ + +ISD GL+  F +   H S    GT GY+APE    G 
Sbjct: 118 ---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGT 171

Query: 225 LTRKS-DVYSFGVLLLEIVSGRT 246
               S D +S G +L +++ G +
Sbjct: 172 AYDSSADWFSLGCMLFKLLRGHS 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 73.6 bits (181), Expect = 7e-15
 Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 34/210 (16%)

Query: 49  KIGEGGFGSVYKGRLQD-GTIVAVKVLSVESK-QGEKEFMSEVASMANVNVC------HE 100
           KIGEG +G+V+K + ++   IVA+K + ++   +G       V S A   +C      H+
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG-------VPSSALREICLLKELKHK 59

Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKR-----RAKFGWKARREIIMGIGR 155
           N+V+L+          LV++Y       Q L    K+           +  +  +  + +
Sbjct: 60  NIVRLYDVLHSDKKLTLVFEY-----CDQDL----KKYFDSCNGDIDPEIVKSFMFQLLK 110

Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
           GLA+ H     +V+HRD+K  N+L+++N   K++DFGL++ F       S  V  TL Y 
Sbjct: 111 GLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYR 166

Query: 216 APEYAISGRLTRKS-DVYSFGVLLLEIVSG 244
            P+     +L   S D++S G +  E+ + 
Sbjct: 167 PPDVLFGAKLYSTSIDMWSAGCIFAELANA 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 73.6 bits (181), Expect = 8e-15
 Identities = 67/231 (29%), Positives = 105/231 (45%), Gaps = 43/231 (18%)

Query: 35  NQLKIATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMA 93
            +     N      +IG G  G VYK R  + G ++AVK +    + G KE    +  + 
Sbjct: 8   QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMR---RTGNKEENKRI--LM 62

Query: 94  NVNV---CHE--NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARRE 148
           +++V    H+   +VK +G        I   D      L  T L +  +R +       E
Sbjct: 63  DLDVVLKSHDCPYIVKCYG------YFITDSDVFICMELMSTCLDKLLKRIQGPIP---E 113

Query: 149 IIMG-----IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 203
            I+G     I + L Y+ E+    V+HRD+K SNILLD + N K+ DFG+S    ++   
Sbjct: 114 DILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK 171

Query: 204 ISTRVAGTLGYLAPEYAISGRLTRK---------SDVYSFGVLLLEIVSGR 245
             TR AG   Y+APE     R+            +DV+S G+ L+E+ +G+
Sbjct: 172 --TRSAGCAAYMAPE-----RIDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 74.0 bits (182), Expect = 8e-15
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 45/202 (22%)

Query: 42  NGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMS-----EVASMANV 95
           + +    KIG+G FG V+K R  +   IVA+K + +E+   EKE        E+  +  +
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMEN---EKEGFPITALREIKILQLL 68

Query: 96  NVCHENLVKLHGGCIDGP-----CR---ILVYDY-------MPNNSLSQTLLGEEKRRAK 140
              HEN+V L   C          +    LV+++       + +N   +  L E K+   
Sbjct: 69  K--HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKK--- 123

Query: 141 FGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--P 198
                   ++  +  GL YIH      ++HRD+K +NIL+ ++   K++DFGL++ F   
Sbjct: 124 --------VMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLS 172

Query: 199 ENT--THISTRVAGTLGYLAPE 218
           +N+     + RV  TL Y  PE
Sbjct: 173 KNSKPNRYTNRVV-TLWYRPPE 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 73.9 bits (182), Expect = 8e-15
 Identities = 54/214 (25%), Positives = 94/214 (43%), Gaps = 16/214 (7%)

Query: 43  GFRWSNKIGEGGFGSVYKGRLQ---DGTIVAVKVLSVESKQGEKEFMSEVASMA-NVNVC 98
            +     IG G +G VYK + +   DG   A+K    + +Q      S    +A    + 
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60

Query: 99  HENLVKLHGGCIDGPCRI--LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRG 156
           HEN+V L    ++   +   L++DY  ++         + +R        + ++  I  G
Sbjct: 61  HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120

Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNP----KISDFGLSKLF--PENTTHISTRVAG 210
           + Y+H      V+HRD+K +NIL+          KI D GL++LF  P         V  
Sbjct: 121 VHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVV 177

Query: 211 TLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVS 243
           T+ Y APE  +  R  T+  D+++ G +  E+++
Sbjct: 178 TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 73.3 bits (180), Expect = 9e-15
 Identities = 61/205 (29%), Positives = 89/205 (43%), Gaps = 18/205 (8%)

Query: 50  IGEGGFGSVY----KGRLQDGTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHEN 101
           +G G +G V+     G    G + A+KVL     V+  +  +   +E   +  V  C   
Sbjct: 8   LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRC-PF 66

Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
           LV LH          L+ DY+    L   L     +R  F     R  I  I   L ++H
Sbjct: 67  LVTLHYAFQTDTKLHLILDYVNGGELFTHLY----QREHFTESEVRVYIAEIVLALDHLH 122

Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI 221
              Q  +++RDIK  NILLD   +  ++DFGLSK F       +    GT+ Y+APE   
Sbjct: 123 ---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIR 179

Query: 222 SGRLTRKS--DVYSFGVLLLEIVSG 244
            G        D +S GVL  E+++G
Sbjct: 180 GGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 73.1 bits (179), Expect = 1e-14
 Identities = 61/201 (30%), Positives = 104/201 (51%), Gaps = 16/201 (7%)

Query: 50  IGEGGFGSVYKG-RLQDG----TIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLV 103
           +G G FG+VYKG  + DG      VA+KVL    S +  KE + E   MA V   +  + 
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPY--VC 72

Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
           +L G C+    + LV   MP   L   +    + + + G +      + I +G++Y+ EE
Sbjct: 73  RLLGICLTSTVQ-LVTQLMPYGCLLDYV---RENKDRIGSQDLLNWCVQIAKGMSYL-EE 127

Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT-LGYLAPEYAIS 222
           ++  +VHRD+   N+L+    + KI+DFGL++L   + T          + ++A E  + 
Sbjct: 128 VR--LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILH 185

Query: 223 GRLTRKSDVYSFGVLLLEIVS 243
            R T +SDV+S+GV + E+++
Sbjct: 186 RRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 73.9 bits (182), Expect = 1e-14
 Identities = 60/239 (25%), Positives = 96/239 (40%), Gaps = 61/239 (25%)

Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLS----VESKQ-----GEKEFMSEVASMANVNVCH 99
           IG G FG V+  R    G + A+KVL     ++  Q      E++ +++  S        
Sbjct: 9   IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPW------ 62

Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKR----RAKFGWKARREIIMGIGR 155
             +VKL+    D     LV +YMP   L   LL  +       A+F + A  E+++ +  
Sbjct: 63  --IVKLYYSFQDEEHLYLVMEYMPGGDL-MNLLIRKDVFPEETARF-YIA--ELVLAL-- 114

Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE---------------- 199
               +H   +   +HRDIK  NIL+D + + K++DFGL K   +                
Sbjct: 115 --DSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169

Query: 200 ------------NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT 246
                            +    GT  Y+APE         + D +S GV+L E++ G  
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP 228

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 57/207 (27%), Positives = 103/207 (49%), Gaps = 16/207 (7%)

Query: 44  FRWSNKIGEGGFGSVYKGR-LQDG----TIVAVKVL-SVESKQGEKEFMSEVASMANVNV 97
           F+    +G G FG+VYKG  + +G      VA+K L    S +  KE + E   MA+V+ 
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD- 67

Query: 98  CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
            + ++ +L G C+    + L+   MP   L   +    + +   G +      + I +G+
Sbjct: 68  -NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGM 122

Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLA 216
            Y+ E     +VHRD+   N+L+    + KI+DFGL+KL   +   + +      + ++A
Sbjct: 123 NYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMA 179

Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVS 243
            E  +    T +SDV+S+GV + E+++
Sbjct: 180 LESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 73.4 bits (180), Expect = 1e-14
 Identities = 69/206 (33%), Positives = 99/206 (48%), Gaps = 24/206 (11%)

Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHEN-----LV 103
           IG+G FG VY+ R +D   I A+KVLS +    +KE    +    N+ V         +V
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGER-NILVRTLLDESPFIV 59

Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGE---EKRRAKFGWKARREIIMGIGRGLAYI 160
            L           LV DYM    L   L  E    + RAKF + A  E+++     L ++
Sbjct: 60  GLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKF-YIA--ELVLA----LEHL 112

Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRV-AGTLGYLAPEY 219
           H+     +V+RD+K  NILLD   +  + DFGLSK     T + +T    GT  YLAPE 
Sbjct: 113 HKY---DIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEV 167

Query: 220 AISGR-LTRKSDVYSFGVLLLEIVSG 244
            +  +  T+  D +S GVL+ E+  G
Sbjct: 168 LLDEKGYTKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 73.1 bits (179), Expect = 1e-14
 Identities = 67/226 (29%), Positives = 101/226 (44%), Gaps = 38/226 (16%)

Query: 42  NGFRWSNKIGEGGFGSVYKGRL-QDGTIV--AVKVLS-VESKQGEKEFMSEVASMANVNV 97
           N  ++ + IGEG FG V K R+ +DG  +  A+K +    SK   ++F  E+  +  +  
Sbjct: 7   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66

Query: 98  CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRA-----KFGWKARREIIMG 152
            H N++ L G C       L  +Y P+ +L   L    K R       F         + 
Sbjct: 67  -HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETDPAFAIANSTASTLS 122

Query: 153 ----------IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 202
                     + RG+ Y+    Q   +HRD+   NIL+ +N+  KI+DFGLS+       
Sbjct: 123 SQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR------- 172

Query: 203 HISTRVAGTLG-----YLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
                V  T+G     ++A E       T  SDV+S+GVLL EIVS
Sbjct: 173 GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 72.3 bits (177), Expect = 1e-14
 Identities = 58/202 (28%), Positives = 98/202 (48%), Gaps = 17/202 (8%)

Query: 49  KIGEGGFGSVYKGRLQ---DGTIVAVKVLSVESKQG--EKEFMSEVASMANVNVCHENLV 103
           ++G G FG+V KG  +       VAVK+L  ++     + E + E   M  ++  +  +V
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLD--NPYIV 59

Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
           ++ G C +    +LV +      L++ L  ++ +      K   E++  +  G+ Y+ E 
Sbjct: 60  RMIGIC-EAESWMLVMELAELGPLNKFL--QKNKHVTE--KNITELVHQVSMGMKYLEET 114

Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT--LGYLAPEYAI 221
              + VHRD+   N+LL      KISDFGLSK    +  +   +  G   + + APE   
Sbjct: 115 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMN 171

Query: 222 SGRLTRKSDVYSFGVLLLEIVS 243
             + + KSDV+SFGVL+ E  S
Sbjct: 172 YYKFSSKSDVWSFGVLMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 70/204 (34%), Positives = 93/204 (45%), Gaps = 23/204 (11%)

Query: 50  IGEGGFGSVYKGRLQ-DGTIVAVKVL---SVESKQGEKEFMSEVASMANVNVCHENLVKL 105
           IG+G FG V   R + +    AVKVL   ++  K+ EK  MSE   +   NV H  LV L
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLK-NVKHPFLVGL 61

Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEE---KRRAKFGWKARREIIMGIGRGLAYIHE 162
           H           V DY+    L   L  E    + RA+F + A       I   L Y+H 
Sbjct: 62  HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAE------IASALGYLH- 113

Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIST--RVAGTLGYLAPEYA 220
               ++V+RD+K  NILLD   +  ++DFGL K   EN  H  T     GT  YLAPE  
Sbjct: 114 --SLNIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNGTTSTFCGTPEYLAPEVL 168

Query: 221 ISGRLTRKSDVYSFGVLLLEIVSG 244
                 R  D +  G +L E++ G
Sbjct: 169 HKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 72.7 bits (178), Expect = 2e-14
 Identities = 62/221 (28%), Positives = 107/221 (48%), Gaps = 13/221 (5%)

Query: 48  NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLVKL 105
            K+GEG + +V+KGR +    +VA+K + +E ++G     + EV+ + ++   H N+V L
Sbjct: 12  EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLK--HANIVTL 69

Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
           H          LV++Y+ +  L Q +   +           +  +  I RGLAY H    
Sbjct: 70  HDIVHTDKSLTLVFEYL-DKDLKQYM---DDCGNIMSMHNVKIFLYQILRGLAYCHRR-- 123

Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI-SGR 224
             V+HRD+K  N+L+++    K++DFGL++     T   S  V  TL Y  P+  + S  
Sbjct: 124 -KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSE 181

Query: 225 LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG 265
            + + D++  G +  E+ SGR          E HL+ +  G
Sbjct: 182 YSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLG 222

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 72.7 bits (178), Expect = 2e-14
 Identities = 68/204 (33%), Positives = 97/204 (47%), Gaps = 23/204 (11%)

Query: 50  IGEGGFGSVY-KGRLQDGTIVAVKVL---SVESKQGEKEFMSEVASMANVNVCHENLVKL 105
           IG+G FG V    R  DG+  AVKVL   ++  K+ +   M+E   +   N+ H  LV L
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLK-NLKHPFLVGL 61

Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEE---KRRAKFGWKARREIIMGIGRGLAYIHE 162
           H           V DY+    L   L  E    + RA+F + A  E+   IG    Y+H 
Sbjct: 62  HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAA--EVASAIG----YLHS 114

Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLGYLAPEYA 220
               ++++RD+K  NILLD   +  ++DFGL K  + PE TT   +   GT  YLAPE  
Sbjct: 115 L---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT---STFCGTPEYLAPEVL 168

Query: 221 ISGRLTRKSDVYSFGVLLLEIVSG 244
                 R  D +  G +L E++ G
Sbjct: 169 RKEPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 72.0 bits (177), Expect = 3e-14
 Identities = 64/218 (29%), Positives = 101/218 (46%), Gaps = 37/218 (16%)

Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVL---------SVESKQGEKEFMSEVASMANVNVCH 99
           +G+G FG V    L+    + AVKVL          VE    EK  ++           H
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGK-------H 55

Query: 100 ENLVKLHGGCIDGPCRI-LVYDYMPNNSLS---QTLLGEEKRRAKFGWKARREIIMGIGR 155
             L +LH  C     R+  V +Y+    L    Q     ++ RA+F + A  EI++G   
Sbjct: 56  PFLTQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARF-YAA--EIVLG--- 108

Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLG 213
            L ++HE     +++RD+K  N+LLD   + KI+DFG+ K  +    TT   +   GT  
Sbjct: 109 -LQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT---STFCGTPD 161

Query: 214 YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 251
           Y+APE           D ++ GVLL E+++G++  + D
Sbjct: 162 YIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD 199

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 71.6 bits (175), Expect = 3e-14
 Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 23/214 (10%)

Query: 44  FRWSNKIGEGGFGSVY------KGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNV 97
           +R    +G+G FG VY       GR      V     S E+ +       E+  + N+  
Sbjct: 4   WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ- 62

Query: 98  CHENLVKLHGGCIDGPCRILV--YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR 155
            HE +V+ +G   D   + L    +YMP  S+   L            K  R+I+     
Sbjct: 63  -HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQIL----E 117

Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE---NTTHISTRVAGTL 212
           G++Y+H  +   +VHRDIK +NIL D   N K+ DFG SK       + T I + V GT 
Sbjct: 118 GMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS-VTGTP 173

Query: 213 GYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGR 245
            +++PE  ISG    RK+DV+S G  ++E+++ +
Sbjct: 174 YWMSPE-VISGEGYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 71.5 bits (175), Expect = 3e-14
 Identities = 65/207 (31%), Positives = 98/207 (47%), Gaps = 24/207 (11%)

Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCHENLVKL 105
           IG GGFG VY  R  D G + A+K L    ++ KQGE   ++E   ++ V+      +  
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 106 HGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARR----EIIMGIGRGLAYI 160
                  P ++  + D M    L   L     +   F     R    EII+G    L ++
Sbjct: 62  MSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEAEMRFYAAEIILG----LEHM 113

Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
           H      VV+RD+K +NILLD++ + +ISD GL+  F +   H S    GT GY+APE  
Sbjct: 114 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVL 167

Query: 221 ISGRLTRKS-DVYSFGVLLLEIVSGRT 246
             G     S D +S G +L +++ G +
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGHS 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 71.9 bits (176), Expect = 4e-14
 Identities = 59/203 (29%), Positives = 104/203 (51%), Gaps = 24/203 (11%)

Query: 49  KIGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGEKEFM-SEVASMANVNVCHENLVKLH 106
           KIG+G  G+VY    +  G  VA+K +++  +Q +KE + +E+  M      H N+V   
Sbjct: 26  KIGQGASGTVYTAIDVATGQEVAIKQMNL-QQQPKKELIINEILVMRENK--HPNIVNYL 82

Query: 107 GGCIDGPCRILVYDYMPNNSLS----QTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE 162
              + G    +V +Y+   SL+    +T + E +  A       RE +    + L ++H 
Sbjct: 83  DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-----VCRECL----QALEFLHS 133

Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGL-SKLFPENTTHISTRVAGTLGYLAPEYAI 221
                V+HRDIK+ NILL  + + K++DFG  +++ PE +    + + GT  ++APE   
Sbjct: 134 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVT 188

Query: 222 SGRLTRKSDVYSFGVLLLEIVSG 244
                 K D++S G++ +E+V G
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 71.5 bits (175), Expect = 4e-14
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 18/207 (8%)

Query: 48  NKIGEGGFGSVYKGRLQDGTIVA---VKVLSVESKQGEK-EFMSEVASMANVNVCHENLV 103
           ++IG G FG V  G    G   A   VK L   +   E+  F+ EV     +N  H N++
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELN--HPNVL 58

Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWK-ARREIIMGIGRGLAYIHE 162
           +  G CI+    +LV ++ P   L   L       A+   K   + +   +  GL ++H 
Sbjct: 59  QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH- 117

Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLS-KLFPENTTHISTRVAGTLGYLAPEYA- 220
             Q   +H D+   N  L  + + KI D+GL+ + +PE+        A  L +LAPE   
Sbjct: 118 --QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVE 175

Query: 221 ------ISGRLTRKSDVYSFGVLLLEI 241
                 +    T+KS+++S GV + E+
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 71.1 bits (175), Expect = 4e-14
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 38/212 (17%)

Query: 48  NKIGEGGFGSVYKGR-LQDGTIVAVKVL-----SVESKQGEKEFMSEVASMANVNVCHEN 101
            KIGEG F  V K +  + G   A+K +     S+E    +   + E+ ++  ++  H N
Sbjct: 5   GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE----QVNNLREIQALRRLSP-HPN 59

Query: 102 LVKLHGGCIDGP--CRILVYDYMPNNSLSQTLLGE--EKRRAKFGWKARREIIMGIGRGL 157
           +++L     D       LV++ M  N      L E  + R+     K  +  +  + + L
Sbjct: 60  ILRLIEVLFDRKTGRLALVFELMDMN------LYELIKGRKRPLPEKRVKSYMYQLLKSL 113

Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG-----LSKLFPENTTHISTRVAGTL 212
            ++H   +  + HRDIK  NIL+  +   K++DFG      SK  P  T +ISTR     
Sbjct: 114 DHMH---RNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSK--PPYTEYISTR----- 162

Query: 213 GYLAPEYAI-SGRLTRKSDVYSFGVLLLEIVS 243
            Y APE  +  G    K D+++ G +  EI+S
Sbjct: 163 WYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 71.0 bits (174), Expect = 5e-14
 Identities = 68/224 (30%), Positives = 106/224 (47%), Gaps = 47/224 (20%)

Query: 44  FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLS---VESKQGE------KEFMSEVASMA 93
           FR    +G+GGFG V   +++  G + A K L    ++ ++GE      K+ + +V S  
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 94  NVNVCHENLVKLHGGCIDGPCRIL-----------VYDYMPNNSLSQTLLGEEKRRAKFG 142
            V++ +    K      D  C +L           +Y+            G ++ RA F 
Sbjct: 62  VVSLAYAYETK------DALCLVLTLMNGGDLKFHIYNMGNP--------GFDEERAVF- 106

Query: 143 WKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 202
           + A  EI  G    L  +H E    +V+RD+K  NILLD   + +ISD GL+   PE  T
Sbjct: 107 YAA--EITCG----LEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157

Query: 203 HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT 246
            I  RV GT+GY+APE   + R T   D +  G L+ E++ G++
Sbjct: 158 -IRGRV-GTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKS 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 71.2 bits (174), Expect = 6e-14
 Identities = 57/205 (27%), Positives = 104/205 (50%), Gaps = 28/205 (13%)

Query: 49  KIGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           KIGEG  G V    ++  G +VAVK + +  +Q  +   +EV  M +    HEN+V+++ 
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ--HENVVEMYN 84

Query: 108 GCIDGPCRILVYDYMPNNSLS----QTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
             + G    +V +++   +L+     T + EE+  A         + + + + L+ +H +
Sbjct: 85  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA---------VCLAVLKALSVLHAQ 135

Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFG----LSKLFPENTTHISTRVAGTLGYLAPEY 219
               V+HRDIK+ +ILL  +   K+SDFG    +SK  P   +     + GT  ++APE 
Sbjct: 136 ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS-----LVGTPYWMAPEL 187

Query: 220 AISGRLTRKSDVYSFGVLLLEIVSG 244
                   + D++S G++++E+V G
Sbjct: 188 ISRLPYGPEVDIWSLGIMVIEMVDG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 71.3 bits (175), Expect = 6e-14
 Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 29/212 (13%)

Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQG-EKEFMSEVASMANVNVCHEN 101
           F    ++G G  G V K      G I+A K++ +E K     + + E+  +   N  +  
Sbjct: 3   FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPY-- 60

Query: 102 LVKLHGGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARR--EIIMG-----I 153
           +V  +G    DG   I + ++M   SL Q L            KA R  E I+G     +
Sbjct: 61  IVGFYGAFYSDGEISICM-EHMDGGSLDQVLK-----------KAGRIPENILGKISIAV 108

Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL Y+ E+ +  ++HRD+K SNIL++     K+ DFG+S    ++   ++    GT  
Sbjct: 109 LRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRS 163

Query: 214 YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
           Y++PE       T +SD++S G+ L+E+  GR
Sbjct: 164 YMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 71.2 bits (174), Expect = 7e-14
 Identities = 60/218 (27%), Positives = 99/218 (45%), Gaps = 30/218 (13%)

Query: 50  IGEGGFGSVY--------KGRLQDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHE 100
           +GEG FG V         K +      VAVK+L  ++   +  + +SE+  M  +   H+
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK-HK 78

Query: 101 NLVKLHGGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARR------------ 147
           N++ L G C  DGP  +LV +Y    +L + L         + +   +            
Sbjct: 79  NIINLLGACTQDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137

Query: 148 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 207
                + RG+ Y+  +     +HRD+   N+L+ ++   KI+DFGL++    N  +    
Sbjct: 138 SCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDV-HNIDYYKKT 193

Query: 208 VAGTL--GYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
             G L   ++APE       T +SDV+SFGVLL EI +
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 70.6 bits (173), Expect = 8e-14
 Identities = 66/226 (29%), Positives = 102/226 (45%), Gaps = 36/226 (15%)

Query: 49  KIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK-QG-------EKEFMSEVASMANVNVCH 99
           KIGEG +G VYK R +     +A+K + +E + +G       E   + E+         H
Sbjct: 9   KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ--------H 60

Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKAR--REIIMGIGRGL 157
            N+V+L           LV++Y     L   L         F    R  +  +  I RG+
Sbjct: 61  GNIVRLQDVVHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGI 115

Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLF--PENT-THISTRVAGTLG 213
           AY H      V+HRD+K  N+L+D+  N  K++DFGL++ F  P  T TH       TL 
Sbjct: 116 AYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV----TLW 168

Query: 214 YLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYH 258
           Y APE  +  R  +   D++S G +  E+V+ +     D ++ E  
Sbjct: 169 YRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELF 214

Length = 294

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 70.6 bits (173), Expect = 8e-14
 Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 23/211 (10%)

Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKV--LSVESKQGEKEFMSEVASMANVNVCHE 100
           F+   KIGEG +G VYK R    G +VA+K   L  E++      + E++ +  +N  H 
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN--HP 59

Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKAR--REIIMGIGRGLA 158
           N+VKL           LV+++     L Q L          G      +  +  + +GLA
Sbjct: 60  NIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLA 114

Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PENT-THISTRVAGTLGYL 215
           + H      V+HRD+K  N+L++     K++DFGL++ F  P  T TH    V  TL Y 
Sbjct: 115 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH---EVV-TLWYR 167

Query: 216 APEYAISGRL-TRKSDVYSFGVLLLEIVSGR 245
           APE  +  +  +   D++S G +  E+V+ R
Sbjct: 168 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 70.5 bits (173), Expect = 9e-14
 Identities = 56/219 (25%), Positives = 103/219 (47%), Gaps = 17/219 (7%)

Query: 37  LKIATNGFRWSNKIGEGGFGSVYKGRLQDGTI-----VAVKVLSVESKQGEKEFM-SEVA 90
           + I+ +    S+ + EG FG ++ G L D        V VK +   + + +   +  E  
Sbjct: 1   IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60

Query: 91  SMANVNVCHENLVKLHGGCIDGPCRILV-YDYMPNNSLSQTL----LGEEKRRAKFGWKA 145
            +  ++  H+N++ +   CI+      V Y YM   +L   L    LGE         + 
Sbjct: 61  LLYGLS--HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQ 118

Query: 146 RREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTHI 204
              + + I  G++Y+H+     V+H+DI   N ++D+    KI+D  LS+ LFP +   +
Sbjct: 119 LVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCL 175

Query: 205 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
                  + ++A E  ++   +  SDV+SFGVLL E+++
Sbjct: 176 GDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 71.0 bits (175), Expect = 9e-14
 Identities = 57/216 (26%), Positives = 99/216 (45%), Gaps = 37/216 (17%)

Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCHENLVKLH 106
           IG G +G V      + G  VA+K +S   +     K  + E+  + ++   HEN++ L 
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLR--HENIIGLL 65

Query: 107 GGCIDGPCRI-------LVYDYMPNNSLSQTL-----LGEEKRRAKFGWKARREIIMGIG 154
              I  P          +V + M  + L + +     L ++  +           +  I 
Sbjct: 66  D--ILRPPSPEDFNDVYIVTELMETD-LHKVIKSPQPLTDDHIQY---------FLYQIL 113

Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF---PENTTHISTRVAGT 211
           RGL Y+H     +V+HRD+K SNIL++ N + KI DFGL++      +    ++  V  T
Sbjct: 114 RGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV-T 169

Query: 212 LGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
             Y APE  +S  R T+  D++S G +  E+++ + 
Sbjct: 170 RWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKP 205

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 70.5 bits (172), Expect = 1e-13
 Identities = 57/205 (27%), Positives = 102/205 (49%), Gaps = 28/205 (13%)

Query: 49  KIGEGGFGSV-YKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           KIGEG  G V        G  VAVK + +  +Q  +   +EV  M + +  HEN+V ++ 
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYH--HENVVDMYN 86

Query: 108 GCIDGPCRILVYDYMPNNSLS----QTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
             + G    +V +++   +L+     T + EE+            + + + R L+Y+H +
Sbjct: 87  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT---------VCLSVLRALSYLHNQ 137

Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFG----LSKLFPENTTHISTRVAGTLGYLAPEY 219
               V+HRDIK+ +ILL  +   K+SDFG    +SK  P+  +     + GT  ++APE 
Sbjct: 138 ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS-----LVGTPYWMAPEV 189

Query: 220 AISGRLTRKSDVYSFGVLLLEIVSG 244
                   + D++S G++++E++ G
Sbjct: 190 ISRLPYGTEVDIWSLGIMVIEMIDG 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 72.2 bits (177), Expect = 1e-13
 Identities = 57/198 (28%), Positives = 94/198 (47%), Gaps = 22/198 (11%)

Query: 64  QDGTIVAVKVLSVESKQGEKE---FMSEVASMANVNVCHENLVKLHGGCIDGPCRIL-VY 119
             G  VA+K+L  ++ + E +   F  E A  A +   H N+V L       P  +  V+
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLY--HPNIVALLDSGEAPPGLLFAVF 58

Query: 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL 179
           +Y+P  +L + L  +    A  G   R  +++ +   LA  H +    +VHRD+K  NI+
Sbjct: 59  EYVPGRTLREVLAADGALPA--GETGR--LMLQVLDALACAHNQ---GIVHRDLKPQNIM 111

Query: 180 L---DQNFNPKISDFGLSKLFP------ENTTHISTRVAGTLGYLAPEYAISGRLTRKSD 230
           +       + K+ DFG+  L P        T   +T V GT  Y APE      +T  SD
Sbjct: 112 VSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSD 171

Query: 231 VYSFGVLLLEIVSGRTAV 248
           +Y++G++ LE ++G+  V
Sbjct: 172 LYAWGLIFLECLTGQRVV 189

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 70.1 bits (171), Expect = 1e-13
 Identities = 60/229 (26%), Positives = 107/229 (46%), Gaps = 31/229 (13%)

Query: 38  KIATNGFRWSNKIGEGGFGSVYKGRL------QDGTIVAVKVLSVESKQG-EKEFMSEVA 90
           +I  +  R+  ++GE  FG VYKG L      +    VA+K L  +++    +EF  E  
Sbjct: 1   EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE-- 58

Query: 91  SMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLL----------GEEKRRAK 140
           +M    + H N+V L G         +++ Y  ++ L + L+           ++ +  K
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118

Query: 141 FGWKARR--EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198
              +      I+  I  G+ ++      HVVH+D+ T N+L+    N KISD G   LF 
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLG---LFR 172

Query: 199 ENTTHISTRVAGT----LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
           E       ++ G     + +++PE  + G+ +  SD++S+GV+L E+ S
Sbjct: 173 EVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 38/96 (39%), Positives = 56/96 (58%), Gaps = 6/96 (6%)

Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS--TRVAG 210
           I RGL YIH     +V+HRD+K SN+LL+ N + KI DFGL+++      H    T    
Sbjct: 115 ILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA 171

Query: 211 TLGYLAPEYAISGRLTRKS-DVYSFGVLLLEIVSGR 245
           T  Y APE  ++ +   K+ D++S G +L E++S R
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 69.7 bits (170), Expect = 1e-13
 Identities = 55/200 (27%), Positives = 101/200 (50%), Gaps = 17/200 (8%)

Query: 49  KIGEGGFGSVYKG---RLQDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHENLVK 104
           KIG+G FG V+KG   R Q   +VA+K++ +E  + E ++   E+  ++  +  +  + K
Sbjct: 11  KIGKGSFGEVFKGIDNRTQ--KVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY--VTK 66

Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
            +G  +      ++ +Y+   S    L        +      REI+    +GL Y+H E 
Sbjct: 67  YYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA-TILREIL----KGLDYLHSEK 121

Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
           +   +HRDIK +N+LL ++   K++DFG++    +     +T V GT  ++APE      
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSA 177

Query: 225 LTRKSDVYSFGVLLLEIVSG 244
              K+D++S G+  +E+  G
Sbjct: 178 YDSKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 70.6 bits (173), Expect = 1e-13
 Identities = 73/250 (29%), Positives = 109/250 (43%), Gaps = 29/250 (11%)

Query: 26  LKNINAF---------SYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDG-TIVAVKVLS 75
            KNI+ F            +L++    F     IG G FG V   R +    + A+K+LS
Sbjct: 18  NKNIDNFLSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLS 77

Query: 76  VES--KQGEKEFM-SEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLL 132
                K+ +  F   E   MA+ N   E +V+LH    D     +V +YMP   L   L+
Sbjct: 78  KFEMIKRSDSAFFWEERDIMAHAN--SEWIVQLHYAFQDDKYLYMVMEYMPGGDLV-NLM 134

Query: 133 GEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG 192
                  K+      E+++     L  IH       +HRD+K  N+LLD++ + K++DFG
Sbjct: 135 SNYDIPEKWARFYTAEVVLA----LDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFG 187

Query: 193 LS-KLFPENTTHISTRVAGTLGYLAPEYAIS----GRLTRKSDVYSFGVLLLEIVSGRTA 247
              K+         T V GT  Y++PE   S    G   R+ D +S GV L E++ G T 
Sbjct: 188 TCMKMDANGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Query: 248 VDFDVQLGEY 257
              D  +G Y
Sbjct: 247 FYADSLVGTY 256

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 69.6 bits (170), Expect = 2e-13
 Identities = 70/218 (32%), Positives = 105/218 (48%), Gaps = 35/218 (16%)

Query: 44  FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLS---VESKQGE------KEFMSEVASMA 93
           FR    +G+GGFG V   +++  G + A K L    ++ ++GE      K+ + +V S  
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 94  NVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLL-----GEEKRRAKFGWKARRE 148
            VN+ +    K      D  C  LV   M    L   +      G E+ RA F      E
Sbjct: 62  VVNLAYAYETK------DALC--LVLTIMNGGDLKFHIYNMGNPGFEEERALF---YAAE 110

Query: 149 IIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRV 208
           I+ G    L  +H E   + V+RD+K  NILLD   + +ISD GL+   PE  + I  RV
Sbjct: 111 ILCG----LEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES-IRGRV 162

Query: 209 AGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT 246
            GT+GY+APE   + R T   D +  G L+ E++ G++
Sbjct: 163 -GTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQS 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 69.7 bits (171), Expect = 2e-13
 Identities = 67/243 (27%), Positives = 111/243 (45%), Gaps = 58/243 (23%)

Query: 49  KIGEGGFGSVYKGRLQD-GTIVAVK--VLSVESKQGEKEFMSEVASMANVNVCHENLV-- 103
           KIGEG +G V+K R ++ G IVA+K  V S +    +K  + E+  +  +   H NLV  
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLK--HPNLVNL 65

Query: 104 --------KLHGGCIDGPCRILVYDYMPNNSLSQTLLGE-EKRRAKFGWKARREIIMGIG 154
                   KLH          LV++Y        T+L E EK          ++II    
Sbjct: 66  IEVFRRKRKLH----------LVFEY-----CDHTVLNELEKNPRGVPEHLIKKIIWQTL 110

Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF----PENTTHISTRVAG 210
           + + + H   + + +HRD+K  NIL+ +    K+ DFG +++      + T +++TR   
Sbjct: 111 QAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR--- 164

Query: 211 TLGYLAPEYAISGRLTRKS--DVYSFGVLLLEIVS------GRTAVDFDVQLGEYHLVDK 262
              Y APE  + G        DV++ G +  E+++      G++ VD   QL   +L+ K
Sbjct: 165 --WYRAPEL-LVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD---QL---YLIRK 215

Query: 263 AWG 265
             G
Sbjct: 216 TLG 218

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 69.7 bits (170), Expect = 2e-13
 Identities = 61/221 (27%), Positives = 107/221 (48%), Gaps = 36/221 (16%)

Query: 50  IGEGGFGSVY--------KGRLQDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHE 100
           +GEG FG V         K +    T VAVK+L  ++ + +  + +SE+  M  +   H+
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK-HK 84

Query: 101 NLVKLHGGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWK---------ARREII 150
           N++ L G C  DGP  ++V +Y    +L + L        ++ +          + ++++
Sbjct: 85  NIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143

Query: 151 ---MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 207
                + RG+ Y+  +     +HRD+   N+L+ ++   KI+DFGL++    +  HI   
Sbjct: 144 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 196

Query: 208 VAGTLG-----YLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
              T G     ++APE       T +SDV+SFGVLL EI +
Sbjct: 197 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 69.3 bits (169), Expect = 2e-13
 Identities = 59/202 (29%), Positives = 102/202 (50%), Gaps = 15/202 (7%)

Query: 48  NKIGEGGFGSVYKGR--LQDGTIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLVK 104
           +K+GEG + +VYKGR  L D  +VA+K + +E ++G     + EV+ + ++   H N+V 
Sbjct: 12  DKLGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLK--HANIVT 68

Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           LH          LV++Y+ +  L Q L   +           +  +  + RGL Y H   
Sbjct: 69  LHDIIHTEKSLTLVFEYL-DKDLKQYL---DDCGNSINMHNVKLFLFQLLRGLNYCHRR- 123

Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI-SG 223
              V+HRD+K  N+L+++    K++DFGL++     T   S  V  TL Y  P+  + S 
Sbjct: 124 --KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGST 180

Query: 224 RLTRKSDVYSFGVLLLEIVSGR 245
             + + D++  G +  E+ +GR
Sbjct: 181 DYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 68.5 bits (167), Expect = 4e-13
 Identities = 65/214 (30%), Positives = 105/214 (49%), Gaps = 27/214 (12%)

Query: 44  FRWSNKIGEGGFGSVYKGRLQD-GTIVAVKVLSVE--SKQGEKEFMS---EVASMANVNV 97
           +R    +G G FG VY     D G  +AVK +  +  S++  KE  +   E+  + N+  
Sbjct: 4   WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR- 62

Query: 98  CHENLVKLHGGCIDGPCR---ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIG 154
            H+ +V+ +G C+  P      +  +YMP  S+   L            +  R+I+ G+ 
Sbjct: 63  -HDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGV- 119

Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS----TRVAG 210
              +Y+H  +   +VHRDIK +NIL D   N K+ DFG SK     T  +S      V G
Sbjct: 120 ---SYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRI--QTICMSGTGIKSVTG 171

Query: 211 TLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVS 243
           T  +++PE  ISG    RK+DV+S    ++E+++
Sbjct: 172 TPYWMSPE-VISGEGYGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 68.3 bits (167), Expect = 4e-13
 Identities = 55/203 (27%), Positives = 101/203 (49%), Gaps = 13/203 (6%)

Query: 49  KIGEGGFGS--VYKGRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVK 104
           KIGEG FG   + K + +DG    +K +++   S +  +E   EVA ++N+   H N+V+
Sbjct: 7   KIGEGSFGKAILVKSK-EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMK--HPNIVQ 63

Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
                 +     +V DY     L + +    +R   F      +  + I   L ++H+  
Sbjct: 64  YQESFEENGNLYIVMDYCEGGDLYKKI--NAQRGVLFPEDQILDWFVQICLALKHVHDR- 120

Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              ++HRDIK+ NI L ++   K+ DFG++++   +T  ++    GT  YL+PE   +  
Sbjct: 121 --KILHRDIKSQNIFLTKDGTIKLGDFGIARVL-NSTVELARTCIGTPYYLSPEICENRP 177

Query: 225 LTRKSDVYSFGVLLLEIVSGRTA 247
              KSD+++ G +L E+ + + A
Sbjct: 178 YNNKSDIWALGCVLYEMCTLKHA 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 68.6 bits (168), Expect = 4e-13
 Identities = 61/240 (25%), Positives = 107/240 (44%), Gaps = 50/240 (20%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKE-----FMSEVASMANVNVCHENL 102
           KIGEG +G VYKGR  + G IVA+K + +ES   E+E      + E++ +  +   H N+
Sbjct: 7   KIGEGTYGVVYKGRNKKTGQIVAMKKIRLES---EEEGVPSTAIREISLLKELQ--HPNI 61

Query: 103 VKLHGGCIDGPCRILVYDYM------------PNNSLSQTLLGEEKRRAKFGWKARREII 150
           V L    +      L+++++                +   L+              +  +
Sbjct: 62  VCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELV--------------KSYL 107

Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRV-- 208
             I +G+ + H      V+HRD+K  N+L+D     K++DFGL++ F      I  RV  
Sbjct: 108 YQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF-----GIPVRVYT 159

Query: 209 --AGTLGYLAPEYAI-SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG 265
               TL Y APE  + S R +   D++S G +  E+ + +     D ++ +   + +  G
Sbjct: 160 HEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILG 219

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 68.9 bits (168), Expect = 4e-13
 Identities = 60/204 (29%), Positives = 105/204 (51%), Gaps = 23/204 (11%)

Query: 49  KIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQG-EKEFMSEVASMANVNVCHENLVKLH 106
           ++G G  G V K + +  G I+A K++ +E K     + + E+  +   N  +  +V  +
Sbjct: 12  ELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY--IVGFY 69

Query: 107 GGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII----MGIGRGLAYIH 161
           G    DG   I + ++M   SL Q L  +E +R         EI+    + + RGLAY+ 
Sbjct: 70  GAFYSDGEISICM-EHMDGGSLDQVL--KEAKRIP------EEILGKVSIAVLRGLAYLR 120

Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI 221
           E+ Q  ++HRD+K SNIL++     K+ DFG+S    ++   ++    GT  Y++PE   
Sbjct: 121 EKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQ 175

Query: 222 SGRLTRKSDVYSFGVLLLEIVSGR 245
               + +SD++S G+ L+E+  GR
Sbjct: 176 GTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 68.5 bits (167), Expect = 4e-13
 Identities = 66/227 (29%), Positives = 114/227 (50%), Gaps = 33/227 (14%)

Query: 49  KIGEGGFGSVYKGR-LQDG-TIVAVKVLSVESKQGEKEFM-----SEVASMANVNVC-HE 100
           +IGEG +G V+K R L++G   VA+K + V   Q  +E M      EVA + ++    H 
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRVRV---QTGEEGMPLSTIREVAVLRHLETFEHP 64

Query: 101 NLVKLHGGCI----DGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR 155
           N+V+L   C     D   ++ LV++++ +  L+  L  ++        +  ++++  + R
Sbjct: 65  NVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL--DKVPEPGVPTETIKDMMFQLLR 121

Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
           GL ++H      VVHRD+K  NIL+  +   K++DFGL++++  +     T V  TL Y 
Sbjct: 122 GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWYR 176

Query: 216 APEYAISGRLTRKSDVYSFGVLLLE------IVSGRTAVDFDVQLGE 256
           APE  +        D++S G +  E      +  G + VD   QLG+
Sbjct: 177 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGK 220

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 68.4 bits (167), Expect = 4e-13
 Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 25/215 (11%)

Query: 50  IGEGGFGSVYKGRL--QDGTI--VAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLV 103
           +G+G FGSV + +L  +DG+   VAVK+L  +  S    +EF+ E A M   +  H N++
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD--HPNVI 64

Query: 104 KLHGGCIDG------PCRILVYDYMPNNSLSQTLL----GEEKRRAKFGWKARREIIMGI 153
           KL G  +        P  +++  +M +  L   LL    GEE          R   ++ I
Sbjct: 65  KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR--FMIDI 122

Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS-KLFPENTTHISTRVAGTL 212
             G+ Y+  +   + +HRD+   N +L++N    ++DFGLS K++  +           +
Sbjct: 123 ASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPV 179

Query: 213 GYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRT 246
            +LA E       T  SDV++FGV + EI++ G+T
Sbjct: 180 KWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQT 214

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 68.1 bits (166), Expect = 6e-13
 Identities = 55/201 (27%), Positives = 103/201 (51%), Gaps = 19/201 (9%)

Query: 49  KIGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           ++G+G FG VYK + ++ G + A KV+  +S++  +++M E+  +A+ +  H N+VKL  
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCD--HPNIVKLLD 69

Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
                    ++ ++    ++   +L  E+   +      R +       L Y+HE     
Sbjct: 70  AFYYENNLWILIEFCAGGAVDAVMLELERPLTE---PQIRVVCKQTLEALNYLHEN---K 123

Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVA--GTLGYLAPEYAISGR- 224
           ++HRD+K  NIL   + + K++DFG+S    +NT  I  R +  GT  ++APE  +    
Sbjct: 124 IIHRDLKAGNILFTLDGDIKLADFGVSA---KNTRTIQRRDSFIGTPYWMAPEVVMCETS 180

Query: 225 ----LTRKSDVYSFGVLLLEI 241
                  K+DV+S G+ L+E+
Sbjct: 181 KDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 67.8 bits (166), Expect = 7e-13
 Identities = 61/202 (30%), Positives = 101/202 (50%), Gaps = 17/202 (8%)

Query: 49  KIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLVKLH 106
           K+GEG + +VYKGR +  G +VA+K + +E ++G     + E + + ++   H N+V LH
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLK--HANIVTLH 69

Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
                     LV++Y+ +  L Q +   +           R  +  + RGLAY H   Q 
Sbjct: 70  DIIHTKKTLTLVFEYL-DTDLKQYM---DDCGGGLSMHNVRLFLFQLLRGLAYCH---QR 122

Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGL--SKLFPENTTHISTRVAGTLGYLAPEYAI-SG 223
            V+HRD+K  N+L+ +    K++DFGL  +K  P  T   S  V  TL Y  P+  + S 
Sbjct: 123 RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT--YSNEVV-TLWYRPPDVLLGST 179

Query: 224 RLTRKSDVYSFGVLLLEIVSGR 245
             +   D++  G +  E+ +GR
Sbjct: 180 EYSTSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 68.5 bits (168), Expect = 8e-13
 Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 41/215 (19%)

Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCHENLVKLH 106
           +G G +G V        G  VA+K LS   +S    K    E+  + +++  HEN++ L 
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMD--HENVIGL- 79

Query: 107 GGCID--GPCRIL-----VYDYMP------NNSLSQTLLGEEKRRAKFGWKARREIIMGI 153
              +D   P   L     VY          NN +    L ++    +F       ++  I
Sbjct: 80  ---LDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDD--HIQF-------LVYQI 127

Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP-ENTTHISTRVAGTL 212
            RGL YIH      ++HRD+K SNI ++++   KI DFGL++    E T +++TR     
Sbjct: 128 LRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR----- 179

Query: 213 GYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRT 246
            Y APE  ++     +  D++S G ++ E+++G+T
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKT 214

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 67.8 bits (165), Expect = 9e-13
 Identities = 69/246 (28%), Positives = 112/246 (45%), Gaps = 28/246 (11%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGE---KEFMSEVASMANVNVCHENLVK 104
           +IG G FG+VY  R ++   +VA+K +S   KQ     ++ + EV  +  +   H N ++
Sbjct: 32  EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK--HPNSIE 89

Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
             G  +      LV +Y    S S  L   +K   +    A   I  G  +GLAY+H   
Sbjct: 90  YKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAA---ITHGALQGLAYLHSH- 144

Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLAPEYAIS- 222
             +++HRDIK  NILL +    K++DFG + +  P N+        GT  ++APE  ++ 
Sbjct: 145 --NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS------FVGTPYWMAPEVILAM 196

Query: 223 --GRLTRKSDVYSFGVLLLEIVSGRTAV-DFDVQLGEYHLVDKAWGMYNSKE----LMNL 275
             G+   K DV+S G+  +E+   +  + + +     YH+         S E      N 
Sbjct: 197 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNF 256

Query: 276 VDPMLY 281
           VD  L 
Sbjct: 257 VDSCLQ 262

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 67.9 bits (166), Expect = 1e-12
 Identities = 37/95 (38%), Positives = 59/95 (62%), Gaps = 10/95 (10%)

Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGT 211
           I RGL Y+H      VVHRD+K SNIL+++N + KI DFGL+++  P+ T ++STR    
Sbjct: 117 ILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY--- 170

Query: 212 LGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGR 245
             Y APE  ++  +   + D++S G +  E++ G+
Sbjct: 171 --YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 67.5 bits (165), Expect = 1e-12
 Identities = 63/206 (30%), Positives = 97/206 (47%), Gaps = 33/206 (16%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQG-EK--EFMSEVASMANVNVCHENLVK 104
           +IG G FG+VY  R ++   +VA+K +S   KQ  EK  + + EV  +  +   H N ++
Sbjct: 22  EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR--HPNTIE 79

Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARRE-----IIMGIGRGLAY 159
             G  +      LV +Y          LG      +   K  +E     I  G  +GLAY
Sbjct: 80  YKGCYLREHTAWLVMEY---------CLGSASDILEVHKKPLQEVEIAAICHGALQGLAY 130

Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLAPE 218
           +H       +HRDIK  NILL +    K++DFG + L  P N+        GT  ++APE
Sbjct: 131 LHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANS------FVGTPYWMAPE 181

Query: 219 YAIS---GRLTRKSDVYSFGVLLLEI 241
             ++   G+   K DV+S G+  +E+
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 67.4 bits (164), Expect = 1e-12
 Identities = 50/198 (25%), Positives = 100/198 (50%), Gaps = 14/198 (7%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           KIG+G  G+V+    +  G  VA+K ++++ +  ++  ++E+  M  +   + N+V    
Sbjct: 26  KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELK--NPNIVNFLD 83

Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
             + G    +V +Y+   SL+  +       A+     R  +     + L ++H      
Sbjct: 84  SFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECL-----QALEFLHAN---Q 135

Query: 168 VVHRDIKTSNILLDQNFNPKISDFGL-SKLFPENTTHISTRVAGTLGYLAPEYAISGRLT 226
           V+HRDIK+ N+LL  + + K++DFG  +++ PE +    + + GT  ++APE        
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYG 193

Query: 227 RKSDVYSFGVLLLEIVSG 244
            K D++S G++ +E+V G
Sbjct: 194 PKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 67.0 bits (163), Expect = 1e-12
 Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 10/204 (4%)

Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVK---VLSVESKQGEKEFMSEVASMANVNVCH 99
           F+   KIG G F  VY+   L D   VA+K   +  +   +  ++ + E+  +  +N  H
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN--H 61

Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
            N++K     I+     +V +      LSQ +   +K++     +   +  + +   + +
Sbjct: 62  PNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH 121

Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEY 219
           +H      V+HRDIK +N+ +      K+ D GL + F   TT   + V GT  Y++PE 
Sbjct: 122 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 177

Query: 220 AISGRLTRKSDVYSFGVLLLEIVS 243
                   KSD++S G LL E+ +
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAA 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 66.9 bits (163), Expect = 1e-12
 Identities = 57/205 (27%), Positives = 100/205 (48%), Gaps = 23/205 (11%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEF--MSEVASMANVNVC-HENLVK 104
           +IG G +G+VYK R    G  VA+K + V++ +       + EVA +  +    H N+V+
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 105 LHGGC----IDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKAR--REIIMGIGRGL 157
           L   C     D   ++ LV+++     + Q L     +    G  A   ++++    RGL
Sbjct: 67  LMDVCATSRTDRETKVTLVFEH-----VDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGL 121

Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS-TRVAGTLGYLA 216
            ++H      +VHRD+K  NIL+      K++DFGL++++   +  ++ T V  TL Y A
Sbjct: 122 DFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYRA 175

Query: 217 PEYAISGRLTRKSDVYSFGVLLLEI 241
           PE  +        D++S G +  E+
Sbjct: 176 PEVLLQSTYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 67.4 bits (164), Expect = 1e-12
 Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 23/201 (11%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGE---KEFMSEVASMANVNVCHENLVK 104
           +IG G FG+VY  R +++  +VA+K +S   KQ     ++ + EV  +  +   H N ++
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR--HPNTIQ 79

Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
             G  +      LV +Y    S S  L   +K   +    A   +  G  +GLAY+H   
Sbjct: 80  YRGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAA---VTHGALQGLAYLHSH- 134

Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLAPEYAIS- 222
             +++HRD+K  NILL +    K+ DFG + +  P N         GT  ++APE  ++ 
Sbjct: 135 --NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX------FVGTPYWMAPEVILAM 186

Query: 223 --GRLTRKSDVYSFGVLLLEI 241
             G+   K DV+S G+  +E+
Sbjct: 187 DEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 67.0 bits (163), Expect = 1e-12
 Identities = 62/220 (28%), Positives = 106/220 (48%), Gaps = 32/220 (14%)

Query: 45  RWSNKIGEGGFGSVYKGRLQ-DGTIV--AVKVL-SVESKQGEKEFMSEVASMANVNVCHE 100
           ++ + IGEG FG V +  ++ DG  +  A+K+L    S+   ++F  E+  +  +   H 
Sbjct: 5   KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH-HP 63

Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSL------SQTLLGEEKRRAKFGWKA---RREII- 150
           N++ L G C +     +  +Y P  +L      S+ L  +     + G  +    ++++ 
Sbjct: 64  NIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQ 123

Query: 151 --MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRV 208
               +  G+ Y+ E+     +HRD+   N+L+ +N   KI+DFGLS+            V
Sbjct: 124 FASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR-------GEEVYV 173

Query: 209 AGTLG-----YLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
             T+G     ++A E       T KSDV+SFGVLL EIVS
Sbjct: 174 KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 56/204 (27%), Positives = 89/204 (43%), Gaps = 25/204 (12%)

Query: 49  KIGEGGFGSVYKGRLQD-GTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCHENLVK 104
           ++G+GG+G V+  + +D G IVA+K +    +      +  ++E   +       E LVK
Sbjct: 8   QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK--SEWLVK 65

Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGE----EKRRAKFGWKARREIIMGIGRGLAYI 160
           L     D     L  +Y+P     +TLL       +  A+F      E +  +   L YI
Sbjct: 66  LLYAFQDDEYLYLAMEYVPGGDF-RTLLNNLGVLSEDHARFYMAEMFEAVDALHE-LGYI 123

Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
                    HRD+K  N L+D + + K++DFGLSK         +  V G+  Y+APE  
Sbjct: 124 ---------HRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVVGSPDYMAPEVL 170

Query: 221 ISGRLTRKSDVYSFGVLLLEIVSG 244
                    D +S G +L E + G
Sbjct: 171 RGKGYDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 66/204 (32%), Positives = 91/204 (44%), Gaps = 23/204 (11%)

Query: 50  IGEGGFGSVY-KGRLQDGTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCHENLVKL 105
           IG+G FG V    R  DG   AVKVL    V +++ +K  M+E   +   NV H  LV L
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLK-NVKHPFLVGL 61

Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEE---KRRAKFGWKARREIIMGIGRGLAYIHE 162
           H           V D++    L   L  E    + RA+F           I   L Y+H 
Sbjct: 62  HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARF-------YAAEIASALGYLH- 113

Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLGYLAPEYA 220
               ++V+RD+K  NILLD   +  ++DFGL K  +   +TT   T   GT  YLAPE  
Sbjct: 114 --SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT---TTFCGTPEYLAPEVI 168

Query: 221 ISGRLTRKSDVYSFGVLLLEIVSG 244
                    D +  G +L E++ G
Sbjct: 169 RKQPYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 66.5 bits (162), Expect = 2e-12
 Identities = 53/202 (26%), Positives = 94/202 (46%), Gaps = 19/202 (9%)

Query: 50  IGEGGFGSVYKGRLQ----DGTIVAVKVL--SVESKQGEKEFMSEVASMANVNVCHENLV 103
           +G G FG + +G L+        VA+  L      KQ  + F++E  ++   +  H N+V
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQ-RRGFLAEALTLGQFD--HSNIV 69

Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
           +L G    G   ++V +YM N +L   L    K   +        ++ G+  G+ Y+ E 
Sbjct: 70  RLEGVITRGNTMMIVTEYMSNGALDSFL---RKHEGQLVAGQLMGMLPGLASGMKYLSEM 126

Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL--APEYAI 221
                VH+ +    +L++ +   KIS F   +L  + +  I T ++G    L  APE   
Sbjct: 127 ---GYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQ 181

Query: 222 SGRLTRKSDVYSFGVLLLEIVS 243
               +  SDV+SFG+++ E++S
Sbjct: 182 YHHFSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 66.4 bits (162), Expect = 2e-12
 Identities = 56/221 (25%), Positives = 98/221 (44%), Gaps = 54/221 (24%)

Query: 45  RWSNKIGEGGFGSVYKG-RLQDGTIVAVKVLSVE-SKQGEKEFMSEVASM---------- 92
           ++   +G G  G+VYK   L    I+AVKV+ ++ + + +K+ MSE+  +          
Sbjct: 4   QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIG 63

Query: 93  --------ANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWK 144
                     +++C E    + GG +D      VY  +P + L +               
Sbjct: 64  FYGAFFVENRISICTE---FMDGGSLD------VYRKIPEHVLGR--------------- 99

Query: 145 ARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 204
               I + + +GL Y+       ++HRD+K SN+L++     K+ DFG+S    +    I
Sbjct: 100 ----IAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVST---QLVNSI 149

Query: 205 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
           +    GT  Y+APE     +    SDV+S G+  +E+  GR
Sbjct: 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 66.2 bits (161), Expect = 2e-12
 Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 22/210 (10%)

Query: 50  IGEGGFGSVYKGRLQ-DGTIV--AVKVL-SVESKQGEKEFMSEVASMANVNVCHENLVKL 105
           IGEG FG V K R++ DG  +  A+K +    SK   ++F  E+  +  +   H N++ L
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG-HHPNIINL 61

Query: 106 HGGCIDGPCRILVYDYMPNNSL------SQTLLGEEKRRAKFGWKA---RREIIM---GI 153
            G C       L  +Y P+ +L      S+ L  +          +    ++++     +
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121

Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RG+ Y+ ++     +HRD+   NIL+ +N+  KI+DFGLS+   +      T     + 
Sbjct: 122 ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVR 176

Query: 214 YLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
           ++A E       T  SDV+S+GVLL EIVS
Sbjct: 177 WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 66.7 bits (162), Expect = 2e-12
 Identities = 53/199 (26%), Positives = 99/199 (49%), Gaps = 16/199 (8%)

Query: 49  KIGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGEKEFMSEVASM-ANVNVCHENLVKLH 106
           KIG+G  G+VY    +  G  VA+K ++++ +  ++  ++E+  M  N N    N+V   
Sbjct: 26  KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKN---PNIVNYL 82

Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
              + G    +V +Y+   SL+  +        +     R  +     + L ++H     
Sbjct: 83  DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALDFLHSN--- 134

Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGL-SKLFPENTTHISTRVAGTLGYLAPEYAISGRL 225
            V+HRDIK+ NILL  + + K++DFG  +++ PE +    + + GT  ++APE       
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAY 192

Query: 226 TRKSDVYSFGVLLLEIVSG 244
             K D++S G++ +E+V G
Sbjct: 193 GPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 65.7 bits (160), Expect = 3e-12
 Identities = 54/199 (27%), Positives = 91/199 (45%), Gaps = 12/199 (6%)

Query: 49  KIGEGGFGSVY--KGRLQDGTIVAVKVLSVESKQGEKEF-MSEVASMANVNVCHENLVKL 105
           KIGEG FG +Y  K +      V  ++   +    EKE    EV  +A +   H N+V  
Sbjct: 7   KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMK--HPNIVTF 64

Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
                +     +V +Y     L + +    +R   F         + I  GL +IH+   
Sbjct: 65  FASFQENGRLFIVMEYCDGGDLMKRI--NRQRGVLFSEDQILSWFVQISLGLKHIHDR-- 120

Query: 166 PHVVHRDIKTSNILLDQN-FNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
             ++HRDIK+ NI L +N    K+ DFG+++    ++  ++    GT  YL+PE   +  
Sbjct: 121 -KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCVGTPYYLSPEICQNRP 178

Query: 225 LTRKSDVYSFGVLLLEIVS 243
              K+D++S G +L E+ +
Sbjct: 179 YNNKTDIWSLGCVLYELCT 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 65/221 (29%), Positives = 104/221 (47%), Gaps = 24/221 (10%)

Query: 48  NKIGEGGFGSVY-KGRLQDGTIVAVKVLSVESKQGE---KEFMSEVASMANVNVCHENLV 103
           ++IG G FG+VY         +VAVK +S   KQ     ++ + EV  +  +   H N +
Sbjct: 27  HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK--HPNTI 84

Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
           +  G  +      LV +Y    S S  L   +K   +    A   I  G  +GLAY+H  
Sbjct: 85  EYKGCYLKEHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAA---ITHGALQGLAYLHSH 140

Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFG-LSKLFPENTTHISTRVAGTLGYLAPEYAIS 222
              +++HRDIK  NILL +    K++DFG  SK  P N+        GT  ++APE  ++
Sbjct: 141 ---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS------FVGTPYWMAPEVILA 191

Query: 223 ---GRLTRKSDVYSFGVLLLEIVSGRTAV-DFDVQLGEYHL 259
              G+   K DV+S G+  +E+   +  + + +     YH+
Sbjct: 192 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 232

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 65.1 bits (158), Expect = 6e-12
 Identities = 51/199 (25%), Positives = 99/199 (49%), Gaps = 16/199 (8%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASM-ANVNVCHENLVKLH 106
           KIG+G  G+VY    +  G  VA++ ++++ +  ++  ++E+  M  N N    N+V   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN---PNIVNYL 83

Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
              + G    +V +Y+   SL+  +        +     R  +     + L ++H     
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHSN--- 135

Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGL-SKLFPENTTHISTRVAGTLGYLAPEYAISGRL 225
            V+HRDIK+ NILL  + + K++DFG  +++ PE +    + + GT  ++APE       
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAY 193

Query: 226 TRKSDVYSFGVLLLEIVSG 244
             K D++S G++ +E++ G
Sbjct: 194 GPKVDIWSLGIMAIEMIEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 65.0 bits (158), Expect = 6e-12
 Identities = 58/224 (25%), Positives = 101/224 (45%), Gaps = 42/224 (18%)

Query: 50  IGEGGFGSVYKGRL----QDGTIVAVKVL----------SVESKQGEKEFMSEVAS---M 92
           +G G +G V+  R       G + A+KVL          + E  + E++ +  +     +
Sbjct: 8   LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67

Query: 93  ANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG 152
             ++   +   KLH          L+ DY+    L   L     +R +F     +E+ + 
Sbjct: 68  VTLHYAFQTDTKLH----------LILDYINGGELFTHL----SQRERF---KEQEVQIY 110

Query: 153 IGR---GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVA 209
            G     L ++H   +  +++RDIK  NILLD N +  ++DFGLSK F E+    +    
Sbjct: 111 SGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFC 167

Query: 210 GTLGYLAPEYAISGRL--TRKSDVYSFGVLLLEIVSGRTAVDFD 251
           GT+ Y+AP+    G     +  D +S GVL+ E+++G +    D
Sbjct: 168 GTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD 211

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 64.8 bits (158), Expect = 8e-12
 Identities = 53/211 (25%), Positives = 91/211 (43%), Gaps = 29/211 (13%)

Query: 44  FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSV---------ESKQGEKEFMSEVASMA 93
                 +G G FG V+  R +      A+KV+++         +    EK  + EV+   
Sbjct: 3   LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS--- 59

Query: 94  NVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGI 153
                H  +++L     D     ++ +Y+P   L   L    +   +F           I
Sbjct: 60  -----HPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYL----RNSGRFSNSTGLFYASEI 110

Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
              L Y+H +    +V+RD+K  NILLD+  + K++DFG +K   + T  +     GT  
Sbjct: 111 VCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTL----CGTPE 163

Query: 214 YLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
           YLAPE   S    +  D ++ G+L+ E++ G
Sbjct: 164 YLAPEVIQSKGHNKAVDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 64.8 bits (158), Expect = 9e-12
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 27/210 (12%)

Query: 44  FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMAN-----VNV 97
           F     +G G FG V   + +  G   A+K L    K+ E   M +V  +A      + +
Sbjct: 20  FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCL----KKREILKMKQVQHVAQEKSILMEL 75

Query: 98  CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEK---RRAKFGWKARREIIMGIG 154
            H  +V +     D      + +++    L   L    +     AKF + A  E+++   
Sbjct: 76  SHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKF-YHA--ELVLA-- 130

Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY 214
               Y+H +    +++RD+K  N+LLD   + K++DFG +K  P+ T  +     GT  Y
Sbjct: 131 --FEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTL----CGTPEY 181

Query: 215 LAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
           LAPE   S    +  D ++ GVLL E ++G
Sbjct: 182 LAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 56/222 (25%), Positives = 97/222 (43%), Gaps = 38/222 (17%)

Query: 50  IGEGGFGSVY--------KGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC--H 99
           +GEG FG V         K R      VAVK+L  +    +K+    ++ M  + +   H
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKML--KDNATDKDLADLISEMELMKLIGKH 77

Query: 100 ENLVKLHGGCI-DGPCRILVYDYMPNNSLSQTLL------------GEEKRRAKFGWKAR 146
           +N++ L G C  +GP  ++V +Y    +L + L               +    +  +K  
Sbjct: 78  KNIINLLGVCTQEGPLYVIV-EYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136

Query: 147 REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIST 206
                 + RG+ Y+        +HRD+   N+L+ ++   KI+DFGL++        I  
Sbjct: 137 VSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLAR----GVHDIDY 189

Query: 207 RVAGTLG-----YLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
               + G     ++APE       T +SDV+SFG+L+ EI +
Sbjct: 190 YKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 64.2 bits (156), Expect = 1e-11
 Identities = 63/220 (28%), Positives = 100/220 (45%), Gaps = 39/220 (17%)

Query: 44  FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCH 99
           FR    +G+GGFG V   +++  G + A K L    ++ ++GE   ++E   +  VN   
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVN--- 58

Query: 100 ENLVKLHGGCIDGPCRILV---YDYMPNNSLSQTLLGEEKRRAKF--------GWKARRE 148
                          R +V   Y Y   ++L   L        KF        G+  +R 
Sbjct: 59  --------------SRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRA 104

Query: 149 IIMG--IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIST 206
           I     +  GL  +  E    +V+RD+K  NILLD   + +ISD GL+   PE  T +  
Sbjct: 105 IFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRG 160

Query: 207 RVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT 246
           RV GT+GY+APE   + + T   D +  G L+ E++ G++
Sbjct: 161 RV-GTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQS 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 63.8 bits (155), Expect = 1e-11
 Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 29/209 (13%)

Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLS---VESKQGEK------EFMSEVASMANVNVCH 99
           +G+GGFG V   ++++ G + A K L    ++ K GEK      E + +V S   VN+ +
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG--IGRGL 157
               K H          LV   M    L   +    +R    G +  R I     I  G+
Sbjct: 61  AFESKTH--------LCLVMSLMNGGDLKYHIYNVGER----GLEMERVIHYSAQITCGI 108

Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
            ++H      +V+RD+K  N+LLD   N ++SD GL+    +  T   T+ AGT GY+AP
Sbjct: 109 LHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAP 163

Query: 218 EYAISGRLTRKSDVYSFGVLLLEIVSGRT 246
           E       +   D ++ G  + E+V+GRT
Sbjct: 164 EILKEEPYSYPVDWFAMGCSIYEMVAGRT 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 64.3 bits (156), Expect = 1e-11
 Identities = 55/205 (26%), Positives = 104/205 (50%), Gaps = 15/205 (7%)

Query: 44  FRWSNKIGEGGFGSVYK-GRLQDGTIVAVKVLSVESKQG-EKEFMSEVASMANVNVCHEN 101
           F   +++G G  G V+K      G I+A K++ +E K     + + E+  +   N  +  
Sbjct: 7   FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY-- 64

Query: 102 LVKLHGGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
           +V  +G    DG   I + ++M   SL Q L    K+  +   +   ++ + + +GL Y+
Sbjct: 65  IVGFYGAFYSDGEISICM-EHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYL 119

Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
            E+ +  ++HRD+K SNIL++     K+ DFG+S    ++   ++    GT  Y++PE  
Sbjct: 120 REKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERL 174

Query: 221 ISGRLTRKSDVYSFGVLLLEIVSGR 245
                + +SD++S G+ L+E+  GR
Sbjct: 175 QGTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 63.5 bits (154), Expect = 2e-11
 Identities = 66/257 (25%), Positives = 115/257 (44%), Gaps = 18/257 (7%)

Query: 42  NGFRWSNKIGEGGFGSVYKGRLQD-GTIVAVKVL--SVESKQGEKEFMSEVASMANVNVC 98
           N F     +GEG +G V K R ++   IVA+K    S E+++ ++  + E+  +  +   
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLK-- 58

Query: 99  HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
            EN+V+L           LV++Y+  N L    L EE        K R  I   I + + 
Sbjct: 59  QENIVELKEAFRRRGKLYLVFEYVEKNMLE---LLEEMPNGVPPEKVRSYIYQLI-KAIH 114

Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE 218
           + H+     +VHRDIK  N+L+  N   K+ DFG ++   E +    T    T  Y +PE
Sbjct: 115 WCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPE 171

Query: 219 YAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDP 278
             +     +  D++S G +L E+  G+     + ++ +   + K  G   ++++      
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQM-----K 226

Query: 279 MLYGNFPENEAIRFLKV 295
           + Y N P    +RF  V
Sbjct: 227 LFYSN-PRFHGLRFPAV 242

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 33/95 (34%), Positives = 52/95 (54%), Gaps = 8/95 (8%)

Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL---FPENTTHISTRVAGT 211
           RGL YIH     +V+HRD+K SN+L++++   +I DFG+++     P    +  T    T
Sbjct: 118 RGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174

Query: 212 LGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGR 245
             Y APE  +S    T   D++S G +  E++ GR
Sbjct: 175 RWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GR 208

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 35/95 (36%), Positives = 54/95 (56%), Gaps = 6/95 (6%)

Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGT 211
           I RGL Y+H      ++HRDIK  N+L++ N   KI DFGL+++  P+ + H++  V  T
Sbjct: 112 ILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-T 167

Query: 212 LGYLAPEYAI-SGRLTRKSDVYSFGVLLLEIVSGR 245
             Y APE  + S   T   D++S G +  E++  R
Sbjct: 168 QYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 63.3 bits (154), Expect = 3e-11
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 26/206 (12%)

Query: 50  IGEGGFGSVY---KGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKL 105
           +G+G FG V+   K    D G + A+KVL   + +      +++       V H  +VKL
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63

Query: 106 HGGCIDGPCRILVYDYMPNNSL-----SQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
           H          L+ D++    L      + +  EE    KF        +  +   L ++
Sbjct: 64  HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED--VKF-------YLAELALALDHL 114

Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVA--GTLGYLAPE 218
           H      +++RD+K  NILLD+  + K++DFGLSK   E+  H     +  GT+ Y+APE
Sbjct: 115 H---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAPE 168

Query: 219 YAISGRLTRKSDVYSFGVLLLEIVSG 244
                  T+ +D +SFGVL+ E+++G
Sbjct: 169 VVNRRGHTQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 66/230 (28%), Positives = 102/230 (44%), Gaps = 39/230 (16%)

Query: 50  IGEGGFGSVYK-GRLQDGTIVAVKVLSVESKQGEKEFMSE---VASMANVNVCHENLVKL 105
           IG+G +G VYK    +DG++ AVK+L   S   E E  +E   + S+ N    H N+VK 
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE-EIEAEYNILQSLPN----HPNVVKF 84

Query: 106 HG------GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
           +G        + G    LV +     S+++ + G      +        I+ G   GL +
Sbjct: 85  YGMFYKADKLVGGQL-WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQH 143

Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE- 218
           +H      ++HRD+K +NILL      K+ DFG+S          +T V GT  ++APE 
Sbjct: 144 LHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEV 199

Query: 219 --------YAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLV 260
                   Y+   R     DV+S G+  +E+  G      D  L + H V
Sbjct: 200 IACEQQYDYSYDAR----CDVWSLGITAIELGDG------DPPLFDMHPV 239

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 63.1 bits (153), Expect = 4e-11
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 31/213 (14%)

Query: 50  IGEGGFGSVYKGRLQ-DGTIVAVKVLS---------VESKQGEKEFMSEVASMANVNVCH 99
           IG G +  V   RL+ +  I A+KV+          ++  Q EK    + +S       +
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASS-------N 55

Query: 100 ENLVKLHGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
             LV LH  C     R+ LV +Y+    L    +   +R+ K   +  R     I   L 
Sbjct: 56  PFLVGLHS-CFQTTSRLFLVIEYVNGGDL----MFHMQRQRKLPEEHARFYAAEICIALN 110

Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLGYLA 216
           ++HE     +++RD+K  N+LLD + + K++D+G+ K  L P +TT   +   GT  Y+A
Sbjct: 111 FLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---STFCGTPNYIA 164

Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVD 249
           PE           D ++ GVL+ E+++GR+  D
Sbjct: 165 PEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 63.2 bits (154), Expect = 4e-11
 Identities = 38/101 (37%), Positives = 57/101 (56%), Gaps = 9/101 (8%)

Query: 150 IMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP----ENTTHIS 205
           I  I  GL YIH     +V+HRD+K  N+L++ +   KI DFGL++ F     EN   ++
Sbjct: 111 IYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMT 167

Query: 206 TRVAGTLGYLAPEYAISGRLTRKS-DVYSFGVLLLEIVSGR 245
             VA T  Y APE  +S +   K+ DV+S G +L E++  +
Sbjct: 168 EYVA-TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 62.4 bits (151), Expect = 4e-11
 Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 20/205 (9%)

Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENL 102
           F    +IG G +G VYK R +  G + A+KV+ +E  +       E+  M +    H N+
Sbjct: 11  FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCK--HSNI 68

Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTL-LGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
           V   G  +      +  ++    SL     +      ++  + +R  +     +GL Y+H
Sbjct: 69  VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLH 123

Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVA--GTLGYLAPEY 219
            + +   +HRDIK +NILL  N + K++DFG+S    + T  I+ R +  GT  ++APE 
Sbjct: 124 SKGK---MHRDIKGANILLTDNGHVKLADFGVSA---QITATIAKRKSFIGTPYWMAPEV 177

Query: 220 AI---SGRLTRKSDVYSFGVLLLEI 241
           A     G   +  D+++ G+  +E+
Sbjct: 178 AAVERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 63.0 bits (154), Expect = 5e-11
 Identities = 38/110 (34%), Positives = 62/110 (56%), Gaps = 18/110 (16%)

Query: 146 RREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN----- 200
           +R I+  + + L YIH     +V+HRD+K SNILL+ +   K++DFGL++   E      
Sbjct: 109 KRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPE 165

Query: 201 ----TTHISTRVAGTLGYLAPEYAI-SGRLTRKSDVYSFGVLLLEIVSGR 245
               T +++TR      Y APE  + S R T+  D++S G +L E++ G+
Sbjct: 166 NPVLTDYVATR-----WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 62.5 bits (152), Expect = 6e-11
 Identities = 64/218 (29%), Positives = 97/218 (44%), Gaps = 41/218 (18%)

Query: 50  IGEGGFGSVYKGRLQDGT-IVAVKVLS---------VESKQGEKEFMSEVASMANVNVCH 99
           IG G +  V    L+    I A+KV+          ++  Q EK    E AS       H
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVF-ETASN------H 55

Query: 100 ENLVKLHGGCIDGPCRI-LVYDYMPNNSL-----SQTLLGEEKRRAKFGWKARREIIMGI 153
             LV LH  C     R+  V +++    L      Q  L EE  R         EI +  
Sbjct: 56  PFLVGLHS-CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSA-----EISLA- 108

Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGT 211
              L ++HE     +++RD+K  N+LLD   + K++D+G+ K  + P +TT  ST   GT
Sbjct: 109 ---LNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT--ST-FCGT 159

Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVD 249
             Y+APE           D ++ GVL+ E+++GR+  D
Sbjct: 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 61.9 bits (150), Expect = 7e-11
 Identities = 48/197 (24%), Positives = 87/197 (44%), Gaps = 9/197 (4%)

Query: 49  KIGEGGFGSVY----KGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVK 104
           ++G+G FG+VY    K  + +  +  +K + V      +   +   +     + H  +VK
Sbjct: 7   RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66

Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
            H   ++     ++ +Y     L   L   +            E  + +  G+ Y+H+  
Sbjct: 67  FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR- 125

Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              ++HRD+K  NI L  N   KI DFG+S+L    +  ++T   GT  Y++PE      
Sbjct: 126 --RILHRDLKAKNIFLKNNL-LKIGDFGVSRLL-MGSCDLATTFTGTPYYMSPEALKHQG 181

Query: 225 LTRKSDVYSFGVLLLEI 241
              KSD++S G +L E+
Sbjct: 182 YDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 61.6 bits (149), Expect = 7e-11
 Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 22/206 (10%)

Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC-HEN 101
           +    ++G G +G VYK R L  G + AVK++ +E   G+ +F      +  V  C H N
Sbjct: 11  YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLE--PGD-DFSLIQQEIFMVKECKHCN 67

Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTL-LGEEKRRAKFGWKARREIIMGIGRGLAYI 160
           +V   G  +      +  +Y    SL     +       +  +  R  +     +GLAY+
Sbjct: 68  IVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYL 122

Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVA--GTLGYLAPE 218
           H + +   +HRDIK +NILL  N + K++DFG++    + T  I+ R +  GT  ++APE
Sbjct: 123 HSKGK---MHRDIKGANILLTDNGDVKLADFGVAA---KITATIAKRKSFIGTPYWMAPE 176

Query: 219 YAI---SGRLTRKSDVYSFGVLLLEI 241
            A    +G   +  D+++ G+  +E+
Sbjct: 177 VAAVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 62.4 bits (151), Expect = 7e-11
 Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 31/213 (14%)

Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLS---------VESKQGEKEFMSEVASMANVNVCH 99
           IG G +  V   RL+    I A+KV+          ++  Q EK    + ++       H
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN-------H 55

Query: 100 ENLVKLHGGCIDGPCRIL-VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
             LV LH  C     R+  V +Y+    L    +   +R+ K   +  R     I   L 
Sbjct: 56  PFLVGLHS-CFQTESRLFFVIEYVNGGDL----MFHMQRQRKLPEEHARFYSAEISLALN 110

Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLGYLA 216
           Y+HE     +++RD+K  N+LLD   + K++D+G+ K  L P +TT   +   GT  Y+A
Sbjct: 111 YLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIA 164

Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVD 249
           PE           D ++ GVL+ E+++GR+  D
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 62.2 bits (151), Expect = 9e-11
 Identities = 41/160 (25%), Positives = 71/160 (44%), Gaps = 33/160 (20%)

Query: 96  NVCHENLVKLHGGCIDGP--CRIL------VYDYMPNNS----LSQTLLGEEKRRAKFGW 143
           NV H +++++    + G   C +L      +Y Y+   S    + Q L+           
Sbjct: 113 NVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALI----------- 161

Query: 144 KARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 203
                I   I  GL Y+H      ++HRD+KT NI ++      I D G ++ FP     
Sbjct: 162 -----IEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQ-FPVVAPA 212

Query: 204 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
               +AGT+   APE     +   K+D++S G++L E+++
Sbjct: 213 F-LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 34/99 (34%), Positives = 55/99 (55%), Gaps = 8/99 (8%)

Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAG 210
           I  GL ++H +    +++RD+K  N++LD   + KI+DFG+ K  +F   TT       G
Sbjct: 110 IAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT---FCG 163

Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVD 249
           T  Y+APE        +  D ++FGVLL E+++G+   D
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 61.1 bits (148), Expect = 1e-10
 Identities = 37/138 (26%), Positives = 70/138 (50%), Gaps = 23/138 (16%)

Query: 148 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 207
           E  + I   L Y+HE+   H++HRD+KT N+ L +    K+ D G++++  EN   +++ 
Sbjct: 106 EWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVL-ENQCDMAST 161

Query: 208 VAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMY 267
           + GT  Y++PE   +     KSDV++ G  + E+ + + A                   +
Sbjct: 162 LIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHA-------------------F 202

Query: 268 NSKELMNLVDPMLYGNFP 285
           N+K++ +LV  ++ G  P
Sbjct: 203 NAKDMNSLVYRIIEGKLP 220

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 23/209 (11%)

Query: 50  IGEGGFGSVYKGRLQDG-TIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLH 106
           IG G FG V   +L++   + A+K+L+     K+ E     E   +  VN  ++ +  LH
Sbjct: 9   IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVL-VNGDNQWITTLH 67

Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKR----RAKFGWKARREIIMGIGRGLAYIHE 162
               D     LV DY     L   L   E R     A+F      E+++ I      +H 
Sbjct: 68  YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARF---YLAEMVIAIDS----VH- 119

Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS 222
             Q H VHRDIK  NIL+D N + +++DFG      E+ T  S+   GT  Y++PE   +
Sbjct: 120 --QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177

Query: 223 -----GRLTRKSDVYSFGVLLLEIVSGRT 246
                G+   + D +S GV + E++ G T
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGET 206

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 61.4 bits (149), Expect = 1e-10
 Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 21/209 (10%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVK--VLSVESKQGEKEFMSEVASMANVNVCHENLVKL 105
           KIGEG +G VYK R    G +VA+K   L ++ +      + E++ +  ++     +V+L
Sbjct: 8   KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES-IYIVRL 66

Query: 106 ----HGGCIDG-PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
               H    +G P   LV++Y+ ++                  K  +  +  + +G+A+ 
Sbjct: 67  LDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHC 126

Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLFP---ENTTHISTRVAGTLGYLA 216
           H+     V+HRD+K  N+L+D+     KI+D GL + F    ++ TH       TL Y A
Sbjct: 127 HKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV----TLWYRA 179

Query: 217 PEYAISGR-LTRKSDVYSFGVLLLEIVSG 244
           PE  +     +   D++S G +  E+   
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 61.1 bits (148), Expect = 1e-10
 Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 16/200 (8%)

Query: 50  IGEGGFGSVYKGRLQDGT-IVAVKVLS---VESKQGEKEFMSEVASMANVNVCHENLVKL 105
           IG+G FG V + R +D   I A+K +    + S+      ++E   +A VN      +K 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 106 HGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
                  P ++ LV  ++    L   L    +R  +F     R     +   L  +H+  
Sbjct: 61  ---SFQSPEKLYLVLAFINGGELFHHL----QREGRFDLSRARFYTAELLCALENLHKF- 112

Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
             +V++RD+K  NILLD   +  + DFGL KL  ++    +T   GT  YLAPE  +   
Sbjct: 113 --NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT-FCGTPEYLAPELLLGHG 169

Query: 225 LTRKSDVYSFGVLLLEIVSG 244
            T+  D ++ GVLL E+++G
Sbjct: 170 YTKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 61.0 bits (148), Expect = 2e-10
 Identities = 65/263 (24%), Positives = 101/263 (38%), Gaps = 66/263 (25%)

Query: 45  RWSNKIGEGGFGSVYK------GRLQDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNV 97
           +    +G G FG V +       +      VAVK+L   +   E K  M+E+  + ++  
Sbjct: 10  KLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGH 69

Query: 98  CHENLVKLHGGCI--DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR 155
            H N+V L G C    GP  ++V +Y    +LS  L  + +  + +  K+ R+  M    
Sbjct: 70  -HLNVVNLLGACTKPGGPLMVIV-EYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKE 127

Query: 156 GLA-----------------------YIHEEIQP-------------------------- 166
           G                            EE +                           
Sbjct: 128 GKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGME 187

Query: 167 -----HVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG-TLGYLAPEYA 220
                  +HRD+   NILL +N   KI DFGL++   ++  ++    A   L ++APE  
Sbjct: 188 FLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESI 247

Query: 221 ISGRLTRKSDVYSFGVLLLEIVS 243
                T +SDV+SFGVLL EI S
Sbjct: 248 FDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 61.1 bits (148), Expect = 2e-10
 Identities = 54/184 (29%), Positives = 91/184 (49%), Gaps = 24/184 (13%)

Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLG 213
           GL ++H +    +++RD+K  N++LD++ + KI+DFG+ K  +F +N    ++   GT  
Sbjct: 108 GLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR---ASTFCGTPD 161

Query: 214 YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAV--DFDVQLGEYHLVDKA----WGMY 267
           Y+APE     + T   D +SFGVLL E++ G++    D + +L E   VD      W   
Sbjct: 162 YIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITK 221

Query: 268 NSKELMNLV---DPM----LYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE 320
            SK+++  +   DP     + GN   +    F K       EK +L P     +K  +  
Sbjct: 222 ESKDILEKLFERDPTRRLGVVGNIRGHP---FFKTINWTALEKRELDPPFKPKVKSPSDY 278

Query: 321 TNID 324
           +N D
Sbjct: 279 SNFD 282

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 60.6 bits (147), Expect = 2e-10
 Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 16/206 (7%)

Query: 48  NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHE-NLVKL 105
           +++G+G +GSVYK   +  G  +A+K + +E    E +F   +  +  ++      +V  
Sbjct: 7   DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELD--ESKFNQIIMELDILHKAVSPYIVDF 64

Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
           +G         +  +YM   SL + L               R I   + +GL ++ EE  
Sbjct: 65  YGAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123

Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL 225
             ++HRD+K +N+L++ N   K+ DFG+S         ++    G   Y+APE   SG  
Sbjct: 124 --IIHRDVKPTNVLVNGNGQVKLCDFGVSGNL---VASLAKTNIGCQSYMAPERIKSGGP 178

Query: 226 ------TRKSDVYSFGVLLLEIVSGR 245
                 T +SDV+S G+ +LE+  GR
Sbjct: 179 NQNPTYTVQSDVWSLGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 60.0 bits (145), Expect = 2e-10
 Identities = 34/88 (38%), Positives = 50/88 (56%), Gaps = 4/88 (4%)

Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
           G+ +IHE+    V+HRDIK+ NI L QN   K+ DFG ++L      +  T V GT  Y+
Sbjct: 112 GVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYV 167

Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVS 243
            PE   +     KSD++S G +L E+ +
Sbjct: 168 PPEIWENMPYNNKSDIWSLGCILYELCT 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 60.7 bits (147), Expect = 3e-10
 Identities = 63/209 (30%), Positives = 97/209 (46%), Gaps = 33/209 (15%)

Query: 50  IGEGGFGSVYKGRL-QDGTIVAVKVLS---------VESKQGEKEFMSEVASMANVNVCH 99
           +G+G FG V   RL + G + AVKVL          VE    EK  +S   +       H
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARN-------H 55

Query: 100 ENLVKLHGGCIDGPCRIL-VYDYMPNNSLS---QTLLGEEKRRAKFGWKARREIIMGIGR 155
             L +L+  C   P R+  V +++    L    Q     ++ RA+F + A  EI      
Sbjct: 56  PFLTQLYC-CFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAA--EIT----S 107

Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
            L ++H++    +++RD+K  N+LLD   + K++DFG+ K    N    ST   GT  Y+
Sbjct: 108 ALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST-FCGTPDYI 163

Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVSG 244
           APE           D ++ GVLL E++ G
Sbjct: 164 APEILQEMLYGPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 60.2 bits (146), Expect = 3e-10
 Identities = 71/261 (27%), Positives = 110/261 (42%), Gaps = 51/261 (19%)

Query: 50  IGEGGFGSVYKGRLQDGT--IVAVKVL---------SVESKQGEKEFMSEVASMANVNVC 98
           +G+G FG V    L+ GT  + A+KVL          V+    EK  ++  A        
Sbjct: 3   LGKGSFGKVMLAELK-GTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAK------- 54

Query: 99  HENLVKLHGGCIDGPCRIL-VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
           H  L  LH  C     R+  V +Y+    L    + + +R  KF     R     +   L
Sbjct: 55  HPFLTALHC-CFQTKDRLFFVMEYVNGGDL----MFQIQRSRKFDEPRSRFYAAEVTLAL 109

Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLGYL 215
            ++H   +  V++RD+K  NILLD   + K++DFG+ K  +    TT   T   GT  Y+
Sbjct: 110 MFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT---TTFCGTPDYI 163

Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMN- 274
           APE           D ++ GVL+ E+++G+   + D                N  +L   
Sbjct: 164 APEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD----------------NEDDLFES 207

Query: 275 -LVDPMLYGNFPENEAIRFLK 294
            L D +LY  +   EA+  LK
Sbjct: 208 ILHDDVLYPVWLSKEAVSILK 228

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 60.0 bits (145), Expect = 4e-10
 Identities = 62/210 (29%), Positives = 92/210 (43%), Gaps = 31/210 (14%)

Query: 50  IGEGGFGSVYKGRLQ-DGTIVAVKVLS---------VESKQGEKEFMSEVASMANVNVCH 99
           +G+G FG V+   L+      A+K L          VE    EK  +S           H
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE-------H 55

Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLS---QTLLGEEKRRAKFGWKARREIIMGIGRG 156
             L  L+           V +Y+    L    Q+    +  RA F + A  EII G    
Sbjct: 56  PFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATF-YAA--EIICG---- 108

Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLA 216
           L ++H +    +V+RD+K  NILLD + + KI+DFG+ K          T   GT  Y+A
Sbjct: 109 LQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT-FCGTPDYIA 164

Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVSGRT 246
           PE  +  +     D +SFGVLL E++ G++
Sbjct: 165 PEILLGQKYNTSVDWWSFGVLLYEMLIGQS 194

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 59.8 bits (145), Expect = 4e-10
 Identities = 40/112 (35%), Positives = 65/112 (58%), Gaps = 11/112 (9%)

Query: 135 EKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 194
           ++ RA+F + A  EII G    L ++H++    +++RD+K  N+LLD++ + KI+DFG+ 
Sbjct: 94  DEARARF-YAA--EIICG----LQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMC 143

Query: 195 KLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT 246
           K         ST   GT  Y+APE     +     D +SFGVLL E++ G++
Sbjct: 144 KENMNGEGKAST-FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQS 194

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 59.8 bits (145), Expect = 4e-10
 Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 24/206 (11%)

Query: 50  IGEGGFGSVYKGRLQDGT----IVAVKVLSVESKQGEKEFMSEVASMANV--NVCHENLV 103
           +G+GG+G V++ R   G     I A+KVL   +    ++  +   +  N+   V H  +V
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63

Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEE---KRRAKFGWKARREIIMGIGRGLAYI 160
            L      G    L+ +Y+    L   L  E    +  A F      EI + +     ++
Sbjct: 64  DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACF---YLSEISLALE----HL 116

Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLGYLAPE 218
           H   Q  +++RD+K  NILLD   + K++DFGL K  +     TH      GT+ Y+APE
Sbjct: 117 H---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGTIEYMAPE 170

Query: 219 YAISGRLTRKSDVYSFGVLLLEIVSG 244
             +     +  D +S G L+ ++++G
Sbjct: 171 ILMRSGHGKAVDWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 59.7 bits (145), Expect = 6e-10
 Identities = 47/160 (29%), Positives = 75/160 (46%), Gaps = 27/160 (16%)

Query: 99  HENLVKLHGGCIDGPCR------ILVYDYMPNN-----SLSQTLLGEEKRRAKFGWKARR 147
           HEN++ +    +  P R       +VY+ M  +       SQTL  +  +          
Sbjct: 63  HENVIAIKD-IMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQY--------- 112

Query: 148 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 207
             +  + RGL YIH     +V+HRD+K SN+LL+ N + KI DFGL++   E    ++  
Sbjct: 113 -FLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEY 168

Query: 208 VAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRT 246
           V  T  Y APE  ++    T   DV+S G +  E++  + 
Sbjct: 169 VV-TRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKP 207

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 59.3 bits (143), Expect = 8e-10
 Identities = 77/288 (26%), Positives = 125/288 (43%), Gaps = 44/288 (15%)

Query: 23  EQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDG-TIVAVKVLS---VES 78
           E+I++ I      +L++    +     IG G FG V   R +    + A+K+LS   +  
Sbjct: 29  EKIVRKIR-----KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIK 83

Query: 79  KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEE--K 136
           +     F  E   MA  N     +V+L     D     +V +YMP   L   +   +  +
Sbjct: 84  RSDSAFFWEERDIMAFAN--SPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE 141

Query: 137 RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS-K 195
           + AKF      E+++     L  IH      ++HRD+K  N+LLD++ + K++DFG   K
Sbjct: 142 KWAKF---YTAEVVLA----LDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMK 191

Query: 196 LFPENTTHISTRVAGTLGYLAPEYAIS----GRLTRKSDVYSFGVLLLEIVSGRTAVDFD 251
           +         T V GT  Y++PE   S    G   R+ D +S GV L E++ G T    D
Sbjct: 192 MDETGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD 250

Query: 252 VQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLC 299
             +G Y             ++M+  + +   NFPE+  I      L+C
Sbjct: 251 SLVGTY------------SKIMDHKNSL---NFPEDVEISKHAKNLIC 283

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 58.8 bits (142), Expect = 8e-10
 Identities = 69/255 (27%), Positives = 112/255 (43%), Gaps = 44/255 (17%)

Query: 49  KIGEGGFGSVYKGRLQDG---TIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVK 104
           +IG G FG V  G +  G     V VK L V  S Q + +F+ E     ++   H NL++
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQ--HSNLLQ 59

Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKAR---------REIIMGIGR 155
             G C +    +LV ++ P        LG+ K   +   KA          + +   I  
Sbjct: 60  CLGQCTEVTPYLLVMEFCP--------LGDLKGYLRSCRKAELMTPDPTTLQRMACEIAL 111

Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL-FPENTTHISTRVAGTLGY 214
           GL ++H+    + +H D+   N LL  +   KI D+GLS   + E+      ++   L +
Sbjct: 112 GLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRW 168

Query: 215 LAPEYA--ISGRL-----TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEY-HLVDKAWGM 266
           +APE    + G L     T++S+V+S GV + E+        F++    Y HL D+    
Sbjct: 169 IAPELVDEVHGNLLVVDQTKESNVWSLGVTIWEL--------FELGSQPYRHLSDEQVLT 220

Query: 267 YNSKE-LMNLVDPML 280
           Y  +E  + L  P L
Sbjct: 221 YTVREQQLKLPKPRL 235

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 59.0 bits (143), Expect = 8e-10
 Identities = 66/211 (31%), Positives = 102/211 (48%), Gaps = 27/211 (12%)

Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLH 106
           IG G FG V   ++++ G + A+K+L+     K+ E     E   +  VN     +  LH
Sbjct: 9   IGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVL-VNGDRRWITNLH 67

Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRR-----AKFGWKARREIIMGIGRGLAYIH 161
               D     LV DY     L  TLL + + R     A+F + A  E+++ I      +H
Sbjct: 68  YAFQDENNLYLVMDYYVGGDL-LTLLSKFEDRLPEDMARF-YLA--EMVLAIDS----VH 119

Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS-KLFPENTTHISTRVAGTLGYLAPEY- 219
              Q   VHRDIK  N+LLD+N + +++DFG   +L  + T   +  V GT  Y++PE  
Sbjct: 120 ---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAV-GTPDYISPEIL 175

Query: 220 -AI---SGRLTRKSDVYSFGVLLLEIVSGRT 246
            A+    GR   + D +S GV + E++ G T
Sbjct: 176 QAMEDGKGRYGPECDWWSLGVCMYEMLYGET 206

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 58.8 bits (142), Expect = 9e-10
 Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 37/214 (17%)

Query: 50  IGEGGFGSVYKGRL----QDGTIVAVKVL----------SVESKQGEK---EFMSEVASM 92
           +G G +G V+  R       G + A+KVL          +VE  + E+   E + +   +
Sbjct: 8   LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67

Query: 93  ANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG 152
             ++   +   KLH          L+ DY+    +   L     +R  F     R     
Sbjct: 68  VTLHYAFQTEAKLH----------LILDYVSGGEMFTHLY----QRDNFSEDEVRFYSGE 113

Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL 212
           I   L ++H   +  +V+RDIK  NILLD   +  ++DFGLSK F       +    GT+
Sbjct: 114 IILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTI 170

Query: 213 GYLAPEYAISGRL--TRKSDVYSFGVLLLEIVSG 244
            Y+APE  I G+    +  D +S G+L+ E+++G
Sbjct: 171 EYMAPE-IIRGKGGHGKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 58.3 bits (141), Expect = 1e-09
 Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 40/215 (18%)

Query: 50  IGEGGFGSVYKGRLQ-DGTIVAVKVLS---VESKQG------EKEFMSEVASMANVNVCH 99
           +G+GGFG V   +++  G + A K L+   ++ ++G      EK  +++V S   V++ +
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 100 ENLVK---------LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 150
               K         ++GG +    R  +Y+    N       G  + RA F + A+    
Sbjct: 61  AFQTKTDLCLVMTIMNGGDL----RYHIYNVDEENP------GFPEPRACF-YTAQ---- 105

Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG 210
             I  GL ++H   Q  +++RD+K  N+LLD + N +ISD GL+    +  +  +   AG
Sbjct: 106 --IISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAG 159

Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
           T G++APE           D ++ GV L E+++ R
Sbjct: 160 TPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 62/209 (29%), Positives = 92/209 (44%), Gaps = 23/209 (11%)

Query: 50  IGEGGFGSVYKGRLQDGT-IVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLH 106
           IG G FG V   +++    I A+K+L+     K+ E     E  ++  VN   + +  LH
Sbjct: 9   IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVL-VNGDCQWITTLH 67

Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKR----RAKFGWKARREIIMGIGRGLAYIHE 162
               D     LV DY     L   L   E R     A+F           I   +  IH 
Sbjct: 68  YAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY----------IAEMVLAIHS 117

Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS 222
             Q H VHRDIK  N+LLD N + +++DFG      ++ T  S+   GT  Y++PE   +
Sbjct: 118 IHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQA 177

Query: 223 -----GRLTRKSDVYSFGVLLLEIVSGRT 246
                G+   + D +S GV + E++ G T
Sbjct: 178 MEDGMGKYGPECDWWSLGVCMYEMLYGET 206

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 58.6 bits (142), Expect = 1e-09
 Identities = 55/219 (25%), Positives = 99/219 (45%), Gaps = 36/219 (16%)

Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG 108
           +G G  G V+     D    VAVK + +   Q  K  + E+  +  ++  H+N+VK++  
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLD--HDNIVKVYEV 70

Query: 109 CIDGPCRI--------------LVYDYMPN---NSLSQTLLGEEKRRAKFGWKARREIIM 151
                  +              +V +YM     N L Q  L EE  R  F ++       
Sbjct: 71  LGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARL-FMYQ------- 122

Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ-NFNPKISDFGLSKLFPENTTHISTRVAG 210
            + RGL YIH     +V+HRD+K +N+ ++  +   KI DFGL+++   + +H      G
Sbjct: 123 -LLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEG 178

Query: 211 TLG--YLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGRT 246
            +   Y +P   +S    T+  D+++ G +  E+++G+ 
Sbjct: 179 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKP 217

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 36/94 (38%), Positives = 51/94 (54%), Gaps = 8/94 (8%)

Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF---PENTTHISTRVA 209
           + RG+ ++        +HRD+   NILL +N   KI DFGL++     P+     S R+ 
Sbjct: 183 VARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239

Query: 210 GTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
             L ++APE       T +SDV+SFGVLL EI S
Sbjct: 240 --LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 34/100 (34%), Positives = 59/100 (59%), Gaps = 10/100 (10%)

Query: 149 IIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT-HISTR 207
           +I  I RGL YIH      ++HRD+K SN+ ++++   KI DFGL++   +  T +++TR
Sbjct: 125 LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 181

Query: 208 VAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
                 Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 182 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 216

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 57.5 bits (139), Expect = 2e-09
 Identities = 36/100 (36%), Positives = 54/100 (54%), Gaps = 12/100 (12%)

Query: 148 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIST- 206
           EI+  +G    Y+H      VV+RD+K  N++LD++ + KI+DFGL K   E  +  +T 
Sbjct: 103 EIVSALG----YLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATM 152

Query: 207 -RVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
               GT  YLAPE        R  D +  GV++ E++ GR
Sbjct: 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 48/208 (23%), Positives = 79/208 (37%), Gaps = 30/208 (14%)

Query: 53  GGFGSVYKGRLQDGTIVAVKVLSVESKQGE--KEFMSEVASMANVNVCHENLVKLHGGCI 110
                + K +    T+VAVK ++++S   E  K    E+ +   +   H N++      I
Sbjct: 13  LMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQL--QHPNILPYVTSFI 69

Query: 111 DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWK--ARREIIMGIGRGLAYIHEEIQPHV 168
                 +V   M   S    L    K     G    A   I+  +   L YIH +     
Sbjct: 70  VDSELYVVSPLMAYGSCEDLL----KTHFPEGLPELAIAFILKDVLNALDYIHSK---GF 122

Query: 169 VHRDIKTSNILLDQNFNPKISDF---------GLSKLFPENTTHISTRVAGTLGYLAPEY 219
           +HR +K S+ILL  +    +S           G  +    +    S +    L +L+PE 
Sbjct: 123 IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN---LPWLSPEV 179

Query: 220 ---AISGRLTRKSDVYSFGVLLLEIVSG 244
               + G    KSD+YS G+   E+ +G
Sbjct: 180 LQQNLQG-YNEKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 36/95 (37%), Positives = 51/95 (53%), Gaps = 8/95 (8%)

Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIST--RVAG 210
           I   L Y+H      VV+RDIK  N++LD++ + KI+DFGL K   E  +  +T     G
Sbjct: 104 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCG 157

Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
           T  YLAPE        R  D +  GV++ E++ GR
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 60/220 (27%), Positives = 95/220 (43%), Gaps = 28/220 (12%)

Query: 42  NGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLS---VESKQGEKEFMSEVASMANVNV 97
             F   + +G G FG V   R    G I A+KV+    + +++    F  E   ++  N 
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN- 59

Query: 98  CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGE-----EKRRAKFGWKARREIIMG 152
               + +L     D     LV +Y P   L  +LL       ++  A+F + A  E+++ 
Sbjct: 60  -SPWIPQLQYAFQDKDNLYLVMEYQPGGDL-LSLLNRYEDQFDEDMAQF-YLA--ELVLA 114

Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL 212
           I       H   Q   VHRDIK  N+L+D+  + K++DFG +     N    S    GT 
Sbjct: 115 I-------HSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTP 167

Query: 213 GYLAPEYAISGRLTRKS------DVYSFGVLLLEIVSGRT 246
            Y+APE   +     K       D +S GV+  E++ GR+
Sbjct: 168 DYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRS 207

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 57.3 bits (139), Expect = 3e-09
 Identities = 64/241 (26%), Positives = 102/241 (42%), Gaps = 51/241 (21%)

Query: 44  FRWSNKIGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEF---MSEVASMANVNVCH 99
           F+    +G+G  G V+  RL+  G + A+KVL  +      +    ++E   +A ++  H
Sbjct: 3   FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD--H 60

Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRR-----AKFGWKARREIIMGIG 154
             L  L+          LV DY P   L + L  +  +      A+F + A  E+++   
Sbjct: 61  PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARF-YAA--EVLLA-- 115

Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK------------------- 195
             L Y+H      +V+RD+K  NILL ++ +  +SDF LSK                   
Sbjct: 116 --LEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRR 170

Query: 196 ---------LFPENTTHISTRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGR 245
                     F E  +  S    GT  Y+APE  ISG       D ++ G+LL E++ G 
Sbjct: 171 SSVNSIPSETFSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAVDWWTLGILLYEMLYGT 229

Query: 246 T 246
           T
Sbjct: 230 T 230

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 35/93 (37%), Positives = 53/93 (56%), Gaps = 3/93 (3%)

Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL 212
           I   L Y+H E   +VV+RD+K  N++LD++ + KI+DFGL K   ++   + T   GT 
Sbjct: 104 IVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTP 160

Query: 213 GYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
            YLAPE        R  D +  GV++ E++ GR
Sbjct: 161 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 57.2 bits (138), Expect = 3e-09
 Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 24/206 (11%)

Query: 50  IGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCHENLVKLH 106
           +G G +GSV      + G  VA+K LS   +S+   K    E+  + ++   HEN++ L 
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQ--HENVIGLL 80

Query: 107 GGCIDGPCRILVYDY---MPNNSLS-QTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE 162
                        D+   MP      Q ++G      K  +     ++  +  GL YIH 
Sbjct: 81  DVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQY-----LVYQMLCGLKYIH- 134

Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLAPEYAI 221
                ++HRD+K  N+ ++++   KI DFGL++    E T ++ TR      Y APE  +
Sbjct: 135 --SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVIL 187

Query: 222 SG-RLTRKSDVYSFGVLLLEIVSGRT 246
           +     +  D++S G ++ E+++G+T
Sbjct: 188 NWMHYNQTVDIWSVGCIMAEMLTGKT 213

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 57.1 bits (138), Expect = 4e-09
 Identities = 54/228 (23%), Positives = 102/228 (44%), Gaps = 41/228 (17%)

Query: 48  NKIGEGGFGSVYKGR-LQDGTIVAVK-VLSVESKQGEKEF-------------MSEVASM 92
             +GEG +G V K      G IVA+K V  +E      +              + E+  M
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 93  ANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG 152
             +   HEN++ L    ++G    LV D M ++ L + +     R+ +      + I++ 
Sbjct: 75  NEIK--HENIMGLVDVYVEGDFINLVMDIMASD-LKKVV----DRKIRLTESQVKCILLQ 127

Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--------------P 198
           I  GL  +H+    + +HRD+  +NI ++     KI+DFGL++ +               
Sbjct: 128 ILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184

Query: 199 ENTTHISTRVAGTLGYLAPEYAI-SGRLTRKSDVYSFGVLLLEIVSGR 245
           +    ++++V  TL Y APE  + + +     D++S G +  E+++G+
Sbjct: 185 QRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 56.4 bits (136), Expect = 4e-09
 Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 34/214 (15%)

Query: 50  IGEGGFGSVYKG---RLQDG-----TIVAVKVLSVESKQGEKEFMSEVASMANVNVCHEN 101
           +G+G F  ++KG    + D      T V +KVL    +   + F  E ASM +  + H++
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFF-EAASMMS-QLSHKH 60

Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY-I 160
           LV  +G C+ G   I+V +Y+   SL  T L + K      WK      + + + LA+ +
Sbjct: 61  LVLNYGVCVCGDESIMVQEYVKFGSLD-TYLKKNKNLINISWK------LEVAKQLAWAL 113

Query: 161 HEEIQPHVVHRDIKTSNILL-----DQNFNP---KISDFGLS-KLFPENTTHISTRVAGT 211
           H      + H ++   N+LL      +  NP   K+SD G+S  + P+    +  R+   
Sbjct: 114 HFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEI--LLERIP-- 169

Query: 212 LGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSG 244
             ++ PE   + + L+  +D +SFG  L EI SG
Sbjct: 170 --WVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 56.7 bits (137), Expect = 5e-09
 Identities = 35/95 (36%), Positives = 51/95 (53%), Gaps = 7/95 (7%)

Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL-FPENTTHIS-TRVAGTL 212
           R L YIH     +V HRD+K  NIL + +   KI DFGL+++ F +  T I  T    T 
Sbjct: 114 RALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170

Query: 213 GYLAPEYAIS--GRLTRKSDVYSFGVLLLEIVSGR 245
            Y APE   S   + T   D++S G +  E+++G+
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 56.9 bits (137), Expect = 5e-09
 Identities = 28/77 (36%), Positives = 50/77 (64%), Gaps = 1/77 (1%)

Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLT 226
           ++HRD+K++NI L      K+ DFG SK + ++ +  +++   GT  YLAPE     R +
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS 249

Query: 227 RKSDVYSFGVLLLEIVS 243
           +K+D++S GV+L E+++
Sbjct: 250 KKADMWSLGVILYELLT 266

Length = 478

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 56.1 bits (135), Expect = 7e-09
 Identities = 54/214 (25%), Positives = 97/214 (45%), Gaps = 22/214 (10%)

Query: 38  KIATNGFRWSNKIGEGGFGSVYKGRLQDGTI--VAVKVLS----VESKQGEKEFMSEVAS 91
           K+    F +   +G G FG V     ++     VA+K       ++ KQ +  F SE   
Sbjct: 26  KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SERKI 84

Query: 92  MANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
           +  +N  H   V L+G   D     LV +++        L   ++     G     +I++
Sbjct: 85  LNYIN--HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL 142

Query: 152 GIGRGLAYIHEEIQP-HVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG 210
                   I E +Q  ++V+RD+K  N+LLD++   K++DFG +K+    T  +     G
Sbjct: 143 --------IFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTL----CG 190

Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
           T  Y+APE  ++    + +D ++ G+ + EI+ G
Sbjct: 191 TPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 56.1 bits (135), Expect = 7e-09
 Identities = 56/209 (26%), Positives = 100/209 (47%), Gaps = 29/209 (13%)

Query: 50  IGEGGFGSV-YKGRLQDGTIVAVKVL--SVESKQGEKEFMSEVASMANVNVCHENLVKLH 106
           +G G +G+V      + G  VA+K L    +S+   K    E+  + ++   HEN++   
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMK--HENVI--- 77

Query: 107 GGCID--GPCRIL-----VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
            G +D   P   L      Y  MP      T LG+  +  K      + ++  + +GL Y
Sbjct: 78  -GLLDVFTPDLSLDRFHDFYLVMP---FMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKY 133

Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLAPE 218
           IH      ++HRD+K  N+ ++++   KI DFGL++    E T ++ TR      Y APE
Sbjct: 134 IH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----WYRAPE 185

Query: 219 YAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
             ++    T+  D++S G ++ E+++G+ 
Sbjct: 186 VILNWMHYTQTVDIWSVGCIMAEMLTGKP 214

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 55.6 bits (134), Expect = 8e-09
 Identities = 48/204 (23%), Positives = 86/204 (42%), Gaps = 15/204 (7%)

Query: 49  KIGEGGFGSVYKGRLQDGTIVA---VKVLSVESKQGEKEFMSEVASMANVNVCHENLVKL 105
           +IG G FG V    +   T VA   VK L   +   E+    +      + + H N+++ 
Sbjct: 2   EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRI-LQHPNILQC 60

Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
            G C++    +LV++Y     L   L  E+  R        + +   I  G+ ++H+   
Sbjct: 61  LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH-- 118

Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLS-KLFPENTTHISTRVAGTLGYLAPEYA---- 220
            + +H D+   N  L  +   K+ D+G+    + E+           L +LAPE      
Sbjct: 119 -NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFH 177

Query: 221 ---ISGRLTRKSDVYSFGVLLLEI 241
              I+   T+ S+V++ GV L E+
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 55.8 bits (134), Expect = 9e-09
 Identities = 33/99 (33%), Positives = 56/99 (56%), Gaps = 8/99 (8%)

Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH-ISTRV-AG 210
           I  GL ++H      +++RD+K  N++LD   + KI+DFG+ K   E+    ++TR   G
Sbjct: 110 ISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCG 163

Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVD 249
           T  Y+APE        +  D +++GVLL E+++G+   D
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 55.2 bits (133), Expect = 1e-08
 Identities = 58/213 (27%), Positives = 95/213 (44%), Gaps = 31/213 (14%)

Query: 50  IGEGGFGSVYKGRLQ-------DGTIVAVKVLSVESKQGEKEFMS--EVASMANVNVCHE 100
           +G+G F ++YKG L+        G    V V+        ++ ++  E AS+ +  + H+
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQ-LSHK 61

Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
           +LVKL+G C+     I+V +Y+    L    L  EK      WK   ++   +   L Y+
Sbjct: 62  HLVKLYGVCVRDE-NIMVEEYVKFGPLD-VFLHREKNNVSLHWKL--DVAKQLASALHYL 117

Query: 161 HEEIQPHVVHRDIKTSNILL---DQNFNP----KISDFGLSKLFPENTTHISTRVAGTLG 213
            ++    +VH ++   NIL+     N       K+SD G+    P        RV   + 
Sbjct: 118 EDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI----PITVLSREERVE-RIP 169

Query: 214 YLAPEY--AISGRLTRKSDVYSFGVLLLEIVSG 244
           ++APE        LT  +D +SFG  LLEI S 
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 66/230 (28%), Positives = 100/230 (43%), Gaps = 20/230 (8%)

Query: 37  LKIATNGFRWSNKIGEGGFGSVYKGRLQDGT-IVAVKVLS---VESKQGEKEFMSEVASM 92
           L++    +     IG G FG V   R +    + A+K+LS   +  +     F  E   M
Sbjct: 38  LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM 97

Query: 93  ANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG 152
           A  N     +V+L     D     +V +YMP   L   L+       K+      E+++ 
Sbjct: 98  AFAN--SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLA 154

Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS-KLFPENTTHISTRVAGT 211
               L  IH       +HRD+K  N+LLD++ + K++DFG   K+  E      T V GT
Sbjct: 155 ----LDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GT 206

Query: 212 LGYLAPEYAIS----GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEY 257
             Y++PE   S    G   R+ D +S GV L E++ G T    D  +G Y
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY 256

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 55.4 bits (134), Expect = 2e-08
 Identities = 67/239 (28%), Positives = 103/239 (43%), Gaps = 56/239 (23%)

Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHEN--LVKLH 106
           IG G FG V   + +D G I A+K L  +S+  EKE ++ V +  ++    +N  +VKL+
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKKLR-KSEMLEKEQVAHVRAERDILAEADNPWVVKLY 67

Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARR----EIIMGIGRGLAYIHE 162
               D     L+ +Y+P   +  TLL    ++  F  +  R    E I+ I      IH 
Sbjct: 68  YSFQDENYLYLIMEYLPGGDM-MTLL---MKKDTFTEEETRFYIAETILAI----DSIH- 118

Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--------LFPENTTHI---------- 204
             +   +HRDIK  N+LLD   + K+SDFGL           F    +H           
Sbjct: 119 --KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFIS 176

Query: 205 ----STRVA---------------GTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
               S R A               GT  Y+APE  +     ++ D +S GV++ E++ G
Sbjct: 177 KPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 32/76 (42%), Positives = 45/76 (59%), Gaps = 1/76 (1%)

Query: 169 VHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG-TLGYLAPEYAISGRLTR 227
           +HRD+   NILL +N   KI DFGL++   ++  ++    A   L ++APE       T 
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 260

Query: 228 KSDVYSFGVLLLEIVS 243
           +SDV+SFGVLL EI S
Sbjct: 261 QSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 57/225 (25%), Positives = 94/225 (41%), Gaps = 33/225 (14%)

Query: 50  IGEGGFGSVYK-GRLQDGTIVAVKVLSV-----ESKQGEKEFMSEVASMANVNVCHENLV 103
           IG+G +G V+K    ++G+  AVK+L       E  + E   +  ++        H N+V
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSD-------HPNVV 78

Query: 104 KLHG-----GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
           K +G        +G    LV +     S++  + G  KR  +        I+     GL 
Sbjct: 79  KFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQ 138

Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE 218
           ++H       +HRD+K +NILL      K+ DFG+S     +T        GT  ++APE
Sbjct: 139 HLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQL-TSTRLRRNTSVGTPFWMAPE 194

Query: 219 Y-----AISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYH 258
                  +      + DV+S G+  +E+  G      D  L + H
Sbjct: 195 VIACEQQLDSTYDARCDVWSLGITAIELGDG------DPPLADLH 233

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 62/236 (26%), Positives = 96/236 (40%), Gaps = 59/236 (25%)

Query: 49  KIGEGGFGSVYKGRLQD---GTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCHENL 102
            IG+GG G VY     D      VA+K +     E+   +K F+ E A +A  ++ H  +
Sbjct: 9   LIGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLKKRFLRE-AKIA-ADLIHPGI 64

Query: 103 VKLHGGCIDGPCRILVYDYMP----------------NNSLSQTLLGEEKRRAKFGWKAR 146
           V ++  C DG     VY  MP                  SLS+ L   EK        A 
Sbjct: 65  VPVYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKEL--AEKTSVG----AF 115

Query: 147 REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK----------- 195
             I   I   + Y+H +    V+HRD+K  NILL       I D+G +            
Sbjct: 116 LSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD 172

Query: 196 --------LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
                    +   T  I  ++ GT  Y+APE  +    +  +D+Y+ GV+L ++++
Sbjct: 173 IDVDERNICYSSMT--IPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 33/99 (33%), Positives = 57/99 (57%), Gaps = 8/99 (8%)

Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT-THISTRV-AG 210
           I  GL ++H +    +++RD+K  N++LD   + KI+DFG+ K   EN    ++T+   G
Sbjct: 110 IAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCG 163

Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVD 249
           T  Y+APE        +  D ++FGVLL E+++G+   +
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 53.8 bits (129), Expect = 3e-08
 Identities = 55/183 (30%), Positives = 89/183 (48%), Gaps = 25/183 (13%)

Query: 69  VAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLS 128
           V +KVL    +     F  E AS+ +  V H +L  +HG C+ G   I+V +++ +  L 
Sbjct: 47  VVLKVLDPSHRDIALAFF-ETASLMS-QVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD 104

Query: 129 QTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL-----LDQN 183
              L +EK R    WK    +   +   L+Y+ ++   ++VH ++   NIL     L + 
Sbjct: 105 -VCLRKEKGRVPVAWKI--TVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEG 158

Query: 184 FNP--KISDFGLSKLFPENTTHIS--TRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLL 238
            +P  K+SD G+S       T +S   RV   + ++APE    G  L+  +D +SFG  L
Sbjct: 159 TSPFIKLSDPGVS------FTALSREERVE-RIPWIAPECVPGGNSLSTAADKWSFGTTL 211

Query: 239 LEI 241
           LEI
Sbjct: 212 LEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 53.5 bits (128), Expect = 5e-08
 Identities = 35/95 (36%), Positives = 51/95 (53%), Gaps = 8/95 (8%)

Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIST--RVAG 210
           I   L Y+H      +V+RD+K  N++LD++ + KI+DFGL K   E  T  +T     G
Sbjct: 104 IVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCK---EGITDAATMKTFCG 157

Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
           T  YLAPE        R  D +  GV++ E++ GR
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 52.8 bits (126), Expect = 9e-08
 Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 19/209 (9%)

Query: 49  KIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANV-NVCHENLVKLHG 107
           K+G G +G VYK + +DG     K  +++  +G    MS    +A +  + H N++ L  
Sbjct: 8   KVGRGTYGHVYKAKRKDGK--DEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQK 65

Query: 108 GCIDGPCR--ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG----IGRGLAYIH 161
             +    R   L++DY  ++           +  K   +  R ++      I  G+ Y+H
Sbjct: 66  VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125

Query: 162 EEIQPHVVHRDIKTSNILL----DQNFNPKISDFGLSKLF--PENTTHISTRVAGTLGYL 215
                 V+HRD+K +NIL+     +    KI+D G ++LF  P         V  T  Y 
Sbjct: 126 AN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182

Query: 216 APEYAISGR-LTRKSDVYSFGVLLLEIVS 243
           APE  +  R  T+  D+++ G +  E+++
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 31/92 (33%), Positives = 51/92 (55%), Gaps = 4/92 (4%)

Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIST-RVAGT 211
           + RG+ ++  +   + VHRD+   N+LL Q    KI DFGL++    ++ ++S       
Sbjct: 246 VARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302

Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
           + ++APE       T  SDV+S+G+LL EI S
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 59/251 (23%), Positives = 98/251 (39%), Gaps = 73/251 (29%)

Query: 50  IGEGGFGSVYKGRLQDGTIV-AVKVL---------SVESKQGEKEFMSEVASMANVNVCH 99
           IG G FG V   R  D   + A+K L              + E++ ++E  +        
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADN-------- 60

Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGE---EKRRAKFGWKARREIIMGIGRG 156
           E +VKL+    D      V DY+P   +   L+     E+  A+F        I  +   
Sbjct: 61  EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARF-------YIAELTCA 113

Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL---------SKLFPENTTH---- 203
           +  +H   +   +HRDIK  NIL+D++ + K++DFGL         SK + +   H    
Sbjct: 114 IESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDS 170

Query: 204 -----------------------------ISTRVAGTLGYLAPEYAISGRLTRKSDVYSF 234
                                        ++  + GT  Y+APE  +    T+  D +S 
Sbjct: 171 MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 230

Query: 235 GVLLLEIVSGR 245
           GV+L E++ G+
Sbjct: 231 GVILYEMLVGQ 241

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 58/232 (25%), Positives = 98/232 (42%), Gaps = 45/232 (19%)

Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHEN--LVKLH 106
           IG G FG V   + +D G I A+K+L  ++   EKE ++ + +  ++ V  +   +VK+ 
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKILR-KADMLEKEQVAHIRAERDILVEADGAWVVKMF 67

Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
               D     L+ +++P   +   L+ ++    +       E ++ I      IH   Q 
Sbjct: 68  YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDA----IH---QL 120

Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGL--------SKLFPENTTH--------------- 203
             +HRDIK  N+LLD   + K+SDFGL           F  N TH               
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKR 180

Query: 204 -----------ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
                      ++    GT  Y+APE  +     +  D +S GV++ E++ G
Sbjct: 181 KAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 55/232 (23%), Positives = 98/232 (42%), Gaps = 45/232 (19%)

Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENL--VKLH 106
           IG G FG V   + +D G + A+K+L  ++   EKE +  + +  ++ V  ++L  VK+ 
Sbjct: 9   IGRGAFGEVRLVQKKDTGHVYAMKILR-KADMLEKEQVGHIRAERDILVEADSLWVVKMF 67

Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
               D     L+ +++P   +   L+ ++    +       E ++ I      IH   Q 
Sbjct: 68  YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDS----IH---QL 120

Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGL--------------------------------- 193
             +HRDIK  N+LLD   + K+SDFGL                                 
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180

Query: 194 -SKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
            ++ +  N   ++    GT  Y+APE  +     +  D +S GV++ E++ G
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 39/136 (28%), Positives = 66/136 (48%), Gaps = 13/136 (9%)

Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN---TTHISTRVAGTL 212
           G+ ++H      ++HRD+K SNI++  +   KI DFGL++    N   T ++ TR     
Sbjct: 135 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRY---- 187

Query: 213 GYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKEL 272
            Y APE  +        D++S G ++ E+V G         + +++ V +  G   S E 
Sbjct: 188 -YRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGT-PSAEF 245

Query: 273 MNLVDPMLYGNFPENE 288
           MN + P +  N+ EN 
Sbjct: 246 MNRLQPTVR-NYVENR 260

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 50.7 bits (121), Expect = 5e-07
 Identities = 29/79 (36%), Positives = 45/79 (56%), Gaps = 7/79 (8%)

Query: 169 VHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT----LGYLAPEYAISGR 224
           +HRD+   NILL      KI DFGL++    ++ ++   V G     + ++APE   +  
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV---VKGNARLPVKWMAPESIFNCV 292

Query: 225 LTRKSDVYSFGVLLLEIVS 243
            T +SDV+S+G+LL EI S
Sbjct: 293 YTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 50.8 bits (121), Expect = 5e-07
 Identities = 30/79 (37%), Positives = 46/79 (58%), Gaps = 7/79 (8%)

Query: 169 VHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT----LGYLAPEYAISGR 224
           VHRD+   N+L+ +    KI DFGL++    ++ +IS    G+    L ++APE   +  
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISK---GSTFLPLKWMAPESIFNNL 317

Query: 225 LTRKSDVYSFGVLLLEIVS 243
            T  SDV+SFG+LL EI +
Sbjct: 318 YTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 50.0 bits (119), Expect = 7e-07
 Identities = 29/93 (31%), Positives = 54/93 (58%), Gaps = 10/93 (10%)

Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLG 213
           RGL YIH      ++HRD+K SN+ ++++   +I DFGL++   +  T +++TR      
Sbjct: 129 RGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----W 180

Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGR 245
           Y APE  ++     +  D++S G ++ E++ G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 50.1 bits (119), Expect = 8e-07
 Identities = 51/209 (24%), Positives = 94/209 (44%), Gaps = 19/209 (9%)

Query: 49  KIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANV-NVCHENLVKLHG 107
           K+G G +G VYK + +DG     +  +++  +G    MS    +A +  + H N++ L  
Sbjct: 8   KVGRGTYGHVYKAKRKDGK--DDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQK 65

Query: 108 GCIDGPCR--ILVYDYMPNNSLS----QTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
             +    R   L++DY  ++              K+  +      + ++  I  G+ Y+H
Sbjct: 66  VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125

Query: 162 EEIQPHVVHRDIKTSNILL----DQNFNPKISDFGLSKLF--PENTTHISTRVAGTLGYL 215
                 V+HRD+K +NIL+     +    KI+D G ++LF  P         V  T  Y 
Sbjct: 126 AN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182

Query: 216 APEYAISGR-LTRKSDVYSFGVLLLEIVS 243
           APE  +  R  T+  D+++ G +  E+++
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 49.8 bits (119), Expect = 8e-07
 Identities = 34/102 (33%), Positives = 52/102 (50%), Gaps = 17/102 (16%)

Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT------HIS--TR- 207
           L Y+H      +VHRD+K  N+L+    + K++DFGLSK+   + T      HI   TR 
Sbjct: 114 LEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170

Query: 208 -----VAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
                V GT  Y+APE  +     +  D ++ G++L E + G
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 49.8 bits (119), Expect = 1e-06
 Identities = 32/90 (35%), Positives = 47/90 (52%), Gaps = 12/90 (13%)

Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS-KLFPENTTHISTRV----AGT 211
           LAY+H      ++HRD+KT NI LD+  N  + DFG + KL      H  T      +GT
Sbjct: 198 LAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL----DAHPDTPQCYGWSGT 250

Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEI 241
           L   +PE         K+D++S G++L E+
Sbjct: 251 LETNSPELLALDPYCAKTDIWSAGLVLFEM 280

Length = 392

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 29/95 (30%), Positives = 52/95 (54%), Gaps = 10/95 (10%)

Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT- 211
           + +G+ ++  +   + +HRD+   N+LL      KI DFGL++    ++ ++   V G  
Sbjct: 221 VAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV---VKGNA 274

Query: 212 ---LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
              + ++APE       T +SDV+S+G+LL EI S
Sbjct: 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 47.5 bits (113), Expect = 5e-06
 Identities = 43/159 (27%), Positives = 74/159 (46%), Gaps = 11/159 (6%)

Query: 42  NGFRWSNKIGEGGFGSV-YKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHE 100
             F     IG+G FG V    +   G I A+K L ++S+  +K+ ++ V +  +V    +
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTL-LKSEMFKKDQLAHVKAERDVLAESD 59

Query: 101 N--LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
           +  +V L+    D     L+ +++P   L   L+    +   F     R  +      + 
Sbjct: 60  SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLI----KYDTFSEDVTRFYMAECVLAIE 115

Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197
            +H   +   +HRDIK  NIL+D+  + K+SDFGLS  F
Sbjct: 116 AVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 47.7 bits (113), Expect = 5e-06
 Identities = 59/252 (23%), Positives = 96/252 (38%), Gaps = 71/252 (28%)

Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVL---------SVESKQGEKEFMSEVASMANVNVCH 99
           +G G FG V   R  D   + A+K L          V   + E++ ++E  +        
Sbjct: 9   LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADN-------- 60

Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
           E +V+L+    D      V DY+P   +   L+    R   F     R  I  +   +  
Sbjct: 61  EWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLI----RMGIFPEDLARFYIAELTCAVES 116

Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF---------------------- 197
           +H   +   +HRDIK  NIL+D++ + K++DFGL   F                      
Sbjct: 117 VH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDF 173

Query: 198 ------PENT---------------TH---ISTRVAGTLGYLAPEYAISGRLTRKSDVYS 233
                 P N                 H   ++  + GT  Y+APE  +    T+  D +S
Sbjct: 174 SNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 233

Query: 234 FGVLLLEIVSGR 245
            GV+L E++ G+
Sbjct: 234 VGVILYEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 47.3 bits (112), Expect = 7e-06
 Identities = 36/134 (26%), Positives = 58/134 (43%), Gaps = 22/134 (16%)

Query: 148 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL---DQNFNP-------------KISDF 191
           +II   G  L Y H E+  H++H D+K  NIL+   D   +P             +I D 
Sbjct: 235 QIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDL 292

Query: 192 GLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 251
           G       +  H  T +  T  Y +PE  +       +D++S G ++ E+ +G+   D  
Sbjct: 293 GGCC----DERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348

Query: 252 VQLGEYHLVDKAWG 265
             L   HL++K  G
Sbjct: 349 DNLEHLHLMEKTLG 362

Length = 467

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 46.9 bits (111), Expect = 8e-06
 Identities = 59/253 (23%), Positives = 96/253 (37%), Gaps = 73/253 (28%)

Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVL---------SVESKQGEKEFMSEVASMANVNVCH 99
           +G G FG V      D   + A+K L          V   + E++ ++E  +        
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADN-------- 60

Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
           E +VKL+    D      V DY+P   +   L+    R   F     R  I  +   +  
Sbjct: 61  EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI----RMEVFPEVLARFYIAELTLAIES 116

Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL---------SKLFPENTTHI------ 204
           +H   +   +HRDIK  NIL+D + + K++DFGL         SK + +  +HI      
Sbjct: 117 VH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY-QKGSHIRQDSME 172

Query: 205 --------------------------------STRVAGTLGYLAPEYAISGRLTRKSDVY 232
                                           +  + GT  Y+APE  +    T+  D +
Sbjct: 173 PSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWW 232

Query: 233 SFGVLLLEIVSGR 245
           S GV+L E++ G+
Sbjct: 233 SVGVILFEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 43/163 (26%), Positives = 73/163 (44%), Gaps = 17/163 (10%)

Query: 87  SEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKAR 146
           +E+ ++  +N  HEN++K     I+   R     YM        L       A F WK R
Sbjct: 212 NEILALGRLN--HENILK-----IEEILRSEANTYMITQKYDFDLYSFMYDEA-FDWKDR 263

Query: 147 ------REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 200
                 R I+  +   + YIH++    ++HRDIK  NI L+ +    + DFG +  F + 
Sbjct: 264 PLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKE 320

Query: 201 TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
                    GT+   +PE          +D++S G++LL+++S
Sbjct: 321 REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 45.6 bits (109), Expect = 1e-05
 Identities = 42/150 (28%), Positives = 70/150 (46%), Gaps = 17/150 (11%)

Query: 98  CHENLVKLHGGCIDGP-CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRG 156
            + N +KL+   +      +L+ DY+ +  L   L    K+  K      ++II  +   
Sbjct: 67  DNPNFIKLYY-SVTTLKGHVLIMDYIKDGDLFDLL----KKEGKLSEAEVKKIIRQLVEA 121

Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLFPENTTHISTRVAGTLGYL 215
           L  +H+    +++H DIK  N+L D+  +   + D+GL K     T   S    GTL Y 
Sbjct: 122 LNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCK--IIGTP--SCY-DGTLDYF 173

Query: 216 APEYAISGRLTRKS-DVYSFGVLLLEIVSG 244
           +PE  I G     S D ++ GVL  E+++G
Sbjct: 174 SPE-KIKGHNYDVSFDWWAVGVLTYELLTG 202

Length = 267

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 27/90 (30%), Positives = 47/90 (52%), Gaps = 5/90 (5%)

Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
           G+ ++H      ++HRD+K SNI++  +   KI DFGL++     T+ + T    T  Y 
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 192

Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
           APE  +        D++S G ++ E++ G 
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 60/230 (26%), Positives = 107/230 (46%), Gaps = 43/230 (18%)

Query: 44  FRWSNKIGEGGFGSVYKGRLQDGT-IVAVKVLSVESKQGEKEFMSEVASMANVNVCHENL 102
           ++  N IG G FG VY+    D +  VA+K +  + +   +E +     M N+N  H N+
Sbjct: 68  YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLI----MKNLN--HINI 121

Query: 103 VKL----HGGCIDGPCRIL----VYDYMPNNSLSQTLLGEEKRRAKFGWKARREII---- 150
           + L    +  C     + +    V +++P     QT+    K  A+        ++    
Sbjct: 122 IFLKDYYYTECFKKNEKNIFLNVVMEFIP-----QTVHKYMKHYARNNHALPLFLVKLYS 176

Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLF---PENTTHIST 206
             + R LAYIH +    + HRD+K  N+L+D N +  K+ DFG +K       + ++I +
Sbjct: 177 YQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICS 233

Query: 207 RVAGTLGYLAPEYAI-SGRLTRKSDVYSFGVLLLEIV------SGRTAVD 249
           R      Y APE  + +   T   D++S G ++ E++      SG+++VD
Sbjct: 234 RF-----YRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD 278

Length = 440

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 45.5 bits (107), Expect = 2e-05
 Identities = 30/100 (30%), Positives = 50/100 (50%), Gaps = 11/100 (11%)

Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
           G+ ++H      ++HRD+K SNI++  +   KI DFGL++     T+ + T    T  Y 
Sbjct: 131 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 185

Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVS------GRTAVD 249
           APE  +        D++S G ++ E+V       GR  +D
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 27/97 (27%), Positives = 48/97 (49%), Gaps = 9/97 (9%)

Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRV---AGT 211
           R + Y+HE     ++HRDIK  NI ++   +  + DFG +  FP +    + +    AGT
Sbjct: 193 RAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDIN--ANKYYGWAGT 246

Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAV 248
           +   APE           D++S G++L E+ +   ++
Sbjct: 247 IATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283

Length = 391

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 43.9 bits (104), Expect = 6e-05
 Identities = 25/78 (32%), Positives = 42/78 (53%), Gaps = 2/78 (2%)

Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR 227
           ++HRD+K SNI++  +   KI DFGL++     T+ + T    T  Y APE  +      
Sbjct: 139 IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKE 196

Query: 228 KSDVYSFGVLLLEIVSGR 245
             D++S G ++ E++ G 
Sbjct: 197 NVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 44.1 bits (104), Expect = 7e-05
 Identities = 28/84 (33%), Positives = 44/84 (52%), Gaps = 6/84 (7%)

Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN--TTHISTRVAGTLGYLA 216
           YIH E    ++HRDIKT N+L++   +  + DFG +  F     +T     +AGT+   A
Sbjct: 275 YIHGE---GIIHRDIKTENVLVNGPEDICLGDFG-AACFARGSWSTPFHYGIAGTVDTNA 330

Query: 217 PEYAISGRLTRKSDVYSFGVLLLE 240
           PE       T   D++S G+++ E
Sbjct: 331 PEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 43.8 bits (103), Expect = 8e-05
 Identities = 56/211 (26%), Positives = 86/211 (40%), Gaps = 25/211 (11%)

Query: 50  IGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANV------------- 95
           IG GGFG VY+ +   D  I    V  +E+ + E   + E     N+             
Sbjct: 20  IGCGGFGCVYETQCASDHCINNQAVAKIENLENET-IVMETLVYNNIYDIDKIALWKNIH 78

Query: 96  NVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR 155
           N+ H  + K +G      CR+  Y ++    L +      KR      K  + I+  +  
Sbjct: 79  NIDHLGIPKYYGCGSFKRCRMY-YRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLT 137

Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVA------ 209
            L YIHE     + H DIK  NI++D N    I D+G++  F  +  HI           
Sbjct: 138 TLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHR 194

Query: 210 GTLGYLAPEYAISGRLTRKSDVYSFGVLLLE 240
           GTL Y   +      +TR+ D+ S G  +L+
Sbjct: 195 GTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225

Length = 294

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 43.0 bits (101), Expect = 1e-04
 Identities = 44/152 (28%), Positives = 66/152 (43%), Gaps = 46/152 (30%)

Query: 112 GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHR 171
           G    L+  Y P   +S+ L+G               I+ G  RGL Y+H   Q   +HR
Sbjct: 84  GSANSLLKTYFPE-GMSEALIGN--------------ILFGALRGLNYLH---QNGYIHR 125

Query: 172 DIKTSNILLDQNFNPKISDFGLSKL---------------FPENTTHISTRVAGTLGYLA 216
           +IK S+IL+  +    +S  GLS L               FP+ +T +       L +L+
Sbjct: 126 NIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSV-------LPWLS 176

Query: 217 PEYA---ISGRLTRKSDVYSFGVLLLEIVSGR 245
           PE     + G    KSD+YS G+   E+ +GR
Sbjct: 177 PELLRQDLYG-YNVKSDIYSVGITACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 41.7 bits (98), Expect = 3e-04
 Identities = 44/206 (21%), Positives = 93/206 (45%), Gaps = 24/206 (11%)

Query: 50  IGEGGFGSVYKGRLQDGTIVAVKVL---SVESKQGEKEFMSEVASMANVNVCHENLVKLH 106
           I E    S+YKG   +   V ++         K       +E+ ++  ++    N++K++
Sbjct: 28  IKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRID--SNNILKIY 84

Query: 107 G---GCIDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE 162
           G     +D   R+ L+ +Y     L + L  E+       +K + ++ +   +GL  +++
Sbjct: 85  GFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD----LSFKTKLDMAIDCCKGLYNLYK 140

Query: 163 EI-QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA- 220
              +P+   +++ + + L+ +N+  KI   GL K+    ++     V   + Y + +   
Sbjct: 141 YTNKPY---KNLTSVSFLVTENYKLKIICHGLEKIL---SSPPFKNV-NFMVYFSYKMLN 193

Query: 221 -ISGRLTRKSDVYSFGVLLLEIVSGR 245
            I    T K D+YS GV+L EI +G+
Sbjct: 194 DIFSEYTIKDDIYSLGVVLWEIFTGK 219

Length = 283

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 42.0 bits (98), Expect = 4e-04
 Identities = 66/236 (27%), Positives = 103/236 (43%), Gaps = 38/236 (16%)

Query: 42  NGFRWSNKIGEGGFGSVY---KGRLQDGTIVAVKVLSVES-KQGEK-EFMSEVASMANVN 96
           N +    KIG G FG V+     R Q+      K +S    K+ EK + + EV  M  + 
Sbjct: 13  NEYEVIKKIGNGRFGEVFLVKHKRTQE--FFCWKAISYRGLKEREKSQLVIEVNVMRELK 70

Query: 97  VCHENLVKLHGGCIDGPCRIL--VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIG 154
             H+N+V+     ++   + L  + ++     LS+ +    K   K    A  +I   + 
Sbjct: 71  --HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLL 128

Query: 155 RGLAYIHE-EIQPH---VVHRDIKTSNILLD-------------QNFN----PKISDFGL 193
             LAY H  +  P+   V+HRD+K  NI L               N N     KI DFGL
Sbjct: 129 HALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGL 188

Query: 194 SK-LFPENTTHISTRVAGTLGYLAPEYAI--SGRLTRKSDVYSFGVLLLEIVSGRT 246
           SK +  E+  H      GT  Y +PE  +  +     KSD+++ G ++ E+ SG+T
Sbjct: 189 SKNIGIESMAH---SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241

Length = 1021

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 39.5 bits (92), Expect = 0.002
 Identities = 16/40 (40%), Positives = 27/40 (67%), Gaps = 3/40 (7%)

Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196
           L Y+H   +  ++HRD+K  N+L+    + K++DFGLSK+
Sbjct: 117 LDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 37.4 bits (87), Expect = 0.004
 Identities = 27/151 (17%), Positives = 54/151 (35%), Gaps = 14/151 (9%)

Query: 49  KIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG 108
            +  G    VY    +D   V +K+     K  ++E   EVA +  +      + K+   
Sbjct: 5   LLKGGLTNRVYLLGTKDEDYV-LKINPSREKGADRE--REVAILQLLARKGLPVPKVLAS 61

Query: 109 CIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHV 168
                   L+ +++   +L +    E++           ++       LA +H+     +
Sbjct: 62  GESDGWSYLLMEWIEGETLDEVSEEEKE-------DIAEQL----AELLAKLHQLPLLVL 110

Query: 169 VHRDIKTSNILLDQNFNPKISDFGLSKLFPE 199
            H D+   NIL+D      I D+  +   P 
Sbjct: 111 CHGDLHPGNILVDDGKILGIIDWEYAGYGPP 141

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 37.9 bits (88), Expect = 0.004
 Identities = 26/93 (27%), Positives = 43/93 (46%), Gaps = 9/93 (9%)

Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG-LSKLFPENTTHISTRVAGTLGYL 215
           L  +H E    +V RD+  +NILLD   + +++ F   S++           +     Y 
Sbjct: 98  LDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YC 149

Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVSGRTAV 248
           APE       T   D +S G +L E+++G+T V
Sbjct: 150 APEVGGISEETEACDWWSLGAILFELLTGKTLV 182

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	358
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.98
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.98
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.95
PLN00181	793	protein SPA1-RELATED; Provisional	99.94
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.94
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.93
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.92
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.91
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.91
PRK09188	365	serine/threonine protein kinase; Provisional	99.91
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.9
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.89
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.89
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.89
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.87
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.87
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.86
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.85
PRK12274	218	serine/threonine protein kinase; Provisional	99.82
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.81
smart00090	237	RIO RIO-like kinase.	99.81
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.8
PRK10345	210	hypothetical protein; Provisional	99.78
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.78
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.76
PRK14879	211	serine/threonine protein kinase; Provisional	99.74
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.73
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.72
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.71
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.68
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.66
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.63
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.61
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.6
KOG1243	690	consensus Protein kinase [General function predict	99.53
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.52
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.48
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.46
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.4
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.39
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.38
COG4248	637	Uncharacterized protein with protein kinase and he	99.38
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.33
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.26
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.25
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.24
KOG3087	229	consensus Serine/threonine protein kinase [General	99.23
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.11
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.09
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.09
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.06
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.92
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.9
PRK09902	216	hypothetical protein; Provisional	98.87
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.86
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.8
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.74
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.66
PF01636	239	APH: Phosphotransferase enzyme family This family	98.59
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.49
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.41
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.24
PLN02876	822	acyl-CoA dehydrogenase	98.13
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.08
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	98.05
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.05
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.04
PRK05231	319	homoserine kinase; Provisional	98.01
PRK10593	297	hypothetical protein; Provisional	97.98
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.86
KOG2270	520	consensus Serine/threonine protein kinase involved	97.82
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.8
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.76
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.74
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.72
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.71
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.68
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.64
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.56
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.45
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.45
PLN02236	344	choline kinase	97.41
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.35
PLN02756	418	S-methyl-5-thioribose kinase	97.34
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.26
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	97.11
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	97.08
PRK12396	409	5-methylribose kinase; Reviewed	97.06
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.02
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.97
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.92
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.9
PRK11768	325	serine/threonine protein kinase; Provisional	96.84
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.68
COG2334	331	Putative homoserine kinase type II (protein kinase	96.59
PRK06148	1013	hypothetical protein; Provisional	96.34
PTZ00384	383	choline kinase; Provisional	95.96
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.66
PF04655	253	APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r	95.44
PTZ00296	442	choline kinase; Provisional	95.29

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-48  Score=360.70  Aligned_cols=247  Identities=24%  Similarity=0.410  Sum_probs=217.9

Q ss_pred             cCCcccceecccCceEEEEEEE-CCCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRL-QDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      .+|...+.||+|||+.||.+++ .+|+.||+|++...   +......+.+|+++.+.++  |||||+++++|++.++.||
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~--HpnIV~f~~~FEDs~nVYi   95 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLK--HPNIVQFYHFFEDSNNVYI   95 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcC--CCcEEeeeeEeecCCceEE
Confidence            5799999999999999999998 78999999999753   5667788999999999999  9999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      |.|.|+.++|.+++    ..++.++|.+++.+++||+.||.|||++   +|+|||||..|+|++++..|||+|||+|...
T Consensus        96 vLELC~~~sL~el~----Krrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~l  168 (592)
T KOG0575|consen   96 VLELCHRGSLMELL----KRRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQL  168 (592)
T ss_pred             EEEecCCccHHHHH----HhcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeee
Confidence            99999999999999    5778999999999999999999999999   9999999999999999999999999999987


Q ss_pred             CCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhc
Q 018263          198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD  277 (358)
Q Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      ..+.. ...+.+||+.|.|||++.....+..+||||+||++|.||.|++||..+.-.+.+..+...              
T Consensus       169 e~~~E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~--------------  233 (592)
T KOG0575|consen  169 EYDGE-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN--------------  233 (592)
T ss_pred             cCccc-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc--------------
Confidence            54433 345688999999999999999999999999999999999999999866544333333211              


Q ss_pred             cccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          278 PMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       278 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                         .-.+|...+....+||.++|+.||.+|||+++|+.
T Consensus       234 ---~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  234 ---EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             ---CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence               11234466778899999999999999999999984

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-48  Score=344.42  Aligned_cols=250  Identities=22%  Similarity=0.316  Sum_probs=208.3

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC-------hhhHHHHHHHHHHhhhcccCCCCceeeeceEEc
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-------KQGEKEFMSEVASMANVNVCHENLVKLHGGCID  111 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~-------~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~  111 (358)
                      ..+.|.+.+.||+|+||.|-+|..+ +|+.||||+++...       ......+.+|+++|++++  |||||+++++|+.
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~--HP~IV~~~d~f~~  247 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLS--HPNIVRIKDFFEV  247 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcC--CCCEEEEeeeeec
Confidence            4678999999999999999999854 79999999996541       123345679999999998  9999999999999


Q ss_pred             CCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCC---CceEE
Q 018263          112 GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN---FNPKI  188 (358)
Q Consensus       112 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~---~~~~l  188 (358)
                      ....|+||||++||.|.+.+    -.++.+.+..-..+++|++.|+.|||+.   ||+||||||+||++..+   ..+||
T Consensus       248 ~ds~YmVlE~v~GGeLfd~v----v~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKI  320 (475)
T KOG0615|consen  248 PDSSYMVLEYVEGGELFDKV----VANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKI  320 (475)
T ss_pred             CCceEEEEEEecCccHHHHH----HhccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEe
Confidence            99999999999999999999    5667788888899999999999999999   99999999999999766   67899


Q ss_pred             eecccccccCCCCcccccccccccCccCccccccCC---CCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhh
Q 018263          189 SDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR---LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG  265 (358)
Q Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~  265 (358)
                      +|||+++..+  ........+||+.|.|||++.+..   +..+.|+|||||++|-+|+|.+||.......          
T Consensus       321 tDFGlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~----------  388 (475)
T KOG0615|consen  321 TDFGLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP----------  388 (475)
T ss_pred             cccchhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc----------
Confidence            9999999865  344566789999999999998654   3348899999999999999999997554322          


Q ss_pred             ccchhhHhhhhccccCC---CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          266 MYNSKELMNLVDPMLYG---NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                           .+.+.+......   ....+.+.+...||.+||.+||++|||+.|+++
T Consensus       389 -----sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  389 -----SLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             -----cHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence                 122222222111   223467888999999999999999999999874

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-47  Score=348.02  Aligned_cols=291  Identities=51%  Similarity=0.862  Sum_probs=249.6

Q ss_pred             cccccCHHHHHHhhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeec
Q 018263           28 NINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG  107 (358)
Q Consensus        28 ~~~~~~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~  107 (358)
                      .+..|++.++..++++|.-...||+|+||.||+|...+|..||||.+.........++..|++.+.+++  |||++++++
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~--H~Nlv~LlG  138 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLR--HPNLVKLLG  138 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCC--CcCcccEEE
Confidence            688899999999999999999999999999999999988999999876544321556999999999998  999999999


Q ss_pred             eEEcCC-eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCce
Q 018263          108 GCIDGP-CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP  186 (358)
Q Consensus       108 ~~~~~~-~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~  186 (358)
                      +|.+.+ ..++|+||+++|+|.+.+......  .++|..+.+|+.++|.||+|||+.+.+.|+|||||++|||+|++...
T Consensus       139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a  216 (361)
T KOG1187|consen  139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA  216 (361)
T ss_pred             EEecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence            999998 499999999999999999543222  88999999999999999999999866679999999999999999999


Q ss_pred             EEeecccccccCCCCccccccc-ccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhh
Q 018263          187 KISDFGLSKLFPENTTHISTRV-AGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG  265 (358)
Q Consensus       187 ~l~Dfg~~~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~  265 (358)
                      ||+|||++...... ....... .||.+|+|||++..+..+.++||||||+++.||++|+.+.+..........+.+.+.
T Consensus       217 KlsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~  295 (361)
T KOG1187|consen  217 KLSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKP  295 (361)
T ss_pred             EccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHH
Confidence            99999999664331 1111122 799999999999999999999999999999999999998886654444446665555


Q ss_pred             ccchhhHhhhhccccC-CCCCH-HHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCC
Q 018263          266 MYNSKELMNLVDPMLY-GNFPE-NEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNI  323 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~  323 (358)
                      ......+.+++|+.+. ..++. .....+.+++.+|++.+|.+||+|.+|++.|+.+...
T Consensus       296 ~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  296 LLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             HHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence            5566689999999987 66664 6777899999999999999999999999999666544

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=8e-48  Score=336.76  Aligned_cols=254  Identities=28%  Similarity=0.432  Sum_probs=215.6

Q ss_pred             HHHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCe
Q 018263           37 LKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC  114 (358)
Q Consensus        37 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~  114 (358)
                      ..+..++.+.++.||+|..|+||+++++ +++.+|+|.+... .....+++.+|++++++.+  ||+||.+++.|++.+.
T Consensus        74 ~~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~--spyIV~~ygaF~~~~~  151 (364)
T KOG0581|consen   74 NGISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQ--SPYIVGFYGAFYSNGE  151 (364)
T ss_pred             cccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC--CCCeeeEeEEEEeCCc
Confidence            3355568888999999999999999976 6899999999544 5666789999999999997  9999999999999995


Q ss_pred             -eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcEEcCCCCCcEEEcCCCceEEeecc
Q 018263          115 -RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNILLDQNFNPKISDFG  192 (358)
Q Consensus       115 -~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg  192 (358)
                       ..|+||||++|+|++++    ...+.++|..+..++.+|++||.|||+ .   +|+||||||+||+|+..|.|||+|||
T Consensus       152 ~isI~mEYMDgGSLd~~~----k~~g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFG  224 (364)
T KOG0581|consen  152 EISICMEYMDGGSLDDIL----KRVGRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFG  224 (364)
T ss_pred             eEEeehhhcCCCCHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEecccc
Confidence             99999999999999999    455889999999999999999999996 7   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCcc--ccccchhhhHhhhhccchh
Q 018263          193 LSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD--VQLGEYHLVDKAWGMYNSK  270 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~--~~~~~~~~~~~~~~~~~~~  270 (358)
                      .+...-..   ......||..|+|||.+.+..|+.++||||||++++|+.+|+.||...  ...+.+.+...+       
T Consensus       225 VS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~I-------  294 (364)
T KOG0581|consen  225 VSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAI-------  294 (364)
T ss_pred             ccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHH-------
Confidence            99865333   345578999999999999999999999999999999999999999764  112222222222       


Q ss_pred             hHhhhhccccCCCCCHH-HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          271 ELMNLVDPMLYGNFPEN-EAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                           ++. ..+..|.. ++.++..+|..||+.||.+||++.++++
T Consensus       295 -----v~~-ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  295 -----VDE-PPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             -----hcC-CCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                 111 12334444 8889999999999999999999999875

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.7e-50  Score=335.76  Aligned_cols=261  Identities=26%  Similarity=0.404  Sum_probs=218.1

Q ss_pred             hcCCcccceecccCceEEEEEEE-CCCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeec-eEEcCCe-e
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRL-QDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHG-GCIDGPC-R  115 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~-~~~~~~~-~  115 (358)
                      ..+|+|++.||.|.||.||++.. .+|..+|.|.++..  +....+.+..|+.+|+.++  ||||+++++ .|..++. +
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~--HpNIVqYy~~~f~~~~evl   95 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLN--HPNIVQYYAHSFIEDNEVL   95 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcC--CchHHHHHHHhhhccchhh
Confidence            46799999999999999999985 58999999998744  5666788999999999999  999999998 5555555 8


Q ss_pred             EEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCC-CCCcEEcCCCCCcEEEcCCCceEEeecccc
Q 018263          116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI-QPHVVHRDIKTSNILLDQNFNPKISDFGLS  194 (358)
Q Consensus       116 ~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~-~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~  194 (358)
                      +||||+|.+|+|...+.+.+...+.+++..+|+++.|++.||..+|++- +.-|.||||||.|||++.+|.+||+|||++
T Consensus        96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~  175 (375)
T KOG0591|consen   96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG  175 (375)
T ss_pred             HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence            9999999999999999988888899999999999999999999999931 124999999999999999999999999999


Q ss_pred             cccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhh
Q 018263          195 KLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMN  274 (358)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                      +.+.... .......|||.|++||.+.+.+|+.++||||+||++|||+..++||.+++   .+.+             ..
T Consensus       176 r~l~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n---~~~L-------------~~  238 (375)
T KOG0591|consen  176 RFLSSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN---LLSL-------------CK  238 (375)
T ss_pred             hHhcchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc---HHHH-------------HH
Confidence            9875433 33455789999999999999999999999999999999999999998662   1111             11


Q ss_pred             hhccccCCCCC-HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 018263          275 LVDPMLYGNFP-ENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE  320 (358)
Q Consensus       275 ~~~~~~~~~~~-~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~  320 (358)
                      .+...-.+..| ..++.++..+|..|+.+||+.||+...++..+...
T Consensus       239 KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~  285 (375)
T KOG0591|consen  239 KIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSE  285 (375)
T ss_pred             HHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHH
Confidence            22222222233 67889999999999999999999966666555553

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-47  Score=330.87  Aligned_cols=261  Identities=24%  Similarity=0.329  Sum_probs=215.5

Q ss_pred             HHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC
Q 018263           38 KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP  113 (358)
Q Consensus        38 ~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~  113 (358)
                      .+..++|++++.||+|+||+|+.++.+ +++.||+|+++..   .....+....|..++..++  ||+||+++-.|.+..
T Consensus        21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~--hPFiv~l~ysFQt~~   98 (357)
T KOG0598|consen   21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIK--HPFIVKLIYSFQTEE   98 (357)
T ss_pred             cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCC--CCcEeeeEEecccCC
Confidence            345789999999999999999999865 6899999998654   3345677889999999988  999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccc
Q 018263          114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL  193 (358)
Q Consensus       114 ~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~  193 (358)
                      .+|+|++|+.||.|...+    ++.+.+++..++.++..|+.||.|||++   ||+||||||+|||++.+|.++|+|||+
T Consensus        99 kLylVld~~~GGeLf~hL----~~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL  171 (357)
T KOG0598|consen   99 KLYLVLDYLNGGELFYHL----QREGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGL  171 (357)
T ss_pred             eEEEEEeccCCccHHHHH----HhcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEecccc
Confidence            999999999999999999    6778899999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHh
Q 018263          194 SKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELM  273 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      ++..... .......+||+.|+|||++.+..|+.++|.||||+++|+|++|.+||...+...-+..+             
T Consensus       172 ~k~~~~~-~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I-------------  237 (357)
T KOG0598|consen  172 CKEDLKD-GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKI-------------  237 (357)
T ss_pred             chhcccC-CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHH-------------
Confidence            9864332 22334479999999999999999999999999999999999999999865432222111             


Q ss_pred             hhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCC
Q 018263          274 NLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNID  324 (358)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~  324 (358)
                         ........+...+.+..+++.++|+.+|++|..+..=.+.++++.-..
T Consensus       238 ---~~~k~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~  285 (357)
T KOG0598|consen  238 ---LKGKLPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFK  285 (357)
T ss_pred             ---hcCcCCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccc
Confidence               111123344446778999999999999999974332233344444333

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=6e-46  Score=339.28  Aligned_cols=272  Identities=31%  Similarity=0.473  Sum_probs=226.7

Q ss_pred             HHHHHHhhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccCh--hhHHHHHHHHHHhhhcccCCCCceeeeceEEc
Q 018263           34 YNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESK--QGEKEFMSEVASMANVNVCHENLVKLHGGCID  111 (358)
Q Consensus        34 ~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~  111 (358)
                      .....++.+...+.+.||.|+||+||++.+.....||+|++.....  ...+.+.+|+.++.+++  ||||+++++++..
T Consensus        33 ~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~--HpNIV~f~G~~~~  110 (362)
T KOG0192|consen   33 LPEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLR--HPNIVQFYGACTS  110 (362)
T ss_pred             ccceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCC--CCCeeeEEEEEcC
Confidence            3455666777777888999999999999998544499999975432  22569999999999998  9999999999999


Q ss_pred             CC-eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCC-cEEcCCCCCcEEEcCCC-ceEE
Q 018263          112 GP-CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH-VVHRDIKTSNILLDQNF-NPKI  188 (358)
Q Consensus       112 ~~-~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~-i~H~di~p~Nilv~~~~-~~~l  188 (358)
                      .. .+++||||+++|+|.+++...  ....++...+..|+.||+.|+.|||++   + |+|+||||+||+++.++ .+||
T Consensus       111 ~~~~~~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI  185 (362)
T KOG0192|consen  111 PPGSLCIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKI  185 (362)
T ss_pred             CCCceEEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEE
Confidence            88 799999999999999999443  467899999999999999999999999   8 99999999999999997 9999


Q ss_pred             eecccccccCCCCcccccccccccCccCccccc--cCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhc
Q 018263          189 SDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI--SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGM  266 (358)
Q Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~  266 (358)
                      +|||+++...... .......||+.|+|||++.  ...++.++||||||+++|||++|+.||......            
T Consensus       186 ~DFGlsr~~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~------------  252 (362)
T KOG0192|consen  186 ADFGLSREKVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV------------  252 (362)
T ss_pred             CCCccceeecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH------------
Confidence            9999998754322 2233367999999999999  568999999999999999999999999855431            


Q ss_pred             cchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCCCCCC
Q 018263          267 YNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNIDGXDV  328 (358)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~~~~~  328 (358)
                         .-....+....+...+..++..+..++.+||+.||.+||++.+++..|+.+...-....
T Consensus       253 ---~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~~  311 (362)
T KOG0192|consen  253 ---QVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSAG  311 (362)
T ss_pred             ---HHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcccC
Confidence               11222333444555666688899999999999999999999999999998876544333

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-46  Score=328.56  Aligned_cols=204  Identities=29%  Similarity=0.544  Sum_probs=184.1

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      ..+|.+.++||.|.|+.||+|+++ ++..||||.+...  .....+.+..|+.+|+.++  |||||.+++++..++..|+
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~--H~nIV~l~d~~~~~~~i~l   86 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELK--HPNIVRLLDCIEDDDFIYL   86 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcC--CcceeeEEEEEecCCeEEE
Confidence            468999999999999999999976 5899999998765  5666778899999999999  9999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCC------CceEEeec
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN------FNPKISDF  191 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~------~~~~l~Df  191 (358)
                      |||||.||+|.+++    .+.+.+++..++.++.||+.||++||++   +|+||||||.||+++..      -.+||+||
T Consensus        87 VMEyC~gGDLs~yi----~~~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADF  159 (429)
T KOG0595|consen   87 VMEYCNGGDLSDYI----RRRGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADF  159 (429)
T ss_pred             EEEeCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEeccc
Confidence            99999999999999    5667899999999999999999999999   99999999999999765      45899999


Q ss_pred             ccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCcccccc
Q 018263          192 GLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG  255 (358)
Q Consensus       192 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~  255 (358)
                      |+++.+..  .......+|++-|+|||++...+|+.|+|+||+|+++|+|++|+.||...+..+
T Consensus       160 GfAR~L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e  221 (429)
T KOG0595|consen  160 GFARFLQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE  221 (429)
T ss_pred             chhhhCCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence            99998753  333456889999999999999999999999999999999999999998665443

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-46  Score=338.78  Aligned_cols=272  Identities=28%  Similarity=0.437  Sum_probs=239.8

Q ss_pred             ccccCHHHHHHhhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeece
Q 018263           29 INAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG  108 (358)
Q Consensus        29 ~~~~~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~  108 (358)
                      ...+..+.+.+..+.+++++.||+|-||.||++.++....|++|.+... .-....+.+|++++++++  |++||+++++
T Consensus       193 ~~~~~~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~--H~~lV~l~gV  269 (468)
T KOG0197|consen  193 TPDLARDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLR--HEKLVKLYGV  269 (468)
T ss_pred             CCccccCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCc--ccCeEEEEEE
Confidence            3344477788888999999999999999999999998889999999743 445567889999999999  9999999999


Q ss_pred             EEcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEE
Q 018263          109 CIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKI  188 (358)
Q Consensus       109 ~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l  188 (358)
                      +..+...+|||||++.|+|.++++.  .....+....+..++.|||.|++||+++   ++|||||...||||+++..+||
T Consensus       270 ~~~~~piyIVtE~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKI  344 (468)
T KOG0197|consen  270 CTKQEPIYIVTEYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKI  344 (468)
T ss_pred             EecCCceEEEEEecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEE
Confidence            9998899999999999999999954  3567788999999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhcc
Q 018263          189 SDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMY  267 (358)
Q Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~  267 (358)
                      +|||+++...++.........-+.-|.|||.+..+.++.+|||||||++||||+| |+.||..-                
T Consensus       345 sDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m----------------  408 (468)
T KOG0197|consen  345 SDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM----------------  408 (468)
T ss_pred             cccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC----------------
Confidence            9999999766666656666667789999999999999999999999999999999 78887643                


Q ss_pred             chhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCC
Q 018263          268 NSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNID  324 (358)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~  324 (358)
                      ...++.+.+++..+-..|..++..+.+|+..||+.+|++|||++.+...|+.+....
T Consensus       409 sn~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~  465 (468)
T KOG0197|consen  409 SNEEVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST  465 (468)
T ss_pred             CHHHHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence            344566667777777788889999999999999999999999999999999876543

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-46  Score=337.11  Aligned_cols=268  Identities=26%  Similarity=0.351  Sum_probs=227.7

Q ss_pred             HhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC-ee
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP-CR  115 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~-~~  115 (358)
                      +.-++|.++++||-|.||.||+|+.+ +|..||||.++.. ..+.+..-.+|+..|+++. .||||+++.+++.+.. .+
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln-~hpniikL~Evi~d~~~~L   85 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLN-PHPNIIKLKEVIRDNDRIL   85 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcC-CCCcchhhHHHhhccCceE
Confidence            45689999999999999999999965 6899999998654 3455566678999999997 6999999999999888 99


Q ss_pred             EEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccc
Q 018263          116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK  195 (358)
Q Consensus       116 ~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~  195 (358)
                      ++||||| ..+|.+++.+   ++..+++..++.|+.||+.||+|+|.+   |+.|||+||+||+|..+..+||+|||+|+
T Consensus        86 ~fVfE~M-d~NLYqLmK~---R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLAR  158 (538)
T KOG0661|consen   86 YFVFEFM-DCNLYQLMKD---RNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAR  158 (538)
T ss_pred             eeeHHhh-hhhHHHHHhh---cCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccc
Confidence            9999999 6799999943   377899999999999999999999999   99999999999999988899999999999


Q ss_pred             ccCCCCcccccccccccCccCccccc-cCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhh
Q 018263          196 LFPENTTHISTRVAGTLGYLAPEYAI-SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMN  274 (358)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                      .......  .+.+..|.+|+|||++. .+.|+.+.|+|++|||++|+.+-++.|.+.++.++...+-.+.+.+..+.+.+
T Consensus       159 ev~SkpP--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e  236 (538)
T KOG0661|consen  159 EVRSKPP--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE  236 (538)
T ss_pred             ccccCCC--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh
Confidence            7643332  35578899999999987 56799999999999999999999999999999999999998888877665544


Q ss_pred             h---hccc---c---CC----CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 018263          275 L---VDPM---L---YG----NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKM  316 (358)
Q Consensus       275 ~---~~~~---~---~~----~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~  316 (358)
                      .   ...+   +   .+    ..-++.+.+..++|..||++||++||||.+.++.
T Consensus       237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            1   1111   1   11    1112478899999999999999999999999873

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-45  Score=335.33  Aligned_cols=251  Identities=25%  Similarity=0.373  Sum_probs=212.0

Q ss_pred             HhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCe
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC  114 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~  114 (358)
                      ...++|...+.||.|.|++|++|+.+ +++.||||++...   .....+-+..|-+.|..+. +||.|++++..|.++..
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~-~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLS-GHPGIVKLYFTFQDEES  148 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhh-CCCCeEEEEEEeecccc
Confidence            34579999999999999999999965 6999999998644   2333345667888888885 59999999999999999


Q ss_pred             eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccc
Q 018263          115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS  194 (358)
Q Consensus       115 ~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~  194 (358)
                      +|+|+||+++|+|.++|    .+.+.+++.-.+.++.+|+.||+|||++   |||||||||+|||++.+++++|+|||.+
T Consensus       149 LYFvLe~A~nGdll~~i----~K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsA  221 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLI----KKYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSA  221 (604)
T ss_pred             eEEEEEecCCCcHHHHH----HHhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccc
Confidence            99999999999999999    5678999999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcc----------cc--cccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHh
Q 018263          195 KLFPENTTH----------IS--TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDK  262 (358)
Q Consensus       195 ~~~~~~~~~----------~~--~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~  262 (358)
                      ..+......          ..  ...+||..|++||++.+...++++|+|+||||+|+|+.|.+||...++--.++.+..
T Consensus       222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~  301 (604)
T KOG0592|consen  222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQA  301 (604)
T ss_pred             ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHH
Confidence            877432211          11  347899999999999999999999999999999999999999987665433333322


Q ss_pred             hhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 018263          263 AWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAI  314 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil  314 (358)
                      .             +    =.++...+....+||.++|..||.+|+|+++|-
T Consensus       302 l-------------~----y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk  336 (604)
T KOG0592|consen  302 L-------------D----YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIK  336 (604)
T ss_pred             h-------------c----ccCCCCCCHHHHHHHHHHHccCccccccHHHHh
Confidence            1             1    124455667899999999999999999996554

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.1e-45  Score=314.30  Aligned_cols=264  Identities=22%  Similarity=0.320  Sum_probs=220.0

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      +.|+.+.++|+|++|.||+++++ +|+.||||.+--.  +....+-.++|+.+|+.++  |+|+|.++++|.....+++|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLk--H~NLVnLiEVFrrkrklhLV   79 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLK--HENLVNLIEVFRRKRKLHLV   79 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcc--cchHHHHHHHHHhcceeEEE
Confidence            46889999999999999999987 5999999998533  3455677889999999999  99999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      +|||+..-|.++-    ....-++.+.+.++++|++.|+.|+|++   +++||||||+||+|+.+|.+||+|||+++...
T Consensus        80 FE~~dhTvL~eLe----~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~  152 (396)
T KOG0593|consen   80 FEYCDHTVLHELE----RYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLS  152 (396)
T ss_pred             eeecchHHHHHHH----hccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhc
Confidence            9999765444443    4556689999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCcccccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhc
Q 018263          199 ENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD  277 (358)
Q Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      . .....+.+..|.+|.|||.+.| .+|+.+.|||++||++.||++|++.|.+.+..++...+....+...+....-+-.
T Consensus       153 ~-pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~  231 (396)
T KOG0593|consen  153 A-PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSS  231 (396)
T ss_pred             C-CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhcc
Confidence            5 3444566788999999999987 6899999999999999999999999999999999988877766555443222221


Q ss_pred             cccC-C-------------CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          278 PMLY-G-------------NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       278 ~~~~-~-------------~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .... +             .--+..+.-+++++.+||+.||++|++-++++.
T Consensus       232 N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  232 NPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             CCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            1110 0             111234557889999999999999999888763

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-45  Score=307.77  Aligned_cols=237  Identities=28%  Similarity=0.369  Sum_probs=209.6

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI  116 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~  116 (358)
                      .++|++++.||.|+||.|.+++.+ +|..||+|++...   ...+.++..+|..+|+...  ||+++++++.+.+.+.+|
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~--~PFlv~l~~t~~d~~~ly  120 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS--HPFLVKLYGTFKDNSNLY  120 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhcc--CceeEEEEEeeccCCeEE
Confidence            467899999999999999999976 6899999999754   3445567888999999998  999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       117 iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      +||||.+||.|..++    ++.+++++..++.++.||+.||+|||++   +|++||+||+|||+|.+|.+||+|||+++.
T Consensus       121 mvmeyv~GGElFS~L----rk~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~  193 (355)
T KOG0616|consen  121 MVMEYVPGGELFSYL----RKSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKR  193 (355)
T ss_pred             EEEeccCCccHHHHH----HhcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEE
Confidence            999999999999999    6788999999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhh
Q 018263          197 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV  276 (358)
Q Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                      ...    .....+||+.|+|||++...+++.++|-|+||+++|||+.|.+||........++.+..              
T Consensus       194 v~~----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~--------------  255 (355)
T KOG0616|consen  194 VSG----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILE--------------  255 (355)
T ss_pred             ecC----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHh--------------
Confidence            532    24568999999999999999999999999999999999999999987765443333321              


Q ss_pred             ccccCCCCCHHHHHHHHHHHhhccCCCCCCC
Q 018263          277 DPMLYGNFPENEAIRFLKVGLLCVQEKSKLR  307 (358)
Q Consensus       277 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R  307 (358)
                       .  .-.+|...+.++.+|+.++|++|-.+|
T Consensus       256 -~--~v~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  256 -G--KVKFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             -C--cccCCcccCHHHHHHHHHHHhhhhHhh
Confidence             1  123677788889999999999999999

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=4.1e-44  Score=299.57  Aligned_cols=283  Identities=21%  Similarity=0.325  Sum_probs=234.4

Q ss_pred             cCCcccceecccCceEEEEEEE-CCCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRL-QDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      ++|...++||+|.||.||+|++ ++|+.||||.++..  .........+|+..|+.++  |+||+.++++|.+.+.+.+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~--h~nIi~LiD~F~~~~~l~lV   79 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELK--HPNIIELIDVFPHKSNLSLV   79 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHcc--CcchhhhhhhccCCCceEEE
Confidence            5789999999999999999985 47999999998754  2334567889999999998  99999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      +||++ .+|...++   .+...++...+..|+.+++.||+|+|++   .|.||||||.|++++.+|.+||+|||+++.++
T Consensus        80 fEfm~-tdLe~vIk---d~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~  152 (318)
T KOG0659|consen   80 FEFMP-TDLEVVIK---DKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFG  152 (318)
T ss_pred             EEecc-ccHHHHhc---ccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccC
Confidence            99995 68999983   3566789999999999999999999999   99999999999999999999999999999886


Q ss_pred             CCCcccccccccccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhc
Q 018263          199 ENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD  277 (358)
Q Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      ...... .....|.+|.|||.+.|. .|+...|+||.||++.||+-|.+-|.+++..++...+....+.+..+.+.++..
T Consensus       153 ~p~~~~-~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~  231 (318)
T KOG0659|consen  153 SPNRIQ-THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTS  231 (318)
T ss_pred             CCCccc-ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccc
Confidence            544433 334688999999998874 799999999999999999999999999999999999999988887776655432


Q ss_pred             cc-----------cCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--hhcCCCCCCCCCCCCCCcc
Q 018263          278 PM-----------LYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKM--MNGETNIDGXDVEISQPGL  335 (358)
Q Consensus       278 ~~-----------~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~--L~~~~~~~~~~~~~~~~~~  335 (358)
                      -.           .....-+..+.+..+|+.+|+..||.+|+|+.|+++.  +.+ .+....+..++-|..
T Consensus       232 lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~-~P~pt~~~~lp~p~~  301 (318)
T KOG0659|consen  232 LPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS-LPLPTPPSKLPIPST  301 (318)
T ss_pred             cccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc-CCCCCChhhCcCCcc
Confidence            11           1111233566788999999999999999999999864  333 333333444444444

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-44  Score=324.51  Aligned_cols=267  Identities=27%  Similarity=0.364  Sum_probs=227.2

Q ss_pred             hhcCCcccceecccCceEEEEEEE-CCCCEEEEEEeeccC--hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC--Ce
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRL-QDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG--PC  114 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~--~~  114 (358)
                      ..+.|+.+++||+|.||.||+|++ .+|+.||+|.+..+.  .....-..+|+.+|+++.  ||||+++.+...+.  ..
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~--HpNIikL~eivt~~~~~s  192 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLD--HPNIIKLEEIVTSKLSGS  192 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcC--CCcccceeeEEEecCCce
Confidence            356899999999999999999985 479999999998764  444567789999999998  99999999998876  68


Q ss_pred             eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccc
Q 018263          115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS  194 (358)
Q Consensus       115 ~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~  194 (358)
                      +|+|+|||+ -+|..++.   ...-.+++.++..++.||+.||+|+|++   ||.|||||.+||||+++|.+||+|||++
T Consensus       193 iYlVFeYMd-hDL~GLl~---~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLA  265 (560)
T KOG0600|consen  193 IYLVFEYMD-HDLSGLLS---SPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLA  265 (560)
T ss_pred             EEEEEeccc-chhhhhhc---CCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccce
Confidence            999999995 57888882   2345799999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcccccccccccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHh
Q 018263          195 KLFPENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELM  273 (358)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      +++........+..+.|.+|.|||++.|. .|+.+.|+||.|||+.||+.|++.|.+..+.++.+.+.+..+.+....|.
T Consensus       266 r~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~  345 (560)
T KOG0600|consen  266 RFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP  345 (560)
T ss_pred             eeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc
Confidence            98776666666778899999999999875 79999999999999999999999999999999999999888877766655


Q ss_pred             hhhccc---cCC--CCC-------HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          274 NLVDPM---LYG--NFP-------ENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       274 ~~~~~~---~~~--~~~-------~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ..--+.   ++.  .+.       ...+...++|+..+|..||.+|.||.++++
T Consensus       346 ~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  346 VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            111110   111  111       135567889999999999999999999875

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-44  Score=298.11  Aligned_cols=269  Identities=22%  Similarity=0.283  Sum_probs=219.5

Q ss_pred             HHHHHhhcCCcccceecccCceEEEEEE-ECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC
Q 018263           35 NQLKIATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP  113 (358)
Q Consensus        35 ~~~~~~~~~y~i~~~lg~g~~g~v~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~  113 (358)
                      ..+-++.+||+|.+.||.|||+.||+++ ..++..||+|.+........+..++|++..++++  |||++++++....+.
T Consensus        14 ~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~--s~~vl~l~dh~l~~~   91 (302)
T KOG2345|consen   14 GTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFN--SPNVLRLVDHQLREE   91 (302)
T ss_pred             CcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhC--CcchHHHHHHHHHhh
Confidence            3456788999999999999999999998 4578899999998888888899999999999999  999999998765443


Q ss_pred             -----eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCC--cEEcCCCCCcEEEcCCCce
Q 018263          114 -----CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH--VVHRDIKTSNILLDQNFNP  186 (358)
Q Consensus       114 -----~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~--i~H~di~p~Nilv~~~~~~  186 (358)
                           ..|++++|+..|+|.+.+.........+++..+..|+.+|++||.+||+.   .  ++|+||||.||++.+.+.+
T Consensus        92 ~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~---~~~yAH~DiKP~NILls~~~~~  168 (302)
T KOG2345|consen   92 KDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK---EPPYAHRDIKPANILLSDSGLP  168 (302)
T ss_pred             ccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc---CCcccccCCCcceeEecCCCce
Confidence                 48999999999999999987777777899999999999999999999999   7  9999999999999999999


Q ss_pred             EEeecccccccCCCCccccc--------ccccccCccCccccc---cCCCCccCceecHHHHHHHHHhCCCCCCcccccc
Q 018263          187 KISDFGLSKLFPENTTHIST--------RVAGTLGYLAPEYAI---SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG  255 (358)
Q Consensus       187 ~l~Dfg~~~~~~~~~~~~~~--------~~~~~~~y~aPE~~~---~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~  255 (358)
                      ++.|||.+....-.......        .-..|..|.|||.+.   +...++++|||||||++|.|+.|..||+...+.+
T Consensus       169 vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G  248 (302)
T KOG2345|consen  169 VLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG  248 (302)
T ss_pred             EEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC
Confidence            99999998865321111111        134678999999886   3457899999999999999999999998554422


Q ss_pred             chhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCC
Q 018263          256 EYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGET  321 (358)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~  321 (358)
                      +......             ......-.....++..+.++|.+||++||.+||++.+++..++.+.
T Consensus       249 gSlaLAv-------------~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  249 GSLALAV-------------QNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             CeEEEee-------------eccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence            2211110             1111111122347888999999999999999999999999988653

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-43  Score=325.18  Aligned_cols=258  Identities=22%  Similarity=0.328  Sum_probs=214.3

Q ss_pred             HHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc----Ch-hhHHHHHHHHHHhhhcccCCCCceeeeceEEc
Q 018263           38 KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE----SK-QGEKEFMSEVASMANVNVCHENLVKLHGGCID  111 (358)
Q Consensus        38 ~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~----~~-~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~  111 (358)
                      .....+|.+.+.||.|.||+|+.|.+. +|..||+|++...    .. ...+.+.+|+.+++.+. .||||+++++++..
T Consensus        13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~-~HpnI~~l~ev~~t   91 (370)
T KOG0583|consen   13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLR-SHPNIIRLLEVFAT   91 (370)
T ss_pred             ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhc-cCCCEeEEEEEEec
Confidence            345679999999999999999999864 6899999987653    22 34567778999999987 59999999999999


Q ss_pred             CCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCC-CceEEee
Q 018263          112 GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN-FNPKISD  190 (358)
Q Consensus       112 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~-~~~~l~D  190 (358)
                      ....++||||+.||+|.+.+    ...+++.+..++.++.||+.|++|+|++   ||+||||||+||+++.+ +.+||+|
T Consensus        92 ~~~~~ivmEy~~gGdL~~~i----~~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~D  164 (370)
T KOG0583|consen   92 PTKIYIVMEYCSGGDLFDYI----VNKGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSD  164 (370)
T ss_pred             CCeEEEEEEecCCccHHHHH----HHcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEec
Confidence            99999999999999999999    4578899999999999999999999999   99999999999999999 9999999


Q ss_pred             cccccccCCCCcccccccccccCccCccccccCC-CC-ccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccc
Q 018263          191 FGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR-LT-RKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYN  268 (358)
Q Consensus       191 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~s-~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  268 (358)
                      ||++.... .........+|++.|+|||++.+.. |+ .++||||+|++||.|++|+.||........+..+        
T Consensus       165 FG~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki--------  235 (370)
T KOG0583|consen  165 FGLSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKI--------  235 (370)
T ss_pred             cccccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHH--------
Confidence            99999763 2333455688999999999999876 75 7899999999999999999999864322211111        


Q ss_pred             hhhHhhhhccccCCCCCHHH-HHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCC
Q 018263          269 SKELMNLVDPMLYGNFPENE-AIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETN  322 (358)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~  322 (358)
                              ... .-.+|... +.++..|+.+||..||.+|+|+.+|+ .-.-.+.
T Consensus       236 --------~~~-~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~  280 (370)
T KOG0583|consen  236 --------RKG-EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK  280 (370)
T ss_pred             --------hcC-CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence                    000 01123333 78899999999999999999999999 5555554

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.2e-44  Score=331.70  Aligned_cols=244  Identities=25%  Similarity=0.392  Sum_probs=214.4

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      .-|++.+.||.|+.|.|-+|++. +|+..|||++...   .......+.+|+-+++.+.  |||++.+++++++..++|+
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~--HpnVl~LydVwe~~~~lyl   89 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIE--HPNVLRLYDVWENKQHLYL   89 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhc--CCCeeeeeeeeccCceEEE
Confidence            35789999999999999999864 7999999999754   3445577889999999998  9999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      |.||++||.|++++    -..+++++..+.++++||+.|+.|+|..   +|||||+||+|++++..+++||+|||+|.. 
T Consensus        90 vlEyv~gGELFdyl----v~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsL-  161 (786)
T KOG0588|consen   90 VLEYVPGGELFDYL----VRKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASL-  161 (786)
T ss_pred             EEEecCCchhHHHH----HhhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeec-
Confidence            99999999999999    6778999999999999999999999999   999999999999999999999999999986 


Q ss_pred             CCCCcccccccccccCccCccccccCCC-CccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhh
Q 018263          198 PENTTHISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV  276 (358)
Q Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                       ........+.||.++|.+||++.|.+| +.++||||.|+|||.||+|+.||+.+                   +++.++
T Consensus       162 -e~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd-------------------Nir~LL  221 (786)
T KOG0588|consen  162 -EVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD-------------------NIRVLL  221 (786)
T ss_pred             -ccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc-------------------cHHHHH
Confidence             333444566899999999999999887 57999999999999999999999843                   334444


Q ss_pred             ccccCCC--CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          277 DPMLYGN--FPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       277 ~~~~~~~--~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .+..++.  .|.+.+.+..+|+.+||.+||.+|.|++||++
T Consensus       222 lKV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k  262 (786)
T KOG0588|consen  222 LKVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILK  262 (786)
T ss_pred             HHHHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence            4444442  45678889999999999999999999999987

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=5.5e-43  Score=323.27  Aligned_cols=267  Identities=26%  Similarity=0.390  Sum_probs=208.0

Q ss_pred             HHHhhcCCcccceecccCceEEEEEEE------CCCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceE
Q 018263           37 LKIATNGFRWSNKIGEGGFGSVYKGRL------QDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGC  109 (358)
Q Consensus        37 ~~~~~~~y~i~~~lg~g~~g~v~~~~~------~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~  109 (358)
                      +.+..++|++.+.||.|+||.||+|.+      .++..||+|++.... ......+..|+..+..+. .||||+++++.+
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-~h~niv~~~~~~   80 (338)
T cd05102           2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIG-NHLNVVNLLGAC   80 (338)
T ss_pred             cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhc-cCcceeeEEeEe
Confidence            345678999999999999999999974      235679999986432 334467889999999983 399999999988


Q ss_pred             EcCC-eeEEEEecCCCCCHHHHhhhcccc---------------------------------------------------
Q 018263          110 IDGP-CRILVYDYMPNNSLSQTLLGEEKR---------------------------------------------------  137 (358)
Q Consensus       110 ~~~~-~~~iv~e~~~~~~L~~~l~~~~~~---------------------------------------------------  137 (358)
                      ...+ ..+++|||+++++|.+++......                                                   
T Consensus        81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (338)
T cd05102          81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP  160 (338)
T ss_pred             cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence            7644 578999999999999998543210                                                   


Q ss_pred             -------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCcc-cccccc
Q 018263          138 -------RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH-ISTRVA  209 (358)
Q Consensus       138 -------~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~  209 (358)
                             ...+++..+..++.||+.||+|||++   |++|+||||+||+++.++.++|+|||++......... ......
T Consensus       161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~  237 (338)
T cd05102         161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR  237 (338)
T ss_pred             hhccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCC
Confidence                   23478889999999999999999999   9999999999999999999999999999754322211 112234


Q ss_pred             cccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCCCCHHH
Q 018263          210 GTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENE  288 (358)
Q Consensus       210 ~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (358)
                      ++..|+|||++.+..++.++||||||+++|+|++ |..||.........               ...+........+...
T Consensus       238 ~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~---------------~~~~~~~~~~~~~~~~  302 (338)
T cd05102         238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF---------------CQRLKDGTRMRAPENA  302 (338)
T ss_pred             CCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHH---------------HHHHhcCCCCCCCCCC
Confidence            5678999999988899999999999999999997 99999754321111               0001111111223445


Q ss_pred             HHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCC
Q 018263          289 AIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETN  322 (358)
Q Consensus       289 ~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~  322 (358)
                      +..+.+++.+||+.+|.+|||+.++++.|+.+..
T Consensus       303 ~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         303 TPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            6679999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-43  Score=312.08  Aligned_cols=258  Identities=27%  Similarity=0.399  Sum_probs=208.5

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC--eeEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP--CRIL  117 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~--~~~i  117 (358)
                      ..+|...+.||+|.||.||++... +|..+|+|.+........+.+.+|+.++..++  |||||+.++......  .+++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~--~p~IV~~~G~~~~~~~~~~~i   93 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLN--HPNIVQYYGSSSSRENDEYNI   93 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCC--CCCEEeeCCccccccCeeeEe
Confidence            567888999999999999999976 48999999997664444667899999999999  999999999855444  6899


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcC-CCceEEeecccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ-NFNPKISDFGLSKL  196 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~-~~~~~l~Dfg~~~~  196 (358)
                      +|||+++|+|.+++..   ..+.+++..++.++.||+.||.|||++   |++|+||||+||+++. ++.+||+|||++..
T Consensus        94 ~mEy~~~GsL~~~~~~---~g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~  167 (313)
T KOG0198|consen   94 FMEYAPGGSLSDLIKR---YGGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKK  167 (313)
T ss_pred             eeeccCCCcHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccc
Confidence            9999999999999932   222799999999999999999999999   9999999999999999 79999999999886


Q ss_pred             cCC--CCcccccccccccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHh
Q 018263          197 FPE--NTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELM  273 (358)
Q Consensus       197 ~~~--~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      ...  ..........||+.|+|||++.++ ....++|||||||++.+|+||++||...  .+....            ..
T Consensus       168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~~------------~~  233 (313)
T KOG0198|consen  168 LESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAEA------------LL  233 (313)
T ss_pred             cccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cchHHH------------HH
Confidence            543  222233457899999999999853 3445999999999999999999998742  011111            11


Q ss_pred             hhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 018263          274 NLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE  320 (358)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~  320 (358)
                      .+......+.+|...+.+..+++.+|++.+|.+||||.++++.---.
T Consensus       234 ~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~  280 (313)
T KOG0198|consen  234 LIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLK  280 (313)
T ss_pred             HHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence            11111122356677888899999999999999999999999754433

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-43  Score=321.26  Aligned_cols=249  Identities=24%  Similarity=0.376  Sum_probs=217.7

Q ss_pred             cCCcccceecccCceEEEEEEE-CCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEe
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRL-QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD  120 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e  120 (358)
                      ..|.-.++||+|+.|.||.|.. .+++.||||.+.........-+.+|+.+++..+  |+|||.+++.|...+.+++|||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~--H~NiVnfl~Sylv~deLWVVME  350 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLH--HPNIVNFLDSYLVGDELWVVME  350 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhcc--chHHHHHHHHhcccceeEEEEe
Confidence            5888899999999999999985 468899999999888888889999999999998  9999999999999999999999


Q ss_pred             cCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCC
Q 018263          121 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN  200 (358)
Q Consensus       121 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~  200 (358)
                      |++||+|.+.+     ....++|.++..++.+++.||+|||.+   ||+|+|||.+||+++.+|.+||+|||++..+...
T Consensus       351 ym~ggsLTDvV-----t~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~  422 (550)
T KOG0578|consen  351 YMEGGSLTDVV-----TKTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE  422 (550)
T ss_pred             ecCCCchhhhh-----hcccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence            99999999999     344589999999999999999999999   9999999999999999999999999999877544


Q ss_pred             CcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhcccc
Q 018263          201 TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPML  280 (358)
Q Consensus       201 ~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (358)
                      .. ......||+.|+|||++....|+++.||||||++++||+-|++||-...+.....++...              ...
T Consensus       423 ~~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n--------------g~P  487 (550)
T KOG0578|consen  423 QS-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN--------------GTP  487 (550)
T ss_pred             cC-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc--------------CCC
Confidence            43 345578999999999999999999999999999999999999999865554433333221              111


Q ss_pred             CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          281 YGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       281 ~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .-..+...+..+.+++.+||+.|+.+|++|.|+|+
T Consensus       488 ~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  488 KLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             CcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            12244567888999999999999999999999986

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2e-43  Score=322.17  Aligned_cols=244  Identities=27%  Similarity=0.428  Sum_probs=214.4

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      ++|.+.+.||+|.||.||+|+.+ +.+.||+|.+...  .+...+.+.+|+++++.++  ||||+.++++|+...++++|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lk--Hpniv~m~esfEt~~~~~vV   79 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLK--HPNIVEMLESFETSAHLWVV   79 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcC--CcchhhHHHhhcccceEEEE
Confidence            57999999999999999999976 6889999998654  3445678999999999999  99999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      .||+.| +|..++    ...+.++++.++.++.+++.||.|||+.   +|.|+|+||.||+++.+|.+|++|||+++.+.
T Consensus        80 te~a~g-~L~~il----~~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~  151 (808)
T KOG0597|consen   80 TEYAVG-DLFTIL----EQDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMS  151 (808)
T ss_pred             ehhhhh-hHHHHH----HhccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcc
Confidence            999966 999999    6778899999999999999999999999   99999999999999999999999999999886


Q ss_pred             CCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhcc
Q 018263          199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDP  278 (358)
Q Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (358)
                      ... ...+...||+.|+|||++.+.+|+..+|+|||||++||++.|++||..                   ..+.+++..
T Consensus       152 ~~t-~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-------------------~si~~Lv~~  211 (808)
T KOG0597|consen  152 TNT-SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-------------------RSITQLVKS  211 (808)
T ss_pred             cCc-eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-------------------HHHHHHHHH
Confidence            533 344557899999999999999999999999999999999999999973                   233333333


Q ss_pred             ccCC--CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          279 MLYG--NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       279 ~~~~--~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ....  .+|.+.+..+..++..+|+.||.+|.|..+++.
T Consensus       212 I~~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  212 ILKDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             HhcCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            3322  355688889999999999999999999998864

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.5e-42  Score=311.45  Aligned_cols=265  Identities=21%  Similarity=0.314  Sum_probs=207.2

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC--hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      ++|++.+.||+|+||.||+++++ +++.|++|++....  ......+.+|+..++.++  ||||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv   78 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLK--QENIVELKEAFRRRGKLYLV   78 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCC--CccccchhhhEecCCEEEEE
Confidence            47999999999999999999976 58889999986542  233466778999999998  99999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      |||++++.+..+.    .....+++..++.++.||+.||.|||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        79 ~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  151 (287)
T cd07848          79 FEYVEKNMLELLE----EMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLS  151 (287)
T ss_pred             EecCCCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccc
Confidence            9999887666554    2345689999999999999999999999   99999999999999999999999999998754


Q ss_pred             CCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhc-
Q 018263          199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD-  277 (358)
Q Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  277 (358)
                      ...........++..|+|||++.+..++.++|+||||+++|+|++|+.||......+....+....+............ 
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (287)
T cd07848         152 EGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSN  231 (287)
T ss_pred             ccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhcc
Confidence            3333333345688999999999888899999999999999999999999986554333332222222211111111100 


Q ss_pred             --------cccC------CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          278 --------PMLY------GNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       278 --------~~~~------~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                              +...      .......+..+.+++.+||+.||.+|||++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             chhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                    0000      0111224567999999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.1e-42  Score=316.62  Aligned_cols=267  Identities=24%  Similarity=0.292  Sum_probs=216.0

Q ss_pred             HHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC
Q 018263           38 KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP  113 (358)
Q Consensus        38 ~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~  113 (358)
                      .+..++|++++.||+|+||.||+|+-+ +|..||+|+++..   ...+.+++..|-.+|....  +|.+|+++-.|.+..
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~d--s~~vVKLyYsFQD~~  214 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVD--SPWVVKLYYSFQDKE  214 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcC--CCcEEEEEEEecCCC
Confidence            345689999999999999999999865 6999999999765   4556678888999999976  999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccc
Q 018263          114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL  193 (358)
Q Consensus       114 ~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~  193 (358)
                      ++|+||||++||++..+|    .+.+.|+++.++.++.+++.|+..+|+.   |++||||||+|+|||..|.+||+|||+
T Consensus       215 ~LYLiMEylPGGD~mTLL----~~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGL  287 (550)
T KOG0605|consen  215 YLYLIMEYLPGGDMMTLL----MRKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGL  287 (550)
T ss_pred             eeEEEEEecCCccHHHHH----HhcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccc
Confidence            999999999999999999    6778999999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCC----------------------CCcc-----cc-------------------cccccccCccCccccccCCCCc
Q 018263          194 SKLFPE----------------------NTTH-----IS-------------------TRVAGTLGYLAPEYAISGRLTR  227 (358)
Q Consensus       194 ~~~~~~----------------------~~~~-----~~-------------------~~~~~~~~y~aPE~~~~~~~s~  227 (358)
                      +.....                      ....     ..                   ....|||.|+|||++.+..|+.
T Consensus       288 s~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~  367 (550)
T KOG0605|consen  288 STGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGK  367 (550)
T ss_pred             cchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCc
Confidence            853210                      0000     00                   0147999999999999999999


Q ss_pred             cCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCC
Q 018263          228 KSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLR  307 (358)
Q Consensus       228 ~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R  307 (358)
                      .+|.||||||+||||.|.+||..+++...+..+......             +.-......+.+..+||.+||. ||.+|
T Consensus       368 ~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~-------------l~fP~~~~~s~eA~DLI~rll~-d~~~R  433 (550)
T KOG0605|consen  368 ECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET-------------LKFPEEVDLSDEAKDLITRLLC-DPENR  433 (550)
T ss_pred             cccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh-------------ccCCCcCcccHHHHHHHHHHhc-CHHHh
Confidence            999999999999999999999988776655444322111             1111112334778899999999 99999


Q ss_pred             CCHHHHHHHhhcCCCCCCCCC
Q 018263          308 PQMSTAIKMMNGETNIDGXDV  328 (358)
Q Consensus       308 pt~~eil~~L~~~~~~~~~~~  328 (358)
                      .. .-=++++.++.-+.+-.+
T Consensus       434 LG-~~G~~EIK~HPfF~~v~W  453 (550)
T KOG0605|consen  434 LG-SKGAEEIKKHPFFKGVDW  453 (550)
T ss_pred             cC-cccHHHHhcCCccccCCc
Confidence            87 333444555554444433

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.5e-43  Score=318.59  Aligned_cols=252  Identities=22%  Similarity=0.380  Sum_probs=217.4

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCe-eE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC-RI  116 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~-~~  116 (358)
                      -++|..++++|+|+||.+++++++ +++.||+|.+...  ....+....+|...++++.  ||||+.+.+.|+.++. .+
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~--hP~iv~y~ds~~~~~~~l~   80 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLL--HPNIVEYKDSFEEDGQLLC   80 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhcc--CCCeeeeccchhcCCceEE
Confidence            368999999999999999999876 6889999998765  3344457889999999988  9999999999998888 99


Q ss_pred             EEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       117 iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      |||+||+||++.+.+...  +...++++.+..|+.|++.|+.|||++   .|+|||||+.|||++.++.|+|+|||+++.
T Consensus        81 Ivm~Y~eGg~l~~~i~~~--k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~  155 (426)
T KOG0589|consen   81 IVMEYCEGGDLAQLIKEQ--KGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKI  155 (426)
T ss_pred             EEEeecCCCCHHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhh
Confidence            999999999999999543  467899999999999999999999999   999999999999999999999999999999


Q ss_pred             cCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhh
Q 018263          197 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV  276 (358)
Q Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                      ++.... ....+.||+.|+.||++.+.+|+.++|||||||++|+|++-+++|...+...                +..-+
T Consensus       156 l~~~~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~----------------Li~ki  218 (426)
T KOG0589|consen  156 LNPEDS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE----------------LILKI  218 (426)
T ss_pred             cCCchh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH----------------HHHHH
Confidence            866552 3455789999999999999999999999999999999999999998543321                11112


Q ss_pred             ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 018263          277 DPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKM  316 (358)
Q Consensus       277 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~  316 (358)
                      .+......+..++.++..+|..||+.+|..||++.+++..
T Consensus       219 ~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  219 NRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             hhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            2222345667889999999999999999999999999876

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-43  Score=305.52  Aligned_cols=266  Identities=24%  Similarity=0.338  Sum_probs=224.7

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEee--ccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEc-----
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID-----  111 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~--~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~-----  111 (358)
                      ...+|...+.||.|++|.|+.|.++ +|+.||||.+.  .......++..+|+..++.++  |+||+.+.+++..     
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~--HeNIi~l~di~~p~~~~~   97 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLR--HENIIGLLDIFRPPSRDK   97 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhc--CCCcceEEeecccccccc
Confidence            4567777899999999999999865 79999999987  556777789999999999999  9999999998875     


Q ss_pred             CCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeec
Q 018263          112 GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF  191 (358)
Q Consensus       112 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Df  191 (358)
                      -+..|+|+|++ +.+|...+    +.++.++++.+..+++||+.||.|+|+.   +++||||||+|++++.+..+|++||
T Consensus        98 f~DvYiV~elM-etDL~~ii----k~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DF  169 (359)
T KOG0660|consen   98 FNDVYLVFELM-ETDLHQII----KSQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDF  169 (359)
T ss_pred             cceeEEehhHH-hhHHHHHH----HcCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccc
Confidence            34679999999 67899998    5556699999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCC-CcccccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccch
Q 018263          192 GLSKLFPEN-TTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNS  269 (358)
Q Consensus       192 g~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      |+++..... .....+.+..|.+|.|||++.+ ..|+.+.||||.|||+.||++|++.|.+.+..++..++....+.+..
T Consensus       170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~  249 (359)
T KOG0660|consen  170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSE  249 (359)
T ss_pred             cceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCH
Confidence            999986432 2233456788999999998864 57999999999999999999999999999999999998888877765


Q ss_pred             hhHhhhhccccC---------CC-----CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          270 KELMNLVDPMLY---------GN-----FPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       270 ~~~~~~~~~~~~---------~~-----~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      +.+..+-....+         +.     .-++.....++|+.+||..||.+|+|++|.++
T Consensus       250 e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  250 EDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence            554444321111         00     11255668899999999999999999999986

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-42  Score=307.07  Aligned_cols=270  Identities=22%  Similarity=0.320  Sum_probs=215.1

Q ss_pred             cCHHHHHHhhcCCcccceecccCceEEEEEEE-CCCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceE
Q 018263           32 FSYNQLKIATNGFRWSNKIGEGGFGSVYKGRL-QDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGC  109 (358)
Q Consensus        32 ~~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~  109 (358)
                      -....+....+.|++.+.||.|..+.||+|+. ..++.||||+++.+. ......+..|+..++.+.  ||||++++.+|
T Consensus        16 ~~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~--HPNIv~~~~sF   93 (516)
T KOG0582|consen   16 SSEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLID--HPNIVTYHCSF   93 (516)
T ss_pred             cccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcC--CCCcceEEEEE
Confidence            34445566789999999999999999999985 468999999998774 334588999999999998  99999999999


Q ss_pred             EcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEe
Q 018263          110 IDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKIS  189 (358)
Q Consensus       110 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~  189 (358)
                      ..+..+++||.|+.+|++.+++...  ...-++|..+..++.++++||.|||.+   |.+|||||+.||+|+.+|.|+|+
T Consensus        94 vv~~~LWvVmpfMa~GS~ldIik~~--~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLa  168 (516)
T KOG0582|consen   94 VVDSELWVVMPFMAGGSLLDIIKTY--YPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLA  168 (516)
T ss_pred             EecceeEEeehhhcCCcHHHHHHHH--ccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEc
Confidence            9999999999999999999999654  334489999999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCccc---ccccccccCccCcccccc--CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhh
Q 018263          190 DFGLSKLFPENTTHI---STRVAGTLGYLAPEYAIS--GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAW  264 (358)
Q Consensus       190 Dfg~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~--~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~  264 (358)
                      |||....+.......   .....|+++|+|||++..  ..|+.|+||||||++..||.+|+.||....+..-..  ....
T Consensus       169 dFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl--~tLq  246 (516)
T KOG0582|consen  169 DFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLL--LTLQ  246 (516)
T ss_pred             CceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHH--HHhc
Confidence            999877554333221   134689999999999553  468999999999999999999999997443321110  1111


Q ss_pred             hccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          265 GMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      +.+...     .-..+..+....+...+.++|..||+.||.+|||++++++
T Consensus       247 n~pp~~-----~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  247 NDPPTL-----LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             CCCCCc-----ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            111100     0011111222345668999999999999999999999875

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.7e-43  Score=307.29  Aligned_cols=252  Identities=24%  Similarity=0.342  Sum_probs=216.9

Q ss_pred             HHHHhhcCCcccceecccCceEEEEEEE-CCCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEc
Q 018263           36 QLKIATNGFRWSNKIGEGGFGSVYKGRL-QDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID  111 (358)
Q Consensus        36 ~~~~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~  111 (358)
                      +.+-...+|++.+.||+|.+|.|-+|.. ..|+.||||.++.+   +..+.-.+.+|++++..++  ||||+.++++|++
T Consensus        47 hkhnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLN--HPhII~IyEVFEN  124 (668)
T KOG0611|consen   47 HKHNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLN--HPHIIQIYEVFEN  124 (668)
T ss_pred             cccchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcC--CCceeehhhhhcC
Confidence            3445568999999999999999999985 68999999999755   4555567899999999998  9999999999999


Q ss_pred             CCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeec
Q 018263          112 GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF  191 (358)
Q Consensus       112 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Df  191 (358)
                      .+...|||||..+|.|.+++    +.++.+++..++.++.||..|+.|.|.+   +++|||||.+||++|+|+++||+||
T Consensus       125 kdKIvivMEYaS~GeLYDYi----Ser~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADF  197 (668)
T KOG0611|consen  125 KDKIVIVMEYASGGELYDYI----SERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADF  197 (668)
T ss_pred             CceEEEEEEecCCccHHHHH----HHhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeecc
Confidence            99999999999999999999    7788999999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccCccCccccccCCC-CccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchh
Q 018263          192 GLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSK  270 (358)
Q Consensus       192 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      |++..+..  ....+.++|++.|.+||++.|.+| ++..|-||||++||.|..|..||++-+                  
T Consensus       198 GLSNly~~--~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D------------------  257 (668)
T KOG0611|consen  198 GLSNLYAD--KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD------------------  257 (668)
T ss_pred             chhhhhcc--ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch------------------
Confidence            99987643  334566899999999999999887 478999999999999999999998543                  


Q ss_pred             hHhhhhccccCC-CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 018263          271 ELMNLVDPMLYG-NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMM  317 (358)
Q Consensus       271 ~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L  317 (358)
                       ...++...-++ ...+..+.+..-||+|||.+||++|.|+++|..--
T Consensus       258 -hk~lvrQIs~GaYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  258 -HKRLVRQISRGAYREPETPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             -HHHHHHHhhcccccCCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence             22222222222 22334566788899999999999999999997653

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.2e-41  Score=302.69  Aligned_cols=259  Identities=27%  Similarity=0.395  Sum_probs=210.7

Q ss_pred             HHhhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           38 KIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        38 ~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      .+..++|++.++||+|++|.||+|...++..|++|.+.... ...+.+.+|+..++.++  |+|++++++.+...+..++
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05072           2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQ--HDKLVRLYAVVTKEEPIYI   78 (261)
T ss_pred             cCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCC--CCCeeeEEEEEcCCCCcEE
Confidence            35578999999999999999999998888889999876433 34567889999999998  9999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      +|||+++++|.+++...  ....+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||.+...
T Consensus        79 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~  153 (261)
T cd05072          79 ITEYMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVI  153 (261)
T ss_pred             EEecCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceec
Confidence            99999999999998432  345678899999999999999999999   9999999999999999999999999999875


Q ss_pred             CCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhHhhhh
Q 018263          198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV  276 (358)
Q Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                      ............++..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+                
T Consensus       154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~----------------  217 (261)
T cd05072         154 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL----------------  217 (261)
T ss_pred             CCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHH----------------
Confidence            4333222223345678999999988889999999999999999998 99999754322111111                


Q ss_pred             ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 018263          277 DPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE  320 (358)
Q Consensus       277 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~  320 (358)
                      ............+..+.+++.+||+.+|++||+++++++.|+..
T Consensus       218 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         218 QRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             HcCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence            11111112223556789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-42  Score=310.35  Aligned_cols=244  Identities=23%  Similarity=0.337  Sum_probs=202.5

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      ++|++.+.||+|+||.||+|..+ +|+.||+|++....   ......+.+|+..++.+.  ||||+++++++.+.+..++
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~~~~l   78 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS--HPFIIRLFWTEHDQRFLYM   78 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCC--CCcHhhhHhhhccCCeEEE
Confidence            47999999999999999999976 68999999986432   234456788999999998  9999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      ||||+++++|.+++    ...+.+++..+..++.||+.||+|||++   |++|+||+|+||+++.++.++|+|||++...
T Consensus        79 v~e~~~~~~L~~~~----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~  151 (291)
T cd05612          79 LMEYVPGGELFSYL----RNSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKL  151 (291)
T ss_pred             EEeCCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhc
Confidence            99999999999998    3456789999999999999999999999   9999999999999999999999999998764


Q ss_pred             CCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhc
Q 018263          198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD  277 (358)
Q Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      ...    .....|++.|+|||++.+..++.++||||||+++|+|++|+.||........+..+               ..
T Consensus       152 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i---------------~~  212 (291)
T cd05612         152 RDR----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI---------------LA  212 (291)
T ss_pred             cCC----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---------------Hh
Confidence            321    22346889999999998888999999999999999999999999754322111111               00


Q ss_pred             cccCCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 018263          278 PMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQ-----MSTAIK  315 (358)
Q Consensus       278 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt-----~~eil~  315 (358)
                      .  ...++...+..+.+++.+||+.||.+||+     ++++++
T Consensus       213 ~--~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         213 G--KLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             C--CcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence            0  11233344667899999999999999995     777663

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.9e-41  Score=300.68  Aligned_cols=254  Identities=23%  Similarity=0.404  Sum_probs=206.0

Q ss_pred             hhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      +.++|++.+.||.|+||.||++.++++..+++|.+... ......+..|+..++.++  ||||+++++++......+++|
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~iv~   78 (256)
T cd05114           2 NPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLS--HPKLVQLYGVCTQQKPLYIVT   78 (256)
T ss_pred             CHHHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCC--CCCceeEEEEEccCCCEEEEE
Confidence            45789999999999999999999888888999987633 334567888999999998  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      ||+++++|.+++..   ....+++..+..++.|++.||.|||++   |++|+||+|+||+++.++.++++|||.+.....
T Consensus        79 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~  152 (256)
T cd05114          79 EFMENGCLLNYLRQ---RQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD  152 (256)
T ss_pred             EcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCC
Confidence            99999999999842   234688999999999999999999999   999999999999999999999999998876533


Q ss_pred             CCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhHhhhhcc
Q 018263          200 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDP  278 (358)
Q Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (358)
                      ..........++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...........+.                .
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~----------------~  216 (256)
T cd05114         153 DEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS----------------R  216 (256)
T ss_pred             CceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH----------------C
Confidence            22222222335568999999988889999999999999999999 899987543221111111                0


Q ss_pred             ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 018263          279 MLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN  318 (358)
Q Consensus       279 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~  318 (358)
                      ......+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus       217 ~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         217 GFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            1111122234567899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.4e-41  Score=303.34  Aligned_cols=258  Identities=21%  Similarity=0.334  Sum_probs=207.6

Q ss_pred             HhhcCCcccceecccCceEEEEEEEC----CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQ----DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP  113 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~----~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~  113 (358)
                      ++.++|++.+.||+|+||.||+|.++    .+..|++|.+.... ......+.+|+..+..++  |||++++++++...+
T Consensus         2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~   79 (266)
T cd05064           2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFD--HSNIVRLEGVITRGN   79 (266)
T ss_pred             CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCC--CCCcCeEEEEEecCC
Confidence            45678999999999999999999753    36689999987543 334467889999999987  999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccc
Q 018263          114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL  193 (358)
Q Consensus       114 ~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~  193 (358)
                      ..++||||+++++|.+++..   ....+++..++.++.||+.||+|||+.   +++|+||+|+||+++.++.++++|||.
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~  153 (266)
T cd05064          80 TMMIVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRR  153 (266)
T ss_pred             CcEEEEEeCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcc
Confidence            99999999999999999842   235689999999999999999999999   999999999999999999999999998


Q ss_pred             ccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhH
Q 018263          194 SKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKEL  272 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      ................++..|+|||.+.+..++.++||||||+++|++++ |..||.........               
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~---------------  218 (266)
T cd05064         154 LQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVI---------------  218 (266)
T ss_pred             cccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHH---------------
Confidence            76532221111112334568999999988899999999999999999775 99999754322111               


Q ss_pred             hhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 018263          273 MNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE  320 (358)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~  320 (358)
                       ..+........+...+..+.+++.+||+.+|.+||++.+|++.|++.
T Consensus       219 -~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         219 -KAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             -HHHHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence             11111112223445677899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.3e-41  Score=307.08  Aligned_cols=265  Identities=23%  Similarity=0.371  Sum_probs=206.6

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      .++|++.+.||.|+||.||+|..+ ++..||+|.+.... ......+.+|+..++.++  ||||+++++++......++|
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv   81 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLK--HANIVTLHDIIHTERCLTLV   81 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCC--CCCEeeEEEEEcCCCeEEEE
Confidence            467999999999999999999875 68899999986442 233456778999999998  99999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      |||+++ +|.+++..   ....+++..+..++.||+.||+|||++   ||+|+||||+||+++.++.++|+|||++....
T Consensus        82 ~e~~~~-~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~  154 (288)
T cd07871          82 FEYLDS-DLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKS  154 (288)
T ss_pred             EeCCCc-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence            999975 88888732   234578999999999999999999999   99999999999999999999999999987543


Q ss_pred             CCCcccccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhh-
Q 018263          199 ENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV-  276 (358)
Q Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  276 (358)
                      .... ......++..|+|||++.+ ..++.++||||+|+++|+|++|+.||......+....+....+.+....+..+. 
T Consensus       155 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07871         155 VPTK-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS  233 (288)
T ss_pred             CCCc-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcccc
Confidence            2221 1223457889999998875 568999999999999999999999998766555444443333333222222211 


Q ss_pred             --------ccccCCC----CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          277 --------DPMLYGN----FPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       277 --------~~~~~~~----~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                              .+.....    .....+.+..+|+.+||+.||.+|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                    1111000    01123457889999999999999999999974

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-41  Score=312.76  Aligned_cols=253  Identities=21%  Similarity=0.297  Sum_probs=206.0

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      ++|++.+.||+|+||.||+|++. +++.||+|++....   ......+..|+..+..+.  ||||+++++.+...+..++
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~--h~~iv~~~~~~~~~~~~~l   78 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK--SEWLVKLLYAFQDDEYLYL   78 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCC--CCCCccEEEEEEcCCEEEE
Confidence            47999999999999999999976 58999999987542   234456788999999988  9999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      ||||+++++|.+++    .....+++..++.++.||+.||.|||+.   |++|+||+|+||+++.++.++|+|||++...
T Consensus        79 v~e~~~g~~L~~~l----~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~  151 (333)
T cd05600          79 AMEYVPGGDFRTLL----NNLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGI  151 (333)
T ss_pred             EEeCCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccc
Confidence            99999999999999    4456789999999999999999999999   9999999999999999999999999998764


Q ss_pred             CCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhc
Q 018263          198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD  277 (358)
Q Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      ..    ......|++.|+|||++.+..++.++|||||||++|+|++|..||...........+...         ...+.
T Consensus       152 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~---------~~~~~  218 (333)
T cd05600         152 VT----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW---------KETLQ  218 (333)
T ss_pred             cc----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhc---------ccccc
Confidence            32    223456899999999999889999999999999999999999999765432222111110         00001


Q ss_pred             cccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 018263          278 PMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKM  316 (358)
Q Consensus       278 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~  316 (358)
                      ...........+..+.+++.+||+.+|.+||++.++++.
T Consensus       219 ~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         219 RPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             CCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            000000112346778999999999999999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-42  Score=319.94  Aligned_cols=247  Identities=24%  Similarity=0.325  Sum_probs=209.7

Q ss_pred             HHHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC
Q 018263           37 LKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG  112 (358)
Q Consensus        37 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~  112 (358)
                      ..+..++|++++.||+|.||+|+++..+ +++.||||+++..   ........+.|..++.... .||+++.++..|...
T Consensus       363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~-~HPFL~~L~~~fQT~  441 (694)
T KOG0694|consen  363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELAN-RHPFLVNLFSCFQTK  441 (694)
T ss_pred             CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhc-cCCeEeecccccccC
Confidence            4566789999999999999999999976 6889999999765   3444556667777777776 699999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecc
Q 018263          113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG  192 (358)
Q Consensus       113 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg  192 (358)
                      .++|+||||+.||++..+     .+.+.+++..++.++..|+.||+|||++   ||+|||||.+||++|.+|.+||+|||
T Consensus       442 ~~l~fvmey~~Ggdm~~~-----~~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFG  513 (694)
T KOG0694|consen  442 EHLFFVMEYVAGGDLMHH-----IHTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFG  513 (694)
T ss_pred             CeEEEEEEecCCCcEEEE-----EecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccc
Confidence            999999999999983333     3667899999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhH
Q 018263          193 LSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKEL  272 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      +++.--. ......+.+||+.|+|||++.+..|+.+.|-|+||+++|+||.|+.||.++++++.+..+.           
T Consensus       514 lcKe~m~-~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~-----------  581 (694)
T KOG0694|consen  514 LCKEGMG-QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV-----------  581 (694)
T ss_pred             cccccCC-CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh-----------
Confidence            9985322 2234566899999999999999999999999999999999999999999776554433221           


Q ss_pred             hhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 018263          273 MNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQM  310 (358)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~  310 (358)
                          ..  ...+|...+.+...+++++|..||++|..+
T Consensus       582 ----~d--~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  582 ----ND--EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             ----cC--CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence                11  124667788889999999999999999876

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.4e-41  Score=312.68  Aligned_cols=244  Identities=23%  Similarity=0.335  Sum_probs=201.6

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI  116 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~  116 (358)
                      .++|++.+.||+|+||.||+|+++ +++.||+|++....   ......+.+|+..++.++  ||||+++++.+...+..+
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~~~~   94 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS--HPFIVNMMCSFQDENRVY   94 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC--CCCCCcEEEEEEcCCEEE
Confidence            468999999999999999999976 68999999986432   233456888999999998  999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       117 iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      ++|||+++++|.+.+    .....+++..+..++.||+.||+|||++   |++|+||+|+||+++.++.++|+|||++..
T Consensus        95 lv~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~  167 (329)
T PTZ00263         95 FLLEFVVGGELFTHL----RKAGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKK  167 (329)
T ss_pred             EEEcCCCCChHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceE
Confidence            999999999999998    3456789999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhh
Q 018263          197 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV  276 (358)
Q Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                      .....    ....|++.|+|||++.+..++.++|||||||++|+|++|+.||........+..   +            .
T Consensus       168 ~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~---i------------~  228 (329)
T PTZ00263        168 VPDRT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEK---I------------L  228 (329)
T ss_pred             cCCCc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHH---H------------h
Confidence            53322    235689999999999988899999999999999999999999975432211111   1            1


Q ss_pred             ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHH
Q 018263          277 DPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQ-----MSTAI  314 (358)
Q Consensus       277 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt-----~~eil  314 (358)
                      ..  ...++...+..+.+++.+||+.||.+||+     +++++
T Consensus       229 ~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll  269 (329)
T PTZ00263        229 AG--RLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVK  269 (329)
T ss_pred             cC--CcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence            10  11123334567889999999999999997     45555

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-41  Score=300.03  Aligned_cols=285  Identities=22%  Similarity=0.253  Sum_probs=231.8

Q ss_pred             ccccccccC-HHHHHHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCC
Q 018263           25 ILKNINAFS-YNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCH   99 (358)
Q Consensus        25 ~~~~~~~~~-~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h   99 (358)
                      .|..+.... ..+..+..++|++++.||+|.-|+||+++.. ++..+|+|++....   .....+++.|-++|+.++  |
T Consensus        59 ~w~a~~~~~~~~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lD--H  136 (459)
T KOG0610|consen   59 RWEAISSIRNSKDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLD--H  136 (459)
T ss_pred             hhhhhccccccCCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcC--C
Confidence            566666666 5677778899999999999999999999976 46899999997653   444567778999999998  9


Q ss_pred             CCceeeeceEEcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEE
Q 018263          100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL  179 (358)
Q Consensus       100 ~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nil  179 (358)
                      |+++.++..|+.+...|++||||+||+|..+.+  ++..+.+++..++.++..++.||+|||-.   |||+|||||+|||
T Consensus       137 PFlPTLYa~fet~~~~cl~meyCpGGdL~~Lrq--kQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENIL  211 (459)
T KOG0610|consen  137 PFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQ--KQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENIL  211 (459)
T ss_pred             CccchhhheeeccceeEEEEecCCCccHHHHHh--hCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeE
Confidence            999999999999999999999999999999984  35667899999999999999999999999   9999999999999


Q ss_pred             EcCCCceEEeecccccccCC---------------------------------C-C---------------------ccc
Q 018263          180 LDQNFNPKISDFGLSKLFPE---------------------------------N-T---------------------THI  204 (358)
Q Consensus       180 v~~~~~~~l~Dfg~~~~~~~---------------------------------~-~---------------------~~~  204 (358)
                      |-++|.+.|+||.++.....                                 . .                     ...
T Consensus       212 vredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~R  291 (459)
T KOG0610|consen  212 VREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGAR  291 (459)
T ss_pred             EecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcc
Confidence            99999999999987653310                                 0 0                     001


Q ss_pred             ccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCCC
Q 018263          205 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNF  284 (358)
Q Consensus       205 ~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (358)
                      ....+||.+|+|||++.|...+.++|-|+||+.+|||+.|..||.+.+....+.-               ++.+.+.=.-
T Consensus       292 SnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~N---------------Iv~~~l~Fp~  356 (459)
T KOG0610|consen  292 SNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRN---------------IVGQPLKFPE  356 (459)
T ss_pred             ccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHH---------------HhcCCCcCCC
Confidence            1125799999999999999999999999999999999999999998775443322               2222221111


Q ss_pred             CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCCCCCCCCC
Q 018263          285 PENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNIDGXDVEIS  331 (358)
Q Consensus       285 ~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~~~~~~~~  331 (358)
                      .+..+..+.+||+++|..||.+|....-=...++++...+|-.+.+.
T Consensus       357 ~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLi  403 (459)
T KOG0610|consen  357 EPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALI  403 (459)
T ss_pred             CCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhhe
Confidence            12567789999999999999999996655666677777777766643

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=4.1e-41  Score=303.10  Aligned_cols=245  Identities=20%  Similarity=0.314  Sum_probs=200.1

Q ss_pred             ceecccCceEEEEEEECCCCEEEEEEeeccChhh---HHHHHHHHHHhhhcccCCCCceeeeceEEc----CCeeEEEEe
Q 018263           48 NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQG---EKEFMSEVASMANVNVCHENLVKLHGGCID----GPCRILVYD  120 (358)
Q Consensus        48 ~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~----~~~~~iv~e  120 (358)
                      ..||+|+++.||+|.. +|+.||+|.+.......   .+.+.+|+..+.+++  ||||+++++++.+    ....+++||
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~nIv~~~g~~~~~~~~~~~~~lv~E  102 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRID--SNNILKIYGFIIDIVDDLPRLSLILE  102 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcC--CCCEEEEeeeEEecccCCCceEEEEE
Confidence            5789999999999998 58899999987543222   466779999999998  9999999999876    456789999


Q ss_pred             cCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          121 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       121 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      |+++++|.+++    ...+.+++.....++.|++.||.+||+ .   +++|+||+|+||++++++.+||+|||++.....
T Consensus       103 y~~~g~L~~~l----~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~  175 (283)
T PHA02988        103 YCTRGYLREVL----DKEKDLSFKTKLDMAIDCCKGLYNLYKYT---NKPYKNLTSVSFLVTENYKLKIICHGLEKILSS  175 (283)
T ss_pred             eCCCCcHHHHH----hhCCCCChhHHHHHHHHHHHHHHHHHhcC---CCCCCcCChhhEEECCCCcEEEcccchHhhhcc
Confidence            99999999999    344578899999999999999999997 5   889999999999999999999999999876432


Q ss_pred             CCcccccccccccCccCcccccc--CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhc
Q 018263          200 NTTHISTRVAGTLGYLAPEYAIS--GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD  277 (358)
Q Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~~--~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      ..    ....++..|+|||++.+  ..++.++||||||+++|+|++|+.||........+..               ++.
T Consensus       176 ~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~---------------i~~  236 (283)
T PHA02988        176 PP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDL---------------IIN  236 (283)
T ss_pred             cc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHH---------------HHh
Confidence            21    22457789999999876  6789999999999999999999999975432211111               111


Q ss_pred             cccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCC
Q 018263          278 PMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGET  321 (358)
Q Consensus       278 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~  321 (358)
                      .......+...+..+.+++.+||+.||++|||+.++++.|+..+
T Consensus       237 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        237 KNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             cCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            11122233356778999999999999999999999999998765

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.6e-41  Score=301.97  Aligned_cols=257  Identities=25%  Similarity=0.422  Sum_probs=213.3

Q ss_pred             hhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      ...+|++.+.||.|++|.||+|...++..+++|.+..........+..|+..++.++  |+|++++++++......+++|
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~lv~   81 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLR--HKHLISLFAVCSVGEPVYIIT   81 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCC--CcchhheeeeEecCCCeEEEE
Confidence            356799999999999999999998889999999998766656677889999999998  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      ||+++++|.+++...  ....+++..++.++.||+.||.|||+.   |++|+||+|+||++++++.++|+|||.+.....
T Consensus        82 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~  156 (261)
T cd05148          82 ELMEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKE  156 (261)
T ss_pred             eecccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence            999999999999432  345688999999999999999999999   999999999999999999999999999876543


Q ss_pred             CCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhHhhhhcc
Q 018263          200 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDP  278 (358)
Q Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (358)
                      .... .....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...........                +..
T Consensus       157 ~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~----------------~~~  219 (261)
T cd05148         157 DVYL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQ----------------ITA  219 (261)
T ss_pred             cccc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH----------------HHh
Confidence            2221 123345678999999988889999999999999999998 8999965432111111                111


Q ss_pred             ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 018263          279 MLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE  320 (358)
Q Consensus       279 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~  320 (358)
                      ......+...+..+.+++.+||+.+|.+|||+.++++.|+++
T Consensus       220 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         220 GYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            112223345667899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=3e-41  Score=300.72  Aligned_cols=258  Identities=26%  Similarity=0.383  Sum_probs=210.3

Q ss_pred             HhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      +...+|.+.+.||.|++|.||+|.++ .++.|++|.+... ......+.+|+..++.++  |+|++++++.+...+..++
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~l   79 (263)
T cd05052           3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIK--HPNLVQLLGVCTREPPFYI   79 (263)
T ss_pred             CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCC--CCChhheEEEEcCCCCcEE
Confidence            45667899999999999999999865 5888999998643 334567888999999988  9999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      +|||+++++|.+++..  .....+++..+..++.|++.+|++||++   |++|+||+|+||++++++.++|+|||.+...
T Consensus        80 v~e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~  154 (263)
T cd05052          80 ITEFMTYGNLLDYLRE--CNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM  154 (263)
T ss_pred             EEEeCCCCcHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccc
Confidence            9999999999999843  2345688999999999999999999999   9999999999999999999999999998865


Q ss_pred             CCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhHhhhh
Q 018263          198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV  276 (358)
Q Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                      .............+..|+|||.+.+..++.++||||||+++|+|++ |..||........                ...+
T Consensus       155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~----------------~~~~  218 (263)
T cd05052         155 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV----------------YELL  218 (263)
T ss_pred             ccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH----------------HHHH
Confidence            4333222222334567999999988899999999999999999998 9999864432111                1111


Q ss_pred             ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 018263          277 DPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE  320 (358)
Q Consensus       277 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~  320 (358)
                      ........+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus       219 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         219 EKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             HCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            11122233445667899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=5.4e-41  Score=309.04  Aligned_cols=266  Identities=22%  Similarity=0.315  Sum_probs=206.8

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      ..++|++.+.||+|+||.||++++. ++..|++|.+... .......+.+|++.++.++  ||||+++++++...+..++
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~l   80 (331)
T cd06649           3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN--SPYIVGFYGAFYSDGEISI   80 (331)
T ss_pred             CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCC--CCCCCeEEEEEEECCEEEE
Confidence            4579999999999999999999976 6889999998765 3344567889999999998  9999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      ||||+++++|.+++    .....+++..+..++.|++.||.|||+++  +++|+||+|+||+++.++.++|+|||++...
T Consensus        81 v~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  154 (331)
T cd06649          81 CMEHMDGGSLDQVL----KEAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  154 (331)
T ss_pred             EeecCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccc
Confidence            99999999999998    34456899999999999999999999851  6999999999999999999999999998754


Q ss_pred             CCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhh-------------
Q 018263          198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAW-------------  264 (358)
Q Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~-------------  264 (358)
                      ....   .....++..|+|||++.+..++.++||||||+++|+|++|+.||................             
T Consensus       155 ~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (331)
T cd06649         155 IDSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISP  231 (331)
T ss_pred             cccc---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCc
Confidence            3221   233568899999999998889999999999999999999999996433211100000000             


Q ss_pred             --------------hccchhhHhhhhc----cccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 018263          265 --------------GMYNSKELMNLVD----PMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKM  316 (358)
Q Consensus       265 --------------~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~  316 (358)
                                    ..........+.+    ...........+.++.+|+.+||+.||++|||++++++-
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             ccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                          0000000001111    111111122456789999999999999999999999863

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.8e-42  Score=295.60  Aligned_cols=264  Identities=22%  Similarity=0.308  Sum_probs=220.5

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChh--hHHHHHHHHHHhhhcccCCCCceeeeceEEcC--CeeE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQ--GEKEFMSEVASMANVNVCHENLVKLHGGCIDG--PCRI  116 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~--~~~~  116 (358)
                      +.|+++.+|+.|.||.||+|+++ +++.||+|.++.+...  ---...+|+.+|.+++  |||||.+..+....  +..|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~--H~NIV~vkEVVvG~~~d~iy  153 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKAR--HPNIVEVKEVVVGSNMDKIY  153 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcC--CCCeeeeEEEEeccccceee
Confidence            57889999999999999999976 6999999999865422  2345678999999998  99999999988743  4689


Q ss_pred             EEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       117 iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      +|||||+ -+|..++..   -.+++...++.-++.|++.|++|||.+   .|+|||||++|+++++.|.+||+|||+++.
T Consensus       154 ~VMe~~E-hDLksl~d~---m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~  226 (419)
T KOG0663|consen  154 IVMEYVE-HDLKSLMET---MKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLARE  226 (419)
T ss_pred             eeHHHHH-hhHHHHHHh---ccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhh
Confidence            9999995 478888833   346889999999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCcccccccccccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhh
Q 018263          197 FPENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNL  275 (358)
Q Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                      ++.+. ...+....|.+|.|||++.+. .|+.+.|+||+|||+.+|+++++.|.+.++.++...+....+.+....+..+
T Consensus       227 ygsp~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~  305 (419)
T KOG0663|consen  227 YGSPL-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY  305 (419)
T ss_pred             hcCCc-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence            86653 334567789999999999875 6999999999999999999999999999999999999888777765554443


Q ss_pred             hccc--------------cCCCCCHH-HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          276 VDPM--------------LYGNFPEN-EAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       276 ~~~~--------------~~~~~~~~-~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      -...              ++..+... .+..-.+|+..+|..||.+|.||+|.|+
T Consensus       306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence            2221              11122222 4466789999999999999999999875

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=6.3e-41  Score=302.24  Aligned_cols=251  Identities=25%  Similarity=0.329  Sum_probs=202.4

Q ss_pred             CCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      .|++.+.||+|+||.||++... +|+.||+|.+....   ......+.+|+..+..+.  |++++++.+.+...+..+++
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~--~~~iv~~~~~~~~~~~~~lv   78 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVN--SRFVVSLAYAYETKDALCLV   78 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcC--CCcEEEEEEEEccCCeEEEE
Confidence            4788999999999999999864 79999999986432   233446778999999998  99999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      |||+++++|.+.+...  ....+++..+..++.|++.||+|||++   +++|+||+|+||+++.++.++|+|||++....
T Consensus        79 ~e~~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~  153 (285)
T cd05631          79 LTIMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIP  153 (285)
T ss_pred             EEecCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcC
Confidence            9999999999887432  234688999999999999999999999   99999999999999999999999999987653


Q ss_pred             CCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhcc
Q 018263          199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDP  278 (358)
Q Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (358)
                      ...  ......++..|+|||++.+..++.++||||||+++|+|++|+.||...........+.            ..+. 
T Consensus       154 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~------------~~~~-  218 (285)
T cd05631         154 EGE--TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD------------RRVK-  218 (285)
T ss_pred             CCC--eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH------------HHhh-
Confidence            222  1233568999999999999899999999999999999999999998654322111111            1010 


Q ss_pred             ccCCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 018263          279 MLYGNFPENEAIRFLKVGLLCVQEKSKLRPQ-----MSTAIK  315 (358)
Q Consensus       279 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt-----~~eil~  315 (358)
                      .....++...+..+.+|+.+||+.||.+||+     ++++++
T Consensus       219 ~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         219 EDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             cccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            0112234456678999999999999999997     677765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.9e-41  Score=298.92  Aligned_cols=257  Identities=28%  Similarity=0.410  Sum_probs=209.5

Q ss_pred             HhhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      +..++|++.+.||.|++|.||+|..++++.|++|.+.... ...+.+.+|+..++.++  |||++++++++...+..+++
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv   79 (261)
T cd05068           3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLR--HPKLIQLYAVCTLEEPIYIV   79 (261)
T ss_pred             cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCC--CCCccceeEEEecCCCeeee
Confidence            4567899999999999999999998778889999986433 34567888999999998  99999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      |||+++++|.+++...  ....+++..+..++.|++.||.+||++   |++|+||+|+||+++.++.++|+|||++....
T Consensus        80 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~  154 (261)
T cd05068          80 TELMKYGSLLEYLQGG--AGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIK  154 (261)
T ss_pred             eecccCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEcc
Confidence            9999999999998432  234689999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhHhhhhc
Q 018263          199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD  277 (358)
Q Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      ............+..|+|||.+.+..++.++|+||||+++|+|++ |+.||...........                +.
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~----------------~~  218 (261)
T cd05068         155 EDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQ----------------VD  218 (261)
T ss_pred             CCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH----------------HH
Confidence            322222222233457999999988889999999999999999999 9999874432111111                11


Q ss_pred             cccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 018263          278 PMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNG  319 (358)
Q Consensus       278 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~  319 (358)
                      .......+...+..+.+++.+||+.+|.+||++.++++.|+.
T Consensus       219 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         219 QGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             cCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            111112233456779999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1e-40  Score=306.25  Aligned_cols=241  Identities=26%  Similarity=0.308  Sum_probs=197.8

Q ss_pred             ceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecCC
Q 018263           48 NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP  123 (358)
Q Consensus        48 ~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~~  123 (358)
                      +.||+|+||.||+|+.+ +|+.||+|++....   ......+..|+..++.+.  ||||+++++.+...+..++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~--hp~i~~~~~~~~~~~~~~lv~e~~~   78 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR--HPFLTALKYSFQTHDRLCFVMEYAN   78 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC--CCCCCCEEEEEEcCCEEEEEEeCCC
Confidence            46899999999999875 68999999987532   233456778999999988  9999999999999999999999999


Q ss_pred             CCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCcc
Q 018263          124 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH  203 (358)
Q Consensus       124 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  203 (358)
                      +++|.+.+    .....+++..+..++.||+.||+|||+.   ||+|+||||+||+++.++.++|+|||++....... .
T Consensus        79 ~~~L~~~l----~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~  150 (323)
T cd05571          79 GGELFFHL----SRERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-A  150 (323)
T ss_pred             CCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-C
Confidence            99999998    3456789999999999999999999999   99999999999999999999999999987532211 1


Q ss_pred             cccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCC
Q 018263          204 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGN  283 (358)
Q Consensus       204 ~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (358)
                      ......|++.|+|||++.+..++.++|||||||++|+|++|+.||...........+               ...  ...
T Consensus       151 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~---------------~~~--~~~  213 (323)
T cd05571         151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI---------------LME--EIR  213 (323)
T ss_pred             cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHH---------------HcC--CCC
Confidence            223456899999999999889999999999999999999999999754321111110               000  112


Q ss_pred             CCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 018263          284 FPENEAIRFLKVGLLCVQEKSKLRP-----QMSTAIK  315 (358)
Q Consensus       284 ~~~~~~~~l~~li~~~l~~~P~~Rp-----t~~eil~  315 (358)
                      ++...+..+.+++.+||+.||.+||     ++.++++
T Consensus       214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            3445667899999999999999999     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-42  Score=327.88  Aligned_cols=272  Identities=21%  Similarity=0.242  Sum_probs=220.5

Q ss_pred             ccCHHHHHHhhcCCcccceecccCceEEEEEEECCC-CEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceE
Q 018263           31 AFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDG-TIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGC  109 (358)
Q Consensus        31 ~~~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~  109 (358)
                      .+....+.+...+++|.+.|.+|||+.||+|.+..+ ..||+|++-..++.....+.+|++.+++|. +|+|||.+++..
T Consensus        26 ~~~G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~-gh~nIV~yidss  104 (738)
T KOG1989|consen   26 YFVGQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLS-GHKNIVSYIDSS  104 (738)
T ss_pred             CCCceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhc-CCCceeeEeccc
Confidence            344456677788999999999999999999997765 999999987778889999999999999998 899999999942


Q ss_pred             -Ec---C---CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcC
Q 018263          110 -ID---G---PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ  182 (358)
Q Consensus       110 -~~---~---~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~  182 (358)
                       ..   .   -..+++||||.|+.|-+++...  ....|++.++++|++|+++|+++||.. ..-|+|||||-+||||..
T Consensus       105 ~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~R--lq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~  181 (738)
T KOG1989|consen  105 AINRSSNNGVWEVLLLMEYCKGGSLVDFMNTR--LQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSA  181 (738)
T ss_pred             cccccCCCceeEEEeehhhccCCcHHHHHHHH--HhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcC
Confidence             21   1   2457999999999999999554  334499999999999999999999998 445999999999999999


Q ss_pred             CCceEEeecccccccCCCCcc--------cccccccccCccCccccc---cCCCCccCceecHHHHHHHHHhCCCCCCcc
Q 018263          183 NFNPKISDFGLSKLFPENTTH--------ISTRVAGTLGYLAPEYAI---SGRLTRKSDVYSFGVLLLEIVSGRTAVDFD  251 (358)
Q Consensus       183 ~~~~~l~Dfg~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~---~~~~s~~sDiwslG~il~~lltg~~pf~~~  251 (358)
                      +|..||||||.+.-.-.....        ..-....|+.|+|||.+.   +...++|+|||+|||+||-|+...+||+..
T Consensus       182 ~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s  261 (738)
T KOG1989|consen  182 DGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES  261 (738)
T ss_pred             CCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence            999999999998743222211        111245889999999875   668999999999999999999999999865


Q ss_pred             ccccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCCC
Q 018263          252 VQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNIDG  325 (358)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~~  325 (358)
                      .....                   ++....-...++++..+..||..||+.||++||++-++++.+-.+.+-.-
T Consensus       262 g~laI-------------------lng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~  316 (738)
T KOG1989|consen  262 GKLAI-------------------LNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC  316 (738)
T ss_pred             cceeE-------------------EeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence            43211                   11111111125788899999999999999999999999999887776553

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=7e-41  Score=308.49  Aligned_cols=252  Identities=25%  Similarity=0.320  Sum_probs=201.1

Q ss_pred             CCcccceecccCceEEEEEEE----CCCCEEEEEEeecc----ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCe
Q 018263           43 GFRWSNKIGEGGFGSVYKGRL----QDGTIVAVKVLSVE----SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC  114 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~----~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~  114 (358)
                      +|++.+.||+|+||.||+++.    .+++.||+|++...    .......+..|+..+..+. .|++|+++++++...+.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~~i~~~~~~~~~~~~   79 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVR-QSPFLVTLHYAFQTEAK   79 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhcc-CCCCcccEEEEEecCCE
Confidence            588999999999999999985    25889999998643    2223456778888888885 49999999999999999


Q ss_pred             eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccc
Q 018263          115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS  194 (358)
Q Consensus       115 ~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~  194 (358)
                      .++||||+++++|.+.+    .....+++..+..++.||+.||.|||++   |++||||||+||+++.++.++|+|||++
T Consensus        80 ~~lv~e~~~~g~L~~~l----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~  152 (332)
T cd05614          80 LHLILDYVSGGEMFTHL----YQRDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLS  152 (332)
T ss_pred             EEEEEeCCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCC
Confidence            99999999999999998    3456789999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCCcccccccccccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHh
Q 018263          195 KLFPENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELM  273 (358)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      ...............|+..|+|||++.+. .++.++||||||+++|+|++|+.||...........+...          
T Consensus       153 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~----------  222 (332)
T cd05614         153 KEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRR----------  222 (332)
T ss_pred             ccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHH----------
Confidence            76533333333345789999999998765 4788999999999999999999999754332221111100          


Q ss_pred             hhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 018263          274 NLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRP-----QMSTAIK  315 (358)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp-----t~~eil~  315 (358)
                       +..  ....++...+..+.+++.+||+.||++||     +++++++
T Consensus       223 -~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         223 -ILK--CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             -Hhc--CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence             000  11223344566789999999999999999     6667764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=5.8e-41  Score=313.71  Aligned_cols=263  Identities=22%  Similarity=0.372  Sum_probs=206.7

Q ss_pred             HHhhcCCcccceecccCceEEEEEEE------CCCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEE
Q 018263           38 KIATNGFRWSNKIGEGGFGSVYKGRL------QDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCI  110 (358)
Q Consensus        38 ~~~~~~y~i~~~lg~g~~g~v~~~~~------~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~  110 (358)
                      .+..++|++.+.||+|+||.||+|++      .++..||+|++.... ......+.+|+..+..+. .||||+++++.+.
T Consensus        31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~-~HpnIv~l~~~~~  109 (375)
T cd05104          31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG-NHINIVNLLGACT  109 (375)
T ss_pred             ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhc-CCcceeeeeeeec
Confidence            34456899999999999999999973      246689999986442 334567888999999983 3999999999999


Q ss_pred             cCCeeEEEEecCCCCCHHHHhhhccc------------------------------------------------------
Q 018263          111 DGPCRILVYDYMPNNSLSQTLLGEEK------------------------------------------------------  136 (358)
Q Consensus       111 ~~~~~~iv~e~~~~~~L~~~l~~~~~------------------------------------------------------  136 (358)
                      ..+..++||||+++|+|.+++.....                                                      
T Consensus       110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  189 (375)
T cd05104         110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV  189 (375)
T ss_pred             cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence            99999999999999999999854221                                                      


Q ss_pred             -----------------cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          137 -----------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       137 -----------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                                       ....+++..+..++.||+.||+|||++   +++|+||||+||+++.++.++|+|||++.....
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~  266 (375)
T cd05104         190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRN  266 (375)
T ss_pred             ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence                             112578899999999999999999999   999999999999999999999999999876533


Q ss_pred             CCcc-cccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhHhhhhc
Q 018263          200 NTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD  277 (358)
Q Consensus       200 ~~~~-~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      .... ......++..|+|||++.+..++.++||||||+++|+|++ |..||........               ....+.
T Consensus       267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~---------------~~~~~~  331 (375)
T cd05104         267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK---------------FYKMIK  331 (375)
T ss_pred             cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH---------------HHHHHH
Confidence            2221 1112334567999999999899999999999999999998 8889864432111               111111


Q ss_pred             cccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 018263          278 PMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNG  319 (358)
Q Consensus       278 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~  319 (358)
                      .......+...+.++.+|+.+||+.||++||++.+|++.|++
T Consensus       332 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         332 EGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             hCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence            111112223345679999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=7.3e-41  Score=297.09  Aligned_cols=254  Identities=26%  Similarity=0.408  Sum_probs=205.5

Q ss_pred             hhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      ..++|++.+.||+|++|.||.++..++..|++|.+... ......+.+|+..+..++  ||||+++++++......+++|
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05113           2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLS--HEKLVQLYGVCTKQRPIYIVT   78 (256)
T ss_pred             ChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCC--CCCeeeEEEEEccCCCcEEEE
Confidence            45789999999999999999999877777999988643 333467889999999998  999999999999888899999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      ||+++++|.+++..   ....+++..++.++.||+.||+|||+.   |++|+||+|+||+++.++.++|+|||.+.....
T Consensus        79 e~~~~~~l~~~i~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~  152 (256)
T cd05113          79 EYMSNGCLLNYLRE---HGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD  152 (256)
T ss_pred             EcCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCC
Confidence            99999999999843   233689999999999999999999999   999999999999999999999999999876543


Q ss_pred             CCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhHhhhhcc
Q 018263          200 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDP  278 (358)
Q Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (358)
                      ..........++..|.|||.+.+..++.++|+||||+++|+|++ |..||..........                .+..
T Consensus       153 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~----------------~~~~  216 (256)
T cd05113         153 DEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVE----------------KVSQ  216 (256)
T ss_pred             CceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHH----------------HHhc
Confidence            32222222345668999999988889999999999999999998 999986433211111                1111


Q ss_pred             ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 018263          279 MLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN  318 (358)
Q Consensus       279 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~  318 (358)
                      ......+...+..+.+++.+||+.+|.+||++.+|++.|+
T Consensus       217 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         217 GLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            1111222334678999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-41  Score=311.63  Aligned_cols=252  Identities=25%  Similarity=0.307  Sum_probs=205.3

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      ++|++.+.||+|+||.||+|+.. +|+.||+|++....   ......+..|+..+..+.  ||||+++++.+.+.+..++
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~~~~~~l   78 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD--SPWIVKLYYSFQDEEHLYL   78 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcC--CCCccchhhheecCCeEEE
Confidence            47999999999999999999976 68999999987432   234567888999999988  9999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      ||||+++++|.+++.    ....+++..++.++.||+.||+|||+.   |++|+||||+||+++.++.++|+|||++...
T Consensus        79 v~e~~~~~~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~  151 (350)
T cd05573          79 VMEYMPGGDLMNLLI----RKDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKM  151 (350)
T ss_pred             EEcCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccC
Confidence            999999999999993    346789999999999999999999999   9999999999999999999999999998765


Q ss_pred             CCCC----------------------------cccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCC
Q 018263          198 PENT----------------------------THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVD  249 (358)
Q Consensus       198 ~~~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~  249 (358)
                      ....                            ........|++.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~  231 (350)
T cd05573         152 NKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFY  231 (350)
T ss_pred             cccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCC
Confidence            4332                            112233568999999999999999999999999999999999999997


Q ss_pred             ccccccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCC-HHHHHHH
Q 018263          250 FDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQ-MSTAIKM  316 (358)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt-~~eil~~  316 (358)
                      ..........+..            .. ...........+..+.++|.+||+ +|.+||+ ++++++.
T Consensus       232 ~~~~~~~~~~i~~------------~~-~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         232 SDTLQETYNKIIN------------WK-ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             CCCHHHHHHHHhc------------cC-CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            6542211111110            00 000001111246778999999998 9999999 9999873

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.3e-40  Score=302.99  Aligned_cols=266  Identities=25%  Similarity=0.405  Sum_probs=204.2

Q ss_pred             hhcCCcccceecccCceEEEEEEECC-----------------CCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCC
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQD-----------------GTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHEN  101 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~~-----------------~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~  101 (358)
                      ..++|++.++||+|+||.||+|.+++                 +..||+|++... .......+.+|+..+..+.  |||
T Consensus         3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~n   80 (304)
T cd05096           3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLK--DPN   80 (304)
T ss_pred             chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcC--CCC
Confidence            35789999999999999999997532                 346999998754 3344567889999999998  999


Q ss_pred             ceeeeceEEcCCeeEEEEecCCCCCHHHHhhhccc---------------cccCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 018263          102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEK---------------RRAKFGWKARREIIMGIGRGLAYIHEEIQP  166 (358)
Q Consensus       102 i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~---------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~  166 (358)
                      |+++++++...+..+++|||+++++|.+++.....               ....+++..++.++.||+.||.|||+.   
T Consensus        81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---  157 (304)
T cd05096          81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---  157 (304)
T ss_pred             eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---
Confidence            99999999999999999999999999999854211               123467889999999999999999999   


Q ss_pred             CcEEcCCCCCcEEEcCCCceEEeecccccccCCCCc-ccccccccccCccCccccccCCCCccCceecHHHHHHHHHh--
Q 018263          167 HVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS--  243 (358)
Q Consensus       167 ~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt--  243 (358)
                      |++|+||||+||+++.++.++|+|||++........ .......++..|+|||++.+..++.++||||||+++|+|++  
T Consensus       158 ~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~  237 (304)
T cd05096         158 NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC  237 (304)
T ss_pred             CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence            999999999999999999999999999875432221 11222345778999999988889999999999999999987  


Q ss_pred             CCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 018263          244 GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNG  319 (358)
Q Consensus       244 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~  319 (358)
                      +..||................        ... ........+..++..+.+++.+||+.+|.+|||+.+|.+.|++
T Consensus       238 ~~~p~~~~~~~~~~~~~~~~~--------~~~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         238 KEQPYGELTDEQVIENAGEFF--------RDQ-GRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCCCCCcCCHHHHHHHHHHHh--------hhc-cccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            456766433211111110000        000 0001111233456779999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.3e-40  Score=299.54  Aligned_cols=259  Identities=27%  Similarity=0.474  Sum_probs=209.6

Q ss_pred             hcCCcccceecccCceEEEEEEECC------CCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQD------GTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP  113 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~~------~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~  113 (358)
                      .++|++.+.||.|++|.||+|....      ...|++|.+.... ......+.+|+..+..+.  ||||+++++++....
T Consensus         4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~--h~~i~~~~~~~~~~~   81 (283)
T cd05048           4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQ--HPNIVCLLGVCTKEQ   81 (283)
T ss_pred             hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcC--CcccceEEEEEcCCC
Confidence            4689999999999999999998642      2579999886443 334567889999999988  999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHhhhccc------------cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEc
Q 018263          114 CRILVYDYMPNNSLSQTLLGEEK------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD  181 (358)
Q Consensus       114 ~~~iv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~  181 (358)
                      ..+++|||+++++|.+++.....            ....+++..+..++.|++.||.|||++   +++|+||+|+||+++
T Consensus        82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~  158 (283)
T cd05048          82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVG  158 (283)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEc
Confidence            99999999999999999854311            115688999999999999999999999   999999999999999


Q ss_pred             CCCceEEeecccccccCCCCc-ccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhh
Q 018263          182 QNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHL  259 (358)
Q Consensus       182 ~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~  259 (358)
                      +++.++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||......     
T Consensus       159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~-----  233 (283)
T cd05048         159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ-----  233 (283)
T ss_pred             CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH-----
Confidence            999999999999876432221 12223446788999999988889999999999999999998 99998754321     


Q ss_pred             hHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 018263          260 VDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE  320 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~  320 (358)
                                 +....+........+..++..+.+|+.+||+.+|.+||++.+|++.|++.
T Consensus       234 -----------~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         234 -----------EVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             -----------HHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence                       11222222222334556778899999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=6.8e-41  Score=309.15  Aligned_cols=263  Identities=23%  Similarity=0.335  Sum_probs=200.7

Q ss_pred             CCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC-----e
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP-----C  114 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~-----~  114 (358)
                      +|++.+.||+|+||.||+|... +|..||+|.+...  .......+.+|+..++.++  ||||+++++++....     .
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~~~~   78 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLR--HPDIVEIKHIMLPPSRREFKD   78 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCC--CCCEeeecceEeccCCCCCce
Confidence            6899999999999999999965 6899999998643  2334456888999999998  999999999876432     4


Q ss_pred             eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccc
Q 018263          115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS  194 (358)
Q Consensus       115 ~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~  194 (358)
                      .++||||+ +++|.+.+    .....+++..+..++.||+.||.|||++   |++|+||||+||+++.++.++|+|||++
T Consensus        79 ~~lv~e~~-~~~L~~~l----~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~  150 (338)
T cd07859          79 IYVVFELM-ESDLHQVI----KANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLA  150 (338)
T ss_pred             EEEEEecC-CCCHHHHH----HhcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccc
Confidence            79999999 46898888    3445689999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCCc--ccccccccccCccCcccccc--CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchh
Q 018263          195 KLFPENTT--HISTRVAGTLGYLAPEYAIS--GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSK  270 (358)
Q Consensus       195 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~--~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      ........  .......++..|+|||++.+  ..++.++||||||+++|+|++|+.||...........+....+.+...
T Consensus       151 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  230 (338)
T cd07859         151 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPE  230 (338)
T ss_pred             cccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            75432211  11233568999999998865  578999999999999999999999997665433333332222222211


Q ss_pred             hHhh--------hhccccC---CCCC---HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          271 ELMN--------LVDPMLY---GNFP---ENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       271 ~~~~--------~~~~~~~---~~~~---~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ....        .+.....   ..+.   ...+..+.+++.+||+.+|++|||++|+++
T Consensus       231 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             HHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            1111        1111100   0000   123456889999999999999999999985

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.5e-40  Score=295.57  Aligned_cols=257  Identities=28%  Similarity=0.419  Sum_probs=208.3

Q ss_pred             HHhhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           38 KIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        38 ~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      .+..++|++.++||+|+||.||+|..++++.|++|.+.... .....+.+|+..++.++  |+|++++++++. .+..++
T Consensus         2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~-~~~~~~   77 (260)
T cd05067           2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQ--HPRLVRLYAVVT-QEPIYI   77 (260)
T ss_pred             ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcC--CcCeeeEEEEEc-cCCcEE
Confidence            45678999999999999999999998889999999986443 33457888999999998  999999998864 456899


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      +|||+++++|.+++...  ....+++..+..++.|++.||+|||+.   |++|+||+|+||+++.++.++|+|||.+...
T Consensus        78 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  152 (260)
T cd05067          78 ITEYMENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLI  152 (260)
T ss_pred             EEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeec
Confidence            99999999999998432  345688999999999999999999999   9999999999999999999999999998765


Q ss_pred             CCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhHhhhh
Q 018263          198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV  276 (358)
Q Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                      ............++..|+|||.+.+..++.++|+||||+++|+|++ |+.||..........                .+
T Consensus       153 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~----------------~~  216 (260)
T cd05067         153 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQ----------------NL  216 (260)
T ss_pred             CCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHH----------------HH
Confidence            4222222223345678999999988889999999999999999998 999997443211111                11


Q ss_pred             ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 018263          277 DPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNG  319 (358)
Q Consensus       277 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~  319 (358)
                      ........+...+..+.+++.+||+.+|++||+++++++.|+.
T Consensus       217 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         217 ERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             HcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            1111122233455679999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.1e-40  Score=299.53  Aligned_cols=258  Identities=26%  Similarity=0.426  Sum_probs=208.8

Q ss_pred             hcCCcccceecccCceEEEEEEEC------CCCEEEEEEeeccChh-hHHHHHHHHHHhhhcccCCCCceeeeceEEcCC
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVESKQ-GEKEFMSEVASMANVNVCHENLVKLHGGCIDGP  113 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~------~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~  113 (358)
                      .++|.+.+.||+|++|.||+|...      ++..|++|.+...... ....+.+|++.++.+.  |+|++++++++....
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~   81 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQ--HENIVKFYGVCTEGD   81 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcC--CCCchheeeEEecCC
Confidence            567999999999999999999863      3578999998755333 5578899999999998  999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHhhhcc----------ccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCC
Q 018263          114 CRILVYDYMPNNSLSQTLLGEE----------KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN  183 (358)
Q Consensus       114 ~~~iv~e~~~~~~L~~~l~~~~----------~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~  183 (358)
                      ..+++|||+++++|.+++....          .....+++..+..++.|++.||.+||++   |++|+||+|+||+++.+
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~  158 (280)
T cd05049          82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYD  158 (280)
T ss_pred             CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCC
Confidence            9999999999999999995432          2235578999999999999999999999   99999999999999999


Q ss_pred             CceEEeecccccccCCCCc-ccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhH
Q 018263          184 FNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVD  261 (358)
Q Consensus       184 ~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~  261 (358)
                      +.++|+|||++........ .......++..|+|||++.+..++.++||||||+++|+|++ |..||........     
T Consensus       159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~-----  233 (280)
T cd05049         159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV-----  233 (280)
T ss_pred             CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH-----
Confidence            9999999999875422211 11223345678999999999999999999999999999998 9999864432211     


Q ss_pred             hhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 018263          262 KAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNG  319 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~  319 (358)
                                 ...+........+...+..+.+++.+||+.+|++||++.||++.|++
T Consensus       234 -----------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         234 -----------IECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             -----------HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence                       11111111122334566789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.1e-40  Score=301.15  Aligned_cols=266  Identities=23%  Similarity=0.351  Sum_probs=199.4

Q ss_pred             cCCcccceecccCceEEEEEEEC--CCCEEEEEEeeccC--hhhHHHHHHHHHHhhhcc-cCCCCceeeeceEE-----c
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ--DGTIVAVKVLSVES--KQGEKEFMSEVASMANVN-VCHENLVKLHGGCI-----D  111 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~-~~h~~i~~~~~~~~-----~  111 (358)
                      ++|++.+.||+|+||.||+|++.  ++..||+|.+....  ......+.+|+..++.+. ..||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            47999999999999999999863  47889999986542  222344556666666552 23999999999875     3


Q ss_pred             CCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeec
Q 018263          112 GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF  191 (358)
Q Consensus       112 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Df  191 (358)
                      ....++||||++ ++|.+++...  ....+++..+..++.||+.||.|||++   |++|+||||+||+++.++.++|+||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df  154 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF  154 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence            456899999995 6898888432  234588999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhh
Q 018263          192 GLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKE  271 (358)
Q Consensus       192 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      |++......  .......++..|+|||.+.+..++.++||||||+++|+|++|.+||......+....+....+.....+
T Consensus       155 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~  232 (290)
T cd07862         155 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED  232 (290)
T ss_pred             cceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhh
Confidence            998765332  222345688999999999888899999999999999999999999987655444333322222222222


Q ss_pred             Hhhhh---ccccC-------CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          272 LMNLV---DPMLY-------GNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       272 ~~~~~---~~~~~-------~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      +....   ...+.       .......+..+.+++.+||+.+|++|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            11111   00000       0011234567789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-42  Score=307.45  Aligned_cols=249  Identities=22%  Similarity=0.381  Sum_probs=215.9

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      ...|+..+.||+|.||.||+|.+. +++.||+|+++.+. ......+++|+..+..++  ++||.++++.+..+..++++
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~--~~~it~yygsyl~g~~Lwii   89 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCD--SPNITEYYGSYLKGTKLWII   89 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcC--cchHHhhhhheeecccHHHH
Confidence            467888899999999999999965 68999999998774 444578999999999998  99999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      |||+.||++.+.+    .....+++..+..++.+++.||.|||+.   +.+|+|||+.||++..+|.++|+|||.+....
T Consensus        90 Mey~~gGsv~~lL----~~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~  162 (467)
T KOG0201|consen   90 MEYCGGGSVLDLL----KSGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLT  162 (467)
T ss_pred             HHHhcCcchhhhh----ccCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeee
Confidence            9999999999999    4555568999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhcc
Q 018263          199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDP  278 (358)
Q Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (358)
                      ...... ....||+-|+|||++.+..|+.++||||||++.++|++|.+|+....+.....++.                .
T Consensus       163 ~~~~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp----------------k  225 (467)
T KOG0201|consen  163 NTVKRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP----------------K  225 (467)
T ss_pred             chhhcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc----------------C
Confidence            444433 56889999999999998899999999999999999999999998666544443332                2


Q ss_pred             ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          279 MLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       279 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ...+.....++..+.++|..||+.||+.||+|.++++
T Consensus       226 ~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  226 SAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             CCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            2223344467778999999999999999999999875

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.6e-40  Score=295.39  Aligned_cols=256  Identities=28%  Similarity=0.434  Sum_probs=206.7

Q ss_pred             HhhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      +..++|++.+.||.|++|.||+|..+++..+++|.+.... .....+.+|+..++.++  |++++++++.+. ....+++
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~--~~~i~~~~~~~~-~~~~~lv   78 (260)
T cd05070           3 IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLR--HDKLVQLYAVVS-EEPIYIV   78 (260)
T ss_pred             CchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCC-CCHHHHHHHHHHHHhcC--CCceEEEEeEEC-CCCcEEE
Confidence            4567899999999999999999998888889999986533 34467889999999998  999999998875 4568899


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      |||+++++|.+++...  ....+++..+..++.|++.||.|||++   +++|+||+|+||++++++.++|+|||.+....
T Consensus        79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~  153 (260)
T cd05070          79 TEYMSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIE  153 (260)
T ss_pred             EEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeecc
Confidence            9999999999998432  234588999999999999999999999   99999999999999999999999999997654


Q ss_pred             CCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhHhhhhc
Q 018263          199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD  277 (358)
Q Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      ...........++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+..                ..+.
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~----------------~~~~  217 (260)
T cd05070         154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVL----------------EQVE  217 (260)
T ss_pred             CcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH----------------HHHH
Confidence            322222222335567999999888889999999999999999999 89998643321111                1111


Q ss_pred             cccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 018263          278 PMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNG  319 (358)
Q Consensus       278 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~  319 (358)
                      .......+...+..+.+++.+||+.+|++|||+.++.+.|++
T Consensus       218 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         218 RGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             cCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            111222334556779999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-40  Score=295.69  Aligned_cols=254  Identities=25%  Similarity=0.394  Sum_probs=205.1

Q ss_pred             hhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      ...+|++.+.||.|++|.||++.++++..+++|++... ......+..|+..++.++  |||++++++++...+..+++|
T Consensus         2 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05059           2 DPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLS--HPNLVQLYGVCTKQRPIFIVT   78 (256)
T ss_pred             ChHHcchhhhhccCCCceEEEeEecCCccEEEEEeccC-CCCHHHHHHHHHHHHhCC--CCCEEEEEEEEcCCCceEEEE
Confidence            35679999999999999999999887778999997533 233456778999999988  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      ||+++++|.+++..   ....+++..+..++.||+.||+|||+.   |++|+||+|+||+++.++.++|+|||.+.....
T Consensus        79 e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~  152 (256)
T cd05059          79 EYMANGCLLNYLRE---RKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLD  152 (256)
T ss_pred             ecCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccc
Confidence            99999999999843   234689999999999999999999999   999999999999999999999999999876533


Q ss_pred             CCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhHhhhhcc
Q 018263          200 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDP  278 (358)
Q Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (358)
                      ..........++..|+|||.+.+..++.++|+||||+++|+|++ |..||...........                +..
T Consensus       153 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~----------------~~~  216 (256)
T cd05059         153 DQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVES----------------VSA  216 (256)
T ss_pred             ccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHH----------------HHc
Confidence            22211112223457999999988889999999999999999999 8999875432211111                111


Q ss_pred             ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 018263          279 MLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN  318 (358)
Q Consensus       279 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~  318 (358)
                      ......+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       217 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         217 GYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence            1122233345678999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=3.2e-40  Score=294.49  Aligned_cols=260  Identities=22%  Similarity=0.343  Sum_probs=211.6

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      ++|++.+.||.|+||.||+|+.. +++.|++|.+...   .......+.+|+..++.++  |||++++++.+...+..++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~~   79 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN--HPNVIKYLDSFIEDNELNI   79 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC--CcceeeeeeeEEECCeEEE
Confidence            58999999999999999999965 6899999987542   3344567888999999998  9999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      ++||+++++|.+++.........+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.++|+|||.+...
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~  156 (267)
T cd08228          80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceec
Confidence            9999999999999865444556689999999999999999999999   9999999999999999999999999998765


Q ss_pred             CCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhc
Q 018263          198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD  277 (358)
Q Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      ...... .....++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...... ....             ...+.
T Consensus       157 ~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-~~~~-------------~~~~~  221 (267)
T cd08228         157 SSKTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LFSL-------------CQKIE  221 (267)
T ss_pred             cchhHH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc-HHHH-------------HHHHh
Confidence            432221 12245778899999998888999999999999999999999998643221 0111             11111


Q ss_pred             cc-cCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCC
Q 018263          278 PM-LYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGET  321 (358)
Q Consensus       278 ~~-~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~  321 (358)
                      .. ..+......+..+.+++.+||+.+|++||++.++++.|++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         222 QCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             cCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence            11 111122346678999999999999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-41  Score=312.03  Aligned_cols=269  Identities=26%  Similarity=0.476  Sum_probs=218.4

Q ss_pred             cCHHHHHHhhcCCcccceecccCceEEEEEEECCCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceE
Q 018263           32 FSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGC  109 (358)
Q Consensus        32 ~~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~  109 (358)
                      ++...+.+..+...+...||+|.||+||+|+|. | .||||+++..  ..+..+.|++|+..+++-+  |.||+-+.+++
T Consensus       382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTR--H~NIlLFMG~~  457 (678)
T KOG0193|consen  382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH-G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTR--HENILLFMGAC  457 (678)
T ss_pred             ccccccccCHHHhhccceeccccccceeecccc-c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcc--hhhheeeehhh
Confidence            344889999999999999999999999999986 3 3899999876  3456689999999999998  99999999999


Q ss_pred             EcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEe
Q 018263          110 IDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKIS  189 (358)
Q Consensus       110 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~  189 (358)
                      ..+.. .||..+|+|.+|..+++..   ...++......|+.||+.|+.|||.+   +|+|+|||..|||+.+++.|||+
T Consensus       458 ~~p~~-AIiTqwCeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIg  530 (678)
T KOG0193|consen  458 MNPPL-AIITQWCEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIG  530 (678)
T ss_pred             cCCce-eeeehhccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEe
Confidence            99887 9999999999999999543   35688899999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCC-CCcccccccccccCccCccccc---cCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhh
Q 018263          190 DFGLSKLFPE-NTTHISTRVAGTLGYLAPEYAI---SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG  265 (358)
Q Consensus       190 Dfg~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~---~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~  265 (358)
                      |||++..... ..........+...|+|||++.   ..+|+..+||||||+++|||++|..||.....+.....+.+.+.
T Consensus       531 DFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l  610 (678)
T KOG0193|consen  531 DFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYL  610 (678)
T ss_pred             cccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEeccccc
Confidence            9999875321 1111222345778999999987   34799999999999999999999999983322222222211111


Q ss_pred             ccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCC
Q 018263          266 MYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNI  323 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~  323 (358)
                      .+.   ..         ....+++..+.+|+..||..++++||++.+|+..|+.+...
T Consensus       611 ~pd---~s---------~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  611 MPD---LS---------KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             Ccc---ch---------hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence            111   00         12245778899999999999999999999999999888774

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=9.9e-41  Score=311.60  Aligned_cols=254  Identities=26%  Similarity=0.334  Sum_probs=204.2

Q ss_pred             HHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC
Q 018263           38 KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP  113 (358)
Q Consensus        38 ~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~  113 (358)
                      .+..++|++.+.||.|+||.||+++.+ +++.||+|++...   .......+.+|+..++.++  ||||+++++++.+.+
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~--h~~iv~~~~~~~~~~  116 (370)
T cd05596          39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN--SEWIVQLHYAFQDDK  116 (370)
T ss_pred             CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC--CCCcceEEEEEecCC
Confidence            345679999999999999999999976 6889999998643   2233455778999999988  999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccc
Q 018263          114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL  193 (358)
Q Consensus       114 ~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~  193 (358)
                      ..++||||++|++|.+++.     ...+++..+..++.||+.||+|||++   ||+||||+|+||+++.++.++|+|||+
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~  188 (370)
T cd05596         117 YLYMVMEYMPGGDLVNLMS-----NYDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT  188 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccc
Confidence            9999999999999999983     34588999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccCccCccccccC----CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccch
Q 018263          194 SKLFPENTTHISTRVAGTLGYLAPEYAISG----RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNS  269 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      +...............|++.|+|||++.+.    .++.++|||||||++|+|++|..||........+..          
T Consensus       189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~----------  258 (370)
T cd05596         189 CMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK----------  258 (370)
T ss_pred             eeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHH----------
Confidence            976543332223345789999999988653    478899999999999999999999986543221111          


Q ss_pred             hhHhhhhccccCCCCC--HHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 018263          270 KELMNLVDPMLYGNFP--ENEAIRFLKVGLLCVQEKSKL--RPQMSTAIKM  316 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~P~~--Rpt~~eil~~  316 (358)
                           +........++  ...+..+.++|.+||+.+|.+  |+++.++++-
T Consensus       259 -----i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         259 -----IMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             -----HHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence                 11110001111  135678899999999999988  9999999753

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.7e-40  Score=319.66  Aligned_cols=253  Identities=21%  Similarity=0.295  Sum_probs=207.4

Q ss_pred             cCCcccceecccCceEEEEEEEC-C-CCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-D-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      ..|.+.+.||+|++|.||.|... + +..|++|.+..........+..|+..+..++  ||||+++++.+...+..++||
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~--Hpniv~~~~~~~~~~~~~lv~  144 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACD--HFGIVKHFDDFKSDDKLLLIM  144 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCC--CCCEeEEEEEEEECCEEEEEE
Confidence            34999999999999999999854 3 6788999876666566667888999999998  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      ||+++++|.+.+.........+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.++|+|||++.....
T Consensus       145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~  221 (478)
T PTZ00267        145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD  221 (478)
T ss_pred             ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence            99999999998854434556789999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCc-ccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhcc
Q 018263          200 NTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDP  278 (358)
Q Consensus       200 ~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (358)
                      ... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........   ...            +.. 
T Consensus       222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~---~~~------------~~~-  285 (478)
T PTZ00267        222 SVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREI---MQQ------------VLY-  285 (478)
T ss_pred             ccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHH------------HHh-
Confidence            222 122345689999999999888999999999999999999999999975432111   111            000 


Q ss_pred             ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          279 MLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       279 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ......+...+..+.++|.+||+.+|++||++.++++
T Consensus       286 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        286 GKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             CCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            0111223345677999999999999999999998864

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=7e-40  Score=292.09  Aligned_cols=260  Identities=23%  Similarity=0.396  Sum_probs=212.6

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      ++|++.+.||.|++|.||+|... +|+.|++|.+...   .......+.+|++.++.++  |++++++++.+...+..++
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~--~~~i~~~~~~~~~~~~~~l   79 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD--HPNVIKYLASFIENNELNI   79 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCC--CCCeeeeeeeeecCCeEEE
Confidence            58999999999999999999976 7999999988642   2334567889999999998  9999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      +|||+++++|..++.........+++..+..++.+++.||.+||+.   |++|+||+|+||+++.++.++|+|||++...
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~  156 (267)
T cd08224          80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeec
Confidence            9999999999999865444456689999999999999999999999   9999999999999999999999999998764


Q ss_pred             CCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhc
Q 018263          198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD  277 (358)
Q Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      ...... .....++..|.|||.+.+..++.++|+||||+++|+|++|+.||...... ..             +..+.+.
T Consensus       157 ~~~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~-------------~~~~~~~  221 (267)
T cd08224         157 SSKTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LY-------------SLCKKIE  221 (267)
T ss_pred             cCCCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-HH-------------HHHhhhh
Confidence            332211 12345778899999998888999999999999999999999998644311 00             0111111


Q ss_pred             cccCCCCC-HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCC
Q 018263          278 PMLYGNFP-ENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGET  321 (358)
Q Consensus       278 ~~~~~~~~-~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~  321 (358)
                      .......+ ...+..+.+++.+||+.+|++|||+.+|++.|++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         222 KCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             cCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            11112222 256678999999999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=9.7e-41  Score=307.29  Aligned_cols=252  Identities=24%  Similarity=0.282  Sum_probs=201.9

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      ++|.+.+.||+|+||.||++... +|+.||+|++....   ......+.+|+.++..+.  |+||+++++.+...+..++
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~--~~~i~~~~~~~~~~~~~~l   78 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN--SPWIPQLQYAFQDKDNLYL   78 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC--CCCCcceeeEEecCCeEEE
Confidence            47999999999999999999875 68999999987542   234456778888888877  9999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      ||||+++++|.+++..   ....+++..++.++.||+.||.|||+.   +++||||+|+||+++.++.++|+|||++...
T Consensus        79 v~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~  152 (330)
T cd05601          79 VMEYQPGGDLLSLLNR---YEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARL  152 (330)
T ss_pred             EECCCCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeEC
Confidence            9999999999999842   235789999999999999999999999   9999999999999999999999999999865


Q ss_pred             CCCCcccccccccccCccCccccc------cCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhh
Q 018263          198 PENTTHISTRVAGTLGYLAPEYAI------SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKE  271 (358)
Q Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~------~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      ............+++.|+|||++.      +..++.++||||||+++|+|++|..||........+..+..         
T Consensus       153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~---------  223 (330)
T cd05601         153 TANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMN---------  223 (330)
T ss_pred             CCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHc---------
Confidence            443333333356889999999986      44678899999999999999999999975443221111100         


Q ss_pred             HhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          272 LMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                         . .....-......+..+.+|+.+||+ +|.+|||++++++
T Consensus       224 ---~-~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         224 ---F-QRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             ---C-CCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence               0 0000001112356678899999998 9999999999875

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-40  Score=293.92  Aligned_cols=257  Identities=27%  Similarity=0.415  Sum_probs=207.3

Q ss_pred             hhcCCcccceecccCceEEEEEEECC----CCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCe
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQD----GTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC  114 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~  114 (358)
                      ..++|++.+.||+|+||.||+|.++.    ...|++|.+... .......+..|+..+..++  ||||+++++.+...+.
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~   79 (266)
T cd05033           2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD--HPNIIRLEGVVTKSRP   79 (266)
T ss_pred             ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCC--CCCcceEeEEEecCCc
Confidence            46789999999999999999998742    457899988654 3344567888999999998  9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccc
Q 018263          115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS  194 (358)
Q Consensus       115 ~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~  194 (358)
                      .+++|||+++++|.+++..   ..+.+++..+..++.|++.||+|||++   +++|+||+|+||+++.++.++|+|||++
T Consensus        80 ~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~  153 (266)
T cd05033          80 VMIITEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLS  153 (266)
T ss_pred             eEEEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchh
Confidence            9999999999999999843   234789999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcc-cccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhH
Q 018263          195 KLFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKEL  272 (358)
Q Consensus       195 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      ......... ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||........                
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~----------------  217 (266)
T cd05033         154 RRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV----------------  217 (266)
T ss_pred             hcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHH----------------
Confidence            876422211 1122334568999999988889999999999999999998 9999864322111                


Q ss_pred             hhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 018263          273 MNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE  320 (358)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~  320 (358)
                      ...+........+...+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus       218 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         218 IKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            111111111122334567799999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.2e-40  Score=311.43  Aligned_cols=265  Identities=22%  Similarity=0.385  Sum_probs=207.4

Q ss_pred             HHHhhcCCcccceecccCceEEEEEEEC------CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceE
Q 018263           37 LKIATNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGC  109 (358)
Q Consensus        37 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~  109 (358)
                      +....++|++.+.||+|+||.||+|.+.      ++..||+|.+.... ......+.+|+..++.+. .|+||+++++.+
T Consensus        33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-~h~nIv~~~~~~  111 (374)
T cd05106          33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLG-QHKNIVNLLGAC  111 (374)
T ss_pred             ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhc-cCCceeeEeeEe
Confidence            3455678999999999999999998742      24579999986542 334466888999999883 399999999999


Q ss_pred             EcCCeeEEEEecCCCCCHHHHhhhccc-----------------------------------------------------
Q 018263          110 IDGPCRILVYDYMPNNSLSQTLLGEEK-----------------------------------------------------  136 (358)
Q Consensus       110 ~~~~~~~iv~e~~~~~~L~~~l~~~~~-----------------------------------------------------  136 (358)
                      ......++||||+++++|.+++.....                                                     
T Consensus       112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (374)
T cd05106         112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS  191 (374)
T ss_pred             cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence            999999999999999999999853211                                                     


Q ss_pred             -------------cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCcc
Q 018263          137 -------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH  203 (358)
Q Consensus       137 -------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  203 (358)
                                   ....+++..++.++.||+.||.|||++   |++||||||+||++++++.++|+|||++.........
T Consensus       192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~  268 (374)
T cd05106         192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY  268 (374)
T ss_pred             cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence                         113478889999999999999999999   9999999999999999999999999998764332221


Q ss_pred             -cccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhHhhhhccccC
Q 018263          204 -ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLY  281 (358)
Q Consensus       204 -~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (358)
                       ......++..|+|||++.+..++.++||||||+++|+|++ |+.||.........               ...+.....
T Consensus       269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~---------------~~~~~~~~~  333 (374)
T cd05106         269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKF---------------YKMVKRGYQ  333 (374)
T ss_pred             eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHH---------------HHHHHcccC
Confidence             1112334567999999988899999999999999999997 99999754322111               111111111


Q ss_pred             CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 018263          282 GNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE  320 (358)
Q Consensus       282 ~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~  320 (358)
                      ...+...+.++.+++.+||+.+|.+|||+.+|++.|+++
T Consensus       334 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         334 MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             ccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            112223456799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.4e-40  Score=290.86  Aligned_cols=269  Identities=23%  Similarity=0.336  Sum_probs=222.8

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccCh--hhHHHHHHHHHHhhhcccCCCC-ceeeeceEEcCC---
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK--QGEKEFMSEVASMANVNVCHEN-LVKLHGGCIDGP---  113 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~~~h~~-i~~~~~~~~~~~---  113 (358)
                      ...|..+++||.|.+|.||+|+.+ +|+.||+|.+..+..  .......+|+..++.++  |+| |+.+.+++...+   
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~--~~~~iv~L~dv~~~~~~~~   87 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLS--HANHIVRLHDVIHTSNNHR   87 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhC--CCcceEEEEeeeeeccccc
Confidence            556788899999999999999965 689999999987644  34566789999999998  999 999999998877   


Q ss_pred             ---eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEee
Q 018263          114 ---CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD  190 (358)
Q Consensus       114 ---~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~D  190 (358)
                         .+++|+||+ ..+|..++.........++...+..++.||+.||+|+|++   +|+||||||.||+|+..|.+||+|
T Consensus        88 ~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaD  163 (323)
T KOG0594|consen   88 GIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLAD  163 (323)
T ss_pred             ccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeec
Confidence               789999999 5789999854332224577799999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccch
Q 018263          191 FGLSKLFPENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNS  269 (358)
Q Consensus       191 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      ||+++....+.. ..+..++|.+|.|||++.+. .|+...||||+|||+.||+++++.|.+..+.++...+....+.+..
T Consensus       164 FGlAra~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e  242 (323)
T KOG0594|consen  164 FGLARAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNE  242 (323)
T ss_pred             cchHHHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCc
Confidence            999996543333 24456788999999999987 7999999999999999999999999999998888888888888776


Q ss_pred             hhHhhhhccc-----cCCCC-CH-------HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 018263          270 KELMNLVDPM-----LYGNF-PE-------NEAIRFLKVGLLCVQEKSKLRPQMSTAIKM  316 (358)
Q Consensus       270 ~~~~~~~~~~-----~~~~~-~~-------~~~~~l~~li~~~l~~~P~~Rpt~~eil~~  316 (358)
                      ..+.....-.     ..... +.       ....+..+++.+||+.+|.+|.|++.+++.
T Consensus       243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            6655543211     11111 11       122478999999999999999999999874

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-40  Score=293.99  Aligned_cols=258  Identities=29%  Similarity=0.436  Sum_probs=209.7

Q ss_pred             HHhhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           38 KIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        38 ~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      .+..++|++.+.||.|++|.||+|..+++..|++|.+... ......+.+|+..++.++  |+|++++++.+......++
T Consensus         2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~~   78 (261)
T cd05034           2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLR--HDKLVQLYAVCSEEEPIYI   78 (261)
T ss_pred             ccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC-ccCHHHHHHHHHHHhhCC--CCCEeeeeeeeecCCceEE
Confidence            3567899999999999999999999888888999998643 334567889999999998  9999999999999899999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      +|||+++++|.+++...  ....+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.++|+|||.+...
T Consensus        79 v~e~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~  153 (261)
T cd05034          79 VTEYMSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLI  153 (261)
T ss_pred             EEeccCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceec
Confidence            99999999999999432  234688999999999999999999999   9999999999999999999999999998765


Q ss_pred             CCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhHhhhh
Q 018263          198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV  276 (358)
Q Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                      .............+..|+|||.+.+..++.++|+||||+++++|++ |+.||...........   .             
T Consensus       154 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~---~-------------  217 (261)
T cd05034         154 EDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQ---V-------------  217 (261)
T ss_pred             cchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---H-------------
Confidence            4322222222334568999999988889999999999999999998 9999864432111111   1             


Q ss_pred             ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 018263          277 DPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNG  319 (358)
Q Consensus       277 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~  319 (358)
                      ........+...+..+.+++.+||+.+|++||+++++++.|+.
T Consensus       218 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         218 ERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             HcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            1111111223345679999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2e-41  Score=295.93  Aligned_cols=269  Identities=23%  Similarity=0.314  Sum_probs=221.1

Q ss_pred             CCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC-----eeE
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP-----CRI  116 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~-----~~~  116 (358)
                      .|+-.+.+|.|.||.||.|... +++.||||.+-.+..-    .-.|+++++.+.  ||||+++.-+|....     ...
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~--HpNIV~L~~~f~~~~~~d~~~ln   98 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLD--HPNIVRLLYFFSSSTESDEVYLN   98 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcC--CcCeeeEEEEEEecCCCchhHHH
Confidence            5777899999999999999965 5789999998654332    226889999887  999999998887533     235


Q ss_pred             EEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCC-CceEEeeccccc
Q 018263          117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN-FNPKISDFGLSK  195 (358)
Q Consensus       117 iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~-~~~~l~Dfg~~~  195 (358)
                      +||||+| .+|.+.++.....+..++...++-+++||++||+|||+.   |||||||||.|++||.+ |.+||+|||.|+
T Consensus        99 lVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK  174 (364)
T KOG0658|consen   99 LVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAK  174 (364)
T ss_pred             HHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcce
Confidence            8999995 689999976656678899999999999999999999999   99999999999999976 899999999999


Q ss_pred             ccCCCCcccccccccccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhh
Q 018263          196 LFPENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMN  274 (358)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                      .......  ...+..+.-|+|||.+.|. .|+.+.||||.||++.||+-|++.|.+++..++...+.+..+.+..+++..
T Consensus       175 ~L~~~ep--niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~  252 (364)
T KOG0658|consen  175 VLVKGEP--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS  252 (364)
T ss_pred             eeccCCC--ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence            7644333  2446678899999999875 799999999999999999999999999999999999999998888777665


Q ss_pred             hhccc-------cCC-----CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHH--HHhhcCCCC
Q 018263          275 LVDPM-------LYG-----NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAI--KMMNGETNI  323 (358)
Q Consensus       275 ~~~~~-------~~~-----~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil--~~L~~~~~~  323 (358)
                      .--..       +..     -+....+.+..+|+.++|+.+|++|.++.|++  .+++.+.+.
T Consensus       253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence            43321       111     13346778899999999999999999999886  344444443

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.7e-40  Score=298.57  Aligned_cols=264  Identities=27%  Similarity=0.422  Sum_probs=210.8

Q ss_pred             HhhcCCcccceecccCceEEEEEEEC------CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG  112 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~  112 (358)
                      +..++|.+.+.||.|+||.||++...      ++..|++|.+..........+.+|++.+..++  |||++++++++...
T Consensus         2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~   79 (288)
T cd05093           2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ--HEHIVKFYGVCVEG   79 (288)
T ss_pred             CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCC--CCCcceEEEEEecC
Confidence            34678999999999999999999842      34568999887665566678899999999998  99999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHhhhcc---------ccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCC
Q 018263          113 PCRILVYDYMPNNSLSQTLLGEE---------KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN  183 (358)
Q Consensus       113 ~~~~iv~e~~~~~~L~~~l~~~~---------~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~  183 (358)
                      +..+++|||+++++|.+++....         .....+++..+..++.|++.||+|||++   |++|+||+|+||+++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~  156 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN  156 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccC
Confidence            99999999999999999985332         1234589999999999999999999999   99999999999999999


Q ss_pred             CceEEeecccccccCCCCc-ccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhH
Q 018263          184 FNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVD  261 (358)
Q Consensus       184 ~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~  261 (358)
                      +.++|+|||++........ .......++..|+|||++.+..++.++|+||||+++|+|++ |..||.........   .
T Consensus       157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~---~  233 (288)
T cd05093         157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI---E  233 (288)
T ss_pred             CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH---H
Confidence            9999999999875432221 11122335678999999988889999999999999999998 89998644322111   1


Q ss_pred             hhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCC
Q 018263          262 KAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNI  323 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~  323 (358)
                      .+             ........+...+..+.+++.+||+.+|.+|||+.++++.|+++...
T Consensus       234 ~i-------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         234 CI-------------TQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             HH-------------HcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            11             00001111223456799999999999999999999999999887643

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=3.3e-40  Score=307.84  Aligned_cols=255  Identities=25%  Similarity=0.329  Sum_probs=202.8

Q ss_pred             HHHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC
Q 018263           37 LKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG  112 (358)
Q Consensus        37 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~  112 (358)
                      +....++|++.+.||+|+||.||+++.. +++.||+|++...   .......+.+|+.+++.+.  ||||+++++.+..+
T Consensus        38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~--hp~iv~~~~~~~~~  115 (370)
T cd05621          38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN--SPWVVQLFCAFQDD  115 (370)
T ss_pred             cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC--CCCEeeEEEEEEcC
Confidence            3444689999999999999999999976 5889999998642   2233456778899999887  99999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecc
Q 018263          113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG  192 (358)
Q Consensus       113 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg  192 (358)
                      +..++||||+++++|.+++.     ...+++..+..++.||+.||+|||++   +|+||||||+||+++.++.++|+|||
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~-----~~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG  187 (370)
T cd05621         116 KYLYMVMEYMPGGDLVNLMS-----NYDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFG  187 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecc
Confidence            99999999999999999983     33588999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccCccCccccccC----CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccc
Q 018263          193 LSKLFPENTTHISTRVAGTLGYLAPEYAISG----RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYN  268 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  268 (358)
                      ++...............||+.|+|||++.+.    .++.++|+||||+++|+|++|+.||........+.          
T Consensus       188 ~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~----------  257 (370)
T cd05621         188 TCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYS----------  257 (370)
T ss_pred             cceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHH----------
Confidence            9986543332223346799999999998754    37889999999999999999999997554322111          


Q ss_pred             hhhHhhhhccccCCCCC--HHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 018263          269 SKELMNLVDPMLYGNFP--ENEAIRFLKVGLLCVQEKSKL--RPQMSTAIKM  316 (358)
Q Consensus       269 ~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~P~~--Rpt~~eil~~  316 (358)
                           .+.+......++  ...+..+.+++.+||+.++.+  |+++.++++.
T Consensus       258 -----~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         258 -----KIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             -----HHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence                 111111111111  234667889999999865544  8899998874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.2e-40  Score=307.39  Aligned_cols=247  Identities=21%  Similarity=0.308  Sum_probs=202.7

Q ss_pred             HhhcCCcccceecccCceEEEEEEECC--CCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQD--GTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP  113 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~~--~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~  113 (358)
                      +..++|.+.+.||+|+||.||+|.++.  +..||+|.+...   .......+..|+..+..+.  ||||+++++++...+
T Consensus        27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~Iv~~~~~~~~~~  104 (340)
T PTZ00426         27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN--HPFCVNLYGSFKDES  104 (340)
T ss_pred             CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC--CCCCcceEEEEEeCC
Confidence            345689999999999999999998543  468999998643   2234456778999999998  999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccc
Q 018263          114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL  193 (358)
Q Consensus       114 ~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~  193 (358)
                      ..++||||+++++|.+++    .....+++..+..++.||+.||.|||++   |++||||||+||+++.++.++|+|||+
T Consensus       105 ~~~lv~Ey~~~g~L~~~i----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~  177 (340)
T PTZ00426        105 YLYLVLEFVIGGEFFTFL----RRNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGF  177 (340)
T ss_pred             EEEEEEeCCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCC
Confidence            999999999999999999    3456789999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHh
Q 018263          194 SKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELM  273 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      +......    .....|++.|+|||++.+..++.++|+|||||++|+|++|..||........+..+             
T Consensus       178 a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i-------------  240 (340)
T PTZ00426        178 AKVVDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKI-------------  240 (340)
T ss_pred             CeecCCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHH-------------
Confidence            9865322    23356899999999998888999999999999999999999999754332111111             


Q ss_pred             hhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 018263          274 NLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRP-----QMSTAIK  315 (358)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp-----t~~eil~  315 (358)
                        ....  ..++...+..+.+++.+||+.+|.+|+     +++++++
T Consensus       241 --~~~~--~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        241 --LEGI--IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             --hcCC--CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence              1110  112334456688999999999999995     7887765

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-40  Score=302.65  Aligned_cols=237  Identities=26%  Similarity=0.332  Sum_probs=193.1

Q ss_pred             ecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecCCCC
Q 018263           50 IGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN  125 (358)
Q Consensus        50 lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~~~~  125 (358)
                      ||+|+||.||+|+.. +++.||+|++...   .......+..|+..+..++  ||||+++++.+...+..++||||++++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~g   78 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN--CPFIVPLKFSFQSPEKLYLVLAFINGG   78 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC--CCcEeceeeEEecCCeEEEEEcCCCCC
Confidence            699999999999976 5889999998643   2334466778999999987  999999999999999999999999999


Q ss_pred             CHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCcccc
Q 018263          126 SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS  205 (358)
Q Consensus       126 ~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~  205 (358)
                      +|.+++    .....+++..+..++.||+.||.|||++   |++||||+|+||+++.++.++|+|||++....... ...
T Consensus        79 ~L~~~l----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~  150 (312)
T cd05585          79 ELFHHL----QREGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKT  150 (312)
T ss_pred             cHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccc
Confidence            999998    3456789999999999999999999999   99999999999999999999999999987532222 122


Q ss_pred             cccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCCCC
Q 018263          206 TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFP  285 (358)
Q Consensus       206 ~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (358)
                      ....|++.|+|||++.+..++.++||||||+++|+|++|+.||.........               ..+...  ...++
T Consensus       151 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~---------------~~~~~~--~~~~~  213 (312)
T cd05585         151 NTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMY---------------RKILQE--PLRFP  213 (312)
T ss_pred             ccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHH---------------HHHHcC--CCCCC
Confidence            3456899999999999989999999999999999999999999754321111               011111  11234


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 018263          286 ENEAIRFLKVGLLCVQEKSKLRPQMSTA  313 (358)
Q Consensus       286 ~~~~~~l~~li~~~l~~~P~~Rpt~~ei  313 (358)
                      ...+..+.+++.+||+.||.+||++..+
T Consensus       214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~  241 (312)
T cd05585         214 DGFDRDAKDLLIGLLSRDPTRRLGYNGA  241 (312)
T ss_pred             CcCCHHHHHHHHHHcCCCHHHcCCCCCH
Confidence            4566778999999999999999864433

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=4e-40  Score=303.40  Aligned_cols=266  Identities=21%  Similarity=0.321  Sum_probs=204.6

Q ss_pred             HhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeE
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI  116 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~  116 (358)
                      +..++|++.++||.|+||.||++.+. ++..+++|.+... .......+.+|+..++.++  ||||+++++++...+..+
T Consensus         2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~   79 (333)
T cd06650           2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN--SPYIVGFYGAFYSDGEIS   79 (333)
T ss_pred             cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCC--CCcccceeEEEEECCEEE
Confidence            34689999999999999999999976 6888999988754 3344567889999999998  999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       117 iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      +||||+++++|.+++    ...+.+++..+..++.|++.||.|||+.+  +++|+||+|+||+++.++.++|+|||++..
T Consensus        80 lv~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~  153 (333)
T cd06650          80 ICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQ  153 (333)
T ss_pred             EEEecCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchh
Confidence            999999999999998    34456899999999999999999999741  799999999999999999999999999875


Q ss_pred             cCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhh-hhcc--------
Q 018263          197 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKA-WGMY--------  267 (358)
Q Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~-~~~~--------  267 (358)
                      .....   .....++..|+|||++.+..++.++|+|||||++|+|++|+.||............... .+..        
T Consensus       154 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (333)
T cd06650         154 LIDSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPR  230 (333)
T ss_pred             hhhhc---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcc
Confidence            43221   22346888999999998888999999999999999999999999754321111000000 0000        


Q ss_pred             -------------------chhhHhhhhccccCCCC-CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          268 -------------------NSKELMNLVDPMLYGNF-PENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       268 -------------------~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                                         ........+........ ....+.++.+|+.+||+.||++|||+.|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             cCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence                               00000000000000111 1124567899999999999999999999964

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3.4e-40  Score=303.29  Aligned_cols=241  Identities=25%  Similarity=0.306  Sum_probs=197.2

Q ss_pred             ceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecCC
Q 018263           48 NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP  123 (358)
Q Consensus        48 ~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~~  123 (358)
                      +.||+|+||.||++... +|+.||+|++...   .......+.+|+..++.+.  ||||+++.+.+...+..++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~~~~lv~Ey~~   78 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTR--HPFLTSLKYSFQTKDRLCFVMEYVN   78 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC--CCCCcceEEEEEcCCEEEEEEeCCC
Confidence            46899999999999975 6899999998753   2334456778999999987  9999999999999999999999999


Q ss_pred             CCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCcc
Q 018263          124 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH  203 (358)
Q Consensus       124 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  203 (358)
                      +++|.+.+    .....+++..+..++.||+.||+|||++   ||+|+||||+||+++.++.++|+|||++....... .
T Consensus        79 ~g~L~~~l----~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~  150 (328)
T cd05593          79 GGELFFHL----SRERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-A  150 (328)
T ss_pred             CCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-c
Confidence            99999888    3456789999999999999999999999   99999999999999999999999999987532211 1


Q ss_pred             cccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCC
Q 018263          204 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGN  283 (358)
Q Consensus       204 ~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (358)
                      ......|++.|+|||++.+..++.++||||||+++|+|++|+.||...........   +            ..  ....
T Consensus       151 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~---~------------~~--~~~~  213 (328)
T cd05593         151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL---I------------LM--EDIK  213 (328)
T ss_pred             ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHH---h------------cc--CCcc
Confidence            22335689999999999888899999999999999999999999975432111110   0            00  0112


Q ss_pred             CCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 018263          284 FPENEAIRFLKVGLLCVQEKSKLRP-----QMSTAIK  315 (358)
Q Consensus       284 ~~~~~~~~l~~li~~~l~~~P~~Rp-----t~~eil~  315 (358)
                      ++...+.++.+++.+||+.||.+||     ++.++++
T Consensus       214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         214 FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence            3344567789999999999999997     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=3.8e-40  Score=293.51  Aligned_cols=257  Identities=29%  Similarity=0.430  Sum_probs=205.7

Q ss_pred             HhhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      +..++|++.++||.|++|.||+|++.+...|++|.+.... .....+..|++.++.++  ||||+++++.+. ....+++
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~--~~~i~~~~~~~~-~~~~~lv   78 (262)
T cd05071           3 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLR--HEKLVQLYAVVS-EEPIYIV   78 (262)
T ss_pred             CChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCC--CCCcceEEEEEC-CCCcEEE
Confidence            4567899999999999999999998776779999987432 23457888999999988  999999998774 4567999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      |||+++++|.+++...  ....+++..+..++.|++.||++||++   +++|+||+|+||++++++.++|+|||.+....
T Consensus        79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~  153 (262)
T cd05071          79 TEYMSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIE  153 (262)
T ss_pred             EEcCCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecc
Confidence            9999999999999432  234578999999999999999999999   99999999999999999999999999997654


Q ss_pred             CCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhHhhhhc
Q 018263          199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD  277 (358)
Q Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      ...........++..|+|||+..+..++.++|+||||+++|+|++ |..||..........   .             +.
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~---~-------------~~  217 (262)
T cd05071         154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD---Q-------------VE  217 (262)
T ss_pred             ccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHH---H-------------Hh
Confidence            333222223345678999999888889999999999999999999 888886443211111   1             11


Q ss_pred             cccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 018263          278 PMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE  320 (358)
Q Consensus       278 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~  320 (358)
                      .......+...+..+.+++.+||+.+|++||++.++++.|+..
T Consensus       218 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         218 RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             cCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            1111122345667789999999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-40  Score=308.16  Aligned_cols=251  Identities=24%  Similarity=0.288  Sum_probs=200.2

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      ++|++.+.||.|+||.||+|+.. +|+.||||++....   ......+..|+..+..++  ||||+++++.+...+..++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~--h~~iv~~~~~~~~~~~~~l   78 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD--NPWVVKLYYSFQDENYLYL   78 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC--CCCCcceEEEEEcCCeEEE
Confidence            47999999999999999999976 68999999997532   334456778999999998  9999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      ||||+++++|.+++.    ....+++..+..++.||+.||+|||++   |++|+||||+||+++.++.++|+|||++...
T Consensus        79 v~E~~~~g~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  151 (364)
T cd05599          79 IMEYLPGGDMMTLLM----KKDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGL  151 (364)
T ss_pred             EECCCCCcHHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceec
Confidence            999999999999983    445789999999999999999999999   9999999999999999999999999998654


Q ss_pred             CCCCcc-------------------------------------cccccccccCccCccccccCCCCccCceecHHHHHHH
Q 018263          198 PENTTH-------------------------------------ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLE  240 (358)
Q Consensus       198 ~~~~~~-------------------------------------~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~  240 (358)
                      ......                                     ......||+.|+|||++.+..++.++|||||||++|+
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e  231 (364)
T cd05599         152 KKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYE  231 (364)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHH
Confidence            211100                                     0112358999999999988899999999999999999


Q ss_pred             HHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCC---HHHHHH
Q 018263          241 IVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQ---MSTAIK  315 (358)
Q Consensus       241 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt---~~eil~  315 (358)
                      |++|..||...........+...             ............+..+.++|.+|+. +|.+|++   +.++++
T Consensus       232 l~~G~~Pf~~~~~~~~~~~i~~~-------------~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         232 MLVGYPPFCSDNPQETYRKIINW-------------KETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             hhcCCCCCCCCCHHHHHHHHHcC-------------CCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            99999999755432211111000             0000000111245678899999997 9999998   888866

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.2e-40  Score=318.19  Aligned_cols=259  Identities=27%  Similarity=0.383  Sum_probs=208.2

Q ss_pred             HHHHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC
Q 018263           36 QLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG  112 (358)
Q Consensus        36 ~~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~  112 (358)
                      ......++|++.+.||+|+||.||+|+.. +|+.||+|++...  .......+..|+..+..+.  |+|++++.+.+...
T Consensus        26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~--h~~iv~~~~~~~~~  103 (496)
T PTZ00283         26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCD--FFSIVKCHEDFAKK  103 (496)
T ss_pred             cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCC--CCcEEEeecceecc
Confidence            33444679999999999999999999864 6899999998654  3344566778999898887  99999998877543


Q ss_pred             C--------eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCC
Q 018263          113 P--------CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF  184 (358)
Q Consensus       113 ~--------~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~  184 (358)
                      .        ..++||||+++++|.+.+.........+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++
T Consensus       104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~  180 (496)
T PTZ00283        104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNG  180 (496)
T ss_pred             cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCC
Confidence            2        36799999999999999965544556799999999999999999999999   999999999999999999


Q ss_pred             ceEEeecccccccCCCC-cccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhh
Q 018263          185 NPKISDFGLSKLFPENT-THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKA  263 (358)
Q Consensus       185 ~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~  263 (358)
                      .++|+|||++....... ........|++.|+|||++.+..++.++||||||+++|+|++|+.||..........   . 
T Consensus       181 ~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~---~-  256 (496)
T PTZ00283        181 LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMH---K-  256 (496)
T ss_pred             CEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH---H-
Confidence            99999999987653322 122234578999999999999899999999999999999999999997543211111   0 


Q ss_pred             hhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          264 WGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                                 .+ .......+...+..+.+++.+||+.+|.+||++.++++
T Consensus       257 -----------~~-~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~  296 (496)
T PTZ00283        257 -----------TL-AGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN  296 (496)
T ss_pred             -----------Hh-cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence                       00 11112234456678999999999999999999999875

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=4.8e-40  Score=297.48  Aligned_cols=266  Identities=24%  Similarity=0.372  Sum_probs=211.9

Q ss_pred             HHHHHhhcCCcccceecccCceEEEEEEEC------CCCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeec
Q 018263           35 NQLKIATNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHG  107 (358)
Q Consensus        35 ~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~  107 (358)
                      ..+.+..++|++.+.||+|++|.||++...      ....+++|.+... .......+..|++.+..+. .|+||+++++
T Consensus         5 ~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~-~h~~i~~~~~   83 (293)
T cd05053           5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-KHKNIINLLG   83 (293)
T ss_pred             cccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhc-CCCCeeeEEE
Confidence            356677889999999999999999999864      2367899988653 2334456888999988883 3999999999


Q ss_pred             eEEcCCeeEEEEecCCCCCHHHHhhhcc------------ccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCC
Q 018263          108 GCIDGPCRILVYDYMPNNSLSQTLLGEE------------KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKT  175 (358)
Q Consensus       108 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~------------~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p  175 (358)
                      ++...+..+++|||+++++|.+++....            .....+++..+..++.|++.||+|||++   +++|+||+|
T Consensus        84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp  160 (293)
T cd05053          84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAA  160 (293)
T ss_pred             EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Cccccccce
Confidence            9999999999999999999999985421            2345688999999999999999999999   999999999


Q ss_pred             CcEEEcCCCceEEeecccccccCCCCcc-cccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCcccc
Q 018263          176 SNILLDQNFNPKISDFGLSKLFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ  253 (358)
Q Consensus       176 ~Nilv~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~  253 (358)
                      +||+++.++.++|+|||.+......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus       161 ~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~  240 (293)
T cd05053         161 RNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV  240 (293)
T ss_pred             eeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH
Confidence            9999999999999999999865432211 1122334567999999888889999999999999999997 9999864322


Q ss_pred             ccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 018263          254 LGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE  320 (358)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~  320 (358)
                      ..                ....+........+...+..+.+|+.+||+.+|++|||+.++++.|+++
T Consensus       241 ~~----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         241 EE----------------LFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             HH----------------HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence            11                1111111112223345567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.5e-40  Score=303.52  Aligned_cols=241  Identities=26%  Similarity=0.315  Sum_probs=196.5

Q ss_pred             ceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecCC
Q 018263           48 NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP  123 (358)
Q Consensus        48 ~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~~  123 (358)
                      +.||+|+||.||++... +|+.||+|++...   .......+..|+..++.+.  ||||+++++.+...+..++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~i~~~~~~~~~~~~~~lv~E~~~   78 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR--HPFLTALKYAFQTHDRLCFVMEYAN   78 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC--CCCCcceeeEEecCCEEEEEEeCCC
Confidence            46899999999999975 6899999998754   2234456678999999988  9999999999999999999999999


Q ss_pred             CCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCcc
Q 018263          124 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH  203 (358)
Q Consensus       124 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  203 (358)
                      +++|...+    .....+++..++.++.||+.||+|||++   |++|+||||+||+++.++.++|+|||++....... .
T Consensus        79 ~~~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~  150 (323)
T cd05595          79 GGELFFHL----SRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-A  150 (323)
T ss_pred             CCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-C
Confidence            99999888    3455789999999999999999999999   99999999999999999999999999887532211 1


Q ss_pred             cccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCC
Q 018263          204 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGN  283 (358)
Q Consensus       204 ~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (358)
                      ......|++.|+|||++.+..++.++||||||+++|+|++|+.||............               ...  ...
T Consensus       151 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~---------------~~~--~~~  213 (323)
T cd05595         151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI---------------LME--EIR  213 (323)
T ss_pred             ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH---------------hcC--CCC
Confidence            223356899999999998889999999999999999999999999754322111110               000  112


Q ss_pred             CCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 018263          284 FPENEAIRFLKVGLLCVQEKSKLRP-----QMSTAIK  315 (358)
Q Consensus       284 ~~~~~~~~l~~li~~~l~~~P~~Rp-----t~~eil~  315 (358)
                      ++...+..+.+++.+||+.||.+||     ++.++++
T Consensus       214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            3344567789999999999999998     7888765

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=4.4e-40  Score=306.95  Aligned_cols=272  Identities=21%  Similarity=0.274  Sum_probs=214.6

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccC----CCCceeeeceEEcCCee
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC----HENLVKLHGGCIDGPCR  115 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~----h~~i~~~~~~~~~~~~~  115 (358)
                      .-+|.|.+.||+|.||.|.+|.+. +++.||||++++.. .-......|+.+|..++..    .-|+|+++++|.+.++.
T Consensus       185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl  263 (586)
T KOG0667|consen  185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL  263 (586)
T ss_pred             EEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence            348999999999999999999865 69999999998553 3334556788888888621    24799999999999999


Q ss_pred             EEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCC--ceEEeeccc
Q 018263          116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF--NPKISDFGL  193 (358)
Q Consensus       116 ~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~--~~~l~Dfg~  193 (358)
                      |||+|.+ ..+|.++++.+  +-..++...++.++.||+.||.+||+.   +|||+||||+|||+.+.+  .+||+|||.
T Consensus       264 ciVfELL-~~NLYellK~n--~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGS  337 (586)
T KOG0667|consen  264 CIVFELL-STNLYELLKNN--KFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGS  337 (586)
T ss_pred             eeeehhh-hhhHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccc
Confidence            9999999 68999999543  445589999999999999999999999   999999999999997543  599999999


Q ss_pred             ccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhH-
Q 018263          194 SKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKEL-  272 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-  272 (358)
                      +......    ...+..+.-|.|||++.|.+|+.+-||||||||++||++|.+.|.++++.++...+.+..+.+...-+ 
T Consensus       338 Sc~~~q~----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~  413 (586)
T KOG0667|consen  338 SCFESQR----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLD  413 (586)
T ss_pred             ccccCCc----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            9864221    12466778999999999999999999999999999999999999999998888777766654432200 


Q ss_pred             -----hhhhcc-----------------------------ccCCCCC-----------HHHHHHHHHHHhhccCCCCCCC
Q 018263          273 -----MNLVDP-----------------------------MLYGNFP-----------ENEAIRFLKVGLLCVQEKSKLR  307 (358)
Q Consensus       273 -----~~~~~~-----------------------------~~~~~~~-----------~~~~~~l~~li~~~l~~~P~~R  307 (358)
                           ..+++.                             ......|           ......+++++.+||++||.+|
T Consensus       414 ~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R  493 (586)
T KOG0667|consen  414 TAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAER  493 (586)
T ss_pred             hccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhc
Confidence                 001111                             0000011           1344568999999999999999


Q ss_pred             CCHHHHHH--HhhcCCCC
Q 018263          308 PQMSTAIK--MMNGETNI  323 (358)
Q Consensus       308 pt~~eil~--~L~~~~~~  323 (358)
                      +|+.+.++  +|.+....
T Consensus       494 ~tp~qal~Hpfl~~~~~~  511 (586)
T KOG0667|consen  494 ITPAQALNHPFLTGTSLE  511 (586)
T ss_pred             CCHHHHhcCccccccccc
Confidence            99999985  34433333

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6e-40  Score=295.54  Aligned_cols=272  Identities=25%  Similarity=0.386  Sum_probs=206.9

Q ss_pred             hcCCcccceecccCceEEEEEEE-----CCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEc--CC
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRL-----QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID--GP  113 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~--~~  113 (358)
                      .++|++.+.||+|+||.||.+..     .++..|++|.+..........+..|++.++.++  |||++++.+++..  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~   80 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQ--HDNIVKYKGVCYSAGRR   80 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCC--CCCeeEEEEEEccCCCC
Confidence            46899999999999999999974     358899999987666666778899999999998  9999999997654  34


Q ss_pred             eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccc
Q 018263          114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL  193 (358)
Q Consensus       114 ~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~  193 (358)
                      ..++|+||+++++|.+++..   ....+++..+..++.|++.||+|||++   |++|+||+|+||+++.++.++|+|||+
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~  154 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGL  154 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcc
Confidence            67899999999999999832   234689999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCccc--ccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhh-hhccchh
Q 018263          194 SKLFPENTTHI--STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKA-WGMYNSK  270 (358)
Q Consensus       194 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~-~~~~~~~  270 (358)
                      +..........  .....++..|+|||++.+..++.++|+||||+++|+|++|..++...... ........ .......
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  233 (284)
T cd05081         155 TKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-FMRMMGNDKQGQMIVY  233 (284)
T ss_pred             cccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh-hhhhcccccccccchH
Confidence            98654322211  11122344699999998888999999999999999999987765432110 00000000 0000011


Q ss_pred             hHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCC
Q 018263          271 ELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGET  321 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~  321 (358)
                      ...+.+........+...+..+.+++.+||+.+|++|||+.+|++.|+.++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~  284 (284)
T cd05081         234 HLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR  284 (284)
T ss_pred             HHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence            111222222222233445678999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2.2e-40  Score=309.81  Aligned_cols=263  Identities=21%  Similarity=0.274  Sum_probs=204.7

Q ss_pred             CCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC-----e
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP-----C  114 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~-----~  114 (358)
                      +|++.+.||+|+||.||++... +|+.||+|.+...  .....+.+.+|+..++.++  |+||+++++++...+     .
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~~   78 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFK--HDNVLSALDILQPPHIDPFEE   78 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCC--CCCcCCHhheecCCCccccce
Confidence            4788999999999999999975 6899999998643  2334567889999999998  999999999998776     7


Q ss_pred             eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccc
Q 018263          115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS  194 (358)
Q Consensus       115 ~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~  194 (358)
                      .++|+||+. ++|.+.+    .....+++..+..++.||+.||.|||+.   |++|+||+|+||+++.++.++|+|||++
T Consensus        79 ~~lv~e~~~-~~l~~~~----~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a  150 (372)
T cd07853          79 IYVVTELMQ-SDLHKII----VSPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLA  150 (372)
T ss_pred             EEEEeeccc-cCHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccce
Confidence            899999995 6788877    3456789999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCCcccccccccccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHh
Q 018263          195 KLFPENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELM  273 (358)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      ...............++..|+|||++.+. .++.++|||||||++|+|++|+.||...........+....+......+.
T Consensus       151 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~  230 (372)
T cd07853         151 RVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMR  230 (372)
T ss_pred             eecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence            76433332233334578899999998774 47899999999999999999999998766554444433332222221111


Q ss_pred             hh-------h-ccccCC-------CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          274 NL-------V-DPMLYG-------NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       274 ~~-------~-~~~~~~-------~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ..       + ......       ......+..+.+|+.+||+.||.+|||+.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence            10       0 000000       011223567889999999999999999999986

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1e-39  Score=306.11  Aligned_cols=252  Identities=23%  Similarity=0.254  Sum_probs=197.7

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      ..|++++.||+|+||.||+|+.. +++.||+|++....   ......+..|+.++..+.  ||||+++++.+...+..++
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~--h~~iv~l~~~~~~~~~~~l   78 (381)
T cd05626           1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD--NEWVVKLYYSFQDKDNLYF   78 (381)
T ss_pred             CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcC--CCCeeeeEEEEecCCEEEE
Confidence            36899999999999999999865 68899999987542   334567888999999988  9999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      ||||++|++|.+++    .....+++..+..++.||+.||.|||+.   ||+||||||+||+++.++.++|+|||++...
T Consensus        79 v~E~~~gg~L~~~l----~~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~  151 (381)
T cd05626          79 VMDYIPGGDMMSLL----IRMEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGF  151 (381)
T ss_pred             EEecCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence            99999999999998    3445689999999999999999999999   9999999999999999999999999987532


Q ss_pred             CCCC----------------------------------------------cccccccccccCccCccccccCCCCccCce
Q 018263          198 PENT----------------------------------------------THISTRVAGTLGYLAPEYAISGRLTRKSDV  231 (358)
Q Consensus       198 ~~~~----------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~s~~sDi  231 (358)
                      ....                                              ........||..|+|||++.+..++.++||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Di  231 (381)
T cd05626         152 RWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDW  231 (381)
T ss_pred             ccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccce
Confidence            1000                                              000123468999999999988889999999


Q ss_pred             ecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhcc--CCCCCCCCC
Q 018263          232 YSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCV--QEKSKLRPQ  309 (358)
Q Consensus       232 wslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l--~~~P~~Rpt  309 (358)
                      |||||++|+|++|..||...........+...             ............+.++.++|.+|+  ..+|..||+
T Consensus       232 wSlG~il~elltG~~Pf~~~~~~~~~~~i~~~-------------~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~  298 (381)
T cd05626         232 WSVGVILFEMLVGQPPFLAPTPTETQLKVINW-------------ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNG  298 (381)
T ss_pred             eehhhHHHHHHhCCCCCcCCCHHHHHHHHHcc-------------ccccCCCCCCCCCHHHHHHHHHHccCcccccCCCC
Confidence            99999999999999999754432111111000             000011111234567788888844  556666999


Q ss_pred             HHHHHH
Q 018263          310 MSTAIK  315 (358)
Q Consensus       310 ~~eil~  315 (358)
                      +.++++
T Consensus       299 ~~~~l~  304 (381)
T cd05626         299 ADDIKA  304 (381)
T ss_pred             HHHHhc
Confidence            999986

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4.5e-40  Score=302.06  Aligned_cols=244  Identities=25%  Similarity=0.327  Sum_probs=194.7

Q ss_pred             CcccceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhh---hcccCCCCceeeeceEEcCCeeE
Q 018263           44 FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMA---NVNVCHENLVKLHGGCIDGPCRI  116 (358)
Q Consensus        44 y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~---~l~~~h~~i~~~~~~~~~~~~~~  116 (358)
                      |++.+.||+|++|.||+|.+. +|+.||+|++....   ......+..|...+.   .+.  ||||+++++++...+..+
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~--hp~i~~~~~~~~~~~~~~   78 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER--HPFLVNLFACFQTEDHVC   78 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccC--CCChhceeeEEEcCCEEE
Confidence            788999999999999999865 68999999987432   223345556655543   444  999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       117 iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      +||||+++++|...+     ....+++..+..++.||+.||.|||++   |++|+||+|+||+++.++.++|+|||++..
T Consensus        79 lv~E~~~~~~L~~~~-----~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~  150 (324)
T cd05589          79 FVMEYAAGGDLMMHI-----HTDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKE  150 (324)
T ss_pred             EEEcCCCCCcHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCcc
Confidence            999999999999887     335689999999999999999999999   999999999999999999999999998865


Q ss_pred             cCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhh
Q 018263          197 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV  276 (358)
Q Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                      ..... .......|++.|+|||++.+..++.++||||||+++|+|++|+.||...........               +.
T Consensus       151 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~---------------i~  214 (324)
T cd05589         151 GMGFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDS---------------IV  214 (324)
T ss_pred             CCCCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHH---------------HH
Confidence            32211 122345689999999999988999999999999999999999999975432211111               11


Q ss_pred             ccccCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 018263          277 DPMLYGNFPENEAIRFLKVGLLCVQEKSKLRP-----QMSTAIK  315 (358)
Q Consensus       277 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp-----t~~eil~  315 (358)
                      ..  ...++...+..+.+++.+||+.||.+||     ++.++++
T Consensus       215 ~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         215 ND--EVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             hC--CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence            10  1123344567789999999999999999     4666654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=7.1e-40  Score=296.23  Aligned_cols=262  Identities=27%  Similarity=0.422  Sum_probs=211.7

Q ss_pred             hcCCcccceecccCceEEEEEEEC------CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCe
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC  114 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~  114 (358)
                      ..+|.+.+.||.|++|.||++...      ++..+++|.+........+.+.+|++.++.+.  |+||+++++++.....
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~   81 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQ--HEHIVKFYGVCGDGDP   81 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCC--CCCcceEEEEEccCCc
Confidence            457889999999999999999742      35568899987666666678899999999988  9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHhhhcc------------ccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcC
Q 018263          115 RILVYDYMPNNSLSQTLLGEE------------KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ  182 (358)
Q Consensus       115 ~~iv~e~~~~~~L~~~l~~~~------------~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~  182 (358)
                      .++||||+++++|.+++....            .....+++..++.++.||+.||+|||++   |++|+||+|+||+++.
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~  158 (291)
T cd05094          82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGA  158 (291)
T ss_pred             eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEcc
Confidence            999999999999999995432            1234588999999999999999999999   9999999999999999


Q ss_pred             CCceEEeecccccccCCCCc-ccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhh
Q 018263          183 NFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLV  260 (358)
Q Consensus       183 ~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~  260 (358)
                      ++.++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||..........  
T Consensus       159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~--  236 (291)
T cd05094         159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE--  236 (291)
T ss_pred             CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH--
Confidence            99999999999875433221 11223445778999999988889999999999999999998 999986543221111  


Q ss_pred             HhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCC
Q 018263          261 DKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNI  323 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~  323 (358)
                                    .+........+...+..+.+++.+||+.+|++|||+.+|++.|+.+...
T Consensus       237 --------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         237 --------------CITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             --------------HHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence                          1111111112234566799999999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-39  Score=289.19  Aligned_cols=251  Identities=25%  Similarity=0.370  Sum_probs=204.5

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC-----hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCee
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-----KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR  115 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~  115 (358)
                      ++|.+.+.||.|++|.||.+... +++.|++|.+....     ......+.+|+..++.++  ||||+++++++......
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~   79 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ--HERIVQYYGCLRDDETL   79 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCC--CCCeeeeEEEEccCCeE
Confidence            67999999999999999999865 68999999986432     122356788999999998  99999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccc
Q 018263          116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK  195 (358)
Q Consensus       116 ~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~  195 (358)
                      ++++||+++++|.+.+    ...+.+++..+..++.|++.||.+||+.   |++|+||+|+||+++.++.++|+|||++.
T Consensus        80 ~~v~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~  152 (263)
T cd06625          80 SIFMEYMPGGSVKDQL----KAYGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK  152 (263)
T ss_pred             EEEEEECCCCcHHHHH----HHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccce
Confidence            9999999999999998    3445688999999999999999999999   99999999999999999999999999987


Q ss_pred             ccCCCCcccc--cccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHh
Q 018263          196 LFPENTTHIS--TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELM  273 (358)
Q Consensus       196 ~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      ..........  ....++..|+|||.+.+..++.++||||||+++|+|++|+.||.........               .
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---------------~  217 (263)
T cd06625         153 RLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI---------------F  217 (263)
T ss_pred             eccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH---------------H
Confidence            5433221111  2345778999999999888999999999999999999999998643221111               1


Q ss_pred             hhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 018263          274 NLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKM  316 (358)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~  316 (358)
                      ...........+...+..+.+++.+||+.+|.+|||+.++++.
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         218 KIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             HHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            1111111223444566789999999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.7e-40  Score=307.56  Aligned_cols=260  Identities=18%  Similarity=0.213  Sum_probs=199.1

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      ...+|++.+.||+|+||.||+|.+. +++.||+|...      ...+.+|+.+++.++  ||||+++++++......+++
T Consensus        90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~--HpnIv~~~~~~~~~~~~~lv  161 (391)
T PHA03212         90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAIN--HPSIIQLKGTFTYNKFTCLI  161 (391)
T ss_pred             ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCC--CCCCCCEeEEEEECCeeEEE
Confidence            3468999999999999999999975 68899999753      234678999999998  99999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      +|++ +++|..++    .....+++..+..++.||+.||.|||++   ||+|+||||+||+++.++.++|+|||++....
T Consensus       162 ~e~~-~~~L~~~l----~~~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~  233 (391)
T PHA03212        162 LPRY-KTDLYCYL----AAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPV  233 (391)
T ss_pred             EecC-CCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence            9999 46888887    3345688999999999999999999999   99999999999999999999999999987543


Q ss_pred             CCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCcccccc-------chhhhHhhhhccc---
Q 018263          199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG-------EYHLVDKAWGMYN---  268 (358)
Q Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~-------~~~~~~~~~~~~~---  268 (358)
                      ...........||+.|+|||++.+..++.++||||||+++|+|++|..||.......       ....+....+...   
T Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~  313 (391)
T PHA03212        234 DINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF  313 (391)
T ss_pred             cccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence            322223334678999999999988899999999999999999999998875432211       1111111111000   


Q ss_pred             ----hhhHhhhh----cc-----ccCCCC--CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          269 ----SKELMNLV----DP-----MLYGNF--PENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       269 ----~~~~~~~~----~~-----~~~~~~--~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                          ........    ..     ..+..+  ....+.++.+|+.+||+.||.+|||++|+++
T Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence                00011100    00     000000  0134567899999999999999999999984

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=5.5e-40  Score=298.69  Aligned_cols=265  Identities=22%  Similarity=0.343  Sum_probs=199.0

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      .++|++.+.||.|+||.||+|+.. +++.||+|++.... ......+.+|+..++.++  ||||+++++++......++|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv   81 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLK--HANIVLLHDIIHTKETLTLV   81 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCC--CCCcCeEEEEEecCCeEEEE
Confidence            478999999999999999999976 68899999986442 233346778999999998  99999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      |||++ ++|.+.+.   .....+++..+..++.||+.||+|||+.   |++|+||||+||+++.++.++|+|||++....
T Consensus        82 ~e~~~-~~l~~~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  154 (303)
T cd07869          82 FEYVH-TDLCQYMD---KHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKS  154 (303)
T ss_pred             EECCC-cCHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence            99995 67777763   2345688999999999999999999999   99999999999999999999999999987543


Q ss_pred             CCCcccccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCCCCCCccccc-cchhhhHhhhhccchhhHhhh-
Q 018263          199 ENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL-GEYHLVDKAWGMYNSKELMNL-  275 (358)
Q Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~-  275 (358)
                      ... .......++..|+|||++.+ ..++.++||||||+++|+|++|..||...... ..........+......+... 
T Consensus       155 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (303)
T cd07869         155 VPS-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVH  233 (303)
T ss_pred             CCC-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchh
Confidence            222 12233567889999998875 45788999999999999999999999754321 111111111111111100000 


Q ss_pred             -----hccccCCCCCH---------HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          276 -----VDPMLYGNFPE---------NEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       276 -----~~~~~~~~~~~---------~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                           .........+.         ..+..+.+|+.+||+.||.+|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence                 00000000000         12356789999999999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=9.9e-40  Score=294.04  Aligned_cols=269  Identities=27%  Similarity=0.406  Sum_probs=207.2

Q ss_pred             cCC-cccceecccCceEEEEEEE-----CCCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC--
Q 018263           42 NGF-RWSNKIGEGGFGSVYKGRL-----QDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG--  112 (358)
Q Consensus        42 ~~y-~i~~~lg~g~~g~v~~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~--  112 (358)
                      ++| ++.+.||.|+||.||++..     .++..|++|.+.... ......+.+|++.++.++  |||++++++++...  
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~   80 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLY--HENIVKYKGCCSEQGG   80 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCC--CCCEeeEEEEEecCCC
Confidence            455 8999999999999988652     357889999987543 334567888999999998  99999999987653  


Q ss_pred             CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecc
Q 018263          113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG  192 (358)
Q Consensus       113 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg  192 (358)
                      ...+++|||+++++|.+++.     ...+++..++.++.|++.||.|||++   +++|+||+|+||+++.++.++|+|||
T Consensus        81 ~~~~lv~e~~~~~~l~~~~~-----~~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg  152 (283)
T cd05080          81 KGLQLIMEYVPLGSLRDYLP-----KHKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFG  152 (283)
T ss_pred             ceEEEEecCCCCCCHHHHHH-----HcCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecc
Confidence            45789999999999999983     24589999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcc--cccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchh
Q 018263          193 LSKLFPENTTH--ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSK  270 (358)
Q Consensus       193 ~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      ++.........  ......++..|+|||.+.+..++.++||||||+++|+|++|..|+......- ........+.....
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~  231 (283)
T cd05080         153 LAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVV  231 (283)
T ss_pred             cccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchh
Confidence            98865432221  1112335567999999988889999999999999999999999986432210 00010111111122


Q ss_pred             hHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCC
Q 018263          271 ELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGET  321 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~  321 (358)
                      .....++.......+...+..+.+++..||+.+|++|||++++++.|+.+.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         232 RLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            223333333333344556778999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=9.6e-40  Score=290.50  Aligned_cols=256  Identities=29%  Similarity=0.416  Sum_probs=204.9

Q ss_pred             HhhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      +..++|++.+.||.|++|.||++.++.+..+++|.+.... .....+.+|+..++.+.  |+|++++++.+. .+..+++
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~-~~~~~~v   78 (260)
T cd05069           3 IPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLR--HDKLVPLYAVVS-EEPIYIV   78 (260)
T ss_pred             CChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCC--CCCeeeEEEEEc-CCCcEEE
Confidence            3457899999999999999999998777789999876432 34466788999999998  999999998875 4568899


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      |||+++++|.+++...  ....+++..+..++.|++.||.|||+.   |++|+||+|+||++++++.++|+|||.+....
T Consensus        79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~  153 (260)
T cd05069          79 TEFMGKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIE  153 (260)
T ss_pred             EEcCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEcc
Confidence            9999999999998432  234578999999999999999999999   99999999999999999999999999997654


Q ss_pred             CCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhHhhhhc
Q 018263          199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD  277 (358)
Q Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      ...........++..|+|||...+..++.++|+||||+++|+|++ |+.||...........                +.
T Consensus       154 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~----------------~~  217 (260)
T cd05069         154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQ----------------VE  217 (260)
T ss_pred             CCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----------------HH
Confidence            322222222345678999999888889999999999999999999 8999875432111110                11


Q ss_pred             cccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 018263          278 PMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNG  319 (358)
Q Consensus       278 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~  319 (358)
                      .......+...+..+.+++.+||+.+|.+||+++++++.|+.
T Consensus       218 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         218 RGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             cCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            111112234456789999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.4e-40  Score=295.79  Aligned_cols=250  Identities=33%  Similarity=0.539  Sum_probs=197.1

Q ss_pred             cccceecccCceEEEEEEEC-----CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           45 RWSNKIGEGGFGSVYKGRLQ-----DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        45 ~i~~~lg~g~~g~v~~~~~~-----~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      .+.+.||.|.||.||+|.+.     .+..|+||.+.... ......+.+|++.+.+++  ||||+++++++...+..++|
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~--h~ni~~~~g~~~~~~~~~lv   79 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLR--HPNIVKLYGFCIENEPLFLV   79 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHS--BTTBE-EEEEEESSSSEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccc--cccccccccccccccccccc
Confidence            35688999999999999976     36679999996543 334688999999999997  99999999999988889999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      +||+++++|.+++...  ....+++..+..|+.||+.||.|||++   +++|++|+++||+++.++.+||+|||+.....
T Consensus        80 ~e~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~  154 (259)
T PF07714_consen   80 MEYCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPIS  154 (259)
T ss_dssp             EE--TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred             cccccccccccccccc--ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc
Confidence            9999999999999432  346789999999999999999999999   99999999999999999999999999998763


Q ss_pred             CC-CcccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhHhhhh
Q 018263          199 EN-TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV  276 (358)
Q Consensus       199 ~~-~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                      .. .............|+|||.+.+..++.++||||||+++|+|++ |+.||.....                .++...+
T Consensus       155 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~----------------~~~~~~~  218 (259)
T PF07714_consen  155 EKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN----------------EEIIEKL  218 (259)
T ss_dssp             TSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH----------------HHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc----------------ccccccc
Confidence            22 2222333456778999999988889999999999999999999 6788754321                1111222


Q ss_pred             ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 018263          277 DPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMM  317 (358)
Q Consensus       277 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L  317 (358)
                      ........+...+..+.+++..||+.+|.+|||+.+++++|
T Consensus       219 ~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  219 KQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             HTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             cccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            22222334455677899999999999999999999999987

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=6e-40  Score=301.22  Aligned_cols=242  Identities=22%  Similarity=0.311  Sum_probs=195.6

Q ss_pred             CCcccceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      +|++.+.||+|+||.||+|+.. +++.||+|++...   .......+..|...+..+. .|++++.+++++...+..++|
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~~i~~~~~~~~~~~~~~lv   79 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPG-KPPFLTQLHSCFQTMDRLYFV   79 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcC-CCCceeeeEEEEEcCCEEEEE
Confidence            5889999999999999999876 5789999998743   2234456677888888876 355688899999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      |||+++++|.+.+    .....+++..+..++.||+.||+|||++   |++|+||||+||+++.++.++|+|||++....
T Consensus        80 ~E~~~~g~L~~~~----~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  152 (324)
T cd05587          80 MEYVNGGDLMYHI----QQVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENI  152 (324)
T ss_pred             EcCCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecC
Confidence            9999999999998    3445688999999999999999999999   99999999999999999999999999986432


Q ss_pred             CCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhcc
Q 018263          199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDP  278 (358)
Q Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (358)
                      ... .......|+..|+|||++.+..++.++|+||||+++|+|++|+.||...........+               .. 
T Consensus       153 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i---------------~~-  215 (324)
T cd05587         153 FGG-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI---------------ME-  215 (324)
T ss_pred             CCC-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH---------------Hc-
Confidence            111 1223356899999999999989999999999999999999999999754322111111               00 


Q ss_pred             ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 018263          279 MLYGNFPENEAIRFLKVGLLCVQEKSKLRPQM  310 (358)
Q Consensus       279 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~  310 (358)
                       ....++...+..+.+++.+||+.+|.+|++.
T Consensus       216 -~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         216 -HNVSYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             -CCCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence             0122334456678999999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=8.8e-40  Score=305.20  Aligned_cols=258  Identities=24%  Similarity=0.304  Sum_probs=204.2

Q ss_pred             HHHHHHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceE
Q 018263           34 YNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGC  109 (358)
Q Consensus        34 ~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~  109 (358)
                      ..++.+..++|++.+.||+|+||.||++..+ +++.||+|++...   .......+.+|...++.+.  ||||+++++.+
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~--hp~iv~~~~~~  112 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN--SPWVVQLFYAF  112 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC--CCCCCeEEEEE
Confidence            4456666799999999999999999999976 6889999998642   2233455778888888887  99999999999


Q ss_pred             EcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEe
Q 018263          110 IDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKIS  189 (358)
Q Consensus       110 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~  189 (358)
                      ...+..++||||+++++|.+++.     ...+++..+..++.||+.||.|||++   ||+||||||+||+++.++.++|+
T Consensus       113 ~~~~~~~lv~Ey~~gg~L~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~  184 (371)
T cd05622         113 QDDRYLYMVMEYMPGGDLVNLMS-----NYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLA  184 (371)
T ss_pred             EcCCEEEEEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEE
Confidence            99999999999999999999983     33588999999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccCccCccccccC----CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhh
Q 018263          190 DFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG----RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG  265 (358)
Q Consensus       190 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~  265 (358)
                      |||++...............||+.|+|||++.+.    .++.++|||||||++|+|++|..||........+..+     
T Consensus       185 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i-----  259 (371)
T cd05622         185 DFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI-----  259 (371)
T ss_pred             eCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHH-----
Confidence            9999986543333333446799999999998753    3788999999999999999999999855432211111     


Q ss_pred             ccchhhHhhhhccccCCCC--CHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 018263          266 MYNSKELMNLVDPMLYGNF--PENEAIRFLKVGLLCVQEKSKL--RPQMSTAIKM  316 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~P~~--Rpt~~eil~~  316 (358)
                                ........+  ....+..+.++|.+||+.++.+  |++++++++-
T Consensus       260 ----------~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         260 ----------MNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             ----------HcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence                      110000011  1245667889999999844443  7788888863

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7e-40  Score=306.98  Aligned_cols=252  Identities=22%  Similarity=0.292  Sum_probs=198.1

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      ++|++++.||.|+||.||++... +++.||+|++...   .......+..|+.++..+.  ||||+++++++.+....|+
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~--hp~iv~~~~~~~~~~~~~l   78 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD--SPWVVSLYYSFQDAQYLYL   78 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCC--CCCcceEEEEEEcCCeeEE
Confidence            47999999999999999999865 6899999998643   2233456788999999987  9999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      ||||++|++|.+++    .....+++..++.++.|++.||+|||+.   ||+|+||||+||+++.++.++|+|||++..+
T Consensus        79 v~E~~~gg~L~~~l----~~~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~  151 (377)
T cd05629          79 IMEFLPGGDLMTML----IKYDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGF  151 (377)
T ss_pred             EEeCCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccc
Confidence            99999999999998    3456789999999999999999999999   9999999999999999999999999998532


Q ss_pred             CCCCc------------c----------------------------------cccccccccCccCccccccCCCCccCce
Q 018263          198 PENTT------------H----------------------------------ISTRVAGTLGYLAPEYAISGRLTRKSDV  231 (358)
Q Consensus       198 ~~~~~------------~----------------------------------~~~~~~~~~~y~aPE~~~~~~~s~~sDi  231 (358)
                      .....            .                                  ......||+.|+|||++.+..++.++||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di  231 (377)
T cd05629         152 HKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDW  231 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceee
Confidence            11000            0                                  0012458999999999988899999999


Q ss_pred             ecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCC---C
Q 018263          232 YSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLR---P  308 (358)
Q Consensus       232 wslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R---p  308 (358)
                      |||||++|+|++|..||........+..+...            ......+ .....+..+.++|.+||+ +|.+|   +
T Consensus       232 wSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------~~~~~~p-~~~~~s~~~~dli~~lL~-~~~~r~~r~  297 (377)
T cd05629         232 WSLGAIMFECLIGWPPFCSENSHETYRKIINW------------RETLYFP-DDIHLSVEAEDLIRRLIT-NAENRLGRG  297 (377)
T ss_pred             EecchhhhhhhcCCCCCCCCCHHHHHHHHHcc------------CCccCCC-CCCCCCHHHHHHHHHHhc-CHhhcCCCC
Confidence            99999999999999999755432221111100            0000000 011245678899999998 67665   5


Q ss_pred             CHHHHHHH
Q 018263          309 QMSTAIKM  316 (358)
Q Consensus       309 t~~eil~~  316 (358)
                      ++.++++.
T Consensus       298 ~~~~~l~h  305 (377)
T cd05629         298 GAHEIKSH  305 (377)
T ss_pred             CHHHHhcC
Confidence            99998764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.5e-39  Score=289.19  Aligned_cols=257  Identities=26%  Similarity=0.422  Sum_probs=207.3

Q ss_pred             HHhhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           38 KIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        38 ~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      .+..++|++.+.||+|++|.||++....+..+++|.+... ......+.+|+..++.++  |+|++++.+.+.. ...++
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~-~~~~~   77 (260)
T cd05073           2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQ--HDKLVKLHAVVTK-EPIYI   77 (260)
T ss_pred             cccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcC--CCCcceEEEEEcC-CCeEE
Confidence            4567899999999999999999999877888999988643 334467888999999988  9999999999887 77899


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      +|||+++++|.+++...  ....+++..+..++.|++.||.+||+.   |++|+||+|+||+++.++.++|+|||.+...
T Consensus        78 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~  152 (260)
T cd05073          78 ITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVI  152 (260)
T ss_pred             EEEeCCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeec
Confidence            99999999999999432  244578899999999999999999999   9999999999999999999999999998765


Q ss_pred             CCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhHhhhh
Q 018263          198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV  276 (358)
Q Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                      ............++..|+|||++.+..++.++|+||||+++|++++ |+.||.........   .             .+
T Consensus       153 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~---~-------------~~  216 (260)
T cd05073         153 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI---R-------------AL  216 (260)
T ss_pred             cCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHH---H-------------HH
Confidence            4322222222345677999999988889999999999999999998 99998744321111   1             11


Q ss_pred             ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 018263          277 DPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNG  319 (358)
Q Consensus       277 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~  319 (358)
                      ........+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus       217 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         217 ERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             hCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            1111112223456679999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=6.5e-40  Score=294.29  Aligned_cols=261  Identities=26%  Similarity=0.389  Sum_probs=204.6

Q ss_pred             HHhhcCCcccceecccCceEEEEEEEC------CCCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEE
Q 018263           38 KIATNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCI  110 (358)
Q Consensus        38 ~~~~~~y~i~~~lg~g~~g~v~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~  110 (358)
                      .+..++|++.+.||+|++|.||.|.+.      .+..|++|.+... .......+.+|+..++.+.  |||++++++++.
T Consensus         2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~--~~~iv~~~~~~~   79 (277)
T cd05062           2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN--CHHVVRLLGVVS   79 (277)
T ss_pred             cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCC--CCCeeeEEEEEc
Confidence            346788999999999999999998753      3567999987543 2334456888999999987  999999999999


Q ss_pred             cCCeeEEEEecCCCCCHHHHhhhcccc------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCC
Q 018263          111 DGPCRILVYDYMPNNSLSQTLLGEEKR------RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF  184 (358)
Q Consensus       111 ~~~~~~iv~e~~~~~~L~~~l~~~~~~------~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~  184 (358)
                      .....++||||+++++|.+++......      ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~  156 (277)
T cd05062          80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF  156 (277)
T ss_pred             CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCC
Confidence            999999999999999999998543211      23467888999999999999999999   999999999999999999


Q ss_pred             ceEEeecccccccCCCCccc-ccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHh
Q 018263          185 NPKISDFGLSKLFPENTTHI-STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDK  262 (358)
Q Consensus       185 ~~~l~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~  262 (358)
                      .++|+|||++.......... .....++..|+|||++.+..++.++|+||||+++|+|++ |..||...........+  
T Consensus       157 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~--  234 (277)
T cd05062         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV--  234 (277)
T ss_pred             CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH--
Confidence            99999999987543222111 112345678999999988889999999999999999999 78888644321111110  


Q ss_pred             hhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 018263          263 AWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNG  319 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~  319 (358)
                                   . .......+...+..+.+++.+||+.+|++|||+.|+++.|+.
T Consensus       235 -------------~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         235 -------------M-EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             -------------H-cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence                         0 001112233455678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=8.3e-40  Score=300.14  Aligned_cols=242  Identities=23%  Similarity=0.346  Sum_probs=196.3

Q ss_pred             cceecccCceEEEEEEE----CCCCEEEEEEeecc----ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           47 SNKIGEGGFGSVYKGRL----QDGTIVAVKVLSVE----SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        47 ~~~lg~g~~g~v~~~~~----~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      ++.||+|+||.||+++.    .+++.||+|++...    .......+..|+.+++.++  ||||+++++.+..++..++|
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~--hp~iv~~~~~~~~~~~~~lv   78 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK--HPFIVDLIYAFQTGGKLYLI   78 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCC--CCchhceeeEEecCCeEEEE
Confidence            46899999999999985    35889999998643    2233456778999999998  99999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      |||+++++|.+.+    ...+.+++..+..++.||+.||.|||++   |++|+||||+||+++.++.++|+|||++....
T Consensus        79 ~e~~~~~~L~~~~----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  151 (323)
T cd05584          79 LEYLSGGELFMHL----EREGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESI  151 (323)
T ss_pred             EeCCCCchHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecc
Confidence            9999999999998    3456788999999999999999999999   99999999999999999999999999987432


Q ss_pred             CCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhcc
Q 018263          199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDP  278 (358)
Q Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (358)
                      .... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||..........               .+...
T Consensus       152 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~---------------~~~~~  215 (323)
T cd05584         152 HEGT-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTID---------------KILKG  215 (323)
T ss_pred             cCCC-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHH---------------HHHcC
Confidence            2221 2233568999999999988889999999999999999999999997543221111               11111


Q ss_pred             ccCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 018263          279 MLYGNFPENEAIRFLKVGLLCVQEKSKLRP-----QMSTAIK  315 (358)
Q Consensus       279 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp-----t~~eil~  315 (358)
                        ....+...+..+.+++.+||+.+|++||     +++++++
T Consensus       216 --~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         216 --KLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             --CCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence              1123334566789999999999999999     7777765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=7.5e-40  Score=307.61  Aligned_cols=268  Identities=23%  Similarity=0.349  Sum_probs=211.2

Q ss_pred             HHHHHhhcCCcccceecccCceEEEEEEEC------CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeec
Q 018263           35 NQLKIATNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHG  107 (358)
Q Consensus        35 ~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~  107 (358)
                      ..+....++|++.+.||.|+||.||+|.+.      .+..||+|.+.... ......+..|+..+..+. .||||+++++
T Consensus        30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~-~HpnIv~l~~  108 (400)
T cd05105          30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLG-PHLNIVNLLG  108 (400)
T ss_pred             CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCCeeeEEE
Confidence            355666889999999999999999999853      23479999986543 334467889999999984 4999999999


Q ss_pred             eEEcCCeeEEEEecCCCCCHHHHhhhccc---------------------------------------------------
Q 018263          108 GCIDGPCRILVYDYMPNNSLSQTLLGEEK---------------------------------------------------  136 (358)
Q Consensus       108 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~---------------------------------------------------  136 (358)
                      ++......++||||+++++|.+++.....                                                   
T Consensus       109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (400)
T cd05105         109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY  188 (400)
T ss_pred             EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence            99999999999999999999998854211                                                   


Q ss_pred             -----------------------------------------cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCC
Q 018263          137 -----------------------------------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKT  175 (358)
Q Consensus       137 -----------------------------------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p  175 (358)
                                                               ....+++..+..++.||+.||+|||+.   +++|+||+|
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp  265 (400)
T cd05105         189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAA  265 (400)
T ss_pred             chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCh
Confidence                                                     013477888999999999999999999   999999999


Q ss_pred             CcEEEcCCCceEEeecccccccCCCCcc-cccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCcccc
Q 018263          176 SNILLDQNFNPKISDFGLSKLFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ  253 (358)
Q Consensus       176 ~Nilv~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~  253 (358)
                      +||+++.++.++|+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus       266 ~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~  345 (400)
T cd05105         266 RNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV  345 (400)
T ss_pred             HhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch
Confidence            9999999999999999998764322221 1122346678999999988889999999999999999997 8999864322


Q ss_pred             ccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCC
Q 018263          254 LGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGET  321 (358)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~  321 (358)
                      ....               ...+........+...+..+.+++.+||+.+|++|||+.+|.+.|+.+.
T Consensus       346 ~~~~---------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         346 DSTF---------------YNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             hHHH---------------HHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence            1111               1111111112233455678999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.5e-40  Score=293.34  Aligned_cols=261  Identities=25%  Similarity=0.382  Sum_probs=208.4

Q ss_pred             HHhhcCCcccceecccCceEEEEEEEC------CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEE
Q 018263           38 KIATNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCI  110 (358)
Q Consensus        38 ~~~~~~y~i~~~lg~g~~g~v~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~  110 (358)
                      .+..++|++.+.||.|+||.||++..+      .+..|++|.+.... ......+.+|+..++.+.  |||++++++++.
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~~~~~~~   79 (277)
T cd05032           2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFN--CHHVVRLLGVVS   79 (277)
T ss_pred             ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCC--CCceeEEEEEEc
Confidence            356789999999999999999999864      24689999986442 344567888999999987  999999999999


Q ss_pred             cCCeeEEEEecCCCCCHHHHhhhccc------cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCC
Q 018263          111 DGPCRILVYDYMPNNSLSQTLLGEEK------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF  184 (358)
Q Consensus       111 ~~~~~~iv~e~~~~~~L~~~l~~~~~------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~  184 (358)
                      .....++||||+++++|.+++.....      ....+++..+..++.|++.||.|||++   +++|+||+|+||+++.++
T Consensus        80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~  156 (277)
T cd05032          80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDL  156 (277)
T ss_pred             CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCC
Confidence            99999999999999999999854322      123478899999999999999999999   999999999999999999


Q ss_pred             ceEEeecccccccCCCCc-ccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHh
Q 018263          185 NPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDK  262 (358)
Q Consensus       185 ~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~  262 (358)
                      .++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |+.||.........     
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~-----  231 (277)
T cd05032         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVL-----  231 (277)
T ss_pred             CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHH-----
Confidence            999999999876533221 11223345778999999988889999999999999999998 99998643321111     


Q ss_pred             hhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 018263          263 AWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNG  319 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~  319 (358)
                                 ..+........+...+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus       232 -----------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         232 -----------KFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             -----------HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence                       1111111122334456789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3.9e-40  Score=308.58  Aligned_cols=252  Identities=25%  Similarity=0.273  Sum_probs=198.6

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      ++|++++.||+|+||.||+|+.. +++.||+|++....   ......+.+|+.++..+.  |+||+++++.+...+..++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~--h~~iv~~~~~~~~~~~~~l   78 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD--NEWVVKLYYSFQDKDNLYF   78 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCC--CCCcceEEEEEEcCCEEEE
Confidence            47999999999999999999965 68999999986432   233456788999999998  9999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      ||||+++++|.+++    ...+.+++..++.++.||+.||+|||++   ||+||||||+||+++.++.++|+|||++..+
T Consensus        79 v~E~~~~g~L~~~i----~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~  151 (376)
T cd05598          79 VMDYIPGGDMMSLL----IRLGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGF  151 (376)
T ss_pred             EEeCCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence            99999999999999    3456789999999999999999999999   9999999999999999999999999987432


Q ss_pred             CCCC------------------------------------------cccccccccccCccCccccccCCCCccCceecHH
Q 018263          198 PENT------------------------------------------THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFG  235 (358)
Q Consensus       198 ~~~~------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG  235 (358)
                      ....                                          ........|++.|+|||++.+..++.++||||||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  231 (376)
T cd05598         152 RWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  231 (376)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecc
Confidence            1000                                          0001124689999999999988999999999999


Q ss_pred             HHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCC---CHHH
Q 018263          236 VLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRP---QMST  312 (358)
Q Consensus       236 ~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp---t~~e  312 (358)
                      |++|+|++|+.||...........+...             ............+..+.++|.+|+ .+|.+|+   ++.+
T Consensus       232 vilyell~G~~Pf~~~~~~~~~~~i~~~-------------~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~e  297 (376)
T cd05598         232 VILYEMLVGQPPFLADTPAETQLKVINW-------------ETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADE  297 (376)
T ss_pred             ceeeehhhCCCCCCCCCHHHHHHHHhcc-------------CccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHH
Confidence            9999999999999765432221111000             000001111234556778888876 4999999   8888


Q ss_pred             HHHH
Q 018263          313 AIKM  316 (358)
Q Consensus       313 il~~  316 (358)
                      +++-
T Consensus       298 ll~h  301 (376)
T cd05598         298 IKAH  301 (376)
T ss_pred             HhCC
Confidence            8754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=8.2e-40  Score=304.94  Aligned_cols=253  Identities=21%  Similarity=0.291  Sum_probs=196.7

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      ++|++.+.||+|+||.||+|... +++.||+|++....   ......+..|+..+..++  |+||+++++.+.+....++
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~--~~~iv~~~~~~~~~~~~~l   78 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEAD--SLWVVKMFYSFQDKLNLYL   78 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCC--CCCcceEEEEEecCCeEEE
Confidence            57999999999999999999865 58999999986432   233456778999999987  9999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      ||||++|++|.+++    ...+.+++..+..++.|++.||+|||++   ||+||||||+||+++.++.++|+|||++...
T Consensus        79 v~E~~~gg~L~~~l----~~~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~  151 (363)
T cd05628          79 IMEFLPGGDMMTLL----MKKDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGL  151 (363)
T ss_pred             EEcCCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccc
Confidence            99999999999999    3456789999999999999999999999   9999999999999999999999999998754


Q ss_pred             CCCCc----------------------------------ccccccccccCccCccccccCCCCccCceecHHHHHHHHHh
Q 018263          198 PENTT----------------------------------HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS  243 (358)
Q Consensus       198 ~~~~~----------------------------------~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt  243 (358)
                      .....                                  .......||+.|+|||++.+..++.++|||||||++|+|++
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~  231 (363)
T cd05628         152 KKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI  231 (363)
T ss_pred             cccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHh
Confidence            21100                                  00123468999999999998899999999999999999999


Q ss_pred             CCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccC--CCCCCCCCHHHHHHH
Q 018263          244 GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQ--EKSKLRPQMSTAIKM  316 (358)
Q Consensus       244 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~--~~P~~Rpt~~eil~~  316 (358)
                      |+.||........+..+....            .....+. ....+..+.+++.+++.  .++..||+++||++-
T Consensus       232 G~~Pf~~~~~~~~~~~i~~~~------------~~~~~p~-~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         232 GYPPFCSETPQETYKKVMNWK------------ETLIFPP-EVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCCCCCCCHHHHHHHHHcCc------------CcccCCC-cCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            999997654322221111100            0000000 01134456677777554  234456899999763

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=4.5e-40  Score=302.16  Aligned_cols=241  Identities=25%  Similarity=0.313  Sum_probs=195.6

Q ss_pred             ceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecCC
Q 018263           48 NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP  123 (358)
Q Consensus        48 ~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~~  123 (358)
                      +.||+|+||.||++... +|+.||+|++...   .......+..|+..+..+.  ||||+++.+.+...+..++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~--hp~i~~~~~~~~~~~~~~lv~E~~~   78 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR--HPFLTALKYSFQTHDRLCFVMEYAN   78 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC--CCCCCceEEEEEcCCEEEEEEeCCC
Confidence            46899999999999865 6899999998753   2233456677888888887  9999999999999999999999999


Q ss_pred             CCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCc
Q 018263          124 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT  202 (358)
Q Consensus       124 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~  202 (358)
                      +++|...+    .....+++..+..++.||+.||+|||+ .   |++|+||||+||+++.++.++|+|||++........
T Consensus        79 ~~~L~~~l----~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~  151 (325)
T cd05594          79 GGELFFHL----SRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA  151 (325)
T ss_pred             CCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc
Confidence            99999888    345578999999999999999999997 7   999999999999999999999999999875322111


Q ss_pred             ccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccCC
Q 018263          203 HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYG  282 (358)
Q Consensus       203 ~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (358)
                       ......|+..|+|||++.+..++.++||||||+++|+|++|+.||...........+               ...  ..
T Consensus       152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i---------------~~~--~~  213 (325)
T cd05594         152 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI---------------LME--EI  213 (325)
T ss_pred             -ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH---------------hcC--CC
Confidence             223356899999999998889999999999999999999999999754322111111               000  11


Q ss_pred             CCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 018263          283 NFPENEAIRFLKVGLLCVQEKSKLRP-----QMSTAIK  315 (358)
Q Consensus       283 ~~~~~~~~~l~~li~~~l~~~P~~Rp-----t~~eil~  315 (358)
                      .++...+..+.+++.+||+.||.+|+     ++.++++
T Consensus       214 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         214 RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence            23334566789999999999999997     8998875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-39  Score=287.98  Aligned_cols=252  Identities=29%  Similarity=0.426  Sum_probs=207.9

Q ss_pred             hhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      ..++|++.+.||.|++|.||+|... |+.|++|.+..... ..+++..|+..+..++  |+|++++++.+......++||
T Consensus         4 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~~v~   79 (256)
T cd05039           4 NSKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLR--HPNLVQLLGVVLQGNPLYIVT   79 (256)
T ss_pred             ChhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcC--CcceeeeEEEEcCCCCeEEEE
Confidence            4678999999999999999999876 78899999875544 5677889999999998  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      ||+++++|.+++...  ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        80 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~  154 (256)
T cd05039          80 EYMAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ  154 (256)
T ss_pred             EecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccc
Confidence            999999999998432  223689999999999999999999999   999999999999999999999999999986532


Q ss_pred             CCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhHhhhhcc
Q 018263          200 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDP  278 (358)
Q Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (358)
                      ...    ....+..|.|||.+.+..++.++|+||||+++++|++ |..||.......                ....+..
T Consensus       155 ~~~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----------------~~~~~~~  214 (256)
T cd05039         155 GQD----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----------------VVPHVEK  214 (256)
T ss_pred             ccc----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH----------------HHHHHhc
Confidence            211    2334567999999988889999999999999999997 999986442211                1111111


Q ss_pred             ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 018263          279 MLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE  320 (358)
Q Consensus       279 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~  320 (358)
                      ......+...+..+.+++.+||+.+|++|||+.+++++|+++
T Consensus       215 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         215 GYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             CCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence            112222334567799999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.1e-39  Score=298.42  Aligned_cols=241  Identities=23%  Similarity=0.305  Sum_probs=190.9

Q ss_pred             ceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecCC
Q 018263           48 NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP  123 (358)
Q Consensus        48 ~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~~  123 (358)
                      +.||+|+||.||+|+.. +++.||+|++....   .........|...+.... .||||+++++++......++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~hp~i~~~~~~~~~~~~~~lv~e~~~   79 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAW-EHPFLTHLFCTFQTKEHLFFVMEYLN   79 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhcc-CCCCccceeeEEEcCCEEEEEEcCCC
Confidence            46999999999999975 58899999987532   222334445555555442 49999999999999999999999999


Q ss_pred             CCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCcc
Q 018263          124 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH  203 (358)
Q Consensus       124 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  203 (358)
                      |++|.+.+    .....+++..+..++.||+.||.|||++   +|+|+||+|+||+++.++.++|+|||++....... .
T Consensus        80 gg~L~~~~----~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~  151 (316)
T cd05592          80 GGDLMFHI----QSSGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-G  151 (316)
T ss_pred             CCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-C
Confidence            99999998    3445789999999999999999999999   99999999999999999999999999987542222 2


Q ss_pred             cccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCC
Q 018263          204 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGN  283 (358)
Q Consensus       204 ~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (358)
                      ......|+..|+|||++.+..++.++||||||+++|+|++|+.||...........   +            ..  ....
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~---i------------~~--~~~~  214 (316)
T cd05592         152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDS---I------------LN--DRPH  214 (316)
T ss_pred             ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHH---H------------Hc--CCCC
Confidence            22345689999999999988899999999999999999999999975432111111   1            00  1122


Q ss_pred             CCHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 018263          284 FPENEAIRFLKVGLLCVQEKSKLRPQMS-TAI  314 (358)
Q Consensus       284 ~~~~~~~~l~~li~~~l~~~P~~Rpt~~-eil  314 (358)
                      ++...+..+.+++.+||+.+|.+||++. +++
T Consensus       215 ~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         215 FPRWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            3344566788999999999999999875 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=7.2e-40  Score=302.07  Aligned_cols=265  Identities=25%  Similarity=0.380  Sum_probs=205.8

Q ss_pred             HHhhcCCcccceecccCceEEEEEEEC------CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEE
Q 018263           38 KIATNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCI  110 (358)
Q Consensus        38 ~~~~~~y~i~~~lg~g~~g~v~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~  110 (358)
                      .+..++|++.+.||.|+||.||+|...      +++.|++|++.... ......+..|+..+..+. .|+||+++++.+.
T Consensus         3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~-~h~niv~~~~~~~   81 (337)
T cd05054           3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIG-HHLNVVNLLGACT   81 (337)
T ss_pred             ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhc-cCcchhheeeeEe
Confidence            345679999999999999999999632      35789999986432 233456778999999883 3999999999876


Q ss_pred             c-CCeeEEEEecCCCCCHHHHhhhcccc----------------------------------------------------
Q 018263          111 D-GPCRILVYDYMPNNSLSQTLLGEEKR----------------------------------------------------  137 (358)
Q Consensus       111 ~-~~~~~iv~e~~~~~~L~~~l~~~~~~----------------------------------------------------  137 (358)
                      . ....++++||+++++|.+++......                                                    
T Consensus        82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (337)
T cd05054          82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE  161 (337)
T ss_pred             cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence            4 45678999999999999998532111                                                    


Q ss_pred             -----ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCcc-cccccccc
Q 018263          138 -----RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH-ISTRVAGT  211 (358)
Q Consensus       138 -----~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~  211 (358)
                           ...+++..+..++.||+.||.|||++   ||+|+||||+||+++.++.++|+|||++......... ......++
T Consensus       162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~  238 (337)
T cd05054         162 GDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP  238 (337)
T ss_pred             hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence                 13678999999999999999999999   9999999999999999999999999999865332221 11223456


Q ss_pred             cCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHH
Q 018263          212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAI  290 (358)
Q Consensus       212 ~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (358)
                      ..|+|||++.+..++.++|||||||++|+|++ |..||......+..               ...+........+...+.
T Consensus       239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~  303 (337)
T cd05054         239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEF---------------CRRLKEGTRMRAPEYATP  303 (337)
T ss_pred             ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHH---------------HHHHhccCCCCCCccCCH
Confidence            78999999999999999999999999999998 99998653221111               111111111122334556


Q ss_pred             HHHHHHhhccCCCCCCCCCHHHHHHHhhcCC
Q 018263          291 RFLKVGLLCVQEKSKLRPQMSTAIKMMNGET  321 (358)
Q Consensus       291 ~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~  321 (358)
                      .+.+++.+||+.+|++||++.++++.|+.+-
T Consensus       304 ~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~  334 (337)
T cd05054         304 EIYSIMLDCWHNNPEDRPTFSELVEILGDLL  334 (337)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            7999999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.2e-39  Score=289.12  Aligned_cols=260  Identities=23%  Similarity=0.359  Sum_probs=210.4

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      ++|++.+.||.|++|.||++... +++.|++|.+...   .......+.+|+..++.+.  |+|++++++.+...+..++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~--h~~i~~~~~~~~~~~~~~~   79 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN--HPNVIKYYASFIEDNELNI   79 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHcc--CCchhhhhheeEeCCeEEE
Confidence            57899999999999999999964 7899999987643   2334467888999999987  9999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      +|||+++++|.+++.........+++..++.++.||+.||.|||++   |++|+||+|+||+++.++.++++|||++...
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd08229          80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence            9999999999999864444456789999999999999999999999   9999999999999999999999999988765


Q ss_pred             CCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhc
Q 018263          198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD  277 (358)
Q Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      ...... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ....             ...+.
T Consensus       157 ~~~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~-------------~~~~~  221 (267)
T cd08229         157 SSKTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSL-------------CKKIE  221 (267)
T ss_pred             ccCCcc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-HHHH-------------hhhhh
Confidence            332221 12345788999999998888999999999999999999999998643221 0000             00111


Q ss_pred             ccc-CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCC
Q 018263          278 PML-YGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGET  321 (358)
Q Consensus       278 ~~~-~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~  321 (358)
                      ... ........+..+.+++.+||+.+|++|||+.+|++.+.+..
T Consensus       222 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         222 QCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             cCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            111 11122346678999999999999999999999999988753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.2e-39  Score=296.45  Aligned_cols=241  Identities=22%  Similarity=0.285  Sum_probs=191.2

Q ss_pred             ceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecCC
Q 018263           48 NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP  123 (358)
Q Consensus        48 ~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~~  123 (358)
                      +.||+|+||.||+|+++ +|+.||+|.+....   .........|...+.... .||||+++++.+...+..++||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~~i~~~~~~~~~~~~~~lv~E~~~   79 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAW-ENPFLTHLYCTFQTKEHLFFVMEFLN   79 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhcc-CCCCccCeeEEEEeCCEEEEEECCCC
Confidence            46999999999999976 68899999987532   223344556666666542 49999999999999999999999999


Q ss_pred             CCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCcc
Q 018263          124 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH  203 (358)
Q Consensus       124 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  203 (358)
                      +++|.+.+    .....+++..+..++.||+.||+|||++   |++|+||||+||+++.++.++|+|||++...... ..
T Consensus        80 ~g~L~~~i----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~  151 (316)
T cd05620          80 GGDLMFHI----QDKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DN  151 (316)
T ss_pred             CCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CC
Confidence            99999988    3446789999999999999999999999   9999999999999999999999999998643211 11


Q ss_pred             cccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCC
Q 018263          204 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGN  283 (358)
Q Consensus       204 ~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (358)
                      ......|+..|+|||++.+..++.++||||||+++|+|++|+.||.........   ..+.             . ....
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~---~~~~-------------~-~~~~  214 (316)
T cd05620         152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELF---ESIR-------------V-DTPH  214 (316)
T ss_pred             ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH---HHHH-------------h-CCCC
Confidence            223456899999999999989999999999999999999999999754321111   1110             0 0112


Q ss_pred             CCHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 018263          284 FPENEAIRFLKVGLLCVQEKSKLRPQMS-TAI  314 (358)
Q Consensus       284 ~~~~~~~~l~~li~~~l~~~P~~Rpt~~-eil  314 (358)
                      ++...+..+.+++.+||+.||++||++. +++
T Consensus       215 ~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         215 YPRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            2333556788999999999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-40  Score=294.99  Aligned_cols=266  Identities=24%  Similarity=0.320  Sum_probs=211.3

Q ss_pred             HHHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC--------------hhhHHHHHHHHHHhhhcccCCCC
Q 018263           37 LKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--------------KQGEKEFMSEVASMANVNVCHEN  101 (358)
Q Consensus        37 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~--------------~~~~~~~~~e~~~l~~l~~~h~~  101 (358)
                      -.+-.++|++.+.||+|.+|.|-+|+.. +++.||||++....              ....+.+.+|+.+++++.  |||
T Consensus        92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~--H~n  169 (576)
T KOG0585|consen   92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH--HPN  169 (576)
T ss_pred             cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC--CcC
Confidence            3444689999999999999999999965 69999999985431              112357889999999998  999


Q ss_pred             ceeeeceEEcC--CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEE
Q 018263          102 LVKLHGGCIDG--PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL  179 (358)
Q Consensus       102 i~~~~~~~~~~--~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nil  179 (358)
                      ||+++++..+.  +.+|+|+|||..|.+...=    .....+++.++++++.+++.||.|||.+   ||+||||||+|+|
T Consensus       170 VV~LiEvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLL  242 (576)
T KOG0585|consen  170 VVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLL  242 (576)
T ss_pred             eeEEEEeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheE
Confidence            99999998764  5789999999888766553    2333399999999999999999999999   9999999999999


Q ss_pred             EcCCCceEEeecccccccCCC----CcccccccccccCccCccccccCC----CCccCceecHHHHHHHHHhCCCCCCcc
Q 018263          180 LDQNFNPKISDFGLSKLFPEN----TTHISTRVAGTLGYLAPEYAISGR----LTRKSDVYSFGVLLLEIVSGRTAVDFD  251 (358)
Q Consensus       180 v~~~~~~~l~Dfg~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~----~s~~sDiwslG~il~~lltg~~pf~~~  251 (358)
                      ++.+|.+||+|||.+..+...    .........||+.|+|||...++.    .+.+.||||+|++||+|+.|+.||..+
T Consensus       243 l~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~  322 (576)
T KOG0585|consen  243 LSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD  322 (576)
T ss_pred             EcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc
Confidence            999999999999999876322    122223368999999999887632    357899999999999999999999866


Q ss_pred             ccccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCCCC
Q 018263          252 VQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNIDGX  326 (358)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~~~  326 (358)
                      .....+..+               +...+.-.-.++....+.+||.+||+.||++|.+..+|....=-.++.+++
T Consensus       323 ~~~~l~~KI---------------vn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~  382 (576)
T KOG0585|consen  323 FELELFDKI---------------VNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSP  382 (576)
T ss_pred             hHHHHHHHH---------------hcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCC
Confidence            543333322               222222122234677899999999999999999999998777666665544

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.9e-39  Score=287.11  Aligned_cols=247  Identities=26%  Similarity=0.380  Sum_probs=198.5

Q ss_pred             ceecccCceEEEEEEEC-CCCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecCCCC
Q 018263           48 NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN  125 (358)
Q Consensus        48 ~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~~~~  125 (358)
                      +.||.|++|.||+|... +++.|++|..... .......+.+|++.++.+.  ||||+++++++......++||||++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYS--HPNIVRLIGVCTQKQPIYIVMELVQGG   78 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCC--CCCcceEEEEEcCCCCeEEEEeeccCC
Confidence            46899999999999875 6889999987543 3445567889999999987  999999999999999999999999999


Q ss_pred             CHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCcccc
Q 018263          126 SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS  205 (358)
Q Consensus       126 ~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~  205 (358)
                      +|.+++..   ....+++..++.++.|++.||.|||++   +++|+||+|+||+++.++.++|+|||.+...........
T Consensus        79 ~L~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  152 (252)
T cd05084          79 DFLTFLRT---EGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST  152 (252)
T ss_pred             cHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence            99999832   234688999999999999999999999   999999999999999999999999999875432211111


Q ss_pred             -cccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCC
Q 018263          206 -TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGN  283 (358)
Q Consensus       206 -~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (358)
                       .....+..|+|||.+.+..++.++|+||||+++|+|++ |..||......                .....+.......
T Consensus       153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~----------------~~~~~~~~~~~~~  216 (252)
T cd05084         153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ----------------QTREAIEQGVRLP  216 (252)
T ss_pred             CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH----------------HHHHHHHcCCCCC
Confidence             11123457999999988889999999999999999998 88888643221                1111111222223


Q ss_pred             CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 018263          284 FPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN  318 (358)
Q Consensus       284 ~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~  318 (358)
                      .+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       217 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         217 CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            34455678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.1e-39  Score=306.26  Aligned_cols=251  Identities=24%  Similarity=0.282  Sum_probs=196.5

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      .+|++++.||+|+||.||+|+.. +++.||+|++....   ......+..|+.+++.+.  ||||+++++.+...+..++
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~--h~~iv~~~~~~~~~~~~~l   78 (382)
T cd05625           1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD--NEWVVRLYYSFQDKDNLYF   78 (382)
T ss_pred             CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCC--CCcCCeEEEEEEeCCEEEE
Confidence            36899999999999999999865 68899999986432   334467888999999988  9999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      ||||+++++|.+++.    ..+.+++..+..++.||+.||+|||++   ||+||||||+||+++.++.++|+|||++...
T Consensus        79 v~E~~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~  151 (382)
T cd05625          79 VMDYIPGGDMMSLLI----RMGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGF  151 (382)
T ss_pred             EEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence            999999999999983    345789999999999999999999999   9999999999999999999999999987532


Q ss_pred             CCCC----------------------------------------------cccccccccccCccCccccccCCCCccCce
Q 018263          198 PENT----------------------------------------------THISTRVAGTLGYLAPEYAISGRLTRKSDV  231 (358)
Q Consensus       198 ~~~~----------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~s~~sDi  231 (358)
                      ....                                              ........||+.|+|||++.+..++.++||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Di  231 (382)
T cd05625         152 RWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW  231 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeE
Confidence            1000                                              000112468999999999998899999999


Q ss_pred             ecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCC--
Q 018263          232 YSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQ--  309 (358)
Q Consensus       232 wslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt--  309 (358)
                      |||||++|+|++|+.||...........+..             .............+....++|.+|+ .+|.+|++  
T Consensus       232 wSlGvil~elltG~~Pf~~~~~~~~~~~i~~-------------~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~  297 (382)
T cd05625         232 WSVGVILYEMLVGQPPFLAQTPLETQMKVIN-------------WQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKN  297 (382)
T ss_pred             EechHHHHHHHhCCCCCCCCCHHHHHHHHHc-------------cCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCC
Confidence            9999999999999999975543211111100             0000111111234566778888876 49999997  


Q ss_pred             -HHHHHH
Q 018263          310 -MSTAIK  315 (358)
Q Consensus       310 -~~eil~  315 (358)
                       +.++++
T Consensus       298 ~~~ei~~  304 (382)
T cd05625         298 GADEIKA  304 (382)
T ss_pred             CHHHHhc
Confidence             777664

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=4.3e-39  Score=285.21  Aligned_cols=250  Identities=26%  Similarity=0.428  Sum_probs=206.3

Q ss_pred             CCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      +|.+.+.||+|++|.||+|..+ +++.|++|.+...  .......+..|++.++.++  |||++++++.+...+..+++|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLD--SSYIIRYYESFLDKGKLNIVM   78 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcC--CCCeehheeeeccCCEEEEEE
Confidence            4788999999999999999975 6899999998643  3445667888999999988  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      ||+++++|.+++...  ....+++..++.++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++.....
T Consensus        79 e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~  153 (256)
T cd08529          79 EYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD  153 (256)
T ss_pred             EeCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccC
Confidence            999999999998432  245788999999999999999999999   999999999999999999999999999886543


Q ss_pred             CCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccc
Q 018263          200 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPM  279 (358)
Q Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (358)
                      .... .....++..|+|||++.+..++.++|+||||+++++|++|+.||.......   ...            ... ..
T Consensus       154 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~------------~~~-~~  216 (256)
T cd08529         154 NTNF-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA---LIL------------KII-RG  216 (256)
T ss_pred             ccch-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHH------------HHH-cC
Confidence            3222 223457889999999998889999999999999999999999997554211   110            111 11


Q ss_pred             cCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 018263          280 LYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKM  316 (358)
Q Consensus       280 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~  316 (358)
                      .....+...+..+.+++.+||+.+|++||++.++++.
T Consensus       217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         217 VFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             CCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            1222333566789999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=9.7e-40  Score=297.88  Aligned_cols=264  Identities=25%  Similarity=0.367  Sum_probs=205.3

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      ++|++.+.||+|+||.||+|+.+ +++.||+|.+.... ......+.+|+..++.++  ||||+++++++...+..++||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~   83 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLK--HANIVTLHDIVHTDKSLTLVF   83 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCC--CCCcceEEEEEeeCCeEEEEE
Confidence            68999999999999999999876 68889999986543 233346778999999998  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      ||+++ +|.+.+..   ....+++..+..++.||+.||+|||++   |++||||+|+||+++.++.++|+|||++.....
T Consensus        84 e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  156 (309)
T cd07872          84 EYLDK-DLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSV  156 (309)
T ss_pred             eCCCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCC
Confidence            99964 78877732   334578999999999999999999999   999999999999999999999999999875432


Q ss_pred             CCcccccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhcc
Q 018263          200 NTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDP  278 (358)
Q Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (358)
                      ... ......++..|+|||++.+ ..++.++||||||+++|+|++|+.||......+....+....+.+....+..+...
T Consensus       157 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
T cd07872         157 PTK-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSN  235 (309)
T ss_pred             Ccc-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcch
Confidence            222 1223457889999998865 46889999999999999999999999876655544444433333222222211110


Q ss_pred             ------ccCC-------CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          279 ------MLYG-------NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       279 ------~~~~-------~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                            ....       ......+..+.+++.+||+.||.+|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         236 DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence                  0000       001134567889999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=5.8e-40  Score=312.60  Aligned_cols=262  Identities=22%  Similarity=0.305  Sum_probs=200.2

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC-------
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG-------  112 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~-------  112 (358)
                      ..+|++.+.||+|+||.||+|... +++.||||.+....    ....+|+.+++.++  ||||+++++++...       
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~--h~niv~l~~~~~~~~~~~~~~  138 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLN--HINIIFLKDYYYTECFKKNEK  138 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcC--CCCCcceeeeEeecccccCCC
Confidence            468999999999999999999875 68899999885432    22346889999998  99999998876432       


Q ss_pred             -CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCC-ceEEee
Q 018263          113 -PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF-NPKISD  190 (358)
Q Consensus       113 -~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~-~~~l~D  190 (358)
                       ...++||||++ ++|.+++.........+++..++.++.||+.||+|||++   +|+||||||+||+++.++ .+||+|
T Consensus       139 ~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~D  214 (440)
T PTZ00036        139 NIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCD  214 (440)
T ss_pred             ceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeec
Confidence             24679999996 578777755445567899999999999999999999999   999999999999998665 699999


Q ss_pred             cccccccCCCCcccccccccccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccch
Q 018263          191 FGLSKLFPENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNS  269 (358)
Q Consensus       191 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      ||++........  .....+++.|+|||++.+. .++.++|||||||++|+|++|.+||......+....+....+.+..
T Consensus       215 FGla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~  292 (440)
T PTZ00036        215 FGSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE  292 (440)
T ss_pred             cccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            999986533221  2235678999999988764 6899999999999999999999999876654444433333333222


Q ss_pred             hhHhhhhc------------cccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 018263          270 KELMNLVD------------PMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAI  314 (358)
Q Consensus       270 ~~~~~~~~------------~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil  314 (358)
                      +.+...-.            ..+...++...+.++.+||.+||+.+|.+|||+.|++
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l  349 (440)
T PTZ00036        293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEAL  349 (440)
T ss_pred             HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence            22211100            0011112233456899999999999999999999987

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.7e-39  Score=286.62  Aligned_cols=250  Identities=23%  Similarity=0.305  Sum_probs=204.3

Q ss_pred             CCcccceecccCceEEEEEEEC-CCCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEe
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD  120 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e  120 (358)
                      +|++.+.||.|++|.||++.+. +++.|++|.+... .....+.+..|+..++.++  |+|++++.+.+...+..+++||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e   78 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMK--HPNIVAFKESFEADGHLYIVME   78 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCC--CCCcceEEEEEEECCEEEEEEe
Confidence            5889999999999999999976 6889999998643 3344567788999999987  9999999999999999999999


Q ss_pred             cCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCC
Q 018263          121 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN  200 (358)
Q Consensus       121 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~  200 (358)
                      |+++++|.+++..  .....+++..+..++.||+.||.+||++   |++|+||+|+||+++.++.++++|||.+......
T Consensus        79 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  153 (255)
T cd08219          79 YCDGGDLMQKIKL--QRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP  153 (255)
T ss_pred             eCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence            9999999998842  2345678999999999999999999999   9999999999999999999999999998765332


Q ss_pred             CcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhcccc
Q 018263          201 TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPML  280 (358)
Q Consensus       201 ~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (358)
                      .. ......++..|+|||++.+..++.++|+||||+++|+|++|..||..........                .+....
T Consensus       154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~----------------~~~~~~  216 (255)
T cd08219         154 GA-YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLIL----------------KVCQGS  216 (255)
T ss_pred             cc-ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHH----------------HHhcCC
Confidence            22 1223567889999999988889999999999999999999999997543211110                011111


Q ss_pred             CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 018263          281 YGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKM  316 (358)
Q Consensus       281 ~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~  316 (358)
                      ....+...+..+.+++.+||+.+|++||++.+++..
T Consensus       217 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         217 YKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            112334456678999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.1e-39  Score=302.98  Aligned_cols=249  Identities=27%  Similarity=0.358  Sum_probs=197.7

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      .++|++.+.||.|+||.||+|++. +++.|+||++... .......+.+|++.++.++  |+||+++++++...+..++|
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv  150 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVN--HPNVVKCHDMFDHNGEIQVL  150 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCC--CCCcceeeeEeccCCeEEEE
Confidence            467888999999999999999875 6899999998644 3344567889999999998  99999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      |||+++++|....        ..++..+..++.||+.||.|||++   |++|+||||+||+++.++.++|+|||++....
T Consensus       151 ~e~~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~  219 (353)
T PLN00034        151 LEFMDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILA  219 (353)
T ss_pred             EecCCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecc
Confidence            9999999876532        345778889999999999999999   99999999999999999999999999987653


Q ss_pred             CCCcccccccccccCccCcccccc-----CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHh
Q 018263          199 ENTTHISTRVAGTLGYLAPEYAIS-----GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELM  273 (358)
Q Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~-----~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      .... ......|+..|+|||++..     ...+.++|||||||++|+|++|+.||......+........          
T Consensus       220 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~----------  288 (353)
T PLN00034        220 QTMD-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI----------  288 (353)
T ss_pred             cccc-cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH----------
Confidence            2211 1223568999999998743     23456899999999999999999999743322211111111          


Q ss_pred             hhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 018263          274 NLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKM  316 (358)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~  316 (358)
                         ........+...+..+.+||.+||+.||++|||+.|+++.
T Consensus       289 ---~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        289 ---CMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             ---hccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               0011122334566789999999999999999999999873

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=3.3e-39  Score=285.13  Aligned_cols=248  Identities=28%  Similarity=0.396  Sum_probs=200.2

Q ss_pred             ceecccCceEEEEEEECCCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecCCCCC
Q 018263           48 NKIGEGGFGSVYKGRLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNS  126 (358)
Q Consensus        48 ~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~~~~~  126 (358)
                      +.||+|++|.||++...++..|++|.+.... ......+.+|++.++.+.  |||++++++.+...+..++||||+++++
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~~   78 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYD--HPNIVKLIGVCTQRQPIYIVMELVPGGD   78 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCC--CCCcCeEEEEEecCCccEEEEECCCCCc
Confidence            4689999999999998888999999986543 334457888999999987  9999999999999999999999999999


Q ss_pred             HHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCccccc
Q 018263          127 LSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIST  206 (358)
Q Consensus       127 L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~  206 (358)
                      |.+++..   ....+++..+..++.|++.+|.|+|++   |++|+||+|+||+++.++.++|+|||++............
T Consensus        79 L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~  152 (250)
T cd05085          79 FLSFLRK---KKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSG  152 (250)
T ss_pred             HHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCC
Confidence            9998832   234578999999999999999999999   9999999999999999999999999998754322221222


Q ss_pred             ccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCCCC
Q 018263          207 RVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFP  285 (358)
Q Consensus       207 ~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (358)
                      ...++..|+|||++.+..++.++|+||||+++|++++ |..||..........                .+........+
T Consensus       153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~----------------~~~~~~~~~~~  216 (250)
T cd05085         153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQARE----------------QVEKGYRMSCP  216 (250)
T ss_pred             CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH----------------HHHcCCCCCCC
Confidence            2334567999999988889999999999999999998 999986443221111                11111122233


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 018263          286 ENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNG  319 (358)
Q Consensus       286 ~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~  319 (358)
                      ...+..+.+++.+||+.+|++||++.++++.|.+
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  250 (250)
T cd05085         217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELAA  250 (250)
T ss_pred             CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhcC
Confidence            3456789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.4e-39  Score=298.38  Aligned_cols=242  Identities=24%  Similarity=0.309  Sum_probs=193.6

Q ss_pred             ceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecCC
Q 018263           48 NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP  123 (358)
Q Consensus        48 ~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~~  123 (358)
                      +.||+|+||.||+|+.. +++.||+|++....   ......+..|..++..+. .||||+++++++...+..++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~-~hp~i~~~~~~~~~~~~~~lv~E~~~   79 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHPFLTALHCCFQTKDRLFFVMEYVN   79 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhcc-CCCCccceeeEEEcCCeEEEEEeCCC
Confidence            46899999999999976 58899999987532   233345666777777653 49999999999999999999999999


Q ss_pred             CCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCcc
Q 018263          124 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH  203 (358)
Q Consensus       124 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  203 (358)
                      +++|...+    .....+++..+..++.||+.||.|||++   |++|+||||+||+++.++.++|+|||++........ 
T Consensus        80 ~~~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-  151 (321)
T cd05591          80 GGDLMFQI----QRSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-  151 (321)
T ss_pred             CCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc-
Confidence            99999988    3455789999999999999999999999   999999999999999999999999999875322221 


Q ss_pred             cccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCC
Q 018263          204 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGN  283 (358)
Q Consensus       204 ~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (358)
                      ......|+..|+|||++.+..++.++||||||+++|+|++|+.||...........+               ....  ..
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i---------------~~~~--~~  214 (321)
T cd05591         152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESI---------------LHDD--VL  214 (321)
T ss_pred             cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHH---------------HcCC--CC
Confidence            223356899999999998889999999999999999999999999755432211111               0000  11


Q ss_pred             CCHHHHHHHHHHHhhccCCCCCCCC-------CHHHHHH
Q 018263          284 FPENEAIRFLKVGLLCVQEKSKLRP-------QMSTAIK  315 (358)
Q Consensus       284 ~~~~~~~~l~~li~~~l~~~P~~Rp-------t~~eil~  315 (358)
                      ++...+..+.+++.+||+.+|++||       +++++++
T Consensus       215 ~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         215 YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence            2233456789999999999999999       6777763

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-39  Score=291.62  Aligned_cols=251  Identities=25%  Similarity=0.330  Sum_probs=202.2

Q ss_pred             CCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      +|++.+.||.|+||.||++... +++.||+|++....   ......+.+|+..++.++  ||||+++++.+..++..++|
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv   78 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN--SRFVVSLAYAYETKDALCLV   78 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcC--CCCEeeeeeeecCCCeEEEE
Confidence            5889999999999999999965 68999999986432   223345678999999998  99999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      |||+++++|.+.+..  .....+++..+..++.|++.||.|||++   |++|+||+|+||++++++.++|+|||++....
T Consensus        79 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  153 (285)
T cd05605          79 LTLMNGGDLKFHIYN--MGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIP  153 (285)
T ss_pred             EeccCCCcHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecC
Confidence            999999999988842  2335689999999999999999999999   99999999999999999999999999987643


Q ss_pred             CCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhcc
Q 018263          199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDP  278 (358)
Q Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (358)
                      ....  .....++..|+|||++.+..++.++||||+|+++|+|++|+.||...........            +...+..
T Consensus       154 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~------------~~~~~~~  219 (285)
T cd05605         154 EGET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREE------------VERRVKE  219 (285)
T ss_pred             CCCc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHH------------HHHHhhh
Confidence            2221  1234678999999999888899999999999999999999999975432211111            1111111


Q ss_pred             ccCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 018263          279 MLYGNFPENEAIRFLKVGLLCVQEKSKLRP-----QMSTAIK  315 (358)
Q Consensus       279 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp-----t~~eil~  315 (358)
                       ....++...+..+.+++.+||+.||.+||     +++++++
T Consensus       220 -~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         220 -DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             -cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence             11223445677899999999999999999     7878754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.5e-39  Score=298.56  Aligned_cols=242  Identities=21%  Similarity=0.309  Sum_probs=195.1

Q ss_pred             CCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      +|++.+.||+|+||.||+|... +++.||+|++....   .........|...+..+. .|++++++++++...+..++|
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~~i~~~~~~~~~~~~~~lv   79 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSG-KPPFLTQLHSCFQTMDRLYFV   79 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcc-CCCeEeeEEEEEecCCEEEEE
Confidence            5889999999999999999876 57899999987542   222344556666666654 489999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      |||+++++|.+.+    .....+++..+..++.||+.||+|||+.   |++|+||||+||+++.++.++|+|||++....
T Consensus        80 ~E~~~~g~L~~~~----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~  152 (323)
T cd05616          80 MEYVNGGDLMYQI----QQVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENM  152 (323)
T ss_pred             EcCCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence            9999999999988    3445689999999999999999999999   99999999999999999999999999987532


Q ss_pred             CCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhcc
Q 018263          199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDP  278 (358)
Q Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (358)
                      .... ......|++.|+|||++.+..++.++|+|||||++|+|++|+.||...........+               ...
T Consensus       153 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i---------------~~~  216 (323)
T cd05616         153 WDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI---------------MEH  216 (323)
T ss_pred             CCCC-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHH---------------HhC
Confidence            2111 223456899999999999999999999999999999999999999754432211111               110


Q ss_pred             ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 018263          279 MLYGNFPENEAIRFLKVGLLCVQEKSKLRPQM  310 (358)
Q Consensus       279 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~  310 (358)
                        ...++...+..+.+++.+||+.+|.+|++.
T Consensus       217 --~~~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         217 --NVAYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             --CCCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence              112334556778999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.9e-39  Score=287.69  Aligned_cols=254  Identities=26%  Similarity=0.441  Sum_probs=204.4

Q ss_pred             hhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      ++.+|++.+.||.|++|.||++.+.++..+++|.+.... .....+..|++.++.+.  |||++++++.+......++++
T Consensus         2 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~~v~   78 (256)
T cd05112           2 HPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLS--HPKLVQLYGVCTERSPICLVF   78 (256)
T ss_pred             ChhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCC--CCCeeeEEEEEccCCceEEEE
Confidence            457899999999999999999998778889999886432 33456888999999998  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      ||+++++|.+++..   ....+++..++.++.|++.+|++||+.   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        79 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  152 (256)
T cd05112          79 EFMEHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLD  152 (256)
T ss_pred             EcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeeccc
Confidence            99999999999832   234678999999999999999999999   999999999999999999999999999876533


Q ss_pred             CCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhHhhhhcc
Q 018263          200 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDP  278 (358)
Q Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (358)
                      ..........++..|+|||.+.+..++.++|+||||+++|+|++ |..||..........                .+..
T Consensus       153 ~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~----------------~~~~  216 (256)
T cd05112         153 DQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVE----------------TINA  216 (256)
T ss_pred             CcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH----------------HHhC
Confidence            22222222334568999999988889999999999999999998 999986433211110                0111


Q ss_pred             ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 018263          279 MLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN  318 (358)
Q Consensus       279 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~  318 (358)
                      ......+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       217 ~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         217 GFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence            1111112234567999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.1e-39  Score=298.88  Aligned_cols=237  Identities=22%  Similarity=0.331  Sum_probs=191.0

Q ss_pred             ceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecCC
Q 018263           48 NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP  123 (358)
Q Consensus        48 ~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~~  123 (358)
                      +.||+|+||.||+|+.+ +++.||+|++...   .......+..|...+..+. .||||+++++++...+..++||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~h~~iv~~~~~~~~~~~~~iv~Ey~~   79 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQLYCCFQTPDRLFFVMEFVN   79 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcc-CCCchhceeeEEEcCCEEEEEEcCCC
Confidence            46899999999999976 5889999998643   2233445666777776653 49999999999999999999999999


Q ss_pred             CCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCcc
Q 018263          124 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH  203 (358)
Q Consensus       124 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  203 (358)
                      +++|.+.+    .....+++..+..++.|++.||.|||++   |++||||||+||+++.++.++|+|||++........ 
T Consensus        80 ~g~L~~~i----~~~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-  151 (320)
T cd05590          80 GGDLMFHI----QKSRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-  151 (320)
T ss_pred             CchHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-
Confidence            99999988    3446789999999999999999999999   999999999999999999999999999875322111 


Q ss_pred             cccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCC
Q 018263          204 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGN  283 (358)
Q Consensus       204 ~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (358)
                      ......|++.|+|||++.+..++.++||||||+++|+|++|+.||...........+               ...  ...
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i---------------~~~--~~~  214 (320)
T cd05590         152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI---------------LND--EVV  214 (320)
T ss_pred             cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH---------------hcC--CCC
Confidence            223356899999999999888999999999999999999999999754432111111               000  011


Q ss_pred             CCHHHHHHHHHHHhhccCCCCCCCCCH
Q 018263          284 FPENEAIRFLKVGLLCVQEKSKLRPQM  310 (358)
Q Consensus       284 ~~~~~~~~l~~li~~~l~~~P~~Rpt~  310 (358)
                      .+...+.++.+++.+||+.||.+||++
T Consensus       215 ~~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         215 YPTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence            233456678999999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=8e-40  Score=298.17  Aligned_cols=270  Identities=23%  Similarity=0.363  Sum_probs=211.3

Q ss_pred             HHHHhhcCCcccceecccCceEEEEEEEC--------CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeee
Q 018263           36 QLKIATNGFRWSNKIGEGGFGSVYKGRLQ--------DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLH  106 (358)
Q Consensus        36 ~~~~~~~~y~i~~~lg~g~~g~v~~~~~~--------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~  106 (358)
                      .+.+..++|.+.+.||+|+||.||++.+.        .+..|++|.+.... ......+..|+..++.+. .|||+++++
T Consensus        12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~-~h~~i~~~~   90 (307)
T cd05098          12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG-KHKNIINLL   90 (307)
T ss_pred             cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhc-CCCCEeeEE
Confidence            34455688999999999999999999753        23569999987542 334456778999999883 399999999


Q ss_pred             ceEEcCCeeEEEEecCCCCCHHHHhhhccc------------cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCC
Q 018263          107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEK------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIK  174 (358)
Q Consensus       107 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~  174 (358)
                      +++...+..++||||+++++|.+++.....            ....+++..+..++.|++.||+|||++   |++|+||+
T Consensus        91 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlk  167 (307)
T cd05098          91 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLA  167 (307)
T ss_pred             EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Cccccccc
Confidence            999999999999999999999999954321            123588899999999999999999999   99999999


Q ss_pred             CCcEEEcCCCceEEeecccccccCCCCccc-ccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccc
Q 018263          175 TSNILLDQNFNPKISDFGLSKLFPENTTHI-STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV  252 (358)
Q Consensus       175 p~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~  252 (358)
                      |+||+++.++.++|+|||.+.......... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||....
T Consensus       168 p~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~  247 (307)
T cd05098         168 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP  247 (307)
T ss_pred             HHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence            999999999999999999987653221111 111224467999999988889999999999999999998 888886432


Q ss_pred             cccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCCC
Q 018263          253 QLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNIDG  325 (358)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~~  325 (358)
                      ..                +....+........+...+..+.+++.+||+.+|++|||+.++++.|+.+.+..+
T Consensus       248 ~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~  304 (307)
T cd05098         248 VE----------------ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS  304 (307)
T ss_pred             HH----------------HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence            11                1111111122223344556789999999999999999999999999998765543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.2e-39  Score=296.58  Aligned_cols=270  Identities=23%  Similarity=0.356  Sum_probs=213.2

Q ss_pred             HHHhhcCCcccceecccCceEEEEEEEC--------CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeec
Q 018263           37 LKIATNGFRWSNKIGEGGFGSVYKGRLQ--------DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHG  107 (358)
Q Consensus        37 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~--------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~  107 (358)
                      +.+..++|.+.+.||+|+||.||+|+..        ++..|++|...... ......+.+|+..++.+. .||||+++++
T Consensus        10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~-~h~~i~~~~~   88 (304)
T cd05101          10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-KHKNIINLLG   88 (304)
T ss_pred             ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhc-cCCCchheeE
Confidence            4567889999999999999999999731        24579999886432 344567888999999883 3999999999


Q ss_pred             eEEcCCeeEEEEecCCCCCHHHHhhhccc------------cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCC
Q 018263          108 GCIDGPCRILVYDYMPNNSLSQTLLGEEK------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKT  175 (358)
Q Consensus       108 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p  175 (358)
                      .+......+++|||+++++|.+++.....            ....+++..+..++.||+.||.|||++   |++|+||+|
T Consensus        89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp  165 (304)
T cd05101          89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAA  165 (304)
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeeccccc
Confidence            99999999999999999999999954321            124578889999999999999999999   999999999


Q ss_pred             CcEEEcCCCceEEeecccccccCCCCccc-ccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCcccc
Q 018263          176 SNILLDQNFNPKISDFGLSKLFPENTTHI-STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ  253 (358)
Q Consensus       176 ~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~  253 (358)
                      +||+++.++.++|+|||.+.......... .....++..|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus       166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~  245 (304)
T cd05101         166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  245 (304)
T ss_pred             ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence            99999999999999999998664322221 122345578999999988889999999999999999998 7888764322


Q ss_pred             ccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCCCC
Q 018263          254 LGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNIDGX  326 (358)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~~~  326 (358)
                      ..                ....+........+...+..+.+++.+||+.+|.+|||+.++++.|+++.....+
T Consensus       246 ~~----------------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~~  302 (304)
T cd05101         246 EE----------------LFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTN  302 (304)
T ss_pred             HH----------------HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhhc
Confidence            11                1111111111222345667899999999999999999999999999998776543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.7e-39  Score=290.87  Aligned_cols=247  Identities=22%  Similarity=0.296  Sum_probs=196.7

Q ss_pred             ecccCceEEEEEEEC-CCCEEEEEEeeccCh---hhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecCCCC
Q 018263           50 IGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK---QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN  125 (358)
Q Consensus        50 lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~~~~  125 (358)
                      ||+|+||.||++.+. +++.||+|.+.....   .....+..|+.+++.+.  |+|++++.+.+......++||||++++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~--~~~i~~~~~~~~~~~~~~lv~e~~~~g   78 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVH--SRFIVSLAYAFQTKTDLCLVMTIMNGG   78 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCC--CCcEeeeeEEEcCCCeEEEEEeCCCCC
Confidence            699999999999875 688999999864322   22345677899999987  999999999999999999999999999


Q ss_pred             CHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCcccc
Q 018263          126 SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS  205 (358)
Q Consensus       126 ~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~  205 (358)
                      +|.+.+.........+++..+..++.||+.||.|||++   +++|+||+|+||+++.++.++|+|||.+........ ..
T Consensus        79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~  154 (280)
T cd05608          79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KT  154 (280)
T ss_pred             CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cc
Confidence            99988854444556799999999999999999999999   999999999999999999999999999876533222 12


Q ss_pred             cccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCCCC
Q 018263          206 TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFP  285 (358)
Q Consensus       206 ~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (358)
                      ....++..|+|||.+.+..++.++|+||||+++|+|++|+.||............           .......  ...++
T Consensus       155 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~-----------~~~~~~~--~~~~~  221 (280)
T cd05608         155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL-----------KQRILND--SVTYP  221 (280)
T ss_pred             cccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHH-----------HHhhccc--CCCCc
Confidence            3356889999999999999999999999999999999999999754322111100           0001111  11233


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 018263          286 ENEAIRFLKVGLLCVQEKSKLRP-----QMSTAIK  315 (358)
Q Consensus       286 ~~~~~~l~~li~~~l~~~P~~Rp-----t~~eil~  315 (358)
                      ...+..+.+++.+||+.||.+||     +++++++
T Consensus       222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            45677899999999999999999     5555554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2.7e-39  Score=297.46  Aligned_cols=246  Identities=22%  Similarity=0.293  Sum_probs=192.3

Q ss_pred             ceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecCC
Q 018263           48 NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP  123 (358)
Q Consensus        48 ~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~~  123 (358)
                      +.||+|+||.||+|+++ +++.||+|++...   .......+..|..++..+. .||||+++++++...+..++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~-~hp~Iv~~~~~~~~~~~~~lv~e~~~   79 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETAS-NHPFLVGLHSCFQTESRLFFVIEFVS   79 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcc-CCCCCCceEEEEEcCCEEEEEEeCCC
Confidence            46899999999999975 6889999999753   2233455777888888774 49999999999999999999999999


Q ss_pred             CCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCcc
Q 018263          124 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH  203 (358)
Q Consensus       124 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  203 (358)
                      +++|.+++    ...+.+++..++.++.||+.||.|||++   |++|+||+|+||+++.++.++|+|||++....... .
T Consensus        80 ~g~L~~~~----~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~  151 (329)
T cd05588          80 GGDLMFHM----QRQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-D  151 (329)
T ss_pred             CCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC-C
Confidence            99999888    3456799999999999999999999999   99999999999999999999999999986422111 1


Q ss_pred             cccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCC
Q 018263          204 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGN  283 (358)
Q Consensus       204 ~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (358)
                      ......|+..|+|||++.+..++.++|+||||+++|+|++|+.||......+......      .......+...  ...
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~------~~~~~~~~~~~--~~~  223 (329)
T cd05588         152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNT------EDYLFQVILEK--QIR  223 (329)
T ss_pred             ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccc------hHHHHHHHHcC--CCC
Confidence            2234568999999999999899999999999999999999999997432211100000      00000111111  112


Q ss_pred             CCHHHHHHHHHHHhhccCCCCCCCCCH
Q 018263          284 FPENEAIRFLKVGLLCVQEKSKLRPQM  310 (358)
Q Consensus       284 ~~~~~~~~l~~li~~~l~~~P~~Rpt~  310 (358)
                      .+...+..+.+++.+||+.||.+||++
T Consensus       224 ~p~~~~~~~~~li~~~L~~dP~~R~~~  250 (329)
T cd05588         224 IPRSLSVKASSVLKGFLNKDPKERLGC  250 (329)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence            334456678999999999999999983

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.1e-39  Score=289.62  Aligned_cols=252  Identities=29%  Similarity=0.456  Sum_probs=202.1

Q ss_pred             CcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHH--HHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEe
Q 018263           44 FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEK--EFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD  120 (358)
Q Consensus        44 y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~--~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e  120 (358)
                      |++.+.||+|+||.||+++.. +++.||+|++.........  ....|+..+..++  ||||+++++++......+++||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~--~~~i~~~~~~~~~~~~~~~v~~   78 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLR--HPNIVQILDVFQDDNYLYIVME   78 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHT--BTTBCHEEEEEEESSEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccc--cccccccccccccccccccccc
Confidence            788999999999999999977 4668999999866444333  3345889999987  9999999999999999999999


Q ss_pred             cCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCC
Q 018263          121 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN  200 (358)
Q Consensus       121 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~  200 (358)
                      ++++++|.+++.    ....+++..+..++.||+.||.+||++   +++|+||+|+||+++.++.++|+|||.+..... 
T Consensus        79 ~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-  150 (260)
T PF00069_consen   79 YCPGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-  150 (260)
T ss_dssp             EETTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTS-
T ss_pred             cccccccccccc----ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-
Confidence            999989999993    567789999999999999999999999   999999999999999999999999999875421 


Q ss_pred             CcccccccccccCccCccccc-cCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccc
Q 018263          201 TTHISTRVAGTLGYLAPEYAI-SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPM  279 (358)
Q Consensus       201 ~~~~~~~~~~~~~y~aPE~~~-~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (358)
                      .........++..|.|||++. +..++.++|+||||+++++|++|..||......+...................     
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  225 (260)
T PF00069_consen  151 NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQ-----  225 (260)
T ss_dssp             TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTS-----
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccc-----
Confidence            222334466888999999988 78899999999999999999999999986522222222221111000000000     


Q ss_pred             cCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          280 LYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       280 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                           .......+.+++.+||+.+|++||++.++++
T Consensus       226 -----~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  226 -----SREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             -----HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             -----cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 0011277999999999999999999999975

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.4e-39  Score=292.92  Aligned_cols=259  Identities=24%  Similarity=0.375  Sum_probs=205.9

Q ss_pred             hhcCCcccceecccCceEEEEEEEC------CCCEEEEEEeeccCh-hhHHHHHHHHHHhhhcccCCCCceeeeceEEcC
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLVKLHGGCIDG  112 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~  112 (358)
                      ...+|++.+.||.|+||.||+|...      .+..|++|.+..... .....+..|...+..++  ||||+++++.+...
T Consensus         3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~--h~~iv~~~~~~~~~   80 (283)
T cd05091           3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQ--HPNIVCLLGVVTKE   80 (283)
T ss_pred             CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCC--CCCcCeEEEEEcCC
Confidence            3456889999999999999999853      257899999875432 33456788999999888  99999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHhhhcc------------ccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEE
Q 018263          113 PCRILVYDYMPNNSLSQTLLGEE------------KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL  180 (358)
Q Consensus       113 ~~~~iv~e~~~~~~L~~~l~~~~------------~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv  180 (358)
                      ...++++||+++++|.+++....            .....+++..+..++.|++.||.|||++   |++|+||||.||++
T Consensus        81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~  157 (283)
T cd05091          81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLV  157 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEe
Confidence            99999999999999999984211            1234588899999999999999999999   99999999999999


Q ss_pred             cCCCceEEeecccccccCCCCc-ccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchh
Q 018263          181 DQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYH  258 (358)
Q Consensus       181 ~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~  258 (358)
                      ++++.++|+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+   
T Consensus       158 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---  234 (283)
T cd05091         158 FDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---  234 (283)
T ss_pred             cCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH---
Confidence            9999999999999876432221 11223345678999999988889999999999999999998 888886433211   


Q ss_pred             hhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 018263          259 LVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNG  319 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~  319 (358)
                                   ....+........+...+..+.+++.+||+.+|.+||++.+|+..|+.
T Consensus       235 -------------~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         235 -------------VIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             -------------HHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence                         111111111223344567779999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.7e-40  Score=301.19  Aligned_cols=239  Identities=25%  Similarity=0.336  Sum_probs=194.3

Q ss_pred             cceecccCceEEEEEEE----CCCCEEEEEEeeccC--hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEe
Q 018263           47 SNKIGEGGFGSVYKGRL----QDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD  120 (358)
Q Consensus        47 ~~~lg~g~~g~v~~~~~----~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e  120 (358)
                      ++.||+|+||.||+++.    .+|+.||+|++....  ......+..|++.+..++  ||||+++++.+...+..++|||
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e   78 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVN--HPFIVKLHYAFQTEGKLYLILD   78 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCC--CCCcccEEEEEEcCCEEEEEEc
Confidence            36799999999999975    358899999987542  223345677899999988  9999999999999999999999


Q ss_pred             cCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCC
Q 018263          121 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN  200 (358)
Q Consensus       121 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~  200 (358)
                      |+++++|.+.+    .....+++..++.++.||+.||+|||+.   |++|+||+|+||+++.++.++|+|||++......
T Consensus        79 ~~~~~~L~~~l----~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~  151 (318)
T cd05582          79 FLRGGDLFTRL----SKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  151 (318)
T ss_pred             CCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCC
Confidence            99999999998    3456789999999999999999999999   9999999999999999999999999998764332


Q ss_pred             CcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhcccc
Q 018263          201 TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPML  280 (358)
Q Consensus       201 ~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (358)
                      . .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...........               +...  
T Consensus       152 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~---------------i~~~--  213 (318)
T cd05582         152 E-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTM---------------ILKA--  213 (318)
T ss_pred             C-CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHH---------------HHcC--
Confidence            1 122345689999999999888899999999999999999999999975432111111               1110  


Q ss_pred             CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 018263          281 YGNFPENEAIRFLKVGLLCVQEKSKLRPQMST  312 (358)
Q Consensus       281 ~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~e  312 (358)
                      ....+...+..+.+++.+||+.||.+||++.+
T Consensus       214 ~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         214 KLGMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            11233345667899999999999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3.6e-39  Score=286.30  Aligned_cols=246  Identities=26%  Similarity=0.388  Sum_probs=197.8

Q ss_pred             eecccCceEEEEEEEC---CCCEEEEEEeeccC--hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecCC
Q 018263           49 KIGEGGFGSVYKGRLQ---DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP  123 (358)
Q Consensus        49 ~lg~g~~g~v~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~~  123 (358)
                      +||+|+||.||+|.++   ++..|++|++....  ......+..|+..++.+.  ||||+++++.+. ....+++|||++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~-~~~~~lv~e~~~   78 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLD--NPYIVRMIGICE-AESWMLVMELAE   78 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCC--CCCcceEEEEEc-CCCcEEEEecCC
Confidence            6899999999999753   57889999986543  334567888999999987  999999999875 456789999999


Q ss_pred             CCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCcc
Q 018263          124 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH  203 (358)
Q Consensus       124 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  203 (358)
                      +++|.+++    .....+++..+..++.|++.||.+||++   |++|+||+|.||+++.++.++|+|||.+.........
T Consensus        79 ~~~L~~~l----~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~  151 (257)
T cd05116          79 LGPLNKFL----QKNKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY  151 (257)
T ss_pred             CCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence            99999998    3445689999999999999999999999   9999999999999999999999999999865433221


Q ss_pred             c--ccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhHhhhhcccc
Q 018263          204 I--STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPML  280 (358)
Q Consensus       204 ~--~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (358)
                      .  .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.......                ....+....
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~----------------~~~~i~~~~  215 (257)
T cd05116         152 YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE----------------VTQMIESGE  215 (257)
T ss_pred             eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH----------------HHHHHHCCC
Confidence            1  112234578999999888888999999999999999998 999997442211                111222222


Q ss_pred             CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 018263          281 YGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE  320 (358)
Q Consensus       281 ~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~  320 (358)
                      ....+...+.++.++|.+||+.+|++||++.+|.+.|++.
T Consensus       216 ~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         216 RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            2334445677899999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.3e-39  Score=289.59  Aligned_cols=261  Identities=23%  Similarity=0.304  Sum_probs=208.2

Q ss_pred             HhhcCCcccceecccCceEEEEEEECC----CCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQD----GTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP  113 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~~----~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~  113 (358)
                      +..++|.+.+.||.|++|.||+|.+.+    ...|++|...... ....+.+.+|+..++.+.  |||++++++++.. .
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~--h~~i~~~~~~~~~-~   79 (270)
T cd05056           3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD--HPHIVKLIGVITE-N   79 (270)
T ss_pred             echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCC--CCchhceeEEEcC-C
Confidence            456789999999999999999998643    3468999886554 455668889999999998  9999999998875 4


Q ss_pred             eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccc
Q 018263          114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL  193 (358)
Q Consensus       114 ~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~  193 (358)
                      ..+++|||+++++|.+++..   ....+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||+
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~  153 (270)
T cd05056          80 PVWIVMELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGL  153 (270)
T ss_pred             CcEEEEEcCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCce
Confidence            57899999999999999943   234589999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhH
Q 018263          194 SKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKEL  272 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      +...............++..|+|||.+.+..++.++||||||+++|++++ |..||............            
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~------------  221 (270)
T cd05056         154 SRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI------------  221 (270)
T ss_pred             eeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH------------
Confidence            87654432222222334568999999888889999999999999999986 99999755432111111            


Q ss_pred             hhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCC
Q 018263          273 MNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNID  324 (358)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~  324 (358)
                          ........+...+..+.+++.+|+..+|++|||+.++++.|+++...+
T Consensus       222 ----~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~  269 (270)
T cd05056         222 ----ENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE  269 (270)
T ss_pred             ----HcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence                111111223445678999999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.3e-39  Score=291.33  Aligned_cols=260  Identities=24%  Similarity=0.392  Sum_probs=207.2

Q ss_pred             HhhcCCcccceecccCceEEEEEEEC------CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG  112 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~  112 (358)
                      +...+|++.++||+|+||.||++...      ++..+++|.+..........+..|++.+..++  |+||+++++++...
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~   79 (280)
T cd05092           2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQ--HQHIVRFYGVCTEG   79 (280)
T ss_pred             CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCC--CCCCceEEEEEecC
Confidence            34578899999999999999999632      36678999887666666678999999999998  99999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHhhhccc-----------cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEc
Q 018263          113 PCRILVYDYMPNNSLSQTLLGEEK-----------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD  181 (358)
Q Consensus       113 ~~~~iv~e~~~~~~L~~~l~~~~~-----------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~  181 (358)
                      ...+++|||+++++|.+++.....           ....+++..+..++.||+.||+|||+.   |++|+||+|+||+++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~  156 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVG  156 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEc
Confidence            999999999999999999854321           113578999999999999999999999   999999999999999


Q ss_pred             CCCceEEeecccccccCCCCc-ccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhh
Q 018263          182 QNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHL  259 (358)
Q Consensus       182 ~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~  259 (358)
                      +++.++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....
T Consensus       157 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  236 (280)
T cd05092         157 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC  236 (280)
T ss_pred             CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence            999999999999875432221 11122334678999999988889999999999999999998 8999864332211111


Q ss_pred             hHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 018263          260 VDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNG  319 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~  319 (358)
                                      +........+...+..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus       237 ----------------~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         237 ----------------ITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             ----------------HHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence                            11111112223455678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=3.4e-39  Score=300.36  Aligned_cols=263  Identities=22%  Similarity=0.281  Sum_probs=199.9

Q ss_pred             HhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC--
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP--  113 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~--  113 (358)
                      ...++|++.+.||+|+||.||++.+. +|+.||+|.+...  .......+.+|+..++.++  ||||+++++++....  
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~   95 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVN--HKNIISLLNVFTPQKSL   95 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCC--CCCEeeeeeeeccCCCc
Confidence            34589999999999999999999875 6899999998643  3344567778999999998  999999999886543  


Q ss_pred             ----eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEe
Q 018263          114 ----CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKIS  189 (358)
Q Consensus       114 ----~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~  189 (358)
                          ..++||||+++ +|...+.      ..+++..+..++.||+.||.|||++   ||+||||+|+||+++.++.++|+
T Consensus        96 ~~~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~  165 (359)
T cd07876          96 EEFQDVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL  165 (359)
T ss_pred             cccceeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEe
Confidence                46999999964 5666651      2478899999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccch
Q 018263          190 DFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNS  269 (358)
Q Consensus       190 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      |||++......  .......++..|+|||++.+..++.++||||||+++|+|++|+.||...+..+.........+....
T Consensus       166 Dfg~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  243 (359)
T cd07876         166 DFGLARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSA  243 (359)
T ss_pred             cCCCccccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcH
Confidence            99998754221  1223356789999999999989999999999999999999999999866543322222111111110


Q ss_pred             h-------hHhhhhc---------------cccC---CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          270 K-------ELMNLVD---------------PMLY---GNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       270 ~-------~~~~~~~---------------~~~~---~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .       .......               ....   .......+..+.+|+.+||+.||++|||+.|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         244 EFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             HHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence            0       0000000               0000   0111123467899999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.5e-39  Score=296.17  Aligned_cols=258  Identities=25%  Similarity=0.392  Sum_probs=204.8

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCC----EEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGT----IVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP  113 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~----~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~  113 (358)
                      ...+|++.+.||+|+||.||+|.+. ++.    .|++|.+... .......+.+|+..++.+.  ||||+++++.+... 
T Consensus         5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~g~~~~~-   81 (316)
T cd05108           5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD--NPHVCRLLGICLTS-   81 (316)
T ss_pred             chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCC--CCCCCeEEEEEcCC-
Confidence            3568999999999999999999854 333    4899998644 3345567888999999998  99999999988765 


Q ss_pred             eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccc
Q 018263          114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL  193 (358)
Q Consensus       114 ~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~  193 (358)
                      ..+++++|+++++|.+++..   ....+++..+..++.||+.||+|||++   |++|+||||+||+++.++.++|+|||+
T Consensus        82 ~~~~v~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~  155 (316)
T cd05108          82 TVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGL  155 (316)
T ss_pred             CceeeeecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccc
Confidence            56799999999999999843   234688999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCccc-ccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhh
Q 018263          194 SKLFPENTTHI-STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKE  271 (358)
Q Consensus       194 ~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      +.......... ......+..|+|||.+.+..++.++||||||+++|+|++ |..||.......                
T Consensus       156 a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~----------------  219 (316)
T cd05108         156 AKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------------  219 (316)
T ss_pred             cccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH----------------
Confidence            98754332211 112334568999999998899999999999999999997 999987432211                


Q ss_pred             HhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCC
Q 018263          272 LMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETN  322 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~  322 (358)
                      ....+........+..++.++.+++.+||+.+|.+||++.+++..|..+..
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~  270 (316)
T cd05108         220 ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  270 (316)
T ss_pred             HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence            111111111122233455678999999999999999999999999887754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3.1e-39  Score=296.11  Aligned_cols=237  Identities=26%  Similarity=0.355  Sum_probs=188.5

Q ss_pred             ceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHH-HhhhcccCCCCceeeeceEEcCCeeEEEEecC
Q 018263           48 NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVA-SMANVNVCHENLVKLHGGCIDGPCRILVYDYM  122 (358)
Q Consensus        48 ~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~-~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~  122 (358)
                      +.||+|+||.||+|+.. +++.||+|++....   ......+..|.. .++.+.  ||||+++++.+...+..++||||+
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~--h~~iv~~~~~~~~~~~~~lv~e~~   78 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLK--HPFLVGLHYSFQTAEKLYFVLDYV   78 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCC--CCCccceeeEEEcCCEEEEEEcCC
Confidence            46899999999999975 58899999986432   222334445544 456666  999999999999999999999999


Q ss_pred             CCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCc
Q 018263          123 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT  202 (358)
Q Consensus       123 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~  202 (358)
                      ++++|...+    .....+++..+..++.||+.||.|||++   |++|+||||+||+++.++.++|+|||++....... 
T Consensus        79 ~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-  150 (321)
T cd05603          79 NGGELFFHL----QRERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-  150 (321)
T ss_pred             CCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-
Confidence            999999888    3456788999999999999999999999   99999999999999999999999999987532221 


Q ss_pred             ccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccCC
Q 018263          203 HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYG  282 (358)
Q Consensus       203 ~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (358)
                      .......+++.|+|||++.+..++.++|||||||++|+|++|..||...+....   ...            +...  ..
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~------------i~~~--~~  213 (321)
T cd05603         151 ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM---YDN------------ILHK--PL  213 (321)
T ss_pred             CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH---HHH------------HhcC--CC
Confidence            122345689999999999888899999999999999999999999975432111   111            1111  11


Q ss_pred             CCCHHHHHHHHHHHhhccCCCCCCCCCHH
Q 018263          283 NFPENEAIRFLKVGLLCVQEKSKLRPQMS  311 (358)
Q Consensus       283 ~~~~~~~~~l~~li~~~l~~~P~~Rpt~~  311 (358)
                      ..+...+..+.+++.+||+.+|.+||++.
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         214 QLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            23334566789999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.3e-39  Score=291.08  Aligned_cols=263  Identities=23%  Similarity=0.340  Sum_probs=209.3

Q ss_pred             HHhhcCCcccceecccCceEEEEEEECC-----CCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEc
Q 018263           38 KIATNGFRWSNKIGEGGFGSVYKGRLQD-----GTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID  111 (358)
Q Consensus        38 ~~~~~~y~i~~~lg~g~~g~v~~~~~~~-----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~  111 (358)
                      .+..++|++.+.||+|+||.||+|.+..     +..|++|.+... .......+.+|+..++.+.  |+|++++++++..
T Consensus         2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~--h~ni~~~~~~~~~   79 (280)
T cd05043           2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLS--HQNILPILHVCIE   79 (280)
T ss_pred             ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCC--CCCCCeEEEEEec
Confidence            4668899999999999999999999765     688999987643 3444567888999999997  9999999998765


Q ss_pred             -CCeeEEEEecCCCCCHHHHhhhcccc----ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCce
Q 018263          112 -GPCRILVYDYMPNNSLSQTLLGEEKR----RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP  186 (358)
Q Consensus       112 -~~~~~iv~e~~~~~~L~~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~  186 (358)
                       ....+++++|+++++|.+++......    ...+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.+
T Consensus        80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~  156 (280)
T cd05043          80 DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQV  156 (280)
T ss_pred             CCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcE
Confidence             56788999999999999998543222    15689999999999999999999999   99999999999999999999


Q ss_pred             EEeecccccccCCCCcc-cccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhh
Q 018263          187 KISDFGLSKLFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAW  264 (358)
Q Consensus       187 ~l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~  264 (358)
                      +|+|||+++.+...... ......++..|+|||++.+..++.++||||||+++|++++ |+.||......+   ...   
T Consensus       157 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~---  230 (280)
T cd05043         157 KITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAA---  230 (280)
T ss_pred             EECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHH---
Confidence            99999999765332211 1112335667999999988889999999999999999999 999997543211   111   


Q ss_pred             hccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCC
Q 018263          265 GMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGET  321 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~  321 (358)
                                .+........+...+..+.+++.+||+.+|++|||+.++++.|+.+.
T Consensus       231 ----------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~  277 (280)
T cd05043         231 ----------YLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH  277 (280)
T ss_pred             ----------HHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence                      11111111122335567899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-38  Score=293.65  Aligned_cols=255  Identities=23%  Similarity=0.282  Sum_probs=197.4

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      ++|++.+.||+|+||.||+++.. +++.||+|++...   .......+.+|...+..++  |+||+++++++...+..++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~~~~~~l   78 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGD--RRWITNLHYAFQDENNLYL   78 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC--CCCCCceEEEEecCCeEEE
Confidence            57999999999999999999965 5899999998642   2233456778888888887  9999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      ||||+++++|.+++..   ....+++..+..++.||+.||+|||++   +++|+||+|+||+++.++.++|+|||++...
T Consensus        79 v~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  152 (331)
T cd05597          79 VMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRL  152 (331)
T ss_pred             EEecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeec
Confidence            9999999999999832   245689999999999999999999999   9999999999999999999999999998765


Q ss_pred             CCCCcccccccccccCccCcccccc-----CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhH
Q 018263          198 PENTTHISTRVAGTLGYLAPEYAIS-----GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKEL  272 (358)
Q Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      ............|++.|+|||++.+     ..++.++|||||||++|+|++|+.||........+..+...      .  
T Consensus       153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~------~--  224 (331)
T cd05597         153 LADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH------K--  224 (331)
T ss_pred             CCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcC------C--
Confidence            4333222233468999999999863     45788999999999999999999999754332211111000      0  


Q ss_pred             hhhhccccCCCCCHHHHHHHHHHHhhccCCCCC--CCCCHHHHHHH
Q 018263          273 MNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSK--LRPQMSTAIKM  316 (358)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~--~Rpt~~eil~~  316 (358)
                          ............+..+.+++.+||...+.  .||+++++++-
T Consensus       225 ----~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         225 ----EHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             ----CcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence                00000111122456788888888865433  37899888765

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=4.6e-39  Score=289.68  Aligned_cols=258  Identities=26%  Similarity=0.417  Sum_probs=204.9

Q ss_pred             hcCCcccceecccCceEEEEEEE-----CCCCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCe
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRL-----QDGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC  114 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~-----~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~  114 (358)
                      -++|++.+.||+|+||.||+|..     .++..|++|.+... .......+.+|+..++.+.  |||++++++++.....
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~   81 (283)
T cd05090           4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELH--HPNIVCLLGVVTQEQP   81 (283)
T ss_pred             hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCC--CCCeeeEEEEEecCCc
Confidence            36788999999999999999984     24678999998643 3334467888999999998  9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHhhhccc-------------cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEc
Q 018263          115 RILVYDYMPNNSLSQTLLGEEK-------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD  181 (358)
Q Consensus       115 ~~iv~e~~~~~~L~~~l~~~~~-------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~  181 (358)
                      .+++|||+++++|.+++.....             ....+++..+..++.|++.||.|||++   +++|+||+|+||+++
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~  158 (283)
T cd05090          82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIG  158 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEc
Confidence            9999999999999999843211             124578899999999999999999999   999999999999999


Q ss_pred             CCCceEEeecccccccCCCCc-ccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhh
Q 018263          182 QNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHL  259 (358)
Q Consensus       182 ~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~  259 (358)
                      .++.++|+|||++........ .......++..|+|||++.+..++.++|+||||+++|+|++ |..||.......    
T Consensus       159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~----  234 (283)
T cd05090         159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE----  234 (283)
T ss_pred             CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH----
Confidence            999999999999976432221 11222345677999999988889999999999999999998 988986432211    


Q ss_pred             hHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 018263          260 VDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNG  319 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~  319 (358)
                                  ..+.+........+...+..+.+++.+||+.+|.+||++.+|++.|.+
T Consensus       235 ------------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         235 ------------VIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             ------------HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence                        111111111112233456678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=4.5e-39  Score=295.92  Aligned_cols=246  Identities=24%  Similarity=0.312  Sum_probs=191.6

Q ss_pred             ceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecCC
Q 018263           48 NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP  123 (358)
Q Consensus        48 ~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~~  123 (358)
                      +.||+|+||.||+|..+ +++.||+|++...   .......+..|...+..+. .||||+++++++...+..++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~-~hp~iv~~~~~~~~~~~~~lv~E~~~   79 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS-NHPFLVGLHSCFQTESRLFFVIEYVN   79 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcC-CCCcCCceeeEEEeCCEEEEEEeCCC
Confidence            46999999999999975 5889999998754   2233455677887777663 49999999999999999999999999


Q ss_pred             CCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCcc
Q 018263          124 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH  203 (358)
Q Consensus       124 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  203 (358)
                      +++|...+    .....+++..++.++.||+.||.|||++   |++|+||||+||+++.++.++|+|||++....... .
T Consensus        80 ~~~L~~~~----~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~  151 (329)
T cd05618          80 GGDLMFHM----QRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-D  151 (329)
T ss_pred             CCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-C
Confidence            99999888    3456789999999999999999999999   99999999999999999999999999987532211 1


Q ss_pred             cccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCC
Q 018263          204 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGN  283 (358)
Q Consensus       204 ~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (358)
                      ......|+..|+|||++.+..++.++|+||||+++|+|++|+.||............       ........+.. ....
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~-------~~~~~~~~i~~-~~~~  223 (329)
T cd05618         152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN-------TEDYLFQVILE-KQIR  223 (329)
T ss_pred             ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccc-------cHHHHHHHHhc-CCCC
Confidence            223356899999999999989999999999999999999999999632211110000       00000000100 1112


Q ss_pred             CCHHHHHHHHHHHhhccCCCCCCCCCH
Q 018263          284 FPENEAIRFLKVGLLCVQEKSKLRPQM  310 (358)
Q Consensus       284 ~~~~~~~~l~~li~~~l~~~P~~Rpt~  310 (358)
                      ++...+..+.+++.+||+.||.+||++
T Consensus       224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         224 IPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence            444566778899999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=7.7e-39  Score=284.05  Aligned_cols=250  Identities=32%  Similarity=0.473  Sum_probs=204.8

Q ss_pred             ceecccCceEEEEEEECC----CCEEEEEEeeccChh-hHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecC
Q 018263           48 NKIGEGGFGSVYKGRLQD----GTIVAVKVLSVESKQ-GEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM  122 (358)
Q Consensus        48 ~~lg~g~~g~v~~~~~~~----~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~  122 (358)
                      +.||+|+||.||+|....    +..|++|.+...... ....+..|+..+..+.  |+|++++++++......+++|||+
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~~~~~~lv~e~~   78 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG--HPNVVRLLGVCTEEEPLYLVLEYM   78 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcC--CCChheeeeeecCCCceEEEEEec
Confidence            468999999999999753    788999998765433 3678889999999998  999999999999999999999999


Q ss_pred             CCCCHHHHhhhcccc-----ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          123 PNNSLSQTLLGEEKR-----RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       123 ~~~~L~~~l~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      ++++|.+++......     ...+++..++.++.|++.||++||++   +++|+||+|+||+++.++.++|+|||.+...
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~  155 (262)
T cd00192          79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDV  155 (262)
T ss_pred             cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccc
Confidence            999999999543221     47789999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCc-ccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhHhhh
Q 018263          198 PENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNL  275 (358)
Q Consensus       198 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                      ..... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.......                ....
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----------------~~~~  219 (262)
T cd00192         156 YDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE----------------VLEY  219 (262)
T ss_pred             ccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH----------------HHHH
Confidence            54321 12233456788999999988889999999999999999999 699987552211                1111


Q ss_pred             hccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 018263          276 VDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN  318 (358)
Q Consensus       276 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~  318 (358)
                      +........+...+..+.+++.+||+.+|.+|||+.++++.|+
T Consensus       220 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         220 LRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             HHcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            1111222334455778999999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.7e-39  Score=291.82  Aligned_cols=265  Identities=22%  Similarity=0.301  Sum_probs=196.3

Q ss_pred             CCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC--hhhHHHHHHHHHHhhhcc-cCCCCceeeeceEEc-----CC
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVN-VCHENLVKLHGGCID-----GP  113 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~-~~h~~i~~~~~~~~~-----~~  113 (358)
                      +|++.+.||+|++|.||+|.+. +++.||+|.+....  ........+|+..++.+. ..||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            5899999999999999999876 68899999986432  222234456666665542 239999999998764     34


Q ss_pred             eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccc
Q 018263          114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL  193 (358)
Q Consensus       114 ~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~  193 (358)
                      ..+++|||++ ++|.+++..  .....+++..+..++.||+.||.|||+.   |++|+||+|+||+++.++.++|+|||+
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~  154 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDK--VPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL  154 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence            5789999996 588888732  2234589999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHh
Q 018263          194 SKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELM  273 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      +.......  ......++..|+|||++.+..++.++||||||+++|+|++|.+||......+....+....+......+.
T Consensus       155 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07863         155 ARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  232 (288)
T ss_pred             cccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence            87653221  1223457889999999988889999999999999999999999997655443333322222111111111


Q ss_pred             hhhc---cccC-------CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          274 NLVD---PMLY-------GNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       274 ~~~~---~~~~-------~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ....   ....       ....+..+..+.+++.+||+.||.+|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            1000   0000       0111234567889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=3.9e-39  Score=287.58  Aligned_cols=255  Identities=22%  Similarity=0.342  Sum_probs=203.1

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      .++|++.+.||+|+||.||+|+.. +++.|++|++..........+.+|+..++.++  |||++++++.+......++|+
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~--h~~ii~~~~~~~~~~~~~iv~   85 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECK--HCNIVAYFGSYLSREKLWICM   85 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcC--CCCeeeeeEEEEeCCEEEEEE
Confidence            468999999999999999999964 68899999997665555567888999999988  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      ||+++++|.+++    .....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        86 e~~~~~~L~~~~----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06646          86 EYCGGGSLQDIY----HVTGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITA  158 (267)
T ss_pred             eCCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence            999999999998    3445789999999999999999999999   999999999999999999999999999876532


Q ss_pred             CCcccccccccccCccCccccc---cCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhh
Q 018263          200 NTTHISTRVAGTLGYLAPEYAI---SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV  276 (358)
Q Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~---~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                      ... ......++..|+|||.+.   ...++.++|+||+|+++|+|++|+.||..............       ..   +.
T Consensus       159 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~-------~~---~~  227 (267)
T cd06646         159 TIA-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSK-------SN---FQ  227 (267)
T ss_pred             ccc-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeec-------CC---CC
Confidence            221 112345778999999874   34578899999999999999999999864332111110000       00   00


Q ss_pred             ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 018263          277 DPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMM  317 (358)
Q Consensus       277 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L  317 (358)
                      .+.  .......+..+.+++.+||+.+|++|||++++++.|
T Consensus       228 ~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         228 PPK--LKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CCC--CccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            000  001123456789999999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=4e-39  Score=289.20  Aligned_cols=258  Identities=28%  Similarity=0.396  Sum_probs=204.6

Q ss_pred             hhcCCcccceecccCceEEEEEEEC------CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG  112 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~  112 (358)
                      ..++|.+.+.||+|++|.||+|.+.      .+..|++|...... ......+..|+..++.+.  |+||+++++++...
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~   81 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFN--HQNIVRLIGVSFER   81 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCC--CCCEeeEEEEEccC
Confidence            3578999999999999999999875      35678999876443 334567888999999998  99999999999998


Q ss_pred             CeeEEEEecCCCCCHHHHhhhccc---cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCC---ce
Q 018263          113 PCRILVYDYMPNNSLSQTLLGEEK---RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF---NP  186 (358)
Q Consensus       113 ~~~~iv~e~~~~~~L~~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~---~~  186 (358)
                      ...+++|||+++++|.+++.....   ....+++..+..++.||+.||+|||++   +++|+||+|+||+++.++   .+
T Consensus        82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~  158 (277)
T cd05036          82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVA  158 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcce
Confidence            899999999999999999854321   123588999999999999999999999   999999999999998654   58


Q ss_pred             EEeecccccccCCCCccc-ccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhh
Q 018263          187 KISDFGLSKLFPENTTHI-STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAW  264 (358)
Q Consensus       187 ~l~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~  264 (358)
                      +|+|||++.......... ......+..|+|||++.+..++.++|||||||++|+|++ |..||........        
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~--------  230 (277)
T cd05036         159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV--------  230 (277)
T ss_pred             EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH--------
Confidence            999999988653221111 112233567999999988899999999999999999997 9999875433211        


Q ss_pred             hccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 018263          265 GMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN  318 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~  318 (358)
                              ...+........+...+..+.+++.+||+.+|++||++.+|++.|+
T Consensus       231 --------~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         231 --------MEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             --------HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence                    1111111222334455678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=6.5e-39  Score=290.70  Aligned_cols=250  Identities=21%  Similarity=0.345  Sum_probs=205.7

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      ..+|++.+.||+|++|.||++... ++..|++|.+..........+.+|+..++.+.  |+|++++++.+......++||
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~--h~~v~~~~~~~~~~~~~~lv~   96 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK--NPNIVNYLDSYLVGDELWVVM   96 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCC--CCCEeeEEEEEEeCCEEEEee
Confidence            479999999999999999999864 68899999987665556677888999999987  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      ||+++++|.+++.     ...+++..+..++.|++.||+|||+.   |++|+||+|+||+++.++.++|+|||.+.....
T Consensus        97 e~~~~~~L~~~~~-----~~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~  168 (296)
T cd06654          97 EYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (296)
T ss_pred             cccCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence            9999999999982     34578999999999999999999999   999999999999999999999999998876432


Q ss_pred             CCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccc
Q 018263          200 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPM  279 (358)
Q Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (358)
                      ... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.............              ....
T Consensus       169 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~--------------~~~~  233 (296)
T cd06654         169 EQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA--------------TNGT  233 (296)
T ss_pred             ccc-ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHh--------------cCCC
Confidence            221 1223457889999999988888999999999999999999999997554322111100              0000


Q ss_pred             cCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          280 LYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       280 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .....+...+..+.+++.+||+.+|.+|||+.++++
T Consensus       234 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         234 PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             CCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            011123345677899999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=4.7e-39  Score=288.85  Aligned_cols=255  Identities=24%  Similarity=0.269  Sum_probs=199.1

Q ss_pred             ecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecCCCC
Q 018263           50 IGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN  125 (358)
Q Consensus        50 lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~~~~  125 (358)
                      ||+|+||.||++..+ +|+.|++|.+....   ......+..|+++++.++  ||||+++.+.+......++||||++|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~--hp~i~~~~~~~~~~~~~~lv~e~~~g~   78 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN--SPFIVNLAYAFESKTHLCLVMSLMNGG   78 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcC--CCcEEEEEEEEecCCeEEEEEecCCCC
Confidence            699999999999875 68999999986421   223345566899999997  999999999999999999999999999


Q ss_pred             CHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCcccc
Q 018263          126 SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS  205 (358)
Q Consensus       126 ~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~  205 (358)
                      +|.+.+...  ....+++..+..++.||+.||+|||+.   |++|+||+|+||+++.++.++|+|||++........  .
T Consensus        79 ~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--~  151 (277)
T cd05607          79 DLKYHIYNV--GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--I  151 (277)
T ss_pred             CHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce--e
Confidence            999888432  334588999999999999999999999   999999999999999999999999999876543221  2


Q ss_pred             cccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCCCC
Q 018263          206 TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFP  285 (358)
Q Consensus       206 ~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (358)
                      ....++..|+|||++.+..++.++|+||||+++|+|++|+.||...........+.           ...+..... ...
T Consensus       152 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~-----------~~~~~~~~~-~~~  219 (277)
T cd05607         152 TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELK-----------RRTLEDEVK-FEH  219 (277)
T ss_pred             eccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHH-----------HHhhccccc-ccc
Confidence            23468889999999988889999999999999999999999996432211100000           000100000 011


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCCC
Q 018263          286 ENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNIDG  325 (358)
Q Consensus       286 ~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~~  325 (358)
                      ...+..+.+++.+||+.||.+||++.|+++.+..++-..+
T Consensus       220 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~  259 (277)
T cd05607         220 QNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKT  259 (277)
T ss_pred             ccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcC
Confidence            2356678999999999999999999888876666655543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.2e-38  Score=293.35  Aligned_cols=254  Identities=23%  Similarity=0.303  Sum_probs=196.9

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      ++|++.+.||+|+||.||+++.. +++.||+|++...   .......+.+|...+..+.  |++|+++++.+...+..++
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~l~~~~~~~~~~~l   78 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGD--CQWITTLHYAFQDENYLYL   78 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCC--CCCEeeEEEEEEcCCEEEE
Confidence            57999999999999999999976 5888999998642   2233445777888888877  9999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      ||||++|++|.+++..   ....+++..+..++.|++.||+|||++   ||+|+||||+||+++.++.++|+|||++...
T Consensus        79 v~Ey~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~  152 (331)
T cd05624          79 VMDYYVGGDLLTLLSK---FEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKM  152 (331)
T ss_pred             EEeCCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeec
Confidence            9999999999999942   235689999999999999999999999   9999999999999999999999999998765


Q ss_pred             CCCCcccccccccccCccCcccccc-----CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhH
Q 018263          198 PENTTHISTRVAGTLGYLAPEYAIS-----GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKEL  272 (358)
Q Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      ............|+..|+|||++.+     ..++.++|+||||+++|+|++|+.||........+..+..      ..  
T Consensus       153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~------~~--  224 (331)
T cd05624         153 NQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN------HE--  224 (331)
T ss_pred             cCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHc------CC--
Confidence            4333322233568999999998875     4678899999999999999999999975433211111100      00  


Q ss_pred             hhhhccccCCCCCHHHHHHHHHHHhhccCCCCCC--CCCHHHHHH
Q 018263          273 MNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKL--RPQMSTAIK  315 (358)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~--Rpt~~eil~  315 (358)
                          .....+......+..+.+++.+||...+.+  |++++++++
T Consensus       225 ----~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         225 ----ERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             ----CcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence                000001111234567889999999876544  467877764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.7e-39  Score=296.08  Aligned_cols=242  Identities=24%  Similarity=0.320  Sum_probs=194.5

Q ss_pred             ceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecCC
Q 018263           48 NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP  123 (358)
Q Consensus        48 ~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~~  123 (358)
                      +.||.|+||.||+|..+ +++.||+|++....   ......+..|..++..+. .||||+++++++...+..++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~   79 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-KHPFLTQLHSCFQTKDRLFFVMEYVN   79 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhcc-CCCCccceeeEEEcCCEEEEEEcCCC
Confidence            46999999999999876 58899999987542   233345667777777764 49999999999999999999999999


Q ss_pred             CCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCcc
Q 018263          124 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH  203 (358)
Q Consensus       124 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  203 (358)
                      +++|.+.+    .....+++..+..++.||+.||.|||++   +++|+||+|+||+++.++.++|+|||++....... .
T Consensus        80 ~~~L~~~~----~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~  151 (318)
T cd05570          80 GGDLMFHI----QRSGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-V  151 (318)
T ss_pred             CCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-C
Confidence            99999988    3445789999999999999999999999   99999999999999999999999999886432111 1


Q ss_pred             cccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCC
Q 018263          204 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGN  283 (358)
Q Consensus       204 ~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (358)
                      ......++..|+|||++.+..++.++|+||||+++|+|++|+.||..........   .+            ...  ...
T Consensus       152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~---~i------------~~~--~~~  214 (318)
T cd05570         152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQ---SI------------LED--EVR  214 (318)
T ss_pred             cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHH---HH------------HcC--CCC
Confidence            1233468899999999999999999999999999999999999997543211111   11            000  112


Q ss_pred             CCHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 018263          284 FPENEAIRFLKVGLLCVQEKSKLRPQM-----STAIK  315 (358)
Q Consensus       284 ~~~~~~~~l~~li~~~l~~~P~~Rpt~-----~eil~  315 (358)
                      ++...+..+.+++.+||+.||.+||++     .++++
T Consensus       215 ~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         215 YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            233456778999999999999999999     77764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.4e-39  Score=297.17  Aligned_cols=238  Identities=29%  Similarity=0.376  Sum_probs=188.8

Q ss_pred             ceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHH-HhhhcccCCCCceeeeceEEcCCeeEEEEecC
Q 018263           48 NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVA-SMANVNVCHENLVKLHGGCIDGPCRILVYDYM  122 (358)
Q Consensus        48 ~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~-~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~  122 (358)
                      +.||+|+||.||+|+.. +|+.||+|++....   ......+..|.. .++.++  ||||+++++.+...+..++||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~--hp~iv~~~~~~~~~~~~~lv~e~~   78 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVK--HPFLVGLHYSFQTADKLYFVLDYV   78 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCC--CCCCCCeeEEEEeCCEEEEEEcCC
Confidence            46899999999999976 68999999986432   222334444444 345566  999999999999999999999999


Q ss_pred             CCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCc
Q 018263          123 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT  202 (358)
Q Consensus       123 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~  202 (358)
                      ++++|...+    .....+++..+..++.||+.||.|||++   |++|+||+|+||+++.++.++|+|||++....... 
T Consensus        79 ~~g~L~~~l----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-  150 (323)
T cd05575          79 NGGELFFHL----QRERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-  150 (323)
T ss_pred             CCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-
Confidence            999999988    3456789999999999999999999999   99999999999999999999999999987532211 


Q ss_pred             ccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccCC
Q 018263          203 HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYG  282 (358)
Q Consensus       203 ~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (358)
                      .......|++.|+|||++.+..++.++||||||+++|+|++|..||.........   .            .+....  .
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~---~------------~i~~~~--~  213 (323)
T cd05575         151 KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMY---D------------NILNKP--L  213 (323)
T ss_pred             CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHH---H------------HHHcCC--C
Confidence            1223456899999999999989999999999999999999999999754321111   1            111111  1


Q ss_pred             CCCHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 018263          283 NFPENEAIRFLKVGLLCVQEKSKLRPQMST  312 (358)
Q Consensus       283 ~~~~~~~~~l~~li~~~l~~~P~~Rpt~~e  312 (358)
                      ..+...+..+.+++.+||+.||.+||++.+
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~  243 (323)
T cd05575         214 RLKPNISVSARHLLEGLLQKDRTKRLGAKD  243 (323)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHHhCCCCCC
Confidence            122334667899999999999999999853

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6.6e-39  Score=288.87  Aligned_cols=271  Identities=25%  Similarity=0.385  Sum_probs=204.6

Q ss_pred             hcCCcccceecccCceEEEEEEE-----CCCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC--
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRL-----QDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG--  112 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~--  112 (358)
                      ..-|++++.||+|+||.||+++.     .++..|++|.+.... ......+.+|+..++.+.  |||++++.+++...  
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~   80 (284)
T cd05079           3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY--HENIVKYKGICTEDGG   80 (284)
T ss_pred             hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCC--CCCeeeeeeEEecCCC
Confidence            34578999999999999999973     357889999986543 344567889999999998  99999999988775  


Q ss_pred             CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecc
Q 018263          113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG  192 (358)
Q Consensus       113 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg  192 (358)
                      ...++||||++|++|.+++..   ....+++..+..++.||+.||+|||++   |++|+||+|+||+++.++.++|+|||
T Consensus        81 ~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg  154 (284)
T cd05079          81 NGIKLIMEFLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFG  154 (284)
T ss_pred             CceEEEEEccCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCc
Confidence            568899999999999999832   234589999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcc--cccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchh
Q 018263          193 LSKLFPENTTH--ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSK  270 (358)
Q Consensus       193 ~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      ++.........  ......++..|+|||.+.+..++.++||||||+++|+|+++..|.......-. .......+.....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~-~~~~~~~~~~~~~  233 (284)
T cd05079         155 LTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFL-KMIGPTHGQMTVT  233 (284)
T ss_pred             cccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhh-hhcccccccccHH
Confidence            98865432221  11234566789999998888899999999999999999998766432211000 0000000000001


Q ss_pred             hHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 018263          271 ELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE  320 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~  320 (358)
                      .....+........+..++..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         234 RLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            11111111112222344667899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=6.3e-39  Score=289.61  Aligned_cols=263  Identities=25%  Similarity=0.397  Sum_probs=206.0

Q ss_pred             HHhhcCCcccceecccCceEEEEEEEC------CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEE
Q 018263           38 KIATNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCI  110 (358)
Q Consensus        38 ~~~~~~y~i~~~lg~g~~g~v~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~  110 (358)
                      .+..++|++.+.||+|++|.||+|..+      .+..|++|.+.... ......+.+|+..++.+.  |||++++++++.
T Consensus         2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~   79 (288)
T cd05061           2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFT--CHHVVRLLGVVS   79 (288)
T ss_pred             cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCC--CCCeeeEEEEEc
Confidence            456789999999999999999999743      24579999876443 233456778999999987  999999999999


Q ss_pred             cCCeeEEEEecCCCCCHHHHhhhccc------cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCC
Q 018263          111 DGPCRILVYDYMPNNSLSQTLLGEEK------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF  184 (358)
Q Consensus       111 ~~~~~~iv~e~~~~~~L~~~l~~~~~------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~  184 (358)
                      ..+..+++|||+++++|.+++.....      ....++...+..++.|++.||.|||++   +++|+||+|+||+++.++
T Consensus        80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~  156 (288)
T cd05061          80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDF  156 (288)
T ss_pred             CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCC
Confidence            99999999999999999999954321      123456788999999999999999999   999999999999999999


Q ss_pred             ceEEeecccccccCCCCcc-cccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHh
Q 018263          185 NPKISDFGLSKLFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDK  262 (358)
Q Consensus       185 ~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~  262 (358)
                      .++|+|||++......... ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+.      
T Consensus       157 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~------  230 (288)
T cd05061         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV------  230 (288)
T ss_pred             cEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHH------
Confidence            9999999998754322211 1112234678999999988889999999999999999998 7888864332111      


Q ss_pred             hhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCC
Q 018263          263 AWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGET  321 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~  321 (358)
                                ...+........+...+..+.+++.+||+.+|++|||+.++++.|....
T Consensus       231 ----------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         231 ----------LKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             ----------HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence                      1111111111222334578999999999999999999999999998854

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-38  Score=285.13  Aligned_cols=256  Identities=25%  Similarity=0.386  Sum_probs=202.1

Q ss_pred             CcccceecccCceEEEEEEEC----CCCEEEEEEeeccC--hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCe---
Q 018263           44 FRWSNKIGEGGFGSVYKGRLQ----DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC---  114 (358)
Q Consensus        44 y~i~~~lg~g~~g~v~~~~~~----~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~---  114 (358)
                      |.+.+.||+|+||.||.|...    .+..||+|.+....  ......+..|+..++.++  |||++++++.+.....   
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~~   78 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFD--HPNVMKLIGVCFEASSLQK   78 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCC--CCCeeeEEeeeccCCcccc
Confidence            678899999999999999864    24679999987542  334467888999999988  9999999998765554   


Q ss_pred             ---eEEEEecCCCCCHHHHhhhcc--ccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEe
Q 018263          115 ---RILVYDYMPNNSLSQTLLGEE--KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKIS  189 (358)
Q Consensus       115 ---~~iv~e~~~~~~L~~~l~~~~--~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~  189 (358)
                         .++++||+++++|..++....  .....+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+
T Consensus        79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~  155 (273)
T cd05035          79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVA  155 (273)
T ss_pred             CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEEC
Confidence               789999999999999985432  2335689999999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCccc-ccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhcc
Q 018263          190 DFGLSKLFPENTTHI-STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMY  267 (358)
Q Consensus       190 Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~  267 (358)
                      |||.+.......... ......+..|+|||.+.+..++.++||||||+++|+|++ |..||........   .       
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~---~-------  225 (273)
T cd05035         156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEI---Y-------  225 (273)
T ss_pred             CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHH---H-------
Confidence            999988653322211 111234568999999988889999999999999999999 8899864432111   1       


Q ss_pred             chhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 018263          268 NSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE  320 (358)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~  320 (358)
                            +.+........+...+..+.+++.+||+.||++|||+.++++.|+++
T Consensus       226 ------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         226 ------DYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             ------HHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                  11111111223345667899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=5.9e-39  Score=286.53  Aligned_cols=257  Identities=26%  Similarity=0.419  Sum_probs=205.2

Q ss_pred             hhcCCcccceecccCceEEEEEEEC----CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCe
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ----DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC  114 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~----~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~  114 (358)
                      ...+|++.+.||.|+||.||+|.+.    .+..+++|.+.... ......+..|+..+..++  ||||+++++++...+.
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~   79 (267)
T cd05066           2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFD--HPNIIHLEGVVTKSKP   79 (267)
T ss_pred             CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCC--CCCcceEEEEEecCCc
Confidence            4678999999999999999999864    23478999886432 334567888999999987  9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccc
Q 018263          115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS  194 (358)
Q Consensus       115 ~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~  194 (358)
                      .+++|||+++++|.+++..   ....+++..+..++.|++.||.+||+.   +++|+||+|+||+++.++.++++|||.+
T Consensus        80 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~  153 (267)
T cd05066          80 VMIVTEYMENGSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLS  153 (267)
T ss_pred             cEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcc
Confidence            9999999999999999843   234678999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCccccc--ccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhh
Q 018263          195 KLFPENTTHIST--RVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKE  271 (358)
Q Consensus       195 ~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      ............  ...++..|+|||.+.+..++.++|+||||+++|++++ |..||......+....+           
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~-----------  222 (267)
T cd05066         154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI-----------  222 (267)
T ss_pred             cccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHH-----------
Confidence            876433222111  1223457999999988889999999999999999886 99998654322111111           


Q ss_pred             HhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 018263          272 LMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE  320 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~  320 (358)
                           ........+...+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus       223 -----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         223 -----EEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             -----hCCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                 01111112233456789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3.7e-39  Score=292.98  Aligned_cols=265  Identities=23%  Similarity=0.348  Sum_probs=204.5

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      .++|++.+.||.|++|.||+|+.. +++.|++|.+.... ......+.+|+..++.++  ||||+++++++...+..++|
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~nI~~~~~~~~~~~~~~lv   82 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLK--HANIVTLHDIIHTEKSLTLV   82 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcC--CCCcceEEEEEecCCeEEEE
Confidence            468999999999999999999875 68899999986543 333456778999999998  99999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      |||++ ++|.+.+..   ....+++..+..++.||+.||.|||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        83 ~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  155 (301)
T cd07873          83 FEYLD-KDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKS  155 (301)
T ss_pred             Eeccc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence            99996 588888732   345688999999999999999999999   99999999999999999999999999987543


Q ss_pred             CCCcccccccccccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhc
Q 018263          199 ENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD  277 (358)
Q Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      ..... .....++..|+|||++.+. .++.++||||||+++|+|++|+.||...+..+....+....+......+..+..
T Consensus       156 ~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (301)
T cd07873         156 IPTKT-YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS  234 (301)
T ss_pred             CCCCc-ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhc
Confidence            22221 1223467899999987654 578899999999999999999999986654433333322222222222211111


Q ss_pred             cc---------cCC----CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          278 PM---------LYG----NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       278 ~~---------~~~----~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ..         ...    ......+..+.+||.+||+.||.+|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            10         000    011234557889999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.1e-38  Score=290.89  Aligned_cols=263  Identities=24%  Similarity=0.353  Sum_probs=203.5

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      ++|++.+.||+|+||.||++.+. ++..|++|.+... .......+.+|++.+..++  ||||+++++.+..++..+++|
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~   78 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECN--SPYIVGFYGAFYSDGEISICM   78 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCC--CCCCCeEEEEEeeCCEEEEEe
Confidence            47999999999999999999865 6888999988754 3334456888999999998  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      ||+++++|.+++    .....+++..+..++.|++.||.|||+ .   +++|+||+|+||+++.++.++|+|||++....
T Consensus        79 ey~~~~~L~~~l----~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  151 (308)
T cd06615          79 EHMDGGSLDQVL----KKAGRIPENILGKISIAVLRGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  151 (308)
T ss_pred             eccCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhhC---CEEECCCChHHEEEecCCcEEEccCCCccccc
Confidence            999999999999    344678999999999999999999997 5   89999999999999999999999999887543


Q ss_pred             CCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccc----------
Q 018263          199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYN----------  268 (358)
Q Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~----------  268 (358)
                      ...   .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||....................          
T Consensus       152 ~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (308)
T cd06615         152 DSM---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSG  228 (308)
T ss_pred             ccc---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccC
Confidence            221   2234678899999998888899999999999999999999999965432211111110000000          


Q ss_pred             -------hhhHhhhhcccc---CCCCC-HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 018263          269 -------SKELMNLVDPML---YGNFP-ENEAIRFLKVGLLCVQEKSKLRPQMSTAIKM  316 (358)
Q Consensus       269 -------~~~~~~~~~~~~---~~~~~-~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~  316 (358)
                             ........+...   .+..+ ...+.++.+++.+||+.+|++|||+.++++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                   000001111100   01111 1255679999999999999999999999865

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=6.4e-39  Score=289.80  Aligned_cols=258  Identities=29%  Similarity=0.399  Sum_probs=205.4

Q ss_pred             CCcccceecccCceEEEEEEEC------CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCee
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR  115 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~  115 (358)
                      +|++.+.||+|+||.||+|...      ....+++|.+.... ......+..|+..++.+.  ||||+++++.+...+..
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~   78 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVN--HPHVIKLYGACSQDGPL   78 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCC--CCCEeeEEEEEecCCCc
Confidence            5788999999999999999853      23568888876543 334467888999999988  99999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhhccc--------------------cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCC
Q 018263          116 ILVYDYMPNNSLSQTLLGEEK--------------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKT  175 (358)
Q Consensus       116 ~iv~e~~~~~~L~~~l~~~~~--------------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p  175 (358)
                      ++++||+++++|.+++.....                    ....+++..++.++.|++.||.|||+.   +++|+||+|
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp  155 (290)
T cd05045          79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAA  155 (290)
T ss_pred             EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhh
Confidence            999999999999999853211                    123578999999999999999999999   999999999


Q ss_pred             CcEEEcCCCceEEeecccccccCCCCcc-cccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCcccc
Q 018263          176 SNILLDQNFNPKISDFGLSKLFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ  253 (358)
Q Consensus       176 ~Nilv~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~  253 (358)
                      +||++++++.++|+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus       156 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~  235 (290)
T cd05045         156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP  235 (290)
T ss_pred             heEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence            9999999999999999998754322211 1122345678999999888889999999999999999998 9999864432


Q ss_pred             ccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCC
Q 018263          254 LGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGET  321 (358)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~  321 (358)
                      .                .....+........+...+..+.+++.+||+.+|.+||++.++++.|+++-
T Consensus       236 ~----------------~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         236 E----------------RLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM  287 (290)
T ss_pred             H----------------HHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence            1                111122222222233445678999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3.3e-39  Score=296.48  Aligned_cols=247  Identities=28%  Similarity=0.327  Sum_probs=193.2

Q ss_pred             ceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHH-HhhhcccCCCCceeeeceEEcCCeeEEEEecC
Q 018263           48 NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVA-SMANVNVCHENLVKLHGGCIDGPCRILVYDYM  122 (358)
Q Consensus        48 ~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~-~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~  122 (358)
                      +.||+|+||.||+|++. +++.||+|++....   ......+..|.. .++.+.  ||||+++++.+...+..++||||+
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~--h~~Iv~~~~~~~~~~~~~lv~e~~   78 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK--HPFLVGLHFSFQTADKLYFVLDYI   78 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCC--CCCCCceeEEEEcCCeEEEEEeCC
Confidence            46999999999999976 57889999986432   222234444443 355566  999999999999999999999999


Q ss_pred             CCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCc
Q 018263          123 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT  202 (358)
Q Consensus       123 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~  202 (358)
                      ++++|.+.+    .....+++..+..++.||+.||.|||++   |++|+||||+||+++.++.++|+|||++........
T Consensus        79 ~~~~L~~~~----~~~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~  151 (325)
T cd05602          79 NGGELFYHL----QRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG  151 (325)
T ss_pred             CCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC
Confidence            999999998    3456688999999999999999999999   999999999999999999999999999875322111


Q ss_pred             ccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccCC
Q 018263          203 HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYG  282 (358)
Q Consensus       203 ~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (358)
                       ......|++.|+|||++.+..++.++||||||+++|+|++|..||........+..               +....  .
T Consensus       152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~---------------i~~~~--~  213 (325)
T cd05602         152 -TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN---------------ILNKP--L  213 (325)
T ss_pred             -CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHH---------------HHhCC--c
Confidence             22345689999999999998999999999999999999999999975432211111               11110  1


Q ss_pred             CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCC
Q 018263          283 NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGET  321 (358)
Q Consensus       283 ~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~  321 (358)
                      ..+...+..+.+++.+||+.+|.+||++.+.++.+.+..
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~  252 (325)
T cd05602         214 QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHI  252 (325)
T ss_pred             CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCc
Confidence            122345667899999999999999999886555444443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=7.1e-39  Score=295.35  Aligned_cols=272  Identities=22%  Similarity=0.347  Sum_probs=212.4

Q ss_pred             HHHHHhhcCCcccceecccCceEEEEEEEC--------CCCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceee
Q 018263           35 NQLKIATNGFRWSNKIGEGGFGSVYKGRLQ--------DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKL  105 (358)
Q Consensus        35 ~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~--------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~  105 (358)
                      +.+.+...+|++.+.||+|+||.||+|.+.        .+..|++|.+... .......+..|+..++.+. .||||+++
T Consensus         5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-~h~~iv~~   83 (334)
T cd05100           5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIG-KHKNIINL   83 (334)
T ss_pred             cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhc-CCCCeeee
Confidence            445666778999999999999999999742        1236899988643 2334567888999999883 39999999


Q ss_pred             eceEEcCCeeEEEEecCCCCCHHHHhhhccc------------cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCC
Q 018263          106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEK------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDI  173 (358)
Q Consensus       106 ~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di  173 (358)
                      ++.+...+..++++||+++++|.+++.....            ....++...+..++.|++.||+|||++   |++|+||
T Consensus        84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dl  160 (334)
T cd05100          84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDL  160 (334)
T ss_pred             eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceecccc
Confidence            9999999999999999999999999854321            123578889999999999999999999   9999999


Q ss_pred             CCCcEEEcCCCceEEeecccccccCCCCccc-ccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCcc
Q 018263          174 KTSNILLDQNFNPKISDFGLSKLFPENTTHI-STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFD  251 (358)
Q Consensus       174 ~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~  251 (358)
                      +|+||+++.++.++|+|||++.......... .....++..|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus       161 kp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~  240 (334)
T cd05100         161 AARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI  240 (334)
T ss_pred             ccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence            9999999999999999999987653322111 111233467999999988889999999999999999998 88888643


Q ss_pred             ccccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCCCC
Q 018263          252 VQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNIDGX  326 (358)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~~~  326 (358)
                      .....                ...+........+...+..+.+++.+||+.+|.+||++.++++.|+.+....+.
T Consensus       241 ~~~~~----------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~~  299 (334)
T cd05100         241 PVEEL----------------FKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTST  299 (334)
T ss_pred             CHHHH----------------HHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcCC
Confidence            22111                111111111223334566799999999999999999999999999999866654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=4.6e-39  Score=294.26  Aligned_cols=241  Identities=23%  Similarity=0.295  Sum_probs=190.8

Q ss_pred             ceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecCC
Q 018263           48 NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP  123 (358)
Q Consensus        48 ~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~~  123 (358)
                      +.||+|+||.||+|... +++.||+|++....   .........|...+.... .||||+++++++...+..++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~hp~iv~~~~~~~~~~~~~lv~ey~~   79 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW-EHPFLTHLYCTFQTKENLFFVMEYLN   79 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhcc-CCCcCcceEEEEEeCCEEEEEEeCCC
Confidence            46899999999999976 58899999987542   223344555666666542 49999999999999999999999999


Q ss_pred             CCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCcc
Q 018263          124 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH  203 (358)
Q Consensus       124 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  203 (358)
                      +++|.+.+    .....+++..+..++.|++.||.|||++   |++|+||+|+||+++.++.++|+|||++....... .
T Consensus        80 ~g~L~~~l----~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~  151 (316)
T cd05619          80 GGDLMFHI----QSCHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-A  151 (316)
T ss_pred             CCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-C
Confidence            99999998    3445688999999999999999999999   99999999999999999999999999987432111 1


Q ss_pred             cccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCC
Q 018263          204 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGN  283 (358)
Q Consensus       204 ~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (358)
                      ......|+..|+|||++.+..++.++||||+||++|+|++|..||...........+                .. ....
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i----------------~~-~~~~  214 (316)
T cd05619         152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI----------------RM-DNPC  214 (316)
T ss_pred             ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHH----------------Hh-CCCC
Confidence            223356899999999999889999999999999999999999999754322111111                00 0112


Q ss_pred             CCHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 018263          284 FPENEAIRFLKVGLLCVQEKSKLRPQMS-TAI  314 (358)
Q Consensus       284 ~~~~~~~~l~~li~~~l~~~P~~Rpt~~-eil  314 (358)
                      ++...+..+.+++.+||+.+|++||++. +++
T Consensus       215 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         215 YPRWLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             CCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence            2334556788999999999999999997 553

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=5.9e-39  Score=291.07  Aligned_cols=263  Identities=25%  Similarity=0.365  Sum_probs=205.9

Q ss_pred             cCCcccceecccCceEEEEEEECC-CC--EEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQD-GT--IVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~~-~~--~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      ++|++.+.||.|+||.||+|..+. +.  .+++|.+... .......+..|+..+.++. .||||+++++.+...+..++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~-~hp~iv~~~~~~~~~~~~~l   80 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLG-HHPNIINLLGACENRGYLYI   80 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhc-CCCchhheEEEEccCCcceE
Confidence            579999999999999999998653 33  4688887632 3344567888999998883 39999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhccc------------cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCc
Q 018263          118 VYDYMPNNSLSQTLLGEEK------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN  185 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~  185 (358)
                      ++||+++++|.+++.....            ....+++..++.++.|++.||+|||+.   |++|+||+|+||+++.++.
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~  157 (297)
T cd05089          81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLA  157 (297)
T ss_pred             EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCe
Confidence            9999999999999954221            123588999999999999999999999   9999999999999999999


Q ss_pred             eEEeecccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhh
Q 018263          186 PKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAW  264 (358)
Q Consensus       186 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~  264 (358)
                      ++|+|||++.......  .......+..|+|||++.+..++.++||||||+++|+|++ |..||.........       
T Consensus       158 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~-------  228 (297)
T cd05089         158 SKIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELY-------  228 (297)
T ss_pred             EEECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-------
Confidence            9999999986421111  1111223457999999988889999999999999999997 99999644321111       


Q ss_pred             hccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCCCC
Q 018263          265 GMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNIDGX  326 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~~~  326 (358)
                               ..+........+...+..+.+++.+||+.+|.+|||+.++++.|+.+.+....
T Consensus       229 ---------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~  281 (297)
T cd05089         229 ---------EKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA  281 (297)
T ss_pred             ---------HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence                     11111112223334567789999999999999999999999999888766533

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=8.5e-39  Score=283.68  Aligned_cols=252  Identities=27%  Similarity=0.400  Sum_probs=202.2

Q ss_pred             HhhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEE-cCCeeEE
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCI-DGPCRIL  117 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~-~~~~~~i  117 (358)
                      +..++|++.+.||.|++|.||++... |..|++|......  ..+.+..|+..++.+.  |+|++++++.+. ..+..++
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~~l   77 (256)
T cd05082           3 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLR--HSNLVQLLGVIVEEKGGLYI   77 (256)
T ss_pred             ccHHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCC--CCCeeeEEEEEEcCCCceEE
Confidence            34568999999999999999999875 7789999986432  3457888999999998  999999998754 4567899


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      ++||+++++|.+++...  ....+++..+..++.|++.||++||++   |++|+||+|+||++++++.++|+|||++...
T Consensus        78 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~  152 (256)
T cd05082          78 VTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA  152 (256)
T ss_pred             EEECCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceec
Confidence            99999999999998432  234588999999999999999999999   9999999999999999999999999998754


Q ss_pred             CCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhHhhhh
Q 018263          198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV  276 (358)
Q Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                      ....    .....+..|+|||++.+..++.++||||||+++|+|++ |+.||.......   ..             ..+
T Consensus       153 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~~-------------~~~  212 (256)
T cd05082         153 SSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV-------------PRV  212 (256)
T ss_pred             cccC----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HH-------------HHH
Confidence            3221    22334568999999988889999999999999999997 999986432111   11             111


Q ss_pred             ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 018263          277 DPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE  320 (358)
Q Consensus       277 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~  320 (358)
                      ........+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       213 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         213 EKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             hcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            11112223344567799999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.8e-40  Score=316.16  Aligned_cols=269  Identities=28%  Similarity=0.455  Sum_probs=225.7

Q ss_pred             HHHHHHhhcCCcccceecccCceEEEEEEEC------CCCEEEEEEeeccChh-hHHHHHHHHHHhhhcccCCCCceeee
Q 018263           34 YNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVESKQ-GEKEFMSEVASMANVNVCHENLVKLH  106 (358)
Q Consensus        34 ~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~------~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~~~h~~i~~~~  106 (358)
                      ....++...+.+..+.||+|.||.||+|+..      ....||||.++..... .+++|++|++.+..++  |||||+++
T Consensus       478 ~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~--H~nIVrLl  555 (774)
T KOG1026|consen  478 LKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQ--HPNIVRLL  555 (774)
T ss_pred             cceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhcc--CCCeEEEE
Confidence            3344555677788999999999999999842      3567999999876555 7789999999999999  99999999


Q ss_pred             ceEEcCCeeEEEEecCCCCCHHHHhhhccc------c----ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCC
Q 018263          107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEK------R----RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTS  176 (358)
Q Consensus       107 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~------~----~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~  176 (358)
                      +++..++-+++|+||+..|+|.++++....      .    ..+++..+.+.++.|||.|+.||-++   .+|||||-..
T Consensus       556 GVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATR  632 (774)
T KOG1026|consen  556 GVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATR  632 (774)
T ss_pred             EEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhh
Confidence            999999999999999999999999964321      1    23488999999999999999999999   9999999999


Q ss_pred             cEEEcCCCceEEeecccccccCC-CCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccc
Q 018263          177 NILLDQNFNPKISDFGLSKLFPE-NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQL  254 (358)
Q Consensus       177 Nilv~~~~~~~l~Dfg~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~  254 (358)
                      |.+|.++..|||+|||+++..-. +..........+..|+|||-+..++||.+|||||+|++|||+++ |..|+.+-++.
T Consensus       633 NCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~  712 (774)
T KOG1026|consen  633 NCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ  712 (774)
T ss_pred             hceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH
Confidence            99999999999999999986433 33333335667889999999999999999999999999999998 88898755443


Q ss_pred             cchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCC
Q 018263          255 GEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNI  323 (358)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~  323 (358)
                                      ++.+.+....--..|.+++..+..|+..||+.+|.+||+++||-.+|+..-..
T Consensus       713 ----------------EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  713 ----------------EVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             ----------------HHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence                            33333333333456788999999999999999999999999999999875443

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-41  Score=280.74  Aligned_cols=253  Identities=23%  Similarity=0.311  Sum_probs=210.1

Q ss_pred             HhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCee
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR  115 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~  115 (358)
                      ...+.|.+.+.||+|.|+.|+++... +|+.+++|+++..  ....-+.+.+|+.+-+.++  ||||+++.+.+.+....
T Consensus         8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~Lq--HP~IvrL~~ti~~~~~~   85 (355)
T KOG0033|consen    8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ--HPNIVRLHDSIQEESFH   85 (355)
T ss_pred             ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcC--CCcEeehhhhhccccee
Confidence            34678999999999999999998754 7999999998643  3446678889999999998  99999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEc---CCCceEEeecc
Q 018263          116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD---QNFNPKISDFG  192 (358)
Q Consensus       116 ~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~---~~~~~~l~Dfg  192 (358)
                      |+|+|++.|++|..-+    -.+..+++..+-..+.||+.||.|.|.+   +|+|||++|+|+++.   ..--+||+|||
T Consensus        86 ylvFe~m~G~dl~~eI----V~R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FG  158 (355)
T KOG0033|consen   86 YLVFDLVTGGELFEDI----VAREFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFG  158 (355)
T ss_pred             EEEEecccchHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccc
Confidence            9999999999988776    3446778999999999999999999999   999999999999994   33458999999


Q ss_pred             cccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhH
Q 018263          193 LSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKEL  272 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      ++...+  ....-....||+.|+|||++...+|+..+|||+.|++||-|+.|.+||.+.++...+..+....-.+     
T Consensus       159 vAi~l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~-----  231 (355)
T KOG0033|consen  159 LAIEVN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDY-----  231 (355)
T ss_pred             eEEEeC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCC-----
Confidence            999876  3333445789999999999999999999999999999999999999999766555444433221111     


Q ss_pred             hhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          273 MNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                              .+..-.+.+++..+|+.+||..||.+|.|+.|.|+
T Consensus       232 --------~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  232 --------PSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             --------CCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence                    11222456677899999999999999999988763

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.3e-38  Score=291.65  Aligned_cols=255  Identities=22%  Similarity=0.285  Sum_probs=197.4

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      ++|++.+.||+|+||.||+++.+ +++.||+|++...   .......+.+|...+..+.  |++|+++++.+...+..++
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~~~~~~l   78 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD--NQWITTLHYAFQDENNLYL   78 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCC--CCCEeeEEEEEecCCEEEE
Confidence            57999999999999999999976 5788999998642   2223345777888888877  9999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      ||||+++++|.+++..   ....+++..+..++.||+.||.|||+.   +++||||||+||+++.++.++|+|||++...
T Consensus        79 v~ey~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~  152 (332)
T cd05623          79 VMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKL  152 (332)
T ss_pred             EEeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheec
Confidence            9999999999999932   245689999999999999999999999   9999999999999999999999999998754


Q ss_pred             CCCCcccccccccccCccCccccc-----cCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhH
Q 018263          198 PENTTHISTRVAGTLGYLAPEYAI-----SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKEL  272 (358)
Q Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      ............|++.|+|||++.     ...++.++||||||+++|+|++|+.||........+..+...   .     
T Consensus       153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~---~-----  224 (332)
T cd05623         153 MEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH---K-----  224 (332)
T ss_pred             ccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCC---C-----
Confidence            333222223356899999999886     345788999999999999999999999755432221111100   0     


Q ss_pred             hhhhccccCCCCCHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 018263          273 MNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKL--RPQMSTAIKM  316 (358)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~--Rpt~~eil~~  316 (358)
                          .....+......+..+.+++.+||..++.+  |+++.++++.
T Consensus       225 ----~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         225 ----ERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             ----ccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence                000011111234667889999988665444  6889888765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=8.2e-39  Score=285.85  Aligned_cols=256  Identities=26%  Similarity=0.452  Sum_probs=203.8

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CC---CEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCee
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DG---TIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR  115 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~---~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~  115 (358)
                      ...|++.+.||+|+||.||+|... ++   ..|++|.+... .......+..|+..++.+.  |||++++.+++......
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~--h~ni~~~~~~~~~~~~~   80 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD--HPNIIHLEGVVTKSRPV   80 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCC--CcCcceEEEEECCCCce
Confidence            456889999999999999999865 23   36999998654 3445578889999999998  99999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccc
Q 018263          116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK  195 (358)
Q Consensus       116 ~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~  195 (358)
                      ++||||+++++|.+++..   ..+.+++..++.++.|++.||.|||++   |++|+||+|+||+++.++.++|+|||++.
T Consensus        81 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~  154 (269)
T cd05065          81 MIITEFMENGALDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSR  154 (269)
T ss_pred             EEEEecCCCCcHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccc
Confidence            999999999999999843   235688999999999999999999999   99999999999999999999999999987


Q ss_pred             ccCCCCcccc--ccc--ccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchh
Q 018263          196 LFPENTTHIS--TRV--AGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSK  270 (358)
Q Consensus       196 ~~~~~~~~~~--~~~--~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      ..........  ...  ..+..|+|||.+.+..++.++||||||+++|++++ |..||......+....           
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~-----------  223 (269)
T cd05065         155 FLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINA-----------  223 (269)
T ss_pred             ccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHH-----------
Confidence            6533221111  111  12347999999988889999999999999999886 9999864432211111           


Q ss_pred             hHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 018263          271 ELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE  320 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~  320 (358)
                           +........+...+..+.+++.+||+.+|++||++.+|+..|+++
T Consensus       224 -----i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         224 -----IEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             -----HHcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                 111111122334566789999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-38  Score=280.94  Aligned_cols=248  Identities=28%  Similarity=0.402  Sum_probs=200.4

Q ss_pred             ceecccCceEEEEEEECCCCEEEEEEeeccChh-hHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecCCCCC
Q 018263           48 NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQ-GEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNS  126 (358)
Q Consensus        48 ~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~~~~~  126 (358)
                      ++||.|++|.||++....++.|++|.+...... ....+..|+..++.+.  |+||+++++++......+++|||+++++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~~v~e~~~~~~   78 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYD--HPNIVKLIGVCVQKQPIYIVMELVPGGS   78 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCC--CCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence            478999999999999877999999998755333 5567889999999998  9999999999999999999999999999


Q ss_pred             HHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCcccc-
Q 018263          127 LSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS-  205 (358)
Q Consensus       127 L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~-  205 (358)
                      |.+++..   ....+++..+..++.+++.+|++||++   +++|+||+|+||+++.++.++|+|||.+........... 
T Consensus        79 l~~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~  152 (251)
T cd05041          79 LLTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD  152 (251)
T ss_pred             HHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence            9999842   234678999999999999999999999   999999999999999999999999999876432111111 


Q ss_pred             cccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCCC
Q 018263          206 TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNF  284 (358)
Q Consensus       206 ~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (358)
                      .....+..|+|||.+.+..++.++|+||||+++|+|++ |..||.........                ..+........
T Consensus       153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~----------------~~~~~~~~~~~  216 (251)
T cd05041         153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR----------------ERIESGYRMPA  216 (251)
T ss_pred             ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHH----------------HHHhcCCCCCC
Confidence            11223567999999988889999999999999999999 88888654321111                11111111223


Q ss_pred             CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 018263          285 PENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNG  319 (358)
Q Consensus       285 ~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~  319 (358)
                      +...+..+.+++.+||+.+|.+|||+.|+++.|+.
T Consensus       217 ~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         217 PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence            34456789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=7.5e-39  Score=291.24  Aligned_cols=262  Identities=27%  Similarity=0.387  Sum_probs=203.8

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCC--EEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGT--IVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI  116 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~--~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~  116 (358)
                      .++|++.+.||.|+||.||+|.+. ++.  .+++|..... .......+.+|++.+..+. .|+|++++++++...+..+
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~-~h~~iv~~~~~~~~~~~~~   84 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG-HHPNIINLLGACEHRGYLY   84 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhc-CCCCcceEEEEECCCCCce
Confidence            568999999999999999999865 454  3566665432 3344567888999999983 3999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhccc------------cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCC
Q 018263          117 LVYDYMPNNSLSQTLLGEEK------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF  184 (358)
Q Consensus       117 iv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~  184 (358)
                      ++|||+++++|.+++.....            ....+++..++.++.||+.||+|||++   |++|+||+|+||+++.++
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~  161 (303)
T cd05088          85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY  161 (303)
T ss_pred             EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCC
Confidence            99999999999999854321            224688999999999999999999999   999999999999999999


Q ss_pred             ceEEeecccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhh
Q 018263          185 NPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKA  263 (358)
Q Consensus       185 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~  263 (358)
                      .++|+|||++.......  .......+..|+|||++.+..++.++||||||+++|+|++ |..||......+....    
T Consensus       162 ~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~----  235 (303)
T cd05088         162 VAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK----  235 (303)
T ss_pred             cEEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHH----
Confidence            99999999986321111  1111223567999999888889999999999999999998 9999864432211110    


Q ss_pred             hhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCC
Q 018263          264 WGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNID  324 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~  324 (358)
                                  +........+...+..+.+++.+||+.+|++||++.++++.|+.+.+..
T Consensus       236 ------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~  284 (303)
T cd05088         236 ------------LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  284 (303)
T ss_pred             ------------HhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence                        1111111222334567899999999999999999999999998765444

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-39  Score=295.64  Aligned_cols=252  Identities=23%  Similarity=0.312  Sum_probs=215.0

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChh---hHHHHHHHHHHhhhcccCCCCceeeeceEEcCCee
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQ---GEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR  115 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~  115 (358)
                      ..+.|++.+.||.|.||.||.++.+ +|+.||+|.+......   ....+.+|+.+++.+. .||||+.+.++|++....
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~-~hpniv~l~~~~e~~~~~  111 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLS-GHPNIVQLKDAFEDPDSV  111 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhcc-CCCCEEEEEEEEEcCCeE
Confidence            4578999999999999999999977 4999999999755332   3468899999999997 599999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcC----CCceEEeec
Q 018263          116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ----NFNPKISDF  191 (358)
Q Consensus       116 ~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~----~~~~~l~Df  191 (358)
                      ++|||++.||.|.+.+...     .+++..+..++.|++.++.|+|+.   |++|+|+||+|+++..    ++.++++||
T Consensus       112 ~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DF  183 (382)
T KOG0032|consen  112 YLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDF  183 (382)
T ss_pred             EEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeC
Confidence            9999999999999999543     399999999999999999999999   9999999999999953    347999999


Q ss_pred             ccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhh
Q 018263          192 GLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKE  271 (358)
Q Consensus       192 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      |++.....  .......+||+.|+|||++....|+...||||+|+++|.|++|.+||...........+....       
T Consensus       184 Gla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~-------  254 (382)
T KOG0032|consen  184 GLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGD-------  254 (382)
T ss_pred             CCceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCC-------
Confidence            99998655  445566889999999999998999999999999999999999999998776544443222110       


Q ss_pred             HhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          272 LMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                            .......-...+....++|..||..||.+|+|+.++++
T Consensus       255 ------~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  255 ------FDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             ------CCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence                  01222333456888999999999999999999999999

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=3.4e-39  Score=300.45  Aligned_cols=247  Identities=23%  Similarity=0.312  Sum_probs=194.8

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      ++|++++.||+|+||.||++..+ +++.||+|++...   .......+..|+..+..++  ||+|+++++.+...+..++
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~iv~~~~~~~~~~~~~l   78 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEAD--GAWVVKMFYSFQDKRNLYL   78 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC--CCCEeeEEEEEEcCCEEEE
Confidence            47899999999999999999875 6899999998643   2334466778999999887  9999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      ||||++|++|.+++    .....+++..+..++.|++.||.|||++   |++|+||||+||+++.++.++|+|||++...
T Consensus        79 v~E~~~gg~L~~~l----~~~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~  151 (360)
T cd05627          79 IMEFLPGGDMMTLL----MKKDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGL  151 (360)
T ss_pred             EEeCCCCccHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccc
Confidence            99999999999998    3456789999999999999999999999   9999999999999999999999999998643


Q ss_pred             CCCCc----------------------------------ccccccccccCccCccccccCCCCccCceecHHHHHHHHHh
Q 018263          198 PENTT----------------------------------HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS  243 (358)
Q Consensus       198 ~~~~~----------------------------------~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt  243 (358)
                      .....                                  .......||+.|+|||++.+..++.++|+|||||++|+|++
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~t  231 (360)
T cd05627         152 KKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI  231 (360)
T ss_pred             ccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeeccc
Confidence            21100                                  00113468999999999999999999999999999999999


Q ss_pred             CCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHH
Q 018263          244 GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMS  311 (358)
Q Consensus       244 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~  311 (358)
                      |+.||...........+...            ......+ .....+..+.++|.+++. +|.+|++..
T Consensus       232 G~~Pf~~~~~~~~~~~i~~~------------~~~~~~p-~~~~~s~~~~~li~~l~~-~p~~R~~~~  285 (360)
T cd05627         232 GYPPFCSETPQETYRKVMNW------------KETLVFP-PEVPISEKAKDLILRFCT-DSENRIGSN  285 (360)
T ss_pred             CCCCCCCCCHHHHHHHHHcC------------CCceecC-CCCCCCHHHHHHHHHhcc-ChhhcCCCC
Confidence            99999765432221111100            0000000 001235567888888774 999999643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.7e-40  Score=271.40  Aligned_cols=248  Identities=27%  Similarity=0.396  Sum_probs=213.3

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI  116 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~  116 (358)
                      .++|++.+.||.|.||.||+|+.+ ++..||+|++-..   .......+.+|+++-..++  ||||++++++|.+....|
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~--hpnilrlY~~fhd~~riy   98 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLR--HPNILRLYGYFHDSKRIY   98 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccC--CccHHhhhhheeccceeE
Confidence            568889999999999999999965 6788999998543   3334567888999999998  999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       117 iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      +++||.+.|++...++.  .....+++...+.++.|++.||.|+|.+   +++||||||+|++++..|.+|++|||-+..
T Consensus        99 LilEya~~gel~k~L~~--~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~  173 (281)
T KOG0580|consen   99 LILEYAPRGELYKDLQE--GRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVH  173 (281)
T ss_pred             EEEEecCCchHHHHHHh--cccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceee
Confidence            99999999999999943  2566789999999999999999999999   999999999999999999999999999876


Q ss_pred             cCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhh
Q 018263          197 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV  276 (358)
Q Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                      .+   .......+||..|++||...+..++...|+|++|++.|+++.|.+||......+.+..+.+.             
T Consensus       174 ~p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~-------------  237 (281)
T KOG0580|consen  174 AP---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV-------------  237 (281)
T ss_pred             cC---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc-------------
Confidence            32   33445678999999999999999999999999999999999999999876654444444322             


Q ss_pred             ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          277 DPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       277 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                          +-.+|...+....++|.+|+..+|.+|.+..|+++
T Consensus       238 ----~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  238 ----DLKFPSTISGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             ----cccCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence                12244667778999999999999999999999875

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=9.8e-39  Score=293.52  Aligned_cols=245  Identities=23%  Similarity=0.313  Sum_probs=193.2

Q ss_pred             ceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecCC
Q 018263           48 NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP  123 (358)
Q Consensus        48 ~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~~  123 (358)
                      +.||+|+||.||+|+.. +++.||+|++....   ......+..|...+..+. .||+|+.+++++...+..++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQAS-SNPFLVGLHSCFQTTSRLFLVIEYVN   79 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhc-CCCCEeeEEEEEEeCCEEEEEEeCCC
Confidence            46999999999999975 57899999997542   233455777888887774 49999999999999999999999999


Q ss_pred             CCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCcc
Q 018263          124 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH  203 (358)
Q Consensus       124 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  203 (358)
                      +++|...+    .....+++..+..++.||+.||+|||++   |++|+||+|+||+++.++.++|+|||++....... .
T Consensus        80 ~~~L~~~~----~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~  151 (327)
T cd05617          80 GGDLMFHM----QRQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-D  151 (327)
T ss_pred             CCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-C
Confidence            99999888    3446799999999999999999999999   99999999999999999999999999987532211 1


Q ss_pred             cccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCC
Q 018263          204 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGN  283 (358)
Q Consensus       204 ~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (358)
                      ......|++.|+|||++.+..++.++||||||+++|+|++|..||................        ......  ...
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~--------~~~~~~--~~~  221 (327)
T cd05617         152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLF--------QVILEK--PIR  221 (327)
T ss_pred             ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHH--------HHHHhC--CCC
Confidence            2234568999999999999899999999999999999999999996433222111111000        001111  112


Q ss_pred             CCHHHHHHHHHHHhhccCCCCCCCCCHH
Q 018263          284 FPENEAIRFLKVGLLCVQEKSKLRPQMS  311 (358)
Q Consensus       284 ~~~~~~~~l~~li~~~l~~~P~~Rpt~~  311 (358)
                      .+...+..+.+++.+||+.||.+|+++.
T Consensus       222 ~p~~~~~~~~~li~~~L~~dP~~R~~~~  249 (327)
T cd05617         222 IPRFLSVKASHVLKGFLNKDPKERLGCQ  249 (327)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence            3344566788999999999999999853

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=7.5e-39  Score=293.78  Aligned_cols=242  Identities=21%  Similarity=0.321  Sum_probs=195.0

Q ss_pred             CCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      +|.+.+.||+|+||.||+|... +|+.||+|++....   ......+..|...+..+. .|++++++.+++...+..++|
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~~i~~~~~~~~~~~~~~lv   79 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD-KPPFLTQLHSCFQTVDRLYFV   79 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcc-CCCchhheeeEEecCCEEEEE
Confidence            4778899999999999999875 68899999987532   233345667777777765 467888999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      |||+++++|.+++    .....+++..+..++.||+.||.|||++   |++|+||+|+||+++.++.++|+|||++....
T Consensus        80 ~Ey~~~g~L~~~i----~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~  152 (323)
T cd05615          80 MEYVNGGDLMYHI----QQVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHM  152 (323)
T ss_pred             EcCCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccC
Confidence            9999999999998    3446789999999999999999999999   99999999999999999999999999987532


Q ss_pred             CCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhcc
Q 018263          199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDP  278 (358)
Q Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (358)
                      .... ......|+..|+|||++.+..++.++|+||||+++|+|++|+.||...........               +...
T Consensus       153 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~---------------i~~~  216 (323)
T cd05615         153 VDGV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQS---------------IMEH  216 (323)
T ss_pred             CCCc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH---------------HHhC
Confidence            2221 22335689999999999888899999999999999999999999975432211111               1110


Q ss_pred             ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 018263          279 MLYGNFPENEAIRFLKVGLLCVQEKSKLRPQM  310 (358)
Q Consensus       279 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~  310 (358)
                        ...++...+..+.+++.+||+.+|.+|++.
T Consensus       217 --~~~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         217 --NVSYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             --CCCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence              112334456678999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=9.4e-39  Score=287.16  Aligned_cols=257  Identities=25%  Similarity=0.358  Sum_probs=200.2

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCC----EEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCe
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGT----IVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC  114 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~----~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~  114 (358)
                      .++|++.+.||.|+||.||+|.+. ++.    .+++|.+.... .....++..|+..+..+.  ||||+++++++.. ..
T Consensus         6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~--h~~iv~~~~~~~~-~~   82 (279)
T cd05111           6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLD--HAYIVRLLGICPG-AS   82 (279)
T ss_pred             HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCC--CCCcceEEEEECC-Cc
Confidence            468899999999999999999864 344    47777775332 223356667777888877  9999999998764 45


Q ss_pred             eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccc
Q 018263          115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS  194 (358)
Q Consensus       115 ~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~  194 (358)
                      .++++||+++++|.+++..   ....+++..+..++.||+.||.|||++   +++|+||+|+||+++.++.++|+|||.+
T Consensus        83 ~~~i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~  156 (279)
T cd05111          83 LQLVTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVA  156 (279)
T ss_pred             cEEEEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccc
Confidence            7789999999999999942   345689999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCc-ccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhH
Q 018263          195 KLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKEL  272 (358)
Q Consensus       195 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      ........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.......                .
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~----------------~  220 (279)
T cd05111         157 DLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE----------------V  220 (279)
T ss_pred             eeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH----------------H
Confidence            76533221 11223456678999999988889999999999999999998 999986543211                1


Q ss_pred             hhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCC
Q 018263          273 MNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETN  322 (358)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~  322 (358)
                      .+++........+..++..+.+++.+||..+|.+|||+.|+++.|..+..
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         221 PDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             HHHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence            11111111111222345578899999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-38  Score=282.00  Aligned_cols=249  Identities=30%  Similarity=0.450  Sum_probs=197.7

Q ss_pred             ceecccCceEEEEEEECC----CCEEEEEEeeccCh-hhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecC
Q 018263           48 NKIGEGGFGSVYKGRLQD----GTIVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM  122 (358)
Q Consensus        48 ~~lg~g~~g~v~~~~~~~----~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~  122 (358)
                      ++||+|+||.||+|.+..    +..|++|.+..... .....+..|+..++.+.  |+|++++++++. .+..+++|||+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~-~~~~~~v~e~~   77 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLD--HPCIVRLIGVCK-GEPLMLVMELA   77 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcC--CCCeeeEEEEEc-CCceEEEEEeC
Confidence            479999999999997532    36899999875433 35567888999999987  999999999876 45679999999


Q ss_pred             CCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCc
Q 018263          123 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT  202 (358)
Q Consensus       123 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~  202 (358)
                      ++++|.+++.    ....+++..+..++.|++.||++||+.   +++|+||+|+||+++.++.++|+|||.+........
T Consensus        78 ~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~  150 (257)
T cd05060          78 PLGPLLKYLK----KRREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD  150 (257)
T ss_pred             CCCcHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence            9999999993    334789999999999999999999999   999999999999999999999999999886543222


Q ss_pred             cccc--ccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhHhhhhccc
Q 018263          203 HIST--RVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPM  279 (358)
Q Consensus       203 ~~~~--~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (358)
                      ....  ...++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   ...             .+...
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~-------------~~~~~  214 (257)
T cd05060         151 YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIA-------------MLESG  214 (257)
T ss_pred             ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHH-------------HHHcC
Confidence            1111  1223457999999988889999999999999999998 999996443211   111             11111


Q ss_pred             cCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCC
Q 018263          280 LYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETN  322 (358)
Q Consensus       280 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~  322 (358)
                      .....+...+..+.+++.+||+.+|++||++.++++.|+++.+
T Consensus       215 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~  257 (257)
T cd05060         215 ERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDPE  257 (257)
T ss_pred             CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhccC
Confidence            1122333455678999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=6.5e-39  Score=298.10  Aligned_cols=264  Identities=22%  Similarity=0.243  Sum_probs=200.7

Q ss_pred             HhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC--
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP--  113 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~--  113 (358)
                      ...++|++.+.||+|+||.||++.+. .++.||+|.+...  .......+.+|+..++.++  ||||+++++++....  
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~   91 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN--HKNIISLLNVFTPQKSL   91 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhC--CCchhceeeeeeccccc
Confidence            34689999999999999999999865 6889999998643  3334467778999999988  999999999886443  


Q ss_pred             ----eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEe
Q 018263          114 ----CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKIS  189 (358)
Q Consensus       114 ----~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~  189 (358)
                          ..+++|||+++ +|.+.+.      ..+++..+..++.|++.||+|||++   |++||||||+||+++.++.++|+
T Consensus        92 ~~~~~~~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~  161 (355)
T cd07874          92 EEFQDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL  161 (355)
T ss_pred             cccceeEEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEe
Confidence                46899999964 6666662      2478899999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccch
Q 018263          190 DFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNS  269 (358)
Q Consensus       190 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      |||++.......  ......++..|+|||++.+..++.++||||||+++|+|++|+.||................+....
T Consensus       162 Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  239 (355)
T cd07874         162 DFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP  239 (355)
T ss_pred             eCcccccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            999997643221  223356889999999999889999999999999999999999999765533332222111111100


Q ss_pred             h-------hHhhhhcc---------------cc---CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 018263          270 K-------ELMNLVDP---------------ML---YGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKM  316 (358)
Q Consensus       270 ~-------~~~~~~~~---------------~~---~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~  316 (358)
                      +       .....++.               ..   ....+......+.+|+.+||+.||.+|||+.|+++-
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence            0       00000000               00   001112234578899999999999999999999973

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=9.2e-39  Score=298.05  Aligned_cols=262  Identities=21%  Similarity=0.249  Sum_probs=200.7

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC----
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG----  112 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~----  112 (358)
                      ..++|++.+.||+|+||.||++.+. .++.||||++...  .......+.+|+..++.+.  ||||+++++++...    
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~ii~~~~~~~~~~~~~   99 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN--HKNIIGLLNVFTPQKSLE   99 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcC--CCCccccceeeccccccc
Confidence            4689999999999999999999865 5889999998643  3344567788999999988  99999999987643    


Q ss_pred             --CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEee
Q 018263          113 --PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD  190 (358)
Q Consensus       113 --~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~D  190 (358)
                        ...|+||||++ ++|.+.+.      ..+++..+..++.|++.||+|||++   ||+|+||||+||+++.++.++|+|
T Consensus       100 ~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~D  169 (364)
T cd07875         100 EFQDVYIVMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD  169 (364)
T ss_pred             ccCeEEEEEeCCC-CCHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEe
Confidence              35799999996 46777762      2478899999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchh
Q 018263          191 FGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSK  270 (358)
Q Consensus       191 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      ||++.......  ......++..|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+....+.+...
T Consensus       170 fG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  247 (364)
T cd07875         170 FGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPE  247 (364)
T ss_pred             CCCccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence            99997643221  2233568899999999999899999999999999999999999998665443333222211111110


Q ss_pred             hH----------------------hhhhcccc---CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          271 EL----------------------MNLVDPML---YGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       271 ~~----------------------~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ..                      ..+.....   ...........+.+++.+||+.||.+|||+.++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             HHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            00                      00000000   00111123457889999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.3e-38  Score=283.89  Aligned_cols=250  Identities=24%  Similarity=0.424  Sum_probs=202.6

Q ss_pred             CCcccceecccCceEEEEEEECCCCEEEEEEeeccC------hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeE
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVES------KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI  116 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~  116 (358)
                      +|++.+.||.|+||.||+|...++..+++|.+....      ......+.+|++.++.++  |+|++++.+++...+..+
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~   78 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK--HVNIVQYLGTCLDDNTIS   78 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcC--CCCEeeEeeEeecCCeEE
Confidence            588999999999999999998889999999886432      222356888999999998  999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       117 iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      +++||+++++|.+++    .....+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||.+..
T Consensus        79 lv~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  151 (265)
T cd06631          79 IFMEFVPGGSISSIL----NRFGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARR  151 (265)
T ss_pred             EEEecCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHh
Confidence            999999999999999    3345688999999999999999999999   999999999999999999999999998875


Q ss_pred             cCCCC-----cccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhh
Q 018263          197 FPENT-----THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKE  271 (358)
Q Consensus       197 ~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      .....     ........++..|+|||.+.+..++.++|+||||+++|+|++|..||..............         
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~---------  222 (265)
T cd06631         152 LAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGA---------  222 (265)
T ss_pred             hhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhh---------
Confidence            42111     1112234578899999999888899999999999999999999999974432111110000         


Q ss_pred             HhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          272 LMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                           ........+...+..+.+++.+||+.+|.+||++.++++
T Consensus       223 -----~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         223 -----HRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             -----ccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                 001112233446677899999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=8.4e-39  Score=290.76  Aligned_cols=262  Identities=24%  Similarity=0.389  Sum_probs=207.2

Q ss_pred             HHhhcCCcccceecccCceEEEEEEEC------CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEE
Q 018263           38 KIATNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCI  110 (358)
Q Consensus        38 ~~~~~~y~i~~~lg~g~~g~v~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~  110 (358)
                      ....++|.+.+.||+|+||.||++...      .+..|++|.+.... ......+.+|+..++.+. .||||+++++.+.
T Consensus        31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-~h~~iv~~~~~~~  109 (302)
T cd05055          31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLG-NHENIVNLLGACT  109 (302)
T ss_pred             cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhcc-CCCCcceEEEEEe
Confidence            355678999999999999999999742      35579999886543 334467889999999983 3999999999999


Q ss_pred             cCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEee
Q 018263          111 DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD  190 (358)
Q Consensus       111 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~D  190 (358)
                      ..+..+++|||+++++|.+++...  ....+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.++++|
T Consensus       110 ~~~~~~lv~e~~~~~~L~~~i~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~d  184 (302)
T cd05055         110 IGGPILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICD  184 (302)
T ss_pred             cCCceEEEEEcCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECC
Confidence            999999999999999999998432  223489999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcc-cccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccc
Q 018263          191 FGLSKLFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYN  268 (358)
Q Consensus       191 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~  268 (358)
                      ||++......... ......++..|+|||.+.+..++.++||||+|+++|+|++ |..||........            
T Consensus       185 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~------------  252 (302)
T cd05055         185 FGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK------------  252 (302)
T ss_pred             CcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH------------
Confidence            9998765432221 1122345678999999988889999999999999999998 9999864432111            


Q ss_pred             hhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 018263          269 SKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE  320 (358)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~  320 (358)
                         ....+........+...+..+.+++.+||+.+|++|||+.++++.|++.
T Consensus       253 ---~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         253 ---FYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             ---HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence               1111111111122233456799999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.1e-38  Score=291.50  Aligned_cols=266  Identities=21%  Similarity=0.348  Sum_probs=208.5

Q ss_pred             HHHhhcCCcccceecccCceEEEEEEEC--------CCCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeec
Q 018263           37 LKIATNGFRWSNKIGEGGFGSVYKGRLQ--------DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHG  107 (358)
Q Consensus        37 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~--------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~  107 (358)
                      +....++|.+.+.||+|++|.||++...        .+..+++|.+... .......+..|+..++.+. .||||+++++
T Consensus         7 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~-~h~~iv~~~~   85 (314)
T cd05099           7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIG-KHKNIINLLG   85 (314)
T ss_pred             ccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhcc-CCCCeeeEEE
Confidence            3445678999999999999999999742        2456899988643 2334556788999888883 4999999999


Q ss_pred             eEEcCCeeEEEEecCCCCCHHHHhhhccc------------cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCC
Q 018263          108 GCIDGPCRILVYDYMPNNSLSQTLLGEEK------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKT  175 (358)
Q Consensus       108 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p  175 (358)
                      ++...+..+++|||+++++|.+++.....            ....+++..+..++.||+.||.|||++   |++|+||+|
T Consensus        86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp  162 (314)
T cd05099          86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAA  162 (314)
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeeccccc
Confidence            99999999999999999999999954321            124588999999999999999999999   999999999


Q ss_pred             CcEEEcCCCceEEeecccccccCCCCccc-ccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCcccc
Q 018263          176 SNILLDQNFNPKISDFGLSKLFPENTTHI-STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ  253 (358)
Q Consensus       176 ~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~  253 (358)
                      +||+++.++.++|+|||.+.......... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus       163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~  242 (314)
T cd05099         163 RNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV  242 (314)
T ss_pred             eeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999999997654322111 111223457999999988889999999999999999999 8888864322


Q ss_pred             ccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCC
Q 018263          254 LGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETN  322 (358)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~  322 (358)
                      .....                .+........+...+..+.+++.+||+.+|.+|||+.++++.|.++..
T Consensus       243 ~~~~~----------------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         243 EELFK----------------LLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             HHHHH----------------HHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence            11111                111111112334456678899999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.8e-39  Score=297.58  Aligned_cols=264  Identities=21%  Similarity=0.264  Sum_probs=199.6

Q ss_pred             HHHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC--hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC-
Q 018263           37 LKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG-  112 (358)
Q Consensus        37 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~-  112 (358)
                      +-...++|++.+.||.|+||.||+|.+. +++.||+|.+....  ......+.+|+..++.++  ||||+++++++... 
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~   87 (343)
T cd07878          10 VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMK--HENVIGLLDVFTPAT   87 (343)
T ss_pred             HhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcC--CCchhhhhhhhcccc
Confidence            3345689999999999999999999865 68899999986432  223456778999999998  99999999987543 


Q ss_pred             -----CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceE
Q 018263          113 -----PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPK  187 (358)
Q Consensus       113 -----~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~  187 (358)
                           ...+++++++ +++|.+++     ....+++..+..++.||+.||.|||++   ||+|+||+|+||+++.++.++
T Consensus        88 ~~~~~~~~~~~~~~~-~~~l~~~~-----~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~k  158 (343)
T cd07878          88 SIENFNEVYLVTNLM-GADLNNIV-----KCQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELR  158 (343)
T ss_pred             cccccCcEEEEeecC-CCCHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEE
Confidence                 3468999988 78898887     345689999999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcccccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhc
Q 018263          188 ISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGM  266 (358)
Q Consensus       188 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~  266 (358)
                      |+|||++......    .....++..|+|||++.+ ..++.++||||||+++|+|++|+.||................+.
T Consensus       159 l~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  234 (343)
T cd07878         159 ILDFGLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGT  234 (343)
T ss_pred             EcCCccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCC
Confidence            9999999864322    233568899999999876 46889999999999999999999999765433322222211111


Q ss_pred             cchhh--------HhhhhccccCCC------CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          267 YNSKE--------LMNLVDPMLYGN------FPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       267 ~~~~~--------~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .....        ....+.......      ........+.+++.+||+.||.+|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         235 PSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             CCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            11110        011111000000      00012345789999999999999999999985

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2.3e-38  Score=284.63  Aligned_cols=251  Identities=23%  Similarity=0.331  Sum_probs=199.3

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      ++|++.+.||+|++|.||+|.+. +++.|++|.+... .......+.+|+..+..+.  |||++++++.+...+..+++|
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~   78 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCD--SPYIIGFYGAFFVENRISICT   78 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCC--CCCeeeEEEEEEECCEEEEEE
Confidence            47889999999999999999864 6889999998654 3344567889999999988  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      ||+++++|..+.        .+++..+..++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++.....
T Consensus        79 e~~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~  147 (279)
T cd06619          79 EFMDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN  147 (279)
T ss_pred             ecCCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence            999999886542        467889999999999999999999   999999999999999999999999999876532


Q ss_pred             CCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccc
Q 018263          200 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPM  279 (358)
Q Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (358)
                      ..   .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||.............        .......+..
T Consensus       148 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~--------~~~~~~~~~~  216 (279)
T cd06619         148 SI---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPL--------QLLQCIVDED  216 (279)
T ss_pred             cc---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchH--------HHHHHHhccC
Confidence            21   223568889999999998889999999999999999999999996533211111000        0001111111


Q ss_pred             cCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 018263          280 LYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKM  316 (358)
Q Consensus       280 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~  316 (358)
                      .........+.++.+++.+||+.+|.+||+++++++.
T Consensus       217 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         217 PPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             CCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            1111122345678999999999999999999999864

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.6e-38  Score=280.45  Aligned_cols=250  Identities=20%  Similarity=0.349  Sum_probs=201.7

Q ss_pred             CCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEc-CCeeEEE
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID-GPCRILV  118 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~-~~~~~iv  118 (358)
                      +|++.+.||.|++|.||++..+ +++.|++|.+...  .......+..|++.++.++  |+|++++.+.+.. ....+++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~~lv   78 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLK--HPNIVAYRESWEGEDGLLYIV   78 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCC--CCCeeeeeeeecCCCCEEEEE
Confidence            5899999999999999999965 5788999998643  2334566888999999988  9999999998764 4467899


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      |||+++++|.+.+..  .....+++..+..++.|++.+|++||++   |++|+||+|+||+++.++.++|+|||++....
T Consensus        79 ~e~~~~~~l~~~l~~--~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~  153 (257)
T cd08223          79 MGFCEGGDLYHKLKE--QKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLE  153 (257)
T ss_pred             ecccCCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEec
Confidence            999999999999843  2345689999999999999999999999   99999999999999999999999999987653


Q ss_pred             CCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhcc
Q 018263          199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDP  278 (358)
Q Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (358)
                      .... ......+++.|+|||++.+..++.++|+||||+++++|++|+.||..........               .+. .
T Consensus       154 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~---------------~~~-~  216 (257)
T cd08223         154 NQCD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVY---------------RII-E  216 (257)
T ss_pred             ccCC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHH---------------HHH-h
Confidence            3221 2233457889999999988889999999999999999999999987443211100               000 1


Q ss_pred             ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 018263          279 MLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKM  316 (358)
Q Consensus       279 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~  316 (358)
                      ......+...+..+.+++.+||+.+|.+|||+.++++.
T Consensus       217 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         217 GKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             cCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            11122344566789999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=3.7e-39  Score=296.14  Aligned_cols=246  Identities=26%  Similarity=0.333  Sum_probs=192.7

Q ss_pred             ceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHH-HhhhcccCCCCceeeeceEEcCCeeEEEEecC
Q 018263           48 NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVA-SMANVNVCHENLVKLHGGCIDGPCRILVYDYM  122 (358)
Q Consensus        48 ~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~-~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~  122 (358)
                      +.||+|+||.||+|+.. +|+.||+|++....   ......+..|.. .++.+.  ||||+++++.+...+..++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~--hp~iv~~~~~~~~~~~~~lv~e~~   78 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVK--HPFLVGLHYSFQTTEKLYFVLDFV   78 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCC--CCCCccEEEEEecCCEEEEEEcCC
Confidence            46899999999999875 68999999986432   223344445544 355566  999999999999999999999999


Q ss_pred             CCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCc
Q 018263          123 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT  202 (358)
Q Consensus       123 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~  202 (358)
                      ++++|...+    .....+++..+..++.||+.||+|||++   |++|+||||+||+++.++.++|+|||++...... .
T Consensus        79 ~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~  150 (325)
T cd05604          79 NGGELFFHL----QRERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-S  150 (325)
T ss_pred             CCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-C
Confidence            999999888    4456789999999999999999999999   9999999999999999999999999998753211 1


Q ss_pred             ccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccCC
Q 018263          203 HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYG  282 (358)
Q Consensus       203 ~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (358)
                      .......|+..|+|||++.+..++.++||||||+++|+|++|..||..........               .+....  .
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~---------------~~~~~~--~  213 (325)
T cd05604         151 DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYD---------------NILHKP--L  213 (325)
T ss_pred             CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHH---------------HHHcCC--c
Confidence            12234568999999999999899999999999999999999999997543221111               111110  0


Q ss_pred             CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 018263          283 NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE  320 (358)
Q Consensus       283 ~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~  320 (358)
                      ..+...+..+.+++.+||+.+|.+||++.+.++.+-.+
T Consensus       214 ~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h  251 (325)
T cd05604         214 VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEH  251 (325)
T ss_pred             cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcC
Confidence            11223456688999999999999999987555544444

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.9e-38  Score=282.97  Aligned_cols=248  Identities=29%  Similarity=0.453  Sum_probs=202.0

Q ss_pred             CCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChh---------hHHHHHHHHHHhhhcccCCCCceeeeceEEcC
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQ---------GEKEFMSEVASMANVNVCHENLVKLHGGCIDG  112 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~---------~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~  112 (358)
                      +|.+.+.||.|++|.||+|... +++.|++|.+......         ..+.+..|+..++.++  ||||+++++++...
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~   78 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ--HENIVQYLGSSLDA   78 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcC--CCCeeeEEEEEEeC
Confidence            5888999999999999999865 5889999988643221         2256788999999998  99999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecc
Q 018263          113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG  192 (358)
Q Consensus       113 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg  192 (358)
                      ...++++||+++++|.+++    ...+.+++..+..++.|++.||++||+.   |++|+||+|+||+++.++.++|+|||
T Consensus        79 ~~~~lv~e~~~~~~L~~~l----~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg  151 (267)
T cd06628          79 DHLNIFLEYVPGGSVAALL----NNYGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFG  151 (267)
T ss_pred             CccEEEEEecCCCCHHHHH----HhccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccC
Confidence            9999999999999999999    3446788999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCc-----ccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhcc
Q 018263          193 LSKLFPENTT-----HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMY  267 (358)
Q Consensus       193 ~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~  267 (358)
                      .+........     .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||........   +       
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~-------  221 (267)
T cd06628         152 ISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA---I-------  221 (267)
T ss_pred             CCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH---H-------
Confidence            9876542111     111124577899999999888899999999999999999999999975322111   0       


Q ss_pred             chhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          268 NSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                           .... .......+...+..+.+++.+||+.+|.+||++.++++
T Consensus       222 -----~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         222 -----FKIG-ENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             -----HHHh-ccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence                 0100 11222344456778999999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.3e-38  Score=286.06  Aligned_cols=260  Identities=27%  Similarity=0.402  Sum_probs=205.6

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCC----EEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGT----IVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP  113 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~----~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~  113 (358)
                      ..++|++.+.||.|+||.||+|.+. ++.    .|++|.+... .......+.+|...+..+.  |||++++++.+... 
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~~-   81 (279)
T cd05109           5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVG--SPYVCRLLGICLTS-   81 (279)
T ss_pred             chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcC--CCCCceEEEEEcCC-
Confidence            3578999999999999999999853 444    4899998644 3444567888999998887  99999999988754 


Q ss_pred             eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccc
Q 018263          114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL  193 (358)
Q Consensus       114 ~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~  193 (358)
                      ..+++++|+++++|.+++..   ....+++..+..++.||+.||.|||++   +++|+||+|+||++++++.++|+|||+
T Consensus        82 ~~~l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~  155 (279)
T cd05109          82 TVQLVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGL  155 (279)
T ss_pred             CcEEEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCc
Confidence            57799999999999999842   245689999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcc-cccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhh
Q 018263          194 SKLFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKE  271 (358)
Q Consensus       194 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      +......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.......                
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~----------------  219 (279)
T cd05109         156 ARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE----------------  219 (279)
T ss_pred             eeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH----------------
Confidence            8865432221 1112234568999999988889999999999999999998 899986432211                


Q ss_pred             HhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCC
Q 018263          272 LMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNID  324 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~  324 (358)
                      ....+........+...+..+.+++.+||+.||++||++.++++.|+.+....
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         220 IPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             HHHHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence            11122222222233445667899999999999999999999999998775443

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-38  Score=284.78  Aligned_cols=247  Identities=26%  Similarity=0.388  Sum_probs=204.0

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      ++|++.+.||.|++|.||+|.+. +++.|++|.+.... ......+.+|+..++.++  |+|++++.+.+......++|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~~v~   78 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCR--SPYITKYYGSFLKGSKLWIIM   78 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcC--CCCeeeeeEEEEECCeEEEEE
Confidence            47899999999999999999976 68899999987553 344467788999999998  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      ||+++++|.+++.     ...+++..++.++.|++.||.+||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        79 e~~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  150 (274)
T cd06609          79 EYCGGGSCLDLLK-----PGKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTS  150 (274)
T ss_pred             EeeCCCcHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecc
Confidence            9999999999983     23789999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccc
Q 018263          200 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPM  279 (358)
Q Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (358)
                      ... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...........                +...
T Consensus       151 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~----------------~~~~  213 (274)
T cd06609         151 TMS-KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFL----------------IPKN  213 (274)
T ss_pred             ccc-ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHH----------------hhhc
Confidence            322 22334577889999999988899999999999999999999999975432111100                1111


Q ss_pred             cCCCCCHH-HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          280 LYGNFPEN-EAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       280 ~~~~~~~~-~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .....+.. .+..+.+++.+||+.+|++|||++++++
T Consensus       214 ~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         214 NPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             CCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            11111222 5667899999999999999999999976

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-38  Score=280.85  Aligned_cols=254  Identities=25%  Similarity=0.371  Sum_probs=206.5

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      .++|++.+.||.|++|.||+|... +++.+++|.+..........+..|++.++.++  |||++++++.+......+++|
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~--h~~i~~~~~~~~~~~~~~l~~   79 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECR--HPNIVAYFGSYLRRDKLWIVM   79 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCC--CCChhceEEEEEeCCEEEEEE
Confidence            468999999999999999999875 57889999998766556778899999999998  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      ||+++++|.+++..   ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        80 e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  153 (262)
T cd06613          80 EYCGGGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTA  153 (262)
T ss_pred             eCCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhh
Confidence            99999999998832   236789999999999999999999999   999999999999999999999999999876533


Q ss_pred             CCcccccccccccCccCccccccC---CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhh
Q 018263          200 NTTHISTRVAGTLGYLAPEYAISG---RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV  276 (358)
Q Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~~~---~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                      ... ......++..|+|||.+.+.   .++.++|+||||+++|+|++|..||..............          .. .
T Consensus       154 ~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~----------~~-~  221 (262)
T cd06613         154 TIA-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISK----------SN-F  221 (262)
T ss_pred             hhh-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----------cc-C
Confidence            221 12234577889999998776   788999999999999999999999975432211111100          00 0


Q ss_pred             ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          277 DPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       277 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                       ...........+..+.+++.+||+.+|.+|||+.+|++
T Consensus       222 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         222 -PPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             -CCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence             00011123456678999999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=4.5e-39  Score=309.44  Aligned_cols=267  Identities=21%  Similarity=0.269  Sum_probs=197.0

Q ss_pred             HHHHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcc----cCCCCceeeeceEE
Q 018263           36 QLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVN----VCHENLVKLHGGCI  110 (358)
Q Consensus        36 ~~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~----~~h~~i~~~~~~~~  110 (358)
                      ++....++|++.+.||+|+||.||+|.+. +++.||||++.... ........|+..+..+.    ..|.+++.+++++.
T Consensus       123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            34455689999999999999999999875 58889999986432 22233445555555553    12556888888887


Q ss_pred             cC-CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcEEcCCCCCcEEEcCCC----
Q 018263          111 DG-PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNILLDQNF----  184 (358)
Q Consensus       111 ~~-~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~~~~i~H~di~p~Nilv~~~~----  184 (358)
                      .. ...++||+++ |++|.+++    ...+.+++..+..++.||+.||.|||+ .   ||+||||||+||+++.++    
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l----~~~~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~  273 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWI----MKHGPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVD  273 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcccc
Confidence            64 4688999988 78888888    344678999999999999999999997 7   999999999999998765    


Q ss_pred             ------------ceEEeecccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccc
Q 018263          185 ------------NPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV  252 (358)
Q Consensus       185 ------------~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~  252 (358)
                                  .+||+|||.+....    .......+|..|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus       274 ~~~~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~  349 (467)
T PTZ00284        274 PVTNRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD  349 (467)
T ss_pred             cccccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                        49999999875421    12234578999999999999999999999999999999999999998766


Q ss_pred             cccchhhhHhhhhccchh--------hHhhhhccc--cCCCCC---------------HHHHHHHHHHHhhccCCCCCCC
Q 018263          253 QLGEYHLVDKAWGMYNSK--------ELMNLVDPM--LYGNFP---------------ENEAIRFLKVGLLCVQEKSKLR  307 (358)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~--------~~~~~~~~~--~~~~~~---------------~~~~~~l~~li~~~l~~~P~~R  307 (358)
                      ..+....+....+.....        +...+....  +.....               ......+.+||.+||+.||.+|
T Consensus       350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R  429 (467)
T PTZ00284        350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR  429 (467)
T ss_pred             hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence            554444443332221110        001111100  000000               0123567899999999999999


Q ss_pred             CCHHHHHH
Q 018263          308 PQMSTAIK  315 (358)
Q Consensus       308 pt~~eil~  315 (358)
                      ||++|+++
T Consensus       430 ~ta~e~L~  437 (467)
T PTZ00284        430 LNARQMTT  437 (467)
T ss_pred             CCHHHHhc
Confidence            99999986

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.2e-38  Score=287.81  Aligned_cols=259  Identities=29%  Similarity=0.443  Sum_probs=204.5

Q ss_pred             hhcCCcccceecccCceEEEEEEEC------CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG  112 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~  112 (358)
                      ..++|++.+.||.|+||.||+|...      ++..|++|.+.... ......+.+|+..+..+.  |||++++++++...
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~--h~~iv~~~~~~~~~   80 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD--HPNIVKLLGVCAVG   80 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcC--CCchheEEEEEcCC
Confidence            4578999999999999999999863      46789999986543 334567888999999998  99999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHhhhcc------------------ccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCC
Q 018263          113 PCRILVYDYMPNNSLSQTLLGEE------------------KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIK  174 (358)
Q Consensus       113 ~~~~iv~e~~~~~~L~~~l~~~~------------------~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~  174 (358)
                      ...++++||+++++|.+++....                  .....+++..++.++.|++.||++||++   +++|+||+
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~  157 (288)
T cd05050          81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLA  157 (288)
T ss_pred             CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ceeccccc
Confidence            99999999999999999995321                  1123478899999999999999999999   99999999


Q ss_pred             CCcEEEcCCCceEEeecccccccCCCCc-ccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccc
Q 018263          175 TSNILLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV  252 (358)
Q Consensus       175 p~Nilv~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~  252 (358)
                      |+||+++.++.++|+|||.+........ ........+..|+|||.+.+..++.++||||||+++|+|++ |..||....
T Consensus       158 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~  237 (288)
T cd05050         158 TRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA  237 (288)
T ss_pred             HhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999875432211 11112234567999999888889999999999999999997 888885432


Q ss_pred             cccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 018263          253 QLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNG  319 (358)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~  319 (358)
                      ...   ..             ..+........+...+..+.+++.+||+.+|.+|||+.|+++.|++
T Consensus       238 ~~~---~~-------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         238 HEE---VI-------------YYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             HHH---HH-------------HHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            211   11             1111111111233456779999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.6e-38  Score=283.82  Aligned_cols=257  Identities=26%  Similarity=0.437  Sum_probs=205.1

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CC---CEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCe
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DG---TIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC  114 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~---~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~  114 (358)
                      ..++|+..+.||.|++|.||+|..+ ++   ..+++|.+... .......+..|++.+..++  |||++++.+++...+.
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~   80 (268)
T cd05063           3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS--HHNIIRLEGVVTKFKP   80 (268)
T ss_pred             ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCC--CCCeeEEEEEEccCCC
Confidence            4568889999999999999999865 23   36899988654 2344567888999999988  9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccc
Q 018263          115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS  194 (358)
Q Consensus       115 ~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~  194 (358)
                      .+++|||+++++|.+++..   ....+++..+..++.|++.||+|||+.   |++|+||+|+||+++.++.++++|||++
T Consensus        81 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~  154 (268)
T cd05063          81 AMIITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLS  154 (268)
T ss_pred             cEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccc
Confidence            9999999999999999832   335688999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCCccccc--ccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhh
Q 018263          195 KLFPENTTHIST--RVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKE  271 (358)
Q Consensus       195 ~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      ............  ....+..|+|||++.+..++.++|+||||+++|+|++ |+.||.........              
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~--------------  220 (268)
T cd05063         155 RVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVM--------------  220 (268)
T ss_pred             eecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHH--------------
Confidence            765432221111  1223457999999988889999999999999999997 99998644321111              


Q ss_pred             HhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 018263          272 LMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE  320 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~  320 (358)
                        ..+........+...+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus       221 --~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         221 --KAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             --HHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence              11111111122234566789999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-38  Score=287.23  Aligned_cols=265  Identities=25%  Similarity=0.372  Sum_probs=206.0

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      ++|++.+.||.|++|.||+|.++ +++.|++|.+...  .......+..|++.++.++  |+|++++++.+...+..+++
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~iv   78 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLR--HENIVNLKEAFRRKGRLYLV   78 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcC--CCCeeehhheEEECCEEEEE
Confidence            47999999999999999999976 5889999988643  3344577889999999998  99999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      +||++++.+..+.    .....+++..+..++.||+.||.|||+.   +++|+||+|+||++++++.++|+|||.+....
T Consensus        79 ~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~  151 (288)
T cd07833          79 FEYVERTLLELLE----ASPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALR  151 (288)
T ss_pred             EecCCCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccC
Confidence            9999887666655    3345689999999999999999999999   99999999999999999999999999988764


Q ss_pred             CCCcccccccccccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhc
Q 018263          199 ENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD  277 (358)
Q Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      ...........++..|+|||++.+. .++.++|+||||+++|+|++|+.||......+.........+............
T Consensus       152 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T cd07833         152 ARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSS  231 (288)
T ss_pred             CCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhccc
Confidence            4332223345677889999999887 789999999999999999999999976543332222222111111110000000


Q ss_pred             -cc--------------cCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          278 -PM--------------LYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       278 -~~--------------~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                       +.              ....++...+..+.++|.+||+.+|++||+++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence             00              000122334778999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.5e-38  Score=286.14  Aligned_cols=271  Identities=27%  Similarity=0.410  Sum_probs=209.1

Q ss_pred             hcCCcccceecccCceEEEEEEEC-----CCCEEEEEEeeccChh-hHHHHHHHHHHhhhcccCCCCceeeeceEEc--C
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-----DGTIVAVKVLSVESKQ-GEKEFMSEVASMANVNVCHENLVKLHGGCID--G  112 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~--~  112 (358)
                      ...|++.+.||+|+||.||++...     +++.|++|.+...... ....+..|+..++.+.  |+|++++++++..  .
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~--~~~i~~~~~~~~~~~~   80 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLD--HENIVKYKGVCEKPGG   80 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCC--CCChheEEeeeecCCC
Confidence            457888999999999999999853     4788999998755443 5678899999999987  9999999999887  5


Q ss_pred             CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecc
Q 018263          113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG  192 (358)
Q Consensus       113 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg  192 (358)
                      ...+++|||+++++|.+++..   ....+++..+..++.|++.||++||++   |++|+||+|+||+++.++.++|+|||
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg  154 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQR---HRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFG  154 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHh---CccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccc
Confidence            578999999999999999942   233589999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcc--cccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchh
Q 018263          193 LSKLFPENTTH--ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSK  270 (358)
Q Consensus       193 ~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      .+.........  ......++..|.|||.+.+..++.++|+||||+++++|++|..|+......... ............
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~  233 (284)
T cd05038         155 LAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR-MIGIAQGQMIVT  233 (284)
T ss_pred             cccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc-ccccccccccHH
Confidence            99876422221  111233456799999998888999999999999999999999998643221100 000000001111


Q ss_pred             hHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 018263          271 ELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE  320 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~  320 (358)
                      .....+........+..++..+.+++.+||+.+|.+|||+.||++.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         234 RLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            22222222222223344567899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.7e-38  Score=280.18  Aligned_cols=251  Identities=31%  Similarity=0.493  Sum_probs=202.5

Q ss_pred             CcccceecccCceEEEEEEECC-----CCEEEEEEeeccChh-hHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           44 FRWSNKIGEGGFGSVYKGRLQD-----GTIVAVKVLSVESKQ-GEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        44 y~i~~~lg~g~~g~v~~~~~~~-----~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      +++.+.||.|+||.||++++..     +..|++|.+...... ....+..|+..+..+.  |+|++++++.+...+..++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~~   78 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLD--HPNIVKLLGVCTEEEPLMI   78 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcC--CCchheEEEEEcCCCeeEE
Confidence            4678999999999999999753     488999998655433 5678889999999997  9999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      +|||+++++|.+++...  ....+++..+..++.|++.||++||+.   +++|+||+|+||+++.++.++|+|||.+...
T Consensus        79 i~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~  153 (258)
T smart00219       79 VMEYMEGGDLLDYLRKN--RPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDL  153 (258)
T ss_pred             EEeccCCCCHHHHHHhh--hhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceec
Confidence            99999999999998432  112289999999999999999999999   9999999999999999999999999999865


Q ss_pred             CCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhHhhhh
Q 018263          198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV  276 (358)
Q Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                      ............++..|+|||.+.+..++.++|+||||+++++|++ |..||........                ...+
T Consensus       154 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~----------------~~~~  217 (258)
T smart00219      154 YDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEV----------------LEYL  217 (258)
T ss_pred             ccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHH----------------HHHH
Confidence            4432222212336788999999888889999999999999999998 7888865322111                1111


Q ss_pred             ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 018263          277 DPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMM  317 (358)
Q Consensus       277 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L  317 (358)
                      ........+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus       218 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      218 KKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             hcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            11112223334667899999999999999999999999875

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.1e-38  Score=287.28  Aligned_cols=265  Identities=24%  Similarity=0.354  Sum_probs=201.2

Q ss_pred             CCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC--hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      +|++.+.||.|++|.||+|+.. +++.|++|.+....  ......+.+|+..++.+.  |||++++++.+..++..++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~~v~   78 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQ--HPNIVCLQDVLMQESRLYLIF   78 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcC--CCCEeeeEEEEeeCCeEEEEE
Confidence            5889999999999999999975 68999999986442  233467788999999998  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      ||++ ++|.+++... .....+++..++.++.||+.||+|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        79 e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  153 (285)
T cd07861          79 EFLS-MDLKKYLDSL-PKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI  153 (285)
T ss_pred             ecCC-CCHHHHHhcC-CCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCC
Confidence            9996 5888887432 2235789999999999999999999999   999999999999999999999999999876533


Q ss_pred             CCcccccccccccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchh--------
Q 018263          200 NTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSK--------  270 (358)
Q Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~--------  270 (358)
                      ... ......++..|+|||++.+. .++.++|+||||+++|+|++|+.||................+.....        
T Consensus       154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (285)
T cd07861         154 PVR-VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL  232 (285)
T ss_pred             Ccc-cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhh
Confidence            221 12223467889999988654 57889999999999999999999998655433222211111111100        


Q ss_pred             -hHhhhhccccCC---CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          271 -ELMNLVDPMLYG---NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       271 -~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                       +...........   ......+.++.++|.+||+.||.+|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence             001000000000   011124567889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2e-38  Score=287.29  Aligned_cols=266  Identities=25%  Similarity=0.430  Sum_probs=205.2

Q ss_pred             hhcCCcccceecccCceEEEEEEECC-----------------CCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCC
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQD-----------------GTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHEN  101 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~~-----------------~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~  101 (358)
                      ..++|++++.||+|+||.||+|....                 +..|++|.+.... ....+.+..|+..++.++  |||
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~--~~~   80 (296)
T cd05051           3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLS--DPN   80 (296)
T ss_pred             chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcC--CCC
Confidence            35789999999999999999998542                 2458999986543 345567888999999998  999


Q ss_pred             ceeeeceEEcCCeeEEEEecCCCCCHHHHhhhccc-------cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCC
Q 018263          102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEK-------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIK  174 (358)
Q Consensus       102 i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~-------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~  174 (358)
                      ++++++++......++++|++++++|.+++.....       ....+++..++.++.|++.||+|||+.   +++|+||+
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlk  157 (296)
T cd05051          81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLA  157 (296)
T ss_pred             EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccc
Confidence            99999999999999999999999999999854321       123689999999999999999999999   99999999


Q ss_pred             CCcEEEcCCCceEEeecccccccCCCCc-ccccccccccCccCccccccCCCCccCceecHHHHHHHHHh--CCCCCCcc
Q 018263          175 TSNILLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS--GRTAVDFD  251 (358)
Q Consensus       175 p~Nilv~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt--g~~pf~~~  251 (358)
                      |+||+++.++.++|+|||.+........ .......++..|+|||.+.+..++.++||||||+++|+|++  +..||...
T Consensus       158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~  237 (296)
T cd05051         158 TRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL  237 (296)
T ss_pred             hhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence            9999999999999999999875432221 11223445678999999988889999999999999999998  66777543


Q ss_pred             ccccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 018263          252 VQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNG  319 (358)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~  319 (358)
                      .....   .......+...      ........+...+.++.+++.+||+.+|.+|||+.+|++.|++
T Consensus       238 ~~~~~---~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         238 TDQQV---IENAGHFFRDD------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             ChHHH---HHHHHhccccc------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence            22111   11110000000      0001111223445789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-38  Score=288.23  Aligned_cols=265  Identities=24%  Similarity=0.388  Sum_probs=202.8

Q ss_pred             hcCCcccceecccCceEEEEEEECC---------------CCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCcee
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQD---------------GTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVK  104 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~~---------------~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~  104 (358)
                      ..+|++.+.||+|+||.||++....               ...|++|.+... .......+.+|++.+..++  |+|+++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~--h~~i~~   81 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLK--NPNIIR   81 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC--CCCcCe
Confidence            4689999999999999999987532               234899998654 3344567889999999998  999999


Q ss_pred             eeceEEcCCeeEEEEecCCCCCHHHHhhhccc--------cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCC
Q 018263          105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEK--------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTS  176 (358)
Q Consensus       105 ~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~--------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~  176 (358)
                      +++++...+..++||||+++++|.+++.....        ....+++..+..++.|++.||+|||+.   +++|+||+|+
T Consensus        82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~  158 (295)
T cd05097          82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATR  158 (295)
T ss_pred             EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChh
Confidence            99999999999999999999999999843221        112468899999999999999999999   9999999999


Q ss_pred             cEEEcCCCceEEeecccccccCCCCcc-cccccccccCccCccccccCCCCccCceecHHHHHHHHHh--CCCCCCcccc
Q 018263          177 NILLDQNFNPKISDFGLSKLFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS--GRTAVDFDVQ  253 (358)
Q Consensus       177 Nilv~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt--g~~pf~~~~~  253 (358)
                      ||+++.++.++|+|||++......... ......++..|+|||++.+..++.++|+||||+++|+|++  +..||.....
T Consensus       159 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~  238 (295)
T cd05097         159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD  238 (295)
T ss_pred             hEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence            999999999999999998754322211 1122334678999999988889999999999999999998  5667764332


Q ss_pred             ccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 018263          254 LGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNG  319 (358)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~  319 (358)
                      ...........   ..      .........+...+..+.+++.+||+.+|++||++.+|++.|..
T Consensus       239 ~~~~~~~~~~~---~~------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         239 EQVIENTGEFF---RN------QGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             HHHHHHHHHhh---hh------ccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence            21111111000   00      00111111223345689999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.6e-38  Score=288.21  Aligned_cols=259  Identities=21%  Similarity=0.336  Sum_probs=209.6

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      .++|++.+.||.|++|.||++... +++.|++|.+..........+.+|+..++.+.  |+|++++++.+..+...++||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~--h~~i~~~~~~~~~~~~~~lv~   95 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENK--NPNIVNYLDSYLVGDELWVVM   95 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCC--CCCEeeEEEEEecCCEEEEee
Confidence            479999999999999999999964 69999999997665555677888999999887  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      ||+++++|.+++.     ...+++..+..++.|++.||.+||+.   |++|+||+|+||+++.++.++|+|||.+.....
T Consensus        96 e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~  167 (297)
T cd06656          96 EYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (297)
T ss_pred             cccCCCCHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence            9999999999982     34578999999999999999999999   999999999999999999999999999876433


Q ss_pred             CCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccc
Q 018263          200 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPM  279 (358)
Q Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (358)
                      ... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||..............              ...
T Consensus       168 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~--------------~~~  232 (297)
T cd06656         168 EQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT--------------NGT  232 (297)
T ss_pred             Ccc-CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc--------------CCC
Confidence            221 12234578899999999888899999999999999999999999975443221111000              000


Q ss_pred             cCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhhcCCCCC
Q 018263          280 LYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK--MMNGETNID  324 (358)
Q Consensus       280 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~--~L~~~~~~~  324 (358)
                      .....+...+..+.+++.+||+.+|++||++.++++  .++..++..
T Consensus       233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  279 (297)
T cd06656         233 PELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLS  279 (297)
T ss_pred             CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccccc
Confidence            001123345566889999999999999999999988  444444433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.3e-38  Score=285.28  Aligned_cols=264  Identities=23%  Similarity=0.360  Sum_probs=205.9

Q ss_pred             CCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC--hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      +|++.+.||.|++|.||+|.+. +|+.|++|++....  ......+.+|+..++.++  |||++++++++......++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~~~~~~~v~   78 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQ--HPYVVKLLDVFPHGSGFVLVM   78 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCC--CCCCcceeeEEecCCeeEEEe
Confidence            5899999999999999999975 68999999987543  344567889999999998  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      ||+ +++|.+++..   ....+++..++.++.||+.||+|||+.   |++|+||+|+||+++.++.++|+|||.+.....
T Consensus        79 e~~-~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~  151 (286)
T cd07832          79 EYM-PSDLSEVLRD---EERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSE  151 (286)
T ss_pred             ccc-CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccC
Confidence            999 9999999843   236689999999999999999999999   999999999999999999999999999887644


Q ss_pred             CCcccccccccccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhc-
Q 018263          200 NTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD-  277 (358)
Q Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  277 (358)
                      ..........++..|+|||.+.+. .++.++||||+|+++++|++|.++|................+......+....+ 
T Consensus       152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07832         152 EEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL  231 (286)
T ss_pred             CCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCc
Confidence            332223335678899999988654 468999999999999999999888876554333322222222111111111000 


Q ss_pred             --------cccC----CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          278 --------PMLY----GNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       278 --------~~~~----~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                              +...    .....+.+..+.+++.+||+.+|.+|||++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                    0000    0011234578999999999999999999999986

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2.7e-38  Score=282.78  Aligned_cols=256  Identities=25%  Similarity=0.382  Sum_probs=198.6

Q ss_pred             CcccceecccCceEEEEEEECC-CC--EEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC------
Q 018263           44 FRWSNKIGEGGFGSVYKGRLQD-GT--IVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG------  112 (358)
Q Consensus        44 y~i~~~lg~g~~g~v~~~~~~~-~~--~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~------  112 (358)
                      |.+.+.||+|+||.||+|.+.. +.  .|++|.+...  .......+..|+..++.++  |+||+++++.+...      
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~~~   78 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFD--HPNVMRLIGVCLQTVESEGY   78 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCC--CCCcceEEEEEccCCcccCC
Confidence            4578899999999999998754 32  5899988653  3444567888999999987  99999999876432      


Q ss_pred             CeeEEEEecCCCCCHHHHhhhcc--ccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEee
Q 018263          113 PCRILVYDYMPNNSLSQTLLGEE--KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD  190 (358)
Q Consensus       113 ~~~~iv~e~~~~~~L~~~l~~~~--~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~D  190 (358)
                      ...++++||+++++|.+++....  .....+++..+..++.||+.||+|||++   +++|+||||+||+++.++.++|+|
T Consensus        79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~D  155 (272)
T cd05075          79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVAD  155 (272)
T ss_pred             CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECC
Confidence            24689999999999998874322  2334589999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCccc-ccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccc
Q 018263          191 FGLSKLFPENTTHI-STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYN  268 (358)
Q Consensus       191 fg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~  268 (358)
                      ||++..+....... .....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||.......   .....     
T Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~~-----  227 (272)
T cd05075         156 FGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---IYDYL-----  227 (272)
T ss_pred             CCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH-----
Confidence            99998654322111 122345678999999988889999999999999999999 888986533211   11111     


Q ss_pred             hhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 018263          269 SKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE  320 (358)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~  320 (358)
                              ........+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       228 --------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         228 --------RQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             --------HcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                    01001112234556789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.1e-38  Score=280.37  Aligned_cols=247  Identities=26%  Similarity=0.396  Sum_probs=197.3

Q ss_pred             eecccCceEEEEEEEC---CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecCCC
Q 018263           49 KIGEGGFGSVYKGRLQ---DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN  124 (358)
Q Consensus        49 ~lg~g~~g~v~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~~~  124 (358)
                      .||.|+||.||+|.+.   .+..|++|+..... ....+.+.+|+..++.+.  ||||+++++++.. ...++||||+++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~--h~~ii~~~~~~~~-~~~~lv~e~~~~   78 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLD--NPYIVRMIGVCEA-EALMLVMEMASG   78 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcC--CCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence            4899999999999754   35579999986543 334467889999999998  9999999998754 568999999999


Q ss_pred             CCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCccc
Q 018263          125 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI  204 (358)
Q Consensus       125 ~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~  204 (358)
                      ++|.+++..   ....+++..+..++.|++.||+|||++   |++|+||+|+||+++.++.++|+|||++..........
T Consensus        79 ~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~  152 (257)
T cd05115          79 GPLNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY  152 (257)
T ss_pred             CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence            999999832   345789999999999999999999999   99999999999999999999999999987543322211


Q ss_pred             --ccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhHhhhhccccC
Q 018263          205 --STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLY  281 (358)
Q Consensus       205 --~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (358)
                        .....++..|+|||.+.+..++.++||||||+++|+|++ |..||......                +....+.....
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----------------~~~~~~~~~~~  216 (257)
T cd05115         153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP----------------EVMSFIEQGKR  216 (257)
T ss_pred             eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH----------------HHHHHHHCCCC
Confidence              111223568999999888889999999999999999996 99998744321                11122222222


Q ss_pred             CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 018263          282 GNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE  320 (358)
Q Consensus       282 ~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~  320 (358)
                      ...+...+..+.+++.+||+.+|++||++.+|++.|+..
T Consensus       217 ~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         217 LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            334455677899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=5.2e-38  Score=278.49  Aligned_cols=250  Identities=22%  Similarity=0.358  Sum_probs=205.3

Q ss_pred             CCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      +|++.+.||.|++|.||.++.. +++.+++|.+...  .......+.+|+..++.++  |+|++++++++...+..+++|
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~--h~~i~~~~~~~~~~~~~~~~~   78 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQ--HPNIIAYYNHFMDDNTLLIEM   78 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCC--CCCeeEEEeEEecCCeEEEEE
Confidence            5899999999999999999864 6889999988654  3445567889999999997  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      ||+++++|.+++...  ....+++..+..++.|++.+|+|||+.   |++|+||+|+||+++.++.++|+|||.+.....
T Consensus        79 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~  153 (256)
T cd08221          79 EYANGGTLYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGS  153 (256)
T ss_pred             EecCCCcHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccc
Confidence            999999999998432  245689999999999999999999999   999999999999999999999999999886544


Q ss_pred             CCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccc
Q 018263          200 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPM  279 (358)
Q Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (358)
                      ... ......++..|.|||.+.+..++.++|+||||+++++|++|..||..........               .+... 
T Consensus       154 ~~~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~---------------~~~~~-  216 (256)
T cd08221         154 EYS-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVV---------------KIVQG-  216 (256)
T ss_pred             ccc-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHH---------------HHHcC-
Confidence            332 2233567899999999988888999999999999999999999997543211111               11111 


Q ss_pred             cCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 018263          280 LYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKM  316 (358)
Q Consensus       280 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~  316 (358)
                      .....+...+..+.+++.+||+.+|.+||+++++++.
T Consensus       217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         217 NYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             CCCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence            1111223456679999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.1e-38  Score=284.11  Aligned_cols=259  Identities=24%  Similarity=0.348  Sum_probs=204.9

Q ss_pred             hcCCcccceecccCceEEEEEEEC------CCCEEEEEEeeccChh-hHHHHHHHHHHhhhcccCCCCceeeeceEEcCC
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVESKQ-GEKEFMSEVASMANVNVCHENLVKLHGGCIDGP  113 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~------~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~  113 (358)
                      .++|++.+.||.|+||.||+|+.+      +.+.|++|.+...... ....+..|+..++.++  |+|++++++++....
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~   81 (275)
T cd05046           4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLS--HKNVVRLLGLCREAE   81 (275)
T ss_pred             hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcC--CcceeeeEEEECCCC
Confidence            478999999999999999999854      2467899988654333 4577889999999998  999999999999989


Q ss_pred             eeEEEEecCCCCCHHHHhhhcccc-----ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEE
Q 018263          114 CRILVYDYMPNNSLSQTLLGEEKR-----RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKI  188 (358)
Q Consensus       114 ~~~iv~e~~~~~~L~~~l~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l  188 (358)
                      ..++||||+++++|.+++......     ...+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.+++
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l  158 (275)
T cd05046          82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKV  158 (275)
T ss_pred             cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEE
Confidence            999999999999999999543211     12689999999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhcc
Q 018263          189 SDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMY  267 (358)
Q Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~  267 (358)
                      +|||++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   .....    
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~~~----  231 (275)
T cd05046         159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLNRL----  231 (275)
T ss_pred             cccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHHHH----
Confidence            9999886432222222233455678999999888888999999999999999998 788886432211   11111    


Q ss_pred             chhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 018263          268 NSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNG  319 (358)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~  319 (358)
                              .........+...+..+.+++.+||+.+|.+|||+.++++.|+.
T Consensus       232 --------~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         232 --------QAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             --------HcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence                    00001111123355679999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.8e-38  Score=280.02  Aligned_cols=250  Identities=26%  Similarity=0.412  Sum_probs=205.3

Q ss_pred             hcCCcccceecccCceEEEEEEECC-CCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      .++|++.+.||.|++|.||++.... +..|++|.+.....  ...+.+|++.++.++  |+|++++++.+......++++
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~--~~~i~~~~~~~~~~~~~~l~~   77 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCD--SPYIVKYYGSYFKNTDLWIVM   77 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCC--CCcEeeeeeeeecCCcEEEEE
Confidence            4689999999999999999999764 88999999865433  678889999999997  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      ||+++++|.+++..   ....+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        78 e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~  151 (256)
T cd06612          78 EYCGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD  151 (256)
T ss_pred             ecCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence            99999999999832   346789999999999999999999999   999999999999999999999999999886543


Q ss_pred             CCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccc
Q 018263          200 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPM  279 (358)
Q Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (358)
                      ... ......++..|+|||++.+..++.++||||||+++|+|++|+.||..............              ...
T Consensus       152 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~--------------~~~  216 (256)
T cd06612         152 TMA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN--------------KPP  216 (256)
T ss_pred             Ccc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc--------------CCC
Confidence            321 12234577899999999888899999999999999999999999975433211110000              000


Q ss_pred             cCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          280 LYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       280 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .....+...+..+.+++.+||+.+|++|||++++++
T Consensus       217 ~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         217 PTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             CCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            011123345677999999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=5.1e-38  Score=282.02  Aligned_cols=248  Identities=23%  Similarity=0.387  Sum_probs=205.5

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      ..|+..+.||.|++|.||.|.+. ++..|++|.+.... ......+.+|+..++.+.  |||++++++.+...+..++||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCD--SPYVTKYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCC--CCCEeeEEEEEEECCEEEEEE
Confidence            56888999999999999999975 58899999987543 345567888999999987  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      ||+++++|.+++.     ...+++..+..++.|++.||++||+.   +++|+||+|+||+++.++.++++|||++.....
T Consensus        82 e~~~~~~L~~~i~-----~~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06640          82 EYLGGGSALDLLR-----AGPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD  153 (277)
T ss_pred             ecCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence            9999999999982     34688999999999999999999999   999999999999999999999999999876533


Q ss_pred             CCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccc
Q 018263          200 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPM  279 (358)
Q Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (358)
                      ... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.........                ..+...
T Consensus       154 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~----------------~~~~~~  216 (277)
T cd06640         154 TQI-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL----------------FLIPKN  216 (277)
T ss_pred             Ccc-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh----------------hhhhcC
Confidence            221 122345778899999998888999999999999999999999998744321111                111111


Q ss_pred             cCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 018263          280 LYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKM  316 (358)
Q Consensus       280 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~  316 (358)
                      .....+...+..+.+++.+||+.+|++||++.++++.
T Consensus       217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         217 NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            2233455678889999999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.9e-38  Score=287.66  Aligned_cols=250  Identities=21%  Similarity=0.349  Sum_probs=205.2

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      .++|++.+.||.|++|.||++... +++.|++|.+..........+.+|+..++.++  |||++++++.+......++|+
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~   95 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELK--NPNIVNFLDSFLVGDELFVVM   95 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcC--CCceeeeeeeEecCceEEEEE
Confidence            457999999999999999999864 68999999987665555677888999999988  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      ||+++++|..++.     ...+++..+..++.|++.||++||+.   |++|+||+|+||+++.++.++|+|||++.....
T Consensus        96 e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~  167 (296)
T cd06655          96 EYLAGGSLTDVVT-----ETCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP  167 (296)
T ss_pred             EecCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence            9999999999882     34689999999999999999999999   999999999999999999999999998876433


Q ss_pred             CCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccc
Q 018263          200 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPM  279 (358)
Q Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (358)
                      ... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...............              ..
T Consensus       168 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~--------------~~  232 (296)
T cd06655         168 EQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN--------------GT  232 (296)
T ss_pred             ccc-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--------------CC
Confidence            222 122345788999999998888999999999999999999999999765432221111000              00


Q ss_pred             cCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          280 LYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       280 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .....+...+..+.++|.+||+.+|.+||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         233 PELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             cccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            001122345567889999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=4.4e-38  Score=279.79  Aligned_cols=251  Identities=26%  Similarity=0.388  Sum_probs=206.0

Q ss_pred             CCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEc--CCeeEE
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID--GPCRIL  117 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~--~~~~~i  117 (358)
                      +|++.+.||.|++|.||++... ++..|++|.+...  .......+..|+..++.++  |+|++++++.+..  ....++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~~~~   78 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELK--HPNIVRYYDRIIDRSNQTLYI   78 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcC--CCccceeeeeeecCCCCEEEE
Confidence            5889999999999999999864 6889999998643  3444567888999999998  9999999997764  456789


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHh-----cCCCCCcEEcCCCCCcEEEcCCCceEEeecc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH-----EEIQPHVVHRDIKTSNILLDQNFNPKISDFG  192 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH-----~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg  192 (358)
                      +|||+++++|.+++.........+++..++.++.||+.||.+||     +.   +++|+||+|+||+++.++.++|+|||
T Consensus        79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g  155 (265)
T cd08217          79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFG  155 (265)
T ss_pred             EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccc
Confidence            99999999999999655444678999999999999999999999     77   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhH
Q 018263          193 LSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKEL  272 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      ++......... .....++..|+|||.+.+..++.++|+||||+++++|++|..||......   .             .
T Consensus       156 ~~~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~-------------~  218 (265)
T cd08217         156 LAKILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---Q-------------L  218 (265)
T ss_pred             ccccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---H-------------H
Confidence            99875433321 22346788999999998888999999999999999999999999754321   1             1


Q ss_pred             hhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          273 MNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ...+........+...+..+.+++.+||+.+|++||++.+|++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         219 ASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             HHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            1111122223345566788999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=4.9e-38  Score=284.33  Aligned_cols=252  Identities=23%  Similarity=0.356  Sum_probs=202.4

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      .+.|++++.||.|++|.||+|+.. +++.|++|.+..........+..|+..++.++  |||++++++.+..++..++||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~   88 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCN--HPYIVKLLGAFYWDGKLWIMI   88 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCC--CCcEeeeEEEEEeCCeEEEEE
Confidence            367999999999999999999976 58899999997766666778889999999988  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      ||+++++|..++..   ....+++..+..++.|++.+|++||+.   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        89 e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  162 (292)
T cd06644          89 EFCPGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK  162 (292)
T ss_pred             ecCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence            99999999888732   235689999999999999999999999   999999999999999999999999998865322


Q ss_pred             CCcccccccccccCccCccccc-----cCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhh
Q 018263          200 NTTHISTRVAGTLGYLAPEYAI-----SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMN  274 (358)
Q Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~-----~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                      ... ......++..|+|||++.     ...++.++|+||||+++|+|++|..||.........   .....   .     
T Consensus       163 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~---~~~~~---~-----  230 (292)
T cd06644         163 TLQ-RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL---LKIAK---S-----  230 (292)
T ss_pred             ccc-ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHH---HHHhc---C-----
Confidence            211 122345778999999875     345688999999999999999999998754321111   00000   0     


Q ss_pred             hhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          275 LVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                       ..+  ....+...+.++.+++.+||+.+|++||+++++++
T Consensus       231 -~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         231 -EPP--TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             -CCc--cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence             000  01122345567899999999999999999999975

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=3.3e-38  Score=286.00  Aligned_cols=265  Identities=25%  Similarity=0.388  Sum_probs=203.4

Q ss_pred             hcCCcccceecccCceEEEEEEEC-----------------CCCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCc
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-----------------DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENL  102 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-----------------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i  102 (358)
                      .++|++.+.||.|+||.||++.+.                 ++..|++|.+... .......+..|+..++.++  |+|+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~--~~~i   81 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLK--DPNI   81 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCC--CCCc
Confidence            467999999999999999998532                 2346899998654 3344567889999999998  9999


Q ss_pred             eeeeceEEcCCeeEEEEecCCCCCHHHHhhhccc-------cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCC
Q 018263          103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEK-------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKT  175 (358)
Q Consensus       103 ~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~-------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p  175 (358)
                      +++++++...+..+++|||+++++|.+++.....       ....+++..+..++.|++.||+|||+.   |++|+||+|
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp  158 (296)
T cd05095          82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLAT  158 (296)
T ss_pred             ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCh
Confidence            9999999999999999999999999999854321       123477889999999999999999999   999999999


Q ss_pred             CcEEEcCCCceEEeecccccccCCCCcc-cccccccccCccCccccccCCCCccCceecHHHHHHHHHh--CCCCCCccc
Q 018263          176 SNILLDQNFNPKISDFGLSKLFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS--GRTAVDFDV  252 (358)
Q Consensus       176 ~Nilv~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt--g~~pf~~~~  252 (358)
                      +||+++.++.++|+|||++..+...... ......++..|+|||...+..++.++|+||||+++|+|++  |..||....
T Consensus       159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05095         159 RNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS  238 (296)
T ss_pred             heEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence            9999999999999999998764332211 1122334578999998888889999999999999999998  678886433


Q ss_pred             cccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 018263          253 QLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNG  319 (358)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~  319 (358)
                      ...........        .... ........+..++..+.+++.+||+.||.+||++.+|++.|+.
T Consensus       239 ~~~~~~~~~~~--------~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         239 DEQVIENTGEF--------FRDQ-GRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             hHHHHHHHHHH--------Hhhc-cccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            22111111000        0000 0000111123355789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.1e-38  Score=282.87  Aligned_cols=253  Identities=24%  Similarity=0.359  Sum_probs=201.8

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      .++|++.+.||.|++|.||+|... +++.|++|.+..........+.+|+..++.++  |||++++++.+...+..++++
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~--h~~ii~~~~~~~~~~~~~lv~   85 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCK--HSNIVAYFGSYLRRDKLWICM   85 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCC--CCCeeeEEEEEEeCCEEEEEE
Confidence            468999999999999999999865 68899999987665555566788999999987  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      ||+++++|.+++    ...+.+++..+..++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++.....
T Consensus        86 e~~~~~~L~~~~----~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06645          86 EFCGGGSLQDIY----HVTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITA  158 (267)
T ss_pred             eccCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence            999999999998    3456789999999999999999999999   999999999999999999999999999876533


Q ss_pred             CCcccccccccccCccCccccc---cCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhh
Q 018263          200 NTTHISTRVAGTLGYLAPEYAI---SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV  276 (358)
Q Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~---~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                      ... ......++..|+|||++.   ...++.++|+||||+++|+|++|..||..............  .        ...
T Consensus       159 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~--~--------~~~  227 (267)
T cd06645         159 TIA-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK--S--------NFQ  227 (267)
T ss_pred             ccc-ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhc--c--------CCC
Confidence            221 122346888999999874   44588899999999999999999999864432211111000  0        000


Q ss_pred             ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          277 DPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       277 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .+...  .....+..+.+++.+||+.+|++||++++|++
T Consensus       228 ~~~~~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         228 PPKLK--DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             CCccc--ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            00000  00123456889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.7e-38  Score=298.40  Aligned_cols=266  Identities=23%  Similarity=0.374  Sum_probs=209.5

Q ss_pred             HHHHhhcCCcccceecccCceEEEEEEEC------CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeece
Q 018263           36 QLKIATNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGG  108 (358)
Q Consensus        36 ~~~~~~~~y~i~~~lg~g~~g~v~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~  108 (358)
                      .+.+..++|.+.+.||+|+||.||+|++.      .++.||+|++.... ......+..|+..+..+. .||||+++++.
T Consensus        31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-~H~niv~~~~~  109 (401)
T cd05107          31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLG-PHLNIVNLLGA  109 (401)
T ss_pred             cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcC-CCCCeEEEEEE
Confidence            36667788999999999999999999853      34679999997543 233456888999999885 49999999999


Q ss_pred             EEcCCeeEEEEecCCCCCHHHHhhhccc----------------------------------------------------
Q 018263          109 CIDGPCRILVYDYMPNNSLSQTLLGEEK----------------------------------------------------  136 (358)
Q Consensus       109 ~~~~~~~~iv~e~~~~~~L~~~l~~~~~----------------------------------------------------  136 (358)
                      +......++|+||+++++|.+++.....                                                    
T Consensus       110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (401)
T cd05107         110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY  189 (401)
T ss_pred             EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence            9999999999999999999999954321                                                    


Q ss_pred             ------------------------------------------cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCC
Q 018263          137 ------------------------------------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIK  174 (358)
Q Consensus       137 ------------------------------------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~  174 (358)
                                                                ....+++..+..++.||+.||+|||+.   +++|+||+
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlk  266 (401)
T cd05107         190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLA  266 (401)
T ss_pred             cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCC
Confidence                                                      112466778899999999999999999   99999999


Q ss_pred             CCcEEEcCCCceEEeecccccccCCCCc-ccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccc
Q 018263          175 TSNILLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV  252 (358)
Q Consensus       175 p~Nilv~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~  252 (358)
                      |.||++++++.++|+|||++........ .......++..|+|||.+.+..++.++|+||||+++|+|++ |..||....
T Consensus       267 p~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~  346 (401)
T cd05107         267 ARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP  346 (401)
T ss_pred             cceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            9999999999999999999875432211 11122346778999999988889999999999999999998 888986432


Q ss_pred             cccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 018263          253 QLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE  320 (358)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~  320 (358)
                      ....               ....+....+...+...+..+.+++.+||+.+|.+||++.+|++.|+++
T Consensus       347 ~~~~---------------~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         347 MNEQ---------------FYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             chHH---------------HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            2111               1111111112223344567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=297.77  Aligned_cols=259  Identities=25%  Similarity=0.424  Sum_probs=214.5

Q ss_pred             ccccCHHHHHHhhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeece
Q 018263           29 INAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG  108 (358)
Q Consensus        29 ~~~~~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~  108 (358)
                      ++.-....|.+..+...-++=||+|+.|.||+++.+ ++.||||.++.-+       ..++.-|++++  |+||+.+.++
T Consensus       111 ~k~qq~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLk--H~NII~FkGV  180 (904)
T KOG4721|consen  111 HKQQQEELWEIPFEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLK--HPNIITFKGV  180 (904)
T ss_pred             hhhhhhhhccCCHHHhhhhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhcc--CcceeeEeee
Confidence            344445556666677777788999999999999997 7789999876322       25677889998  9999999999


Q ss_pred             EEcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEE
Q 018263          109 CIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKI  188 (358)
Q Consensus       109 ~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l  188 (358)
                      |.....+|||||||..|-|.+.+    +...++....+..|..+|+.++.|||.+   .|+|||||.-||+|..+..|||
T Consensus       181 CtqsPcyCIiMEfCa~GqL~~VL----ka~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKI  253 (904)
T KOG4721|consen  181 CTQSPCYCIIMEFCAQGQLYEVL----KAGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKI  253 (904)
T ss_pred             ecCCceeEEeeeccccccHHHHH----hccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEe
Confidence            99999999999999999999999    5677888999999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccc
Q 018263          189 SDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYN  268 (358)
Q Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  268 (358)
                      +|||-++.......  .-.++||..|+|||++.+.+.++|+||||||++||+||||..||..-+..      ..+|+-  
T Consensus       254 sDFGTS~e~~~~ST--kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss------AIIwGV--  323 (904)
T KOG4721|consen  254 SDFGTSKELSDKST--KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS------AIIWGV--  323 (904)
T ss_pred             ccccchHhhhhhhh--hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh------eeEEec--
Confidence            99999886543321  22378999999999999999999999999999999999999999633221      111211  


Q ss_pred             hhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCC
Q 018263          269 SKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGET  321 (358)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~  321 (358)
                      +       ...+.-..|..++..+.-|++.||+..|.+||++.+|+.-|+-..
T Consensus       324 G-------sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~  369 (904)
T KOG4721|consen  324 G-------SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS  369 (904)
T ss_pred             c-------CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence            1       122233456788889999999999999999999999999887544

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3.2e-38  Score=284.61  Aligned_cols=251  Identities=27%  Similarity=0.350  Sum_probs=200.0

Q ss_pred             CCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      .|++.+.||+|+||.||++.+. +++.||+|.+....   ......+..|+.+++.++  |++++.+++.+...+..+++
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~--~~~i~~~~~~~~~~~~~~lv   78 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVN--SRFVVSLAYAYETKDALCLV   78 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCC--CCCeeeeeEEEecCCEEEEE
Confidence            4788899999999999999875 68899999886432   222345678999999987  99999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      |||+++++|.+.+...  ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        79 ~e~~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~  153 (285)
T cd05630          79 LTLMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP  153 (285)
T ss_pred             EEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecC
Confidence            9999999999988432  234588999999999999999999999   99999999999999999999999999987543


Q ss_pred             CCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhcc
Q 018263          199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDP  278 (358)
Q Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (358)
                      ....  .....++..|+|||.+.+..++.++|+||+|+++|+|++|+.||............            ......
T Consensus       154 ~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~------------~~~~~~  219 (285)
T cd05630         154 EGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV------------ERLVKE  219 (285)
T ss_pred             CCcc--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHH------------Hhhhhh
Confidence            2221  12346889999999998888999999999999999999999999754321111111            111110


Q ss_pred             ccCCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 018263          279 MLYGNFPENEAIRFLKVGLLCVQEKSKLRPQ-----MSTAIK  315 (358)
Q Consensus       279 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt-----~~eil~  315 (358)
                       ....++...+..+.+|+.+||+.||.+|||     ++|+++
T Consensus       220 -~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         220 -VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             -hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence             011123345667899999999999999999     778775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.4e-38  Score=283.49  Aligned_cols=265  Identities=23%  Similarity=0.304  Sum_probs=207.6

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      ..++|++.+.||+|++|.||++... +|+.|++|++.... ......+.+|++.++.++  |||++++++.+...+..++
T Consensus         3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~l   80 (284)
T cd06620           3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECR--SPYIVSFYGAFLNENNICM   80 (284)
T ss_pred             cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcC--CCCcceEeeeEecCCEEEE
Confidence            4578999999999999999999865 58899999886543 345678889999999998  9999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      ||||+++++|.+++    ...+.+++..+..++.+++.+|.|||+ .   +++|+||+|+||++++++.++|+|||++..
T Consensus        81 v~e~~~~~~L~~~~----~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~~~~~l~d~gl~~~  153 (284)
T cd06620          81 CMEFMDCGSLDRIY----KKGGPIPVEILGKIAVAVVEGLTYLYNVH---RIMHRDIKPSNILVNSRGQIKLCDFGVSGE  153 (284)
T ss_pred             EEecCCCCCHHHHH----HhccCCCHHHHHHHHHHHHHHHHHHHHhc---CeeccCCCHHHEEECCCCcEEEccCCcccc
Confidence            99999999999998    344578999999999999999999996 5   899999999999999999999999998865


Q ss_pred             cCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhh
Q 018263          197 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV  276 (358)
Q Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                      .....   .....++..|+|||++.+..++.++|+||||+++|+|++|..||................    .......+
T Consensus       154 ~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~----~~~~~~~~  226 (284)
T cd06620         154 LINSI---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGI----LDLLQQIV  226 (284)
T ss_pred             hhhhc---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHH----HHHHHHHh
Confidence            42211   123467889999999988889999999999999999999999998544321110000000    00011111


Q ss_pred             ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 018263          277 DPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE  320 (358)
Q Consensus       277 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~  320 (358)
                      ............+..+.+++.+||+.||++|||+.|+++..--+
T Consensus       227 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~  270 (284)
T cd06620         227 QEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI  270 (284)
T ss_pred             hccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence            11111111123567799999999999999999999999864333

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=5.3e-38  Score=283.15  Aligned_cols=251  Identities=25%  Similarity=0.328  Sum_probs=199.1

Q ss_pred             CCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      .|+..+.||.|+||.||.+.+. +++.||+|.+....   ......+..|++.++.+.  |++++.+.+.+..++..+++
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~--~~~i~~~~~~~~~~~~~~lv   78 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVN--SQFVVNLAYAYETKDALCLV   78 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC--CcCceeEEEEEecCCEEEEE
Confidence            4778899999999999999875 68899999986432   223345678999999987  99999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      |||+++++|.+.+..  .....+++..+..++.|++.||.|||++   ||+|+||+|+||+++.++.++|+|||++....
T Consensus        79 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~  153 (285)
T cd05632          79 LTIMNGGDLKFHIYN--MGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIP  153 (285)
T ss_pred             EEeccCccHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecC
Confidence            999999999988843  2234689999999999999999999999   99999999999999999999999999887543


Q ss_pred             CCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhcc
Q 018263          199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDP  278 (358)
Q Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (358)
                      ...  ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+...            +..
T Consensus       154 ~~~--~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~------------~~~  219 (285)
T cd05632         154 EGE--SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRR------------VLE  219 (285)
T ss_pred             CCC--cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh------------hhc
Confidence            221  123356889999999998888999999999999999999999999754322111111100            000


Q ss_pred             ccCCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 018263          279 MLYGNFPENEAIRFLKVGLLCVQEKSKLRPQ-----MSTAIK  315 (358)
Q Consensus       279 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt-----~~eil~  315 (358)
                      . ...++...+..+.+|+.+||+.+|.+||+     +.++++
T Consensus       220 ~-~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         220 T-EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             c-ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence            0 01123345567889999999999999999     556554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=4.7e-38  Score=278.90  Aligned_cols=248  Identities=27%  Similarity=0.421  Sum_probs=199.2

Q ss_pred             ceecccCceEEEEEEECC--C--CEEEEEEeeccCh-hhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecC
Q 018263           48 NKIGEGGFGSVYKGRLQD--G--TIVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM  122 (358)
Q Consensus        48 ~~lg~g~~g~v~~~~~~~--~--~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~  122 (358)
                      +.||+|++|.||+|.+.+  +  ..|++|.+..... ...+.+..|+..++.++  |||++++++.+.. ...++++||+
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~-~~~~~v~e~~   77 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLD--HENLIRLYGVVLT-HPLMMVTELA   77 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcC--CCCccceeEEEcC-CeEEEEEEec
Confidence            468999999999998643  3  3689999876655 56678899999999998  9999999999988 8899999999


Q ss_pred             CCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCc
Q 018263          123 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT  202 (358)
Q Consensus       123 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~  202 (358)
                      ++++|.+.+.....  ..+++..++.++.|++.||++||++   |++|+||+|+||+++.++.++|+|||.+........
T Consensus        78 ~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~  152 (257)
T cd05040          78 PLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED  152 (257)
T ss_pred             CCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccccccc
Confidence            99999999954321  5689999999999999999999999   999999999999999999999999999887643221


Q ss_pred             c--cccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhHhhhhccc
Q 018263          203 H--ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPM  279 (358)
Q Consensus       203 ~--~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (358)
                      .  ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||.............               ...
T Consensus       153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~---------------~~~  217 (257)
T cd05040         153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKID---------------KEG  217 (257)
T ss_pred             ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---------------hcC
Confidence            1  1112446678999999988889999999999999999998 999986433221111110               000


Q ss_pred             cCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 018263          280 LYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN  318 (358)
Q Consensus       280 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~  318 (358)
                      .....+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus       218 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         218 ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            111122345678999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=7.1e-38  Score=277.60  Aligned_cols=249  Identities=23%  Similarity=0.384  Sum_probs=203.4

Q ss_pred             CCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      +|++.+.||+|++|.+|.+... +|+.|++|.+...  .......+.+|+..++.++  |||++++.+.+...+..++|+
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMK--HPNIVQYQESFEENGNLYIVM   78 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCC--CCCeeeeEeeecCCCeEEEEE
Confidence            5899999999999999999865 6889999998643  2334467888999999998  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      ||+++++|.+.+..  .....+++..+..++.|++.||.+||++   +++|+||+|+||+++.++.++++|||.+.....
T Consensus        79 e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~  153 (256)
T cd08218          79 DYCEGGDLYKKINA--QRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS  153 (256)
T ss_pred             ecCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCc
Confidence            99999999998842  2234578999999999999999999999   999999999999999999999999999876533


Q ss_pred             CCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccc
Q 018263          200 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPM  279 (358)
Q Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (358)
                      ... ......++..|+|||++.+..++.++|+||||+++++|++|..||......+.   .            ...+. .
T Consensus       154 ~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~---~------------~~~~~-~  216 (256)
T cd08218         154 TVE-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL---V------------LKIIR-G  216 (256)
T ss_pred             chh-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH---H------------HHHhc-C
Confidence            221 12234577889999999888899999999999999999999999864322111   0            11111 1


Q ss_pred             cCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          280 LYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       280 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .....+...+..+.++|.+||+.+|++||++.+|++
T Consensus       217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         217 SYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             CCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            112234456778999999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.1e-38  Score=315.26  Aligned_cols=266  Identities=22%  Similarity=0.313  Sum_probs=204.8

Q ss_pred             HHHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEc--
Q 018263           37 LKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID--  111 (358)
Q Consensus        37 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~--  111 (358)
                      -.+..++|++++.||.|+||.||+|++. ++..|++|.+...  .......+..|+.++..+.  ||||++++++|..  
T Consensus         8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~--HPNIVrl~d~f~de~   85 (1021)
T PTZ00266          8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELK--HKNIVRYIDRFLNKA   85 (1021)
T ss_pred             CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcC--CCCcCeEEEEEEecC
Confidence            3445679999999999999999999976 5778999988644  3344567888999999998  9999999998864  


Q ss_pred             CCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCC----CCCcEEcCCCCCcEEEcC-----
Q 018263          112 GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI----QPHVVHRDIKTSNILLDQ-----  182 (358)
Q Consensus       112 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~----~~~i~H~di~p~Nilv~~-----  182 (358)
                      ...+++||||+++++|.+++.........+++..++.|+.||+.||+|||+..    ..+|+|+||||+||||+.     
T Consensus        86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l  165 (1021)
T PTZ00266         86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI  165 (1021)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence            45689999999999999999544344567999999999999999999999851    015999999999999964     


Q ss_pred             ------------CCceEEeecccccccCCCCcccccccccccCccCcccccc--CCCCccCceecHHHHHHHHHhCCCCC
Q 018263          183 ------------NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS--GRLTRKSDVYSFGVLLLEIVSGRTAV  248 (358)
Q Consensus       183 ------------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~s~~sDiwslG~il~~lltg~~pf  248 (358)
                                  .+.++|+|||++.......  ......+++.|+|||++.+  ..++.++|||||||++|+|++|..||
T Consensus       166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF  243 (1021)
T PTZ00266        166 GKITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF  243 (1021)
T ss_pred             ccccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence                        2348999999997653322  1233568999999998864  45889999999999999999999999


Q ss_pred             CccccccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHH--HHhhcCCC
Q 018263          249 DFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAI--KMMNGETN  322 (358)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil--~~L~~~~~  322 (358)
                      ........  .....             .... .......+..+.+||..||+.+|.+||++.+++  ..+..+.+
T Consensus       244 ~~~~~~~q--li~~l-------------k~~p-~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~  303 (1021)
T PTZ00266        244 HKANNFSQ--LISEL-------------KRGP-DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP  303 (1021)
T ss_pred             CcCCcHHH--HHHHH-------------hcCC-CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence            74432111  11111             0000 000122456799999999999999999999998  45555443

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=5.8e-38  Score=282.62  Aligned_cols=263  Identities=23%  Similarity=0.307  Sum_probs=202.7

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC--hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      ++|++.+.||+|++|.||+|..+ +|+.|++|.+....  ....+.+.+|+..++.++  |+|++++++.+......+++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~--h~~i~~~~~~~~~~~~~~~v   78 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLK--HPNLVNLIEVFRRKRKLHLV   78 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCC--CCCEeeeeeEEeeCCEEEEE
Confidence            57999999999999999999976 58999999886432  233456788999999998  99999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      |||+++++|..++    .....+++..+..++.||+.+|.|||+.   |++|+||+|+||+++.++.++|+|||++....
T Consensus        79 ~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  151 (286)
T cd07847          79 FEYCDHTVLNELE----KNPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILT  151 (286)
T ss_pred             EeccCccHHHHHH----hCCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecC
Confidence            9999998888776    3445689999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCcccccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhc
Q 018263          199 ENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD  277 (358)
Q Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      .... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||......+.........+..... .....+
T Consensus       152 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  229 (286)
T cd07847         152 GPGD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPR-HQQIFS  229 (286)
T ss_pred             CCcc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChH-Hhhhcc
Confidence            3322 1223456788999998876 467899999999999999999999997655433222221111110000 000000


Q ss_pred             ----------cccCCC-----CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          278 ----------PMLYGN-----FPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       278 ----------~~~~~~-----~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                                +.....     .....+..+.+++.+||+.+|++||++.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             cccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence                      000000     01123567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=3.2e-38  Score=292.03  Aligned_cols=264  Identities=23%  Similarity=0.354  Sum_probs=203.0

Q ss_pred             HhhcCCcccceecccCceEEEEEEE------CCCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEc
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRL------QDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCID  111 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~------~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~  111 (358)
                      ...++|++.+.||.|+||.||+|.+      .+++.||||++.... ......+..|+..+..+. .|||++++++++..
T Consensus         4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-~h~niv~~~~~~~~   82 (343)
T cd05103           4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG-HHLNVVNLLGACTK   82 (343)
T ss_pred             cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhcc-CCccHhhhcceeec
Confidence            4467999999999999999999974      247889999987543 333457888999999985 48999999998765


Q ss_pred             C-CeeEEEEecCCCCCHHHHhhhccc------------------------------------------------------
Q 018263          112 G-PCRILVYDYMPNNSLSQTLLGEEK------------------------------------------------------  136 (358)
Q Consensus       112 ~-~~~~iv~e~~~~~~L~~~l~~~~~------------------------------------------------------  136 (358)
                      . ...+++|||+++++|.+++.....                                                      
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (343)
T cd05103          83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE  162 (343)
T ss_pred             CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence            4 457899999999999999854211                                                      


Q ss_pred             ---------cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCc-cccc
Q 018263          137 ---------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT-HIST  206 (358)
Q Consensus       137 ---------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~-~~~~  206 (358)
                               ....+++..+..++.||+.||+|||++   |++|+||+|+||+++.++.++|+|||++........ ....
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  239 (343)
T cd05103         163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG  239 (343)
T ss_pred             hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence                     012467888899999999999999999   999999999999999999999999999876432221 1112


Q ss_pred             ccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCCCC
Q 018263          207 RVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFP  285 (358)
Q Consensus       207 ~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (358)
                      ...++..|+|||.+.+..++.++||||||+++|+|++ |..||.........  .             ..+........+
T Consensus       240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~--~-------------~~~~~~~~~~~~  304 (343)
T cd05103         240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--C-------------RRLKEGTRMRAP  304 (343)
T ss_pred             CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHH--H-------------HHHhccCCCCCC
Confidence            2335567999999988889999999999999999997 89998643221110  0             001111111112


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCC
Q 018263          286 ENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGET  321 (358)
Q Consensus       286 ~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~  321 (358)
                      ...+..+.+++..||+.+|.+|||+.+|++.|+.+.
T Consensus       305 ~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~  340 (343)
T cd05103         305 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  340 (343)
T ss_pred             CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            223456899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=6.3e-38  Score=277.96  Aligned_cols=247  Identities=28%  Similarity=0.417  Sum_probs=202.7

Q ss_pred             CCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC-----hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeE
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-----KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI  116 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~  116 (358)
                      +|+..+.||+|++|.||+|... ++..|++|.+....     ......+..|+..++.++  |+|++++.+.+......+
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~--h~~i~~~~~~~~~~~~~~   78 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ--HPNIVQYLGTEREEDNLY   78 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcC--CCCchheeeeEecCCeEE
Confidence            5888899999999999999976 78999999986543     234567888999999988  999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       117 iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      +++||+++++|.+++.    ....+++..+..++.||+.||++||+.   |++|+||+|+||+++.++.++|+|||.+..
T Consensus        79 lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~  151 (258)
T cd06632          79 IFLELVPGGSLAKLLK----KYGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQ  151 (258)
T ss_pred             EEEEecCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCcccee
Confidence            9999999999999983    345688999999999999999999999   999999999999999999999999999876


Q ss_pred             cCCCCcccccccccccCccCccccccCC-CCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhh
Q 018263          197 FPENTTHISTRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNL  275 (358)
Q Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                      .....  ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||.........   ..            .
T Consensus       152 ~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~---~~------------~  214 (258)
T cd06632         152 VVEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV---FK------------I  214 (258)
T ss_pred             ccccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH---HH------------H
Confidence            53322  223455788899999987766 899999999999999999999999744311111   00            0


Q ss_pred             hccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          276 VDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       276 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .........+......+.+++.+||+.+|.+||++.++++
T Consensus       215 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         215 GRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             HhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            0001112234455677899999999999999999999975

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-39  Score=297.03  Aligned_cols=272  Identities=29%  Similarity=0.395  Sum_probs=222.6

Q ss_pred             cccCHHHHHHhhcCCcccceecccCceEEEEEEECC--C--CE-EEEEEeec---cChhhHHHHHHHHHHhhhcccCCCC
Q 018263           30 NAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQD--G--TI-VAVKVLSV---ESKQGEKEFMSEVASMANVNVCHEN  101 (358)
Q Consensus        30 ~~~~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~--~--~~-vaiK~~~~---~~~~~~~~~~~e~~~l~~l~~~h~~  101 (358)
                      .......|.+.-++..+.++||+|+||.||+|+.+.  +  .. ||+|....   ......+.+..|.++++.++  |||
T Consensus       145 ~PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~--H~N  222 (474)
T KOG0194|consen  145 RPIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLN--HPN  222 (474)
T ss_pred             ccccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCC--CCC
Confidence            334445566667778888999999999999998542  2  23 89999875   34677789999999999998  999


Q ss_pred             ceeeeceEEcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEc
Q 018263          102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD  181 (358)
Q Consensus       102 i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~  181 (358)
                      |++++++.....-+++|||+|+||+|.++++.   +...++......++++.+.||+|||++   +++||||-..|+|++
T Consensus       223 VVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k---~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~  296 (474)
T KOG0194|consen  223 VVRFYGVAVLEEPLMLVMELCNGGSLDDYLKK---NKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYS  296 (474)
T ss_pred             EEEEEEEEcCCCccEEEEEecCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheec
Confidence            99999999999999999999999999999942   333699999999999999999999999   999999999999999


Q ss_pred             CCCceEEeecccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhh
Q 018263          182 QNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLV  260 (358)
Q Consensus       182 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~  260 (358)
                      .++.+||+|||++.... ...........+..|+|||.+....++.++||||||+++||+++ |..||.+-...      
T Consensus       297 ~~~~vKISDFGLs~~~~-~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~------  369 (474)
T KOG0194|consen  297 KKGVVKISDFGLSRAGS-QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY------  369 (474)
T ss_pred             CCCeEEeCccccccCCc-ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH------
Confidence            99899999999987632 11111112246689999999999999999999999999999999 78898755432      


Q ss_pred             HhhhhccchhhHhhhh-ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCCCC
Q 018263          261 DKAWGMYNSKELMNLV-DPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNIDGX  326 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~~~  326 (358)
                                ++...+ ....+...+...+..+..++.+||..+|++||||.++.+.|+.+.....+
T Consensus       370 ----------~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  370 ----------EVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             ----------HHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence                      222222 33344445567788899999999999999999999999999988766543

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-38  Score=291.83  Aligned_cols=242  Identities=25%  Similarity=0.266  Sum_probs=184.5

Q ss_pred             ecccCceEEEEEEEC-CCCEEEEEEeeccCh---hhHHHHHHHHHHhhhcc-cCCCCceeeeceEEcCCeeEEEEecCCC
Q 018263           50 IGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK---QGEKEFMSEVASMANVN-VCHENLVKLHGGCIDGPCRILVYDYMPN  124 (358)
Q Consensus        50 lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~-~~h~~i~~~~~~~~~~~~~~iv~e~~~~  124 (358)
                      ||+|+||.||+|+.. +++.||+|++.....   ........|...+.... ..||||+.+++.+...+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999976 589999999864321   12223334444444331 1399999999999999999999999999


Q ss_pred             CCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCccc
Q 018263          125 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI  204 (358)
Q Consensus       125 ~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~  204 (358)
                      ++|.+.+    .....+++..++.++.||+.||+|||++   ||+|+||||+||+++.++.++|+|||++........ .
T Consensus        81 g~L~~~l----~~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~  152 (330)
T cd05586          81 GELFWHL----QKEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-T  152 (330)
T ss_pred             ChHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-C
Confidence            9999988    3456789999999999999999999999   999999999999999999999999999875322221 2


Q ss_pred             ccccccccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCC
Q 018263          205 STRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGN  283 (358)
Q Consensus       205 ~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (358)
                      .....|+..|+|||++.+. .++.++||||||+++|+|++|..||...........   +            ..... .-
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~---i------------~~~~~-~~  216 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRN---I------------AFGKV-RF  216 (330)
T ss_pred             ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHH---H------------HcCCC-CC
Confidence            2345689999999998764 478999999999999999999999975432111111   0            00000 00


Q ss_pred             CCHHHHHHHHHHHhhccCCCCCCCCC----HHHHHH
Q 018263          284 FPENEAIRFLKVGLLCVQEKSKLRPQ----MSTAIK  315 (358)
Q Consensus       284 ~~~~~~~~l~~li~~~l~~~P~~Rpt----~~eil~  315 (358)
                      .....+..+.+++.+||+.||.+||+    +.++++
T Consensus       217 ~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         217 PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            11124567889999999999999995    555544

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-39  Score=294.80  Aligned_cols=256  Identities=23%  Similarity=0.347  Sum_probs=202.4

Q ss_pred             HHHhhcCCcccceecccCceEEEEEEECCCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCe
Q 018263           37 LKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC  114 (358)
Q Consensus        37 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~  114 (358)
                      +.+.+..|+++++||+||.+.||++...+...||+|.+...  +.....-+.+|+..|.+++ +|.+|++++++-..++.
T Consensus       356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLk-g~~~IIqL~DYEv~d~~  434 (677)
T KOG0596|consen  356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLK-GHDKIIQLYDYEVTDGY  434 (677)
T ss_pred             EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhc-CCceEEEEeeeeccCce
Confidence            45567899999999999999999999887788888876533  4445577999999999998 79999999999999999


Q ss_pred             eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccc
Q 018263          115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS  194 (358)
Q Consensus       115 ~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~  194 (358)
                      +|+|||+- ..+|..++..   .....+.-.++.+..|++.|+.++|..   ||||.||||.|+++-. |++||+|||.+
T Consensus       435 lYmvmE~G-d~DL~kiL~k---~~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA  506 (677)
T KOG0596|consen  435 LYMVMECG-DIDLNKILKK---KKSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIA  506 (677)
T ss_pred             EEEEeecc-cccHHHHHHh---ccCCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechh
Confidence            99999976 6789999932   223334458999999999999999999   9999999999998855 48999999999


Q ss_pred             cccCCCCccc-ccccccccCccCccccccCC-----------CCccCceecHHHHHHHHHhCCCCCCccccccchhhhHh
Q 018263          195 KLFPENTTHI-STRVAGTLGYLAPEYAISGR-----------LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDK  262 (358)
Q Consensus       195 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~-----------~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~  262 (358)
                      ..+..+.... ....+||..|++||.+....           .++++||||||||||+|+.|++||..-.     ..+  
T Consensus       507 ~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----n~~--  579 (677)
T KOG0596|consen  507 NAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----NQI--  579 (677)
T ss_pred             cccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----HHH--
Confidence            9886655443 33578999999999885322           5679999999999999999999997221     011  


Q ss_pred             hhhccchhhHhhhhccccCCCCCHHHHH-HHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          263 AWGMYNSKELMNLVDPMLYGNFPENEAI-RFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                             ..+..+.++.-.-+|+..-.. .++++++.||+.||.+|||+.++|+
T Consensus       580 -------aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  580 -------AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             -------HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence                   122233333222223221111 2999999999999999999999986

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-38  Score=284.22  Aligned_cols=253  Identities=23%  Similarity=0.349  Sum_probs=204.3

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      .++|++.+.||.|++|.||++... ++..|++|.+..........+..|+..++.++  |||++++++.+..+...++||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECK--HPNIVGLYEAYFYENKLWILI   81 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCC--CCceeEEEEEEecCCeEEEEe
Confidence            467999999999999999999975 68999999998766666778889999999998  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      ||+++++|.+++..   ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        82 e~~~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~  155 (280)
T cd06611          82 EFCDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS  155 (280)
T ss_pred             eccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence            99999999999832   235689999999999999999999999   999999999999999999999999998765432


Q ss_pred             CCcccccccccccCccCccccc-----cCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhh
Q 018263          200 NTTHISTRVAGTLGYLAPEYAI-----SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMN  274 (358)
Q Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~-----~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                      ... ......++..|+|||.+.     +..++.++|+||||+++|+|++|+.||.........   ....         .
T Consensus       156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~---~~~~---------~  222 (280)
T cd06611         156 TLQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL---LKIL---------K  222 (280)
T ss_pred             ccc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHH---HHHh---------c
Confidence            221 122345788999999875     345678999999999999999999999754321111   1110         0


Q ss_pred             hhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 018263          275 LVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKM  316 (358)
Q Consensus       275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~  316 (358)
                      ...+  .-..+...+..+.+++.+||+.+|.+||++.++++-
T Consensus       223 ~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         223 SEPP--TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             CCCC--CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            0000  011223455678999999999999999999999763

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=7.5e-38  Score=281.63  Aligned_cols=250  Identities=22%  Similarity=0.355  Sum_probs=200.1

Q ss_pred             CCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEec
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY  121 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~  121 (358)
                      -|++.+.||.|++|.||++... ++..+++|.+..........+..|++.++.+.  |||++++++.+...+..++|+||
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~--h~~ii~~~~~~~~~~~~~~v~e~   83 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCD--HPNIVKLLDAFYYENNLWILIEF   83 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCC--CCCeeeEEEEEeeCCEEEEEEEe
Confidence            3788999999999999999976 57788999987655566677888999999998  99999999999999999999999


Q ss_pred             CCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCC
Q 018263          122 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT  201 (358)
Q Consensus       122 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~  201 (358)
                      +++++|...+..   ....+++..+..++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++.......
T Consensus        84 ~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~  157 (282)
T cd06643          84 CAGGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI  157 (282)
T ss_pred             cCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc
Confidence            999999988732   345689999999999999999999999   99999999999999999999999999987543221


Q ss_pred             cccccccccccCccCccccc-----cCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhh
Q 018263          202 THISTRVAGTLGYLAPEYAI-----SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV  276 (358)
Q Consensus       202 ~~~~~~~~~~~~y~aPE~~~-----~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                       .......++..|+|||++.     +..++.++|+||+|+++|+|++|+.||...............            .
T Consensus       158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~------------~  224 (282)
T cd06643         158 -QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS------------E  224 (282)
T ss_pred             -cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhc------------C
Confidence             1122345788999999874     345778999999999999999999998754321111110000            0


Q ss_pred             ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          277 DPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       277 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .+  ....+...+..+.+++.+||+.+|.+||++.++++
T Consensus       225 ~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         225 PP--TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             CC--CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00  01122345677999999999999999999999874

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.7e-39  Score=272.92  Aligned_cols=251  Identities=24%  Similarity=0.327  Sum_probs=203.6

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC--------hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--------KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG  112 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~  112 (358)
                      +.|.-.+.||.|..+.|-++..+ +|+.+++|++....        ..-.+.-..|+.+|+++. +||+|+++.+++.++
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~-GHP~II~l~D~yes~   95 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVM-GHPYIIDLQDVYESD   95 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhc-CCCcEEEeeeeccCc
Confidence            46777889999999999888754 68889999886432        112234556899999997 799999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecc
Q 018263          113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG  192 (358)
Q Consensus       113 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg  192 (358)
                      ...++|+|.++.|.|+|++    ...-+++++..+.++.|++.+++|||.+   +|+||||||+||+++++-+++|+|||
T Consensus        96 sF~FlVFdl~prGELFDyL----ts~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFG  168 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYL----TSKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFG  168 (411)
T ss_pred             chhhhhhhhcccchHHHHh----hhheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccc
Confidence            9999999999999999999    6678899999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccCccCcccccc------CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhc
Q 018263          193 LSKLFPENTTHISTRVAGTLGYLAPEYAIS------GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGM  266 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~  266 (358)
                      ++.....  .......+||++|+|||.+..      ..|+...|+|++|+++|.|+.|.+||.-..+.--...+...   
T Consensus       169 Fa~~l~~--GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeG---  243 (411)
T KOG0599|consen  169 FACQLEP--GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEG---  243 (411)
T ss_pred             eeeccCC--chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhc---
Confidence            9987643  444567899999999998752      35788899999999999999999999633221111111110   


Q ss_pred             cchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          267 YNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                                ...+...--.+.+.+..+||.+||++||.+|.|++|.+.
T Consensus       244 ----------kyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  244 ----------KYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             ----------ccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence                      011112222456778999999999999999999999874

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=7.3e-38  Score=279.98  Aligned_cols=252  Identities=28%  Similarity=0.385  Sum_probs=196.0

Q ss_pred             ceecccCceEEEEEEECC-CC--EEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecCC
Q 018263           48 NKIGEGGFGSVYKGRLQD-GT--IVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP  123 (358)
Q Consensus        48 ~~lg~g~~g~v~~~~~~~-~~--~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~~  123 (358)
                      +.||+|++|.||+|..+. +.  .+++|.+... .......+..|++.++.+. .|||++++++.+...+..+++|||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~-~h~~iv~~~~~~~~~~~~~lv~e~~~   79 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG-HHPNIINLLGACEHRGYLYLAIEYAP   79 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhc-cCCCeeeEEEEEecCCCceEEEEeCC
Confidence            368999999999999753 43  4688887643 3344567888999999984 39999999999999999999999999


Q ss_pred             CCCHHHHhhhccc------------cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeec
Q 018263          124 NNSLSQTLLGEEK------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF  191 (358)
Q Consensus       124 ~~~L~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Df  191 (358)
                      +++|.+++.....            ....+++..+..++.|++.||+|||+.   |++|+||+|+||+++.++.++++||
T Consensus        80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~df  156 (270)
T cd05047          80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADF  156 (270)
T ss_pred             CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCC
Confidence            9999999854321            123578999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchh
Q 018263          192 GLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSK  270 (358)
Q Consensus       192 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      |++.....  .........+..|+|||++.+..++.++|+||||+++|+|++ |..||......+....           
T Consensus       157 gl~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~-----------  223 (270)
T cd05047         157 GLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK-----------  223 (270)
T ss_pred             CCccccch--hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHH-----------
Confidence            98853211  111111223567999999988889999999999999999997 9999964432111111           


Q ss_pred             hHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCC
Q 018263          271 ELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGET  321 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~  321 (358)
                           +........+...+..+.+++.+||+.+|.+|||+.++++.|+++.
T Consensus       224 -----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         224 -----LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             -----HhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence                 1111111222334567899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=7.5e-38  Score=286.39  Aligned_cols=261  Identities=20%  Similarity=0.307  Sum_probs=189.0

Q ss_pred             cceecccCceEEEEEEEC---CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEc--CCeeEEEEec
Q 018263           47 SNKIGEGGFGSVYKGRLQ---DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID--GPCRILVYDY  121 (358)
Q Consensus        47 ~~~lg~g~~g~v~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~--~~~~~iv~e~  121 (358)
                      .++||+|+||.||+|+.+   +++.||+|.+....  ....+.+|+..++.++  ||||+++++.+..  ....++++||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELK--HPNVISLQKVFLSHADRKVWLLFDY   81 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcC--CCCCcceeeeEecCCCcEEEEEEec
Confidence            468999999999999864   46789999986432  2345678999999998  9999999998864  4567899999


Q ss_pred             CCCCCHHHHhhhccc-----cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEE----cCCCceEEeecc
Q 018263          122 MPNNSLSQTLLGEEK-----RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL----DQNFNPKISDFG  192 (358)
Q Consensus       122 ~~~~~L~~~l~~~~~-----~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv----~~~~~~~l~Dfg  192 (358)
                      +. ++|.+++.....     ....+++..++.++.||+.||.|||++   |++|+||||+||++    +..+.+||+|||
T Consensus        82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07868          82 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             cC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence            84 588887743211     223589999999999999999999999   99999999999999    456789999999


Q ss_pred             cccccCCCCc--ccccccccccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCCCccccccc---------hhhh
Q 018263          193 LSKLFPENTT--HISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE---------YHLV  260 (358)
Q Consensus       193 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~---------~~~~  260 (358)
                      ++........  .......+|..|+|||++.+. .++.++||||+||++|+|++|++||........         ...+
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~  237 (317)
T cd07868         158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI  237 (317)
T ss_pred             ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHH
Confidence            9986543221  122345688999999998764 589999999999999999999999975443211         1111


Q ss_pred             HhhhhccchhhHhhhh---------ccccCCCC------------CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          261 DKAWGMYNSKELMNLV---------DPMLYGNF------------PENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~---------~~~~~~~~------------~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ....+.+....+....         ........            .......+.+|+.+||+.||.+|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~  313 (317)
T cd07868         238 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  313 (317)
T ss_pred             HHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence            1111111111111110         00000000            0011235789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-38  Score=286.25  Aligned_cols=261  Identities=23%  Similarity=0.253  Sum_probs=204.4

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccCh---hhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK---QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      ++|++.+.||+|++|.||+|... +++.|++|.+.....   .....+..|++.+..+.  |+||+++++.+......++
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~l   78 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD--HPFLPTLYASFQTETYLCL   78 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCC--CCCchhheeeeecCCEEEE
Confidence            47899999999999999999976 489999999875432   24456888999999998  9999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      +|||+.+++|.+++..  .....+++..+..++.|++.||+|||+.   |++|+||+|+||+++.++.++|+|||++...
T Consensus        79 v~e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  153 (316)
T cd05574          79 VMDYCPGGELFRLLQR--QPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQS  153 (316)
T ss_pred             EEEecCCCCHHHHHHh--CCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcc
Confidence            9999999999999842  2346789999999999999999999999   9999999999999999999999999988754


Q ss_pred             CCCCcc----------------------------cccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCC
Q 018263          198 PENTTH----------------------------ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVD  249 (358)
Q Consensus       198 ~~~~~~----------------------------~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~  249 (358)
                      ......                            ......++..|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~  233 (316)
T cd05574         154 DVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFK  233 (316)
T ss_pred             cccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCC
Confidence            221110                            1112357888999999988889999999999999999999999997


Q ss_pred             ccccccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCC
Q 018263          250 FDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNID  324 (358)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~  324 (358)
                      ........               .........-......+..+.+++.+||+.+|++|||....++.+-++.-+.
T Consensus       234 ~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~  293 (316)
T cd05574         234 GSNRDETF---------------SNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFR  293 (316)
T ss_pred             CCchHHHH---------------HHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhh
Confidence            55432111               1111111111111125678999999999999999999444444444444333

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.1e-38  Score=281.95  Aligned_cols=252  Identities=23%  Similarity=0.377  Sum_probs=202.3

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      ++|++.+.||.|++|.||++.++ +++.|++|.+... .......+.+|+..++.++  |+||+++++.+...+..+++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~~~~~~lv~   78 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAV--SPYIVDFYGAFFIEGAVYMCM   78 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcC--CCcHHhhhhheecCCeEEEEE
Confidence            47899999999999999999976 6899999988654 3334467888999999987  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      ||+++++|..++... .....+++..+..++.|++.||.|||+ .   +++|+||+|+||+++.++.++|+|||.+....
T Consensus        79 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  154 (286)
T cd06622          79 EYMDAGSLDKLYAGG-VATEGIPEDVLRRITYAVVKGLKFLKEEH---NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV  154 (286)
T ss_pred             eecCCCCHHHHHHhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcC---CEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            999999999888432 123478999999999999999999996 6   99999999999999999999999999987543


Q ss_pred             CCCcccccccccccCccCccccccCC------CCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhH
Q 018263          199 ENTTHISTRVAGTLGYLAPEYAISGR------LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKEL  272 (358)
Q Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~~~------~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      ...   .....++..|+|||.+.+..      ++.++|+||||+++|+|++|..||............            
T Consensus       155 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~------------  219 (286)
T cd06622         155 ASL---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQL------------  219 (286)
T ss_pred             CCc---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHH------------
Confidence            221   12245778899999885443      478999999999999999999999643221111111            


Q ss_pred             hhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          273 MNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ..+.. ......+..++.++.+++.+||+.+|++||++.++++
T Consensus       220 ~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         220 SAIVD-GDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             HHHhh-cCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            11111 1122344557788999999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.6e-37  Score=277.15  Aligned_cols=249  Identities=24%  Similarity=0.376  Sum_probs=197.7

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC-----hhhHHHHHHHHHHhhhcccCCCCceeeeceEEc--CC
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-----KQGEKEFMSEVASMANVNVCHENLVKLHGGCID--GP  113 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~--~~  113 (358)
                      .+|++.+.||+|++|.||+|... ++..|++|.+....     ......+.+|+..++.++  |||++++++.+..  ..
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~   79 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ--HERIVQYYGCLRDRAEK   79 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcC--CCCeeeEEEEEEcCCCC
Confidence            57999999999999999999875 58899999886432     223456788999999998  9999999998875  35


Q ss_pred             eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccc
Q 018263          114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL  193 (358)
Q Consensus       114 ~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~  193 (358)
                      ..++++||+++++|.+.+    .....+++..++.++.|++.||.+||+.   +++|+||+|+||+++.++.++|+|||+
T Consensus        80 ~~~l~~e~~~~~~L~~~l----~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~  152 (266)
T cd06651          80 TLTIFMEYMPGGSVKDQL----KAYGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGA  152 (266)
T ss_pred             EEEEEEeCCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCC
Confidence            678999999999999998    3445688999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCC--cccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhh
Q 018263          194 SKLFPENT--THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKE  271 (358)
Q Consensus       194 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      +.......  ........++..|+|||.+.+..++.++|+||+|+++|+|++|+.||.......               .
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~---------------~  217 (266)
T cd06651         153 SKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA---------------A  217 (266)
T ss_pred             ccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH---------------H
Confidence            87543211  111122457889999999988889999999999999999999999997432111               1


Q ss_pred             HhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          272 LMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .............+......+..++ +||..+|++||+++||++
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         218 IFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             HHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            1111111122334445556677777 688899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.1e-37  Score=277.39  Aligned_cols=251  Identities=27%  Similarity=0.410  Sum_probs=208.1

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccCh-hhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      ++|++.+.||.|++|.||+|... +++.|++|.+..... .....+..|+..+..++  |+|++++++.+...+..++++
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCE--SPYVVKCYGAFYKEGEISIVL   78 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcC--CCCeeeEEEEEccCCeEEEEE
Confidence            47889999999999999999976 599999999876543 45677889999999998  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      ||+++++|.+++.    ....+++..++.++.|++.||++||+ .   +++|+||+|+||+++.++.++|+|||.+....
T Consensus        79 e~~~~~~L~~~l~----~~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~  151 (264)
T cd06623          79 EYMDGGSLADLLK----KVGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLE  151 (264)
T ss_pred             EecCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecc
Confidence            9999999999993    33778999999999999999999999 9   99999999999999999999999999988654


Q ss_pred             CCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhcc
Q 018263          199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDP  278 (358)
Q Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (358)
                      ...... ....++..|+|||.+.+..++.++|+||||+++|+|++|..||...............            . .
T Consensus       152 ~~~~~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~------------~-~  217 (264)
T cd06623         152 NTLDQC-NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI------------C-D  217 (264)
T ss_pred             cCCCcc-cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHH------------h-c
Confidence            333221 2345788999999998888999999999999999999999999765431111111111            1 1


Q ss_pred             ccCCCCCHH-HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          279 MLYGNFPEN-EAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       279 ~~~~~~~~~-~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ......+.. .+..+.+++.+||+.+|++||++.++++
T Consensus       218 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         218 GPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             CCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            111223333 6678999999999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=4.4e-38  Score=278.75  Aligned_cols=248  Identities=27%  Similarity=0.402  Sum_probs=200.3

Q ss_pred             hcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEe
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD  120 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e  120 (358)
                      .++|++.+.||+|+||.||.+.. +++.|++|.+....  ....+.+|+..+..++  |||++++++.+... ..+++||
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~~-~~~~v~e   78 (254)
T cd05083           5 LQKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLH--HKNLVRLLGVILHN-GLYIVME   78 (254)
T ss_pred             HHHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCC--CCCcCeEEEEEcCC-CcEEEEE
Confidence            46799999999999999999875 57889999986432  3457888999999988  99999999998764 4799999


Q ss_pred             cCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCC
Q 018263          121 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN  200 (358)
Q Consensus       121 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~  200 (358)
                      |+++++|.+++...  ....+++..+..++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||.+......
T Consensus        79 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~  153 (254)
T cd05083          79 LMSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG  153 (254)
T ss_pred             CCCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc
Confidence            99999999999432  234578999999999999999999999   9999999999999999999999999998753221


Q ss_pred             CcccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhHhhhhccc
Q 018263          201 TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPM  279 (358)
Q Consensus       201 ~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (358)
                      .    .....+..|.|||.+.+..++.++|+||||+++|+|++ |+.||........                ...+...
T Consensus       154 ~----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~----------------~~~~~~~  213 (254)
T cd05083         154 V----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV----------------KECVEKG  213 (254)
T ss_pred             C----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH----------------HHHHhCC
Confidence            1    12234567999999988889999999999999999997 9999875432111                1111111


Q ss_pred             cCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 018263          280 LYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNG  319 (358)
Q Consensus       280 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~  319 (358)
                      .....+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus       214 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         214 YRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            1222233456778999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.3e-37  Score=277.74  Aligned_cols=252  Identities=24%  Similarity=0.437  Sum_probs=204.5

Q ss_pred             CCcccceecccCceEEEEEEE-CCCCEEEEEEeeccC------hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCee
Q 018263           43 GFRWSNKIGEGGFGSVYKGRL-QDGTIVAVKVLSVES------KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR  115 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~-~~~~~vaiK~~~~~~------~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~  115 (358)
                      +|+..+.||+|++|.||++.. .+++.|++|.+....      ......+..|+..++.++  |+|++++++.+.+.+..
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~   78 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN--HPHIIRMLGATCEDSHF   78 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcC--CCceehhhceeccCCeE
Confidence            588899999999999999986 468999999986432      123467888999999998  99999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCC-ceEEeecccc
Q 018263          116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF-NPKISDFGLS  194 (358)
Q Consensus       116 ~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~-~~~l~Dfg~~  194 (358)
                      ++|+||+++++|.+++.    ....+++..+..++.||+.||.+||++   |++|+||+|+||+++.++ .++|+|||.+
T Consensus        79 ~~v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~  151 (268)
T cd06630          79 NLFVEWMAGGSVSHLLS----KYGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAA  151 (268)
T ss_pred             EEEEeccCCCcHHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccc
Confidence            99999999999999983    445788999999999999999999999   999999999999998775 5899999998


Q ss_pred             cccCCCCc---ccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhh
Q 018263          195 KLFPENTT---HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKE  271 (358)
Q Consensus       195 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      ........   .......++..|+|||.+.+..++.++|+||+|+++++|++|+.||.............          
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~----------  221 (268)
T cd06630         152 ARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIF----------  221 (268)
T ss_pred             cccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHH----------
Confidence            76543211   11223457889999999988889999999999999999999999997543322111111          


Q ss_pred             HhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          272 LMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                        ...........+...+.++.+++.+||+.+|++||++.++++
T Consensus       222 --~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         222 --KIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             --HHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence              111111223455667788999999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1e-37  Score=278.77  Aligned_cols=254  Identities=23%  Similarity=0.382  Sum_probs=201.8

Q ss_pred             CCcccceecccCceEEEEEEECC--CCEEEEEEeeccC----------hhhHHHHHHHHHHhhh-cccCCCCceeeeceE
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQD--GTIVAVKVLSVES----------KQGEKEFMSEVASMAN-VNVCHENLVKLHGGC  109 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~~--~~~vaiK~~~~~~----------~~~~~~~~~e~~~l~~-l~~~h~~i~~~~~~~  109 (358)
                      +|++.+.||+|++|.||.+.+..  ++.+++|.+....          ......+..|+..+.+ +.  |||++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~--h~~i~~~~~~~   78 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR--HPNIVRYYKTF   78 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCC--CCCeeeEEeeE
Confidence            48899999999999999999764  7889999875321          2223445667776665 44  99999999999


Q ss_pred             EcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcEEcCCCCCcEEEcCCCceEE
Q 018263          110 IDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNILLDQNFNPKI  188 (358)
Q Consensus       110 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~~~~i~H~di~p~Nilv~~~~~~~l  188 (358)
                      ...+..+++|||+++++|.+++.........+++..++.++.|++.+|.+||+ .   +++|+||+|+||+++.++.++|
T Consensus        79 ~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l  155 (269)
T cd08528          79 LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTI  155 (269)
T ss_pred             ccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEE
Confidence            99999999999999999999885544455678999999999999999999996 6   8999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccc
Q 018263          189 SDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYN  268 (358)
Q Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  268 (358)
                      +|||.+.......  ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.........           
T Consensus       156 ~dfg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~-----------  222 (269)
T cd08528         156 TDFGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLA-----------  222 (269)
T ss_pred             ecccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHH-----------
Confidence            9999998654332  223456788999999998888999999999999999999999998643221110           


Q ss_pred             hhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 018263          269 SKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN  318 (358)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~  318 (358)
                          ................+..+.+++.+||+.||++||++.|+...++
T Consensus       223 ----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         223 ----TKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             ----HHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence                0111111111111234567999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4e-38  Score=296.39  Aligned_cols=261  Identities=18%  Similarity=0.207  Sum_probs=200.3

Q ss_pred             hhcCCcccceecccCceEEEEEEEC---CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeE
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ---DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI  116 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~  116 (358)
                      ...+|++++.||.|++|.||++...   .+..|++|.+...     ....+|+.+++.++  ||||+++++.+......+
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~--h~~iv~~~~~~~~~~~~~  162 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTIS--HRAIINLIHAYRWKSTVC  162 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcC--CCCccceeeeEeeCCEEE
Confidence            3568999999999999999999753   3678999987532     23457999999998  999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       117 iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      ++||++. ++|.+++    .....+++..+..++.||+.||.|||++   ||+|+||||+||+++.++.++|+|||++..
T Consensus       163 lv~e~~~-~~l~~~l----~~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~  234 (392)
T PHA03207        163 MVMPKYK-CDLFTYV----DRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACK  234 (392)
T ss_pred             EEehhcC-CCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccc
Confidence            9999994 6888887    3456789999999999999999999999   999999999999999999999999999876


Q ss_pred             cCCCCc-ccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccc-------
Q 018263          197 FPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYN-------  268 (358)
Q Consensus       197 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~-------  268 (358)
                      ...... .......|+..|+|||++.+..++.++|||||||++|+|++|+.||..............+.....       
T Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~  314 (392)
T PHA03207        235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP  314 (392)
T ss_pred             cCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence            543222 122345689999999999988999999999999999999999999976544322211111110000       


Q ss_pred             ---h----hhHhhhhccccCCCCC-------HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 018263          269 ---S----KELMNLVDPMLYGNFP-------ENEAIRFLKVGLLCVQEKSKLRPQMSTAIKM  316 (358)
Q Consensus       269 ---~----~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~  316 (358)
                         .    ..+... ....+..+.       ...+.++.++|.+||+.+|++|||+.|++..
T Consensus       315 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        315 QNGSTNLCKHFKQY-AIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             CccchhHHHHHHhh-cccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence               0    000000 000111111       1234578899999999999999999999864

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=8.6e-38  Score=279.57  Aligned_cols=253  Identities=25%  Similarity=0.368  Sum_probs=198.6

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC------
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG------  112 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~------  112 (358)
                      ....|++.+.||.|++|.||+|... +++.|++|.+.... .....+..|+..+..+. .|+|++++++.+...      
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~-~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYS-HHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhc-CCCCeeeEeeEEeecCCCCCC
Confidence            4567999999999999999999865 58899999986543 34457788888888873 399999999998753      


Q ss_pred             CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecc
Q 018263          113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG  192 (358)
Q Consensus       113 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg  192 (358)
                      ...+++|||+++++|.+++...  ....+++..+..++.|++.||+|||++   +++|+||+|+||++++++.++|+|||
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg  156 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG  156 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCC
Confidence            4578999999999999998432  235688999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccCccCccccc-----cCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhcc
Q 018263          193 LSKLFPENTTHISTRVAGTLGYLAPEYAI-----SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMY  267 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~  267 (358)
                      ++........ ......++..|+|||++.     +..++.++|+||+|+++|+|++|..||............       
T Consensus       157 ~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~-------  228 (272)
T cd06637         157 VSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI-------  228 (272)
T ss_pred             Cceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH-------
Confidence            9876432221 223356888999999886     335788999999999999999999999643321111100       


Q ss_pred             chhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          268 NSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                              .........+...+..+.+++.+||+.+|.+|||+.++++
T Consensus       229 --------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         229 --------PRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             --------hcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence                    0011111112234567899999999999999999999975

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=6e-38  Score=282.70  Aligned_cols=262  Identities=23%  Similarity=0.312  Sum_probs=202.3

Q ss_pred             HHHHHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEE---
Q 018263           35 NQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCI---  110 (358)
Q Consensus        35 ~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~---  110 (358)
                      +.+....++|++.+.||+|++|.||++... +++.|++|++.... .....+..|+..++.+. .|||++++++.+.   
T Consensus        11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~-~h~~i~~~~~~~~~~~   88 (286)
T cd06638          11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALS-DHPNVVKFYGMYYKKD   88 (286)
T ss_pred             ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHh-cCCCeeeeeeeeeecc
Confidence            445556789999999999999999999875 58899999876432 23356778888888873 3999999999874   


Q ss_pred             --cCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEE
Q 018263          111 --DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKI  188 (358)
Q Consensus       111 --~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l  188 (358)
                        .+...+++|||+++++|.+++.........+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl  165 (286)
T cd06638          89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKL  165 (286)
T ss_pred             cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEE
Confidence              34568999999999999998854333456789999999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccCccCcccccc-----CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhh
Q 018263          189 SDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS-----GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKA  263 (358)
Q Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~  263 (358)
                      +|||++........ ......++..|+|||++..     ..++.++|+||+|+++|+|++|+.||............   
T Consensus       166 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~---  241 (286)
T cd06638         166 VDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKI---  241 (286)
T ss_pred             ccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhc---
Confidence            99999876533221 1223458889999998753     44788999999999999999999998754321111000   


Q ss_pred             hhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 018263          264 WGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKM  316 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~  316 (358)
                      .    ..     ...  ....+...+..+.+++.+||+.+|++|||+.|+++.
T Consensus       242 ~----~~-----~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         242 P----RN-----PPP--TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             c----cc-----CCC--cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            0    00     000  000122245578999999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=4.5e-38  Score=282.33  Aligned_cols=247  Identities=23%  Similarity=0.403  Sum_probs=202.4

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      +.|++.+.||.|++|.||+|.+. ++..|++|.+.... ......+..|+..++.+.  |||++++++.+...+..++|+
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCD--SPYITRYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCC--CCccHhhhcccccCCceEEEE
Confidence            45778899999999999999865 57889999986443 344567889999999987  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      ||+++++|.+++     ....+++..+..++.|++.|+.|||++   +++|+||+|+||+++.++.++++|||++.....
T Consensus        82 e~~~~~~L~~~~-----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06642          82 EYLGGGSALDLL-----KPGPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD  153 (277)
T ss_pred             EccCCCcHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccC
Confidence            999999999988     235688999999999999999999999   999999999999999999999999999876533


Q ss_pred             CCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccc
Q 018263          200 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPM  279 (358)
Q Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (358)
                      ... ......++..|+|||++.+..++.++|+||||+++|+|++|+.||..........                .+...
T Consensus       154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~----------------~~~~~  216 (277)
T cd06642         154 TQI-KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF----------------LIPKN  216 (277)
T ss_pred             cch-hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh----------------hhhcC
Confidence            221 1122457788999999988889999999999999999999999986433211110                11111


Q ss_pred             cCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          280 LYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       280 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .....+...+..+.+++.+||+.+|++||++.++++
T Consensus       217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         217 SPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            122233445677999999999999999999999987

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=3.2e-38  Score=284.24  Aligned_cols=263  Identities=21%  Similarity=0.291  Sum_probs=197.9

Q ss_pred             CCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC--hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      +|++.+.||.|++|.||+|++. +|+.|++|.+....  ......+..|+..++.++  |||++++++++.+....++++
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~--h~~i~~~~~~~~~~~~~~lv~   78 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK--HKNIVRLYDVLHSDKKLTLVF   78 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcC--CCCeeeHHHHhccCCceEEEE
Confidence            5889999999999999999975 68999999986532  223356778999999998  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      ||++ ++|.+.+.   .....+++..++.++.||+.||.|||++   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        79 e~~~-~~l~~~~~---~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  151 (284)
T cd07839          79 EYCD-QDLKKYFD---SCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGI  151 (284)
T ss_pred             ecCC-CCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCC
Confidence            9996 57877763   2345689999999999999999999999   999999999999999999999999999876533


Q ss_pred             CCcccccccccccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCCCcccc-ccchhhhHhhhhccchhhHh---h
Q 018263          200 NTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ-LGEYHLVDKAWGMYNSKELM---N  274 (358)
Q Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~---~  274 (358)
                      ... ......++..|+|||.+.+. .++.++||||||+++|+|++|..|+..... ......+....+......+.   .
T Consensus       152 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07839         152 PVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSK  230 (284)
T ss_pred             CCC-CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhh
Confidence            222 12234567899999988764 478999999999999999999988643222 11111111111111111110   0


Q ss_pred             hhccccCC---------CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          275 LVDPMLYG---------NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       275 ~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ..+.....         ......+..+.+++.+||+.||.+|||++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            00000000         111234567889999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2e-37  Score=275.74  Aligned_cols=249  Identities=28%  Similarity=0.420  Sum_probs=202.0

Q ss_pred             CCcccceecccCceEEEEEEEC-CCCEEEEEEeeccCh--hhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK--QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      +|.+.+.||+|++|.||++... +++.|++|.+.....  .....+..|++.++.++  |+||+++++.+...+..++|+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~--~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLK--HPNLVKYYGVEVHREKVYIFM   78 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCC--CCChhheeeeEecCCEEEEEE
Confidence            6899999999999999999865 688999999876543  36678899999999998  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      ||+++++|.+++    .....+++..+..++.|++.||.+||+.   |++|+||+|+||+++.++.++|+|||.+.....
T Consensus        79 e~~~~~~L~~~~----~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~  151 (264)
T cd06626          79 EYCSGGTLEELL----EHGRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN  151 (264)
T ss_pred             ecCCCCcHHHHH----hhcCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCC
Confidence            999999999998    3445688999999999999999999999   999999999999999999999999999887543


Q ss_pred             CCcccc---cccccccCccCccccccCC---CCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHh
Q 018263          200 NTTHIS---TRVAGTLGYLAPEYAISGR---LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELM  273 (358)
Q Consensus       200 ~~~~~~---~~~~~~~~y~aPE~~~~~~---~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      ......   ....++..|+|||.+.+..   ++.++||||||++++++++|+.||.......  ......          
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~--~~~~~~----------  219 (264)
T cd06626         152 NTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF--QIMFHV----------  219 (264)
T ss_pred             CCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH--HHHHHH----------
Confidence            322211   1345778999999988765   8899999999999999999999996432110  000000          


Q ss_pred             hhhccccCCCCCH--HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          274 NLVDPMLYGNFPE--NEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       274 ~~~~~~~~~~~~~--~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                         ........+.  ..+..+.+++.+||+.+|.+|||+.+++.
T Consensus       220 ---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         220 ---GAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             ---hcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence               0011111222  23667889999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.2e-37  Score=276.06  Aligned_cols=250  Identities=24%  Similarity=0.349  Sum_probs=199.6

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC-----hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC--
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-----KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG--  112 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~--  112 (358)
                      +++|++.+.||+|++|.||.+... ++..|++|.+....     ......+.+|+..++.+.  |||++++++.+...  
T Consensus         1 ~~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~   78 (265)
T cd06652           1 PTNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL--HERIVQYYGCLRDPME   78 (265)
T ss_pred             CCcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcC--CCCeeeEEeEeccCCC
Confidence            368999999999999999999875 58999999875432     223457788999999998  99999999988763  


Q ss_pred             CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecc
Q 018263          113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG  192 (358)
Q Consensus       113 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg  192 (358)
                      ...+++|||+++++|.+++    .....+++..+..++.|++.||.+||+.   +++|+||+|+||+++.++.++|+|||
T Consensus        79 ~~~~~v~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg  151 (265)
T cd06652          79 RTLSIFMEHMPGGSIKDQL----KSYGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFG  151 (265)
T ss_pred             ceEEEEEEecCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCc
Confidence            4678999999999999998    3445688999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCc--ccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchh
Q 018263          193 LSKLFPENTT--HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSK  270 (358)
Q Consensus       193 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      .+........  .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.......               
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---------------  216 (265)
T cd06652         152 ASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA---------------  216 (265)
T ss_pred             cccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH---------------
Confidence            8875432111  11223457889999999988889999999999999999999999996432111               


Q ss_pred             hHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          271 ELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ..............+......+..++.+|+. +|.+||+++++++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         217 AIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             HHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            1111111112233455667788899999995 9999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=4.1e-38  Score=283.73  Aligned_cols=264  Identities=25%  Similarity=0.352  Sum_probs=202.3

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC--hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      ++|++.+.||.|++|.||+|.++ +++.|++|.+....  ....+.+.+|++.++.++  |||++++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv   78 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR--HENLVNLIEVFRRKKRLYLV   78 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcC--CcchhhHHHhcccCCeEEEE
Confidence            47899999999999999999976 58999999875432  223566788999999988  99999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      +||++++.|..+.    .....+++..+..++.||+.||+|||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        79 ~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~  151 (286)
T cd07846          79 FEFVDHTVLDDLE----KYPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLA  151 (286)
T ss_pred             EecCCccHHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeecc
Confidence            9999998888876    3344589999999999999999999999   99999999999999999999999999987653


Q ss_pred             CCCcccccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHh----
Q 018263          199 ENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELM----  273 (358)
Q Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----  273 (358)
                      ... .......++..|+|||++.+ ..++.++||||||+++|+|++|++||......+..................    
T Consensus       152 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07846         152 APG-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQK  230 (286)
T ss_pred             CCc-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhcc
Confidence            322 22233457889999998875 357889999999999999999999997554332222221111111100000    


Q ss_pred             -hhhccccCCC---------CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          274 -NLVDPMLYGN---------FPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       274 -~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                       ..........         ..+..+..+.+++.+||+.+|++||++.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         231 NPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             chHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence             0000000000         11234677999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-38  Score=314.26  Aligned_cols=275  Identities=27%  Similarity=0.410  Sum_probs=224.6

Q ss_pred             ccccccCHHHHHHh-----hcCCcccceecccCceEEEEEEEC--CCC----EEEEEEeecc-ChhhHHHHHHHHHHhhh
Q 018263           27 KNINAFSYNQLKIA-----TNGFRWSNKIGEGGFGSVYKGRLQ--DGT----IVAVKVLSVE-SKQGEKEFMSEVASMAN   94 (358)
Q Consensus        27 ~~~~~~~~~~~~~~-----~~~y~i~~~lg~g~~g~v~~~~~~--~~~----~vaiK~~~~~-~~~~~~~~~~e~~~l~~   94 (358)
                      -++......+..+.     .+..++...||+|.||.||.|...  .|.    .|++|.+... +......|..|...+.+
T Consensus       672 ~~~~~~~~~~~~~~lp~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~  751 (1025)
T KOG1095|consen  672 NPFINSAGKDTLISLPEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSK  751 (1025)
T ss_pred             HHHhhhhccccccccccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhc
Confidence            33444444444444     677888899999999999999854  243    4888888654 56667899999999999


Q ss_pred             cccCCCCceeeeceEEcCCeeEEEEecCCCCCHHHHhhhccc---cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEc
Q 018263           95 VNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEK---RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHR  171 (358)
Q Consensus        95 l~~~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~  171 (358)
                      ++  ||||+++++++......+|++|||+||+|..+++..+.   ....++...+..++.|||+|+.||+++   .+|||
T Consensus       752 f~--HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHR  826 (1025)
T KOG1095|consen  752 FD--HPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHR  826 (1025)
T ss_pred             CC--CcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCc
Confidence            99  99999999999999999999999999999999965422   145688999999999999999999999   99999


Q ss_pred             CCCCCcEEEcCCCceEEeecccccccCCCCc-ccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCC
Q 018263          172 DIKTSNILLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVD  249 (358)
Q Consensus       172 di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~  249 (358)
                      ||...|+|++....+||+|||+++.+-.... ........+..|+|||.+..+.++.++||||||+++||+++ |..||.
T Consensus       827 DLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~  906 (1025)
T KOG1095|consen  827 DLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYP  906 (1025)
T ss_pred             chhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCC
Confidence            9999999999999999999999995433222 22222356679999999999999999999999999999999 888987


Q ss_pred             ccccccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCC
Q 018263          250 FDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETN  322 (358)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~  322 (358)
                      ...+.                ++...+...-+-..|..++..+.+|+..||+.+|++||++..|++++..+-+
T Consensus       907 ~~~n~----------------~v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~  963 (1025)
T KOG1095|consen  907 SRSNF----------------EVLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN  963 (1025)
T ss_pred             CcchH----------------HHHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence            54432                2222222222556778899999999999999999999999999999988763

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=8.4e-38  Score=310.91  Aligned_cols=261  Identities=21%  Similarity=0.243  Sum_probs=203.9

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      ++|++.+.||+|+||.||+|.+. +|+.||+|++....   .....++.+|+..+..+.  |||++++++++...+..++
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~--HPNIVkl~~v~~d~~~lyL   79 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI--HPGIVPVYSICSDGDPVYY   79 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCC--CcCcCeEEEEEeeCCEEEE
Confidence            58999999999999999999976 58999999986432   234567889999999998  9999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhccc-------cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEee
Q 018263          118 VYDYMPNNSLSQTLLGEEK-------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD  190 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~-------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~D  190 (358)
                      +|||++|++|.+++.....       .....+...+..++.||+.||+|||++   |++||||||+||+++.++.++|+|
T Consensus        80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiD  156 (932)
T PRK13184         80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILD  156 (932)
T ss_pred             EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEe
Confidence            9999999999999853211       123456678899999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCC-----------------cccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCcccc
Q 018263          191 FGLSKLFPENT-----------------THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ  253 (358)
Q Consensus       191 fg~~~~~~~~~-----------------~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~  253 (358)
                      ||++.......                 ........||+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus       157 FGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~  236 (932)
T PRK13184        157 WGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG  236 (932)
T ss_pred             cCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch
Confidence            99997652110                 0111124689999999999998999999999999999999999999975322


Q ss_pred             ccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHhhcCC
Q 018263          254 LGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRP-QMSTAIKMMNGET  321 (358)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp-t~~eil~~L~~~~  321 (358)
                      ......             .....+.. .......+..+.+++.+||+.||++|| +++++++.|+...
T Consensus       237 ~ki~~~-------------~~i~~P~~-~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l  291 (932)
T PRK13184        237 RKISYR-------------DVILSPIE-VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL  291 (932)
T ss_pred             hhhhhh-------------hhccChhh-ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            111000             00000000 000123456688999999999999996 6777888777654

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-37  Score=280.22  Aligned_cols=257  Identities=27%  Similarity=0.420  Sum_probs=205.0

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCC----EEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGT----IVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP  113 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~----~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~  113 (358)
                      ...+|++.+.||+|+||.||+|.++ +|.    .+++|...... ......+.+|+..++.+.  |||++++++++.. .
T Consensus         5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~-~   81 (279)
T cd05057           5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVD--HPHVVRLLGICLS-S   81 (279)
T ss_pred             CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCC--CCCcceEEEEEec-C
Confidence            3578899999999999999999864 233    58999876553 334567888999999997  9999999999887 7


Q ss_pred             eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccc
Q 018263          114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL  193 (358)
Q Consensus       114 ~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~  193 (358)
                      ..++++||+++++|.+.+..   ....+++..+..++.||+.||+|||+.   +++|+||+|+||+++.++.++|+|||.
T Consensus        82 ~~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~  155 (279)
T cd05057          82 QVQLITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGL  155 (279)
T ss_pred             ceEEEEecCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcc
Confidence            78999999999999999842   344689999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCccc-ccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhh
Q 018263          194 SKLFPENTTHI-STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKE  271 (358)
Q Consensus       194 ~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      +.......... .....++..|+|||.+.+..++.++|+||||+++|++++ |..||......                +
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----------------~  219 (279)
T cd05057         156 AKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV----------------E  219 (279)
T ss_pred             cccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH----------------H
Confidence            97654322211 111223567999999888889999999999999999998 99998754321                1


Q ss_pred             HhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCC
Q 018263          272 LMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGET  321 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~  321 (358)
                      +...+........+...+..+.+++.+||..+|.+||++.++++.|+.+.
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~  269 (279)
T cd05057         220 IPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA  269 (279)
T ss_pred             HHHHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            11111111112223345567899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.3e-37  Score=281.38  Aligned_cols=243  Identities=26%  Similarity=0.386  Sum_probs=201.1

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      ++|++.+.||.|++|.||++.+. +++.|++|.+....   ......+.+|++.++.+.  ||||+++++++...+..++
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~~   78 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR--HPFLVNLYGSFQDDSNLYL   78 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC--CCCccceeeEEEcCCeEEE
Confidence            47999999999999999999976 58999999986432   234567888999999998  9999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      +|||+++++|.+++    .....+++..+..++.||+.||.+||+.   |++|+||+|.||+++.++.++|+|||++...
T Consensus        79 v~e~~~~~~L~~~~----~~~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~  151 (290)
T cd05580          79 VMEYVPGGELFSHL----RKSGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRV  151 (290)
T ss_pred             EEecCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCcccc
Confidence            99999999999998    3446789999999999999999999999   9999999999999999999999999998865


Q ss_pred             CCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhc
Q 018263          198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD  277 (358)
Q Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      ...    .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||..........   .            ...
T Consensus       152 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~------------~~~  212 (290)
T cd05580         152 KGR----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYE---K------------ILE  212 (290)
T ss_pred             CCC----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHH---H------------Hhc
Confidence            433    233467889999999988888999999999999999999999997543211000   0            010


Q ss_pred             cccCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHH
Q 018263          278 PMLYGNFPENEAIRFLKVGLLCVQEKSKLRP-----QMSTAI  314 (358)
Q Consensus       278 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp-----t~~eil  314 (358)
                      .  ....+...+..+.+++.+||+.+|.+|+     +++|++
T Consensus       213 ~--~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         213 G--KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             C--CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence            0  1123334467889999999999999998     566655

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-37  Score=278.53  Aligned_cols=255  Identities=28%  Similarity=0.401  Sum_probs=202.0

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC-----
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP-----  113 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~-----  113 (358)
                      ..++|++.+.||.|++|.||+|..+ +++.|++|++..... ....+..|+..++.+. .|+|++++++.+....     
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~-~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYS-NHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhc-CCCChheEEEEEEecCCCCcc
Confidence            4589999999999999999999975 578899999875443 4467889999999883 3999999999987644     


Q ss_pred             -eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecc
Q 018263          114 -CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG  192 (358)
Q Consensus       114 -~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg  192 (358)
                       ..+++|||+++++|.+++.........+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCc
Confidence             47999999999999999854433456789999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccCccCcccccc-----CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhcc
Q 018263          193 LSKLFPENTTHISTRVAGTLGYLAPEYAIS-----GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMY  267 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~  267 (358)
                      .+........ ......++..|+|||++..     ..++.++||||||+++|+|++|+.||...........        
T Consensus       159 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~--------  229 (275)
T cd06608         159 VSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFK--------  229 (275)
T ss_pred             cceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHH--------
Confidence            9876432221 2233557889999998753     3467899999999999999999999964322111111        


Q ss_pred             chhhHhhhhcc-ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          268 NSKELMNLVDP-MLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       268 ~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                             +... ......+...+..+.+++.+||..||++|||+.++++
T Consensus       230 -------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         230 -------IPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             -------hhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence                   0000 0001112335668999999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=8.2e-38  Score=278.54  Aligned_cols=252  Identities=25%  Similarity=0.408  Sum_probs=203.6

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      ++|++.+.||.|++|.||++.++ +++.+++|.+.... ......+.+|++.++.+.  |||++++++.+...+..++++
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~~~~~~lv~   78 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCN--SPYIVGFYGAFYNNGDISICM   78 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCC--CCchhhhheeeecCCEEEEEE
Confidence            46889999999999999999976 68899999987653 345567888999999988  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      ||+++++|.+++...   ...+++..+..++.|++.||++||+ .   +++|+||+|+||+++.++.++|+|||.+....
T Consensus        79 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~  152 (265)
T cd06605          79 EYMDGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV  152 (265)
T ss_pred             EecCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence            999999999998432   2678999999999999999999999 8   99999999999999999999999999887543


Q ss_pred             CCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhcc
Q 018263          199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDP  278 (358)
Q Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (358)
                      ....   ....++..|+|||.+.+..++.++|+||||+++|+|++|..||.......... .         .........
T Consensus       153 ~~~~---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~---------~~~~~~~~~  219 (265)
T cd06605         153 NSLA---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGI-F---------ELLQYIVNE  219 (265)
T ss_pred             HHHh---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccH-H---------HHHHHHhcC
Confidence            2211   11567889999999988899999999999999999999999997543211100 0         001111111


Q ss_pred             ccCCCCCHH-HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          279 MLYGNFPEN-EAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       279 ~~~~~~~~~-~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                       .....+.. .+..+.++|.+||..+|.+|||+.++++
T Consensus       220 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         220 -PPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             -CCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence             11112222 6677999999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.5e-37  Score=279.61  Aligned_cols=260  Identities=25%  Similarity=0.358  Sum_probs=202.1

Q ss_pred             CHHHHHHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEc
Q 018263           33 SYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID  111 (358)
Q Consensus        33 ~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~  111 (358)
                      ...+.......|++.+.||.|+||.||+|... +++.|++|++.... .....+..|+..+..+. .|+|++++++.+..
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~-~h~~i~~~~~~~~~   84 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYS-HHRNIATYYGAFIK   84 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhc-CCCcEEEEeeehhc
Confidence            44455556789999999999999999999975 68899999986543 33456778888888874 49999999998853


Q ss_pred             ------CCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCc
Q 018263          112 ------GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN  185 (358)
Q Consensus       112 ------~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~  185 (358)
                            ....+++|||+++++|.+++...  ....+++..+..++.||+.||+|||+.   +++|+||+|+||+++.++.
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~  159 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNT--KGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAE  159 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCC
Confidence                  45789999999999999998432  234588999999999999999999999   9999999999999999999


Q ss_pred             eEEeecccccccCCCCcccccccccccCccCccccc-----cCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhh
Q 018263          186 PKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI-----SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLV  260 (358)
Q Consensus       186 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~  260 (358)
                      ++|+|||++........ ......++..|+|||.+.     +..++.++|+||||+++|+|++|..||............
T Consensus       160 ~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~  238 (282)
T cd06636         160 VKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI  238 (282)
T ss_pred             EEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhH
Confidence            99999999875432111 122345788999999875     345788999999999999999999999644321111110


Q ss_pred             HhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          261 DKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                                     .............+..+.++|.+||+.||.+|||+.||++
T Consensus       239 ---------------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         239 ---------------PRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             ---------------hhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence                           0010111112245667999999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.4e-37  Score=274.00  Aligned_cols=248  Identities=24%  Similarity=0.370  Sum_probs=201.7

Q ss_pred             CCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      +|++.+.||.|++|.||++... +++.+++|.+...  .......+.+|++.++.++  |||++++++.+...+..++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLS--HPNIIEYYENFLEDKALMIVM   78 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCC--CCchhheeeeEecCCEEEEEE
Confidence            5889999999999999999865 6888999998654  2344567888999999998  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCC-ceEEeecccccccC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF-NPKISDFGLSKLFP  198 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~-~~~l~Dfg~~~~~~  198 (358)
                      ||+++++|.+++...  ....+++..+..++.+++.+|.+||++   |++|+||+|+||+++.++ .++|+|||.+....
T Consensus        79 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~  153 (256)
T cd08220          79 EYAPGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILS  153 (256)
T ss_pred             ecCCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecC
Confidence            999999999999432  244589999999999999999999999   999999999999998654 57999999998654


Q ss_pred             CCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhcc
Q 018263          199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDP  278 (358)
Q Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (358)
                      ...  ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.........   ...            .. 
T Consensus       154 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~---~~~------------~~-  215 (256)
T cd08220         154 SKS--KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALV---LKI------------MS-  215 (256)
T ss_pred             CCc--cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHH---HHH------------Hh-
Confidence            322  122345788999999998888899999999999999999999999754321111   000            00 


Q ss_pred             ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          279 MLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       279 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ......+...+..+.+++.+||+.+|++|||+.++++
T Consensus       216 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         216 GTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             cCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            1111223345677999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.6e-37  Score=281.63  Aligned_cols=263  Identities=21%  Similarity=0.301  Sum_probs=201.9

Q ss_pred             CCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChh-----hHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeE
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQ-----GEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI  116 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~-----~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~  116 (358)
                      +|.+.+.||.|++|.||+|... +|+.|++|.+......     ....+..|++.++.++  |+|++++++++...+..+
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~--h~~i~~~~~~~~~~~~~~   78 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK--HPNIIGLLDVFGHKSNIN   78 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcC--CCCChhhhheeecCCEEE
Confidence            5888999999999999999975 6899999998754322     3456778999999988  999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       117 iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      +||||+ +++|.+++...   ...+++..+..++.||+.||+|||++   |++|+||+|+||+++.++.++|+|||++..
T Consensus        79 lv~e~~-~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~  151 (298)
T cd07841          79 LVFEFM-ETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARS  151 (298)
T ss_pred             EEEccc-CCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeee
Confidence            999999 89999998321   13789999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCcccccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhh-
Q 018263          197 FPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMN-  274 (358)
Q Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-  274 (358)
                      ....... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|.++|......+.........+.+....+.. 
T Consensus       152 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (298)
T cd07841         152 FGSPNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGV  230 (298)
T ss_pred             ccCCCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhc
Confidence            5433221 122345778999998865 4578899999999999999999888876544332222221111111111110 


Q ss_pred             -----hhccccCCC-----CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          275 -----LVDPMLYGN-----FPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       275 -----~~~~~~~~~-----~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                           .........     .....+..+.++|.+||+.+|++|||+.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence                 000000011     11234677899999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.1e-37  Score=276.87  Aligned_cols=247  Identities=24%  Similarity=0.313  Sum_probs=203.9

Q ss_pred             CCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      +|++.+.||.|++|.||+|.+. +++.|++|.+....   ....+.+.+|++.++.++  |||++++++.+......+++
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv   78 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN--HPFLVNLWYSFQDEENMYLV   78 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCC--CCChHHHHHhhcCCCeEEEE
Confidence            5889999999999999999976 68999999987542   244578889999999998  99999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      +||+.+++|.+.+    .....+++..+..++.||+.||.|||++   +++|+||+|+||++++++.++|+|||.+....
T Consensus        79 ~e~~~~~~L~~~l----~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~  151 (258)
T cd05578          79 VDLLLGGDLRYHL----SQKVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVT  151 (258)
T ss_pred             EeCCCCCCHHHHH----HhcCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccC
Confidence            9999999999998    3336789999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhcc
Q 018263          199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDP  278 (358)
Q Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (358)
                      ...  ......++..|+|||.+.+..++.++|+||||+++|+|++|..||............             .....
T Consensus       152 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-------------~~~~~  216 (258)
T cd05578         152 PDT--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR-------------AKQET  216 (258)
T ss_pred             CCc--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH-------------HHhcc
Confidence            332  223355788999999998888999999999999999999999999855432111111             11110


Q ss_pred             ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCH--HHHH
Q 018263          279 MLYGNFPENEAIRFLKVGLLCVQEKSKLRPQM--STAI  314 (358)
Q Consensus       279 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~--~eil  314 (358)
                       .....+...+..+.+++.+||+.+|.+||++  +|++
T Consensus       217 -~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         217 -ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             -ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence             1223444566889999999999999999999  5554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.5e-37  Score=277.55  Aligned_cols=251  Identities=28%  Similarity=0.428  Sum_probs=197.8

Q ss_pred             ceecccCceEEEEEEECC-------CCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           48 NKIGEGGFGSVYKGRLQD-------GTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        48 ~~lg~g~~g~v~~~~~~~-------~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      +.||.|++|.||+++.++       +..|++|.+.... ......+.+|+..++.++  ||||+++++++......+++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~~v~   78 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFN--HPNIVKLLGVCLLNEPQYIIM   78 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcC--CCCeeeEeeeecCCCCeEEEE
Confidence            368999999999998642       3578999875432 244567888999999998  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccc---cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCC-----ceEEeec
Q 018263          120 DYMPNNSLSQTLLGEEK---RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF-----NPKISDF  191 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~-----~~~l~Df  191 (358)
                      ||+++++|.+++.....   ....+++..+..++.|++.||.|||++   +++|+||+|+||+++.++     .++++||
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~df  155 (269)
T cd05044          79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDF  155 (269)
T ss_pred             eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCc
Confidence            99999999999954322   224578899999999999999999999   999999999999999887     8999999


Q ss_pred             ccccccCCCCc-ccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccch
Q 018263          192 GLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNS  269 (358)
Q Consensus       192 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      |++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |+.||........   .         
T Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~---~---------  223 (269)
T cd05044         156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV---L---------  223 (269)
T ss_pred             ccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHH---H---------
Confidence            99875432211 11112345678999999998899999999999999999998 9999864432111   1         


Q ss_pred             hhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 018263          270 KELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNG  319 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~  319 (358)
                          ..+........+...+..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus       224 ----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         224 ----QHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             ----HHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                1111111122334566788999999999999999999999999863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.3e-37  Score=279.71  Aligned_cols=264  Identities=24%  Similarity=0.325  Sum_probs=203.6

Q ss_pred             cCHHHHHHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEE
Q 018263           32 FSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCI  110 (358)
Q Consensus        32 ~~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~  110 (358)
                      +.+.++....++|.+.+.||.|++|.||++..+ +++.|++|.+... ......+..|+..++.+. .|||++++++++.
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~-~h~ni~~~~~~~~   89 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-SDVDEEIEAEYNILQSLP-NHPNVVKFYGMFY   89 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc-ccHHHHHHHHHHHHHHhc-CCCCeEEEEEEEE
Confidence            334555556789999999999999999999975 6889999998643 233456678888888873 3999999999887


Q ss_pred             cC-----CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCc
Q 018263          111 DG-----PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN  185 (358)
Q Consensus       111 ~~-----~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~  185 (358)
                      ..     +..++|+||+++++|.+++.........+++..++.++.|++.||.+||+.   +++|+||+|+||+++.++.
T Consensus        90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~  166 (291)
T cd06639          90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGG  166 (291)
T ss_pred             eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCC
Confidence            43     357999999999999998854434456789999999999999999999999   9999999999999999999


Q ss_pred             eEEeecccccccCCCCcccccccccccCccCccccccC-----CCCccCceecHHHHHHHHHhCCCCCCccccccchhhh
Q 018263          186 PKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG-----RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLV  260 (358)
Q Consensus       186 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~  260 (358)
                      ++|+|||.+......... .....++..|+|||.+...     .++.++|+||||+++|+|++|+.||..........  
T Consensus       167 ~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~--  243 (291)
T cd06639         167 VKLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF--  243 (291)
T ss_pred             EEEeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHH--
Confidence            999999998765332211 1234578899999987543     36889999999999999999999997443211111  


Q ss_pred             HhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          261 DKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                       ....           .....-..+......+.++|.+||+.+|++||++.++++
T Consensus       244 -~~~~-----------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         244 -KIPR-----------NPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             -HHhc-----------CCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence             1000           000000112334567999999999999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=6.8e-38  Score=283.45  Aligned_cols=250  Identities=22%  Similarity=0.341  Sum_probs=201.4

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEe
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD  120 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e  120 (358)
                      +.|.....||.|++|.||++... ++..|+||.+..........+.+|+..++.+.  |+|++++++.+...+..+++||
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~--h~~ii~~~~~~~~~~~~~lv~e   99 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYH--HENVVDMYNSYLVGDELWVVME   99 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCC--CCcHHHHHHheecCCeEEEEEe
Confidence            44555678999999999999865 68899999987665556677889999999987  9999999999999999999999


Q ss_pred             cCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCC
Q 018263          121 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN  200 (358)
Q Consensus       121 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~  200 (358)
                      |+++++|.+++     ..+.+++..+..++.||+.||.|||++   +++|+||+|+||+++.++.++|+|||++......
T Consensus       100 ~~~~~~L~~~~-----~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~  171 (292)
T cd06658         100 FLEGGALTDIV-----THTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE  171 (292)
T ss_pred             CCCCCcHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccc
Confidence            99999999987     234588999999999999999999999   9999999999999999999999999998754322


Q ss_pred             CcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhcccc
Q 018263          201 TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPML  280 (358)
Q Consensus       201 ~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (358)
                      .. ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...........+            ........
T Consensus       172 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~------------~~~~~~~~  238 (292)
T cd06658         172 VP-KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI------------RDNLPPRV  238 (292)
T ss_pred             cc-cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------------HhcCCCcc
Confidence            22 122345788999999998888999999999999999999999999754322111110            00011111


Q ss_pred             CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 018263          281 YGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKM  316 (358)
Q Consensus       281 ~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~  316 (358)
                      .  .....+..+..++.+||+.+|.+|||++++++.
T Consensus       239 ~--~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         239 K--DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             c--cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            0  112345578899999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.7e-37  Score=273.59  Aligned_cols=250  Identities=30%  Similarity=0.443  Sum_probs=207.7

Q ss_pred             CCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      +|++.+.||.|++|.||++..+ +++.|++|.+...  .......+..|+..++.++  |+||+++.+++......++|+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~~v~   78 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVN--HPNIISYKEAFLDGNKLCIVM   78 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCC--CCCchhhhhhhccCCEEEEEe
Confidence            5889999999999999999865 6889999998754  2344556778999999998  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      ||+++++|.+++.........+++..++.++.|++.||++||+.   |++|+||+|+||+++.++.++|+|||++.....
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~  155 (256)
T cd08530          79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKK  155 (256)
T ss_pred             hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence            99999999999865444456789999999999999999999999   999999999999999999999999999987544


Q ss_pred             CCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccc
Q 018263          200 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPM  279 (358)
Q Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (358)
                      .   ......++..|+|||.+.+..++.++|+||||+++++|++|+.||...+..                .....+...
T Consensus       156 ~---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~----------------~~~~~~~~~  216 (256)
T cd08530         156 N---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ----------------DLRYKVQRG  216 (256)
T ss_pred             C---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHhcC
Confidence            3   222345788999999998888999999999999999999999999754321                111111222


Q ss_pred             cCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 018263          280 LYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKM  316 (358)
Q Consensus       280 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~  316 (358)
                      .....+...+.++.+++.+||+.+|++||++.++++.
T Consensus       217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         217 KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             CCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            2233445677889999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.9e-37  Score=282.25  Aligned_cols=256  Identities=20%  Similarity=0.255  Sum_probs=201.9

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      ++|++.+.||.|++|.||++... +++.|++|.+....   ......+.+|+..++.++  ||||+++++.+..++..++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~~~~~~l   78 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE--NPFVVSMFCSFETKRHLCM   78 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC--CCCeeeeEEEEecCCEEEE
Confidence            47899999999999999999976 57899999986543   223456778999999887  9999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      +|||++|++|.+++    .....+++..+..++.|++.||.|||+.   +++|+||+|.||+++.++.++|+|||++...
T Consensus        79 v~e~~~g~~L~~~l----~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~  151 (305)
T cd05609          79 VMEYVEGGDCATLL----KNIGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIG  151 (305)
T ss_pred             EEecCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCcccc
Confidence            99999999999999    3446789999999999999999999999   9999999999999999999999999987631


Q ss_pred             CCCC--------------cccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhh
Q 018263          198 PENT--------------THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKA  263 (358)
Q Consensus       198 ~~~~--------------~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~  263 (358)
                      ....              ........++..|+|||.+.+..++.++|+||||+++|+|++|..||.............. 
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~-  230 (305)
T cd05609         152 LMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS-  230 (305)
T ss_pred             CcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-
Confidence            1000              0011123467789999999888899999999999999999999999974432111110000 


Q ss_pred             hhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 018263          264 WGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE  320 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~  320 (358)
                                   ............+..+.+++.+||+.+|++||++.++.+.|+.-
T Consensus       231 -------------~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~  274 (305)
T cd05609         231 -------------DDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR  274 (305)
T ss_pred             -------------cccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence                         00000111123566789999999999999999987777777663

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-37  Score=280.24  Aligned_cols=265  Identities=24%  Similarity=0.388  Sum_probs=197.9

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccCh-hhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      .++|++.+.||.|++|.||++..+ +++.|++|.+..... .....+.+|++.++.++  |+||+++++++......++|
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv   81 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLK--HANIVTLHDIIHTKKTLTLV   81 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCC--CcceeeEEEEEecCCeEEEE
Confidence            478999999999999999999976 689999999865432 22345678999999998  99999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      |||+++ +|.+++..   ....+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.++|+|||.+....
T Consensus        82 ~e~~~~-~L~~~~~~---~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  154 (291)
T cd07844          82 FEYLDT-DLKQYMDD---CGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKS  154 (291)
T ss_pred             EecCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccC
Confidence            999974 89888732   234688999999999999999999999   99999999999999999999999999986532


Q ss_pred             CCCcccccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCCCCCCcccc-ccchhhhHhhhhccchhhHhhhh
Q 018263          199 ENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ-LGEYHLVDKAWGMYNSKELMNLV  276 (358)
Q Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                      ..... .....++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||..... .+.........+......+....
T Consensus       155 ~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07844         155 VPSKT-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVS  233 (291)
T ss_pred             CCCcc-ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhh
Confidence            21111 122345788999998875 4588999999999999999999999965441 11111111111111111111100


Q ss_pred             cc---------c-----cCCCCC-HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          277 DP---------M-----LYGNFP-ENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       277 ~~---------~-----~~~~~~-~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ..         .     .....+ ......+.+++.+||+.+|++|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             hccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            00         0     000000 011257789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2e-37  Score=275.98  Aligned_cols=240  Identities=21%  Similarity=0.329  Sum_probs=188.5

Q ss_pred             ceecccCceEEEEEEECC-------------CCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCe
Q 018263           48 NKIGEGGFGSVYKGRLQD-------------GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC  114 (358)
Q Consensus        48 ~~lg~g~~g~v~~~~~~~-------------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~  114 (358)
                      +.||+|+||.||+|+...             ...+++|.+..........+.+|+..+..++  ||||+++++++.....
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~--hp~iv~~~~~~~~~~~   78 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS--HKHIVLLYGVCVRDVE   78 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCC--CCCEeeEEEEEecCCC
Confidence            468999999999998432             2358889887655555667888899999988  9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCc-------eE
Q 018263          115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN-------PK  187 (358)
Q Consensus       115 ~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~-------~~  187 (358)
                      .+++|||+++++|..++.   .....+++..+..++.||+.||+|||++   +++|+||+|+||+++.++.       ++
T Consensus        79 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~  152 (262)
T cd05077          79 NIMVEEFVEFGPLDLFMH---RKSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIK  152 (262)
T ss_pred             CEEEEecccCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeE
Confidence            999999999999988873   2345689999999999999999999999   9999999999999987664       89


Q ss_pred             EeecccccccCCCCcccccccccccCccCccccc-cCCCCccCceecHHHHHHHHH-hCCCCCCccccccchhhhHhhhh
Q 018263          188 ISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI-SGRLTRKSDVYSFGVLLLEIV-SGRTAVDFDVQLGEYHLVDKAWG  265 (358)
Q Consensus       188 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~s~~sDiwslG~il~~ll-tg~~pf~~~~~~~~~~~~~~~~~  265 (358)
                      ++|||.+......     ....++..|+|||.+. +..++.++||||||+++|+|+ .|..||.........        
T Consensus       153 l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~--------  219 (262)
T cd05077         153 LSDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE--------  219 (262)
T ss_pred             eCCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH--------
Confidence            9999988654221     2244678899999886 466889999999999999997 588887643211110        


Q ss_pred             ccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 018263          266 MYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN  318 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~  318 (358)
                              .+......  .......++.+|+.+||+.||.+||++.+|++.|+
T Consensus       220 --------~~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         220 --------RFYEGQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             --------HHHhcCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence                    00000000  11112456889999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.5e-37  Score=285.75  Aligned_cols=261  Identities=21%  Similarity=0.249  Sum_probs=193.7

Q ss_pred             ccceeccc--CceEEEEEEEC-CCCEEEEEEeeccC--hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEe
Q 018263           46 WSNKIGEG--GFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD  120 (358)
Q Consensus        46 i~~~lg~g--~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e  120 (358)
                      +++.||+|  ++++||++..+ +|+.||+|.+....  ......+.+|+..++.++  ||||+++++++..++..++|||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~--hpniv~~~~~~~~~~~~~lv~e   79 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFN--HPNIVPYRATFIADNELWVVTS   79 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcC--CCCeeeEEEEEEECCEEEEEEe
Confidence            57889999  68899999865 78999999987542  334456778999999988  9999999999999999999999


Q ss_pred             cCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCC
Q 018263          121 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN  200 (358)
Q Consensus       121 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~  200 (358)
                      |+++++|.+++...  ....+++..++.++.|++.||+|||++   +++|+||||+||+++.++.+++.||+........
T Consensus        80 ~~~~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~  154 (327)
T cd08227          80 FMAYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINH  154 (327)
T ss_pred             ccCCCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccc
Confidence            99999999998432  234588999999999999999999999   9999999999999999999999999865432111


Q ss_pred             Ccc------cccccccccCccCcccccc--CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhcc-----
Q 018263          201 TTH------ISTRVAGTLGYLAPEYAIS--GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMY-----  267 (358)
Q Consensus       201 ~~~------~~~~~~~~~~y~aPE~~~~--~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~-----  267 (358)
                      ...      ......++..|+|||++.+  ..++.++|||||||++|+|++|+.||..........  .......     
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~  232 (327)
T cd08227         155 GQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL--EKLNGTVPCLLD  232 (327)
T ss_pred             cccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHH--HHhcCCcccccc
Confidence            110      1112345677999999875  458899999999999999999999997432211100  0000000     


Q ss_pred             ----chhhHh---------h------h-------hccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          268 ----NSKELM---------N------L-------VDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       268 ----~~~~~~---------~------~-------~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                          ..+...         .      .       .............+..+.+++.+||+.||++|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         233 TTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             ccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence                000000         0      0       0000000122245667899999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.5e-37  Score=275.72  Aligned_cols=253  Identities=25%  Similarity=0.367  Sum_probs=198.6

Q ss_pred             CCcccceecccCceEEEEEEEC-CCCEEEEEEeeccCh----------hhHHHHHHHHHHhhhcccCCCCceeeeceEEc
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK----------QGEKEFMSEVASMANVNVCHENLVKLHGGCID  111 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~----------~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~  111 (358)
                      +|.+.+.||.|++|.||+|... +|+.|++|.+.....          ...+.+..|+..++.+.  |||++++++++..
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~   79 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD--HLNIVQYLGFETT   79 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcC--CCCcceEEEEecc
Confidence            5888999999999999999865 688999998754211          11245778999999998  9999999999999


Q ss_pred             CCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeec
Q 018263          112 GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF  191 (358)
Q Consensus       112 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Df  191 (358)
                      .+..++|+||+++++|.+.+.    ....+++..+..++.||+.||.+||++   +++|+||+|+||+++.++.++++||
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~  152 (272)
T cd06629          80 EEYLSIFLEYVPGGSIGSCLR----TYGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDF  152 (272)
T ss_pred             CCceEEEEecCCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeec
Confidence            999999999999999999983    336789999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcc-cccccccccCccCccccccCC--CCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccc
Q 018263          192 GLSKLFPENTTH-ISTRVAGTLGYLAPEYAISGR--LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYN  268 (358)
Q Consensus       192 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~--~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  268 (358)
                      |++......... ......++..|+|||.+.+..  ++.++|+||||+++|++++|..||........   .....   .
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~---~  226 (272)
T cd06629         153 GISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA---MFKLG---N  226 (272)
T ss_pred             cccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH---HHHhh---c
Confidence            998764322111 122345788999999887654  78999999999999999999999863322111   10000   0


Q ss_pred             hhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          269 SKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .     ..............+..+.+++.+||+.+|++||++.++++
T Consensus       227 ~-----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         227 K-----RSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             c-----ccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            0     00111111222335678999999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3.8e-37  Score=274.98  Aligned_cols=255  Identities=23%  Similarity=0.307  Sum_probs=201.1

Q ss_pred             HHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeE
Q 018263           38 KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI  116 (358)
Q Consensus        38 ~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~  116 (358)
                      ..+.+.......||+|+||.||+|.+. ++..|++|.+..........+.+|+..++.++  |+||+++++.+...+..+
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~   81 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLK--HRNIVQYLGSDSENGFFK   81 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcC--CCCeeeeeeeeccCCEEE
Confidence            344555556678999999999999865 57889999987666666778899999999998  999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhccccccCC--CHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcC-CCceEEeeccc
Q 018263          117 LVYDYMPNNSLSQTLLGEEKRRAKF--GWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ-NFNPKISDFGL  193 (358)
Q Consensus       117 iv~e~~~~~~L~~~l~~~~~~~~~l--~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~-~~~~~l~Dfg~  193 (358)
                      +++||+++++|.+++...   ...+  ++..+..++.||+.||+|||++   |++|+||+|+||+++. ++.++|+|||.
T Consensus        82 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~  155 (268)
T cd06624          82 IFMEQVPGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGT  155 (268)
T ss_pred             EEEecCCCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchh
Confidence            999999999999998432   2334  7888999999999999999999   9999999999999976 67899999999


Q ss_pred             ccccCCCCcccccccccccCccCccccccCC--CCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhh
Q 018263          194 SKLFPENTTHISTRVAGTLGYLAPEYAISGR--LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKE  271 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      +........ ......++..|+|||++.+..  ++.++|+||+|+++|+|++|+.||..........             
T Consensus       156 ~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~-------------  221 (268)
T cd06624         156 SKRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM-------------  221 (268)
T ss_pred             heecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH-------------
Confidence            876532221 122245788999999886543  7889999999999999999999986432111000             


Q ss_pred             HhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          272 LMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                       ............+......+.+++.+||+.+|.+|||+.++++
T Consensus       222 -~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         222 -FKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             -hhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence             0000001112334456677999999999999999999999986

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2e-37  Score=280.62  Aligned_cols=268  Identities=22%  Similarity=0.280  Sum_probs=199.1

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC--hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCe----
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC----  114 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~----  114 (358)
                      ++|++.+.||.|++|.||+|.+. +++.|++|......  ......+.+|+..++.+. .|||++++++++.....    
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~~i~~~~~~~~~~~~~~~~   79 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLS-ESIYIVRLLDVEHVEEKNGKP   79 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHcc-CCCCccceeeeEeecCCCCCc
Confidence            47999999999999999999975 68999999876542  223456788999999986 47999999999887665    


Q ss_pred             -eEEEEecCCCCCHHHHhhhcccc-ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcC-CCceEEeec
Q 018263          115 -RILVYDYMPNNSLSQTLLGEEKR-RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ-NFNPKISDF  191 (358)
Q Consensus       115 -~~iv~e~~~~~~L~~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~-~~~~~l~Df  191 (358)
                       .+++|||+++ +|.+++...... ...+++..++.++.||+.||.|||++   |++|+||+|+||+++. ++.++|+||
T Consensus        80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~df  155 (295)
T cd07837          80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADL  155 (295)
T ss_pred             eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeec
Confidence             8999999975 788887543222 45689999999999999999999999   9999999999999998 889999999


Q ss_pred             ccccccCCCCcccccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchh
Q 018263          192 GLSKLFPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSK  270 (358)
Q Consensus       192 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      |.+......... .....+++.|.|||++.+ ..++.++|+||||+++|+|++|..||...+.......+..........
T Consensus       156 g~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (295)
T cd07837         156 GLGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ  234 (295)
T ss_pred             ccceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            998754322211 122346778999998865 457899999999999999999999997654433222221111111111


Q ss_pred             hHhhhhc-------cccC----CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          271 ELMNLVD-------PMLY----GNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       271 ~~~~~~~-------~~~~----~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .+.....       +...    .......+..+.++|.+||+.+|.+||++.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            1000000       0000    0011235567899999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=3.3e-37  Score=274.76  Aligned_cols=256  Identities=26%  Similarity=0.380  Sum_probs=204.1

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      ++|++.+.||.|++|.||+|... ++..+++|++.... ......+.+|+..++.++  |+|++++++.+...+..++++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~iv~   78 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCN--HPNVVKYYTSFVVGDELWLVM   78 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcC--CCCEEEEEEEEeeCCEEEEEE
Confidence            57999999999999999999865 68889999986432 335577889999999987  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      |++++++|.+++.... ....+++..+..++.|++.||++||+.   |++|+||+|+||++++++.++|+|||++.....
T Consensus        79 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~  154 (267)
T cd06610          79 PYLSGGSLLDIMKSSY-PRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLAD  154 (267)
T ss_pred             eccCCCcHHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence            9999999999994321 125689999999999999999999999   999999999999999999999999999876543


Q ss_pred             CCcc---cccccccccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhh
Q 018263          200 NTTH---ISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNL  275 (358)
Q Consensus       200 ~~~~---~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                      ....   ......++..|+|||++... .++.++|+||||+++++|++|+.||...........   ....         
T Consensus       155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~---~~~~---------  222 (267)
T cd06610         155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLML---TLQN---------  222 (267)
T ss_pred             CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHH---HhcC---------
Confidence            2221   12234578899999998776 789999999999999999999999975433211111   1000         


Q ss_pred             hccccCCC-CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          276 VDPMLYGN-FPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       276 ~~~~~~~~-~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ..+..... .....+..+.+++.+||+.||++||++.++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         223 DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            00000000 11345677899999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=3.8e-37  Score=272.51  Aligned_cols=251  Identities=25%  Similarity=0.412  Sum_probs=207.6

Q ss_pred             CCcccceecccCceEEEEEEEC-CCCEEEEEEeeccCh--hhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK--QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      +|++.+.||.|++|.||++.+. ++..|++|.+.....  .....+..|++.++.++  |||++++.+.+......++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~~~~~~~~~~~~~~~~lv~   78 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLN--HPNIIKYYESFEEKGKLCIVM   78 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcC--CCChhheEEEEecCCEEEEEE
Confidence            5889999999999999999975 688999999876533  55677889999999998  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      |++++++|.+.+.........+++..+..++.+++.||.+||+.   |++|+||+|+||+++.++.++|+|||.+.....
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~  155 (258)
T cd08215          79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS  155 (258)
T ss_pred             EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeeccc
Confidence            99999999999954433357899999999999999999999999   999999999999999999999999999886544


Q ss_pred             CCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccc
Q 018263          200 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPM  279 (358)
Q Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (358)
                      .. .......+++.|+|||.+.+..++.++|+||+|+++++|++|..||........   ..            ... ..
T Consensus       156 ~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~---~~------------~~~-~~  218 (258)
T cd08215         156 TV-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLEL---AL------------KIL-KG  218 (258)
T ss_pred             Cc-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHH---HH------------HHh-cC
Confidence            32 122334678899999998888899999999999999999999999865432111   10            011 11


Q ss_pred             cCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          280 LYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       280 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .....+...+..+.+++.+||+.+|++|||+.++++
T Consensus       219 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         219 QYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            112233345677999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.9e-37  Score=288.26  Aligned_cols=193  Identities=24%  Similarity=0.361  Sum_probs=163.3

Q ss_pred             HhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      ....+|++++.||.|+||.||+|+.. ++..||+|+....      ....|+.+++.++  ||||+++++++......++
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~l  134 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVN--HPSVIRMKDTLVSGAITCM  134 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCC--CCCCcChhheEEeCCeeEE
Confidence            34468999999999999999999976 5778999975422      2245788888887  9999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      |+|++. ++|.+++.   .....+++..+..++.||+.||.|||++   ||+||||||+||+++.++.++|+|||++...
T Consensus       135 v~e~~~-~~l~~~l~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  207 (357)
T PHA03209        135 VLPHYS-SDLYTYLT---KRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFP  207 (357)
T ss_pred             EEEccC-CcHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcccccc
Confidence            999995 67888773   2345789999999999999999999999   9999999999999999999999999998753


Q ss_pred             CCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCC
Q 018263          198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAV  248 (358)
Q Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf  248 (358)
                      ...  .......++..|+|||++.+..++.++||||||+++|+|+++..++
T Consensus       208 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        208 VVA--PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             ccC--cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            221  1223356889999999999889999999999999999999865554

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.4e-37  Score=287.02  Aligned_cols=275  Identities=21%  Similarity=0.308  Sum_probs=208.7

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC-----
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG-----  112 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~-----  112 (358)
                      ..+|.+.+.||.|++|.||+++.. +++.|++|.+...  .......+..|+..++.++  |+||+++++++...     
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~ni~~~~~~~~~~~~~~~   81 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLD--HENVIAIKDIMPPPHREAF   81 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcC--CCCccchHHheeccccccc
Confidence            468999999999999999999865 6899999998643  2334456778999999987  99999999987654     


Q ss_pred             CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecc
Q 018263          113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG  192 (358)
Q Consensus       113 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg  192 (358)
                      ...++++||+. ++|.+++    .....+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.++|+|||
T Consensus        82 ~~~~lv~e~~~-~~L~~~~----~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg  153 (337)
T cd07858          82 NDVYIVYELMD-TDLHQII----RSSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFG  153 (337)
T ss_pred             CcEEEEEeCCC-CCHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCc
Confidence            34799999995 6888888    3456799999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhh
Q 018263          193 LSKLFPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKE  271 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      ++....... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||................+......
T Consensus       154 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  232 (337)
T cd07858         154 LARTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEED  232 (337)
T ss_pred             cccccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHH
Confidence            988654322 22233457889999998765 4688999999999999999999999976543333322222222111111


Q ss_pred             H--------hhhhccc---cCC---CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--hhcCCCCCCC
Q 018263          272 L--------MNLVDPM---LYG---NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKM--MNGETNIDGX  326 (358)
Q Consensus       272 ~--------~~~~~~~---~~~---~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~--L~~~~~~~~~  326 (358)
                      .        ...+...   ...   ......+..+.+++.+||+.+|.+|||++++++-  +...+.....
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~  303 (337)
T cd07858         233 LGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDE  303 (337)
T ss_pred             hhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccC
Confidence            1        1111000   000   0112356778999999999999999999999877  7776655543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.9e-37  Score=277.11  Aligned_cols=257  Identities=27%  Similarity=0.382  Sum_probs=202.9

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC--CeeEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG--PCRIL  117 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~--~~~~i  117 (358)
                      ++|+..+.||.|++|.||++... +++.|++|.+.... ......+.+|++.++.+.  ||||+++++.+...  +..++
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~~~l   78 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCK--SPYIVKYYGAFLDESSSSIGI   78 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCC--CCCeeeeeeEEEccCCCeEEE
Confidence            47889999999999999999975 58899999987543 344567889999999987  99999999988653  46899


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      ||||+++++|.+++.........+++..+..++.||+.||.|||+.   |++|+||+|+||+++.++.++|+|||++...
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~  155 (287)
T cd06621          79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGEL  155 (287)
T ss_pred             EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccc
Confidence            9999999999998754444556789999999999999999999999   9999999999999999999999999998754


Q ss_pred             CCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccc--cchhhhHhhhhccchhhHhhh
Q 018263          198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL--GEYHLVDKAWGMYNSKELMNL  275 (358)
Q Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~  275 (358)
                      .....   ....++..|+|||.+.+..++.++|+||||+++|+|++|..||......  ...........         .
T Consensus       156 ~~~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------~  223 (287)
T cd06621         156 VNSLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN---------M  223 (287)
T ss_pred             ccccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc---------C
Confidence            32221   2345678899999998888999999999999999999999999755321  11111111100         0


Q ss_pred             hccccCCCCC--HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          276 VDPMLYGNFP--ENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       276 ~~~~~~~~~~--~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      -.+.+.....  ...+..+.+++.+||+.+|.+|||+.|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         224 PNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             CchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            0001111111  234667899999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.8e-37  Score=280.64  Aligned_cols=265  Identities=23%  Similarity=0.329  Sum_probs=203.1

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccCh--hhHHHHHHHHHHhhhcccCCCCceeeeceEEcC--Cee
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK--QGEKEFMSEVASMANVNVCHENLVKLHGGCIDG--PCR  115 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~--~~~  115 (358)
                      .++|++.+.||.|++|.||+|.++ +++.+++|.+.....  .....+.+|+..+..+.  |||++++++++...  ...
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~--h~ni~~~~~~~~~~~~~~~   81 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQ--HPNIVTVKEVVVGSNLDKI   81 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcC--CCCEEEEEEEEEecCCCcE
Confidence            358999999999999999999976 588999999875432  22345678999999998  99999999998877  889


Q ss_pred             EEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccc
Q 018263          116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK  195 (358)
Q Consensus       116 ~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~  195 (358)
                      ++++||++ ++|.+++..   ....+++..+..++.||+.||+|||++   |++|+||+|+||+++.++.++|+|||.+.
T Consensus        82 ~lv~e~~~-~~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~  154 (293)
T cd07843          82 YMVMEYVE-HDLKSLMET---MKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAR  154 (293)
T ss_pred             EEEehhcC-cCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCcee
Confidence            99999996 589888832   234689999999999999999999999   99999999999999999999999999988


Q ss_pred             ccCCCCcccccccccccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhh
Q 018263          196 LFPENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMN  274 (358)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                      ........ .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||...........+....+......+..
T Consensus       155 ~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (293)
T cd07843         155 EYGSPLKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPG  233 (293)
T ss_pred             eccCCccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHH
Confidence            66443221 1224467889999988764 468899999999999999999999986654433333222221111111111


Q ss_pred             h--------------hccccCCCCCHH-HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          275 L--------------VDPMLYGNFPEN-EAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       275 ~--------------~~~~~~~~~~~~-~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      +              ....+...++.. .+..+.++|.+||+.+|++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         234 FSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             hhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            0              000111122222 4667889999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=5.2e-37  Score=276.10  Aligned_cols=253  Identities=26%  Similarity=0.367  Sum_probs=194.3

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC-hhhHHHHHHHHHH-hhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVAS-MANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~-l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      ++|++.+.||.|+||.||++.++ +|+.||+|.+.... ......+..|+.. ++.+.  |||++++++.+...+..+++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~--~~~iv~~~~~~~~~~~~~lv   78 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVD--CPYTVTFYGALFREGDVWIC   78 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcC--CCCeeeeeEEEecCCcEEEE
Confidence            47899999999999999999976 69999999986542 2334455556655 44444  99999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      |||++ ++|.+++.........+++..++.++.||+.||+|||++.  +++|+||+|+||+++.++.++|+|||++....
T Consensus        79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (283)
T cd06617          79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLV  155 (283)
T ss_pred             hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence            99995 6888887544344567899999999999999999999742  89999999999999999999999999987653


Q ss_pred             CCCcccccccccccCccCcccccc----CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhh
Q 018263          199 ENTTHISTRVAGTLGYLAPEYAIS----GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMN  274 (358)
Q Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~----~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                      ...  ......++..|+|||.+.+    ..++.++|+||||+++|+|++|+.||.....  ....            ...
T Consensus       156 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~------------~~~  219 (283)
T cd06617         156 DSV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT--PFQQ------------LKQ  219 (283)
T ss_pred             ccc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc--CHHH------------HHH
Confidence            221  1122457788999998764    4468899999999999999999999863211  0111            111


Q ss_pred             hhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          275 LVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .+............+..+.+++.+||+.+|.+||++.++++
T Consensus       220 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         220 VVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             HHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11111111111235667999999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=3.2e-37  Score=274.32  Aligned_cols=250  Identities=26%  Similarity=0.377  Sum_probs=191.4

Q ss_pred             ceecccCceEEEEEEEC----CCCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEE-cCCeeEEEEec
Q 018263           48 NKIGEGGFGSVYKGRLQ----DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCI-DGPCRILVYDY  121 (358)
Q Consensus        48 ~~lg~g~~g~v~~~~~~----~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~-~~~~~~iv~e~  121 (358)
                      +.||+|+||.||+|.+.    .+..|++|.+... .......+..|+..++.++  |||++++++.+. .++..++++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~~lv~e~   78 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFS--HPNVLSLLGICLPSEGSPLVVLPY   78 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCC--CCCcceEEEEeecCCCCcEEEEec
Confidence            46899999999999853    2457999987533 3344567888999999887  999999999765 45568899999


Q ss_pred             CCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCC
Q 018263          122 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT  201 (358)
Q Consensus       122 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~  201 (358)
                      +++++|.+++..   ....+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        79 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~  152 (262)
T cd05058          79 MKHGDLRNFIRS---ETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE  152 (262)
T ss_pred             CCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence            999999999842   234467788889999999999999999   99999999999999999999999999987543211


Q ss_pred             c---ccccccccccCccCccccccCCCCccCceecHHHHHHHHHhC-CCCCCccccccchhhhHhhhhccchhhHhhhhc
Q 018263          202 T---HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG-RTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD  277 (358)
Q Consensus       202 ~---~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      .   .......++..|+|||.+.+..++.++||||||+++|+|++| .+||......   ......             .
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~~~~~-------------~  216 (262)
T cd05058         153 YYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF---DITVYL-------------L  216 (262)
T ss_pred             ceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH-------------h
Confidence            1   111123456789999999888899999999999999999995 5566432211   111111             1


Q ss_pred             cccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCC
Q 018263          278 PMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGET  321 (358)
Q Consensus       278 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~  321 (358)
                      .......+...+..+.+++.+||+.+|++||++.+|++.|+++.
T Consensus       217 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         217 QGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             cCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence            11111122234567899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=7.9e-37  Score=269.39  Aligned_cols=247  Identities=27%  Similarity=0.434  Sum_probs=204.7

Q ss_pred             CCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEec
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY  121 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~  121 (358)
                      +|++.+.||+|++|.||++... +++.+++|++..........+.+|+..++.+.  |++++++.+.+......++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~l~~e~   78 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCK--HPNIVKYYGSYLKKDELWIVMEF   78 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCC--CCCEeEEEEEEecCCeEEEEEec
Confidence            4888999999999999999976 68899999997665556678899999999998  99999999999999999999999


Q ss_pred             CCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCC
Q 018263          122 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT  201 (358)
Q Consensus       122 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~  201 (358)
                      +++++|.+++...   ...+++..+..++.|++.||.+||+.   |++|+||+|+||++++++.++|+|||.+.......
T Consensus        79 ~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  152 (253)
T cd05122          79 CSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK  152 (253)
T ss_pred             CCCCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence            9999999998332   25789999999999999999999999   99999999999999999999999999988754433


Q ss_pred             cccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccC
Q 018263          202 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLY  281 (358)
Q Consensus       202 ~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (358)
                      .  .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.........                ....
T Consensus       153 ~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~----------------~~~~  214 (253)
T cd05122         153 A--RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA----------------TNGP  214 (253)
T ss_pred             c--ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH----------------hcCC
Confidence            2  234567889999999988888999999999999999999999987543211111100                0001


Q ss_pred             CCCC--HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          282 GNFP--ENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       282 ~~~~--~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ...+  ...+..+.+++.+||+.+|++|||+.++++
T Consensus       215 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         215 PGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             CCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1111  112567999999999999999999999986

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.5e-37  Score=281.92  Aligned_cols=250  Identities=21%  Similarity=0.327  Sum_probs=201.6

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEe
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD  120 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e  120 (358)
                      ..|.....||.|+||.||++... +++.|++|.+..........+.+|+..+..+.  |||++++++.+..++..++++|
T Consensus        21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~--hp~i~~~~~~~~~~~~~~iv~e   98 (297)
T cd06659          21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ--HQNVVEMYKSYLVGEELWVLME   98 (297)
T ss_pred             hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCC--CCchhhhhhheeeCCeEEEEEe
Confidence            34555668999999999999875 68999999987655555667888999999987  9999999999999999999999


Q ss_pred             cCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCC
Q 018263          121 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN  200 (358)
Q Consensus       121 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~  200 (358)
                      |+++++|..++     ....+++..++.++.|++.||++||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus        99 ~~~~~~L~~~~-----~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~  170 (297)
T cd06659          99 FLQGGALTDIV-----SQTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD  170 (297)
T ss_pred             cCCCCCHHHHH-----hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccc
Confidence            99999999887     335688999999999999999999999   9999999999999999999999999998754332


Q ss_pred             CcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhcccc
Q 018263          201 TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPML  280 (358)
Q Consensus       201 ~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (358)
                      .. ......++..|+|||++.+..++.++|+||||+++|+|++|+.||............   ....         ..  
T Consensus       171 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~---~~~~---------~~--  235 (297)
T cd06659         171 VP-KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL---RDSP---------PP--  235 (297)
T ss_pred             cc-cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---hccC---------CC--
Confidence            21 122356788999999998888999999999999999999999999754322211111   0000         00  


Q ss_pred             CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 018263          281 YGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKM  316 (358)
Q Consensus       281 ~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~  316 (358)
                      ........+..+.+++.+||+.+|.+||+++++++.
T Consensus       236 ~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         236 KLKNAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            001112345568899999999999999999999883

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=6.3e-37  Score=273.74  Aligned_cols=254  Identities=23%  Similarity=0.320  Sum_probs=191.3

Q ss_pred             ceecccCceEEEEEEEC---CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecCC
Q 018263           48 NKIGEGGFGSVYKGRLQ---DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP  123 (358)
Q Consensus        48 ~~lg~g~~g~v~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~~  123 (358)
                      +.||+|+||.||+|...   ++..+++|.+.... ......+.+|+..++.++  |||++++++.+.+....++||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQ--HSNLLQCLGQCTEVTPYLLVMEFCP   78 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCC--CCCEeeEEEEEcCCCCcEEEEECCC
Confidence            46899999999999864   34578999886543 334457888999999998  9999999999999999999999999


Q ss_pred             CCCHHHHhhhccc-cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCc
Q 018263          124 NNSLSQTLLGEEK-RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT  202 (358)
Q Consensus       124 ~~~L~~~l~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~  202 (358)
                      +++|.+++..... .....++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||.+........
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~  155 (269)
T cd05087          79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY  155 (269)
T ss_pred             CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcce
Confidence            9999999954322 223566788889999999999999999   999999999999999999999999999875432221


Q ss_pred             c-cccccccccCccCccccccC-------CCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhHh
Q 018263          203 H-ISTRVAGTLGYLAPEYAISG-------RLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELM  273 (358)
Q Consensus       203 ~-~~~~~~~~~~y~aPE~~~~~-------~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      . ......++..|+|||++.+.       .++.++|+||||+++|+|++ |..||.............       ...  
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~~--  226 (269)
T cd05087         156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTV-------REQ--  226 (269)
T ss_pred             eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHh-------hcc--
Confidence            1 11224567789999987642       35789999999999999996 999996543222111100       000  


Q ss_pred             hhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 018263          274 NLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN  318 (358)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~  318 (358)
                        ......+......+..+.+++..|+ .+|++|||++||+..|+
T Consensus       227 --~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         227 --QLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             --cCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence              0011111111223455788999998 58999999999999886

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=4.7e-37  Score=281.05  Aligned_cols=261  Identities=20%  Similarity=0.304  Sum_probs=188.3

Q ss_pred             cceecccCceEEEEEEEC---CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEc--CCeeEEEEec
Q 018263           47 SNKIGEGGFGSVYKGRLQ---DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID--GPCRILVYDY  121 (358)
Q Consensus        47 ~~~lg~g~~g~v~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~--~~~~~iv~e~  121 (358)
                      .++||+|+||.||+|+.+   ++..||+|.+....  ....+.+|+..++.++  |||++++++++..  +...++++||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELK--HPNVIALQKVFLSHSDRKVWLLFDY   81 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCC--CCCeeeEEEEEeccCCCeEEEEEee
Confidence            358999999999999865   45789999886432  2345778999999998  9999999998853  5567899999


Q ss_pred             CCCCCHHHHhhhcc-----ccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEE----cCCCceEEeecc
Q 018263          122 MPNNSLSQTLLGEE-----KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL----DQNFNPKISDFG  192 (358)
Q Consensus       122 ~~~~~L~~~l~~~~-----~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv----~~~~~~~l~Dfg  192 (358)
                      ++ ++|.+.+....     .....+++..++.++.||+.||.|||+.   +++|+||||+||++    +.++.++|+|||
T Consensus        82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07867          82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence            95 57777764221     1234588999999999999999999999   99999999999999    566789999999


Q ss_pred             cccccCCCCc--ccccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCCCCCCccccccc---------hhhh
Q 018263          193 LSKLFPENTT--HISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE---------YHLV  260 (358)
Q Consensus       193 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~---------~~~~  260 (358)
                      ++........  .......++..|+|||++.+ ..++.++||||||+++|+|++|++||........         ....
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~  237 (317)
T cd07867         158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI  237 (317)
T ss_pred             ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence            9986543222  12233567889999998876 4578999999999999999999999975443211         0001


Q ss_pred             HhhhhccchhhHhhhh---------ccccCC------------CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          261 DKAWGMYNSKELMNLV---------DPMLYG------------NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~---------~~~~~~------------~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ....+......+....         ......            .........+.+|+.+||+.||.+|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~  313 (317)
T cd07867         238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ  313 (317)
T ss_pred             HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence            1111111111111100         000000            000112345888999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.2e-37  Score=281.59  Aligned_cols=260  Identities=26%  Similarity=0.406  Sum_probs=202.6

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCC----EEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGT----IVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP  113 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~----~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~  113 (358)
                      ..++|++.+.||+|++|.||+|.+. +|.    .|++|.+.... ......+.+|+..+..+.  ||||+++++.+... 
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~--h~niv~~~~~~~~~-   81 (303)
T cd05110           5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD--HPHLVRLLGVCLSP-   81 (303)
T ss_pred             chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCC--CCCcccEEEEEcCC-
Confidence            3568889999999999999999864 343    57888876443 233346788999999987  99999999988754 


Q ss_pred             eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccc
Q 018263          114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL  193 (358)
Q Consensus       114 ~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~  193 (358)
                      ..+++++|+++++|.+++..   ....+++..+..++.|++.||+|||++   +++|+||+|+||+++.++.++|+|||+
T Consensus        82 ~~~~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~  155 (303)
T cd05110          82 TIQLVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGL  155 (303)
T ss_pred             CceeeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccc
Confidence            46789999999999999832   234688999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcc-cccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhh
Q 018263          194 SKLFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKE  271 (358)
Q Consensus       194 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      +......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.......                
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~----------------  219 (303)
T cd05110         156 ARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE----------------  219 (303)
T ss_pred             cccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----------------
Confidence            9865432221 1122345678999999988889999999999999999997 889986432111                


Q ss_pred             HhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCC
Q 018263          272 LMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNID  324 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~  324 (358)
                      ...++........+...+..+.+++.+||..+|++||++.++++.|..+..-.
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~  272 (303)
T cd05110         220 IPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP  272 (303)
T ss_pred             HHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence            11111111111122334567899999999999999999999999999875443

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-37  Score=286.49  Aligned_cols=282  Identities=23%  Similarity=0.309  Sum_probs=208.5

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC-----C
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG-----P  113 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~-----~  113 (358)
                      +++|++.+.||+|++|.||+|.+. +|+.|++|.+... .......+..|+..++.++  |+|++++++++...     .
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~   81 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFK--HENIIGILDIIRPPSFESFN   81 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCC--CCCcCchhheeecccccccc
Confidence            578999999999999999999865 6899999998643 2334456778999999998  99999999886644     3


Q ss_pred             eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccc
Q 018263          114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL  193 (358)
Q Consensus       114 ~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~  193 (358)
                      ..++++||++ ++|...+     ....+++..++.++.|++.||++||+.   |++|+||+|+||+++.++.++|+|||+
T Consensus        82 ~~~lv~e~~~-~~l~~~~-----~~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~  152 (336)
T cd07849          82 DVYIVQELME-TDLYKLI-----KTQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGL  152 (336)
T ss_pred             eEEEEehhcc-cCHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccc
Confidence            5799999995 5787776     345689999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcc--cccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchh
Q 018263          194 SKLFPENTTH--ISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSK  270 (358)
Q Consensus       194 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      +.........  ......++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||...........+....+....+
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~  232 (336)
T cd07849         153 ARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQE  232 (336)
T ss_pred             eeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence            8764322211  1123467889999998754 468899999999999999999999997654332222222222222222


Q ss_pred             hHhhhhccccC---------CC-----CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--hhcCCCCCCCCCCCCCCc
Q 018263          271 ELMNLVDPMLY---------GN-----FPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKM--MNGETNIDGXDVEISQPG  334 (358)
Q Consensus       271 ~~~~~~~~~~~---------~~-----~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~--L~~~~~~~~~~~~~~~~~  334 (358)
                      ....+......         ..     ..+..+..+.+++.+||+.+|.+|||+.++++.  ++.....  .+++..++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~--~~~~~~~~~  310 (336)
T cd07849         233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP--SDEPVAEEP  310 (336)
T ss_pred             HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC--CCcccCCCC
Confidence            22221111100         00     011235678999999999999999999999886  6655432  234444443


Q ss_pred             c
Q 018263          335 L  335 (358)
Q Consensus       335 ~  335 (358)
                      +
T Consensus       311 ~  311 (336)
T cd07849         311 F  311 (336)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=4.8e-37  Score=278.06  Aligned_cols=251  Identities=22%  Similarity=0.349  Sum_probs=204.6

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      .++|++.+.||+|++|.||++... ++..|++|.+..........+.+|+..++.+.  |||++++++.+...+..++|+
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~--hp~i~~~~~~~~~~~~~~lv~   95 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENK--HPNIVNYLDSYLVGDELWVVM   95 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcC--CCCeeehhheeeeCCcEEEEE
Confidence            479999999999999999999864 68889999987655555677888999999987  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      ||+++++|.+++.     ...+++..+..++.|++.||.+||++   |++|+||+|+||+++.++.++|+|||++.....
T Consensus        96 e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~  167 (293)
T cd06647          96 EYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (293)
T ss_pred             ecCCCCcHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence            9999999999982     34578999999999999999999999   999999999999999999999999998875433


Q ss_pred             CCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccc
Q 018263          200 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPM  279 (358)
Q Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (358)
                      ... ......++..|+|||.+.+..++.++|+||||+++|++++|+.||..............              ...
T Consensus       168 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~--------------~~~  232 (293)
T cd06647         168 EQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT--------------NGT  232 (293)
T ss_pred             ccc-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc--------------CCC
Confidence            222 22234577889999999888899999999999999999999999975443222111100              000


Q ss_pred             cCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 018263          280 LYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKM  316 (358)
Q Consensus       280 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~  316 (358)
                      .....+...+..+.+++.+||+.+|++||++.++++.
T Consensus       233 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         233 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0011122345678899999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=5.2e-37  Score=285.06  Aligned_cols=264  Identities=21%  Similarity=0.258  Sum_probs=201.5

Q ss_pred             HhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC---
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG---  112 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~---  112 (358)
                      ...++|++.+.||.|++|.||+|... +|+.|++|.+...  .......+.+|+..++.++  |||++++++++...   
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~   90 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVN--HKNIIGLLNVFTPQKSL   90 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcC--CCCCcceeeeeccCCCc
Confidence            45689999999999999999999965 6899999998643  2334456778999999988  99999999987643   


Q ss_pred             ---CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEe
Q 018263          113 ---PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKIS  189 (358)
Q Consensus       113 ---~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~  189 (358)
                         ...++||||+. ++|.+.+.    .  .+++..+..++.|++.||+|||+.   |++|+||+|+||+++.++.++|+
T Consensus        91 ~~~~~~~lv~e~~~-~~l~~~~~----~--~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~  160 (353)
T cd07850          91 EEFQDVYLVMELMD-ANLCQVIQ----M--DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL  160 (353)
T ss_pred             cccCcEEEEEeccC-CCHHHHHh----h--cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEc
Confidence               35699999995 57888772    1  288999999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccch
Q 018263          190 DFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNS  269 (358)
Q Consensus       190 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      |||++........  .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+....+.+..
T Consensus       161 Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  238 (353)
T cd07850         161 DFGLARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSD  238 (353)
T ss_pred             cCccceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence            9999986543222  22345778999999999989999999999999999999999999765543332222211111110


Q ss_pred             h----------------------hHhhhhcccc----CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 018263          270 K----------------------ELMNLVDPML----YGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKM  316 (358)
Q Consensus       270 ~----------------------~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~  316 (358)
                      .                      .+..+.....    ....+...+..+.+++.+||+.||.+|||+.|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         239 EFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0                      0001111000    011122356678899999999999999999999853

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.9e-37  Score=273.12  Aligned_cols=238  Identities=25%  Similarity=0.412  Sum_probs=187.9

Q ss_pred             ceecccCceEEEEEEECCCC-----------EEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeE
Q 018263           48 NKIGEGGFGSVYKGRLQDGT-----------IVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI  116 (358)
Q Consensus        48 ~~lg~g~~g~v~~~~~~~~~-----------~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~  116 (358)
                      +.||+|+||.||+|......           .+++|.+...... ...+.+|+..++.++  |||++++++++.. ...+
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~--h~~i~~~~~~~~~-~~~~   76 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLS--HKHLVKLYGVCVR-DENI   76 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCC--CcchhheeeEEec-CCcE
Confidence            46899999999999976422           4777877544333 678889999999998  9999999999888 7789


Q ss_pred             EEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCC-------ceEEe
Q 018263          117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF-------NPKIS  189 (358)
Q Consensus       117 iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~-------~~~l~  189 (358)
                      +||||+++++|.+++...   ...+++..+..++.||+.||+|||+.   |++|+||+|+||+++.++       .++|+
T Consensus        77 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~  150 (259)
T cd05037          77 MVEEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLS  150 (259)
T ss_pred             EEEEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeC
Confidence            999999999999998432   22688999999999999999999999   999999999999999887       79999


Q ss_pred             ecccccccCCCCcccccccccccCccCccccccC--CCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhc
Q 018263          190 DFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG--RLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGM  266 (358)
Q Consensus       190 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~  266 (358)
                      |||++.....     .....++..|+|||++.+.  .++.++|+||||+++|+|++ |..||.............     
T Consensus       151 Dfg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-----  220 (259)
T cd05037         151 DPGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-----  220 (259)
T ss_pred             CCCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-----
Confidence            9999886433     1223456789999998876  78999999999999999999 577775443211111000     


Q ss_pred             cchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 018263          267 YNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN  318 (358)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~  318 (358)
                                ..   ...+......+.+++.+||..+|.+|||+.++++.|+
T Consensus       221 ----------~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         221 ----------DQ---HRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             ----------cC---CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                      00   0001111267899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-37  Score=281.47  Aligned_cols=267  Identities=22%  Similarity=0.322  Sum_probs=199.1

Q ss_pred             CCcccceecccCceEEEEEEEC---CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC--Ce
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQ---DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG--PC  114 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~---~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~--~~  114 (358)
                      +|.+.+.||+|++|.||+|...   ++..||+|.+....   ......+.+|+..+..++  |||++++++.+...  ..
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~   78 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK--HENVVSLVEVFLEHADKS   78 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcC--CCCccceEEEEeCCCCce
Confidence            5889999999999999999975   47899999987632   344466778999999998  99999999999988  78


Q ss_pred             eEEEEecCCCCCHHHHhhhccccc-cCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcC----CCceEEe
Q 018263          115 RILVYDYMPNNSLSQTLLGEEKRR-AKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ----NFNPKIS  189 (358)
Q Consensus       115 ~~iv~e~~~~~~L~~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~----~~~~~l~  189 (358)
                      .++||||++ ++|.+.+....... ..+++..++.++.||+.||+|||+.   +++|+||+|+||+++.    ++.++|+
T Consensus        79 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~  154 (316)
T cd07842          79 VYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIG  154 (316)
T ss_pred             EEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEEC
Confidence            999999996 46777764433333 4789999999999999999999999   9999999999999999    9999999


Q ss_pred             ecccccccCCCCc--ccccccccccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCCCccccccch------hhh
Q 018263          190 DFGLSKLFPENTT--HISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEY------HLV  260 (358)
Q Consensus       190 Dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~------~~~  260 (358)
                      |||++........  .......++..|+|||.+.+. .++.++|+||||+++++|++|+.||.........      ...
T Consensus       155 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~  234 (316)
T cd07842         155 DLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQL  234 (316)
T ss_pred             CCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHH
Confidence            9999886533222  112234578889999987764 5789999999999999999999999765443210      000


Q ss_pred             H---hhhhccchh---------hHhhhhccccCCCCC-----H------HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          261 D---KAWGMYNSK---------ELMNLVDPMLYGNFP-----E------NEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       261 ~---~~~~~~~~~---------~~~~~~~~~~~~~~~-----~------~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .   ...+.....         +.....+......++     .      .....+.+++.+||+.||.+|||+.|+++
T Consensus       235 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         235 ERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            0   000000000         000000000111111     0      23456889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=9.8e-38  Score=277.29  Aligned_cols=240  Identities=22%  Similarity=0.365  Sum_probs=189.0

Q ss_pred             ceecccCceEEEEEEECC--------CCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           48 NKIGEGGFGSVYKGRLQD--------GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        48 ~~lg~g~~g~v~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      +.||.|+||.||+|....        ...|++|.+..........+.+|...++.+.  |||++++++++......++||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~--h~~iv~~~~~~~~~~~~~lv~   78 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLS--HKHLVLNYGVCVCGDESIMVQ   78 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCC--CCChhheeeEEEeCCCcEEEE
Confidence            468999999999998642        2348888876555555567888999999987  999999999999989999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCc--------eEEeec
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN--------PKISDF  191 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~--------~~l~Df  191 (358)
                      ||+++++|.+++..   ....+++..+..++.||+.||+|||++   |++|+||+|+||+++.++.        ++++||
T Consensus        79 e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~  152 (258)
T cd05078          79 EYVKFGSLDTYLKK---NKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP  152 (258)
T ss_pred             ecCCCCcHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccc
Confidence            99999999999842   234688999999999999999999999   9999999999999987765        589999


Q ss_pred             ccccccCCCCcccccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCC-CCCCccccccchhhhHhhhhccch
Q 018263          192 GLSKLFPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGR-TAVDFDVQLGEYHLVDKAWGMYNS  269 (358)
Q Consensus       192 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~-~pf~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      |.+......     ....++..|+|||++.+ ..++.++|+||||+++|+|++|. .||..........           
T Consensus       153 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-----------  216 (258)
T cd05078         153 GISITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-----------  216 (258)
T ss_pred             ccccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-----------
Confidence            988654321     22456788999999876 45789999999999999999985 5554322211100           


Q ss_pred             hhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 018263          270 KELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN  318 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~  318 (358)
                           ....  ....+......+.+++.+||+.+|++|||++++++.|+
T Consensus       217 -----~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         217 -----FYED--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             -----HHHc--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                 0000  11223334467899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.6e-37  Score=278.23  Aligned_cols=264  Identities=23%  Similarity=0.333  Sum_probs=199.7

Q ss_pred             CCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC--hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      +|++.+.||.|++|.||+|+.. +|+.|++|.+....  ......+..|++.++.++  |||++++++++.+....+++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~~v~   78 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN--HPNIVKLLDVIHTENKLYLVF   78 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcC--CCCCcchhhhcccCCcEEEEe
Confidence            4889999999999999999875 68999999886442  233457888999999998  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      ||+. ++|..++..  .....+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        79 e~~~-~~l~~~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~  152 (284)
T cd07860          79 EFLH-QDLKKFMDA--SPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV  152 (284)
T ss_pred             eccc-cCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhccc
Confidence            9995 588888743  2345689999999999999999999999   999999999999999999999999999875432


Q ss_pred             CCcccccccccccCccCccccccCC-CCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchh------hH
Q 018263          200 NTTHISTRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSK------EL  272 (358)
Q Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~~~~-~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~------~~  272 (358)
                      ... ......++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||......+.........+.....      ..
T Consensus       153 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07860         153 PVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL  231 (284)
T ss_pred             Ccc-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHH
Confidence            221 112234678899999887644 6889999999999999999999997655433322221111111100      00


Q ss_pred             h---hhhccccCC---CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          273 M---NLVDPMLYG---NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       273 ~---~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .   .........   ......+..+.++|.+||+.||.+|||++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         232 PDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            0   000000000   001123456789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.2e-36  Score=273.18  Aligned_cols=247  Identities=23%  Similarity=0.389  Sum_probs=201.4

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      +-|++.+.||.|+||.||++.+. ++..|++|...... ......+.+|+..+..+.  |||++++++.+..+...++||
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~   81 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD--SPYVTKYYGSYLKDTKLWIIM   81 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcC--CCCEeEEEEEEEeCCeEEEEE
Confidence            34778899999999999999865 68899999876432 334467888999999988  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      ||+++++|.+++.     ...+++..+..++.|++.++.+||+.   |++|+||+|+||+++.++.++++|||++.....
T Consensus        82 e~~~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06641          82 EYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  153 (277)
T ss_pred             EeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence            9999999999982     34688999999999999999999999   999999999999999999999999998875433


Q ss_pred             CCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccc
Q 018263          200 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPM  279 (358)
Q Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (358)
                      ... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.......   ..             ..+...
T Consensus       154 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~-------------~~~~~~  216 (277)
T cd06641         154 TQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK---VL-------------FLIPKN  216 (277)
T ss_pred             chh-hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH---HH-------------HHHhcC
Confidence            221 1222457788999999988888999999999999999999999986432211   11             011111


Q ss_pred             cCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          280 LYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       280 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .....+...+..+.+++.+||+.+|.+||++.++++
T Consensus       217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  252 (277)
T cd06641         217 NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK  252 (277)
T ss_pred             CCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            122233455677899999999999999999999998

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-37  Score=277.63  Aligned_cols=263  Identities=25%  Similarity=0.363  Sum_probs=201.7

Q ss_pred             CcccceecccCceEEEEEEEC-CCCEEEEEEeeccC--hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC--CeeEEE
Q 018263           44 FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG--PCRILV  118 (358)
Q Consensus        44 y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~--~~~~iv  118 (358)
                      |++.+.||.|++|.||+|+.. +++.|++|.+....  ......+..|+..++.+.  |+|++++++++...  ...++|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~~~lv   78 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLR--HPNIVRLKEIVTSKGKGSIYMV   78 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhcc--CCCeeeheeeEecCCCCcEEEE
Confidence            678999999999999999976 58899999997653  334466788999999998  99999999999988  889999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      +||++ ++|.+++..   ....+++..++.++.||+.||++||+.   |++|+||+|+||++++++.++|+|||.+....
T Consensus        79 ~e~~~-~~l~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~  151 (287)
T cd07840          79 FEYMD-HDLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYT  151 (287)
T ss_pred             ecccc-ccHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeecc
Confidence            99996 488888732   225789999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCcccccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhc
Q 018263          199 ENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD  277 (358)
Q Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      ...........++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.......................+....+
T Consensus       152 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (287)
T cd07840         152 KRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSK  231 (287)
T ss_pred             CCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccccc
Confidence            433222233456788999998765 4578999999999999999999999976554333222222111111111111000


Q ss_pred             --------c------ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          278 --------P------MLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       278 --------~------~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                              .      .+...+...++..+.+++.+||+.+|.+||+++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                    0      0000011113667899999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-37  Score=276.52  Aligned_cols=262  Identities=23%  Similarity=0.342  Sum_probs=204.6

Q ss_pred             CcccceecccCceEEEEEEEC-CCCEEEEEEeeccCh--hhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEe
Q 018263           44 FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK--QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD  120 (358)
Q Consensus        44 y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e  120 (358)
                      |++.+.||.|++|.||++..+ +++.+++|.+.....  .....+..|+..++.++  |+|++++++.+..++..++++|
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~~v~e   78 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELN--HPNIIKLLDVFRHKGDLYLVFE   78 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhc--CCCcchHHHhhccCCCEEEEEe
Confidence            678899999999999999875 688999999865432  34567788999999998  9999999999999999999999


Q ss_pred             cCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCC
Q 018263          121 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN  200 (358)
Q Consensus       121 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~  200 (358)
                      |+++ +|.+.+..   ....+++..+..++.||+.||.+||+.   +++|+||+|+||+++.++.++|+|||.+......
T Consensus        79 ~~~~-~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~  151 (283)
T cd05118          79 FMDT-DLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSP  151 (283)
T ss_pred             ccCC-CHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCC
Confidence            9965 88888732   235789999999999999999999999   9999999999999999999999999998766443


Q ss_pred             CcccccccccccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhc--
Q 018263          201 TTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD--  277 (358)
Q Consensus       201 ~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  277 (358)
                      . .......++..|.|||.+.+. .++.++|+||||+++|+|++|+.||...+..+.........+......+..+.+  
T Consensus       152 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd05118         152 V-RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA  230 (283)
T ss_pred             c-ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhh
Confidence            3 112234577889999998776 789999999999999999999999976655443333322222211111111111  


Q ss_pred             -----------cccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          278 -----------PMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       278 -----------~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                                 ...........+..+.++|.+||+.+|.+||++.+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                       00001112345678999999999999999999999985

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=7.4e-37  Score=273.22  Aligned_cols=254  Identities=20%  Similarity=0.323  Sum_probs=189.5

Q ss_pred             ceecccCceEEEEEEECCC---CEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecCC
Q 018263           48 NKIGEGGFGSVYKGRLQDG---TIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP  123 (358)
Q Consensus        48 ~~lg~g~~g~v~~~~~~~~---~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~~  123 (358)
                      +.||+|+||.||++...++   ..+++|...... ......+.+|+..++.++  |||++++++.+......++||||++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~   78 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQ--HPNILQCLGQCVEAIPYLLVFEYCE   78 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccC--CcchhheEEEecCCCccEEEEecCC
Confidence            3689999999999975432   345667665432 344567888999999887  9999999999999999999999999


Q ss_pred             CCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCC-Cc
Q 018263          124 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN-TT  202 (358)
Q Consensus       124 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~-~~  202 (358)
                      +++|.+++..........++..+..++.||+.||+|||+.   +++|+||+|+||+++.++.++|+|||++...... ..
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~  155 (268)
T cd05086          79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI  155 (268)
T ss_pred             CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhh
Confidence            9999999965433445677888999999999999999999   9999999999999999999999999987542211 11


Q ss_pred             ccccccccccCccCcccccc-------CCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhHhh
Q 018263          203 HISTRVAGTLGYLAPEYAIS-------GRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMN  274 (358)
Q Consensus       203 ~~~~~~~~~~~y~aPE~~~~-------~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                      .......++..|+|||++..       ..++.++||||||+++|+|++ |..||......+....+.       ......
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~-------~~~~~~  228 (268)
T cd05086         156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVI-------KDQQVK  228 (268)
T ss_pred             hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------hhcccc
Confidence            12223457789999998743       235789999999999999997 566775433221111110       011111


Q ss_pred             hhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 018263          275 LVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN  318 (358)
Q Consensus       275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~  318 (358)
                      +.+    +.........+.+++..|| .+|++||++++|++.|.
T Consensus       229 ~~~----~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         229 LFK----PQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             cCC----CccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            111    2222234566788999999 67999999999999885

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.3e-36  Score=274.10  Aligned_cols=251  Identities=25%  Similarity=0.401  Sum_probs=204.0

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      ..+.|++.+.||.|++|.||++.++ ++..|++|++..... ....+..|++.++.++  |+|++++++.+......+++
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~lv   93 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCK--HPNIVDYYDSYLVGDELWVV   93 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCC--CCCeeEEEEEEEECCEEEEE
Confidence            3567999999999999999999976 688999999875544 5667888999999998  99999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      +||+++++|.+++...   ...+++..+..++.|++.||.+||+.   |++|+||+|+||+++.++.++|+|||.+....
T Consensus        94 ~e~~~~~~L~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  167 (286)
T cd06614          94 MEYMDGGSLTDIITQN---FVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLT  167 (286)
T ss_pred             EeccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence            9999999999999432   13789999999999999999999999   99999999999999999999999999876543


Q ss_pred             CCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhcc
Q 018263          199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDP  278 (358)
Q Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (358)
                      .... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||............               ...
T Consensus       168 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~---------------~~~  231 (286)
T cd06614         168 KEKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLI---------------TTK  231 (286)
T ss_pred             cchh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---------------Hhc
Confidence            2221 112344678899999998888999999999999999999999998744322111100               000


Q ss_pred             cc-CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          279 ML-YGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       279 ~~-~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .. ....+...+..+.+++.+||+.+|.+||++.++++
T Consensus       232 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         232 GIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             CCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            00 00111235667999999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=8.1e-37  Score=273.43  Aligned_cols=256  Identities=25%  Similarity=0.360  Sum_probs=199.0

Q ss_pred             CcccceecccCceEEEEEEEC----CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC----
Q 018263           44 FRWSNKIGEGGFGSVYKGRLQ----DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP----  113 (358)
Q Consensus        44 y~i~~~lg~g~~g~v~~~~~~----~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~----  113 (358)
                      |++.+.||+|++|.||+|...    ++..|++|++...  .....+.+..|+..++.++  |||++++++++....    
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~~   78 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD--HPNVIKLIGVSLRSRAKGR   78 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCC--CCCcceEEEEEccCCCCCc
Confidence            678899999999999999853    4688999998654  3344567888999999998  999999999886542    


Q ss_pred             --eeEEEEecCCCCCHHHHhhhcc--ccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEe
Q 018263          114 --CRILVYDYMPNNSLSQTLLGEE--KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKIS  189 (358)
Q Consensus       114 --~~~iv~e~~~~~~L~~~l~~~~--~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~  189 (358)
                        ..+++++|+++++|.+++....  .....+++..+..++.|++.||+|||++   +++|+||+|+||+++.++.++++
T Consensus        79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~  155 (273)
T cd05074          79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVA  155 (273)
T ss_pred             ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEEC
Confidence              2368899999999998874321  1223578999999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcc-cccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhcc
Q 018263          190 DFGLSKLFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMY  267 (358)
Q Consensus       190 Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~  267 (358)
                      |||.+......... ......++..|++||.+.+..++.++||||||+++|+|++ |..||.............      
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~------  229 (273)
T cd05074         156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI------  229 (273)
T ss_pred             cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHH------
Confidence            99998865332211 1122335578999999988889999999999999999999 888886443211111110      


Q ss_pred             chhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 018263          268 NSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE  320 (358)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~  320 (358)
                                .......+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus       230 ----------~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         230 ----------KGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             ----------cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                      0001111233456799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=9.3e-37  Score=274.60  Aligned_cols=265  Identities=23%  Similarity=0.372  Sum_probs=203.6

Q ss_pred             CCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEe
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD  120 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e  120 (358)
                      +|++.+.||.|++|.||+|+.. +|+.|++|.+.... ......+.+|+..++.++  |+|++++++.+...+..++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e   78 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELK--HENIVRLHDVIHTENKLMLVFE   78 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhc--CCCEeeeeeeEeeCCcEEEEEe
Confidence            5889999999999999999976 68899999987543 233456778999999997  9999999999999999999999


Q ss_pred             cCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCC
Q 018263          121 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN  200 (358)
Q Consensus       121 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~  200 (358)
                      |+++ +|.+++.... ....+++..+..++.|++.||+|||+.   |++|+||+|+||+++.++.++|+|||.+......
T Consensus        79 ~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~  153 (284)
T cd07836          79 YMDK-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIP  153 (284)
T ss_pred             cCCc-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC
Confidence            9975 8888874332 235689999999999999999999999   9999999999999999999999999998754332


Q ss_pred             CcccccccccccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhcc-
Q 018263          201 TTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDP-  278 (358)
Q Consensus       201 ~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  278 (358)
                      .. ......++..|++||.+.+. .++.++|+|+||+++|+|++|+.||......+...........+....+..+... 
T Consensus       154 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07836         154 VN-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLP  232 (284)
T ss_pred             cc-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCc
Confidence            21 11223467889999988664 5688999999999999999999999866544333333222222222222111110 


Q ss_pred             ccCC-----------CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          279 MLYG-----------NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       279 ~~~~-----------~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ....           ...+..+..+.+++.+||+.+|.+||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0000           111234567889999999999999999999985

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.1e-36  Score=274.57  Aligned_cols=248  Identities=21%  Similarity=0.326  Sum_probs=200.9

Q ss_pred             CCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEec
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY  121 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~  121 (358)
                      .|.-.+.||.|++|.||++... +++.+++|.+..........+.+|+..++.+.  |||++++++.+...+..++++||
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~--h~~vv~~~~~~~~~~~~~~v~e~   97 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQ--HPNIVEMYSSYLVGDELWVVMEF   97 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcC--CCChheEEEEEEcCCeEEEEEec
Confidence            4555689999999999999864 68899999987665556667889999999987  99999999999999999999999


Q ss_pred             CCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCC
Q 018263          122 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT  201 (358)
Q Consensus       122 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~  201 (358)
                      +++++|.+++.    . ..+++..+..++.|++.||++||++   |++|+||+|+||+++.++.++|+|||.+.......
T Consensus        98 ~~~~~L~~~~~----~-~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~  169 (285)
T cd06648          98 LEGGALTDIVT----H-TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV  169 (285)
T ss_pred             cCCCCHHHHHH----h-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCC
Confidence            99999999983    2 5688999999999999999999999   99999999999999999999999999877543322


Q ss_pred             cccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccC
Q 018263          202 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLY  281 (358)
Q Consensus       202 ~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (358)
                      . ......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||........   ......         ...+.  
T Consensus       170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~---~~~~~~---------~~~~~--  234 (285)
T cd06648         170 P-RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA---MKRIRD---------NLPPK--  234 (285)
T ss_pred             c-ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH---HHHHHh---------cCCCC--
Confidence            2 12234578899999999888899999999999999999999999975432111   111110         00000  


Q ss_pred             CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          282 GNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       282 ~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ...+...+..+.+++.+||+.+|++||++.++++
T Consensus       235 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         235 LKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             CcccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            0011224567999999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.6e-36  Score=268.54  Aligned_cols=250  Identities=26%  Similarity=0.378  Sum_probs=207.0

Q ss_pred             CCcccceecccCceEEEEEEEC-CCCEEEEEEeeccCh--hhHHHHHHHHHHhhhcccCCCCceeeeceEEcC--CeeEE
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK--QGEKEFMSEVASMANVNVCHENLVKLHGGCIDG--PCRIL  117 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~--~~~~i  117 (358)
                      +|++.+.||+|++|.||+|... +++.|++|++.....  .....+.+|+..++.++  |+|++++++.+...  ...++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~~~l   78 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQ--HPNIVRYYGSERDEEKNTLNI   78 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcC--CCCEeeEEEEEecCCCCeEEE
Confidence            5788999999999999999976 689999999875542  45678889999999998  99999999999988  88999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      ++||+++++|.+++.    ....+++..++.++.|++.+|+|||+.   +++|+||+|+||+++.++.++|+|||.+...
T Consensus        79 v~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~  151 (260)
T cd06606          79 FLEYVSGGSLSSLLK----KFGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRL  151 (260)
T ss_pred             EEEecCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEec
Confidence            999999999999983    334889999999999999999999999   9999999999999999999999999998876


Q ss_pred             CCCCcc-cccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhh
Q 018263          198 PENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV  276 (358)
Q Consensus       198 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                      ...... ......++..|.|||.+.+...+.++|+||||+++++|++|..||.....  ....            ...+.
T Consensus       152 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~------------~~~~~  217 (260)
T cd06606         152 GDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN--PMAA------------LYKIG  217 (260)
T ss_pred             ccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHHH------------HHhcc
Confidence            443321 12335678899999999888899999999999999999999999975541  1111            11111


Q ss_pred             ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          277 DPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       277 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ........+...+..+.+++.+||+.+|++||++.++++
T Consensus       218 ~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         218 SSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             ccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            112223344555788999999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=6.4e-37  Score=273.62  Aligned_cols=254  Identities=22%  Similarity=0.312  Sum_probs=189.4

Q ss_pred             ceecccCceEEEEEEECC---CCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecCC
Q 018263           48 NKIGEGGFGSVYKGRLQD---GTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP  123 (358)
Q Consensus        48 ~~lg~g~~g~v~~~~~~~---~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~~  123 (358)
                      +.||+|+||.||+|...+   ...+++|.+.... ......+.+|+..++.++  |+||+++++.+......++||||++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~--h~nii~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELN--HPNVLQCLGQCIESIPYLLVLEFCP   78 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCC--CCCcceEEEEECCCCceEEEEEeCC
Confidence            368999999999997542   4568888775443 334456788999999887  9999999999999999999999999


Q ss_pred             CCCHHHHhhhccc-cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCc
Q 018263          124 NNSLSQTLLGEEK-RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT  202 (358)
Q Consensus       124 ~~~L~~~l~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~  202 (358)
                      +++|.+++..... .....++..+..++.||+.||+|||++   +++|+||||+||+++.++.++|+|||++........
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~  155 (269)
T cd05042          79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY  155 (269)
T ss_pred             CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchh
Confidence            9999999955432 223456888999999999999999999   999999999999999999999999999865322211


Q ss_pred             -ccccccccccCccCcccccc-------CCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhHh
Q 018263          203 -HISTRVAGTLGYLAPEYAIS-------GRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELM  273 (358)
Q Consensus       203 -~~~~~~~~~~~y~aPE~~~~-------~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                       .......++..|+|||++..       ..++.++||||||+++|+|++ |..||......+.....  ..         
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~--~~---------  224 (269)
T cd05042         156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV--VR---------  224 (269)
T ss_pred             eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH--hh---------
Confidence             11122345677999998642       356789999999999999999 78888644322111100  00         


Q ss_pred             hhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 018263          274 NLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN  318 (358)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~  318 (358)
                      ........+..+...+..+.+++..|+ .+|++|||+++|++.|.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         225 EQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             ccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            000011112223345566777888888 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-38  Score=274.65  Aligned_cols=268  Identities=20%  Similarity=0.264  Sum_probs=214.6

Q ss_pred             HHHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCC----ceeeeceEEc
Q 018263           37 LKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHEN----LVKLHGGCID  111 (358)
Q Consensus        37 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~----i~~~~~~~~~  111 (358)
                      -....++|.+++.+|+|.||.|..+.+. .+..||||+++... .-..+.+-|++.++++....|+    ++++.++|..
T Consensus        84 gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy  162 (415)
T KOG0671|consen   84 GDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY  162 (415)
T ss_pred             ccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence            3344789999999999999999999865 47899999997543 3445566799999999644443    8889999999


Q ss_pred             CCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEc----------
Q 018263          112 GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD----------  181 (358)
Q Consensus       112 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~----------  181 (358)
                      .++.|||+|.+ |.++.+++..  .+..+++...++.+++|++.++++||+.   +++|.||||+||++.          
T Consensus       163 rghiCivfell-G~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~  236 (415)
T KOG0671|consen  163 RGHICIVFELL-GLSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNP  236 (415)
T ss_pred             cCceEEEEecc-ChhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEecc
Confidence            99999999998 8899999943  4567789999999999999999999999   999999999999982          


Q ss_pred             ----------CCCceEEeecccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCcc
Q 018263          182 ----------QNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD  251 (358)
Q Consensus       182 ----------~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~  251 (358)
                                ++..++++|||.+......    ......|..|.|||++.+..|+.++||||+||||+||.+|...|..-
T Consensus       237 k~~~~~~r~~ks~~I~vIDFGsAtf~~e~----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH  312 (415)
T KOG0671|consen  237 KKKVCFIRPLKSTAIKVIDFGSATFDHEH----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH  312 (415)
T ss_pred             CCccceeccCCCcceEEEecCCcceeccC----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence                      2345899999999874332    24567899999999999999999999999999999999999999888


Q ss_pred             ccccchhhhHhhhhccchhhHhhh-----hccc----------------cCC--------CCCHHHHHHHHHHHhhccCC
Q 018263          252 VQLGEYHLVDKAWGMYNSKELMNL-----VDPM----------------LYG--------NFPENEAIRFLKVGLLCVQE  302 (358)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~----------------~~~--------~~~~~~~~~l~~li~~~l~~  302 (358)
                      ++.+....++.+.+.....-....     ....                +..        .....+...+.+|+++||..
T Consensus       313 en~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f  392 (415)
T KOG0671|consen  313 ENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF  392 (415)
T ss_pred             CcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence            777777777777654432211111     0000                000        12235667899999999999


Q ss_pred             CCCCCCCHHHHHH
Q 018263          303 KSKLRPQMSTAIK  315 (358)
Q Consensus       303 ~P~~Rpt~~eil~  315 (358)
                      ||.+|+|+.|++.
T Consensus       393 DP~~RiTl~EAL~  405 (415)
T KOG0671|consen  393 DPARRITLREALS  405 (415)
T ss_pred             CccccccHHHHhc
Confidence            9999999999975

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-36  Score=273.22  Aligned_cols=248  Identities=25%  Similarity=0.424  Sum_probs=198.6

Q ss_pred             CCcccceecccCceEEEEEEEC-CCCEEEEEEeecc-ChhhHHHHHHHHHHhhhcc-cCCCCceeeeceEEcCCeeEEEE
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVN-VCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~-~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      .|++.+.||.|++|.||+|.+. +++.|++|.+... .......+.+|+..++.+. ..|||++++++.+......+++|
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            5888999999999999999964 6899999998654 3344456778888887774 13999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      ||+++++|.+++.     ...+++..++.++.|++.+|.+||+.   |++|+||+|+||+++.++.++|+|||.+.....
T Consensus        82 e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06917          82 EYAEGGSVRTLMK-----AGPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ  153 (277)
T ss_pred             ecCCCCcHHHHHH-----ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence            9999999999982     23789999999999999999999999   999999999999999999999999999886644


Q ss_pred             CCcccccccccccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhcc
Q 018263          200 NTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDP  278 (358)
Q Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (358)
                      .... .....++..|+|||.+.++ .++.++|+||||+++|+|++|..||...........                +..
T Consensus       154 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~----------------~~~  216 (277)
T cd06917         154 NSSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML----------------IPK  216 (277)
T ss_pred             Cccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc----------------ccc
Confidence            3322 2334578899999988654 578899999999999999999999975432211110                000


Q ss_pred             ccCCCCCH-HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          279 MLYGNFPE-NEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       279 ~~~~~~~~-~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ......+. ..+..+.+++.+||+.+|++||++.++++
T Consensus       217 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         217 SKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             CCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            01111111 25567899999999999999999999976

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=5.2e-37  Score=279.87  Aligned_cols=265  Identities=26%  Similarity=0.377  Sum_probs=199.9

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccCh--hhHHHHHHHHHHhhhcccCCCCceeeeceEEcC--Cee
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK--QGEKEFMSEVASMANVNVCHENLVKLHGGCIDG--PCR  115 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~--~~~  115 (358)
                      .++|++.+.||.|++|.||+|.+. +|+.||+|.+.....  .....+.+|+..++.++  |+|++++++++...  +..
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~~   83 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLR--HPNIVELKEVVVGKHLDSI   83 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCC--CCCCcceEEEEecCCCCeE
Confidence            578999999999999999999975 689999999865432  22345667999999998  99999999998765  468


Q ss_pred             EEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccc
Q 018263          116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK  195 (358)
Q Consensus       116 ~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~  195 (358)
                      ++||||+. ++|.+++..   ....+++..+..++.||+.||+|||+.   |++|+||+|+||+++.++.++|+|||.+.
T Consensus        84 ~lv~e~~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~  156 (309)
T cd07845          84 FLVMEYCE-QDLASLLDN---MPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLAR  156 (309)
T ss_pred             EEEEecCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceee
Confidence            99999996 578888732   236789999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCcccccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhh
Q 018263          196 LFPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMN  274 (358)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                      ........ .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+.......+....+......+..
T Consensus       157 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
T cd07845         157 TYGLPAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPG  235 (309)
T ss_pred             ecCCccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchh
Confidence            65432211 122335678999998865 4578999999999999999999999986654443333322221111111000


Q ss_pred             hhc-----cc-cC----CCC---CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          275 LVD-----PM-LY----GNF---PENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       275 ~~~-----~~-~~----~~~---~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      +..     .. ..    ...   ....+..+.++|.+||+.||++|||++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            000     00 00    000   0123567789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4e-37  Score=275.88  Aligned_cols=240  Identities=23%  Similarity=0.379  Sum_probs=187.1

Q ss_pred             ceecccCceEEEEEEECC-------------------------CCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCc
Q 018263           48 NKIGEGGFGSVYKGRLQD-------------------------GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENL  102 (358)
Q Consensus        48 ~~lg~g~~g~v~~~~~~~-------------------------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i  102 (358)
                      ..||+|+||.||+|....                         ...|++|++..........+.+|+..++.++  ||||
T Consensus         1 ~~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~--h~ni   78 (274)
T cd05076           1 AHLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVS--HIHL   78 (274)
T ss_pred             CCcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCC--CCCe
Confidence            368999999999987421                         2358889886555555567788888888887  9999


Q ss_pred             eeeeceEEcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcC
Q 018263          103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ  182 (358)
Q Consensus       103 ~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~  182 (358)
                      +++++++......++||||+++++|..++..   ..+.+++..+..++.||+.||+|||++   +++|+||+|+||+++.
T Consensus        79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~  152 (274)
T cd05076          79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLAR  152 (274)
T ss_pred             eeEEEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEec
Confidence            9999999999999999999999999998832   345688999999999999999999999   9999999999999976


Q ss_pred             CC-------ceEEeecccccccCCCCcccccccccccCccCcccccc-CCCCccCceecHHHHHHHHH-hCCCCCCcccc
Q 018263          183 NF-------NPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIV-SGRTAVDFDVQ  253 (358)
Q Consensus       183 ~~-------~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll-tg~~pf~~~~~  253 (358)
                      .+       .++++|||.+......     ....++..|+|||.+.+ ..++.++|+||||+++|+|+ +|+.||.....
T Consensus       153 ~~~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~  227 (274)
T cd05076         153 LGLAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP  227 (274)
T ss_pred             cCcccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence            43       3799999987643211     12346778999998875 56889999999999999984 68999875432


Q ss_pred             ccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 018263          254 LGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN  318 (358)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~  318 (358)
                      ......                ....  ...+......+.+++.+||+.+|++|||+.+|++.|+
T Consensus       228 ~~~~~~----------------~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         228 SEKERF----------------YEKK--HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HHHHHH----------------HHhc--cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            211110                0000  0111122346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.4e-36  Score=270.36  Aligned_cols=242  Identities=24%  Similarity=0.327  Sum_probs=197.8

Q ss_pred             ecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecCCCC
Q 018263           50 IGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN  125 (358)
Q Consensus        50 lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~~~~  125 (358)
                      ||.|++|.||+++.. +++.|++|++....   ....+.+.+|+..++.+.  ||||+++++.+.++...++++||++++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN--HPFIVKLYRTFKDKKYIYMLMEYCLGG   78 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCC--CCCEeeeeeeEEcCCccEEEEecCCCC
Confidence            689999999999976 48899999986432   234567889999999998  999999999999999999999999999


Q ss_pred             CHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCcccc
Q 018263          126 SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS  205 (358)
Q Consensus       126 ~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~  205 (358)
                      +|.+++    .....+++..+..++.||+.||.|||+.   +++|+||+|+||+++.++.++|+|||.+.......  ..
T Consensus        79 ~L~~~l----~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~  149 (262)
T cd05572          79 ELWTIL----RDRGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KT  149 (262)
T ss_pred             cHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cc
Confidence            999999    3345689999999999999999999999   99999999999999999999999999998754332  12


Q ss_pred             cccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCCCC
Q 018263          206 TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFP  285 (358)
Q Consensus       206 ~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (358)
                      ....++..|+|||.+.+..++.++|+||+|+++|+|++|..||...... ....            ............++
T Consensus       150 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~------------~~~~~~~~~~~~~~  216 (262)
T cd05572         150 WTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED-PMEI------------YNDILKGNGKLEFP  216 (262)
T ss_pred             ccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC-HHHH------------HHHHhccCCCCCCC
Confidence            2345788999999988888999999999999999999999999755421 1111            11111112223344


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 018263          286 ENEAIRFLKVGLLCVQEKSKLRPQ-----MSTAIK  315 (358)
Q Consensus       286 ~~~~~~l~~li~~~l~~~P~~Rpt-----~~eil~  315 (358)
                      ...+..+.+++.+||+.+|++||+     ++|+++
T Consensus       217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            445778999999999999999999     777765

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-37  Score=276.43  Aligned_cols=263  Identities=24%  Similarity=0.342  Sum_probs=199.4

Q ss_pred             CcccceecccCceEEEEEEEC-CCCEEEEEEeeccC--hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEe
Q 018263           44 FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD  120 (358)
Q Consensus        44 y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e  120 (358)
                      |++.+.||.|++|.||+|..+ +|..|++|++....  ......+.+|++.++.++  |||++++++++...+..++++|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~--~~~iv~~~~~~~~~~~~~iv~e   78 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELN--HPNIVRLLDVVHSENKLYLVFE   78 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcC--CCCccCHhheeccCCeEEEEEe
Confidence            678899999999999999875 69999999987543  223456788999999998  9999999999999999999999


Q ss_pred             cCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCC
Q 018263          121 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN  200 (358)
Q Consensus       121 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~  200 (358)
                      |++ ++|.+++...  ....+++..+..++.|++.||+|||++   +++|+||+|+||+++.++.++|+|||.+......
T Consensus        79 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~  152 (283)
T cd07835          79 FLD-LDLKKYMDSS--PLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVP  152 (283)
T ss_pred             ccC-cCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCC
Confidence            995 6899988322  124689999999999999999999999   9999999999999999999999999998765322


Q ss_pred             CcccccccccccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhH-------
Q 018263          201 TTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKEL-------  272 (358)
Q Consensus       201 ~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------  272 (358)
                      ... .....++..|+|||++.+. .++.++|+||||+++|+|++|+.||...........+......+....+       
T Consensus       153 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07835         153 VRT-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP  231 (283)
T ss_pred             ccc-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhch
Confidence            211 1223457889999987664 5788999999999999999999999765443322222111111111100       


Q ss_pred             --hhhhcccc---CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          273 --MNLVDPML---YGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       273 --~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                        ........   ........+..+.+++.+||+.+|.+|||++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence              00000000   00111234467889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-37  Score=279.79  Aligned_cols=248  Identities=23%  Similarity=0.328  Sum_probs=212.0

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      ..-|.+.+.||+|-|+.|-+|++- +|+.||||++...  +......+.+|+.-++..+  |||||++|++...+..+|+
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQ--HpNiVRLYEViDTQTKlyL   94 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQ--HPNIVRLYEVIDTQTKLYL   94 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhc--CcCeeeeeehhcccceEEE
Confidence            456889999999999999999854 7999999999766  3445578889999999988  9999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEE-cCCCceEEeecccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL-DQNFNPKISDFGLSKL  196 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv-~~~~~~~l~Dfg~~~~  196 (358)
                      |+|.-++|+|.++|..+   ..-+++....+++.||+.|+.|.|+.   .+|||||||+||.+ .+-|-|||.|||++..
T Consensus        95 iLELGD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNk  168 (864)
T KOG4717|consen   95 ILELGDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNK  168 (864)
T ss_pred             EEEecCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeecccccc
Confidence            99999999999999643   45689999999999999999999999   99999999999866 5678899999999987


Q ss_pred             cCCCCcccccccccccCccCccccccCCCC-ccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhh
Q 018263          197 FPENTTHISTRVAGTLGYLAPEYAISGRLT-RKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNL  275 (358)
Q Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s-~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                      +..  .......+|...|.|||++.|..|+ ++.||||||+|||.|.+|++||...+..+....+               
T Consensus       169 f~P--G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI---------------  231 (864)
T KOG4717|consen  169 FQP--GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI---------------  231 (864)
T ss_pred             CCC--cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh---------------
Confidence            643  3344567899999999999998876 6899999999999999999999866544333332               


Q ss_pred             hccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          276 VDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       276 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ++.  .=..|...+.++.+||..||..||.+|.+.++|..
T Consensus       232 mDC--KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  232 MDC--KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             hcc--cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence            222  12356788999999999999999999999999864

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=7.6e-37  Score=270.96  Aligned_cols=250  Identities=23%  Similarity=0.387  Sum_probs=201.1

Q ss_pred             CCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC--hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      +|.+.+.||.|++|.||++..+ +|..|++|.+....  ......+.+|+..++.++  |+|++++++.+......++++
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~--h~~i~~~~~~~~~~~~~~lv~   78 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMK--HPNIVTFFASFQENGRLFIVM   78 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCC--CCChhhhhheeccCCeEEEEE
Confidence            5889999999999999999976 58889999986542  234456778999999998  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCc-eEEeecccccccC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN-PKISDFGLSKLFP  198 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~-~~l~Dfg~~~~~~  198 (358)
                      ||+++++|.+++..  .....+++..+..++.|++.||.|||+.   +++|+||+|+||++++++. ++++|||.+....
T Consensus        79 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~  153 (257)
T cd08225          79 EYCDGGDLMKRINR--QRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN  153 (257)
T ss_pred             ecCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhcc
Confidence            99999999999843  2234578999999999999999999999   9999999999999988864 6999999887654


Q ss_pred             CCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhcc
Q 018263          199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDP  278 (358)
Q Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (358)
                      .... ......++..|.|||++.+..++.++|+||||+++++|++|..||.......   ...            .....
T Consensus       154 ~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~------------~~~~~  217 (257)
T cd08225         154 DSME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ---LVL------------KICQG  217 (257)
T ss_pred             CCcc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHH------------HHhcc
Confidence            3222 2223457889999999888889999999999999999999999986443211   110            11111


Q ss_pred             ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 018263          279 MLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKM  316 (358)
Q Consensus       279 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~  316 (358)
                      . ........+..+.+++.+||+.+|++|||+.++++.
T Consensus       218 ~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         218 Y-FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             c-CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            1 111223455679999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=8.5e-37  Score=277.37  Aligned_cols=267  Identities=25%  Similarity=0.362  Sum_probs=202.2

Q ss_pred             HhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC--hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC--
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP--  113 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~--  113 (358)
                      ...++|++.+.||.|++|.||+|..+ +|+.|++|.+....  ......+..|++.++.++  |||++++++++....  
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~--h~~i~~~~~~~~~~~~~   81 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLN--HRNIVNLKEIVTDKQDA   81 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCC--CCCeeeeeheecCcchh
Confidence            45678999999999999999999976 58899999987543  233456778999999998  999999999887654  


Q ss_pred             --------eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCc
Q 018263          114 --------CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN  185 (358)
Q Consensus       114 --------~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~  185 (358)
                              ..++++||+++ ++...+.   .....+++..++.++.||+.||+|||+.   |++|+||+|+||++++++.
T Consensus        82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~  154 (302)
T cd07864          82 LDFKKDKGAFYLVFEYMDH-DLMGLLE---SGLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQ  154 (302)
T ss_pred             hhccccCCcEEEEEcccCc-cHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCc
Confidence                    78999999975 6766662   2345689999999999999999999999   9999999999999999999


Q ss_pred             eEEeecccccccCCCCcccccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhh
Q 018263          186 PKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAW  264 (358)
Q Consensus       186 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~  264 (358)
                      ++|+|||.+...............++..|+|||.+.+ ..++.++||||||+++++|++|++||...........+....
T Consensus       155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~  234 (302)
T cd07864         155 IKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLC  234 (302)
T ss_pred             EEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence            9999999987654332222222345678999998765 357889999999999999999999998655433333333322


Q ss_pred             hccchhhHhhhhcc--------------ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          265 GMYNSKELMNLVDP--------------MLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       265 ~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      +......+..+...              ..... ....+..+.+++..||+.+|.+||+++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             CCCChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            22222111111100              00000 1123567899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4e-37  Score=283.17  Aligned_cols=270  Identities=23%  Similarity=0.317  Sum_probs=209.1

Q ss_pred             CCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC--hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC-----e
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP-----C  114 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~-----~  114 (358)
                      +|++.+.||.|++|.||+|+.. +++.|++|.+....  ....+.+..|+..++.++  |+|++++.+++....     .
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~~~~   78 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLR--HENIIGLLDILRPPSPEDFND   78 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcC--CcchhhhhhhhcccCcccccc
Confidence            6899999999999999999976 58999999986543  444567888999999998  999999999988775     7


Q ss_pred             eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccc
Q 018263          115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS  194 (358)
Q Consensus       115 ~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~  194 (358)
                      .+++|+|++ ++|.+.+    .....+++..++.++.||+.||++||+.   |++|+||+|.||+++.++.++|+|||.+
T Consensus        79 ~~lv~e~~~-~~l~~~l----~~~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~  150 (330)
T cd07834          79 VYIVTELME-TDLHKVI----KSPQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLA  150 (330)
T ss_pred             eEEEecchh-hhHHHHH----hCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCce
Confidence            899999996 5788888    3344899999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCc--ccccccccccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhh
Q 018263          195 KLFPENTT--HISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKE  271 (358)
Q Consensus       195 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      ........  .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...........+....+.+....
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  230 (330)
T cd07834         151 RGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEED  230 (330)
T ss_pred             EeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhH
Confidence            87644321  112334578889999999887 789999999999999999999999986654433333322222221111


Q ss_pred             Hh--------hhhccccC------CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--hhcCCC
Q 018263          272 LM--------NLVDPMLY------GNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKM--MNGETN  322 (358)
Q Consensus       272 ~~--------~~~~~~~~------~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~--L~~~~~  322 (358)
                      +.        ..+.....      .......+..+.+++.+||+.+|.+|||++++++.  +++.+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence            11        11110000      00112246778999999999999999999999873  665554

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.3e-37  Score=290.52  Aligned_cols=261  Identities=18%  Similarity=0.217  Sum_probs=194.6

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      ..+|.+.+.||.|+||.||++.+. .++.|++|....      ....+|+.+++.++  |+||+++++++...+..+++|
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~--HpnIv~l~~~~~~~~~~~lv~  239 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLS--HPAVLALLDVRVVGGLTCLVL  239 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCC--CCCCCcEEEEEEECCEEEEEE
Confidence            458999999999999999999976 588899996432      23457999999998  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      +++ .++|.+++..   ....+++..+..++.||+.||.|||++   ||+|+||||+||+++.++.++|+|||++.....
T Consensus       240 e~~-~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~  312 (461)
T PHA03211        240 PKY-RSDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARG  312 (461)
T ss_pred             Ecc-CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence            999 4688888732   234689999999999999999999999   999999999999999999999999999876532


Q ss_pred             CCcc-cccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccc-----hhhhHhhh--hc----c
Q 018263          200 NTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE-----YHLVDKAW--GM----Y  267 (358)
Q Consensus       200 ~~~~-~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~-----~~~~~~~~--~~----~  267 (358)
                      .... ......||..|+|||++.+..++.++|||||||++|+|++|..++-.......     ......+.  ..    +
T Consensus       313 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~  392 (461)
T PHA03211        313 SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEF  392 (461)
T ss_pred             ccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccC
Confidence            2211 12235689999999999998999999999999999999998866533221110     00111000  00    0


Q ss_pred             c---hhhHhhhh-c---cccCCC-----CC--HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 018263          268 N---SKELMNLV-D---PMLYGN-----FP--ENEAIRFLKVGLLCVQEKSKLRPQMSTAIKM  316 (358)
Q Consensus       268 ~---~~~~~~~~-~---~~~~~~-----~~--~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~  316 (358)
                      .   ...+.... .   ......     +.  ......+.+||.+||+.||.+|||+.|+++.
T Consensus       393 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        393 PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             CCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            0   00000000 0   000000     00  0233478899999999999999999999863

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-36  Score=268.89  Aligned_cols=250  Identities=24%  Similarity=0.342  Sum_probs=201.2

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc-----ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC--
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE-----SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG--  112 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~--  112 (358)
                      +.+|++.+.||+|++|.||++.+. +++.|++|.+...     .......+.+|++.++.++  |+|++++++.+.+.  
T Consensus         1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~--h~~i~~~~~~~~~~~~   78 (264)
T cd06653           1 PVNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR--HDRIVQYYGCLRDPEE   78 (264)
T ss_pred             CCceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcC--CCCcceEEEEEEcCCC
Confidence            368999999999999999999865 5899999987532     1233457888999999998  99999999998764  


Q ss_pred             CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecc
Q 018263          113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG  192 (358)
Q Consensus       113 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg  192 (358)
                      ...++++||+++++|.+.+    .....+++..+..++.|++.||.+||+.   |++|+||+|+||+++.++.++|+|||
T Consensus        79 ~~~~~v~e~~~~~~L~~~~----~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg  151 (264)
T cd06653          79 KKLSIFVEYMPGGSIKDQL----KAYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFG  151 (264)
T ss_pred             CEEEEEEEeCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccc
Confidence            4578999999999999998    3445688999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCc--ccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchh
Q 018263          193 LSKLFPENTT--HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSK  270 (358)
Q Consensus       193 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      .+........  .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||......               .
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---------------~  216 (264)
T cd06653         152 ASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM---------------A  216 (264)
T ss_pred             cccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH---------------H
Confidence            9876432111  1112345788999999998888899999999999999999999999743221               1


Q ss_pred             hHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          271 ELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ..............+...+..+.+++.+||+ +|..||++.++++
T Consensus       217 ~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         217 AIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             HHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            1111122222334556677789999999999 5799999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=3.5e-36  Score=274.21  Aligned_cols=246  Identities=26%  Similarity=0.352  Sum_probs=196.7

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      ++|.+.+.||.|++|.||+|... +++.|++|.+....   ......+.+|++.++.++  |||++++.+++...+..++
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~--h~niv~~~~~~~~~~~~~l   92 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR--HPNTIEYKGCYLREHTAWL   92 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCC--CCCEEEEEEEEEeCCeEEE
Confidence            67999999999999999999875 68999999886432   233456888999999998  9999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      |+||++ +++.+.+.   .....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++...
T Consensus        93 v~e~~~-g~l~~~~~---~~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~  165 (307)
T cd06607          93 VMEYCL-GSASDILE---VHKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLV  165 (307)
T ss_pred             EHHhhC-CCHHHHHH---HcccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceec
Confidence            999996 56777663   2345689999999999999999999999   9999999999999999999999999988754


Q ss_pred             CCCCcccccccccccCccCccccc---cCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhh
Q 018263          198 PENTTHISTRVAGTLGYLAPEYAI---SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMN  274 (358)
Q Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                      ...     ....++..|+|||++.   ...++.++||||||+++|+|++|+.||............              
T Consensus       166 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~--------------  226 (307)
T cd06607         166 SPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--------------  226 (307)
T ss_pred             CCC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHH--------------
Confidence            322     2245778899999874   356888999999999999999999998644321111000              


Q ss_pred             hhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 018263          275 LVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKM  316 (358)
Q Consensus       275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~  316 (358)
                       .........+...+..+.+++.+||+.+|++||++.++++.
T Consensus       227 -~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         227 -AQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             -hcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence             00000111123456679999999999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6e-37  Score=296.21  Aligned_cols=270  Identities=19%  Similarity=0.267  Sum_probs=190.4

Q ss_pred             hhcCCcccceecccCceEEEEEEEC--CCCEEEEEEe--------------e---ccChhhHHHHHHHHHHhhhcccCCC
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ--DGTIVAVKVL--------------S---VESKQGEKEFMSEVASMANVNVCHE  100 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~--~~~~vaiK~~--------------~---~~~~~~~~~~~~e~~~l~~l~~~h~  100 (358)
                      ..++|++++.||+|+||.||++..+  .+..++.|.+              .   .........+.+|+.+++.++  ||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~--Hp  223 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLN--HE  223 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCC--CC
Confidence            4579999999999999999998753  2222222211              0   012223456788999999998  99


Q ss_pred             CceeeeceEEcCCeeEEEEecCCCCCHHHHhhhccc-cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEE
Q 018263          101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEK-RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL  179 (358)
Q Consensus       101 ~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nil  179 (358)
                      ||+++++++...+..+++++++ +++|.+++..... .........+..++.||+.||.|||++   ||+|+||||+||+
T Consensus       224 nIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NIL  299 (501)
T PHA03210        224 NILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIF  299 (501)
T ss_pred             CcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEE
Confidence            9999999999999999999999 4677777643221 122334677889999999999999999   9999999999999


Q ss_pred             EcCCCceEEeecccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCcccccc-chh
Q 018263          180 LDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG-EYH  258 (358)
Q Consensus       180 v~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~-~~~  258 (358)
                      ++.++.++|+|||++..+............|+..|+|||++.+..++.++|||||||++|+|++|..++....... ...
T Consensus       300 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~  379 (501)
T PHA03210        300 LNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ  379 (501)
T ss_pred             ECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence            9999999999999998765443333344678999999999999899999999999999999999875443222111 111


Q ss_pred             hhHhhh--hc----c--chhhHhhhhccccCCC----CCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          259 LVDKAW--GM----Y--NSKELMNLVDPMLYGN----FPE-----NEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       259 ~~~~~~--~~----~--~~~~~~~~~~~~~~~~----~~~-----~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ....+.  ..    +  ...+..+.++......    .+.     ..+.++.+++.+||+.||.+|||+.|+++
T Consensus       380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            111110  00    0  0001111111110000    000     12345778899999999999999999986

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.3e-36  Score=271.67  Aligned_cols=260  Identities=22%  Similarity=0.297  Sum_probs=195.3

Q ss_pred             CcccceecccCceEEEEEEEC-CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC--CeeEEEE
Q 018263           44 FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG--PCRILVY  119 (358)
Q Consensus        44 y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~--~~~~iv~  119 (358)
                      |++.+.||.|++|.||++... +++.|++|.+.... .........|+..+..+. .|+|++++++++...  +..++|+
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~-~h~~i~~~~~~~~~~~~~~~~lv~   79 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLS-PHPNILRLIEVLFDRKTGRLALVF   79 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcC-CCCCccceEEEEecCCCCcEEEEE
Confidence            678999999999999999865 68899999986532 222334456777777774 499999999999987  8899999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      ||++ ++|.+.+..   ....+++..++.++.|++.||.|||+.   |++|+||+|+||+++. +.++|+|||.+.....
T Consensus        80 e~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~  151 (282)
T cd07831          80 ELMD-MNLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYS  151 (282)
T ss_pred             ecCC-ccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence            9996 577777732   235789999999999999999999999   9999999999999999 9999999999976533


Q ss_pred             CCcccccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhcc
Q 018263          200 NTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDP  278 (358)
Q Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (358)
                      ...  .....++..|+|||++.+ ..++.++|+||||+++|+|++|..||...+..+.........+.... .+......
T Consensus       152 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  228 (282)
T cd07831         152 KPP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDA-EVLKKFRK  228 (282)
T ss_pred             CCC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCH-HHHHhhcc
Confidence            222  122457789999997654 55788999999999999999999999766543332222222111111 11111100


Q ss_pred             cc--CCC-----------CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          279 ML--YGN-----------FPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       279 ~~--~~~-----------~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ..  ...           .....+..+.++|.+||+.+|++||+++++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            00  000           11245678999999999999999999999986

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2.1e-36  Score=273.40  Aligned_cols=265  Identities=22%  Similarity=0.339  Sum_probs=195.7

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      .++|++.+.||.|++|.||+|... +|..|++|.+.... ......+.+|+..++.++  |+||+++.+++......++|
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~--h~ni~~~~~~~~~~~~~~lv   81 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLK--HANIVLLHDIIHTKETLTFV   81 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcC--CCCEeEEEEEEecCCeEEEE
Confidence            478999999999999999999865 68899999986543 233346678999999988  99999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      +||+. ++|.+.+.   .....+++..+..++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++....
T Consensus        82 ~e~~~-~~l~~~~~---~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  154 (291)
T cd07870          82 FEYMH-TDLAQYMI---QHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKS  154 (291)
T ss_pred             Eeccc-CCHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccC
Confidence            99995 67776663   2234578888999999999999999999   99999999999999999999999999987543


Q ss_pred             CCCcccccccccccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCCCccccc-cchhhhHhhhhccchhhHhhh-
Q 018263          199 ENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL-GEYHLVDKAWGMYNSKELMNL-  275 (358)
Q Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~-  275 (358)
                      ..... .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||...... ..........+.+.......+ 
T Consensus       155 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07870         155 IPSQT-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS  233 (291)
T ss_pred             CCCCC-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence            22211 1223467899999988754 5788999999999999999999999754321 111111000110100000000 


Q ss_pred             -----hccccCCCCC---------HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          276 -----VDPMLYGNFP---------ENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       276 -----~~~~~~~~~~---------~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                           .........+         ......+.+++.+|++.||.+|||+.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence                 0000000000         012456889999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-36  Score=266.01  Aligned_cols=247  Identities=29%  Similarity=0.457  Sum_probs=204.2

Q ss_pred             CCcccceecccCceEEEEEEEC-CCCEEEEEEeeccCh--hhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK--QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      +|++.+.||+|++|.||++... +++.|++|.+.....  .....+.+|++.+..+.  |+|++++.+++...+..++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~~v~   78 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK--HPNIVKYIGSIETSDSLYIIL   78 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCC--CCCccEEEEEEEeCCEEEEEE
Confidence            5889999999999999999876 588999999876543  45567889999999998  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      ||+++++|.+++    .....+++..++.++.|++.+|.+||+.   |++|+||+|+||+++.++.++|+|||.+.....
T Consensus        79 e~~~~~~L~~~~----~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  151 (254)
T cd06627          79 EYAENGSLRQII----KKFGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLND  151 (254)
T ss_pred             ecCCCCcHHHHH----HhccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCC
Confidence            999999999998    3346789999999999999999999999   999999999999999999999999999987644


Q ss_pred             CCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccc
Q 018263          200 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPM  279 (358)
Q Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (358)
                      .... .....++..|+|||...+..++.++|+|++|+++++|++|..||.......   ....            .. ..
T Consensus       152 ~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~---~~~~------------~~-~~  214 (254)
T cd06627         152 VSKD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA---ALFR------------IV-QD  214 (254)
T ss_pred             Cccc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH---HHHH------------Hh-cc
Confidence            3322 223457889999999888778999999999999999999999986433111   0000            00 01


Q ss_pred             cCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          280 LYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       280 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .....+...+..+.+++.+||+.+|++|||+.+++.
T Consensus       215 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         215 DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            112234455678899999999999999999999974

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=6.7e-37  Score=282.21  Aligned_cols=265  Identities=22%  Similarity=0.303  Sum_probs=201.7

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC--hhhHHHHHHHHHHhhhcccCCCCceeeeceEEc----CC
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCID----GP  113 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~----~~  113 (358)
                      ..+|++.+.||.|++|.||++..+ +|+.|++|.+....  ......+..|+..++.++  ||||+++++++..    ..
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~~   81 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFK--HDNIIAIRDILRPPGADFK   81 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcC--CCCccCHHHhccccCCCCc
Confidence            478999999999999999999865 69999999986542  234466778999999998  9999999998763    35


Q ss_pred             eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccc
Q 018263          114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL  193 (358)
Q Consensus       114 ~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~  193 (358)
                      ..++|+||+. ++|.+++    .....+++..++.++.||+.||+|||++   +++|+||+|+||+++.++.++|+|||+
T Consensus        82 ~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~  153 (334)
T cd07855          82 DVYVVMDLME-SDLHHII----HSDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGM  153 (334)
T ss_pred             eEEEEEehhh-hhHHHHh----ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccc
Confidence            6799999995 6888888    3455689999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcc---cccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccc-
Q 018263          194 SKLFPENTTH---ISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYN-  268 (358)
Q Consensus       194 ~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~-  268 (358)
                      +.........   ......++..|.|||.+.+ ..++.++|+||||+++|+|++|+.||...........+....+.+. 
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~  233 (334)
T cd07855         154 ARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSE  233 (334)
T ss_pred             ceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChh
Confidence            8764322211   1123467889999998765 4688999999999999999999999976544333222222111111 


Q ss_pred             -------hhhHhhhhccccC-CCC-----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          269 -------SKELMNLVDPMLY-GNF-----PENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       269 -------~~~~~~~~~~~~~-~~~-----~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                             ........+.... ...     ....+..+.++|.+||+.+|.+|||+.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         234 EVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             HhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                   1111111111000 011     1234678999999999999999999999876

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-36  Score=269.13  Aligned_cols=245  Identities=22%  Similarity=0.258  Sum_probs=188.9

Q ss_pred             ceecccCceEEEEEEEC-CCCEEEEEEeeccChh---hHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecCC
Q 018263           48 NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQ---GEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP  123 (358)
Q Consensus        48 ~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~~  123 (358)
                      +.||.|++|.||+|... +++.|++|.+......   ....+..|...+.... .|+|++++++.+...+..++++||++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQG-ESPYVAKLYYSFQSKDYLYLVMEYLN   80 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcC-CCCCeeeeeeeEEcCCeEEEEEeccC
Confidence            57899999999999875 5889999998644221   1223333443333322 49999999999999999999999999


Q ss_pred             CCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCcc
Q 018263          124 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH  203 (358)
Q Consensus       124 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  203 (358)
                      +++|.+++    .....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....    
T Consensus        81 ~~~L~~~l----~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----  149 (260)
T cd05611          81 GGDCASLI----KTLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----  149 (260)
T ss_pred             CCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc----
Confidence            99999998    3445789999999999999999999999   999999999999999999999999998875322    


Q ss_pred             cccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCC
Q 018263          204 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGN  283 (358)
Q Consensus       204 ~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (358)
                       .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...............             .......
T Consensus       150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------------~~~~~~~  215 (260)
T cd05611         150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSR-------------RINWPEE  215 (260)
T ss_pred             -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc-------------ccCCCCc
Confidence             22345778899999998888899999999999999999999999754322111110000             0001111


Q ss_pred             CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 018263          284 FPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN  318 (358)
Q Consensus       284 ~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~  318 (358)
                      .....+..+.+++.+||+.+|++||++.++.+.|+
T Consensus       216 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~  250 (260)
T cd05611         216 VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS  250 (260)
T ss_pred             ccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence            22245678999999999999999998876665543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-38  Score=269.06  Aligned_cols=243  Identities=26%  Similarity=0.321  Sum_probs=207.1

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCee
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR  115 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~  115 (358)
                      .-++|..++.||+|.||+|.+++.+ +++.||+|+++.+   .....++-..|-..|+...  ||++..+.-.|...+.+
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~--HPFLt~LKYsFQt~drl  243 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCR--HPFLTSLKYSFQTQDRL  243 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhcc--CcHHHHhhhhhccCceE
Confidence            3468889999999999999999976 7999999999765   3344455667888899888  99999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccc
Q 018263          116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK  195 (358)
Q Consensus       116 ~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~  195 (358)
                      |+||||..||.|.-.+    ++...+++...+.+-..|+.||.|||++   +|++||+|.+|+++|.+|.+||.|||+++
T Consensus       244 CFVMeyanGGeLf~HL----srer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCK  316 (516)
T KOG0690|consen  244 CFVMEYANGGELFFHL----SRERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCK  316 (516)
T ss_pred             EEEEEEccCceEeeeh----hhhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccch
Confidence            9999999999999998    5667789999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhh
Q 018263          196 LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNL  275 (358)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                      .-- .........+||+.|+|||++....|+.+.|-|.+|+++|+|++|+.||...+....+.++-.             
T Consensus       317 E~I-~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~-------------  382 (516)
T KOG0690|consen  317 EEI-KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM-------------  382 (516)
T ss_pred             hcc-cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh-------------
Confidence            522 223344568999999999999999999999999999999999999999986655443333311             


Q ss_pred             hccccCCCCCHHHHHHHHHHHhhccCCCCCCCCC
Q 018263          276 VDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQ  309 (358)
Q Consensus       276 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt  309 (358)
                          -.-.+|...+.+...|+..+|..||.+|..
T Consensus       383 ----ed~kFPr~ls~eAktLLsGLL~kdP~kRLG  412 (516)
T KOG0690|consen  383 ----EDLKFPRTLSPEAKTLLSGLLKKDPKKRLG  412 (516)
T ss_pred             ----hhccCCccCCHHHHHHHHHHhhcChHhhcC
Confidence                112366677788899999999999999964

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.9e-36  Score=272.18  Aligned_cols=257  Identities=26%  Similarity=0.349  Sum_probs=202.8

Q ss_pred             CCcccceecccCceEEEEEEEC----CCCEEEEEEeeccC----hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCe
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQ----DGTIVAVKVLSVES----KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC  114 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~----~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~  114 (358)
                      +|++.+.||.|++|.||+++..    +++.|++|.+....    ......+..|+..+..+. .|||++++++.+.....
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~-~~~~i~~~~~~~~~~~~   79 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVR-RCPFLVTLHYAFQTDTK   79 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhcc-CCcchhhhheeeecCCE
Confidence            4888999999999999999742    57889999986432    223356778999999885 49999999999999999


Q ss_pred             eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccc
Q 018263          115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS  194 (358)
Q Consensus       115 ~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~  194 (358)
                      .++||||+++++|.+.+.    ....+++..+..++.|++.+|.+||+.   +++|+||+|+||+++.++.++|+|||++
T Consensus        80 ~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~  152 (288)
T cd05583          80 LHLILDYVNGGELFTHLY----QREHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLS  152 (288)
T ss_pred             EEEEEecCCCCcHHHHHh----hcCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccc
Confidence            999999999999999983    345688999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCCcccccccccccCccCccccccCC--CCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhH
Q 018263          195 KLFPENTTHISTRVAGTLGYLAPEYAISGR--LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKEL  272 (358)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      ...............++..|+|||.+.+..  .+.++|+||||+++|+|++|..||..............          
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~----------  222 (288)
T cd05583         153 KEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR----------  222 (288)
T ss_pred             cccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHH----------
Confidence            765433222222345788999999887654  78899999999999999999999964322111111100          


Q ss_pred             hhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 018263          273 MNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE  320 (358)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~  320 (358)
                       .....  ....+...+..+.+++.+||+.+|++|||+.++.+.|+-.
T Consensus       223 -~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         223 -RILKS--KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             -HHHcc--CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence             00110  1123344566789999999999999999999998887764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.1e-36  Score=268.99  Aligned_cols=243  Identities=24%  Similarity=0.363  Sum_probs=196.3

Q ss_pred             ecccCceEEEEEEEC-CCCEEEEEEeeccCh---hhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecCCCC
Q 018263           50 IGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK---QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN  125 (358)
Q Consensus        50 lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~~~~  125 (358)
                      ||.|++|.||++... +|+.|++|.+.....   .....+.+|++.++.+.  |||++++++.+......++++||++++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~--h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ--SPYVVKLYYSFQGKKNLYLVMEYLPGG   78 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCC--CcchhHHHHheecCcEEEEEEecCCCC
Confidence            689999999999986 499999999865433   45567888999999998  999999999999999999999999999


Q ss_pred             CHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCc---
Q 018263          126 SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT---  202 (358)
Q Consensus       126 ~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~---  202 (358)
                      +|.+++.    ....+++..+..++.||+.||++||+.   +++|+||+|+||+++.++.++|+|||++........   
T Consensus        79 ~L~~~l~----~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  151 (265)
T cd05579          79 DLASLLE----NVGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL  151 (265)
T ss_pred             cHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc
Confidence            9999983    334789999999999999999999999   999999999999999999999999998875432211   


Q ss_pred             ----ccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhcc
Q 018263          203 ----HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDP  278 (358)
Q Consensus       203 ----~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (358)
                          .......++..|+|||...+...+.++|+||||+++|+|++|..||............               ...
T Consensus       152 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~---------------~~~  216 (265)
T cd05579         152 NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNI---------------LNG  216 (265)
T ss_pred             ccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---------------hcC
Confidence                1222345778899999998888899999999999999999999999754422111111               000


Q ss_pred             ccCCCCCHH--HHHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 018263          279 MLYGNFPEN--EAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN  318 (358)
Q Consensus       279 ~~~~~~~~~--~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~  318 (358)
                        ....+..  .+..+.+++.+||+.+|.+|||+..+.+.|+
T Consensus       217 --~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         217 --KIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             --CcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence              0111222  3677899999999999999999966666554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.3e-36  Score=272.78  Aligned_cols=249  Identities=24%  Similarity=0.370  Sum_probs=203.0

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      ++|.+.+.||+|++|.||++... +++.|++|++...   .......+..|.+.++.+. .||||+++++++...+..++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~~i~~~~~~~~~~~~~~l   79 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLN-GHPGIIKLYYTFQDEENLYF   79 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcc-cCCCchhHHHHhcCCceEEE
Confidence            57999999999999999999975 6999999998653   2233456778888888875 59999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      +||++++++|.+++    .....+++..++.++.|++.||.+||+.   |++|+||+|+||+++.++.++++|||++...
T Consensus        80 v~e~~~~~~L~~~l----~~~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~  152 (280)
T cd05581          80 VLEYAPNGELLQYI----RKYGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVL  152 (280)
T ss_pred             EEcCCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCcccccc
Confidence            99999999999999    3445799999999999999999999999   9999999999999999999999999998865


Q ss_pred             CCCCc-------------------ccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchh
Q 018263          198 PENTT-------------------HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYH  258 (358)
Q Consensus       198 ~~~~~-------------------~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~  258 (358)
                      .....                   .......++..|+|||.+.+..++.++|+||||++++++++|+.||........+ 
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-  231 (280)
T cd05581         153 DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTF-  231 (280)
T ss_pred             CCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHH-
Confidence            43322                   1222345778999999988888999999999999999999999999855421111 


Q ss_pred             hhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCH----HHHHH
Q 018263          259 LVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQM----STAIK  315 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~----~eil~  315 (358)
                        .            ...  .....++...+..+.+++.+||+.+|++||++    +++++
T Consensus       232 --~------------~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         232 --Q------------KIL--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             --H------------HHH--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence              0            000  01122334456779999999999999999999    66653

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2.1e-36  Score=273.88  Aligned_cols=265  Identities=23%  Similarity=0.335  Sum_probs=198.2

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC--hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      ++|++.+.||.|++|.||+|..+ +|+.|++|.+....  ......+.+|+..++.+.  |||++++++++......++|
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv   79 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ--HGNIVRLQDVVHSEKRLYLV   79 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhcc--CCCEeeEEEEEecCCeEEEE
Confidence            57999999999999999999976 68899999986442  233456788999999998  99999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcC-CCceEEeeccccccc
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ-NFNPKISDFGLSKLF  197 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~-~~~~~l~Dfg~~~~~  197 (358)
                      |||++ ++|.+.+..  .....+++..++.++.||+.||+|||++   +++|+||+|+||+++. ++.++|+|||++...
T Consensus        80 ~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~  153 (294)
T PLN00009         80 FEYLD-LDLKKHMDS--SPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF  153 (294)
T ss_pred             Eeccc-ccHHHHHHh--CCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEccccccccc
Confidence            99995 578777732  2233467899999999999999999999   9999999999999985 567999999999764


Q ss_pred             CCCCcccccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHh---
Q 018263          198 PENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELM---  273 (358)
Q Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---  273 (358)
                      ..... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||......+.........+......+.   
T Consensus       154 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (294)
T PLN00009        154 GIPVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT  232 (294)
T ss_pred             CCCcc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccc
Confidence            33211 1223456789999998866 457899999999999999999999997654433322221111111110000   


Q ss_pred             ---hhhc--cccCC----CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          274 ---NLVD--PMLYG----NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       274 ---~~~~--~~~~~----~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                         ....  +....    ......+..+.+++.+||+.+|++||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence               0000  00000    011234556889999999999999999999986

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.8e-36  Score=274.82  Aligned_cols=267  Identities=24%  Similarity=0.337  Sum_probs=198.1

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC--hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC---
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP---  113 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~---  113 (358)
                      ..++|++.+.||.|++|.||+|... +++.|++|.+....  ......+.+|+..++.++  ||||+++++++....   
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~   87 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLK--HENVVNLIEICRTKATPY   87 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCC--CCCccceEEEEecccccc
Confidence            4568999999999999999999975 68999999886442  223345667999999998  999999999876543   


Q ss_pred             -----eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEE
Q 018263          114 -----CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKI  188 (358)
Q Consensus       114 -----~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l  188 (358)
                           ..++||||+. ++|.+.+.   .....+++..++.++.||+.||.|||++   |++|+||+|+||+++.++.++|
T Consensus        88 ~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl  160 (310)
T cd07865          88 NRYKGSFYLVFEFCE-HDLAGLLS---NKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKL  160 (310)
T ss_pred             cCCCceEEEEEcCCC-cCHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEE
Confidence                 3599999995 57887773   2234689999999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcc---cccccccccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhh
Q 018263          189 SDFGLSKLFPENTTH---ISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAW  264 (358)
Q Consensus       189 ~Dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~  264 (358)
                      +|||++.........   ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...........+....
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~  240 (310)
T cd07865         161 ADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLC  240 (310)
T ss_pred             CcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            999999765332211   11234567889999987664 47889999999999999999999997665443333333332


Q ss_pred             hccchhhHhh-----hhcccc-CCCC---------CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          265 GMYNSKELMN-----LVDPML-YGNF---------PENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       265 ~~~~~~~~~~-----~~~~~~-~~~~---------~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      +.........     ..+... ....         +......+.++|.+||+.||.+|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         241 GSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             CCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            2111110000     000000 0000         0012345678999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=4.2e-36  Score=269.64  Aligned_cols=241  Identities=24%  Similarity=0.294  Sum_probs=190.8

Q ss_pred             ecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecCCCC
Q 018263           50 IGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN  125 (358)
Q Consensus        50 lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~~~~  125 (358)
                      ||.|+||.||+|..+ +|+.|++|.+....   ......+..|++.++.++  |||++++++.+...+..++||||++++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS--SRFIVSLAYAFETKDDLCLVMTLMNGG   78 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCC--CCCEeeeeeEEecCCeEEEEEecCCCC
Confidence            689999999999865 68899999986432   223445678999999998  999999999999999999999999999


Q ss_pred             CHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCcccc
Q 018263          126 SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS  205 (358)
Q Consensus       126 ~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~  205 (358)
                      +|.+++...  ....+++..+..++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||.+......  ...
T Consensus        79 ~L~~~l~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~  151 (277)
T cd05577          79 DLKYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKI  151 (277)
T ss_pred             cHHHHHHHc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC--Ccc
Confidence            999998432  224689999999999999999999999   9999999999999999999999999988764331  112


Q ss_pred             cccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCCCC
Q 018263          206 TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFP  285 (358)
Q Consensus       206 ~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (358)
                      ....++..|+|||.+.+..++.++|+||||+++|+|++|+.||............            ...... .....+
T Consensus       152 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~------------~~~~~~-~~~~~~  218 (277)
T cd05577         152 KGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEEL------------KRRTLE-MAVEYP  218 (277)
T ss_pred             ccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHH------------Hhcccc-ccccCC
Confidence            2345678999999998888999999999999999999999999754331111111            000000 112233


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHH
Q 018263          286 ENEAIRFLKVGLLCVQEKSKLRPQMST  312 (358)
Q Consensus       286 ~~~~~~l~~li~~~l~~~P~~Rpt~~e  312 (358)
                      ...+..+.+++.+||+.+|.+||++.+
T Consensus       219 ~~~~~~~~~li~~~l~~~p~~R~~~~~  245 (277)
T cd05577         219 DKFSPEAKDLCEALLQKDPEKRLGCRG  245 (277)
T ss_pred             ccCCHHHHHHHHHHccCChhHccCCCc
Confidence            445778999999999999999994444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=4.9e-36  Score=270.91  Aligned_cols=252  Identities=25%  Similarity=0.342  Sum_probs=197.6

Q ss_pred             CCcccceecccCceEEEEEEE----CCCCEEEEEEeeccC----hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCe
Q 018263           43 GFRWSNKIGEGGFGSVYKGRL----QDGTIVAVKVLSVES----KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC  114 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~----~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~  114 (358)
                      +|++.+.||.|++|.||.|..    .+|..|++|++....    ......+..|+..+..+. .|++|+.+++.+..+..
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~~i~~~~~~~~~~~~   79 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR-QSPFLVTLHYAFQTDTK   79 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcc-cCCChhceeeEeecCCe
Confidence            488999999999999999986    368899999986432    223456778999999885 49999999999999999


Q ss_pred             eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccc
Q 018263          115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS  194 (358)
Q Consensus       115 ~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~  194 (358)
                      .++|+||+++++|.+++    .....+++..+..++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++
T Consensus        80 ~~lv~e~~~~~~L~~~l----~~~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~  152 (290)
T cd05613          80 LHLILDYINGGELFTHL----SQRERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS  152 (290)
T ss_pred             EEEEEecCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccc
Confidence            99999999999999998    3445688999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCCcccccccccccCccCccccccC--CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhH
Q 018263          195 KLFPENTTHISTRVAGTLGYLAPEYAISG--RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKEL  272 (358)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      ...............++..|+|||.+.+.  .++.++||||||+++|+|++|..||.............           
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~-----------  221 (290)
T cd05613         153 KEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEIS-----------  221 (290)
T ss_pred             eecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHH-----------
Confidence            76543322222335578899999988653  46789999999999999999999997433221111111           


Q ss_pred             hhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 018263          273 MNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRP-----QMSTAIK  315 (358)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp-----t~~eil~  315 (358)
                       ..+... ...++...+..+.+++.+||+.+|++||     +++++++
T Consensus       222 -~~~~~~-~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         222 -RRILKS-EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             -HHhhcc-CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence             000000 1123344566789999999999999997     5555543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-37  Score=284.57  Aligned_cols=276  Identities=25%  Similarity=0.369  Sum_probs=236.1

Q ss_pred             cccCCCcccccccccccCHHHHHHhhcCCcccceecccCceEEEEEEECC-CCEEEEEEeeccChhhHHHHHHHHHHhhh
Q 018263           16 AENTIGGEQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMAN   94 (358)
Q Consensus        16 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~   94 (358)
                      +.|-++.+-.-|+-..     |+....+.+...+||.|-+|.||.+.|+. .-.||||.++ ++.....+|+.|..+++.
T Consensus       246 K~nKptvygvSPn~Dk-----WEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK-EDtMeveEFLkEAAvMKe  319 (1157)
T KOG4278|consen  246 KKNKPTVYGVSPNADK-----WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKE  319 (1157)
T ss_pred             cCCCCceeeecCCcch-----hhccchheeeeeccCCCcccceeeeeeeccceeeehhhhh-hcchhHHHHHHHHHHHHh
Confidence            4455555554454444     44445566677899999999999999874 5668999986 556667789999999999


Q ss_pred             cccCCCCceeeeceEEcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCC
Q 018263           95 VNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIK  174 (358)
Q Consensus        95 l~~~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~  174 (358)
                      ++  |||+|+++++|.+..-+|||.|||..|+|.++++.  .++..++.-.+..++.||..|+.||..+   +++||||.
T Consensus       320 ik--HpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRe--cnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLA  392 (1157)
T KOG4278|consen  320 IK--HPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRE--CNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLA  392 (1157)
T ss_pred             hc--CccHHHHhhhhccCCCeEEEEecccCccHHHHHHH--hchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhh
Confidence            98  99999999999999999999999999999999953  4667788899999999999999999999   99999999


Q ss_pred             CCcEEEcCCCceEEeecccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCcccc
Q 018263          175 TSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ  253 (358)
Q Consensus       175 p~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~  253 (358)
                      ..|.+|.++..+|++|||+++.+..+.........-+.-|.|||-+....++.++|||+||++||++.| |-.||.+-  
T Consensus       393 ARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi--  470 (1157)
T KOG4278|consen  393 ARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI--  470 (1157)
T ss_pred             hhhccccccceEEeeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc--
Confidence            999999999999999999999997777666665666789999999998999999999999999999988 77777643  


Q ss_pred             ccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 018263          254 LGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE  320 (358)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~  320 (358)
                                    ...++..+++...+..-|..++..+.+|++.||+++|.+||++.|+-+.|+..
T Consensus       471 --------------dlSqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm  523 (1157)
T KOG4278|consen  471 --------------DLSQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM  523 (1157)
T ss_pred             --------------cHHHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence                          34566777778888888899999999999999999999999999998887754

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=7.6e-36  Score=266.56  Aligned_cols=248  Identities=21%  Similarity=0.272  Sum_probs=192.1

Q ss_pred             HHHhhcCCccccee--cccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC
Q 018263           37 LKIATNGFRWSNKI--GEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP  113 (358)
Q Consensus        37 ~~~~~~~y~i~~~l--g~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~  113 (358)
                      ..-..++|++.+.+  |.|+||.||++..+ ++..+++|.+........     |......+. .|||++++++.+...+
T Consensus         9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~-~h~~iv~~~~~~~~~~   82 (267)
T PHA03390          9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMK-DNPNFIKLYYSVTTLK   82 (267)
T ss_pred             HHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhh-cCCCEEEEEEEEecCC
Confidence            33345688888876  99999999999865 688899999864322111     122222121 4999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCC-ceEEeecc
Q 018263          114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF-NPKISDFG  192 (358)
Q Consensus       114 ~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~-~~~l~Dfg  192 (358)
                      ..++||||+++++|.+++.    ....+++..+..++.||+.||.+||+.   |++|+||+|+||+++.++ .++|+|||
T Consensus        83 ~~~iv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg  155 (267)
T PHA03390         83 GHVLIMDYIKDGDLFDLLK----KEGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYG  155 (267)
T ss_pred             eeEEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCc
Confidence            9999999999999999993    334889999999999999999999999   999999999999999988 99999999


Q ss_pred             cccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhH
Q 018263          193 LSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKEL  272 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      .+......     ....++..|+|||++.+..++.++|+||+|+++|+|++|..||....... ...          ..+
T Consensus       156 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~----------~~~  219 (267)
T PHA03390        156 LCKIIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDL----------ESL  219 (267)
T ss_pred             cceecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhH----------HHH
Confidence            98764322     12357889999999988889999999999999999999999997443221 100          011


Q ss_pred             hhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCC-HHHHHH
Q 018263          273 MNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQ-MSTAIK  315 (358)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt-~~eil~  315 (358)
                      .....  .....+...+..+.+++.+||+.+|.+||+ ++++++
T Consensus       220 ~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        220 LKRQQ--KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             HHhhc--ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            11110  011223356778999999999999999996 588873

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=5.7e-36  Score=269.12  Aligned_cols=243  Identities=26%  Similarity=0.340  Sum_probs=187.4

Q ss_pred             eecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcc-cCCCCceeeeceEEcCCeeEEEEecCC
Q 018263           49 KIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVN-VCHENLVKLHGGCIDGPCRILVYDYMP  123 (358)
Q Consensus        49 ~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-~~h~~i~~~~~~~~~~~~~~iv~e~~~  123 (358)
                      .||+|+||.||++... +++.||+|.+....   ........++...++.+. ..||+++.+++.+...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999975 58899999886432   122233334443333321 139999999999999999999999999


Q ss_pred             CCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCcc
Q 018263          124 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH  203 (358)
Q Consensus       124 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  203 (358)
                      +++|.+++    ...+.+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......  
T Consensus        81 ~~~L~~~i----~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--  151 (279)
T cd05633          81 GGDLHYHL----SQHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--  151 (279)
T ss_pred             CCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence            99999988    3456799999999999999999999999   99999999999999999999999999987543222  


Q ss_pred             cccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccCC
Q 018263          204 ISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYG  282 (358)
Q Consensus       204 ~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (358)
                       .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.......... ...            .. .....
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~------------~~-~~~~~  216 (279)
T cd05633         152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDR------------MT-LTVNV  216 (279)
T ss_pred             -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH-HHH------------Hh-hcCCc
Confidence             123458899999998864 568899999999999999999999997543221111 100            00 01112


Q ss_pred             CCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 018263          283 NFPENEAIRFLKVGLLCVQEKSKLRP-----QMSTAIK  315 (358)
Q Consensus       283 ~~~~~~~~~l~~li~~~l~~~P~~Rp-----t~~eil~  315 (358)
                      ..+...+..+.+++.+||+.||.+||     ++.++++
T Consensus       217 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  254 (279)
T cd05633         217 ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE  254 (279)
T ss_pred             CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence            33445677899999999999999999     5888876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.9e-36  Score=278.35  Aligned_cols=266  Identities=23%  Similarity=0.340  Sum_probs=200.9

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhc-ccCCCCceeeeceEEcC--C
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANV-NVCHENLVKLHGGCIDG--P  113 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l-~~~h~~i~~~~~~~~~~--~  113 (358)
                      ..++|++.+.||+|++|.||+|.+. +|+.+++|.+...  .......+..|+..++.+ +  ||||+++++++...  .
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~--h~ni~~~~~~~~~~~~~   82 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGD--HPNIVKLLNVIKAENDK   82 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcC--CCCccceeeeeccCCCc
Confidence            3578999999999999999999976 5889999987532  233445677899999999 6  99999999988643  4


Q ss_pred             eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccc
Q 018263          114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL  193 (358)
Q Consensus       114 ~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~  193 (358)
                      ..++||||++ ++|...+.    . ..+++..+..++.||+.||+|||++   |++|+||+|+||+++.++.++|+|||.
T Consensus        83 ~~~lv~e~~~-~~L~~~~~----~-~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~  153 (337)
T cd07852          83 DIYLVFEYME-TDLHAVIR----A-NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGL  153 (337)
T ss_pred             eEEEEecccc-cCHHHHHh----c-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccc
Confidence            6799999996 58888872    2 2778899999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCc----ccccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccc
Q 018263          194 SKLFPENTT----HISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYN  268 (358)
Q Consensus       194 ~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  268 (358)
                      +........    .......++..|+|||++.+ ..++.++|+||||+++|+|++|+.||................+...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  233 (337)
T cd07852         154 ARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPS  233 (337)
T ss_pred             hhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            876533221    12223457889999998765 4578899999999999999999999976554433333222222211


Q ss_pred             hhhHhh--------hhccccCC------CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 018263          269 SKELMN--------LVDPMLYG------NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKM  316 (358)
Q Consensus       269 ~~~~~~--------~~~~~~~~------~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~  316 (358)
                      ...+..        +++.....      ......+..+.++|.+||+.+|++|||+.++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            111111        11110000      1111246678999999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-37  Score=260.73  Aligned_cols=270  Identities=21%  Similarity=0.227  Sum_probs=202.6

Q ss_pred             CcccccccccccCHHHHH--HhhcCCcccc-eecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcc
Q 018263           21 GGEQILKNINAFSYNQLK--IATNGFRWSN-KIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVN   96 (358)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~--~~~~~y~i~~-~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~   96 (358)
                      .+.+..+.+..-+--++.  -..++|.+.. .||-|-.|.|..+..+ +|+++|+|++.-.     ....+|++..-...
T Consensus        38 p~~q~~~~~~~~~~m~~k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s  112 (400)
T KOG0604|consen   38 PAEQIKPPMSEESDMDFKEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMAS  112 (400)
T ss_pred             CccccCCCcchhhhcchhcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhc
Confidence            444555554433332222  2357787775 6999999999998865 7999999998622     23345666544444


Q ss_pred             cCCCCceeeeceEEc----CCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcC
Q 018263           97 VCHENLVKLHGGCID----GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRD  172 (358)
Q Consensus        97 ~~h~~i~~~~~~~~~----~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~d  172 (358)
                       +|||||.++++|.+    ...+.+|||.++||.|+..+..  +..+.+++..+..|+.||+.|+.|||+.   +|.|||
T Consensus       113 -~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~--~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRD  186 (400)
T KOG0604|consen  113 -GHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQD--RGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRD  186 (400)
T ss_pred             -CCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHH--cccccchHHHHHHHHHHHHHHHHHHHhc---chhhcc
Confidence             69999999998874    3456799999999999999943  3456799999999999999999999999   999999


Q ss_pred             CCCCcEEEcC---CCceEEeecccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCC
Q 018263          173 IKTSNILLDQ---NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVD  249 (358)
Q Consensus       173 i~p~Nilv~~---~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~  249 (358)
                      |||+|++...   |..+||+|||+++....  .......+.|+.|.|||++...+|+.+.|+||+|+++|-|++|.+||.
T Consensus       187 lKpENLLyt~t~~na~lKLtDfGFAK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFY  264 (400)
T KOG0604|consen  187 LKPENLLYTTTSPNAPLKLTDFGFAKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY  264 (400)
T ss_pred             CChhheeeecCCCCcceEecccccccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCccc
Confidence            9999999964   45589999999987432  223344678999999999988889999999999999999999999997


Q ss_pred             ccccccchhhhHhhhhccchhhHhhhhccccCC---CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          250 FDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYG---NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .....            ..+.....-+......   .--...+....++|+.+|+.+|.+|.|++++++
T Consensus       265 S~hg~------------aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  265 SNHGL------------AISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             ccCCc------------cCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            44321            0111122222221111   112357888999999999999999999999875

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3.3e-36  Score=272.38  Aligned_cols=245  Identities=22%  Similarity=0.354  Sum_probs=197.7

Q ss_pred             ccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecCCC
Q 018263           46 WSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN  124 (358)
Q Consensus        46 i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~~~  124 (358)
                      ...+||.|++|.||++..+ +++.|++|.+..........+.+|+..++.+.  |+|++++++.+...+..+++|||+++
T Consensus        24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~  101 (292)
T cd06657          24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ--HENVVEMYNSYLVGDELWVVMEFLEG  101 (292)
T ss_pred             hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcC--CcchhheeeEEEeCCEEEEEEecCCC
Confidence            3478999999999999875 68999999986555556677889999999988  99999999999999999999999999


Q ss_pred             CCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCccc
Q 018263          125 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI  204 (358)
Q Consensus       125 ~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~  204 (358)
                      ++|.+++     ....+++..+..++.|++.+|+|||+.   |++|+||+|+||+++.++.++|+|||.+........ .
T Consensus       102 ~~L~~~~-----~~~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~  172 (292)
T cd06657         102 GALTDIV-----THTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-R  172 (292)
T ss_pred             CcHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-c
Confidence            9999987     234578999999999999999999999   999999999999999999999999998875433221 1


Q ss_pred             ccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCCC
Q 018263          205 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNF  284 (358)
Q Consensus       205 ~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (358)
                      .....++..|+|||.+.+..++.++|+||+|+++|+|++|..||..............            .......  .
T Consensus       173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~------------~~~~~~~--~  238 (292)
T cd06657         173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD------------NLPPKLK--N  238 (292)
T ss_pred             ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------------hCCcccC--C
Confidence            2234577889999998888889999999999999999999999875432211111100            0000000  1


Q ss_pred             CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          285 PENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       285 ~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ....+..+.+++.+||+.+|.+||++.++++
T Consensus       239 ~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         239 LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             cccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            1234556889999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-37  Score=285.88  Aligned_cols=244  Identities=26%  Similarity=0.388  Sum_probs=204.2

Q ss_pred             eecccCceEEEEEEECC-CCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecCCCCCH
Q 018263           49 KIGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSL  127 (358)
Q Consensus        49 ~lg~g~~g~v~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L  127 (358)
                      .||+|.+|+||-|++.+ ...+|||.+...+....+.+.+|+...+.++  |.|||++++.+..++.+-|+||.++||+|
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~Lr--HkNIVrYLGs~senGf~kIFMEqVPGGSL  659 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLR--HKNIVRYLGSVSENGFFKIFMEQVPGGSL  659 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHh--hHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence            68999999999999764 5678999998777777788999999999998  99999999999999999999999999999


Q ss_pred             HHHhhhccccccCC--CHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcC-CCceEEeecccccccCCCCccc
Q 018263          128 SQTLLGEEKRRAKF--GWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ-NFNPKISDFGLSKLFPENTTHI  204 (358)
Q Consensus       128 ~~~l~~~~~~~~~l--~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~-~~~~~l~Dfg~~~~~~~~~~~~  204 (358)
                      ..+++   .+=+++  ++.++-.+..||++||.|||++   .|||||||-+||+|+. .|.+||.|||-++...... ..
T Consensus       660 SsLLr---skWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin-P~  732 (1226)
T KOG4279|consen  660 SSLLR---SKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN-PC  732 (1226)
T ss_pred             HHHHH---hccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCC-cc
Confidence            99993   344666  7899999999999999999999   9999999999999965 6789999999998764322 23


Q ss_pred             ccccccccCccCccccccC--CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccCC
Q 018263          205 STRVAGTLGYLAPEYAISG--RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYG  282 (358)
Q Consensus       205 ~~~~~~~~~y~aPE~~~~~--~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (358)
                      .....||..|+|||++..+  .|+.++|||||||++.||.||++||..-...   +..           ....-.-..-+
T Consensus       733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp---qAA-----------MFkVGmyKvHP  798 (1226)
T KOG4279|consen  733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP---QAA-----------MFKVGMYKVHP  798 (1226)
T ss_pred             ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh---hHh-----------hhhhcceecCC
Confidence            4457799999999999865  4889999999999999999999999633211   000           00011111235


Q ss_pred             CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          283 NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       283 ~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ..|...+++...+|.+|...+|.+||+|.++++
T Consensus       799 ~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  799 PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             CCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            678889999999999999999999999999985

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.6e-35  Score=271.10  Aligned_cols=251  Identities=25%  Similarity=0.340  Sum_probs=198.7

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      +.|...+.||+|+||.||+++.. ++..|++|.+....   ......+..|+..++.++  |||++++++++......++
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~l  102 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK--HPNSIEYKGCYLREHTAWL  102 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCC--CCCEEEEEEEEeeCCeEEE
Confidence            34778899999999999999965 68899999986432   233456888999999998  9999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      ||||++| +|.+.+.   .....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++...
T Consensus       103 v~e~~~g-~l~~~~~---~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~  175 (317)
T cd06635         103 VMEYCLG-SASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIA  175 (317)
T ss_pred             EEeCCCC-CHHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCcccc
Confidence            9999965 7777763   2345689999999999999999999999   9999999999999999999999999988654


Q ss_pred             CCCCcccccccccccCccCccccc---cCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhh
Q 018263          198 PENTTHISTRVAGTLGYLAPEYAI---SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMN  274 (358)
Q Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                      ...     ....++..|+|||++.   +..++.++|+||||+++|+|++|..||...........               
T Consensus       176 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~---------------  235 (317)
T cd06635         176 SPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH---------------  235 (317)
T ss_pred             CCc-----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHH---------------
Confidence            321     2245778899999874   45688999999999999999999999864322111111               


Q ss_pred             hhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCC
Q 018263          275 LVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGET  321 (358)
Q Consensus       275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~  321 (358)
                      +.............+..+.+++.+||+.+|.+||++.++++.+--..
T Consensus       236 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         236 IAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             HHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence            11111111122345567899999999999999999999998655443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=3.8e-36  Score=277.30  Aligned_cols=265  Identities=22%  Similarity=0.307  Sum_probs=200.1

Q ss_pred             hcCCccc-ceecccCceEEEEEEEC-CCCEEEEEEeeccChhh--------------HHHHHHHHHHhhhcccCCCCcee
Q 018263           41 TNGFRWS-NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQG--------------EKEFMSEVASMANVNVCHENLVK  104 (358)
Q Consensus        41 ~~~y~i~-~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~--------------~~~~~~e~~~l~~l~~~h~~i~~  104 (358)
                      .++|..+ +.||.|++|.||+|.++ +++.||+|.+.......              ...+.+|+..+..++  |+||++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~   84 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK--HENIMG   84 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC--Ccceee
Confidence            4677654 67999999999999965 68999999986442221              124678999999998  999999


Q ss_pred             eeceEEcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCC
Q 018263          105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF  184 (358)
Q Consensus       105 ~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~  184 (358)
                      +++++...+..+++|||++ ++|.+.+    .....+++..+..++.|++.||.+||+.   |++|+||+|+||+++.++
T Consensus        85 ~~~~~~~~~~~~lv~e~~~-~~l~~~l----~~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~  156 (335)
T PTZ00024         85 LVDVYVEGDFINLVMDIMA-SDLKKVV----DRKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKG  156 (335)
T ss_pred             eeEEEecCCcEEEEEeccc-cCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCC
Confidence            9999999999999999996 6898888    3456689999999999999999999999   999999999999999999


Q ss_pred             ceEEeecccccccCCCC-------------cccccccccccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCCCc
Q 018263          185 NPKISDFGLSKLFPENT-------------THISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDF  250 (358)
Q Consensus       185 ~~~l~Dfg~~~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf~~  250 (358)
                      .++|+|||.+.......             ........++..|+|||.+.+. .++.++|+||||+++|+|++|..||..
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~  236 (335)
T PTZ00024        157 ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG  236 (335)
T ss_pred             CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            99999999987654111             1111123457789999988764 468899999999999999999999986


Q ss_pred             cccccchhhhHhhhhccchhhHhhhhc--------cccCC---CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          251 DVQLGEYHLVDKAWGMYNSKELMNLVD--------PMLYG---NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~---~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ....+....+....+......+.....        .....   ......+..+.+++.+||+.+|++|||+++++.
T Consensus       237 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        237 ENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             CCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            655443332222222111111111100        00000   011123567889999999999999999999985

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2.4e-36  Score=279.44  Aligned_cols=264  Identities=21%  Similarity=0.286  Sum_probs=196.4

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC-------
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG-------  112 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~-------  112 (358)
                      ..+|++.+.||.|++|.||+|... +|+.|++|.+........+.+.+|++.++.++  |||++++++.+...       
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~--h~~i~~~~~~~~~~~~~~~~~   81 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLD--HDNIVKVYEVLGPSGSDLTED   81 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcC--CCcchhhHhhhcccccccccc
Confidence            479999999999999999999875 68999999987766666677889999999998  99999999876543       


Q ss_pred             -------CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEc-CCC
Q 018263          113 -------PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD-QNF  184 (358)
Q Consensus       113 -------~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~-~~~  184 (358)
                             ...++++||++ ++|.+.+     ....+++..++.++.||+.||.|||+.   |++|+||+|+||+++ .++
T Consensus        82 ~~~~~~~~~~~lv~e~~~-~~L~~~~-----~~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~  152 (342)
T cd07854          82 VGSLTELNSVYIVQEYME-TDLANVL-----EQGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDL  152 (342)
T ss_pred             cccccccceEEEEeeccc-ccHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCc
Confidence                   35789999996 5888887     234688999999999999999999999   999999999999997 455


Q ss_pred             ceEEeecccccccCCCCcc--cccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhH
Q 018263          185 NPKISDFGLSKLFPENTTH--ISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVD  261 (358)
Q Consensus       185 ~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~  261 (358)
                      .++++|||.+.........  ......++..|.|||.+.+ ..++.++||||||+++|+|++|+.||.............
T Consensus       153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~  232 (342)
T cd07854         153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL  232 (342)
T ss_pred             eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            7899999998764322111  1122346788999998754 467889999999999999999999997554322221111


Q ss_pred             hhhhccchhhHhhhh-------c-cccCCC-----CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          262 KAWGMYNSKELMNLV-------D-PMLYGN-----FPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~-------~-~~~~~~-----~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ...............       . ......     .....+..+.+++.+||+.+|.+|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            111000000000000       0 000000     11124567889999999999999999999984

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-37  Score=282.54  Aligned_cols=264  Identities=25%  Similarity=0.380  Sum_probs=224.9

Q ss_pred             HHHHHHhhcCCcccceecccCceEEEEEEEC---CC--CEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeec
Q 018263           34 YNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ---DG--TIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHG  107 (358)
Q Consensus        34 ~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~---~~--~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~  107 (358)
                      .+++.+..+..++.+.||.|-||.||.|...   .|  -.||||..+.+ .....+.|..|..+++.++  ||||+++++
T Consensus       381 ~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfd--HphIikLIG  458 (974)
T KOG4257|consen  381 VRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFD--HPHIIKLIG  458 (974)
T ss_pred             CCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCC--Ccchhheee
Confidence            4466777778888889999999999999842   23  35888988764 3445788999999999999  999999999


Q ss_pred             eEEcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceE
Q 018263          108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPK  187 (358)
Q Consensus       108 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~  187 (358)
                      ++... -.+||||.++.|.|..++.   .+...++...+..+++||+.||+|||++   .+|||||...||+|....-+|
T Consensus       459 v~~e~-P~WivmEL~~~GELr~yLq---~nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVK  531 (974)
T KOG4257|consen  459 VCVEQ-PMWIVMELAPLGELREYLQ---QNKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVK  531 (974)
T ss_pred             eeecc-ceeEEEecccchhHHHHHH---hccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceee
Confidence            99865 4789999999999999994   4567799999999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhc
Q 018263          188 ISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGM  266 (358)
Q Consensus       188 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~  266 (358)
                      |+|||+++.+.............+.-|+|||-+.-..++.++|||-||+++||+++ |..||.+-.+.+..-.       
T Consensus       532 LaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~-------  604 (974)
T KOG4257|consen  532 LADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGH-------  604 (974)
T ss_pred             ecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEE-------
Confidence            99999999987777766666677889999999999999999999999999999987 8999986655443322       


Q ss_pred             cchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCC
Q 018263          267 YNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETN  322 (358)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~  322 (358)
                               ++..-+...|++++..+..|+.+||..+|.+||.+.++...|+.+..
T Consensus       605 ---------iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  605 ---------IENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             ---------ecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence                     23333455677899999999999999999999999999888876554

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-35  Score=266.42  Aligned_cols=264  Identities=23%  Similarity=0.327  Sum_probs=196.6

Q ss_pred             CcccceecccCceEEEEEEEC-CCCEEEEEEeeccCh--hhHHHHHHHHHHhhhcc-cCCCCceeeeceEEcCCe-----
Q 018263           44 FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK--QGEKEFMSEVASMANVN-VCHENLVKLHGGCIDGPC-----  114 (358)
Q Consensus        44 y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~-~~h~~i~~~~~~~~~~~~-----  114 (358)
                      |++.+.||.|++|.||+|+.+ +++.|++|.+.....  .....+..|+..+..+. ..|+|++++++.+.....     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            678899999999999999986 489999999874422  22344556766665552 239999999999987776     


Q ss_pred             eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccc
Q 018263          115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS  194 (358)
Q Consensus       115 ~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~  194 (358)
                      .+++|||++ ++|.+++...  ....+++..++.++.|++.||.+||+.   +++|+||+|+||+++.++.++|+|||.+
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~--~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~  154 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKC--PKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA  154 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence            899999996 4788887432  223589999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhh
Q 018263          195 KLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMN  274 (358)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                      ........  .....++..|+|||.+.+..++.++|+||||+++|+|++|.+||......+....+...........+..
T Consensus       155 ~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07838         155 RIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR  232 (287)
T ss_pred             eeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCC
Confidence            76533221  1223467889999999988899999999999999999999999986654433322221111111100000


Q ss_pred             -------hhccccC---CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          275 -------LVDPMLY---GNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       275 -------~~~~~~~---~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                             .......   ..........+.+++.+||+.+|.+||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence                   0000000   1111234567889999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-37  Score=301.05  Aligned_cols=257  Identities=27%  Similarity=0.347  Sum_probs=214.5

Q ss_pred             CHHHHHHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeece
Q 018263           33 SYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGG  108 (358)
Q Consensus        33 ~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~  108 (358)
                      ....+....++|.|++.||+|+||.|.+++.+ +++.||+|+++..   .....+-|.+|-.++...+  .+=|+.++-.
T Consensus        66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~n--s~Wiv~LhyA  143 (1317)
T KOG0612|consen   66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGN--SEWIVQLHYA  143 (1317)
T ss_pred             HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCC--cHHHHHHHHH
Confidence            34556667899999999999999999999975 6899999999763   4556677888888888877  8889999999


Q ss_pred             EEcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEE
Q 018263          109 CIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKI  188 (358)
Q Consensus       109 ~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l  188 (358)
                      |.+..++|+||||++||+|-.++    ++...+|++.++.++..|+.||..||+.   |+|||||||+||++|..|.++|
T Consensus       144 FQD~~~LYlVMdY~pGGDlltLl----Sk~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikL  216 (1317)
T KOG0612|consen  144 FQDERYLYLVMDYMPGGDLLTLL----SKFDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKL  216 (1317)
T ss_pred             hcCccceEEEEecccCchHHHHH----hhcCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEee
Confidence            99999999999999999999999    5555899999999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccCccCccccc----c-CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhh
Q 018263          189 SDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI----S-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKA  263 (358)
Q Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~----~-~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~  263 (358)
                      +|||.+..+...+.-.....+|||.|.+||++.    + +.|++..|.||+|+++|+|+.|..||..++-.+.|..+...
T Consensus       217 ADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h  296 (1317)
T KOG0612|consen  217 ADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH  296 (1317)
T ss_pred             ccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch
Confidence            999999998877776677788999999999986    2 56899999999999999999999999877655555444322


Q ss_pred             hhccchhhHhhhhccccCCCCC--HHHHHHHHHHHhhccCCCCCCCCC---HHHHH
Q 018263          264 WGMYNSKELMNLVDPMLYGNFP--ENEAIRFLKVGLLCVQEKSKLRPQ---MSTAI  314 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~P~~Rpt---~~eil  314 (358)
                            .+..         .||  ...+....+||++.+. +|+.|..   ++++-
T Consensus       297 ------k~~l---------~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik  336 (1317)
T KOG0612|consen  297 ------KESL---------SFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIK  336 (1317)
T ss_pred             ------hhhc---------CCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHH
Confidence                  1111         122  3366677788887765 6777777   66653

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1e-35  Score=269.54  Aligned_cols=261  Identities=21%  Similarity=0.245  Sum_probs=186.9

Q ss_pred             HhhcCCcccceecccCceEEEEEEECC----CCEEEEEEeeccChhhH-----------HHHHHHHHHhhhcccCCCCce
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQD----GTIVAVKVLSVESKQGE-----------KEFMSEVASMANVNVCHENLV  103 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~~----~~~vaiK~~~~~~~~~~-----------~~~~~e~~~l~~l~~~h~~i~  103 (358)
                      +..++|++.+.||+|+||.||+|.+.+    +..+++|+.........           .....++..+..+.  |++++
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~--h~~i~   86 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNID--HLGIP   86 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCC--CCCCC
Confidence            556899999999999999999998653    45667776543322111           11112233344445  99999


Q ss_pred             eeeceEEcCC----eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEE
Q 018263          104 KLHGGCIDGP----CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL  179 (358)
Q Consensus       104 ~~~~~~~~~~----~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nil  179 (358)
                      .+++......    ..+++++++ ..++.+.+    ......++..+..++.|++.||+|||++   +++||||||+||+
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nil  158 (294)
T PHA02882         87 KYYGCGSFKRCRMYYRFILLEKL-VENTKEIF----KRIKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIM  158 (294)
T ss_pred             cEEEeeeEecCCceEEEEEEehh-ccCHHHHH----HhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEE
Confidence            9998765443    346788877 45676666    2233457888999999999999999999   9999999999999


Q ss_pred             EcCCCceEEeecccccccCCCCc------ccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCcccc
Q 018263          180 LDQNFNPKISDFGLSKLFPENTT------HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ  253 (358)
Q Consensus       180 v~~~~~~~l~Dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~  253 (358)
                      ++.++.++|+|||++........      .......||+.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus       159 l~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~  238 (294)
T PHA02882        159 VDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGH  238 (294)
T ss_pred             EcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcccc
Confidence            99999999999999976532211      111224689999999999999999999999999999999999999976533


Q ss_pred             ccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 018263          254 LGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN  318 (358)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~  318 (358)
                      ..........      +-...+.....   .....+..+.+++..|++.+|++||++.++++.|+
T Consensus       239 ~~~~~~~~~~------~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        239 NGNLIHAAKC------DFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             chHHHHHhHH------HHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            2221111100      00011111100   11223567899999999999999999999999874

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=6.2e-36  Score=269.92  Aligned_cols=257  Identities=25%  Similarity=0.347  Sum_probs=195.7

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      ++|...+.||+|++|.||++... +++.|++|.+.... ......+..|+..+.++. .|+||+++++++......+++|
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~-~~~~iv~~~~~~~~~~~~~~~~   82 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS-DCPYIVKFYGALFREGDCWICM   82 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhc-CCCCEeeeeeEEecCCcEEEEE
Confidence            46667889999999999999875 58999999986442 344567788888888874 4999999999999999999999


Q ss_pred             ecCCCCCHHHHhhh-ccccccCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          120 DYMPNNSLSQTLLG-EEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       120 e~~~~~~L~~~l~~-~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      ||++ .++.++... .......+++..+..++.|++.||+|||+ .   +++|+||+|+||+++.++.++|+|||++...
T Consensus        83 e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  158 (288)
T cd06616          83 ELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL---KIIHRDVKPSNILLDRNGNIKLCDFGISGQL  158 (288)
T ss_pred             eccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC---CeeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence            9985 566554421 11234678999999999999999999996 5   9999999999999999999999999998754


Q ss_pred             CCCCcccccccccccCccCccccccC---CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhh
Q 018263          198 PENTTHISTRVAGTLGYLAPEYAISG---RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMN  274 (358)
Q Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~~~---~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                      .....  .....++..|+|||++.+.   .++.++||||||+++|+|++|+.||.....  .........   .      
T Consensus       159 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~---~------  225 (288)
T cd06616         159 VDSIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVV---K------  225 (288)
T ss_pred             ccCCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhc---C------
Confidence            32221  1223578889999998765   688999999999999999999999974321  111110000   0      


Q ss_pred             hhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 018263          275 LVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKM  316 (358)
Q Consensus       275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~  316 (358)
                      ...+.+....+...+..+.+|+.+||+.+|++|||+++|++.
T Consensus       226 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         226 GDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            000111112223466789999999999999999999999763

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=5.5e-36  Score=275.31  Aligned_cols=264  Identities=24%  Similarity=0.331  Sum_probs=201.6

Q ss_pred             HHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEc-CC
Q 018263           38 KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID-GP  113 (358)
Q Consensus        38 ~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~-~~  113 (358)
                      ....++|++.+.||.|++|.||+|... +++.|++|.+...  .....+.+..|++.++.+.  |||++++.+++.. ..
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~   83 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLR--HENIISLSDIFISPLE   83 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcC--CCCeeeEeeeEecCCC
Confidence            346789999999999999999999865 7899999987543  2334567788999999998  9999999999875 55


Q ss_pred             eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccc
Q 018263          114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL  193 (358)
Q Consensus       114 ~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~  193 (358)
                      ..++++||+ +++|.+++     +...+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.++|+|||.
T Consensus        84 ~~~lv~e~~-~~~L~~~~-----~~~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~  154 (328)
T cd07856          84 DIYFVTELL-GTDLHRLL-----TSRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGL  154 (328)
T ss_pred             cEEEEeehh-ccCHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccc
Confidence            789999998 66888887     334678899999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchh--
Q 018263          194 SKLFPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSK--  270 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~--  270 (358)
                      +......    .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||................+....+  
T Consensus       155 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~  230 (328)
T cd07856         155 ARIQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVI  230 (328)
T ss_pred             ccccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            8754321    122456788999998765 568999999999999999999999997654433222222221111111  


Q ss_pred             ------hHhhhhccccC-CCCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 018263          271 ------ELMNLVDPMLY-GNFP-----ENEAIRFLKVGLLCVQEKSKLRPQMSTAIKM  316 (358)
Q Consensus       271 ------~~~~~~~~~~~-~~~~-----~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~  316 (358)
                            ....++..... ...+     ...+..+.++|.+||+.+|++|||+.+++..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         231 NTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             HhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                  00111111100 1111     1245679999999999999999999999765

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=6.8e-36  Score=272.41  Aligned_cols=266  Identities=26%  Similarity=0.380  Sum_probs=196.7

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC--hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC----
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP----  113 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~----  113 (358)
                      .++|++.+.||.|++|.||+|.++ +++.|++|.+....  ......+.+|++.++.++  ||||+++++.+....    
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~~   84 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK--HPNVVPLIDMAVERPDKSK   84 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcC--CCCccchhhheeccccccc
Confidence            579999999999999999999976 68899999886442  222345678999999998  999999999875433    


Q ss_pred             ----eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEe
Q 018263          114 ----CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKIS  189 (358)
Q Consensus       114 ----~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~  189 (358)
                          ..+++++|+. .+|...+.   .....+++..+..++.|++.||+|||++   |++|+||+|+||+++.++.++|+
T Consensus        85 ~~~~~~~lv~~~~~-~~l~~~~~---~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~  157 (311)
T cd07866          85 RKRGSVYMVTPYMD-HDLSGLLE---NPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIA  157 (311)
T ss_pred             ccCceEEEEEecCC-cCHHHHHh---ccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEC
Confidence                4689999995 46776663   2345789999999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcc----------cccccccccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCCCccccccchh
Q 018263          190 DFGLSKLFPENTTH----------ISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYH  258 (358)
Q Consensus       190 Dfg~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~  258 (358)
                      |||++.........          ......++..|+|||.+.+. .++.++||||||+++|+|++|++||..........
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~  237 (311)
T cd07866         158 DFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLH  237 (311)
T ss_pred             cCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            99998765322211          11123467789999987654 57899999999999999999999997665543333


Q ss_pred             hhHhhhhccchhhHhh------hhccccCCCCC-------HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          259 LVDKAWGMYNSKELMN------LVDPMLYGNFP-------ENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~------~~~~~~~~~~~-------~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .+....+......+..      ..........+       ......+.+++.+||+.+|.+|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            3222221111111100      00000000000       122357889999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-35  Score=266.45  Aligned_cols=263  Identities=25%  Similarity=0.344  Sum_probs=198.1

Q ss_pred             CcccceecccCceEEEEEEEC-CCCEEEEEEeeccCh-hhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEec
Q 018263           44 FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY  121 (358)
Q Consensus        44 y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~  121 (358)
                      |++.+.||.|++|.||+|+.. +++.|+||.+..... .......+|+..+..+. .|+|++++++.+...+..++||||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~-~h~~i~~~~~~~~~~~~~~lv~e~   79 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLN-EHPNIVKLKEVFRENDELYFVFEY   79 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhcc-CCCCchhHHHHhhcCCcEEEEEec
Confidence            678899999999999999976 588899998764422 23334456777777774 499999999999999999999999


Q ss_pred             CCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCC
Q 018263          122 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT  201 (358)
Q Consensus       122 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~  201 (358)
                      + +++|.+.+...  ....+++..+..++.|++.+|.|||++   +++|+||+|+||+++.++.++|+|||.+.......
T Consensus        80 ~-~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (283)
T cd07830          80 M-EGNLYQLMKDR--KGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP  153 (283)
T ss_pred             C-CCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence            9 78898888332  234789999999999999999999999   99999999999999999999999999987653322


Q ss_pred             cccccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhh------
Q 018263          202 THISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMN------  274 (358)
Q Consensus       202 ~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------  274 (358)
                      .  .....++..|+|||++.+ ..++.++|+||||+++++|++|++||......+.........+......+..      
T Consensus       154 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07830         154 P--YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS  231 (283)
T ss_pred             C--cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence            1  123457788999998754 4578999999999999999999999976655443332222222111111110      


Q ss_pred             hhccccCC-------CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          275 LVDPMLYG-------NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       275 ~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .++.....       ......+..+.+++.+||+.+|++|||++|++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            00000000       001122467999999999999999999999975

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-37  Score=285.96  Aligned_cols=252  Identities=21%  Similarity=0.351  Sum_probs=207.9

Q ss_pred             hcCCcccceecccCceEEEEEEECC-CCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      .+.|.|+..||-|+||.||+|..++ +-..|-|++...+.....++.-|+++|..+.  ||+|+++++.|+..+.++|+.
T Consensus        31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~Cd--HP~ivkLl~ayy~enkLwili  108 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECD--HPVIVKLLSAYYFENKLWILI  108 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCC--ChHHHHHHHHHhccCceEEEE
Confidence            3678999999999999999999774 4445668887777888899999999999998  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      |||.||.++..+..   -...+.+.++..+++|++.||.|||++   +|+|||||..||+++-+|.++|+|||.+.... 
T Consensus       109 EFC~GGAVDaimlE---L~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~-  181 (1187)
T KOG0579|consen  109 EFCGGGAVDAIMLE---LGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNK-  181 (1187)
T ss_pred             eecCCchHhHHHHH---hccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccch-
Confidence            99999999998843   456789999999999999999999999   99999999999999999999999999875421 


Q ss_pred             CCcccccccccccCccCccccc-----cCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhh
Q 018263          200 NTTHISTRVAGTLGYLAPEYAI-----SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMN  274 (358)
Q Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~-----~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                      ........+.||+.|+|||++.     ..+|+.++||||||++|.+|..+.+|-..-++......+.+       .+-..
T Consensus       182 ~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaK-------SePPT  254 (1187)
T KOG0579|consen  182 STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK-------SEPPT  254 (1187)
T ss_pred             hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhh-------cCCCc
Confidence            1222334578999999999875     56899999999999999999999999654433222221111       11111


Q ss_pred             hhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          275 LVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ++       .|...+..+.+++.+||..||..||++.++++
T Consensus       255 Ll-------qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  255 LL-------QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             cc-------CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            11       24567788999999999999999999998875

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.5e-35  Score=272.59  Aligned_cols=260  Identities=23%  Similarity=0.305  Sum_probs=192.0

Q ss_pred             cceeccc--CceEEEEEEEC-CCCEEEEEEeeccC--hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEec
Q 018263           47 SNKIGEG--GFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY  121 (358)
Q Consensus        47 ~~~lg~g--~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~  121 (358)
                      ...||.|  ++|.||++++. +|+.||+|+.....  ....+.+.+|+..++.++  ||||+++++++...+..++++||
T Consensus         3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~--h~niv~~~~~~~~~~~~~~v~e~   80 (328)
T cd08226           3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFR--HPNIMTSWTVFTTGSWLWVISPF   80 (328)
T ss_pred             HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCC--CCCcceEeeeEecCCceEEEEec
Confidence            3456666  89999999975 79999999986542  333467888888888887  99999999999999999999999


Q ss_pred             CCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCC
Q 018263          122 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT  201 (358)
Q Consensus       122 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~  201 (358)
                      +++++|.+++...  ....+++..+..++.|++.||+|||++   |++|+||||+||+++.++.++++||+.+.......
T Consensus        81 ~~~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~  155 (328)
T cd08226          81 MAYGSANSLLKTY--FPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNG  155 (328)
T ss_pred             ccCCCHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccC
Confidence            9999999998433  234588999999999999999999999   99999999999999999999999997654321111


Q ss_pred             ccc------ccccccccCccCccccccC--CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccc-----
Q 018263          202 THI------STRVAGTLGYLAPEYAISG--RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYN-----  268 (358)
Q Consensus       202 ~~~------~~~~~~~~~y~aPE~~~~~--~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~-----  268 (358)
                      ...      .....++..|+|||++.+.  .++.++||||||+++|+|++|..||..........  ........     
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~  233 (328)
T cd08226         156 QKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLL--QKLKGPPYSPLDI  233 (328)
T ss_pred             ccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHH--HHhcCCCCCCccc
Confidence            100      0112345679999998763  47899999999999999999999997543221110  00000000     


Q ss_pred             -----hh--------hH---------h-----hhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          269 -----SK--------EL---------M-----NLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       269 -----~~--------~~---------~-----~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                           ..        ..         .     ...........+..++..+.+|+.+||+.||.+|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         234 TTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             cccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                 00        00         0     001111122233456778999999999999999999999974

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.3e-35  Score=263.68  Aligned_cols=250  Identities=22%  Similarity=0.355  Sum_probs=197.3

Q ss_pred             CCcccceecccCceEEEEEEECC-CCEEEEEEeecc-----ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeE
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQD-GTIVAVKVLSVE-----SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI  116 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~~-~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~  116 (358)
                      +|.+.+.||+|++|.||++.+.. +..+++|+....     .......+..|+..+..++  |||++++++.+......+
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~   78 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD--HPAIVKFHASFLERDAFC   78 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCC--CCcHHHHHHHHhcCCceE
Confidence            68999999999999999998653 444555554321     1223345667888888887  999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       117 iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      +++||+++++|.+.+.........+++..++.++.|++.||.|||+.   |++|+||+|+||+++. +.++|+|||.+..
T Consensus        79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~  154 (260)
T cd08222          79 IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRL  154 (260)
T ss_pred             EEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceee
Confidence            99999999999999865444567799999999999999999999999   9999999999999976 5799999998876


Q ss_pred             cCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhh
Q 018263          197 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV  276 (358)
Q Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                      ...... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||......   .....             +
T Consensus       155 ~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~---~~~~~-------------~  217 (260)
T cd08222         155 LMGSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL---SVVLR-------------I  217 (260)
T ss_pred             cCCCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH---HHHHH-------------H
Confidence            533222 222345778999999988888899999999999999999999998643211   11110             1


Q ss_pred             ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          277 DPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       277 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ........+...+..+.++|.+||+.+|++||++.++++
T Consensus       218 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         218 VEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             HcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            111122334566778999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=4.3e-37  Score=262.74  Aligned_cols=271  Identities=21%  Similarity=0.277  Sum_probs=212.0

Q ss_pred             HhhcCCcccceecccCceEEEEEEEC---C--CCEEEEEEeeccC--hhhHHHHHHHHHHhhhcccCCCCceeeeceEEc
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQ---D--GTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCID  111 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~---~--~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~  111 (358)
                      .....|+++..||+|.+|.||+|..+   +  .+.||||.+..++  ........+|+..++.++  |||++.+..+|..
T Consensus        21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~--h~nvi~Lv~Vfl~   98 (438)
T KOG0666|consen   21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELK--HPNVISLVKVFLS   98 (438)
T ss_pred             HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhc--CCcchhHHHHHhc
Confidence            34568999999999999999999633   2  3478999986552  233456778999999998  9999999999887


Q ss_pred             -CCeeEEEEecCCCCCHHHHhhhccc-cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCC----Cc
Q 018263          112 -GPCRILVYDYMPNNSLSQTLLGEEK-RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN----FN  185 (358)
Q Consensus       112 -~~~~~iv~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~----~~  185 (358)
                       +...++++||.+ -+|.+.++.++. ....++...+..+++||+.|+.|||++   -|.||||||.||+|..+    |+
T Consensus        99 ~d~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~  174 (438)
T KOG0666|consen   99 HDKKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGR  174 (438)
T ss_pred             cCceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCe
Confidence             778899999995 579999876543 345789999999999999999999999   99999999999999887    99


Q ss_pred             eEEeecccccccCCCCcc--cccccccccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCCCcccc---------
Q 018263          186 PKISDFGLSKLFPENTTH--ISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ---------  253 (358)
Q Consensus       186 ~~l~Dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf~~~~~---------  253 (358)
                      |||+|+|+++.+..+...  ....+..|.+|.|||.+.|. -||.+.|+|++|||+.||++.++.|.+...         
T Consensus       175 VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq  254 (438)
T KOG0666|consen  175 VKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQ  254 (438)
T ss_pred             eEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCch
Confidence            999999999987544332  23457789999999999875 589999999999999999999999976543         


Q ss_pred             ccchhhhHhhhhccchhhHhhhhcc---------ccCCCCCH-----------HHHHHHHHHHhhccCCCCCCCCCHHHH
Q 018263          254 LGEYHLVDKAWGMYNSKELMNLVDP---------MLYGNFPE-----------NEAIRFLKVGLLCVQEKSKLRPQMSTA  313 (358)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~-----------~~~~~l~~li~~~l~~~P~~Rpt~~ei  313 (358)
                      .++...+..+.+.+...++..+..-         .....+..           .-+....+|+.++|+.||.+|.|+++.
T Consensus       255 ~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qA  334 (438)
T KOG0666|consen  255 HDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQA  334 (438)
T ss_pred             HHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHH
Confidence            2333455555666655555444331         11111111           112237789999999999999999988


Q ss_pred             HH
Q 018263          314 IK  315 (358)
Q Consensus       314 l~  315 (358)
                      ++
T Consensus       335 le  336 (438)
T KOG0666|consen  335 LE  336 (438)
T ss_pred             hc
Confidence            76

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=278.31  Aligned_cols=265  Identities=26%  Similarity=0.428  Sum_probs=215.8

Q ss_pred             HHHhhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccCh-hhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCee
Q 018263           37 LKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR  115 (358)
Q Consensus        37 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~  115 (358)
                      .+...+...+.++||+|-||.|.++....+.+||+|.++.... ..+.++..|+..|.+++  ||||+.++++|..++.+
T Consensus       533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLk--hPNIveLvGVC~~DePi  610 (807)
T KOG1094|consen  533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLK--HPNIVELLGVCVQDDPL  610 (807)
T ss_pred             hhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccC--CCCeeEEEeeeecCCch
Confidence            3445678999999999999999999998789999999987644 44589999999999998  99999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccc
Q 018263          116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK  195 (358)
Q Consensus       116 ~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~  195 (358)
                      ++++||++.|+|..++..+..  ..+......+++.||+.|++||.+.   ++|||||.+.|+++++++.+||+|||+++
T Consensus       611 cmI~EYmEnGDLnqFl~ahea--pt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR  685 (807)
T KOG1094|consen  611 CMITEYMENGDLNQFLSAHEL--PTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSR  685 (807)
T ss_pred             HHHHHHHhcCcHHHHHHhccC--cccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccccc
Confidence            999999999999999954422  2245566677999999999999999   99999999999999999999999999998


Q ss_pred             cc-CCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHh--CCCCCCccccccchhhhHhhhhccchhhH
Q 018263          196 LF-PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS--GRTAVDFDVQLGEYHLVDKAWGMYNSKEL  272 (358)
Q Consensus       196 ~~-~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      .. ..+..........+..|+|+|.+..++++.++|+|+||+++||+++  .+.||..-..+   +.+.         +.
T Consensus       686 ~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e---~vve---------n~  753 (807)
T KOG1094|consen  686 NLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE---QVVE---------NA  753 (807)
T ss_pred             ccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH---HHHH---------hh
Confidence            44 3333444445667889999999999999999999999999999977  56777533221   1111         11


Q ss_pred             hhhhccc---cCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 018263          273 MNLVDPM---LYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE  320 (358)
Q Consensus       273 ~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~  320 (358)
                      ..+++..   .....|.-++..+.+++..||+.+-.+||+++++-..|...
T Consensus       754 ~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  754 GEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             hhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            1222211   12234567888999999999999999999999998887653

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.3e-36  Score=276.28  Aligned_cols=261  Identities=23%  Similarity=0.322  Sum_probs=200.9

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCe--
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC--  114 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~--  114 (358)
                      ..++|++.+.||.|++|.||+|+.. +++.|++|.+...  .......+..|+..++.+.  |||++++.+++.....  
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~   90 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMD--HENVIGLLDVFTPASSLE   90 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhcc--CCCHHHHHHHhhcccccc
Confidence            4688999999999999999999976 5889999988643  2334456778999999987  9999999998776554  


Q ss_pred             ----eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEee
Q 018263          115 ----RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD  190 (358)
Q Consensus       115 ----~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~D  190 (358)
                          .++|+||+ +++|.+++.     ...+++..++.++.|++.||++||+.   |++|+||+|+||+++.++.++|+|
T Consensus        91 ~~~~~~lv~e~~-~~~L~~~~~-----~~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~d  161 (343)
T cd07851          91 DFQDVYLVTHLM-GADLNNIVK-----CQKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILD  161 (343)
T ss_pred             ccccEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcc
Confidence                89999998 679999882     35689999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccc-
Q 018263          191 FGLSKLFPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYN-  268 (358)
Q Consensus       191 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~-  268 (358)
                      ||++......    .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+....+... 
T Consensus       162 fg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  237 (343)
T cd07851         162 FGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDE  237 (343)
T ss_pred             cccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Confidence            9999865332    233457788999998765 3678899999999999999999999976554333222222111111 


Q ss_pred             -------hhhHhhhhccccC---CCCC---HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          269 -------SKELMNLVDPMLY---GNFP---ENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       269 -------~~~~~~~~~~~~~---~~~~---~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                             ......++.....   ..+.   ...+..+.+++.+||+.+|.+|||+.+|++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence                   1111111111111   1111   123667999999999999999999999975

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.1e-36  Score=276.16  Aligned_cols=269  Identities=25%  Similarity=0.290  Sum_probs=201.1

Q ss_pred             CHHHHHHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceE
Q 018263           33 SYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGC  109 (358)
Q Consensus        33 ~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~  109 (358)
                      ...++....++|.+.+.||+|+||.||++... +++.||+|.+...  .......+.+|+..+.+++  ||||+++.+++
T Consensus         8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~--h~~iv~~~~~~   85 (345)
T cd07877           8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--HENVIGLLDVF   85 (345)
T ss_pred             HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcC--CCcccceeeee
Confidence            34556667899999999999999999999864 6899999998643  2233456778999999998  99999999987


Q ss_pred             EcC------CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCC
Q 018263          110 IDG------PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN  183 (358)
Q Consensus       110 ~~~------~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~  183 (358)
                      ...      ...+++++++ +++|.+++     ....+++..++.++.|++.||+|||+.   |++|+||+|+||+++.+
T Consensus        86 ~~~~~~~~~~~~~lv~~~~-~~~L~~~~-----~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~  156 (345)
T cd07877          86 TPARSLEEFNDVYLVTHLM-GADLNNIV-----KCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNED  156 (345)
T ss_pred             eecccccccccEEEEehhc-ccCHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCC
Confidence            643      3467888877 78998887     234589999999999999999999999   99999999999999999


Q ss_pred             CceEEeecccccccCCCCcccccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHh
Q 018263          184 FNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDK  262 (358)
Q Consensus       184 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~  262 (358)
                      +.++|+|||++.....    ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||..............
T Consensus       157 ~~~kl~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~  232 (345)
T cd07877         157 CELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR  232 (345)
T ss_pred             CCEEEecccccccccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            9999999999875422    1223457888999998766 4688899999999999999999999975443322222111


Q ss_pred             hhhccchhh--------Hhhhh---ccccCCCC---CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 018263          263 AWGMYNSKE--------LMNLV---DPMLYGNF---PENEAIRFLKVGLLCVQEKSKLRPQMSTAIKM  316 (358)
Q Consensus       263 ~~~~~~~~~--------~~~~~---~~~~~~~~---~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~  316 (358)
                      .........        ....+   .......+   ....+..+.++|.+||+.+|.+||++.++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         233 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            111111110        00110   00000000   01235578899999999999999999998754

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.8e-36  Score=279.09  Aligned_cols=245  Identities=28%  Similarity=0.377  Sum_probs=208.5

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC--hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      ...|.+.+.||+|.|+.|.++++. ++..||||++....  ......+.+|++++..++  ||||++++.+......+|+
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~--HPnIvkl~~v~~t~~~lyl  132 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLN--HPNIVKLFSVIETEATLYL  132 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcC--CcceeeeeeeeeecceeEE
Confidence            358999999999999999999865 69999999997653  334455888999999998  9999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      ||||+.++.+++++    .+.+...+..+..++.|++.|++|+|++   +|||+|||++||+++.+..+||+|||++..+
T Consensus       133 V~eya~~ge~~~yl----~~~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~  205 (596)
T KOG0586|consen  133 VMEYASGGELFDYL----VKHGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFF  205 (596)
T ss_pred             EEEeccCchhHHHH----HhcccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceee
Confidence            99999999999999    5566677899999999999999999999   9999999999999999999999999999987


Q ss_pred             CCCCcccccccccccCccCccccccCCC-CccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhh
Q 018263          198 PENTTHISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV  276 (358)
Q Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                      .  ........+|++.|.|||++.+..+ ++..|+|++|+++|.|+.|..||++..-.                   ++-
T Consensus       206 ~--~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk-------------------~Lr  264 (596)
T KOG0586|consen  206 D--YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK-------------------ELR  264 (596)
T ss_pred             c--ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc-------------------ccc
Confidence            5  3344566889999999999998775 58999999999999999999999855322                   222


Q ss_pred             ccccCC--CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          277 DPMLYG--NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       277 ~~~~~~--~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .+.+++  ..+--.+.++.++|+++|-.+|.+|++++++.+
T Consensus       265 ~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  265 PRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             chheeeeecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence            222222  233345667889999999999999999998865

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-35  Score=266.76  Aligned_cols=262  Identities=24%  Similarity=0.349  Sum_probs=202.8

Q ss_pred             CcccceecccCceEEEEEEEC-CCCEEEEEEeeccC--hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEe
Q 018263           44 FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD  120 (358)
Q Consensus        44 y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e  120 (358)
                      |++.+.||.|++|.||+|+.. +++.|++|.+....  ......+..|+..++.++  |+|++++++.+......++|+|
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~~~~~~~v~e   78 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELK--HPNIVKLLDVIHTERKLYLVFE   78 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcC--CCCHHHHHhhhhcCCceEEEec
Confidence            677889999999999999976 58999999987653  334467778999999998  9999999999999999999999


Q ss_pred             cCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCC
Q 018263          121 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN  200 (358)
Q Consensus       121 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~  200 (358)
                      |++ ++|.+++...   ...+++..+..++.|++.||.+||+.   |++|+||+|+||++++++.++|+|||.+......
T Consensus        79 ~~~-~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~  151 (282)
T cd07829          79 YCD-MDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIP  151 (282)
T ss_pred             CcC-cCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCC
Confidence            997 5899998432   25789999999999999999999999   9999999999999999999999999998765432


Q ss_pred             CcccccccccccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhcc-
Q 018263          201 TTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDP-  278 (358)
Q Consensus       201 ~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  278 (358)
                      .. .......+..|+|||.+.+. .++.++|+||||+++++|++|+.||......+....+....+......+....+- 
T Consensus       152 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07829         152 LR-TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP  230 (282)
T ss_pred             cc-ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc
Confidence            22 12223456789999998766 7899999999999999999999999776544333332222222222111111100 


Q ss_pred             ----cc----CC---CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          279 ----ML----YG---NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       279 ----~~----~~---~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                          ..    ..   ...+..+..+.+++.+||+.+|++||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         231 DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence                00    00   001123567999999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.4e-35  Score=273.24  Aligned_cols=264  Identities=23%  Similarity=0.298  Sum_probs=195.1

Q ss_pred             CCcccceecccCceEEEEEEEC-C--CCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEc----CC
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQ-D--GTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID----GP  113 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~-~--~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~----~~  113 (358)
                      +|++.+.||.|+||.||+++.. +  +..||+|.+...  .....+.+..|+..++.+. .||||+++++....    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-~h~~iv~~~~~~~~~~~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFR-GHKNITCLYDMDIVFPGNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhc-CCCChheeeeeeeeccccCC
Confidence            5889999999999999999965 3  788999988643  2233566778999998884 49999999986543    24


Q ss_pred             eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccc
Q 018263          114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL  193 (358)
Q Consensus       114 ~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~  193 (358)
                      ..+++++++. ++|.+.+    .....+++..+..++.||+.||.|||++   |++|+||+|+||+++.++.++|+|||.
T Consensus        80 ~~~~~~e~~~-~~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~  151 (332)
T cd07857          80 ELYLYEELME-ADLHQII----RSGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGL  151 (332)
T ss_pred             cEEEEEeccc-CCHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCC
Confidence            5688899884 6898888    3456789999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcc---cccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccch
Q 018263          194 SKLFPENTTH---ISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNS  269 (358)
Q Consensus       194 ~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      +.........   ......++..|+|||++.+ ..++.++|+||+|+++|+|++|.+||...........+....+.+..
T Consensus       152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  231 (332)
T cd07857         152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE  231 (332)
T ss_pred             ceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCH
Confidence            9765432211   1123467889999998765 46889999999999999999999999765433222222211111111


Q ss_pred             hhHhhh--------hcc---ccCC---CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          270 KELMNL--------VDP---MLYG---NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       270 ~~~~~~--------~~~---~~~~---~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .....+        ...   ....   ......+..+.+++.+||+.+|.+|||+.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            111110        000   0000   011123567899999999999999999999863

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2e-35  Score=269.96  Aligned_cols=261  Identities=21%  Similarity=0.230  Sum_probs=191.6

Q ss_pred             cccceecccCceEEEEEEECCCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecC
Q 018263           45 RWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM  122 (358)
Q Consensus        45 ~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~  122 (358)
                      .+.+.+|.|+++.++.+.. +++.||+|++...  .......+..|+..++.++  |+||+++++++...+..+++|||+
T Consensus         5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~--h~~i~~~~~~~~~~~~~~~~~e~~   81 (314)
T cd08216           5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQ--HPNILPYVTSFIVDSELYVVSPLM   81 (314)
T ss_pred             hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcC--CcchhhhhheeecCCeEEEEEecc
Confidence            3444455555555554444 6899999998754  3445578889999999998  999999999999999999999999


Q ss_pred             CCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCc
Q 018263          123 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT  202 (358)
Q Consensus       123 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~  202 (358)
                      ++++|.+++...  ....+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.++++||+.+........
T Consensus        82 ~~~~l~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~  156 (314)
T cd08216          82 AYGSCEDLLKTH--FPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGK  156 (314)
T ss_pred             CCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccc
Confidence            999999998432  234688999999999999999999999   999999999999999999999999998865422111


Q ss_pred             ------ccccccccccCccCcccccc--CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhcc----chh
Q 018263          203 ------HISTRVAGTLGYLAPEYAIS--GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMY----NSK  270 (358)
Q Consensus       203 ------~~~~~~~~~~~y~aPE~~~~--~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~----~~~  270 (358)
                            .......++..|+|||++.+  ..++.++|+||+|+++++|++|..||........  ......+..    ...
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~  234 (314)
T cd08216         157 RQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKS  234 (314)
T ss_pred             cccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccC
Confidence                  11122346678999998865  3588899999999999999999999975432111  111110000    000


Q ss_pred             hHhhh---------------hccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          271 ELMNL---------------VDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       271 ~~~~~---------------~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .....               ................+.+++.+||+.||++|||++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         235 TYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             chhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence            00000               0000111223355678899999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-35  Score=274.52  Aligned_cols=268  Identities=22%  Similarity=0.295  Sum_probs=201.4

Q ss_pred             HHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC-
Q 018263           38 KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP-  113 (358)
Q Consensus        38 ~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~-  113 (358)
                      ....++|++.+.||.|++|.||++... ++..||+|.+...  .......+..|+..++.++  ||||+++++++.... 
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~   88 (343)
T cd07880          11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMK--HENVIGLLDVFTPDLS   88 (343)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcC--CCCccceeeeecCCcc
Confidence            335789999999999999999999865 6899999998543  2333456788999999998  999999999887554 


Q ss_pred             -----eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEE
Q 018263          114 -----CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKI  188 (358)
Q Consensus       114 -----~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l  188 (358)
                           ..++||+|+ +++|.+++     ....+++..++.++.||+.||+|||+.   |++|+||+|+||+++.++.++|
T Consensus        89 ~~~~~~~~lv~e~~-~~~l~~~~-----~~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl  159 (343)
T cd07880          89 LDRFHDFYLVMPFM-GTDLGKLM-----KHEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKI  159 (343)
T ss_pred             ccccceEEEEEecC-CCCHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEE
Confidence                 358999999 78898887     235689999999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhcc
Q 018263          189 SDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMY  267 (358)
Q Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~  267 (358)
                      +|||++......    .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...................
T Consensus       160 ~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  235 (343)
T cd07880         160 LDFGLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTP  235 (343)
T ss_pred             eecccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            999998764322    123456788999998876 458889999999999999999999997654322221111111100


Q ss_pred             c--------hhhHhhhhcc---ccCC---CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHH--HHhhcC
Q 018263          268 N--------SKELMNLVDP---MLYG---NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAI--KMMNGE  320 (358)
Q Consensus       268 ~--------~~~~~~~~~~---~~~~---~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil--~~L~~~  320 (358)
                      .        ..........   ....   ......+..+.+++.+||+.||.+|||+.+++  ..++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~  304 (343)
T cd07880         236 SKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF  304 (343)
T ss_pred             CHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence            0        0000011000   0000   11123455688999999999999999999998  444444

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-36  Score=238.91  Aligned_cols=263  Identities=22%  Similarity=0.353  Sum_probs=220.3

Q ss_pred             CCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      +|.-.++||+|.+|+|++++.. +++.||+|.++.+  ++.......+|+..++.++  |.||++++++..++..+.+|+
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelk--hknivrl~dvlhsdkkltlvf   80 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK--HKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhh--hcceeehhhhhccCceeEEeH
Confidence            5677889999999999999955 6899999998765  3444567889999999999  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      ||| .-+|..+.   ++-++.++.+.++.++.|++.+|.+.|+.   ++.|||+||.|++|+.+|.+|++|||+++.++-
T Consensus        81 e~c-dqdlkkyf---dslng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgi  153 (292)
T KOG0662|consen   81 EFC-DQDLKKYF---DSLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGI  153 (292)
T ss_pred             HHh-hHHHHHHH---HhcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCC
Confidence            999 45677776   45678899999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCcccccccccccCccCccccccC-CCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhHhhhh-
Q 018263          200 NTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV-  276 (358)
Q Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  276 (358)
                      +-...+ .-..|.+|.+|.++.|. -|+.+-|+||.||++.|+.. |++.|.+.+..++...+.+..+.+..+++..+. 
T Consensus       154 pvrcys-aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~  232 (292)
T KOG0662|consen  154 PVRCYS-AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTK  232 (292)
T ss_pred             ceEeee-ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcccc
Confidence            544333 34578899999999875 48899999999999999987 778888888888888888888887777665533 


Q ss_pred             --ccccCCCCCH---------HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          277 --DPMLYGNFPE---------NEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       277 --~~~~~~~~~~---------~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                        +....+.++.         +....-.++++++|.-+|.+|.++++.++
T Consensus       233 lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  233 LPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence              3333333332         34445678888999999999999998875

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.1e-35  Score=273.15  Aligned_cols=267  Identities=22%  Similarity=0.313  Sum_probs=200.3

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC----
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP----  113 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~----  113 (358)
                      .++|.+.+.||.|++|.||+|.+. +|+.||+|.+...  .......+.+|+..++.+.  ||||+++++++....    
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~~   91 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQ--HENVIGLLDVFTSAVSGDE   91 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcC--CCCccchhheecccccCCC
Confidence            479999999999999999999965 6899999998643  2223456788999999988  999999999987543    


Q ss_pred             --eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeec
Q 018263          114 --CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF  191 (358)
Q Consensus       114 --~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Df  191 (358)
                        ..++++||+. .+|....      ...+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+||
T Consensus        92 ~~~~~lv~e~~~-~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~df  161 (342)
T cd07879          92 FQDFYLVMPYMQ-TDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDF  161 (342)
T ss_pred             CceEEEEecccc-cCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeC
Confidence              4589999985 4666654      23588999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchh
Q 018263          192 GLSKLFPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSK  270 (358)
Q Consensus       192 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      |++......    .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||................+.... 
T Consensus       162 g~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-  236 (342)
T cd07879         162 GLARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGP-  236 (342)
T ss_pred             CCCcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH-
Confidence            998764221    123456788999998876 46888999999999999999999999866543333222221111111 


Q ss_pred             hHhhhhcc------------ccCCCC---CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhhcCCCCC
Q 018263          271 ELMNLVDP------------MLYGNF---PENEAIRFLKVGLLCVQEKSKLRPQMSTAIK--MMNGETNID  324 (358)
Q Consensus       271 ~~~~~~~~------------~~~~~~---~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~--~L~~~~~~~  324 (358)
                      .+...+..            ......   .+..+..+.++|.+||+.||.+||++.++++  .++..++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~  307 (342)
T cd07879         237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDAD  307 (342)
T ss_pred             HHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccc
Confidence            11110000            000000   0123456889999999999999999999984  477766543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=4.6e-35  Score=263.06  Aligned_cols=243  Identities=26%  Similarity=0.331  Sum_probs=187.0

Q ss_pred             eecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcc-cCCCCceeeeceEEcCCeeEEEEecCC
Q 018263           49 KIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVN-VCHENLVKLHGGCIDGPCRILVYDYMP  123 (358)
Q Consensus        49 ~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-~~h~~i~~~~~~~~~~~~~~iv~e~~~  123 (358)
                      .||+|+||.||+|... +++.||+|.+....   .........|...++.+. ..||+++.+.+.+...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4799999999999865 58899999986432   111222333333332221 139999999999999999999999999


Q ss_pred             CCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCcc
Q 018263          124 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH  203 (358)
Q Consensus       124 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  203 (358)
                      |++|.+++    ...+.+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......  
T Consensus        81 g~~L~~~l----~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--  151 (278)
T cd05606          81 GGDLHYHL----SQHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--  151 (278)
T ss_pred             CCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence            99999988    3456799999999999999999999999   99999999999999999999999999987543221  


Q ss_pred             cccccccccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccCC
Q 018263          204 ISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYG  282 (358)
Q Consensus       204 ~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (358)
                       .....++..|+|||.+.++ .++.++|+||+|+++|+|++|+.||............             ... .....
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~-------------~~~-~~~~~  216 (278)
T cd05606         152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-------------RMT-LTMAV  216 (278)
T ss_pred             -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH-------------HHh-hccCC
Confidence             1234688999999998754 6899999999999999999999999754322111110             000 00112


Q ss_pred             CCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 018263          283 NFPENEAIRFLKVGLLCVQEKSKLRP-----QMSTAIK  315 (358)
Q Consensus       283 ~~~~~~~~~l~~li~~~l~~~P~~Rp-----t~~eil~  315 (358)
                      ..+...+..+.+++.+||+.+|.+||     ++.++++
T Consensus       217 ~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         217 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            23344567899999999999999999     9999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=6.3e-35  Score=304.18  Aligned_cols=264  Identities=27%  Similarity=0.498  Sum_probs=204.0

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      ...|.....||+|+||.||+|+.. ++..||+|.+.......    ..|++.+++++  ||||+++++++......++||
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~l~~l~--HpnIv~~~~~~~~~~~~~lv~  762 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SSEIADMGKLQ--HPNIVKLIGLCRSEKGAYLIH  762 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc----HHHHHHHhhCC--CCCcceEEEEEEcCCCCEEEE
Confidence            356777889999999999999974 78999999886433222    24577888887  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      ||+++++|.+++.       .+++..+..++.||+.||+|||..+..+++||||||+||+++.++..++. ++.......
T Consensus       763 Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~  834 (968)
T PLN00113        763 EYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT  834 (968)
T ss_pred             eCCCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence            9999999999982       27899999999999999999994434499999999999999998887765 554432211


Q ss_pred             CCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccc
Q 018263          200 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPM  279 (358)
Q Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (358)
                           .....++..|+|||++.+..++.++||||||+++|||++|+.||....... .....+.............+++.
T Consensus       835 -----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  908 (968)
T PLN00113        835 -----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVH-GSIVEWARYCYSDCHLDMWIDPS  908 (968)
T ss_pred             -----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCC-CcHHHHHHHhcCccchhheeCcc
Confidence                 112357889999999998899999999999999999999999995432211 11222221112222334445554


Q ss_pred             cCC--CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCC
Q 018263          280 LYG--NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNID  324 (358)
Q Consensus       280 ~~~--~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~  324 (358)
                      ...  ..+..+..++.+++.+||+.+|++|||+.|+++.|+++....
T Consensus       909 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  955 (968)
T PLN00113        909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS  955 (968)
T ss_pred             ccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence            433  234566778899999999999999999999999999886544

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=8.4e-35  Score=265.84  Aligned_cols=243  Identities=25%  Similarity=0.360  Sum_probs=192.6

Q ss_pred             CcccceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           44 FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        44 y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      |...+.||.|++|.||+|+.. +++.|++|.+....   ......+..|++.++.++  |||++++++++.+....+++|
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~  100 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK--HPNTIEYKGCYLKEHTAWLVM  100 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCC--CCCCccEEEEEEeCCEEEEEE
Confidence            666788999999999999865 68899999986432   233356788999999998  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      ||+. +++.+.+.   .....+++..+..++.||+.||.|||++   |++|+||+|+||+++.++.++|+|||++.....
T Consensus       101 e~~~-~~l~~~l~---~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~  173 (313)
T cd06633         101 EYCL-GSASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP  173 (313)
T ss_pred             ecCC-CCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC
Confidence            9995 57777763   2345689999999999999999999999   999999999999999999999999998864321


Q ss_pred             CCcccccccccccCccCccccc---cCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhh
Q 018263          200 NTTHISTRVAGTLGYLAPEYAI---SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV  276 (358)
Q Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~---~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                           .....++..|+|||++.   +..++.++|+||||+++|+|++|..||.............               
T Consensus       174 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~---------------  233 (313)
T cd06633         174 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA---------------  233 (313)
T ss_pred             -----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH---------------
Confidence                 12345788899999874   3568889999999999999999999986543221111110               


Q ss_pred             ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          277 DPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       277 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ............+..+.+++.+||+.+|.+||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         234 QNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             hcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000011112234456889999999999999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=7e-38  Score=266.55  Aligned_cols=249  Identities=25%  Similarity=0.382  Sum_probs=210.5

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEe
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD  120 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e  120 (358)
                      +-|.++++||.|.+|+||+|.++ +|..+|||.+..+  ...+++..|+.++++++  .|++|++++.+.....++||||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~--S~yVVKYYGSYFK~sDLWIVME  108 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCK--SKYVVKYYGSYFKHSDLWIVME  108 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcC--CchhhhhhhhhccCCceEeehh
Confidence            56889999999999999999865 6999999998754  45678889999999998  9999999999999999999999


Q ss_pred             cCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCC
Q 018263          121 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN  200 (358)
Q Consensus       121 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~  200 (358)
                      ||..|++.+.++   .+++++++..+..++..-+.+|+|||..   .-+|||||..||+++.+|..||+|||.+-..-. 
T Consensus       109 YCGAGSiSDI~R---~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD-  181 (502)
T KOG0574|consen  109 YCGAGSISDIMR---ARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD-  181 (502)
T ss_pred             hcCCCcHHHHHH---HhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhh-
Confidence            999999999993   5678999999999999999999999999   899999999999999999999999999875422 


Q ss_pred             CcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhcccc
Q 018263          201 TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPML  280 (358)
Q Consensus       201 ~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (358)
                      .-.....+.||+-|+|||++..-.|+.++||||||++..+|..|++||..-.+......+.-.              +..
T Consensus       182 TMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~--------------PPP  247 (502)
T KOG0574|consen  182 TMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTK--------------PPP  247 (502)
T ss_pred             hHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCC--------------CCC
Confidence            222334578999999999999889999999999999999999999999755443333222110              000


Q ss_pred             CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          281 YGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       281 ~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .=..|...+.++.+++++||-.+|++|-|+.++++
T Consensus       248 TF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  248 TFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             CCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            01124567778999999999999999999998876

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=5.4e-35  Score=266.51  Aligned_cols=247  Identities=25%  Similarity=0.351  Sum_probs=195.6

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      +.|...+.||.|++|.||+|+.. ++..+++|.+...   .......+.+|++.++.++  |+|++++.+++......++
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~l   92 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR--HPNTIQYRGCYLREHTAWL   92 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCC--CCCcccEEEEEEcCCeeEE
Confidence            45888899999999999999975 5888999988642   2233456778999999998  9999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      |+||+. +++.+.+..   ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++...
T Consensus        93 v~e~~~-~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  165 (308)
T cd06634          93 VMEYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM  165 (308)
T ss_pred             EEEccC-CCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceee
Confidence            999996 577777632   335588999999999999999999999   9999999999999999999999999988754


Q ss_pred             CCCCcccccccccccCccCccccc---cCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhh
Q 018263          198 PENTTHISTRVAGTLGYLAPEYAI---SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMN  274 (358)
Q Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                      ...     ....++..|+|||.+.   ...++.++||||||+++|+|++|..||...........               
T Consensus       166 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~---------------  225 (308)
T cd06634         166 APA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH---------------  225 (308)
T ss_pred             cCc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHH---------------
Confidence            322     2245778899999875   34678899999999999999999999864322111110               


Q ss_pred             hhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 018263          275 LVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMM  317 (358)
Q Consensus       275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L  317 (358)
                      ..............+..+.++|.+||+.+|.+||++.++++..
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         226 IAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             HhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence            0111111111234667789999999999999999999998653

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.6e-35  Score=267.03  Aligned_cols=256  Identities=25%  Similarity=0.370  Sum_probs=195.3

Q ss_pred             HHHhhcCCcccceecccCceEEEEEEECC-CCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCe
Q 018263           37 LKIATNGFRWSNKIGEGGFGSVYKGRLQD-GTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC  114 (358)
Q Consensus        37 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~  114 (358)
                      +.+..++|++.+.||.|++|.||+|.++. ++.|++|.+.... ......+..|+..+.... .|+||+++++++.....
T Consensus        10 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~-~~~~i~~~~~~~~~~~~   88 (296)
T cd06618          10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSH-DCPYIVKCYGYFITDSD   88 (296)
T ss_pred             ccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhcc-CCCchHhhheeeecCCe
Confidence            34556789999999999999999999874 8999999986542 233445566666565553 49999999999999999


Q ss_pred             eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcEEcCCCCCcEEEcCCCceEEeeccc
Q 018263          115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNILLDQNFNPKISDFGL  193 (358)
Q Consensus       115 ~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~  193 (358)
                      .+++|||++ ++|.+++..   ....+++..+..++.||+.||+|||+ .   |++|+||+|+||++++++.++|+|||.
T Consensus        89 ~~~v~e~~~-~~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~  161 (296)
T cd06618          89 VFICMELMS-TCLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGI  161 (296)
T ss_pred             EEEEeeccC-cCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECcccc
Confidence            999999984 577777632   23478999999999999999999997 6   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccCccCccccccCC----CCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccch
Q 018263          194 SKLFPENTTHISTRVAGTLGYLAPEYAISGR----LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNS  269 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      +.........  ....++..|+|||.+.+..    ++.++|+||||+++|+|++|+.||......  .......      
T Consensus       162 ~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~------  231 (296)
T cd06618         162 SGRLVDSKAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVLTKI------  231 (296)
T ss_pred             chhccCCCcc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHHHHHH------
Confidence            8765332221  2234677899999887543    788999999999999999999999642211  1111111      


Q ss_pred             hhHhhhhcccc-CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 018263          270 KELMNLVDPML-YGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKM  316 (358)
Q Consensus       270 ~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~  316 (358)
                            +.... .......++..+.+++.+||+.+|.+||+++++++.
T Consensus       232 ------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         232 ------LQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             ------hcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                  10000 001111345678999999999999999999999754

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=271.19  Aligned_cols=266  Identities=23%  Similarity=0.303  Sum_probs=214.9

Q ss_pred             HHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC
Q 018263           38 KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP  113 (358)
Q Consensus        38 ~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~  113 (358)
                      .+..+.|+..+.||+||||.||-+... +|+-||+|.+...   ....+.-.++|..+|++..  .++||.+--.|...+
T Consensus       181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~--s~FiVslaYAfeTkd  258 (591)
T KOG0986|consen  181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVS--SPFIVSLAYAFETKD  258 (591)
T ss_pred             hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhc--cCcEEEEeeeecCCC
Confidence            344578899999999999999999854 7999999988532   4556667888999999998  899999999999999


Q ss_pred             eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccc
Q 018263          114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL  193 (358)
Q Consensus       114 ~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~  193 (358)
                      .+++|+..|+||+|.-.|.+.  ...-+++..+..++.+|+.||++||+.   +||+||+||+||++|+.|.++|+|+|+
T Consensus       259 ~LClVLtlMNGGDLkfHiyn~--g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGL  333 (591)
T KOG0986|consen  259 ALCLVLTLMNGGDLKFHIYNH--GNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGL  333 (591)
T ss_pred             ceEEEEEeecCCceeEEeecc--CCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccce
Confidence            999999999999999988433  224789999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHh
Q 018263          194 SKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELM  273 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      +..++....  .....||.+|+|||++.+..|+.+.|.|+|||++|+|+.|+.||........            .+++.
T Consensus       334 Avei~~g~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk------------~eEvd  399 (591)
T KOG0986|consen  334 AVEIPEGKP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK------------REEVD  399 (591)
T ss_pred             EEecCCCCc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh------------HHHHH
Confidence            998765444  3345899999999999999999999999999999999999999974322111            11222


Q ss_pred             hhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHH-HHHHHhhcCCCCCC
Q 018263          274 NLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMS-TAIKMMNGETNIDG  325 (358)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~-eil~~L~~~~~~~~  325 (358)
                      ..+.. -...++..++.+..++...+|+.||.+|.... +=.+.+..+....+
T Consensus       400 rr~~~-~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~  451 (591)
T KOG0986|consen  400 RRTLE-DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD  451 (591)
T ss_pred             HHHhc-chhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence            21111 11346678888999999999999999998755 33444444444443

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-36  Score=277.18  Aligned_cols=245  Identities=27%  Similarity=0.396  Sum_probs=200.7

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      +.|.=++.||.|+||.||-|++. +.+.||||.....   +...-.++..|+..|+.+.  |||++.+.++|......++
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~--HPntieYkgCyLre~TaWL  103 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLR--HPNTIEYKGCYLREHTAWL  103 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhcc--CCCcccccceeeccchHHH
Confidence            35666889999999999999965 6888999998654   3344568999999999998  9999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      ||||| -|+-.|++   +-..+++-+..+..|+.+.+.||+|||+.   +.+|||||..||++++.|.|||+|||.+..+
T Consensus       104 VMEYC-lGSAsDll---eVhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~  176 (948)
T KOG0577|consen  104 VMEYC-LGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIM  176 (948)
T ss_pred             HHHHH-hccHHHHH---HHHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhc
Confidence            99999 67888887   23567889999999999999999999999   9999999999999999999999999999765


Q ss_pred             CCCCcccccccccccCccCccccc---cCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhh
Q 018263          198 PENTTHISTRVAGTLGYLAPEYAI---SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMN  274 (358)
Q Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                      .+.     ..+.|||.|+|||++.   .+.|+-++||||||++-.+|.-.++|+-.-+.......+...           
T Consensus       177 ~PA-----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQN-----------  240 (948)
T KOG0577|consen  177 APA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-----------  240 (948)
T ss_pred             Cch-----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhc-----------
Confidence            432     3367999999999986   578999999999999999999999886422222222222111           


Q ss_pred             hhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          275 LVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                       -.+.+   ..+..+..+.+++..||+.-|.+|||.+++++
T Consensus       241 -esPtL---qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  241 -ESPTL---QSNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             -CCCCC---CCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence             11111   13466777999999999999999999877653

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=287.24  Aligned_cols=263  Identities=25%  Similarity=0.438  Sum_probs=222.8

Q ss_pred             HHhhcCCcccceecccCceEEEEEEEC----CCCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC
Q 018263           38 KIATNGFRWSNKIGEGGFGSVYKGRLQ----DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG  112 (358)
Q Consensus        38 ~~~~~~y~i~~~lg~g~~g~v~~~~~~----~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~  112 (358)
                      +++.+...|.+.||.|.||.|+.|+.+    ....||||.++.- .+.++.+|+.|+.++-+++  ||||+.+.++....
T Consensus       625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd--HPNIIrLEGVVTks  702 (996)
T KOG0196|consen  625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD--HPNIIRLEGVVTKS  702 (996)
T ss_pred             hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC--CCcEEEEEEEEecC
Confidence            455667788899999999999999965    2456999999865 4566789999999999999  99999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecc
Q 018263          113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG  192 (358)
Q Consensus       113 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg  192 (358)
                      .-..||.|||++|+|+.+++.+   .+.++..++.-++..|+.|+.||.++   ++|||||...||||+.+..+|++|||
T Consensus       703 ~PvMIiTEyMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFG  776 (996)
T KOG0196|consen  703 KPVMIITEYMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFG  776 (996)
T ss_pred             ceeEEEhhhhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEecccc
Confidence            9999999999999999999543   45688999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccc--cccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccch
Q 018263          193 LSKLFPENTTHISTR--VAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNS  269 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~--~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      +++...++.....+.  -.-+..|.|||.+...+++.++||||+|+++||.++ |+.||-.-+                .
T Consensus       777 LSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS----------------N  840 (996)
T KOG0196|consen  777 LSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS----------------N  840 (996)
T ss_pred             ceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc----------------h
Confidence            999764444222222  223468999999999999999999999999999876 999985333                3


Q ss_pred             hhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCC
Q 018263          270 KELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNID  324 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~  324 (358)
                      .++..-++...+-..|.+++..|.+|+..|||.|-.+||++.+|+..|+++-...
T Consensus       841 QdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP  895 (996)
T KOG0196|consen  841 QDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP  895 (996)
T ss_pred             HHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence            3444445555566677889999999999999999999999999999999875433

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-35  Score=256.56  Aligned_cols=236  Identities=27%  Similarity=0.382  Sum_probs=193.5

Q ss_pred             ecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecCCCC
Q 018263           50 IGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN  125 (358)
Q Consensus        50 lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~~~~  125 (358)
                      ||.|++|.||++... +++.|++|.+....   ......+..|+..++.+.  |+|++++++.+..+...+++|||++++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~~v~e~~~~~   78 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN--HPFIVKLHYAFQTEEKLYLVLEYAPGG   78 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcC--CCcHHHHHHHeecCCeeEEEEecCCCC
Confidence            689999999999976 58999999986542   224557888999999998  999999999999999999999999999


Q ss_pred             CHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCcccc
Q 018263          126 SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS  205 (358)
Q Consensus       126 ~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~  205 (358)
                      +|.+++    .....+++..+..++.|++.||.+||+.   +++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus        79 ~L~~~l----~~~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~  150 (250)
T cd05123          79 ELFSHL----SKEGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRT  150 (250)
T ss_pred             cHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-Ccc
Confidence            999999    3445789999999999999999999999   99999999999999999999999999987653322 122


Q ss_pred             cccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCCCC
Q 018263          206 TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFP  285 (358)
Q Consensus       206 ~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (358)
                      ....++..|+|||...+..++.++|+||||+++|+|++|..||.......   ..            .....  ....++
T Consensus       151 ~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~------------~~~~~--~~~~~~  213 (250)
T cd05123         151 NTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE---IY------------EKILK--DPLRFP  213 (250)
T ss_pred             cCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HH------------HHHhc--CCCCCC
Confidence            33557889999999988888999999999999999999999996443210   01            11111  112234


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHH
Q 018263          286 ENEAIRFLKVGLLCVQEKSKLRPQMST  312 (358)
Q Consensus       286 ~~~~~~l~~li~~~l~~~P~~Rpt~~e  312 (358)
                      ...+..+.+++.+||..+|++||++.+
T Consensus       214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         214 EFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            445678899999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-36  Score=278.37  Aligned_cols=253  Identities=25%  Similarity=0.378  Sum_probs=214.4

Q ss_pred             HhhcCCcccceecccCceEEEEEEEC--CCC--EEEEEEeeccChh-hHHHHHHHHHHhhhcccCCCCceeeeceEEcCC
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQ--DGT--IVAVKVLSVESKQ-GEKEFMSEVASMANVNVCHENLVKLHGGCIDGP  113 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~--~~~--~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~  113 (358)
                      |..++.++.++||.|.||.|++|.|.  +|+  .||||.+...... ....|.+|+..+.+++  |+|+++++++..+ .
T Consensus       107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~--H~hliRLyGvVl~-q  183 (1039)
T KOG0199|consen  107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQ--HPHLIRLYGVVLD-Q  183 (1039)
T ss_pred             ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhcc--CcceeEEeeeecc-c
Confidence            33567788999999999999999876  354  4799999866544 5678999999999999  9999999999988 6


Q ss_pred             eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccc
Q 018263          114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL  193 (358)
Q Consensus       114 ~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~  193 (358)
                      ...+|+|.+++|+|.+.++.  .....+....+..++.||+.|+.||.++   ++|||||...|+++.....|||+|||+
T Consensus       184 p~mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGL  258 (1039)
T KOG0199|consen  184 PAMMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGL  258 (1039)
T ss_pred             hhhHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccc
Confidence            67899999999999999954  4667788999999999999999999999   999999999999999998999999999


Q ss_pred             ccccCCCCccc--ccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchh
Q 018263          194 SKLFPENTTHI--STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSK  270 (358)
Q Consensus       194 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      .+..+......  .........|+|||.+....++.++|+|++|+++|||++ |+.||.+..                ..
T Consensus       259 mRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~----------------g~  322 (1039)
T KOG0199|consen  259 MRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR----------------GI  322 (1039)
T ss_pred             eeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC----------------HH
Confidence            99876443322  122445678999999999999999999999999999999 778876543                33


Q ss_pred             hHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          271 ELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .+.+.+|..-+-.-+..++.++.+++..||..+|.+|||+..|.+
T Consensus       323 qIL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~  367 (1039)
T KOG0199|consen  323 QILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE  367 (1039)
T ss_pred             HHHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence            445555554455567789999999999999999999999999973

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-37  Score=277.74  Aligned_cols=265  Identities=21%  Similarity=0.305  Sum_probs=222.3

Q ss_pred             hcCCcccceecccCceEEEEEEECCCC-EEEEEEeec---cChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQDGT-IVAVKVLSV---ESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI  116 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~~~~-~vaiK~~~~---~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~  116 (358)
                      .++++++..||.|+||.|-++..++.. .+|+|+++.   .+..++.++..|-.++....  .|+|++++..|.+..+.|
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~--s~fIvrLYrTfrd~kyvY  496 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECR--SDFIVRLYRTFRDSKYVY  496 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcC--chHHHHHHHHhccchhhh
Confidence            467888899999999999999876433 378887753   36677788999999999988  999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       117 iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      ++||-|-||.|+..+    +.++.+++.+.+.++..++.|++|||++   ||++|||||+|++++.+|-+||.|||+++.
T Consensus       497 mLmEaClGGElWTiL----rdRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKk  569 (732)
T KOG0614|consen  497 MLMEACLGGELWTIL----RDRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKK  569 (732)
T ss_pred             hhHHhhcCchhhhhh----hhcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHH
Confidence            999999999999999    7889999999999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhh
Q 018263          197 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV  276 (358)
Q Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                      .+....  ....+||+.|+|||++.+...+.++|+|+||+++|||++|.+||...++...|+.+-+...           
T Consensus       570 i~~g~K--TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid-----------  636 (732)
T KOG0614|consen  570 IGSGRK--TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID-----------  636 (732)
T ss_pred             hccCCc--eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh-----------
Confidence            765443  4568999999999999999999999999999999999999999998888777766643211           


Q ss_pred             ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCC--HHHHHHHhhcCCCCCCCCCCCCC
Q 018263          277 DPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQ--MSTAIKMMNGETNIDGXDVEISQ  332 (358)
Q Consensus       277 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt--~~eil~~L~~~~~~~~~~~~~~~  332 (358)
                          .-.+|........+||+++...+|.+|..  ... +.-+..+.=+.|.++..+.
T Consensus       637 ----~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~g-I~DIkkH~Wf~gfdweglr  689 (732)
T KOG0614|consen  637 ----KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGG-INDIKKHRWFEGFDWEGLR  689 (732)
T ss_pred             ----hhhcccccchhHHHHHHHHHhcCcHhhhccccCC-hHHHHhhhhhhcCChhhhh
Confidence                12355667778899999999999999986  222 2233444444444454433

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1e-35  Score=292.41  Aligned_cols=253  Identities=25%  Similarity=0.377  Sum_probs=190.7

Q ss_pred             HHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEc----
Q 018263           38 KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCID----  111 (358)
Q Consensus        38 ~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~----  111 (358)
                      ..-..+|+.++.||+||||.||+++.+ +|..||||.+.... ...-..+.+|+..+.+++  |||+|+++..+..    
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLn--HpNVVRYysAWVEs~~~  552 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLN--HPNVVRYYSAWVESTAE  552 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcC--CcceeeeehhhhccCCc
Confidence            344578889999999999999999988 89999999997653 344467888999999998  9999999863210    


Q ss_pred             --------------------------------------------------------------------------------
Q 018263          112 --------------------------------------------------------------------------------  111 (358)
Q Consensus       112 --------------------------------------------------------------------------------  111 (358)
                                                                                                      
T Consensus       553 ~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~  632 (1351)
T KOG1035|consen  553 LTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSN  632 (1351)
T ss_pred             cccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccc
Confidence                                                                                            


Q ss_pred             ---------------------------C--------CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHH
Q 018263          112 ---------------------------G--------PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRG  156 (358)
Q Consensus       112 ---------------------------~--------~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~a  156 (358)
                                                 .        ..+||=||||+..+|.+++..+...+   .....|+++.+|+.|
T Consensus       633 tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEG  709 (1351)
T KOG1035|consen  633 TSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEG  709 (1351)
T ss_pred             ccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHH
Confidence                                       0        12467789998888888873221111   478999999999999


Q ss_pred             HHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC-----------------CCCcccccccccccCccCccc
Q 018263          157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP-----------------ENTTHISTRVAGTLGYLAPEY  219 (358)
Q Consensus       157 L~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~-----------------~~~~~~~~~~~~~~~y~aPE~  219 (358)
                      |+|+|+.   |++||||||.|||++.++.|||+|||++....                 .......+...||.-|+|||+
T Consensus       710 LaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl  786 (1351)
T KOG1035|consen  710 LAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL  786 (1351)
T ss_pred             HHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence            9999999   99999999999999999999999999997611                 011113445789999999999


Q ss_pred             cccC---CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccC--CCCCHHHHHHHHH
Q 018263          220 AISG---RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLY--GNFPENEAIRFLK  294 (358)
Q Consensus       220 ~~~~---~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~  294 (358)
                      +.+.   .|+.|.|+||||++++||+.   ||...-  +.......            +-+..+.  ..+.......-.+
T Consensus       787 l~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--ERa~iL~~------------LR~g~iP~~~~f~~~~~~~e~s  849 (1351)
T KOG1035|consen  787 LSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM--ERASILTN------------LRKGSIPEPADFFDPEHPEEAS  849 (1351)
T ss_pred             hcccccccccchhhhHHHHHHHHHHhc---cCCchH--HHHHHHHh------------cccCCCCCCcccccccchHHHH
Confidence            8764   49999999999999999986   455221  11111111            1111111  1223344555679


Q ss_pred             HHhhccCCCCCCCCCHHHHHH
Q 018263          295 VGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       295 li~~~l~~~P~~Rpt~~eil~  315 (358)
                      +|.+|++.||.+||||.|+|.
T Consensus       850 lI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  850 LIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HHHHHhcCCCccCCCHHHHhh
Confidence            999999999999999999985

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-36  Score=299.19  Aligned_cols=250  Identities=27%  Similarity=0.348  Sum_probs=206.8

Q ss_pred             CCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC--hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      +|.-..+||.|.||.||.|... +|...|+|.+...+  ....+.+.+|..++..++  |||+++++++-.+++..+|.|
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~ln--HpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLN--HPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhcc--CccccccCceeecHHHHHHHH
Confidence            5666678999999999999854 69999999886553  333467888999999998  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      |||++|+|.+++    ......++.....+..|++.|++|||+.   |||||||||.||+++.+|.+|++|||.+.....
T Consensus      1314 EyC~~GsLa~ll----~~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1314 EYCEGGSLASLL----EHGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred             HHhccCcHHHHH----HhcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecC
Confidence            999999999999    5556678888889999999999999999   999999999999999999999999999987654


Q ss_pred             CCcc---cccccccccCccCccccccC---CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHh
Q 018263          200 NTTH---ISTRVAGTLGYLAPEYAISG---RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELM  273 (358)
Q Consensus       200 ~~~~---~~~~~~~~~~y~aPE~~~~~---~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      ....   ......||+.|+|||++.+.   ....++|||||||++.||.||+.||..-++.  ...+             
T Consensus      1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne--~aIM------------- 1451 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE--WAIM------------- 1451 (1509)
T ss_pred             chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch--hHHH-------------
Confidence            4322   22347899999999999864   3567999999999999999999999633221  1111             


Q ss_pred             hhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 018263          274 NLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKM  316 (358)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~  316 (358)
                      =-+-.+-.+.+|.+.+..-.+++..||+.||+.|-++.++++.
T Consensus      1452 y~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1452 YHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             hHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            1122333456777788899999999999999999888877764

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-36  Score=251.19  Aligned_cols=259  Identities=24%  Similarity=0.400  Sum_probs=202.9

Q ss_pred             HHHHHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC
Q 018263           35 NQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG  112 (358)
Q Consensus        35 ~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~  112 (358)
                      +.+..+.++.+++..||.|..|.||+++.. +|...|||..... +.+..+++...+.+..+.. .+|+||+.+++|..+
T Consensus        85 ~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~-dcpyIV~c~GyFi~n  163 (391)
T KOG0983|consen   85 QRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSH-DCPYIVQCFGYFITN  163 (391)
T ss_pred             cccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhcc-CCCeeeeeeeEEeeC
Confidence            344455667778899999999999999976 5899999998765 4555678888888776654 489999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecc
Q 018263          113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG  192 (358)
Q Consensus       113 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg  192 (358)
                      ...++.||.+ ...++.+++   +-.++++|..+-++...++.||.||-.++  ||+|||+||+||++|+.|.+|++|||
T Consensus       164 ~dV~IcMelM-s~C~ekLlk---rik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFG  237 (391)
T KOG0983|consen  164 TDVFICMELM-STCAEKLLK---RIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFG  237 (391)
T ss_pred             chHHHHHHHH-HHHHHHHHH---HhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeeccc
Confidence            9999999988 344555552   34567999999999999999999999876  99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccCccCcccccc---CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccch
Q 018263          193 LSKLFPENTTHISTRVAGTLGYLAPEYAIS---GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNS  269 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      .+-.+-+.  ...+...|.+.|+|||.+.-   ..|+.++||||||++++||.||+.||.+...  ++.....+..    
T Consensus       238 IsGrlvdS--kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t--dFe~ltkvln----  309 (391)
T KOG0983|consen  238 ISGRLVDS--KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT--DFEVLTKVLN----  309 (391)
T ss_pred             ccceeecc--cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc--cHHHHHHHHh----
Confidence            98765332  23345678899999998863   4688899999999999999999999976432  1222222210    


Q ss_pred             hhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          270 KELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                           -.-+.+.+.  ..++.++++++..||+.|+.+||...++++
T Consensus       310 -----~ePP~L~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  310 -----EEPPLLPGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             -----cCCCCCCcc--cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence                 000111111  127788999999999999999999998875

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.4e-35  Score=273.31  Aligned_cols=245  Identities=23%  Similarity=0.380  Sum_probs=194.0

Q ss_pred             cccceecccCceEEEEEEEC-CCCEEEEEEeec----cChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCe--eEE
Q 018263           45 RWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSV----ESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC--RIL  117 (358)
Q Consensus        45 ~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~----~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~--~~i  117 (358)
                      +....||+|.|-+||+|.+. +|..||=..++.    .......++..|+.+|+.|+  ||||+++++++.+...  ..+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~--H~NIirfy~SW~d~~n~~in~  120 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLK--HPNIIRFYDSWVDTDNKTINF  120 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCC--CCceeeeeeheecCCCceeee
Confidence            34568999999999999875 466665333322    13444588999999999998  9999999999987665  778


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcC-CCceEEeecccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ-NFNPKISDFGLSKL  196 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~-~~~~~l~Dfg~~~~  196 (358)
                      |+|.+..|+|..+.    .+.+.++.+.+.+|+.||+.||.|||++ .+.|+|||||-+||||+. .|.|||+|+|+|..
T Consensus       121 iTEL~TSGtLr~Y~----kk~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl  195 (632)
T KOG0584|consen  121 ITELFTSGTLREYR----KKHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL  195 (632)
T ss_pred             eeecccCCcHHHHH----HHhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHH
Confidence            99999999999999    4556788899999999999999999998 889999999999999975 68999999999987


Q ss_pred             cCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhh
Q 018263          197 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV  276 (358)
Q Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                      +.....   ..+.|||.|+|||+.. ..|++..||||||++++||.|+..||....+..+  ...++-....+..+..  
T Consensus       196 ~r~s~a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ--IYKKV~SGiKP~sl~k--  267 (632)
T KOG0584|consen  196 LRKSHA---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ--IYKKVTSGIKPAALSK--  267 (632)
T ss_pred             hhcccc---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH--HHHHHHcCCCHHHhhc--
Confidence            643332   3378999999999654 7899999999999999999999999965443221  1111111111221211  


Q ss_pred             ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          277 DPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       277 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                                -....+.++|.+||.. .++|||+.|+|+
T Consensus       268 ----------V~dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  268 ----------VKDPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             ----------cCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence                      1234689999999999 999999999985

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-35  Score=252.40  Aligned_cols=262  Identities=21%  Similarity=0.321  Sum_probs=201.6

Q ss_pred             CCccc-ceecccCceEEEEEE-ECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEe
Q 018263           43 GFRWS-NKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD  120 (358)
Q Consensus        43 ~y~i~-~~lg~g~~g~v~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e  120 (358)
                      -|++. +.||+|+++.|-.+. ..+|..||||++.......+.++.+|++.+...+ +|+||++++++|+++..+|+|||
T Consensus        78 ~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cq-gh~nilqLiefFEdd~~FYLVfE  156 (463)
T KOG0607|consen   78 MYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQ-GHKNILQLIEFFEDDTRFYLVFE  156 (463)
T ss_pred             HHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhc-CCccHHHHHHHhcccceEEEEEe
Confidence            34444 479999999998887 5689999999998888899999999999999998 89999999999999999999999


Q ss_pred             cCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCc---eEEeeccccccc
Q 018263          121 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN---PKISDFGLSKLF  197 (358)
Q Consensus       121 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~---~~l~Dfg~~~~~  197 (358)
                      -+.||.|...|    ..+..+++..+.++..+|+.||.+||.+   ||.|||+||+||+....+.   +||+||.+..-+
T Consensus       157 Km~GGplLshI----~~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~  229 (463)
T KOG0607|consen  157 KMRGGPLLSHI----QKRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGI  229 (463)
T ss_pred             cccCchHHHHH----HHhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeecccccccc
Confidence            99999999999    5678899999999999999999999999   9999999999999976655   699999876533


Q ss_pred             C--C----CCcccccccccccCccCccccc-----cCCCCccCceecHHHHHHHHHhCCCCCCcc-ccccchhhhHhhhh
Q 018263          198 P--E----NTTHISTRVAGTLGYLAPEYAI-----SGRLTRKSDVYSFGVLLLEIVSGRTAVDFD-VQLGEYHLVDKAWG  265 (358)
Q Consensus       198 ~--~----~~~~~~~~~~~~~~y~aPE~~~-----~~~~s~~sDiwslG~il~~lltg~~pf~~~-~~~~~~~~~~~~~~  265 (358)
                      .  .    .........+|+..|+|||+..     ...|+.+.|.||||+|+|-||+|.+||.+- ..+.+...-.... 
T Consensus       230 k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr-  308 (463)
T KOG0607|consen  230 KLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCR-  308 (463)
T ss_pred             ccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccH-
Confidence            2  1    1112223467888999999864     235889999999999999999999999642 1111110000000 


Q ss_pred             ccchhhHhhhhccccCCCCC----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          266 MYNSKELMNLVDPMLYGNFP----ENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                       .-...+.+-+...-. ++|    ...+....++|..+|..++.+|.++..++.
T Consensus       309 -~CQ~~LFesIQEGkY-eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  309 -VCQNKLFESIQEGKY-EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             -HHHHHHHHHHhccCC-cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence             000111111111111 122    245667888999999999999999988876

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-35  Score=271.85  Aligned_cols=240  Identities=25%  Similarity=0.329  Sum_probs=195.2

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      .+.|.+...+|.|+|+.|-.+... +++.+++|++....    .+..+|+..+.... .||||++..+++.+..+.++||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~-~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVR-DHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhc-CCCcceeecceecCCceeeeee
Confidence            578999999999999999888754 68889999986541    12234554444443 5999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEE-cCCCceEEeecccccccC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL-DQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv-~~~~~~~l~Dfg~~~~~~  198 (358)
                      |.+.|+.+.+.+.    ..... ...+..|+.+|+.|+.|||++   |++||||||+||++ +..+.++|+|||.+....
T Consensus       396 e~l~g~ell~ri~----~~~~~-~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~  467 (612)
T KOG0603|consen  396 ELLDGGELLRRIR----SKPEF-CSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE  467 (612)
T ss_pred             hhccccHHHHHHH----hcchh-HHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence            9999998888872    22333 377788999999999999999   99999999999999 688999999999998754


Q ss_pred             CCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhcc
Q 018263          199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDP  278 (358)
Q Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (358)
                      ..    ....+-|..|.|||++....|++++|+||||++||+||+|+.||......                  .++...
T Consensus       468 ~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------------------~ei~~~  525 (612)
T KOG0603|consen  468 RS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------------------IEIHTR  525 (612)
T ss_pred             hh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------------------HHHHHh
Confidence            33    22345788999999999889999999999999999999999999743221                  233334


Q ss_pred             ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          279 MLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       279 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ...+.+....+....+|+.+||+.||.+||++.++..
T Consensus       526 i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  526 IQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             hcCCccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence            4445555677888999999999999999999999854

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-35  Score=274.48  Aligned_cols=270  Identities=23%  Similarity=0.305  Sum_probs=202.3

Q ss_pred             CCcccceecccCceEEEEEEEC-CCCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC------e
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP------C  114 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~------~  114 (358)
                      .|...+.||+|+||.||+++.+ +|+.||||.++.. ......+...|++++++++  |+|||++.++-....      .
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLn--h~NIVk~f~iee~~~~~~~~~~   91 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLN--HPNIVKLFDIEETKFLGLVTRL   91 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcC--chhhhhhcccCCccccCccccc
Confidence            3445678999999999999954 7999999999765 3455677889999999999  999999999866544      4


Q ss_pred             eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEc--CCC--ceEEee
Q 018263          115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD--QNF--NPKISD  190 (358)
Q Consensus       115 ~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~--~~~--~~~l~D  190 (358)
                      ..++||||.||+|...+... .+..-+++..+..++.+++.||.|||++   ||+||||||.||++-  .+|  ..||+|
T Consensus        92 ~vlvmEyC~gGsL~~~L~~P-EN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtD  167 (732)
T KOG4250|consen   92 PVLVMEYCSGGSLRKVLNSP-ENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTD  167 (732)
T ss_pred             ceEEEeecCCCcHHHHhcCc-ccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeec
Confidence            58999999999999999765 4556699999999999999999999999   999999999999983  333  369999


Q ss_pred             cccccccCCCCcccccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCCCCCCcccccc-chhhhHhhhhccc
Q 018263          191 FGLSKLFPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG-EYHLVDKAWGMYN  268 (358)
Q Consensus       191 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~-~~~~~~~~~~~~~  268 (358)
                      ||.++...+..  ......||..|++||++.. ..|+...|.|||||++|++.||..||..-.... .+..+..+.... 
T Consensus       168 fG~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkk-  244 (732)
T KOG4250|consen  168 FGAARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKK-  244 (732)
T ss_pred             ccccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccC-
Confidence            99999865444  4566889999999999884 789999999999999999999999996544332 122221111111 


Q ss_pred             hhhHhhhhccccC------------CCCCHHHHHHHHHHHhhccCCCCCCCC--CHHHHHHHhhcCC
Q 018263          269 SKELMNLVDPMLY------------GNFPENEAIRFLKVGLLCVQEKSKLRP--QMSTAIKMMNGET  321 (358)
Q Consensus       269 ~~~~~~~~~~~~~------------~~~~~~~~~~l~~li~~~l~~~P~~Rp--t~~eil~~L~~~~  321 (358)
                      ...+.....+..+            ..........+-+.+..+|..+|.+|=  ...+....+..+.
T Consensus       245 p~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL  311 (732)
T KOG4250|consen  245 PSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL  311 (732)
T ss_pred             CCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence            1111111111111            112234455677788888999999997  5555544444443

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=2.7e-34  Score=252.07  Aligned_cols=220  Identities=20%  Similarity=0.165  Sum_probs=174.5

Q ss_pred             cCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecCCCCCHHHHh
Q 018263           53 GGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTL  131 (358)
Q Consensus        53 g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l  131 (358)
                      |.+|.||+++++ +++.||+|.+.....     ...+...+....  |||++++++.+......+++|||+++++|.+.+
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-----~~~~~~~~~~~~--~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l   76 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-----YSRERLTIIPHC--VPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI   76 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh-----hhhHHHHHHhcC--CCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence            889999999975 689999999865432     223333333334  999999999999999999999999999999998


Q ss_pred             hhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCcccccccccc
Q 018263          132 LGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT  211 (358)
Q Consensus       132 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~  211 (358)
                      .    ....+++..+..++.|++.||.|||++   |++|+||+|+||+++.++.++++|||.+......    .....++
T Consensus        77 ~----~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~  145 (237)
T cd05576          77 S----KFLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVE  145 (237)
T ss_pred             H----HhcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcC
Confidence            3    334689999999999999999999999   9999999999999999999999999987654321    1223456


Q ss_pred             cCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHH
Q 018263          212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIR  291 (358)
Q Consensus       212 ~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (358)
                      ..|+|||...+..++.++|+||+|+++|+|++|+.|+......                     +........+...+..
T Consensus       146 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~  204 (237)
T cd05576         146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG---------------------INTHTTLNIPEWVSEE  204 (237)
T ss_pred             ccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh---------------------cccccccCCcccCCHH
Confidence            7799999988888899999999999999999999887532110                     0000001223345567


Q ss_pred             HHHHHhhccCCCCCCCCCHH
Q 018263          292 FLKVGLLCVQEKSKLRPQMS  311 (358)
Q Consensus       292 l~~li~~~l~~~P~~Rpt~~  311 (358)
                      +.+++.+||+.||++||++.
T Consensus       205 ~~~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         205 ARSLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             HHHHHHHHccCCHHHhcCCC
Confidence            89999999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-35  Score=259.34  Aligned_cols=260  Identities=22%  Similarity=0.288  Sum_probs=210.7

Q ss_pred             ccccccccccCHHHHHHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccCh---hhHHHHHHHHHHhhhcccC
Q 018263           23 EQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK---QGEKEFMSEVASMANVNVC   98 (358)
Q Consensus        23 ~~~~~~~~~~~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~~~   98 (358)
                      .....+....+..+ .+...+|..+..||+|+||.|.+|..+ +.+.||||+++.+..   ...+--+.|-..|.... .
T Consensus       331 ~~~~~~~~~~~~~d-~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~-k  408 (683)
T KOG0696|consen  331 MPTDSKFHNSSKRD-RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPG-K  408 (683)
T ss_pred             CCCcccCCCCCccc-ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCC-C
Confidence            33445555666666 677889999999999999999999865 578899999875421   11122233445555443 4


Q ss_pred             CCCceeeeceEEcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcE
Q 018263           99 HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNI  178 (358)
Q Consensus        99 h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Ni  178 (358)
                      .|+++++...|..-+.+|+||||+.||+|-..+    +.-+.+-+..+..++..|+.||-+||++   ||++||||.+||
T Consensus       409 ppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhi----QQ~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNv  481 (683)
T KOG0696|consen  409 PPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHI----QQVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNV  481 (683)
T ss_pred             CchHHHHHHHhhhhhheeeEEEEecCchhhhHH----HHhcccCCchhhhhhHHHHHHhhhhhcC---Ceeeeeccccce
Confidence            789999999999999999999999999998888    5667788899999999999999999999   999999999999


Q ss_pred             EEcCCCceEEeecccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchh
Q 018263          179 LLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYH  258 (358)
Q Consensus       179 lv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~  258 (358)
                      +++.+|.+||+|||++..---. .......+||+.|+|||++...+|+.++|-||+|++||||+.|++||+++++.+.++
T Consensus       482 mLd~eGHiKi~DFGmcKEni~~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~  560 (683)
T KOG0696|consen  482 MLDSEGHIKIADFGMCKENIFD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ  560 (683)
T ss_pred             EeccCCceEeeecccccccccC-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            9999999999999999752211 223345899999999999999999999999999999999999999999887655544


Q ss_pred             hhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCC
Q 018263          259 LVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQ  309 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt  309 (358)
                      .+...                 .-.+|...+.+...++...|..+|.+|..
T Consensus       561 aI~eh-----------------nvsyPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  561 AIMEH-----------------NVSYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             HHHHc-----------------cCcCcccccHHHHHHHHHHhhcCCccccC
Confidence            43221                 23466778888999999999999999965

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.2e-33  Score=281.46  Aligned_cols=146  Identities=27%  Similarity=0.404  Sum_probs=130.6

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI  116 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~  116 (358)
                      .++|++.++||+|+||.||+|.+. +++.||||++....   ......+..|+..+..++  ||||+++++.+......|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~--hp~Iv~~~~~~~~~~~~~   80 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK--SPFIVHLYYSLQSANNVY   80 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcC--CCCcCeEEEEEEECCEEE
Confidence            468999999999999999999976 68999999986432   333466788889998887  999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccc
Q 018263          117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK  195 (358)
Q Consensus       117 iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~  195 (358)
                      +||||++|++|.+++.    ..+.+++..++.++.||+.||.|||++   +|+|+||||+||+++.++.++|+|||++.
T Consensus        81 lVmEy~~g~~L~~li~----~~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          81 LVMEYLIGGDVKSLLH----IYGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEEeCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999999983    345688999999999999999999999   99999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=258.37  Aligned_cols=258  Identities=26%  Similarity=0.356  Sum_probs=200.9

Q ss_pred             HHhhcCCcccceecccCceEEEEEEE-CCCCEEEEEEeeccChhh-------HHHHHHHHHHhhhcccCCCCceeeeceE
Q 018263           38 KIATNGFRWSNKIGEGGFGSVYKGRL-QDGTIVAVKVLSVESKQG-------EKEFMSEVASMANVNVCHENLVKLHGGC  109 (358)
Q Consensus        38 ~~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~vaiK~~~~~~~~~-------~~~~~~e~~~l~~l~~~h~~i~~~~~~~  109 (358)
                      ....++|-++..||+|||+.||+|.+ ...+.||+|+-.....+.       -+...+|..+.+.+.  ||.||+++++|
T Consensus       459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLD--HpRIVKlYDyf  536 (775)
T KOG1151|consen  459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELD--HPRIVKLYDYF  536 (775)
T ss_pred             cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccC--cceeeeeeeee
Confidence            34467999999999999999999985 458889999976553332       245778999999998  99999999998


Q ss_pred             E-cCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEc---CCCc
Q 018263          110 I-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD---QNFN  185 (358)
Q Consensus       110 ~-~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~---~~~~  185 (358)
                      . +...+|-|+|||+|.+|+-++    ...+.++++.++.|+.||+.||.||.+. ...|+|.||||.||++-   ..|.
T Consensus       537 slDtdsFCTVLEYceGNDLDFYL----KQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGe  611 (775)
T KOG1151|consen  537 SLDTDSFCTVLEYCEGNDLDFYL----KQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGE  611 (775)
T ss_pred             eeccccceeeeeecCCCchhHHH----HhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccce
Confidence            7 556789999999999999999    4566789999999999999999999987 77999999999999994   4578


Q ss_pred             eEEeecccccccCCCCcc------cccccccccCccCccccccC----CCCccCceecHHHHHHHHHhCCCCCCcccccc
Q 018263          186 PKISDFGLSKLFPENTTH------ISTRVAGTLGYLAPEYAISG----RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG  255 (358)
Q Consensus       186 ~~l~Dfg~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~----~~s~~sDiwslG~il~~lltg~~pf~~~~~~~  255 (358)
                      +||.|||++..+......      ......||.+|++||.+.-+    ..+.+.||||+|+|+|+++.|+.||.......
T Consensus       612 IKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ  691 (775)
T KOG1151|consen  612 IKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ  691 (775)
T ss_pred             eEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH
Confidence            999999999988544332      22336799999999998633    46889999999999999999999997542211


Q ss_pred             chhhhHhhhhccchhhHhhhhccc-cCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 018263          256 EYHLVDKAWGMYNSKELMNLVDPM-LYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAI  314 (358)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil  314 (358)
                      +....            ..++... ..=...+..+.....+|++||+..-++|....++.
T Consensus       692 dILqe------------NTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  692 DILQE------------NTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             HHHhh------------hchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence            11000            0011100 00011134566788999999999999999887764

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-33  Score=275.59  Aligned_cols=266  Identities=27%  Similarity=0.387  Sum_probs=222.9

Q ss_pred             HHHHhhcCCcccceecccCceEEEEEEEC----C----CCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeee
Q 018263           36 QLKIATNGFRWSNKIGEGGFGSVYKGRLQ----D----GTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLH  106 (358)
Q Consensus        36 ~~~~~~~~y~i~~~lg~g~~g~v~~~~~~----~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~  106 (358)
                      .+.+..++..+.+.||.|.||.|++|...    .    ...||+|.++.. .....+.+..|++.++.+. .|+|++.++
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g-~H~niv~ll  368 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELG-KHPNIVNLL  368 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhc-CCcchhhhe
Confidence            67777888888889999999999999733    1    446899998754 3356688999999999997 699999999


Q ss_pred             ceEEcCCeeEEEEecCCCCCHHHHhhhcc---cc-------c--cCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCC
Q 018263          107 GGCIDGPCRILVYDYMPNNSLSQTLLGEE---KR-------R--AKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIK  174 (358)
Q Consensus       107 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~---~~-------~--~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~  174 (358)
                      +.+...+..++|+||+..|+|..+++..+   .-       .  ..++...+..+++||+.|++||++.   .++||||.
T Consensus       369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLA  445 (609)
T KOG0200|consen  369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLA  445 (609)
T ss_pred             eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhh
Confidence            99999999999999999999999996654   00       0  2489999999999999999999999   99999999


Q ss_pred             CCcEEEcCCCceEEeecccccccCCCCcccccccc--cccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCcc
Q 018263          175 TSNILLDQNFNPKISDFGLSKLFPENTTHISTRVA--GTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFD  251 (358)
Q Consensus       175 p~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~--~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~  251 (358)
                      ..||+++++..+|++|||+++..............  .+..|+|||.+....|+.++||||+|+++||+++ |..||.+-
T Consensus       446 aRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~  525 (609)
T KOG0200|consen  446 ARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI  525 (609)
T ss_pred             hhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence            99999999999999999999865443333322222  4556999999999999999999999999999999 77887631


Q ss_pred             ccccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 018263          252 VQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE  320 (358)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~  320 (358)
                                     ....++.+.+.+..+...|..++.++.++++.||+.+|++||++.++.+.|+.+
T Consensus       526 ---------------~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  526 ---------------PPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             ---------------CcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence                           113344556677777788888899999999999999999999999999999994

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-33  Score=251.74  Aligned_cols=275  Identities=27%  Similarity=0.408  Sum_probs=211.5

Q ss_pred             cCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC----eeEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP----CRIL  117 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~----~~~i  117 (358)
                      ....+.+.+|+|.||.||+|... ++.||||++..   ...+.+..|-++.......|+||+++++.-....    .+.+
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL  285 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL  285 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence            45567789999999999999986 68999999874   3445666777776666556999999999876555    7899


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCC------CCCcEEcCCCCCcEEEcCCCceEEeec
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI------QPHVVHRDIKTSNILLDQNFNPKISDF  191 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~------~~~i~H~di~p~Nilv~~~~~~~l~Df  191 (358)
                      |++|.+.|+|.+++     ....+++....+++..+++||+|||+..      .+.|+|||||..||+|.+++.+.|+||
T Consensus       286 Vt~fh~kGsL~dyL-----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF  360 (534)
T KOG3653|consen  286 VTEFHPKGSLCDYL-----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF  360 (534)
T ss_pred             EeeeccCCcHHHHH-----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence            99999999999999     5667899999999999999999999853      568999999999999999999999999


Q ss_pred             ccccccCCCC-cccccccccccCccCccccccC-CCC-----ccCceecHHHHHHHHHhCCCCCCccccccchhh--hHh
Q 018263          192 GLSKLFPENT-THISTRVAGTLGYLAPEYAISG-RLT-----RKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHL--VDK  262 (358)
Q Consensus       192 g~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~s-----~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~--~~~  262 (358)
                      |++..+.... ........||..|+|||++.+. ++.     .+.||||+|.++|||++.-.-+.. ...+.|+.  -.+
T Consensus       361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~-~~vp~Yqlpfe~e  439 (534)
T KOG3653|consen  361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADP-GPVPEYQLPFEAE  439 (534)
T ss_pred             ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccC-CCCCcccCchhHH
Confidence            9998764322 2223347899999999998764 333     368999999999999997655543 22222222  223


Q ss_pred             hhhccchhhHhhhh-ccccCCCCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCCCC
Q 018263          263 AWGMYNSKELMNLV-DPMLYGNFPE-----NEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNIDGX  326 (358)
Q Consensus       263 ~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~~~  326 (358)
                      +...+..++...++ ....++.++.     .....+.+.+..||..||+.|.|+.=+.+++..+.-+...
T Consensus       440 vG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~  509 (534)
T KOG3653|consen  440 VGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED  509 (534)
T ss_pred             hcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence            33344444444433 3334444443     3456789999999999999999999999988888766633

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-34  Score=259.63  Aligned_cols=246  Identities=25%  Similarity=0.340  Sum_probs=202.0

Q ss_pred             CCccc--ceecccCceEEEEEEE-CCCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           43 GFRWS--NKIGEGGFGSVYKGRL-QDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        43 ~y~i~--~~lg~g~~g~v~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      -|.|.  +.||+|-||+||-|++ ++|+.||||++...  ....+..+.+|+.+|+++.  ||.||.+--.|+..+..++
T Consensus       563 vYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~--HPGiV~le~M~ET~ervFV  640 (888)
T KOG4236|consen  563 VYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLH--HPGIVNLECMFETPERVFV  640 (888)
T ss_pred             HHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcC--CCCeeEEEEeecCCceEEE
Confidence            34443  6899999999999986 47999999998643  4556688999999999998  9999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcC---CCceEEeecccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ---NFNPKISDFGLS  194 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~---~~~~~l~Dfg~~  194 (358)
                      |||.+.|.-|..++   .+..+++++..-..++.||+.||.|||-+   +|+|+||||+||++..   -..+||+|||++
T Consensus       641 VMEKl~GDMLEMIL---SsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfA  714 (888)
T KOG4236|consen  641 VMEKLHGDMLEMIL---SSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFA  714 (888)
T ss_pred             EehhhcchHHHHHH---HhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccce
Confidence            99999766566555   24568899999999999999999999999   9999999999999954   456899999999


Q ss_pred             cccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhh
Q 018263          195 KLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMN  274 (358)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                      +.+++...  .....||+.|+|||++.++.|..+-|+||.|+|+|.-++|..||+.+....+.-.               
T Consensus       715 RiIgEksF--RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQ---------------  777 (888)
T KOG4236|consen  715 RIIGEKSF--RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQ---------------  777 (888)
T ss_pred             eecchhhh--hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhh---------------
Confidence            98765443  4557899999999999999999999999999999999999999986544322100               


Q ss_pred             hhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 018263          275 LVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTA  313 (358)
Q Consensus       275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ei  313 (358)
                      ...-+..++.-.+.+...++||..+|++.-.+|-+...-
T Consensus       778 NAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~  816 (888)
T KOG4236|consen  778 NAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKS  816 (888)
T ss_pred             ccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhh
Confidence            001112223335667788999999999999999987654

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.1e-32  Score=241.29  Aligned_cols=236  Identities=28%  Similarity=0.402  Sum_probs=192.2

Q ss_pred             CceEEEEEEEC-CCCEEEEEEeeccChhh-HHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecCCCCCHHHHh
Q 018263           54 GFGSVYKGRLQ-DGTIVAVKVLSVESKQG-EKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTL  131 (358)
Q Consensus        54 ~~g~v~~~~~~-~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l  131 (358)
                      ++|.||++... +|+.+++|++....... ...+..|+..++.++  |+|++++.+.+......++++|++++++|.+++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~--~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~   78 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLK--HPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL   78 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCC--CCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence            58999999986 48999999987654444 678889999999997  999999999999999999999999998999998


Q ss_pred             hhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCcccccccccc
Q 018263          132 LGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT  211 (358)
Q Consensus       132 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~  211 (358)
                      ..    ...++...++.++.+++.++.+||+.   +++|+||+|.||+++.++.++++|||.+.......  ......++
T Consensus        79 ~~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~  149 (244)
T smart00220       79 KK----RGRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGT  149 (244)
T ss_pred             Hh----ccCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCC
Confidence            32    23388999999999999999999999   99999999999999999999999999998764432  23345678


Q ss_pred             cCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCCCCHH--HH
Q 018263          212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPEN--EA  289 (358)
Q Consensus       212 ~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~  289 (358)
                      ..|++||.+.+..++.++|+|+||+++++|++|..||......               ....+.+...........  .+
T Consensus       150 ~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~  214 (244)
T smart00220      150 PEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL---------------LELFKKIGKPKPPFPPPEWKIS  214 (244)
T ss_pred             cCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH---------------HHHHHHHhccCCCCccccccCC
Confidence            8999999998888899999999999999999999998753111               111111111111111111  55


Q ss_pred             HHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          290 IRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       290 ~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ..+.+++.+||..+|++||++.++++
T Consensus       215 ~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      215 PEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHHHHHccCCchhccCHHHHhh
Confidence            67999999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-33  Score=250.28  Aligned_cols=264  Identities=27%  Similarity=0.365  Sum_probs=203.3

Q ss_pred             hcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC----eeE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP----CRI  116 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~----~~~  116 (358)
                      ..+.++.+.||+|.||.||+|+|. |+.||||++...   ++....+|.++.+..-..|+||+.+++.-..++    .++
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw  285 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW  285 (513)
T ss_pred             hheeEEEEEecCccccceeecccc-CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence            568889999999999999999997 889999998643   344556777777766556999999998755433    468


Q ss_pred             EEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCcEEcCCCCCcEEEcCCCceEEeec
Q 018263          117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE-----IQPHVVHRDIKTSNILLDQNFNPKISDF  191 (358)
Q Consensus       117 iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-----~~~~i~H~di~p~Nilv~~~~~~~l~Df  191 (358)
                      +|.+|.+.|+|.|++     ++.+++.+...+++..++.||++||-.     ..+.|+|||||.+||+|+.++.+.|+|+
T Consensus       286 LvTdYHe~GSL~DyL-----~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL  360 (513)
T KOG2052|consen  286 LVTDYHEHGSLYDYL-----NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  360 (513)
T ss_pred             EeeecccCCcHHHHH-----hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence            999999999999999     557899999999999999999999964     3669999999999999999999999999


Q ss_pred             ccccccCCCCcc---cccccccccCccCccccccCC----CC--ccCceecHHHHHHHHHhC----------CCCCCccc
Q 018263          192 GLSKLFPENTTH---ISTRVAGTLGYLAPEYAISGR----LT--RKSDVYSFGVLLLEIVSG----------RTAVDFDV  252 (358)
Q Consensus       192 g~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~----~s--~~sDiwslG~il~~lltg----------~~pf~~~~  252 (358)
                      |++.........   .....+||..|+|||++...-    +.  ..+||||||.++||+.-.          +.||..-.
T Consensus       361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V  440 (513)
T KOG2052|consen  361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV  440 (513)
T ss_pred             eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence            999876543221   233478999999999986432    11  368999999999999862          34554322


Q ss_pred             cccchhhhHhhhhccchhhHhh-hhccccCCCCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCC
Q 018263          253 QLGEYHLVDKAWGMYNSKELMN-LVDPMLYGNFP-----ENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNID  324 (358)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~  324 (358)
                      +.+.           .-++..+ .....+++..|     ......+.++++.||..||.-|.|+--|-+.|.++.+.+
T Consensus       441 p~DP-----------s~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~  507 (513)
T KOG2052|consen  441 PSDP-----------SFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSD  507 (513)
T ss_pred             CCCC-----------CHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcCh
Confidence            2111           1111111 11122333333     356778999999999999999999999999998887643

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-33  Score=267.70  Aligned_cols=252  Identities=28%  Similarity=0.417  Sum_probs=214.8

Q ss_pred             CCcccceecccCceEEEEEEEC-C----CCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeE
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQ-D----GTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI  116 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~-~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~  116 (358)
                      ..+..++||+|+||+||+|.+- .    +-+|+||++... ......++.+|+..+.++.  |||++++++++.... ..
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masld--Hpnl~RLLgvc~~s~-~q  773 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLD--HPNLLRLLGVCMLST-LQ  773 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCC--CchHHHHhhhcccch-HH
Confidence            4556789999999999999852 3    446899988543 4555678999999999998  999999999998876 77


Q ss_pred             EEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       117 iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      ||++|+++|+|.++++.   ++..+..+..+.|.+||++|+.|||.+   .++||||-..||+|+....+|+.|||+++.
T Consensus       774 lvtq~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~l  847 (1177)
T KOG1025|consen  774 LVTQLMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKL  847 (1177)
T ss_pred             HHHHhcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhc
Confidence            89999999999999954   566788899999999999999999999   999999999999999999999999999997


Q ss_pred             cCCCCccccc-ccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhHhh
Q 018263          197 FPENTTHIST-RVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMN  274 (358)
Q Consensus       197 ~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                      .......... .....+-|+|-|.+....++.++||||+|+++||++| |..|+.+.                ..+++.+
T Consensus       848 l~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi----------------~~~eI~d  911 (1177)
T KOG1025|consen  848 LAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGI----------------PAEEIPD  911 (1177)
T ss_pred             cCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCC----------------CHHHhhH
Confidence            7544433322 2345568899998889999999999999999999999 88887643                3556677


Q ss_pred             hhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 018263          275 LVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNG  319 (358)
Q Consensus       275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~  319 (358)
                      +++..-+-..|+.++.++..++.+||..|+..||+++++...+..
T Consensus       912 lle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~  956 (1177)
T KOG1025|consen  912 LLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR  956 (1177)
T ss_pred             HHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence            777777778889999999999999999999999999999887764

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.4e-35  Score=242.80  Aligned_cols=275  Identities=23%  Similarity=0.369  Sum_probs=210.4

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEc------
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID------  111 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~------  111 (358)
                      .+.|+-+.++|+|.||.||+|+.+ +|+.|++|++-.+  ...--....+|+.+|+.++  |+|++.+++.+..      
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lk--Henv~nliEic~tk~Tp~~   93 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLK--HENVVNLIEICRTKATPTN   93 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhc--chhHHHHHHHHhhccCCcc
Confidence            467777889999999999999965 5888888876432  3333456778999999998  9999998887642      


Q ss_pred             --CCeeEEEEecCCCCCHHHHhhhcccc-ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEE
Q 018263          112 --GPCRILVYDYMPNNSLSQTLLGEEKR-RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKI  188 (358)
Q Consensus       112 --~~~~~iv~e~~~~~~L~~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l  188 (358)
                        ...+|+||++|+ -+|..++    .+ ...++...+.+++.+++.||.|+|++   .|+|||+|+.|++|+.+|.++|
T Consensus        94 r~r~t~ylVf~~ce-hDLaGlL----sn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilkl  165 (376)
T KOG0669|consen   94 RDRATFYLVFDFCE-HDLAGLL----SNRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKL  165 (376)
T ss_pred             cccceeeeeHHHhh-hhHHHHh----cCccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEe
Confidence              345799999995 5788888    33 36789999999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCc---ccccccccccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhh
Q 018263          189 SDFGLSKLFPENTT---HISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAW  264 (358)
Q Consensus       189 ~Dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~  264 (358)
                      +|||+++.+.....   ...+....|.+|++||.+.|. .|+++.|||+.||++.+|+++.+-+.+.++..+.+++....
T Consensus       166 ADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~Lc  245 (376)
T KOG0669|consen  166 ADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLC  245 (376)
T ss_pred             eccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHh
Confidence            99999987643221   223345678999999998874 79999999999999999999999999998888887776665


Q ss_pred             hccchhhHhhhhc-----cc----c-CCCCC--HHH------HHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCCCC
Q 018263          265 GMYNSKELMNLVD-----PM----L-YGNFP--ENE------AIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNIDGX  326 (358)
Q Consensus       265 ~~~~~~~~~~~~~-----~~----~-~~~~~--~~~------~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~~~  326 (358)
                      +....+-+....+     ..    + .+.+.  .+.      ..+.++|+.++|..||.+|+++.+++.    +.-++..
T Consensus       246 Gs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln----h~~F~kd  321 (376)
T KOG0669|consen  246 GSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN----HDFFWKD  321 (376)
T ss_pred             ccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc----hhhhhcC
Confidence            5444332222111     11    1 00000  111      226788999999999999999999874    3344444


Q ss_pred             CCC
Q 018263          327 DVE  329 (358)
Q Consensus       327 ~~~  329 (358)
                      ++|
T Consensus       322 p~p  324 (376)
T KOG0669|consen  322 PMP  324 (376)
T ss_pred             Ccc
Confidence            444

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-32  Score=244.99  Aligned_cols=264  Identities=20%  Similarity=0.279  Sum_probs=196.6

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCC------CCceeeeceEEc---
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCH------ENLVKLHGGCID---  111 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h------~~i~~~~~~~~~---  111 (358)
                      .+|.+.++||+|-|++||+|.+. ..+.||+|+.+ ....-.+....|+.+|+......      .+||++++.|.+   
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvK-SAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVK-SAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEe-hhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            79999999999999999999864 67889999986 44455667788999999886332      369999999975   


Q ss_pred             -CCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCC-------
Q 018263          112 -GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN-------  183 (358)
Q Consensus       112 -~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~-------  183 (358)
                       +.+.|+|+|++ |.+|..+|..  ...+-++...+.+|+.||+.||.|||+.|  ||+|.||||+|||+..+       
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~--s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~~~  231 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKY--SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPAKD  231 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHH--hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchhhh
Confidence             55789999999 8899999943  45667899999999999999999999987  99999999999999200       


Q ss_pred             -------------------------------------------------------------------------------C
Q 018263          184 -------------------------------------------------------------------------------F  184 (358)
Q Consensus       184 -------------------------------------------------------------------------------~  184 (358)
                                                                                                     +
T Consensus       232 ~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~  311 (590)
T KOG1290|consen  232 AREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRING  311 (590)
T ss_pred             hhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCc
Confidence                                                                                           0


Q ss_pred             --------------------------------------------------------------------------------
Q 018263          185 --------------------------------------------------------------------------------  184 (358)
Q Consensus       185 --------------------------------------------------------------------------------  184 (358)
                                                                                                      
T Consensus       312 ~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di  391 (590)
T KOG1290|consen  312 NESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDI  391 (590)
T ss_pred             cccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccce
Confidence                                                                                            


Q ss_pred             ceEEeecccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCcccccc------chh
Q 018263          185 NPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG------EYH  258 (358)
Q Consensus       185 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~------~~~  258 (358)
                      ++||+|||.+....    ...+.-..|..|.|||++.|..|+..+||||++|+++||.||...|+..+..+      ...
T Consensus       392 ~vKIaDlGNACW~~----khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA  467 (590)
T KOG1290|consen  392 RVKIADLGNACWVH----KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIA  467 (590)
T ss_pred             eEEEeeccchhhhh----hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHH
Confidence            02233333222211    01111245678999999999999999999999999999999999997654322      222


Q ss_pred             hhHhhhhccc------hhhHhhhhccc--------cC-----------CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 018263          259 LVDKAWGMYN------SKELMNLVDPM--------LY-----------GNFPENEAIRFLKVGLLCVQEKSKLRPQMSTA  313 (358)
Q Consensus       259 ~~~~~~~~~~------~~~~~~~~~~~--------~~-----------~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ei  313 (358)
                      ++.+.++...      +...++++++.        ++           =.++.....++.+++.-||+.+|.+||||.+.
T Consensus       468 ~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~c  547 (590)
T KOG1290|consen  468 LIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQC  547 (590)
T ss_pred             HHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHH
Confidence            2222222221      11222222221        00           14667888999999999999999999999998


Q ss_pred             HH
Q 018263          314 IK  315 (358)
Q Consensus       314 l~  315 (358)
                      ++
T Consensus       548 l~  549 (590)
T KOG1290|consen  548 LK  549 (590)
T ss_pred             hc
Confidence            75

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-33  Score=241.01  Aligned_cols=255  Identities=22%  Similarity=0.294  Sum_probs=202.5

Q ss_pred             HHHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC
Q 018263           37 LKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG  112 (358)
Q Consensus        37 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~  112 (358)
                      +.+..++|.++..||+|++++|.+++.+ +.+.||+|+++.+   ..+...-.+.|........ +||+++.+...|...
T Consensus       245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~as-n~pflvglhscfqte  323 (593)
T KOG0695|consen  245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS-NNPFLVGLHSCFQTE  323 (593)
T ss_pred             cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhcc-CCCeEEehhhhhccc
Confidence            3445679999999999999999999865 6888999998654   3444455666777777665 699999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecc
Q 018263          113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG  192 (358)
Q Consensus       113 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg  192 (358)
                      ..+++|.||++||+|--.+    +.+..++++.++.+...|+.||.|||+.   ||++||+|.+||+++..|.+||.|+|
T Consensus       324 srlffvieyv~ggdlmfhm----qrqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdyg  396 (593)
T KOG0695|consen  324 SRLFFVIEYVNGGDLMFHM----QRQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYG  396 (593)
T ss_pred             ceEEEEEEEecCcceeeeh----hhhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccc
Confidence            9999999999999887777    5667899999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhH
Q 018263          193 LSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKEL  272 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      +++.-..+ .......+||+.|.|||++.+..|..+.|-|+||+++++|+.|+.||+.-...+...-.       ...-+
T Consensus       397 mcke~l~~-gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~nt-------edylf  468 (593)
T KOG0695|consen  397 MCKEGLGP-GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNT-------EDYLF  468 (593)
T ss_pred             hhhcCCCC-CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccch-------hHHHH
Confidence            99863332 33345689999999999999999999999999999999999999999743321110000       00011


Q ss_pred             hhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCC
Q 018263          273 MNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQ  309 (358)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt  309 (358)
                      .-+++...  ..|...+.....+++..|+.||.+|..
T Consensus       469 qvilekqi--riprslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  469 QVILEKQI--RIPRSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             HHHhhhcc--cccceeehhhHHHHHHhhcCCcHHhcC
Confidence            11222222  234445556677888999999999964

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=2.4e-33  Score=230.37  Aligned_cols=259  Identities=16%  Similarity=0.265  Sum_probs=201.0

Q ss_pred             hcCCcccceecccCceEEEEEEE-CCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC--eeEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRL-QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP--CRIL  117 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~--~~~i  117 (358)
                      .++|++++++|+|.++.|+.|.. .++++++||++++.   ..+.+.+|+.+|+.+. +||||++++++..++.  ...+
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~-gg~NIi~L~DiV~Dp~SktpaL  112 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLR-GGPNIIKLLDIVKDPESKTPSL  112 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhcc-CCCCeeehhhhhcCccccCchh
Confidence            47999999999999999999984 56889999999754   3456789999999998 7999999999988654  4579


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCC-CceEEeecccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN-FNPKISDFGLSKL  196 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~-~~~~l~Dfg~~~~  196 (358)
                      ++||+.+.+...+.       ++++...++.++.+++.||.|.|++   ||.|||+||.|++|+.. ..++|+|||++.+
T Consensus       113 iFE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEF  182 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  182 (338)
T ss_pred             HhhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhh
Confidence            99999877766665       5688899999999999999999999   99999999999999864 4689999999998


Q ss_pred             cCCCCcccccccccccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCC-CccccccchhhhHhhhhccc------
Q 018263          197 FPENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAV-DFDVQLGEYHLVDKAWGMYN------  268 (358)
Q Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf-~~~~~~~~~~~~~~~~~~~~------  268 (358)
                      .........  ...+.-|--||.+... .|+.+-|+|||||++..|+..+.|| .+.++.++...+..+.+.-.      
T Consensus       183 YHp~~eYnV--RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~  260 (338)
T KOG0668|consen  183 YHPGKEYNV--RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN  260 (338)
T ss_pred             cCCCceeee--eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH
Confidence            754443322  2344567889988764 5889999999999999999998888 55666666666555543221      


Q ss_pred             ------hhhHhhhhccccC--------CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          269 ------SKELMNLVDPMLY--------GNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       269 ------~~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                            ..++..++....+        .+...-.+.+.++++.++|..|-.+|+|+.|.+.
T Consensus       261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence                  1122222221111        1112234567899999999999999999999864

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1e-31  Score=261.58  Aligned_cols=264  Identities=22%  Similarity=0.250  Sum_probs=169.5

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-C----CCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeece------
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-D----GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG------  108 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~----~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~------  108 (358)
                      ..++|.+.+.||+|+||.||+|++. +    +..||+|.+...... + ....+  .+....  +.++..+...      
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-e-~~~~e--~l~~~~--~~~~~~~~~~~~~~~~  203 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-E-IWMNE--RVRRAC--PNSCADFVYGFLEPVS  203 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-H-HHHHH--HHHhhc--hhhHHHHHHhhhcccc
Confidence            5679999999999999999999975 4    689999987533211 1 11111  111111  2222222221      


Q ss_pred             EEcCCeeEEEEecCCCCCHHHHhhhcccc----------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcC
Q 018263          109 CIDGPCRILVYDYMPNNSLSQTLLGEEKR----------------RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRD  172 (358)
Q Consensus       109 ~~~~~~~~iv~e~~~~~~L~~~l~~~~~~----------------~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~d  172 (358)
                      .......++|+||+++++|.+++......                ........+..++.||+.||.|||+.   +|+|||
T Consensus       204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRD  280 (566)
T PLN03225        204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRD  280 (566)
T ss_pred             cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCc
Confidence            23556789999999999999998432100                01112345778999999999999999   999999


Q ss_pred             CCCCcEEEcC-CCceEEeecccccccCCCCcccccccccccCccCccccccC----------------------CCCccC
Q 018263          173 IKTSNILLDQ-NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG----------------------RLTRKS  229 (358)
Q Consensus       173 i~p~Nilv~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~s~~s  229 (358)
                      |||+||+++. ++.+||+|||++...............+++.|+|||.+...                      .++.++
T Consensus       281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~  360 (566)
T PLN03225        281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF  360 (566)
T ss_pred             CCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence            9999999985 57899999999986543333334456788999999965422                      233456


Q ss_pred             ceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCCC------CHHHHHHHHHHHhhccCCC
Q 018263          230 DVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNF------PENEAIRFLKVGLLCVQEK  303 (358)
Q Consensus       230 DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~~  303 (358)
                      |||||||++|+|+++..++...  ...+....... ......+...+.+......      .........+||.+||+.|
T Consensus       361 DVwSlGviL~el~~~~~~~~~~--~~~~~~~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d  437 (566)
T PLN03225        361 DIYSAGLIFLQMAFPNLRSDSN--LIQFNRQLKRN-DYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK  437 (566)
T ss_pred             ccHHHHHHHHHHHhCcCCCchH--HHHHHHHHHhc-CCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence            9999999999999876654321  11110000000 0011111111111110000      0011223558999999999


Q ss_pred             CCCCCCHHHHHH
Q 018263          304 SKLRPQMSTAIK  315 (358)
Q Consensus       304 P~~Rpt~~eil~  315 (358)
                      |.+|||+.++++
T Consensus       438 P~kR~ta~e~L~  449 (566)
T PLN03225        438 GRQRISAKAALA  449 (566)
T ss_pred             cccCCCHHHHhC
Confidence            999999999987

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.98  E-value=4.7e-34  Score=239.30  Aligned_cols=257  Identities=23%  Similarity=0.316  Sum_probs=197.1

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccCh-hhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      ++.+-+..||.|+||+|++..++ +|+..|||.+..... ...+++..|.+...+.. .+||||++++..-.++..+|.|
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~-~cp~IVkfyGa~F~EGdcWiCM  142 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSS-NCPNIVKFYGALFSEGDCWICM  142 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhc-CCcHHHHHhhhhhcCCceeeeH
Confidence            44555678999999999999876 699999999976643 56678888888877765 5999999999999999999999


Q ss_pred             ecCCCCCHHHHhhh-ccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          120 DYMPNNSLSQTLLG-EEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       120 e~~~~~~L~~~l~~-~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      |.+ ..+|+.+... ..-....++|..+-.++...+.||.||-...  .|+|||+||+||+++..|.+||+|||.+-..-
T Consensus       143 ELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv  219 (361)
T KOG1006|consen  143 ELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLV  219 (361)
T ss_pred             HHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHH
Confidence            999 5677766532 2234567999999999999999999998763  99999999999999999999999999986542


Q ss_pred             CCCcccccccccccCccCcccccc--CCCCccCceecHHHHHHHHHhCCCCCCcccc-ccchhhhHhhhhccchhhHhhh
Q 018263          199 ENTTHISTRVAGTLGYLAPEYAIS--GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ-LGEYHLVDKAWGMYNSKELMNL  275 (358)
Q Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~--~~~s~~sDiwslG~il~~lltg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                      ...  ..+.-.|...|+|||.+..  ..|+.++|+||||+++||+.||+.|+..... .++...+.       ..+...+
T Consensus       220 ~Si--AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv-------~gdpp~l  290 (361)
T KOG1006|consen  220 DSI--AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVV-------IGDPPIL  290 (361)
T ss_pred             HHH--HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHH-------cCCCCee
Confidence            221  2233457789999998863  3588999999999999999999999874332 11111110       0000001


Q ss_pred             hccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          276 VDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       276 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ...    .-.-+++..+..+|.-||-.|.++||...++.+
T Consensus       291 ~~~----~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  291 LFD----KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             cCc----ccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            000    011246778999999999999999999998865

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.98  E-value=1.7e-31  Score=255.43  Aligned_cols=261  Identities=26%  Similarity=0.394  Sum_probs=209.7

Q ss_pred             CHHHHHHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEE-
Q 018263           33 SYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCI-  110 (358)
Q Consensus        33 ~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~-  110 (358)
                      ..+.+....+.|+|.+.||.|.+|.||+++.. +++..|+|+.... ...+.+++.|.++++... .|||++.++++|. 
T Consensus        10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~-~hpnv~~fyg~~~k   87 (953)
T KOG0587|consen   10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYS-HHPNVATFYGAFIK   87 (953)
T ss_pred             chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhcc-CCCCcceEEEEEEE
Confidence            33444445678999999999999999999854 6888999998644 344556778888888876 7999999999887 


Q ss_pred             ----cCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCce
Q 018263          111 ----DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP  186 (358)
Q Consensus       111 ----~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~  186 (358)
                          .++.+++|||||.||+..|+++..  ....+.|..+..|+..++.||.+||.+   .++|||||-.||+++.++.|
T Consensus        88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~--~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~V  162 (953)
T KOG0587|consen   88 KDPGNGDQLWLVMEFCGGGSVTDLVKNT--KGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEV  162 (953)
T ss_pred             ecCCCCCeEEEEeeccCCccHHHHHhhh--cccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcE
Confidence                356789999999999999999654  377899999999999999999999999   99999999999999999999


Q ss_pred             EEeecccccccCCCCcccccccccccCccCcccccc-----CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhH
Q 018263          187 KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS-----GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVD  261 (358)
Q Consensus       187 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~  261 (358)
                      ||+|||.+..... .........||+.|+|||++..     ..|+..+|+||||++..+|.-|.+|+..-.+......+.
T Consensus       163 KLvDFGvSaQlds-T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~Ip  241 (953)
T KOG0587|consen  163 KLVDFGVSAQLDS-TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP  241 (953)
T ss_pred             EEeeeeeeeeeec-ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCC
Confidence            9999999876532 2223344779999999999863     346779999999999999999999986443322222221


Q ss_pred             hhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          262 KAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      +.              +...-..+....+.+.++|..||..|-.+||++.++++
T Consensus       242 RN--------------PPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  242 RN--------------PPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             CC--------------CCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            11              11112234678889999999999999999999998875

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.97  E-value=5e-32  Score=245.59  Aligned_cols=275  Identities=20%  Similarity=0.209  Sum_probs=209.9

Q ss_pred             cCHHHHHHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCC----CCceeee
Q 018263           32 FSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCH----ENLVKLH  106 (358)
Q Consensus        32 ~~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h----~~i~~~~  106 (358)
                      |.+.-=.+.-.+|.+....|+|-|++|..|.+. -|..||||++.... .--+.=+.|+++|++|....    -|++.++
T Consensus       422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~  500 (752)
T KOG0670|consen  422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLF  500 (752)
T ss_pred             EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence            334444555689999999999999999999875 47899999997542 22234457899999986333    3799999


Q ss_pred             ceEEcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCC-Cc
Q 018263          107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN-FN  185 (358)
Q Consensus       107 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~-~~  185 (358)
                      ..|.+.+++|+|+|.+ ..+|.+.+..... .--|....++.++.|++.||..|-..   ||+|.||||+||||++. ..
T Consensus       501 r~F~hknHLClVFE~L-slNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~i  575 (752)
T KOG0670|consen  501 RHFKHKNHLCLVFEPL-SLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNI  575 (752)
T ss_pred             HHhhhcceeEEEehhh-hchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcce
Confidence            9999999999999998 6899999966543 34477899999999999999999999   99999999999999865 45


Q ss_pred             eEEeecccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhh
Q 018263          186 PKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG  265 (358)
Q Consensus       186 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~  265 (358)
                      +||||||.+...+...   .+++..+..|.|||++.|.+|+..-|+||.||+||+|.||+..|.+..+..-+.+.....+
T Consensus       576 LKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KG  652 (752)
T KOG0670|consen  576 LKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKG  652 (752)
T ss_pred             eeeccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcC
Confidence            7999999998754433   2445566789999999999999999999999999999999999998766433333222222


Q ss_pred             ccch------------------------------------------hhHhh-hhccccCCCCCHHHHHHHHHHHhhccCC
Q 018263          266 MYNS------------------------------------------KELMN-LVDPMLYGNFPENEAIRFLKVGLLCVQE  302 (358)
Q Consensus       266 ~~~~------------------------------------------~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~  302 (358)
                      .+..                                          .++.. ++.....+.-.......+..|+.+||..
T Consensus       653 k~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~L  732 (752)
T KOG0670|consen  653 KFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLIL  732 (752)
T ss_pred             CCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhcc
Confidence            2211                                          11111 1111111122234566788999999999


Q ss_pred             CCCCCCCHHHHHH
Q 018263          303 KSKLRPQMSTAIK  315 (358)
Q Consensus       303 ~P~~Rpt~~eil~  315 (358)
                      ||.+|.|..+.|+
T Consensus       733 dP~KRit~nqAL~  745 (752)
T KOG0670|consen  733 DPEKRITVNQALK  745 (752)
T ss_pred             ChhhcCCHHHHhc
Confidence            9999999999875

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=1.1e-30  Score=248.76  Aligned_cols=267  Identities=18%  Similarity=0.231  Sum_probs=178.1

Q ss_pred             hhcCCcccceecccCceEEEEEEE-----------------CCCCEEEEEEeeccChhhHHHHH--------------HH
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRL-----------------QDGTIVAVKVLSVESKQGEKEFM--------------SE   88 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~-----------------~~~~~vaiK~~~~~~~~~~~~~~--------------~e   88 (358)
                      ..++|++.++||+|+||.||+|..                 ..++.||||.+.........++.              .|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            477999999999999999999863                 23567999998654333222222              34


Q ss_pred             HHHhhhcccCCC-----CceeeeceEEc--------CCeeEEEEecCCCCCHHHHhhhccc-------------------
Q 018263           89 VASMANVNVCHE-----NLVKLHGGCID--------GPCRILVYDYMPNNSLSQTLLGEEK-------------------  136 (358)
Q Consensus        89 ~~~l~~l~~~h~-----~i~~~~~~~~~--------~~~~~iv~e~~~~~~L~~~l~~~~~-------------------  136 (358)
                      +..+..+.  |.     +++.+++++..        .+..++||||+++++|.+++.....                   
T Consensus       223 ~~~l~~l~--~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~  300 (507)
T PLN03224        223 AYMCAKIK--RNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN  300 (507)
T ss_pred             HHHHHHhh--cccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence            45555554  33     34566666543        3567999999999999998853210                   


Q ss_pred             -cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCcccccccccccCcc
Q 018263          137 -RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL  215 (358)
Q Consensus       137 -~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~  215 (358)
                       ....+++..++.++.|++.+|.|||+.   +++|+||||+||+++.++.++|+|||++...............+++.|+
T Consensus       301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~  377 (507)
T PLN03224        301 MPQDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYS  377 (507)
T ss_pred             cccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCccee
Confidence             112346778999999999999999999   9999999999999999999999999998765332222222234578999


Q ss_pred             CccccccCC--------------------C--CccCceecHHHHHHHHHhCCC-CCCccccccchhhhHhhhhccchhhH
Q 018263          216 APEYAISGR--------------------L--TRKSDVYSFGVLLLEIVSGRT-AVDFDVQLGEYHLVDKAWGMYNSKEL  272 (358)
Q Consensus       216 aPE~~~~~~--------------------~--s~~sDiwslG~il~~lltg~~-pf~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      |||.+....                    +  ..+.|+||+||++|+|++|.. ||...........   .. ......+
T Consensus       378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~---~~-~~~~~~~  453 (507)
T PLN03224        378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELR---QY-DNDLNRW  453 (507)
T ss_pred             ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHh---hc-cchHHHH
Confidence            999875322                    1  134699999999999999875 6642211100000   00 0000001


Q ss_pred             hhhhccccCCCCCHHHHHHHHHHHhhccCCCC---CCCCCHHHHHH
Q 018263          273 MNLVDPMLYGNFPENEAIRFLKVGLLCVQEKS---KLRPQMSTAIK  315 (358)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P---~~Rpt~~eil~  315 (358)
                      .........-......+....+|+.+||..+|   .+|+|+.|+++
T Consensus       454 r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        454 RMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             HhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            11111111111123456678899999999766   68999999985

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1.2e-31  Score=248.12  Aligned_cols=217  Identities=27%  Similarity=0.366  Sum_probs=182.2

Q ss_pred             HHHHHHhhcCCcccceecccCceEEEEEEE-CCCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceE
Q 018263           34 YNQLKIATNGFRWSNKIGEGGFGSVYKGRL-QDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGC  109 (358)
Q Consensus        34 ~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~  109 (358)
                      .+.-.-+..-|..++.||-|+||.|.++.- .+...||+|.+...   ........+.|-.+|....  .+-+|+++-.|
T Consensus       621 LkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEAD--n~WVVrLyySF  698 (1034)
T KOG0608|consen  621 LKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEAD--NEWVVRLYYSF  698 (1034)
T ss_pred             HHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcC--CcceEEEEEEe
Confidence            334444567899999999999999999974 35778999988643   3445567788888999887  99999999999


Q ss_pred             EcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEe
Q 018263          110 IDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKIS  189 (358)
Q Consensus       110 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~  189 (358)
                      .+.+.+|+||+|++||++-.++    -+.+-+.|..++.++..+..|+++.|..   |++||||||+|||||.+|.+||.
T Consensus       699 QDkdnLYFVMdYIPGGDmMSLL----IrmgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLT  771 (1034)
T KOG0608|consen  699 QDKDNLYFVMDYIPGGDMMSLL----IRMGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLT  771 (1034)
T ss_pred             ccCCceEEEEeccCCccHHHHH----HHhccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeee
Confidence            9999999999999999999988    4667899999999999999999999999   99999999999999999999999


Q ss_pred             ecccccccC---------CCC-----------------cc---------------cccccccccCccCccccccCCCCcc
Q 018263          190 DFGLSKLFP---------ENT-----------------TH---------------ISTRVAGTLGYLAPEYAISGRLTRK  228 (358)
Q Consensus       190 Dfg~~~~~~---------~~~-----------------~~---------------~~~~~~~~~~y~aPE~~~~~~~s~~  228 (358)
                      |||++.-+.         ...                 ..               ......||+.|+|||++....++..
T Consensus       772 DFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~  851 (1034)
T KOG0608|consen  772 DFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQL  851 (1034)
T ss_pred             eccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcccc
Confidence            999985320         000                 00               0001479999999999999999999


Q ss_pred             CceecHHHHHHHHHhCCCCCCccccccchhh
Q 018263          229 SDVYSFGVLLLEIVSGRTAVDFDVQLGEYHL  259 (358)
Q Consensus       229 sDiwslG~il~~lltg~~pf~~~~~~~~~~~  259 (358)
                      .|.|+.|+|||+|+.|+.||..+.+.+....
T Consensus       852 cdwws~gvil~em~~g~~pf~~~tp~~tq~k  882 (1034)
T KOG0608|consen  852 CDWWSVGVILYEMLVGQPPFLADTPGETQYK  882 (1034)
T ss_pred             chhhHhhHHHHHHhhCCCCccCCCCCcceee
Confidence            9999999999999999999988877655443

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=8.2e-33  Score=232.83  Aligned_cols=265  Identities=20%  Similarity=0.298  Sum_probs=214.4

Q ss_pred             CCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC-----e
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP-----C  114 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~-----~  114 (358)
                      +.+-.+.||.|+||.||.+++. +|+.|++|.+...  .-...+.+-+|+.++..++  |.|++..+++..-..     .
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFk--HdNVLSaLDILQPph~dfFqE  131 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFR--HDNVLSLLDILQPANPSFFQE  131 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhc--cccHHHHHHhcCCCCchHHHH
Confidence            4445678999999999999875 7999999988643  3445678889999999999  999999888765332     3


Q ss_pred             eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccc
Q 018263          115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS  194 (358)
Q Consensus       115 ~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~  194 (358)
                      .|++.|.+ ..+|..++    -..+.++.+.+.-+++||++||.|||+.   +|.||||||.|++|+.|..+||+|||++
T Consensus       132 iYV~TELm-QSDLHKII----VSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLA  203 (449)
T KOG0664|consen  132 LYVLTELM-QSDLHKII----VSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLA  203 (449)
T ss_pred             HHHHHHHH-Hhhhhhee----ccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccc
Confidence            46777877 45677776    5678899999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcccccccccccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHh
Q 018263          195 KLFPENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELM  273 (358)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      +..........+.-..|..|.|||++.|. .|+.+.||||.||++.||+..+..|...++..+..++....+.+..+..+
T Consensus       204 Rvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr  283 (449)
T KOG0664|consen  204 RTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMK  283 (449)
T ss_pred             cccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHH
Confidence            98655555556666778899999999875 68999999999999999999999999999988999888888887766554


Q ss_pred             hhhc--------cccCC---------CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 018263          274 NLVD--------PMLYG---------NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMM  317 (358)
Q Consensus       274 ~~~~--------~~~~~---------~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L  317 (358)
                      .-.+        ...+.         ..+.........+...++..+|++|.+..+.+.-+
T Consensus       284 ~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  284 YACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             HHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence            4332        11111         11123445667788899999999999988877654

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-31  Score=216.47  Aligned_cols=217  Identities=24%  Similarity=0.348  Sum_probs=180.2

Q ss_pred             cccccCHHHHHHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceee
Q 018263           28 NINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKL  105 (358)
Q Consensus        28 ~~~~~~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~  105 (358)
                      .+.....+.+.+..+...-...||+|++|.|-+.++. +|...|+|.+... .....++...|+.+..... .+|+++.+
T Consensus        32 a~i~I~~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~-~CPf~V~F  110 (282)
T KOG0984|consen   32 ALIYIGDRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTV-DCPFTVHF  110 (282)
T ss_pred             ceEEEecCccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCC-CCCeEEEe
Confidence            3444444557888889999999999999999877754 7999999999765 3445567778888776654 59999999


Q ss_pred             eceEEcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCc
Q 018263          106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN  185 (358)
Q Consensus       106 ~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~  185 (358)
                      ++........+|.||.+ ..+|+.+..+--...+.++|..+-+++..++.||.|||++  ..++|||+||+||+++.+|+
T Consensus       111 yGa~~regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~Gq  187 (282)
T KOG0984|consen  111 YGALFREGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQ  187 (282)
T ss_pred             ehhhhccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCc
Confidence            99999999999999999 5788888766666788999999999999999999999997  49999999999999999999


Q ss_pred             eEEeecccccccCCCCcccccccccccCccCcccccc----CCCCccCceecHHHHHHHHHhCCCCCCc
Q 018263          186 PKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS----GRLTRKSDVYSFGVLLLEIVSGRTAVDF  250 (358)
Q Consensus       186 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~s~~sDiwslG~il~~lltg~~pf~~  250 (358)
                      +|++|||.+-..-+.-.  .+-..|...|+|||.+..    ..|+-++||||||+++.||.+++.||+.
T Consensus       188 VKiCDFGIsG~L~dSiA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~  254 (282)
T KOG0984|consen  188 VKICDFGISGYLVDSIA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES  254 (282)
T ss_pred             EEEcccccceeehhhhH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence            99999999865422221  122457789999998753    3688999999999999999999999873

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-31  Score=254.39  Aligned_cols=242  Identities=24%  Similarity=0.317  Sum_probs=184.4

Q ss_pred             ceecccCceE-EEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecCCCCC
Q 018263           48 NKIGEGGFGS-VYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNS  126 (358)
Q Consensus        48 ~~lg~g~~g~-v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~~~~~  126 (358)
                      +.+|.|..|+ ||+|... |+.||||.+....   ...+.+|+..|+.-. .||||+++++.-.+++..||..|.| ..+
T Consensus       515 eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~---~~~A~rEi~lL~eSD-~H~NviRyyc~E~d~qF~YIalELC-~~s  588 (903)
T KOG1027|consen  515 EILGYGSNGTVVFRGVYE-GREVAVKRLLEEF---FDFAQREIQLLQESD-EHPNVIRYYCSEQDRQFLYIALELC-ACS  588 (903)
T ss_pred             HHcccCCCCcEEEEEeeC-CceehHHHHhhHh---HHHHHHHHHHHHhcc-CCCceEEEEeeccCCceEEEEehHh-hhh
Confidence            5678998875 5899885 8899999986433   335668999999887 6999999999999999999999999 689


Q ss_pred             HHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcC---C--CceEEeecccccccCCCC
Q 018263          127 LSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ---N--FNPKISDFGLSKLFPENT  201 (358)
Q Consensus       127 L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~---~--~~~~l~Dfg~~~~~~~~~  201 (358)
                      |.+++...............+....|++.||++||+.   +|+||||||.||+|+.   +  .+++|+|||+++......
T Consensus       589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~  665 (903)
T KOG1027|consen  589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK  665 (903)
T ss_pred             HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence            9999954211111122245678899999999999999   9999999999999975   2  468999999999876544


Q ss_pred             ccc--ccccccccCccCccccccCCCCccCceecHHHHHHHHHhC-CCCCCccccccchhhhHhhhhccchhhHhhhhcc
Q 018263          202 THI--STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG-RTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDP  278 (358)
Q Consensus       202 ~~~--~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (358)
                      ...  .....||.+|.|||++....-+.++|||||||++|+.++| .+||+..-..+..-+.       ....+.. +  
T Consensus       666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~-------~~~~L~~-L--  735 (903)
T KOG1027|consen  666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILT-------GNYTLVH-L--  735 (903)
T ss_pred             chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhc-------Cccceee-e--
Confidence            433  3357799999999999988888899999999999999986 9999844321110000       0000000 0  


Q ss_pred             ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 018263          279 MLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAI  314 (358)
Q Consensus       279 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil  314 (358)
                          ....++  ...+||.+|+..+|..||+|.+|+
T Consensus       736 ----~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL  765 (903)
T KOG1027|consen  736 ----EPLPDC--EAKDLISRMLNPDPQLRPSATDVL  765 (903)
T ss_pred             ----ccCchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence                001111  678999999999999999999987

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.97  E-value=4.2e-31  Score=227.00  Aligned_cols=262  Identities=22%  Similarity=0.257  Sum_probs=210.2

Q ss_pred             HhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC--
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP--  113 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~--  113 (358)
                      ....+|.-++.+|.|.. .|..|.+. .++.|++|....+  .....++..+|+..+..+.  |+|++.++.+|.-..  
T Consensus        14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~--~~nii~l~n~ftP~~~l   90 (369)
T KOG0665|consen   14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVN--HKNIISLLNVFTPQKTL   90 (369)
T ss_pred             eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhc--ccceeeeeeccCccccH
Confidence            34678999999999998 66666654 6888999987543  3445567788999999988  999999999987443  


Q ss_pred             ----eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEe
Q 018263          114 ----CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKIS  189 (358)
Q Consensus       114 ----~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~  189 (358)
                          ..|+|||++ ..+|...+.      ..++-+.+..+++|++.|+.+||+.   ||+||||||+||++..++.+||.
T Consensus        91 ~~~~e~y~v~e~m-~~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~  160 (369)
T KOG0665|consen   91 EEFQEVYLVMELM-DANLCQVIL------MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKIL  160 (369)
T ss_pred             HHHHhHHHHHHhh-hhHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeec
Confidence                468999999 678888873      4567889999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccch
Q 018263          190 DFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNS  269 (358)
Q Consensus       190 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      |||++..-.  .....+.+..+.-|.|||++.+..+.+.+||||+||++.+|++|+..|.+.+..+++..+....+.+..
T Consensus       161 dfg~ar~e~--~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~  238 (369)
T KOG0665|consen  161 DFGLARTED--TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDP  238 (369)
T ss_pred             cchhhcccC--cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCH
Confidence            999998632  224567788899999999999988999999999999999999999999999888888877766655543


Q ss_pred             hhHhhhhcc-----------------------ccCC--CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          270 KELMNLVDP-----------------------MLYG--NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       270 ~~~~~~~~~-----------------------~~~~--~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .-..++...                       .+..  +.+........+++.+||-.||++|.+++++|+
T Consensus       239 ~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  239 SFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             HHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence            322111110                       0000  111234456789999999999999999999986

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=4.2e-29  Score=213.38  Aligned_cols=211  Identities=34%  Similarity=0.564  Sum_probs=182.1

Q ss_pred             ecccCceEEEEEEECC-CCEEEEEEeeccChh-hHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecCCCCCH
Q 018263           50 IGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQ-GEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSL  127 (358)
Q Consensus        50 lg~g~~g~v~~~~~~~-~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L  127 (358)
                      ||.|.+|.||++.... ++.+++|++...... ....+.+|+..++.+.  |++++++++.+......++++|++++++|
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~--~~~i~~~~~~~~~~~~~~~~~e~~~~~~l   78 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLN--HPNIVKLYGVFEDENHLYLVMEYCEGGSL   78 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcC--CCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence            6899999999999764 899999998755432 3567889999999998  99999999999999999999999998999


Q ss_pred             HHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcC-CCceEEeecccccccCCCCccccc
Q 018263          128 SQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ-NFNPKISDFGLSKLFPENTTHIST  206 (358)
Q Consensus       128 ~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~-~~~~~l~Dfg~~~~~~~~~~~~~~  206 (358)
                      .+++...   ...++...++.++.+++.++.+||+.   |++|+||+|.||+++. ++.++|+||+.+........ ...
T Consensus        79 ~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~  151 (215)
T cd00180          79 KDLLKEN---EGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLK  151 (215)
T ss_pred             HHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhh
Confidence            9998322   14688999999999999999999999   9999999999999999 89999999999986543321 123


Q ss_pred             ccccccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCCCC
Q 018263          207 RVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFP  285 (358)
Q Consensus       207 ~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (358)
                      ...+...|.+||.+... ..+.++|+|++|+++++|                                            
T Consensus       152 ~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------  187 (215)
T cd00180         152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------  187 (215)
T ss_pred             cccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------------
Confidence            34577889999988776 788999999999999999                                            


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 018263          286 ENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMM  317 (358)
Q Consensus       286 ~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L  317 (358)
                          ..+.+++.+|++.+|++||++.++++.+
T Consensus       188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 ----PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             ----HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                3488999999999999999999998754

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=5.3e-30  Score=225.43  Aligned_cols=266  Identities=21%  Similarity=0.264  Sum_probs=213.2

Q ss_pred             CHHHHHHhhcCCcccceecccCceEEEEEEEC------CCCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceee
Q 018263           33 SYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKL  105 (358)
Q Consensus        33 ~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~  105 (358)
                      ...++.+-..|+++...+-+|.||.||.|.+.      +.+.|.+|.++.. +..+...+..|-..+..+.  |||++.+
T Consensus       275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~s--H~nll~V  352 (563)
T KOG1024|consen  275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGAS--HPNLLSV  352 (563)
T ss_pred             hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCc--CCCccce
Confidence            44566667788999999999999999999653      3445677777544 3445567778888888887  9999999


Q ss_pred             eceEEc-CCeeEEEEecCCCCCHHHHhhh----ccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEE
Q 018263          106 HGGCID-GPCRILVYDYMPNNSLSQTLLG----EEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL  180 (358)
Q Consensus       106 ~~~~~~-~~~~~iv~e~~~~~~L~~~l~~----~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv  180 (358)
                      .++... ....++++.+..-++|..++..    .....+.++..++..++.|++.|++|||+.   |++|.||...|.+|
T Consensus       353 ~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvI  429 (563)
T KOG1024|consen  353 LGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVI  429 (563)
T ss_pred             eEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhccee
Confidence            998764 4567889999999999999962    123456788899999999999999999999   99999999999999


Q ss_pred             cCCCceEEeecccccccCCCCccc-ccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchh
Q 018263          181 DQNFNPKISDFGLSKLFPENTTHI-STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYH  258 (358)
Q Consensus       181 ~~~~~~~l~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~  258 (358)
                      ++.-++||+|-.+++..-+..... ...-..+.-|++||.+.+..|+.++|+||||+++|||+| |+.|+..-+      
T Consensus       430 dd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID------  503 (563)
T KOG1024|consen  430 DDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID------  503 (563)
T ss_pred             hhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC------
Confidence            999999999998887543322221 122234568999999999999999999999999999998 888876332      


Q ss_pred             hhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 018263          259 LVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNG  319 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~  319 (358)
                                ..+....+...-+-..|.+++.++..++.-||...|++||+++++..-|..
T Consensus       504 ----------PfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse  554 (563)
T KOG1024|consen  504 ----------PFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE  554 (563)
T ss_pred             ----------HHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence                      344455555555566778899999999999999999999999999887764

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1e-29  Score=213.93  Aligned_cols=250  Identities=18%  Similarity=0.296  Sum_probs=189.4

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeece-EEcCCeeEEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG-CIDGPCRILV  118 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~-~~~~~~~~iv  118 (358)
                      .+.|.|.+.||.|.||.+-++.++ +++.+++|-+..+ ....+++.+|+..--.+. .|.||+..+++ |...+..+++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls-~H~hIi~tY~vaFqt~d~YvF~  100 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLS-PHQHIIDTYEVAFQTSDAYVFV  100 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeec-cchhhhHHHHHHhhcCceEEEe
Confidence            578999999999999999999976 5888999998644 345578889998877776 59999998875 6677788899


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEc--CCCceEEeecccccc
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD--QNFNPKISDFGLSKL  196 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~--~~~~~~l~Dfg~~~~  196 (358)
                      +||+|.|+|...+    . ..-+.+..-..++.|++.|+.|+|++   ++||||||.+||+|-  +..++||+|||....
T Consensus       101 qE~aP~gdL~snv----~-~~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k  172 (378)
T KOG1345|consen  101 QEFAPRGDLRSNV----E-AAGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRK  172 (378)
T ss_pred             eccCccchhhhhc----C-cccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccc
Confidence            9999999999998    2 24477888999999999999999999   999999999999994  455899999999986


Q ss_pred             cCCCCcccccccccccCccCccccccC-----CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhh
Q 018263          197 FPENTTHISTRVAGTLGYLAPEYAISG-----RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKE  271 (358)
Q Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      .+.    ..........|.+||+....     ...+.+|+|.||+++|.+++|..||......+....-...|..-....
T Consensus       173 ~g~----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~  248 (378)
T KOG1345|consen  173 VGT----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPA  248 (378)
T ss_pred             cCc----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCcc
Confidence            432    12223345679999976532     356789999999999999999999985544443322221211111111


Q ss_pred             HhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 018263          272 LMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTA  313 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ei  313 (358)
                      .         +..-...+..+.++.++-|..+|++|-.+.++
T Consensus       249 ~---------P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~  281 (378)
T KOG1345|consen  249 L---------PKKFNPFSEKALRLFKKSLTPRFKDRCKIWTA  281 (378)
T ss_pred             C---------chhhcccCHHHHHHHHHhcCCcccccchhHHH
Confidence            1         11112355678889999999999999554444

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=5.4e-30  Score=235.07  Aligned_cols=199  Identities=24%  Similarity=0.332  Sum_probs=169.8

Q ss_pred             hcCCcccceecccCceEEEEEEECC-CCEEEEEEeecc----Chhh----HHHHHHHHHHhhhcc-cCCCCceeeeceEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQD-GTIVAVKVLSVE----SKQG----EKEFMSEVASMANVN-VCHENLVKLHGGCI  110 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~~-~~~vaiK~~~~~----~~~~----~~~~~~e~~~l~~l~-~~h~~i~~~~~~~~  110 (358)
                      ..+|..++.+|.|+||.|++|.++. ...|+||.+..+    +.+.    .-.+-.|++++..++ ..|+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            4579999999999999999999874 667899987543    1111    123456888888875 34999999999999


Q ss_pred             cCCeeEEEEecC-CCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEe
Q 018263          111 DGPCRILVYDYM-PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKIS  189 (358)
Q Consensus       111 ~~~~~~iv~e~~-~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~  189 (358)
                      +++++|++||.. +|.+|++++    .....++|..+..++.||+-|+++||+.   ||+|||||-+||.++.+|.+||+
T Consensus       640 ddd~yyl~te~hg~gIDLFd~I----E~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~kli  712 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFI----EFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLI  712 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhh----hccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEe
Confidence            999999999965 677899999    6778899999999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccCccCccccccCCC-CccCceecHHHHHHHHHhCCCCCC
Q 018263          190 DFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVD  249 (358)
Q Consensus       190 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-s~~sDiwslG~il~~lltg~~pf~  249 (358)
                      |||.+......+.   ....||..|.|||++.|.+| +..-|||+||+++|.+...+.||.
T Consensus       713 dfgsaa~~ksgpf---d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  713 DFGSAAYTKSGPF---DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             eccchhhhcCCCc---ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9999987655443   34679999999999988765 567899999999999999999875

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.96  E-value=6.5e-29  Score=220.88  Aligned_cols=265  Identities=24%  Similarity=0.340  Sum_probs=198.7

Q ss_pred             HHhhcCCcccceecccCceEEEEEEEC----CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC
Q 018263           38 KIATNGFRWSNKIGEGGFGSVYKGRLQ----DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP  113 (358)
Q Consensus        38 ~~~~~~y~i~~~lg~g~~g~v~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~  113 (358)
                      .-..+.|.++++||.|.|++||++.+.    .++.||+|.+...+..  .++..|++.|..+. ++.||+++.+.+...+
T Consensus        32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~g-G~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLG-GSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhc-cchhhhcchhhhccCC
Confidence            334578999999999999999999843    4778999998765433  45889999999997 7999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcC-CCceEEeecc
Q 018263          114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ-NFNPKISDFG  192 (358)
Q Consensus       114 ~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~-~~~~~l~Dfg  192 (358)
                      ...+|+||++.....+++       ..++...+..+++.++.||.++|.+   ||+||||||+|++.+. .++-.|+|||
T Consensus       109 ~v~ivlp~~~H~~f~~l~-------~~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFg  178 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLY-------RSLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFG  178 (418)
T ss_pred             eeEEEecccCccCHHHHH-------hcCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEech
Confidence            999999999999888887       2356899999999999999999999   9999999999999974 5678999999


Q ss_pred             cccccC-----------------C----------------C----------CcccccccccccCccCccccccC-CCCcc
Q 018263          193 LSKLFP-----------------E----------------N----------TTHISTRVAGTLGYLAPEYAISG-RLTRK  228 (358)
Q Consensus       193 ~~~~~~-----------------~----------------~----------~~~~~~~~~~~~~y~aPE~~~~~-~~s~~  228 (358)
                      ++....                 .                +          .........||++|.|||++... .-+.+
T Consensus       179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta  258 (418)
T KOG1167|consen  179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA  258 (418)
T ss_pred             hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence            987210                 0                0          00011125799999999998864 46889


Q ss_pred             CceecHHHHHHHHHhCCCCCCccccccc-hhhhHhh------------hhc--cch-h----------hHhhh-hccccC
Q 018263          229 SDVYSFGVLLLEIVSGRTAVDFDVQLGE-YHLVDKA------------WGM--YNS-K----------ELMNL-VDPMLY  281 (358)
Q Consensus       229 sDiwslG~il~~lltg~~pf~~~~~~~~-~~~~~~~------------~~~--~~~-~----------~~~~~-~~~~~~  281 (358)
                      .||||.|+|+..+++++.||-....+-. ...+.-+            .+.  ... .          .+..+ +.....
T Consensus       259 iDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~  338 (418)
T KOG1167|consen  259 IDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYK  338 (418)
T ss_pred             cceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccc
Confidence            9999999999999999999965443211 1111111            111  000 0          11111 011111


Q ss_pred             --------CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          282 --------GNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       282 --------~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                              .......+..+.+++.+||+.||.+|.|+++.|+
T Consensus       339 ~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  339 SRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             ccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence                    1122234557899999999999999999999985

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=3.9e-28  Score=210.27  Aligned_cols=198  Identities=33%  Similarity=0.499  Sum_probs=171.6

Q ss_pred             CcccceecccCceEEEEEEECC-CCEEEEEEeeccChh-hHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEec
Q 018263           44 FRWSNKIGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQ-GEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY  121 (358)
Q Consensus        44 y~i~~~lg~g~~g~v~~~~~~~-~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~  121 (358)
                      |.+.+.||.|++|.||++.... ++.+++|.+...... ..+.+..|++.+..++  |+|++++++.+......++++|+
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~--~~~i~~~~~~~~~~~~~~~v~e~   78 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLK--HPNIVKLYGVFEDPEPLYLVMEY   78 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCC--CCChhhheeeeecCCceEEEEec
Confidence            6778999999999999999764 889999999765544 5678888999999997  99999999999999999999999


Q ss_pred             CCCCCHHHHhhhccccccC-CCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCC
Q 018263          122 MPNNSLSQTLLGEEKRRAK-FGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN  200 (358)
Q Consensus       122 ~~~~~L~~~l~~~~~~~~~-l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~  200 (358)
                      +++++|.+++..    ... +++..+..++.+++.++.+||+.   +++|+|++|.||+++.++.++|+|||.+......
T Consensus        79 ~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~  151 (225)
T smart00221       79 CEGGDLFDYLRK----KGGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRD  151 (225)
T ss_pred             cCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence            999999999832    233 78999999999999999999999   9999999999999999999999999998876443


Q ss_pred             CcccccccccccCccCcccc-ccCCCCccCceecHHHHHHHHHhCCCCCCc
Q 018263          201 TTHISTRVAGTLGYLAPEYA-ISGRLTRKSDVYSFGVLLLEIVSGRTAVDF  250 (358)
Q Consensus       201 ~~~~~~~~~~~~~y~aPE~~-~~~~~s~~sDiwslG~il~~lltg~~pf~~  250 (358)
                      .........++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus       152 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      152 LAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            31122335577889999988 566788899999999999999999999964

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.95  E-value=1.9e-29  Score=234.90  Aligned_cols=252  Identities=23%  Similarity=0.339  Sum_probs=208.1

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      .++|+++..+|+|.+|.||+++++ +++..|+|+++.+.....+-+++|+-+++..+  ||||+.+++.+.....+++.|
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~--h~nivay~gsylr~dklwicM   91 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCR--HPNIVAYFGSYLRRDKLWICM   91 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCC--CcChHHHHhhhhhhcCcEEEE
Confidence            479999999999999999999975 69999999999998888888999999999998  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      |||.||+|.+..    .-.+++++.++.......+.+|+|||+.   |-+|||||-.||++++.|.+++.|||.+-.+..
T Consensus        92 EycgggslQdiy----~~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqita  164 (829)
T KOG0576|consen   92 EYCGGGSLQDIY----HVTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITA  164 (829)
T ss_pred             EecCCCccccee----eecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhh
Confidence            999999999998    5678999999999999999999999999   999999999999999999999999998876532


Q ss_pred             CCcccccccccccCccCccccc---cCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhh
Q 018263          200 NTTHISTRVAGTLGYLAPEYAI---SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV  276 (358)
Q Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~---~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                       .........||+-|+|||+..   .+.|...+|||++|++..++--.++|.....+.....++.+-     .      .
T Consensus       165 -ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS-----~------~  232 (829)
T KOG0576|consen  165 -TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKS-----G------F  232 (829)
T ss_pred             -hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhcc-----C------C
Confidence             223344578999999999864   467889999999999999998888775433332222222111     0      0


Q ss_pred             ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 018263          277 DPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAI  314 (358)
Q Consensus       277 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil  314 (358)
                      ++.- ..-.......+.++++.+|-.+|.+|||++-++
T Consensus       233 qpp~-lkDk~kws~~fh~fvK~altknpKkRptaeklL  269 (829)
T KOG0576|consen  233 QPPT-LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLL  269 (829)
T ss_pred             CCCc-ccCCccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence            0000 011234566788999999999999999987554

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.94  E-value=3.4e-27  Score=240.49  Aligned_cols=191  Identities=16%  Similarity=0.128  Sum_probs=133.6

Q ss_pred             CCceeeeceE-------EcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcC
Q 018263          100 ENLVKLHGGC-------IDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRD  172 (358)
Q Consensus       100 ~~i~~~~~~~-------~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~d  172 (358)
                      .||+.+++++       .+...++.++|++ +++|.+++..   ....+++..+..++.||+.||+|||++   ||+|||
T Consensus        33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---gIvHrD  105 (793)
T PLN00181         33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQ---GIVVHN  105 (793)
T ss_pred             HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhC---Ceeecc
Confidence            4666677766       2334567888987 6799999932   245689999999999999999999999   999999


Q ss_pred             CCCCcEEEcCCCceEEe-------------------ecccccccCCCC---------------cccccccccccCccCcc
Q 018263          173 IKTSNILLDQNFNPKIS-------------------DFGLSKLFPENT---------------THISTRVAGTLGYLAPE  218 (358)
Q Consensus       173 i~p~Nilv~~~~~~~l~-------------------Dfg~~~~~~~~~---------------~~~~~~~~~~~~y~aPE  218 (358)
                      |||+||||+..+.++++                   |||+++......               ........+|+.|+|||
T Consensus       106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE  185 (793)
T PLN00181        106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPE  185 (793)
T ss_pred             CCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChh
Confidence            99999999765555555                   444443211000               00001134788899999


Q ss_pred             ccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhh
Q 018263          219 YAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLL  298 (358)
Q Consensus       219 ~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  298 (358)
                      ++.+..++.++|||||||++|||++|..|+.....     .....         ..   ...... ..........++.+
T Consensus       186 ~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----~~~~~---------~~---~~~~~~-~~~~~~~~~~~~~~  247 (793)
T PLN00181        186 EDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----TMSSL---------RH---RVLPPQ-ILLNWPKEASFCLW  247 (793)
T ss_pred             hhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----HHHHH---------HH---hhcChh-hhhcCHHHHHHHHH
Confidence            99999999999999999999999999888652211     00000         00   000000 01122345688899


Q ss_pred             ccCCCCCCCCCHHHHHH
Q 018263          299 CVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       299 ~l~~~P~~Rpt~~eil~  315 (358)
                      ||+.+|.+||++.|+++
T Consensus       248 ~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        248 LLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             hCCCChhhCcChHHHhh
Confidence            99999999999999975

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.94  E-value=3.1e-26  Score=191.41  Aligned_cols=167  Identities=19%  Similarity=0.181  Sum_probs=124.7

Q ss_pred             CCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCccc
Q 018263          125 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI  204 (358)
Q Consensus       125 ~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~  204 (358)
                      |+|.+++..   ....+++..++.++.||+.||.|||+.   +      ||+||+++.++.+++  ||.+.......   
T Consensus         1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---   63 (176)
T smart00750        1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ---   63 (176)
T ss_pred             CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence            578888832   245699999999999999999999998   6      999999999999999  99987653321   


Q ss_pred             ccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCCC
Q 018263          205 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNF  284 (358)
Q Consensus       205 ~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (358)
                         ..+++.|+|||++.+..++.++||||||+++|+|++|+.||.........  ..........      ..+. ....
T Consensus        64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~--~~~~~~~~~~------~~~~-~~~~  131 (176)
T smart00750       64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAI--LEILLNGMPA------DDPR-DRSN  131 (176)
T ss_pred             ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHH--HHHHHHHhcc------CCcc-cccc
Confidence               25789999999999999999999999999999999999999644321111  0000000000      0000 0011


Q ss_pred             CHHHHH--HHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 018263          285 PENEAI--RFLKVGLLCVQEKSKLRPQMSTAIKMMNGE  320 (358)
Q Consensus       285 ~~~~~~--~l~~li~~~l~~~P~~Rpt~~eil~~L~~~  320 (358)
                      +.....  .+.+++.+||+.+|.+||++.++++.+...
T Consensus       132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence            223333  699999999999999999999999887654

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=1.2e-24  Score=199.08  Aligned_cols=264  Identities=20%  Similarity=0.235  Sum_probs=198.0

Q ss_pred             CCcccceecccCceEEEEEEECCC--CEEEEEEeeccChhhHHHHHHHHHHhhhccc--CCCCceeeeceE-EcCCeeEE
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQDG--TIVAVKVLSVESKQGEKEFMSEVASMANVNV--CHENLVKLHGGC-IDGPCRIL  117 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~~~--~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~--~h~~i~~~~~~~-~~~~~~~i  117 (358)
                      +|++.++||+|+||.||.+.....  ..+|+|............+..|...+..+..  ..+++..+++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            899999999999999999997653  5799999876543333366677777777762  246899999998 57778999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCC-----CceEEeecc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN-----FNPKISDFG  192 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~-----~~~~l~Dfg  192 (358)
                      ||+.+ |.+|.++.....  .+.++..++..++.|++.+|.+||+.   |++||||||.|+++...     ..+.|.|||
T Consensus        99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG  172 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFG  172 (322)
T ss_pred             EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence            99988 999999874432  57899999999999999999999999   99999999999999765     358999999


Q ss_pred             ccc--ccCCCCc------cc-ccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhh
Q 018263          193 LSK--LFPENTT------HI-STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKA  263 (358)
Q Consensus       193 ~~~--~~~~~~~------~~-~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~  263 (358)
                      +++  .+.....      .. .....||..|.++....+...+++.|+||++.++.+++.|..||...............
T Consensus       173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~  252 (322)
T KOG1164|consen  173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD  252 (322)
T ss_pred             CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence            998  3221111      01 22356999999999999999999999999999999999999999654433222222111


Q ss_pred             hhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCC
Q 018263          264 WGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNID  324 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~  324 (358)
                      ..       ......     .....+..+.++...+-+.+...+|....+.+.|.......
T Consensus       253 ~~-------~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  253 PR-------KLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             hh-------hhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence            10       000000     11223344555555555689999999999998877665544

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=2.5e-24  Score=178.70  Aligned_cols=255  Identities=21%  Similarity=0.255  Sum_probs=194.0

Q ss_pred             HhhcCCcccceecccCceEEEEEE-ECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      +....|+++++||+|+||.+|+|. ..+|+.||||+........  .+..|..+...++ ....|..+..+........+
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp--qL~yEskvY~iL~-~g~GiP~i~~y~~e~~ynvl   88 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP--QLLYESKVYRILQ-GGVGIPHIRHYGTEKDYNVL   88 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc--chhHHHHHHHHhc-cCCCCchhhhhcccccccee
Confidence            446799999999999999999998 4579999999987654444  4455666666665 46788888888999999999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEc---CCCceEEeecccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD---QNFNPKISDFGLS  194 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~---~~~~~~l~Dfg~~  194 (358)
                      ||+.. |.+|.+++..   ....++.+++.-++-|++.-++|+|.+   +++||||||+|++..   ....+.++|||++
T Consensus        89 VMdLL-GPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa  161 (341)
T KOG1163|consen   89 VMDLL-GPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLA  161 (341)
T ss_pred             eeecc-CccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccch
Confidence            99998 9999999842   456688999999999999999999999   999999999999995   3456899999999


Q ss_pred             cccCCCCcc------cccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccc
Q 018263          195 KLFPENTTH------ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYN  268 (358)
Q Consensus       195 ~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  268 (358)
                      +.+.+....      ......||..|.+-....+..-+.+.|+-|+|.++.++.-|..||.+-......+...++.....
T Consensus       162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~  241 (341)
T KOG1163|consen  162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKM  241 (341)
T ss_pred             hhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhc
Confidence            876443322      23346789999888877777788999999999999999999999998776666666666654444


Q ss_pred             hhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 018263          269 SKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMST  312 (358)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~e  312 (358)
                      +.....+...         .+.++.-.+..|-...-.+-|.-.-
T Consensus       242 s~~ie~LC~G---------~P~EF~myl~Y~R~L~F~E~Pdy~y  276 (341)
T KOG1163|consen  242 STPIEVLCKG---------FPAEFAMYLNYCRGLGFEEKPDYMY  276 (341)
T ss_pred             CCCHHHHhCC---------CcHHHHHHHHHHhhcCCCCCCcHHH
Confidence            4444333332         2233444444444444444454333

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.91  E-value=3.4e-25  Score=216.80  Aligned_cols=255  Identities=21%  Similarity=0.283  Sum_probs=193.9

Q ss_pred             CCcccceecccCceEEEEEEECCCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEec
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY  121 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~  121 (358)
                      +|...+.||.+.|-+|.+|++..|. |++|++-..+ ......+.+.++..+.....+||.+++.-+.......|+|.+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            7888999999999999999998888 8889875443 4445555555555544433499999999998888888999999


Q ss_pred             CCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc--CC
Q 018263          122 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PE  199 (358)
Q Consensus       122 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~--~~  199 (358)
                      . ..+|.|.+    +.+..+.+-+...++.|++.||...|..   ||||||||.+||+|+.-+-+.|+||-..+..  ++
T Consensus       103 v-khnLyDRl----STRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe  174 (1431)
T KOG1240|consen  103 V-KHNLYDRL----STRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE  174 (1431)
T ss_pred             H-hhhhhhhh----ccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence            9 56899999    7888899999999999999999999999   9999999999999999999999999866533  22


Q ss_pred             CC----cccccccccccCccCccccccC----------C-CCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhh
Q 018263          200 NT----THISTRVAGTLGYLAPEYAISG----------R-LTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKA  263 (358)
Q Consensus       200 ~~----~~~~~~~~~~~~y~aPE~~~~~----------~-~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~  263 (358)
                      +.    ...........+|.|||.+...          . .+++.||||+||++.||++ |++||....      +...-
T Consensus       175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ------L~aYr  248 (1431)
T KOG1240|consen  175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ------LLAYR  248 (1431)
T ss_pred             CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH------HHhHh
Confidence            22    2233334556799999987531          1 5789999999999999998 688886321      11111


Q ss_pred             hhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCC
Q 018263          264 WGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETN  322 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~  322 (358)
                      .+  ...+...+++.+-        ...+.++|..|++.||++|.+|++.|+.-.+...
T Consensus       249 ~~--~~~~~e~~Le~Ie--------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~F  297 (1431)
T KOG1240|consen  249 SG--NADDPEQLLEKIE--------DVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVF  297 (1431)
T ss_pred             cc--CccCHHHHHHhCc--------CccHHHHHHHHHccCchhccCHHHHHHhhhcccc
Confidence            11  1122222222211        2258899999999999999999999998666543

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=5e-24  Score=184.45  Aligned_cols=264  Identities=20%  Similarity=0.250  Sum_probs=205.7

Q ss_pred             HHHHHHhhcCCcccceecccCceEEEEEEE-CCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC
Q 018263           34 YNQLKIATNGFRWSNKIGEGGFGSVYKGRL-QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG  112 (358)
Q Consensus        34 ~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~  112 (358)
                      .+.+.+-+-.|++.++||+|.||.++.|+. -++++||||.....++..  .+..|....+.+. +.+.|..++-+-..+
T Consensus        20 ~s~~~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~AP--QLrdEYr~YKlL~-g~~GIP~vYYFGqeG   96 (449)
T KOG1165|consen   20 SSGVLMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAP--QLRDEYRTYKLLG-GTEGIPQVYYFGQEG   96 (449)
T ss_pred             CCCceEecccceeccccccCcceeeecccccccCceEEEEeccccCCcc--hHHHHHHHHHHHc-CCCCCCceeeecccc
Confidence            345556678999999999999999999984 369999999987655443  5667777777776 689999999888888


Q ss_pred             CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcC-----CCceE
Q 018263          113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ-----NFNPK  187 (358)
Q Consensus       113 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~-----~~~~~  187 (358)
                      .+..+|+|.+ |.+|+|++   +.....++.+++..++.|++.-++++|++   .+|+|||||+|++|..     ...+.
T Consensus        97 ~~NiLVidLL-GPSLEDLF---D~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~Ih  169 (449)
T KOG1165|consen   97 KYNILVIDLL-GPSLEDLF---DLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIH  169 (449)
T ss_pred             chhhhhhhhh-CcCHHHHH---HHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEE
Confidence            8889999998 89999998   45677899999999999999999999999   9999999999999953     34589


Q ss_pred             EeecccccccCCCCccc------ccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhH
Q 018263          188 ISDFGLSKLFPENTTHI------STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVD  261 (358)
Q Consensus       188 l~Dfg~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~  261 (358)
                      ++|||+++.+.++....      .....||..|++.....|..-+++.|+-|||-++++.|-|..||.+-.....-....
T Consensus       170 iiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYe  249 (449)
T KOG1165|consen  170 IIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYE  249 (449)
T ss_pred             EEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHH
Confidence            99999999875544332      233679999999999999999999999999999999999999998776655555555


Q ss_pred             hhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 018263          262 KAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKM  316 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~  316 (358)
                      ++-.......+..+...         ++.++...+...-+.+-.+-|..+-+..-
T Consensus       250 KIGe~Kr~T~i~~Lc~g---------~P~efa~Yl~yvR~L~F~E~PDYdylr~L  295 (449)
T KOG1165|consen  250 KIGETKRSTPIEVLCEG---------FPEEFATYLRYVRRLDFFETPDYDYLRKL  295 (449)
T ss_pred             HhccccccCCHHHHHhc---------CHHHHHHHHHHHHhcCcccCCCHHHHHHH
Confidence            55555555555554442         23334444444444455666765444433

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.91  E-value=1.6e-23  Score=191.87  Aligned_cols=166  Identities=19%  Similarity=0.196  Sum_probs=129.1

Q ss_pred             HHHHhhcCCcccceecccCceEEEEEEEC--CCCEEEEEEeecc-----ChhhHHHHHHHHHHhhhcccCCCCcee-eec
Q 018263           36 QLKIATNGFRWSNKIGEGGFGSVYKGRLQ--DGTIVAVKVLSVE-----SKQGEKEFMSEVASMANVNVCHENLVK-LHG  107 (358)
Q Consensus        36 ~~~~~~~~y~i~~~lg~g~~g~v~~~~~~--~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~~~h~~i~~-~~~  107 (358)
                      ......++|++.+.||+|+||.||+|.+.  +++.||||.....     .......+.+|++.++.+.  |+|+++ +++
T Consensus        12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~--h~~iv~~l~~   89 (365)
T PRK09188         12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVR--GIGVVPQLLA   89 (365)
T ss_pred             ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhcc--CCCCCcEEEE
Confidence            34566789999999999999999999864  5777899986432     2234567899999999998  999885 443


Q ss_pred             eEEcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCC-CCCcEEEcCCCce
Q 018263          108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDI-KTSNILLDQNFNP  186 (358)
Q Consensus       108 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di-~p~Nilv~~~~~~  186 (358)
                          .+..++||||++|++|....     ...      ...++.|++.+|.|||+.   ||+|||| ||+||+++.++.+
T Consensus        90 ----~~~~~LVmE~~~G~~L~~~~-----~~~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~i  151 (365)
T PRK09188         90 ----TGKDGLVRGWTEGVPLHLAR-----PHG------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEA  151 (365)
T ss_pred             ----cCCcEEEEEccCCCCHHHhC-----ccc------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCE
Confidence                24579999999999986321     111      146788999999999999   9999999 9999999999999


Q ss_pred             EEeecccccccCCCCcc-------cccccccccCccCccccc
Q 018263          187 KISDFGLSKLFPENTTH-------ISTRVAGTLGYLAPEYAI  221 (358)
Q Consensus       187 ~l~Dfg~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~  221 (358)
                      +|+|||++..+......       ......++..|.|||.+.
T Consensus       152 kLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        152 AVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             EEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            99999999866432211       112456777899999875

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.4e-24  Score=183.17  Aligned_cols=252  Identities=21%  Similarity=0.371  Sum_probs=197.9

Q ss_pred             hcCCcccceecccCceEEEEEEECCCCEEEEEEeeccC--hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      -++..+..+|.....|..|+++++ |.-++.|++....  .....+|.+|+-.++.+.  ||||+++++.+....++.++
T Consensus       189 ~~~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifs--hpnilpvlgacnsppnlv~i  265 (448)
T KOG0195|consen  189 VSSLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFS--HPNILPVLGACNSPPNLVII  265 (448)
T ss_pred             hhhhhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeec--CCchhhhhhhccCCCCceEe
Confidence            345556778899999999999998 4556678876543  333467888999999998  99999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEe--ecccccc
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKIS--DFGLSKL  196 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~--Dfg~~~~  196 (358)
                      ..|++.++|...+.  +......+..++.+++.+|+.+++|||+. .+-|---.++...|+||++...+|.  |--++. 
T Consensus       266 sq~mp~gslynvlh--e~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsf-  341 (448)
T KOG0195|consen  266 SQYMPFGSLYNVLH--EQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSF-  341 (448)
T ss_pred             eeeccchHHHHHHh--cCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeee-
Confidence            99999999999994  34555677889999999999999999997 3345555688999999998776653  322221 


Q ss_pred             cCCCCcccccccccccCccCccccccCCC---CccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHh
Q 018263          197 FPENTTHISTRVAGTLGYLAPEYAISGRL---TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELM  273 (358)
Q Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                             ........+.|++||.++..+-   -+++|+|||++++|||-|.+.||..-++.+-               -.
T Consensus       342 -------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec---------------gm  399 (448)
T KOG0195|consen  342 -------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC---------------GM  399 (448)
T ss_pred             -------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh---------------hh
Confidence                   1122345688999999886653   3589999999999999999999975443211               12


Q ss_pred             hhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCC
Q 018263          274 NLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGET  321 (358)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~  321 (358)
                      .+.-+.++...|+..+..+.+|+.-|++.||.+||.+..|+-+|++..
T Consensus       400 kialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  400 KIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             hhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            233355666778888999999999999999999999999999988753

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.89  E-value=5.5e-24  Score=207.14  Aligned_cols=253  Identities=20%  Similarity=0.219  Sum_probs=186.1

Q ss_pred             cccceecccCceEEEEEEEC-CCCEEEEEEee-----ccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           45 RWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLS-----VES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        45 ~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~-----~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      .....+|.|.+|.++.+... ..+.+..|...     ... ......+..|+.+-..+.  |+|++..+..+.+.....-
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~--h~~~~e~l~~~~~~~~~~~  398 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLS--HPNIIETLDIVQEIDGILQ  398 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeeccccc--CCchhhhHHHHhhcccchh
Confidence            45668899999977777643 23333333322     111 111223556777777777  9999888887776666656


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      .||||++ +|..++    .....+....+..++.|++.|+.|+|+.   |+.|+|+|++|+++..+|.+|++|||.+..+
T Consensus       399 ~mE~~~~-Dlf~~~----~~~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf  470 (601)
T KOG0590|consen  399 SMEYCPY-DLFSLV----MSNGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVF  470 (601)
T ss_pred             hhhcccH-HHHHHH----hcccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceee
Confidence            6999998 999998    3445788899999999999999999999   9999999999999999999999999998876


Q ss_pred             CCCCc---ccccccccccCccCccccccCCCCc-cCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHh
Q 018263          198 PENTT---HISTRVAGTLGYLAPEYAISGRLTR-KSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELM  273 (358)
Q Consensus       198 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~s~-~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      ..+..   ......+|+..|+|||++.+..|.+ ..||||.|+++..|.+|+.||......+.............     
T Consensus       471 ~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~-----  545 (601)
T KOG0590|consen  471 RYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRN-----  545 (601)
T ss_pred             ccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccc-----
Confidence            43333   4455688999999999999888765 68999999999999999999986655443321100000000     


Q ss_pred             hhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          274 NLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                         ...-........+.....++.+||+++|.+|.|+++|++
T Consensus       546 ---~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  546 ---IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             ---cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence               000001122356667889999999999999999999875

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.89  E-value=5.8e-23  Score=175.45  Aligned_cols=173  Identities=14%  Similarity=0.145  Sum_probs=134.1

Q ss_pred             HHhhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHH---------HHHHHHHhhhcccCCCCceeeece
Q 018263           38 KIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKE---------FMSEVASMANVNVCHENLVKLHGG  108 (358)
Q Consensus        38 ~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~---------~~~e~~~l~~l~~~h~~i~~~~~~  108 (358)
                      .+...+|++.+.+|.|+||.||++.. ++..||+|++..........         +.+|+..+.++.  |++|..+.++
T Consensus        27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~--~~GI~~~~d~  103 (232)
T PRK10359         27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVR--SEGLASLNDF  103 (232)
T ss_pred             HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHH--HCCCCcceEe
Confidence            45578999999999999999999776 46789999997553333322         578888999998  9999999888


Q ss_pred             EEcC--------CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEE
Q 018263          109 CIDG--------PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL  180 (358)
Q Consensus       109 ~~~~--------~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv  180 (358)
                      +...        +..+++|||++|.+|.+...        +++    ....+++.++..+|+.   |++|+|++|+||++
T Consensus       104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili  168 (232)
T PRK10359        104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIV  168 (232)
T ss_pred             eeecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEE
Confidence            6533        35789999999999988741        222    2455899999999999   99999999999999


Q ss_pred             cCCCceEEeecccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHH
Q 018263          181 DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIV  242 (358)
Q Consensus       181 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll  242 (358)
                      +.+| ++++|||.............             ++....+..++|+|+||+++..+.
T Consensus       169 ~~~g-i~liDfg~~~~~~e~~a~d~-------------~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        169 SKNG-LRIIDLSGKRCTAQRKAKDR-------------IDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             eCCC-EEEEECCCcccccchhhHHH-------------HHHHhHhcccccccceeEeehHHH
Confidence            9988 99999998865422111110             234445667999999999987664

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.89  E-value=1.3e-21  Score=178.14  Aligned_cols=260  Identities=28%  Similarity=0.419  Sum_probs=196.5

Q ss_pred             CcccceecccCceEEEEEEECCCCEEEEEEeeccChh---hHHHHHHHHHHhhhcccCCC-CceeeeceEEcCCeeEEEE
Q 018263           44 FRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQ---GEKEFMSEVASMANVNVCHE-NLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        44 y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~~~h~-~i~~~~~~~~~~~~~~iv~  119 (358)
                      |.+.+.||.|+|+.||.+...  ..+++|.+......   ....+.+|...+..+.  |+ +++.+.+.+......++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~   77 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLN--HPPNIVKLYDFFQDEGSLYLVM   77 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHcc--CCcceeeEEEEEecCCEEEEEE
Confidence            788999999999999999987  77899988655322   4677888999999988  77 7999999998877789999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCC-ceEEeecccccccC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF-NPKISDFGLSKLFP  198 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~-~~~l~Dfg~~~~~~  198 (358)
                      +++.++++.+++...... ..++......++.|++.++.++|+.   +++|+|++|+||+++..+ .++++|||.+....
T Consensus        78 ~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~  153 (384)
T COG0515          78 EYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP  153 (384)
T ss_pred             ecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence            999999999776221111 3788999999999999999999999   999999999999999988 69999999998554


Q ss_pred             CCCcc-----cccccccccCccCcccccc---CCCCccCceecHHHHHHHHHhCCCCCCcccccc-chhhhHhhhhccch
Q 018263          199 ENTTH-----ISTRVAGTLGYLAPEYAIS---GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG-EYHLVDKAWGMYNS  269 (358)
Q Consensus       199 ~~~~~-----~~~~~~~~~~y~aPE~~~~---~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~-~~~~~~~~~~~~~~  269 (358)
                      .....     ......++..|.|||.+.+   ...+...|+|++|+++++++.|..||....... ..............
T Consensus       154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  233 (384)
T COG0515         154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP  233 (384)
T ss_pred             CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc
Confidence            33322     2355789999999999887   578889999999999999999999976554310 00111000000000


Q ss_pred             hhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 018263          270 KELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKM  316 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~  316 (358)
                           .................+.+++..++..+|..|.+..+....
T Consensus       234 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         234 -----SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             -----ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence                 000000000002234578899999999999999998887664

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=1.7e-22  Score=201.00  Aligned_cols=204  Identities=19%  Similarity=0.210  Sum_probs=168.5

Q ss_pred             HHHHHhhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCe
Q 018263           35 NQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC  114 (358)
Q Consensus        35 ~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~  114 (358)
                      .+..+.++.|.|.+.||.|++|+||.|...+|+.||||+-...+.+.---..+-...|+ .. --+.|..+...+...+.
T Consensus       691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk-~~-~~~~~~~~~~a~~~~~~  768 (974)
T KOG1166|consen  691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLK-PQ-MLPSIMHISSAHVFQNA  768 (974)
T ss_pred             ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhc-hh-hhcchHHHHHHHccCCc
Confidence            34456678999999999999999999998889999999988766554322222223333 11 14567777777888888


Q ss_pred             eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEc-------CCCceE
Q 018263          115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD-------QNFNPK  187 (358)
Q Consensus       115 ~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~-------~~~~~~  187 (358)
                      .++|++|.+.|+|.+++    ...+..++..+..+++|++..+..||..   +||||||||+|+++.       +.-.++
T Consensus       769 S~lv~ey~~~Gtlld~~----N~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~  841 (974)
T KOG1166|consen  769 SVLVSEYSPYGTLLDLI----NTNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLY  841 (974)
T ss_pred             ceeeeeccccccHHHhh----ccCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceE
Confidence            89999999999999999    4778899999999999999999999999   999999999999993       334589


Q ss_pred             EeecccccccC-CCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCC
Q 018263          188 ISDFGLSKLFP-ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTA  247 (358)
Q Consensus       188 l~Dfg~~~~~~-~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~p  247 (358)
                      |+|||.+..+. -+........++|..+--+|...|.+|++..|.|+|+.+++.||.|+..
T Consensus       842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            99999998664 2333456678899999999999999999999999999999999999865

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.87  E-value=1e-21  Score=172.71  Aligned_cols=236  Identities=19%  Similarity=0.189  Sum_probs=149.1

Q ss_pred             CCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChh---hHHHHHHHHHHhhhccc-C-------CCCceeeeceEE
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQ---GEKEFMSEVASMANVNV-C-------HENLVKLHGGCI  110 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~~-~-------h~~i~~~~~~~~  110 (358)
                      .++....||.|+++.||.+++. +|+.+++|+.......   ..+.+++|......+.. .       |-.++..++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            4455678999999999999987 5999999998655322   33455555554444320 0       112222222211


Q ss_pred             ---------cC---C-----eeEEEEecCCCCCHHHHhhhcccc---ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEE
Q 018263          111 ---------DG---P-----CRILVYDYMPNNSLSQTLLGEEKR---RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVH  170 (358)
Q Consensus       111 ---------~~---~-----~~~iv~e~~~~~~L~~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H  170 (358)
                               ..   +     +.+++|+-+ .++|.+++......   ...+.......+..|++..+++||+.   |++|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEe
Confidence                     11   1     236778877 56888876422221   12244455567779999999999999   9999


Q ss_pred             cCCCCCcEEEcCCCceEEeecccccccCCCCcccccccccccCccCcccccc--------CCCCccCceecHHHHHHHHH
Q 018263          171 RDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS--------GRLTRKSDVYSFGVLLLEIV  242 (358)
Q Consensus       171 ~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~s~~sDiwslG~il~~ll  242 (358)
                      +||+|+|++++.+|.++|+||+.....+.....    ...+..|.+||....        -.++.+.|.|+||+++|.|+
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            999999999999999999999988764332221    334577899996643        24688999999999999999


Q ss_pred             hCCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCC
Q 018263          243 SGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLR  307 (358)
Q Consensus       243 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R  307 (358)
                      ++..||+..........                   .+.. -. +.+..+..||..+|+.||.+|
T Consensus       245 C~~lPf~~~~~~~~~~~-------------------~f~~-C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  245 CGRLPFGLSSPEADPEW-------------------DFSR-CR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HSS-STCCCGGGSTSGG-------------------GGTT-SS----HHHHHHHHHHT-SSGGGS
T ss_pred             HccCCCCCCCccccccc-------------------cchh-cC-CcCHHHHHHHHHHccCCcccC
Confidence            99999986543222111                   1111 12 677789999999999999988

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.86  E-value=3.1e-21  Score=162.66  Aligned_cols=140  Identities=15%  Similarity=0.179  Sum_probs=107.9

Q ss_pred             ccceecccCceEEEEEEECCCCEEEEEEeeccChh--h------------------------HHHHHHHHHHhhhcccCC
Q 018263           46 WSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQ--G------------------------EKEFMSEVASMANVNVCH   99 (358)
Q Consensus        46 i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~--~------------------------~~~~~~e~~~l~~l~~~h   99 (358)
                      +...||+|++|.||+|...+|+.||+|+++.....  .                        ......|+..+..+.  +
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--~   78 (190)
T cd05147           1 INGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLV--T   78 (190)
T ss_pred             CCCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHH--H
Confidence            35789999999999999888999999998754211  1                        122344888888887  6


Q ss_pred             CCceeeeceEEcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHH-hcCCCCCcEEcCCCCCcE
Q 018263          100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI-HEEIQPHVVHRDIKTSNI  178 (358)
Q Consensus       100 ~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~L-H~~~~~~i~H~di~p~Ni  178 (358)
                      +++........  ...++||||++|+++....    .....+++..+..++.|++.+|.++ |+.   |++|+||||+||
T Consensus        79 ~~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~----~~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NI  149 (190)
T cd05147          79 AGIPCPEPILL--KSHVLVMEFIGDDGWAAPR----LKDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNL  149 (190)
T ss_pred             CCCCCCcEEEe--cCCEEEEEEeCCCCCcchh----hhcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHE
Confidence            65533322222  2248999999887766553    1335688999999999999999999 788   999999999999


Q ss_pred             EEcCCCceEEeeccccccc
Q 018263          179 LLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       179 lv~~~~~~~l~Dfg~~~~~  197 (358)
                      ++++ +.++|+|||++...
T Consensus       150 li~~-~~v~LiDFG~a~~~  167 (190)
T cd05147         150 LYHD-GKLYIIDVSQSVEH  167 (190)
T ss_pred             EEEC-CcEEEEEccccccC
Confidence            9984 78999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.85  E-value=2.6e-20  Score=157.53  Aligned_cols=142  Identities=17%  Similarity=0.200  Sum_probs=110.6

Q ss_pred             ccceecccCceEEEEEEECCCCEEEEEEeeccChh--------------------------hHHHHHHHHHHhhhcccCC
Q 018263           46 WSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQ--------------------------GEKEFMSEVASMANVNVCH   99 (358)
Q Consensus        46 i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~--------------------------~~~~~~~e~~~l~~l~~~h   99 (358)
                      +...||+|++|.||+|...+|+.||||+++.....                          .......|...+..+.  +
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--~   78 (190)
T cd05145           1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLY--E   78 (190)
T ss_pred             CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHH--h
Confidence            46789999999999999878999999998754211                          0122356788888887  7


Q ss_pred             CCceeeeceEEcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcEEcCCCCCcE
Q 018263          100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNI  178 (358)
Q Consensus       100 ~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~~~~i~H~di~p~Ni  178 (358)
                      +++.........  ..++||||++|+++.....    ....++...+..++.|++.++.++|+ .   |++|+||||+||
T Consensus        79 ~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l----~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NI  149 (190)
T cd05145          79 AGVPVPEPILLK--KNVLVMEFIGDDGSPAPRL----KDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNI  149 (190)
T ss_pred             CCCCCceEEEec--CCEEEEEEecCCCchhhhh----hhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhE
Confidence            776444433333  2489999998875544321    23457788999999999999999999 8   999999999999


Q ss_pred             EEcCCCceEEeecccccccCC
Q 018263          179 LLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       179 lv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      +++ ++.++|+|||++.....
T Consensus       150 ll~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         150 LYH-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             EEE-CCCEEEEEcccceecCC
Confidence            999 78999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=1.3e-19  Score=151.64  Aligned_cols=189  Identities=17%  Similarity=0.094  Sum_probs=141.4

Q ss_pred             cccceecccCceEEEEEEECCCCEEEEEEeeccChhhH----HHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEe
Q 018263           45 RWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGE----KEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD  120 (358)
Q Consensus        45 ~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e  120 (358)
                      .+...|++|+||+|+.+.. .+.+++.+.+........    ..+.+|++.++.+. .++++++++++    +..+++|+
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~-~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLD-GLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcC-CCCCCCEEEEE----cCEEEEEe
Confidence            3577899999999997776 577888777765443222    25788999999996 36889999886    44689999


Q ss_pred             cCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCC-CCCcEEEcCCCceEEeecccccccCC
Q 018263          121 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDI-KTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       121 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di-~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      |+.|.+|.....     .     . ...++.|++.+|.++|+.   ||+|+|| +|.||+++.++.++|+|||++.....
T Consensus        79 yI~G~~L~~~~~-----~-----~-~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~  144 (218)
T PRK12274         79 YLAGAAMYQRPP-----R-----G-DLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP  144 (218)
T ss_pred             eecCccHHhhhh-----h-----h-hHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence            999998875541     1     1 134778999999999999   9999999 79999999999999999999986543


Q ss_pred             CCcc----cc--------cccccccCccCccccccC-CCC-ccCceecHHHHHHHHHhCCCCCCcccc
Q 018263          200 NTTH----IS--------TRVAGTLGYLAPEYAISG-RLT-RKSDVYSFGVLLLEIVSGRTAVDFDVQ  253 (358)
Q Consensus       200 ~~~~----~~--------~~~~~~~~y~aPE~~~~~-~~s-~~sDiwslG~il~~lltg~~pf~~~~~  253 (358)
                      ....    ..        .-...++.|++|+...-. ..+ .+.+-++.|+-+|.++|+..+.-.+.+
T Consensus       145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~  212 (218)
T PRK12274        145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE  212 (218)
T ss_pred             cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence            3311    00        012356778888854322 223 466888999999999999988765543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.81  E-value=1.3e-20  Score=176.36  Aligned_cols=225  Identities=24%  Similarity=0.302  Sum_probs=180.6

Q ss_pred             ecccCceEEEEEE----ECCCCEEEEEEeeccCh--hhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecCC
Q 018263           50 IGEGGFGSVYKGR----LQDGTIVAVKVLSVESK--QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP  123 (358)
Q Consensus        50 lg~g~~g~v~~~~----~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~~  123 (358)
                      +|.|.+|.|+++.    ...|..|++|+......  ........|-..+...+ .||.++++.-.+..+...++++++..
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~-~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVH-NTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhcc-CCCceeeeeeeeccccchhHhhhhcc
Confidence            6899999999886    23478899998754311  11114445555666655 59999999999999999999999999


Q ss_pred             CCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCcc
Q 018263          124 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH  203 (358)
Q Consensus       124 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  203 (358)
                      |+.|...+    .+...+++.....+...++.+++++|+.   +++|+|+|++||+++.+|.+++.|||+.+..-.... 
T Consensus        81 gg~lft~l----~~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-  152 (612)
T KOG0603|consen   81 GGDLFTRL----SKEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-  152 (612)
T ss_pred             cchhhhcc----ccCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh-
Confidence            99998888    6677788899999999999999999999   999999999999999999999999999986422222 


Q ss_pred             cccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCC
Q 018263          204 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGN  283 (358)
Q Consensus       204 ~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (358)
                          .+|+..|+|||++.  ....++|-||+|++.++|++|..||..+                   ....++..  ...
T Consensus       153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~-------------------~~~~Il~~--~~~  205 (612)
T KOG0603|consen  153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD-------------------TMKRILKA--ELE  205 (612)
T ss_pred             ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH-------------------HHHHHhhh--ccC
Confidence                18999999999887  5677899999999999999999999841                   11111111  123


Q ss_pred             CCHHHHHHHHHHHhhccCCCCCCCCCH
Q 018263          284 FPENEAIRFLKVGLLCVQEKSKLRPQM  310 (358)
Q Consensus       284 ~~~~~~~~l~~li~~~l~~~P~~Rpt~  310 (358)
                      .|.........++..++..+|.+|...
T Consensus       206 ~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  206 MPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             CchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            567778888899999999999999866

>smart00090 RIO RIO-like kinase

Probab=99.81  E-value=3.5e-19  Score=155.26  Aligned_cols=166  Identities=17%  Similarity=0.099  Sum_probs=121.4

Q ss_pred             CCcccccccccccCHHHHHHhhcCCcccceecccCceEEEEEE--ECCCCEEEEEEeeccChh-----------------
Q 018263           20 IGGEQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGR--LQDGTIVAVKVLSVESKQ-----------------   80 (358)
Q Consensus        20 ~~~~~~~~~~~~~~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~--~~~~~~vaiK~~~~~~~~-----------------   80 (358)
                      ++..+.++.........+...+--|.+.+.||.|++|.||+|.  ..+|+.||+|++......                 
T Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~   85 (237)
T smart00090        6 ATYEEVLDGRTRLALYSLLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYR   85 (237)
T ss_pred             eehhhccChHHHHHHHHHHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccC
Confidence            3333433434444444444445569999999999999999998  457999999998643210                 


Q ss_pred             -------hHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHH
Q 018263           81 -------GEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGI  153 (358)
Q Consensus        81 -------~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi  153 (358)
                             ....+..|+..+..+......+.++++.    ...++||||++|.+|....    .....+....+..++.||
T Consensus        86 ~~~~~~~~~~~~~~E~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~----~~~~~~~~~~~~~i~~qi  157 (237)
T smart00090       86 KINPRKLVRLWAEKEFRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPR----LKDVEPEEEEEFELYDDI  157 (237)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccc----cccCCcchHHHHHHHHHH
Confidence                   1133567899998886222334444432    2358999999998877654    223445666778999999


Q ss_pred             HHHHHHHhcCCCCC-cEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          154 GRGLAYIHEEIQPH-VVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       154 ~~aL~~LH~~~~~~-i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      +.++.+||+.   | ++|+||+|+||+++ ++.++|+|||.+...
T Consensus       158 ~~~l~~LH~~---g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      158 LEEMRKLYKE---GELVHGDLSEYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             HHHHHHHHhc---CCEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence            9999999999   9 99999999999999 789999999988753

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.80  E-value=3.7e-19  Score=157.90  Aligned_cols=197  Identities=20%  Similarity=0.253  Sum_probs=143.8

Q ss_pred             CCCCceeeeceEEc---------------------------CCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHH
Q 018263           98 CHENLVKLHGGCID---------------------------GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII  150 (358)
Q Consensus        98 ~h~~i~~~~~~~~~---------------------------~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~  150 (358)
                      .||||+.+...|.+                           ...+|+||..+ ..+|.+++.     ....+.....-++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~-----~~~~s~r~~~~~l  347 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLW-----TRHRSYRTGRVIL  347 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHh-----cCCCchHHHHHHH
Confidence            49999999887643                           34578999988 568999983     3445667778899


Q ss_pred             HHHHHHHHHHhcCCCCCcEEcCCCCCcEEEc--CC--CceEEeecccccccCC-----CCcccccccccccCccCccccc
Q 018263          151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLD--QN--FNPKISDFGLSKLFPE-----NTTHISTRVAGTLGYLAPEYAI  221 (358)
Q Consensus       151 ~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~--~~--~~~~l~Dfg~~~~~~~-----~~~~~~~~~~~~~~y~aPE~~~  221 (358)
                      .|+++|+.|||++   |+.|||+|.+||++.  ++  ..++++|||++.....     +.........|....+|||+..
T Consensus       348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t  424 (598)
T KOG4158|consen  348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT  424 (598)
T ss_pred             HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence            9999999999999   999999999999993  33  3468999998865432     1122222345777889999876


Q ss_pred             cCC------CCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHH
Q 018263          222 SGR------LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKV  295 (358)
Q Consensus       222 ~~~------~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  295 (358)
                      ..+      .-.++|.|+.|.+.||++....||....+...           ....    ..+...+..+..++..+.+|
T Consensus       425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L-----------~~r~----Yqe~qLPalp~~vpp~~rql  489 (598)
T KOG4158|consen  425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL-----------DTRT----YQESQLPALPSRVPPVARQL  489 (598)
T ss_pred             cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee-----------chhh----hhhhhCCCCcccCChHHHHH
Confidence            432      12589999999999999999999985332111           1111    11112234456677889999


Q ss_pred             HhhccCCCCCCCCCHHHHHHHhh
Q 018263          296 GLLCVQEKSKLRPQMSTAIKMMN  318 (358)
Q Consensus       296 i~~~l~~~P~~Rpt~~eil~~L~  318 (358)
                      +...|+.||++|+++.-....|.
T Consensus       490 V~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  490 VFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHHHhcCCccccCCccHHHhHHH
Confidence            99999999999999776655543

>PRK10345 hypothetical protein; Provisional

Probab=99.78  E-value=4.3e-18  Score=144.99  Aligned_cols=137  Identities=17%  Similarity=0.261  Sum_probs=105.8

Q ss_pred             ccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhccc---CCCCceeeeceEEcCC---eeE-EE
Q 018263           46 WSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNV---CHENLVKLHGGCIDGP---CRI-LV  118 (358)
Q Consensus        46 i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~---~h~~i~~~~~~~~~~~---~~~-iv  118 (358)
                      -.+.||+|+++.||. .-.++.. +||+...........+.+|+..++.+..   .||||+++++++.++.   ..+ +|
T Consensus         6 ~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I   83 (210)
T PRK10345          6 EQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI   83 (210)
T ss_pred             CcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence            357899999999995 3234444 6898876555566788999999999842   3899999999998874   333 78


Q ss_pred             Eec--CCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHH-HHHhcCCCCCcEEcCCCCCcEEEcC----CCceEEeec
Q 018263          119 YDY--MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL-AYIHEEIQPHVVHRDIKTSNILLDQ----NFNPKISDF  191 (358)
Q Consensus       119 ~e~--~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL-~~LH~~~~~~i~H~di~p~Nilv~~----~~~~~l~Df  191 (358)
                      +||  +++++|.+++..     ..+++.  ..++.+++.++ +|||++   +|+|+||||+||+++.    ++.++|+|+
T Consensus        84 ~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg  153 (210)
T PRK10345         84 ADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDN  153 (210)
T ss_pred             ecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence            999  557999999932     235555  35678888888 999999   9999999999999974    347999995


Q ss_pred             ccc
Q 018263          192 GLS  194 (358)
Q Consensus       192 g~~  194 (358)
                      +.+
T Consensus       154 ~G~  156 (210)
T PRK10345        154 IGE  156 (210)
T ss_pred             CCC
Confidence            444

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.78  E-value=1.7e-18  Score=161.79  Aligned_cols=215  Identities=25%  Similarity=0.393  Sum_probs=163.8

Q ss_pred             hhcccCCCCceeeeceEEcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCc-EEc
Q 018263           93 ANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHV-VHR  171 (358)
Q Consensus        93 ~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i-~H~  171 (358)
                      +.+.  |.|+.++++.+.++...++|.+||.-|+|.|.+..   ....+++.....++.+|+.+|+|||..   .| .|+
T Consensus         2 ~~l~--h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg   73 (484)
T KOG1023|consen    2 RQLD--HDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHG   73 (484)
T ss_pred             cccc--hhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC---cceeee
Confidence            3444  99999999999999999999999999999999943   467789999999999999999999987   55 999


Q ss_pred             CCCCCcEEEcCCCceEEeecccccccCC-CCcccccccccccCccCccccccCC-------CCccCceecHHHHHHHHHh
Q 018263          172 DIKTSNILLDQNFNPKISDFGLSKLFPE-NTTHISTRVAGTLGYLAPEYAISGR-------LTRKSDVYSFGVLLLEIVS  243 (358)
Q Consensus       172 di~p~Nilv~~~~~~~l~Dfg~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~-------~s~~sDiwslG~il~~llt  243 (358)
                      .++..|.+++....+|+.|||+...... ..............|.|||.+.+..       .+.++|+||+|++++++++
T Consensus        74 ~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~  153 (484)
T KOG1023|consen   74 ALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILF  153 (484)
T ss_pred             eeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHh
Confidence            9999999999999999999999876532 0111111223456799999887531       4667999999999999999


Q ss_pred             CCCCCCccccccc-hhhhHhhhhccchhhHhhhhccccCCCCC-H-HHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 018263          244 GRTAVDFDVQLGE-YHLVDKAWGMYNSKELMNLVDPMLYGNFP-E-NEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE  320 (358)
Q Consensus       244 g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~  320 (358)
                      ...||........ ...+..+..         ...+.+++... . .....+..++..||..+|.+||+++.|...++.+
T Consensus       154 r~~~~~~~~~~~~~~eii~~~~~---------~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~  224 (484)
T KOG1023|consen  154 RSGPFDLRNLVEDPDEIILRVKK---------GGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI  224 (484)
T ss_pred             ccCccccccccCChHHHHHHHHh---------cCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence            9999986443222 122222111         01111222211 1 3344799999999999999999999999999888


Q ss_pred             CCCC
Q 018263          321 TNID  324 (358)
Q Consensus       321 ~~~~  324 (358)
                      ....
T Consensus       225 ~~~~  228 (484)
T KOG1023|consen  225 NKGG  228 (484)
T ss_pred             cccc
Confidence            7754

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.76  E-value=2.4e-19  Score=164.72  Aligned_cols=171  Identities=22%  Similarity=0.295  Sum_probs=130.0

Q ss_pred             CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecc
Q 018263          113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG  192 (358)
Q Consensus       113 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg  192 (358)
                      .++||.|++|.-.+|.+++.+. ......+......++.|++.++.|   +   +.+|+|++|.||+...+..++|+|||
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr-~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFg  401 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRR-RTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFG  401 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCC-CcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhh
Confidence            3578999999999999999543 334456788899999999999999   7   99999999999999999999999999


Q ss_pred             cccccCCCC-----cccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhc
Q 018263          193 LSKLFPENT-----THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGM  266 (358)
Q Consensus       193 ~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~  266 (358)
                      +........     ....+...||..|++||++.+..|+.++|||+||+++++|+. -..++...               
T Consensus       402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~---------------  466 (516)
T KOG1033|consen  402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI---------------  466 (516)
T ss_pred             heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH---------------
Confidence            998765444     334555789999999999999999999999999999999998 33332210               


Q ss_pred             cchhhHhhhhccccCCCCCHHH---HHHHHHHHhhccCCCCCCCCCHHH
Q 018263          267 YNSKELMNLVDPMLYGNFPENE---AIRFLKVGLLCVQEKSKLRPQMST  312 (358)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~---~~~l~~li~~~l~~~P~~Rpt~~e  312 (358)
                         .-..+    ...+.+|+..   .+.-..|+.+++...|.+||++.+
T Consensus       467 ---~t~~d----~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  467 ---ATLTD----IRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             ---Hhhhh----hhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHH
Confidence               00111    1112222211   112347888999999999995443

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.74  E-value=3.1e-17  Score=141.10  Aligned_cols=135  Identities=21%  Similarity=0.279  Sum_probs=111.0

Q ss_pred             cceecccCceEEEEEEECCCCEEEEEEeeccCh--------hhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           47 SNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESK--------QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        47 ~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      ++.||+|++|.||+|.. .|..+++|+......        .....+..|+..+..+.  |+++.....++......+++
T Consensus         1 ~~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--~~~i~~p~~~~~~~~~~~lv   77 (211)
T PRK14879          1 MKLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRAR--KAGVNVPAVYFVDPENFIIV   77 (211)
T ss_pred             CcccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHH--HCCCCCCeEEEEeCCCCEEE
Confidence            36789999999999988 577789998653221        11245677888998887  88887777777777788999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      |||++|.+|.+.+..    ..   . ....++.+++.+|.++|+.   +++|+|++|.||+++ ++.++++|||.+..
T Consensus        78 ~e~~~G~~L~~~~~~----~~---~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         78 MEYIEGEPLKDLINS----NG---M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEEeCCcCHHHHHHh----cc---H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999999999832    11   1 7888999999999999999   999999999999999 77899999998865

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.73  E-value=2.3e-18  Score=169.06  Aligned_cols=211  Identities=21%  Similarity=0.231  Sum_probs=150.7

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      .++|..++.+..|++|.||+++++ +.+.+++|+-+.. ..     .+.  ++.-..  .|+++                
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~-li-----lRn--ilt~a~--npfvv----------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN-LI-----LRN--ILTFAG--NPFVV----------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcccccc-hh-----hhc--cccccC--Cccee----------------
Confidence            478999999999999999999987 4667777553211 00     000  111111  33333                


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                           |+....+    .+.++++...        +.+++|||+.   ||+|+|++|+|++|+.-|.+|++|||+.+....
T Consensus       136 -----gDc~tll----k~~g~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLm  195 (1205)
T KOG0606|consen  136 -----GDCATLL----KNIGPLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLM  195 (1205)
T ss_pred             -----chhhhhc----ccCCCCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhh
Confidence                 4445555    4456666555        6789999999   999999999999999999999999998764311


Q ss_pred             CC--------------cccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhh
Q 018263          200 NT--------------THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG  265 (358)
Q Consensus       200 ~~--------------~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~  265 (358)
                      ..              .......++|+.|.|||++....|+..+|.|++|+|+|+.+-|..||.++.+++.+..+.....
T Consensus       196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i  275 (1205)
T KOG0606|consen  196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI  275 (1205)
T ss_pred             hccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc
Confidence            10              1112236899999999999999999999999999999999999999998877655543322211


Q ss_pred             ccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHH
Q 018263          266 MYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMS  311 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~  311 (358)
                      .+..              -....+.+...+|..+|+.+|..|--..
T Consensus       276 ~wpE--------------~dea~p~Ea~dli~~LL~qnp~~Rlgt~  307 (1205)
T KOG0606|consen  276 EWPE--------------EDEALPPEAQDLIEQLLRQNPLCRLGTG  307 (1205)
T ss_pred             cccc--------------cCcCCCHHHHHHHHHHHHhChHhhcccc
Confidence            1111              1233456788999999999999996433

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.72  E-value=8.5e-17  Score=137.00  Aligned_cols=137  Identities=20%  Similarity=0.194  Sum_probs=107.6

Q ss_pred             cCCcccceecccCceEEEEEEECCCCEEEEEEeeccCh----------------------hhHHHHHHHHHHhhhcccCC
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESK----------------------QGEKEFMSEVASMANVNVCH   99 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~----------------------~~~~~~~~e~~~l~~l~~~h   99 (358)
                      ..|.+.+.||.|++|.||++...+|+.|++|++.....                      ........|+..+..+.  +
T Consensus        15 ~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--~   92 (198)
T cd05144          15 VVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY--E   92 (198)
T ss_pred             chhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH--H
Confidence            34888999999999999999988899999998754321                      01123566788888876  5


Q ss_pred             CC--ceeeeceEEcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCc
Q 018263          100 EN--LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSN  177 (358)
Q Consensus       100 ~~--i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~N  177 (358)
                      ++  +...++    ....+++|||++|++|.....          ......++.+++.++.++|+.   |++|+||+|+|
T Consensus        93 ~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~----------~~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~N  155 (198)
T cd05144          93 EGFPVPKPID----WNRHAVVMEYIDGVELYRVRV----------LEDPEEVLDEILEEIVKAYKH---GIIHGDLSEFN  155 (198)
T ss_pred             cCCCCCceee----cCCceEEEEEeCCcchhhccc----------cccHHHHHHHHHHHHHHHHHC---CCCcCCCCccc
Confidence            53  333333    244589999999998877641          034567889999999999999   99999999999


Q ss_pred             EEEcCCCceEEeeccccccc
Q 018263          178 ILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       178 ilv~~~~~~~l~Dfg~~~~~  197 (358)
                      |+++.++.++|+|||.+...
T Consensus       156 ill~~~~~~~liDfg~~~~~  175 (198)
T cd05144         156 ILVDDDEKIYIIDWPQMVST  175 (198)
T ss_pred             EEEcCCCcEEEEECCccccC
Confidence            99999999999999999654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.71  E-value=1.4e-16  Score=135.84  Aligned_cols=130  Identities=22%  Similarity=0.329  Sum_probs=103.5

Q ss_pred             eecccCceEEEEEEECCCCEEEEEEeeccC--------hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEe
Q 018263           49 KIGEGGFGSVYKGRLQDGTIVAVKVLSVES--------KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD  120 (358)
Q Consensus        49 ~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e  120 (358)
                      .||+|++|.||++.+ +|..+++|......        .....++.+|++.+..+.  ++++.....++......+++||
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--~~~i~~p~~~~~~~~~~~lv~e   77 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRAR--KAGVNTPVVYDVDPDNKTIVME   77 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHH--HCCCCCCEEEEEECCCCEEEEE
Confidence            379999999999986 47789999864321        112356678999999987  6665554445556667789999


Q ss_pred             cCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          121 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       121 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      |++|++|.+.+...    ..       .++.+++.+|.+||+.   |++|+|++|.||+++ ++.++++|||.+..
T Consensus        78 ~~~g~~l~~~~~~~----~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        78 YIEGKPLKDVIEEG----ND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             EECCccHHHHHhhc----HH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999999987221    10       7899999999999999   999999999999999 78999999998865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.68  E-value=5.4e-16  Score=151.47  Aligned_cols=136  Identities=20%  Similarity=0.276  Sum_probs=109.7

Q ss_pred             cCCcccceecccCceEEEEEEECCCCEEEEEEeecc--C------hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVE--S------KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP  113 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~--~------~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~  113 (358)
                      ..|...+.||+|+||.||++.+.... +++|+....  .      .....++.+|++.+..++  |++++....+.....
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--~~~i~~p~~~~~~~~  409 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEAR--RAGVPTPVIYDVDPE  409 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhc--ccCCCeeEEEEEeCC
Confidence            34566889999999999999876443 444432211  1      112356788999999998  999888777777777


Q ss_pred             eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccc
Q 018263          114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL  193 (358)
Q Consensus       114 ~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~  193 (358)
                      ..++||||++|++|.+.+.            ....++.+++.+|.+||+.   +++||||+|+||++ .++.++|+|||+
T Consensus       410 ~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGl  473 (535)
T PRK09605        410 EKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGL  473 (535)
T ss_pred             CCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcc
Confidence            7899999999999999882            3467899999999999999   99999999999999 577899999999


Q ss_pred             ccc
Q 018263          194 SKL  196 (358)
Q Consensus       194 ~~~  196 (358)
                      +..
T Consensus       474 a~~  476 (535)
T PRK09605        474 GKY  476 (535)
T ss_pred             ccc
Confidence            975

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.66  E-value=1.3e-15  Score=128.41  Aligned_cols=139  Identities=20%  Similarity=0.203  Sum_probs=97.0

Q ss_pred             ccceecccCceEEEEEEECCCCEEEEEEeeccChhh--HHH----------------------HHHHHHHhhhcccCCCC
Q 018263           46 WSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQG--EKE----------------------FMSEVASMANVNVCHEN  101 (358)
Q Consensus        46 i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~--~~~----------------------~~~e~~~l~~l~~~h~~  101 (358)
                      +.+.||+|++|.||+|...+|+.||+|++.......  ...                      ...|...+..+...+..
T Consensus         1 ~~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           1 VGGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CCcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            357899999999999998889999999986532111  111                      13455555555411222


Q ss_pred             ceeeeceEEcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcEEcCCCCCcEEE
Q 018263          102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNILL  180 (358)
Q Consensus       102 i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~~~~i~H~di~p~Nilv  180 (358)
                      +.+.+..    ...+++|||++++.+.......    ... ...+..++.+++.++.++|+ .   +++|+||+|+||++
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~----~~~-~~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili  148 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKD----VRL-LEDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV  148 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhh----hhh-cccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence            3333332    2358999999985433211000    000 16678899999999999999 8   99999999999999


Q ss_pred             cCCCceEEeeccccccc
Q 018263          181 DQNFNPKISDFGLSKLF  197 (358)
Q Consensus       181 ~~~~~~~l~Dfg~~~~~  197 (358)
                      + ++.++++|||.+...
T Consensus       149 ~-~~~~~liDfg~a~~~  164 (187)
T cd05119         149 D-DGKVYIIDVPQAVEI  164 (187)
T ss_pred             E-CCcEEEEECcccccc
Confidence            9 889999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.63  E-value=6e-15  Score=119.34  Aligned_cols=137  Identities=18%  Similarity=0.155  Sum_probs=112.1

Q ss_pred             ccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecCCCC
Q 018263           46 WSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN  125 (358)
Q Consensus        46 i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~~~~  125 (358)
                      +++.||.|.++.||++...+ ..+++|.......  ...+..|+..+..+.....++++++......+..++++||++|.
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            56789999999999999864 7799999865433  56788899999988721258888888888888899999999877


Q ss_pred             CHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          126 SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       126 ~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      .+...           +......++.+++.+++.+|.....+++|+|++|.||++++.+.++++||+.+..
T Consensus        79 ~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            65543           4566677899999999999985223799999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.61  E-value=8.3e-17  Score=157.10  Aligned_cols=257  Identities=22%  Similarity=0.250  Sum_probs=192.0

Q ss_pred             hhcCCcccceecccCceEEEEEEEC--CCCEEEEEEeeccC--hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCee
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ--DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR  115 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~  115 (358)
                      ....|.+.+.||+|.++.+-.+...  ....++.|.+....  .....++..|...-..+. .|+|++.+++...+....
T Consensus        18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s-~h~n~~~~~~~~~~~~~~   96 (601)
T KOG0590|consen   18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLS-KHSNTVHMIEPSSSPRSY   96 (601)
T ss_pred             ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCcccccccccc-ccccccccCCccCCCccc
Confidence            3567888999999999999887753  24456666665443  333344555666666665 499999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHh-cCCCCCcEEcCCCCCcEEEcCCC-ceEEeeccc
Q 018263          116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH-EEIQPHVVHRDIKTSNILLDQNF-NPKISDFGL  193 (358)
Q Consensus       116 ~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH-~~~~~~i~H~di~p~Nilv~~~~-~~~l~Dfg~  193 (358)
                      +++.++..|+++.+.+..  ......+......++.|+..++.|+| ..   ++.|+|++|+|.+++..+ .+++.|||+
T Consensus        97 ~~~~~~s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~  171 (601)
T KOG0590|consen   97 LLSLSYSDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGL  171 (601)
T ss_pred             ccccCccccccccccccc--CCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchh
Confidence            999999999999988831  22224567778889999999999999 88   999999999999999999 999999999


Q ss_pred             ccccCC--CCccccccccc-ccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccch
Q 018263          194 SKLFPE--NTTHISTRVAG-TLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNS  269 (358)
Q Consensus       194 ~~~~~~--~~~~~~~~~~~-~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      +..+..  .........+| ++.|.|||...+. ...+..|+||.|+++..+++|..|+..............      .
T Consensus       172 At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~------~  245 (601)
T KOG0590|consen  172 ATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWK------S  245 (601)
T ss_pred             hccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeec------c
Confidence            987654  33333444677 9999999988874 457889999999999999999999986655432211100      0


Q ss_pred             hhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 018263          270 KELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAI  314 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil  314 (358)
                      ..      ................+++.+++..+|..|.+.+++-
T Consensus       246 ~~------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  246 NK------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             cc------cccccCccccCChhhhhcccccccCCchhcccccccc
Confidence            00      0001112233445577888899999999999988874

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.60  E-value=2e-14  Score=125.56  Aligned_cols=134  Identities=18%  Similarity=0.215  Sum_probs=101.9

Q ss_pred             ceec-ccCceEEEEEEECCCCEEEEEEeeccC-------------hhhHHHHHHHHHHhhhcccCCCC--ceeeeceEEc
Q 018263           48 NKIG-EGGFGSVYKGRLQDGTIVAVKVLSVES-------------KQGEKEFMSEVASMANVNVCHEN--LVKLHGGCID  111 (358)
Q Consensus        48 ~~lg-~g~~g~v~~~~~~~~~~vaiK~~~~~~-------------~~~~~~~~~e~~~l~~l~~~h~~--i~~~~~~~~~  111 (358)
                      ..|| .||.|+||.+... +..++||.+....             ......+.+|+..+..+.  |++  ++..++....
T Consensus        37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~--~~gi~vP~pl~~~~~  113 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLY--EAGLPVPRPIAARVV  113 (239)
T ss_pred             ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHH--hCCCCCceeEeeeee
Confidence            4576 7888999988875 6778988874311             123456788999999998  665  4666665433


Q ss_pred             CCe----eEEEEecCCC-CCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCce
Q 018263          112 GPC----RILVYDYMPN-NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP  186 (358)
Q Consensus       112 ~~~----~~iv~e~~~~-~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~  186 (358)
                      ...    .++|+|+++| .+|.+++.     ...+++..    +.+|+.+|.+||+.   ||+|+||+|.||+++.++.+
T Consensus       114 ~~~~~~~~~lV~e~l~G~~~L~~~l~-----~~~l~~~~----~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v  181 (239)
T PRK01723        114 RHGLFYRADILIERIEGARDLVALLQ-----EAPLSEEQ----WQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKF  181 (239)
T ss_pred             ecCcceeeeEEEEecCCCCCHHHHHh-----cCCCCHHH----HHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCE
Confidence            222    2599999997 68988872     23455443    56899999999999   99999999999999998899


Q ss_pred             EEeecccccc
Q 018263          187 KISDFGLSKL  196 (358)
Q Consensus       187 ~l~Dfg~~~~  196 (358)
                      +|+|||.+..
T Consensus       182 ~LIDfg~~~~  191 (239)
T PRK01723        182 WLIDFDRGEL  191 (239)
T ss_pred             EEEECCCccc
Confidence            9999998876

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.53  E-value=1.3e-13  Score=130.88  Aligned_cols=166  Identities=16%  Similarity=0.196  Sum_probs=129.0

Q ss_pred             ECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecCCCCCHHHHhhhccccccCCC
Q 018263           63 LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFG  142 (358)
Q Consensus        63 ~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~  142 (358)
                      ..++.+|.+...............+.+..++.++  ||||+++++.++..+..|+|+|.+  ..|...+..       +.
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlR--HP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~-------l~  102 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLR--HPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE-------LG  102 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhcc--CchhhhhhhhhcccCceEEEeecc--ccHHHHHHH-------hH
Confidence            3468888888887766655667888999999998  999999999999999999999988  356777622       23


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCcccccccccccCccCcccccc
Q 018263          143 WKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS  222 (358)
Q Consensus       143 ~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  222 (358)
                      ...+..-++||+.||.+||..+  +++|++++...|+|+..|..+|++|..+........ .......-..|..|+.+..
T Consensus       103 ~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~  179 (690)
T KOG1243|consen  103 KEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDP  179 (690)
T ss_pred             HHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCc
Confidence            6777788999999999998654  999999999999999999999999988765322221 1122233345667775432


Q ss_pred             CCCCccCceecHHHHHHHHHhC
Q 018263          223 GRLTRKSDVYSFGVLLLEIVSG  244 (358)
Q Consensus       223 ~~~s~~sDiwslG~il~~lltg  244 (358)
                      ..  -..|.|.||+++++++.|
T Consensus       180 s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  180 SE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             cc--cchhhhhHHHHHHHHhCc
Confidence            22  356999999999999999

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.52  E-value=1.1e-14  Score=126.84  Aligned_cols=204  Identities=21%  Similarity=0.234  Sum_probs=143.3

Q ss_pred             HHHHhhhcccCCCCceeeeceEEcCC-----eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhc
Q 018263           88 EVASMANVNVCHENLVKLHGGCIDGP-----CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE  162 (358)
Q Consensus        88 e~~~l~~l~~~h~~i~~~~~~~~~~~-----~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~  162 (358)
                      -+..+..+-  |.|+++++.++.+..     ...++.||+..+++..++++...+...+......+|+.||+.||.|||+
T Consensus       117 vFdnllqlv--HsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs  194 (458)
T KOG1266|consen  117 VFDNLLQLV--HSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS  194 (458)
T ss_pred             HHHHHHHHH--HHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc
Confidence            344455555  999999998877544     3678899999999999999888888999999999999999999999999


Q ss_pred             CCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCC----CcccccccccccCccCccccccCCCCccCceecHHHHH
Q 018263          163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN----TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLL  238 (358)
Q Consensus       163 ~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il  238 (358)
                      . .+-++|+++.-+.|++..+|-+|++- +........    .......-.+-++|.+||.-...+.+.++|||++|+..
T Consensus       195 ~-~PpiihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcA  272 (458)
T KOG1266|consen  195 C-DPPIIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCA  272 (458)
T ss_pred             c-CCccccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHH
Confidence            6 78999999999999999998887742 211111100    00111112356789999976666778899999999999


Q ss_pred             HHHHhCCCCCC-ccccccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          239 LEIVSGRTAVD-FDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       239 ~~lltg~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .+|..+..--. ..+.......         ..+....+...           .-..++.+|++..|..||+|.+++-
T Consensus       273 lemailEiq~tnseS~~~~ee~---------ia~~i~~len~-----------lqr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  273 LEMAILEIQSTNSESKVEVEEN---------IANVIIGLENG-----------LQRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             HHHHHheeccCCCcceeehhhh---------hhhheeeccCc-----------cccCcCcccccCCCCCCcchhhhhc
Confidence            99988765321 1111000000         00000111111           1235677899999999999998753

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.48  E-value=4.5e-14  Score=132.49  Aligned_cols=251  Identities=22%  Similarity=0.258  Sum_probs=186.0

Q ss_pred             HhhcCCcccceecc--cCceEEEEEEE--C-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEc
Q 018263           39 IATNGFRWSNKIGE--GGFGSVYKGRL--Q-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID  111 (358)
Q Consensus        39 ~~~~~y~i~~~lg~--g~~g~v~~~~~--~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~  111 (358)
                      .....+.+.+.+|.  |.+|.+|.+..  . ++..+++|.-...  .......-.+++....++. .|++.++....+..
T Consensus       111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~-~~~~~v~~~~~~e~  189 (524)
T KOG0601|consen  111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKID-SHENPVRDSPAWEG  189 (524)
T ss_pred             hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccC-ccccccccCccccc
Confidence            33567888899999  99999999986  3 5788898884433  3344455567788777776 59999998899999


Q ss_pred             CCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHH----HHHHHhcCCCCCcEEcCCCCCcEEEcCC-Cce
Q 018263          112 GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR----GLAYIHEEIQPHVVHRDIKTSNILLDQN-FNP  186 (358)
Q Consensus       112 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~----aL~~LH~~~~~~i~H~di~p~Nilv~~~-~~~  186 (358)
                      .+..++-.|.+ +.+|..+..   .....++...++..+.+...    ||.++|+.   +++|-|++|.||+...+ ...
T Consensus       190 ~~~lfiqtE~~-~~sl~~~~~---~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~  262 (524)
T KOG0601|consen  190 SGILFIQTELC-GESLQSYCH---TPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSC  262 (524)
T ss_pred             CCcceeeeccc-cchhHHhhh---cccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheeccccccee
Confidence            99999999998 677777762   33455888999999999999    99999999   99999999999999998 889


Q ss_pred             EEeecccccccCCCCccc----ccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHh
Q 018263          187 KISDFGLSKLFPENTTHI----STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDK  262 (358)
Q Consensus       187 ~l~Dfg~~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~  262 (358)
                      +++|||+...++......    .....+..-|.+||. ..+.++.++|+|++|.++.+-..+.++....-.         
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~-~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~---------  332 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKEL-LNGLATFASDIFSLGEVILEAILGSHLPSVGKN---------  332 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhh-hccccchHhhhcchhhhhHhhHhhcccccCCCC---------
Confidence            999999998876544211    122357788999995 455678899999999999999888776542211         


Q ss_pred             hhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 018263          263 AWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAI  314 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil  314 (358)
                             ..+.++-.-.+..++-..-...+..++..|++.+|..|++++.+.
T Consensus       333 -------~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~  377 (524)
T KOG0601|consen  333 -------SSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT  377 (524)
T ss_pred             -------CCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence                   001111111111112222334455688899999999999987764

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.46  E-value=4.4e-13  Score=127.10  Aligned_cols=143  Identities=20%  Similarity=0.254  Sum_probs=96.5

Q ss_pred             cceecccCceEEEEEEECCCCEEEEEEeeccChhh----------------------------------------HHHHH
Q 018263           47 SNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQG----------------------------------------EKEFM   86 (358)
Q Consensus        47 ~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~----------------------------------------~~~~~   86 (358)
                      .+.||+|+.|.||+|+.++|+.||||+........                                        +-++.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            36799999999999999999999999985431110                                        01233


Q ss_pred             HHHHHhhhccc---CCCCceeeeceEEcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHH-HHHHHhc
Q 018263           87 SEVASMANVNV---CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR-GLAYIHE  162 (358)
Q Consensus        87 ~e~~~l~~l~~---~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~-aL~~LH~  162 (358)
                      .|...+..+..   .++++.-..-+....+..++||||++|.+|.+.....   ....+   ...++.+++. .+..+|.
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~---~~~~~---~~~ia~~~~~~~l~ql~~  275 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALD---EAGLD---RKALAENLARSFLNQVLR  275 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHH---hcCCC---HHHHHHHHHHHHHHHHHh
Confidence            34444444321   1333222221222344578999999999998876321   11112   2345555555 4678898


Q ss_pred             CCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       163 ~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      .   |++|+|++|.||+++.++.++++|||++....
T Consensus       276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             C---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            8   99999999999999999999999999997653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.40  E-value=7.9e-12  Score=104.77  Aligned_cols=139  Identities=16%  Similarity=0.111  Sum_probs=101.3

Q ss_pred             cceecccCceEEEEEEECC-------CCEEEEEEeeccC----------------------hhhHH----HHHHHHHHhh
Q 018263           47 SNKIGEGGFGSVYKGRLQD-------GTIVAVKVLSVES----------------------KQGEK----EFMSEVASMA   93 (358)
Q Consensus        47 ~~~lg~g~~g~v~~~~~~~-------~~~vaiK~~~~~~----------------------~~~~~----~~~~e~~~l~   93 (358)
                      ...||.|.-+.||.|...+       +..+|||+.+...                      ....+    ....|+..|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4578999999999998543       4789999974310                      01122    2347888888


Q ss_pred             hcccCCCCceeeeceEEcCCeeEEEEecCCCCCHHH-HhhhccccccCCCHHHHHHHHHHHHHHHHHH-hcCCCCCcEEc
Q 018263           94 NVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQ-TLLGEEKRRAKFGWKARREIIMGIGRGLAYI-HEEIQPHVVHR  171 (358)
Q Consensus        94 ~l~~~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~-~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~L-H~~~~~~i~H~  171 (358)
                      .+....-++..++++    ...++||||+.+..+.. .+     ....++......+..+++.+|..+ |+.   |++||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L-----kd~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHG  149 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL-----KDAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHA  149 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh-----hccccCHHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence            887445566677754    45789999996643322 22     122345566778889999999998 888   99999


Q ss_pred             CCCCCcEEEcCCCceEEeecccccccC
Q 018263          172 DIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       172 di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      ||++.||++.+ +.+.++|||.+....
T Consensus       150 DLs~~NIL~~~-~~v~iIDF~qav~~~  175 (197)
T cd05146         150 DLSEYNMLWHD-GKVWFIDVSQSVEPT  175 (197)
T ss_pred             CCCHHHEEEEC-CcEEEEECCCceeCC
Confidence            99999999974 589999999887643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.39  E-value=6.7e-13  Score=127.48  Aligned_cols=147  Identities=18%  Similarity=0.204  Sum_probs=95.0

Q ss_pred             hcCCcccceecccCceEEEEEEECC-CCEEEEEEeeccChh----------------------------------hHH--
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQ----------------------------------GEK--   83 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~~-~~~vaiK~~~~~~~~----------------------------------~~~--   83 (358)
                      ...|.. +.||+|+.|.||.|+.++ |+.||||+..+....                                  -.+  
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            456776 799999999999999887 999999998643110                                  011  


Q ss_pred             ----HHHHHHHHhhhcccC--CCCceeeeceEE-cCCeeEEEEecCCCCCHHHHhh--hccccccCCCHHHHHHHHHHHH
Q 018263           84 ----EFMSEVASMANVNVC--HENLVKLHGGCI-DGPCRILVYDYMPNNSLSQTLL--GEEKRRAKFGWKARREIIMGIG  154 (358)
Q Consensus        84 ----~~~~e~~~l~~l~~~--h~~i~~~~~~~~-~~~~~~iv~e~~~~~~L~~~l~--~~~~~~~~l~~~~~~~~~~qi~  154 (358)
                          ++..|......+...  +...+.+=.++. .....++||||++|+.+.+...  ........+.+..+..++.|++
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif  277 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF  277 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence                122333333333211  122222222222 2445679999999999987531  1111122345555556666654


Q ss_pred             HHHHHHhcCCCCCcEEcCCCCCcEEEcCCC----ceEEeecccccccC
Q 018263          155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNF----NPKISDFGLSKLFP  198 (358)
Q Consensus       155 ~aL~~LH~~~~~~i~H~di~p~Nilv~~~~----~~~l~Dfg~~~~~~  198 (358)
                             ..   |++|+|++|.||+++.++    +++++|||++....
T Consensus       278 -------~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        278 -------RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             -------hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence                   35   999999999999999888    99999999987653

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.38  E-value=3e-12  Score=106.01  Aligned_cols=128  Identities=15%  Similarity=0.116  Sum_probs=94.1

Q ss_pred             cceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCC-ceeeeceEEcCCeeEEEEecCCCC
Q 018263           47 SNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHEN-LVKLHGGCIDGPCRILVYDYMPNN  125 (358)
Q Consensus        47 ~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~-i~~~~~~~~~~~~~~iv~e~~~~~  125 (358)
                      ++.++.|.++.||++... +..|++|+...... ....+..|+..+..+.  +.+ +.+++...  ....++||||++|.
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~--~~~~~P~~~~~~--~~~~~lv~e~i~G~   76 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAA--EAGIGPKLYYFD--PETGVLITEFIEGS   76 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHH--HhCCCCceEEEe--CCCCeEEEEecCCC
Confidence            467889999999999876 77899999754322 2234567888888775  333 34454443  23457999999998


Q ss_pred             CHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCc-----EEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          126 SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHV-----VHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       126 ~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i-----~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      ++...-            .....++.+++.+|+.||+.   ++     +|+|++|.||+++ ++.++++||+.+..
T Consensus        77 ~l~~~~------------~~~~~~~~~l~~~l~~LH~~---~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          77 ELLTED------------FSDPENLEKIAKLLKKLHSS---PLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cccccc------------ccCHHHHHHHHHHHHHHhCC---CCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            765431            11134567899999999998   64     9999999999999 66899999998864

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.38  E-value=2.3e-11  Score=109.85  Aligned_cols=266  Identities=11%  Similarity=0.096  Sum_probs=166.0

Q ss_pred             cccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCC----ceeeeceEE--cCC-eeEE
Q 018263           45 RWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHEN----LVKLHGGCI--DGP-CRIL  117 (358)
Q Consensus        45 ~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~----i~~~~~~~~--~~~-~~~i  117 (358)
                      .....||+|+-+.+|..-.- +. .+-|++...........   ...+.... .||-    ++.......  +.+ ...+
T Consensus        14 ~~gr~LgqGgea~ly~l~e~-~d-~VAKIYh~Pppa~~aqk---~a~la~~p-~~p~~~~rvaWPqa~L~G~~~~~~iGf   87 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEV-RD-QVAKIYHAPPPAAQAQK---VAELAATP-DAPLLNYRVAWPQATLHGGRRGKVIGF   87 (637)
T ss_pred             CCCccccCCccceeeecchh-hc-hhheeecCCCchHHHHH---HHHhccCC-CCcchhhhhcccHHHhhCCCccceeEE
Confidence            45678999999999876432 22 24477765544443333   23333332 2442    222222222  222 2568


Q ss_pred             EEecCCCCC-HHHHhh--hccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccc
Q 018263          118 VYDYMPNNS-LSQTLL--GEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS  194 (358)
Q Consensus       118 v~e~~~~~~-L~~~l~--~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~  194 (358)
                      +|..++|.. +.+++.  +.++.....++..+.+.+..++.+.+.||..   |.+-||++++|++|++++.+.|+|-...
T Consensus        88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsf  164 (637)
T COG4248          88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSF  164 (637)
T ss_pred             ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccce
Confidence            888887653 222221  1222334567899999999999999999999   9999999999999999999999987655


Q ss_pred             cccCCCCcccccccccccCccCccccc-----cCCCCccCceecHHHHHHHHHhC-CCCCCccccccc----hh-hhHhh
Q 018263          195 KLFPENTTHISTRVAGTLGYLAPEYAI-----SGRLTRKSDVYSFGVLLLEIVSG-RTAVDFDVQLGE----YH-LVDKA  263 (358)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~s~~sDiwslG~il~~lltg-~~pf~~~~~~~~----~~-~~~~~  263 (358)
                      ...  .......+..+..+|++||...     +-..+..+|.|.||+++++++.| ++||.+-.....    +. .+...
T Consensus       165 qi~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g  242 (637)
T COG4248         165 QIN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG  242 (637)
T ss_pred             eec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence            543  2334455677899999999654     23456789999999999999987 999975432111    11 11100


Q ss_pred             hhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCC--CCCCCCCHHHHHHHhhcCCC
Q 018263          264 WGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQE--KSKLRPQMSTAIKMMNGETN  322 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~--~P~~Rpt~~eil~~L~~~~~  322 (358)
                      . .....+..--..+......-...+.++..+...|...  ++.-|||++.++..|..+..
T Consensus       243 ~-f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~  302 (637)
T COG4248         243 R-FAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ  302 (637)
T ss_pred             e-eeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence            0 0001111111111111122235566788888888864  57899999999888776543

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.33  E-value=2.6e-11  Score=112.08  Aligned_cols=171  Identities=23%  Similarity=0.320  Sum_probs=129.6

Q ss_pred             CceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEE----cCCeeEEEEecCCCC-CH
Q 018263           54 GFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCI----DGPCRILVYDYMPNN-SL  127 (358)
Q Consensus        54 ~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~----~~~~~~iv~e~~~~~-~L  127 (358)
                      -..+.|++..+ +|..|++|+++............-++.++++.  |+|+|++.++|.    .+..+++|++|+|+. +|
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~--h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL  365 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLC--HTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL  365 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhc--cCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence            34677999865 79999999995443333334456688889988  999999999887    455789999999864 67


Q ss_pred             HHHhhhcc-----------ccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          128 SQTLLGEE-----------KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       128 ~~~l~~~~-----------~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      .++.....           ......++..+|.++.|+..||.++|+.   |+..+-|.|.+|+++++.+++|..+|....
T Consensus       366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dv  442 (655)
T KOG3741|consen  366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDV  442 (655)
T ss_pred             HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceee
Confidence            77664322           1234578999999999999999999999   999999999999999999999998887765


Q ss_pred             cCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCC
Q 018263          197 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTA  247 (358)
Q Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~p  247 (358)
                      .-.+..               |.+.+.   .+.|.=.||.+++.|.+|..-
T Consensus       443 l~~d~~---------------~~le~~---Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  443 LQEDPT---------------EPLESQ---QQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             ecCCCC---------------cchhHH---hhhhHHHHHHHHHHHhhcccc
Confidence            322220               111111   246888999999999998653

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.26  E-value=4.4e-12  Score=119.23  Aligned_cols=262  Identities=20%  Similarity=0.184  Sum_probs=181.2

Q ss_pred             ccccccCHHH-HHHhhcCCcccceecccCceEEEEEEE--CCCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCC
Q 018263           27 KNINAFSYNQ-LKIATNGFRWSNKIGEGGFGSVYKGRL--QDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHEN  101 (358)
Q Consensus        27 ~~~~~~~~~~-~~~~~~~y~i~~~lg~g~~g~v~~~~~--~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~  101 (358)
                      +..+.+...+ ...-..+|..+..||.|.|+.|+.+..  .++..|++|.....  ....+..-..|+.....+. .|.+
T Consensus       249 kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~-~~~~  327 (524)
T KOG0601|consen  249 KPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILG-SHLP  327 (524)
T ss_pred             chhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhh-cccc
Confidence            3344444445 333456889999999999999998863  36888998887543  2222333345666666665 4888


Q ss_pred             ceeeeceEEcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEc
Q 018263          102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD  181 (358)
Q Consensus       102 i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~  181 (358)
                      .+.....+..-...|+=-|||.++++....    .....+++...+.+..|++.++.++|++   .++|+|++|+||++.
T Consensus       328 ~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~----~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~  400 (524)
T KOG0601|consen  328 SVGKNSSWSQLRQGYIPLEFCEGGSSSLRS----VTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILIS  400 (524)
T ss_pred             cCCCCCCccccccccCchhhhcCcchhhhh----HHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeec
Confidence            888777777666777889999999888776    4556788899999999999999999999   999999999999998


Q ss_pred             CC-CceEEeecccccccCCCCcccccccccccCcc--CccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchh
Q 018263          182 QN-FNPKISDFGLSKLFPENTTHISTRVAGTLGYL--APEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYH  258 (358)
Q Consensus       182 ~~-~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~--aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~  258 (358)
                      .+ +..+++|++....+.-...   . ......+.  ++.......+..+.|+++||..+.+.+++...-...       
T Consensus       401 ~~~~~~~~~~~~~~t~~~~~~~---~-~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~-------  469 (524)
T KOG0601|consen  401 NDGFFSKLGDFGCWTRLAFSSG---V-FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG-------  469 (524)
T ss_pred             cchhhhhccccccccccceecc---c-ccccccccccchhhccccccccccccccccccccccccCcccCccc-------
Confidence            86 6778999998864211111   1 11222333  555555677889999999999999999886542211       


Q ss_pred             hhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 018263          259 LVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE  320 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~  320 (358)
                                 ..+.. +........+... ..+..+...++..++..||.+.++....+-+
T Consensus       470 -----------~~~~~-i~~~~~p~~~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  470 -----------VQSLT-IRSGDTPNLPGLK-LQLQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             -----------cccee-eecccccCCCchH-HhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence                       11111 1111111222222 5677777889999999999998876554433

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.25  E-value=1.3e-10  Score=94.47  Aligned_cols=131  Identities=23%  Similarity=0.309  Sum_probs=97.7

Q ss_pred             ceecccCceEEEEEEECCCCEEEEEEeecc--------ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           48 NKIGEGGFGSVYKGRLQDGTIVAVKVLSVE--------SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        48 ~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~--------~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      ..+++|+-+.++.+.+. |..+++|.-...        ..-...+-.+|+.++.++.  .-.+....-+..+.+...|+|
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~--~~GV~~P~v~dvD~~~~~I~m   78 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAR--EAGVPVPIVYDVDPDNGLIVM   78 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHH--HcCCCCCeEEEEcCCCCEEEE
Confidence            35788999999999775 444777764322        1112245566888888887  334444444555777788999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      ||++|..|.+.+...           ...++..+-..+.-||..   ||+||||.++||++...+ +.++|||++..
T Consensus        79 e~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          79 EYIEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             EEeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            999999999898322           245667777888999999   999999999999998874 99999999975

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.24  E-value=9.6e-11  Score=101.24  Aligned_cols=145  Identities=18%  Similarity=0.236  Sum_probs=108.2

Q ss_pred             cceecccCceEEEEEEECCCCEEEEEEeeccCh-hhHHHHHHHHHHhhhcccCCCCceeeeceEEcC---CeeEEEEecC
Q 018263           47 SNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLVKLHGGCIDG---PCRILVYDYM  122 (358)
Q Consensus        47 ~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~---~~~~iv~e~~  122 (358)
                      ++.|+.|..+.+|++...+|+.|++|....... .....+..|...+..+...+..+.+++.+....   +..++||||+
T Consensus         3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            367899999999999887678899999754322 134567888888888873334456666665543   2568999999


Q ss_pred             CCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCC--------------------------------------
Q 018263          123 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI--------------------------------------  164 (358)
Q Consensus       123 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--------------------------------------  164 (358)
                      +|.++.+.+.     ...++......++.+++.+|..||+..                                      
T Consensus        83 ~G~~l~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (223)
T cd05154          83 DGRVLRDRLL-----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM  157 (223)
T ss_pred             CCEecCCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence            9988877651     134667777778888888888888520                                      


Q ss_pred             ---------------CCCcEEcCCCCCcEEEcC--CCceEEeecccccc
Q 018263          165 ---------------QPHVVHRDIKTSNILLDQ--NFNPKISDFGLSKL  196 (358)
Q Consensus       165 ---------------~~~i~H~di~p~Nilv~~--~~~~~l~Dfg~~~~  196 (358)
                                     ...++|+|+++.||+++.  ++.+.++||+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                           236799999999999998  56688999988764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.23  E-value=1.8e-10  Score=93.31  Aligned_cols=143  Identities=22%  Similarity=0.282  Sum_probs=106.4

Q ss_pred             ccceecccCceEEEEEEECCCCEEEEEEeecc--------ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           46 WSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVE--------SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        46 i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~--------~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      ....+.+|+-+.|+++.+. |+.++||.-...        ..-...+..+|...+.++.  --.|.-..-++.+.....+
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~--~~GI~~P~l~~~D~~~~~i   87 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCR--ALGIPAPRLIFIDTYGGQI   87 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHH--HhCCCCceEEEEecCCCeE
Confidence            5778889999999999986 788888864322        1223466778888888886  3455555556667777889


Q ss_pred             EEecCCC-CCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCc---eEEeeccc
Q 018263          118 VYDYMPN-NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN---PKISDFGL  193 (358)
Q Consensus       118 v~e~~~~-~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~---~~l~Dfg~  193 (358)
                      +|||++| .++.++++..-.  ..........++.+|-..+.-||.+   +++||||..+||++..++.   +.++|||+
T Consensus        88 ~ME~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgl  162 (229)
T KOG3087|consen   88 YMEFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGL  162 (229)
T ss_pred             EEEeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecc
Confidence            9999977 478888754322  2222334478899999999999999   9999999999999965443   48999999


Q ss_pred             ccc
Q 018263          194 SKL  196 (358)
Q Consensus       194 ~~~  196 (358)
                      +..
T Consensus       163 s~~  165 (229)
T KOG3087|consen  163 SSV  165 (229)
T ss_pred             hhc
Confidence            865

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.11  E-value=6.5e-10  Score=92.87  Aligned_cols=127  Identities=21%  Similarity=0.216  Sum_probs=83.2

Q ss_pred             EEEEEEECCCCEEEEEEeeccC--------------------------hhhHHHHHHHHHHhhhcccCCCCceeeeceEE
Q 018263           57 SVYKGRLQDGTIVAVKVLSVES--------------------------KQGEKEFMSEVASMANVNVCHENLVKLHGGCI  110 (358)
Q Consensus        57 ~v~~~~~~~~~~vaiK~~~~~~--------------------------~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~  110 (358)
                      .||.|...+|..+|+|+.....                          .........|+..|..+....-++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            4899999889999999974310                          1123557789999999974444566776542 


Q ss_pred             cCCeeEEEEecCC--CCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHH-HhcCCCCCcEEcCCCCCcEEEcCCCceE
Q 018263          111 DGPCRILVYDYMP--NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY-IHEEIQPHVVHRDIKTSNILLDQNFNPK  187 (358)
Q Consensus       111 ~~~~~~iv~e~~~--~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~-LH~~~~~~i~H~di~p~Nilv~~~~~~~  187 (358)
                         ..++||||++  |..+..+...      .++......++.+++..+.. +|+.   |++|||+++.||+++++ .+.
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~------~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~  146 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDV------DLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY  146 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHC------GGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred             ---CCEEEEEecCCCccchhhHHhc------cccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence               3469999997  5555544311      11134455667777775555 5788   99999999999999988 899


Q ss_pred             Eeeccccccc
Q 018263          188 ISDFGLSKLF  197 (358)
Q Consensus       188 l~Dfg~~~~~  197 (358)
                      ++|||.+...
T Consensus       147 iIDf~qav~~  156 (188)
T PF01163_consen  147 IIDFGQAVDS  156 (188)
T ss_dssp             E--GTTEEET
T ss_pred             EEecCcceec
Confidence            9999988764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.09  E-value=1e-09  Score=94.52  Aligned_cols=140  Identities=19%  Similarity=0.133  Sum_probs=101.4

Q ss_pred             cCCcccceecccCceEEEEEEECCCCEEEEEEeecc--------------------C--hhhHHHHHHHHHHhhhcccCC
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVE--------------------S--KQGEKEFMSEVASMANVNVCH   99 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~--------------------~--~~~~~~~~~e~~~l~~l~~~h   99 (358)
                      .=+.+..+||-|.-|.||.|....|.+++||.-+.-                    +  ......+++|++.|+.+....
T Consensus        91 ~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G  170 (304)
T COG0478          91 IVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG  170 (304)
T ss_pred             hHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence            345677899999999999999999999999985320                    0  113456788999999986211


Q ss_pred             CCceeeeceEEcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEE
Q 018263          100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL  179 (358)
Q Consensus       100 ~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nil  179 (358)
                      -.+.+.+++    +..++|||+++|..|...-         ++.+....++..|+.-+.-+-..   |++|||+++-||+
T Consensus       171 ~~VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIl  234 (304)
T COG0478         171 VKVPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNIL  234 (304)
T ss_pred             CCCCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEE
Confidence            256666655    4457999999886554442         12333444455555555555567   9999999999999


Q ss_pred             EcCCCceEEeeccccccc
Q 018263          180 LDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       180 v~~~~~~~l~Dfg~~~~~  197 (358)
                      |+++|.+.++||-.+...
T Consensus       235 V~~dg~~~vIDwPQ~v~~  252 (304)
T COG0478         235 VTEDGDIVVIDWPQAVPI  252 (304)
T ss_pred             EecCCCEEEEeCcccccC
Confidence            999999999999877653

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.09  E-value=2.8e-11  Score=119.97  Aligned_cols=258  Identities=19%  Similarity=0.238  Sum_probs=176.7

Q ss_pred             ccCHHHHHHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHH---HHHHHHhhhcccCCCCceeee
Q 018263           31 AFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEF---MSEVASMANVNVCHENLVKLH  106 (358)
Q Consensus        31 ~~~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~---~~e~~~l~~l~~~h~~i~~~~  106 (358)
                      ......++...+.+.+.+.+-+|.++.+..+.-. .|....+|+..........++   ..+-..+-.-.  +|.++...
T Consensus       793 P~sp~~yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~--~P~v~~~~  870 (1205)
T KOG0606|consen  793 PRSPTKYRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPR--SPAVVRSF  870 (1205)
T ss_pred             CCCcccccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCC--CCceeccc
Confidence            3333346777889999999999999999888733 343334444322111111111   11111111111  45555554


Q ss_pred             ceEEcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCce
Q 018263          107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP  186 (358)
Q Consensus       107 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~  186 (358)
                      -.+.-....+++++|..+++|...+    .+.+..+.+..+.....+..++++||+.   .+.|+|++|.|.++..++..
T Consensus       871 ~s~~~rsP~~L~~~~~~~~~~~Skl----~~~~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~  943 (1205)
T KOG0606|consen  871 PSFPCRSPLPLVGHYLNGGDLPSKL----HNSGCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHR  943 (1205)
T ss_pred             CCCCCCCCcchhhHHhccCCchhhh----hcCCCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCc
Confidence            4555666789999999999999998    4566788888888999999999999998   89999999999999999999


Q ss_pred             EEeecccccccCC------C------------------------CcccccccccccCccCccccccCCCCccCceecHHH
Q 018263          187 KISDFGLSKLFPE------N------------------------TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGV  236 (358)
Q Consensus       187 ~l~Dfg~~~~~~~------~------------------------~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~  236 (358)
                      .+.||+.....+.      .                        .........+|+.|.+||...+......+|.|+.|+
T Consensus       944 ~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~ 1023 (1205)
T KOG0606|consen  944 PLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGV 1023 (1205)
T ss_pred             ccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhh
Confidence            9999973322110      0                        001122356899999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhcccc-CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 018263          237 LLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPML-YGNFPENEAIRFLKVGLLCVQEKSKLRPQMST  312 (358)
Q Consensus       237 il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~e  312 (358)
                      ++++.++|.+||........+.               .++.... -..-+...+....+++...+..+|.+|..+..
T Consensus      1024 ~l~e~l~g~pp~na~tpq~~f~---------------ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~ 1085 (1205)
T KOG0606|consen 1024 CLFEVLTGIPPFNAETPQQIFE---------------NILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKG 1085 (1205)
T ss_pred             hhhhhhcCCCCCCCcchhhhhh---------------ccccCCCCCCCCccccChhhhhhhhhhhccCchhccCccc
Confidence            9999999999998554432221               1111100 01223345666788888999999999988763

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.06  E-value=6.5e-09  Score=91.99  Aligned_cols=137  Identities=11%  Similarity=0.023  Sum_probs=95.3

Q ss_pred             CceEEEEEEECCCCEEEEEEeeccChh-----------hHHHHHHHHHHhhhcccCCCCceeeeceEEc-----CCeeEE
Q 018263           54 GFGSVYKGRLQDGTIVAVKVLSVESKQ-----------GEKEFMSEVASMANVNVCHENLVKLHGGCID-----GPCRIL  117 (358)
Q Consensus        54 ~~g~v~~~~~~~~~~vaiK~~~~~~~~-----------~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~-----~~~~~i  117 (358)
                      ....|..+.. +|+.|+||........           ....+.+|+..+..+....-..+.++.+...     ....++
T Consensus        34 ~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~L  112 (268)
T PRK15123         34 EGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFI  112 (268)
T ss_pred             CCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEE
Confidence            3334556655 4778999977433211           1123667888777775222223334444432     234689


Q ss_pred             EEecCCCC-CHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcC-------CCceEEe
Q 018263          118 VYDYMPNN-SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ-------NFNPKIS  189 (358)
Q Consensus       118 v~e~~~~~-~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~-------~~~~~l~  189 (358)
                      |+|++++. +|.+++...  .....+......++.+++..+..||..   |++|+|++++||+++.       +..+.++
T Consensus       113 Vte~l~~~~sL~~~~~~~--~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LI  187 (268)
T PRK15123        113 ITEDLAPTISLEDYCADW--ATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVI  187 (268)
T ss_pred             EEeeCCCCccHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEEEE
Confidence            99999876 799988322  124456778889999999999999999   9999999999999975       4678999


Q ss_pred             ecccccc
Q 018263          190 DFGLSKL  196 (358)
Q Consensus       190 Dfg~~~~  196 (358)
                      ||+.+..
T Consensus       188 Dl~r~~~  194 (268)
T PRK15123        188 DLHRAQI  194 (268)
T ss_pred             ECCcccc
Confidence            9998864

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.92  E-value=4.5e-10  Score=107.47  Aligned_cols=149  Identities=23%  Similarity=0.334  Sum_probs=105.0

Q ss_pred             HHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCccccc--------ccccccCccCccccccC
Q 018263          152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIST--------RVAGTLGYLAPEYAISG  223 (358)
Q Consensus       152 qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~--------~~~~~~~y~aPE~~~~~  223 (358)
                      +++.|+.++|..  +++||++|.|++|.++.++..|++.|+.+.....+......        .......|.|||++.+.
T Consensus       107 ~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  107 NVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             cccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            344899999976  59999999999999999999999999987654332211111        12345689999999988


Q ss_pred             CCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCC
Q 018263          224 RLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQE  302 (358)
Q Consensus       224 ~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  302 (358)
                      ..+.++|+||+|+++|.+.. |+.-+........+...             ...+....-.+..+.+.++.+=+.+++..
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~-------------~~~~~~~~~~~s~~~p~el~~~l~k~l~~  251 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS-------------RNLLNAGAFGYSNNLPSELRESLKKLLNG  251 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcchhhhh-------------hcccccccccccccCcHHHHHHHHHHhcC
Confidence            88999999999999999994 55544433322222111             11111112223356677788888899999


Q ss_pred             CCCCCCCHHHHHH
Q 018263          303 KSKLRPQMSTAIK  315 (358)
Q Consensus       303 ~P~~Rpt~~eil~  315 (358)
                      ++.-||++..+..
T Consensus       252 ~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  252 DSAVRPTLDLLLS  264 (700)
T ss_pred             CcccCcchhhhhc
Confidence            9999997666543

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.90  E-value=5.1e-09  Score=100.22  Aligned_cols=144  Identities=18%  Similarity=0.183  Sum_probs=92.6

Q ss_pred             ceecccCceEEEEEEECCCCEEEEEEeeccChh----------------------------------------hHHHHHH
Q 018263           48 NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQ----------------------------------------GEKEFMS   87 (358)
Q Consensus        48 ~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~----------------------------------------~~~~~~~   87 (358)
                      +.|+.++-|.||.|+.++|+.||||+..+.-..                                        .+-++..
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            789999999999999999999999998642111                                        1112333


Q ss_pred             HHHHhhhccc---CCCCceeeeceEEcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCC
Q 018263           88 EVASMANVNV---CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI  164 (358)
Q Consensus        88 e~~~l~~l~~---~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~  164 (358)
                      |......+..   ..+++.-..=+....+..+++|||++|..+.+.....   ....+.+.+.....++..-  .+-.. 
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~---~~g~d~k~ia~~~~~~f~~--q~~~d-  284 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK---SAGIDRKELAELLVRAFLR--QLLRD-  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH---hcCCCHHHHHHHHHHHHHH--HHHhc-
Confidence            4433333321   1333333333334456678999999999998885222   1233333333333222221  11123 


Q ss_pred             CCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       165 ~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                        |++|+|.+|.||+|..+|++.+.|||+....++
T Consensus       285 --gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         285 --GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             --CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence              999999999999999999999999999876543

>PRK09902 hypothetical protein; Provisional

Probab=98.87  E-value=7.4e-08  Score=81.13  Aligned_cols=140  Identities=15%  Similarity=0.121  Sum_probs=102.2

Q ss_pred             cccCceEEEEEEECCCCEEEEEEeecc------ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEc----CCeeEEEEe
Q 018263           51 GEGGFGSVYKGRLQDGTIVAVKVLSVE------SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID----GPCRILVYD  120 (358)
Q Consensus        51 g~g~~g~v~~~~~~~~~~vaiK~~~~~------~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~----~~~~~iv~e  120 (358)
                      |+||.|.|+..... |+.|.+|.....      ....+..+.+|+..++.+....-.+.++...-..    .-..+||+|
T Consensus        27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe  105 (216)
T PRK09902         27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTE  105 (216)
T ss_pred             CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEE
Confidence            56999999998775 446888876421      1336778999999999886333335554422111    113479999


Q ss_pred             cCCC-CCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCc--eEEeecccccc
Q 018263          121 YMPN-NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN--PKISDFGLSKL  196 (358)
Q Consensus       121 ~~~~-~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~--~~l~Dfg~~~~  196 (358)
                      -++| -+|.+++...  ...+.+......++.+++.++..||+.   |+.|+|+.+.||+++.++.  +.++||.-++.
T Consensus       106 ~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        106 DMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             eCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            7743 4788887322  233567788889999999999999999   9999999999999986667  99999987654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.86  E-value=2.6e-08  Score=85.16  Aligned_cols=125  Identities=18%  Similarity=0.162  Sum_probs=89.4

Q ss_pred             CCCEEEEEEeecc-C------hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC----eeEEEEecCCCC-CHHHHhh
Q 018263           65 DGTIVAVKVLSVE-S------KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP----CRILVYDYMPNN-SLSQTLL  132 (358)
Q Consensus        65 ~~~~vaiK~~~~~-~------~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~----~~~iv~e~~~~~-~L~~~l~  132 (358)
                      .++.|.+|..... .      ........+|+..+..+....=..++++.+.....    ..++|+|++++. +|.+++.
T Consensus        31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~  110 (206)
T PF06293_consen   31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ  110 (206)
T ss_pred             cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence            3566666654221 1      12344567777777666533333455555554422    347999999874 7999983


Q ss_pred             hccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCC---ceEEeecccccc
Q 018263          133 GEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF---NPKISDFGLSKL  196 (358)
Q Consensus       133 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~---~~~l~Dfg~~~~  196 (358)
                      .    ....+......++.+++..+.-||..   |++|+|+++.||+++.++   .+.++||+.+..
T Consensus       111 ~----~~~~~~~~~~~ll~~l~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  111 Q----WEQLDPSQRRELLRALARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             h----hcccchhhHHHHHHHHHHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            2    22266777889999999999999999   999999999999999887   899999998765

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.80  E-value=9.2e-08  Score=80.88  Aligned_cols=141  Identities=14%  Similarity=0.148  Sum_probs=94.6

Q ss_pred             HhhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHH---------HHHHHhhhccc-CCCCceeeece
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFM---------SEVASMANVNV-CHENLVKLHGG  108 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~---------~e~~~l~~l~~-~h~~i~~~~~~  108 (358)
                      +...+|.+.+.+.......|.+.... |+.+++|.........+..+.         +.+.....+.. +.-.+..++.+
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            34578999999988888888777775 788999998765444333322         33343333321 12222222222


Q ss_pred             -----EEcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCC
Q 018263          109 -----CIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN  183 (358)
Q Consensus       109 -----~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~  183 (358)
                           +......+++|||++|..|.+...        +++    .++..+..++..||+.   |++|||++|.|++++++
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~  171 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN  171 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC
Confidence                 222344568999999988776641        222    2445677789999999   99999999999999866


Q ss_pred             CceEEeecccccc
Q 018263          184 FNPKISDFGLSKL  196 (358)
Q Consensus       184 ~~~~l~Dfg~~~~  196 (358)
                       .++++|++....
T Consensus       172 -~i~iID~~~k~~  183 (229)
T PF06176_consen  172 -GIRIIDTQGKRM  183 (229)
T ss_pred             -cEEEEECccccc
Confidence             599999976653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.74  E-value=2.2e-07  Score=79.42  Aligned_cols=158  Identities=15%  Similarity=0.156  Sum_probs=105.5

Q ss_pred             ccccCHHHHHHhhcCCcccceec---ccCceEEEEEEECCCCEEEEEEeeccChh------------------------h
Q 018263           29 INAFSYNQLKIATNGFRWSNKIG---EGGFGSVYKGRLQDGTIVAVKVLSVESKQ------------------------G   81 (358)
Q Consensus        29 ~~~~~~~~~~~~~~~y~i~~~lg---~g~~g~v~~~~~~~~~~vaiK~~~~~~~~------------------------~   81 (358)
                      +...+...+....++..+....|   +|.-+.||+|...++..+|+|++......                        .
T Consensus        32 ~D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv  111 (268)
T COG1718          32 FDKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLV  111 (268)
T ss_pred             hhhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHH
Confidence            44445556666667777776555   56677899999888999999998643111                        1


Q ss_pred             HHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHh
Q 018263           82 EKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH  161 (358)
Q Consensus        82 ~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH  161 (358)
                      ......|+..|..+...+=.+.+.+.+..    ..+||||+...  ..-.  ..-+.-.+..+....+..+++..+.-|-
T Consensus       112 ~~W~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~--g~pA--P~LkDv~~e~~e~~~~~~~~v~~~~~l~  183 (268)
T COG1718         112 FAWARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDD--GLPA--PRLKDVPLELEEAEGLYEDVVEYMRRLY  183 (268)
T ss_pred             HHHHHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCC--CCCC--CCcccCCcCchhHHHHHHHHHHHHHHHH
Confidence            12244566677766544545555555543    46999999433  1110  1112222333367777788888888887


Q ss_pred             c-CCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          162 E-EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       162 ~-~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      . .   ++||+||+.-||++. ++.+.++|++.+....
T Consensus       184 ~~a---~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         184 KEA---GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             Hhc---CcccccchhhheEEE-CCeEEEEECccccccC
Confidence            7 5   999999999999999 7799999999887543

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.66  E-value=7.8e-07  Score=77.09  Aligned_cols=135  Identities=18%  Similarity=0.148  Sum_probs=84.1

Q ss_pred             ceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecCCCCC-
Q 018263           48 NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNS-  126 (358)
Q Consensus        48 ~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~~~~~-  126 (358)
                      .+||.|..+.||+.   .|..+++|......  ......+|.+.+..+....--+.+++++....+...++||+++|.+ 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            57899999999974   24567889876432  3345678888888876222235667777777777889999998863 


Q ss_pred             HHHHhhhccccccCCCHHHHHHHHHHHHHHH---------------------------------------HHHhcC-CCC
Q 018263          127 LSQTLLGEEKRRAKFGWKARREIIMGIGRGL---------------------------------------AYIHEE-IQP  166 (358)
Q Consensus       127 L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL---------------------------------------~~LH~~-~~~  166 (358)
                      +...+..        +......++.+++..+                                       .+|.+. ...
T Consensus        82 ~~~~~~~--------~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~  153 (226)
T TIGR02172        82 FSRIISD--------NPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTS  153 (226)
T ss_pred             hhhhhcC--------CHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCC
Confidence            2211100        0000111111111111                                       111111 133


Q ss_pred             CcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          167 HVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       167 ~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      .++|+|++|.||++++++ +.++||+.+..
T Consensus       154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       154 TCLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             ceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            679999999999999887 99999987753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.59  E-value=8.4e-07  Score=77.05  Aligned_cols=80  Identities=14%  Similarity=0.148  Sum_probs=56.2

Q ss_pred             cceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEE---cCCeeEEEEecCC
Q 018263           47 SNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCI---DGPCRILVYDYMP  123 (358)
Q Consensus        47 ~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~---~~~~~~iv~e~~~  123 (358)
                      ++.++.|..+.||.+...+ ..+++|.....  .....+..|...++.+.....-+..++....   .....+++|++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            4678999999999999886 58999997544  4556677788887777522223455555332   3334689999999


Q ss_pred             CCCHHH
Q 018263          124 NNSLSQ  129 (358)
Q Consensus       124 ~~~L~~  129 (358)
                      |..+..
T Consensus        79 g~~~~~   84 (239)
T PF01636_consen   79 GRPLDD   84 (239)
T ss_dssp             SEEHHH
T ss_pred             cccccc
Confidence            987777

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.49  E-value=6e-07  Score=85.93  Aligned_cols=142  Identities=18%  Similarity=0.173  Sum_probs=88.1

Q ss_pred             cceecccCceEEEEEEECCCCEEEEEEeeccChh-------------------------------------hHHHHHHHH
Q 018263           47 SNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQ-------------------------------------GEKEFMSEV   89 (358)
Q Consensus        47 ~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~-------------------------------------~~~~~~~e~   89 (358)
                      .+.||....|.|++|+.++|+.||+|+.++.-..                                     .+-++..|.
T Consensus       166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            4689999999999999999999999997542111                                     111233333


Q ss_pred             HHhhhcccC--CCC------ceeeeceEEcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHh
Q 018263           90 ASMANVNVC--HEN------LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH  161 (358)
Q Consensus        90 ~~l~~l~~~--h~~------i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH  161 (358)
                      +...+....  |-+      |.+++-  ......+++|||++|..+.+.-.-   ....++...+..-+.+...-  .+-
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i---~~~gi~~~~i~~~l~~~~~~--qIf  318 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAI---DKRGISPHDILNKLVEAYLE--QIF  318 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHH---HHcCCCHHHHHHHHHHHHHH--HHH
Confidence            333332211  222      222222  233457899999999877776421   22234444443333333221  222


Q ss_pred             cCCCCCcEEcCCCCCcEEEc----CCCceEEeecccccccC
Q 018263          162 EEIQPHVVHRDIKTSNILLD----QNFNPKISDFGLSKLFP  198 (358)
Q Consensus       162 ~~~~~~i~H~di~p~Nilv~----~~~~~~l~Dfg~~~~~~  198 (358)
                      ..   |++|+|-+|.||++.    .++++.+.|+|+.....
T Consensus       319 ~~---GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  319 KT---GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             hc---CCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            23   999999999999998    36789999999987653

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.41  E-value=4.2e-06  Score=73.55  Aligned_cols=77  Identities=13%  Similarity=0.086  Sum_probs=53.3

Q ss_pred             eecccCc-eEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecCCCCCH
Q 018263           49 KIGEGGF-GSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSL  127 (358)
Q Consensus        49 ~lg~g~~-g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L  127 (358)
                      .|..|.+ ..||++... +..+++|+.....   ...+..|+..+..+.. +--+.+++......+..++||++++|.++
T Consensus         5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~-~~~vP~v~~~~~~~~~~~lv~e~i~G~~l   79 (244)
T cd05150           5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAG-KLPVPEVIDYGSDDGRAWLLTSAVPGVPA   79 (244)
T ss_pred             ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHh-cCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence            4445555 788998765 4678889875432   3345678888777752 33456677777666678999999999877


Q ss_pred             HHH
Q 018263          128 SQT  130 (358)
Q Consensus       128 ~~~  130 (358)
                      ...
T Consensus        80 ~~~   82 (244)
T cd05150          80 AAL   82 (244)
T ss_pred             hHh
Confidence            654

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.24  E-value=1e-05  Score=65.74  Aligned_cols=130  Identities=18%  Similarity=0.255  Sum_probs=90.7

Q ss_pred             CCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCC-ceeeeceEEcCCeeEEEEec
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHEN-LVKLHGGCIDGPCRILVYDY  121 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~-i~~~~~~~~~~~~~~iv~e~  121 (358)
                      ..++.+.|++|..|.||++.+. |..+++|+-..  +.....+..|.+++..+.  .-+ ..+++.+-.+    ++.|||
T Consensus        23 ~~~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~--ds~r~~l~kEakiLeil~--g~~~~p~vy~yg~~----~i~me~   93 (201)
T COG2112          23 ELRVEKELAKGTTSVVYLGEWR-GGEVALKVRRR--DSPRRNLEKEAKILEILA--GEGVTPEVYFYGED----FIRMEY   93 (201)
T ss_pred             hhhhhhhhhcccccEEEEeecc-CceEEEEEecC--CcchhhHHHHHHHHHHhh--hcCCCceEEEechh----hhhhhh
Confidence            4456778999999999999997 55788888654  345667888999888886  333 3334443332    355999


Q ss_pred             CCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCC--CcEEEcCCCceEEeecccccc
Q 018263          122 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKT--SNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       122 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p--~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      ..|..|.+.....       +.+    -...++.+-.-|...   ||-|+.|+-  +||++.. +.+.|+||..+..
T Consensus        94 i~G~~L~~~~~~~-------~rk----~l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~-~~~~iIDFd~At~  155 (201)
T COG2112          94 IDGRPLGKLEIGG-------DRK----HLLRVLEKAYKLDRL---GIEHGELSRPWKNVLVND-RDVYIIDFDSATF  155 (201)
T ss_pred             hcCcchhhhhhcc-------cHH----HHHHHHHHHHHHHHh---ccchhhhcCCceeEEecC-CcEEEEEccchhh
Confidence            9988888876211       122    234456666667777   999999975  4555544 4899999998874

>PLN02876 acyl-CoA dehydrogenase

Probab=98.13  E-value=4.5e-05  Score=78.64  Aligned_cols=80  Identities=13%  Similarity=0.228  Sum_probs=55.3

Q ss_pred             cceecccCceEEEEEEECCC---CEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCC--ceeeeceEEcC---CeeEE
Q 018263           47 SNKIGEGGFGSVYKGRLQDG---TIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHEN--LVKLHGGCIDG---PCRIL  117 (358)
Q Consensus        47 ~~~lg~g~~g~v~~~~~~~~---~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~--i~~~~~~~~~~---~~~~i  117 (358)
                      +++++.|.+..+|+....++   ..+++|+..... ......+.+|+..++.+. .|.+  +.+++.++.+.   +..|+
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~-~~~~vpVP~v~~~~~d~~v~G~~fl  121 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALG-EHTDVPVPKVYCLCTDASVIGTAFY  121 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHh-hcCCCCCCcEEEEecCCCcCCCceE
Confidence            57788899999999886643   468888764322 122346778999988885 2444  46666666554   45789


Q ss_pred             EEecCCCCCH
Q 018263          118 VYDYMPNNSL  127 (358)
Q Consensus       118 v~e~~~~~~L  127 (358)
                      ||||++|..+
T Consensus       122 VME~v~G~~~  131 (822)
T PLN02876        122 IMEYLEGRIF  131 (822)
T ss_pred             EEEecCCccc
Confidence            9999988653

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.08  E-value=1.9e-05  Score=69.84  Aligned_cols=141  Identities=11%  Similarity=0.049  Sum_probs=75.9

Q ss_pred             eecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecCCCCCHH
Q 018263           49 KIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLS  128 (358)
Q Consensus        49 ~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~  128 (358)
                      .+..|-...+|+... ++..+++|+..........+...|...++.+.. +.-..+++...  .  .++|+||++|..+.
T Consensus         3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~-~g~~P~~i~~~--~--~~~v~e~i~G~~~~   76 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSA-LGLAPKPILVN--E--HWLLVEWLEGEVIT   76 (256)
T ss_pred             cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHh-cCCCCceEEEe--C--CEEEEEeccCcccc
Confidence            455677788998874 467888998654322211234567777777751 21123333332  2  36899999987654


Q ss_pred             HH--------------h---hhccccccCCCHH-HHHHHHHHH---------HHHHHHHhcC-----CCCCcEEcCCCCC
Q 018263          129 QT--------------L---LGEEKRRAKFGWK-ARREIIMGI---------GRGLAYIHEE-----IQPHVVHRDIKTS  176 (358)
Q Consensus       129 ~~--------------l---~~~~~~~~~l~~~-~~~~~~~qi---------~~aL~~LH~~-----~~~~i~H~di~p~  176 (358)
                      ..              +   +.......+++.. .+..+..++         ...+..+-..     ....+||+|+.|.
T Consensus        77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~  156 (256)
T TIGR02721        77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY  156 (256)
T ss_pred             cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence            21              0   0000001111111 111211111         1111112111     1236899999999


Q ss_pred             cEEEcCCCceEEeecccccc
Q 018263          177 NILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       177 Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      ||++++++ +.++||..+..
T Consensus       157 Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       157 NLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             cEEEeCCC-CEEEeccccCc
Confidence            99999876 78999987754

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=98.05  E-value=4.3e-05  Score=69.17  Aligned_cols=146  Identities=12%  Similarity=0.091  Sum_probs=81.8

Q ss_pred             cceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeece------EEcCCeeEEEEe
Q 018263           47 SNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG------CIDGPCRILVYD  120 (358)
Q Consensus        47 ~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~------~~~~~~~~iv~e  120 (358)
                      ++.+..|....+|++...+ ..+++|+...   .....+..|+..+..+....-.+.+++..      ....+..+++++
T Consensus        19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            4567777778999987654 4688898764   22345556676666664212123444332      233456789999


Q ss_pred             cCCCCCHHH----Hh----------hhc-ccccc------CCCHHHH----------HHHHHHHHHHHHHHhc----CCC
Q 018263          121 YMPNNSLSQ----TL----------LGE-EKRRA------KFGWKAR----------REIIMGIGRGLAYIHE----EIQ  165 (358)
Q Consensus       121 ~~~~~~L~~----~l----------~~~-~~~~~------~l~~~~~----------~~~~~qi~~aL~~LH~----~~~  165 (358)
                      |++|..+..    .+          +.. .....      ...+...          ......+..++.++.+    ...
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            999876432    00          000 00000      0000000          0011112233444442    112


Q ss_pred             CCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       166 ~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      .++||+|++|.||++++++.+.|+||+.+..
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            3899999999999999987778999987754

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.05  E-value=4.9e-05  Score=66.26  Aligned_cols=76  Identities=17%  Similarity=0.167  Sum_probs=48.1

Q ss_pred             cceecccCceEEEEEEECC--CCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecCCC
Q 018263           47 SNKIGEGGFGSVYKGRLQD--GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN  124 (358)
Q Consensus        47 ~~~lg~g~~g~v~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~~~  124 (358)
                      ++.|..|-...+|++...+  ++.|++|+..... ........|+..+..+.. +.-.++++....    ..++|||++|
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~-~~~~d~~~E~~~~~~l~~-~gl~P~v~~~~~----~~~l~e~i~G   76 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT-ELIIDRERELRIHKLLSK-HGLAPKLYATFQ----NGLIYEFIPG   76 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCc-cceecHHHHHHHHHHHHh-CCCCCeEEEEeC----CcEEEEeeCC
Confidence            4567778888999998764  6789999875332 111233467777777641 222444544332    2489999998


Q ss_pred             CCHH
Q 018263          125 NSLS  128 (358)
Q Consensus       125 ~~L~  128 (358)
                      .++.
T Consensus        77 ~~l~   80 (235)
T cd05157          77 RTLE   80 (235)
T ss_pred             CcCC
Confidence            7653

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.04  E-value=4.8e-05  Score=66.41  Aligned_cols=76  Identities=14%  Similarity=0.202  Sum_probs=45.2

Q ss_pred             cceecccCce-EEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccC-CCCceeeeceEEcC---CeeEEEEec
Q 018263           47 SNKIGEGGFG-SVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC-HENLVKLHGGCIDG---PCRILVYDY  121 (358)
Q Consensus        47 ~~~lg~g~~g-~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~-h~~i~~~~~~~~~~---~~~~iv~e~  121 (358)
                      ++.|+.|+.. .||..    +..+++|....  ......+..|.+.+..+... .--+..++......   ...+++|++
T Consensus         2 ~~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           2 IEPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             ceeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            4567877776 58876    23477887543  22344677888888777521 11233333332221   234789999


Q ss_pred             CCCCCHH
Q 018263          122 MPNNSLS  128 (358)
Q Consensus       122 ~~~~~L~  128 (358)
                      ++|.++.
T Consensus        76 i~G~~l~   82 (235)
T cd05155          76 LEGETAT   82 (235)
T ss_pred             ecCCCCC
Confidence            9987764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK05231 homoserine kinase; Provisional

Probab=98.01  E-value=0.00029  Score=64.45  Aligned_cols=31  Identities=23%  Similarity=0.305  Sum_probs=26.5

Q ss_pred             CCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       166 ~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      .++||+|+.++||+++++...-++||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            4899999999999999765558999998864

>PRK10593 hypothetical protein; Provisional

Probab=97.98  E-value=0.00017  Score=65.34  Aligned_cols=82  Identities=9%  Similarity=0.013  Sum_probs=57.4

Q ss_pred             CCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCC-CCceeeeceEEc---CCeeEEE
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCH-ENLVKLHGGCID---GPCRILV  118 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h-~~i~~~~~~~~~---~~~~~iv  118 (358)
                      ...-.+.||.|..+.||.....+++ +++|..+.  ......+..|.+.++.+.... -.+.++++++..   .+..++|
T Consensus        15 ~~~~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV   91 (297)
T PRK10593         15 KLSRVECISEQPYAALWALYDSQGN-PMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL   91 (297)
T ss_pred             hhheeeecCCccceeEEEEEcCCCC-EEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence            3334567999999999999876564 77787542  113346778888888886322 357777776643   3568999


Q ss_pred             EecCCCCCH
Q 018263          119 YDYMPNNSL  127 (358)
Q Consensus       119 ~e~~~~~~L  127 (358)
                      ||+++|.++
T Consensus        92 mE~i~G~~~  100 (297)
T PRK10593         92 LERLRGVSV  100 (297)
T ss_pred             EeccCCEec
Confidence            999998765

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.86  E-value=0.00068  Score=57.23  Aligned_cols=130  Identities=19%  Similarity=0.270  Sum_probs=86.8

Q ss_pred             cceecccCceEEEEEEECCCCEEEEEEeeccC----------------hhhHHHHHHHHHHhhhcc----cCCCCceeee
Q 018263           47 SNKIGEGGFGSVYKGRLQDGTIVAVKVLSVES----------------KQGEKEFMSEVASMANVN----VCHENLVKLH  106 (358)
Q Consensus        47 ~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~e~~~l~~l~----~~h~~i~~~~  106 (358)
                      ...||+|+.=.||.-  ++.....||+.....                ........+|+.....+.    ..+.+|.+++
T Consensus         6 ~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            457899999988853  344556788876544                122344445555444433    2377899999


Q ss_pred             ceEEcCCeeEEEEecCCC------CCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEE
Q 018263          107 GGCIDGPCRILVYDYMPN------NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL  180 (358)
Q Consensus       107 ~~~~~~~~~~iv~e~~~~------~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv  180 (358)
                      ++...+-...+|+|.+.+      .+|.+++     ..+.+++ .+...   +-.-..+|-+.   .|+.+|++|+||++
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l-----~~~~~~~-~~~~~---L~~f~~~l~~~---~Iv~~dl~~~NIv~  151 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYL-----KEGGLTE-ELRQA---LDEFKRYLLDH---HIVIRDLNPHNIVV  151 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHH-----HcCCccH-HHHHH---HHHHHHHHHHc---CCeecCCCcccEEE
Confidence            999999999999987632      2688887     2334544 33333   33445677777   99999999999999


Q ss_pred             cCCC----ceEEee
Q 018263          181 DQNF----NPKISD  190 (358)
Q Consensus       181 ~~~~----~~~l~D  190 (358)
                      ....    .+.|+|
T Consensus       152 ~~~~~~~~~lvlID  165 (199)
T PF10707_consen  152 QRRDSGEFRLVLID  165 (199)
T ss_pred             EecCCCceEEEEEe
Confidence            5332    577777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.82  E-value=0.00016  Score=65.58  Aligned_cols=176  Identities=18%  Similarity=0.150  Sum_probs=108.3

Q ss_pred             ecccCccc---------ccccCCCcccccccccccCHHHHHHhhcCCccc---ceecccCceEEEEEEECCCCEEEEEEe
Q 018263            7 CFSFPSRV---------SAENTIGGEQILKNINAFSYNQLKIATNGFRWS---NKIGEGGFGSVYKGRLQDGTIVAVKVL   74 (358)
Q Consensus         7 ~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~i~---~~lg~g~~g~v~~~~~~~~~~vaiK~~   74 (358)
                      .++|+|+.         -+++-+|++|++-+=+..-   +.....+=.|.   .-|..|.-+.||.|...+|..+|||++
T Consensus       100 ~~~~~~~~~~~~~~r~kDKaDRATvEqVLDPRTrmv---Lfrll~RG~i~~inGCiSTGKEANVYHat~~dG~~~AIKIY  176 (520)
T KOG2270|consen  100 RSSYSLVDTERDRKRVKDKADRATVEQVLDPRTRMV---LFRLLNRGVIVEINGCISTGKEANVYHATEEDGSEFAIKIY  176 (520)
T ss_pred             hhhchhhhhhhhhhhcccchhhhhHHHhcChHHHHH---HHHHHhcCeeeecccccccCccceeEeeecCCCceEEEEEE
Confidence            35677763         3467777777654322221   12222333333   356778899999999999999999997


Q ss_pred             ecc---------------------C-----hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecCCCCCHH
Q 018263           75 SVE---------------------S-----KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLS  128 (358)
Q Consensus        75 ~~~---------------------~-----~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~  128 (358)
                      +-.                     +     .-.......|+..|..+.  ...|.-.--+...  ..++||+|+. .+-+
T Consensus       177 KTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~--~aGIP~PePIlLk--~hVLVM~FlG-rdgw  251 (520)
T KOG2270|consen  177 KTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLN--NAGIPCPEPILLK--NHVLVMEFLG-RDGW  251 (520)
T ss_pred             eeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHH--hcCCCCCCceeee--cceEeeeecc-CCCC
Confidence            421                     0     011223445666666664  2222211111111  2468999994 3211


Q ss_pred             HHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          129 QTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       129 ~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      -.   ...+...++...+..+-.+++..+.-|-+.|  ++||.||+--|+++-++ .+.++|-+.+..
T Consensus       252 ~a---PkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~LyhdG-~lyiIDVSQSVE  313 (520)
T KOG2270|consen  252 AA---PKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYHDG-KLYIIDVSQSVE  313 (520)
T ss_pred             cC---cccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEECC-EEEEEEcccccc
Confidence            11   1123445666778888888888888887765  99999999999998654 899999887654

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.80  E-value=7.3e-05  Score=76.49  Aligned_cols=196  Identities=21%  Similarity=0.222  Sum_probs=134.5

Q ss_pred             HHHHHHHHhhhcccCCCCceeeeceEEcCCeeE----EEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHH
Q 018263           84 EFMSEVASMANVNVCHENLVKLHGGCIDGPCRI----LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY  159 (358)
Q Consensus        84 ~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~----iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~  159 (358)
                      ....|++.+.+..  |+|+..++.+-.......    +..+++...++...+    ...+.++...++.+..++..+|.+
T Consensus       228 ~~E~e~~~l~k~~--~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~----q~v~~i~~~~~r~~~~~~~~GL~~  301 (1351)
T KOG1035|consen  228 TTEIELESLSKIA--HDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL----QSVGSIPLETLRILHQKLLEGLAY  301 (1351)
T ss_pred             HHHHHHHHHHhhc--cccccceeEEeehhhcchHHHHHHHhhcCccchHHHH----hhccccCHHHHHHHHHHHhhhHHH
Confidence            3344666666666  999999998876544333    345788888888888    677889999999999999999999


Q ss_pred             HhcCCCCCcEEcCCCCC---cEEEcCCCceEEe--ecccccccCCCCcccccccccccCccCccccccCCC--CccCcee
Q 018263          160 IHEEIQPHVVHRDIKTS---NILLDQNFNPKIS--DFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL--TRKSDVY  232 (358)
Q Consensus       160 LH~~~~~~i~H~di~p~---Nilv~~~~~~~l~--Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--s~~sDiw  232 (358)
                      +|+.   ...|.-+..+   +.-++..+.+..+  ||+.....+......  ....+..+.++|.......  ....|+|
T Consensus       302 ~h~~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~--~~~~~~~~~~~e~~~~~~~~~~r~~dL~  376 (1351)
T KOG1035|consen  302 LHSL---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF--SDLLAEIRNADEDLKENTAKKSRLTDLW  376 (1351)
T ss_pred             HHHh---ccceeEEecccccccccCccceeecchhhhcccccCCCcccch--hhcCccccccccccccccchhhhhhHHH
Confidence            9998   6666655555   4445566666666  888777654333222  2234556777886665444  3457999


Q ss_pred             cHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 018263          233 SFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMST  312 (358)
Q Consensus       233 slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~e  312 (358)
                      .+|.....+..|..+-....                  ....+++.    .    ....+.....+|+.-++++|+++.+
T Consensus       377 ~lgll~~~~~~~~~i~~~~~------------------~~~~~l~~----~----~~~~~~d~~~~~~~~~~~~Rl~~~~  430 (1351)
T KOG1035|consen  377 CLGLLLLQLSQGEDISEKSA------------------VPVSLLDV----L----STSELLDALPKCLDEDSEERLSALE  430 (1351)
T ss_pred             HHHHHHhhhhhcCccccccc------------------chhhhhcc----c----cchhhhhhhhhhcchhhhhccchhh
Confidence            99999999998876532110                  01111111    1    1114667888999999999999999


Q ss_pred             HHHH
Q 018263          313 AIKM  316 (358)
Q Consensus       313 il~~  316 (358)
                      ++.-
T Consensus       431 ll~~  434 (1351)
T KOG1035|consen  431 LLTH  434 (1351)
T ss_pred             hhhc
Confidence            9764

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.76  E-value=0.00017  Score=60.44  Aligned_cols=104  Identities=18%  Similarity=0.184  Sum_probs=79.8

Q ss_pred             HHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 018263           87 SEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP  166 (358)
Q Consensus        87 ~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~  166 (358)
                      .|..+++.++ ..++++++++++-    .+++.||.+.+++.+..... ..-...++..+.+++.+++..+.+|+.....
T Consensus         8 ~E~lll~~l~-~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l-~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~   81 (188)
T PF12260_consen    8 NEPLLLQLLQ-GSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPL-SQFLQSPWEQRAKIALQLLELLEELDHGPLG   81 (188)
T ss_pred             cHHHHHHHcC-CCCCCCCeeeECC----CEEEEEeecCcccccccccc-ccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            5777888887 2459999999983    35788999766554321000 1223457999999999999999999985434


Q ss_pred             CcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          167 HVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       167 ~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      .+...|++++|+-++++++++++|...+..
T Consensus        82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             cEEEeecchHHeEEeCCCcEEEEechhcch
Confidence            788999999999999999999999987754

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.74  E-value=6.3e-06  Score=79.01  Aligned_cols=187  Identities=18%  Similarity=0.132  Sum_probs=128.1

Q ss_pred             CCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCC-ceeeeceEEcCCeeEEEEec
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHEN-LVKLHGGCIDGPCRILVYDY  121 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~-i~~~~~~~~~~~~~~iv~e~  121 (358)
                      -|....-+++++.+++++.+..-.+....+.+...     ....-+++.|.+.+  ||| .+..++.+..+....+.+++
T Consensus       243 ws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n--~P~~~v~~~~d~~~E~~~~i~~~i  315 (829)
T KOG0576|consen  243 WSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVN--NPNPVVRYLEDYDGEDYLWIPMRI  315 (829)
T ss_pred             chHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHcc--CCCCcccccccCCcccccchhhhh
Confidence            34445567788888888887543333335554432     44556888999998  999 66666777777788899999


Q ss_pred             CCCC-CHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCC
Q 018263          122 MPNN-SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN  200 (358)
Q Consensus       122 ~~~~-~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~  200 (358)
                      +.++ +....+.   ...-.+.+.+.......-..+++++|+.   .-+|+|    ||+..+ +..+.+|++........
T Consensus       316 ~s~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~  384 (829)
T KOG0576|consen  316 CSTGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRT  384 (829)
T ss_pred             hcCCccccccCC---hhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCcc
Confidence            9766 2222210   1112233444455566667789999987   668887    666655 57899999887765332


Q ss_pred             CcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCC
Q 018263          201 TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVD  249 (358)
Q Consensus       201 ~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~  249 (358)
                      .  ......+++.++|||+.....+....|.|++|.--.++.-|.+|-.
T Consensus       385 ~--~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  385 M--KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             c--ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            2  2344678999999999999999999999999987777777766643

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.72  E-value=0.0013  Score=59.80  Aligned_cols=147  Identities=16%  Similarity=0.171  Sum_probs=78.7

Q ss_pred             cceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeece------EEcCCeeEEEEe
Q 018263           47 SNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG------CIDGPCRILVYD  120 (358)
Q Consensus        47 ~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~------~~~~~~~~iv~e  120 (358)
                      ++.++.|....+|++...+| .+++|+......  ...+..+.+.+..+....-.+.+++..      ....+..+++++
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            45667777789999887655 578898754221  223445555555553112123333332      122456789999


Q ss_pred             cCCCCCHHH-----------Hhhh-cc-ccc--c------CCC-HHHHH------------HHHHHHHHHHHHHhc----
Q 018263          121 YMPNNSLSQ-----------TLLG-EE-KRR--A------KFG-WKARR------------EIIMGIGRGLAYIHE----  162 (358)
Q Consensus       121 ~~~~~~L~~-----------~l~~-~~-~~~--~------~l~-~~~~~------------~~~~qi~~aL~~LH~----  162 (358)
                      |++|..+..           .+.. +. ...  .      ..+ +....            .....+...++++..    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            998854321           1100 00 000  0      000 00000            001112334444432    


Q ss_pred             CCCCCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       163 ~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      ....++||+|+++.||++++++.+.++||+.+..
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence            1134999999999999999887678999988753

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.71  E-value=4.5e-05  Score=67.92  Aligned_cols=138  Identities=15%  Similarity=0.092  Sum_probs=95.1

Q ss_pred             CCcccceecccCceEEEEEEECCCCEEEEEEeecc--C-----------------h---hhHHHHHHHHHHhhhcccCCC
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVE--S-----------------K---QGEKEFMSEVASMANVNVCHE  100 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~--~-----------------~---~~~~~~~~e~~~l~~l~~~h~  100 (358)
                      -+.+..+||-|.-+.+|.+-+..|++.++|.-+.-  +                 .   -.+..+..|+..++.+.. |.
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e-~g  171 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYE-RG  171 (465)
T ss_pred             hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHH-cC
Confidence            46677899999999999999999999999974210  0                 0   022345667777777751 22


Q ss_pred             C-ceeeeceEEcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEE
Q 018263          101 N-LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL  179 (358)
Q Consensus       101 ~-i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nil  179 (358)
                      + +.+.++    .+..++|||++.|..|...-       ...+..   .+...++..+--|-..   |++|||++--||+
T Consensus       172 fpVPkpiD----~~RH~Vvmelv~g~Pl~~v~-------~v~d~~---~ly~~lm~~Iv~la~~---GlIHgDFNEFNim  234 (465)
T KOG2268|consen  172 FPVPKPID----HNRHCVVMELVDGYPLRQVR-------HVEDPP---TLYDDLMGLIVRLANH---GLIHGDFNEFNIM  234 (465)
T ss_pred             CCCCCccc----ccceeeHHHhhcccceeeee-------ecCChH---HHHHHHHHHHHHHHHc---CceecccchheeE
Confidence            2 333333    34567999999887665543       111222   3344455555667777   9999999999999


Q ss_pred             EcCCCceEEeecccccccC
Q 018263          180 LDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       180 v~~~~~~~l~Dfg~~~~~~  198 (358)
                      |++++.++++||.......
T Consensus       235 v~dd~~i~vIDFPQmvS~s  253 (465)
T KOG2268|consen  235 VKDDDKIVVIDFPQMVSTS  253 (465)
T ss_pred             EecCCCEEEeechHhhccC
Confidence            9999999999998765543

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.68  E-value=0.0016  Score=61.01  Aligned_cols=78  Identities=15%  Similarity=0.138  Sum_probs=53.5

Q ss_pred             cceecccCceEEEEEEECCC-CEEEEEEeeccC-------hhhHHHHHHHHHHhhhcccC-CCCceeeeceEEcCCeeEE
Q 018263           47 SNKIGEGGFGSVYKGRLQDG-TIVAVKVLSVES-------KQGEKEFMSEVASMANVNVC-HENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        47 ~~~lg~g~~g~v~~~~~~~~-~~vaiK~~~~~~-------~~~~~~~~~e~~~l~~l~~~-h~~i~~~~~~~~~~~~~~i  117 (358)
                      .+.||.|....||++...+| +.++||.-....       .-...+...|.+.|+.+... ..++++++.+  +....++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            46789999999999998876 589999854221       11334566677777776422 2356667766  4455789


Q ss_pred             EEecCCCCC
Q 018263          118 VYDYMPNNS  126 (358)
Q Consensus       118 v~e~~~~~~  126 (358)
                      |||++++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999997643

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.64  E-value=0.00031  Score=63.74  Aligned_cols=77  Identities=22%  Similarity=0.204  Sum_probs=47.9

Q ss_pred             cceecccCceEEEEEEECC-------CCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           47 SNKIGEGGFGSVYKGRLQD-------GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        47 ~~~lg~g~~g~v~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      ++.+..|-...+|++...+       ++.|++|+..... ....+...|...+..+.... -..+++..+..    .+|+
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g-~~P~~~~~~~~----~~v~   76 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERN-LGPKLYGIFPN----GRIE   76 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCC-CCCceEEEeCC----Cchh
Confidence            3456667777999988654       5789999976432 22234567777777765222 23445544432    3689


Q ss_pred             ecCCCCCHHH
Q 018263          120 DYMPNNSLSQ  129 (358)
Q Consensus       120 e~~~~~~L~~  129 (358)
                      +|++|.++..
T Consensus        77 e~i~G~~l~~   86 (302)
T cd05156          77 EFIPSRTLTT   86 (302)
T ss_pred             heeCCCcCCH
Confidence            9998876543

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.56  E-value=0.0014  Score=59.34  Aligned_cols=143  Identities=17%  Similarity=0.271  Sum_probs=86.4

Q ss_pred             CCcccceecccCceEEEEEEECCCCEEEEEEeec--cChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC--eeEEE
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSV--ESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP--CRILV  118 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~--~~~iv  118 (358)
                      ...+++.+..|-...+|..... ++.++++ .+.  ..........+|+..+..+....-=....++.+..+.  ..+.|
T Consensus        26 ~~~~v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v  103 (321)
T COG3173          26 GLLIVEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV  103 (321)
T ss_pred             CCceeeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence            4445555545555566666654 7888988 331  2333444556677777776421111223344444444  66999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHH-HHHHHHHHHhcC----------------------------------
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM-GIGRGLAYIHEE----------------------------------  163 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~-qi~~aL~~LH~~----------------------------------  163 (358)
                      |+|++|..+...+.     ....+    .+.+. .++..|+.||+-                                  
T Consensus       104 ~~~veGe~~~~~~~-----~~~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~  174 (321)
T COG3173         104 MEWVEGEVVWSALP-----PESLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELG  174 (321)
T ss_pred             EEEecceeccCcCC-----cccch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhcc
Confidence            99998854333331     01111    12222 555555555542                                  


Q ss_pred             ---------------------CCCCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          164 ---------------------IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       164 ---------------------~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                                           ....++|||+++.|+++++++.+-++||+++..
T Consensus       175 ~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         175 GRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             CCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence                                 134789999999999999998899999999876

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.45  E-value=0.0055  Score=51.55  Aligned_cols=139  Identities=26%  Similarity=0.408  Sum_probs=91.4

Q ss_pred             ccccccccCHHHHHHhhcCCcccceecccCc-eEEEEEEECCCCEEEEEEeec---cC---------h---------hhH
Q 018263           25 ILKNINAFSYNQLKIATNGFRWSNKIGEGGF-GSVYKGRLQDGTIVAVKVLSV---ES---------K---------QGE   82 (358)
Q Consensus        25 ~~~~~~~~~~~~~~~~~~~y~i~~~lg~g~~-g~v~~~~~~~~~~vaiK~~~~---~~---------~---------~~~   82 (358)
                      .-|++..|..     ...+++.++.||.|.- |.||+++.. |+.||||+...   ..         .         ...
T Consensus        25 ~gPKL~~F~~-----h~~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~   98 (207)
T PF13095_consen   25 PGPKLEPFTH-----HGDDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYA   98 (207)
T ss_pred             CCCCcCCcCC-----CCCcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhc
Confidence            4466666666     2389999999999999 999999986 77999999322   10         0         111


Q ss_pred             HHHHHHHHHhhhcccC-CCCc--eeeeceEEcC------------------CeeEEEEecCCCCCHHHHhhhccccccCC
Q 018263           83 KEFMSEVASMANVNVC-HENL--VKLHGGCIDG------------------PCRILVYDYMPNNSLSQTLLGEEKRRAKF  141 (358)
Q Consensus        83 ~~~~~e~~~l~~l~~~-h~~i--~~~~~~~~~~------------------~~~~iv~e~~~~~~L~~~l~~~~~~~~~l  141 (358)
                      ..+..|......++.. +.++  ++.+++..-.                  ....||.||.+...             .+
T Consensus        99 ~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~  165 (207)
T PF13095_consen   99 DPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PL  165 (207)
T ss_pred             ChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------cc
Confidence            2344555555544322 4355  7777776322                  12356777765432             11


Q ss_pred             CHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccc
Q 018263          142 GWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS  194 (358)
Q Consensus       142 ~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~  194 (358)
                      ..    .-+.+|..-+..+|..   ||+-+|+++.|..     .-+|+|||.+
T Consensus       166 ~~----~~~~~~~~dl~~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  166 QI----RDIPQMLRDLKILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             ch----hHHHHHHHHHHHHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence            22    2345677788999999   9999999999985     3488999864

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.45  E-value=0.0014  Score=58.73  Aligned_cols=76  Identities=17%  Similarity=0.194  Sum_probs=48.6

Q ss_pred             ccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccC-CCCceeeeceEEcCCeeEEEEecCCC
Q 018263           46 WSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC-HENLVKLHGGCIDGPCRILVYDYMPN  124 (358)
Q Consensus        46 i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~-h~~i~~~~~~~~~~~~~~iv~e~~~~  124 (358)
                      -.+.|+.|....+|+.. .+++.+++|+-.   ......+..|.+-|+.+... .-.+++++.+....+..++++||++.
T Consensus        21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~   96 (288)
T PF03881_consen   21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM   96 (288)
T ss_dssp             EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred             eeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence            34578889999999988 567889999976   23334567788887777422 44677889888877778999999976


Q ss_pred             C
Q 018263          125 N  125 (358)
Q Consensus       125 ~  125 (358)
                      +
T Consensus        97 ~   97 (288)
T PF03881_consen   97 G   97 (288)
T ss_dssp             -
T ss_pred             C
Confidence            6

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN02236 choline kinase

Probab=97.41  E-value=0.0014  Score=60.61  Aligned_cols=144  Identities=15%  Similarity=0.197  Sum_probs=79.8

Q ss_pred             cceecccCceEEEEEEECC-----CCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEec
Q 018263           47 SNKIGEGGFGSVYKGRLQD-----GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY  121 (358)
Q Consensus        47 ~~~lg~g~~g~v~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~  121 (358)
                      ++.+..|-.-.+|++...+     ++.|++|+...... ..-+-..|...++.+. .+.--.++++.+...    .|.+|
T Consensus        41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-~~idR~~E~~~~~~l~-~~gl~P~~~~~~~~g----~v~ef  114 (344)
T PLN02236         41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-LFFDRDDEIRTFECMS-RHGQGPRLLGRFPNG----RVEEF  114 (344)
T ss_pred             EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-eeechHHHHHHHHHHH-HcCCCCceEEEECCc----eEEEe
Confidence            4455557788999987532     36899998865432 2222356777777665 122233455555332    57899


Q ss_pred             CCCCCHHHHh-----------------hhcccc--ccCCCHHHHHHHHHHHH-----------------HHHHHH----h
Q 018263          122 MPNNSLSQTL-----------------LGEEKR--RAKFGWKARREIIMGIG-----------------RGLAYI----H  161 (358)
Q Consensus       122 ~~~~~L~~~l-----------------~~~~~~--~~~l~~~~~~~~~~qi~-----------------~aL~~L----H  161 (358)
                      +++.++...-                 +.....  ........+..+..++.                 ..+..|    .
T Consensus       115 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~  194 (344)
T PLN02236        115 IHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELS  194 (344)
T ss_pred             eCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhc
Confidence            8877654210                 000000  00111333334432221                 111111    1


Q ss_pred             c-CCCCCcEEcCCCCCcEEEcC-CCceEEeecccccc
Q 018263          162 E-EIQPHVVHRDIKTSNILLDQ-NFNPKISDFGLSKL  196 (358)
Q Consensus       162 ~-~~~~~i~H~di~p~Nilv~~-~~~~~l~Dfg~~~~  196 (358)
                      . .....+||+|+++.||++++ ++.+.++||..+..
T Consensus       195 ~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        195 GDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             ccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            1 11237899999999999986 46799999987754

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.35  E-value=0.0031  Score=56.37  Aligned_cols=30  Identities=27%  Similarity=0.511  Sum_probs=25.4

Q ss_pred             CcEEcCCCCCcEEEcCCCc-eEEeecccccc
Q 018263          167 HVVHRDIKTSNILLDQNFN-PKISDFGLSKL  196 (358)
Q Consensus       167 ~i~H~di~p~Nilv~~~~~-~~l~Dfg~~~~  196 (358)
                      .++|+|+++.||+++++++ .-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            6899999999999997555 46999998864

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.34  E-value=0.0041  Score=58.21  Aligned_cols=75  Identities=9%  Similarity=0.078  Sum_probs=49.3

Q ss_pred             cceecccCceEEEEEEECCCCEEEEEEeecc----Ch---hhHHHHHHHHHHhhhcccCC-CCceeeeceEEcCCeeEEE
Q 018263           47 SNKIGEGGFGSVYKGRLQDGTIVAVKVLSVE----SK---QGEKEFMSEVASMANVNVCH-ENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        47 ~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~----~~---~~~~~~~~e~~~l~~l~~~h-~~i~~~~~~~~~~~~~~iv  118 (358)
                      .+.||.|....||++... +..|+||+-...    ..   ....+...|.+.|+.+.... ..+.+++.+..  ...+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            668899999999999875 456899986521    11   13334444566665553222 36777777766  446788


Q ss_pred             EecCCC
Q 018263          119 YDYMPN  124 (358)
Q Consensus       119 ~e~~~~  124 (358)
                      ||++++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999976

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.26  E-value=0.005  Score=56.63  Aligned_cols=74  Identities=15%  Similarity=0.122  Sum_probs=47.6

Q ss_pred             eecccCceEEEEEEECCC-CEEEEEEeecc------C-hhhHHHHHHHHHHhhhcccCCC-CceeeeceEEcCCeeEEEE
Q 018263           49 KIGEGGFGSVYKGRLQDG-TIVAVKVLSVE------S-KQGEKEFMSEVASMANVNVCHE-NLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        49 ~lg~g~~g~v~~~~~~~~-~~vaiK~~~~~------~-~~~~~~~~~e~~~l~~l~~~h~-~i~~~~~~~~~~~~~~iv~  119 (358)
                      .||-|....||++..++| +.++||.-...      + .-...+...|.+.|+......| .+++++.+  ++....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            578899999999997654 67999985321      1 2223455566677766543345 34444443  555667999


Q ss_pred             ecCCC
Q 018263          120 DYMPN  124 (358)
Q Consensus       120 e~~~~  124 (358)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=97.11  E-value=0.013  Score=53.30  Aligned_cols=30  Identities=27%  Similarity=0.379  Sum_probs=25.9

Q ss_pred             CCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       166 ~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      .++||||+++.||+++. +.+.++||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~  216 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI  216 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence            48999999999999988 5789999987653

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=97.08  E-value=0.0086  Score=54.54  Aligned_cols=32  Identities=19%  Similarity=0.308  Sum_probs=28.5

Q ss_pred             CCCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       165 ~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      ..++||+|+.++|+++++++.+.++||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            34899999999999999998999999988764

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PRK12396 5-methylribose kinase; Reviewed

Probab=97.06  E-value=0.0036  Score=58.22  Aligned_cols=76  Identities=16%  Similarity=0.110  Sum_probs=50.3

Q ss_pred             cceecccCceEEEEEEECC-CCEEEEEEeecc-----C-hhhHHHHHHHHHHhhhcccCCC-CceeeeceEEcCCeeEEE
Q 018263           47 SNKIGEGGFGSVYKGRLQD-GTIVAVKVLSVE-----S-KQGEKEFMSEVASMANVNVCHE-NLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        47 ~~~lg~g~~g~v~~~~~~~-~~~vaiK~~~~~-----~-~~~~~~~~~e~~~l~~l~~~h~-~i~~~~~~~~~~~~~~iv  118 (358)
                      .+.||-|....||++...+ ++.++||.-...     + .-...+...|.+.|+....-.| ++++++.+  ++....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            5688999999999999753 567999985321     1 2234556667777776653355 34445544  55556788


Q ss_pred             EecCCC
Q 018263          119 YDYMPN  124 (358)
Q Consensus       119 ~e~~~~  124 (358)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            998854

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.02  E-value=0.0016  Score=61.61  Aligned_cols=185  Identities=18%  Similarity=0.182  Sum_probs=102.2

Q ss_pred             EEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC-CeeEEEEecCCCCCHHHHhhhccc
Q 018263           58 VYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG-PCRILVYDYMPNNSLSQTLLGEEK  136 (358)
Q Consensus        58 v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~-~~~~iv~e~~~~~~L~~~l~~~~~  136 (358)
                      ++.|..+.|..+ ..-+.  -......+...+.+++.+.  |+|..+.+++.... ....+|+|++ +.+|.+.+..+. 
T Consensus         5 ~~~a~~~~~~~c-~nglp--lt~~s~~ilgr~~~lktl~--~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-   77 (725)
T KOG1093|consen    5 TFFAQEKPGDVC-SNGLP--LTPNSIQILGRFQYLKSLQ--HDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-   77 (725)
T ss_pred             EEehhcCCCccc-cCCCc--CCCcHHHHhhhhHHHHhhc--CccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-
Confidence            345555555544 23232  2344566778889999998  99999999886643 3467899999 789999984332 


Q ss_pred             cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCcccccccccccCccC
Q 018263          137 RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLA  216 (358)
Q Consensus       137 ~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~a  216 (358)
                          +-.....            .|     ++.|-     |+       .+.+| -+...    .               
T Consensus        78 ----l~~~s~~------------~~-----~~~~~-----~~-------~~~td-~~~t~----~---------------  104 (725)
T KOG1093|consen   78 ----LKDESLL------------AH-----GVLHL-----NI-------IYITD-HFLTK----Y---------------  104 (725)
T ss_pred             ----cchhhhc------------cc-----cccee-----hh-------hhccc-ccccc----C---------------
Confidence                1001100            12     33332     22       22222 00000    0               


Q ss_pred             ccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHH
Q 018263          217 PEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVG  296 (358)
Q Consensus       217 PE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  296 (358)
                      |     .+..+++|||++|.++.++.-|...+......+....+....-. ... ...+...  . .+.-.....++++.
T Consensus       105 ~-----~~~~pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~-d~~-~~~~a~e--~-~~~~~~d~~~~~~~  174 (725)
T KOG1093|consen  105 P-----SPIGPKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTD-DQE-LLSTAME--H-LIQLLADKKRLPLL  174 (725)
T ss_pred             C-----CCCCcchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccC-chh-HHHHHHH--H-HHHHhhhHhHHHHh
Confidence            0     01114999999999999999988776544433333222221100 000 0000000  0 12234556788999


Q ss_pred             hhccCCCCCCCCCHHH
Q 018263          297 LLCVQEKSKLRPQMST  312 (358)
Q Consensus       297 ~~~l~~~P~~Rpt~~e  312 (358)
                      .+|+-..|..||...+
T Consensus       175 ~~c~~~~~~ir~l~~~  190 (725)
T KOG1093|consen  175 KKCLWLEPIIRPLPME  190 (725)
T ss_pred             ccCCccccccccchhH
Confidence            9999999998886443

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.97  E-value=0.0056  Score=56.33  Aligned_cols=144  Identities=13%  Similarity=0.143  Sum_probs=76.2

Q ss_pred             cceecccCceEEEEEEECC----CCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecC
Q 018263           47 SNKIGEGGFGSVYKGRLQD----GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM  122 (358)
Q Consensus        47 ~~~lg~g~~g~v~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~  122 (358)
                      ++.|..|-...+|++...+    +..|++|+...... ..-+-.+|...++.+. .+.--.+++..+.. +   ++.+|+
T Consensus        19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~-~~gl~P~~l~~~~~-G---~i~~fi   92 (330)
T PLN02421         19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLS-AAGFGAKLLGVFGN-G---MIQSFI   92 (330)
T ss_pred             EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHH-hcCCCCceeEEeCC-c---Eeehhh
Confidence            4555557777889887542    34799998764322 2223346666666665 12222345555432 1   588998


Q ss_pred             CCCCHHHH-------h-------hh-cccc----ccCCCHHHHHHHHHHH-------------------------HHHHH
Q 018263          123 PNNSLSQT-------L-------LG-EEKR----RAKFGWKARREIIMGI-------------------------GRGLA  158 (358)
Q Consensus       123 ~~~~L~~~-------l-------~~-~~~~----~~~l~~~~~~~~~~qi-------------------------~~aL~  158 (358)
                      +|.+|...       +       .. +...    ..+-....+..+..++                         +..+.
T Consensus        93 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~  172 (330)
T PLN02421         93 NARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELK  172 (330)
T ss_pred             cCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHH
Confidence            87765321       1       00 0000    0011122222222221                         11111


Q ss_pred             HHh-cC-CCCCcEEcCCCCCcEEEcC-CCceEEeecccccc
Q 018263          159 YIH-EE-IQPHVVHRDIKTSNILLDQ-NFNPKISDFGLSKL  196 (358)
Q Consensus       159 ~LH-~~-~~~~i~H~di~p~Nilv~~-~~~~~l~Dfg~~~~  196 (358)
                      .+. .. ...-+||+|+.+.||++++ ++.++++||..+-.
T Consensus       173 ~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        173 EITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            121 11 0124799999999999974 57899999987754

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.92  E-value=0.006  Score=51.79  Aligned_cols=118  Identities=16%  Similarity=0.172  Sum_probs=75.8

Q ss_pred             cCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecCCCCCHHHHhh
Q 018263           53 GGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLL  132 (358)
Q Consensus        53 g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~  132 (358)
                      ++.++...++.+-|..++-|+...+..-..+.+..+..++.++    -.|+++..-  ..-...++.|+|....      
T Consensus        73 ~gNsTl~~~kt~iG~L~lKKi~slp~~~~~~~y~nky~v~Arm----hGilrL~ND--n~~~yGvIlE~Cy~~~------  140 (308)
T PF07387_consen   73 NGNSTLLIGKTKIGPLFLKKIRSLPCCINDALYFNKYRVFARM----HGILRLKND--NNYKYGVILERCYKIK------  140 (308)
T ss_pred             CCceEEEEeccccchhhhhhccCCCcccchhhhhhhhhHHHHh----hheeEeecC--CCceeEEEEeeccCcc------
Confidence            4556655555555665555555444444566677788887774    356666633  3334568889884221      


Q ss_pred             hccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccc
Q 018263          133 GEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS  194 (358)
Q Consensus       133 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~  194 (358)
                             -.   .. .++.-=+.+|.-+|+. +.+.+|||..|+|||-|..|.+||.|-+..
T Consensus       141 -------i~---~~-N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  141 -------IN---FS-NFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             -------cc---hh-HHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhh
Confidence                   01   11 1122224678888965 559999999999999999999999996543

The function of this family is unknown.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.90  E-value=0.0024  Score=54.71  Aligned_cols=30  Identities=27%  Similarity=0.475  Sum_probs=21.4

Q ss_pred             CcEEcCCCCCcEEE-cCCCceEEeecccccc
Q 018263          167 HVVHRDIKTSNILL-DQNFNPKISDFGLSKL  196 (358)
Q Consensus       167 ~i~H~di~p~Nilv-~~~~~~~l~Dfg~~~~  196 (358)
                      .++|+|+.+.||++ +.++.++++||..+..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            78999999999999 8888999999987753

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.84  E-value=0.063  Score=49.29  Aligned_cols=97  Identities=12%  Similarity=0.062  Sum_probs=54.4

Q ss_pred             ccccCHHHHHHhhcCCccc--c--eecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCcee
Q 018263           29 INAFSYNQLKIATNGFRWS--N--KIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVK  104 (358)
Q Consensus        29 ~~~~~~~~~~~~~~~y~i~--~--~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~  104 (358)
                      +...+...+.-....+-+.  .  ..-.+.-..||.+...++..|++|+.. ........+..|...+..+....-.++.
T Consensus         8 ~~~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r-~~~~~~~~i~~E~~~l~~L~~~gipv~~   86 (325)
T PRK11768          8 FQTLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYR-PERWSDAQILEEHAFALELAEAEIPVVA   86 (325)
T ss_pred             CCCCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcC-cccCCHHHHHHHHHHHHHHHHCCCCCCC
Confidence            3444455555444544432  1  122345567899988888889999975 3233455666677766666421111222


Q ss_pred             ee---c--eEEcCCeeEEEEecCCCCC
Q 018263          105 LH---G--GCIDGPCRILVYDYMPNNS  126 (358)
Q Consensus       105 ~~---~--~~~~~~~~~iv~e~~~~~~  126 (358)
                      ..   +  ....++..+.++++.+|..
T Consensus        87 p~~~~G~~~~~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         87 PLAFNGQTLHEHQGFRFALFPRRGGRA  113 (325)
T ss_pred             CccCCCCEEEEECCEEEEEEeeeCCCC
Confidence            11   1  1233456788999998764

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.68  E-value=0.00013  Score=76.59  Aligned_cols=160  Identities=13%  Similarity=0.002  Sum_probs=117.9

Q ss_pred             HHHHHhhhcccCCCCceeeeceEE--cCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCC
Q 018263           87 SEVASMANVNVCHENLVKLHGGCI--DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI  164 (358)
Q Consensus        87 ~e~~~l~~l~~~h~~i~~~~~~~~--~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~  164 (358)
                      .|...++...  |+++.....-..  .....+..++++.+|.+.+.+..+-.....++...+.....+.+.+..-.|+..
T Consensus      1278 ~e~de~~~~~--h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1278 SERDELREAK--HYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhh--ceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            3444444555  887766554433  233457889999999999999877667777776666655555566666666542


Q ss_pred             --CCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHH
Q 018263          165 --QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIV  242 (358)
Q Consensus       165 --~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll  242 (358)
                        ..-.+|.++++-|.+|..+..++++++|+.+.. .+.........+++-|++|++.+.-.++.++|+|..|+.+|.+.
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIk-np~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIK-NPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCccccccccccccc-CchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence              224589999999999999999999999999832 22233334456777888999888888898899999999999999


Q ss_pred             hCCCCCC
Q 018263          243 SGRTAVD  249 (358)
Q Consensus       243 tg~~pf~  249 (358)
                      .|..+|.
T Consensus      1435 ~~n~~fi 1441 (2724)
T KOG1826|consen 1435 DGNAYFI 1441 (2724)
T ss_pred             cccHHHH
Confidence            8888774

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.59  E-value=0.042  Score=50.30  Aligned_cols=140  Identities=15%  Similarity=0.227  Sum_probs=80.6

Q ss_pred             CceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccC-CCCcee---eec--eEEcCC--eeEEEEecCCCC
Q 018263           54 GFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC-HENLVK---LHG--GCIDGP--CRILVYDYMPNN  125 (358)
Q Consensus        54 ~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~-h~~i~~---~~~--~~~~~~--~~~iv~e~~~~~  125 (358)
                      .-..+|+....+|.. ++|+....  .....+..|+..++.+... .+-.++   .-+  ......  ..+-+++|++|.
T Consensus        37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~  113 (331)
T COG2334          37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR  113 (331)
T ss_pred             ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence            456789998877776 88998754  5566677777777777522 121122   111  111233  678899999988


Q ss_pred             CHHH-Hh--------------hh--------ccccccCCCHHH-------------HHHHHHHHHHHHHHHhcCC-----
Q 018263          126 SLSQ-TL--------------LG--------EEKRRAKFGWKA-------------RREIIMGIGRGLAYIHEEI-----  164 (358)
Q Consensus       126 ~L~~-~l--------------~~--------~~~~~~~l~~~~-------------~~~~~~qi~~aL~~LH~~~-----  164 (358)
                      .+.. .-              +.        +........+..             -.....++...+..+.+.-     
T Consensus       114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp  193 (331)
T COG2334         114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP  193 (331)
T ss_pred             CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence            7772 11              00        000000111210             0112233444444444321     


Q ss_pred             CCC--cEEcCCCCCcEEEcCCCc-eEEeecccccc
Q 018263          165 QPH--VVHRDIKTSNILLDQNFN-PKISDFGLSKL  196 (358)
Q Consensus       165 ~~~--i~H~di~p~Nilv~~~~~-~~l~Dfg~~~~  196 (358)
                      ..+  +||+|+.|.||+++.+.. +-++||+-+..
T Consensus       194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~  228 (331)
T COG2334         194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY  228 (331)
T ss_pred             cccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence            113  999999999999999875 78999987753

>PRK06148 hypothetical protein; Provisional

Probab=96.34  E-value=0.053  Score=57.42  Aligned_cols=154  Identities=16%  Similarity=0.235  Sum_probs=82.9

Q ss_pred             HhhcCCccc---ceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccC-----CCCceeeec---
Q 018263           39 IATNGFRWS---NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC-----HENLVKLHG---  107 (358)
Q Consensus        39 ~~~~~y~i~---~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~-----h~~i~~~~~---  107 (358)
                      +..+.|-+.   +.|+ |..-.+|++...+|..|++|+.+....  ......+...+..+...     .|.+++..+   
T Consensus        19 ~~~~~ygl~~~~~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~--~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~   95 (1013)
T PRK06148         19 LLAQHFGISATATPLD-GERDLNFRLTTDDGADYILKIVNPSEP--RVESDFQTAALDHLAAVAPDLPVPRLIPSLSGAS   95 (1013)
T ss_pred             HHHHHcCCceEEeecC-CcCCceEEEEeCCCCeEEEEEcCCccc--hhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCe
Confidence            334555553   3454 455778999888888999999875432  22333344444444321     344444322   


Q ss_pred             --eEEc-CC--eeEEEEecCCCCCHHHHhhh-----------------------ccccccCCCH----------------
Q 018263          108 --GCID-GP--CRILVYDYMPNNSLSQTLLG-----------------------EEKRRAKFGW----------------  143 (358)
Q Consensus       108 --~~~~-~~--~~~iv~e~~~~~~L~~~l~~-----------------------~~~~~~~l~~----------------  143 (358)
                        .... .+  ..+.+++|++|..+.+....                       .......+.|                
T Consensus        96 ~~~v~~~~G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~  175 (1013)
T PRK06148         96 LASAQDPDGEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFID  175 (1013)
T ss_pred             EEEeecCCCceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcC
Confidence              1111 22  45778999999877651100                       0000001111                


Q ss_pred             -HHHHHHHHHHHHHHH-----HHhcCCCCCcEEcCCCCCcEEEcCCC--ceE-Eeecccccc
Q 018263          144 -KARREIIMGIGRGLA-----YIHEEIQPHVVHRDIKTSNILLDQNF--NPK-ISDFGLSKL  196 (358)
Q Consensus       144 -~~~~~~~~qi~~aL~-----~LH~~~~~~i~H~di~p~Nilv~~~~--~~~-l~Dfg~~~~  196 (358)
                       ...+.++.+++..+.     .+.+. ..++||+|+++.||+++.++  ++. |+|||-+..
T Consensus       176 d~~~r~~l~~~~~~~~~~v~p~l~~L-p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        176 DPEDRALVERFLARFERNVAPRLAAL-PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHHHhcC-CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence             111222333333322     12221 33899999999999999875  555 999998764

>PTZ00384 choline kinase; Provisional

Probab=95.96  E-value=0.061  Score=50.43  Aligned_cols=77  Identities=18%  Similarity=0.146  Sum_probs=44.9

Q ss_pred             ccceecccCceEEEEEEECCC--CE-----EEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           46 WSNKIGEGGFGSVYKGRLQDG--TI-----VAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        46 i~~~lg~g~~g~v~~~~~~~~--~~-----vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      .++.|..|-...+|++...++  ..     |+++... ......-+-..|+.+++.+. .+..-.++++.+..    +++
T Consensus        54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g-~~~~l~IdR~~E~~i~~~Ls-~~glgP~l~~~f~~----g~l  127 (383)
T PTZ00384         54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSS-TYNSLVIDNDLQYNIAKLLG-DNNFGPKIIGRFGD----FTI  127 (383)
T ss_pred             EEEEeCCcccceEEEEEecCCCCCccccceEEEEecc-CCCceEeccHHHHHHHHHHH-hCCCCCeEEEecCC----EEE
Confidence            355666688889999975432  22     4444432 11111122345677777775 24445566666653    489


Q ss_pred             EecCCCCCHH
Q 018263          119 YDYMPNNSLS  128 (358)
Q Consensus       119 ~e~~~~~~L~  128 (358)
                      .||++|.+|.
T Consensus       128 ~efIeGr~l~  137 (383)
T PTZ00384        128 QEWVEGNTMG  137 (383)
T ss_pred             EEEeccccCC
Confidence            9999987654

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.66  E-value=0.11  Score=44.58  Aligned_cols=80  Identities=15%  Similarity=0.194  Sum_probs=56.4

Q ss_pred             cccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccC-CCCceeeeceEEcCCeeEEEEecCC
Q 018263           45 RWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC-HENLVKLHGGCIDGPCRILVYDYMP  123 (358)
Q Consensus        45 ~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~-h~~i~~~~~~~~~~~~~~iv~e~~~  123 (358)
                      +..+.+..|.--..|.+.+. ...|.+|.-.   ......+..|+.-|..+... .-.+.+++.+-.+.++.|+|+||++
T Consensus        19 ~er~~v~gG~inea~~v~dg-~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~   94 (286)
T COG3001          19 KEREEVSGGDINEAWRLRDG-TDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLP   94 (286)
T ss_pred             hcccccCCccccceeEeecC-CcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeecc
Confidence            33456666777777877764 5668888754   33445666777766666522 3567888888889999999999998


Q ss_pred             CCCHH
Q 018263          124 NNSLS  128 (358)
Q Consensus       124 ~~~L~  128 (358)
                      .+.+.
T Consensus        95 ~~~~d   99 (286)
T COG3001          95 TGPLD   99 (286)
T ss_pred             CCCCC
Confidence            76554

>PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties []

Probab=95.44  E-value=0.079  Score=46.55  Aligned_cols=79  Identities=19%  Similarity=0.170  Sum_probs=53.1

Q ss_pred             cceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecC-CCC
Q 018263           47 SNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM-PNN  125 (358)
Q Consensus        47 ~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~-~~~  125 (358)
                      ...+..|..+.|+.++..+|.+.++|+.........+.  .....|+...  -...+++++.-.  ....+++|.+ ++.
T Consensus         7 ~~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~~E~--~g~~~L~~w~--G~GaVrll~~d~--~~~AlLLErl~~g~   80 (253)
T PF04655_consen    7 DGPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAEHEA--RGEAALRWWN--GRGAVRLLAADP--ERGALLLERLDPGR   80 (253)
T ss_pred             CCCCCCCcceEEEEEEcCCCCeEEEEecCCcccchhhh--hHHhHhheeC--CCCceeeecccc--ccchhhhhhccCCC
Confidence            34566788999999999999999999986433222111  1113366665  667788888753  3456888988 556


Q ss_pred             CHHHHh
Q 018263          126 SLSQTL  131 (358)
Q Consensus       126 ~L~~~l  131 (358)
                      +|.+..
T Consensus        81 ~L~~~~   86 (253)
T PF04655_consen   81 SLASLP   86 (253)
T ss_pred             chhhcc
Confidence            776654

Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process

>PTZ00296 choline kinase; Provisional

Probab=95.29  E-value=0.2  Score=47.93  Aligned_cols=28  Identities=25%  Similarity=0.417  Sum_probs=24.0

Q ss_pred             CcEEcCCCCCcEEEcCCCceEEeeccccc
Q 018263          167 HVVHRDIKTSNILLDQNFNPKISDFGLSK  195 (358)
Q Consensus       167 ~i~H~di~p~Nilv~~~~~~~l~Dfg~~~  195 (358)
                      .+||.|+.+.||+.+++ .++++||..+.
T Consensus       285 VfCHNDl~~~NiL~~~~-~l~LIDfEYAg  312 (442)
T PTZ00296        285 VFCHNDLQENNIINTNK-CLRLIDFEYSG  312 (442)
T ss_pred             eEEeCCCCccceeecCC-CEEEEeecccc
Confidence            78999999999988655 49999997765

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	358
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		8e-63
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-61
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		4e-48
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		8e-48
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-40
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		4e-40
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		9e-40
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-37
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		5e-27
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-26
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		3e-26
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-25
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		6e-25
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-23
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		4e-23
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		5e-23
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		5e-23
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		5e-23
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		8e-23
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		8e-23
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		8e-23
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		8e-23
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		9e-23
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-22
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-22
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-22
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-22
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-22
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-22
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-22
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-22
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		4e-22
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-21
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-21
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-21
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		7e-21
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		7e-21
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		8e-21
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		9e-21
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-20
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-20
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-20
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-20
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-20
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-20
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-20
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-20
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-20
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-20
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-20
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-20
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-20
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-20
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-19
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-19
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-19
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-19
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-19
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-19
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-19
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-19
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		4e-19
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		6e-19
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		6e-19
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		6e-19
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-19
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		7e-19
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		8e-19
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		8e-19
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-19
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		9e-19
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		9e-19
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		9e-19
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-18
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-18
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-18
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-18
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-18
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-18
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-18
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-18
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-18
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-18
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-18
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-18
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-18
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-18
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-18
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-18
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-18
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-18
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-18
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-18
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-18
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-18
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-18
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-18
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-18
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-18
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-18
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-18
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-18
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-18
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-18
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-18
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-18
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-18
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-18
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-18
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-18
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-18
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-18
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-18
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-18
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-18
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		4e-18
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-18
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-18
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-18
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		6e-18
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		6e-18
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		6e-18
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		7e-18
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		7e-18
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		7e-18
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		7e-18
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		7e-18
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		8e-18
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		8e-18
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-18
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		8e-18
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		9e-18
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-17
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-17
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-17
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-17
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-17
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-17
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-17
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-17
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-17
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-17
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-17
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-17
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-17
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-17
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-17
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-17
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-17
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-17
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-17
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-17
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-17
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-17
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-17
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-17
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-17
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-17
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-17
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-17
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-17
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-17
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-17
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		4e-17
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-17
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-17
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-17
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		5e-17
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		5e-17
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		5e-17
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		5e-17
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		5e-17
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		5e-17
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-17
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-17
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		7e-17
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		8e-17
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		9e-17
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-16
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-16
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		4e-16
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		6e-16
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		6e-16
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-16
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		6e-16
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		7e-16
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-16
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-16
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-15
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-15
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-15
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-15
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-15
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-15
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-15
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-15
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-15
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-15
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		4e-15
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-15
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-15
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-15
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-15
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		4e-15
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-15
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-15
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		4e-15
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		4e-15
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		4e-15
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		5e-15
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		6e-15
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		6e-15
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		8e-15
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		9e-15
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-14
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-14
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-14
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-14
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-14
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-14
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-14
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-14
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-14
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-14
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-14
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-14
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-14
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-14
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-14
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-14
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-14
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-14
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-14
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-14
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-14
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-14
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-14
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-14
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-14
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-14
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-14
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-14
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-14
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-14
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-14
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-14
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-14
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-14
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-14
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-14
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-14
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-14
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-14
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-14
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-14
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-14
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-14
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-14
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-14
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-14
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-14
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-14
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-14
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-14
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-14
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-14
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-14
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		4e-14
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		5e-14
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		5e-14
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		5e-14
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		5e-14
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		5e-14
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		5e-14
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		5e-14
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		5e-14
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		6e-14
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		6e-14
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		6e-14
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		6e-14
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		6e-14
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		7e-14
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		7e-14
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		7e-14
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		8e-14
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		9e-14
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		9e-14
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		9e-14
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-13
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-13
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-13
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-13
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-13
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-13
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-13
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-13
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-13
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-13
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-13
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-13
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-13
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-13
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-13
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-13
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-13
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-13
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-13
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-13
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-13
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-13
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-13
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-13
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-13
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-13
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-13
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-13
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		3e-13
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		3e-13
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-13
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-13
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-13
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-13
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-13
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		4e-13
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		4e-13
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-13
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		4e-13
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		4e-13
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-13
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-13
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		4e-13
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-13
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		4e-13
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		4e-13
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-13
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-13
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		5e-13
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		5e-13
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-13
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		6e-13
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		6e-13
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		7e-13
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		7e-13
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-13
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		7e-13
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		7e-13
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		8e-13
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		8e-13
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		8e-13
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		9e-13
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		9e-13
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		9e-13
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		9e-13
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		9e-13
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		9e-13
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		9e-13
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		9e-13
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		9e-13
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-12
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-12
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-12
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-12
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-12
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-12
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-12
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-12
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-12
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-12
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-12
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-12
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-12
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-12
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-12
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-12
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-12
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-12
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-12
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-12
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-12
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-12
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-12
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-12
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-12
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-12
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-12
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-12
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-12
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-12
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-12
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-12
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-12
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-12
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-12
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-12
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		4e-12
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		4e-12
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-12
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		5e-12
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-12
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		5e-12
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		5e-12
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		5e-12
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		5e-12
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		5e-12
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		5e-12
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		5e-12
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-12
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-12
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		5e-12
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		5e-12
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		5e-12
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-12
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		6e-12
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		6e-12
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		6e-12
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		6e-12
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		6e-12
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		6e-12
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		6e-12
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		6e-12
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		6e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		6e-12
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		6e-12
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		6e-12
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		6e-12
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		6e-12
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		6e-12
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		6e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		7e-12
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-12
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		7e-12
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-12
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		7e-12
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		7e-12
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		7e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		7e-12
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		7e-12
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		7e-12
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		7e-12
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		7e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-12
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		7e-12
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-12
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		7e-12
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		7e-12
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		8e-12
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		8e-12
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		8e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		8e-12
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		8e-12
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		8e-12
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		8e-12
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		8e-12
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		8e-12
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		8e-12
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		8e-12
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		8e-12
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		9e-12
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		9e-12
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		9e-12
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		9e-12
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		9e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		9e-12
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		9e-12
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-11
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-11
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-11
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-11
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-11
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-11
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-11
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-11
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-11
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-11
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-11
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-11
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-11
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-11
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-11
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-11
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-11
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-11
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-11
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-11
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-11
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-11
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-11
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-11
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-11
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-11
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-11
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-11
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-11
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-11
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-11
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-11
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-11
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-11
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-11
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-11
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-11
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-11
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-11
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-11
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-11
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-11
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-11
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-11
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-11
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-11
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-11
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-11
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-11
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-11
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-11
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-11
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-11
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-11
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-11
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-11
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-11
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-11
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		3e-11
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-11
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-11
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-11
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-11
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-11
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-11
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-11
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-11
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-11
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-11
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-11
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-11
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-11
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-11
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-11
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-11
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-11
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-11
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-11
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-11
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-11
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-11
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-11
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-11
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-11
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-11
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-11
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-11
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-11
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-11
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-11
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-11
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-11
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-11
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-11
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-11
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-11
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-11
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-11
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-11
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-11
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-11
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-11
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		4e-11
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-11
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		4e-11
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		4e-11
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		5e-11
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		5e-11
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		6e-11
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		6e-11
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		6e-11
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-11
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-11
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		6e-11
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		6e-11
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-11
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		6e-11
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		6e-11
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		6e-11
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-11
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-11
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		6e-11
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		7e-11
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		7e-11
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		7e-11
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		7e-11
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-11
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		7e-11
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		7e-11
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		7e-11
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		8e-11
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		8e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		8e-11
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		8e-11
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		8e-11
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		9e-11
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		9e-11
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		9e-11
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		9e-11
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		9e-11
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-10
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-10
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-10
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-10
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-10
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-10
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-10
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-10
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-10
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-10
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-10
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-10
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-10
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-10
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-10
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-10
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-10
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-10
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-10
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-10
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-10
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-10
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-10
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-10
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-10
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-10
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-10
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		5e-10
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-10
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		5e-10
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		5e-10
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-10
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		5e-10
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-10
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		5e-10
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		5e-10
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		5e-10
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		5e-10
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		6e-10
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		6e-10
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		6e-10
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		6e-10
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		6e-10
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		6e-10
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		6e-10
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-10
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-10
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		7e-10
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		7e-10
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		7e-10
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		7e-10
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		7e-10
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		7e-10
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		8e-10
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		8e-10
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		8e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		8e-10
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		9e-10
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		9e-10
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		9e-10
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		9e-10
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		9e-10
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		9e-10
3kk8_A	284	Camkii Substrate Complex A Length = 284		9e-10
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-09
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-09
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-09
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-09
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-09
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-09
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-09
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-09
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-09
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-09
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-09
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-09
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-09
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-09
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-09
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-09
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-09
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-09
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-09
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-09
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-09
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-09
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-09
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-09
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-09
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-09
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-09
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-09
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-09
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-09
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-09
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-09
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-09
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-09
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-09
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-09
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-09
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-09
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-09
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-09
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-09
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-09
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-09
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-09
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-09
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-09
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-09
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-09
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-09
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-09
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-09
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-09
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-09
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-09
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-09
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-09
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-09
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-09
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-09
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-09
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-09
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-09
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-09
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-09
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-09
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-09
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-09
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-09
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-09
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-09
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-09
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-09
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-09
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-09
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-09
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		4e-09
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-09
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		5e-09
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		5e-09
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		5e-09
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		5e-09
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-09
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		5e-09
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		6e-09
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		6e-09
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		6e-09
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		6e-09
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-09
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-09
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		6e-09
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-09
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		6e-09
4exu_A	371	Mapk13, Inactive Form Length = 371		7e-09
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		7e-09
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		7e-09
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		8e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		9e-09
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		9e-09
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		9e-09
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-08
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-08
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-08
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-08
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-08
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-08
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-08
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-08
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-08
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-08
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-08
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-08
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-08
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		1e-08
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-08
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-08
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-08
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-08
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-08
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-08
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-08
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-08
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-08
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-08
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		1e-08
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-08
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-08
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-08
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-08
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-08
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-08
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-08
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-08
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-08
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-08
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-08
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-08
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-08
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-08
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-08
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-08
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-08
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-08
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-08
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-08
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-08
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-08
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-08
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-08
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-08
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-08
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-08
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-08
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-08
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-08
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-08
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-08
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-08
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-08
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-08
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-08
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-08
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-08
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-08
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-08
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		6e-08
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		6e-08
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		6e-08
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		7e-08
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		8e-08
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		9e-08
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-07
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-07
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-07
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-07
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-07
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-07
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-07
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-07
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-07
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-07
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-07
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-07
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-07
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-07
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-07
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		3e-07
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		3e-07
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-07
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		3e-07
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-07
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		4e-07
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		4e-07
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		6e-07
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		6e-07
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		7e-07
3soa_A	444	Full-Length Human Camkii Length = 444		8e-07
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		8e-07
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		8e-07
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		9e-07
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		9e-07
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		9e-07
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		9e-07
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		9e-07
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-06
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-06
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-06
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-06
2oza_A	356	Structure Of P38alpha Complex Length = 356		1e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-06
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		2e-06
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		2e-06
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		2e-06
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		2e-06
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-06
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		3e-06
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		3e-06
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		4e-06
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		4e-06
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		4e-06
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		6e-06
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		6e-06
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		7e-06
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-05
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		1e-05
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-05
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-05
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-05
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-05
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-05
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-05
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		1e-05
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-05
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-05
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-05
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-05
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-05
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-05
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-05
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-05
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-05
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-05
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-05
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-05
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-05
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-05
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-05
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-05
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-05
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		4e-05
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-05
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-05
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		4e-05
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		5e-05
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		6e-05
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		6e-05
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		6e-05
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		6e-05
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		7e-05
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		7e-05
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		7e-05
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		7e-05
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		7e-05
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		7e-05
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		7e-05
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		7e-05
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		7e-05
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		7e-05
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		8e-05
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		8e-05
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		8e-05
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		8e-05
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		8e-05
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		8e-05
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		8e-05
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		9e-05
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		9e-05
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		9e-05
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		9e-05
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		9e-05
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-04
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-04
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-04
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-04
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  237 bits (604), Expect = 8e-63,   Method: Compositional matrix adjust.
 Identities = 126/319 (39%), Positives = 187/319 (58%), Gaps = 17/319 (5%)
Query: 8   FSFPSRVSAENTIGGEQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGT 67
           F  P+    E  +G       +  FS  +L++A++ F   N +G GGFG VYKGRL DGT
Sbjct: 10  FDVPAEEDPEVHLG------QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGT 63
Query: 68  IVAVKVLSVESKQG-EKEFMSEVA--SMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 124
           +VAVK L  E  QG E +F +EV   SMA     H NL++L G C+    R+LVY YM N
Sbjct: 64  LVAVKRLKEERXQGGELQFQTEVEMISMA----VHRNLLRLRGFCMTPTERLLVYPYMAN 119
Query: 125 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF 184
            S++  L    + +    W  R+ I +G  RGLAY+H+   P ++HRD+K +NILLD+ F
Sbjct: 120 GSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF 179
Query: 185 NPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
              + DFGL+KL      H+   V GT+G++APEY  +G+ + K+DV+ +GV+LLE+++G
Sbjct: 180 EAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 239
Query: 245 RTAVDFDVQLG---EYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQ 301
           + A D   +L    +  L+D   G+   K+L  LVD  L GN+ + E  + ++V LLC Q
Sbjct: 240 QRAFDL-ARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQ 298
Query: 302 EKSKLRPQMSTAIKMMNGE 320
                RP+MS  ++M+ G+
Sbjct: 299 SSPMERPKMSEVVRMLEGD 317

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  233 bits (593), Expect = 1e-61,   Method: Compositional matrix adjust.
 Identities = 124/319 (38%), Positives = 185/319 (57%), Gaps = 17/319 (5%)
Query: 8   FSFPSRVSAENTIGGEQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGT 67
           F  P+    E  +G       +  FS  +L++A++ F   N +G GGFG VYKGRL DG 
Sbjct: 2   FDVPAEEDPEVHLG------QLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGX 55
Query: 68  IVAVKVLSVESKQG-EKEFMSEVA--SMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 124
           +VAVK L  E  QG E +F +EV   SMA     H NL++L G C+    R+LVY YM N
Sbjct: 56  LVAVKRLKEERTQGGELQFQTEVEMISMA----VHRNLLRLRGFCMTPTERLLVYPYMAN 111
Query: 125 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF 184
            S++  L    + +    W  R+ I +G  RGLAY+H+   P ++HRD+K +NILLD+ F
Sbjct: 112 GSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF 171
Query: 185 NPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
              + DFGL+KL      H+   V G +G++APEY  +G+ + K+DV+ +GV+LLE+++G
Sbjct: 172 EAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 231
Query: 245 RTAVDFDVQLG---EYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQ 301
           + A D   +L    +  L+D   G+   K+L  LVD  L GN+ + E  + ++V LLC Q
Sbjct: 232 QRAFDL-ARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQ 290
Query: 302 EKSKLRPQMSTAIKMMNGE 320
                RP+MS  ++M+ G+
Sbjct: 291 SSPMERPKMSEVVRMLEGD 309

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  188 bits (478), Expect = 4e-48,   Method: Compositional matrix adjust.
 Identities = 115/279 (41%), Positives = 161/279 (57%), Gaps = 6/279 (2%)
Query: 37  LKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVN 96
           L+ ATN F     IG G FG VYKG L+DG  VA+K  + ES QG +EF +E+ +++   
Sbjct: 34  LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCR 93
Query: 97  VCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRG 156
             H +LV L G C +    IL+Y YM N +L + L G +       W+ R EI +G  RG
Sbjct: 94  --HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARG 151
Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE-NTTHISTRVAGTLGYL 215
           L Y+H      ++HRD+K+ NILLD+NF PKI+DFG+SK   E + TH+   V GTLGY+
Sbjct: 152 LHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYI 208
Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNL 275
            PEY I GRLT KSDVYSFGV+L E++  R+A+   +     +L + A   +N+ +L  +
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI 268
Query: 276 VDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAI 314
           VDP L          +F    + C+   S+ RP M   +
Sbjct: 269 VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  187 bits (475), Expect = 8e-48,   Method: Compositional matrix adjust.
 Identities = 115/279 (41%), Positives = 160/279 (57%), Gaps = 6/279 (2%)
Query: 37  LKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVN 96
           L+ ATN F     IG G FG VYKG L+DG  VA+K  + ES QG +EF +E+ +++   
Sbjct: 34  LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCR 93
Query: 97  VCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRG 156
             H +LV L G C +    IL+Y YM N +L + L G +       W+ R EI +G  RG
Sbjct: 94  --HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARG 151
Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE-NTTHISTRVAGTLGYL 215
           L Y+H      ++HRD+K+ NILLD+NF PKI+DFG+SK   E   TH+   V GTLGY+
Sbjct: 152 LHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYI 208
Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNL 275
            PEY I GRLT KSDVYSFGV+L E++  R+A+   +     +L + A   +N+ +L  +
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI 268
Query: 276 VDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAI 314
           VDP L          +F    + C+   S+ RP M   +
Sbjct: 269 VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 101/232 (43%), Positives = 140/232 (60%), Gaps = 19/232 (8%)
Query: 29  INAFSYNQLKIATNGFRWS------NKIGEGGFGSVYKGRLQDGTIVAVKVLS----VES 78
            ++FS+ +LK  TN F         NK+GEGGFG VYKG + + T VAVK L+    + +
Sbjct: 12  FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITT 70
Query: 79  KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRR 138
           ++ +++F  E+  MA     HENLV+L G   DG    LVY YMPN SL   L   +   
Sbjct: 71  EELKQQFDQEIKVMAKCQ--HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT- 127
Query: 139 AKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198
               W  R +I  G   G+ ++HE    H +HRDIK++NILLD+ F  KISDFGL++   
Sbjct: 128 PPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASE 184
Query: 199 E-NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVD 249
           +   T + +R+ GT  Y+APE A+ G +T KSD+YSFGV+LLEI++G  AVD
Sbjct: 185 KFAQTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVD 235

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  162 bits (409), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 101/232 (43%), Positives = 139/232 (59%), Gaps = 19/232 (8%)
Query: 29  INAFSYNQLKIATNGFRWS------NKIGEGGFGSVYKGRLQDGTIVAVKVLS----VES 78
            ++FS+ +LK  TN F         NK+GEGGFG VYKG + + T VAVK L+    + +
Sbjct: 12  FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITT 70
Query: 79  KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRR 138
           ++ +++F  E+  MA     HENLV+L G   DG    LVY YMPN SL   L   +   
Sbjct: 71  EELKQQFDQEIKVMAKCQ--HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT- 127
Query: 139 AKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198
               W  R +I  G   G+ ++HE    H +HRDIK++NILLD+ F  KISDFGL++   
Sbjct: 128 PPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASE 184
Query: 199 E-NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVD 249
           +   T +  R+ GT  Y+APE A+ G +T KSD+YSFGV+LLEI++G  AVD
Sbjct: 185 KFAQTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVD 235

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  160 bits (405), Expect = 9e-40,   Method: Compositional matrix adjust.
 Identities = 100/232 (43%), Positives = 138/232 (59%), Gaps = 19/232 (8%)
Query: 29  INAFSYNQLKIATNGFRWS------NKIGEGGFGSVYKGRLQDGTIVAVKVLS----VES 78
            ++FS+ +LK  TN F         NK+GEGGFG VYKG + + T VAVK L+    + +
Sbjct: 6   FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITT 64
Query: 79  KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRR 138
           ++ +++F  E+  MA     HENLV+L G   DG    LVY YMPN SL   L   +   
Sbjct: 65  EELKQQFDQEIKVMAKCQ--HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT- 121
Query: 139 AKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198
               W  R +I  G   G+ ++HE    H +HRDIK++NILLD+ F  KISDFGL++   
Sbjct: 122 PPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASE 178
Query: 199 ENTTHI-STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVD 249
           +    +   R+ GT  Y+APE A+ G +T KSD+YSFGV+LLEI++G  AVD
Sbjct: 179 KFAQXVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVD 229

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 98/232 (42%), Positives = 135/232 (58%), Gaps = 19/232 (8%)
Query: 29  INAFSYNQLKIATNGFRWS------NKIGEGGFGSVYKGRLQDGTIVAVKVLS----VES 78
            ++FS+ +LK  TN F         NK GEGGFG VYKG + + T VAVK L+    + +
Sbjct: 3   FHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITT 61
Query: 79  KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRR 138
           ++ +++F  E+   A     HENLV+L G   DG    LVY Y PN SL   L   +   
Sbjct: 62  EELKQQFDQEIKVXAKCQ--HENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGT- 118
Query: 139 AKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198
               W  R +I  G   G+ ++HE    H +HRDIK++NILLD+ F  KISDFGL++   
Sbjct: 119 PPLSWHXRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASE 175
Query: 199 ENTTHI-STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVD 249
           +    +  +R+ GT  Y APE A+ G +T KSD+YSFGV+LLEI++G  AVD
Sbjct: 176 KFAQXVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVD 226

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  118 bits (295), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 92/296 (31%), Positives = 148/296 (50%), Gaps = 42/296 (14%)
Query: 39  IATNGFRWSNKIGEGGFGSVYKGRL-QDGTIVAVKVLSVESKQGE-------KEFMSEVA 90
           +A N   +  +IG+GGFG V+KGRL +D ++VA+K L +   +GE       +EF  EV 
Sbjct: 16  LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 91  SMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 150
            M+N+N  H N+VKL+ G +  P R +V +++P   L   LL    +     W  +  ++
Sbjct: 76  IMSNLN--HPNIVKLY-GLMHNPPR-MVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLM 128
Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNIL---LDQN--FNPKISDFGLSKLFPENTTHIS 205
           + I  G+ Y+  +  P +VHRD+++ NI    LD+N     K++DFGLS    + + H  
Sbjct: 129 LDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS----QQSVHSV 183
Query: 206 TRVAGTLGYLAPEY--AISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKA 263
           + + G   ++APE   A     T K+D YSF ++L  I++G    D      EY      
Sbjct: 184 SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD------EYS----- 232
Query: 264 WGMYNSKELMNLV-DPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN 318
              Y   + +N++ +  L    PE+   R   V  LC     K RP  S  +K ++
Sbjct: 233 ---YGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 91/296 (30%), Positives = 147/296 (49%), Gaps = 42/296 (14%)
Query: 39  IATNGFRWSNKIGEGGFGSVYKGRL-QDGTIVAVKVLSVESKQGE-------KEFMSEVA 90
           +A N   +  +IG+GGFG V+KGRL +D ++VA+K L +   +GE       +EF  EV 
Sbjct: 16  LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 91  SMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 150
            M+N+N  H N+VKL+ G +  P R +V +++P   L   LL    +     W  +  ++
Sbjct: 76  IMSNLN--HPNIVKLY-GLMHNPPR-MVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLM 128
Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNIL---LDQN--FNPKISDFGLSKLFPENTTHIS 205
           + I  G+ Y+  +  P +VHRD+++ NI    LD+N     K++DFG S    + + H  
Sbjct: 129 LDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTS----QQSVHSV 183
Query: 206 TRVAGTLGYLAPEY--AISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKA 263
           + + G   ++APE   A     T K+D YSF ++L  I++G    D      EY      
Sbjct: 184 SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD------EYS----- 232
Query: 264 WGMYNSKELMNLV-DPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN 318
              Y   + +N++ +  L    PE+   R   V  LC     K RP  S  +K ++
Sbjct: 233 ---YGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 91/296 (30%), Positives = 147/296 (49%), Gaps = 42/296 (14%)
Query: 39  IATNGFRWSNKIGEGGFGSVYKGRL-QDGTIVAVKVLSVESKQGE-------KEFMSEVA 90
           +A N   +  +IG+GGFG V+KGRL +D ++VA+K L +   +GE       +EF  EV 
Sbjct: 16  LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 91  SMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 150
            M+N+N  H N+VKL+ G +  P R +V +++P   L   LL    +     W  +  ++
Sbjct: 76  IMSNLN--HPNIVKLY-GLMHNPPR-MVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLM 128
Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNIL---LDQN--FNPKISDFGLSKLFPENTTHIS 205
           + I  G+ Y+  +  P +VHRD+++ NI    LD+N     K++DF LS    + + H  
Sbjct: 129 LDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLS----QQSVHSV 183
Query: 206 TRVAGTLGYLAPEY--AISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKA 263
           + + G   ++APE   A     T K+D YSF ++L  I++G    D      EY      
Sbjct: 184 SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD------EYS----- 232
Query: 264 WGMYNSKELMNLV-DPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN 318
              Y   + +N++ +  L    PE+   R   V  LC     K RP  S  +K ++
Sbjct: 233 ---YGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 70/198 (35%), Positives = 112/198 (56%), Gaps = 10/198 (5%)
Query: 49  KIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEK--EFMSEVASMANVNVCHENLVKLH 106
           KIG G FG+V++     G+ VAVK+L  +    E+  EF+ EVA M  +   H N+V   
Sbjct: 44  KIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLR--HPNIVLFM 100
Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
           G     P   +V +Y+   SL + LL +   R +   + R  +   + +G+ Y+H    P
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYR-LLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NP 158
Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR-VAGTLGYLAPEYAISGRL 225
            +VHR++K+ N+L+D+ +  K+ DFGLS+L  + +T +S++  AGT  ++APE       
Sbjct: 159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPS 216
Query: 226 TRKSDVYSFGVLLLEIVS 243
             KSDVYSFGV+L E+ +
Sbjct: 217 NEKSDVYSFGVILWELAT 234

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 70/197 (35%), Positives = 107/197 (54%), Gaps = 8/197 (4%)
Query: 49  KIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEK--EFMSEVASMANVNVCHENLVKLH 106
           KIG G FG+V++     G+ VAVK+L  +    E+  EF+ EVA M  +   H N+V   
Sbjct: 44  KIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLR--HPNIVLFM 100
Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
           G     P   +V +Y+   SL + LL +   R +   + R  +   + +G+ Y+H    P
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYR-LLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NP 158
Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLT 226
            +VHRD+K+ N+L+D+ +  K+ DFGLS+L   +    S   AGT  ++APE        
Sbjct: 159 PIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-KASXFLXSKXAAGTPEWMAPEVLRDEPSN 217
Query: 227 RKSDVYSFGVLLLEIVS 243
            KSDVYSFGV+L E+ +
Sbjct: 218 EKSDVYSFGVILWELAT 234

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 107/209 (51%), Gaps = 9/209 (4%)
Query: 35  NQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMAN 94
           +  +I     R   K+G+G FG V+ G     T VA+K L   +   E  F+ E   M  
Sbjct: 1   DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKK 59
Query: 95  VNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIG 154
           +   HE LV+L+    + P  I V +YM   SL   L GE  +  +       ++   I 
Sbjct: 60  LR--HEKLVQLYAVVSEEPIXI-VTEYMSKGSLLDFLKGETGKYLRL--PQLVDMAAQIA 114
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY 214
            G+AY+    + + VHRD++ +NIL+ +N   K++DFGL++L  +N           + +
Sbjct: 115 SGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKW 171
Query: 215 LAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
            APE A+ GR T KSDV+SFG+LL E+ +
Sbjct: 172 TAPEAALYGRFTIKSDVWSFGILLTELTT 200

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 109/216 (50%), Gaps = 9/216 (4%)
Query: 28  NINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMS 87
                + +  +I     R   K+G+G FG V+ G     T VA+K L   +   E  F+ 
Sbjct: 4   QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQ 62
Query: 88  EVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARR 147
           E   M  +   HE LV+L+    + P  I++ +YM   SL   L GE  +  +       
Sbjct: 63  EAQVMKKLR--HEKLVQLYAVVSEEPIYIVI-EYMSKGSLLDFLKGEMGKYLRL--PQLV 117
Query: 148 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 207
           ++   I  G+AY+    + + VHRD++ +NIL+ +N   K++DFGL++L  +N       
Sbjct: 118 DMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQG 174
Query: 208 VAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
               + + APE A+ GR T KSDV+SFG+LL E+ +
Sbjct: 175 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 108/216 (50%), Gaps = 9/216 (4%)
Query: 28  NINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMS 87
                + +  +I     R   K+G+G FG V+ G     T VA+K L   +   E  F+ 
Sbjct: 4   QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQ 62
Query: 88  EVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARR 147
           E   M  +   HE LV+L+    + P  I V +YM   SL   L GE  +  +       
Sbjct: 63  EAQVMKKIR--HEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRL--PQLV 117
Query: 148 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 207
           ++   I  G+AY+    + + VHRD++ +NIL+ +N   K++DFGL++L  +N       
Sbjct: 118 DMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 174
Query: 208 VAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
               + + APE A+ GR T KSDV+SFG+LL E+ +
Sbjct: 175 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 107/209 (51%), Gaps = 9/209 (4%)
Query: 35  NQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMAN 94
           +  +I     R   K+G+G FG V+ G     T VA+K L   +   E  F+ E   M  
Sbjct: 4   DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKK 62
Query: 95  VNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIG 154
           +   HE LV+L+    + P  I V +YM   SL   L GE  +  +       ++   I 
Sbjct: 63  LR--HEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGETGKYLRL--PQLVDMAAQIA 117
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY 214
            G+AY+    + + VHRD++ +NIL+ +N   K++DFGL++L  +N           + +
Sbjct: 118 SGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 174
Query: 215 LAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
            APE A+ GR T KSDV+SFG+LL E+ +
Sbjct: 175 TAPEAALYGRFTIKSDVWSFGILLTELTT 203

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 109/216 (50%), Gaps = 9/216 (4%)
Query: 28  NINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMS 87
                + +  +I     R   K+G+G FG V+ G     T VA+K L   +   E  F+ 
Sbjct: 4   QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQ 62
Query: 88  EVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARR 147
           E   M  +   HE LV+L+    + P  I++ +YM   SL   L GE  +  +       
Sbjct: 63  EAQVMKKLR--HEKLVQLYAVVSEEPIYIVI-EYMSKGSLLDFLKGEMGKYLRL--PQLV 117
Query: 148 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 207
           ++   I  G+AY+    + + VHRD++ +NIL+ +N   K++DFGL++L  +N       
Sbjct: 118 DMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 174
Query: 208 VAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
               + + APE A+ GR T KSDV+SFG+LL E+ +
Sbjct: 175 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 107/209 (51%), Gaps = 9/209 (4%)
Query: 35  NQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMAN 94
           +  +I     R   K+G+G FG V+ G     T VA+K L   +   E  F+ E   M  
Sbjct: 2   DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKK 60
Query: 95  VNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIG 154
           +   HE LV+L+    + P  I V +YM   SL   L GE  +  +       ++   I 
Sbjct: 61  LR--HEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRL--PQLVDMAAQIA 115
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY 214
            G+AY+    + + VHRD++ +NIL+ +N   K++DFGL++L  +N           + +
Sbjct: 116 SGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 172
Query: 215 LAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
            APE A+ GR T KSDV+SFG+LL E+ +
Sbjct: 173 TAPEAALYGRFTIKSDVWSFGILLTELTT 201

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 106/206 (51%), Gaps = 9/206 (4%)
Query: 38  KIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNV 97
           +I     R   K+G+G FG V+ G     T VA+K L   +   E  F+ E   M  +  
Sbjct: 3   EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLR- 60
Query: 98  CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
            HE LV+L+    + P  I V +YM   SL   L GE  +  +       ++   I  G+
Sbjct: 61  -HEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRL--PQLVDMAAQIASGM 116
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
           AY+    + + VHRD++ +NIL+ +N   K++DFGL++L  +N           + + AP
Sbjct: 117 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 173
Query: 218 EYAISGRLTRKSDVYSFGVLLLEIVS 243
           E A+ GR T KSDV+SFG+LL E+ +
Sbjct: 174 EAALYGRFTIKSDVWSFGILLTELTT 199

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 108/216 (50%), Gaps = 9/216 (4%)
Query: 28  NINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMS 87
                + +  +I     R   K+G+G FG V+ G     T VA+K L   +   E  F+ 
Sbjct: 4   QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQ 62
Query: 88  EVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARR 147
           E   M  +   HE LV+L+    + P  I V +YM   SL   L GE  +  +       
Sbjct: 63  EAQVMKKLR--HEKLVQLYAVVSEEPIYI-VCEYMSKGSLLDFLKGEMGKYLRL--PQLV 117
Query: 148 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 207
           ++   I  G+AY+    + + VHRD++ +NIL+ +N   K++DFGL++L  +N       
Sbjct: 118 DMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 174
Query: 208 VAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
               + + APE A+ GR T KSDV+SFG+LL E+ +
Sbjct: 175 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 108/216 (50%), Gaps = 9/216 (4%)
Query: 28  NINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMS 87
                + +  +I     R   K+G+G FG V+ G     T VA+K L   +   E  F+ 
Sbjct: 4   QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQ 62
Query: 88  EVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARR 147
           E   M  +   HE LV+L+    + P  I V +YM   SL   L GE  +  +       
Sbjct: 63  EAQVMKKLR--HEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRL--PQLV 117
Query: 148 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 207
           ++   I  G+AY+    + + VHRD++ +NIL+ +N   K++DFGL++L  +N       
Sbjct: 118 DMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 174
Query: 208 VAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
               + + APE A+ GR T KSDV+SFG+LL E+ +
Sbjct: 175 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 107/209 (51%), Gaps = 9/209 (4%)
Query: 35  NQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMAN 94
           +  +I     R   K+G+G FG V+ G     T VA+K L   +   E  F+ E   M  
Sbjct: 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKK 235
Query: 95  VNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIG 154
           +   HE LV+L+    + P  I V +YM   SL   L GE  +  +       ++   I 
Sbjct: 236 LR--HEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGETGKYLRL--PQLVDMAAQIA 290
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY 214
            G+AY+    + + VHRD++ +NIL+ +N   K++DFGL++L  +N           + +
Sbjct: 291 SGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 347
Query: 215 LAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
            APE A+ GR T KSDV+SFG+LL E+ +
Sbjct: 348 TAPEAALYGRFTIKSDVWSFGILLTELTT 376

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 107/209 (51%), Gaps = 9/209 (4%)
Query: 35  NQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMAN 94
           +  +I     R   K+G+G FG V+ G     T VA+K L   +   E  F+ E   M  
Sbjct: 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKK 235
Query: 95  VNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIG 154
           +   HE LV+L+    + P  I V +YM   SL   L GE  +  +       ++   I 
Sbjct: 236 LR--HEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGETGKYLRL--PQLVDMAAQIA 290
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY 214
            G+AY+    + + VHRD++ +NIL+ +N   K++DFGL++L  +N           + +
Sbjct: 291 SGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 347
Query: 215 LAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
            APE A+ GR T KSDV+SFG+LL E+ +
Sbjct: 348 TAPEAALYGRFTIKSDVWSFGILLTELTT 376

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 108/216 (50%), Gaps = 9/216 (4%)
Query: 28  NINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMS 87
                + +  +I     R   K+G+G FG V+ G     T VA+K L   +   E  F+ 
Sbjct: 1   QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQ 59
Query: 88  EVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARR 147
           E   M  +   HE LV+L+    + P  I V +YM   SL   L GE  +  +       
Sbjct: 60  EAQVMKKLR--HEKLVQLYAVVSEEPIYI-VTEYMNKGSLLDFLKGETGKYLRL--PQLV 114
Query: 148 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 207
           ++   I  G+AY+    + + VHRD++ +NIL+ +N   K++DFGL++L  +N       
Sbjct: 115 DMSAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQG 171
Query: 208 VAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
               + + APE A+ GR T KSDV+SFG+LL E+ +
Sbjct: 172 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 207

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 107/209 (51%), Gaps = 9/209 (4%)
Query: 35  NQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMAN 94
           +  +I     R   K+G+G FG V+ G     T VA+K L   +   E  F+ E   M  
Sbjct: 8   DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKK 66
Query: 95  VNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIG 154
           +   HE LV+L+    + P  I V +YM   SL   L GE  +  +       ++   I 
Sbjct: 67  LR--HEKLVQLYAVVSEEPIYI-VTEYMNKGSLLDFLKGETGKYLRL--PQLVDMSAQIA 121
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY 214
            G+AY+    + + VHRD++ +NIL+ +N   K++DFGL++L  +N           + +
Sbjct: 122 SGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 178
Query: 215 LAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
            APE A+ GR T KSDV+SFG+LL E+ +
Sbjct: 179 TAPEAALYGRFTIKSDVWSFGILLTELTT 207

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 107/209 (51%), Gaps = 9/209 (4%)
Query: 35  NQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMAN 94
           +  +I     R   K+G+G FG V+ G     T VA+K L   +   E  F+ E   M  
Sbjct: 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKK 235
Query: 95  VNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIG 154
           +   HE LV+L+    + P  I V +YM   SL   L GE  +  +       ++   I 
Sbjct: 236 LR--HEKLVQLYAVVSEEPIYI-VGEYMSKGSLLDFLKGETGKYLRL--PQLVDMAAQIA 290
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY 214
            G+AY+    + + VHRD++ +NIL+ +N   K++DFGL++L  +N           + +
Sbjct: 291 SGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 347
Query: 215 LAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
            APE A+ GR T KSDV+SFG+LL E+ +
Sbjct: 348 TAPEAALYGRFTIKSDVWSFGILLTELTT 376

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 107/216 (49%), Gaps = 9/216 (4%)
Query: 28  NINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMS 87
                + +  +I     R   K+G+G FG V+ G     T VA+K L   +   E  F+ 
Sbjct: 4   QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQ 62
Query: 88  EVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARR 147
           E   M  +   HE LV+L+    + P  I V +YM   SL   L GE  +  +       
Sbjct: 63  EAQVMKKLR--HEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRL--PQLV 117
Query: 148 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 207
           ++   I  G+AY+    + + VHRD+  +NIL+ +N   K++DFGL++L  +N       
Sbjct: 118 DMAAQIASGMAYVE---RMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQG 174
Query: 208 VAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
               + + APE A+ GR T KSDV+SFG+LL E+ +
Sbjct: 175 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 107/216 (49%), Gaps = 9/216 (4%)
Query: 28  NINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMS 87
                + +  +I     R   K+G+G FG V+ G     T VA+K L   +   E  F+ 
Sbjct: 4   QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQ 62
Query: 88  EVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARR 147
           E   M  +   HE LV+L+    + P  I V +YM    L   L GE  +  +       
Sbjct: 63  EAQVMKKLR--HEKLVQLYAVVSEEPIYI-VMEYMSKGCLLDFLKGEMGKYLRL--PQLV 117
Query: 148 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 207
           ++   I  G+AY+    + + VHRD++ +NIL+ +N   K++DFGL++L  +N       
Sbjct: 118 DMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 174
Query: 208 VAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
               + + APE A+ GR T KSDV+SFG+LL E+ +
Sbjct: 175 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 107/209 (51%), Gaps = 9/209 (4%)
Query: 35  NQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMAN 94
           +  +I     R   K+G+G FG V+ G     T VA+K L   +   E  F+ E   M  
Sbjct: 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKK 318
Query: 95  VNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIG 154
           +   HE LV+L+    + P  I V +YM   SL   L GE  +  +       ++   I 
Sbjct: 319 LR--HEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGETGKYLRL--PQLVDMAAQIA 373
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY 214
            G+AY+    + + VHRD++ +NIL+ +N   K++DFGL++L  +N           + +
Sbjct: 374 SGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 430
Query: 215 LAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
            APE A+ GR T KSDV+SFG+LL E+ +
Sbjct: 431 TAPEAALYGRFTIKSDVWSFGILLTELTT 459

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 107/216 (49%), Gaps = 9/216 (4%)
Query: 28  NINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMS 87
                + +  +I     R   K+G+G FG V+ G     T VA+K L   +   E  F+ 
Sbjct: 4   QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQ 62
Query: 88  EVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARR 147
           E   M  +   HE LV+L+    + P  I V +YM    L   L GE  +  +       
Sbjct: 63  EAQVMKKLR--HEKLVQLYAVVSEEPIYI-VTEYMSKGCLLDFLKGEMGKYLRL--PQLV 117
Query: 148 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 207
           ++   I  G+AY+    + + VHRD++ +NIL+ +N   K++DFGL++L  +N       
Sbjct: 118 DMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 174
Query: 208 VAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
               + + APE A+ GR T KSDV+SFG+LL E+ +
Sbjct: 175 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 106/209 (50%), Gaps = 9/209 (4%)
Query: 35  NQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMAN 94
           +  +I     R   K+G+G FG V+ G     T VA+K L   +   E  F+ E   M  
Sbjct: 178 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEA-FLQEAQVMKK 236
Query: 95  VNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIG 154
           +   HE LV+L+    + P  I V +YM   SL   L GE  +  +       ++   I 
Sbjct: 237 LR--HEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRL--PQLVDMAAQIA 291
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY 214
            G+AY+    + + VHRD++ +NIL+ +N   K++DFGL +L  +N           + +
Sbjct: 292 SGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKW 348
Query: 215 LAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
            APE A+ GR T KSDV+SFG+LL E+ +
Sbjct: 349 TAPEAALYGRFTIKSDVWSFGILLTELTT 377

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 104/211 (49%), Gaps = 21/211 (9%)
Query: 49  KIGEGGFGSVYKGRL------QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENL 102
           ++GEG FG V+          QD  +VAVK L   S    K+F  E   + N+   HE++
Sbjct: 20  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ--HEHI 77
Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQ---------TLLGEEKRRAKFGWKARREIIMGI 153
           VK +G C++G   I+V++YM +  L++          L+ E     +        I   I
Sbjct: 78  VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQI 137
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTHISTRVAGTL 212
             G+ Y+  +   H VHRD+ T N L+ +N   KI DFG+S+ ++  +   +       +
Sbjct: 138 AAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 194
Query: 213 GYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
            ++ PE  +  + T +SDV+S GV+L EI +
Sbjct: 195 RWMPPESIMYRKFTTESDVWSLGVVLWEIFT 225

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 106/215 (49%), Gaps = 24/215 (11%)
Query: 48  NKIGEGGFGSVYKGRL------QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHEN 101
            ++GEG FG V+          +D  +VAVK L   +    K+F  E   + N+   HE+
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQ--HEH 78
Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGE----------EKRRAK--FGWKARREI 149
           +VK +G C DG   I+V++YM +  L++ L             + R+AK   G      I
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 150 IMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTHISTRV 208
              I  G+ Y+  +   H VHRD+ T N L+  N   KI DFG+S+ ++  +   +    
Sbjct: 139 ASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195
Query: 209 AGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
              + ++ PE  +  + T +SDV+SFGV+L EI +
Sbjct: 196 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 89/298 (29%), Positives = 133/298 (44%), Gaps = 46/298 (15%)
Query: 22  GEQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQG 81
           G Q  K    +  ++ ++     +   ++G G FG V+ G     T VAVK L    KQG
Sbjct: 1   GSQTQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL----KQG 56
Query: 82  EKEFMSEVASMANVNVC----HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKR 137
               MS  A +A  N+     H+ LV+L+      P  I+  +YM N SL   L  +   
Sbjct: 57  S---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFL--KTPS 110
Query: 138 RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197
             K       ++   I  G+A+I E    + +HRD++ +NIL+    + KI+DFGL++L 
Sbjct: 111 GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI 167
Query: 198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGE 256
            +N           + + APE    G  T KSDV+SFG+LL EIV+ GR           
Sbjct: 168 EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP------- 220
Query: 257 YHLVDKAWGMYNSKELMNL------VDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRP 308
                   GM N + + NL      V P    N PE       ++  LC +E+ + RP
Sbjct: 221 --------GMTNPEVIQNLERGYRMVRP---DNCPEE----LYQLMRLCWKERPEDRP 263

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 103/196 (52%), Gaps = 9/196 (4%)
Query: 48  NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
            +IG G FG V+ G   +   VA+K +  E    E++F+ E   M  ++  H  LV+L+G
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLS--HPKLVQLYG 69
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
            C++     LV+++M +  LS  L     +R  F  +    + + +  G+AY+ E     
Sbjct: 70  VCLEQAPICLVFEFMEHGCLSDYL---RTQRGLFAAETLLGMCLDVCEGMAYLEEAC--- 123
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR 227
           V+HRD+   N L+ +N   K+SDFG+++   ++    ST     + + +PE     R + 
Sbjct: 124 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 183
Query: 228 KSDVYSFGVLLLEIVS 243
           KSDV+SFGVL+ E+ S
Sbjct: 184 KSDVWSFGVLMWEVFS 199

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 97.8 bits (242), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 103/196 (52%), Gaps = 9/196 (4%)
Query: 48  NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
            +IG G FG V+ G   +   VA+K +  E    E++F+ E   M  ++  H  LV+L+G
Sbjct: 11  QEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLS--HPKLVQLYG 67
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
            C++     LV+++M +  LS  L     +R  F  +    + + +  G+AY+ E     
Sbjct: 68  VCLEQAPICLVFEFMEHGCLSDYL---RTQRGLFAAETLLGMCLDVCEGMAYLEEAC--- 121
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR 227
           V+HRD+   N L+ +N   K+SDFG+++   ++    ST     + + +PE     R + 
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 228 KSDVYSFGVLLLEIVS 243
           KSDV+SFGVL+ E+ S
Sbjct: 182 KSDVWSFGVLMWEVFS 197

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 103/196 (52%), Gaps = 9/196 (4%)
Query: 48  NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
            +IG G FG V+ G   +   VA+K +  E    E++F+ E   M  ++  H  LV+L+G
Sbjct: 16  QEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLS--HPKLVQLYG 72
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
            C++     LV+++M +  LS  L     +R  F  +    + + +  G+AY+ E     
Sbjct: 73  VCLEQAPICLVFEFMEHGCLSDYL---RTQRGLFAAETLLGMCLDVCEGMAYLEEAC--- 126
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR 227
           V+HRD+   N L+ +N   K+SDFG+++   ++    ST     + + +PE     R + 
Sbjct: 127 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 186
Query: 228 KSDVYSFGVLLLEIVS 243
           KSDV+SFGVL+ E+ S
Sbjct: 187 KSDVWSFGVLMWEVFS 202

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 103/196 (52%), Gaps = 9/196 (4%)
Query: 48  NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
            +IG G FG V+ G   +   VA+K +  E    E++F+ E   M  ++  H  LV+L+G
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLS--HPKLVQLYG 69
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
            C++     LV+++M +  LS  L     +R  F  +    + + +  G+AY+ E     
Sbjct: 70  VCLEQAPICLVFEFMEHGCLSDYL---RTQRGLFAAETLLGMCLDVCEGMAYLEE---AS 123
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR 227
           V+HRD+   N L+ +N   K+SDFG+++   ++    ST     + + +PE     R + 
Sbjct: 124 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 183
Query: 228 KSDVYSFGVLLLEIVS 243
           KSDV+SFGVL+ E+ S
Sbjct: 184 KSDVWSFGVLMWEVFS 199

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 102/196 (52%), Gaps = 9/196 (4%)
Query: 48  NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
            +IG G FG V+ G   +   VA+K +  E    E +F+ E   M  ++  H  LV+L+G
Sbjct: 33  QEIGSGQFGLVHLGYWLNKDKVAIKTIK-EGSMSEDDFIEEAEVMMKLS--HPKLVQLYG 89
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
            C++     LV+++M +  LS  L     +R  F  +    + + +  G+AY+ E     
Sbjct: 90  VCLEQAPICLVFEFMEHGCLSDYL---RTQRGLFAAETLLGMCLDVCEGMAYLEEAC--- 143
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR 227
           V+HRD+   N L+ +N   K+SDFG+++   ++    ST     + + +PE     R + 
Sbjct: 144 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 203
Query: 228 KSDVYSFGVLLLEIVS 243
           KSDV+SFGVL+ E+ S
Sbjct: 204 KSDVWSFGVLMWEVFS 219

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/261 (29%), Positives = 126/261 (48%), Gaps = 26/261 (9%)
Query: 49  KIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG 108
           ++G G FG V+ G     T VA+K L   +   E  F+ E   M  +   H+ LV+L+  
Sbjct: 16  RLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPES-FLEEAQIMKKLK--HDKLVQLYAV 72
Query: 109 CIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHV 168
             + P  I V +YM   SL   L   E R  K       ++   +  G+AYI    + + 
Sbjct: 73  VSEEPIYI-VTEYMNKGSLLDFLKDGEGRALKL--PNLVDMAAQVAAGMAYIE---RMNY 126
Query: 169 VHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRK 228
           +HRD++++NIL+      KI+DFGL++L  +N           + + APE A+ GR T K
Sbjct: 127 IHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIK 186
Query: 229 SDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPEN 287
           SDV+SFG+LL E+V+ GR                   GM N++E++  V+       P++
Sbjct: 187 SDVWSFGILLTELVTKGRVPYP---------------GM-NNREVLEQVERGYRMPCPQD 230
Query: 288 EAIRFLKVGLLCVQEKSKLRP 308
             I   ++ + C ++  + RP
Sbjct: 231 CPISLHELMIHCWKKDPEERP 251

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 88/296 (29%), Positives = 132/296 (44%), Gaps = 46/296 (15%)
Query: 24  QILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEK 83
           Q  K    +  ++ ++     +   ++G G FG V+ G     T VAVK L    KQG  
Sbjct: 1   QTQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL----KQGS- 55
Query: 84  EFMSEVASMANVNVC----HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRA 139
             MS  A +A  N+     H+ LV+L+      P  I+  +YM N SL   L  +     
Sbjct: 56  --MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFL--KTPSGI 110
Query: 140 KFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 199
           K       ++   I  G+A+I E    + +HRD++ +NIL+    + KI+DFGL++L  +
Sbjct: 111 KLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIED 167
Query: 200 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYH 258
           N           + + APE    G  T KSDV+SFG+LL EIV+ GR             
Sbjct: 168 NEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP--------- 218
Query: 259 LVDKAWGMYNSKELMNL------VDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRP 308
                 GM N + + NL      V P    N PE       ++  LC +E+ + RP
Sbjct: 219 ------GMTNPEVIQNLERGYRMVRP---DNCPEE----LYQLMRLCWKERPEDRP 261

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 86/285 (30%), Positives = 129/285 (45%), Gaps = 46/285 (16%)
Query: 35  NQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMAN 94
           ++ ++     +   ++G G FG V+ G     T VAVK L    KQG    MS  A +A 
Sbjct: 8   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL----KQGS---MSPDAFLAE 60
Query: 95  VNVC----HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 150
            N+     H+ LV+L+      P  I+  +YM N SL   L  +     K       ++ 
Sbjct: 61  ANLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFL--KTPSGIKLTINKLLDMA 117
Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG 210
             I  G+A+I E    + +HRD++ +NIL+    + KI+DFGL++L  +N          
Sbjct: 118 AQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF 174
Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNS 269
            + + APE    G  T KSDV+SFG+LL EIV+ GR                   GM N 
Sbjct: 175 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP---------------GMTNP 219
Query: 270 KELMNL------VDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRP 308
           + + NL      V P    N PE       ++  LC +E+ + RP
Sbjct: 220 EVIQNLERGYRMVRP---DNCPEE----LYQLMRLCWKERPEDRP 257

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 88/296 (29%), Positives = 132/296 (44%), Gaps = 46/296 (15%)
Query: 24  QILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEK 83
           Q  K    +  ++ ++     +   ++G G FG V+ G     T VAVK L    KQG  
Sbjct: 5   QTQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL----KQGS- 59
Query: 84  EFMSEVASMANVNVC----HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRA 139
             MS  A +A  N+     H+ LV+L+      P  I+  +YM N SL   L  +     
Sbjct: 60  --MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFL--KTPSGI 114
Query: 140 KFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 199
           K       ++   I  G+A+I E    + +HRD++ +NIL+    + KI+DFGL++L  +
Sbjct: 115 KLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIED 171
Query: 200 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYH 258
           N           + + APE    G  T KSDV+SFG+LL EIV+ GR             
Sbjct: 172 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP--------- 222
Query: 259 LVDKAWGMYNSKELMNL------VDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRP 308
                 GM N + + NL      V P    N PE       ++  LC +E+ + RP
Sbjct: 223 ------GMTNPEVIQNLERGYRMVRP---DNCPEE----LYQLMRLCWKERPEDRP 265

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 86/285 (30%), Positives = 129/285 (45%), Gaps = 46/285 (16%)
Query: 35  NQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMAN 94
           ++ ++     +   ++G G FG V+ G     T VAVK L    KQG    MS  A +A 
Sbjct: 15  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL----KQGS---MSPDAFLAE 67
Query: 95  VNVC----HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 150
            N+     H+ LV+L+      P  I+  +YM N SL   L  +     K       ++ 
Sbjct: 68  ANLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFL--KTPSGIKLTINKLLDMA 124
Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG 210
             I  G+A+I E    + +HRD++ +NIL+    + KI+DFGL++L  +N          
Sbjct: 125 AQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF 181
Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNS 269
            + + APE    G  T KSDV+SFG+LL EIV+ GR                   GM N 
Sbjct: 182 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP---------------GMTNP 226
Query: 270 KELMNL------VDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRP 308
           + + NL      V P    N PE       ++  LC +E+ + RP
Sbjct: 227 EVIQNLERGYRMVRP---DNCPEE----LYQLMRLCWKERPEDRP 264

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 86/285 (30%), Positives = 129/285 (45%), Gaps = 46/285 (16%)
Query: 35  NQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMAN 94
           ++ ++     +   ++G G FG V+ G     T VAVK L    KQG    MS  A +A 
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL----KQGS---MSPDAFLAE 58
Query: 95  VNVC----HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 150
            N+     H+ LV+L+      P  I+  +YM N SL   L  +     K       ++ 
Sbjct: 59  ANLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFL--KTPSGIKLTINKLLDMA 115
Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG 210
             I  G+A+I E    + +HRD++ +NIL+    + KI+DFGL++L  +N          
Sbjct: 116 AQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF 172
Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNS 269
            + + APE    G  T KSDV+SFG+LL EIV+ GR                   GM N 
Sbjct: 173 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP---------------GMTNP 217
Query: 270 KELMNL------VDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRP 308
           + + NL      V P    N PE       ++  LC +E+ + RP
Sbjct: 218 EVIQNLERGYRMVRP---DNCPEE----LYQLMRLCWKERPEDRP 255

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 86/285 (30%), Positives = 129/285 (45%), Gaps = 46/285 (16%)
Query: 35  NQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMAN 94
           ++ ++     +   ++G G FG V+ G     T VAVK L    KQG    MS  A +A 
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL----KQGS---MSPDAFLAE 58
Query: 95  VNVC----HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 150
            N+     H+ LV+L+      P  I+  +YM N SL   L  +     K       ++ 
Sbjct: 59  ANLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFL--KTPSGIKLTINKLLDMA 115
Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG 210
             I  G+A+I E    + +HRD++ +NIL+    + KI+DFGL++L  +N          
Sbjct: 116 AQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF 172
Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNS 269
            + + APE    G  T KSDV+SFG+LL EIV+ GR                   GM N 
Sbjct: 173 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP---------------GMTNP 217
Query: 270 KELMNL------VDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRP 308
           + + NL      V P    N PE       ++  LC +E+ + RP
Sbjct: 218 EVIQNLERGYRMVRP---DNCPEE----LYQLMRLCWKERPEDRP 255

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 88/296 (29%), Positives = 132/296 (44%), Gaps = 46/296 (15%)
Query: 24  QILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEK 83
           Q  K    +  ++ ++     +   ++G G FG V+ G     T VAVK L    KQG  
Sbjct: 1   QTQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL----KQGS- 55
Query: 84  EFMSEVASMANVNVC----HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRA 139
             MS  A +A  N+     H+ LV+L+      P  I+  +YM N SL   L  +     
Sbjct: 56  --MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFL--KTPSGI 110
Query: 140 KFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 199
           K       ++   I  G+A+I E    + +HRD++ +NIL+    + KI+DFGL++L  +
Sbjct: 111 KLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIED 167
Query: 200 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYH 258
           N           + + APE    G  T KSDV+SFG+LL EIV+ GR             
Sbjct: 168 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP--------- 218
Query: 259 LVDKAWGMYNSKELMNL------VDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRP 308
                 GM N + + NL      V P    N PE       ++  LC +E+ + RP
Sbjct: 219 ------GMTNPEVIQNLERGYRMVRP---DNCPEE----LYQLMRLCWKERPEDRP 261

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 86/285 (30%), Positives = 129/285 (45%), Gaps = 46/285 (16%)
Query: 35  NQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMAN 94
           ++ ++     +   ++G G FG V+ G     T VAVK L    KQG    MS  A +A 
Sbjct: 7   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL----KQGS---MSPDAFLAE 59
Query: 95  VNVC----HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 150
            N+     H+ LV+L+      P  I+  +YM N SL   L  +     K       ++ 
Sbjct: 60  ANLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFL--KTPSGIKLTINKLLDMA 116
Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG 210
             I  G+A+I E    + +HRD++ +NIL+    + KI+DFGL++L  +N          
Sbjct: 117 AQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF 173
Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNS 269
            + + APE    G  T KSDV+SFG+LL EIV+ GR                   GM N 
Sbjct: 174 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP---------------GMTNP 218
Query: 270 KELMNL------VDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRP 308
           + + NL      V P    N PE       ++  LC +E+ + RP
Sbjct: 219 EVIQNLERGYRMVRP---DNCPEE----LYQLMRLCWKERPEDRP 256

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 86/285 (30%), Positives = 129/285 (45%), Gaps = 46/285 (16%)
Query: 35  NQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMAN 94
           ++ ++     +   ++G G FG V+ G     T VAVK L    KQG    MS  A +A 
Sbjct: 11  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL----KQGS---MSPDAFLAE 63
Query: 95  VNVC----HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 150
            N+     H+ LV+L+      P  I+  +YM N SL   L  +     K       ++ 
Sbjct: 64  ANLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFL--KTPSGIKLTINKLLDMA 120
Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG 210
             I  G+A+I E    + +HRD++ +NIL+    + KI+DFGL++L  +N          
Sbjct: 121 AQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF 177
Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNS 269
            + + APE    G  T KSDV+SFG+LL EIV+ GR                   GM N 
Sbjct: 178 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP---------------GMTNP 222
Query: 270 KELMNL------VDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRP 308
           + + NL      V P    N PE       ++  LC +E+ + RP
Sbjct: 223 EVIQNLERGYRMVRP---DNCPEE----LYQLMRLCWKERPEDRP 260

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 86/285 (30%), Positives = 129/285 (45%), Gaps = 46/285 (16%)
Query: 35  NQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMAN 94
           ++ ++     +   ++G G FG V+ G     T VAVK L    KQG    MS  A +A 
Sbjct: 1   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL----KQGS---MSPDAFLAE 53
Query: 95  VNVC----HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 150
            N+     H+ LV+L+      P  I+  +YM N SL   L  +     K       ++ 
Sbjct: 54  ANLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFL--KTPSGIKLTINKLLDMA 110
Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG 210
             I  G+A+I E    + +HRD++ +NIL+    + KI+DFGL++L  +N          
Sbjct: 111 AQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF 167
Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNS 269
            + + APE    G  T KSDV+SFG+LL EIV+ GR                   GM N 
Sbjct: 168 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP---------------GMTNP 212
Query: 270 KELMNL------VDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRP 308
           + + NL      V P    N PE       ++  LC +E+ + RP
Sbjct: 213 EVIQNLERGYRMVRP---DNCPEE----LYQLMRLCWKERPEDRP 250

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 86/285 (30%), Positives = 129/285 (45%), Gaps = 46/285 (16%)
Query: 35  NQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMAN 94
           ++ ++     +   ++G G FG V+ G     T VAVK L    KQG    MS  A +A 
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL----KQGS---MSPDAFLAE 58
Query: 95  VNVC----HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 150
            N+     H+ LV+L+      P  I+  +YM N SL   L  +     K       ++ 
Sbjct: 59  ANLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFL--KTPSGIKLTINKLLDMA 115
Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG 210
             I  G+A+I E    + +HRD++ +NIL+    + KI+DFGL++L  +N          
Sbjct: 116 AQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF 172
Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNS 269
            + + APE    G  T KSDV+SFG+LL EIV+ GR                   GM N 
Sbjct: 173 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP---------------GMTNP 217
Query: 270 KELMNL------VDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRP 308
           + + NL      V P    N PE       ++  LC +E+ + RP
Sbjct: 218 EVIQNLERGYRMVRP---DNCPEE----LYQLMRLCWKERPEDRP 255

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 102/196 (52%), Gaps = 9/196 (4%)
Query: 48  NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
            +IG G FG V+ G   +   VA+K +  E    E++F+ E   M  ++  H  LV+L+G
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLS--HPKLVQLYG 70
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
            C++     LV ++M +  LS  L     +R  F  +    + + +  G+AY+ E     
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYL---RTQRGLFAAETLLGMCLDVCEGMAYLEEAC--- 124
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR 227
           V+HRD+   N L+ +N   K+SDFG+++   ++    ST     + + +PE     R + 
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 184
Query: 228 KSDVYSFGVLLLEIVS 243
           KSDV+SFGVL+ E+ S
Sbjct: 185 KSDVWSFGVLMWEVFS 200

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 101/209 (48%), Gaps = 9/209 (4%)
Query: 35  NQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMAN 94
           +  +I     +   K+G G FG V+       T VAVK +   S   E  F++E   M  
Sbjct: 8   DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKT 66
Query: 95  VNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIG 154
           +   H+ LVKLH      P  I+  ++M   SL   L  +E  +         +    I 
Sbjct: 67  LQ--HDKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIA 121
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY 214
            G+A+I    Q + +HRD++ +NIL+  +   KI+DFGL+++  +N           + +
Sbjct: 122 EGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW 178
Query: 215 LAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
            APE    G  T KSDV+SFG+LL+EIV+
Sbjct: 179 TAPEAINFGSFTIKSDVWSFGILLMEIVT 207

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 101/209 (48%), Gaps = 9/209 (4%)
Query: 35  NQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMAN 94
           +  +I     +   K+G G FG V+       T VAVK +   S   E  F++E   M  
Sbjct: 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKT 239
Query: 95  VNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIG 154
           +   H+ LVKLH      P  I+  ++M   SL   L  +E  +         +    I 
Sbjct: 240 LQ--HDKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIA 294
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY 214
            G+A+I    Q + +HRD++ +NIL+  +   KI+DFGL+++  +N           + +
Sbjct: 295 EGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW 351
Query: 215 LAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
            APE    G  T KSDV+SFG+LL+EIV+
Sbjct: 352 TAPEAINFGSFTIKSDVWSFGILLMEIVT 380

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 105/208 (50%), Gaps = 21/208 (10%)
Query: 50  IGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC--HENLVKLHG 107
           IG GGFG VY+     G  VAVK    +  +   + +  V   A +     H N++ L G
Sbjct: 15  IGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEE-KRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
            C+  P   LV ++     L++ L G+         W  +      I RG+ Y+H+E   
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQ------IARGMNYLHDEAIV 127
Query: 167 HVVHRDIKTSNILLDQ--------NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE 218
            ++HRD+K+SNIL+ Q        N   KI+DFGL++ +   TT +S   AG   ++APE
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW-HRTTKMSA--AGAYAWMAPE 184
Query: 219 YAISGRLTRKSDVYSFGVLLLEIVSGRT 246
              +   ++ SDV+S+GVLL E+++G  
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGEV 212

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 85/271 (31%), Positives = 124/271 (45%), Gaps = 46/271 (16%)
Query: 49  KIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC----HENLVK 104
           ++G G FG V+ G     T VAVK L    KQG    MS  A +A  N+     H+ LV+
Sbjct: 16  RLGAGQFGEVWMGYYNGHTKVAVKSL----KQGS---MSPDAFLAEANLMKQLQHQRLVR 68
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L+      P  I+  +YM N SL   L  +     K       ++   I  G+A+I E  
Sbjct: 69  LYAVVTQEPIYIIT-EYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER- 124
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
             + +HR+++ +NIL+    + KI+DFGL++L  +N           + + APE    G 
Sbjct: 125 --NYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 182
Query: 225 LTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNL------VD 277
            T KSDV+SFG+LL EIV+ GR                   GM N + + NL      V 
Sbjct: 183 FTIKSDVWSFGILLTEIVTHGRIPYP---------------GMTNPEVIQNLERGYRMVR 227
Query: 278 PMLYGNFPENEAIRFLKVGLLCVQEKSKLRP 308
           P    N PE       ++  LC +E+ + RP
Sbjct: 228 P---DNCPEE----LYQLMRLCWKERPEDRP 251

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 127/270 (47%), Gaps = 27/270 (10%)
Query: 50  IGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGC 109
           +G G FG V K + +    VA+K   +ES+   K F+ E+  ++ VN  H N+VKL+G C
Sbjct: 16  VGRGAFGVVCKAKWR-AKDVAIK--QIESESERKAFIVELRQLSRVN--HPNIVKLYGAC 70
Query: 110 IDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVV 169
           ++  C  LV +Y    SL   L G E         A     +   +G+AY+H      ++
Sbjct: 71  LNPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAM-SWCLQCSQGVAYLHSMQPKALI 127
Query: 170 HRDIKTSNILLDQNFNP-KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRK 228
           HRD+K  N+LL       KI DFG +    +  TH+ T   G+  ++APE       + K
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTAC---DIQTHM-TNNKGSAAWMAPEVFEGSNYSEK 183
Query: 229 SDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENE 288
            DV+S+G++L E+++ R   D ++    + ++   W ++N         P L  N P  +
Sbjct: 184 CDVFSWGIILWEVITRRKPFD-EIGGPAFRIM---WAVHNGTR------PPLIKNLP--K 231
Query: 289 AIRFLKVGLLCVQEKSKLRPQMSTAIKMMN 318
            I  L     C  +    RP M   +K+M 
Sbjct: 232 PIESLMTR--CWSKDPSQRPSMEEIVKIMT 259

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 127/270 (47%), Gaps = 27/270 (10%)
Query: 50  IGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGC 109
           +G G FG V K + +    VA+K   +ES+   K F+ E+  ++ VN  H N+VKL+G C
Sbjct: 17  VGRGAFGVVCKAKWR-AKDVAIK--QIESESERKAFIVELRQLSRVN--HPNIVKLYGAC 71
Query: 110 IDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVV 169
           ++  C  LV +Y    SL   L G E         A     +   +G+AY+H      ++
Sbjct: 72  LNPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAM-SWCLQCSQGVAYLHSMQPKALI 128
Query: 170 HRDIKTSNILLDQNFNP-KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRK 228
           HRD+K  N+LL       KI DFG +    +  TH+ T   G+  ++APE       + K
Sbjct: 129 HRDLKPPNLLLVAGGTVLKICDFGTAC---DIQTHM-TNNKGSAAWMAPEVFEGSNYSEK 184
Query: 229 SDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENE 288
            DV+S+G++L E+++ R   D ++    + ++   W ++N         P L  N P  +
Sbjct: 185 CDVFSWGIILWEVITRRKPFD-EIGGPAFRIM---WAVHNGTR------PPLIKNLP--K 232
Query: 289 AIRFLKVGLLCVQEKSKLRPQMSTAIKMMN 318
            I  L     C  +    RP M   +K+M 
Sbjct: 233 PIESLMT--RCWSKDPSQRPSMEEIVKIMT 260

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 112/220 (50%), Gaps = 17/220 (7%)
Query: 33  SYNQLKIATNGFRWSNKIGEGGFGSVYKGR---LQD--GTIVAVKVLSVESKQGEKEFMS 87
           S+N  +      ++  ++G+G FGSV   R   LQD  G +VAVK L   +++  ++F  
Sbjct: 19  SHNMTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 78
Query: 88  EVASMANVNVCHENLVKLHGGCIDGPCR--ILVYDYMPNNSLSQTLLGEEKRRAKFGWKA 145
           E+  + ++   H+N+VK  G C     R   L+ +Y+P  SL   L   +K + +     
Sbjct: 79  EIEILKSLQ--HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIK 133
Query: 146 RREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS 205
             +    I +G+ Y+  +     +HRD+ T NIL++     KI DFGL+K+ P++     
Sbjct: 134 LLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK 190
Query: 206 TRVAG--TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
            +  G   + + APE     + +  SDV+SFGV+L E+ +
Sbjct: 191 VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 112/220 (50%), Gaps = 17/220 (7%)
Query: 33  SYNQLKIATNGFRWSNKIGEGGFGSVYKGR---LQD--GTIVAVKVLSVESKQGEKEFMS 87
           S+N  +      ++  ++G+G FGSV   R   LQD  G +VAVK L   +++  ++F  
Sbjct: 19  SHNMTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 78
Query: 88  EVASMANVNVCHENLVKLHGGCIDGPCR--ILVYDYMPNNSLSQTLLGEEKRRAKFGWKA 145
           E+  + ++   H+N+VK  G C     R   L+ +Y+P  SL   L   +K + +     
Sbjct: 79  EIEILKSLQ--HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIK 133
Query: 146 RREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS 205
             +    I +G+ Y+  +     +HRD+ T NIL++     KI DFGL+K+ P++     
Sbjct: 134 LLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK 190
Query: 206 TRVAG--TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
            +  G   + + APE     + +  SDV+SFGV+L E+ +
Sbjct: 191 VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 114/241 (47%), Gaps = 28/241 (11%)
Query: 24  QILKNINAFS---YNQLKIATNGFRWSNKIGEGGFGSVYKGRL------QDGTIVAVKVL 74
            I++N   FS    + +K      +W  ++GEG FG V+          QD  +VAVK L
Sbjct: 22  HIIENPQYFSDACVHHIKRRDIVLKW--ELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL 79
Query: 75  SVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLL-- 132
              S+   ++F  E   +  +   H+++V+  G C +G   ++V++YM +  L++ L   
Sbjct: 80  KEASESARQDFQREAELLTMLQ--HQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSH 137
Query: 133 ---------GEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN 183
                    GE+      G      +   +  G+ Y+      H VHRD+ T N L+ Q 
Sbjct: 138 GPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQG 194
Query: 184 FNPKISDFGLSK-LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIV 242
              KI DFG+S+ ++  +   +  R    + ++ PE  +  + T +SDV+SFGV+L EI 
Sbjct: 195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIF 254
Query: 243 S 243
           +
Sbjct: 255 T 255

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 105/218 (48%), Gaps = 25/218 (11%)
Query: 44  FRWSNKIGEGGFGSVYKGRL------QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNV 97
            +W  ++GEG FG V+          QD  +VAVK L   S+   ++F  E   +  +  
Sbjct: 22  LKW--ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQ- 78
Query: 98  CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLL-----------GEEKRRAKFGWKAR 146
            H+++V+  G C +G   ++V++YM +  L++ L            GE+      G    
Sbjct: 79  -HQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 137
Query: 147 REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTHIS 205
             +   +  G+ Y+      H VHRD+ T N L+ Q    KI DFG+S+ ++  +   + 
Sbjct: 138 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 194
Query: 206 TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
            R    + ++ PE  +  + T +SDV+SFGV+L EI +
Sbjct: 195 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 232

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 105/218 (48%), Gaps = 25/218 (11%)
Query: 44  FRWSNKIGEGGFGSVYKGRL------QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNV 97
            +W  ++GEG FG V+          QD  +VAVK L   S+   ++F  E   +  +  
Sbjct: 16  LKW--ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQ- 72
Query: 98  CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLL-----------GEEKRRAKFGWKAR 146
            H+++V+  G C +G   ++V++YM +  L++ L            GE+      G    
Sbjct: 73  -HQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 131
Query: 147 REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTHIS 205
             +   +  G+ Y+      H VHRD+ T N L+ Q    KI DFG+S+ ++  +   + 
Sbjct: 132 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 188
Query: 206 TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
            R    + ++ PE  +  + T +SDV+SFGV+L EI +
Sbjct: 189 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 226

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 74/276 (26%), Positives = 129/276 (46%), Gaps = 30/276 (10%)
Query: 50  IGEGGFGSVYKGRLQ----DGTIVAVKVLSV-ESKQGEKEFMSEVASMANVNVCHENLVK 104
           IG G FG V  GRL+        VA+K L    + +  ++F+SE + M   +  H N++ 
Sbjct: 37  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFD--HPNIIH 94
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L G        +++ +YM N SL   L    K   +F       ++ GIG G+ Y+ +  
Sbjct: 95  LEGVVTKCKPVMIITEYMENGSLDAFL---RKNDGRFTVIQLVGMLRGIGSGMKYLSDM- 150
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG--YLAPEYAIS 222
               VHRD+   NIL++ N   K+SDFG+S++  ++     T   G +   + APE    
Sbjct: 151 --SAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 208
Query: 223 GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYG 282
            + T  SDV+S+G+++ E++S           GE       W M N ++++  ++     
Sbjct: 209 RKFTSASDVWSYGIVMWEVMS----------YGERPY----WDMSN-QDVIKAIEEGYRL 253
Query: 283 NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN 318
             P +  I   ++ L C Q++   RP+    + M++
Sbjct: 254 PPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLD 289

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 129/276 (46%), Gaps = 30/276 (10%)
Query: 50  IGEGGFGSVYKGRLQ----DGTIVAVKVLSV-ESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V  GRL+        VA+K L V  +++  ++F+ E + M   +  H N+++
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD--HPNIIR 110
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L G        ++V +YM N SL   L    K  A+F       ++ GI  G+ Y+ +  
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSDM- 166
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG--YLAPEYAIS 222
               VHRD+   NIL++ N   K+SDFGLS++  ++     T   G +   + +PE    
Sbjct: 167 --GFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 223 GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYG 282
            + T  SDV+S+G++L E++S           GE       W M N ++++  VD     
Sbjct: 225 RKFTSASDVWSYGIVLWEVMS----------YGER----PYWEMSN-QDVIKAVDEGYRL 269
Query: 283 NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN 318
             P +      ++ L C Q+    RP+    + +++
Sbjct: 270 PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 129/276 (46%), Gaps = 30/276 (10%)
Query: 50  IGEGGFGSVYKGRLQ----DGTIVAVKVLSV-ESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V  GRL+        VA+K L V  +++  ++F+ E + M   +  H N+++
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD--HPNIIR 81
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L G        ++V +YM N SL   L    K  A+F       ++ GI  G+ Y+ +  
Sbjct: 82  LEGVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSDM- 137
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG--YLAPEYAIS 222
               VHRD+   NIL++ N   K+SDFGLS++  ++     T   G +   + +PE    
Sbjct: 138 --GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 195
Query: 223 GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYG 282
            + T  SDV+S+G++L E++S           GE       W M N ++++  VD     
Sbjct: 196 RKFTSASDVWSYGIVLWEVMS----------YGERPY----WEMSN-QDVIKAVDEGYRL 240
Query: 283 NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN 318
             P +      ++ L C Q+    RP+    + +++
Sbjct: 241 PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 276

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 129/276 (46%), Gaps = 30/276 (10%)
Query: 50  IGEGGFGSVYKGRLQ----DGTIVAVKVLSV-ESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V  GRL+        VA+K L V  +++  ++F+ E + M   +  H N+++
Sbjct: 41  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD--HPNIIR 98
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L G        ++V +YM N SL   L    K  A+F       ++ GI  G+ Y+ +  
Sbjct: 99  LEGVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSDM- 154
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG--YLAPEYAIS 222
               VHRD+   NIL++ N   K+SDFGLS++  ++     T   G +   + +PE    
Sbjct: 155 --GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 212
Query: 223 GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYG 282
            + T  SDV+S+G++L E++S           GE       W M N ++++  VD     
Sbjct: 213 RKFTSASDVWSYGIVLWEVMS----------YGERPY----WEMSN-QDVIKAVDEGYRL 257
Query: 283 NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN 318
             P +      ++ L C Q+    RP+    + +++
Sbjct: 258 PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 293

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 71/242 (29%), Positives = 119/242 (49%), Gaps = 10/242 (4%)
Query: 27  KNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTI-VAVKVLSVESKQGEKEF 85
           +N+   S ++ ++        +K+G G +G VY G  +  ++ VAVK L  ++ + E EF
Sbjct: 17  ENLYFQSMDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVE-EF 75
Query: 86  MSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKA 145
           + E A M  +   H NLV+L G C   P   +V +YMP  +L   L   E  R +     
Sbjct: 76  LKEAAVMKEIK--HPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYL--RECNREEVTAVV 131
Query: 146 RREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS 205
              +   I   + Y+ ++   + +HRD+   N L+ +N   K++DFGLS+L   +T    
Sbjct: 132 LLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAH 188
Query: 206 TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE-YHLVDKAW 264
                 + + APE       + KSDV++FGVLL EI +   +    + L + Y L++K +
Sbjct: 189 AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYDLLEKGY 248
Query: 265 GM 266
            M
Sbjct: 249 RM 250

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 129/276 (46%), Gaps = 30/276 (10%)
Query: 50  IGEGGFGSVYKGRLQ----DGTIVAVKVLSV-ESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V  GRL+        VA+K L V  +++  ++F+ E + M   +  H N+++
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD--HPNIIR 110
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L G        ++V +YM N SL   L    K  A+F       ++ GI  G+ Y+ +  
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSDM- 166
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG--YLAPEYAIS 222
               VHRD+   NIL++ N   K+SDFGLS++  ++     T   G +   + +PE    
Sbjct: 167 --GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 223 GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYG 282
            + T  SDV+S+G++L E++S           GE       W M N ++++  VD     
Sbjct: 225 RKFTSASDVWSYGIVLWEVMS----------YGER----PYWEMSN-QDVIKAVDEGYRL 269
Query: 283 NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN 318
             P +      ++ L C Q+    RP+    + +++
Sbjct: 270 PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 129/276 (46%), Gaps = 30/276 (10%)
Query: 50  IGEGGFGSVYKGRLQ----DGTIVAVKVLSV-ESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V  GRL+        VA+K L V  +++  ++F+ E + M   +  H N+++
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD--HPNIIR 110
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L G        ++V +YM N SL   L    K  A+F       ++ GI  G+ Y+ +  
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSDM- 166
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG--YLAPEYAIS 222
               VHRD+   NIL++ N   K+SDFGLS++  ++     T   G +   + +PE    
Sbjct: 167 --GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 223 GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYG 282
            + T  SDV+S+G++L E++S           GE       W M N ++++  VD     
Sbjct: 225 RKFTSASDVWSYGIVLWEVMS----------YGER----PYWEMSN-QDVIKAVDEGYRL 269
Query: 283 NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN 318
             P +      ++ L C Q+    RP+    + +++
Sbjct: 270 PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 129/276 (46%), Gaps = 30/276 (10%)
Query: 50  IGEGGFGSVYKGRLQ----DGTIVAVKVLSV-ESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V  GRL+        VA+K L V  +++  ++F+ E + M   +  H N+++
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD--HPNIIR 110
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L G        ++V +YM N SL   L    K  A+F       ++ GI  G+ Y+ +  
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSDM- 166
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG--YLAPEYAIS 222
               VHRD+   NIL++ N   K+SDFGLS++  ++     T   G +   + +PE    
Sbjct: 167 --GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 223 GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYG 282
            + T  SDV+S+G++L E++S           GE       W M N ++++  VD     
Sbjct: 225 RKFTSASDVWSYGIVLWEVMS----------YGER----PYWEMSN-QDVIKAVDEGYRL 269
Query: 283 NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN 318
             P +      ++ L C Q+    RP+    + +++
Sbjct: 270 PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 129/276 (46%), Gaps = 30/276 (10%)
Query: 50  IGEGGFGSVYKGRLQ----DGTIVAVKVLSV-ESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V  GRL+        VA+K L V  +++  ++F+ E + M   +  H N+++
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD--HPNIIR 110
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L G        ++V +YM N SL   L    K  A+F       ++ GI  G+ Y+ +  
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSDM- 166
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG--YLAPEYAIS 222
               VHRD+   NIL++ N   K+SDFGLS++  ++     T   G +   + +PE    
Sbjct: 167 --GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 223 GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYG 282
            + T  SDV+S+G++L E++S           GE       W M N ++++  VD     
Sbjct: 225 RKFTSASDVWSYGIVLWEVMS----------YGER----PYWEMSN-QDVIKAVDEGYRL 269
Query: 283 NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN 318
             P +      ++ L C Q+    RP+    + +++
Sbjct: 270 PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 129/276 (46%), Gaps = 30/276 (10%)
Query: 50  IGEGGFGSVYKGRLQ----DGTIVAVKVLSV-ESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V  GRL+        VA+K L V  +++  ++F+ E + M   +  H N+++
Sbjct: 51  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD--HPNIIR 108
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L G        ++V +YM N SL   L    K  A+F       ++ GI  G+ Y+ +  
Sbjct: 109 LEGVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSDM- 164
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG--YLAPEYAIS 222
               VHRD+   NIL++ N   K+SDFGLS++  ++     T   G +   + +PE    
Sbjct: 165 --GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 222
Query: 223 GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYG 282
            + T  SDV+S+G++L E++S           GE       W M N ++++  VD     
Sbjct: 223 RKFTSASDVWSYGIVLWEVMS----------YGER----PYWEMSN-QDVIKAVDEGYRL 267
Query: 283 NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN 318
             P +      ++ L C Q+    RP+    + +++
Sbjct: 268 PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 303

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 108/209 (51%), Gaps = 17/209 (8%)
Query: 44  FRWSNKIGEGGFGSVYKGR---LQD--GTIVAVKVLSVESKQGEKEFMSEVASMANVNVC 98
            ++  ++G+G FGSV   R   LQD  G +VAVK L   +++  ++F  E+  + ++   
Sbjct: 12  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-- 69
Query: 99  HENLVKLHGGCIDGPCR--ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRG 156
           H+N+VK  G C     R   L+ +Y+P  SL   L   +K + +       +    I +G
Sbjct: 70  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKG 126
Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG--TLGY 214
           + Y+  +     +HRD+ T NIL++     KI DFGL+K+ P++      +  G   + +
Sbjct: 127 MEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFW 183
Query: 215 LAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
            APE     + +  SDV+SFGV+L E+ +
Sbjct: 184 YAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/276 (26%), Positives = 129/276 (46%), Gaps = 30/276 (10%)
Query: 50  IGEGGFGSVYKGRLQ----DGTIVAVKVLSV-ESKQGEKEFMSEVASMANVNVCHENLVK 104
           IG G FG V  GRL+        VA+K L    + +  ++F+SE + M   +  H N++ 
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFD--HPNIIH 79
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L G        +++ +YM N SL   L    K   +F       ++ GIG G+ Y+ +  
Sbjct: 80  LEGVVTKCKPVMIITEYMENGSLDAFL---RKNDGRFTVIQLVGMLRGIGSGMKYLSDM- 135
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG--YLAPEYAIS 222
               VHRD+   NIL++ N   K+SDFG+S++  ++     T   G +   + APE    
Sbjct: 136 --SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 193
Query: 223 GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYG 282
            + T  SDV+S+G+++ E++S           GE       W M N ++++  ++     
Sbjct: 194 RKFTSASDVWSYGIVMWEVMS----------YGERPY----WDMSN-QDVIKAIEEGYRL 238
Query: 283 NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN 318
             P +  I   ++ L C Q++   RP+    + M++
Sbjct: 239 PPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLD 274

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 118/236 (50%), Gaps = 10/236 (4%)
Query: 33  SYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTI-VAVKVLSVESKQGEKEFMSEVAS 91
           +Y++ ++        +K+G G +G VY+G  +  ++ VAVK L  ++ + E EF+ E A 
Sbjct: 5   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 63
Query: 92  MANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
           M  +   H NLV+L G C   P   ++ ++M   +L   L   E  R +        +  
Sbjct: 64  MKEIK--HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL--RECNRQEVNAVVLLYMAT 119
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT 211
            I   + Y+ ++   + +HRD+   N L+ +N   K++DFGLS+L   +T          
Sbjct: 120 QISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFP 176
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE-YHLVDKAWGM 266
           + + APE     + + KSDV++FGVLL EI +   +    + L + Y L++K + M
Sbjct: 177 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 232

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/276 (26%), Positives = 129/276 (46%), Gaps = 30/276 (10%)
Query: 50  IGEGGFGSVYKGRLQ----DGTIVAVKVLSV-ESKQGEKEFMSEVASMANVNVCHENLVK 104
           IG G FG V  GRL+        VA+K L    + +  ++F+SE + M   +  H N++ 
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFD--HPNIIH 73
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L G        +++ +YM N SL   L    K   +F       ++ GIG G+ Y+ +  
Sbjct: 74  LEGVVTKCKPVMIITEYMENGSLDAFL---RKNDGRFTVIQLVGMLRGIGSGMKYLSDM- 129
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG--YLAPEYAIS 222
               VHRD+   NIL++ N   K+SDFG+S++  ++     T   G +   + APE    
Sbjct: 130 --SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 187
Query: 223 GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYG 282
            + T  SDV+S+G+++ E++S           GE       W M N ++++  ++     
Sbjct: 188 RKFTSASDVWSYGIVMWEVMS----------YGERPY----WDMSN-QDVIKAIEEGYRL 232
Query: 283 NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN 318
             P +  I   ++ L C Q++   RP+    + M++
Sbjct: 233 PPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLD 268

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 108/209 (51%), Gaps = 17/209 (8%)
Query: 44  FRWSNKIGEGGFGSVYKGR---LQD--GTIVAVKVLSVESKQGEKEFMSEVASMANVNVC 98
            ++  ++G+G FGSV   R   LQD  G +VAVK L   +++  ++F  E+  + ++   
Sbjct: 43  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-- 100
Query: 99  HENLVKLHGGCIDGPCR--ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRG 156
           H+N+VK  G C     R   L+ +Y+P  SL   L   +K + +       +    I +G
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKG 157
Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG--TLGY 214
           + Y+  +     +HRD+ T NIL++     KI DFGL+K+ P++      +  G   + +
Sbjct: 158 MEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 214
Query: 215 LAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
            APE     + +  SDV+SFGV+L E+ +
Sbjct: 215 YAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 118/236 (50%), Gaps = 10/236 (4%)
Query: 33  SYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTI-VAVKVLSVESKQGEKEFMSEVAS 91
           +Y++ ++        +K+G G +G VY+G  +  ++ VAVK L  ++ + E EF+ E A 
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 67
Query: 92  MANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
           M  +   H NLV+L G C   P   ++ ++M   +L   L   E  R +        +  
Sbjct: 68  MKEIK--HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMAT 123
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT 211
            I   + Y+ ++   + +HRD+   N L+ +N   K++DFGLS+L   +T          
Sbjct: 124 QISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFP 180
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE-YHLVDKAWGM 266
           + + APE     + + KSDV++FGVLL EI +   +    + L + Y L++K + M
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 236

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 87/308 (28%), Positives = 136/308 (44%), Gaps = 54/308 (17%)
Query: 42  NGFRWSNKIGEGGFGSVYKGR------LQDGTIVAVKVLSVE-SKQGEKEFMSEVASMAN 94
           N   +   IGEG FG V++ R       +  T+VAVK+L  E S   + +F  E A MA 
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 95  VNVCHENLVKLHGGCIDGPCRILVYDYM-------------PNN--SLSQTLLGEEKRRA 139
            +  + N+VKL G C  G    L+++YM             P+   SLS + L    R +
Sbjct: 107 FD--NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 164
Query: 140 KFG-----WKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 194
             G        +  I   +  G+AY+ E      VHRD+ T N L+ +N   KI+DFGLS
Sbjct: 165 SPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLS 221
Query: 195 K-LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253
           + ++  +        A  + ++ PE     R T +SDV+++GV+L EI        F   
Sbjct: 222 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI--------FSYG 273
Query: 254 LGEYHLVDKAWGMYNSKELMNLVDPMLYGNF---PENEAIRFLKVGLLCVQEKSKLRPQM 310
           L  Y+      GM + + +  + D    GN    PEN  +    +  LC  +    RP  
Sbjct: 274 LQPYY------GMAHEEVIYYVRD----GNILACPENCPLELYNLMRLCWSKLPADRPSF 323
Query: 311 STAIKMMN 318
            +  +++ 
Sbjct: 324 CSIHRILQ 331

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 108/209 (51%), Gaps = 17/209 (8%)
Query: 44  FRWSNKIGEGGFGSVYKGR---LQD--GTIVAVKVLSVESKQGEKEFMSEVASMANVNVC 98
            ++  ++G+G FGSV   R   LQD  G +VAVK L   +++  ++F  E+  + ++   
Sbjct: 11  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-- 68
Query: 99  HENLVKLHGGCIDGPCR--ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRG 156
           H+N+VK  G C     R   L+ +Y+P  SL   L   +K + +       +    I +G
Sbjct: 69  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKG 125
Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG--TLGY 214
           + Y+  +     +HRD+ T NIL++     KI DFGL+K+ P++      +  G   + +
Sbjct: 126 MEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 182
Query: 215 LAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
            APE     + +  SDV+SFGV+L E+ +
Sbjct: 183 YAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 118/236 (50%), Gaps = 10/236 (4%)
Query: 33  SYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTI-VAVKVLSVESKQGEKEFMSEVAS 91
           +Y++ ++        +K+G G +G VY+G  +  ++ VAVK L  ++ + E EF+ E A 
Sbjct: 5   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 63
Query: 92  MANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
           M  +   H NLV+L G C   P   ++ ++M   +L   L   E  R +        +  
Sbjct: 64  MKEIK--HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMAT 119
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT 211
            I   + Y+ ++   + +HRD+   N L+ +N   K++DFGLS+L   +T          
Sbjct: 120 QISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFP 176
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE-YHLVDKAWGM 266
           + + APE     + + KSDV++FGVLL EI +   +    + L + Y L++K + M
Sbjct: 177 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 232

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 108/209 (51%), Gaps = 17/209 (8%)
Query: 44  FRWSNKIGEGGFGSVYKGR---LQD--GTIVAVKVLSVESKQGEKEFMSEVASMANVNVC 98
            ++  ++G+G FGSV   R   LQD  G +VAVK L   +++  ++F  E+  + ++   
Sbjct: 12  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-- 69
Query: 99  HENLVKLHGGCIDGPCR--ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRG 156
           H+N+VK  G C     R   L+ +Y+P  SL   L   +K + +       +    I +G
Sbjct: 70  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKG 126
Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG--TLGY 214
           + Y+  +     +HRD+ T NIL++     KI DFGL+K+ P++      +  G   + +
Sbjct: 127 MEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 183
Query: 215 LAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
            APE     + +  SDV+SFGV+L E+ +
Sbjct: 184 YAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 108/209 (51%), Gaps = 17/209 (8%)
Query: 44  FRWSNKIGEGGFGSVYKGR---LQD--GTIVAVKVLSVESKQGEKEFMSEVASMANVNVC 98
            ++  ++G+G FGSV   R   LQD  G +VAVK L   +++  ++F  E+  + ++   
Sbjct: 10  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-- 67
Query: 99  HENLVKLHGGCIDGPCR--ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRG 156
           H+N+VK  G C     R   L+ +Y+P  SL   L   +K + +       +    I +G
Sbjct: 68  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKG 124
Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG--TLGY 214
           + Y+  +     +HRD+ T NIL++     KI DFGL+K+ P++      +  G   + +
Sbjct: 125 MEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 181
Query: 215 LAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
            APE     + +  SDV+SFGV+L E+ +
Sbjct: 182 YAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 108/209 (51%), Gaps = 17/209 (8%)
Query: 44  FRWSNKIGEGGFGSVYKGR---LQD--GTIVAVKVLSVESKQGEKEFMSEVASMANVNVC 98
            ++  ++G+G FGSV   R   LQD  G +VAVK L   +++  ++F  E+  + ++   
Sbjct: 15  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-- 72
Query: 99  HENLVKLHGGCIDGPCR--ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRG 156
           H+N+VK  G C     R   L+ +Y+P  SL   L   +K + +       +    I +G
Sbjct: 73  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKG 129
Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG--TLGY 214
           + Y+  +     +HRD+ T NIL++     KI DFGL+K+ P++      +  G   + +
Sbjct: 130 MEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 186
Query: 215 LAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
            APE     + +  SDV+SFGV+L E+ +
Sbjct: 187 YAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 118/236 (50%), Gaps = 10/236 (4%)
Query: 33  SYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTI-VAVKVLSVESKQGEKEFMSEVAS 91
           +Y++ ++        +K+G G +G VY+G  +  ++ VAVK L  ++ + E EF+ E A 
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 62
Query: 92  MANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
           M  +   H NLV+L G C   P   ++ ++M   +L   L   E  R +        +  
Sbjct: 63  MKEIK--HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL--RECNRQEVSAVVLLYMAT 118
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT 211
            I   + Y+ ++   + +HRD+   N L+ +N   K++DFGLS+L   +T          
Sbjct: 119 QISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 175
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE-YHLVDKAWGM 266
           + + APE     + + KSDV++FGVLL EI +   +    + L + Y L++K + M
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 231

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 108/209 (51%), Gaps = 17/209 (8%)
Query: 44  FRWSNKIGEGGFGSVYKGR---LQD--GTIVAVKVLSVESKQGEKEFMSEVASMANVNVC 98
            ++  ++G+G FGSV   R   LQD  G +VAVK L   +++  ++F  E+  + ++   
Sbjct: 17  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-- 74
Query: 99  HENLVKLHGGCIDGPCR--ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRG 156
           H+N+VK  G C     R   L+ +Y+P  SL   L   +K + +       +    I +G
Sbjct: 75  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKG 131
Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG--TLGY 214
           + Y+  +     +HRD+ T NIL++     KI DFGL+K+ P++      +  G   + +
Sbjct: 132 MEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 188
Query: 215 LAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
            APE     + +  SDV+SFGV+L E+ +
Sbjct: 189 YAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 108/209 (51%), Gaps = 17/209 (8%)
Query: 44  FRWSNKIGEGGFGSVYKGR---LQD--GTIVAVKVLSVESKQGEKEFMSEVASMANVNVC 98
            ++  ++G+G FGSV   R   LQD  G +VAVK L   +++  ++F  E+  + ++   
Sbjct: 18  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-- 75
Query: 99  HENLVKLHGGCIDGPCR--ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRG 156
           H+N+VK  G C     R   L+ +Y+P  SL   L   +K + +       +    I +G
Sbjct: 76  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKG 132
Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG--TLGY 214
           + Y+  +     +HRD+ T NIL++     KI DFGL+K+ P++      +  G   + +
Sbjct: 133 MEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 189
Query: 215 LAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
            APE     + +  SDV+SFGV+L E+ +
Sbjct: 190 YAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 108/209 (51%), Gaps = 17/209 (8%)
Query: 44  FRWSNKIGEGGFGSVYKGR---LQD--GTIVAVKVLSVESKQGEKEFMSEVASMANVNVC 98
            ++  ++G+G FGSV   R   LQD  G +VAVK L   +++  ++F  E+  + ++   
Sbjct: 12  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-- 69
Query: 99  HENLVKLHGGCIDGPCR--ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRG 156
           H+N+VK  G C     R   L+ +Y+P  SL   L   +K + +       +    I +G
Sbjct: 70  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKG 126
Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG--TLGY 214
           + Y+  +     +HRD+ T NIL++     KI DFGL+K+ P++      +  G   + +
Sbjct: 127 MEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 183
Query: 215 LAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
            APE     + +  SDV+SFGV+L E+ +
Sbjct: 184 YAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 108/209 (51%), Gaps = 17/209 (8%)
Query: 44  FRWSNKIGEGGFGSVYKGR---LQD--GTIVAVKVLSVESKQGEKEFMSEVASMANVNVC 98
            ++  ++G+G FGSV   R   LQD  G +VAVK L   +++  ++F  E+  + ++   
Sbjct: 16  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-- 73
Query: 99  HENLVKLHGGCIDGPCR--ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRG 156
           H+N+VK  G C     R   L+ +Y+P  SL   L   +K + +       +    I +G
Sbjct: 74  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKG 130
Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG--TLGY 214
           + Y+  +     +HRD+ T NIL++     KI DFGL+K+ P++      +  G   + +
Sbjct: 131 MEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 187
Query: 215 LAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
            APE     + +  SDV+SFGV+L E+ +
Sbjct: 188 YAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 118/236 (50%), Gaps = 10/236 (4%)
Query: 33  SYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTI-VAVKVLSVESKQGEKEFMSEVAS 91
           +Y++ ++        +K+G G +G VY+G  +  ++ VAVK L  ++ + E EF+ E A 
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 62
Query: 92  MANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
           M  +   H NLV+L G C   P   ++ ++M   +L   L   E  R +        +  
Sbjct: 63  MKEIK--HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL--RECNRQEVSAVVLLYMAT 118
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT 211
            I   + Y+ ++   + +HRD+   N L+ +N   K++DFGLS+L   +T          
Sbjct: 119 QISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 175
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE-YHLVDKAWGM 266
           + + APE     + + KSDV++FGVLL EI +   +    + L + Y L++K + M
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 231

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 118/236 (50%), Gaps = 10/236 (4%)
Query: 33  SYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTI-VAVKVLSVESKQGEKEFMSEVAS 91
           +Y++ ++        +K+G G +G VY+G  +  ++ VAVK L  ++ + E EF+ E A 
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 67
Query: 92  MANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
           M  +   H NLV+L G C   P   ++ ++M   +L   L   E  R +        +  
Sbjct: 68  MKEIK--HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL--RECNRQEVNAVVLLYMAT 123
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT 211
            I   + Y+ ++   + +HRD+   N L+ +N   K++DFGLS+L   +T          
Sbjct: 124 QISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 180
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE-YHLVDKAWGM 266
           + + APE     + + KSDV++FGVLL EI +   +    + L + Y L++K + M
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 236

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 118/236 (50%), Gaps = 10/236 (4%)
Query: 33  SYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTI-VAVKVLSVESKQGEKEFMSEVAS 91
           +Y++ ++        +K+G G +G VY+G  +  ++ VAVK L  ++ + E EF+ E A 
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 64
Query: 92  MANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
           M  +   H NLV+L G C   P   ++ ++M   +L   L   E  R +        +  
Sbjct: 65  MKEIK--HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMAT 120
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT 211
            I   + Y+ ++   + +HRD+   N L+ +N   K++DFGLS+L   +T          
Sbjct: 121 QISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFP 177
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE-YHLVDKAWGM 266
           + + APE     + + KSDV++FGVLL EI +   +    + L + Y L++K + M
Sbjct: 178 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 233

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 118/236 (50%), Gaps = 10/236 (4%)
Query: 33  SYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTI-VAVKVLSVESKQGEKEFMSEVAS 91
           +Y++ ++        +K+G G +G VY+G  +  ++ VAVK L  ++ + E EF+ E A 
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 67
Query: 92  MANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
           M  +   H NLV+L G C   P   ++ ++M   +L   L   E  R +        +  
Sbjct: 68  MKEIK--HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMAT 123
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT 211
            I   + Y+ ++   + +HRD+   N L+ +N   K++DFGLS+L   +T          
Sbjct: 124 QISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 180
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE-YHLVDKAWGM 266
           + + APE     + + KSDV++FGVLL EI +   +    + L + Y L++K + M
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 236

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/276 (26%), Positives = 129/276 (46%), Gaps = 30/276 (10%)
Query: 50  IGEGGFGSVYKGRLQ----DGTIVAVKVLSV-ESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V  GRL+        VA+K L V  +++  ++F+ E + M   +  H N+++
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD--HPNIIR 110
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L G        ++V +YM N SL   L    K  A+F       ++ GI  G+ Y+ +  
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSDM- 166
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG--YLAPEYAIS 222
               VHRD+   NIL++ N   K+SDFGL+++  ++     T   G +   + +PE    
Sbjct: 167 --GYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 223 GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYG 282
            + T  SDV+S+G++L E++S           GE       W M N ++++  VD     
Sbjct: 225 RKFTSASDVWSYGIVLWEVMS----------YGER----PYWEMSN-QDVIKAVDEGYRL 269
Query: 283 NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN 318
             P +      ++ L C Q+    RP+    + +++
Sbjct: 270 PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 108/209 (51%), Gaps = 17/209 (8%)
Query: 44  FRWSNKIGEGGFGSVYKGR---LQD--GTIVAVKVLSVESKQGEKEFMSEVASMANVNVC 98
            ++  ++G+G FGSV   R   LQD  G +VAVK L   +++  ++F  E+  + ++   
Sbjct: 19  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-- 76
Query: 99  HENLVKLHGGCIDGPCR--ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRG 156
           H+N+VK  G C     R   L+ +Y+P  SL   L   +K + +       +    I +G
Sbjct: 77  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKG 133
Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG--TLGY 214
           + Y+  +     +HRD+ T NIL++     KI DFGL+K+ P++      +  G   + +
Sbjct: 134 MEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 190
Query: 215 LAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
            APE     + +  SDV+SFGV+L E+ +
Sbjct: 191 YAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 118/236 (50%), Gaps = 10/236 (4%)
Query: 33  SYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTI-VAVKVLSVESKQGEKEFMSEVAS 91
           +Y++ ++        +K+G G +G VY+G  +  ++ VAVK L  ++ + E EF+ E A 
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 67
Query: 92  MANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
           M  +   H NLV+L G C   P   ++ ++M   +L   L   E  R +        +  
Sbjct: 68  MKEIK--HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMAT 123
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT 211
            I   + Y+ ++   + +HRD+   N L+ +N   K++DFGLS+L   +T          
Sbjct: 124 QISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 180
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE-YHLVDKAWGM 266
           + + APE     + + KSDV++FGVLL EI +   +    + L + Y L++K + M
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 236

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 118/236 (50%), Gaps = 10/236 (4%)
Query: 33  SYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTI-VAVKVLSVESKQGEKEFMSEVAS 91
           +Y++ ++        +K+G G +G VY+G  +  ++ VAVK L  ++ + E EF+ E A 
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 62
Query: 92  MANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
           M  +   H NLV+L G C   P   ++ ++M   +L   L   E  R +        +  
Sbjct: 63  MKEIK--HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMAT 118
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT 211
            I   + Y+ ++   + +HRD+   N L+ +N   K++DFGLS+L   +T          
Sbjct: 119 QISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 175
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE-YHLVDKAWGM 266
           + + APE     + + KSDV++FGVLL EI +   +    + L + Y L++K + M
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 231

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 118/236 (50%), Gaps = 10/236 (4%)
Query: 33  SYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTI-VAVKVLSVESKQGEKEFMSEVAS 91
           +Y++ ++        +K+G G +G VY+G  +  ++ VAVK L  ++ + E EF+ E A 
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 62
Query: 92  MANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
           M  +   H NLV+L G C   P   ++ ++M   +L   L   E  R +        +  
Sbjct: 63  MKEIK--HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMAT 118
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT 211
            I   + Y+ ++   + +HRD+   N L+ +N   K++DFGLS+L   +T          
Sbjct: 119 QISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 175
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE-YHLVDKAWGM 266
           + + APE     + + KSDV++FGVLL EI +   +    + L + Y L++K + M
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 231

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 118/236 (50%), Gaps = 10/236 (4%)
Query: 33  SYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTI-VAVKVLSVESKQGEKEFMSEVAS 91
           +Y++ ++        +K+G G +G VY+G  +  ++ VAVK L  ++ + E EF+ E A 
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 62
Query: 92  MANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
           M  +   H NLV+L G C   P   ++ ++M   +L   L   E  R +        +  
Sbjct: 63  MKEIK--HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMAT 118
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT 211
            I   + Y+ ++   + +HRD+   N L+ +N   K++DFGLS+L   +T          
Sbjct: 119 QISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 175
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE-YHLVDKAWGM 266
           + + APE     + + KSDV++FGVLL EI +   +    + L + Y L++K + M
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 231

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 118/236 (50%), Gaps = 10/236 (4%)
Query: 33  SYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTI-VAVKVLSVESKQGEKEFMSEVAS 91
           +Y++ ++        +K+G G +G VY+G  +  ++ VAVK L  ++ + E EF+ E A 
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 62
Query: 92  MANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
           M  +   H NLV+L G C   P   ++ ++M   +L   L   E  R +        +  
Sbjct: 63  MKEIK--HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMAT 118
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT 211
            I   + Y+ ++   + +HRD+   N L+ +N   K++DFGLS+L   +T          
Sbjct: 119 QISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 175
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE-YHLVDKAWGM 266
           + + APE     + + KSDV++FGVLL EI +   +    + L + Y L++K + M
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 231

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 118/236 (50%), Gaps = 10/236 (4%)
Query: 33  SYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTI-VAVKVLSVESKQGEKEFMSEVAS 91
           +Y++ ++        +K+G G +G VY+G  +  ++ VAVK L  ++ + E EF+ E A 
Sbjct: 8   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 66
Query: 92  MANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
           M  +   H NLV+L G C   P   ++ ++M   +L   L   E  R +        +  
Sbjct: 67  MKEIK--HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMAT 122
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT 211
            I   + Y+ ++   + +HRD+   N L+ +N   K++DFGLS+L   +T          
Sbjct: 123 QISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 179
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE-YHLVDKAWGM 266
           + + APE     + + KSDV++FGVLL EI +   +    + L + Y L++K + M
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 235

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 118/236 (50%), Gaps = 10/236 (4%)
Query: 33  SYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTI-VAVKVLSVESKQGEKEFMSEVAS 91
           +Y++ ++        +K+G G +G VY+G  +  ++ VAVK L  ++ + E EF+ E A 
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 64
Query: 92  MANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
           M  +   H NLV+L G C   P   ++ ++M   +L   L   E  R +        +  
Sbjct: 65  MKEIK--HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMAT 120
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT 211
            I   + Y+ ++   + +HRD+   N L+ +N   K++DFGLS+L   +T          
Sbjct: 121 QISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 177
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE-YHLVDKAWGM 266
           + + APE     + + KSDV++FGVLL EI +   +    + L + Y L++K + M
Sbjct: 178 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 233

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 118/236 (50%), Gaps = 10/236 (4%)
Query: 33  SYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTI-VAVKVLSVESKQGEKEFMSEVAS 91
           +Y++ ++        +K+G G +G VY+G  +  ++ VAVK L  ++ + E EF+ E A 
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 67
Query: 92  MANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
           M  +   H NLV+L G C   P   ++ ++M   +L   L   E  R +        +  
Sbjct: 68  MKEIK--HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMAT 123
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT 211
            I   + Y+ ++   + +HRD+   N L+ +N   K++DFGLS+L   +T          
Sbjct: 124 QISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 180
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE-YHLVDKAWGM 266
           + + APE     + + KSDV++FGVLL EI +   +    + L + Y L++K + M
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 236

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 118/236 (50%), Gaps = 10/236 (4%)
Query: 33  SYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTI-VAVKVLSVESKQGEKEFMSEVAS 91
           +Y++ ++        +K+G G +G VY+G  +  ++ VAVK L  ++ + E EF+ E A 
Sbjct: 17  NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 75
Query: 92  MANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
           M  +   H NLV+L G C   P   ++ ++M   +L   L   E  R +        +  
Sbjct: 76  MKEIK--HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMAT 131
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT 211
            I   + Y+ ++   + +HRD+   N L+ +N   K++DFGLS+L   +T          
Sbjct: 132 QISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 188
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE-YHLVDKAWGM 266
           + + APE     + + KSDV++FGVLL EI +   +    + L + Y L++K + M
Sbjct: 189 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 244

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/271 (30%), Positives = 122/271 (45%), Gaps = 46/271 (16%)
Query: 49  KIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC----HENLVK 104
           ++G G  G V+ G     T VAVK L    KQG    MS  A +A  N+     H+ LV+
Sbjct: 20  RLGAGQAGEVWMGYYNGHTKVAVKSL----KQGS---MSPDAFLAEANLMKQLQHQRLVR 72
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L+      P  I+  +YM N SL   L  +     K       ++   I  G+A+I E  
Sbjct: 73  LYAVVTQEPIYIIT-EYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER- 128
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
             + +HRD++ +NIL+    + KI+DFGL++L  +            + + APE    G 
Sbjct: 129 --NYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGT 186
Query: 225 LTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNL------VD 277
            T KSDV+SFG+LL EIV+ GR                   GM N + + NL      V 
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYP---------------GMTNPEVIQNLERGYRMVR 231
Query: 278 PMLYGNFPENEAIRFLKVGLLCVQEKSKLRP 308
           P    N PE       ++  LC +E+ + RP
Sbjct: 232 P---DNCPEE----LYQLMRLCWKERPEDRP 255

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 118/236 (50%), Gaps = 10/236 (4%)
Query: 33  SYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTI-VAVKVLSVESKQGEKEFMSEVAS 91
           +Y++ ++        +K+G G +G VY+G  +  ++ VAVK L  ++ + E EF+ E A 
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 64
Query: 92  MANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
           M  +   H NLV+L G C   P   ++ ++M   +L   L   E  R +        +  
Sbjct: 65  MKEIK--HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMAT 120
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT 211
            I   + Y+ ++   + +HRD+   N L+ +N   K++DFGLS+L   +T          
Sbjct: 121 QISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 177
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE-YHLVDKAWGM 266
           + + APE     + + KSDV++FGVLL EI +   +    + L + Y L++K + M
Sbjct: 178 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 233

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 101/197 (51%), Gaps = 9/197 (4%)
Query: 48  NKIGEGGFGSVYKGRLQDGTI-VAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLH 106
           +K+G G FG VY+G  +  ++ VAVK L  ++ + E EF+ E A M  +   H NLV+L 
Sbjct: 17  HKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK--HPNLVQLL 73
Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
           G C   P   ++ ++M   +L   L   E  R +        +   I   + Y+ ++   
Sbjct: 74  GVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK--- 128
Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLT 226
           + +HRD+   N L+ +N   K++DFGLS+L   +T          + + APE     + +
Sbjct: 129 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFS 188
Query: 227 RKSDVYSFGVLLLEIVS 243
            KSDV++FGVLL EI +
Sbjct: 189 IKSDVWAFGVLLWEIAT 205

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 129/276 (46%), Gaps = 30/276 (10%)
Query: 50  IGEGGFGSVYKGRLQ----DGTIVAVKVLSV-ESKQGEKEFMSEVASMANVNVCHENLVK 104
           IG G FG V  GRL+        VA+K L V  +++  ++F+ E + M   +  H N++ 
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFD--HPNIIH 87
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L G        ++V +YM N SL   L   +K   +F       ++ GI  G+ Y+ +  
Sbjct: 88  LEGVVTKSKPVMIVTEYMENGSLDTFL---KKNDGQFTVIQLVGMLRGISAGMKYLSDM- 143
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG--YLAPEYAIS 222
               VHRD+   NIL++ N   K+SDFGLS++  ++     T   G +   + APE    
Sbjct: 144 --GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAF 201
Query: 223 GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYG 282
            + T  SDV+S+G+++ E+VS           GE       W M N ++++  V+     
Sbjct: 202 RKFTSASDVWSYGIVMWEVVS----------YGE----RPYWEMTN-QDVIKAVEEGYRL 246
Query: 283 NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN 318
             P +      ++ L C Q++   RP+    + M++
Sbjct: 247 PSPMDCPAALYQLMLDCWQKERNSRPKFDEIVNMLD 282

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 102/201 (50%), Gaps = 15/201 (7%)
Query: 50  IGEGGFGSVYKGRL----QDGTIVAVKVLSV-ESKQGEKEFMSEVASMANVNVCHENLVK 104
           IG G  G V  GRL    Q    VA+K L    +++  ++F+SE + M   +  H N+++
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD--HPNIIR 114
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L G    G   ++V +YM N SL   L   +    +F       ++ G+G G+ Y+ +  
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHD---GQFTIMQLVGMLRGVGAGMRYLSDL- 170
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG--YLAPEYAIS 222
               VHRD+   N+L+D N   K+SDFGLS++  ++     T   G +   + APE    
Sbjct: 171 --GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAF 228
Query: 223 GRLTRKSDVYSFGVLLLEIVS 243
              +  SDV+SFGV++ E+++
Sbjct: 229 RTFSSASDVWSFGVVMWEVLA 249

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 109/209 (52%), Gaps = 17/209 (8%)
Query: 44  FRWSNKIGEGGFGSVYKGR---LQD--GTIVAVKVLSVESKQGEKEFMSEVASMANVNVC 98
            ++  ++G+G FGSV   R   LQD  G +VAVK L   +++  ++F  E+  + ++   
Sbjct: 13  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-- 70
Query: 99  HENLVKLHGGCIDGPCR--ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRG 156
           H+N+VK  G C     R   L+ +Y+P  SL   L   +K + +       +    I +G
Sbjct: 71  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKG 127
Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG--TLGY 214
           + Y+  +     +HR++ T NIL++     KI DFGL+K+ P++  +   +  G   + +
Sbjct: 128 MEYLGTK---RYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFW 184
Query: 215 LAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
            APE     + +  SDV+SFGV+L E+ +
Sbjct: 185 YAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 109/209 (52%), Gaps = 17/209 (8%)
Query: 44  FRWSNKIGEGGFGSVYKGR---LQD--GTIVAVKVLSVESKQGEKEFMSEVASMANVNVC 98
            ++  ++G+G FGSV   R   LQD  G +VAVK L   +++  ++F  E+  + ++   
Sbjct: 15  LKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-- 72
Query: 99  HENLVKLHGGCIDGPCR--ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRG 156
           H+N+VK  G C     R   L+ +++P  SL + L   +K + +       +    I +G
Sbjct: 73  HDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYL---QKHKERIDHIKLLQYTSQICKG 129
Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG--TLGY 214
           + Y+  +     +HRD+ T NIL++     KI DFGL+K+ P++      +  G   + +
Sbjct: 130 MEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 186
Query: 215 LAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
            APE     + +  SDV+SFGV+L E+ +
Sbjct: 187 YAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 74/276 (26%), Positives = 128/276 (46%), Gaps = 30/276 (10%)
Query: 50  IGEGGFGSVYKGRLQ----DGTIVAVKVLSV-ESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V  GRL+        VA+K L V  +++  ++F+ E + M   +  H N+++
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD--HPNIIR 110
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L G        ++V +YM N SL   L    K  A+F       ++ GI  G+ Y+ +  
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSDM- 166
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG--YLAPEYAIS 222
               VHRD+   NIL++ N   K+SDFGL ++  ++     T   G +   + +PE    
Sbjct: 167 --GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 223 GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYG 282
            + T  SDV+S+G++L E++S           GE       W M N ++++  VD     
Sbjct: 225 RKFTSASDVWSYGIVLWEVMS----------YGER----PYWEMSN-QDVIKAVDEGYRL 269
Query: 283 NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN 318
             P +      ++ L C Q+    RP+    + +++
Sbjct: 270 PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 102/201 (50%), Gaps = 15/201 (7%)
Query: 50  IGEGGFGSVYKGRL----QDGTIVAVKVLSV-ESKQGEKEFMSEVASMANVNVCHENLVK 104
           IG G  G V  GRL    Q    VA+K L    +++  ++F+SE + M   +  H N+++
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD--HPNIIR 114
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L G    G   ++V +YM N SL   L   +    +F       ++ G+G G+ Y+ +  
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHD---GQFTIMQLVGMLRGVGAGMRYLSDL- 170
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG--YLAPEYAIS 222
               VHRD+   N+L+D N   K+SDFGLS++  ++     T   G +   + APE    
Sbjct: 171 --GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF 228
Query: 223 GRLTRKSDVYSFGVLLLEIVS 243
              +  SDV+SFGV++ E+++
Sbjct: 229 RTFSSASDVWSFGVVMWEVLA 249

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 103/201 (51%), Gaps = 15/201 (7%)
Query: 50  IGEGGFGSVYKGRLQ----DGTIVAVKVLSV-ESKQGEKEFMSEVASMANVNVCHENLVK 104
           IG G FG V  GRL+        VA+K L V  +++  ++F+ E + M   +  H N+V 
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFD--HPNVVH 108
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L G    G   ++V ++M N +L   L    K   +F       ++ GI  G+ Y+ +  
Sbjct: 109 LEGVVTRGKPVMIVIEFMENGALDAFL---RKHDGQFTVIQLVGMLRGIAAGMRYLADM- 164
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG--YLAPEYAIS 222
               VHRD+   NIL++ N   K+SDFGLS++  ++   + T   G +   + APE    
Sbjct: 165 --GYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQY 222
Query: 223 GRLTRKSDVYSFGVLLLEIVS 243
            + T  SDV+S+G+++ E++S
Sbjct: 223 RKFTSASDVWSYGIVMWEVMS 243

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 106/229 (46%), Gaps = 15/229 (6%)
Query: 35  NQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMAN 94
           +  +I     +   ++G G FG V+ G   + T VAVK L        + F+ E   M  
Sbjct: 6   DAWEIPRESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKT 64
Query: 95  VNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIG 154
           +   H+ LV+L+          ++ +YM   SL   L  +E  +         +    I 
Sbjct: 65  LQ--HDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIA 120
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY 214
            G+AYI  +   + +HRD++ +N+L+ ++   KI+DFGL+++  +N           + +
Sbjct: 121 EGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKW 177
Query: 215 LAPEYAISGRLTRKSDVYSFGVLLLEIVS-------GRTAVDFDVQLGE 256
            APE    G  T KSDV+SFG+LL EIV+       GRT  D    L +
Sbjct: 178 TAPEAINFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQ 226

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 101/197 (51%), Gaps = 9/197 (4%)
Query: 48  NKIGEGGFGSVYKGRLQDGTI-VAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLH 106
           +K+G G +G VY+G  +  ++ VAVK L  ++ + E EF+ E A M  +   H NLV+L 
Sbjct: 17  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK--HPNLVQLL 73
Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
           G C   P   ++ ++M   +L   L   E  R +        +   I   + Y+ ++   
Sbjct: 74  GVCTREPPFYIIIEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK--- 128
Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLT 226
           + +HRD+   N L+ +N   K++DFGLS+L   +T          + + APE     + +
Sbjct: 129 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFS 188
Query: 227 RKSDVYSFGVLLLEIVS 243
            KSDV++FGVLL EI +
Sbjct: 189 IKSDVWAFGVLLWEIAT 205

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 74/276 (26%), Positives = 128/276 (46%), Gaps = 30/276 (10%)
Query: 50  IGEGGFGSVYKGRLQ----DGTIVAVKVLSV-ESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V  GRL+        VA+K L V  +++  ++F+ E + M   +  H N+++
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD--HPNIIR 110
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L G        ++V + M N SL   L    K  A+F       ++ GI  G+ Y+ +  
Sbjct: 111 LEGVVTKSKPVMIVTEXMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSDM- 166
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG--YLAPEYAIS 222
               VHRD+   NIL++ N   K+SDFGLS++  ++     T   G +   + +PE    
Sbjct: 167 --GAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 223 GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYG 282
            + T  SDV+S+G++L E++S           GE       W M N ++++  VD     
Sbjct: 225 RKFTSASDVWSYGIVLWEVMS----------YGER----PYWEMSN-QDVIKAVDEGYRL 269
Query: 283 NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN 318
             P +      ++ L C Q+    RP+    + +++
Sbjct: 270 PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 105/212 (49%), Gaps = 13/212 (6%)
Query: 34  YNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMA 93
           Y   +I      +  ++G G FG V  G+ +    VA+K++  E    E EF+ E   M 
Sbjct: 16  YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMM 74
Query: 94  NVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGI 153
           N++  HE LV+L+G C       ++ +YM N  L   L    + R +F  +   E+   +
Sbjct: 75  NLS--HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDV 129
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGT 211
              + Y+  +     +HRD+   N L++     K+SDFGLS+  L  E T+ + ++    
Sbjct: 130 CEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFP-- 184
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
           + +  PE  +  + + KSD+++FGVL+ EI S
Sbjct: 185 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 101/210 (48%), Gaps = 9/210 (4%)
Query: 34  YNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMA 93
           Y   +I      +  ++G G FG V  G+ +    VA+K++  E    E EF+ E   M 
Sbjct: 7   YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMM 65
Query: 94  NVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGI 153
           N++  HE LV+L+G C       ++ +YM N  L   L    + R +F  +   E+   +
Sbjct: 66  NLS--HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDV 120
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
              + Y+  +     +HRD+   N L++     K+SDFGLS+   ++    S      + 
Sbjct: 121 CEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR 177
Query: 214 YLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
           +  PE  +  + + KSD+++FGVL+ EI S
Sbjct: 178 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 207

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 74/276 (26%), Positives = 128/276 (46%), Gaps = 30/276 (10%)
Query: 50  IGEGGFGSVYKGRLQ----DGTIVAVKVLSV-ESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V  GRL+        VA+K L V  +++  ++F+ E + M   +  H N+++
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD--HPNIIR 81
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L G        ++V + M N SL   L    K  A+F       ++ GI  G+ Y+ +  
Sbjct: 82  LEGVVTKSKPVMIVTEXMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSDM- 137
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG--YLAPEYAIS 222
               VHRD+   NIL++ N   K+SDFGLS++  ++     T   G +   + +PE    
Sbjct: 138 --GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 195
Query: 223 GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYG 282
            + T  SDV+S+G++L E++S           GE       W M N ++++  VD     
Sbjct: 196 RKFTSASDVWSYGIVLWEVMS----------YGERPY----WEMSN-QDVIKAVDEGYRL 240
Query: 283 NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN 318
             P +      ++ L C Q+    RP+    + +++
Sbjct: 241 PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 276

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 71/237 (29%), Positives = 112/237 (47%), Gaps = 18/237 (7%)
Query: 31  AFSYNQLKIATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVL---SVESKQGEKEFM 86
           A    + + A   F     +G+G FG+VY  R  Q   I+A+KVL    +E    E +  
Sbjct: 2   AMESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 61
Query: 87  SEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKAR 146
            EV   +++   H N+++L+G   D     L+ +Y P   + + L    ++ +KF  +  
Sbjct: 62  REVEIQSHLR--HPNILRLYGYFHDATRVYLILEYAPRGEVYKEL----QKLSKFDEQRT 115
Query: 147 REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIST 206
              I  +   L+Y H +    V+HRDIK  N+LL      KI+DFG S   P +     T
Sbjct: 116 ATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RT 169
Query: 207 RVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDK 262
            + GTL YL PE  I GR+   K D++S GVL  E + G+   + +     Y  + +
Sbjct: 170 TLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR 225

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 106/209 (50%), Gaps = 17/209 (8%)
Query: 44  FRWSNKIGEGGFGSVYKGR---LQD--GTIVAVKVLSVESKQGEKEFMSEVASMANVNVC 98
            ++  ++G+G FGSV   R   LQD  G +VAVK L   +++  ++F  E+  + ++   
Sbjct: 15  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-- 72
Query: 99  HENLVKLHGGCIDGPCR--ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRG 156
           H+N+VK  G C     R   L+ +Y+P  SL   L    +R          +    I +G
Sbjct: 73  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKL---LQYTSQICKG 129
Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG--TLGY 214
           + Y+  +     +HRD+ T NIL++     KI DFGL+K+ P++      +  G   + +
Sbjct: 130 MEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 186
Query: 215 LAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
            APE     + +  SDV+SFGV+L E+ +
Sbjct: 187 YAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 132/278 (47%), Gaps = 32/278 (11%)
Query: 50  IGEGGFGSVYKGRLQ----DGTIVAVKVLSV-ESKQGEKEFMSEVASMANVNVCHENLVK 104
           IG G FG V +GRL+      + VA+K L    +++  +EF+SE + M      H N+++
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFE--HPNIIR 79
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L G   +    +++ ++M N +L   L   +    +F       ++ GI  G+ Y+ E  
Sbjct: 80  LEGVVTNSMPVMILTEFMENGALDSFLRLND---GQFTVIQLVGMLRGIASGMRYLAEM- 135
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH--ISTRVAGTLG--YLAPEYA 220
               VHRD+   NIL++ N   K+SDFGLS+   EN++    ++ + G +   + APE  
Sbjct: 136 --SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAI 193
Query: 221 ISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPML 280
              + T  SD +S+G+++ E++S           GE       W M N ++++N ++   
Sbjct: 194 AFRKFTSASDAWSYGIVMWEVMS----------FGERPY----WDMSN-QDVINAIEQDY 238
Query: 281 YGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN 318
               P +      ++ L C Q+    RP+    +  ++
Sbjct: 239 RLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALD 276

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 101/210 (48%), Gaps = 9/210 (4%)
Query: 34  YNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMA 93
           Y   +I      +  ++G G FG V  G+ +    VA+K++  E    E EF+ E   M 
Sbjct: 16  YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMM 74
Query: 94  NVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGI 153
           N++  HE LV+L+G C       ++ +YM N  L   L    + R +F  +   E+   +
Sbjct: 75  NLS--HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDV 129
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
              + Y+  +     +HRD+   N L++     K+SDFGLS+   ++    S      + 
Sbjct: 130 CEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR 186
Query: 214 YLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
           +  PE  +  + + KSD+++FGVL+ EI S
Sbjct: 187 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 130/277 (46%), Gaps = 31/277 (11%)
Query: 50  IGEGGFGSVYKGRLQDGT-----IVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLV 103
           IG G FG VYKG L+  +      VA+K L     + ++ +F+ E   M   +  H N++
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS--HHNII 109
Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
           +L G        +++ +YM N +L + L    ++  +F       ++ GI  G+ Y+   
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFL---REKDGEFSVLQLVGMLRGIAAGMKYLANM 166
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG--YLAPEYAI 221
              + VHRD+   NIL++ N   K+SDFGLS++  ++     T   G +   + APE   
Sbjct: 167 ---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223
Query: 222 SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLY 281
             + T  SDV+SFG+++ E+++           GE       W + N  E+M  ++    
Sbjct: 224 YRKFTSASDVWSFGIVMWEVMT----------YGE----RPYWELSN-HEVMKAINDGFR 268
Query: 282 GNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN 318
              P +      ++ + C Q++   RP+ +  + +++
Sbjct: 269 LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILD 305

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 110/228 (48%), Gaps = 18/228 (7%)
Query: 40  ATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVL---SVESKQGEKEFMSEVASMANV 95
           A   F     +G+G FG+VY  R  Q   I+A+KVL    +E    E +   EV   +++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 96  NVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR 155
              H N+++L+G   D     L+ +Y P  ++ + L    ++ +KF  +     I  +  
Sbjct: 66  R--HPNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELAN 119
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
            L+Y H +    V+HRDIK  N+LL      KI+DFG S   P +     T + GTL YL
Sbjct: 120 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTELCGTLDYL 173
Query: 216 APEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDK 262
            PE  I GR+   K D++S GVL  E + G+   + +     Y  + +
Sbjct: 174 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR 220

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 101/212 (47%), Gaps = 25/212 (11%)
Query: 35  NQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMAN 94
           +  +I     +   K+G G FG V+       T VAVK +   S   E  F++E   M  
Sbjct: 175 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKT 233
Query: 95  VNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIG 154
           +   H+ LVKLH      P  I+  ++M   SL   L  +E  +         +    I 
Sbjct: 234 LQ--HDKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIA 288
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL---FPENTTHISTRVAGT 211
            G+A+I    Q + +HRD++ +NIL+  +   KI+DFGL+++   FP             
Sbjct: 289 EGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVGAKFP------------- 332
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
           + + APE    G  T KSDV+SFG+LL+EIV+
Sbjct: 333 IKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 364

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 101/197 (51%), Gaps = 9/197 (4%)
Query: 48  NKIGEGGFGSVYKGRLQDGTI-VAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLH 106
           +K+G G +G VY+G  +  ++ VAVK L  ++ + E EF+ E A M  +   H NLV+L 
Sbjct: 17  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK--HPNLVQLL 73
Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
           G C   P   ++ ++M   +L   L   E  R +        +   I   + Y+ ++   
Sbjct: 74  GVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK--- 128
Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLT 226
           + +HRD+   N L+ +N   K++DFGLS+L   +T          + + APE     + +
Sbjct: 129 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFS 188
Query: 227 RKSDVYSFGVLLLEIVS 243
            KSDV++FGVLL EI +
Sbjct: 189 IKSDVWAFGVLLWEIAT 205

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 74/276 (26%), Positives = 128/276 (46%), Gaps = 30/276 (10%)
Query: 50  IGEGGFGSVYKGRLQ----DGTIVAVKVLSV-ESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V  GRL+        VA+K L V  +++  ++F+ E + M   +  H N+++
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD--HPNIIR 110
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L G        ++V + M N SL   L    K  A+F       ++ GI  G+ Y+ +  
Sbjct: 111 LEGVVTKSKPVMIVTEXMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSDM- 166
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG--YLAPEYAIS 222
               VHRD+   NIL++ N   K+SDFGLS++  ++     T   G +   + +PE    
Sbjct: 167 --GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 223 GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYG 282
            + T  SDV+S+G++L E++S           GE       W M N ++++  VD     
Sbjct: 225 RKFTSASDVWSYGIVLWEVMS----------YGER----PYWEMSN-QDVIKAVDEGYRL 269
Query: 283 NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN 318
             P +      ++ L C Q+    RP+    + +++
Sbjct: 270 PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 77/257 (29%), Positives = 120/257 (46%), Gaps = 19/257 (7%)
Query: 11  PSRVSAENTIGGEQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGR-LQDGTIV 69
           P   + EN    E   K  N  S  + + A   F     +G+G FG+VY  R  Q   I+
Sbjct: 4   PLPSAPENNPEEELASKQKNEES-KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFIL 62
Query: 70  AVKVL---SVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNS 126
           A+KVL    +E    E +   EV   +++   H N+++L+G   D     L+ +Y P  +
Sbjct: 63  ALKVLFKAQLEKAGVEHQLRREVEIQSHLR--HPNILRLYGYFHDATRVYLILEYAPLGT 120
Query: 127 LSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP 186
           + + L    ++ +KF  +     I  +   L+Y H +    V+HRDIK  N+LL      
Sbjct: 121 VYREL----QKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGEL 173
Query: 187 KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGR 245
           KI+DFG S   P +     T + GTL YL PE  I GR+   K D++S GVL  E + G+
Sbjct: 174 KIADFGWSVHAPSSR---RTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGK 229
Query: 246 TAVDFDVQLGEYHLVDK 262
              + +     Y  + +
Sbjct: 230 PPFEANTYQETYKRISR 246

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/237 (29%), Positives = 113/237 (47%), Gaps = 18/237 (7%)
Query: 31  AFSYNQLKIATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVL---SVESKQGEKEFM 86
           A    + + A   F     +G+G FG+VY  R  Q   I+A+KVL    +E    E +  
Sbjct: 2   AMESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 61
Query: 87  SEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKAR 146
            EV   +++   H N+++L+G   D     L+ +Y P  ++ + L    ++ +KF  +  
Sbjct: 62  REVEIQSHLR--HPNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRT 115
Query: 147 REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIST 206
              I  +   L+Y H +    V+HRDIK  N+LL      KI+DFG S   P +     T
Sbjct: 116 ATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RT 169
Query: 207 RVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDK 262
            + GTL YL PE  I GR+   K D++S GVL  E + G+   + +     Y  + +
Sbjct: 170 TLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR 225

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 110/228 (48%), Gaps = 18/228 (7%)
Query: 40  ATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVL---SVESKQGEKEFMSEVASMANV 95
           A   F     +G+G FG+VY  R  Q   I+A+KVL    +E    E +   EV   +++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 96  NVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR 155
              H N+++L+G   D     L+ +Y P  ++ + L    ++ +KF  +     I  +  
Sbjct: 69  R--HPNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELAN 122
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
            L+Y H +    V+HRDIK  N+LL      KI+DFG S   P +     T + GTL YL
Sbjct: 123 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYL 176
Query: 216 APEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDK 262
            PE  I GR+   K D++S GVL  E + G+   + +     Y  + +
Sbjct: 177 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR 223

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/280 (26%), Positives = 131/280 (46%), Gaps = 36/280 (12%)
Query: 50  IGEGGFGSVYKGRLQ----DGTIVAVKVLSV-ESKQGEKEFMSEVASMANVNVCHENLVK 104
           IG G FG V +GRL+      + VA+K L    +++  +EF+SE + M      H N+++
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFE--HPNIIR 81
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L G   +    +++ ++M N +L   L   +    +F       ++ GI  G+ Y+ E  
Sbjct: 82  LEGVVTNSMPVMILTEFMENGALDSFLRLND---GQFTVIQLVGMLRGIASGMRYLAEM- 137
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG------YLAPE 218
               VHRD+   NIL++ N   K+SDFGLS+   EN++  +     +LG      + APE
Sbjct: 138 --SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTE--TSSLGGKIPIRWTAPE 193
Query: 219 YAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDP 278
                + T  SD +S+G+++ E++S           GE       W M N ++++N ++ 
Sbjct: 194 AIAFRKFTSASDAWSYGIVMWEVMS----------FGERPY----WDMSN-QDVINAIEQ 238
Query: 279 MLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN 318
                 P +      ++ L C Q+    RP+    +  ++
Sbjct: 239 DYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALD 278

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 110/228 (48%), Gaps = 18/228 (7%)
Query: 40  ATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVL---SVESKQGEKEFMSEVASMANV 95
           A   F     +G+G FG+VY  R  Q   I+A+KVL    +E    E +   EV   +++
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 96  NVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR 155
              H N+++L+G   D     L+ +Y P  ++ + L    ++ +KF  +     I  +  
Sbjct: 83  R--HPNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELAN 136
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
            L+Y H +    V+HRDIK  N+LL      KI+DFG S   P +     T + GTL YL
Sbjct: 137 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYL 190
Query: 216 APEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDK 262
            PE  I GR+   K D++S GVL  E + G+   + +     Y  + +
Sbjct: 191 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR 237

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 110/228 (48%), Gaps = 18/228 (7%)
Query: 40  ATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVL---SVESKQGEKEFMSEVASMANV 95
           A   F     +G+G FG+VY  R  Q   I+A+KVL    +E    E +   EV   +++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 96  NVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR 155
              H N+++L+G   D     L+ +Y P  ++ + L    ++ +KF  +     I  +  
Sbjct: 66  R--HPNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELAN 119
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
            L+Y H +    V+HRDIK  N+LL      KI+DFG S   P +     T + GTL YL
Sbjct: 120 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYL 173
Query: 216 APEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDK 262
            PE  I GR+   K D++S GVL  E + G+   + +     Y  + +
Sbjct: 174 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR 220

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 111/228 (48%), Gaps = 18/228 (7%)
Query: 40  ATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVL---SVESKQGEKEFMSEVASMANV 95
           A   F     +G+G FG+VY  R  Q   I+A+KVL    +E    E +   EV   +++
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 96  NVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR 155
              H N+++L+G   D     L+ +Y P  ++ + L    ++ +KF  +     I  +  
Sbjct: 67  R--HPNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELAN 120
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
            L+Y H +    V+HRDIK  N+LL      KI+DFG S   P +     T ++GTL YL
Sbjct: 121 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSR---RTTLSGTLDYL 174
Query: 216 APEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDK 262
            PE  I GR+   K D++S GVL  E + G+   + +     Y  + +
Sbjct: 175 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR 221

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 110/228 (48%), Gaps = 18/228 (7%)
Query: 40  ATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVL---SVESKQGEKEFMSEVASMANV 95
           A   F     +G+G FG+VY  R  Q   I+A+KVL    +E    E +   EV   +++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 96  NVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR 155
              H N+++L+G   D     L+ +Y P  ++ + L    ++ +KF  +     I  +  
Sbjct: 66  R--HPNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELAN 119
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
            L+Y H +    V+HRDIK  N+LL      KI+DFG S   P +     T + GTL YL
Sbjct: 120 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTXLCGTLDYL 173
Query: 216 APEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDK 262
            PE  I GR+   K D++S GVL  E + G+   + +     Y  + +
Sbjct: 174 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR 220

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 110/228 (48%), Gaps = 18/228 (7%)
Query: 40  ATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVL---SVESKQGEKEFMSEVASMANV 95
           A   F     +G+G FG+VY  R  Q   I+A+KVL    +E    E +   EV   +++
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 96  NVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR 155
              H N+++L+G   D     L+ +Y P  ++ + L    ++ +KF  +     I  +  
Sbjct: 67  R--HPNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELAN 120
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
            L+Y H +    V+HRDIK  N+LL      KI+DFG S   P +     T + GTL YL
Sbjct: 121 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGTLDYL 174
Query: 216 APEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDK 262
            PE  I GR+   K D++S GVL  E + G+   + +     Y  + +
Sbjct: 175 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR 221

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 110/228 (48%), Gaps = 18/228 (7%)
Query: 40  ATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVL---SVESKQGEKEFMSEVASMANV 95
           A   F     +G+G FG+VY  R  Q   I+A+KVL    +E    E +   EV   +++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 96  NVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR 155
              H N+++L+G   D     L+ +Y P  ++ + L    ++ +KF  +     I  +  
Sbjct: 66  R--HPNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELAN 119
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
            L+Y H +    V+HRDIK  N+LL      KI+DFG S   P +     T + GTL YL
Sbjct: 120 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGTLDYL 173
Query: 216 APEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDK 262
            PE  I GR+   K D++S GVL  E + G+   + +     Y  + +
Sbjct: 174 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR 220

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 110/228 (48%), Gaps = 18/228 (7%)
Query: 40  ATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVL---SVESKQGEKEFMSEVASMANV 95
           A   F     +G+G FG+VY  R  Q   I+A+KVL    +E    E +   EV   +++
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 96  NVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR 155
              H N+++L+G   D     L+ +Y P  ++ + L    ++ +KF  +     I  +  
Sbjct: 65  R--HPNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELAN 118
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
            L+Y H +    V+HRDIK  N+LL      KI+DFG S   P +     T + GTL YL
Sbjct: 119 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYL 172
Query: 216 APEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDK 262
            PE  I GR+   K D++S GVL  E + G+   + +     Y  + +
Sbjct: 173 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR 219

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 106/215 (49%), Gaps = 18/215 (8%)
Query: 40  ATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVL---SVESKQGEKEFMSEVASMANV 95
           A   F     +G+G FG+VY  R  Q   I+A+KVL    +E    E +   EV   +++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 96  NVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR 155
              H N+++L+G   D     L+ +Y P  ++ + L    ++ +KF  +     I  +  
Sbjct: 69  R--HPNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELAN 122
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
            L+Y H +    V+HRDIK  N+LL      KI+DFG S   P +     T + GTL YL
Sbjct: 123 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYL 176
Query: 216 APEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVD 249
            PE  I GR+   K D++S GVL  E + G+   +
Sbjct: 177 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 105/215 (48%), Gaps = 19/215 (8%)
Query: 38  KIATNGFRWSNKIGEGGFGSVYKGRLQDGTI----VAVKVLSVESKQGE---KEFMSEVA 90
           KI    ++  +K+G GG  +VY   L + TI    VA+K + +  ++ E   K F  EV 
Sbjct: 7   KIINERYKIVDKLGGGGMSTVY---LAEDTILNIKVAIKAIFIPPREKEETLKRFEREVH 63
Query: 91  SMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 150
           + + ++  H+N+V +     +  C  LV +Y+   +LS+ +                +I+
Sbjct: 64  NSSQLS--HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQIL 121
Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG 210
            GI       H+     +VHRDIK  NIL+D N   KI DFG++K   E +   +  V G
Sbjct: 122 DGIKHA----HDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLG 174
Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
           T+ Y +PE A        +D+YS G++L E++ G 
Sbjct: 175 TVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE 209

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 110/228 (48%), Gaps = 18/228 (7%)
Query: 40  ATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVL---SVESKQGEKEFMSEVASMANV 95
           A   F     +G+G FG+VY  R  Q   I+A+KVL    +E    E +   EV   +++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 96  NVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR 155
              H N+++L+G   D     L+ +Y P  ++ + L    ++ +KF  +     I  +  
Sbjct: 66  R--HPNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELAN 119
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
            L+Y H +    V+HRDIK  N+LL      KI+DFG S   P +     T + GTL YL
Sbjct: 120 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGTLDYL 173
Query: 216 APEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDK 262
            PE  I GR+   K D++S GVL  E + G+   + +     Y  + +
Sbjct: 174 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR 220

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 110/228 (48%), Gaps = 18/228 (7%)
Query: 40  ATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVL---SVESKQGEKEFMSEVASMANV 95
           A   F     +G+G FG+VY  R  Q   I+A+KVL    +E    E +   EV   +++
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 96  NVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR 155
              H N+++L+G   D     L+ +Y P  ++ + L    ++ +KF  +     I  +  
Sbjct: 70  R--HPNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELAN 123
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
            L+Y H +    V+HRDIK  N+LL      KI+DFG S   P +     T + GTL YL
Sbjct: 124 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYL 177
Query: 216 APEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDK 262
            PE  I GR+   K D++S GVL  E + G+   + +     Y  + +
Sbjct: 178 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR 224

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 110/228 (48%), Gaps = 18/228 (7%)
Query: 40  ATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVL---SVESKQGEKEFMSEVASMANV 95
           A   F     +G+G FG+VY  R  Q   I+A+KVL    +E    E +   EV   +++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 96  NVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR 155
              H N+++L+G   D     L+ +Y P  ++ + L    ++ +KF  +     I  +  
Sbjct: 71  R--HPNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELAN 124
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
            L+Y H +    V+HRDIK  N+LL      KI+DFG S   P +     T + GTL YL
Sbjct: 125 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGTLDYL 178
Query: 216 APEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDK 262
            PE  I GR+   K D++S GVL  E + G+   + +     Y  + +
Sbjct: 179 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR 225

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 97/196 (49%), Gaps = 9/196 (4%)
Query: 48  NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
            ++G G FG V  G+ +    VA+K++  E    E EF+ E   M N++  HE LV+L+G
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLS--HEKLVQLYG 71
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
            C       ++ +YM N  L   L    + R +F  +   E+   +   + Y+  +    
Sbjct: 72  VCTKQRPIFIITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDVCEAMEYLESK---Q 125
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR 227
            +HRD+   N L++     K+SDFGLS+   ++    S      + +  PE  +  + + 
Sbjct: 126 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 185
Query: 228 KSDVYSFGVLLLEIVS 243
           KSD+++FGVL+ EI S
Sbjct: 186 KSDIWAFGVLMWEIYS 201

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 97/196 (49%), Gaps = 9/196 (4%)
Query: 48  NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
            ++G G FG V  G+ +    VA+K++  E    E EF+ E   M N++  HE LV+L+G
Sbjct: 14  KELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLS--HEKLVQLYG 70
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
            C       ++ +YM N  L   L    + R +F  +   E+   +   + Y+  +    
Sbjct: 71  VCTKQRPIFIITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDVCEAMEYLESK---Q 124
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR 227
            +HRD+   N L++     K+SDFGLS+   ++    S      + +  PE  +  + + 
Sbjct: 125 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 184
Query: 228 KSDVYSFGVLLLEIVS 243
           KSD+++FGVL+ EI S
Sbjct: 185 KSDIWAFGVLMWEIYS 200

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 97/196 (49%), Gaps = 9/196 (4%)
Query: 48  NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
            ++G G FG V  G+ +    VA+K++  E    E EF+ E   M N++  HE LV+L+G
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLS--HEKLVQLYG 66
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
            C       ++ +YM N  L   L    + R +F  +   E+   +   + Y+  +    
Sbjct: 67  VCTKQRPIFIITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDVCEAMEYLESK---Q 120
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR 227
            +HRD+   N L++     K+SDFGLS+   ++    S      + +  PE  +  + + 
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 228 KSDVYSFGVLLLEIVS 243
           KSD+++FGVL+ EI S
Sbjct: 181 KSDIWAFGVLMWEIYS 196

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 118/236 (50%), Gaps = 10/236 (4%)
Query: 33  SYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTI-VAVKVLSVESKQGEKEFMSEVAS 91
           +Y++ ++        +K+G G +G VY+G  +  ++ VAVK L  ++ + E EF+ E A 
Sbjct: 211 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 269
Query: 92  MANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
           M  +   H NLV+L G C   P   ++ ++M   +L   L   E  R +        +  
Sbjct: 270 MKEIK--HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMAT 325
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT 211
            I   + Y+ ++   + +HR++   N L+ +N   K++DFGLS+L   +T          
Sbjct: 326 QISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 382
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE-YHLVDKAWGM 266
           + + APE     + + KSDV++FGVLL EI +   +    + L + Y L++K + M
Sbjct: 383 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 438

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 97/196 (49%), Gaps = 9/196 (4%)
Query: 48  NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
            ++G G FG V  G+ +    VA+K++  E    E EF+ E   M N++  HE LV+L+G
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLS--HEKLVQLYG 71
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
            C       ++ +YM N  L   L    + R +F  +   E+   +   + Y+  +    
Sbjct: 72  VCTKQRPIFIITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDVCEAMEYLESK---Q 125
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR 227
            +HRD+   N L++     K+SDFGLS+   ++    S      + +  PE  +  + + 
Sbjct: 126 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSS 185
Query: 228 KSDVYSFGVLLLEIVS 243
           KSD+++FGVL+ EI S
Sbjct: 186 KSDIWAFGVLMWEIYS 201

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 106/215 (49%), Gaps = 18/215 (8%)
Query: 40  ATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVL---SVESKQGEKEFMSEVASMANV 95
           A   F     +G+G FG+VY  R  Q   I+A+KVL    +E    E +   EV   +++
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 96  NVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR 155
              H N+++L+G   D     L+ +Y P  ++ + L    ++ +KF  +     I  +  
Sbjct: 63  R--HPNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELAN 116
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
            L+Y H +    V+HRDIK  N+LL      KI+DFG S   P +     T + GTL YL
Sbjct: 117 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYL 170
Query: 216 APEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVD 249
            PE  I GR+   K D++S GVL  E + G+   +
Sbjct: 171 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 204

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/200 (33%), Positives = 103/200 (51%), Gaps = 18/200 (9%)
Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVL---SVESKQGEKEFMSEVASMANVNVCHENLVKL 105
           +G+G FG+VY  R  Q   I+A+KVL    +E    E +   EV   +++   H N+++L
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLR--HPNILRL 77
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
           +G   D     L+ +Y P  ++ + L    ++ ++F  +     I  +   L+Y H +  
Sbjct: 78  YGYFHDATRVYLILEYAPLGTVYREL----QKLSRFDEQRTATYITELANALSYCHSK-- 131
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL 225
             V+HRDIK  N+LL  N   KI+DFG S   P +     T + GTL YL PE  I GR+
Sbjct: 132 -RVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSR---RTTLCGTLDYLPPE-MIEGRM 186
Query: 226 -TRKSDVYSFGVLLLEIVSG 244
              K D++S GVL  E + G
Sbjct: 187 HDEKVDLWSLGVLCYEFLVG 206

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 118/236 (50%), Gaps = 10/236 (4%)
Query: 33  SYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTI-VAVKVLSVESKQGEKEFMSEVAS 91
           +Y++ ++        +K+G G +G VY+G  +  ++ VAVK L  ++ + E EF+ E A 
Sbjct: 250 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 308
Query: 92  MANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
           M  +   H NLV+L G C   P   ++ ++M   +L   L   E  R +        +  
Sbjct: 309 MKEIK--HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMAT 364
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT 211
            I   + Y+ ++   + +HR++   N L+ +N   K++DFGLS+L   +T          
Sbjct: 365 QISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 421
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE-YHLVDKAWGM 266
           + + APE     + + KSDV++FGVLL EI +   +    + L + Y L++K + M
Sbjct: 422 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 477

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 103/219 (47%), Gaps = 15/219 (6%)
Query: 38  KIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNV 97
           +I     +   K+G G FG V+ G   + T VAVK L        + F+ E   M  +  
Sbjct: 8   EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQ- 65
Query: 98  CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
            H+ LV+L+          ++ ++M   SL   L  +E    K       +    I  G+
Sbjct: 66  -HDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEG--GKVLLPKLIDFSAQIAEGM 122
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
           AYI  +   + +HRD++ +N+L+ ++   KI+DFGL+++  +N           + + AP
Sbjct: 123 AYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAP 179
Query: 218 EYAISGRLTRKSDVYSFGVLLLEIVS-------GRTAVD 249
           E    G  T KS+V+SFG+LL EIV+       GRT  D
Sbjct: 180 EAINFGCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNAD 218

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 110/204 (53%), Gaps = 17/204 (8%)
Query: 48  NKIGEGGFGSVYKGRLQDGTIVAVKVLSV--ESKQGEKEFMSEVASMANVNVCHENLVKL 105
            +IG G FG+VYKG+      VAVK+L+V   + Q  + F +EV  +      H N++ L
Sbjct: 18  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR--HVNIL-L 72
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
             G    P   +V  +   +SL   L   E    KF  K   +I     RG+ Y+H +  
Sbjct: 73  FMGYSTKPQLAIVTQWCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHAK-- 127
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE-NTTHISTRVAGTLGYLAPE---YAI 221
             ++HRD+K++NI L ++   KI DFGL+ +    + +H   +++G++ ++APE      
Sbjct: 128 -SIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 186
Query: 222 SGRLTRKSDVYSFGVLLLEIVSGR 245
           S   + +SDVY+FG++L E+++G+
Sbjct: 187 SNPYSFQSDVYAFGIVLYELMTGQ 210

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 107/212 (50%), Gaps = 23/212 (10%)
Query: 44  FRWSNKIGEGGFGSVYKGRLQD-----GTIVAVKVLSVESKQGEKEFMSEVASMANVNVC 98
            ++ +++G+G FGSV   R        G +VAVK L       +++F  E+  +  +   
Sbjct: 25  LKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL--- 81
Query: 99  HENLVKLHGGCIDGPCRI---LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG--I 153
           H + +  + G   GP R    LV +Y+P+  L   L   ++ RA+    A R ++    I
Sbjct: 82  HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL---QRHRARL--DASRLLLYSSQI 136
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG--T 211
            +G+ Y+        VHRD+   NIL++   + KI+DFGL+KL P +  +   R  G   
Sbjct: 137 CKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 193
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
           + + APE       +R+SDV+SFGV+L E+ +
Sbjct: 194 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 107/212 (50%), Gaps = 23/212 (10%)
Query: 44  FRWSNKIGEGGFGSVYKGRLQD-----GTIVAVKVLSVESKQGEKEFMSEVASMANVNVC 98
            ++ +++G+G FGSV   R        G +VAVK L       +++F  E+  +  +   
Sbjct: 12  LKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL--- 68
Query: 99  HENLVKLHGGCIDGPCRI---LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG--I 153
           H + +  + G   GP R    LV +Y+P+  L   L   ++ RA+    A R ++    I
Sbjct: 69  HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL---QRHRARL--DASRLLLYSSQI 123
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG--T 211
            +G+ Y+        VHRD+   NIL++   + KI+DFGL+KL P +  +   R  G   
Sbjct: 124 CKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 180
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
           + + APE       +R+SDV+SFGV+L E+ +
Sbjct: 181 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 107/212 (50%), Gaps = 23/212 (10%)
Query: 44  FRWSNKIGEGGFGSVYKGRLQD-----GTIVAVKVLSVESKQGEKEFMSEVASMANVNVC 98
            ++ +++G+G FGSV   R        G +VAVK L       +++F  E+  +  +   
Sbjct: 13  LKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL--- 69
Query: 99  HENLVKLHGGCIDGPCRI---LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG--I 153
           H + +  + G   GP R    LV +Y+P+  L   L   ++ RA+    A R ++    I
Sbjct: 70  HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL---QRHRARL--DASRLLLYSSQI 124
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG--T 211
            +G+ Y+        VHRD+   NIL++   + KI+DFGL+KL P +  +   R  G   
Sbjct: 125 CKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 181
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
           + + APE       +R+SDV+SFGV+L E+ +
Sbjct: 182 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 109/228 (47%), Gaps = 18/228 (7%)
Query: 40  ATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVL---SVESKQGEKEFMSEVASMANV 95
           A   F     +G+G FG+VY  R  Q   I+A+KVL    +E    E +   EV   +++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 96  NVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR 155
              H N+++L+G   D     L+ +Y P  ++ + L    ++ +KF  +     I  +  
Sbjct: 71  R--HPNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELAN 124
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
            L+Y H +    V+HRDIK  N+LL      KI+DFG S   P +     T + GTL YL
Sbjct: 125 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYL 178
Query: 216 APEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDK 262
            PE  I GR    K D++S GVL  E + G+   + +     Y  + +
Sbjct: 179 PPE-XIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR 225

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 111/237 (46%), Gaps = 18/237 (7%)
Query: 31  AFSYNQLKIATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVL---SVESKQGEKEFM 86
           A    + + A   F     +G+G FG+VY  R  Q   I+A+KVL    +E    E +  
Sbjct: 2   AMESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 61
Query: 87  SEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKAR 146
            EV   +++   H N+++L+G   D     L+ +Y P   + + L    ++ +KF  +  
Sbjct: 62  REVEIQSHLR--HPNILRLYGYFHDATRVYLILEYAPRGEVYKEL----QKLSKFDEQRT 115
Query: 147 REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIST 206
              I  +   L+Y H +    V+HRDIK  N+LL      KI+DFG S   P +      
Sbjct: 116 ATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RX 169
Query: 207 RVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDK 262
            + GTL YL PE  I GR+   K D++S GVL  E + G+   + +     Y  + +
Sbjct: 170 XLXGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR 225

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 106/212 (50%), Gaps = 23/212 (10%)
Query: 44  FRWSNKIGEGGFGSVYKGRLQD-----GTIVAVKVLSVESKQGEKEFMSEVASMANVNVC 98
            ++ +++G+G FGSV   R        G +VAVK L       +++F  E+  +  +   
Sbjct: 9   LKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL--- 65
Query: 99  HENLVKLHGGCIDGPCRI---LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG--I 153
           H + +  + G   GP R    LV +Y+P+  L   L   ++ RA+    A R ++    I
Sbjct: 66  HSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFL---QRHRARL--DASRLLLYSSQI 120
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG--T 211
            +G+ Y+        VHRD+   NIL++   + KI+DFGL+KL P +      R  G   
Sbjct: 121 CKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSP 177
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
           + + APE       +R+SDV+SFGV+L E+ +
Sbjct: 178 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 109/228 (47%), Gaps = 18/228 (7%)
Query: 40  ATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVL---SVESKQGEKEFMSEVASMANV 95
           A   F     +G+G FG+VY  R  Q   I+A+KVL    +E    E +   EV   +++
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 96  NVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR 155
              H N+++L+G   D     L+ +Y P  ++ + L    ++ +KF  +     I  +  
Sbjct: 68  R--HPNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELAN 121
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
            L+Y H +    V+HRDIK  N+LL      KI+DFG S   P +       + GTL YL
Sbjct: 122 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RXXLCGTLDYL 175
Query: 216 APEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDK 262
            PE  I GR+   K D++S GVL  E + G+   + +     Y  + +
Sbjct: 176 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR 222

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 109/204 (53%), Gaps = 17/204 (8%)
Query: 48  NKIGEGGFGSVYKGRLQDGTIVAVKVLSV--ESKQGEKEFMSEVASMANVNVCHENLVKL 105
            +IG G FG+VYKG+      VAVK+L+V   + Q  + F +EV  +      H N++ L
Sbjct: 30  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR--HVNIL-L 84
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
             G    P   +V  +   +SL   L   E    KF  K   +I     RG+ Y+H +  
Sbjct: 85  FMGYSTAPQLAIVTQWCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHAK-- 139
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE-NTTHISTRVAGTLGYLAPE---YAI 221
             ++HRD+K++NI L ++   KI DFGL+      + +H   +++G++ ++APE      
Sbjct: 140 -SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 222 SGRLTRKSDVYSFGVLLLEIVSGR 245
           S   + +SDVY+FG++L E+++G+
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 109/228 (47%), Gaps = 18/228 (7%)
Query: 40  ATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVL---SVESKQGEKEFMSEVASMANV 95
           A   F     +G+G FG+VY  R  Q   I+A+KVL    +E    E +   EV   +++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 96  NVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR 155
              H N+++L+G   D     L+ +Y P  ++ + L    ++ +KF  +     I  +  
Sbjct: 69  R--HPNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELAN 122
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
            L+Y H +    V+HRDIK  N+LL      KI+DFG S   P +       + GTL YL
Sbjct: 123 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RAALCGTLDYL 176
Query: 216 APEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDK 262
            PE  I GR+   K D++S GVL  E + G+   + +     Y  + +
Sbjct: 177 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR 223

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 110/228 (48%), Gaps = 18/228 (7%)
Query: 40  ATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVL---SVESKQGEKEFMSEVASMANV 95
           A   F     +G+G FG+VY  R  Q   I+A+KVL    +E    E +   EV   +++
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 96  NVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR 155
              H N+++L+G   D     L+ +Y P  ++ + L    ++ +KF  +     I  +  
Sbjct: 68  R--HPNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELAN 121
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
            L+Y H +    V+HRDIK  N+LL      KI++FG S   P +     T + GTL YL
Sbjct: 122 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSR---RTTLCGTLDYL 175
Query: 216 APEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDK 262
            PE  I GR+   K D++S GVL  E + G+   + +     Y  + +
Sbjct: 176 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR 222

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 109/228 (47%), Gaps = 18/228 (7%)
Query: 40  ATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVL---SVESKQGEKEFMSEVASMANV 95
           A   F     +G+G FG+VY  R  Q   I+A+KVL    +E    E +   EV   +++
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 96  NVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR 155
              H N+++L+G   D     L+ +Y P  ++ + L    ++ +KF  +     I  +  
Sbjct: 67  R--HPNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELAN 120
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
            L+Y H +    V+HRDIK  N+LL      KI+DFG S   P +       + GTL YL
Sbjct: 121 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDT---LCGTLDYL 174
Query: 216 APEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDK 262
            PE  I GR+   K D++S GVL  E + G+   + +     Y  + +
Sbjct: 175 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR 221

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 110/228 (48%), Gaps = 18/228 (7%)
Query: 40  ATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVL---SVESKQGEKEFMSEVASMANV 95
           A   F     +G+G FG+VY  R  Q   I+A+KVL    +E    E +   EV   +++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 96  NVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR 155
              H N+++L+G   D     L+ +Y P  ++ + L    ++ +KF  +     I  +  
Sbjct: 69  R--HPNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELAN 122
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
            L+Y H +    V+HRDIK  N+LL      KI++FG S   P +     T + GTL YL
Sbjct: 123 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSR---RTTLCGTLDYL 176
Query: 216 APEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDK 262
            PE  I GR+   K D++S GVL  E + G+   + +     Y  + +
Sbjct: 177 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR 223

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 105/215 (48%), Gaps = 18/215 (8%)
Query: 40  ATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVL---SVESKQGEKEFMSEVASMANV 95
           A   F     +G+G FG+VY  R  Q   I+A+KVL    +E    E +   EV   +++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 96  NVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR 155
              H N+++L+G   D     L+ +Y P  ++ + L    ++ +KF  +     I  +  
Sbjct: 69  R--HPNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELAN 122
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
            L+Y H +    V+HRDIK  N+LL      KI+DFG S   P +       + GTL YL
Sbjct: 123 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RXXLCGTLDYL 176
Query: 216 APEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVD 249
            PE  I GR+   K D++S GVL  E + G+   +
Sbjct: 177 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 105/215 (48%), Gaps = 18/215 (8%)
Query: 40  ATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVL---SVESKQGEKEFMSEVASMANV 95
           A   F     +G+G FG+VY  R  Q   I+A+KVL    +E    E +   EV   +++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 96  NVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR 155
              H N+++L+G   D     L+ +Y P  ++ + L    ++ +KF  +     I  +  
Sbjct: 66  R--HPNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELAN 119
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
            L+Y H +    V+HRDIK  N+LL      KI+DFG S   P +       + GTL YL
Sbjct: 120 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RXXLCGTLDYL 173
Query: 216 APEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVD 249
            PE  I GR+   K D++S GVL  E + G+   +
Sbjct: 174 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 76/257 (29%), Positives = 119/257 (46%), Gaps = 19/257 (7%)
Query: 11  PSRVSAENTIGGEQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGR-LQDGTIV 69
           P   + EN    E   K  N  S  + + A   F     +G+G FG+VY  R  Q   I+
Sbjct: 4   PLPSAPENNPEEELASKQKNEES-KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFIL 62
Query: 70  AVKVL---SVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNS 126
           A+KVL    +E    E +   EV   +++   H N+++L+G   D     L+ +Y P  +
Sbjct: 63  ALKVLFKAQLEKAGVEHQLRREVEIQSHLR--HPNILRLYGYFHDATRVYLILEYAPLGT 120
Query: 127 LSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP 186
           + + L    ++ +KF  +     I  +   L+Y H +    V+HRDIK  N+LL      
Sbjct: 121 VYREL----QKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGEL 173
Query: 187 KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGR 245
           KI+DFG S   P +       + GTL YL PE  I GR+   K D++S GVL  E + G+
Sbjct: 174 KIADFGWSVHAPSSR---RDDLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGK 229
Query: 246 TAVDFDVQLGEYHLVDK 262
              + +     Y  + +
Sbjct: 230 PPFEANTYQETYKRISR 246

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 105/215 (48%), Gaps = 18/215 (8%)
Query: 40  ATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVL---SVESKQGEKEFMSEVASMANV 95
           A   F     +G+G FG+VY  R  Q   I+A+KVL    +E    E +   EV   +++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 96  NVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR 155
              H N+++L+G   D     L+ +Y P  ++ + L    ++ +KF  +     I  +  
Sbjct: 66  R--HPNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELAN 119
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
            L+Y H +    V+HRDIK  N+LL      KI+DFG S   P +       + GTL YL
Sbjct: 120 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RAALCGTLDYL 173
Query: 216 APEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVD 249
            PE  I GR+   K D++S GVL  E + G+   +
Sbjct: 174 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 109/204 (53%), Gaps = 17/204 (8%)
Query: 48  NKIGEGGFGSVYKGRLQDGTIVAVKVLSV--ESKQGEKEFMSEVASMANVNVCHENLVKL 105
            +IG G FG+VYKG+      VAVK+L+V   + Q  + F +EV  +      H N++ L
Sbjct: 30  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR--HVNIL-L 84
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
             G    P   +V  +   +SL   L   E    KF  K   +I     RG+ Y+H +  
Sbjct: 85  FMGYSTKPQLAIVTQWCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHAK-- 139
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE-NTTHISTRVAGTLGYLAPE---YAI 221
             ++HRD+K++NI L ++   KI DFGL+      + +H   +++G++ ++APE      
Sbjct: 140 -SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 222 SGRLTRKSDVYSFGVLLLEIVSGR 245
           S   + +SDVY+FG++L E+++G+
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 105/215 (48%), Gaps = 18/215 (8%)
Query: 40  ATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVL---SVESKQGEKEFMSEVASMANV 95
           A   F     +G+G FG+VY  R  Q   I+A+KVL    +E    E +   EV   +++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 96  NVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR 155
              H N+++L+G   D     L+ +Y P  ++ + L    ++ +KF  +     I  +  
Sbjct: 69  R--HPNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELAN 122
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
            L+Y H +    V+HRDIK  N+LL      KI+DFG S   P +       + GTL YL
Sbjct: 123 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RDDLCGTLDYL 176
Query: 216 APEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVD 249
            PE  I GR+   K D++S GVL  E + G+   +
Sbjct: 177 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 110/228 (48%), Gaps = 18/228 (7%)
Query: 40  ATNGFRWSNKIGEGGFGSVYKGRLQDGT-IVAVKVL---SVESKQGEKEFMSEVASMANV 95
           A   F     +G+G FG+VY  R ++   I+A+KVL    +E    E +   EV   +++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 96  NVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR 155
              H N+++L+G   D     L+ +Y P  ++ + L    ++ +KF  +     I  +  
Sbjct: 66  R--HPNILRLYGYFHDSTRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELAN 119
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
            L+Y H +    V+HRDIK  N+LL      KI+DFG S   P +       + GTL YL
Sbjct: 120 ALSYCHSK---KVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RAALCGTLDYL 173
Query: 216 APEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDK 262
            PE  I GR+   K D++S GVL  E + G+   + +     Y  + +
Sbjct: 174 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISR 220

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 102/200 (51%), Gaps = 18/200 (9%)
Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVL---SVESKQGEKEFMSEVASMANVNVCHENLVKL 105
           +G+G FG+VY  R  Q   I+A+KVL    +E    E +   EV   +++   H N+++L
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLR--HPNILRL 77
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
           +G   D     L+ +Y P  ++ + L    ++ ++F  +     I  +   L+Y H +  
Sbjct: 78  YGYFHDATRVYLILEYAPLGTVYREL----QKLSRFDEQRTATYITELANALSYCHSK-- 131
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL 225
             V+HRDIK  N+LL  N   KI+DFG S   P +       + GTL YL PE  I GR+
Sbjct: 132 -RVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDT---LCGTLDYLPPE-MIEGRM 186
Query: 226 -TRKSDVYSFGVLLLEIVSG 244
              K D++S GVL  E + G
Sbjct: 187 HDEKVDLWSLGVLCYEFLVG 206

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 130/278 (46%), Gaps = 32/278 (11%)
Query: 50  IGEGGFGSVYKGRLQ----DGTIVAVKVL-SVESKQGEKEFMSEVASMANVNVCHENLVK 104
           IG G FG V  G L+        VA+K L S  +++  ++F+SE + M   +  H N++ 
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD--HPNVIH 98
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L G        +++ ++M N SL   L    +   +F       ++ GI  G+ Y+ +  
Sbjct: 99  LEGVVTKSTPVMIITEFMENGSLDSFL---RQNDGQFTVIQLVGMLRGIAAGMKYLADM- 154
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS-TRVAG---TLGYLAPEYA 220
             + VHRD+   NIL++ N   K+SDFGLS+   ++T+  + T   G    + + APE  
Sbjct: 155 --NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 212
Query: 221 ISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPML 280
              + T  SDV+S+G+++ E++S           GE       W M N ++++N ++   
Sbjct: 213 QYRKFTSASDVWSYGIVMWEVMS----------YGER----PYWDMTN-QDVINAIEQDY 257
Query: 281 YGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN 318
               P +      ++ L C Q+    RP+    +  ++
Sbjct: 258 RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 295

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 127/287 (44%), Gaps = 53/287 (18%)
Query: 50  IGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG 108
           IG GGFG V+K + + DG    +K +   +++ E+E +  +A + +VN+ H N      G
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE-VKALAKLDHVNIVHYN------G 71
Query: 109 CIDG-----------------PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
           C DG                  C  +  ++    +L Q +  E++R  K       E+  
Sbjct: 72  CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI--EKRRGEKLDKVLALELFE 129
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT 211
            I +G+ YIH +    +++RD+K SNI L      KI DFGL      +      R  GT
Sbjct: 130 QITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--XRSKGT 184
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKE 271
           L Y++PE   S    ++ D+Y+ G++L E++               H+ D A+    SK 
Sbjct: 185 LRYMSPEQISSQDYGKEVDLYALGLILAELL---------------HVCDTAFE--TSKF 227
Query: 272 LMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN 318
             +L D ++   F + E     K+    + +K + RP  S  ++ + 
Sbjct: 228 FTDLRDGIISDIFDKKEKTLLQKL----LSKKPEDRPNTSEILRTLT 270

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 97/204 (47%), Gaps = 20/204 (9%)
Query: 50  IGEGGFGSV---YKGRLQDGT--IVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLV 103
           +GEG FG V         DGT  +VAVK L  ++  Q    +  E+  +  +   HE+++
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLY--HEHII 96
Query: 104 KLHGGCID-GPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
           K  G C D G   + LV +Y+P  SL   L      R   G          I  G+AY+H
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYL-----PRHSIGLAQLLLFAQQICEGMAYLH 151
Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG--TLGYLAPEY 219
            +   H +HRD+   N+LLD +   KI DFGL+K  PE       R  G   + + APE 
Sbjct: 152 AQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPEC 208
Query: 220 AISGRLTRKSDVYSFGVLLLEIVS 243
               +    SDV+SFGV L E+++
Sbjct: 209 LKEYKFYYASDVWSFGVTLYELLT 232

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 104/218 (47%), Gaps = 30/218 (13%)
Query: 51  GEGGFGSVYKGRLQDGTIVAVKVLSVESKQG-EKEFMSEVASMANVNVCHENLVKLHGGC 109
             G FG V+K +L +   VAVK+  ++ KQ  + E+  EV S+  +   HEN+++  G  
Sbjct: 33  ARGRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQNEY--EVYSLPGMK--HENILQFIGAE 87
Query: 110 IDGPC----RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI- 164
             G        L+  +    SLS  L     +     W     I   + RGLAY+HE+I 
Sbjct: 88  KRGTSVDVDLWLITAFHEKGSLSDFL-----KANVVSWNELCHIAETMARGLAYLHEDIP 142
Query: 165 ------QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR-VAGTLGYLAP 217
                 +P + HRDIK+ N+LL  N    I+DFGL+  F    +   T    GT  Y+AP
Sbjct: 143 GLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAP 202
Query: 218 EYAISGRLTRKS------DVYSFGVLLLEIVSGRTAVD 249
           E  + G +  +       D+Y+ G++L E+ S  TA D
Sbjct: 203 E-VLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 75/300 (25%), Positives = 128/300 (42%), Gaps = 66/300 (22%)
Query: 50  IGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG 108
           IG GGFG V+K + + DG    ++ +   +++ E+E +  +A + +VN+ H N      G
Sbjct: 20  IGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAERE-VKALAKLDHVNIVHYN------G 72
Query: 109 CIDG------------------------------PCRILVYDYMPNNSLSQTLLGEEKRR 138
           C DG                               C  +  ++    +L Q +  E++R 
Sbjct: 73  CWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWI--EKRRG 130
Query: 139 AKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198
            K       E+   I +G+ YIH +    ++HRD+K SNI L      KI DFGL     
Sbjct: 131 EKLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLK 187
Query: 199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYH 258
            +     TR  GTL Y++PE   S    ++ D+Y+ G++L E++               H
Sbjct: 188 NDGKR--TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL---------------H 230
Query: 259 LVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN 318
           + D A+    SK   +L D ++   F + E     K+    + +K + RP  S  ++ + 
Sbjct: 231 VCDTAFE--TSKFFTDLRDGIISDIFDKKEKTLLQKL----LSKKPEDRPNTSEILRTLT 284

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 76/308 (24%), Positives = 141/308 (45%), Gaps = 40/308 (12%)
Query: 30  NAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQD------GTIVAVKVLSVESKQGEK 83
           + F  ++ +++        ++G+G FG VY+G  +D       T VAVK ++  +   E+
Sbjct: 2   SVFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER 61
Query: 84  -EFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLS---QTLLGEEKRRA 139
            EF++E + M     CH ++V+L G    G   ++V + M +  L    ++L  E +   
Sbjct: 62  IEFLNEASVMKGFT-CH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNP 119
Query: 140 KFGWKARREIIM---GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196
                  +E+I     I  G+AY++ +     VHRD+   N ++  +F  KI DFG+++ 
Sbjct: 120 GRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRD 176
Query: 197 FPENTTHISTRVAG----TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252
             E       R  G     + ++APE    G  T  SD++SFGV+L EI S         
Sbjct: 177 IXETDX---XRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS--------- 224
Query: 253 QLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMST 312
                 L ++ +   ++++++  V    Y + P+N   R   +  +C Q   K+RP    
Sbjct: 225 ------LAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLE 278
Query: 313 AIKMMNGE 320
            + ++  +
Sbjct: 279 IVNLLKDD 286

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 77/306 (25%), Positives = 142/306 (46%), Gaps = 36/306 (11%)
Query: 30  NAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQD------GTIVAVKVLSVESKQGEK 83
           + F  ++ +++        ++G+G FG VY+G  +D       T VAVK ++  +   E+
Sbjct: 5   SVFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER 64
Query: 84  -EFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLS---QTLLGEEKRRA 139
            EF++E + M     CH ++V+L G    G   ++V + M +  L    ++L  E +   
Sbjct: 65  IEFLNEASVMKGFT-CH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNP 122
Query: 140 KFGWKARREIIM---GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196
                  +E+I     I  G+AY++ +     VHRD+   N ++  +F  KI DFG+++ 
Sbjct: 123 GRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRD 179
Query: 197 FPENTTHISTRVAGTLG--YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254
             E T +      G L   ++APE    G  T  SD++SFGV+L EI S           
Sbjct: 180 IYE-TAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS----------- 227
Query: 255 GEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAI 314
               L ++ +   ++++++  V    Y + P+N   R   +  +C Q   K+RP     +
Sbjct: 228 ----LAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 283
Query: 315 KMMNGE 320
            ++  +
Sbjct: 284 NLLKDD 289

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 105/213 (49%), Gaps = 15/213 (7%)
Query: 38  KIATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVE--SKQGEKEFMSEVASMAN 94
           K +   F+    +G G FG V+  R   +G   A+KVL  E   +  + E  ++   M +
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 95  VNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIG 154
           + V H  ++++ G   D     ++ DY+    L   L    ++  +F     +     + 
Sbjct: 62  I-VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL----RKSQRFPNPVAKFYAAEVC 116
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY 214
             L Y+H +    +++RD+K  NILLD+N + KI+DFG +K  P+    ++  + GT  Y
Sbjct: 117 LALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYXLCGTPDY 169
Query: 215 LAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTA 247
           +APE   +    +  D +SFG+L+ E+++G T 
Sbjct: 170 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 76/308 (24%), Positives = 141/308 (45%), Gaps = 40/308 (12%)
Query: 30  NAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQD------GTIVAVKVLSVESKQGEK 83
           + F  ++ +++        ++G+G FG VY+G  +D       T VAVK ++  +   E+
Sbjct: 5   SVFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER 64
Query: 84  -EFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLS---QTLLGEEKRRA 139
            EF++E + M     CH ++V+L G    G   ++V + M +  L    ++L  E +   
Sbjct: 65  IEFLNEASVMKGFT-CH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNP 122
Query: 140 KFGWKARREIIM---GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196
                  +E+I     I  G+AY++ +     VHRD+   N ++  +F  KI DFG+++ 
Sbjct: 123 GRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRD 179
Query: 197 FPENTTHISTRVAG----TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252
             E       R  G     + ++APE    G  T  SD++SFGV+L EI S         
Sbjct: 180 IXETDX---XRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS--------- 227
Query: 253 QLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMST 312
                 L ++ +   ++++++  V    Y + P+N   R   +  +C Q   K+RP    
Sbjct: 228 ------LAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLE 281
Query: 313 AIKMMNGE 320
            + ++  +
Sbjct: 282 IVNLLKDD 289

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 77/306 (25%), Positives = 142/306 (46%), Gaps = 36/306 (11%)
Query: 30  NAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQD------GTIVAVKVLSVESKQGEK 83
           + F  ++ +++        ++G+G FG VY+G  +D       T VAVK ++  +   E+
Sbjct: 5   SVFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER 64
Query: 84  -EFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLS---QTLLGEEKRRA 139
            EF++E + M     CH ++V+L G    G   ++V + M +  L    ++L  E +   
Sbjct: 65  IEFLNEASVMKGFT-CH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNP 122
Query: 140 KFGWKARREIIM---GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196
                  +E+I     I  G+AY++ +     VHRD+   N ++  +F  KI DFG+++ 
Sbjct: 123 GRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRD 179
Query: 197 FPENTTHISTRVAGTLG--YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254
             E T +      G L   ++APE    G  T  SD++SFGV+L EI S           
Sbjct: 180 IYE-TDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS----------- 227
Query: 255 GEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAI 314
               L ++ +   ++++++  V    Y + P+N   R   +  +C Q   K+RP     +
Sbjct: 228 ----LAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 283
Query: 315 KMMNGE 320
            ++  +
Sbjct: 284 NLLKDD 289

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/287 (26%), Positives = 135/287 (47%), Gaps = 36/287 (12%)
Query: 49  KIGEGGFGSVYKGRLQD------GTIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHEN 101
           ++G+G FG VY+G  +D       T VAVK ++  +   E+ EF++E + M     CH +
Sbjct: 23  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFT-CH-H 80
Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLS---QTLLGEEKRRAKFGWKARREIIM---GIGR 155
           +V+L G    G   ++V + M +  L    ++L  E +          +E+I     I  
Sbjct: 81  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 140
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG-- 213
           G+AY++ +     VHRD+   N ++  +F  KI DFG+++   E T +      G L   
Sbjct: 141 GMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE-TDYYRKGGKGLLPVR 196
Query: 214 YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELM 273
           ++APE    G  T  SD++SFGV+L EI S               L ++ +   ++++++
Sbjct: 197 WMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVL 241
Query: 274 NLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE 320
             V    Y + P+N   R   +  +C Q   K+RP     + ++  +
Sbjct: 242 KFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 288

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/255 (28%), Positives = 120/255 (47%), Gaps = 32/255 (12%)
Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENL 102
           F+  N +G+G F  VY+   +  G  VA+K++       +K+ M +   +  V    +N 
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMI-------DKKAMYKAGMVQRV----QNE 61
Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLL-----GEEKRRAK-----FGWKARREIIMG 152
           VK+H   +  P  + +Y+Y  +++    +L     GE  R  K     F     R  +  
Sbjct: 62  VKIHCQ-LKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQ 120
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL-SKLFPENTTHISTRVAGT 211
           I  G+ Y+H      ++HRD+  SN+LL +N N KI+DFGL ++L   +  H +  + GT
Sbjct: 121 IITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGT 175
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV---QLGEYHLVDKAWGMYN 268
             Y++PE A       +SDV+S G +   ++ GR   D D     L +  L D     + 
Sbjct: 176 PNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFL 235
Query: 269 SKELMNLVDPMLYGN 283
           S E  +L+  +L  N
Sbjct: 236 SIEAKDLIHQLLRRN 250

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 116/220 (52%), Gaps = 30/220 (13%)
Query: 40  ATNGFRWSNKIGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGEKEF-MSEVASMANVNV 97
           +++ F+   K+G G + +VYKG     G  VA+K + ++S++G     + E++ M  +  
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK- 61
Query: 98  CHENLVKLHGGCIDGPCRILVYDYMPNN--------SLSQTLLGEEKRRAK-FGWKARRE 148
            HEN+V+L+          LV+++M N+        ++  T  G E    K F W+    
Sbjct: 62  -HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ---- 116
Query: 149 IIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PENTTHIST 206
               + +GLA+ HE     ++HRD+K  N+L+++    K+ DFGL++ F  P NT   S+
Sbjct: 117 ----LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT--FSS 167
Query: 207 RVAGTLGYLAPEYAISGRLTRKS-DVYSFGVLLLEIVSGR 245
            V  TL Y AP+  +  R    S D++S G +L E+++G+
Sbjct: 168 EVV-TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 48  NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
            ++G G FG V  G+ +    VAVK++  E    E EF  E  +M  ++  H  LVK +G
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLS--HPKLVKFYG 70
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARR--EIIMGIGRGLAYIHEEIQ 165
            C       +V +Y+ N  L   L    K     G +  +  E+   +  G+A++     
Sbjct: 71  VCSKEYPIYIVTEYISNGCLLNYLRSHGK-----GLEPSQLLEMCYDVCEGMAFLESH-- 123
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL 225
              +HRD+   N L+D++   K+SDFG+++   ++    S      + + APE     + 
Sbjct: 124 -QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKY 182
Query: 226 TRKSDVYSFGVLLLEIVS-GRTAVDF 250
           + KSDV++FG+L+ E+ S G+   D 
Sbjct: 183 SSKSDVWAFGILMWEVFSLGKMPYDL 208

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 108/204 (52%), Gaps = 17/204 (8%)
Query: 48  NKIGEGGFGSVYKGRLQDGTIVAVKVLSV--ESKQGEKEFMSEVASMANVNVCHENLVKL 105
            +IG G FG+VYKG+      VAVK+L+V   + Q  + F +EV  +      H N++ L
Sbjct: 14  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR--HVNIL-L 68
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
             G    P   +V  +   +SL   L   E    KF      +I     +G+ Y+H +  
Sbjct: 69  FMGYSTAPQLAIVTQWCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYLHAK-- 123
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT-THISTRVAGTLGYLAPE---YAI 221
             ++HRD+K++NI L ++   KI DFGL+ +    + +H   +++G++ ++APE      
Sbjct: 124 -SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 222 SGRLTRKSDVYSFGVLLLEIVSGR 245
               + +SDVY+FG++L E+++G+
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 50  IGEGGFGSV---YKGRLQDGT--IVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLV 103
           +GEG FG V         DGT  +VAVK L  +   Q    +  E+  +  +   HE+++
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLY--HEHII 79
Query: 104 KLHGGCIDGPCRIL--VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
           K  G C D   + L  V +Y+P  SL   L      R   G          I  G+AY+H
Sbjct: 80  KYKGCCEDQGEKSLQLVMEYVPLGSLRDYL-----PRHSIGLAQLLLFAQQICEGMAYLH 134
Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG--TLGYLAPEY 219
            +   H +HR++   N+LLD +   KI DFGL+K  PE   +   R  G   + + APE 
Sbjct: 135 SQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 191
Query: 220 AISGRLTRKSDVYSFGVLLLEIVS 243
               +    SDV+SFGV L E+++
Sbjct: 192 LKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 50  IGEGGFGSV---YKGRLQDGT--IVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLV 103
           +GEG FG V         DGT  +VAVK L  +   Q    +  E+  +  +   HE+++
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLY--HEHII 79
Query: 104 KLHGGCIDGPCRIL--VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
           K  G C D   + L  V +Y+P  SL   L      R   G          I  G+AY+H
Sbjct: 80  KYKGCCEDQGEKSLQLVMEYVPLGSLRDYL-----PRHSIGLAQLLLFAQQICEGMAYLH 134
Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG--TLGYLAPEY 219
            +   H +HR++   N+LLD +   KI DFGL+K  PE   +   R  G   + + APE 
Sbjct: 135 AQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 191
Query: 220 AISGRLTRKSDVYSFGVLLLEIVS 243
               +    SDV+SFGV L E+++
Sbjct: 192 LKEYKFYYASDVWSFGVTLYELLT 215

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 76/227 (33%), Positives = 110/227 (48%), Gaps = 43/227 (18%)
Query: 50  IGEGGFGSV-------YKGRLQDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHEN 101
           +GEG FG V        KGR    T VAVK+L   +   E ++ +SE   +  VN  H +
Sbjct: 31  LGEGEFGKVVKATAFHLKGR-AGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN--HPH 87
Query: 102 LVKLHGGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGW--------------KAR 146
           ++KL+G C  DGP  +L+ +Y    SL   L   E R+   G+                 
Sbjct: 88  VIKLYGACSQDGPL-LLIVEYAKYGSLRGFL--RESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 147 REIIMG--------IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198
           R + MG        I +G+ Y+ E     +VHRD+   NIL+ +    KISDFGLS+   
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVY 201
Query: 199 ENTTHISTRVAGTL--GYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
           E  +++  R  G +   ++A E       T +SDV+SFGVLL EIV+
Sbjct: 202 EEDSYVK-RSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 103/203 (50%), Gaps = 17/203 (8%)
Query: 50  IGEGGFGSVYKGRLQ----DGTIVAVKVL-SVESKQGEKEFMSEVASMANVNVCHENLVK 104
           IG G FG V  G L+        VA+K L S  +++  ++F+SE + M   +  H N++ 
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD--HPNVIH 72
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L G        +++ ++M N SL   L    +   +F       ++ GI  G+ Y+ +  
Sbjct: 73  LEGVVTKSTPVMIITEFMENGSLDSFL---RQNDGQFTVIQLVGMLRGIAAGMKYLADM- 128
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS-TRVAG---TLGYLAPEYA 220
             + VHR +   NIL++ N   K+SDFGLS+   ++T+  + T   G    + + APE  
Sbjct: 129 --NYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 186
Query: 221 ISGRLTRKSDVYSFGVLLLEIVS 243
              + T  SDV+S+G+++ E++S
Sbjct: 187 QYRKFTSASDVWSYGIVMWEVMS 209

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 108/204 (52%), Gaps = 17/204 (8%)
Query: 48  NKIGEGGFGSVYKGRLQDGTIVAVKVLSV--ESKQGEKEFMSEVASMANVNVCHENLVKL 105
            +IG G FG+VYKG+      VAVK+L+V   + Q  + F +EV  +      H N++ L
Sbjct: 14  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR--HVNIL-L 68
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
             G    P   +V  +   +SL   L   E    KF      +I     +G+ Y+H +  
Sbjct: 69  FMGYSTKPQLAIVTQWCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYLHAK-- 123
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT-THISTRVAGTLGYLAPE---YAI 221
             ++HRD+K++NI L ++   KI DFGL+ +    + +H   +++G++ ++APE      
Sbjct: 124 -SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 222 SGRLTRKSDVYSFGVLLLEIVSGR 245
               + +SDVY+FG++L E+++G+
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 104/217 (47%), Gaps = 34/217 (15%)
Query: 50  IGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG- 108
           IG G +G+VYKG L D   VAVKV S  ++Q    F++E        + H+N+ +   G 
Sbjct: 21  IGRGRYGAVYKGSL-DERPVAVKVFSFANRQN---FINEKNIYRVPLMEHDNIARFIVGD 76
Query: 109 ---CIDGPCR-ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
                DG    +LV +Y PN SL + L           W +   +   + RGLAY+H E+
Sbjct: 77  ERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS-----DWVSSCRLAHSVTRGLAYLHTEL 131
Query: 165 ------QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-------PENTTHISTRVAGT 211
                 +P + HRD+ + N+L+  +    ISDFGLS          P    + +    GT
Sbjct: 132 PRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGT 191
Query: 212 LGYLAPEY---AISGR----LTRKSDVYSFGVLLLEI 241
           + Y+APE    A++ R      ++ D+Y+ G++  EI
Sbjct: 192 IRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 74/226 (32%), Positives = 111/226 (49%), Gaps = 41/226 (18%)
Query: 50  IGEGGFGSV-------YKGRLQDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHEN 101
           +GEG FG V        KGR    T VAVK+L   +   E ++ +SE   +  VN  H +
Sbjct: 31  LGEGEFGKVVKATAFHLKGR-AGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN--HPH 87
Query: 102 LVKLHGGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGW--------------KAR 146
           ++KL+G C  DGP  +L+ +Y    SL   L   E R+   G+                 
Sbjct: 88  VIKLYGACSQDGPL-LLIVEYAKYGSLRGFL--RESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 147 REIIMG--------IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LF 197
           R + MG        I +G+ Y+ E     +VHRD+   NIL+ +    KISDFGLS+ ++
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVY 201
Query: 198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
            E++    ++    + ++A E       T +SDV+SFGVLL EIV+
Sbjct: 202 EEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 108/204 (52%), Gaps = 17/204 (8%)
Query: 48  NKIGEGGFGSVYKGRLQDGTIVAVKVLSV--ESKQGEKEFMSEVASMANVNVCHENLVKL 105
            +IG G FG+VYKG+      VAVK+L+V   + Q  + F +EV  +      H N++ L
Sbjct: 16  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR--HVNIL-L 70
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
             G    P   +V  +   +SL   L   E    KF      +I     +G+ Y+H +  
Sbjct: 71  FMGYSTKPQLAIVTQWCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYLHAK-- 125
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT-THISTRVAGTLGYLAPE---YAI 221
             ++HRD+K++NI L ++   KI DFGL+ +    + +H   +++G++ ++APE      
Sbjct: 126 -SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 184
Query: 222 SGRLTRKSDVYSFGVLLLEIVSGR 245
               + +SDVY+FG++L E+++G+
Sbjct: 185 KNPYSFQSDVYAFGIVLYELMTGQ 208

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 108/204 (52%), Gaps = 17/204 (8%)
Query: 48  NKIGEGGFGSVYKGRLQDGTIVAVKVLSV--ESKQGEKEFMSEVASMANVNVCHENLVKL 105
            +IG G FG+VYKG+      VAVK+L+V   + Q  + F +EV  +      H N++ L
Sbjct: 19  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR--HVNIL-L 73
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
             G    P   +V  +   +SL   L   E    KF      +I     +G+ Y+H +  
Sbjct: 74  FMGYSTKPQLAIVTQWCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYLHAK-- 128
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT-THISTRVAGTLGYLAPE---YAI 221
             ++HRD+K++NI L ++   KI DFGL+ +    + +H   +++G++ ++APE      
Sbjct: 129 -SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 187
Query: 222 SGRLTRKSDVYSFGVLLLEIVSGR 245
               + +SDVY+FG++L E+++G+
Sbjct: 188 KNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 108/204 (52%), Gaps = 17/204 (8%)
Query: 48  NKIGEGGFGSVYKGRLQDGTIVAVKVLSV--ESKQGEKEFMSEVASMANVNVCHENLVKL 105
            +IG G FG+VYKG+      VAVK+L+V   + Q  + F +EV  +      H N++ L
Sbjct: 19  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR--HVNIL-L 73
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
             G    P   +V  +   +SL   L   E    KF      +I     +G+ Y+H +  
Sbjct: 74  FMGYSTKPQLAIVTQWCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYLHAK-- 128
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT-THISTRVAGTLGYLAPE---YAI 221
             ++HRD+K++NI L ++   KI DFGL+ +    + +H   +++G++ ++APE      
Sbjct: 129 -SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 187
Query: 222 SGRLTRKSDVYSFGVLLLEIVSGR 245
               + +SDVY+FG++L E+++G+
Sbjct: 188 KNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 106/201 (52%), Gaps = 15/201 (7%)
Query: 49  KIGEGGFGSVYKG--RLQDGTI-VAVKVLSVESKQGE-KEFMSEVASMANVNVCHENLVK 104
           ++G G FGSV +G  R++   I VA+KVL   +++ + +E M E   M  ++  +  +V+
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD--NPYIVR 74
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L G C      +LV +      L + L+G   +R +       E++  +  G+ Y+ E+ 
Sbjct: 75  LIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK- 129
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG--TLGYLAPEYAIS 222
             + VHRD+   N+LL      KISDFGLSK    + ++ + R AG   L + APE    
Sbjct: 130 --NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 187
Query: 223 GRLTRKSDVYSFGVLLLEIVS 243
            + + +SDV+S+GV + E +S
Sbjct: 188 RKFSSRSDVWSYGVTMWEALS 208

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 74/226 (32%), Positives = 111/226 (49%), Gaps = 41/226 (18%)
Query: 50  IGEGGFGSV-------YKGRLQDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHEN 101
           +GEG FG V        KGR    T VAVK+L   +   E ++ +SE   +  VN  H +
Sbjct: 31  LGEGEFGKVVKATAFHLKGR-AGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN--HPH 87
Query: 102 LVKLHGGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGW--------------KAR 146
           ++KL+G C  DGP  +L+ +Y    SL   L   E R+   G+                 
Sbjct: 88  VIKLYGACSQDGPL-LLIVEYAKYGSLRGFL--RESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 147 REIIMG--------IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LF 197
           R + MG        I +G+ Y+ E     +VHRD+   NIL+ +    KISDFGLS+ ++
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEM---SLVHRDLAARNILVAEGRKMKISDFGLSRDVY 201
Query: 198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
            E++    ++    + ++A E       T +SDV+SFGVLL EIV+
Sbjct: 202 EEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 80/287 (27%), Positives = 138/287 (48%), Gaps = 43/287 (14%)
Query: 47  SNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEK--EFMSEVASMANVNVCHENLVK 104
           S +IG G FG+VYKG+      VAVK+L V     E+   F +EVA +      H N++ 
Sbjct: 41  STRIGSGSFGTVYKGKWHGD--VAVKILKVVDPTPEQFQAFRNEVAVLRKTR--HVNIL- 95
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L  G +      +V  +   +SL + L  +E    KF      +I     +G+ Y+H + 
Sbjct: 96  LFMGYMTKDNLAIVTQWCEGSSLYKHLHVQE---TKFQMFQLIDIARQTAQGMDYLHAK- 151
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT-THISTRVAGTLGYLAPE---YA 220
             +++HRD+K++NI L +    KI DFGL+ +    + +    +  G++ ++APE     
Sbjct: 152 --NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQ 209
Query: 221 ISGRLTRKSDVYSFGVLLLEIVSG---------RTAVDFDVQLGEYHLVDKAWGMYNSKE 271
            +   + +SDVYS+G++L E+++G         R  + F V  G           Y S +
Sbjct: 210 DNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRG-----------YASPD 258
Query: 272 LMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN 318
           L       LY N P+    R +   +  V+E+  L PQ+ ++I+++ 
Sbjct: 259 LSK-----LYKNCPKAMK-RLVADCVKKVKEERPLFPQILSSIELLQ 299

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 133/289 (46%), Gaps = 40/289 (13%)
Query: 49  KIGEGGFGSVYKGRLQD------GTIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHEN 101
           ++G+G FG VY+G  +D       T VAVK ++  +   E+ EF++E + M     CH +
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFT-CH-H 81
Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLS---QTLLGEEKRRAKFGWKARREIIM---GIGR 155
           +V+L G    G   ++V + M +  L    ++L  E +          +E+I     I  
Sbjct: 82  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG----T 211
           G+AY++ +     VHRD+   N ++  +F  KI DFG+++   E       R  G     
Sbjct: 142 GMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDX---XRKGGKGLLP 195
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKE 271
           + ++APE    G  T  SD++SFGV+L EI S               L ++ +   ++++
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQ 240
Query: 272 LMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE 320
           ++  V    Y + P+N   R   +  +C Q    +RP     + ++  +
Sbjct: 241 VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDD 289

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 138/294 (46%), Gaps = 36/294 (12%)
Query: 30  NAFSYNQLKIATNGFRWSNKIGEGGFGSVYKG------RLQDGTIVAVKVLSVESKQGEK 83
           + F  ++ ++A      S ++G+G FG VY+G      + +  T VA+K ++  +   E+
Sbjct: 4   DVFVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER 63
Query: 84  -EFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLS---QTLLGEEKRRA 139
            EF++E + M   N CH ++V+L G    G   +++ + M    L    ++L  E +   
Sbjct: 64  IEFLNEASVMKEFN-CH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP 121
Query: 140 KFGWKARREIIMGIGR---GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196
                +  ++I   G    G+AY++       VHRD+   N ++ ++F  KI DFG+++ 
Sbjct: 122 VLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD 178
Query: 197 FPENTTHISTRVAGTLG--YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254
             E T +      G L   +++PE    G  T  SDV+SFGV+L EI +           
Sbjct: 179 IYE-TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------- 226
Query: 255 GEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRP 308
               L ++ +   ++++++  V      + P+N      ++  +C Q   K+RP
Sbjct: 227 ----LAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRP 276

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 108/204 (52%), Gaps = 17/204 (8%)
Query: 48  NKIGEGGFGSVYKGRLQDGTIVAVKVLSV--ESKQGEKEFMSEVASMANVNVCHENLVKL 105
            +IG G FG+VYKG+      VAVK+L+V   + Q  + F +EV  +      H N++ L
Sbjct: 41  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR--HVNIL-L 95
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
             G    P   +V  +   +SL   L   E    KF      +I     +G+ Y+H +  
Sbjct: 96  FMGYSTKPQLAIVTQWCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYLHAK-- 150
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT-THISTRVAGTLGYLAPE---YAI 221
             ++HRD+K++NI L ++   KI DFGL+ +    + +H   +++G++ ++APE      
Sbjct: 151 -SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 209
Query: 222 SGRLTRKSDVYSFGVLLLEIVSGR 245
               + +SDVY+FG++L E+++G+
Sbjct: 210 KNPYSFQSDVYAFGIVLYELMTGQ 233

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 108/204 (52%), Gaps = 17/204 (8%)
Query: 48  NKIGEGGFGSVYKGRLQDGTIVAVKVLSV--ESKQGEKEFMSEVASMANVNVCHENLVKL 105
            +IG G FG+VYKG+      VAVK+L+V   + Q  + F +EV  +      H N++ L
Sbjct: 42  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR--HVNIL-L 96
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
             G    P   +V  +   +SL   L   E    KF      +I     +G+ Y+H +  
Sbjct: 97  FMGYSTKPQLAIVTQWCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYLHAK-- 151
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE-NTTHISTRVAGTLGYLAPE---YAI 221
             ++HRD+K++NI L ++   KI DFGL+ +    + +H   +++G++ ++APE      
Sbjct: 152 -SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 210
Query: 222 SGRLTRKSDVYSFGVLLLEIVSGR 245
               + +SDVY+FG++L E+++G+
Sbjct: 211 KNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 104/201 (51%), Gaps = 16/201 (7%)
Query: 50  IGEGGFGSVYKG-RLQDGTIV----AVKVLS-VESKQGEKEFMSEVASMANVNVCHENLV 103
           +G G FG+VYKG  + +G  V    A+K+L+     +   EFM E   MA+++  H +LV
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD--HPHLV 80
Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
           +L G C+  P   LV   MP+  L + +    + +   G +      + I +G+ Y+ E 
Sbjct: 81  RLLGVCL-SPTIQLVTQLMPHGCLLEYV---HEHKDNIGSQLLLNWCVQIAKGMMYLEER 136
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG-TLGYLAPEYAIS 222
               +VHRD+   N+L+    + KI+DFGL++L   +    +       + ++A E    
Sbjct: 137 ---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY 193
Query: 223 GRLTRKSDVYSFGVLLLEIVS 243
            + T +SDV+S+GV + E+++
Sbjct: 194 RKFTHQSDVWSYGVTIWELMT 214

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 136/291 (46%), Gaps = 40/291 (13%)
Query: 35  NQLKIATNGFRWSNKIGEGGFGSVYKG------RLQDGTIVAVKVLSVESKQGEK-EFMS 87
           ++ ++A      S ++G+G FG VY+G      + +  T VA+K ++  +   E+ EF++
Sbjct: 3   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 62
Query: 88  EVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLS---QTLLGEEKRRAKFGWK 144
           E + M   N CH ++V+L G    G   +++ + M    L    ++L  E +        
Sbjct: 63  EASVMKEFN-CH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 120
Query: 145 ARREIIMGIGR---GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 201
           +  ++I   G    G+AY++       VHRD+   N ++ ++F  KI DFG+++   E  
Sbjct: 121 SLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETD 177
Query: 202 THISTRVAG----TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEY 257
                R  G     + +++PE    G  T  SDV+SFGV+L EI +              
Sbjct: 178 X---XRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-------------- 220
Query: 258 HLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRP 308
            L ++ +   ++++++  V      + P+N     L++  +C Q   K+RP
Sbjct: 221 -LAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLLELMRMCWQYNPKMRP 270

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 104/201 (51%), Gaps = 16/201 (7%)
Query: 50  IGEGGFGSVYKG-RLQDGTIV----AVKVLS-VESKQGEKEFMSEVASMANVNVCHENLV 103
           +G G FG+VYKG  + +G  V    A+K+L+     +   EFM E   MA+++  H +LV
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD--HPHLV 103
Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
           +L G C+  P   LV   MP+  L + +    + +   G +      + I +G+ Y+ E 
Sbjct: 104 RLLGVCL-SPTIQLVTQLMPHGCLLEYV---HEHKDNIGSQLLLNWCVQIAKGMMYLEER 159
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG-TLGYLAPEYAIS 222
               +VHRD+   N+L+    + KI+DFGL++L   +    +       + ++A E    
Sbjct: 160 ---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY 216
Query: 223 GRLTRKSDVYSFGVLLLEIVS 243
            + T +SDV+S+GV + E+++
Sbjct: 217 RKFTHQSDVWSYGVTIWELMT 237

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 128/284 (45%), Gaps = 42/284 (14%)
Query: 50  IGEGGFGSVYKGRLQDG----TIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHENLVK 104
           IG G FG VY G L D        AVK L+  +  GE  +F++E   M + +  H N++ 
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS--HPNVLS 94
Query: 105 LHGGCIDGP-CRILVYDYMPNNSLSQTLLGEE-----KRRAKFGWKARREIIMGIGRGLA 158
           L G C+      ++V  YM +  L   +  E      K    FG        + + +G+ 
Sbjct: 95  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG--------LQVAKGMK 146
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTHISTRVAGTLG--YL 215
           Y+  +     VHRD+   N +LD+ F  K++DFGL++ ++ +    +  +    L   ++
Sbjct: 147 YLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWM 203
Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNL 275
           A E   + + T KSDV+SFGVLL E+++ R A  +     + +  D    +   + L+  
Sbjct: 204 ALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYP----DVNTFDITVYLLQGRRLLQ- 257
Query: 276 VDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNG 319
                    PE       +V L C   K+++RP  S  +  ++ 
Sbjct: 258 ---------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 292

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 30/218 (13%)
Query: 50  IGEGGFGSVY--------KGRLQDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHE 100
           +GEG FG V         K + ++   VAVK+L  ++ + +  + +SE+  M  +   H+
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK-HK 101
Query: 101 NLVKLHGGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARR------------ 147
           N++ L G C  DGP  ++V +Y    +L + L        ++ +   R            
Sbjct: 102 NIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 148 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 207
                + RG+ Y+  +     +HRD+   N+L+ +N   KI+DFGL++    N  +    
Sbjct: 161 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYKNT 216
Query: 208 VAGTLG--YLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
             G L   ++APE       T +SDV+SFGVL+ EI +
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 107/204 (52%), Gaps = 17/204 (8%)
Query: 48  NKIGEGGFGSVYKGRLQDGTIVAVKVLSV--ESKQGEKEFMSEVASMANVNVCHENLVKL 105
            +IG G FG+VYKG+      VAVK+L+V   + Q  + F +EV  +      H N++ L
Sbjct: 14  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR--HVNIL-L 68
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
             G    P   +V  +   +SL   L   E    KF      +I     +G+ Y+H +  
Sbjct: 69  FMGYSTKPQLAIVTQWCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYLHAK-- 123
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT-THISTRVAGTLGYLAPE---YAI 221
             ++HRD+K++NI L ++   KI DFGL+      + +H   +++G++ ++APE      
Sbjct: 124 -SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 222 SGRLTRKSDVYSFGVLLLEIVSGR 245
               + +SDVY+FG++L E+++G+
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/306 (24%), Positives = 141/306 (46%), Gaps = 36/306 (11%)
Query: 30  NAFSYNQLKIATNGFRWSNKIGEGGFGSVYKG------RLQDGTIVAVKVLSVESKQGEK 83
           + +  ++ ++A      S ++G+G FG VY+G      + +  T VA+K ++  +   E+
Sbjct: 7   DVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER 66
Query: 84  -EFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLS---QTLLGEEKRRA 139
            EF++E + M   N CH ++V+L G    G   +++ + M    L    ++L  E +   
Sbjct: 67  IEFLNEASVMKEFN-CH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP 124
Query: 140 KFGWKARREIIMGIGR---GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196
                +  ++I   G    G+AY++       VHRD+   N ++ ++F  KI DFG+++ 
Sbjct: 125 VLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD 181
Query: 197 FPENTTHISTRVAGTLG--YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254
             E T +      G L   +++PE    G  T  SDV+SFGV+L EI +           
Sbjct: 182 IYE-TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------- 229
Query: 255 GEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAI 314
               L ++ +   ++++++  V      + P+N      ++  +C Q   K+RP     I
Sbjct: 230 ----LAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 285
Query: 315 KMMNGE 320
             +  E
Sbjct: 286 SSIKEE 291

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 126/282 (44%), Gaps = 38/282 (13%)
Query: 50  IGEGGFGSVYKGRLQDG----TIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHENLVK 104
           IG G FG VY G L D        AVK L+  +  GE  +F++E   M + +  H N++ 
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS--HPNVLS 87
Query: 105 LHGGCIDGP-CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII---MGIGRGLAYI 160
           L G C+      ++V  YM +  L   +  E            +++I   + + +G+ Y+
Sbjct: 88  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKYL 141
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN---TTHISTRVAGTLGYLAP 217
             +     VHRD+   N +LD+ F  K++DFGL++   +    + H  T     + ++A 
Sbjct: 142 ASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 198
Query: 218 EYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD 277
           E   + + T KSDV+SFGVLL E+++       DV     +  D    +   + L+    
Sbjct: 199 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-----NTFDITVYLLQGRRLLQ--- 250
Query: 278 PMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNG 319
                  PE       +V L C   K+++RP  S  +  ++ 
Sbjct: 251 -------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 285

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 125/282 (44%), Gaps = 38/282 (13%)
Query: 50  IGEGGFGSVYKGRLQDG----TIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHENLVK 104
           IG G FG VY G L D        AVK L+  +  GE  +F++E   M + +  H N++ 
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS--HPNVLS 93
Query: 105 LHGGCIDGP-CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII---MGIGRGLAYI 160
           L G C+      ++V  YM +  L   +  E            +++I   + + +G+ Y+
Sbjct: 94  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKYL 147
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN---TTHISTRVAGTLGYLAP 217
             +     VHRD+   N +LD+ F  K++DFGL++   +    + H  T     + ++A 
Sbjct: 148 ASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 204
Query: 218 EYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD 277
           E   + + T KSDV+SFGVLL E+++       DV        D    +   + L+    
Sbjct: 205 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-----TFDITVYLLQGRRLLQ--- 256
Query: 278 PMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNG 319
                  PE       +V L C   K+++RP  S  +  ++ 
Sbjct: 257 -------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 291

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/296 (23%), Positives = 137/296 (46%), Gaps = 40/296 (13%)
Query: 30  NAFSYNQLKIATNGFRWSNKIGEGGFGSVYKG------RLQDGTIVAVKVLSVESKQGEK 83
           + +  ++ ++A      S ++G+G FG VY+G      + +  T VA+K ++  +   E+
Sbjct: 7   DVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER 66
Query: 84  -EFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLS---QTLLGEEKRRA 139
            EF++E + M   N CH ++V+L G    G   +++ + M    L    ++L  E +   
Sbjct: 67  IEFLNEASVMKEFN-CH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP 124
Query: 140 KFGWKARREIIMGIGR---GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196
                +  ++I   G    G+AY++       VHRD+   N ++ ++F  KI DFG+++ 
Sbjct: 125 VLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD 181
Query: 197 FPENTTHISTRVAG----TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252
             E       R  G     + +++PE    G  T  SDV+SFGV+L EI +         
Sbjct: 182 IXETDX---XRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT--------- 229
Query: 253 QLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRP 308
                 L ++ +   ++++++  V      + P+N      ++  +C Q   K+RP
Sbjct: 230 ------LAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRP 279

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 124/284 (43%), Gaps = 42/284 (14%)
Query: 50  IGEGGFGSVYKGRLQDG----TIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHENLVK 104
           IG G FG VY G L D        AVK L+  +  GE  +F++E   M + +  H N++ 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS--HPNVLS 95
Query: 105 LHGGCIDGP-CRILVYDYMPNNSLSQTLLGEE-----KRRAKFGWKARREIIMGIGRGLA 158
           L G C+      ++V  YM +  L   +  E      K    FG        + + +G+ 
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG--------LQVAKGMK 147
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN---TTHISTRVAGTLGYL 215
           Y+  +     VHRD+   N +LD+ F  K++DFGL++   +    + H  T     + ++
Sbjct: 148 YLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 204
Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNL 275
           A E   + + T KSDV+SFGVLL E+++       DV        D    +   + L+  
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-----TFDITVYLLQGRRLLQ- 258
Query: 276 VDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNG 319
                    PE       +V L C   K+++RP  S  +  ++ 
Sbjct: 259 ---------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 293

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 124/284 (43%), Gaps = 42/284 (14%)
Query: 50  IGEGGFGSVYKGRLQDG----TIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHENLVK 104
           IG G FG VY G L D        AVK L+  +  GE  +F++E   M + +  H N++ 
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS--HPNVLS 92
Query: 105 LHGGCIDGP-CRILVYDYMPNNSLSQTLLGEE-----KRRAKFGWKARREIIMGIGRGLA 158
           L G C+      ++V  YM +  L   +  E      K    FG        + + +G+ 
Sbjct: 93  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG--------LQVAKGMK 144
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN---TTHISTRVAGTLGYL 215
           Y+  +     VHRD+   N +LD+ F  K++DFGL++   +    + H  T     + ++
Sbjct: 145 YLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 201
Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNL 275
           A E   + + T KSDV+SFGVLL E+++       DV        D    +   + L+  
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-----TFDITVYLLQGRRLLQ- 255
Query: 276 VDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNG 319
                    PE       +V L C   K+++RP  S  +  ++ 
Sbjct: 256 ---------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 290

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/306 (24%), Positives = 141/306 (46%), Gaps = 36/306 (11%)
Query: 30  NAFSYNQLKIATNGFRWSNKIGEGGFGSVYKG------RLQDGTIVAVKVLSVESKQGEK 83
           + +  ++ ++A      S ++G+G FG VY+G      + +  T VA+K ++  +   E+
Sbjct: 13  DVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER 72
Query: 84  -EFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLS---QTLLGEEKRRA 139
            EF++E + M   N CH ++V+L G    G   +++ + M    L    ++L  E +   
Sbjct: 73  IEFLNEASVMKEFN-CH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP 130
Query: 140 KFGWKARREIIMGIGR---GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196
                +  ++I   G    G+AY++       VHRD+   N ++ ++F  KI DFG+++ 
Sbjct: 131 VLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD 187
Query: 197 FPENTTHISTRVAGTLG--YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254
             E T +      G L   +++PE    G  T  SDV+SFGV+L EI +           
Sbjct: 188 IYE-TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------- 235
Query: 255 GEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAI 314
               L ++ +   ++++++  V      + P+N      ++  +C Q   K+RP     I
Sbjct: 236 ----LAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 291
Query: 315 KMMNGE 320
             +  E
Sbjct: 292 SSIKEE 297

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/294 (24%), Positives = 138/294 (46%), Gaps = 36/294 (12%)
Query: 30  NAFSYNQLKIATNGFRWSNKIGEGGFGSVYKG------RLQDGTIVAVKVLSVESKQGEK 83
           + +  ++ ++A      S ++G+G FG VY+G      + +  T VA+K ++  +   E+
Sbjct: 6   DVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER 65
Query: 84  -EFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLS---QTLLGEEKRRA 139
            EF++E + M   N CH ++V+L G    G   +++ + M    L    ++L  E +   
Sbjct: 66  IEFLNEASVMKEFN-CH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP 123
Query: 140 KFGWKARREIIMGIGR---GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196
                +  ++I   G    G+AY++       VHRD+   N ++ ++F  KI DFG+++ 
Sbjct: 124 VLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD 180
Query: 197 FPENTTHISTRVAGTLG--YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254
             E T +      G L   +++PE    G  T  SDV+SFGV+L EI +           
Sbjct: 181 IYE-TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------- 228
Query: 255 GEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRP 308
               L ++ +   ++++++  V      + P+N      ++  +C Q   K+RP
Sbjct: 229 ----LAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRP 278

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/294 (24%), Positives = 138/294 (46%), Gaps = 36/294 (12%)
Query: 30  NAFSYNQLKIATNGFRWSNKIGEGGFGSVYKG------RLQDGTIVAVKVLSVESKQGEK 83
           + +  ++ ++A      S ++G+G FG VY+G      + +  T VA+K ++  +   E+
Sbjct: 6   DVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER 65
Query: 84  -EFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLS---QTLLGEEKRRA 139
            EF++E + M   N CH ++V+L G    G   +++ + M    L    ++L  E +   
Sbjct: 66  IEFLNEASVMKEFN-CH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP 123
Query: 140 KFGWKARREIIMGIGR---GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196
                +  ++I   G    G+AY++       VHRD+   N ++ ++F  KI DFG+++ 
Sbjct: 124 VLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD 180
Query: 197 FPENTTHISTRVAGTLG--YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254
             E T +      G L   +++PE    G  T  SDV+SFGV+L EI +           
Sbjct: 181 IYE-TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------- 228
Query: 255 GEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRP 308
               L ++ +   ++++++  V      + P+N      ++  +C Q   K+RP
Sbjct: 229 ----LAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRP 278

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 128/282 (45%), Gaps = 38/282 (13%)
Query: 50  IGEGGFGSVYKGRLQDG----TIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHENLVK 104
           IG G FG VY G L D        AVK L+  +  GE  +F++E   M + +  H N++ 
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS--HPNVLS 113
Query: 105 LHGGCIDGP-CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII---MGIGRGLAYI 160
           L G C+      ++V  YM +  L   +  E            +++I   + + +G+ Y+
Sbjct: 114 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKYL 167
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN---TTHISTRVAGTLGYLAP 217
             +     VHRD+   N +LD+ F  K++DFGL++   +    + H  T     + ++A 
Sbjct: 168 ASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 224
Query: 218 EYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD 277
           E   + + T KSDV+SFGVLL E+++ R A  +     + +  D    +   + L+    
Sbjct: 225 ESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYP----DVNTFDITVYLLQGRRLLQ--- 276
Query: 278 PMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNG 319
                  PE       +V L C   K+++RP  S  +  ++ 
Sbjct: 277 -------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 311

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 125/282 (44%), Gaps = 38/282 (13%)
Query: 50  IGEGGFGSVYKGRLQDG----TIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHENLVK 104
           IG G FG VY G L D        AVK L+  +  GE  +F++E   M + +  H N++ 
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS--HPNVLS 90
Query: 105 LHGGCIDGP-CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII---MGIGRGLAYI 160
           L G C+      ++V  YM +  L   +  E            +++I   + + +G+ Y+
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKYL 144
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN---TTHISTRVAGTLGYLAP 217
             +     VHRD+   N +LD+ F  K++DFGL++   +    + H  T     + ++A 
Sbjct: 145 ASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 201
Query: 218 EYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD 277
           E   + + T KSDV+SFGVLL E+++       DV        D    +   + L+    
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-----TFDITVYLLQGRRLLQ--- 253
Query: 278 PMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNG 319
                  PE       +V L C   K+++RP  S  +  ++ 
Sbjct: 254 -------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 288

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 127/284 (44%), Gaps = 42/284 (14%)
Query: 50  IGEGGFGSVYKGRLQDG----TIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHENLVK 104
           IG G FG VY G L D        AVK L+  +  GE  +F++E   M + +  H N++ 
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS--HPNVLS 114
Query: 105 LHGGCIDGP-CRILVYDYMPNNSLSQTLLGEE-----KRRAKFGWKARREIIMGIGRGLA 158
           L G C+      ++V  YM +  L   +  E      K    FG        + + +G+ 
Sbjct: 115 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG--------LQVAKGMK 166
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN---TTHISTRVAGTLGYL 215
           Y+  +     VHRD+   N +LD+ F  K++DFGL++   +    + H  T     + ++
Sbjct: 167 YLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 223
Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNL 275
           A E   + + T KSDV+SFGVLL E+++ R A  +     + +  D    +   + L+  
Sbjct: 224 ALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYP----DVNTFDITVYLLQGRRLLQ- 277
Query: 276 VDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNG 319
                    PE       +V L C   K+++RP  S  +  ++ 
Sbjct: 278 ---------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 312

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 30/218 (13%)
Query: 50  IGEGGFGSVY--------KGRLQDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHE 100
           +GEG FG V         K + ++   VAVK+L  ++ + +  + +SE+  M  +   H+
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK-HK 101
Query: 101 NLVKLHGGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARR------------ 147
           N++ L G C  DGP  ++V +Y    +L + L        ++ +   R            
Sbjct: 102 NIIHLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 148 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 207
                + RG+ Y+  +     +HRD+   N+L+ +N   KI+DFGL++    N  +    
Sbjct: 161 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYKKT 216
Query: 208 VAGTLG--YLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
             G L   ++APE       T +SDV+SFGVL+ EI +
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 125/282 (44%), Gaps = 38/282 (13%)
Query: 50  IGEGGFGSVYKGRLQDG----TIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHENLVK 104
           IG G FG VY G L D        AVK L+  +  GE  +F++E   M + +  H N++ 
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS--HPNVLS 94
Query: 105 LHGGCIDGP-CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII---MGIGRGLAYI 160
           L G C+      ++V  YM +  L   +  E            +++I   + + +G+ Y+
Sbjct: 95  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKYL 148
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN---TTHISTRVAGTLGYLAP 217
             +     VHRD+   N +LD+ F  K++DFGL++   +    + H  T     + ++A 
Sbjct: 149 ASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 205
Query: 218 EYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD 277
           E   + + T KSDV+SFGVLL E+++       DV        D    +   + L+    
Sbjct: 206 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-----TFDITVYLLQGRRLLQ--- 257
Query: 278 PMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNG 319
                  PE       +V L C   K+++RP  S  +  ++ 
Sbjct: 258 -------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 292

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 30/218 (13%)
Query: 50  IGEGGFGSVY--------KGRLQDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHE 100
           +GEG FG V         K + ++   VAVK+L  ++ + +  + +SE+  M  +   H+
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK-HK 101
Query: 101 NLVKLHGGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARR------------ 147
           N++ L G C  DGP  ++V +Y    +L + L        ++ +   R            
Sbjct: 102 NIITLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 148 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 207
                + RG+ Y+  +     +HRD+   N+L+ +N   KI+DFGL++    N  +    
Sbjct: 161 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYKKT 216
Query: 208 VAGTLG--YLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
             G L   ++APE       T +SDV+SFGVL+ EI +
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 125/282 (44%), Gaps = 38/282 (13%)
Query: 50  IGEGGFGSVYKGRLQDG----TIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHENLVK 104
           IG G FG VY G L D        AVK L+  +  GE  +F++E   M + +  H N++ 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS--HPNVLS 95
Query: 105 LHGGCIDGP-CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII---MGIGRGLAYI 160
           L G C+      ++V  YM +  L   +  E            +++I   + + +G+ Y+
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKYL 149
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN---TTHISTRVAGTLGYLAP 217
             +     VHRD+   N +LD+ F  K++DFGL++   +    + H  T     + ++A 
Sbjct: 150 ASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 206
Query: 218 EYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD 277
           E   + + T KSDV+SFGVLL E+++       DV        D    +   + L+    
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-----TFDITVYLLQGRRLLQ--- 258
Query: 278 PMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNG 319
                  PE       +V L C   K+++RP  S  +  ++ 
Sbjct: 259 -------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 293

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 107/204 (52%), Gaps = 17/204 (8%)
Query: 48  NKIGEGGFGSVYKGRLQDGTIVAVKVLSV--ESKQGEKEFMSEVASMANVNVCHENLVKL 105
            +IG G FG+VYKG+      VAVK+L+V   + Q  + F +EV  +      H N++ L
Sbjct: 34  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR--HVNIL-L 88
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
             G    P   +V  +   +SL   L   E    KF      +I     +G+ Y+H +  
Sbjct: 89  FMGYSTKPQLAIVTQWCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYLHAK-- 143
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT-THISTRVAGTLGYLAPE---YAI 221
             ++HRD+K++NI L ++   KI DFGL+      + +H   +++G++ ++APE      
Sbjct: 144 -SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 202
Query: 222 SGRLTRKSDVYSFGVLLLEIVSGR 245
               + +SDVY+FG++L E+++G+
Sbjct: 203 KNPYSFQSDVYAFGIVLYELMTGQ 226

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 30/218 (13%)
Query: 50  IGEGGFGSVY--------KGRLQDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHE 100
           +GEG FG V         K + ++   VAVK+L  ++ + +  + +SE+  M  +   H+
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGK-HK 101
Query: 101 NLVKLHGGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARR------------ 147
           N++ L G C  DGP  ++V +Y    +L + L        ++ +   R            
Sbjct: 102 NIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 148 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 207
                + RG+ Y+  +     +HRD+   N+L+ +N   KI+DFGL++    N  +    
Sbjct: 161 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYKKT 216
Query: 208 VAGTLG--YLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
             G L   ++APE       T +SDV+SFGVL+ EI +
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/289 (24%), Positives = 136/289 (47%), Gaps = 36/289 (12%)
Query: 35  NQLKIATNGFRWSNKIGEGGFGSVYKG------RLQDGTIVAVKVLSVESKQGEK-EFMS 87
           ++ ++A      S ++G+G FG VY+G      + +  T VA+K ++  +   E+ EF++
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 64
Query: 88  EVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLS---QTLLGEEKRRAKFGWK 144
           E + M   N CH ++V+L G    G   +++ + M    L    ++L  E +        
Sbjct: 65  EASVMKEFN-CH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 122
Query: 145 ARREIIMGIGR---GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 201
           +  ++I   G    G+AY++       VHRD+   N ++ ++F  KI DFG+++   E T
Sbjct: 123 SLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE-T 178
Query: 202 THISTRVAGTLG--YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHL 259
            +      G L   +++PE    G  T  SDV+SFGV+L EI +               L
Sbjct: 179 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------L 223
Query: 260 VDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRP 308
            ++ +   ++++++  V      + P+N      ++  +C Q   K+RP
Sbjct: 224 AEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRP 272

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 107/204 (52%), Gaps = 17/204 (8%)
Query: 48  NKIGEGGFGSVYKGRLQDGTIVAVKVLSV--ESKQGEKEFMSEVASMANVNVCHENLVKL 105
            +IG G FG+VYKG+      VAVK+L+V   + Q  + F +EV  +      H N++ L
Sbjct: 42  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR--HVNIL-L 96
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
             G    P   +V  +   +SL   L   E    KF      +I     +G+ Y+H +  
Sbjct: 97  FMGYSTKPQLAIVTQWCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYLHAK-- 151
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE-NTTHISTRVAGTLGYLAPE---YAI 221
             ++HRD+K++NI L ++   KI DFGL+      + +H   +++G++ ++APE      
Sbjct: 152 -SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 210
Query: 222 SGRLTRKSDVYSFGVLLLEIVSGR 245
               + +SDVY+FG++L E+++G+
Sbjct: 211 KNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/306 (24%), Positives = 141/306 (46%), Gaps = 36/306 (11%)
Query: 30  NAFSYNQLKIATNGFRWSNKIGEGGFGSVYKG------RLQDGTIVAVKVLSVESKQGEK 83
           + +  ++ ++A      S ++G+G FG VY+G      + +  T VA+K ++  +   E+
Sbjct: 35  DVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER 94
Query: 84  -EFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLS---QTLLGEEKRRA 139
            EF++E + M   N CH ++V+L G    G   +++ + M    L    ++L  E +   
Sbjct: 95  IEFLNEASVMKEFN-CH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP 152
Query: 140 KFGWKARREIIMGIGR---GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196
                +  ++I   G    G+AY++       VHRD+   N ++ ++F  KI DFG+++ 
Sbjct: 153 VLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD 209
Query: 197 FPENTTHISTRVAGTLG--YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254
             E T +      G L   +++PE    G  T  SDV+SFGV+L EI +           
Sbjct: 210 IYE-TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------- 257
Query: 255 GEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAI 314
               L ++ +   ++++++  V      + P+N      ++  +C Q   K+RP     I
Sbjct: 258 ----LAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 313
Query: 315 KMMNGE 320
             +  E
Sbjct: 314 SSIKEE 319

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 139/301 (46%), Gaps = 36/301 (11%)
Query: 35  NQLKIATNGFRWSNKIGEGGFGSVYKG------RLQDGTIVAVKVLSVESKQGEK-EFMS 87
           ++ ++A      S ++G+G FG VY+G      + +  T VA+K ++  +   E+ EF++
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 64
Query: 88  EVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLS---QTLLGEEKRRAKFGWK 144
           E + M   N CH ++V+L G    G   +++ + M    L    ++L  E +        
Sbjct: 65  EASVMKEFN-CH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 122
Query: 145 ARREIIMGIGR---GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 201
           +  ++I   G    G+AY++       VHRD+   N  + ++F  KI DFG+++   E T
Sbjct: 123 SLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYE-T 178
Query: 202 THISTRVAGTLG--YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHL 259
            +      G L   +++PE    G  T  SDV+SFGV+L EI +               L
Sbjct: 179 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------L 223
Query: 260 VDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNG 319
            ++ +   ++++++  V      + P+N     L++  +C Q   K+RP     I  +  
Sbjct: 224 AEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLLELMRMCWQYNPKMRPSFLEIISSIKE 283
Query: 320 E 320
           E
Sbjct: 284 E 284

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 109/229 (47%), Gaps = 23/229 (10%)
Query: 32  FSYNQ-LKIATNGFRWSNKIGEGGFGSVYKGRL-----QDGTI-VAVKVLSVESKQGEKE 84
             YN+  +   N  ++   +G G FG V +        +D  + VAVK+L   +   EKE
Sbjct: 27  LPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKE 86
Query: 85  -FMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGW 143
             MSE+  M+++   HEN+V L G C  G   +++ +Y     L   L    K  A    
Sbjct: 87  ALMSELKIMSHLGQ-HENIVNLLGACTHGGPVLVITEYCCYGDLLNFL--RRKAEADLDK 143
Query: 144 KARREIIM--------GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK 195
           +  R + +         + +G+A++  +   + +HRD+   N+LL      KI DFGL++
Sbjct: 144 EDGRPLELRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLAR 200
Query: 196 LFPENTTHISTRVAG-TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
               ++ +I    A   + ++APE       T +SDV+S+G+LL EI S
Sbjct: 201 DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 105/208 (50%), Gaps = 19/208 (9%)
Query: 50  IGEGGFGSVYKGRL--QDGTI--VAVKVLSVE-SKQGE-KEFMSEVASMANVNVCHENLV 103
           +GEG FGSV +G L  +DGT   VAVK + ++ S Q E +EF+SE A M + +  H N++
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFS--HPNVI 99
Query: 104 KLHGGCIDG-----PCRILVYDYMPNNSLSQTLLGE--EKRRAKFGWKARREIIMGIGRG 156
           +L G CI+      P  +++  +M    L   LL    E        +   + ++ I  G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG-TLGYL 215
           + Y+      + +HRD+   N +L  +    ++DFGLSK       +   R+A   + ++
Sbjct: 160 MEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216
Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVS 243
           A E       T KSDV++FGV + EI +
Sbjct: 217 AIESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 134/287 (46%), Gaps = 36/287 (12%)
Query: 49  KIGEGGFGSVYKGRLQD------GTIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHEN 101
           ++G+G FG VY+G  +D       T VAVK ++  +   E+ EF++E + M     CH +
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFT-CH-H 81
Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLS---QTLLGEEKRRAKFGWKARREIIM---GIGR 155
           +V+L G    G   ++V + M +  L    ++L  E +          +E+I     I  
Sbjct: 82  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG-- 213
           G+AY++ +     VHR++   N ++  +F  KI DFG+++   E T +      G L   
Sbjct: 142 GMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYE-TDYYRKGGKGLLPVR 197
Query: 214 YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELM 273
           ++APE    G  T  SD++SFGV+L EI S               L ++ +   ++++++
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVL 242
Query: 274 NLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE 320
             V    Y + P+N   R   +  +C Q    +RP     + ++  +
Sbjct: 243 KFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDD 289

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 134/287 (46%), Gaps = 36/287 (12%)
Query: 49  KIGEGGFGSVYKGRLQD------GTIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHEN 101
           ++G+G FG VY+G  +D       T VAVK ++  +   E+ EF++E + M     CH +
Sbjct: 25  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFT-CH-H 82
Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLS---QTLLGEEKRRAKFGWKARREIIM---GIGR 155
           +V+L G    G   ++V + M +  L    ++L  E +          +E+I     I  
Sbjct: 83  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 142
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG-- 213
           G+AY++ +     VHR++   N ++  +F  KI DFG+++   E T +      G L   
Sbjct: 143 GMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYE-TDYYRKGGKGLLPVR 198
Query: 214 YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELM 273
           ++APE    G  T  SD++SFGV+L EI S               L ++ +   ++++++
Sbjct: 199 WMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVL 243
Query: 274 NLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE 320
             V    Y + P+N   R   +  +C Q    +RP     + ++  +
Sbjct: 244 KFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDD 290

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 109/229 (47%), Gaps = 23/229 (10%)
Query: 32  FSYNQ-LKIATNGFRWSNKIGEGGFGSVYKGRL-----QDGTI-VAVKVLSVESKQGEKE 84
             YN+  +   N  ++   +G G FG V +        +D  + VAVK+L   +   EKE
Sbjct: 35  LPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKE 94
Query: 85  -FMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGW 143
             MSE+  M+++   HEN+V L G C  G   +++ +Y     L   L    K  A    
Sbjct: 95  ALMSELKIMSHLGQ-HENIVNLLGACTHGGPVLVITEYCCYGDLLNFL--RRKAEADLDK 151
Query: 144 KARREIIM--------GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK 195
           +  R + +         + +G+A++  +   + +HRD+   N+LL      KI DFGL++
Sbjct: 152 EDGRPLELRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLAR 208
Query: 196 LFPENTTHISTRVAG-TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
               ++ +I    A   + ++APE       T +SDV+S+G+LL EI S
Sbjct: 209 DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 126/282 (44%), Gaps = 38/282 (13%)
Query: 50  IGEGGFGSVYKGRLQDG----TIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHENLVK 104
           IG G FG VY G L D        AVK L+  +  GE  +F++E   M + +  H N++ 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS--HPNVLS 95
Query: 105 LHGGCIDGP-CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII---MGIGRGLAYI 160
           L G C+      ++V  YM +  L   +  E            +++I   + + +G+ ++
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKFL 149
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE---NTTHISTRVAGTLGYLAP 217
             +     VHRD+   N +LD+ F  K++DFGL++   +   ++ H  T     + ++A 
Sbjct: 150 ASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 206
Query: 218 EYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD 277
           E   + + T KSDV+SFGVLL E+++       DV        D    +   + L+    
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-----TFDITVYLLQGRRLLQ--- 258
Query: 278 PMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNG 319
                  PE       +V L C   K+++RP  S  +  ++ 
Sbjct: 259 -------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 293

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 30/218 (13%)
Query: 50  IGEGGFGSVY--------KGRLQDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHE 100
           +GEG FG V         K + ++   VAVK+L  ++ + +  + +SE+  M  +   H+
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK-HK 88
Query: 101 NLVKLHGGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARR------------ 147
           N++ L G C  DGP  ++V +Y    +L + L        ++ +   R            
Sbjct: 89  NIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 147
Query: 148 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 207
                + RG+ Y+  +     +HRD+   N+L+ +N   KI+DFGL++    N  +    
Sbjct: 148 SCTYQLARGMEYLASQ---KCIHRDLTARNVLVTENNVMKIADFGLARDI-NNIDYYKKT 203
Query: 208 VAGTLG--YLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
             G L   ++APE       T +SDV+SFGVL+ EI +
Sbjct: 204 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 106/201 (52%), Gaps = 16/201 (7%)
Query: 50  IGEGGFGSVYKG-RLQDG----TIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLV 103
           +G G FG+VYKG  + DG      VA+KVL    S +  KE + E   MA V   +  + 
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPY--VS 82
Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
           +L G C+    + LV   MP   L   +    + R + G +      M I +G++Y+ E+
Sbjct: 83  RLLGICLTSTVQ-LVTQLMPYGCLLDHV---RENRGRLGSQDLLNWCMQIAKGMSYL-ED 137
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP-ENTTHISTRVAGTLGYLAPEYAIS 222
           ++  +VHRD+   N+L+    + KI+DFGL++L   + T + +      + ++A E  + 
Sbjct: 138 VR--LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILR 195
Query: 223 GRLTRKSDVYSFGVLLLEIVS 243
            R T +SDV+S+GV + E+++
Sbjct: 196 RRFTHQSDVWSYGVTVWELMT 216

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 126/282 (44%), Gaps = 38/282 (13%)
Query: 50  IGEGGFGSVYKGRLQDG----TIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHENLVK 104
           IG G FG VY G L D        AVK L+  +  GE  +F++E   M + +  H N++ 
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS--HPNVLS 93
Query: 105 LHGGCIDGP-CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII---MGIGRGLAYI 160
           L G C+      ++V  YM +  L   +  E            +++I   + + +G+ ++
Sbjct: 94  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKFL 147
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE---NTTHISTRVAGTLGYLAP 217
             +     VHRD+   N +LD+ F  K++DFGL++   +   ++ H  T     + ++A 
Sbjct: 148 ASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 204
Query: 218 EYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD 277
           E   + + T KSDV+SFGVLL E+++       DV        D    +   + L+    
Sbjct: 205 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-----TFDITVYLLQGRRLLQ--- 256
Query: 278 PMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNG 319
                  PE       +V L C   K+++RP  S  +  ++ 
Sbjct: 257 -------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 291

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 126/282 (44%), Gaps = 38/282 (13%)
Query: 50  IGEGGFGSVYKGRLQDG----TIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHENLVK 104
           IG G FG VY G L D        AVK L+  +  GE  +F++E   M + +  H N++ 
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS--HPNVLS 96
Query: 105 LHGGCIDGP-CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII---MGIGRGLAYI 160
           L G C+      ++V  YM +  L   +  E            +++I   + + +G+ ++
Sbjct: 97  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKFL 150
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE---NTTHISTRVAGTLGYLAP 217
             +     VHRD+   N +LD+ F  K++DFGL++   +   ++ H  T     + ++A 
Sbjct: 151 ASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 207
Query: 218 EYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD 277
           E   + + T KSDV+SFGVLL E+++       DV        D    +   + L+    
Sbjct: 208 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-----TFDITVYLLQGRRLLQ--- 259
Query: 278 PMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNG 319
                  PE       +V L C   K+++RP  S  +  ++ 
Sbjct: 260 -------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 294

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 126/282 (44%), Gaps = 38/282 (13%)
Query: 50  IGEGGFGSVYKGRLQDG----TIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHENLVK 104
           IG G FG VY G L D        AVK L+  +  GE  +F++E   M + +  H N++ 
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS--HPNVLS 100
Query: 105 LHGGCIDGP-CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII---MGIGRGLAYI 160
           L G C+      ++V  YM +  L   +  E            +++I   + + +G+ ++
Sbjct: 101 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKFL 154
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE---NTTHISTRVAGTLGYLAP 217
             +     VHRD+   N +LD+ F  K++DFGL++   +   ++ H  T     + ++A 
Sbjct: 155 ASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 211
Query: 218 EYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD 277
           E   + + T KSDV+SFGVLL E+++       DV        D    +   + L+    
Sbjct: 212 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-----TFDITVYLLQGRRLLQ--- 263
Query: 278 PMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNG 319
                  PE       +V L C   K+++RP  S  +  ++ 
Sbjct: 264 -------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 298

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 129/282 (45%), Gaps = 38/282 (13%)
Query: 50  IGEGGFGSVYKGRLQDG----TIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHENLVK 104
           IG G FG VY G L D        AVK L+  +  GE  +F++E   M + +  H N++ 
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS--HPNVLS 96
Query: 105 LHGGCIDGP-CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII---MGIGRGLAYI 160
           L G C+      ++V  YM +  L   +  E            +++I   + + +G+ ++
Sbjct: 97  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKFL 150
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE---NTTHISTRVAGTLGYLAP 217
             +     VHRD+   N +LD+ F  K++DFGL++   +   ++ H  T     + ++A 
Sbjct: 151 ASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMAL 207
Query: 218 EYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD 277
           E   + + T KSDV+SFGVLL E+++ R A  +     + +  D    +   + L+    
Sbjct: 208 ESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYP----DVNTFDITVYLLQGRRLLQ--- 259
Query: 278 PMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNG 319
                  PE       +V L C   K+++RP  S  +  ++ 
Sbjct: 260 -------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 294

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 129/282 (45%), Gaps = 38/282 (13%)
Query: 50  IGEGGFGSVYKGRLQDG----TIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHENLVK 104
           IG G FG VY G L D        AVK L+  +  GE  +F++E   M + +  H N++ 
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS--HPNVLS 154
Query: 105 LHGGCIDGP-CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII---MGIGRGLAYI 160
           L G C+      ++V  YM +  L   +  E            +++I   + + +G+ ++
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKFL 208
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE---NTTHISTRVAGTLGYLAP 217
             +     VHRD+   N +LD+ F  K++DFGL++   +   ++ H  T     + ++A 
Sbjct: 209 ASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 265
Query: 218 EYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD 277
           E   + + T KSDV+SFGVLL E+++ R A  +     + +  D    +   + L+    
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYP----DVNTFDITVYLLQGRRLLQ--- 317
Query: 278 PMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNG 319
                  PE       +V L C   K+++RP  S  +  ++ 
Sbjct: 318 -------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 352

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 30/218 (13%)
Query: 50  IGEGGFGSVY--------KGRLQDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHE 100
           +GEG FG V         K + ++   VAVK+L  ++ + +  + +SE+  M  +   H+
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK-HK 93
Query: 101 NLVKLHGGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARR------------ 147
           N++ L G C  DGP  ++V +Y    +L + L        ++ +   R            
Sbjct: 94  NIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 152
Query: 148 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 207
                + RG+ Y+  +     +HRD+   N+L+ +N   KI+DFGL++    N  +    
Sbjct: 153 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYKKT 208
Query: 208 VAGTLG--YLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
             G L   ++APE       T +SDV+SFGVL+ EI +
Sbjct: 209 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 103/218 (47%), Gaps = 30/218 (13%)
Query: 50  IGEGGFGSVY--------KGRLQDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHE 100
           +GEG FG V         K + ++   VAVK+L  ++ + +  + +SE+  M  +   H+
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK-HK 101
Query: 101 NLVKLHGGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARR------------ 147
           N++ L G C  DGP  ++V +Y    +L + L        ++ +   R            
Sbjct: 102 NIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 148 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 207
                + RG+ Y+  +     +HRD+   N+L+ +N   +I+DFGL++    N  +    
Sbjct: 161 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMRIADFGLARDI-NNIDYYKKT 216
Query: 208 VAGTLG--YLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
             G L   ++APE       T +SDV+SFGVL+ EI +
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 30/218 (13%)
Query: 50  IGEGGFGSVY--------KGRLQDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHE 100
           +GEG FG V         K + ++   VAVK+L  ++ + +  + +SE+  M  +   H+
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK-HK 90
Query: 101 NLVKLHGGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARR------------ 147
           N++ L G C  DGP  ++V +Y    +L + L        ++ +   R            
Sbjct: 91  NIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 149
Query: 148 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 207
                + RG+ Y+  +     +HRD+   N+L+ +N   KI+DFGL++    N  +    
Sbjct: 150 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYKKT 205
Query: 208 VAGTLG--YLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
             G L   ++APE       T +SDV+SFGVL+ EI +
Sbjct: 206 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 129/282 (45%), Gaps = 38/282 (13%)
Query: 50  IGEGGFGSVYKGRLQDG----TIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHENLVK 104
           IG G FG VY G L D        AVK L+  +  GE  +F++E   M + +  H N++ 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS--HPNVLS 95
Query: 105 LHGGCIDGP-CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII---MGIGRGLAYI 160
           L G C+      ++V  YM +  L   +  E            +++I   + + +G+ ++
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKFL 149
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE---NTTHISTRVAGTLGYLAP 217
             +     VHRD+   N +LD+ F  K++DFGL++   +   ++ H  T     + ++A 
Sbjct: 150 ASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 206
Query: 218 EYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD 277
           E   + + T KSDV+SFGVLL E+++ R A  +     + +  D    +   + L+    
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYP----DVNTFDITVYLLQGRRLLQ--- 258
Query: 278 PMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNG 319
                  PE       +V L C   K+++RP  S  +  ++ 
Sbjct: 259 -------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 293

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 30/218 (13%)
Query: 50  IGEGGFGSVY--------KGRLQDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHE 100
           +GEG FG V         K + ++   VAVK+L  ++ + +  + +SE+  M  +   H+
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK-HK 147
Query: 101 NLVKLHGGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARR------------ 147
           N++ L G C  DGP  ++V +Y    +L + L        ++ +   R            
Sbjct: 148 NIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 148 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 207
                + RG+ Y+  +     +HRD+   N+L+ +N   KI+DFGL++    N  +    
Sbjct: 207 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYKKT 262
Query: 208 VAGTLG--YLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
             G L   ++APE       T +SDV+SFGVL+ EI +
Sbjct: 263 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 102/218 (46%), Gaps = 30/218 (13%)
Query: 50  IGEGGFGSVY--------KGRLQDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHE 100
           +GEG FG V         K + ++   VAVK+L  ++ + +  + +SE+  M  +   H+
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK-HK 101
Query: 101 NLVKLHGGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARR------------ 147
           N++ L G C  DGP  ++V +Y    +L + L        ++ +   R            
Sbjct: 102 NIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 148 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 207
                + RG+ Y+  +     +HRD+   N+L+ +N   KI+DFGL++    N       
Sbjct: 161 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDXXKKT 216
Query: 208 VAGTLG--YLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
             G L   ++APE       T +SDV+SFGVL+ EI +
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 102/218 (46%), Gaps = 30/218 (13%)
Query: 50  IGEGGFGSVY--------KGRLQDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHE 100
           +GEG FG V         K + ++   VAVK+L  ++ + +  + +SE+  M  +   H+
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK-HK 101
Query: 101 NLVKLHGGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARR------------ 147
           N++ L G C  DGP  ++V  Y    +L + L        ++ +   R            
Sbjct: 102 NIINLLGACTQDGPLYVIVA-YASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 148 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 207
                + RG+ Y+  +     +HRD+   N+L+ +N   KI+DFGL++    N  +    
Sbjct: 161 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYKKT 216
Query: 208 VAGTLG--YLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
             G L   ++APE       T +SDV+SFGVL+ EI +
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/294 (24%), Positives = 134/294 (45%), Gaps = 36/294 (12%)
Query: 30  NAFSYNQLKIATNGFRWSNKIGEGGFGSVYKG------RLQDGTIVAVKVLSVESKQGEK 83
           + +  ++ ++A      S ++G+G FG VY+G      + +  T VA+K ++  +   E+
Sbjct: 13  DVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER 72
Query: 84  -EFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTL------LGEEK 136
            EF++E + M   N CH ++V+L G    G   +++ + M    L   L      +    
Sbjct: 73  IEFLNEASVMKEFN-CH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNP 130
Query: 137 RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196
             A        ++   I  G+AY++       VHRD+   N ++ ++F  KI DFG+++ 
Sbjct: 131 VLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD 187
Query: 197 FPENTTHISTRVAGTLG--YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254
             E T +      G L   +++PE    G  T  SDV+SFGV+L EI +           
Sbjct: 188 IYE-TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------- 235
Query: 255 GEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRP 308
               L ++ +   ++++++  V      + P+N      ++  +C Q   K+RP
Sbjct: 236 ----LAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRP 285

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/294 (24%), Positives = 134/294 (45%), Gaps = 36/294 (12%)
Query: 30  NAFSYNQLKIATNGFRWSNKIGEGGFGSVYKG------RLQDGTIVAVKVLSVESKQGEK 83
           + +  ++ ++A      S ++G+G FG VY+G      + +  T VA+K ++  +   E+
Sbjct: 3   DVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER 62
Query: 84  -EFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTL------LGEEK 136
            EF++E + M   N CH ++V+L G    G   +++ + M    L   L      +    
Sbjct: 63  IEFLNEASVMKEFN-CH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNP 120
Query: 137 RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196
             A        ++   I  G+AY++       VHRD+   N ++ ++F  KI DFG+++ 
Sbjct: 121 VLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD 177
Query: 197 FPENTTHISTRVAGTLG--YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254
             E T +      G L   +++PE    G  T  SDV+SFGV+L EI +           
Sbjct: 178 IYE-TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------- 225
Query: 255 GEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRP 308
               L ++ +   ++++++  V      + P+N      ++  +C Q   K+RP
Sbjct: 226 ----LAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRP 275

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 50  IGEGGFGSV---YKGRLQDGT--IVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLV 103
           +GEG FG V         DGT  +VAVK L      Q    +  E+  +  +   HE++V
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLY--HEHIV 73
Query: 104 KLHGGCID-GPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
           K  G C D G   + LV +Y+P  SL   L      R   G          I  G+AY+H
Sbjct: 74  KYKGCCEDQGEKSVQLVMEYVPLGSLRDYL-----PRHCVGLAQLLLFAQQICEGMAYLH 128
Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG--TLGYLAPEY 219
            +   H +HR +   N+LLD +   KI DFGL+K  PE   +   R  G   + + APE 
Sbjct: 129 AQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 185
Query: 220 AISGRLTRKSDVYSFGVLLLEIVS 243
               +    SDV+SFGV L E+++
Sbjct: 186 LKECKFYYASDVWSFGVTLYELLT 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 50  IGEGGFGSV---YKGRLQDGT--IVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLV 103
           +GEG FG V         DGT  +VAVK L      Q    +  E+  +  +   HE++V
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLY--HEHIV 74
Query: 104 KLHGGCID-GPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
           K  G C D G   + LV +Y+P  SL   L      R   G          I  G+AY+H
Sbjct: 75  KYKGCCEDQGEKSVQLVMEYVPLGSLRDYL-----PRHCVGLAQLLLFAQQICEGMAYLH 129
Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG--TLGYLAPEY 219
            +   H +HR +   N+LLD +   KI DFGL+K  PE   +   R  G   + + APE 
Sbjct: 130 AQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 186
Query: 220 AISGRLTRKSDVYSFGVLLLEIVS 243
               +    SDV+SFGV L E+++
Sbjct: 187 LKECKFYYASDVWSFGVTLYELLT 210

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/207 (33%), Positives = 92/207 (44%), Gaps = 17/207 (8%)
Query: 44  FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVL---SVESKQGEKEFMSEVASMANVNVCH 99
           F +   IG+G FG V   R + +    AVKVL   ++  K+ EK  MSE   +   NV H
Sbjct: 40  FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLK-NVKH 98
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
             LV LH           V DY+    L   L    +R   F     R     I   L Y
Sbjct: 99  PFLVGLHFSFQTADKLYFVLDYINGGELFYHL----QRERCFLEPRARFYAAEIASALGY 154
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIST--RVAGTLGYLAP 217
           +H     ++V+RD+K  NILLD   +  ++DFGL K   EN  H ST     GT  YLAP
Sbjct: 155 LHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNSTTSTFCGTPEYLAP 208
Query: 218 EYAISGRLTRKSDVYSFGVLLLEIVSG 244
           E        R  D +  G +L E++ G
Sbjct: 209 EVLHKQPYDRTVDWWCLGAVLYEMLYG 235

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 116/248 (46%), Gaps = 25/248 (10%)
Query: 17  ENTIGGEQILKNINAFSYNQ-LKIATNGFRWSNKIGEGGFGSVYKGRL-----QDGTI-V 69
           E+  G      +     YN+  +   N  ++   +G G FG V +        +D  + V
Sbjct: 20  ESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKV 79
Query: 70  AVKVLSVESKQGEKE-FMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLS 128
           AVK+L   +   EKE  MSE+  M+++   HEN+V L G C  G   +++ +Y     L 
Sbjct: 80  AVKMLKSTAHADEKEALMSELKIMSHLGQ-HENIVNLLGACTHGGPVLVITEYCCYGDLL 138
Query: 129 QTLLGEEKRRAKFGWK---------ARREIIM---GIGRGLAYIHEEIQPHVVHRDIKTS 176
             L  +     ++ +          + R+++     + +G+A++  +   + +HRD+   
Sbjct: 139 NFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASK---NCIHRDVAAR 195
Query: 177 NILLDQNFNPKISDFGLSKLFPENTTHISTRVAG-TLGYLAPEYAISGRLTRKSDVYSFG 235
           N+LL      KI DFGL++    ++ +I    A   + ++APE       T +SDV+S+G
Sbjct: 196 NVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYG 255
Query: 236 VLLLEIVS 243
           +LL EI S
Sbjct: 256 ILLWEIFS 263

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 102/218 (46%), Gaps = 30/218 (13%)
Query: 50  IGEGGFGSVY--------KGRLQDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHE 100
           +GEG FG V         K + ++   VAVK+L  ++ + +  + +SE+  M  +   H+
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK-HK 101
Query: 101 NLVKLHGGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARR------------ 147
           N++ L G C  DGP  ++V  Y    +L + L        ++ +   R            
Sbjct: 102 NIINLLGACTQDGPLYVIV-GYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 148 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 207
                + RG+ Y+  +     +HRD+   N+L+ +N   KI+DFGL++    N  +    
Sbjct: 161 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYKKT 216
Query: 208 VAGTLG--YLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
             G L   ++APE       T +SDV+SFGVL+ EI +
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 111/236 (47%), Gaps = 26/236 (11%)
Query: 29  INAFSYNQLK-IATNGFRWSNKIGEGGFGSVYKGRL------QDGTIVAVKVLSVESKQG 81
           IN     +LK I+ +  R+  ++GE  FG VYKG L      +    VA+K L  +++  
Sbjct: 12  INQHKQAKLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGP 71
Query: 82  -EKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLL-------- 132
             +EF  E  +M    + H N+V L G         +++ Y  +  L + L+        
Sbjct: 72  LREEFRHE--AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDV 129
Query: 133 --GEEKRRAKFGWKARR--EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKI 188
              ++ R  K   +      ++  I  G+ Y+      HVVH+D+ T N+L+    N KI
Sbjct: 130 GSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKI 186
Query: 189 SDFGLSK-LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
           SD GL + ++  +   +       + ++APE  + G+ +  SD++S+GV+L E+ S
Sbjct: 187 SDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 111/229 (48%), Gaps = 23/229 (10%)
Query: 34  YNQ-LKIATNGFRWSNKIGEGGFGSVYKGRL-----QDGTI-VAVKVLSVESKQGEKE-F 85
           YN+  +   N  ++   +G G FG V +        +D  + VAVK+L   +   EKE  
Sbjct: 37  YNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEAL 96
Query: 86  MSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSL-------SQTLLGEEKRR 138
           MSE+  M+++   HEN+V L G C  G   +++ +Y     L       S+ L  +    
Sbjct: 97  MSELKIMSHLGQ-HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFA 155
Query: 139 AKFGWKARREIIM---GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK 195
                 + R+++     + +G+A++  +   + +HRD+   N+LL      KI DFGL++
Sbjct: 156 IANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLAR 212
Query: 196 LFPENTTHISTRVAG-TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
               ++ +I    A   + ++APE       T +SDV+S+G+LL EI S
Sbjct: 213 DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 106/201 (52%), Gaps = 15/201 (7%)
Query: 49  KIGEGGFGSVYKG--RLQDGTI-VAVKVLSVESKQGE-KEFMSEVASMANVNVCHENLVK 104
           ++G G FGSV +G  R++   I VA+KVL   +++ + +E M E   M  ++  +  +V+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD--NPYIVR 400
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L G C      +LV +      L + L+G   +R +       E++  +  G+ Y+ E+ 
Sbjct: 401 LIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK- 455
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG--TLGYLAPEYAIS 222
             + VHR++   N+LL      KISDFGLSK    + ++ + R AG   L + APE    
Sbjct: 456 --NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 513
Query: 223 GRLTRKSDVYSFGVLLLEIVS 243
            + + +SDV+S+GV + E +S
Sbjct: 514 RKFSSRSDVWSYGVTMWEALS 534

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 104/231 (45%), Gaps = 37/231 (16%)
Query: 51  GEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCI 110
             G FG V+K +L +   VAVK+  ++ KQ    + SE    +   + HENL++      
Sbjct: 24  ARGRFGCVWKAQLMN-DFVAVKIFPLQDKQS---WQSEREIFSTPGMKHENLLQFIAAEK 79
Query: 111 DGPCR----ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI-- 164
            G        L+  +    SL+  L G         W     +   + RGL+Y+HE++  
Sbjct: 80  RGSNLEVELWLITAFHDKGSLTDYLKGN-----IITWNELCHVAETMSRGLSYLHEDVPW 134
Query: 165 ------QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF----PENTTHISTRVAGTLGY 214
                 +P + HRD K+ N+LL  +    ++DFGL+  F    P   TH      GT  Y
Sbjct: 135 CRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQV---GTRRY 191
Query: 215 LAPEYAISGRLTRKS------DVYSFGVLLLEIVSGRTAVDFDVQLGEYHL 259
           +APE  + G +  +       D+Y+ G++L E+VS   A D  V   EY L
Sbjct: 192 MAPE-VLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVD--EYML 239

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 89/325 (27%), Positives = 150/325 (46%), Gaps = 38/325 (11%)
Query: 50  IGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKE--FMSEVASMANVNVCHENLVKLH 106
           +G+G FG V K + +      AVKV++  S + +     + EV  +  ++  H N++KL 
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD--HPNIMKLF 87
Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
               D     +V +      L   ++    +R +F       II  +  G+ Y+H+    
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEII----KRKRFSEHDAARIIKQVFSGITYMHKH--- 140
Query: 167 HVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG 223
           ++VHRD+K  NILL   +++ + KI DFGLS  F +N T +  R+ GT  Y+APE  + G
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI-GTAYYIAPE-VLRG 197
Query: 224 RLTRKSDVYSFGVLLLEIVSGRTAV----DFD----VQLGEYHLVDKAWGMYNSKELMNL 275
               K DV+S GV+L  ++SG        ++D    V+ G+Y      W    S +  +L
Sbjct: 198 TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTI-SDDAKDL 256
Query: 276 VDPMLYGNFPENEAIRFLKVGLL---CVQEKSKLRPQMSTAIKMMNGETNIDGXDVE--I 330
           +  ML      + ++R      L    +Q+ S   P +S    + +  TNI     E  +
Sbjct: 257 IRKMLTF----HPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKL 312
Query: 331 SQPGLIGDIMDVKVGQRSSSKSMTE 355
           +Q  L+   M  K+     +K +TE
Sbjct: 313 AQAALL--YMASKLTTLDETKQLTE 335

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 18/214 (8%)
Query: 39  IATNGFRWSNKIGEGGFGSVYKGRLQDGT----IVAVKVLS---VESKQGEKEFMSEVAS 91
           I     R   K+G+G FG V +G     +     VAVK L    +   +   +F+ EV +
Sbjct: 15  IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 74
Query: 92  MANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
           M +++  H NL++L+G  +  P + +V +  P  SL   L    K +  F         +
Sbjct: 75  MHSLD--HRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRL---RKHQGHFLLGTLSRYAV 128
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH--ISTRVA 209
            +  G+ Y+  +     +HRD+   N+LL      KI DFGL +  P+N  H  +     
Sbjct: 129 QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRK 185
Query: 210 GTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
               + APE   +   +  SD + FGV L E+ +
Sbjct: 186 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 18/214 (8%)
Query: 39  IATNGFRWSNKIGEGGFGSVYKGRLQDGT----IVAVKVLS---VESKQGEKEFMSEVAS 91
           I     R   K+G+G FG V +G     +     VAVK L    +   +   +F+ EV +
Sbjct: 9   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 68
Query: 92  MANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
           M +++  H NL++L+G  +  P + +V +  P  SL   L    K +  F         +
Sbjct: 69  MHSLD--HRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRL---RKHQGHFLLGTLSRYAV 122
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH--ISTRVA 209
            +  G+ Y+  +     +HRD+   N+LL      KI DFGL +  P+N  H  +     
Sbjct: 123 QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 179
Query: 210 GTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
               + APE   +   +  SD + FGV L E+ +
Sbjct: 180 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 18/214 (8%)
Query: 39  IATNGFRWSNKIGEGGFGSVYKGRLQDGT----IVAVKVLS---VESKQGEKEFMSEVAS 91
           I     R   K+G+G FG V +G     +     VAVK L    +   +   +F+ EV +
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 92  MANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
           M +++  H NL++L+G  +  P + +V +  P  SL   L    K +  F         +
Sbjct: 65  MHSLD--HRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRL---RKHQGHFLLGTLSRYAV 118
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH--ISTRVA 209
            +  G+ Y+  +     +HRD+   N+LL      KI DFGL +  P+N  H  +     
Sbjct: 119 QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175
Query: 210 GTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
               + APE   +   +  SD + FGV L E+ +
Sbjct: 176 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 18/214 (8%)
Query: 39  IATNGFRWSNKIGEGGFGSVYKGRLQDGT----IVAVKVLS---VESKQGEKEFMSEVAS 91
           I     R   K+G+G FG V +G     +     VAVK L    +   +   +F+ EV +
Sbjct: 15  IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 74
Query: 92  MANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
           M +++  H NL++L+G  +  P + +V +  P  SL   L    K +  F         +
Sbjct: 75  MHSLD--HRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRL---RKHQGHFLLGTLSRYAV 128
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH--ISTRVA 209
            +  G+ Y+  +     +HRD+   N+LL      KI DFGL +  P+N  H  +     
Sbjct: 129 QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 185
Query: 210 GTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
               + APE   +   +  SD + FGV L E+ +
Sbjct: 186 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 18/214 (8%)
Query: 39  IATNGFRWSNKIGEGGFGSVYKGRLQDGT----IVAVKVLS---VESKQGEKEFMSEVAS 91
           I     R   K+G+G FG V +G     +     VAVK L    +   +   +F+ EV +
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 92  MANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
           M +++  H NL++L+G  +  P + +V +  P  SL   L    K +  F         +
Sbjct: 65  MHSLD--HRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRL---RKHQGHFLLGTLSRYAV 118
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH--ISTRVA 209
            +  G+ Y+  +     +HRD+   N+LL      KI DFGL +  P+N  H  +     
Sbjct: 119 QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRK 175
Query: 210 GTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
               + APE   +   +  SD + FGV L E+ +
Sbjct: 176 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 113/240 (47%), Gaps = 24/240 (10%)
Query: 19  TIGGEQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVE 77
           ++  +   ++++    + L+     F     +G G +G VYKGR ++ G + A+KV+ V 
Sbjct: 1   SMASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT 60
Query: 78  SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID-GPCRI-----LVYDYMPNNSLSQTL 131
             + E+E   E+ +M      H N+   +G  I   P  +     LV ++    S++  +
Sbjct: 61  GDE-EEEIKQEI-NMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI 118
Query: 132 LGEEKRRAKFGWKAR--REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKIS 189
              +    K  W A   REI+    RGL+++H   Q  V+HRDIK  N+LL +N   K+ 
Sbjct: 119 KNTKGNTLKEEWIAYICREIL----RGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLV 171
Query: 190 DFGLSKLFPENTTHISTRVAGTLGYLAPEYAI-----SGRLTRKSDVYSFGVLLLEIVSG 244
           DFG+S          +T + GT  ++APE              KSD++S G+  +E+  G
Sbjct: 172 DFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 18/214 (8%)
Query: 39  IATNGFRWSNKIGEGGFGSVYKGRLQDGT----IVAVKVLS---VESKQGEKEFMSEVAS 91
           I     R   K+G+G FG V +G     +     VAVK L    +   +   +F+ EV +
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 92  MANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
           M +++  H NL++L+G  +  P + +V +  P  SL   L    K +  F         +
Sbjct: 65  MHSLD--HRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRL---RKHQGHFLLGTLSRYAV 118
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH--ISTRVA 209
            +  G+ Y+  +     +HRD+   N+LL      KI DFGL +  P+N  H  +     
Sbjct: 119 QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175
Query: 210 GTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
               + APE   +   +  SD + FGV L E+ +
Sbjct: 176 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 111/229 (48%), Gaps = 23/229 (10%)
Query: 34  YNQ-LKIATNGFRWSNKIGEGGFGSVYKGRL-----QDGTI-VAVKVLSVESKQGEKE-F 85
           YN+  +   N  ++   +G G FG V +        +D  + VAVK+L   +   EKE  
Sbjct: 37  YNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEAL 96
Query: 86  MSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSL-------SQTLLGEEKRR 138
           MSE+  M+++   HEN+V L G C  G   +++ +Y     L       S+ L  +    
Sbjct: 97  MSELKIMSHLGQ-HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFA 155
Query: 139 AKFGWKARREIIM---GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK 195
                 + R+++     + +G+A++  +   + +HRD+   N+LL      KI DFGL++
Sbjct: 156 IANSTLSTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLAR 212
Query: 196 LFPENTTHISTRVAG-TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
               ++ +I    A   + ++APE       T +SDV+S+G+LL EI S
Sbjct: 213 DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 18/214 (8%)
Query: 39  IATNGFRWSNKIGEGGFGSVYKGRLQDGT----IVAVKVLS---VESKQGEKEFMSEVAS 91
           I     R   K+G+G FG V +G     +     VAVK L    +   +   +F+ EV +
Sbjct: 9   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 68
Query: 92  MANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
           M +++  H NL++L+G  +  P + +V +  P  SL   L    K +  F         +
Sbjct: 69  MHSLD--HRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRL---RKHQGHFLLGTLSRYAV 122
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH--ISTRVA 209
            +  G+ Y+  +     +HRD+   N+LL      KI DFGL +  P+N  H  +     
Sbjct: 123 QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 179
Query: 210 GTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
               + APE   +   +  SD + FGV L E+ +
Sbjct: 180 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 98/205 (47%), Gaps = 20/205 (9%)
Query: 50  IGEGGFGSVYKGRLQD-----GTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHENLV 103
           +GEG FG V   R        G  VAVK L  ES      +   E+  + N+   HEN+V
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY--HENIV 74
Query: 104 KLHGGCI-DGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
           K  G C  DG   I L+ +++P+ SL + L    K + K   K + +  + I +G+ Y+ 
Sbjct: 75  KYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PKNKNKINLKQQLKYAVQICKGMDYLG 131
Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF---PENTTHISTRVAGTLGYLAPE 218
                  VHRD+   N+L++     KI DFGL+K      E  T    R +    Y APE
Sbjct: 132 SR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APE 187
Query: 219 YAISGRLTRKSDVYSFGVLLLEIVS 243
             +  +    SDV+SFGV L E+++
Sbjct: 188 CLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 98/205 (47%), Gaps = 20/205 (9%)
Query: 50  IGEGGFGSVYKGRLQD-----GTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHENLV 103
           +GEG FG V   R        G  VAVK L  ES      +   E+  + N+   HEN+V
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY--HENIV 86
Query: 104 KLHGGCI-DGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
           K  G C  DG   I L+ +++P+ SL + L    K + K   K + +  + I +G+ Y+ 
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PKNKNKINLKQQLKYAVQICKGMDYLG 143
Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF---PENTTHISTRVAGTLGYLAPE 218
                  VHRD+   N+L++     KI DFGL+K      E  T    R +    Y APE
Sbjct: 144 SR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APE 199
Query: 219 YAISGRLTRKSDVYSFGVLLLEIVS 243
             +  +    SDV+SFGV L E+++
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 108/221 (48%), Gaps = 36/221 (16%)
Query: 50  IGEGGFGSVY--------KGRLQDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHE 100
           +GEG FG V         K +    T VAVK+L  ++ + +  + +SE+  M  +   H+
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK-HK 94
Query: 101 NLVKLHGGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWK---------ARREII 150
           N++ L G C  DGP  ++V +Y    +L + L   E    ++ +          + ++++
Sbjct: 95  NIINLLGACTQDGPLYVIV-EYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 151 ---MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 207
                + RG+ Y+  +     +HRD+   N+L+ ++   KI+DFGL++    +  HI   
Sbjct: 154 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 206
Query: 208 VAGTLG-----YLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
              T G     ++APE       T +SDV+SFGVLL EI +
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 102/199 (51%), Gaps = 12/199 (6%)
Query: 50  IGEGGFGSVYKG-RLQDGTIVAVKVL--SVESKQGEKEFMSEVASMANV-NVCHENLVKL 105
           +G G FG+V+KG  + +G  + + V    +E K G + F +    M  + ++ H ++V+L
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
            G C  G    LV  Y+P  SL   +    + R   G +      + I +G+ Y+ E   
Sbjct: 81  LGLC-PGSSLQLVTQYLPLGSLLDHV---RQHRGALGPQLLLNWGVQIAKGMYYLEEH-- 134
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT-LGYLAPEYAISGR 224
             +VHR++   N+LL      +++DFG++ L P +   +    A T + ++A E    G+
Sbjct: 135 -GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK 193
Query: 225 LTRKSDVYSFGVLLLEIVS 243
            T +SDV+S+GV + E+++
Sbjct: 194 YTHQSDVWSYGVTVWELMT 212

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 102/199 (51%), Gaps = 12/199 (6%)
Query: 50  IGEGGFGSVYKG-RLQDGTIVAVKVL--SVESKQGEKEFMSEVASMANV-NVCHENLVKL 105
           +G G FG+V+KG  + +G  + + V    +E K G + F +    M  + ++ H ++V+L
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 98
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
            G C  G    LV  Y+P  SL   +    + R   G +      + I +G+ Y+ E   
Sbjct: 99  LGLC-PGSSLQLVTQYLPLGSLLDHV---RQHRGALGPQLLLNWGVQIAKGMYYLEEH-- 152
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT-LGYLAPEYAISGR 224
             +VHR++   N+LL      +++DFG++ L P +   +    A T + ++A E    G+
Sbjct: 153 -GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK 211
Query: 225 LTRKSDVYSFGVLLLEIVS 243
            T +SDV+S+GV + E+++
Sbjct: 212 YTHQSDVWSYGVTVWELMT 230

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 107/226 (47%), Gaps = 25/226 (11%)
Query: 38  KIATNGFRWSNKIGEGGFGSVYKGRL------QDGTIVAVKVLSVESKQG-EKEFMSEVA 90
           +I+ +  R+  ++GE  FG VYKG L      +    VA+K L  +++    +EF  E  
Sbjct: 5   EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHE-- 62
Query: 91  SMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLL----------GEEKRRAK 140
           +M    + H N+V L G         +++ Y  +  L + L+           ++ R  K
Sbjct: 63  AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122
Query: 141 FGWKARR--EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LF 197
              +      ++  I  G+ Y+      HVVH+D+ T N+L+    N KISD GL + ++
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVY 179
Query: 198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
             +   +       + ++APE  + G+ +  SD++S+GV+L E+ S
Sbjct: 180 AADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 30/218 (13%)
Query: 50  IGEGGFGSVY--------KGRLQDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHE 100
           +GEG FG V         K + ++   VAVK+L  ++ + +  + +SE+  M  +   H+
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK-HK 101
Query: 101 NLVKLHGGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARR------------ 147
           N++ L G C  DGP  ++V +Y    +L + L        +  +   R            
Sbjct: 102 NIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLV 160
Query: 148 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 207
                + RG+ Y+  +     +HRD+   N+L+ +N   KI+DFGL++    N       
Sbjct: 161 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDXXKKT 216
Query: 208 VAGTLG--YLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
             G L   ++APE       T +SDV+SFGVL+ EI +
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 99/216 (45%), Gaps = 16/216 (7%)
Query: 37  LKIATNGFRWSNKIGEGGFGSVYKGRLQD-GTIVAVKVLS---VESKQGEKEFMSEVASM 92
           + +  N F     IG GGFG VY  R  D G + A+K L    ++ KQGE   ++E   +
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 93  ANVNVCHENLVKLHGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
           + V+      +         P ++  + D M    L   L     +   F     R    
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAA 299
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT 211
            I  GL ++H      VV+RD+K +NILLD++ + +ISD GL+  F +   H S    GT
Sbjct: 300 EIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GT 353
Query: 212 LGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
            GY+APE    G      +D +S G +L +++ G +
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 99/216 (45%), Gaps = 16/216 (7%)
Query: 37  LKIATNGFRWSNKIGEGGFGSVYKGRLQD-GTIVAVKVLS---VESKQGEKEFMSEVASM 92
           + +  N F     IG GGFG VY  R  D G + A+K L    ++ KQGE   ++E   +
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 93  ANVNVCHENLVKLHGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
           + V+      +         P ++  + D M    L   L     +   F     R    
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAA 299
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT 211
            I  GL ++H      VV+RD+K +NILLD++ + +ISD GL+  F +   H S    GT
Sbjct: 300 EIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GT 353
Query: 212 LGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
            GY+APE    G      +D +S G +L +++ G +
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 99/216 (45%), Gaps = 16/216 (7%)
Query: 37  LKIATNGFRWSNKIGEGGFGSVYKGRLQD-GTIVAVKVLS---VESKQGEKEFMSEVASM 92
           + +  N F     IG GGFG VY  R  D G + A+K L    ++ KQGE   ++E   +
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 93  ANVNVCHENLVKLHGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
           + V+      +         P ++  + D M    L   L     +   F     R    
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAA 299
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT 211
            I  GL ++H      VV+RD+K +NILLD++ + +ISD GL+  F +   H S    GT
Sbjct: 300 EIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GT 353
Query: 212 LGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
            GY+APE    G      +D +S G +L +++ G +
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 99/216 (45%), Gaps = 16/216 (7%)
Query: 37  LKIATNGFRWSNKIGEGGFGSVYKGRLQD-GTIVAVKVLS---VESKQGEKEFMSEVASM 92
           + +  N F     IG GGFG VY  R  D G + A+K L    ++ KQGE   ++E   +
Sbjct: 183 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 242
Query: 93  ANVNVCHENLVKLHGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
           + V+      +         P ++  + D M    L   L     +   F     R    
Sbjct: 243 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAA 298
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT 211
            I  GL ++H      VV+RD+K +NILLD++ + +ISD GL+  F +   H S    GT
Sbjct: 299 EIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GT 352
Query: 212 LGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
            GY+APE    G      +D +S G +L +++ G +
Sbjct: 353 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 388

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 107/221 (48%), Gaps = 36/221 (16%)
Query: 50  IGEGGFGSVY--------KGRLQDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHE 100
           +GEG FG V         K +    T VAVK+L  ++ + +  + +SE+  M  +   H+
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK-HK 94
Query: 101 NLVKLHGGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWK---------ARREII 150
           N++ L G C  DGP  ++V +Y    +L + L        +F +          + ++++
Sbjct: 95  NIINLLGACTQDGPLYVIV-EYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLV 153
Query: 151 ---MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 207
                + RG+ Y+  +     +HRD+   N+L+ ++   KI+DFGL++    +  HI   
Sbjct: 154 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDXX 206
Query: 208 VAGTLG-----YLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
              T G     ++APE       T +SDV+SFGVLL EI +
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 103/217 (47%), Gaps = 25/217 (11%)
Query: 50  IGEGGFGSVYK-GRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG 108
           +G+G FG   K    + G ++ +K L    ++ ++ F+ EV  M  +   H N++K  G 
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLE--HPNVLKFIGV 75
Query: 109 CIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHV 168
                    + +Y+   +L   +   +   +++ W  R      I  G+AY+H     ++
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIKSMD---SQYPWSQRVSFAKDIASGMAYLHSM---NI 129
Query: 169 VHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS-------------TRVAGTLGYL 215
           +HRD+ + N L+ +N N  ++DFGL++L  +  T                  V G   ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 216 APEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAVDFD 251
           APE  I+GR    K DV+SFG++L EI+ GR   D D
Sbjct: 190 APE-MINGRSYDEKVDVFSFGIVLCEII-GRVNADPD 224

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 10/204 (4%)
Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVK---VLSVESKQGEKEFMSEVASMANVNVCH 99
           FR   KIG G F  VY+   L DG  VA+K   +  +   +   + + E+  +  +N  H
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN--H 91
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
            N++K +   I+     +V +      LS+ +   +K++     +   +  + +   L +
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEY 219
           +H      V+HRDIK +N+ +      K+ D GL + F   TT   + V GT  Y++PE 
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 207
Query: 220 AISGRLTRKSDVYSFGVLLLEIVS 243
                   KSD++S G LL E+ +
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAA 231

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 102/203 (50%), Gaps = 19/203 (9%)
Query: 49  KIGEGGFGSVYKGRLQDGTIVAVKV--LSVESKQGEKEFMSEVASMANVNVCHENLVKLH 106
           K+GEG +G VYK +   G IVA+K   L  E +      + E++ +  ++  H N+V L 
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELH--HPNIVSLI 85
Query: 107 GGCIDGPCRILVYDYMPNN---SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
                  C  LV+++M  +    L +   G +  + K         +  + RG+A+ H  
Sbjct: 86  DVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKI-------YLYQLLRGVAHCH-- 136
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI-S 222
            Q  ++HRD+K  N+L++ +   K++DFGL++ F       +  V  TL Y AP+  + S
Sbjct: 137 -QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMGS 194
Query: 223 GRLTRKSDVYSFGVLLLEIVSGR 245
            + +   D++S G +  E+++G+
Sbjct: 195 KKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 102/203 (50%), Gaps = 19/203 (9%)
Query: 49  KIGEGGFGSVYKGRLQDGTIVAVKV--LSVESKQGEKEFMSEVASMANVNVCHENLVKLH 106
           K+GEG +G VYK +   G IVA+K   L  E +      + E++ +  ++  H N+V L 
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELH--HPNIVSLI 85
Query: 107 GGCIDGPCRILVYDYMPNN---SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
                  C  LV+++M  +    L +   G +  + K         +  + RG+A+ H  
Sbjct: 86  DVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKI-------YLYQLLRGVAHCH-- 136
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI-S 222
            Q  ++HRD+K  N+L++ +   K++DFGL++ F       +  V  TL Y AP+  + S
Sbjct: 137 -QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMGS 194
Query: 223 GRLTRKSDVYSFGVLLLEIVSGR 245
            + +   D++S G +  E+++G+
Sbjct: 195 KKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 16/216 (7%)
Query: 38  KIATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVL---SVESKQGEKEFMSEVASMA 93
           K   + F     +G+G FG+VY  R  Q+  I+A+KVL    +E +  E +   E+   +
Sbjct: 11  KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 70
Query: 94  NVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGI 153
           ++   H N+++++    D     L+ ++ P   L + L    ++  +F  +     +  +
Sbjct: 71  HLR--HPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL----QKHGRFDEQRSATFMEEL 124
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
              L Y HE     V+HRDIK  N+L+      KI+DFG S   P         + GTL 
Sbjct: 125 ADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR---RRXMCGTLD 178
Query: 214 YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVD 249
           YL PE         K D++  GVL  E + G    D
Sbjct: 179 YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/270 (28%), Positives = 123/270 (45%), Gaps = 39/270 (14%)
Query: 48  NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
            +IG+G +G V+ G+ + G  VAVKV        E  +  E      V + HEN++    
Sbjct: 43  KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIA 98
Query: 108 GCIDGPCR----ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
             I G        L+ DY  N SL   L     +      K+  ++      GL ++H E
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSLYDYL-----KSTTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 164 I-----QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI----STRVAGTLGY 214
           I     +P + HRD+K+ NIL+ +N    I+D GL+  F  +T  +    +TRV GT  Y
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV-GTKRY 212
Query: 215 LAPEYAISGRLTRK-------SDVYSFGVLLLEI----VSGRTAVDFDVQLGEYHLVDKA 263
           + PE  +   L R        +D+YSFG++L E+    VSG    ++  QL  + LV   
Sbjct: 213 MPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY--QLPYHDLVPSD 269
Query: 264 WGMYNSKELMNL--VDPMLYGNFPENEAIR 291
               + +E++ +  + P     +  +E +R
Sbjct: 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLR 299

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 99/197 (50%), Gaps = 19/197 (9%)
Query: 50  IGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGC 109
           IG+G FG V  G  + G  VAVK   +++    + F++E + M  +   H NLV+L G  
Sbjct: 29  IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLR--HSNLVQLLGVI 83
Query: 110 IDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHV 168
           ++    + +V +YM   SL   L    + R+  G     +  + +   + Y+      + 
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NF 138
Query: 169 VHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL--GYLAPEYAISGRLT 226
           VHRD+   N+L+ ++   K+SDFGL+K         ST+  G L   + APE     + +
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALREKKFS 192
Query: 227 RKSDVYSFGVLLLEIVS 243
            KSDV+SFG+LL EI S
Sbjct: 193 TKSDVWSFGILLWEIYS 209

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/243 (29%), Positives = 119/243 (48%), Gaps = 23/243 (9%)
Query: 12  SRVSAENTIGG--EQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVY--KGRLQDGT 67
           SR  A  T GG  + +      F  +   I ++ ++    +G+G FG V   K ++  G 
Sbjct: 17  SRGHAAGTSGGPGDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQ 75
Query: 68  IVAVKVLS---VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 124
             AVKV+S   V+ K  ++  + EV  +  ++  H N++KL+    D     LV +    
Sbjct: 76  ECAVKVISKRQVKQKTDKESLLREVQLLKQLD--HPNIMKLYEFFEDKGYFYLVGEVYTG 133
Query: 125 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD--- 181
             L   ++     R +F       II  +  G+ Y+H+     +VHRD+K  N+LL+   
Sbjct: 134 GELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKS 186
Query: 182 QNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEI 241
           ++ N +I DFGLS  F E +  +  ++ GT  Y+APE  + G    K DV+S GV+L  +
Sbjct: 187 KDANIRIIDFGLSTHF-EASKKMKDKI-GTAYYIAPE-VLHGTYDEKCDVWSTGVILYIL 243
Query: 242 VSG 244
           +SG
Sbjct: 244 LSG 246

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/243 (29%), Positives = 119/243 (48%), Gaps = 23/243 (9%)
Query: 12  SRVSAENTIGG--EQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVY--KGRLQDGT 67
           SR  A  T GG  + +      F  +   I ++ ++    +G+G FG V   K ++  G 
Sbjct: 18  SRGHAAGTSGGPGDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQ 76
Query: 68  IVAVKVLS---VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 124
             AVKV+S   V+ K  ++  + EV  +  ++  H N++KL+    D     LV +    
Sbjct: 77  ECAVKVISKRQVKQKTDKESLLREVQLLKQLD--HPNIMKLYEFFEDKGYFYLVGEVYTG 134
Query: 125 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD--- 181
             L   ++     R +F       II  +  G+ Y+H+     +VHRD+K  N+LL+   
Sbjct: 135 GELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKS 187
Query: 182 QNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEI 241
           ++ N +I DFGLS  F E +  +  ++ GT  Y+APE  + G    K DV+S GV+L  +
Sbjct: 188 KDANIRIIDFGLSTHF-EASKKMKDKI-GTAYYIAPE-VLHGTYDEKCDVWSTGVILYIL 244
Query: 242 VSG 244
           +SG
Sbjct: 245 LSG 247

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 99/197 (50%), Gaps = 19/197 (9%)
Query: 50  IGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGC 109
           IG+G FG V  G  + G  VAVK   +++    + F++E + M  +   H NLV+L G  
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVK--CIKNDATAQAFLAEASVMTQLR--HSNLVQLLGVI 68
Query: 110 IDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHV 168
           ++    + +V +YM   SL   L    + R+  G     +  + +   + Y+      + 
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NF 123
Query: 169 VHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL--GYLAPEYAISGRLT 226
           VHRD+   N+L+ ++   K+SDFGL+K         ST+  G L   + APE     + +
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALREKKFS 177
Query: 227 RKSDVYSFGVLLLEIVS 243
            KSDV+SFG+LL EI S
Sbjct: 178 TKSDVWSFGILLWEIYS 194

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 16/216 (7%)
Query: 38  KIATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVL---SVESKQGEKEFMSEVASMA 93
           K   + F     +G+G FG+VY  R  Q+  I+A+KVL    +E +  E +   E+   +
Sbjct: 10  KFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 69
Query: 94  NVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGI 153
           ++   H N+++++    D     L+ ++ P   L + L    ++  +F  +     +  +
Sbjct: 70  HLR--HPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL----QKHGRFDEQRSATFMEEL 123
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
              L Y HE     V+HRDIK  N+L+      KI+DFG S   P         + GTL 
Sbjct: 124 ADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR---RRXMCGTLD 177
Query: 214 YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVD 249
           YL PE         K D++  GVL  E + G    D
Sbjct: 178 YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 83/307 (27%), Positives = 139/307 (45%), Gaps = 36/307 (11%)
Query: 49  KIGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           K+GEG +GSVYK    + G IVA+K + VES    +E + E++ M   +  H  +VK +G
Sbjct: 36  KLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL--QEIIKEISIMQQCDSPH--VVKYYG 91
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
                    +V +Y    S+S  +     R           I+    +GL Y+H   +  
Sbjct: 92  SYFKNTDLWIVMEYCGAGSVSDII---RLRNKTLTEDEIATILQSTLKGLEYLHFMRK-- 146
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR--VAGTLGYLAPEYAISGRL 225
            +HRDIK  NILL+   + K++DFG++      T  ++ R  V GT  ++APE       
Sbjct: 147 -IHRDIKAGNILLNTEGHAKLADFGVAGQL---TDXMAKRNXVIGTPFWMAPEVIQEIGY 202
Query: 226 TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYG-NF 284
              +D++S G+  +E+  G+          + H + +A  M  +        P L+  NF
Sbjct: 203 NCVADIWSLGITAIEMAEGKPP------YADIHPM-RAIFMIPTNPPPTFRKPELWSDNF 255
Query: 285 PENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNIDGXDVEISQPGLIGDIMDVKV 344
            +     F+K  L+   E      Q +TA +++          V I +  LI + MDVK+
Sbjct: 256 TD-----FVKQCLVKSPE------QRATATQLLQHPFVRSAKGVSILR-DLINEAMDVKL 303
Query: 345 GQRSSSK 351
            ++ S +
Sbjct: 304 KRQESQQ 310

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 99/197 (50%), Gaps = 19/197 (9%)
Query: 50  IGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGC 109
           IG+G FG V  G  + G  VAVK   +++    + F++E + M  +   H NLV+L G  
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLR--HSNLVQLLGVI 255
Query: 110 IDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHV 168
           ++    + +V +YM   SL   L    + R+  G     +  + +   + Y+      + 
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NF 310
Query: 169 VHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL--GYLAPEYAISGRLT 226
           VHRD+   N+L+ ++   K+SDFGL+K         ST+  G L   + APE     + +
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALREKKFS 364
Query: 227 RKSDVYSFGVLLLEIVS 243
            KSDV+SFG+LL EI S
Sbjct: 365 TKSDVWSFGILLWEIYS 381

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 115/245 (46%), Gaps = 42/245 (17%)
Query: 32  FSYNQ-LKIATNGFRWSNKIGEGGFGSVYKGRL-----QDGTI-VAVKVLSVESKQGEKE 84
             YN+  +   N  ++   +G G FG V +        +D  + VAVK+L   +   EKE
Sbjct: 20  LPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKE 79
Query: 85  -FMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSL-------SQTLLG--- 133
             MSE+  M+++   HEN+V L G C  G   +++ +Y     L       ++ +LG   
Sbjct: 80  ALMSELKIMSHLGQ-HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSL 138
Query: 134 -----------EEKRRAKFGWKARREIIM---GIGRGLAYIHEEIQPHVVHRDIKTSNIL 179
                      E+ R  +      R+++     + +G+A++  +   + +HRD+   N+L
Sbjct: 139 APGQDPEGLDKEDGRPLEL-----RDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVL 190
Query: 180 LDQNFNPKISDFGLSKLFPENTTHISTRVAG-TLGYLAPEYAISGRLTRKSDVYSFGVLL 238
           L      KI DFGL++    ++ +I    A   + ++APE       T +SDV+S+G+LL
Sbjct: 191 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 250
Query: 239 LEIVS 243
            EI S
Sbjct: 251 WEIFS 255

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 103/201 (51%), Gaps = 18/201 (8%)
Query: 50  IGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGE--KEFMSEVASMANVNVCHENLVKLH 106
           +G+G FG V K + +      AVKV++  S + +     + EV  +  ++  H N++KL 
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD--HPNIMKLF 87
Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
               D     +V +      L   ++    +R +F       II  +  G+ Y+H+    
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEII----KRKRFSEHDAARIIKQVFSGITYMHKH--- 140
Query: 167 HVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG 223
           ++VHRD+K  NILL   +++ + KI DFGLS  F +NT  +  R+ GT  Y+APE  + G
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRI-GTAYYIAPE-VLRG 197
Query: 224 RLTRKSDVYSFGVLLLEIVSG 244
               K DV+S GV+L  ++SG
Sbjct: 198 TYDEKCDVWSAGVILYILLSG 218

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 103/201 (51%), Gaps = 18/201 (8%)
Query: 50  IGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGE--KEFMSEVASMANVNVCHENLVKLH 106
           +G+G FG V K + +      AVKV++  S + +     + EV  +  ++  H N++KL 
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD--HPNIMKLF 87
Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
               D     +V +      L   ++    +R +F       II  +  G+ Y+H+    
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEII----KRKRFSEHDAARIIKQVFSGITYMHKH--- 140
Query: 167 HVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG 223
           ++VHRD+K  NILL   +++ + KI DFGLS  F +NT  +  R+ GT  Y+APE  + G
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRI-GTAYYIAPE-VLRG 197
Query: 224 RLTRKSDVYSFGVLLLEIVSG 244
               K DV+S GV+L  ++SG
Sbjct: 198 TYDEKCDVWSAGVILYILLSG 218

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 101/215 (46%), Gaps = 18/215 (8%)
Query: 36  QLKIATNGFRWSNKIGEGGFGSVYKGRLQ----DGTIVAVKVLSVESKQGEKE-FMSEVA 90
           Q  IA      +  +GEG FG VY+G       +   VAVK    +     KE FMSE  
Sbjct: 6   QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAV 65
Query: 91  SMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 150
            M N++  H ++VKL G   + P  I++  Y P   L   L      R K   K    ++
Sbjct: 66  IMKNLD--HPHIVKLIGIIEEEPTWIIMELY-PYGELGHYL-----ERNKNSLKVLTLVL 117
Query: 151 --MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRV 208
             + I + +AY+ E I  + VHRDI   NIL+      K+ DFGLS+   +   + ++  
Sbjct: 118 YSLQICKAMAYL-ESI--NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVT 174
Query: 209 AGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
              + +++PE     R T  SDV+ F V + EI+S
Sbjct: 175 RLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS 209

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 101/215 (46%), Gaps = 18/215 (8%)
Query: 36  QLKIATNGFRWSNKIGEGGFGSVYKGRLQ----DGTIVAVKVLSVESKQGEKE-FMSEVA 90
           Q  IA      +  +GEG FG VY+G       +   VAVK    +     KE FMSE  
Sbjct: 2   QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAV 61
Query: 91  SMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 150
            M N++  H ++VKL G   + P  I++  Y P   L   L      R K   K    ++
Sbjct: 62  IMKNLD--HPHIVKLIGIIEEEPTWIIMELY-PYGELGHYL-----ERNKNSLKVLTLVL 113
Query: 151 --MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRV 208
             + I + +AY+ E I  + VHRDI   NIL+      K+ DFGLS+   +   + ++  
Sbjct: 114 YSLQICKAMAYL-ESI--NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVT 170
Query: 209 AGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
              + +++PE     R T  SDV+ F V + EI+S
Sbjct: 171 RLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS 205

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 101/215 (46%), Gaps = 18/215 (8%)
Query: 36  QLKIATNGFRWSNKIGEGGFGSVYKGRLQ----DGTIVAVKVLSVESKQGEKE-FMSEVA 90
           Q  IA      +  +GEG FG VY+G       +   VAVK    +     KE FMSE  
Sbjct: 18  QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAV 77
Query: 91  SMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 150
            M N++  H ++VKL G   + P  I++  Y P   L   L      R K   K    ++
Sbjct: 78  IMKNLD--HPHIVKLIGIIEEEPTWIIMELY-PYGELGHYL-----ERNKNSLKVLTLVL 129
Query: 151 --MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRV 208
             + I + +AY+ E I  + VHRDI   NIL+      K+ DFGLS+   +   + ++  
Sbjct: 130 YSLQICKAMAYL-ESI--NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVT 186
Query: 209 AGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
              + +++PE     R T  SDV+ F V + EI+S
Sbjct: 187 RLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS 221

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 19/214 (8%)
Query: 41  TNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEK---EFMSEVASMANVN 96
           ++ +     +G GG   V+  R L+D   VAVKVL  +  +       F  E  + A +N
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 97  VCHENLVKLH----GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG 152
             H  +V ++         GP   +V +Y+   +L   +  E     K       E+I  
Sbjct: 71  --HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI----EVIAD 124
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE--NTTHISTRVAG 210
             + L + H   Q  ++HRD+K +NIL+      K+ DFG+++   +  N+   +  V G
Sbjct: 125 ACQALNFSH---QNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIG 181
Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
           T  YL+PE A    +  +SDVYS G +L E+++G
Sbjct: 182 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 98/197 (49%), Gaps = 19/197 (9%)
Query: 50  IGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGC 109
           IG+G FG V  G  + G  VAVK   +++    + F++E + M  +   H NLV+L G  
Sbjct: 20  IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLR--HSNLVQLLGVI 74
Query: 110 IDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHV 168
           ++    + +V +YM   SL   L    + R+  G     +  + +   + Y+      + 
Sbjct: 75  VEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NF 129
Query: 169 VHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL--GYLAPEYAISGRLT 226
           VHRD+   N+L+ ++   K+SDFGL+K         ST+  G L   + APE       +
Sbjct: 130 VHRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALREAAFS 183
Query: 227 RKSDVYSFGVLLLEIVS 243
            KSDV+SFG+LL EI S
Sbjct: 184 TKSDVWSFGILLWEIYS 200

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 107/221 (48%), Gaps = 36/221 (16%)
Query: 50  IGEGGFGSVY--------KGRLQDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHE 100
           +GEG FG V         K +    T VAVK+L  ++ + +  + +SE+  M  +   H+
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK-HK 87
Query: 101 NLVKLHGGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWK---------ARREII 150
           N++ L G C  DGP  ++V +Y    +L + L        ++ +          + ++++
Sbjct: 88  NIINLLGACTQDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 146
Query: 151 ---MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 207
                + RG+ Y+  +     +HRD+   N+L+ ++   KI+DFGL++    +  HI   
Sbjct: 147 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 199
Query: 208 VAGTLG-----YLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
              T G     ++APE       T +SDV+SFGVLL EI +
Sbjct: 200 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 107/221 (48%), Gaps = 36/221 (16%)
Query: 50  IGEGGFGSVY--------KGRLQDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHE 100
           +GEG FG V         K +    T VAVK+L  ++ + +  + +SE+  M  +   H+
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK-HK 94
Query: 101 NLVKLHGGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWK---------ARREII 150
           N++ L G C  DGP  ++V +Y    +L + L        ++ +          + ++++
Sbjct: 95  NIINLLGACTQDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 151 ---MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 207
                + RG+ Y+  +     +HRD+   N+L+ ++   KI+DFGL++    +  HI   
Sbjct: 154 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 206
Query: 208 VAGTLG-----YLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
              T G     ++APE       T +SDV+SFGVLL EI +
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 19/208 (9%)
Query: 50  IGEGGFGSVYKGRLQ------DGTIVAVKVLS-VESKQGEKEFMSEVASMANVNVCHENL 102
           +G G FG VY+G++           VAVK L  V S+Q E +F+ E   ++ +N  H+N+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLN--HQNI 96
Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII---MGIGRGLAY 159
           V+  G  +    R ++ + M    L   L     R ++    A  +++     I  G  Y
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 160 IHEEIQPHVVHRDIKTSNILLD---QNFNPKISDFGLSKLFPENTTHISTRVAG-TLGYL 215
           + E    H +HRDI   N LL         KI DFG+++     + +     A   + ++
Sbjct: 157 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 213
Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVS 243
            PE  + G  T K+D +SFGVLL EI S
Sbjct: 214 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 19/208 (9%)
Query: 50  IGEGGFGSVYKGRLQ------DGTIVAVKVLS-VESKQGEKEFMSEVASMANVNVCHENL 102
           +G G FG VY+G++           VAVK L  V S+Q E +F+ E   ++ +N  H+N+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLN--HQNI 110
Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII---MGIGRGLAY 159
           V+  G  +    R ++ + M    L   L     R ++    A  +++     I  G  Y
Sbjct: 111 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 160 IHEEIQPHVVHRDIKTSNILLD---QNFNPKISDFGLSKLFPENTTHISTRVAG-TLGYL 215
           + E    H +HRDI   N LL         KI DFG+++     + +     A   + ++
Sbjct: 171 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 227
Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVS 243
            PE  + G  T K+D +SFGVLL EI S
Sbjct: 228 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 107/221 (48%), Gaps = 36/221 (16%)
Query: 50  IGEGGFGSVY--------KGRLQDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHE 100
           +GEG FG V         K +    T VAVK+L  ++ + +  + +SE+  M  +   H+
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK-HK 135
Query: 101 NLVKLHGGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWK---------ARREII 150
           N++ L G C  DGP  ++V +Y    +L + L        ++ +          + ++++
Sbjct: 136 NIINLLGACTQDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 151 ---MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 207
                + RG+ Y+  +     +HRD+   N+L+ ++   KI+DFGL++    +  HI   
Sbjct: 195 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 247
Query: 208 VAGTLG-----YLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
              T G     ++APE       T +SDV+SFGVLL EI +
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 111/221 (50%), Gaps = 21/221 (9%)
Query: 32  FSYNQLKIATNGFRWSNKIGEGGFGSVY--KGRLQDGTIVAVKVLS---VESKQGEKEFM 86
           F  +   I ++ ++    +G+G FG V   K ++  G   AVKV+S   V+ K  ++  +
Sbjct: 16  FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLL 74
Query: 87  SEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKAR 146
            EV  +  ++  H N++KL+    D     LV +      L   ++     R +F     
Sbjct: 75  REVQLLKQLD--HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS----RKRFSEVDA 128
Query: 147 REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD---QNFNPKISDFGLSKLFPENTTH 203
             II  +  G+ Y+H   +  +VHRD+K  N+LL+   ++ N +I DFGLS  F E +  
Sbjct: 129 ARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF-EASKK 184
Query: 204 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
           +  ++ GT  Y+APE  + G    K DV+S GV+L  ++SG
Sbjct: 185 MKDKI-GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 107/221 (48%), Gaps = 36/221 (16%)
Query: 50  IGEGGFGSVY--------KGRLQDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHE 100
           +GEG FG V         K +    T VAVK+L  ++ + +  + +SE+  M  +   H+
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK-HK 83
Query: 101 NLVKLHGGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWK---------ARREII 150
           N++ L G C  DGP  ++V +Y    +L + L        ++ +          + ++++
Sbjct: 84  NIINLLGACTQDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 142
Query: 151 ---MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 207
                + RG+ Y+  +     +HRD+   N+L+ ++   KI+DFGL++    +  HI   
Sbjct: 143 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 195
Query: 208 VAGTLG-----YLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
              T G     ++APE       T +SDV+SFGVLL EI +
Sbjct: 196 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 107/221 (48%), Gaps = 36/221 (16%)
Query: 50  IGEGGFGSVY--------KGRLQDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHE 100
           +GEG FG V         K +    T VAVK+L  ++ + +  + +SE+  M  +   H+
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK-HK 86
Query: 101 NLVKLHGGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWK---------ARREII 150
           N++ L G C  DGP  ++V +Y    +L + L        ++ +          + ++++
Sbjct: 87  NIINLLGACTQDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 145
Query: 151 ---MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 207
                + RG+ Y+  +     +HRD+   N+L+ ++   KI+DFGL++    +  HI   
Sbjct: 146 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 198
Query: 208 VAGTLG-----YLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
              T G     ++APE       T +SDV+SFGVLL EI +
Sbjct: 199 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 100/208 (48%), Gaps = 18/208 (8%)
Query: 42  NGFRWSNKIGEGGFGSVYKGRLQDGT-IVAVKVL---SVESKQGEKEFMSEVASMANVNV 97
           + F     +G+G FG+VY  R +    IVA+KVL    +E +  E +   E+   A+++ 
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLH- 81
Query: 98  CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
            H N+++L+    D     L+ +Y P   L + L    ++   F  +    I+  +   L
Sbjct: 82  -HPNILRLYNYFYDRRRIYLILEYAPRGELYKEL----QKSCTFDEQRTATIMEELADAL 136
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
            Y H +    V+HRDIK  N+LL      KI+DFG S   P         + GTL YL P
Sbjct: 137 MYCHGK---KVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLR---RKTMCGTLDYLPP 190
Query: 218 EYAISGRL-TRKSDVYSFGVLLLEIVSG 244
           E  I GR+   K D++  GVL  E++ G
Sbjct: 191 E-MIEGRMHNEKVDLWCIGVLCYELLVG 217

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 50  IGEGGFGSVYKGRLQ------DGTIVAVKVLS-VESKQGEKEFMSEVASMANVNVCHENL 102
           +G G FG VY+G++           VAVK L  V S+Q E +F+ E   ++  N  H+N+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFN--HQNI 110
Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII---MGIGRGLAY 159
           V+  G  +    R ++ + M    L   L     R ++    A  +++     I  G  Y
Sbjct: 111 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 160 IHEEIQPHVVHRDIKTSNILLD---QNFNPKISDFGLSKLFPENTTHISTRVAG-TLGYL 215
           + E    H +HRDI   N LL         KI DFG+++     + +     A   + ++
Sbjct: 171 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 227
Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVS 243
            PE  + G  T K+D +SFGVLL EI S
Sbjct: 228 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 101/209 (48%), Gaps = 16/209 (7%)
Query: 48  NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC-HENLVKL 105
           + +G G FG V  G+ +  G  VAVK+L+ +  +           + N+ +  H +++KL
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 106 HGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           +   I  P  I +V +Y+    L   +     +  +   K  R +   I  G+ Y H  +
Sbjct: 82  YQ-VISTPSDIFMVMEYVSGGELFDYIC----KNGRLDEKESRRLFQQILSGVDYCHRHM 136
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              VVHRD+K  N+LLD + N KI+DFGLS +  +          G+  Y APE  ISGR
Sbjct: 137 ---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FLRXSCGSPNYAAPE-VISGR 190
Query: 225 LTR--KSDVYSFGVLLLEIVSGRTAVDFD 251
           L    + D++S GV+L  ++ G    D D
Sbjct: 191 LYAGPEVDIWSSGVILYALLCGTLPFDDD 219

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 97/223 (43%), Gaps = 32/223 (14%)
Query: 42  NGFRWSNKIGEGGFGSVYKGRLQDGTI---VAVKVL-SVESKQGEKEFMSEVASMANVNV 97
           N  ++ + IGEG FG V K R++   +    A+K +    SK   ++F  E+  +  +  
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 98  CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEE------------KRRAKFGWKA 145
            H N++ L G C       L  +Y P+ +L   L                   +    + 
Sbjct: 85  -HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143
Query: 146 RREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS 205
                  + RG+ Y+    Q   +HRD+   NIL+ +N+  KI+DFGLS+          
Sbjct: 144 LLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR-------GQE 193
Query: 206 TRVAGTLG-----YLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
             V  T+G     ++A E       T  SDV+S+GVLL EIVS
Sbjct: 194 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 50  IGEGGFGSVYKGRLQ------DGTIVAVKVLS-VESKQGEKEFMSEVASMANVNVCHENL 102
           +G G FG VY+G++           VAVK L  V S+Q E +F+ E   ++  N  H+N+
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN--HQNI 112
Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII---MGIGRGLAY 159
           V+  G  +    R ++ + M    L   L     R ++    A  +++     I  G  Y
Sbjct: 113 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 172
Query: 160 IHEEIQPHVVHRDIKTSNILLD---QNFNPKISDFGLSKLFPENTTHISTRVAG-TLGYL 215
           + E    H +HRDI   N LL         KI DFG+++     + +     A   + ++
Sbjct: 173 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 229
Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVS 243
            PE  + G  T K+D +SFGVLL EI S
Sbjct: 230 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 50  IGEGGFGSVYKGRLQ------DGTIVAVKVLS-VESKQGEKEFMSEVASMANVNVCHENL 102
           +G G FG VY+G++           VAVK L  V S+Q E +F+ E   ++  N  H+N+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN--HQNI 95
Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII---MGIGRGLAY 159
           V+  G  +    R ++ + M    L   L     R ++    A  +++     I  G  Y
Sbjct: 96  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 160 IHEEIQPHVVHRDIKTSNILLD---QNFNPKISDFGLSKLFPENTTHISTRVAG-TLGYL 215
           + E    H +HRDI   N LL         KI DFG+++     + +     A   + ++
Sbjct: 156 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 212
Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVS 243
            PE  + G  T K+D +SFGVLL EI S
Sbjct: 213 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 50  IGEGGFGSVYKGRLQ------DGTIVAVKVLS-VESKQGEKEFMSEVASMANVNVCHENL 102
           +G G FG VY+G++           VAVK L  V S+Q E +F+ E   ++  N  H+N+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN--HQNI 96
Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII---MGIGRGLAY 159
           V+  G  +    R ++ + M    L   L     R ++    A  +++     I  G  Y
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 160 IHEEIQPHVVHRDIKTSNILLD---QNFNPKISDFGLSKLFPENTTHISTRVAG-TLGYL 215
           + E    H +HRDI   N LL         KI DFG+++     + +     A   + ++
Sbjct: 157 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 213
Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVS 243
            PE  + G  T K+D +SFGVLL EI S
Sbjct: 214 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 50  IGEGGFGSVYKGRLQ------DGTIVAVKVLS-VESKQGEKEFMSEVASMANVNVCHENL 102
           +G G FG VY+G++           VAVK L  V S+Q E +F+ E   ++  N  H+N+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN--HQNI 95
Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII---MGIGRGLAY 159
           V+  G  +    R ++ + M    L   L     R ++    A  +++     I  G  Y
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 160 IHEEIQPHVVHRDIKTSNILLD---QNFNPKISDFGLSKLFPENTTHISTRVAG-TLGYL 215
           + E    H +HRDI   N LL         KI DFG+++     + +     A   + ++
Sbjct: 156 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 212
Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVS 243
            PE  + G  T K+D +SFGVLL EI S
Sbjct: 213 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 97/223 (43%), Gaps = 32/223 (14%)
Query: 42  NGFRWSNKIGEGGFGSVYKGRLQDGTI---VAVKVL-SVESKQGEKEFMSEVASMANVNV 97
           N  ++ + IGEG FG V K R++   +    A+K +    SK   ++F  E+  +  +  
Sbjct: 15  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 74
Query: 98  CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEE------------KRRAKFGWKA 145
            H N++ L G C       L  +Y P+ +L   L                   +    + 
Sbjct: 75  -HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 133
Query: 146 RREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS 205
                  + RG+ Y+    Q   +HRD+   NIL+ +N+  KI+DFGLS+          
Sbjct: 134 LLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR-------GQE 183
Query: 206 TRVAGTLG-----YLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
             V  T+G     ++A E       T  SDV+S+GVLL EIVS
Sbjct: 184 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 107/221 (48%), Gaps = 36/221 (16%)
Query: 50  IGEGGFGSVY--------KGRLQDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHE 100
           +GEG FG V         K +    T VAVK+L  ++ + +  + +SE+  M  +   H+
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK-HK 94
Query: 101 NLVKLHGGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWK---------ARREII 150
           N++ L G C  DGP  ++V +Y    +L + L        ++ +          + ++++
Sbjct: 95  NIINLLGACTQDGPLYVIV-EYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 153
Query: 151 ---MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 207
                + RG+ Y+  +     +HRD+   N+L+ ++   KI+DFGL++    +  HI   
Sbjct: 154 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 206
Query: 208 VAGTLG-----YLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
              T G     ++APE       T +SDV+SFGVLL EI +
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 50  IGEGGFGSVYKGRLQ------DGTIVAVKVLS-VESKQGEKEFMSEVASMANVNVCHENL 102
           +G G FG VY+G++           VAVK L  V S+Q E +F+ E   ++  N  H+N+
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN--HQNI 87
Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII---MGIGRGLAY 159
           V+  G  +    R ++ + M    L   L     R ++    A  +++     I  G  Y
Sbjct: 88  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 147
Query: 160 IHEEIQPHVVHRDIKTSNILLD---QNFNPKISDFGLSKLFPENTTHISTRVAG-TLGYL 215
           + E    H +HRDI   N LL         KI DFG+++     + +     A   + ++
Sbjct: 148 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 204
Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVS 243
            PE  + G  T K+D +SFGVLL EI S
Sbjct: 205 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 107/221 (48%), Gaps = 36/221 (16%)
Query: 50  IGEGGFGSVY--------KGRLQDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHE 100
           +GEG FG V         K +    T VAVK+L  ++ + +  + +SE+  M  +   H+
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK-HK 79
Query: 101 NLVKLHGGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWK---------ARREII 150
           N++ L G C  DGP  ++V +Y    +L + L        ++ +          + ++++
Sbjct: 80  NIINLLGACTQDGPLYVIV-EYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 138
Query: 151 ---MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 207
                + RG+ Y+  +     +HRD+   N+L+ ++   KI+DFGL++    +  HI   
Sbjct: 139 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 191
Query: 208 VAGTLG-----YLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
              T G     ++APE       T +SDV+SFGVLL EI +
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 50  IGEGGFGSVYKGRLQ------DGTIVAVKVLS-VESKQGEKEFMSEVASMANVNVCHENL 102
           +G G FG VY+G++           VAVK L  V S+Q E +F+ E   ++  N  H+N+
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN--HQNI 102
Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII---MGIGRGLAY 159
           V+  G  +    R ++ + M    L   L     R ++    A  +++     I  G  Y
Sbjct: 103 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 162
Query: 160 IHEEIQPHVVHRDIKTSNILLD---QNFNPKISDFGLSKLFPENTTHISTRVAG-TLGYL 215
           + E    H +HRDI   N LL         KI DFG+++     + +     A   + ++
Sbjct: 163 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 219
Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVS 243
            PE  + G  T K+D +SFGVLL EI S
Sbjct: 220 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 50  IGEGGFGSVYKGRLQ------DGTIVAVKVLS-VESKQGEKEFMSEVASMANVNVCHENL 102
           +G G FG VY+G++           VAVK L  V S+Q E +F+ E   ++  N  H+N+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN--HQNI 110
Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM---GIGRGLAY 159
           V+  G  +    R ++ + M    L   L     R ++    A  +++     I  G  Y
Sbjct: 111 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 160 IHEEIQPHVVHRDIKTSNILLD---QNFNPKISDFGLSKLFPENTTHISTRVAG-TLGYL 215
           + E    H +HRDI   N LL         KI DFG+++     + +     A   + ++
Sbjct: 171 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 227
Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVS 243
            PE  + G  T K+D +SFGVLL EI S
Sbjct: 228 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 19/214 (8%)
Query: 41  TNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEK---EFMSEVASMANVN 96
           ++ +     +G GG   V+  R L+D   VAVKVL  +  +       F  E  + A +N
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 97  VCHENLVKLH----GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG 152
             H  +V ++         GP   +V +Y+   +L   +  E     K       E+I  
Sbjct: 71  --HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI----EVIAD 124
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE--NTTHISTRVAG 210
             + L + H   Q  ++HRD+K +NI++      K+ DFG+++   +  N+   +  V G
Sbjct: 125 ACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 181
Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
           T  YL+PE A    +  +SDVYS G +L E+++G
Sbjct: 182 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 110/220 (50%), Gaps = 19/220 (8%)
Query: 32  FSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLS---VESKQGEKEFMS 87
           F  +   I ++ ++    +G+G FG V   + +  G   AVKV+S   V+ K  ++  + 
Sbjct: 22  FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR 81
Query: 88  EVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARR 147
           EV  +  ++  H N++KL+    D     LV +      L   ++     R +F      
Sbjct: 82  EVQLLKQLD--HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS----RKRFSEVDAA 135
Query: 148 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD---QNFNPKISDFGLSKLFPENTTHI 204
            II  +  G+ Y+H+     +VHRD+K  N+LL+   ++ N +I DFGLS  F E +  +
Sbjct: 136 RIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF-EASKKM 191
Query: 205 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
             ++ GT  Y+APE  + G    K DV+S GV+L  ++SG
Sbjct: 192 KDKI-GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 50  IGEGGFGSVYKGRLQ------DGTIVAVKVLS-VESKQGEKEFMSEVASMANVNVCHENL 102
           +G G FG VY+G++           VAVK L  V S+Q E +F+ E   ++  N  H+N+
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN--HQNI 122
Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII---MGIGRGLAY 159
           V+  G  +    R ++ + M    L   L     R ++    A  +++     I  G  Y
Sbjct: 123 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 182
Query: 160 IHEEIQPHVVHRDIKTSNILLD---QNFNPKISDFGLSKLFPENTTHISTRVAG-TLGYL 215
           + E    H +HRDI   N LL         KI DFG+++     + +     A   + ++
Sbjct: 183 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 239
Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVS 243
            PE  + G  T K+D +SFGVLL EI S
Sbjct: 240 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 19/214 (8%)
Query: 41  TNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEK---EFMSEVASMANVN 96
           ++ +     +G GG   V+  R L+D   VAVKVL  +  +       F  E  + A +N
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 97  VCHENLVKLH----GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG 152
             H  +V ++         GP   +V +Y+   +L   +  E     K       E+I  
Sbjct: 71  --HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI----EVIAD 124
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE--NTTHISTRVAG 210
             + L + H   Q  ++HRD+K +NI++      K+ DFG+++   +  N+   +  V G
Sbjct: 125 ACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 181
Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
           T  YL+PE A    +  +SDVYS G +L E+++G
Sbjct: 182 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 50  IGEGGFGSVYKGRLQ------DGTIVAVKVLS-VESKQGEKEFMSEVASMANVNVCHENL 102
           +G G FG VY+G++           VAVK L  V S+Q E +F+ E   ++  N  H+N+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN--HQNI 96
Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII---MGIGRGLAY 159
           V+  G  +    R ++ + M    L   L     R ++    A  +++     I  G  Y
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 160 IHEEIQPHVVHRDIKTSNILLD---QNFNPKISDFGLSKLFPENTTHISTRVAG-TLGYL 215
           + E    H +HRDI   N LL         KI DFG+++     + +     A   + ++
Sbjct: 157 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWM 213
Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVS 243
            PE  + G  T K+D +SFGVLL EI S
Sbjct: 214 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 106/227 (46%), Gaps = 24/227 (10%)
Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG 108
           +G+G +G VY GR L +   +A+K +     +  +    E+A   ++   H+N+V+  G 
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLK--HKNIVQYLGS 87
Query: 109 CIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG-----IGRGLAYIHEE 163
             +     +  + +P  SLS  L      R+K+G     E  +G     I  GL Y+H+ 
Sbjct: 88  FSENGFIKIFMEQVPGGSLSALL------RSKWGPLKDNEQTIGFYTKQILEGLKYLHDN 141
Query: 164 IQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS 222
               +VHRDIK  N+L++      KISDFG SK         +    GTL Y+APE    
Sbjct: 142 ---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRL-AGINPCTETFTGTLQYMAPEIIDK 197
Query: 223 GR--LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMY 267
           G     + +D++S G  ++E+ +G+       +LGE        GM+
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGKPPF---YELGEPQAAMFKVGMF 241

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 48  NKIGEGGFGSVYKGRLQ-DGTIVAVK-VLSVESKQGEKEFMSEVASMANVNVCHENLVKL 105
            +IG G FG V+ GRL+ D T+VAVK          + +F+ E   +   +  H N+V+L
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYS--HPNIVRL 177
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
            G C       +V + +       T L  E  R +   K   +++     G+ Y+  +  
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFL-TFLRTEGARLRV--KTLLQMVGDAAAGMEYLESKC- 233
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG----TLGYLAPEYAI 221
              +HRD+   N L+ +    KISDFG+S+   E    +     G     + + APE   
Sbjct: 234 --CIHRDLAARNCLVTEKNVLKISDFGMSR---EEADGVXAASGGLRQVPVKWTAPEALN 288
Query: 222 SGRLTRKSDVYSFGVLLLEIVS 243
            GR + +SDV+SFG+LL E  S
Sbjct: 289 YGRYSSESDVWSFGILLWETFS 310

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 93/198 (46%), Gaps = 14/198 (7%)
Query: 50  IGEGGFGSVYKGRLQD----GTIVAVKVL-SVESKQGEKEFMSEVASMANVNVCHENLVK 104
           IGEG FG V++G           VA+K   +  S    ++F+ E  +M   +  H ++VK
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD--HPHIVK 75
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L G   + P    V+  M   +L +     + R+      +       +   LAY+  + 
Sbjct: 76  LIGVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK- 130
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
               VHRDI   N+L+  N   K+ DFGLS+   ++T + +++    + ++APE     R
Sbjct: 131 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 188
Query: 225 LTRKSDVYSFGVLLLEIV 242
            T  SDV+ FGV + EI+
Sbjct: 189 FTSASDVWMFGVCMWEIL 206

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 98/215 (45%), Gaps = 25/215 (11%)
Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHE 100
           +R    IG+G F  V   R +  G  VAVK++     +    ++   EV  M  +N  H 
Sbjct: 17  YRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILN--HP 74
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLG-----EEKRRAKFGWKARREIIMGIGR 155
           N+VKL           LV +Y     +   L+      E++ RAKF     R+I+  +  
Sbjct: 75  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF-----RQIVSAV-- 127
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
              Y H   Q ++VHRD+K  N+LLD + N KI+DFG S  F     +      G+  Y 
Sbjct: 128 --QYCH---QKYIVHRDLKAENLLLDGDMNIKIADFGFSNEF--TVGNKLDTFCGSPPYA 180
Query: 216 APEYAISGRLT-RKSDVYSFGVLLLEIVSGRTAVD 249
           APE     +    + DV+S GV+L  +VSG    D
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 95/208 (45%), Gaps = 19/208 (9%)
Query: 50  IGEGGFGSVYKGRLQ------DGTIVAVKVLS-VESKQGEKEFMSEVASMANVNVCHENL 102
           +G G FG VY+G++           VAVK L  V S+Q E +F+ E   ++  N  H+N+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN--HQNI 136
Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII---MGIGRGLAY 159
           V+  G  +    R ++ + M    L   L     R ++    A  +++     I  G  Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 160 IHEEIQPHVVHRDIKTSNILLD---QNFNPKISDFGLSK-LFPENTTHISTRVAGTLGYL 215
           + E    H +HRDI   N LL         KI DFG+++ ++              + ++
Sbjct: 197 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWM 253
Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVS 243
            PE  + G  T K+D +SFGVLL EI S
Sbjct: 254 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 95/208 (45%), Gaps = 19/208 (9%)
Query: 50  IGEGGFGSVYKGRLQ------DGTIVAVKVLS-VESKQGEKEFMSEVASMANVNVCHENL 102
           +G G FG VY+G++           VAVK L  V S+Q E +F+ E   ++  N  H+N+
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN--HQNI 113
Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII---MGIGRGLAY 159
           V+  G  +    R ++ + M    L   L     R ++    A  +++     I  G  Y
Sbjct: 114 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 173
Query: 160 IHEEIQPHVVHRDIKTSNILLD---QNFNPKISDFGLSK-LFPENTTHISTRVAGTLGYL 215
           + E    H +HRDI   N LL         KI DFG+++ ++              + ++
Sbjct: 174 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWM 230
Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVS 243
            PE  + G  T K+D +SFGVLL EI S
Sbjct: 231 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 95/203 (46%), Gaps = 24/203 (11%)
Query: 50  IGEGGFGSVYKGRLQD----GTIVAVKVL-SVESKQGEKEFMSEVASMANVNVCHENLVK 104
           IGEG FG V++G           VA+K   +  S    ++F+ E  +M   +  H ++VK
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD--HPHIVK 455
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEK---RRAKFGWKARREIIMG--IGRGLAY 159
           L G   + P  I+         +    LGE +   +  KF       I+    +   LAY
Sbjct: 456 LIGVITENPVWII---------MELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAY 506
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEY 219
           +  +     VHRDI   N+L+  N   K+ DFGLS+   ++T + +++    + ++APE 
Sbjct: 507 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 563
Query: 220 AISGRLTRKSDVYSFGVLLLEIV 242
               R T  SDV+ FGV + EI+
Sbjct: 564 INFRRFTSASDVWMFGVCMWEIL 586

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 93/198 (46%), Gaps = 14/198 (7%)
Query: 50  IGEGGFGSVYKGRLQD----GTIVAVKVL-SVESKQGEKEFMSEVASMANVNVCHENLVK 104
           IGEG FG V++G           VA+K   +  S    ++F+ E  +M   +  H ++VK
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD--HPHIVK 103
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L G   + P  I+    M   +L +     + R+      +       +   LAY+  + 
Sbjct: 104 LIGVITENPVWII----MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK- 158
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
               VHRDI   N+L+  N   K+ DFGLS+   ++T + +++    + ++APE     R
Sbjct: 159 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 216
Query: 225 LTRKSDVYSFGVLLLEIV 242
            T  SDV+ FGV + EI+
Sbjct: 217 FTSASDVWMFGVCMWEIL 234

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 28/205 (13%)
Query: 49  KIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           KIGEG  G V   R +  G  VAVK++ +  +Q  +   +EV  M +    H N+V+++ 
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ--HFNVVEMYK 109
Query: 108 GCIDGPCRILVYDYMPNNSL----SQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
             + G    ++ +++   +L    SQ  L EE+            +   + + LAY+H +
Sbjct: 110 SYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIAT---------VCEAVLQALAYLHAQ 160
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFG----LSKLFPENTTHISTRVAGTLGYLAPEY 219
               V+HRDIK+ +ILL  +   K+SDFG    +SK  P+        + GT  ++APE 
Sbjct: 161 ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKX-----LVGTPYWMAPEV 212
Query: 220 AISGRLTRKSDVYSFGVLLLEIVSG 244
                   + D++S G++++E+V G
Sbjct: 213 ISRSLYATEVDIWSLGIMVIEMVDG 237

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 93/198 (46%), Gaps = 14/198 (7%)
Query: 50  IGEGGFGSVYKGRLQD----GTIVAVKVL-SVESKQGEKEFMSEVASMANVNVCHENLVK 104
           IGEG FG V++G           VA+K   +  S    ++F+ E  +M   +  H ++VK
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD--HPHIVK 75
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L G   + P    V+  M   +L +     + R+      +       +   LAY+  + 
Sbjct: 76  LIGVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK- 130
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
               VHRDI   N+L+  N   K+ DFGLS+   ++T + +++    + ++APE     R
Sbjct: 131 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 188
Query: 225 LTRKSDVYSFGVLLLEIV 242
            T  SDV+ FGV + EI+
Sbjct: 189 FTSASDVWMFGVCMWEIL 206

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 106/227 (46%), Gaps = 24/227 (10%)
Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG 108
           +G+G +G VY GR L +   +A+K +     +  +    E+A   ++   H+N+V+  G 
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLK--HKNIVQYLGS 73
Query: 109 CIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG-----IGRGLAYIHEE 163
             +     +  + +P  SLS  L      R+K+G     E  +G     I  GL Y+H+ 
Sbjct: 74  FSENGFIKIFMEQVPGGSLSALL------RSKWGPLKDNEQTIGFYTKQILEGLKYLHDN 127
Query: 164 IQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS 222
               +VHRDIK  N+L++      KISDFG SK         +    GTL Y+APE    
Sbjct: 128 ---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRL-AGINPCTETFTGTLQYMAPEIIDK 183
Query: 223 GR--LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMY 267
           G     + +D++S G  ++E+ +G+       +LGE        GM+
Sbjct: 184 GPRGYGKAADIWSLGCTIIEMATGKPPF---YELGEPQAAMFKVGMF 227

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 112/241 (46%), Gaps = 30/241 (12%)
Query: 48  NKIGEGGFG-SVYKGRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVK 104
            KIGEG FG ++     +DG    +K +++   S +  +E   EVA +AN+   H N+V+
Sbjct: 30  QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMK--HPNIVQ 87
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
                 +     +V DY     L + +    ++   F      +  + I   L ++H+  
Sbjct: 88  YRESFEENGSLYIVMDYCEGGDLFKRI--NAQKGVLFQEDQILDWFVQICLALKHVHDR- 144
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              ++HRDIK+ NI L ++   ++ DFG++++   +T  ++    GT  YL+PE   +  
Sbjct: 145 --KILHRDIKSQNIFLTKDGTVQLGDFGIARVL-NSTVELARACIGTPYYLSPEICENKP 201
Query: 225 LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNF 284
              KSD+++ G +L E+ + + A                   + +  + NLV  ++ G+F
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHA-------------------FEAGSMKNLVLKIISGSF 242
Query: 285 P 285
           P
Sbjct: 243 P 243

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 71/216 (32%), Positives = 100/216 (46%), Gaps = 27/216 (12%)
Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCH 99
           +R    IG+G F  V   R +  G  VAVK++    + S   +K F  EV  M  +N  H
Sbjct: 9   YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLF-REVRIMKVLN--H 65
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLG-----EEKRRAKFGWKARREIIMGIG 154
            N+VKL           LV +Y     +   L+      E++ RAKF     R+I+  + 
Sbjct: 66  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKF-----RQIVSAV- 119
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY 214
               Y H   Q  +VHRD+K  N+LLD + N KI+DFG S  F      + T   G+  Y
Sbjct: 120 ---QYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-LDT-FCGSPPY 171
Query: 215 LAPEYAISGRLT-RKSDVYSFGVLLLEIVSGRTAVD 249
            APE     +    + DV+S GV+L  +VSG    D
Sbjct: 172 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 107/213 (50%), Gaps = 29/213 (13%)
Query: 49  KIGEGGFGSVYKGRLQDG-TIVAVKVL----------SVESKQGEK---EFMSEVASMAN 94
           K+G G +G V   + ++G +  A+KV+          S ++K  EK   E  +E++ + +
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 95  VNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIG 154
           ++  H N++KL     D     LV ++     L + ++     R KF       I+  I 
Sbjct: 103 LD--HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQIL 156
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQN---FNPKISDFGLSKLFPENTTHISTRVAGT 211
            G+ Y+H   + ++VHRDIK  NILL+      N KI DFGLS  F ++   +  R+ GT
Sbjct: 157 SGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK-LRDRL-GT 211
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
             Y+APE  +  +   K DV+S GV++  ++ G
Sbjct: 212 AYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 94/203 (46%), Gaps = 24/203 (11%)
Query: 50  IGEGGFGSVYKGRLQD----GTIVAVKVL-SVESKQGEKEFMSEVASMANVNVCHENLVK 104
           IGEG FG V++G           VA+K   +  S    ++F+ E  +M   +  H ++VK
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD--HPHIVK 75
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEK---RRAKFGWKARREIIMG--IGRGLAY 159
           L G   + P  I+         +    LGE +   +  KF       I+    +   LAY
Sbjct: 76  LIGVITENPVWII---------MELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAY 126
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEY 219
           +  +     VHRDI   N+L+  N   K+ DFGLS+   ++T   +++    + ++APE 
Sbjct: 127 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPES 183
Query: 220 AISGRLTRKSDVYSFGVLLLEIV 242
               R T  SDV+ FGV + EI+
Sbjct: 184 INFRRFTSASDVWMFGVCMWEIL 206

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 93/198 (46%), Gaps = 14/198 (7%)
Query: 50  IGEGGFGSVYKGRLQD----GTIVAVKVL-SVESKQGEKEFMSEVASMANVNVCHENLVK 104
           IGEG FG V++G           VA+K   +  S    ++F+ E  +M   +  H ++VK
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD--HPHIVK 80
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L G   + P    V+  M   +L +     + R+      +       +   LAY+  + 
Sbjct: 81  LIGVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK- 135
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
               VHRDI   N+L+  N   K+ DFGLS+   ++T + +++    + ++APE     R
Sbjct: 136 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 193
Query: 225 LTRKSDVYSFGVLLLEIV 242
            T  SDV+ FGV + EI+
Sbjct: 194 FTSASDVWMFGVCMWEIL 211

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 93/198 (46%), Gaps = 14/198 (7%)
Query: 50  IGEGGFGSVYKGRLQD----GTIVAVKVL-SVESKQGEKEFMSEVASMANVNVCHENLVK 104
           IGEG FG V++G           VA+K   +  S    ++F+ E  +M   +  H ++VK
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD--HPHIVK 72
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L G   + P    V+  M   +L +     + R+      +       +   LAY+  + 
Sbjct: 73  LIGVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK- 127
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
               VHRDI   N+L+  N   K+ DFGLS+   ++T + +++    + ++APE     R
Sbjct: 128 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 185
Query: 225 LTRKSDVYSFGVLLLEIV 242
            T  SDV+ FGV + EI+
Sbjct: 186 FTSASDVWMFGVCMWEIL 203

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 48  NKIGEGGFGSVYKGRLQ-DGTIVAVK-VLSVESKQGEKEFMSEVASMANVNVCHENLVKL 105
            +IG G FG V+ GRL+ D T+VAVK          + +F+ E   +   +  H N+V+L
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYS--HPNIVRL 177
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
            G C       +V + +       T L  E  R +   K   +++     G+ Y+  +  
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFL-TFLRTEGARLRV--KTLLQMVGDAAAGMEYLESKC- 233
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG----TLGYLAPEYAI 221
              +HRD+   N L+ +    KISDFG+S+   E    +     G     + + APE   
Sbjct: 234 --CIHRDLAARNCLVTEKNVLKISDFGMSR---EEADGVYAASGGLRQVPVKWTAPEALN 288
Query: 222 SGRLTRKSDVYSFGVLLLEIVS 243
            GR + +SDV+SFG+LL E  S
Sbjct: 289 YGRYSSESDVWSFGILLWETFS 310

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 93/198 (46%), Gaps = 14/198 (7%)
Query: 50  IGEGGFGSVYKGRLQD----GTIVAVKVL-SVESKQGEKEFMSEVASMANVNVCHENLVK 104
           IGEG FG V++G           VA+K   +  S    ++F+ E  +M   +  H ++VK
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD--HPHIVK 77
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L G   + P    V+  M   +L +     + R+      +       +   LAY+  + 
Sbjct: 78  LIGVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK- 132
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
               VHRDI   N+L+  N   K+ DFGLS+   ++T + +++    + ++APE     R
Sbjct: 133 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 190
Query: 225 LTRKSDVYSFGVLLLEIV 242
            T  SDV+ FGV + EI+
Sbjct: 191 FTSASDVWMFGVCMWEIL 208

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 104/211 (49%), Gaps = 33/211 (15%)
Query: 50  IGEGGFGSVYKG----RLQDGTIVAVKVLS-VESKQGEKEFMSEVASMANVNVCHENLVK 104
           IG+G FG VY G    + Q+    A+K LS +   Q  + F+ E   M  +N  H N++ 
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN--HPNVLA 86
Query: 105 LHGGCI--DGPCRILVYDYMPNNSLSQTLLGEEKRRA-----KFGWKARREIIMGIGRGL 157
           L G  +  +G   +L+  YM +  L Q +   ++         FG        + + RG+
Sbjct: 87  LIGIMLPPEGLPHVLL-PYMCHGDLLQFIRSPQRNPTVKDLISFG--------LQVARGM 137
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN-----TTHISTRVAGTL 212
            Y+ E+     VHRD+   N +LD++F  K++DFGL++   +        H   R+   +
Sbjct: 138 EYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLP--V 192
Query: 213 GYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
            + A E   + R T KSDV+SFGVLL E+++
Sbjct: 193 KWTALESLQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 93/198 (46%), Gaps = 14/198 (7%)
Query: 50  IGEGGFGSVYKGRLQD----GTIVAVKVL-SVESKQGEKEFMSEVASMANVNVCHENLVK 104
           IGEG FG V++G           VA+K   +  S    ++F+ E  +M   +  H ++VK
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD--HPHIVK 78
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L G   + P    V+  M   +L +     + R+      +       +   LAY+  + 
Sbjct: 79  LIGVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK- 133
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
               VHRDI   N+L+  N   K+ DFGLS+   ++T + +++    + ++APE     R
Sbjct: 134 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 191
Query: 225 LTRKSDVYSFGVLLLEIV 242
            T  SDV+ FGV + EI+
Sbjct: 192 FTSASDVWMFGVCMWEIL 209

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 103/200 (51%), Gaps = 17/200 (8%)
Query: 49  KIGEGGFGSVYKG---RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLV-K 104
           +IG+G FG V+KG   R Q   +VA+K++ +E  + E E + +  ++  ++ C  + V K
Sbjct: 30  RIGKGSFGEVFKGIDNRTQQ--VVAIKIIDLEEAEDEIEDIQQEITV--LSQCDSSYVTK 85
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
            +G  + G    ++ +Y+   S    L     R   F       ++  I +GL Y+H E 
Sbjct: 86  YYGSYLKGSKLWIIMEYLGGGSALDLL-----RAGPFDEFQIATMLKEILKGLDYLHSEK 140
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
           +   +HRDIK +N+LL +  + K++DFG++    +     +T V GT  ++APE      
Sbjct: 141 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSA 196
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
              K+D++S G+  +E+  G
Sbjct: 197 YDSKADIWSLGITAIELAKG 216

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/216 (32%), Positives = 100/216 (46%), Gaps = 27/216 (12%)
Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVL---SVESKQGEKEFMSEVASMANVNVCH 99
           +R    IG+G F  V   R +  G  VAVK++    + S   +K F  EV  M  +N  H
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLF-REVRIMKVLN--H 72
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLG-----EEKRRAKFGWKARREIIMGIG 154
            N+VKL           LV +Y     +   L+      E++ RAKF     R+I+  + 
Sbjct: 73  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF-----RQIVSAV- 126
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY 214
               Y H   Q  +VHRD+K  N+LLD + N KI+DFG S  F      + T   G+  Y
Sbjct: 127 ---QYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-LDT-FCGSPPY 178
Query: 215 LAPEYAISGRLT-RKSDVYSFGVLLLEIVSGRTAVD 249
            APE     +    + DV+S GV+L  +VSG    D
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/216 (32%), Positives = 100/216 (46%), Gaps = 27/216 (12%)
Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCH 99
           +R    IG+G F  V   R +  G  VAVK++    + S   +K F  EV  M  +N  H
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLF-REVRIMKVLN--H 72
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLG-----EEKRRAKFGWKARREIIMGIG 154
            N+VKL           LV +Y     +   L+      E++ RAKF     R+I+  + 
Sbjct: 73  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF-----RQIVSAV- 126
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY 214
               Y H   Q  +VHRD+K  N+LLD + N KI+DFG S  F      + T   G+  Y
Sbjct: 127 ---QYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-LDT-FCGSPPY 178
Query: 215 LAPEYAISGRLT-RKSDVYSFGVLLLEIVSGRTAVD 249
            APE     +    + DV+S GV+L  +VSG    D
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/262 (25%), Positives = 113/262 (43%), Gaps = 41/262 (15%)
Query: 14  VSAENTIGGEQILKNINAFSYNQL-----KIATNGFRWSNKIGEGGFGSVYKGR----LQ 64
            SA+   GGEQ+L   +      L     K+    F     +G G +G V+  R      
Sbjct: 21  TSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHD 80
Query: 65  DGTIVAVKVL----------SVESKQGEKEFMSEVAS---MANVNVCHENLVKLHGGCID 111
            G + A+KVL          + E  + E++ +  +     +  ++   +   KLH     
Sbjct: 81  TGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH----- 135
Query: 112 GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHR 171
                L+ DY+    L   L     +R +F      E+ + +G  +  +    +  +++R
Sbjct: 136 -----LILDYINGGELFTHL----SQRERF---TEHEVQIYVGEIVLALEHLHKLGIIYR 183
Query: 172 DIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR--LTRKS 229
           DIK  NILLD N +  ++DFGLSK F  + T  +    GT+ Y+AP+    G     +  
Sbjct: 184 DIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAV 243
Query: 230 DVYSFGVLLLEIVSGRTAVDFD 251
           D +S GVL+ E+++G +    D
Sbjct: 244 DWWSLGVLMYELLTGASPFTVD 265

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 134/293 (45%), Gaps = 62/293 (21%)
Query: 49  KIGEGGFGSVYKG-RLQDGTIVAVK-VLSVESKQGEKEFMSEVASMANVNVCHENLVKLH 106
           +IG G +GSV K      G I+AVK + S   ++ +K+ + ++  +   + C   +V+ +
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDC-PYIVQFY 87
Query: 107 GGCI-DGPCRILV----------YDYMP---NNSLSQTLLGEEKRRAKFGWKARREIIMG 152
           G    +G C I +          Y Y+    ++ + + +LG+              I + 
Sbjct: 88  GALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGK--------------ITLA 133
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL 212
             + L ++ E ++  ++HRDIK SNILLD++ N K+ DFG+S    ++     TR AG  
Sbjct: 134 TVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA--KTRDAGCR 189
Query: 213 GYLAPEYAISGRLTR-----KSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMY 267
            Y+APE  I    +R     +SDV+S G+ L E+ +GR                  +  +
Sbjct: 190 PYMAPE-RIDPSASRQGYDVRSDVWSLGITLYELATGRF----------------PYPKW 232
Query: 268 NS--KELMNLV--DPMLYGNFPENE-AIRFLKVGLLCVQEKSKLRPQMSTAIK 315
           NS   +L  +V  DP    N  E E +  F+    LC+ +    RP+    +K
Sbjct: 233 NSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 103/205 (50%), Gaps = 28/205 (13%)
Query: 49  KIGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           KIGEG  G V    ++  G +VAVK + +  +Q  +   +EV  M +    HEN+V+++ 
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ--HENVVEMYN 84
Query: 108 GCIDGPCRILVYDYMPNNSLS----QTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
             + G    +V +++   +L+     T + EE+  A         + + + + L+ +H +
Sbjct: 85  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA---------VCLAVLQALSVLHAQ 135
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFG----LSKLFPENTTHISTRVAGTLGYLAPEY 219
               V+HRDIK+ +ILL  +   K+SDFG    +SK  P         + GT  ++APE 
Sbjct: 136 ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX-----LVGTPYWMAPEL 187
Query: 220 AISGRLTRKSDVYSFGVLLLEIVSG 244
                   + D++S G++++E+V G
Sbjct: 188 ISRLPYGPEVDIWSLGIMVIEMVDG 212

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 103/205 (50%), Gaps = 28/205 (13%)
Query: 49  KIGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           KIGEG  G V    ++  G +VAVK + +  +Q  +   +EV  M +    HEN+V+++ 
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ--HENVVEMYN 95
Query: 108 GCIDGPCRILVYDYMPNNSLS----QTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
             + G    +V +++   +L+     T + EE+  A         + + + + L+ +H +
Sbjct: 96  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA---------VCLAVLQALSVLHAQ 146
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFG----LSKLFPENTTHISTRVAGTLGYLAPEY 219
               V+HRDIK+ +ILL  +   K+SDFG    +SK  P         + GT  ++APE 
Sbjct: 147 ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX-----LVGTPYWMAPEL 198
Query: 220 AISGRLTRKSDVYSFGVLLLEIVSG 244
                   + D++S G++++E+V G
Sbjct: 199 ISRLPYGPEVDIWSLGIMVIEMVDG 223

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 103/205 (50%), Gaps = 28/205 (13%)
Query: 49  KIGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           KIGEG  G V    ++  G +VAVK + +  +Q  +   +EV  M +    HEN+V+++ 
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ--HENVVEMYN 88
Query: 108 GCIDGPCRILVYDYMPNNSLS----QTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
             + G    +V +++   +L+     T + EE+  A         + + + + L+ +H +
Sbjct: 89  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA---------VCLAVLQALSVLHAQ 139
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFG----LSKLFPENTTHISTRVAGTLGYLAPEY 219
               V+HRDIK+ +ILL  +   K+SDFG    +SK  P         + GT  ++APE 
Sbjct: 140 ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX-----LVGTPYWMAPEL 191
Query: 220 AISGRLTRKSDVYSFGVLLLEIVSG 244
                   + D++S G++++E+V G
Sbjct: 192 ISRLPYGPEVDIWSLGIMVIEMVDG 216

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 103/205 (50%), Gaps = 28/205 (13%)
Query: 49  KIGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           KIGEG  G V    ++  G +VAVK + +  +Q  +   +EV  M +    HEN+V+++ 
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ--HENVVEMYN 93
Query: 108 GCIDGPCRILVYDYMPNNSLS----QTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
             + G    +V +++   +L+     T + EE+  A         + + + + L+ +H +
Sbjct: 94  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA---------VCLAVLQALSVLHAQ 144
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFG----LSKLFPENTTHISTRVAGTLGYLAPEY 219
               V+HRDIK+ +ILL  +   K+SDFG    +SK  P         + GT  ++APE 
Sbjct: 145 ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX-----LVGTPYWMAPEL 196
Query: 220 AISGRLTRKSDVYSFGVLLLEIVSG 244
                   + D++S G++++E+V G
Sbjct: 197 ISRLPYGPEVDIWSLGIMVIEMVDG 221

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 97/223 (43%), Gaps = 32/223 (14%)
Query: 42  NGFRWSNKIGEGGFGSVYKGRLQDGTI---VAVKVL-SVESKQGEKEFMSEVASMANVNV 97
           N  ++ + IGEG FG V K R++   +    A+K +    SK   ++F  E+  +  +  
Sbjct: 22  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 81
Query: 98  CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEE------------KRRAKFGWKA 145
            H N++ L G C       L  +Y P+ +L   L                   +    + 
Sbjct: 82  -HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 140
Query: 146 RREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS 205
                  + RG+ Y+    Q   +HR++   NIL+ +N+  KI+DFGLS+          
Sbjct: 141 LLHFAADVARGMDYLS---QKQFIHRNLAARNILVGENYVAKIADFGLSR-------GQE 190
Query: 206 TRVAGTLG-----YLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
             V  T+G     ++A E       T  SDV+S+GVLL EIVS
Sbjct: 191 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 94/201 (46%), Gaps = 10/201 (4%)
Query: 50  IGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFM-SEVASMANVNVCHENLVKLH 106
           IG G +G   K R + DG I+  K L   S  + EK+ + SEV  +  +   H N+V+ +
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK--HPNIVRYY 71
Query: 107 GGCIDGPCRIL--VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
              ID     L  V +Y     L+  +    K R     +    ++  +   L   H   
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 165 Q--PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS 222
                V+HRD+K +N+ LD   N K+ DFGL+++   +T+   T V GT  Y++PE    
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMNR 190
Query: 223 GRLTRKSDVYSFGVLLLEIVS 243
                KSD++S G LL E+ +
Sbjct: 191 MSYNEKSDIWSLGCLLYELCA 211

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 98/216 (45%), Gaps = 27/216 (12%)
Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVL---SVESKQGEKEFMSEVASMANVNVCH 99
           +R    IG+G F  V   R +  G  VAVK++    + S   +K F  EV  M  +N  H
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLF-REVRIMKVLN--H 72
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLG-----EEKRRAKFGWKARREIIMGIG 154
            N+VKL           LV +Y     +   L+      E++ RAKF     R+I+  + 
Sbjct: 73  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF-----RQIVSAV- 126
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY 214
               Y H   Q  +VHRD+K  N+LLD + N KI+DFG S  F       +    G   Y
Sbjct: 127 ---QYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDA--FCGAPPY 178
Query: 215 LAPEYAISGRLT-RKSDVYSFGVLLLEIVSGRTAVD 249
            APE     +    + DV+S GV+L  +VSG    D
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 99/216 (45%), Gaps = 27/216 (12%)
Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVL---SVESKQGEKEFMSEVASMANVNVCH 99
           +R    IG+G F  V   R +  G  VAV+++    + S   +K F  EV  M  +N  H
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLF-REVRIMKVLN--H 72
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLG-----EEKRRAKFGWKARREIIMGIG 154
            N+VKL           LV +Y     +   L+      E++ RAKF     R+I+  + 
Sbjct: 73  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF-----RQIVSAV- 126
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY 214
               Y H   Q  +VHRD+K  N+LLD + N KI+DFG S  F     +      G+  Y
Sbjct: 127 ---QYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEF--TFGNKLDEFCGSPPY 178
Query: 215 LAPEYAISGRLT-RKSDVYSFGVLLLEIVSGRTAVD 249
            APE     +    + DV+S GV+L  +VSG    D
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/331 (25%), Positives = 148/331 (44%), Gaps = 38/331 (11%)
Query: 44  FRWSNKIGEGGFGSVYKGRLQ----DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCH 99
           ++   K+G G +G V   R +    +  I  ++  SV +    K  + EVA +  ++  H
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSK-LLEEVAVLKLLD--H 95
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
            N++KL+    D     LV +      L   ++     R KF       II  +  G+ Y
Sbjct: 96  PNIMKLYDFFEDKRNYYLVMECYKGGELFDEII----HRMKFNEVDAAVIIKQVLSGVTY 151
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNP---KISDFGLSKLFPENTTHISTRVAGTLGYLA 216
           +H+    ++VHRD+K  N+LL+        KI DFGLS +F EN   +  R+ GT  Y+A
Sbjct: 152 LHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF-ENQKKMKERL-GTAYYIA 206
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMN-- 274
           PE  +  +   K DV+S GV+L  +++G               V+K    ++S E  N  
Sbjct: 207 PE-VLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVS 265
Query: 275 -----LVDPMLYGN----FPENEAIRFLKVGLLCVQEKSKLR-PQMSTAIKMMNGETNID 324
                L+  ML  +        +A+    +  +C +++S +  P ++ AI+ M    N  
Sbjct: 266 EGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQN-- 323
Query: 325 GXDVEISQPGLIGDIMDVKVGQRSSSKSMTE 355
               +++Q  L+   M  K+  +  +K +T+
Sbjct: 324 --SQKLAQAALL--YMASKLTSQEETKELTD 350

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 100/216 (46%), Gaps = 27/216 (12%)
Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCH 99
           +R    IG+G F  V   R +  G  VAV+++    + S   +K F  EV  M  +N  H
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLF-REVRIMKVLN--H 72
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLG-----EEKRRAKFGWKARREIIMGIG 154
            N+VKL           LV +Y     +   L+      E++ RAKF     R+I+  + 
Sbjct: 73  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF-----RQIVSAV- 126
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY 214
               Y H   Q  +VHRD+K  N+LLD + N KI+DFG S  F      + T   G+  Y
Sbjct: 127 ---QYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-LDT-FCGSPPY 178
Query: 215 LAPEYAISGRLT-RKSDVYSFGVLLLEIVSGRTAVD 249
            APE     +    + DV+S GV+L  +VSG    D
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 103/207 (49%), Gaps = 15/207 (7%)
Query: 44  FRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANV--NVCHEN 101
           F +  K+G G FG V+   +++ +    +V+   +K   +  M ++ +   V  ++ H N
Sbjct: 24  FIFKRKLGSGAFGDVH--LVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN 81
Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
           ++K+     D     +V +      L + ++  + R          E++  +   LAY H
Sbjct: 82  IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 162 EEIQPHVVHRDIKTSNILLDQNFNP----KISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
            +   HVVH+D+K  NIL  Q+ +P    KI DFGL++LF  +    ST  AGT  Y+AP
Sbjct: 142 SQ---HVVHKDLKPENILF-QDTSPHSPIKIIDFGLAELFKSDEH--STNAAGTALYMAP 195
Query: 218 EYAISGRLTRKSDVYSFGVLLLEIVSG 244
           E      +T K D++S GV++  +++G
Sbjct: 196 E-VFKRDVTFKCDIWSAGVVMYFLLTG 221

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 103/205 (50%), Gaps = 28/205 (13%)
Query: 49  KIGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           KIGEG  G V    ++  G +VAVK + +  +Q  +   +EV  M +    HEN+V+++ 
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ--HENVVEMYN 138
Query: 108 GCIDGPCRILVYDYMPNNSLS----QTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
             + G    +V +++   +L+     T + EE+  A         + + + + L+ +H +
Sbjct: 139 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA---------VCLAVLQALSVLHAQ 189
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFG----LSKLFPENTTHISTRVAGTLGYLAPEY 219
               V+HRDIK+ +ILL  +   K+SDFG    +SK  P         + GT  ++APE 
Sbjct: 190 ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX-----LVGTPYWMAPEL 241
Query: 220 AISGRLTRKSDVYSFGVLLLEIVSG 244
                   + D++S G++++E+V G
Sbjct: 242 ISRLPYGPEVDIWSLGIMVIEMVDG 266

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 24/203 (11%)
Query: 50  IGEGGFGSVYKGRLQD----GTIVAVKVL-SVESKQGEKEFMSEVASMANVNVCHENLVK 104
           IGEG FG V++G           VA+K   +  S    ++F+ E  +M   +  H ++VK
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD--HPHIVK 75
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEK---RRAKFGWKARREIIMG--IGRGLAY 159
           L G   + P  I+         +    LGE +   +  KF       I+    +   LAY
Sbjct: 76  LIGVITENPVWII---------MELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAY 126
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEY 219
           +  +     VHRDI   N+L+      K+ DFGLS+   ++T + +++    + ++APE 
Sbjct: 127 LESK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 183
Query: 220 AISGRLTRKSDVYSFGVLLLEIV 242
               R T  SDV+ FGV + EI+
Sbjct: 184 INFRRFTSASDVWMFGVCMWEIL 206

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 103/205 (50%), Gaps = 28/205 (13%)
Query: 49  KIGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           KIGEG  G V    ++  G +VAVK + +  +Q  +   +EV  M +    HEN+V+++ 
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ--HENVVEMYN 215
Query: 108 GCIDGPCRILVYDYMPNNSLS----QTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
             + G    +V +++   +L+     T + EE+  A         + + + + L+ +H +
Sbjct: 216 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA---------VCLAVLQALSVLHAQ 266
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFG----LSKLFPENTTHISTRVAGTLGYLAPEY 219
               V+HRDIK+ +ILL  +   K+SDFG    +SK  P         + GT  ++APE 
Sbjct: 267 ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX-----LVGTPYWMAPEL 318
Query: 220 AISGRLTRKSDVYSFGVLLLEIVSG 244
                   + D++S G++++E+V G
Sbjct: 319 ISRLPYGPEVDIWSLGIMVIEMVDG 343

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 50  IGEGGFGSVYKG--RLQDGTIVAVKVLSVESKQGEKE-FMSEVASMANVNVCHENLVKLH 106
           +GEG +G V     R+ +   VAVK++ ++      E    E+   A +N  HEN+VK +
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINAMLN--HENVVKFY 71
Query: 107 GGCIDGPCRILVYDYMPNNSLSQTL---LGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
           G   +G  + L  +Y     L   +   +G  +  A+            +  G+ Y+H  
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-------RFFHQLMAGVVYLH-- 122
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP-ENTTHISTRVAGTLGYLAPEYAIS 222
               + HRDIK  N+LLD+  N KISDFGL+ +F   N   +  ++ GTL Y+APE    
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 223 GRL-TRKSDVYSFGVLLLEIVSGRTAVD 249
                   DV+S G++L  +++G    D
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 108/221 (48%), Gaps = 21/221 (9%)
Query: 32  FSYNQLKIATNGFRWSNKIGEGGFGSVY--KGRLQDGTIVAVKVLS---VESKQGEKEFM 86
           F  +   I ++ ++    +G+G FG V   K ++  G   AVKV+S   V+ K  ++  +
Sbjct: 16  FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLL 74
Query: 87  SEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKAR 146
            EV  +  ++  H N+ KL+    D     LV +      L   ++     R +F     
Sbjct: 75  REVQLLKQLD--HPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIIS----RKRFSEVDA 128
Query: 147 REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD---QNFNPKISDFGLSKLFPENTTH 203
             II  +  G+ Y H   +  +VHRD+K  N+LL+   ++ N +I DFGLS  F E +  
Sbjct: 129 ARIIRQVLSGITYXH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF-EASKK 184
Query: 204 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
              ++ GT  Y+APE  + G    K DV+S GV+L  ++SG
Sbjct: 185 XKDKI-GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 16/201 (7%)
Query: 50  IGEGGFGSVYKGRLQDGT----IVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKL 105
           +G+G FG V+  +   G+    + A+KVL   + +      +++     V V H  +VKL
Sbjct: 33  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 92
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
           H          L+ D++    L   L     +   F  +  +  +  +   L ++H    
Sbjct: 93  HYAFQTEGKLYLILDFLRGGDLFTRL----SKEVMFTEEDVKFYLAELALALDHLH---S 145
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH--ISTRVAGTLGYLAPEYAISG 223
             +++RD+K  NILLD+  + K++DFGLSK   E+  H   +    GT+ Y+APE     
Sbjct: 146 LGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAPEVVNRR 202
Query: 224 RLTRKSDVYSFGVLLLEIVSG 244
             T+ +D +SFGVL+ E+++G
Sbjct: 203 GHTQSADWWSFGVLMFEMLTG 223

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 16/201 (7%)
Query: 50  IGEGGFGSVYKGRLQDGT----IVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKL 105
           +G+G FG V+  +   G+    + A+KVL   + +      +++     V V H  +VKL
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
           H          L+ D++    L   L     +   F  +  +  +  +   L ++H    
Sbjct: 92  HYAFQTEGKLYLILDFLRGGDLFTRL----SKEVMFTEEDVKFYLAELALALDHLH---S 144
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH--ISTRVAGTLGYLAPEYAISG 223
             +++RD+K  NILLD+  + K++DFGLSK   E+  H   +    GT+ Y+APE     
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAPEVVNRR 201
Query: 224 RLTRKSDVYSFGVLLLEIVSG 244
             T+ +D +SFGVL+ E+++G
Sbjct: 202 GHTQSADWWSFGVLMFEMLTG 222

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 16/207 (7%)
Query: 44  FRWSNKIGEGGFGSVYKG-RLQDGTIVAVKVLSVE-----SKQGEKEFMSEVASMANVNV 97
           F+    +G G FG+VYKG  + +G  V + V  +E     S +  KE + E   MA+V+ 
Sbjct: 51  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDN 110
Query: 98  CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
            H  + +L G C+    + L+   MP   L   +    + +   G +      + I +G+
Sbjct: 111 PH--VCRLLGICLTSTVQ-LITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGM 164
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLA 216
            Y+ +     +VHRD+   N+L+    + KI+DFGL+KL   E   + +      + ++A
Sbjct: 165 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 221
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVS 243
            E  +    T +SDV+S+GV + E+++
Sbjct: 222 LESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/258 (27%), Positives = 123/258 (47%), Gaps = 27/258 (10%)
Query: 49  KIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGE---KEFMSEVASMANVNVCHENLVKL 105
           KIGEG +G VYK +   G   A+K + +E K+ E      + E++ +  +   H N+VKL
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLE-KEDEGIPSTTIREISILKELK--HSNIVKL 65
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLL----GEEKRRAKFGWKARREIIMGIGRGLAYIH 161
           +         +LV++++ +  L + L     G E   AK         ++ +  G+AY H
Sbjct: 66  YDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAK-------SFLLQLLNGIAYCH 117
Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI 221
           +     V+HRD+K  N+L+++    KI+DFGL++ F       +  V  TL Y AP+  +
Sbjct: 118 DR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPDVLM 173
Query: 222 -SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD-PM 279
            S + +   D++S G +  E+V+G        +  +   + +  G  NSK   N+ + P 
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 280 LYGNFPENEAI---RFLK 294
              NF   E +    FLK
Sbjct: 234 YDPNFTVYEPLPWESFLK 251

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 16/201 (7%)
Query: 50  IGEGGFGSVYKGRLQDGT----IVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKL 105
           +G+G FG V+  +   G+    + A+KVL   + +      +++     V V H  +VKL
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
           H          L+ D++    L   L     +   F  +  +  +  +   L ++H    
Sbjct: 92  HYAFQTEGKLYLILDFLRGGDLFTRL----SKEVMFTEEDVKFYLAELALALDHLH---S 144
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH--ISTRVAGTLGYLAPEYAISG 223
             +++RD+K  NILLD+  + K++DFGLSK   E+  H   +    GT+ Y+APE     
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAPEVVNRR 201
Query: 224 RLTRKSDVYSFGVLLLEIVSG 244
             T+ +D +SFGVL+ E+++G
Sbjct: 202 GHTQSADWWSFGVLMFEMLTG 222

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 104/220 (47%), Gaps = 29/220 (13%)
Query: 39  IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQ---------GEKEFMSE 88
           +  N FR    +G+GGFG V   +++  G + A K L  +  +          EK+ + +
Sbjct: 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEK 240
Query: 89  VASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARRE 148
           V S   V++ +    K      D  C  LV   M    L   +        + G+   R 
Sbjct: 241 VNSRFVVSLAYAYETK------DALC--LVLTLMNGGDLKFHIY----HMGQAGFPEARA 288
Query: 149 IIMG--IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIST 206
           +     I  GL  +H E    +V+RD+K  NILLD + + +ISD GL+   PE  T I  
Sbjct: 289 VFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKG 344
Query: 207 RVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT 246
           RV GT+GY+APE   + R T   D ++ G LL E+++G++
Sbjct: 345 RV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 383

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 101/216 (46%), Gaps = 15/216 (6%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVL--SVESKQGEKEFMSEVASMANVNVCHENLVKLH 106
           +GEG +G V K R +D G IVA+K    S + K  +K  M E+  +  +   HENLV L 
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR--HENLVNLL 90
Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
             C       LV++++ +  L    L       +   K   +II GIG    + H     
Sbjct: 91  EVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIG----FCHSH--- 143
Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG-RL 225
           +++HRDIK  NIL+ Q+   K+ DFG ++            VA T  Y APE  +   + 
Sbjct: 144 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRAPELLVGDVKY 202
Query: 226 TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE-YHLV 260
            +  DV++ G L+ E+  G      D  + + YH++
Sbjct: 203 GKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIM 238

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/258 (27%), Positives = 123/258 (47%), Gaps = 27/258 (10%)
Query: 49  KIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGE---KEFMSEVASMANVNVCHENLVKL 105
           KIGEG +G VYK +   G   A+K + +E K+ E      + E++ +  +   H N+VKL
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLE-KEDEGIPSTTIREISILKELK--HSNIVKL 65
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLL----GEEKRRAKFGWKARREIIMGIGRGLAYIH 161
           +         +LV++++ +  L + L     G E   AK         ++ +  G+AY H
Sbjct: 66  YDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAK-------SFLLQLLNGIAYCH 117
Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI 221
           +     V+HRD+K  N+L+++    KI+DFGL++ F       +  V  TL Y AP+  +
Sbjct: 118 DR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPDVLM 173
Query: 222 -SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD-PM 279
            S + +   D++S G +  E+V+G        +  +   + +  G  NSK   N+ + P 
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 280 LYGNFPENEAI---RFLK 294
              NF   E +    FLK
Sbjct: 234 YDPNFTVYEPLPWESFLK 251

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 103/202 (50%), Gaps = 15/202 (7%)
Query: 48  NKIGEGGFGSVYKGR--LQDGTIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLVK 104
           +K+GEG + +VYKG+  L D  +VA+K + +E ++G     + EV+ + ++   H N+V 
Sbjct: 8   DKLGEGTYATVYKGKSKLTDN-LVALKEIRLEHEEGAPCTAIREVSLLKDLK--HANIVT 64
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           LH          LV++Y+ +  L Q L   +           +  +  + RGLAY H + 
Sbjct: 65  LHDIIHTEKSLTLVFEYL-DKDLKQYL---DDCGNIINMHNVKLFLFQLLRGLAYCHRQ- 119
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI-SG 223
              V+HRD+K  N+L+++    K++DFGL++     T      V  TL Y  P+  + S 
Sbjct: 120 --KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILLGST 176
Query: 224 RLTRKSDVYSFGVLLLEIVSGR 245
             + + D++  G +  E+ +GR
Sbjct: 177 DYSTQIDMWGVGCIFYEMATGR 198

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 104/220 (47%), Gaps = 29/220 (13%)
Query: 39  IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQ---------GEKEFMSE 88
           +  N FR    +G+GGFG V   +++  G + A K L  +  +          EK+ + +
Sbjct: 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEK 240
Query: 89  VASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARRE 148
           V S   V++ +    K      D  C  LV   M    L   +        + G+   R 
Sbjct: 241 VNSRFVVSLAYAYETK------DALC--LVLTLMNGGDLKFHIY----HMGQAGFPEARA 288
Query: 149 IIMG--IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIST 206
           +     I  GL  +H E    +V+RD+K  NILLD + + +ISD GL+   PE  T I  
Sbjct: 289 VFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKG 344
Query: 207 RVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT 246
           RV GT+GY+APE   + R T   D ++ G LL E+++G++
Sbjct: 345 RV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 383

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 115/232 (49%), Gaps = 18/232 (7%)
Query: 23  EQILKNINAFSYNQLKIAT---NGFRWSNKIGEGGFGSVYK-GRLQDGTIVAVKVLSVES 78
           EQ  K + AF   + K+     + F   +++G G  G V+K      G ++A K++ +E 
Sbjct: 11  EQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI 70
Query: 79  KQG-EKEFMSEVASMANVNVCHENLVKLHGGCI-DGPCRILVYDYMPNNSLSQTLLGEEK 136
           K     + + E+  +   N  +  +V  +G    DG   I + ++M   SL Q L    K
Sbjct: 71  KPAIRNQIIRELQVLHECNSPY--IVGFYGAFYSDGEISICM-EHMDGGSLDQVL----K 123
Query: 137 RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196
           +  +   +   ++ + + +GL Y+ E+ +  ++HRD+K SNIL++     K+ DFG+S  
Sbjct: 124 KAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQ 181
Query: 197 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAV 248
             ++   ++    GT  Y++PE       + +SD++S G+ L+E+  GR  +
Sbjct: 182 LIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 24/203 (11%)
Query: 50  IGEGGFGSVYKGRLQD----GTIVAVKVL-SVESKQGEKEFMSEVASMANVNVCHENLVK 104
           IGEG FG V++G           VA+K   +  S    ++F+ E  +M   +  H ++VK
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD--HPHIVK 455
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEK---RRAKFGWKARREIIMG--IGRGLAY 159
           L G   + P  I+         +    LGE +   +  KF       I+    +   LAY
Sbjct: 456 LIGVITENPVWII---------MELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAY 506
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEY 219
           +  +     VHRDI   N+L+      K+ DFGLS+   ++T + +++    + ++APE 
Sbjct: 507 LESK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 563
Query: 220 AISGRLTRKSDVYSFGVLLLEIV 242
               R T  SDV+ FGV + EI+
Sbjct: 564 INFRRFTSASDVWMFGVCMWEIL 586

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 109/214 (50%), Gaps = 15/214 (7%)
Query: 38  KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQG-EKEFMSEVASMANV 95
           ++  + F   +++G G  G V K + +  G I+A K++ +E K     + + E+  +   
Sbjct: 12  ELKDDDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 71
Query: 96  NVCHENLVKLHGGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIG 154
           N  +  +V  +G    DG   I + ++M   SL Q L    K   +   +   ++ + + 
Sbjct: 72  NSPY--IVGFYGAFYSDGEISICM-EHMDGGSLDQVL----KEAKRIPEEILGKVSIAVL 124
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY 214
           RGLAY+ E+ Q  ++HRD+K SNIL++     K+ DFG+S    ++   ++    GT  Y
Sbjct: 125 RGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSY 179
Query: 215 LAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAV 248
           +APE       + +SD++S G+ L+E+  GR  +
Sbjct: 180 MAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPI 213

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 115/232 (49%), Gaps = 18/232 (7%)
Query: 23  EQILKNINAFSYNQLKIA---TNGFRWSNKIGEGGFGSVYK-GRLQDGTIVAVKVLSVES 78
           EQ  K + AF   + K+     + F   +++G G  G V+K      G ++A K++ +E 
Sbjct: 46  EQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI 105
Query: 79  KQG-EKEFMSEVASMANVNVCHENLVKLHGGCI-DGPCRILVYDYMPNNSLSQTLLGEEK 136
           K     + + E+  +   N  +  +V  +G    DG   I + ++M   SL Q L    K
Sbjct: 106 KPAIRNQIIRELQVLHECNSPY--IVGFYGAFYSDGEISICM-EHMDGGSLDQVL----K 158
Query: 137 RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196
           +  +   +   ++ + + +GL Y+ E+ +  ++HRD+K SNIL++     K+ DFG+S  
Sbjct: 159 KAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQ 216
Query: 197 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAV 248
             ++   ++    GT  Y++PE       + +SD++S G+ L+E+  GR  +
Sbjct: 217 LIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 265

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 105/235 (44%), Gaps = 37/235 (15%)
Query: 50  IGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGC 109
           IG+G FG V++G+ + G  VAVK+ S    + E+ +  E      V + HEN++    G 
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENIL----GF 62
Query: 110 IDGPCR--------ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
           I    +         LV DY  + SL   L      R     +   ++ +    GLA++H
Sbjct: 63  IAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLH 117
Query: 162 EEI-----QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS---TRVAGTLG 213
            EI     +P + HRD+K+ NIL+ +N    I+D GL+      T  I        GT  
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177
Query: 214 YLAPEYAISG------RLTRKSDVYSFGVLLLEIVSGRT--AVDFDVQLGEYHLV 260
           Y+APE              +++D+Y+ G++  EI    +   +  D QL  Y LV
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 33/213 (15%)
Query: 50  IGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGC 109
           +G+G +G V++G  Q G  VAVK+ S    + EK +  E      V + HEN++      
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIAS- 70
Query: 110 IDGPCR------ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
            D   R       L+  Y    SL   L     +       +   I++ I  GLA++H E
Sbjct: 71  -DMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 164 I-----QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIST----RVAGTLGY 214
           I     +P + HRD+K+ NIL+ +N    I+D GL+ +  ++T  +      RV GT  Y
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRY 183
Query: 215 LAPEYAISGRLT------RKSDVYSFGVLLLEI 241
           +APE              ++ D+++FG++L E+
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 105/235 (44%), Gaps = 37/235 (15%)
Query: 50  IGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGC 109
           IG+G FG V++G+ + G  VAVK+ S    + E+ +  E      V + HEN++    G 
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENIL----GF 63
Query: 110 IDGPCR--------ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
           I    +         LV DY  + SL   L      R     +   ++ +    GLA++H
Sbjct: 64  IAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLH 118
Query: 162 EEI-----QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS---TRVAGTLG 213
            EI     +P + HRD+K+ NIL+ +N    I+D GL+      T  I        GT  
Sbjct: 119 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 178
Query: 214 YLAPEYAISG------RLTRKSDVYSFGVLLLEIVSGRT--AVDFDVQLGEYHLV 260
           Y+APE              +++D+Y+ G++  EI    +   +  D QL  Y LV
Sbjct: 179 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 233

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 123/258 (47%), Gaps = 27/258 (10%)
Query: 49  KIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGE---KEFMSEVASMANVNVCHENLVKL 105
           KIGEG +G VYK +   G   A+K + +E K+ E      + E++ +  +   H N+VKL
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLE-KEDEGIPSTTIREISILKELK--HSNIVKL 65
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLL----GEEKRRAKFGWKARREIIMGIGRGLAYIH 161
           +         +LV++++ +  L + L     G E   AK         ++ +  G+AY H
Sbjct: 66  YDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAK-------SFLLQLLNGIAYCH 117
Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI 221
           +     V+HRD+K  N+L+++    KI+DFGL++ F       +  +  TL Y AP+  +
Sbjct: 118 DR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLM 173
Query: 222 -SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD-PM 279
            S + +   D++S G +  E+V+G        +  +   + +  G  NSK   N+ + P 
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 280 LYGNFPENEAI---RFLK 294
              NF   E +    FLK
Sbjct: 234 YDPNFTVYEPLPWESFLK 251

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 105/235 (44%), Gaps = 37/235 (15%)
Query: 50  IGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGC 109
           IG+G FG V++G+ + G  VAVK+ S    + E+ +  E      V + HEN++    G 
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENIL----GF 88
Query: 110 IDGPCR--------ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
           I    +         LV DY  + SL   L      R     +   ++ +    GLA++H
Sbjct: 89  IAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLH 143
Query: 162 EEI-----QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS---TRVAGTLG 213
            EI     +P + HRD+K+ NIL+ +N    I+D GL+      T  I        GT  
Sbjct: 144 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 203
Query: 214 YLAPEYAISG------RLTRKSDVYSFGVLLLEIVSGRT--AVDFDVQLGEYHLV 260
           Y+APE              +++D+Y+ G++  EI    +   +  D QL  Y LV
Sbjct: 204 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 258

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 92/217 (42%), Gaps = 29/217 (13%)
Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHE 100
           +R    IG+G F  V   R +  G  VA+K++     +    ++   EV  M  +N  H 
Sbjct: 17  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILN--HP 74
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
           N+VKL           L+ +Y     +   L+   + + K      R+I+  +     Y 
Sbjct: 75  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAV----QYC 130
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL--APE 218
           H   Q  +VHRD+K  N+LLD + N KI+DFG S  F          V G L     AP 
Sbjct: 131 H---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT---------VGGKLDAFCGAPP 178
Query: 219 YAISGRLTRKS------DVYSFGVLLLEIVSGRTAVD 249
           YA       K       DV+S GV+L  +VSG    D
Sbjct: 179 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 105/235 (44%), Gaps = 37/235 (15%)
Query: 50  IGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGC 109
           IG+G FG V++G+ + G  VAVK+ S    + E+ +  E      V + HEN++    G 
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENIL----GF 101
Query: 110 IDGPCR--------ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
           I    +         LV DY  + SL   L      R     +   ++ +    GLA++H
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLH 156
Query: 162 EEI-----QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS---TRVAGTLG 213
            EI     +P + HRD+K+ NIL+ +N    I+D GL+      T  I        GT  
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216
Query: 214 YLAPEYAISG------RLTRKSDVYSFGVLLLEIVSGRT--AVDFDVQLGEYHLV 260
           Y+APE              +++D+Y+ G++  EI    +   +  D QL  Y LV
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 33/213 (15%)
Query: 50  IGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGC 109
           +G+G +G V++G  Q G  VAVK+ S    + EK +  E      V + HEN++      
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIAS- 70
Query: 110 IDGPCR------ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
            D   R       L+  Y    SL   L     +       +   I++ I  GLA++H E
Sbjct: 71  -DMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 164 I-----QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIST----RVAGTLGY 214
           I     +P + HRD+K+ NIL+ +N    I+D GL+ +  ++T  +      RV GT  Y
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRY 183
Query: 215 LAPEYAISGRLT------RKSDVYSFGVLLLEI 241
           +APE              ++ D+++FG++L E+
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 105/235 (44%), Gaps = 37/235 (15%)
Query: 50  IGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGC 109
           IG+G FG V++G+ + G  VAVK+ S    + E+ +  E      V + HEN++    G 
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENIL----GF 68
Query: 110 IDGPCR--------ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
           I    +         LV DY  + SL   L      R     +   ++ +    GLA++H
Sbjct: 69  IAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLH 123
Query: 162 EEI-----QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS---TRVAGTLG 213
            EI     +P + HRD+K+ NIL+ +N    I+D GL+      T  I        GT  
Sbjct: 124 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 183
Query: 214 YLAPEYAISG------RLTRKSDVYSFGVLLLEIVSGRT--AVDFDVQLGEYHLV 260
           Y+APE              +++D+Y+ G++  EI    +   +  D QL  Y LV
Sbjct: 184 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 238

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 105/235 (44%), Gaps = 37/235 (15%)
Query: 50  IGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGC 109
           IG+G FG V++G+ + G  VAVK+ S    + E+ +  E      V + HEN++    G 
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENIL----GF 65
Query: 110 IDGPCR--------ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
           I    +         LV DY  + SL   L      R     +   ++ +    GLA++H
Sbjct: 66  IAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLH 120
Query: 162 EEI-----QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS---TRVAGTLG 213
            EI     +P + HRD+K+ NIL+ +N    I+D GL+      T  I        GT  
Sbjct: 121 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 180
Query: 214 YLAPEYAISG------RLTRKSDVYSFGVLLLEIVSGRT--AVDFDVQLGEYHLV 260
           Y+APE              +++D+Y+ G++  EI    +   +  D QL  Y LV
Sbjct: 181 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 235

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 44  FRWSNKIGEGGFGSVYKG-RLQDGTIVAVKVLSVE-----SKQGEKEFMSEVASMANVNV 97
           F+    +G G FG+VYKG  + +G  V + V   E     S +  KE + E   MA+V+ 
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 98  CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
            H  + +L G C+    + L+   MP   L   +    + +   G +      + I +G+
Sbjct: 80  PH--VCRLLGICLTSTVQ-LIMQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGM 133
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLA 216
            Y+ +     +VHRD+   N+L+    + KI+DFGL+KL   E   + +      + ++A
Sbjct: 134 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVS 243
            E  +    T +SDV+S+GV + E+++
Sbjct: 191 LESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 33/213 (15%)
Query: 50  IGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGC 109
           +G+G +G V++G  Q G  VAVK+ S    + EK +  E      V + HEN++      
Sbjct: 45  VGKGRYGEVWRGSWQ-GENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIAS- 99
Query: 110 IDGPCR------ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
            D   R       L+  Y    SL   L     +       +   I++ I  GLA++H E
Sbjct: 100 -DMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHIE 153
Query: 164 I-----QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIST----RVAGTLGY 214
           I     +P + HRD+K+ NIL+ +N    I+D GL+ +  ++T  +      RV GT  Y
Sbjct: 154 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRY 212
Query: 215 LAPEYAISGRLT------RKSDVYSFGVLLLEI 241
           +APE              ++ D+++FG++L E+
Sbjct: 213 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 44  FRWSNKIGEGGFGSVYKG-RLQDGTIVAVKVLSVE-----SKQGEKEFMSEVASMANVNV 97
           F+    +G G FG+VYKG  + +G  V + V   E     S +  KE + E   MA+V+ 
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 98  CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
            H  + +L G C+    + L+   MP   L   +    + +   G +      + I +G+
Sbjct: 78  PH--VCRLLGICLTSTVQ-LIMQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGM 131
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLA 216
            Y+ +     +VHRD+   N+L+    + KI+DFGL+KL   E   + +      + ++A
Sbjct: 132 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 188
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVS 243
            E  +    T +SDV+S+GV + E+++
Sbjct: 189 LESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 44  FRWSNKIGEGGFGSVYKG-RLQDGTIVAVKVLSVE-----SKQGEKEFMSEVASMANVNV 97
           F+    +G G FG+VYKG  + +G  V + V   E     S +  KE + E   MA+V+ 
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 98  CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
            H  + +L G C+    + L+   MP   L   +    + +   G +      + I +G+
Sbjct: 77  PH--VCRLLGICLTSTVQ-LIMQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGM 130
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLA 216
            Y+ +     +VHRD+   N+L+    + KI+DFGL+KL   E   + +      + ++A
Sbjct: 131 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVS 243
            E  +    T +SDV+S+GV + E+++
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 44  FRWSNKIGEGGFGSVYKG-RLQDGTIVAVKVLSVE-----SKQGEKEFMSEVASMANVNV 97
           F+    +G G FG+VYKG  + +G  V + V   E     S +  KE + E   MA+V+ 
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 98  CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
            H  + +L G C+    + L+   MP   L   +    + +   G +      + I +G+
Sbjct: 79  PH--VCRLLGICLTSTVQ-LIMQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGM 132
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLA 216
            Y+ +     +VHRD+   N+L+    + KI+DFGL+KL   E   + +      + ++A
Sbjct: 133 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVS 243
            E  +    T +SDV+S+GV + E+++
Sbjct: 190 LESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 98/201 (48%), Gaps = 20/201 (9%)
Query: 49  KIGEGGFGSV-YKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           KIGEG  G V        G  VAVK + +  +Q  +   +EV  M + +  H+N+V ++ 
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYH--HDNVVDMYS 109
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
             + G    +V +++   +L+  +        +        + + + R L+Y+H +    
Sbjct: 110 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----TVCLSVLRALSYLHNQ---G 161
Query: 168 VVHRDIKTSNILLDQNFNPKISDFG----LSKLFPENTTHISTRVAGTLGYLAPEYAISG 223
           V+HRDIK+ +ILL  +   K+SDFG    +SK  P+        + GT  ++APE     
Sbjct: 162 VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKX-----LVGTPYWMAPEVISRL 216
Query: 224 RLTRKSDVYSFGVLLLEIVSG 244
               + D++S G++++E++ G
Sbjct: 217 PYGTEVDIWSLGIMVIEMIDG 237

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 100/222 (45%), Gaps = 33/222 (14%)
Query: 50  IGEGGFGSVYKG------RLQDGTIVAVKVLSVESKQGEKE-FMSEVASMANVNVCHENL 102
           +G G FG V         +      VAVK+L  ++   E+E  MSE+  M  +   HEN+
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG-SHENI 111
Query: 103 VKLHGGC-IDGPCRILVYDYMPNNSL-------------------SQTLLGEEKRRAKFG 142
           V L G C + GP   L+++Y     L                   +Q  L EE+      
Sbjct: 112 VNLLGACTLSGPI-YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 143 WKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 202
           ++        + +G+ ++  +     VHRD+   N+L+      KI DFGL++    ++ 
Sbjct: 171 FEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227
Query: 203 HISTRVAG-TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
           ++    A   + ++APE    G  T KSDV+S+G+LL EI S
Sbjct: 228 YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 44  FRWSNKIGEGGFGSVYKG-RLQDGTIVAVKVLSVE-----SKQGEKEFMSEVASMANVNV 97
           F+    +G G FG+VYKG  + +G  V + V   E     S +  KE + E   MA+V+ 
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 98  CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
            H  + +L G C+    + L+   MP   L   +    + +   G +      + I +G+
Sbjct: 78  PH--VCRLLGICLTSTVQ-LIMQLMPFGXLLDYV---REHKDNIGSQYLLNWCVQIAKGM 131
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLA 216
            Y+ +     +VHRD+   N+L+    + KI+DFGL+KL   E   + +      + ++A
Sbjct: 132 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 188
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVS 243
            E  +    T +SDV+S+GV + E+++
Sbjct: 189 LESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 50  IGEGGFGSVYKG--RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           +GEG +G V     R+ +   VAVK++ ++      E + +   + N  + HEN+VK +G
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICI-NKMLNHENVVKFYG 71
Query: 108 GCIDGPCRILVYDYMPNNSLSQTL---LGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
              +G  + L  +Y     L   +   +G  +  A+            +  G+ Y+H   
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-------RFFHQLMAGVVYLH--- 121
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP-ENTTHISTRVAGTLGYLAPEYAISG 223
              + HRDIK  N+LLD+  N KISDFGL+ +F   N   +  ++ GTL Y+APE     
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 224 RL-TRKSDVYSFGVLLLEIVSGRTAVD 249
                  DV+S G++L  +++G    D
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 44  FRWSNKIGEGGFGSVYKG-RLQDGTIVAVKVLSVE-----SKQGEKEFMSEVASMANVNV 97
           F+    +G G FG+VYKG  + +G  V + V   E     S +  KE + E   MA+V+ 
Sbjct: 42  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 101
Query: 98  CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
            H  + +L G C+    + L+   MP   L   +    + +   G +      + I +G+
Sbjct: 102 PH--VCRLLGICLTSTVQ-LITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGM 155
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLA 216
            Y+ +     +VHRD+   N+L+    + KI+DFGL+KL   E   + +      + ++A
Sbjct: 156 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 212
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVS 243
            E  +    T +SDV+S+GV + E+++
Sbjct: 213 LESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 94/210 (44%), Gaps = 15/210 (7%)
Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHE 100
           +R    IG+G F  V   R +  G  VA+K++     +    ++   EV  M  +N  H 
Sbjct: 14  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILN--HP 71
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
           N+VKL           L+ +Y     +   L+   + + K      R+I+  +     Y 
Sbjct: 72  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAV----QYC 127
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
           H   Q  +VHRD+K  N+LLD + N KI+DFG S  F      + T   G+  Y APE  
Sbjct: 128 H---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK-LDT-FCGSPPYAAPELF 182
Query: 221 ISGRLT-RKSDVYSFGVLLLEIVSGRTAVD 249
              +    + DV+S GV+L  +VSG    D
Sbjct: 183 QGKKYDGPEVDVWSLGVILYTLVSGSLPFD 212

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 44  FRWSNKIGEGGFGSVYKG-RLQDGTIVAVKVLSVE-----SKQGEKEFMSEVASMANVNV 97
           F+    +G G FG+VYKG  + +G  V + V   E     S +  KE + E   MA+V+ 
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 98  CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
            H  + +L G C+    + L+   MP   L   +    + +   G +      + I +G+
Sbjct: 81  PH--VCRLLGICLTSTVQ-LIMQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGM 134
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLA 216
            Y+ +     +VHRD+   N+L+    + KI+DFGL+KL   E   + +      + ++A
Sbjct: 135 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 191
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVS 243
            E  +    T +SDV+S+GV + E+++
Sbjct: 192 LESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 50  IGEGGFGSVYKG--RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           +GEG +G V     R+ +   VAVK++ ++      E + +   + N  + HEN+VK +G
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICI-NKMLNHENVVKFYG 71
Query: 108 GCIDGPCRILVYDYMPNNSLSQTL---LGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
              +G  + L  +Y     L   +   +G  +  A+            +  G+ Y+H   
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-------RFFHQLMAGVVYLH--- 121
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP-ENTTHISTRVAGTLGYLAPEYAISG 223
              + HRDIK  N+LLD+  N KISDFGL+ +F   N   +  ++ GTL Y+APE     
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 224 RL-TRKSDVYSFGVLLLEIVSGRTAVD 249
                  DV+S G++L  +++G    D
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 50  IGEGGFGSVYKG--RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           +GEG +G V     R+ +   VAVK++ ++      E + +   + N  + HEN+VK +G
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICI-NKMLNHENVVKFYG 71
Query: 108 GCIDGPCRILVYDYMPNNSLSQTL---LGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
              +G  + L  +Y     L   +   +G  +  A+            +  G+ Y+H   
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-------RFFHQLMAGVVYLH--- 121
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP-ENTTHISTRVAGTLGYLAPEYAISG 223
              + HRDIK  N+LLD+  N KISDFGL+ +F   N   +  ++ GTL Y+APE     
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 224 RL-TRKSDVYSFGVLLLEIVSGRTAVD 249
                  DV+S G++L  +++G    D
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 50  IGEGGFGSVYKG--RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           +GEG +G V     R+ +   VAVK++ ++      E + +   + N  + HEN+VK +G
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICI-NKMLNHENVVKFYG 72
Query: 108 GCIDGPCRILVYDYMPNNSLSQTL---LGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
              +G  + L  +Y     L   +   +G  +  A+            +  G+ Y+H   
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-------RFFHQLMAGVVYLH--- 122
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP-ENTTHISTRVAGTLGYLAPEYAISG 223
              + HRDIK  N+LLD+  N KISDFGL+ +F   N   +  ++ GTL Y+APE     
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 224 RL-TRKSDVYSFGVLLLEIVSGRTAVD 249
                  DV+S G++L  +++G    D
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 93/201 (46%), Gaps = 10/201 (4%)
Query: 50  IGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFM-SEVASMANVNVCHENLVKLH 106
           IG G +G   K R + DG I+  K L   S  + EK+ + SEV  +  +   H N+V+ +
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK--HPNIVRYY 71
Query: 107 GGCIDGPCRIL--VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
              ID     L  V +Y     L+  +    K R     +    ++  +   L   H   
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 165 Q--PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS 222
                V+HRD+K +N+ LD   N K+ DFGL+++   +T+  +    GT  Y++PE    
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS-FAKAFVGTPYYMSPEQMNR 190
Query: 223 GRLTRKSDVYSFGVLLLEIVS 243
                KSD++S G LL E+ +
Sbjct: 191 MSYNEKSDIWSLGCLLYELCA 211

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 44  FRWSNKIGEGGFGSVYKG-RLQDGTIVAVKVLSVE-----SKQGEKEFMSEVASMANVNV 97
           F+    +G G FG+VYKG  + +G  V + V   E     S +  KE + E   MA+V+ 
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 98  CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
            H  + +L G C+    + L+   MP   L   +    + +   G +      + I +G+
Sbjct: 80  PH--VCRLLGICLTSTVQ-LITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGM 133
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLA 216
            Y+ +     +VHRD+   N+L+    + KI+DFGL+KL   E   + +      + ++A
Sbjct: 134 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVS 243
            E  +    T +SDV+S+GV + E+++
Sbjct: 191 LESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 104/201 (51%), Gaps = 19/201 (9%)
Query: 49  KIGEGGFGSVYKGRLQDGTIVAV-KVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           ++G+G FG VYK + ++ +++A  KV+  +S++  +++M E+  +A+ +  H N+VKL  
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD--HPNIVKLLD 101
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
                    ++ ++    ++   +L  E+   +   +    +       L Y+H+     
Sbjct: 102 AFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQV---VCKQTLDALNYLHDN---K 155
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVA--GTLGYLAPEYAISGR- 224
           ++HRD+K  NIL   + + K++DFG+S    +NT  I  R +  GT  ++APE  +    
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVSA---KNTRXIQRRDSFIGTPYWMAPEVVMCETS 212
Query: 225 ----LTRKSDVYSFGVLLLEI 241
                  K+DV+S G+ L+E+
Sbjct: 213 KDRPYDYKADVWSLGITLIEM 233

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 16/201 (7%)
Query: 50  IGEGGFGSVYKG-RLQDGTIVAVKVLSVE-----SKQGEKEFMSEVASMANVNVCHENLV 103
           +G G FG+VYKG  + +G  V + V   E     S +  KE + E   MA+V+  H  + 
Sbjct: 33  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH--VC 90
Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
           +L G C+    + L+   MP   L   +    + +   G +      + I +G+ Y+ + 
Sbjct: 91  RLLGICLTSTVQ-LITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGMNYLEDR 146
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLAPEYAIS 222
               +VHRD+   N+L+    + KI+DFGL+KL   E   + +      + ++A E  + 
Sbjct: 147 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 203
Query: 223 GRLTRKSDVYSFGVLLLEIVS 243
              T +SDV+S+GV + E+++
Sbjct: 204 RIYTHQSDVWSYGVTVWELMT 224

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 44  FRWSNKIGEGGFGSVYKG-RLQDGTIVAVKVLSVE-----SKQGEKEFMSEVASMANVNV 97
           F+    +G G FG+VYKG  + +G  V + V   E     S +  KE + E   MA+V+ 
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 98  CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
            H  + +L G C+    + L+   MP   L   +    + +   G +      + I +G+
Sbjct: 84  PH--VCRLLGICLTSTVQ-LITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGM 137
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLA 216
            Y+ +     +VHRD+   N+L+    + KI+DFGL+KL   E   + +      + ++A
Sbjct: 138 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVS 243
            E  +    T +SDV+S+GV + E+++
Sbjct: 195 LESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 16/201 (7%)
Query: 50  IGEGGFGSVYKG-RLQDGTIVAVKVLSVE-----SKQGEKEFMSEVASMANVNVCHENLV 103
           +G G FG+VYKG  + +G  V + V   E     S +  KE + E   MA+V+  H  + 
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH--VC 80
Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
           +L G C+    + L+   MP   L   +    + +   G +      + I +G+ Y+ + 
Sbjct: 81  RLLGICLTSTVQ-LITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLAPEYAIS 222
               +VHRD+   N+L+    + KI+DFGL+KL   E   + +      + ++A E  + 
Sbjct: 137 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 223 GRLTRKSDVYSFGVLLLEIVS 243
              T +SDV+S+GV + E+++
Sbjct: 194 RIYTHQSDVWSYGVTVWELMT 214

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 44  FRWSNKIGEGGFGSVYKG-RLQDGTIVAVKVLSVE-----SKQGEKEFMSEVASMANVNV 97
           F+    +G G FG+VYKG  + +G  V + V   E     S +  KE + E   MA+V+ 
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 98  CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
            H  + +L G C+    + L+   MP   L   +    + +   G +      + I +G+
Sbjct: 79  PH--VCRLLGICLTSTVQ-LITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGM 132
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLA 216
            Y+ +     +VHRD+   N+L+    + KI+DFGL+KL   E   + +      + ++A
Sbjct: 133 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVS 243
            E  +    T +SDV+S+GV + E+++
Sbjct: 190 LESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 44  FRWSNKIGEGGFGSVYKG-RLQDGTIVAVKVLSVE-----SKQGEKEFMSEVASMANVNV 97
           F+    +G G FG+VYKG  + +G  V + V   E     S +  KE + E   MA+V+ 
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 98  CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
            H  + +L G C+    + L+   MP   L   +    + +   G +      + I +G+
Sbjct: 80  PH--VCRLLGICLTSTVQ-LITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGM 133
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLA 216
            Y+ +     +VHRD+   N+L+    + KI+DFGL+KL   E   + +      + ++A
Sbjct: 134 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVS 243
            E  +    T +SDV+S+GV + E+++
Sbjct: 191 LESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 50  IGEGGFGSVYKG--RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           +GEG +G V     R+ +   VAVK++ ++      E + +   + N  + HEN+VK +G
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICI-NKMLNHENVVKFYG 71
Query: 108 GCIDGPCRILVYDYMPNNSLSQTL---LGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
              +G  + L  +Y     L   +   +G  +  A+            +  G+ Y+H   
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-------RFFHQLMAGVVYLH--- 121
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP-ENTTHISTRVAGTLGYLAPEYAISG 223
              + HRDIK  N+LLD+  N KISDFGL+ +F   N   +  ++ GTL Y+APE     
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 224 RL-TRKSDVYSFGVLLLEIVSGRTAVD 249
                  DV+S G++L  +++G    D
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 38  KIATNGFRWSNKIGEGGFGSVY----KGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMA 93
           K   + F     +G+G FG V+      R   G + A+KVL   + +      +++    
Sbjct: 24  KADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDI 83
Query: 94  NVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGI 153
             +V H  +VKLH          L+ D++    L   L     +   F  +  +  +  +
Sbjct: 84  LADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRL----SKEVMFTEEDVKFYLAEL 139
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH--ISTRVAGT 211
             GL ++H      +++RD+K  NILLD+  + K++DFGLSK   E   H   +    GT
Sbjct: 140 ALGLDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK---EAIDHEKKAYSFCGT 193
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
           + Y+APE       +  +D +S+GVL+ E+++G
Sbjct: 194 VEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 44  FRWSNKIGEGGFGSVYKG-RLQDGTIVAVKVLSVE-----SKQGEKEFMSEVASMANVNV 97
           F+    +G G FG+VYKG  + +G  V + V   E     S +  KE + E   MA+V+ 
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 98  CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
            H  + +L G C+    + L+   MP   L   +    + +   G +      + I +G+
Sbjct: 77  PH--VCRLLGICLTSTVQ-LITQLMPFGXLLDYV---REHKDNIGSQYLLNWCVQIAKGM 130
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLA 216
            Y+ +     +VHRD+   N+L+    + KI+DFGL+KL   E   + +      + ++A
Sbjct: 131 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVS 243
            E  +    T +SDV+S+GV + E+++
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 50  IGEGGFGSVYKG--RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           +GEG +G V     R+ +   VAVK++ ++      E + +   + N  + HEN+VK +G
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICI-NKMLNHENVVKFYG 72
Query: 108 GCIDGPCRILVYDYMPNNSLSQTL---LGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
              +G  + L  +Y     L   +   +G  +  A+            +  G+ Y+H   
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-------RFFHQLMAGVVYLH--- 122
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP-ENTTHISTRVAGTLGYLAPEYAISG 223
              + HRDIK  N+LLD+  N KISDFGL+ +F   N   +  ++ GTL Y+APE     
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 224 RL-TRKSDVYSFGVLLLEIVSGRTAVD 249
                  DV+S G++L  +++G    D
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 44  FRWSNKIGEGGFGSVYKG-RLQDGTIVAVKVLSVE-----SKQGEKEFMSEVASMANVNV 97
           F+    +G G FG+VYKG  + +G  V + V   E     S +  KE + E   MA+V+ 
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 98  CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
            H  + +L G C+    + L+   MP   L   +    + +   G +      + I +G+
Sbjct: 77  PH--VCRLLGICLTSTVQ-LITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGM 130
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLA 216
            Y+ +     +VHRD+   N+L+    + KI+DFGL+KL   E   + +      + ++A
Sbjct: 131 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVS 243
            E  +    T +SDV+S+GV + E+++
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 44  FRWSNKIGEGGFGSVYKG-RLQDGTIVAVKVLSVE-----SKQGEKEFMSEVASMANVNV 97
           F+    +G G FG+VYKG  + +G  V + V   E     S +  KE + E   MA+V+ 
Sbjct: 23  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 82
Query: 98  CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
            H  + +L G C+    + L+   MP   L   +    + +   G +      + I +G+
Sbjct: 83  PH--VCRLLGICLTSTVQ-LITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGM 136
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLA 216
            Y+ +     +VHRD+   N+L+    + KI+DFGL+KL   E   + +      + ++A
Sbjct: 137 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 193
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVS 243
            E  +    T +SDV+S+GV + E+++
Sbjct: 194 LESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 23/208 (11%)
Query: 50  IGEGGFGSV------YKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLV 103
           +GEG FG V        G+     I+  KVL+    QG  E   E++ +  +   H +++
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR--HPHII 77
Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
           KL+         I+V +Y  N      +     +R K   +  R     I   + Y H  
Sbjct: 78  KLYDVIKSKDEIIMVIEYAGNELFDYIV-----QRDKMSEQEARRFFQQIISAVEYCHRH 132
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG 223
               +VHRD+K  N+LLD++ N KI+DFGLS +  +     ++   G+  Y APE  ISG
Sbjct: 133 ---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPE-VISG 186
Query: 224 RLTR--KSDVYSFGVLLLEIVSGRTAVD 249
           +L    + DV+S GV+L  ++  R   D
Sbjct: 187 KLYAGPEVDVWSCGVILYVMLCRRLPFD 214

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 23/208 (11%)
Query: 50  IGEGGFGSV------YKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLV 103
           +GEG FG V        G+     I+  KVL+    QG  E   E++ +  +   H +++
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR--HPHII 67
Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
           KL+         I+V +Y  N      +     +R K   +  R     I   + Y H  
Sbjct: 68  KLYDVIKSKDEIIMVIEYAGNELFDYIV-----QRDKMSEQEARRFFQQIISAVEYCHRH 122
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG 223
               +VHRD+K  N+LLD++ N KI+DFGLS +  +     ++   G+  Y APE  ISG
Sbjct: 123 ---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPE-VISG 176
Query: 224 RLTR--KSDVYSFGVLLLEIVSGRTAVD 249
           +L    + DV+S GV+L  ++  R   D
Sbjct: 177 KLYAGPEVDVWSCGVILYVMLCRRLPFD 204

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 103/201 (51%), Gaps = 19/201 (9%)
Query: 49  KIGEGGFGSVYKGRLQDGTIVAV-KVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           ++G+G FG VYK + ++ +++A  KV+  +S++  +++M E+  +A+ +  H N+VKL  
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD--HPNIVKLLD 101
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
                    ++ ++    ++   +L  E+   +   +    +       L Y+H+     
Sbjct: 102 AFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQV---VCKQTLDALNYLHDN---K 155
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR--VAGTLGYLAPEYAISGR- 224
           ++HRD+K  NIL   + + K++DFG+S    +NT  I  R    GT  ++APE  +    
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVSA---KNTRXIQRRDXFIGTPYWMAPEVVMCETS 212
Query: 225 ----LTRKSDVYSFGVLLLEI 241
                  K+DV+S G+ L+E+
Sbjct: 213 KDRPYDYKADVWSLGITLIEM 233

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 44  FRWSNKIGEGGFGSVYKG-RLQDGTIVAVKVLSVE-----SKQGEKEFMSEVASMANVNV 97
           F+    +G G FG+VYKG  + +G  V + V   E     S +  KE + E   MA+V+ 
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 98  CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
            H  + +L G C+    + L+   MP   L   +    + +   G +      + I +G+
Sbjct: 80  PH--VCRLLGICLTSTVQ-LITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGM 133
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLA 216
            Y+ +     +VHRD+   N+L+    + KI+DFGL+KL   E   + +      + ++A
Sbjct: 134 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVS 243
            E  +    T +SDV+S+GV + E+++
Sbjct: 191 LESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 50  IGEGGFGSVYKG--RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           +GEG +G V     R+ +   VAVK++ ++      E + +   + N  + HEN+VK +G
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICI-NKMLNHENVVKFYG 72
Query: 108 GCIDGPCRILVYDYMPNNSLSQTL---LGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
              +G  + L  +Y     L   +   +G  +  A+            +  G+ Y+H   
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-------RFFHQLMAGVVYLH--- 122
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP-ENTTHISTRVAGTLGYLAPEYAISG 223
              + HRDIK  N+LLD+  N KISDFGL+ +F   N   +  ++ GTL Y+APE     
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 224 RL-TRKSDVYSFGVLLLEIVSGRTAVD 249
                  DV+S G++L  +++G    D
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 50  IGEGGFGSVYKG--RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           +GEG +G V     R+ +   VAVK++ ++      E + +   + N  + HEN+VK +G
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICI-NKMLNHENVVKFYG 72
Query: 108 GCIDGPCRILVYDYMPNNSLSQTL---LGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
              +G  + L  +Y     L   +   +G  +  A+            +  G+ Y+H   
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-------RFFHQLMAGVVYLH--- 122
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP-ENTTHISTRVAGTLGYLAPEYAISG 223
              + HRDIK  N+LLD+  N KISDFGL+ +F   N   +  ++ GTL Y+APE     
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 224 RL-TRKSDVYSFGVLLLEIVSGRTAVD 249
                  DV+S G++L  +++G    D
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 50  IGEGGFGSVYKG--RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           +GEG +G V     R+ +   VAVK++ ++      E + +   + N  + HEN+VK +G
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICI-NKMLNHENVVKFYG 71
Query: 108 GCIDGPCRILVYDYMPNNSLSQTL---LGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
              +G  + L  +Y     L   +   +G  +  A+            +  G+ Y+H   
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-------RFFHQLMAGVVYLH--- 121
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP-ENTTHISTRVAGTLGYLAPEYAISG 223
              + HRDIK  N+LLD+  N KISDFGL+ +F   N   +  ++ GTL Y+APE     
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 224 RL-TRKSDVYSFGVLLLEIVSGRTAVD 249
                  DV+S G++L  +++G    D
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 104/201 (51%), Gaps = 19/201 (9%)
Query: 49  KIGEGGFGSVYKGRLQDGTIVAV-KVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           ++G+G FG VYK + ++ +++A  KV+  +S++  +++M E+  +A+ +  H N+VKL  
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD--HPNIVKLLD 101
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
                    ++ ++    ++   +L  E+   +   +    +       L Y+H+     
Sbjct: 102 AFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQV---VCKQTLDALNYLHDN---K 155
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVA--GTLGYLAPEYAISGR- 224
           ++HRD+K  NIL   + + K++DFG+S    +NT  I  R +  GT  ++APE  +    
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVSA---KNTRTIQRRDSFIGTPYWMAPEVVMCETS 212
Query: 225 ----LTRKSDVYSFGVLLLEI 241
                  K+DV+S G+ L+E+
Sbjct: 213 KDRPYDYKADVWSLGITLIEM 233

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 50  IGEGGFGSVYKG--RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           +GEG +G V     R+ +   VAVK++ ++      E + +   + N  + HEN+VK +G
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICI-NKMLNHENVVKFYG 72
Query: 108 GCIDGPCRILVYDYMPNNSLSQTL---LGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
              +G  + L  +Y     L   +   +G  +  A+            +  G+ Y+H   
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-------RFFHQLMAGVVYLH--- 122
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP-ENTTHISTRVAGTLGYLAPEYAISG 223
              + HRDIK  N+LLD+  N KISDFGL+ +F   N   +  ++ GTL Y+APE     
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 224 RL-TRKSDVYSFGVLLLEIVSGRTAVD 249
                  DV+S G++L  +++G    D
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 98/200 (49%), Gaps = 13/200 (6%)
Query: 49  KIGEGGFGSVYKGRLQDGTIVAVKVLSV-ESKQGEKEFMSEVASMANVNVCHEN--LVKL 105
           ++G G FG+V KG  Q   +V    + + +++  +     E+ + ANV    +N  +V++
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
            G C +    +LV +      L++ L  ++ R  K   K   E++  +  G+ Y+ E   
Sbjct: 78  IGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD--KNIIELVHQVSMGMKYLEES-- 130
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PENTTHISTRVAGTLGYLAPEYAISG 223
            + VHRD+   N+LL      KISDFGLSK     EN     T     + + APE     
Sbjct: 131 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYY 189
Query: 224 RLTRKSDVYSFGVLLLEIVS 243
           + + KSDV+SFGVL+ E  S
Sbjct: 190 KFSSKSDVWSFGVLMWEAFS 209

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 50  IGEGGFGSVYKG--RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           +GEG +G V     R+ +   VAVK++ ++      E + +   + N  + HEN+VK +G
Sbjct: 13  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICI-NKMLNHENVVKFYG 70
Query: 108 GCIDGPCRILVYDYMPNNSLSQTL---LGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
              +G  + L  +Y     L   +   +G  +  A+            +  G+ Y+H   
Sbjct: 71  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-------RFFHQLMAGVVYLH--- 120
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP-ENTTHISTRVAGTLGYLAPEYAISG 223
              + HRDIK  N+LLD+  N KISDFGL+ +F   N   +  ++ GTL Y+APE     
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 224 RL-TRKSDVYSFGVLLLEIVSGRTAVD 249
                  DV+S G++L  +++G    D
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWD 207

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 23/208 (11%)
Query: 50  IGEGGFGSV------YKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLV 103
           +GEG FG V        G+     I+  KVL+    QG  E   E++ +  +   H +++
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR--HPHII 76
Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
           KL+         I+V +Y  N      +     +R K   +  R     I   + Y H  
Sbjct: 77  KLYDVIKSKDEIIMVIEYAGNELFDYIV-----QRDKMSEQEARRFFQQIISAVEYCHRH 131
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG 223
               +VHRD+K  N+LLD++ N KI+DFGLS +  +     ++   G+  Y APE  ISG
Sbjct: 132 ---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPE-VISG 185
Query: 224 RLTR--KSDVYSFGVLLLEIVSGRTAVD 249
           +L    + DV+S GV+L  ++  R   D
Sbjct: 186 KLYAGPEVDVWSCGVILYVMLCRRLPFD 213

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 16/201 (7%)
Query: 50  IGEGGFGSVYKG-RLQDGTIVAVKVLSVE-----SKQGEKEFMSEVASMANVNVCHENLV 103
           +G G FG+VYKG  + +G  V + V   E     S +  KE + E   MA+V+  H  + 
Sbjct: 17  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH--VC 74
Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
           +L G C+    + L+   MP   L   +    + +   G +      + I +G+ Y+ + 
Sbjct: 75  RLLGICLTSTVQ-LITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGMNYLEDR 130
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLAPEYAIS 222
               +VHRD+   N+L+    + KI+DFGL+KL   E   + +      + ++A E  + 
Sbjct: 131 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 187
Query: 223 GRLTRKSDVYSFGVLLLEIVS 243
              T +SDV+S+GV + E+++
Sbjct: 188 RIYTHQSDVWSYGVTVWELMT 208

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 50  IGEGGFGSVYKG--RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           +GEG +G V     R+ +   VAVK++ ++      E + +   + N  + HEN+VK +G
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICI-NKMLNHENVVKFYG 72
Query: 108 GCIDGPCRILVYDYMPNNSLSQTL---LGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
              +G  + L  +Y     L   +   +G  +  A+            +  G+ Y+H   
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-------RFFHQLMAGVVYLH--- 122
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP-ENTTHISTRVAGTLGYLAPEYAISG 223
              + HRDIK  N+LLD+  N KISDFGL+ +F   N   +  ++ GTL Y+APE     
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 224 RL-TRKSDVYSFGVLLLEIVSGRTAVD 249
                  DV+S G++L  +++G    D
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 50  IGEGGFGSVYKG--RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           +GEG +G V     R+ +   VAVK++ ++      E + +   + N  + HEN+VK +G
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICI-NKMLNHENVVKFYG 71
Query: 108 GCIDGPCRILVYDYMPNNSLSQTL---LGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
              +G  + L  +Y     L   +   +G  +  A+            +  G+ Y+H   
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-------RFFHQLMAGVVYLH--- 121
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP-ENTTHISTRVAGTLGYLAPEYAISG 223
              + HRDIK  N+LLD+  N KISDFGL+ +F   N   +  ++ GTL Y+APE     
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 224 RL-TRKSDVYSFGVLLLEIVSGRTAVD 249
                  DV+S G++L  +++G    D
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 41  TNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEK---EFMSEVASMANVN 96
           ++ +     +G GG   V+  R L+    VAVKVL  +  +       F  E  + A +N
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 97  VCHENLVKLHGG----CIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG 152
             H  +V ++         GP   +V +Y+   +L   +  E     K       E+I  
Sbjct: 71  --HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI----EVIAD 124
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE--NTTHISTRVAG 210
             + L + H   Q  ++HRD+K +NI++      K+ DFG+++   +  N+   +  V G
Sbjct: 125 ACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 181
Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
           T  YL+PE A    +  +SDVYS G +L E+++G
Sbjct: 182 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 98/200 (49%), Gaps = 13/200 (6%)
Query: 49  KIGEGGFGSVYKGRLQDGTIVAVKVLSV-ESKQGEKEFMSEVASMANVNVCHEN--LVKL 105
           ++G G FG+V KG  Q   +V    + + +++  +     E+ + ANV    +N  +V++
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
            G C +    +LV +      L++ L  ++ R  K   K   E++  +  G+ Y+ E   
Sbjct: 74  IGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD--KNIIELVHQVSMGMKYLEES-- 126
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PENTTHISTRVAGTLGYLAPEYAISG 223
            + VHRD+   N+LL      KISDFGLSK     EN     T     + + APE     
Sbjct: 127 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 224 RLTRKSDVYSFGVLLLEIVS 243
           + + KSDV+SFGVL+ E  S
Sbjct: 186 KFSSKSDVWSFGVLMWEAFS 205

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 50  IGEGGFGSVYKG--RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           +GEG +G V     R+ +   VAVK++ ++      E + +   + N  + HEN+VK +G
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICI-NKMLNHENVVKFYG 71
Query: 108 GCIDGPCRILVYDYMPNNSLSQTL---LGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
              +G  + L  +Y     L   +   +G  +  A+            +  G+ Y+H   
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-------RFFHQLMAGVVYLH--- 121
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP-ENTTHISTRVAGTLGYLAPEYAISG 223
              + HRDIK  N+LLD+  N KISDFGL+ +F   N   +  ++ GTL Y+APE     
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 224 RL-TRKSDVYSFGVLLLEIVSGRTAVD 249
                  DV+S G++L  +++G    D
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 50  IGEGGFGSVYKG--RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           +GEG +G V     R+ +   VAVK++ ++      E + +   + N  + HEN+VK +G
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEIXI-NKMLNHENVVKFYG 71
Query: 108 GCIDGPCRILVYDYMPNNSLSQTL---LGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
              +G  + L  +Y     L   +   +G  +  A+            +  G+ Y+H   
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-------RFFHQLMAGVVYLH--- 121
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP-ENTTHISTRVAGTLGYLAPEYAISG 223
              + HRDIK  N+LLD+  N KISDFGL+ +F   N   +  ++ GTL Y+APE     
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 224 RL-TRKSDVYSFGVLLLEIVSGRTAVD 249
                  DV+S G++L  +++G    D
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 110/214 (51%), Gaps = 22/214 (10%)
Query: 40  ATNGFRWSNKIGEGGFGSVYKGR-LQDG-TIVAVKVLSVESKQGEK----EFMSEVASMA 93
           A   +    +IGEG +G V+K R L++G   VA+K + V++  GE+      + EVA + 
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT--GEEGMPLSTIREVAVLR 66
Query: 94  NVNVC-HENLVKLHGGCI----DGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARR 147
           ++    H N+V+L   C     D   ++ LV++++ +  L+  L  ++        +  +
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL--DKVPEPGVPTETIK 123
Query: 148 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 207
           +++  + RGL ++H      VVHRD+K  NIL+  +   K++DFGL++++  +     T 
Sbjct: 124 DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTS 178
Query: 208 VAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEI 241
           V  TL Y APE  +        D++S G +  E+
Sbjct: 179 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 23/214 (10%)
Query: 44  FRWSNKIGEGGFGSV------YKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNV 97
           ++    +GEG FG V        G+     I+  KVL+    QG  E   E++ +  +  
Sbjct: 10  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR- 66
Query: 98  CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
            H +++KL+         I+V +Y  N      +     +R K   +  R     I   +
Sbjct: 67  -HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV-----QRDKMSEQEARRFFQQIISAV 120
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
            Y H      +VHRD+K  N+LLD++ N KI+DFGLS +  +     ++   G+  Y AP
Sbjct: 121 EYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAP 175
Query: 218 EYAISGRLTR--KSDVYSFGVLLLEIVSGRTAVD 249
           E  ISG+L    + DV+S GV+L  ++  R   D
Sbjct: 176 E-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 208

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 110/214 (51%), Gaps = 22/214 (10%)
Query: 40  ATNGFRWSNKIGEGGFGSVYKGR-LQDG-TIVAVKVLSVESKQGEK----EFMSEVASMA 93
           A   +    +IGEG +G V+K R L++G   VA+K + V++  GE+      + EVA + 
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT--GEEGMPLSTIREVAVLR 66
Query: 94  NVNVC-HENLVKLHGGCI----DGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARR 147
           ++    H N+V+L   C     D   ++ LV++++ +  L+  L  ++        +  +
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL--DKVPEPGVPTETIK 123
Query: 148 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 207
           +++  + RGL ++H      VVHRD+K  NIL+  +   K++DFGL++++  +     T 
Sbjct: 124 DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTS 178
Query: 208 VAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEI 241
           V  TL Y APE  +        D++S G +  E+
Sbjct: 179 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 98/200 (49%), Gaps = 13/200 (6%)
Query: 49  KIGEGGFGSVYKGRLQDGTIVAVKVLSV-ESKQGEKEFMSEVASMANVNVCHEN--LVKL 105
           ++G G FG+V KG  Q   +V    + + +++  +     E+ + ANV    +N  +V++
Sbjct: 12  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 71
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
            G C +    +LV +      L++ L  ++ R  K   K   E++  +  G+ Y+ E   
Sbjct: 72  IGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD--KNIIELVHQVSMGMKYLEES-- 124
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PENTTHISTRVAGTLGYLAPEYAISG 223
            + VHRD+   N+LL      KISDFGLSK     EN     T     + + APE     
Sbjct: 125 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 183
Query: 224 RLTRKSDVYSFGVLLLEIVS 243
           + + KSDV+SFGVL+ E  S
Sbjct: 184 KFSSKSDVWSFGVLMWEAFS 203

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 110/214 (51%), Gaps = 22/214 (10%)
Query: 40  ATNGFRWSNKIGEGGFGSVYKGR-LQDG-TIVAVKVLSVESKQGEK----EFMSEVASMA 93
           A   +    +IGEG +G V+K R L++G   VA+K + V++  GE+      + EVA + 
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT--GEEGMPLSTIREVAVLR 66
Query: 94  NVNVC-HENLVKLHGGCI----DGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARR 147
           ++    H N+V+L   C     D   ++ LV++++ +  L+  L  ++        +  +
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL--DKVPEPGVPTETIK 123
Query: 148 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 207
           +++  + RGL ++H      VVHRD+K  NIL+  +   K++DFGL++++  +     T 
Sbjct: 124 DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTS 178
Query: 208 VAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEI 241
           V  TL Y APE  +        D++S G +  E+
Sbjct: 179 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 98/200 (49%), Gaps = 13/200 (6%)
Query: 49  KIGEGGFGSVYKGRLQDGTIVAVKVLSV-ESKQGEKEFMSEVASMANVNVCHEN--LVKL 105
           ++G G FG+V KG  Q   +V    + + +++  +     E+ + ANV    +N  +V++
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
            G C +    +LV +      L++ L  ++ R  K   K   E++  +  G+ Y+ E   
Sbjct: 78  IGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD--KNIIELVHQVSMGMKYLEES-- 130
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PENTTHISTRVAGTLGYLAPEYAISG 223
            + VHRD+   N+LL      KISDFGLSK     EN     T     + + APE     
Sbjct: 131 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 189
Query: 224 RLTRKSDVYSFGVLLLEIVS 243
           + + KSDV+SFGVL+ E  S
Sbjct: 190 KFSSKSDVWSFGVLMWEAFS 209

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 13/210 (6%)
Query: 43  GFRWSN--KIGEGGFGSVYKG--RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC 98
           G R++N   IGEG +G V      L    +   K+   E +   +  + E+  +      
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFR-- 83
Query: 99  HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
           HEN++ +    I  P    + D      L +T L +  +            +  I RGL 
Sbjct: 84  HENIIGI-NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 142
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS--TRVAGTLGYLA 216
           YIH     +V+HRD+K SN+LL+   + KI DFGL+++   +  H    T    T  Y A
Sbjct: 143 YIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 217 PEYAISGR-LTRKSDVYSFGVLLLEIVSGR 245
           PE  ++ +  T+  D++S G +L E++S R
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 50  IGEGGFGSVYKG--RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           +GEG +G V     R+ +   VAVK++ ++      E + +   + N  + HEN+VK +G
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEIXI-NKMLNHENVVKFYG 72
Query: 108 GCIDGPCRILVYDYMPNNSLSQTL---LGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
              +G  + L  +Y     L   +   +G  +  A+            +  G+ Y+H   
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-------RFFHQLMAGVVYLH--- 122
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP-ENTTHISTRVAGTLGYLAPEYAISG 223
              + HRDIK  N+LLD+  N KISDFGL+ +F   N   +  ++ GTL Y+APE     
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 182
Query: 224 RL-TRKSDVYSFGVLLLEIVSGRTAVD 249
                  DV+S G++L  +++G    D
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 50  IGEGGFGSVYKG--RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           +GEG +G V     R+ +   VAVK++ ++      E + +   + N  + HEN+VK +G
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICI-NKMLNHENVVKFYG 71
Query: 108 GCIDGPCRILVYDYMPNNSLSQTL---LGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
              +G  + L  +Y     L   +   +G  +  A+            +  G+ Y+H   
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-------RFFHQLMAGVVYLH--- 121
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP-ENTTHISTRVAGTLGYLAPEYAISG 223
              + HRDIK  N+LLD+  N KISDFGL+ +F   N   +  ++ GTL Y+APE     
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 224 RL-TRKSDVYSFGVLLLEIVSGRTAVD 249
                  DV+S G++L  +++G    D
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 50  IGEGGFGSVYKG--RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           +GEG +G V     R+ +   VAVK++ ++      E + +   + N  + HEN+VK +G
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICI-NKMLNHENVVKFYG 71
Query: 108 GCIDGPCRILVYDYMPNNSLSQTL---LGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
              +G  + L  +Y     L   +   +G  +  A+            +  G+ Y+H   
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-------RFFHQLMAGVVYLH--- 121
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP-ENTTHISTRVAGTLGYLAPEYAISG 223
              + HRDIK  N+LLD+  N KISDFGL+ +F   N   +  ++ GTL Y+APE     
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 224 RL-TRKSDVYSFGVLLLEIVSGRTAVD 249
                  DV+S G++L  +++G    D
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 41  TNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEK---EFMSEVASMANVN 96
           ++ +     +G GG   V+  R L+    VAVKVL  +  +       F  E  + A +N
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 97  VCHENLVKLH----GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG 152
             H  +V ++         GP   +V +Y+   +L   +  E     K       E+I  
Sbjct: 88  --HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI----EVIAD 141
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE--NTTHISTRVAG 210
             + L + H   Q  ++HRD+K +NI++      K+ DFG+++   +  N+   +  V G
Sbjct: 142 ACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 198
Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
           T  YL+PE A    +  +SDVYS G +L E+++G
Sbjct: 199 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 232

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 98/200 (49%), Gaps = 13/200 (6%)
Query: 49  KIGEGGFGSVYKGRLQDGTIVAVKVLSV-ESKQGEKEFMSEVASMANVNVCHEN--LVKL 105
           ++G G FG+V KG  Q   +V    + + +++  +     E+ + ANV    +N  +V++
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
            G C +    +LV +      L++ L  ++ R  K   K   E++  +  G+ Y+ E   
Sbjct: 84  IGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD--KNIIELVHQVSMGMKYLEES-- 136
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PENTTHISTRVAGTLGYLAPEYAISG 223
            + VHRD+   N+LL      KISDFGLSK     EN     T     + + APE     
Sbjct: 137 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 195
Query: 224 RLTRKSDVYSFGVLLLEIVS 243
           + + KSDV+SFGVL+ E  S
Sbjct: 196 KFSSKSDVWSFGVLMWEAFS 215

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 50  IGEGGFGSVYKG--RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           +GEG +G V     R+ +   VAVK++ ++      E + +   + N  + HEN+VK +G
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEIXI-NKMLNHENVVKFYG 71
Query: 108 GCIDGPCRILVYDYMPNNSLSQTL---LGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
              +G  + L  +Y     L   +   +G  +  A+            +  G+ Y+H   
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-------RFFHQLMAGVVYLH--- 121
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP-ENTTHISTRVAGTLGYLAPEYAISG 223
              + HRDIK  N+LLD+  N KISDFGL+ +F   N   +  ++ GTL Y+APE     
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 224 RL-TRKSDVYSFGVLLLEIVSGRTAVD 249
                  DV+S G++L  +++G    D
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 41  TNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEK---EFMSEVASMANVN 96
           ++ +     +G GG   V+  R L+    VAVKVL  +  +       F  E  + A +N
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 97  VCHENLVKLH----GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG 152
             H  +V ++         GP   +V +Y+   +L   +  E     K       E+I  
Sbjct: 71  --HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI----EVIAD 124
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE--NTTHISTRVAG 210
             + L + H   Q  ++HRD+K +NI++      K+ DFG+++   +  N+   +  V G
Sbjct: 125 ACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 181
Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
           T  YL+PE A    +  +SDVYS G +L E+++G
Sbjct: 182 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 98/200 (49%), Gaps = 13/200 (6%)
Query: 49  KIGEGGFGSVYKGRLQDGTIVAVKVLSV-ESKQGEKEFMSEVASMANVNVCHEN--LVKL 105
           ++G G FG+V KG  Q   +V    + + +++  +     E+ + ANV    +N  +V++
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
            G C +    +LV +      L++ L  ++ R  K   K   E++  +  G+ Y+ E   
Sbjct: 94  IGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD--KNIIELVHQVSMGMKYLEES-- 146
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PENTTHISTRVAGTLGYLAPEYAISG 223
            + VHRD+   N+LL      KISDFGLSK     EN     T     + + APE     
Sbjct: 147 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 205
Query: 224 RLTRKSDVYSFGVLLLEIVS 243
           + + KSDV+SFGVL+ E  S
Sbjct: 206 KFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 98/200 (49%), Gaps = 13/200 (6%)
Query: 49  KIGEGGFGSVYKGRLQDGTIVAVKVLSV-ESKQGEKEFMSEVASMANVNVCHEN--LVKL 105
           ++G G FG+V KG  Q   +V    + + +++  +     E+ + ANV    +N  +V++
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
            G C +    +LV +      L++ L  ++ R  K   K   E++  +  G+ Y+ E   
Sbjct: 94  IGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD--KNIIELVHQVSMGMKYLEES-- 146
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PENTTHISTRVAGTLGYLAPEYAISG 223
            + VHRD+   N+LL      KISDFGLSK     EN     T     + + APE     
Sbjct: 147 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 205
Query: 224 RLTRKSDVYSFGVLLLEIVS 243
           + + KSDV+SFGVL+ E  S
Sbjct: 206 KFSSKSDVWSFGVLMWEAFS 225

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 98/200 (49%), Gaps = 13/200 (6%)
Query: 49  KIGEGGFGSVYKGRLQDGTIVAVKVLSV-ESKQGEKEFMSEVASMANVNVCHEN--LVKL 105
           ++G G FG+V KG  Q   +V    + + +++  +     E+ + ANV    +N  +V++
Sbjct: 32  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 91
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
            G C +    +LV +      L++ L  ++ R  K   K   E++  +  G+ Y+ E   
Sbjct: 92  IGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD--KNIIELVHQVSMGMKYLEES-- 144
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PENTTHISTRVAGTLGYLAPEYAISG 223
            + VHRD+   N+LL      KISDFGLSK     EN     T     + + APE     
Sbjct: 145 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 203
Query: 224 RLTRKSDVYSFGVLLLEIVS 243
           + + KSDV+SFGVL+ E  S
Sbjct: 204 KFSSKSDVWSFGVLMWEAFS 223

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 117/272 (43%), Gaps = 39/272 (14%)
Query: 47  SNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLH 106
           S  +G G  G V K   +  T   V +  +  ++       E     NV    E L KL+
Sbjct: 14  SKTLGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 72
Query: 107 GGCI-------DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
             CI       D     +V + M    L   ++G ++ +         ++++ +     Y
Sbjct: 73  HPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV----QY 128
Query: 160 IHEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLA 216
           +HE     ++HRD+K  N+LL   +++   KI+DFG SK+  E  T +   + GT  YLA
Sbjct: 129 LHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGTPTYLA 183
Query: 217 PEYAIS---GRLTRKSDVYSFGVLLLEIVSG-------RTAVDFDVQL--GEYHLVDKAW 264
           PE  +S       R  D +S GV+L   +SG       RT V    Q+  G+Y+ + + W
Sbjct: 184 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 243
Query: 265 GMYNSKEL-----MNLVDPMLYGNFPENEAIR 291
              + K L     + +VDP     F   EA+R
Sbjct: 244 AEVSEKALDLVKKLLVVDPK--ARFTTEEALR 273

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 117/272 (43%), Gaps = 39/272 (14%)
Query: 47  SNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLH 106
           S  +G G  G V K   +  T   V +  +  ++       E     NV    E L KL+
Sbjct: 15  SKTLGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 73
Query: 107 GGCI-------DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
             CI       D     +V + M    L   ++G ++ +         ++++ +     Y
Sbjct: 74  HPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV----QY 129
Query: 160 IHEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLA 216
           +HE     ++HRD+K  N+LL   +++   KI+DFG SK+  E  T +   + GT  YLA
Sbjct: 130 LHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGTPTYLA 184
Query: 217 PEYAIS---GRLTRKSDVYSFGVLLLEIVSG-------RTAVDFDVQL--GEYHLVDKAW 264
           PE  +S       R  D +S GV+L   +SG       RT V    Q+  G+Y+ + + W
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 244
Query: 265 GMYNSKEL-----MNLVDPMLYGNFPENEAIR 291
              + K L     + +VDP     F   EA+R
Sbjct: 245 AEVSEKALDLVKKLLVVDPK--ARFTTEEALR 274

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 117/272 (43%), Gaps = 39/272 (14%)
Query: 47  SNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLH 106
           S  +G G  G V K   +  T   V +  +  ++       E     NV    E L KL+
Sbjct: 15  SKTLGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 73
Query: 107 GGCI-------DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
             CI       D     +V + M    L   ++G ++ +         ++++ +     Y
Sbjct: 74  HPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV----QY 129
Query: 160 IHEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLA 216
           +HE     ++HRD+K  N+LL   +++   KI+DFG SK+  E  T +   + GT  YLA
Sbjct: 130 LHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGTPTYLA 184
Query: 217 PEYAIS---GRLTRKSDVYSFGVLLLEIVSG-------RTAVDFDVQL--GEYHLVDKAW 264
           PE  +S       R  D +S GV+L   +SG       RT V    Q+  G+Y+ + + W
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 244
Query: 265 GMYNSKEL-----MNLVDPMLYGNFPENEAIR 291
              + K L     + +VDP     F   EA+R
Sbjct: 245 AEVSEKALDLVKKLLVVDPK--ARFTTEEALR 274

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 100/207 (48%), Gaps = 16/207 (7%)
Query: 44  FRWSNKIGEGGFGSVYKG-RLQDGTIVAVKVLSVE-----SKQGEKEFMSEVASMANVNV 97
           F+    +G G FG+VYKG  + +G  V + V   E     S +  KE + E   MA+V+ 
Sbjct: 14  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 73
Query: 98  CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
            H  + +L G C+    + L+   MP   L   +    + +   G +      + I  G+
Sbjct: 74  PH--VCRLLGICLTSTVQ-LITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAEGM 127
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLA 216
            Y+ +     +VHRD+   N+L+    + KI+DFGL+KL   E   + +      + ++A
Sbjct: 128 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 184
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVS 243
            E  +    T +SDV+S+GV + E+++
Sbjct: 185 LESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 117/272 (43%), Gaps = 39/272 (14%)
Query: 47  SNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLH 106
           S  +G G  G V K   +  T   V +  +  ++       E     NV    E L KL+
Sbjct: 154 SKTLGSGACGEV-KLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN 212
Query: 107 GGCI-------DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
             CI       D     +V + M    L   ++G ++ +         ++++ +     Y
Sbjct: 213 HPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV----QY 268
Query: 160 IHEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLA 216
           +HE     ++HRD+K  N+LL   +++   KI+DFG SK+  E  T +   + GT  YLA
Sbjct: 269 LHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGTPTYLA 323
Query: 217 PEYAIS---GRLTRKSDVYSFGVLLLEIVSG-------RTAVDFDVQL--GEYHLVDKAW 264
           PE  +S       R  D +S GV+L   +SG       RT V    Q+  G+Y+ + + W
Sbjct: 324 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 383
Query: 265 GMYNSKEL-----MNLVDPMLYGNFPENEAIR 291
              + K L     + +VDP     F   EA+R
Sbjct: 384 AEVSEKALDLVKKLLVVDPK--ARFTTEEALR 413

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 117/272 (43%), Gaps = 39/272 (14%)
Query: 47  SNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLH 106
           S  +G G  G V K   +  T   V +  +  ++       E     NV    E L KL+
Sbjct: 15  SKTLGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 73
Query: 107 GGCI-------DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
             CI       D     +V + M    L   ++G ++ +         ++++ +     Y
Sbjct: 74  HPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV----QY 129
Query: 160 IHEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLA 216
           +HE     ++HRD+K  N+LL   +++   KI+DFG SK+  E  T +   + GT  YLA
Sbjct: 130 LHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGTPTYLA 184
Query: 217 PEYAIS---GRLTRKSDVYSFGVLLLEIVSG-------RTAVDFDVQL--GEYHLVDKAW 264
           PE  +S       R  D +S GV+L   +SG       RT V    Q+  G+Y+ + + W
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 244
Query: 265 GMYNSKEL-----MNLVDPMLYGNFPENEAIR 291
              + K L     + +VDP     F   EA+R
Sbjct: 245 AEVSEKALDLVKKLLVVDPK--ARFTTEEALR 274

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 117/272 (43%), Gaps = 39/272 (14%)
Query: 47  SNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLH 106
           S  +G G  G V K   +  T   V +  +  ++       E     NV    E L KL+
Sbjct: 21  SKTLGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 79
Query: 107 GGCI-------DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
             CI       D     +V + M    L   ++G ++ +         ++++ +     Y
Sbjct: 80  HPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV----QY 135
Query: 160 IHEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLA 216
           +HE     ++HRD+K  N+LL   +++   KI+DFG SK+  E  T +   + GT  YLA
Sbjct: 136 LHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGTPTYLA 190
Query: 217 PEYAIS---GRLTRKSDVYSFGVLLLEIVSG-------RTAVDFDVQL--GEYHLVDKAW 264
           PE  +S       R  D +S GV+L   +SG       RT V    Q+  G+Y+ + + W
Sbjct: 191 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 250
Query: 265 GMYNSKEL-----MNLVDPMLYGNFPENEAIR 291
              + K L     + +VDP     F   EA+R
Sbjct: 251 AEVSEKALDLVKKLLVVDPK--ARFTTEEALR 280

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 117/272 (43%), Gaps = 39/272 (14%)
Query: 47  SNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLH 106
           S  +G G  G V K   +  T   V +  +  ++       E     NV    E L KL+
Sbjct: 140 SKTLGSGACGEV-KLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN 198
Query: 107 GGCI-------DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
             CI       D     +V + M    L   ++G ++ +         ++++ +     Y
Sbjct: 199 HPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV----QY 254
Query: 160 IHEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLA 216
           +HE     ++HRD+K  N+LL   +++   KI+DFG SK+  E  T +   + GT  YLA
Sbjct: 255 LHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGTPTYLA 309
Query: 217 PEYAIS---GRLTRKSDVYSFGVLLLEIVSG-------RTAVDFDVQL--GEYHLVDKAW 264
           PE  +S       R  D +S GV+L   +SG       RT V    Q+  G+Y+ + + W
Sbjct: 310 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 369
Query: 265 GMYNSKEL-----MNLVDPMLYGNFPENEAIR 291
              + K L     + +VDP     F   EA+R
Sbjct: 370 AEVSEKALDLVKKLLVVDPK--ARFTTEEALR 399

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 13/210 (6%)
Query: 43  GFRWSN--KIGEGGFGSVYKG--RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC 98
           G R++N   IGEG +G V      L    +   K+   E +   +  + E+  +      
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-- 83
Query: 99  HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
           HEN++ +    I  P    + D      L +T L +  +            +  I RGL 
Sbjct: 84  HENIIGI-NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 142
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS--TRVAGTLGYLA 216
           YIH     +V+HRD+K SN+LL+   + KI DFGL+++   +  H    T    T  Y A
Sbjct: 143 YIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 217 PEYAISGR-LTRKSDVYSFGVLLLEIVSGR 245
           PE  ++ +  T+  D++S G +L E++S R
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 13/210 (6%)
Query: 43  GFRWSN--KIGEGGFGSVYKG--RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC 98
           G R++N   IGEG +G V      L    +   K+   E +   +  + E+  +      
Sbjct: 27  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-- 84
Query: 99  HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
           HEN++ +    I  P    + D      L +T L +  +            +  I RGL 
Sbjct: 85  HENIIGI-NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 143
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS--TRVAGTLGYLA 216
           YIH     +V+HRD+K SN+LL+   + KI DFGL+++   +  H    T    T  Y A
Sbjct: 144 YIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 200
Query: 217 PEYAISGR-LTRKSDVYSFGVLLLEIVSGR 245
           PE  ++ +  T+  D++S G +L E++S R
Sbjct: 201 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 13/210 (6%)
Query: 43  GFRWSN--KIGEGGFGSVYKG--RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC 98
           G R++N   IGEG +G V      L    +   K+   E +   +  + E+  +      
Sbjct: 20  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-- 77
Query: 99  HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
           HEN++ +    I  P    + D      L +T L +  +            +  I RGL 
Sbjct: 78  HENIIGI-NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 136
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS--TRVAGTLGYLA 216
           YIH     +V+HRD+K SN+LL+   + KI DFGL+++   +  H    T    T  Y A
Sbjct: 137 YIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 193
Query: 217 PEYAISGR-LTRKSDVYSFGVLLLEIVSGR 245
           PE  ++ +  T+  D++S G +L E++S R
Sbjct: 194 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 13/210 (6%)
Query: 43  GFRWSN--KIGEGGFGSVYKG--RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC 98
           G R++N   IGEG +G V      L    +   K+   E +   +  + E+  +      
Sbjct: 28  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-- 85
Query: 99  HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
           HEN++ +    I  P    + D      L +T L +  +            +  I RGL 
Sbjct: 86  HENIIGI-NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 144
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS--TRVAGTLGYLA 216
           YIH     +V+HRD+K SN+LL+   + KI DFGL+++   +  H    T    T  Y A
Sbjct: 145 YIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 201
Query: 217 PEYAISGR-LTRKSDVYSFGVLLLEIVSGR 245
           PE  ++ +  T+  D++S G +L E++S R
Sbjct: 202 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 13/210 (6%)
Query: 43  GFRWSN--KIGEGGFGSVYKG--RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC 98
           G R++N   IGEG +G V      L    +   K+   E +   +  + E+  +      
Sbjct: 19  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-- 76
Query: 99  HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
           HEN++ +    I  P    + D      L +T L +  +            +  I RGL 
Sbjct: 77  HENIIGI-NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 135
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS--TRVAGTLGYLA 216
           YIH     +V+HRD+K SN+LL+   + KI DFGL+++   +  H    T    T  Y A
Sbjct: 136 YIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 192
Query: 217 PEYAISGR-LTRKSDVYSFGVLLLEIVSGR 245
           PE  ++ +  T+  D++S G +L E++S R
Sbjct: 193 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 13/210 (6%)
Query: 43  GFRWSN--KIGEGGFGSVYKG--RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC 98
           G R++N   IGEG +G V      L    +   K+   E +   +  + E+  +      
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-- 83
Query: 99  HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
           HEN++ +    I  P    + D      L +T L +  +            +  I RGL 
Sbjct: 84  HENIIGI-NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 142
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS--TRVAGTLGYLA 216
           YIH     +V+HRD+K SN+LL+   + KI DFGL+++   +  H    T    T  Y A
Sbjct: 143 YIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 217 PEYAISGR-LTRKSDVYSFGVLLLEIVSGR 245
           PE  ++ +  T+  D++S G +L E++S R
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 13/210 (6%)
Query: 43  GFRWSN--KIGEGGFGSVYKG--RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC 98
           G R++N   IGEG +G V      L    +   K+   E +   +  + E+  +      
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFR-- 83
Query: 99  HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
           HEN++ +    I  P    + D      L +T L +  +            +  I RGL 
Sbjct: 84  HENIIGI-NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 142
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS--TRVAGTLGYLA 216
           YIH     +V+HRD+K SN+LL+   + KI DFGL+++   +  H    T    T  Y A
Sbjct: 143 YIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 217 PEYAISGR-LTRKSDVYSFGVLLLEIVSGR 245
           PE  ++ +  T+  D++S G +L E++S R
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 98/198 (49%), Gaps = 14/198 (7%)
Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           KIG+G  G+VY    +  G  VA++ ++++ +  ++  ++E+  M      + N+V    
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK--NPNIVNYLD 84
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
             + G    +V +Y+   SL+  +        +     R  +     + L ++H      
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHSN---Q 136
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGL-SKLFPENTTHISTRVAGTLGYLAPEYAISGRLT 226
           V+HRDIK+ NILL  + + K++DFG  +++ PE +    + + GT  ++APE        
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SEMVGTPYWMAPEVVTRKAYG 194
Query: 227 RKSDVYSFGVLLLEIVSG 244
            K D++S G++ +E++ G
Sbjct: 195 PKVDIWSLGIMAIEMIEG 212

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 13/210 (6%)
Query: 43  GFRWSN--KIGEGGFGSVYKG--RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC 98
           G R++N   IGEG +G V      L    +   K+   E +   +  + E+  +      
Sbjct: 20  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-- 77
Query: 99  HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
           HEN++ +    I  P    + D      L +T L +  +            +  I RGL 
Sbjct: 78  HENIIGI-NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 136
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS--TRVAGTLGYLA 216
           YIH     +V+HRD+K SN+LL+   + KI DFGL+++   +  H    T    T  Y A
Sbjct: 137 YIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 193
Query: 217 PEYAISGR-LTRKSDVYSFGVLLLEIVSGR 245
           PE  ++ +  T+  D++S G +L E++S R
Sbjct: 194 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 13/210 (6%)
Query: 43  GFRWSN--KIGEGGFGSVYKGRLQDGTI-VAVKVLS-VESKQGEKEFMSEVASMANVNVC 98
           G R++N   IGEG +G V         + VA+K +S  E +   +  + E+  +      
Sbjct: 24  GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-- 81
Query: 99  HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
           HEN++ +    I  P    + D      L +T L +  +            +  I RGL 
Sbjct: 82  HENIIGI-NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 140
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS--TRVAGTLGYLA 216
           YIH     +V+HRD+K SN+LL+   + KI DFGL+++   +  H    T    T  Y A
Sbjct: 141 YIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 197
Query: 217 PEYAISGR-LTRKSDVYSFGVLLLEIVSGR 245
           PE  ++ +  T+  D++S G +L E++S R
Sbjct: 198 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 13/210 (6%)
Query: 43  GFRWSN--KIGEGGFGSVYKGRLQDGTI-VAVKVLS-VESKQGEKEFMSEVASMANVNVC 98
           G R++N   IGEG +G V         + VA+K +S  E +   +  + E+  +      
Sbjct: 22  GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-- 79
Query: 99  HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
           HEN++ +    I  P    + D      L +T L +  +            +  I RGL 
Sbjct: 80  HENIIGI-NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 138
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS--TRVAGTLGYLA 216
           YIH     +V+HRD+K SN+LL+   + KI DFGL+++   +  H    T    T  Y A
Sbjct: 139 YIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 217 PEYAISGR-LTRKSDVYSFGVLLLEIVSGR 245
           PE  ++ +  T+  D++S G +L E++S R
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 13/210 (6%)
Query: 43  GFRWSN--KIGEGGFGSVYKGRLQDGTI-VAVKVLS-VESKQGEKEFMSEVASMANVNVC 98
           G R++N   IGEG +G V         + VA+K +S  E +   +  + E+  +      
Sbjct: 22  GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-- 79
Query: 99  HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
           HEN++ +    I  P    + D      L +T L +  +            +  I RGL 
Sbjct: 80  HENIIGI-NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 138
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS--TRVAGTLGYLA 216
           YIH     +V+HRD+K SN+LL+   + KI DFGL+++   +  H    T    T  Y A
Sbjct: 139 YIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 217 PEYAISGR-LTRKSDVYSFGVLLLEIVSGR 245
           PE  ++ +  T+  D++S G +L E++S R
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 13/210 (6%)
Query: 43  GFRWSN--KIGEGGFGSVYKGRLQDGTI-VAVKVLS-VESKQGEKEFMSEVASMANVNVC 98
           G R++N   IGEG +G V         + VA+K +S  E +   +  + E+  +      
Sbjct: 22  GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-- 79
Query: 99  HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
           HEN++ +    I  P    + D      L +T L +  +            +  I RGL 
Sbjct: 80  HENIIGI-NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 138
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS--TRVAGTLGYLA 216
           YIH     +V+HRD+K SN+LL+   + KI DFGL+++   +  H    T    T  Y A
Sbjct: 139 YIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 217 PEYAISGR-LTRKSDVYSFGVLLLEIVSGR 245
           PE  ++ +  T+  D++S G +L E++S R
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 113/228 (49%), Gaps = 18/228 (7%)
Query: 27  KNINAFSYNQLKIAT---NGFRWSNKIGEGGFGSVYK-GRLQDGTIVAVKVLSVESKQG- 81
           K + AF   + K+     + F   +++G G  G V+K      G ++A K++ +E K   
Sbjct: 7   KRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI 66
Query: 82  EKEFMSEVASMANVNVCHENLVKLHGGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAK 140
             + + E+  +   N  +  +V  +G    DG   I + ++M   SL Q L    K+  +
Sbjct: 67  RNQIIRELQVLHECNSPY--IVGFYGAFYSDGEISICM-EHMDGGSLDQVL----KKAGR 119
Query: 141 FGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 200
              +   ++ + + +GL Y+ E+ +  ++HRD+K SNIL++     K+ DFG+S    ++
Sbjct: 120 IPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 177
Query: 201 TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAV 248
              ++    GT  Y++PE       + +SD++S G+ L+E+  GR  +
Sbjct: 178 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 222

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 13/210 (6%)
Query: 43  GFRWSN--KIGEGGFGSVYKGRLQDGTI-VAVKVLS-VESKQGEKEFMSEVASMANVNVC 98
           G R++N   IGEG +G V         + VA+K +S  E +   +  + E+  +      
Sbjct: 30  GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-- 87
Query: 99  HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
           HEN++ +    I  P    + D      L +T L +  +            +  I RGL 
Sbjct: 88  HENIIGI-NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 146
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS--TRVAGTLGYLA 216
           YIH     +V+HRD+K SN+LL+   + KI DFGL+++   +  H    T    T  Y A
Sbjct: 147 YIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 203
Query: 217 PEYAISGR-LTRKSDVYSFGVLLLEIVSGR 245
           PE  ++ +  T+  D++S G +L E++S R
Sbjct: 204 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 13/210 (6%)
Query: 43  GFRWSN--KIGEGGFGSVYKGRLQDGTI-VAVKVLS-VESKQGEKEFMSEVASMANVNVC 98
           G R++N   IGEG +G V         + VA+K +S  E +   +  + E+  +      
Sbjct: 22  GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-- 79
Query: 99  HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
           HEN++ +    I  P    + D      L +T L +  +            +  I RGL 
Sbjct: 80  HENIIGI-NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 138
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS--TRVAGTLGYLA 216
           YIH     +V+HRD+K SN+LL+   + KI DFGL+++   +  H    T    T  Y A
Sbjct: 139 YIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 217 PEYAISGR-LTRKSDVYSFGVLLLEIVSGR 245
           PE  ++ +  T+  D++S G +L E++S R
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 101/216 (46%), Gaps = 25/216 (11%)
Query: 39  IATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEF----MSEVASMA 93
           +AT+ +    +IG G +G+VYK R    G  VA+K  SV    GE+      + EVA + 
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALK--SVRVPNGEEGLPISTVREVALLR 58
Query: 94  NVNVC-HENLVKLHGGC----IDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKAR- 146
            +    H N+V+L   C     D   ++ LV+++     + Q L     +    G  A  
Sbjct: 59  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEH-----VDQDLRTYLDKAPPPGLPAET 113
Query: 147 -REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS 205
            ++++    RGL ++H      +VHRD+K  NIL+      K++DFGL++++        
Sbjct: 114 IKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFP 170
Query: 206 TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEI 241
             V  TL Y APE  +        D++S G +  E+
Sbjct: 171 VVV--TLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 98/198 (49%), Gaps = 14/198 (7%)
Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           KIG+G  G+VY    +  G  VA++ ++++ +  ++  ++E+  M      + N+V    
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK--NPNIVNYLD 84
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
             + G    +V +Y+   SL+  +        +     R  +     + L ++H      
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHSN---Q 136
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGL-SKLFPENTTHISTRVAGTLGYLAPEYAISGRLT 226
           V+HRDIK+ NILL  + + K++DFG  +++ PE +    + + GT  ++APE        
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYG 194
Query: 227 RKSDVYSFGVLLLEIVSG 244
            K D++S G++ +E++ G
Sbjct: 195 PKVDIWSLGIMAIEMIEG 212

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 105/219 (47%), Gaps = 20/219 (9%)
Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVN-VCHENLVKLH 106
           +IG G FG+VY  R +++  +VA+K +S   KQ  +++   +  +  +  + H N ++  
Sbjct: 61  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120
Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
           G  +      LV +Y    S S  L   +K   +    A   +  G  +GLAY+H     
Sbjct: 121 GCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAA---VTHGALQGLAYLHSH--- 173
Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLAPEYAIS--- 222
           +++HRD+K  NILL +    K+ DFG + +  P N         GT  ++APE  ++   
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX------FVGTPYWMAPEVILAMDE 227
Query: 223 GRLTRKSDVYSFGVLLLEIVSGRTAV-DFDVQLGEYHLV 260
           G+   K DV+S G+  +E+   +  + + +     YH+ 
Sbjct: 228 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA 266

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 109/228 (47%), Gaps = 17/228 (7%)
Query: 44  FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKV--LSVESKQGEKEFMSEVASMANVNVCHE 100
           F+   KIGEG +G VYK R +  G +VA+K   L  E++      + E++ +  +N  H 
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN--HP 69
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
           N+VKL           LV++++ +  L + +  +            +  +  + +GLA+ 
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PENTTHISTRVAGTLGYLAPE 218
           H      V+HRD+K  N+L++     K++DFGL++ F  P  T    T    TL Y APE
Sbjct: 127 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT---YTHEVVTLWYRAPE 180
Query: 219 YAISGRLTRKS-DVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG 265
             +  +    + D++S G +  E+V+ R     D ++ +   + +  G
Sbjct: 181 ILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 228

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVES--KQGEKEFMS-EVASMANVNVCH 99
           F++   +GEG F +V   R L      A+K+L      K+ +  +++ E   M+ ++  H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD--H 91
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
              VKL+    D         Y  N  L + +    ++   F     R     I   L Y
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYI----RKIGSFDETCTRFYTAEIVSALEY 147
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTHISTRVAGTLGYLAPE 218
           +H +    ++HRD+K  NILL+++ + +I+DFG +K L PE+    +    GT  Y++PE
Sbjct: 148 LHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 204
Query: 219 YAISGRLTRKSDVYSFGVLLLEIVSG 244
                  ++ SD+++ G ++ ++V+G
Sbjct: 205 LLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 97/222 (43%), Gaps = 21/222 (9%)
Query: 49  KIGEGGFGSVYKGRLQD-GTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLH 106
           ++G GGFG V +   QD G  VA+K    E S +  + +  E+  M  +N  H N+V   
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN--HPNVVSAR 78
Query: 107 GGCIDGPCRI-------LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
               DG  ++       L  +Y     L +  L + +          R ++  I   L Y
Sbjct: 79  E-VPDGLQKLAPNDLPLLAMEYCEGGDLRK-YLNQFENCCGLKEGPIRTLLSDISSALRY 136
Query: 160 IHEEIQPHVVHRDIKTSNILLD---QNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLA 216
           +HE     ++HRD+K  NI+L    Q    KI D G +K    +   + T   GTL YLA
Sbjct: 137 LHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEFVGTLQYLA 191
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYH 258
           PE     + T   D +SFG L  E ++G      + Q  ++H
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWH 233

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 13/210 (6%)
Query: 43  GFRWSN--KIGEGGFGSVYKGRLQDGTI-VAVKVLS-VESKQGEKEFMSEVASMANVNVC 98
           G R++N   IGEG +G V         + VA+K +S  E +   +  + E+  +      
Sbjct: 42  GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-- 99
Query: 99  HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
           HEN++ +    I  P    + D      L +T L +  +            +  I RGL 
Sbjct: 100 HENIIGI-NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 158
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS--TRVAGTLGYLA 216
           YIH     +V+HRD+K SN+LL+   + KI DFGL+++   +  H    T    T  Y A
Sbjct: 159 YIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 215
Query: 217 PEYAISGR-LTRKSDVYSFGVLLLEIVSGR 245
           PE  ++ +  T+  D++S G +L E++S R
Sbjct: 216 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 25/216 (11%)
Query: 39  IATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEF----MSEVASMA 93
           +AT+ +    +IG G +G+VYK R    G  VA+K  SV    GE+      + EVA + 
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALK--SVRVPNGEEGLPISTVREVALLR 58
Query: 94  NVNVC-HENLVKLHGGC----IDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKAR- 146
            +    H N+V+L   C     D   ++ LV+++     + Q L     +    G  A  
Sbjct: 59  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEH-----VDQDLRTYLDKAPPPGLPAET 113
Query: 147 -REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS 205
            ++++    RGL ++H      +VHRD+K  NIL+      K++DFGL++++  +     
Sbjct: 114 IKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY--SYQMAL 168
Query: 206 TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEI 241
             V  TL Y APE  +        D++S G +  E+
Sbjct: 169 APVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 98/198 (49%), Gaps = 14/198 (7%)
Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           KIG+G  G+VY    +  G  VA++ ++++ +  ++  ++E+  M      + N+V    
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK--NPNIVNYLD 84
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
             + G    +V +Y+   SL+  +        +     R  +     + L ++H      
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHSN---Q 136
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGL-SKLFPENTTHISTRVAGTLGYLAPEYAISGRLT 226
           V+HRDIK+ NILL  + + K++DFG  +++ PE +    + + GT  ++APE        
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SXMVGTPYWMAPEVVTRKAYG 194
Query: 227 RKSDVYSFGVLLLEIVSG 244
            K D++S G++ +E++ G
Sbjct: 195 PKVDIWSLGIMAIEMIEG 212

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 97/216 (44%), Gaps = 27/216 (12%)
Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCH 99
           +R    IG+G F  V   R +  G  VAVK++    + S   +K F  EV     +N  H
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLF-REVRIXKVLN--H 72
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLG-----EEKRRAKFGWKARREIIMGIG 154
            N+VKL           LV +Y     +   L+      E++ RAKF     R+I+  + 
Sbjct: 73  PNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKF-----RQIVSAV- 126
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY 214
               Y H   Q  +VHRD+K  N+LLD + N KI+DFG S  F     +      G   Y
Sbjct: 127 ---QYCH---QKFIVHRDLKAENLLLDADXNIKIADFGFSNEF--TFGNKLDAFCGAPPY 178
Query: 215 LAPEYAISGRLT-RKSDVYSFGVLLLEIVSGRTAVD 249
            APE     +    + DV+S GV+L  +VSG    D
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 98/198 (49%), Gaps = 14/198 (7%)
Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           KIG+G  G+VY    +  G  VA++ ++++ +  ++  ++E+  M      + N+V    
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK--NPNIVNYLD 85
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
             + G    +V +Y+   SL+  +        +     R  +     + L ++H      
Sbjct: 86  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHSN---Q 137
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGL-SKLFPENTTHISTRVAGTLGYLAPEYAISGRLT 226
           V+HRDIK+ NILL  + + K++DFG  +++ PE +    + + GT  ++APE        
Sbjct: 138 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SXMVGTPYWMAPEVVTRKAYG 195
Query: 227 RKSDVYSFGVLLLEIVSG 244
            K D++S G++ +E++ G
Sbjct: 196 PKVDIWSLGIMAIEMIEG 213

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 13/210 (6%)
Query: 43  GFRWSN--KIGEGGFGSVYKG--RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC 98
           G R++N   IGEG +G V      L    +   K+   E +   +  + E+  +      
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-- 83
Query: 99  HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
           HEN++ +    I  P    + D      L +T L +  +            +  I RGL 
Sbjct: 84  HENIIGI-NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLK 142
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS--TRVAGTLGYLA 216
           YIH     +V+HRD+K SN+LL+   + KI DFGL+++   +  H    T    T  Y A
Sbjct: 143 YIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 217 PEYAISGR-LTRKSDVYSFGVLLLEIVSGR 245
           PE  ++ +  T+  D++S G +L E++S R
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 109/228 (47%), Gaps = 17/228 (7%)
Query: 44  FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKV--LSVESKQGEKEFMSEVASMANVNVCHE 100
           F+   KIGEG +G VYK R +  G +VA+K   L  E++      + E++ +  +N  H 
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN--HP 62
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
           N+VKL           LV++++ +  L + +  +            +  +  + +GLA+ 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PENTTHISTRVAGTLGYLAPE 218
           H      V+HRD+K  N+L++     K++DFGL++ F  P  T    T    TL Y APE
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT---YTHEVVTLWYRAPE 173
Query: 219 YAISGRLTRKS-DVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG 265
             +  +    + D++S G +  E+V+ R     D ++ +   + +  G
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 221

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 109/228 (47%), Gaps = 17/228 (7%)
Query: 44  FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKV--LSVESKQGEKEFMSEVASMANVNVCHE 100
           F+   KIGEG +G VYK R +  G +VA+K   L  E++      + E++ +  +N  H 
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN--HP 61
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
           N+VKL           LV++++ +  L + +  +            +  +  + +GLA+ 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PENTTHISTRVAGTLGYLAPE 218
           H      V+HRD+K  N+L++     K++DFGL++ F  P  T    T    TL Y APE
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT---YTHEVVTLWYRAPE 172
Query: 219 YAISGRLTRKS-DVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG 265
             +  +    + D++S G +  E+V+ R     D ++ +   + +  G
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 220

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 99/200 (49%), Gaps = 13/200 (6%)
Query: 49  KIGEGGFGSVYKGRLQDGTIVAVKVLSV-ESKQGEKEFMSEVASMANVNVCHEN--LVKL 105
           ++G G FG+V KG  Q   +V    + + +++  +     E+ + ANV    +N  +V++
Sbjct: 376 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 435
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
            G C +    +LV +      L++ L  ++ R  K   K   E++  +  G+ Y+ E   
Sbjct: 436 IGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD--KNIIELVHQVSMGMKYLEES-- 488
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG--TLGYLAPEYAISG 223
            + VHRD+   N+LL      KISDFGLSK    +  +   +  G   + + APE     
Sbjct: 489 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 547
Query: 224 RLTRKSDVYSFGVLLLEIVS 243
           + + KSDV+SFGVL+ E  S
Sbjct: 548 KFSSKSDVWSFGVLMWEAFS 567

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 97/222 (43%), Gaps = 21/222 (9%)
Query: 49  KIGEGGFGSVYKGRLQD-GTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLH 106
           ++G GGFG V +   QD G  VA+K    E S +  + +  E+  M  +N  H N+V   
Sbjct: 22  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN--HPNVVSAR 79
Query: 107 GGCIDGPCRI-------LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
               DG  ++       L  +Y     L +  L + +          R ++  I   L Y
Sbjct: 80  E-VPDGLQKLAPNDLPLLAMEYCEGGDLRK-YLNQFENCCGLKEGPIRTLLSDISSALRY 137
Query: 160 IHEEIQPHVVHRDIKTSNILLD---QNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLA 216
           +HE     ++HRD+K  NI+L    Q    KI D G +K    +   + T   GTL YLA
Sbjct: 138 LHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEFVGTLQYLA 192
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYH 258
           PE     + T   D +SFG L  E ++G      + Q  ++H
Sbjct: 193 PELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWH 234

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 109/228 (47%), Gaps = 17/228 (7%)
Query: 44  FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKV--LSVESKQGEKEFMSEVASMANVNVCHE 100
           F+   KIGEG +G VYK R +  G +VA+K   L  E++      + E++ +  +N  H 
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN--HP 69
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
           N+VKL           LV++++ +  L + +  +            +  +  + +GLA+ 
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PENTTHISTRVAGTLGYLAPE 218
           H      V+HRD+K  N+L++     K++DFGL++ F  P  T    T    TL Y APE
Sbjct: 127 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT---YTHEVVTLWYRAPE 180
Query: 219 YAISGRLTRKS-DVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG 265
             +  +    + D++S G +  E+V+ R     D ++ +   + +  G
Sbjct: 181 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 228

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 109/228 (47%), Gaps = 17/228 (7%)
Query: 44  FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKV--LSVESKQGEKEFMSEVASMANVNVCHE 100
           F+   KIGEG +G VYK R +  G +VA+K   L  E++      + E++ +  +N  H 
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN--HP 62
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
           N+VKL           LV++++ +  L + +  +            +  +  + +GLA+ 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PENTTHISTRVAGTLGYLAPE 218
           H      V+HRD+K  N+L++     K++DFGL++ F  P  T    T    TL Y APE
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT---YTHEVVTLWYRAPE 173
Query: 219 YAISGRLTRKS-DVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG 265
             +  +    + D++S G +  E+V+ R     D ++ +   + +  G
Sbjct: 174 ILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 221

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 13/210 (6%)
Query: 43  GFRWSN--KIGEGGFGSVYKGRLQDGTI-VAVKVLS-VESKQGEKEFMSEVASMANVNVC 98
           G R++N   IGEG +G V         + VA+K +S  E +   +  + E+  +      
Sbjct: 22  GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-- 79
Query: 99  HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
           HEN++ +    I  P    + D      L +T L +  +            +  I RGL 
Sbjct: 80  HENIIGI-NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 138
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS--TRVAGTLGYLA 216
           YIH     +V+HRD+K SN+LL+   + KI DFGL+++   +  H    T    T  Y A
Sbjct: 139 YIHSA---NVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 217 PEYAISGR-LTRKSDVYSFGVLLLEIVSGR 245
           PE  ++ +  T+  D++S G +L E++S R
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 110/233 (47%), Gaps = 17/233 (7%)
Query: 39  IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKV--LSVESKQGEKEFMSEVASMANV 95
           +    F+   KIGEG +G VYK R +  G +VA+K   L  E++      + E++ +  +
Sbjct: 4   VDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 63
Query: 96  NVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR 155
           N  H N+VKL           LV++++ +  L + +  +            +  +  + +
Sbjct: 64  N--HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQ 118
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PENTTHISTRVAGTLG 213
           GLA+ H      V+HRD+K  N+L++     K++DFGL++ F  P  T    T    TL 
Sbjct: 119 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT---YTHEVVTLW 172
Query: 214 YLAPEYAISGRLTRKS-DVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG 265
           Y APE  +  +    + D++S G +  E+V+ R     D ++ +   + +  G
Sbjct: 173 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 225

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 103/234 (44%), Gaps = 32/234 (13%)
Query: 35  NQLKIATNGFRWSNKIGEGGFGSVYKG------RLQDGTIVAVKVLSVESKQGEKE-FMS 87
           ++ +   N   +   +G G FG V +       +      VAVK+L   +   E+E  MS
Sbjct: 32  HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS 91
Query: 88  EVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARR 147
           E+  ++ +   H N+V L G C  G   +++ +Y     L   L    ++R  F      
Sbjct: 92  ELKVLSYLGN-HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL---RRKRDSFICSKTS 147
Query: 148 EIIMG-----------------IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD 190
             IM                  + +G+A++  +   + +HRD+   NILL      KI D
Sbjct: 148 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICD 204
Query: 191 FGLSKLFPENTTHISTRVAG-TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
           FGL++    ++ ++    A   + ++APE   +   T +SDV+S+G+ L E+ S
Sbjct: 205 FGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 258

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 106/202 (52%), Gaps = 21/202 (10%)
Query: 49  KIGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           ++G+G FG VYK + ++ G + A KV+  +S++  ++++ E+  +A  +  H  +VKL G
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCD--HPYIVKLLG 75
Query: 108 GCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
               DG   I++ ++ P  ++   +L  ++   +   +    +   +   L ++H +   
Sbjct: 76  AYYHDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQV---VCRQMLEALNFLHSK--- 128
Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR--VAGTLGYLAPEYAISGR 224
            ++HRD+K  N+L+    + +++DFG+S    +N   +  R    GT  ++APE  +   
Sbjct: 129 RIIHRDLKAGNVLMTLEGDIRLADFGVSA---KNLKTLQKRDSFIGTPYWMAPEVVMCET 185
Query: 225 LTR-----KSDVYSFGVLLLEI 241
           +       K+D++S G+ L+E+
Sbjct: 186 MKDTPYDYKADIWSLGITLIEM 207

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 99/220 (45%), Gaps = 21/220 (9%)
Query: 36  QLKIATNGFRWSNKIGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMAN 94
           Q+K+    F     +G+G FG V+    +      A+K L  +    + +    +     
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 71
Query: 95  VNVCHENLVKLHGGCI--DGPCRILVYDYMPNNSLS---QTLLGEEKRRAKFGWKARREI 149
           +++  E+    H  C          V +Y+    L    Q+    +  RA F      EI
Sbjct: 72  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF---YAAEI 128
Query: 150 IMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT--THISTR 207
           I+G    L ++H +    +V+RD+K  NILLD++ + KI+DFG+ K   EN      +  
Sbjct: 129 ILG----LQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK---ENMLGDAKTNE 178
Query: 208 VAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTA 247
             GT  Y+APE  +  +     D +SFGVLL E++ G++ 
Sbjct: 179 FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 218

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 109/228 (47%), Gaps = 17/228 (7%)
Query: 44  FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKV--LSVESKQGEKEFMSEVASMANVNVCHE 100
           F+   KIGEG +G VYK R +  G +VA+K   L  E++      + E++ +  +N  H 
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN--HP 61
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
           N+VKL           LV++++ +  L + +  +            +  +  + +GLA+ 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PENTTHISTRVAGTLGYLAPE 218
           H      V+HRD+K  N+L++     K++DFGL++ F  P  T    T    TL Y APE
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT---YTHEVVTLWYRAPE 172
Query: 219 YAISGRLTRKS-DVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG 265
             +  +    + D++S G +  E+V+ R     D ++ +   + +  G
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 220

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 109/228 (47%), Gaps = 17/228 (7%)
Query: 44  FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKV--LSVESKQGEKEFMSEVASMANVNVCHE 100
           F+   KIGEG +G VYK R +  G +VA+K   L  E++      + E++ +  +N  H 
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN--HP 63
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
           N+VKL           LV++++ +  L + +  +            +  +  + +GLA+ 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PENTTHISTRVAGTLGYLAPE 218
           H      V+HRD+K  N+L++     K++DFGL++ F  P  T    T    TL Y APE
Sbjct: 121 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT---YTHEVVTLWYRAPE 174
Query: 219 YAISGRLTRKS-DVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG 265
             +  +    + D++S G +  E+V+ R     D ++ +   + +  G
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 222

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 13/210 (6%)
Query: 43  GFRWSN--KIGEGGFGSVYKGRLQDGTI-VAVKVLS-VESKQGEKEFMSEVASMANVNVC 98
           G R++N   IGEG +G V         + VA+K +S  E +   +  + E+  +      
Sbjct: 24  GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFR-- 81
Query: 99  HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
           HEN++ +    I  P    + D      L +T L +  +            +  I RGL 
Sbjct: 82  HENIIGI-NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 140
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS--TRVAGTLGYLA 216
           YIH     +V+HRD+K SN+LL+   + KI DFGL+++   +  H    T    T  Y A
Sbjct: 141 YIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 197
Query: 217 PEYAISGR-LTRKSDVYSFGVLLLEIVSGR 245
           PE  ++ +  T+  D++S G +L E++S R
Sbjct: 198 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 109/228 (47%), Gaps = 17/228 (7%)
Query: 44  FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKV--LSVESKQGEKEFMSEVASMANVNVCHE 100
           F+   KIGEG +G VYK R +  G +VA+K   L  E++      + E++ +  +N  H 
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN--HP 62
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
           N+VKL           LV++++ +  L + +  +            +  +  + +GLA+ 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PENTTHISTRVAGTLGYLAPE 218
           H      V+HRD+K  N+L++     K++DFGL++ F  P  T    T    TL Y APE
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT---YTHEVVTLWYRAPE 173
Query: 219 YAISGRLTRKS-DVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG 265
             +  +    + D++S G +  E+V+ R     D ++ +   + +  G
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 221

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVES--KQGEKEFMS-EVASMANVNVCH 99
           F++   +GEG F +V   R L      A+K+L      K+ +  +++ E   M+ ++  H
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD--H 88
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
              VKL+    D         Y  N  L + +    ++   F     R     I   L Y
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEY 144
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLAPE 218
           +H +    ++HRD+K  NILL+++ + +I+DFG +K+  PE+    +    GT  Y++PE
Sbjct: 145 LHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 201
Query: 219 YAISGRLTRKSDVYSFGVLLLEIVSG 244
                   + SD+++ G ++ ++V+G
Sbjct: 202 LLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 109/215 (50%), Gaps = 15/215 (6%)
Query: 37  LKIATNGFRWSNKIGEGGFGSVYK-GRLQDGTIVAVKVLSVESKQG-EKEFMSEVASMAN 94
           +++  + F   +++G G  G V+K      G ++A K++ +E K     + + E+  +  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 95  VNVCHENLVKLHGGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGI 153
            N  +  +V  +G    DG   I + ++M   SL Q L    K+  +   +   ++ + +
Sbjct: 61  CNSPY--IVGFYGAFYSDGEISICM-EHMDGGSLDQVL----KKAGRIPEQILGKVSIAV 113
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            +GL Y+ E+ +  ++HRD+K SNIL++     K+ DFG+S    ++   ++    GT  
Sbjct: 114 IKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRS 168
Query: 214 YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAV 248
           Y++PE       + +SD++S G+ L+E+  GR  +
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVES--KQGEKEFMS-EVASMANVNVCH 99
           F++   +GEG F +V   R L      A+K+L      K+ +  +++ E   M+ ++  H
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD--H 88
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
              VKL+    D         Y  N  L + +    ++   F     R     I   L Y
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEY 144
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTHISTRVAGTLGYLAPE 218
           +H +    ++HRD+K  NILL+++ + +I+DFG +K L PE+    +    GT  Y++PE
Sbjct: 145 LHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 201
Query: 219 YAISGRLTRKSDVYSFGVLLLEIVSG 244
                   + SD+++ G ++ ++V+G
Sbjct: 202 LLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 24/217 (11%)
Query: 39  IATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMS-----EVASM 92
           +AT+ +    +IG G +G+VYK R    G  VA+K + V +  G    +      EVA +
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 93  ANVNVC-HENLVKLHGGC----IDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKAR 146
             +    H N+V+L   C     D   ++ LV++++      Q L     +    G  A 
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-----DQDLRTYLDKAPPPGLPAE 120
Query: 147 --REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 204
             ++++    RGL ++H      +VHRD+K  NIL+      K++DFGL++++  +    
Sbjct: 121 TIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY--SYQMA 175
Query: 205 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEI 241
            T V  TL Y APE  +        D++S G +  E+
Sbjct: 176 LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 212

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 106/202 (52%), Gaps = 21/202 (10%)
Query: 49  KIGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           ++G+G FG VYK + ++ G + A KV+  +S++  ++++ E+  +A  +  H  +VKL G
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCD--HPYIVKLLG 83
Query: 108 GCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
               DG   I++ ++ P  ++   +L  ++   +   +    +   +   L ++H +   
Sbjct: 84  AYYHDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQV---VCRQMLEALNFLHSK--- 136
Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR--VAGTLGYLAPEYAISGR 224
            ++HRD+K  N+L+    + +++DFG+S    +N   +  R    GT  ++APE  +   
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSA---KNLKTLQKRDSFIGTPYWMAPEVVMCET 193
Query: 225 LTR-----KSDVYSFGVLLLEI 241
           +       K+D++S G+ L+E+
Sbjct: 194 MKDTPYDYKADIWSLGITLIEM 215

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 103/234 (44%), Gaps = 32/234 (13%)
Query: 35  NQLKIATNGFRWSNKIGEGGFGSVYKG------RLQDGTIVAVKVLSVESKQGEKE-FMS 87
           ++ +   N   +   +G G FG V +       +      VAVK+L   +   E+E  MS
Sbjct: 39  HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS 98
Query: 88  EVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARR 147
           E+  ++ +   H N+V L G C  G   +++ +Y     L   L    ++R  F      
Sbjct: 99  ELKVLSYLGN-HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL---RRKRDSFICSKTS 154
Query: 148 EIIMG-----------------IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD 190
             IM                  + +G+A++  +   + +HRD+   NILL      KI D
Sbjct: 155 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICD 211
Query: 191 FGLSKLFPENTTHISTRVAG-TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
           FGL++    ++ ++    A   + ++APE   +   T +SDV+S+G+ L E+ S
Sbjct: 212 FGLARHIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 106/221 (47%), Gaps = 24/221 (10%)
Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEF---MSEVASMANVNVCHENLVK 104
           +IG G FG+VY  R +++  +VA+K +S   KQ  +++   + EV  +  +   H N ++
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR--HPNTIQ 79
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
             G  +      LV +Y    S S  L   +K   +    A   +  G  +GLAY+H   
Sbjct: 80  YRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAA---VTHGALQGLAYLHSH- 134
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLAPEYAIS- 222
             +++HRD+K  NILL +    K+ DFG + +  P N         GT  ++APE  ++ 
Sbjct: 135 --NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX------FVGTPYWMAPEVILAM 186
Query: 223 --GRLTRKSDVYSFGVLLLEIVSGRTAV-DFDVQLGEYHLV 260
             G+   K DV+S G+  +E+   +  + + +     YH+ 
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA 227

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVES--KQGEKEFMS-EVASMANVNVCH 99
           F++   +GEG F +V   R L      A+K+L      K+ +  +++ E   M+ ++  H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD--H 91
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
              VKL+    D         Y  N  L + +    ++   F     R     I   L Y
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEY 147
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTHISTRVAGTLGYLAPE 218
           +H +    ++HRD+K  NILL+++ + +I+DFG +K L PE+    +    GT  Y++PE
Sbjct: 148 LHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 219 YAISGRLTRKSDVYSFGVLLLEIVSG 244
                   + SD+++ G ++ ++V+G
Sbjct: 205 LLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 109/215 (50%), Gaps = 15/215 (6%)
Query: 37  LKIATNGFRWSNKIGEGGFGSVYK-GRLQDGTIVAVKVLSVESKQG-EKEFMSEVASMAN 94
           +++  + F   +++G G  G V+K      G ++A K++ +E K     + + E+  +  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 95  VNVCHENLVKLHGGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGI 153
            N  +  +V  +G    DG   I + ++M   SL Q L    K+  +   +   ++ + +
Sbjct: 61  CNSPY--IVGFYGAFYSDGEISICM-EHMDGGSLDQVL----KKAGRIPEQILGKVSIAV 113
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            +GL Y+ E+ +  ++HRD+K SNIL++     K+ DFG+S    ++   ++    GT  
Sbjct: 114 IKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRS 168
Query: 214 YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAV 248
           Y++PE       + +SD++S G+ L+E+  GR  +
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 100/207 (48%), Gaps = 16/207 (7%)
Query: 44  FRWSNKIGEGGFGSVYKG-RLQDGTIVAVKVLSVE-----SKQGEKEFMSEVASMANVNV 97
           F+    +  G FG+VYKG  + +G  V + V   E     S +  KE + E   MA+V+ 
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 98  CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
            H  + +L G C+    + L+   MP   L   +    + +   G +      + I +G+
Sbjct: 84  PH--VCRLLGICLTSTVQ-LIMQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGM 137
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLA 216
            Y+ +     +VHRD+   N+L+    + KI+DFGL+KL   E   + +      + ++A
Sbjct: 138 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVS 243
            E  +    T +SDV+S+GV + E+++
Sbjct: 195 LESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVES--KQGEKEFMS-EVASMANVNVCH 99
           F++   +GEG F +V   R L      A+K+L      K+ +  +++ E   M+ ++  H
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD--H 89
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
              VKL+    D         Y  N  L + +    ++   F     R     I   L Y
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEY 145
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTHISTRVAGTLGYLAPE 218
           +H +    ++HRD+K  NILL+++ + +I+DFG +K L PE+    +    GT  Y++PE
Sbjct: 146 LHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 202
Query: 219 YAISGRLTRKSDVYSFGVLLLEIVSG 244
                   + SD+++ G ++ ++V+G
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 92/200 (46%), Gaps = 19/200 (9%)
Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           IG G FG V   + ++ G   A+K+L     V+ KQ E   ++E   +  VN     LVK
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPF--LVK 105
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L     D     +V +YMP   +   L    +R  +F     R     I     Y+H   
Sbjct: 106 LEFSFKDNSNLYMVMEYMPGGDMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH--- 158
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              +++RD+K  N+L+DQ    K++DFG +K     T  +     GT  YLAPE  +S  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXL----CGTPEYLAPEIILSKG 214
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
             +  D ++ GVL+ E+ +G
Sbjct: 215 YNKAVDWWALGVLIYEMAAG 234

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVES--KQGEKEFMS-EVASMANVNVCH 99
           F++   +GEG F +V   R L      A+K+L      K+ +  +++ E   M+ ++  H
Sbjct: 11  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD--H 68
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
              VKL+    D         Y  N  L + +    ++   F     R     I   L Y
Sbjct: 69  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEY 124
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTHISTRVAGTLGYLAPE 218
           +H +    ++HRD+K  NILL+++ + +I+DFG +K L PE+    +    GT  Y++PE
Sbjct: 125 LHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 181
Query: 219 YAISGRLTRKSDVYSFGVLLLEIVSG 244
                   + SD+++ G ++ ++V+G
Sbjct: 182 LLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 13/226 (5%)
Query: 44  FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKV--LSVESKQGEKEFMSEVASMANVNVCHE 100
           F+   KIGEG +G VYK R +  G +VA+K   L  E++      + E++ +  +N  H 
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN--HP 65
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
           N+VKL           LV++++   S+      +            +  +  + +GLA+ 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
           H      V+HRD+K  N+L++     K++DFGL++ F          V  TL Y APE  
Sbjct: 123 HSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEIL 178
Query: 221 ISGRLTRKS-DVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG 265
           +  +    + D++S G +  E+V+ R     D ++ +   + +  G
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 224

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 99/200 (49%), Gaps = 13/200 (6%)
Query: 49  KIGEGGFGSVYKGRLQDGTIVAVKVLSV-ESKQGEKEFMSEVASMANVNVCHEN--LVKL 105
           ++G G FG+V KG  Q   +V    + + +++  +     E+ + ANV    +N  +V++
Sbjct: 377 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 436
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
            G C +    +LV +      L++ L  ++ R  K   K   E++  +  G+ Y+ E   
Sbjct: 437 IGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD--KNIIELVHQVSMGMKYLEES-- 489
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG--TLGYLAPEYAISG 223
            + VHRD+   N+LL      KISDFGLSK    +  +   +  G   + + APE     
Sbjct: 490 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 548
Query: 224 RLTRKSDVYSFGVLLLEIVS 243
           + + KSDV+SFGVL+ E  S
Sbjct: 549 KFSSKSDVWSFGVLMWEAFS 568

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 109/215 (50%), Gaps = 15/215 (6%)
Query: 37  LKIATNGFRWSNKIGEGGFGSVYK-GRLQDGTIVAVKVLSVESKQG-EKEFMSEVASMAN 94
           +++  + F   +++G G  G V+K      G ++A K++ +E K     + + E+  +  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 95  VNVCHENLVKLHGGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGI 153
            N  +  +V  +G    DG   I + ++M   SL Q L    K+  +   +   ++ + +
Sbjct: 61  CNSPY--IVGFYGAFYSDGEISICM-EHMDGGSLDQVL----KKAGRIPEQILGKVSIAV 113
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            +GL Y+ E+ +  ++HRD+K SNIL++     K+ DFG+S    ++   ++    GT  
Sbjct: 114 IKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRS 168
Query: 214 YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAV 248
           Y++PE       + +SD++S G+ L+E+  GR  +
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVES--KQGEKEFMS-EVASMANVNVCH 99
           F++   +GEG F +V   R L      A+K+L      K+ +  +++ E   M+ ++  H
Sbjct: 12  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD--H 69
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
              VKL+    D         Y  N  L + +    ++   F     R     I   L Y
Sbjct: 70  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEY 125
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTHISTRVAGTLGYLAPE 218
           +H +    ++HRD+K  NILL+++ + +I+DFG +K L PE+    +    GT  Y++PE
Sbjct: 126 LHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 182
Query: 219 YAISGRLTRKSDVYSFGVLLLEIVSG 244
                   + SD+++ G ++ ++V+G
Sbjct: 183 LLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVES--KQGEKEFMS-EVASMANVNVCH 99
           F++   +GEG F +V   R L      A+K+L      K+ +  +++ E   M+ ++  H
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD--H 96
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
              VKL+    D         Y  N  L + +    ++   F     R     I   L Y
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEY 152
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTHISTRVAGTLGYLAPE 218
           +H +    ++HRD+K  NILL+++ + +I+DFG +K L PE+    +    GT  Y++PE
Sbjct: 153 LHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 209
Query: 219 YAISGRLTRKSDVYSFGVLLLEIVSG 244
                   + SD+++ G ++ ++V+G
Sbjct: 210 LLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 13/226 (5%)
Query: 44  FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKV--LSVESKQGEKEFMSEVASMANVNVCHE 100
           F+   KIGEG +G VYK R +  G +VA+K   L  E++      + E++ +  +N  H 
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN--HP 63
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
           N+VKL           LV++++   S+      +            +  +  + +GLA+ 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
           H      V+HRD+K  N+L++     K++DFGL++ F          V  TL Y APE  
Sbjct: 121 HSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEIL 176
Query: 221 ISGRLTRKS-DVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG 265
           +  +    + D++S G +  E+V+ R     D ++ +   + +  G
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 222

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVES--KQGEKEFMS-EVASMANVNVCH 99
           F++   +GEG F +V   R L      A+K+L      K+ +  +++ E   M+ ++  H
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD--H 73
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
              VKL+    D         Y  N  L + +    ++   F     R     I   L Y
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEY 129
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTHISTRVAGTLGYLAPE 218
           +H +    ++HRD+K  NILL+++ + +I+DFG +K L PE+    +    GT  Y++PE
Sbjct: 130 LHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 186
Query: 219 YAISGRLTRKSDVYSFGVLLLEIVSG 244
                   + SD+++ G ++ ++V+G
Sbjct: 187 LLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 100/207 (48%), Gaps = 16/207 (7%)
Query: 44  FRWSNKIGEGGFGSVYKG-RLQDGTIVAVKVLSVE-----SKQGEKEFMSEVASMANVNV 97
           F+    +  G FG+VYKG  + +G  V + V   E     S +  KE + E   MA+V+ 
Sbjct: 17  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 98  CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
            H  + +L G C+    + L+   MP   L   +    + +   G +      + I +G+
Sbjct: 77  PH--VCRLLGICLTSTVQ-LITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGM 130
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLA 216
            Y+ +     +VHRD+   N+L+    + KI+DFGL+KL   E   + +      + ++A
Sbjct: 131 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVS 243
            E  +    T +SDV+S+GV + E+++
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVES--KQGEKEFMS-EVASMANVNVCH 99
           F++   +GEG F +V   R L      A+K+L      K+ +  +++ E   M+ ++  H
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD--H 67
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
              VKL+    D         Y  N  L + +    ++   F     R     I   L Y
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEY 123
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTHISTRVAGTLGYLAPE 218
           +H +    ++HRD+K  NILL+++ + +I+DFG +K L PE+    +    GT  Y++PE
Sbjct: 124 LHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 180
Query: 219 YAISGRLTRKSDVYSFGVLLLEIVSG 244
                   + SD+++ G ++ ++V+G
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 103/234 (44%), Gaps = 32/234 (13%)
Query: 35  NQLKIATNGFRWSNKIGEGGFGSVYKG------RLQDGTIVAVKVLSVESKQGEKE-FMS 87
           ++ +   N   +   +G G FG V +       +      VAVK+L   +   E+E  MS
Sbjct: 34  HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS 93
Query: 88  EVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARR 147
           E+  ++ +   H N+V L G C  G   +++ +Y     L   L    ++R  F      
Sbjct: 94  ELKVLSYLGN-HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL---RRKRDSFICSKTS 149
Query: 148 EIIMG-----------------IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD 190
             IM                  + +G+A++  +   + +HRD+   NILL      KI D
Sbjct: 150 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICD 206
Query: 191 FGLSKLFPENTTHISTRVAG-TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
           FGL++    ++ ++    A   + ++APE   +   T +SDV+S+G+ L E+ S
Sbjct: 207 FGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 260

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 92/200 (46%), Gaps = 19/200 (9%)
Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           IG G FG V   + ++ G   A+K+L     V+ KQ E   ++E   +  VN     LVK
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPF--LVK 105
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L     D     +V +YMP   +   L    +R  +F     R     I     Y+H   
Sbjct: 106 LEFSFKDNSNLYMVMEYMPGGDMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH--- 158
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              +++RD+K  N+L+DQ    K++DFG +K     T  +     GT  YLAPE  +S  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXL----CGTPEYLAPEIILSKG 214
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
             +  D ++ GVL+ E+ +G
Sbjct: 215 YNKAVDWWALGVLIYEMAAG 234

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 109/215 (50%), Gaps = 15/215 (6%)
Query: 37  LKIATNGFRWSNKIGEGGFGSVYK-GRLQDGTIVAVKVLSVESKQG-EKEFMSEVASMAN 94
           +++  + F   +++G G  G V+K      G ++A K++ +E K     + + E+  +  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 95  VNVCHENLVKLHGGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGI 153
            N  +  +V  +G    DG   I + ++M   SL Q L    K+  +   +   ++ + +
Sbjct: 61  CNSPY--IVGFYGAFYSDGEISICM-EHMDGGSLDQVL----KKAGRIPEQILGKVSIAV 113
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            +GL Y+ E+ +  ++HRD+K SNIL++     K+ DFG+S    ++   ++    GT  
Sbjct: 114 IKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRS 168
Query: 214 YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAV 248
           Y++PE       + +SD++S G+ L+E+  GR  +
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 109/215 (50%), Gaps = 15/215 (6%)
Query: 37  LKIATNGFRWSNKIGEGGFGSVYK-GRLQDGTIVAVKVLSVESKQG-EKEFMSEVASMAN 94
           +++  + F   +++G G  G V+K      G ++A K++ +E K     + + E+  +  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 95  VNVCHENLVKLHGGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGI 153
            N  +  +V  +G    DG   I + ++M   SL Q L    K+  +   +   ++ + +
Sbjct: 61  CNSPY--IVGFYGAFYSDGEISICM-EHMDGGSLDQVL----KKAGRIPEQILGKVSIAV 113
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            +GL Y+ E+ +  ++HRD+K SNIL++     K+ DFG+S    ++   ++    GT  
Sbjct: 114 IKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRS 168
Query: 214 YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAV 248
           Y++PE       + +SD++S G+ L+E+  GR  +
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVES--KQGEKEFMS-EVASMANVNVCH 99
           F++   +GEG F +V   R L      A+K+L      K+ +  +++ E   M+ ++  H
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD--H 89
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
              VKL+    D         Y  N  L + +    ++   F     R     I   L Y
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEY 145
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTHISTRVAGTLGYLAPE 218
           +H +    ++HRD+K  NILL+++ + +I+DFG +K L PE+    +    GT  Y++PE
Sbjct: 146 LHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 202
Query: 219 YAISGRLTRKSDVYSFGVLLLEIVSG 244
                   + SD+++ G ++ ++V+G
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVES--KQGEKEFMS-EVASMANVNVCH 99
           F++   +GEG F +V   R L      A+K+L      K+ +  +++ E   M+ ++  H
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD--H 92
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
              VKL+    D         Y  N  L + +    ++   F     R     I   L Y
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEY 148
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTHISTRVAGTLGYLAPE 218
           +H +    ++HRD+K  NILL+++ + +I+DFG +K L PE+    +    GT  Y++PE
Sbjct: 149 LHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 205
Query: 219 YAISGRLTRKSDVYSFGVLLLEIVSG 244
                   + SD+++ G ++ ++V+G
Sbjct: 206 LLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 103/234 (44%), Gaps = 32/234 (13%)
Query: 35  NQLKIATNGFRWSNKIGEGGFGSVYKG------RLQDGTIVAVKVLSVESKQGEKE-FMS 87
           ++ +   N   +   +G G FG V +       +      VAVK+L   +   E+E  MS
Sbjct: 16  HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS 75
Query: 88  EVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARR 147
           E+  ++ +   H N+V L G C  G   +++ +Y     L   L    ++R  F      
Sbjct: 76  ELKVLSYLGN-HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL---RRKRDSFICSKTS 131
Query: 148 EIIMG-----------------IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD 190
             IM                  + +G+A++  +   + +HRD+   NILL      KI D
Sbjct: 132 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICD 188
Query: 191 FGLSKLFPENTTHISTRVAG-TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
           FGL++    ++ ++    A   + ++APE   +   T +SDV+S+G+ L E+ S
Sbjct: 189 FGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVES--KQGEKEFMS-EVASMANVNVCH 99
           F++   +GEG F +V   R L      A+K+L      K+ +  +++ E   M+ ++  H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD--H 91
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
              VKL+    D         Y  N  L + +    ++   F     R     I   L Y
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEY 147
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTHISTRVAGTLGYLAPE 218
           +H +    ++HRD+K  NILL+++ + +I+DFG +K L PE+    +    GT  Y++PE
Sbjct: 148 LHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 219 YAISGRLTRKSDVYSFGVLLLEIVSG 244
                   + SD+++ G ++ ++V+G
Sbjct: 205 LLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 25/216 (11%)
Query: 39  IATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEF----MSEVASMA 93
           +AT+ +    +IG G +G+VYK R    G  VA+K  SV    GE+      + EVA + 
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALK--SVRVPNGEEGLPISTVREVALLR 58
Query: 94  NVNVC-HENLVKLHGGC----IDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKAR- 146
            +    H N+V+L   C     D   ++ LV+++     + Q L     +    G  A  
Sbjct: 59  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEH-----VDQDLRTYLDKAPPPGLPAET 113
Query: 147 -REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS 205
            ++++    RGL ++H      +VHRD+K  NIL+      K++DFGL++++  +     
Sbjct: 114 IKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY--SYQMAL 168
Query: 206 TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEI 241
             V  TL Y APE  +        D++S G +  E+
Sbjct: 169 DPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 50  IGEGGFGSVYKG--RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           +GEG  G V     R+ +   VAVK++ ++      E + +   + N  + HEN+VK +G
Sbjct: 14  LGEGAAGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICI-NKMLNHENVVKFYG 71
Query: 108 GCIDGPCRILVYDYMPNNSLSQTL---LGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
              +G  + L  +Y     L   +   +G  +  A+            +  G+ Y+H   
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-------RFFHQLMAGVVYLH--- 121
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP-ENTTHISTRVAGTLGYLAPEYAISG 223
              + HRDIK  N+LLD+  N KISDFGL+ +F   N   +  ++ GTL Y+APE     
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 224 RL-TRKSDVYSFGVLLLEIVSGRTAVD 249
                  DV+S G++L  +++G    D
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVES--KQGEKEFMS-EVASMANVNVCH 99
           F++   +GEG F +V   R L      A+K+L      K+ +  +++ E   M+ ++  H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD--H 91
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
              VKL+    D         Y  N  L + +    ++   F     R     I   L Y
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEY 147
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTHISTRVAGTLGYLAPE 218
           +H +    ++HRD+K  NILL+++ + +I+DFG +K L PE+    +    GT  Y++PE
Sbjct: 148 LHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 219 YAISGRLTRKSDVYSFGVLLLEIVSG 244
                   + SD+++ G ++ ++V+G
Sbjct: 205 LLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 103/234 (44%), Gaps = 32/234 (13%)
Query: 35  NQLKIATNGFRWSNKIGEGGFGSVYKG------RLQDGTIVAVKVLSVESKQGEKE-FMS 87
           ++ +   N   +   +G G FG V +       +      VAVK+L   +   E+E  MS
Sbjct: 39  HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS 98
Query: 88  EVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARR 147
           E+  ++ +   H N+V L G C  G   +++ +Y     L   L    ++R  F      
Sbjct: 99  ELKVLSYLGN-HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL---RRKRDSFICSKTS 154
Query: 148 EIIMG-----------------IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD 190
             IM                  + +G+A++  +   + +HRD+   NILL      KI D
Sbjct: 155 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICD 211
Query: 191 FGLSKLFPENTTHISTRVAG-TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
           FGL++    ++ ++    A   + ++APE   +   T +SDV+S+G+ L E+ S
Sbjct: 212 FGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 100/207 (48%), Gaps = 16/207 (7%)
Query: 44  FRWSNKIGEGGFGSVYKG-RLQDGTIVAVKVLSVE-----SKQGEKEFMSEVASMANVNV 97
           F+    +  G FG+VYKG  + +G  V + V   E     S +  KE + E   MA+V+ 
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 98  CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
            H  + +L G C+    + L+   MP   L   +    + +   G +      + I +G+
Sbjct: 84  PH--VCRLLGICLTSTVQ-LITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGM 137
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLA 216
            Y+ +     +VHRD+   N+L+    + KI+DFGL+KL   E   + +      + ++A
Sbjct: 138 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVS 243
            E  +    T +SDV+S+GV + E+++
Sbjct: 195 LESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 100/207 (48%), Gaps = 16/207 (7%)
Query: 44  FRWSNKIGEGGFGSVYKG-RLQDGTIVAVKVLSVE-----SKQGEKEFMSEVASMANVNV 97
           F+    +G G FG+VYKG  + +G  V + V   E     S +  KE + E   MA+V+ 
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 98  CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
            H  + +L G C+    + L+   MP   L   +    + +   G +      + I +G+
Sbjct: 79  PH--VCRLLGICLTSTVQ-LIMQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGM 132
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLA 216
            Y+ +     +VHRD+   N+L+    + KI+DFG +KL   E   + +      + ++A
Sbjct: 133 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVS 243
            E  +    T +SDV+S+GV + E+++
Sbjct: 190 LESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVES--KQGEKEFMS-EVASMANVNVCH 99
           F++   +GEG F +V   R L      A+K+L      K+ +  +++ E   M+ ++  H
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD--H 92
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
              VKL+    D         Y  N  L + +    ++   F     R     I   L Y
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEY 148
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTHISTRVAGTLGYLAPE 218
           +H +    ++HRD+K  NILL+++ + +I+DFG +K L PE+    +    GT  Y++PE
Sbjct: 149 LHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 205
Query: 219 YAISGRLTRKSDVYSFGVLLLEIVSG 244
                   + SD+++ G ++ ++V+G
Sbjct: 206 LLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 108/224 (48%), Gaps = 43/224 (19%)
Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG 108
           +G+G FG V K R   D    A+K +   +++     +SEV  +A++N  H+ +V+ +  
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLN--HQYVVRYYAA 70
Query: 109 CID-------------GPCRILVYDYMPNNSLSQTLLGEE--KRRAKFGWKARREIIMGI 153
            ++                  +  +Y  N +L   +  E   ++R ++ W+  R+I+   
Sbjct: 71  WLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEY-WRLFRQIL--- 126
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--------------LFPE 199
              L+YIH +    ++HRD+K  NI +D++ N KI DFGL+K                P 
Sbjct: 127 -EALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 200 NTTHISTRVAGTLGYLAPEYAI-SGRLTRKSDVYSFGVLLLEIV 242
           ++ ++++ + GT  Y+A E    +G    K D+YS G++  E++
Sbjct: 183 SSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVES--KQGEKEFMS-EVASMANVNVCH 99
           F++   +GEG F +V   R L      A+K+L      K+ +  +++ E   M+ ++  H
Sbjct: 9   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD--H 66
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
              VKL+    D         Y  N  L + +    ++   F     R     I   L Y
Sbjct: 67  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEY 122
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTHISTRVAGTLGYLAPE 218
           +H +    ++HRD+K  NILL+++ + +I+DFG +K L PE+    +    GT  Y++PE
Sbjct: 123 LHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 179
Query: 219 YAISGRLTRKSDVYSFGVLLLEIVSG 244
                   + SD+++ G ++ ++V+G
Sbjct: 180 LLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 98/219 (44%), Gaps = 15/219 (6%)
Query: 36  QLKIATNGFRWSNKIGEGGFGSVYKGRLQDGT-IVAVKVLSVES--KQGEKEFMSEVASM 92
           Q+++    F     IG G FG V   +L++   + A+K+L+     K+ E     E   +
Sbjct: 68  QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDV 127
Query: 93  ANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG 152
             VN   + +  LH    D     LV DY     L   L   E R  +   +  R  +  
Sbjct: 128 L-VNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPE---EMARFYLAE 183
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL 212
           +   +  +H   Q H VHRDIK  NIL+D N + +++DFG      E+ T  S+   GT 
Sbjct: 184 MVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTP 240
Query: 213 GYLAPEYAIS-----GRLTRKSDVYSFGVLLLEIVSGRT 246
            Y++PE   +     GR   + D +S GV + E++ G T
Sbjct: 241 DYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVES--KQGEKEFMS-EVASMANVNVCH 99
           F++   +GEG F +V   R L      A+K+L      K+ +  +++ E   M+ ++  H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD--H 91
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
              VKL+    D         Y  N  L + +    ++   F     R     I   L Y
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEY 147
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTHISTRVAGTLGYLAPE 218
           +H +    ++HRD+K  NILL+++ + +I+DFG +K L PE+    +    GT  Y++PE
Sbjct: 148 LHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 219 YAISGRLTRKSDVYSFGVLLLEIVSG 244
                   + SD+++ G ++ ++V+G
Sbjct: 205 LLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVES--KQGEKEFMS-EVASMANVNVCH 99
           F++   +GEG F +V   R L      A+K+L      K+ +  +++ E   M+ ++  H
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD--H 94
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
              VKL+    D         Y  N  L + +    ++   F     R     I   L Y
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEY 150
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTHISTRVAGTLGYLAPE 218
           +H +    ++HRD+K  NILL+++ + +I+DFG +K L PE+    +    GT  Y++PE
Sbjct: 151 LHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 207
Query: 219 YAISGRLTRKSDVYSFGVLLLEIVSG 244
                   + SD+++ G ++ ++V+G
Sbjct: 208 LLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 100/207 (48%), Gaps = 16/207 (7%)
Query: 44  FRWSNKIGEGGFGSVYKG-RLQDGTIVAVKVLSVE-----SKQGEKEFMSEVASMANVNV 97
           F+    +G G FG+VYKG  + +G  V + V   E     S +  KE + E   MA+V+ 
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 98  CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
            H  + +L G C+    + L+   MP   L   +    + +   G +      + I +G+
Sbjct: 81  PH--VCRLLGICLTSTVQ-LIMQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGM 134
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLA 216
            Y+ +     +VHRD+   N+L+    + KI+DFG +KL   E   + +      + ++A
Sbjct: 135 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 191
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVS 243
            E  +    T +SDV+S+GV + E+++
Sbjct: 192 LESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 98/201 (48%), Gaps = 16/201 (7%)
Query: 50  IGEGGFGSVYKG-RLQDGTIVAVKVLSVE-----SKQGEKEFMSEVASMANVNVCHENLV 103
           +G G FG+VYKG  + +G  V + V   E     S +  KE + E   MA+V+  H  + 
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH--VC 82
Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
           +L G C+    + L+   MP   L   +    + +   G +      + I +G+ Y+ + 
Sbjct: 83  RLLGICLTSTVQ-LIMQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGMNYLEDR 138
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLAPEYAIS 222
               +VHRD+   N+L+    + KI+DFG +KL   E   + +      + ++A E  + 
Sbjct: 139 ---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH 195
Query: 223 GRLTRKSDVYSFGVLLLEIVS 243
              T +SDV+S+GV + E+++
Sbjct: 196 RIYTHQSDVWSYGVTVWELMT 216

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVES--KQGEKEFMS-EVASMANVNVCH 99
           F++   +GEG F +V   R L      A+K+L      K+ +  +++ E   M+ ++  H
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD--H 89
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
              VKL+    D         Y  N  L + +    ++   F     R     I   L Y
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEY 145
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTHISTRVAGTLGYLAPE 218
           +H +    ++HRD+K  NILL+++ + +I+DFG +K L PE+    +    GT  Y++PE
Sbjct: 146 LHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPE 202
Query: 219 YAISGRLTRKSDVYSFGVLLLEIVSG 244
                   + SD+++ G ++ ++V+G
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 16/217 (7%)
Query: 38  KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVN 96
           ++    +   + +G G FG V  G  Q  G  VAVK+L+ +  +           + N+ 
Sbjct: 7   RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLK 66
Query: 97  VC-HENLVKLHGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIG 154
           +  H +++KL+   I  P    +V +Y+    L   +     +  +      R +   I 
Sbjct: 67  LFRHPHIIKLYQ-VISTPTDFFMVMEYVSGGELFDYIC----KHGRVEEMEARRLFQQIL 121
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY 214
             + Y H  +   VVHRD+K  N+LLD + N KI+DFGLS +  +     ++   G+  Y
Sbjct: 122 SAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNY 176
Query: 215 LAPEYAISGRLTR--KSDVYSFGVLLLEIVSGRTAVD 249
            APE  ISGRL    + D++S GV+L  ++ G    D
Sbjct: 177 AAPE-VISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 13/226 (5%)
Query: 44  FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKV--LSVESKQGEKEFMSEVASMANVNVCHE 100
           F+   KIGEG +G VYK R +  G +VA+K   L  E++      + E++ +  +N  H 
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN--HP 65
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
           N+VKL           LV++++   S+      +            +  +  + +GLA+ 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
           H      V+HRD+K  N+L++     K++DFGL++ F          V  TL Y APE  
Sbjct: 123 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEIL 178
Query: 221 ISGRLTRKS-DVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG 265
           +  +    + D++S G +  E+V+ R     D ++ +   + +  G
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 224

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 13/210 (6%)
Query: 43  GFRWSN--KIGEGGFGSVYKGRLQDGTI-VAVKVLS-VESKQGEKEFMSEVASMANVNVC 98
           G R++N   IGEG +G V         + VA+K +S  E +   +  + E+  +      
Sbjct: 24  GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFR-- 81
Query: 99  HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
           HEN++ +    I  P    + D      L +T L +  +            +  I RGL 
Sbjct: 82  HENIIGI-NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 140
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS--TRVAGTLGYLA 216
           YIH     +V+HRD+K SN+LL+   + KI DFGL+++   +  H    T    T  Y A
Sbjct: 141 YIHSA---NVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 197
Query: 217 PEYAISGR-LTRKSDVYSFGVLLLEIVSGR 245
           PE  ++ +  T+  D++S G +L E++S R
Sbjct: 198 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 10/201 (4%)
Query: 50  IGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFM-SEVASMANVNVCHENLVKLH 106
           IG G +G   K R + DG I+  K L   S  + EK+ + SEV  +  +   H N+V+ +
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK--HPNIVRYY 71
Query: 107 GGCIDGPCRIL--VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
              ID     L  V +Y     L+  +    K R     +    ++  +   L   H   
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 165 Q--PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS 222
                V+HRD+K +N+ LD   N K+ DFGL+++   +    +    GT  Y++PE    
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDED-FAKEFVGTPYYMSPEQMNR 190
Query: 223 GRLTRKSDVYSFGVLLLEIVS 243
                KSD++S G LL E+ +
Sbjct: 191 MSYNEKSDIWSLGCLLYELCA 211

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 13/226 (5%)
Query: 44  FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKV--LSVESKQGEKEFMSEVASMANVNVCHE 100
           F+   KIGEG +G VYK R +  G +VA+K   L  E++      + E++ +  +N  H 
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN--HP 64
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
           N+VKL           LV++++   S+      +            +  +  + +GLA+ 
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
           H      V+HRD+K  N+L++     K++DFGL++ F          V  TL Y APE  
Sbjct: 122 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEIL 177
Query: 221 ISGRLTRKS-DVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG 265
           +  +    + D++S G +  E+V+ R     D ++ +   + +  G
Sbjct: 178 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 223

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVES--KQGEKEFMS-EVASMANVNVCH 99
           F++   +GEG F +V   R L      A+K+L      K+ +  +++ E   M+ ++  H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD--H 91
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
              VKL+    D         Y  N  L + +    ++   F     R     I   L Y
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEY 147
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTHISTRVAGTLGYLAPE 218
           +H +    ++HRD+K  NILL+++ + +I+DFG +K L PE+    +    GT  Y++PE
Sbjct: 148 LHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 219 YAISGRLTRKSDVYSFGVLLLEIVSG 244
                   + SD+++ G ++ ++V+G
Sbjct: 205 LLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 100/207 (48%), Gaps = 16/207 (7%)
Query: 44  FRWSNKIGEGGFGSVYKG-RLQDGTIVAVKVLSVE-----SKQGEKEFMSEVASMANVNV 97
           F+    +G G FG+VYKG  + +G  V + V   E     S +  KE + E   MA+V+ 
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 98  CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
            H  + +L G C+    + L+   MP   L   +    + +   G +      + I +G+
Sbjct: 84  PH--VCRLLGICLTSTVQ-LITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGM 137
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLA 216
            Y+ +     +VHRD+   N+L+    + KI+DFG +KL   E   + +      + ++A
Sbjct: 138 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVS 243
            E  +    T +SDV+S+GV + E+++
Sbjct: 195 LESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 108/224 (48%), Gaps = 43/224 (19%)
Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG 108
           +G+G FG V K R   D    A+K +   +++     +SEV  +A++N  H+ +V+ +  
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLN--HQYVVRYYAA 70
Query: 109 CID-------------GPCRILVYDYMPNNSLSQTLLGEE--KRRAKFGWKARREIIMGI 153
            ++                  +  +Y  N +L   +  E   ++R ++ W+  R+I+   
Sbjct: 71  WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY-WRLFRQIL--- 126
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--------------LFPE 199
              L+YIH +    ++HRD+K  NI +D++ N KI DFGL+K                P 
Sbjct: 127 -EALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 200 NTTHISTRVAGTLGYLAPEYAI-SGRLTRKSDVYSFGVLLLEIV 242
           ++ ++++ + GT  Y+A E    +G    K D+YS G++  E++
Sbjct: 183 SSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 98/201 (48%), Gaps = 16/201 (7%)
Query: 50  IGEGGFGSVYKG-RLQDGTIVAVKVLSVE-----SKQGEKEFMSEVASMANVNVCHENLV 103
           +G G FG+VYKG  + +G  V + V   E     S +  KE + E   MA+V+  H  + 
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH--VC 80
Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
           +L G C+    + L+   MP   L   +    + +   G +      + I +G+ Y+ + 
Sbjct: 81  RLLGICLTSTVQ-LITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLAPEYAIS 222
               +VHRD+   N+L+    + KI+DFG +KL   E   + +      + ++A E  + 
Sbjct: 137 ---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 223 GRLTRKSDVYSFGVLLLEIVS 243
              T +SDV+S+GV + E+++
Sbjct: 194 RIYTHQSDVWSYGVTVWELMT 214

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 98/201 (48%), Gaps = 16/201 (7%)
Query: 50  IGEGGFGSVYKG-RLQDGTIVAVKVLSVE-----SKQGEKEFMSEVASMANVNVCHENLV 103
           +G G FG+VYKG  + +G  V + V   E     S +  KE + E   MA+V+  H  + 
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH--VC 82
Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
           +L G C+    + L+   MP   L   +    + +   G +      + I +G+ Y+ + 
Sbjct: 83  RLLGICLTSTVQ-LITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGMNYLEDR 138
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLAPEYAIS 222
               +VHRD+   N+L+    + KI+DFG +KL   E   + +      + ++A E  + 
Sbjct: 139 ---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH 195
Query: 223 GRLTRKSDVYSFGVLLLEIVS 243
              T +SDV+S+GV + E+++
Sbjct: 196 RIYTHQSDVWSYGVTVWELMT 216

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 16/217 (7%)
Query: 38  KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVN 96
           ++    +   + +G G FG V  G  Q  G  VAVK+L+ +  +           + N+ 
Sbjct: 7   RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLK 66
Query: 97  VC-HENLVKLHGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIG 154
           +  H +++KL+   I  P    +V +Y+    L   +     +  +      R +   I 
Sbjct: 67  LFRHPHIIKLYQ-VISTPTDFFMVMEYVSGGELFDYIC----KHGRVEEMEARRLFQQIL 121
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY 214
             + Y H  +   VVHRD+K  N+LLD + N KI+DFGLS +  +          G+  Y
Sbjct: 122 SAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FLRDSCGSPNY 176
Query: 215 LAPEYAISGRLTR--KSDVYSFGVLLLEIVSGRTAVD 249
            APE  ISGRL    + D++S GV+L  ++ G    D
Sbjct: 177 AAPE-VISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 108/212 (50%), Gaps = 17/212 (8%)
Query: 38  KIATNGFRWSNKIGEGGFGSVYK-GRLQDGTIVAVKVLSVESKQG-EKEFMSEVASMANV 95
           ++  + F   +++G G  G V+K      G ++A K++ +E K     + + E+  +   
Sbjct: 5   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 64
Query: 96  NVCHENLVKLHGGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIG 154
           N  +  +V  +G    DG   I + ++M   SL Q L    K+  +   +   ++ + + 
Sbjct: 65  NSPY--IVGFYGAFYSDGEISICM-EHMDGGSLDQVL----KKAGRIPEQILGKVSIAVI 117
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS-KLFPENTTHISTRVAGTLG 213
           +GL Y+ E+ +  ++HRD+K SNIL++     K+ DFG+S +L  E    ++    GT  
Sbjct: 118 KGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDE----MANEFVGTRS 171
Query: 214 YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
           Y++PE       + +SD++S G+ L+E+  GR
Sbjct: 172 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 107/226 (47%), Gaps = 13/226 (5%)
Query: 44  FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKV--LSVESKQGEKEFMSEVASMANVNVCHE 100
           F+   KIGEG +G VYK R +  G +VA+K   L  E++      + E++ +  +N  H 
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN--HP 62
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
           N+VKL           LV++++ +  L + +  +            +  +  + +GLA+ 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
           H      V+HRD+K  N+L++     K++DFGL++ F          V  TL Y APE  
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEIL 175
Query: 221 ISGRLTRKS-DVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG 265
           +  +    + D++S G +  E+V+ R     D ++ +   + +  G
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 221

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 107/226 (47%), Gaps = 13/226 (5%)
Query: 44  FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKV--LSVESKQGEKEFMSEVASMANVNVCHE 100
           F+   KIGEG +G VYK R +  G +VA+K   L  E++      + E++ +  +N  H 
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN--HP 66
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
           N+VKL           LV++++ +  L + +  +            +  +  + +GLA+ 
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFC 123
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
           H      V+HRD+K  N+L++     K++DFGL++ F          V  TL Y APE  
Sbjct: 124 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEIL 179
Query: 221 ISGRLTRKS-DVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG 265
           +  +    + D++S G +  E+V+ R     D ++ +   + +  G
Sbjct: 180 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 225

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 23/208 (11%)
Query: 50  IGEGGFGSV-----YKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC-HENLV 103
           +GEG FG V     YK + +    VA+K +S +  +     M     ++ + +  H +++
Sbjct: 17  LGEGSFGKVKLATHYKTQQK----VALKFISRQLLKKSDMHMRVEREISYLKLLRHPHII 72
Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
           KL+   I  P  I++        L   ++ +++     G +  ++II  I     Y H  
Sbjct: 73  KLYD-VITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAI----EYCHRH 127
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG 223
               +VHRD+K  N+LLD N N KI+DFGLS +  +     ++   G+  Y APE  I+G
Sbjct: 128 ---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPE-VING 181
Query: 224 RLTR--KSDVYSFGVLLLEIVSGRTAVD 249
           +L    + DV+S G++L  ++ GR   D
Sbjct: 182 KLYAGPEVDVWSCGIVLYVMLVGRLPFD 209

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 107/226 (47%), Gaps = 13/226 (5%)
Query: 44  FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKV--LSVESKQGEKEFMSEVASMANVNVCHE 100
           F+   KIGEG +G VYK R +  G +VA+K   L  E++      + E++ +  +N  H 
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN--HP 64
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
           N+VKL           LV++++ +  L + +  +            +  +  + +GLA+ 
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
           H      V+HRD+K  N+L++     K++DFGL++ F          V  TL Y APE  
Sbjct: 122 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEIL 177
Query: 221 ISGRLTRKS-DVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG 265
           +  +    + D++S G +  E+V+ R     D ++ +   + +  G
Sbjct: 178 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 223

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 107/226 (47%), Gaps = 13/226 (5%)
Query: 44  FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKV--LSVESKQGEKEFMSEVASMANVNVCHE 100
           F+   KIGEG +G VYK R +  G +VA+K   L  E++      + E++ +  +N  H 
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN--HP 64
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
           N+VKL           LV++++ +  L + +  +            +  +  + +GLA+ 
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
           H      V+HRD+K  N+L++     K++DFGL++ F          V  TL Y APE  
Sbjct: 122 HSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEIL 177
Query: 221 ISGRLTRKS-DVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG 265
           +  +    + D++S G +  E+V+ R     D ++ +   + +  G
Sbjct: 178 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 223

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 107/226 (47%), Gaps = 13/226 (5%)
Query: 44  FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKV--LSVESKQGEKEFMSEVASMANVNVCHE 100
           F+   KIGEG +G VYK R +  G +VA+K   L  E++      + E++ +  +N  H 
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN--HP 62
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
           N+VKL           LV++++ +  L + +  +            +  +  + +GLA+ 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
           H      V+HRD+K  N+L++     K++DFGL++ F          V  TL Y APE  
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEIL 175
Query: 221 ISGRLTRKS-DVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG 265
           +  +    + D++S G +  E+V+ R     D ++ +   + +  G
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 221

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 99/220 (45%), Gaps = 21/220 (9%)
Query: 36  QLKIATNGFRWSNKIGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMAN 94
           Q+K+    F     +G+G FG V+    +      A+K L  +    + +    +     
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 70
Query: 95  VNVCHENLVKLHGGCI--DGPCRILVYDYMPNNSLS---QTLLGEEKRRAKFGWKARREI 149
           +++  E+    H  C          V +Y+    L    Q+    +  RA F      EI
Sbjct: 71  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF---YAAEI 127
Query: 150 IMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT--THISTR 207
           I+G    L ++H +    +V+RD+K  NILLD++ + KI+DFG+ K   EN      +  
Sbjct: 128 ILG----LQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK---ENMLGDAKTNX 177
Query: 208 VAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTA 247
             GT  Y+APE  +  +     D +SFGVLL E++ G++ 
Sbjct: 178 FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 107/226 (47%), Gaps = 13/226 (5%)
Query: 44  FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKV--LSVESKQGEKEFMSEVASMANVNVCHE 100
           F+   KIGEG +G VYK R +  G +VA+K   L  E++      + E++ +  +N  H 
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN--HP 65
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
           N+VKL           LV++++ +  L + +  +            +  +  + +GLA+ 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
           H      V+HRD+K  N+L++     K++DFGL++ F          V  TL Y APE  
Sbjct: 123 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEIL 178
Query: 221 ISGRLTRKS-DVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG 265
           +  +    + D++S G +  E+V+ R     D ++ +   + +  G
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 224

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 107/226 (47%), Gaps = 13/226 (5%)
Query: 44  FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKV--LSVESKQGEKEFMSEVASMANVNVCHE 100
           F+   KIGEG +G VYK R +  G +VA+K   L  E++      + E++ +  +N  H 
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN--HP 64
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
           N+VKL           LV++++ +  L + +  +            +  +  + +GLA+ 
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
           H      V+HRD+K  N+L++     K++DFGL++ F          V  TL Y APE  
Sbjct: 122 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEIL 177
Query: 221 ISGRLTRKS-DVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG 265
           +  +    + D++S G +  E+V+ R     D ++ +   + +  G
Sbjct: 178 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 223

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 107/226 (47%), Gaps = 13/226 (5%)
Query: 44  FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKV--LSVESKQGEKEFMSEVASMANVNVCHE 100
           F+   KIGEG +G VYK R +  G +VA+K   L  E++      + E++ +  +N  H 
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN--HP 61
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
           N+VKL           LV++++ +  L + +  +            +  +  + +GLA+ 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
           H      V+HRD+K  N+L++     K++DFGL++ F          V  TL Y APE  
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEIL 174
Query: 221 ISGRLTRKS-DVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG 265
           +  +    + D++S G +  E+V+ R     D ++ +   + +  G
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 220

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 107/226 (47%), Gaps = 13/226 (5%)
Query: 44  FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKV--LSVESKQGEKEFMSEVASMANVNVCHE 100
           F+   KIGEG +G VYK R +  G +VA+K   L  E++      + E++ +  +N  H 
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN--HP 63
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
           N+VKL           LV++++ +  L + +  +            +  +  + +GLA+ 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
           H      V+HRD+K  N+L++     K++DFGL++ F          V  TL Y APE  
Sbjct: 121 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEIL 176
Query: 221 ISGRLTRKS-DVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG 265
           +  +    + D++S G +  E+V+ R     D ++ +   + +  G
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 222

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 107/226 (47%), Gaps = 13/226 (5%)
Query: 44  FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKV--LSVESKQGEKEFMSEVASMANVNVCHE 100
           F+   KIGEG +G VYK R +  G +VA+K   L  E++      + E++ +  +N  H 
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN--HP 63
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
           N+VKL           LV++++ +  L + +  +            +  +  + +GLA+ 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
           H      V+HRD+K  N+L++     K++DFGL++ F          V  TL Y APE  
Sbjct: 121 HSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEIL 176
Query: 221 ISGRLTRKS-DVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG 265
           +  +    + D++S G +  E+V+ R     D ++ +   + +  G
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 222

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 109/228 (47%), Gaps = 17/228 (7%)
Query: 44  FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKV--LSVESKQGEKEFMSEVASMANVNVCHE 100
           F+   KIGEG +G VYK R +  G +VA+K   L  E++      + E++ +  +N  H 
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN--HP 62
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
           N+VKL           LV++++ +  L + +  +            +  +  + +GL++ 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLSFC 119
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PENTTHISTRVAGTLGYLAPE 218
           H      V+HRD+K  N+L++     K++DFGL++ F  P  T    T    TL Y APE
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT---YTHEVVTLWYRAPE 173
Query: 219 YAISGRLTRKS-DVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG 265
             +  +    + D++S G +  E+V+ R     D ++ +   + +  G
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 221

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 107/226 (47%), Gaps = 13/226 (5%)
Query: 44  FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKV--LSVESKQGEKEFMSEVASMANVNVCHE 100
           F+   KIGEG +G VYK R +  G +VA+K   L  E++      + E++ +  +N  H 
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN--HP 65
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
           N+VKL           LV++++ +  L + +  +            +  +  + +GLA+ 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
           H      V+HRD+K  N+L++     K++DFGL++ F          V  TL Y APE  
Sbjct: 123 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEIL 178
Query: 221 ISGRLTRKS-DVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG 265
           +  +    + D++S G +  E+V+ R     D ++ +   + +  G
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 224

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 107/226 (47%), Gaps = 13/226 (5%)
Query: 44  FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKV--LSVESKQGEKEFMSEVASMANVNVCHE 100
           F+   KIGEG +G VYK R +  G +VA+K   L  E++      + E++ +  +N  H 
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN--HP 63
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
           N+VKL           LV++++ +  L + +  +            +  +  + +GLA+ 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
           H      V+HRD+K  N+L++     K++DFGL++ F          V  TL Y APE  
Sbjct: 121 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEIL 176
Query: 221 ISGRLTRKS-DVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG 265
           +  +    + D++S G +  E+V+ R     D ++ +   + +  G
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 222

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 107/226 (47%), Gaps = 13/226 (5%)
Query: 44  FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKV--LSVESKQGEKEFMSEVASMANVNVCHE 100
           F+   KIGEG +G VYK R +  G +VA+K   L  E++      + E++ +  +N  H 
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN--HP 61
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
           N+VKL           LV++++ +  L + +  +            +  +  + +GLA+ 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
           H      V+HRD+K  N+L++     K++DFGL++ F          V  TL Y APE  
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEIL 174
Query: 221 ISGRLTRKS-DVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG 265
           +  +    + D++S G +  E+V+ R     D ++ +   + +  G
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 220

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 107/226 (47%), Gaps = 13/226 (5%)
Query: 44  FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKV--LSVESKQGEKEFMSEVASMANVNVCHE 100
           F+   KIGEG +G VYK R +  G +VA+K   L  E++      + E++ +  +N  H 
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN--HP 62
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
           N+VKL           LV++++ +  L + +  +            +  +  + +GLA+ 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
           H      V+HRD+K  N+L++     K++DFGL++ F          V  TL Y APE  
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEIL 175
Query: 221 ISGRLTRKS-DVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG 265
           +  +    + D++S G +  E+V+ R     D ++ +   + +  G
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 221

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 107/226 (47%), Gaps = 13/226 (5%)
Query: 44  FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKV--LSVESKQGEKEFMSEVASMANVNVCHE 100
           F+   KIGEG +G VYK R +  G +VA+K   L  E++      + E++ +  +N  H 
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN--HP 62
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
           N+VKL           LV++++ +  L + +  +            +  +  + +GLA+ 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
           H      V+HRD+K  N+L++     K++DFGL++ F          V  TL Y APE  
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEIL 175
Query: 221 ISGRLTRKS-DVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG 265
           +  +    + D++S G +  E+V+ R     D ++ +   + +  G
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 221

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 48  NKIGEGGFGSVYKG---RLQDGTIVAVKVLSVESKQGEKEF-MSEVASMANVNVCHENLV 103
            KIG+G FG V+KG   R Q   +VA+K++ +E  + E E    E+  ++  +  +  + 
Sbjct: 13  EKIGKGSFGEVFKGIDNRTQ--KVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY--VT 68
Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
           K +G  +      ++ +Y+   S    L        +        I+  I +GL Y+H E
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA-----TILREILKGLDYLHSE 123
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG 223
            +   +HRDIK +N+LL ++   K++DFG++    +     +T V GT  ++APE     
Sbjct: 124 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQS 179
Query: 224 RLTRKSDVYSFGVLLLEIVSG 244
               K+D++S G+  +E+  G
Sbjct: 180 AYDSKADIWSLGITAIELARG 200

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 13/210 (6%)
Query: 43  GFRWSN--KIGEGGFGSVYKG--RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC 98
           G R++N   IGEG +G V      L    +   K+   E +   +  + E+  +      
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-- 83
Query: 99  HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
           HEN++ +    I  P    + D      L +T L +  +            +  I RGL 
Sbjct: 84  HENIIGI-NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 142
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS--TRVAGTLGYLA 216
           YIH     +V+HRD+K SN+LL+   + KI DFGL+++   +  H         T  Y A
Sbjct: 143 YIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRA 199
Query: 217 PEYAISGR-LTRKSDVYSFGVLLLEIVSGR 245
           PE  ++ +  T+  D++S G +L E++S R
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 13/210 (6%)
Query: 43  GFRWSN--KIGEGGFGSVYKG--RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC 98
           G R++N   IGEG +G V      L    +   K+   E +   +  + E+  +      
Sbjct: 27  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-- 84
Query: 99  HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
           HEN++ +    I  P    + D      L +T L +  +            +  I RGL 
Sbjct: 85  HENIIGI-NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 143
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS--TRVAGTLGYLA 216
           YIH     +V+HRD+K SN+LL+   + KI DFGL+++   +  H         T  Y A
Sbjct: 144 YIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRA 200
Query: 217 PEYAISGR-LTRKSDVYSFGVLLLEIVSGR 245
           PE  ++ +  T+  D++S G +L E++S R
Sbjct: 201 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 44  FRWSNKIGEGGFGSVYKG---RLQDGTIVAVKVLSVESKQGEKEF-MSEVASMANVNVCH 99
           F    KIG+G FG V+KG   R Q   +VA+K++ +E  + E E    E+  ++  +  +
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQ--KVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 86
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
             + K +G  +      ++ +Y+   S    L        +        I+  I +GL Y
Sbjct: 87  --VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA-----TILREILKGLDY 139
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEY 219
           +H E +   +HRDIK +N+LL ++   K++DFG++    +     +T V GT  ++APE 
Sbjct: 140 LHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEV 195
Query: 220 AISGRLTRKSDVYSFGVLLLEIVSGR 245
                   K+D++S G+  +E+  G 
Sbjct: 196 IKQSAYDSKADIWSLGITAIELARGE 221

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 109/228 (47%), Gaps = 17/228 (7%)
Query: 44  FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKV--LSVESKQGEKEFMSEVASMANVNVCHE 100
           F+   KIGEG +G VYK R +  G +VA+K   L  E++      + E++ +  +N  H 
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN--HP 61
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
           N+VKL           LV++++  +   +T + +            +  +  + +GLA+ 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHVHQDL--KTFM-DASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PENTTHISTRVAGTLGYLAPE 218
           H      V+HRD+K  N+L++     K++DFGL++ F  P  T    T    TL Y APE
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT---YTHEVVTLWYRAPE 172
Query: 219 YAISGRLTRKS-DVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG 265
             +  +    + D++S G +  E+V+ R     D ++ +   + +  G
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 220

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 106/228 (46%), Gaps = 17/228 (7%)
Query: 44  FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKV--LSVESKQGEKEFMSEVASMANVNVCHE 100
           F+   KIGEG +G VYK R +  G +VA+K   L  E++      + E++ +  +N  H 
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN--HP 65
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKAR--REIIMGIGRGLA 158
           N+VKL           LV+++     L Q L       A  G      +  +  + +GLA
Sbjct: 66  NIVKLLDVIHTENKLYLVFEF-----LHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE 218
           + H      V+HRD+K  N+L++     K++DFGL++ F          V  TL Y APE
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 176
Query: 219 YAISGRLTRKS-DVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG 265
             +  +    + D++S G +  E+V+ R     D ++ +   + +  G
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 224

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 97/206 (47%), Gaps = 14/206 (6%)
Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVES--KQGEKEFMS-EVASMANVNVCH 99
           F++   +GEG F +    R L      A+K+L      K+ +  +++ E   M+ ++  H
Sbjct: 32  FKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD--H 89
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
              VKL+    D         Y  N  L + +    ++   F     R     I   L Y
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEY 145
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTHISTRVAGTLGYLAPE 218
           +H +    ++HRD+K  NILL+++ + +I+DFG +K L PE+    +    GT  Y++PE
Sbjct: 146 LHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 202
Query: 219 YAISGRLTRKSDVYSFGVLLLEIVSG 244
                   + SD+++ G ++ ++V+G
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 69/256 (26%), Positives = 109/256 (42%), Gaps = 43/256 (16%)
Query: 3   SIFSCFSFPSRVSAENTIGGEQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGR 62
           S+ S  SFP + S  +    E  +       + QL+I          IG+G FG VY GR
Sbjct: 7   SLLSARSFPRKASQTSIFLQEWDI------PFEQLEIG-------ELIGKGRFGQVYHGR 53
Query: 63  LQDGTIVAVKVLSVESKQGE--KEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 120
                 VA++++ +E    +  K F  EV  MA     HEN+V   G C+  P   ++  
Sbjct: 54  WHGE--VAIRLIDIERDNEDQLKAFKREV--MAYRQTRHENVVLFMGACMSPPHLAIITS 109
Query: 121 YMPNNSLSQTLLGEEKRRAK--FGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNI 178
                +L   +     R AK        R+I   I +G+ Y+H +    ++H+D+K+ N+
Sbjct: 110 LCKGRTLYSVV-----RDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNV 161
Query: 179 LLDQNFNPKISDFGL---SKLFPENTTHISTRVA-GTLGYLAPEYAISGR---------L 225
             D N    I+DFGL   S +          R+  G L +LAPE                
Sbjct: 162 FYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPF 220
Query: 226 TRKSDVYSFGVLLLEI 241
           ++ SDV++ G +  E+
Sbjct: 221 SKHSDVFALGTIWYEL 236

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 21/214 (9%)
Query: 43  GFRWSN--KIGEGGFGSVYKGRLQDGTI-VAVKVLS-VESKQGEKEFMSEVASMANVNVC 98
           G R++N   IGEG +G V         + VA+K +S  E +   +  + E+  +      
Sbjct: 42  GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-- 99
Query: 99  HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARRE----IIMGIG 154
           HEN++      I+   R    + M +  L   L+G +  +         +     +  I 
Sbjct: 100 HENIIG-----INDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQIL 154
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS--TRVAGTL 212
           RGL YIH     +V+HRD+K SN+LL+   + KI DFGL+++   +  H    T    T 
Sbjct: 155 RGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 211
Query: 213 GYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGR 245
            Y APE  ++ +  T+  D++S G +L E++S R
Sbjct: 212 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 106/228 (46%), Gaps = 17/228 (7%)
Query: 44  FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKV--LSVESKQGEKEFMSEVASMANVNVCHE 100
           F+   KIGEG +G VYK R +  G +VA+K   L  E++      + E++ +  +N  H 
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN--HP 62
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKAR--REIIMGIGRGLA 158
           N+VKL           LV+++     L Q L       A  G      +  +  + +GLA
Sbjct: 63  NIVKLLDVIHTENKLYLVFEF-----LHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE 218
           + H      V+HRD+K  N+L++     K++DFGL++ F          V  TL Y APE
Sbjct: 118 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 173
Query: 219 YAISGRLTRKS-DVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG 265
             +  +    + D++S G +  E+V+ R     D ++ +   + +  G
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 221

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 98/198 (49%), Gaps = 14/198 (7%)
Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           KIG+G  G+VY    +  G  VA++ ++++ +  ++  ++E+  M      + N+V    
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK--NPNIVNYLD 85
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
             + G    +V +Y+   SL+  +        +     R  +     + L ++H      
Sbjct: 86  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHSN---Q 137
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGL-SKLFPENTTHISTRVAGTLGYLAPEYAISGRLT 226
           V+HR+IK+ NILL  + + K++DFG  +++ PE +    + + GT  ++APE        
Sbjct: 138 VIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYG 195
Query: 227 RKSDVYSFGVLLLEIVSG 244
            K D++S G++ +E++ G
Sbjct: 196 PKVDIWSLGIMAIEMIEG 213

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 108/228 (47%), Gaps = 17/228 (7%)
Query: 44  FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKV--LSVESKQGEKEFMSEVASMANVNVCHE 100
           F+   KIGEG +G VYK R +  G +VA+    L  E++      + E++ +  +N  H 
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELN--HP 62
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
           N+VKL           LV++++ +  L + +  +            +  +  + +GLA+ 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PENTTHISTRVAGTLGYLAPE 218
           H      V+HRD+K  N+L++     K++DFGL++ F  P  T    T    TL Y APE
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT---YTHEVVTLWYRAPE 173
Query: 219 YAISGRLTRKS-DVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG 265
             +  +    + D++S G +  E+V+ R     D ++ +   + +  G
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 221

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 108/228 (47%), Gaps = 17/228 (7%)
Query: 44  FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKV--LSVESKQGEKEFMSEVASMANVNVCHE 100
           F+   KIGEG +G VYK R +  G +VA+    L  E++      + E++ +  +N  H 
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELN--HP 61
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
           N+VKL           LV++++ +  L + +  +            +  +  + +GLA+ 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PENTTHISTRVAGTLGYLAPE 218
           H      V+HRD+K  N+L++     K++DFGL++ F  P  T    T    TL Y APE
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT---YTHEVVTLWYRAPE 172
Query: 219 YAISGRLTRKS-DVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG 265
             +  +    + D++S G +  E+V+ R     D ++ +   + +  G
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 220

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 31/213 (14%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVL---------SVESKQGEKEFMSEVASMANVNVCH 99
           IG G +  V   RL+    I A+KV+          ++  Q EK    + ++       H
Sbjct: 28  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN-------H 80
Query: 100 ENLVKLHGGCIDGPCRIL-VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
             LV LH  C     R+  V +Y+    L    +   +R+ K   +  R     I   L 
Sbjct: 81  PFLVGLHS-CFQTESRLFFVIEYVNGGDL----MFHMQRQRKLPEEHARFYSAEISLALN 135
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLGYLA 216
           Y+HE     +++RD+K  N+LLD   + K++D+G+ K  L P +TT   +   GT  Y+A
Sbjct: 136 YLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---SXFCGTPNYIA 189
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVD 249
           PE           D ++ GVL+ E+++GR+  D
Sbjct: 190 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 31/213 (14%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVL---------SVESKQGEKEFMSEVASMANVNVCH 99
           IG G +  V   RL+    I A+KV+          ++  Q EK    + ++       H
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN-------H 69
Query: 100 ENLVKLHGGCIDGPCRIL-VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
             LV LH  C     R+  V +Y+    L    +   +R+ K   +  R     I   L 
Sbjct: 70  PFLVGLHS-CFQTESRLFFVIEYVNGGDL----MFHMQRQRKLPEEHARFYSAEISLALN 124
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLGYLA 216
           Y+HE     +++RD+K  N+LLD   + K++D+G+ K  L P +TT   +   GT  Y+A
Sbjct: 125 YLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---SXFCGTPNYIA 178
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVD 249
           PE           D ++ GVL+ E+++GR+  D
Sbjct: 179 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 50  IGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC--HENLVKLH 106
           +GEG F    K    +     AVK++S   K+ E     E+ ++    +C  H N+VKLH
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIIS---KRMEANTQKEITAL---KLCEGHPNIVKLH 72
Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
               D     LV + +    L + +    K++  F       I+  +   ++++H+    
Sbjct: 73  EVFHDQLHTFLVMELLNGGELFERI----KKKKHFSETEASYIMRKLVSAVSHMHD---V 125
Query: 167 HVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG 223
            VVHRD+K  N+L    + N   KI DFG ++L P +   + T    TL Y APE     
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF-TLHYAAPELLNQN 184
Query: 224 RLTRKSDVYSFGVLLLEIVSGR 245
                 D++S GV+L  ++SG+
Sbjct: 185 GYDESCDLWSLGVILYTMLSGQ 206

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 31/213 (14%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVL---------SVESKQGEKEFMSEVASMANVNVCH 99
           IG G +  V   RL+    I A+KV+          ++  Q EK    + ++       H
Sbjct: 13  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN-------H 65
Query: 100 ENLVKLHGGCIDGPCRIL-VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
             LV LH  C     R+  V +Y+    L    +   +R+ K   +  R     I   L 
Sbjct: 66  PFLVGLHS-CFQTESRLFFVIEYVNGGDL----MFHMQRQRKLPEEHARFYSAEISLALN 120
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLGYLA 216
           Y+HE     +++RD+K  N+LLD   + K++D+G+ K  L P +TT   +   GT  Y+A
Sbjct: 121 YLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---SXFCGTPNYIA 174
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVD 249
           PE           D ++ GVL+ E+++GR+  D
Sbjct: 175 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 104/236 (44%), Gaps = 31/236 (13%)
Query: 32  FSYNQLKIATNGFRWSNKIGEGGFGSVYKG------RLQDGTIVAVKVLSVESKQGE-KE 84
           +  ++ +   +  +    +G G FG V +       +      VAVK+L   +   E + 
Sbjct: 17  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 76
Query: 85  FMSEVASMANVNVCHENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEEKRRAKFG 142
            MSE+  + ++   H N+V L G C    GP  ++V ++    +LS  L    KR     
Sbjct: 77  LMSELKILIHIGH-HLNVVNLLGACTKPGGPLMVIV-EFCKFGNLSTYL--RSKRNEFVP 132
Query: 143 WKARREII--------------MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKI 188
           +K   E +                + +G+ ++        +HRD+   NILL +    KI
Sbjct: 133 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKI 189
Query: 189 SDFGLSKLFPENTTHISTRVAG-TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
            DFGL++   ++  ++    A   L ++APE       T +SDV+SFGVLL EI S
Sbjct: 190 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 104/236 (44%), Gaps = 31/236 (13%)
Query: 32  FSYNQLKIATNGFRWSNKIGEGGFGSVYKG------RLQDGTIVAVKVLSVESKQGE-KE 84
           +  ++ +   +  +    +G G FG V +       +      VAVK+L   +   E + 
Sbjct: 54  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 113
Query: 85  FMSEVASMANVNVCHENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEEKRRAKFG 142
            MSE+  + ++   H N+V L G C    GP  ++V ++    +LS  L    KR     
Sbjct: 114 LMSELKILIHIGH-HLNVVNLLGACTKPGGPLMVIV-EFCKFGNLSTYL--RSKRNEFVP 169
Query: 143 WKARREII--------------MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKI 188
           +K   E +                + +G+ ++        +HRD+   NILL +    KI
Sbjct: 170 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKI 226
Query: 189 SDFGLSKLFPENTTHISTRVAG-TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
            DFGL++   ++  ++    A   L ++APE       T +SDV+SFGVLL EI S
Sbjct: 227 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 92/200 (46%), Gaps = 19/200 (9%)
Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           IG G FG V   + ++ G   A+K+L     V+ KQ E   ++E   +  VN     LVK
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPF--LVK 105
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L     D     +V +Y+P   +   L    +R  +F     R     I     Y+H   
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH--- 158
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              +++RD+K  N+L+DQ    K++DFG +K     T  +     GT  YLAPE  +S  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXL----CGTPEYLAPEIILSKG 214
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
             +  D ++ GVL+ E+ +G
Sbjct: 215 YNKAVDWWALGVLIYEMAAG 234

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 107/226 (47%), Gaps = 13/226 (5%)
Query: 44  FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKV--LSVESKQGEKEFMSEVASMANVNVCHE 100
           F+   KIGEG +G VYK R +  G +VA+K   L  E++      + E++ +  +N  H 
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN--HP 65
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
           N+VKL           LV++++ +  L + +  +            +  +  + +GLA+ 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEHV-DQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
           H      V+HRD+K  N+L++     K++DFGL++ F          V  TL Y APE  
Sbjct: 123 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEIL 178
Query: 221 ISGRLTRKS-DVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG 265
           +  +    + D++S G +  E+V+ R     D ++ +   + +  G
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 224

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 110/246 (44%), Gaps = 29/246 (11%)
Query: 23  EQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGT-IVAVKVLS---VES 78
           E+I+K I       L++    +     IG G FG V   R +    + A+K+LS   +  
Sbjct: 61  EKIVKKIRG-----LQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIK 115
Query: 79  KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEE--K 136
           +     F  E   MA  N     +V+L     D     +V +YMP   L   +   +  +
Sbjct: 116 RSDSAFFWEERDIMAFAN--SPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE 173
Query: 137 RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS-K 195
           + AKF      E+++     L  IH      ++HRD+K  N+LLD++ + K++DFG   K
Sbjct: 174 KWAKF---YTAEVVLA----LDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMK 223
Query: 196 LFPENTTHISTRVAGTLGYLAPEYAIS----GRLTRKSDVYSFGVLLLEIVSGRTAVDFD 251
           +      H  T V GT  Y++PE   S    G   R+ D +S GV L E++ G T    D
Sbjct: 224 MDETGMVHCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD 282
Query: 252 VQLGEY 257
             +G Y
Sbjct: 283 SLVGTY 288

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 104/236 (44%), Gaps = 31/236 (13%)
Query: 32  FSYNQLKIATNGFRWSNKIGEGGFGSVYKG------RLQDGTIVAVKVLSVESKQGE-KE 84
           +  ++ +   +  +    +G G FG V +       +      VAVK+L   +   E + 
Sbjct: 19  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 78
Query: 85  FMSEVASMANVNVCHENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEEKRRAKFG 142
            MSE+  + ++   H N+V L G C    GP  ++V ++    +LS  L    KR     
Sbjct: 79  LMSELKILIHIGH-HLNVVNLLGACTKPGGPLMVIV-EFCKFGNLSTYL--RSKRNEFVP 134
Query: 143 WKARREII--------------MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKI 188
           +K   E +                + +G+ ++        +HRD+   NILL +    KI
Sbjct: 135 YKEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKI 191
Query: 189 SDFGLSKLFPENTTHISTRVAG-TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
            DFGL++   ++  ++    A   L ++APE       T +SDV+SFGVLL EI S
Sbjct: 192 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 20/220 (9%)
Query: 39  IATNGFRWSNKIGEGGFGSVYKGRL--QDGTIV--AVKVLSVE--SKQGEKEFMSEVASM 92
           I    F     +G+G FGSV + +L  +DG+ V  AVK+L  +  +    +EF+ E A M
Sbjct: 20  IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACM 79
Query: 93  ANVNVCHENLVKLHGGCIDG------PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKAR 146
              +  H ++ KL G  +        P  +++  +M +  L   LL        F    +
Sbjct: 80  KEFD--HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQ 137
Query: 147 REI--IMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS-KLFPENTTH 203
             +  ++ I  G+ Y+      + +HRD+   N +L ++    ++DFGLS K++  +   
Sbjct: 138 TLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR 194
Query: 204 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
                   + +LA E       T  SDV++FGV + EI++
Sbjct: 195 QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/298 (24%), Positives = 130/298 (43%), Gaps = 28/298 (9%)
Query: 21  GGEQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKG-RLQDGTIVAVKVLSVESK 79
           GG+Q+ +  + F  N     ++ +    ++G+G F  V +      G   A K+++ + K
Sbjct: 9   GGQQMGRG-SEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTK-K 66
Query: 80  QGEKEFMS-EVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRR 138
              ++F   E  +     + H N+V+LH    +     LV+D +    L + ++     R
Sbjct: 67  LSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA----R 122
Query: 139 AKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN---PKISDFGLSK 195
             +        I  I   +AY H      +VHR++K  N+LL         K++DFGL+ 
Sbjct: 123 EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA- 178
Query: 196 LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAV-DFD--- 251
               N +      AGT GYL+PE       ++  D+++ GV+L  ++ G     D D   
Sbjct: 179 -IEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR 237
Query: 252 ----VQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENE--AIRFLKVGLLCVQEK 303
               ++ G Y      W    + E  +L+D ML  N P+    A + LKV  +C +E+
Sbjct: 238 LYAQIKAGAYDYPSPEWDTV-TPEAKSLIDSMLTVN-PKKRITADQALKVPWICNRER 293

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 128/291 (43%), Gaps = 56/291 (19%)
Query: 50  IGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGC 109
           +G+G +G V++G L  G  VAVK+ S    + E+ +  E      V + H+N++      
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFS---SRDEQSWFRETEIYNTVLLRHDNILGFIAS- 70
Query: 110 IDGPCR------ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
            D   R       L+  Y  + SL   L     +R          + +    GLA++H E
Sbjct: 71  -DMTSRNSSTQLWLITHYHEHGSLYDFL-----QRQTLEPHLALRLAVSAACGLAHLHVE 124
Query: 164 I-----QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI----STRVAGTLGY 214
           I     +P + HRD K+ N+L+  N    I+D GL+ +  + + ++    + RV GT  Y
Sbjct: 125 IFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRV-GTKRY 183
Query: 215 LAPEYAISGRLT------RKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYN 268
           +APE       T      + +D+++FG++L EI + RT V+  V+  +Y           
Sbjct: 184 MAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEI-ARRTIVNGIVE--DYR---------- 230
Query: 269 SKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNG 319
                    P  Y   P + +   +K  ++CV +++   P    A  +++G
Sbjct: 231 ---------PPFYDVVPNDPSFEDMK-KVVCVDQQTPTIPNRLAADPVLSG 271

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 103/236 (43%), Gaps = 31/236 (13%)
Query: 32  FSYNQLKIATNGFRWSNKIGEGGFGSVYKG------RLQDGTIVAVKVLSVESKQGE-KE 84
           +  ++ +   +  +    +G G FG V +       +      VAVK+L   +   E + 
Sbjct: 17  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 76
Query: 85  FMSEVASMANVNVCHENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEEKRRAKFG 142
            MSE+  + ++   H N+V L G C    GP  ++V ++    +LS  L    KR     
Sbjct: 77  LMSELKILIHIGH-HLNVVNLLGACTKPGGPLMVIV-EFCKFGNLSTYL--RSKRNEFVP 132
Query: 143 WKARREII--------------MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKI 188
           +K   E +                + +G+ ++        +HRD+   NILL +    KI
Sbjct: 133 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKI 189
Query: 189 SDFGLSKLFPENTTHISTRVAG-TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
            DFGL++   ++   +    A   L ++APE       T +SDV+SFGVLL EI S
Sbjct: 190 CDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 14/213 (6%)
Query: 38  KIATNGFRWSNKIGEGGFGSVYKGR----LQDGTIVAVKVLSVESKQGEKEFMSEVASMA 93
           KI    F     +G+GG+G V++ R       G I A+KVL         +  +   +  
Sbjct: 13  KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAER 72
Query: 94  NV--NVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
           N+   V H  +V L      G    L+ +Y+    L   L    +R   F        + 
Sbjct: 73  NILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL----EREGIFMEDTACFYLA 128
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT 211
            I   L ++H   Q  +++RD+K  NI+L+   + K++DFGL K    + T ++    GT
Sbjct: 129 EISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT-VTHXFCGT 184
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
           + Y+APE  +     R  D +S G L+ ++++G
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 14/213 (6%)
Query: 38  KIATNGFRWSNKIGEGGFGSVYKGR----LQDGTIVAVKVLSVESKQGEKEFMSEVASMA 93
           KI    F     +G+GG+G V++ R       G I A+KVL         +  +   +  
Sbjct: 13  KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAER 72
Query: 94  NV--NVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
           N+   V H  +V L      G    L+ +Y+    L   L    +R   F        + 
Sbjct: 73  NILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL----EREGIFMEDTACFYLA 128
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT 211
            I   L ++H   Q  +++RD+K  NI+L+   + K++DFGL K    + T ++    GT
Sbjct: 129 EISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT-VTHTFCGT 184
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
           + Y+APE  +     R  D +S G L+ ++++G
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 103/236 (43%), Gaps = 31/236 (13%)
Query: 32  FSYNQLKIATNGFRWSNKIGEGGFGSVYKG------RLQDGTIVAVKVLSVESKQGE-KE 84
           +  ++ +   +  +    +G G FG V +       +      VAVK+L   +   E + 
Sbjct: 8   YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 67
Query: 85  FMSEVASMANVNVCHENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEEKRRAKFG 142
            MSE+  + ++   H N+V L G C    GP  ++V ++    +LS  L    KR     
Sbjct: 68  LMSELKILIHIGH-HLNVVNLLGACTKPGGPLMVIV-EFCKFGNLSTYL--RSKRNEFVP 123
Query: 143 WKARREII--------------MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKI 188
           +K   E +                + +G+ ++        +HRD+   NILL +    KI
Sbjct: 124 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKI 180
Query: 189 SDFGLSKLFPENTTHISTRVAG-TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
            DFGL++   ++   +    A   L ++APE       T +SDV+SFGVLL EI S
Sbjct: 181 CDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 97/217 (44%), Gaps = 30/217 (13%)
Query: 50  IGEGGFGSVYKG------RLQDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHENL 102
           +G G FG V +       +      VAVK+L   +   E +  MSE+  + ++   H N+
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH-HLNV 94
Query: 103 VKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII---------- 150
           V L G C    GP  ++V ++    +LS  L    KR     +K   ++           
Sbjct: 95  VNLLGACTKPGGPLMVIV-EFCKFGNLSTYL--RSKRNEFVPYKTPEDLYKDFLTLEHLI 151
Query: 151 ---MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 207
                + +G+ ++        +HRD+   NILL +    KI DFGL++   ++   +   
Sbjct: 152 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 208
Query: 208 VAG-TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
            A   L ++APE       T +SDV+SFGVLL EI S
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 31/213 (14%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVL---------SVESKQGEKEFMSEVASMANVNVCH 99
           IG G +  V   RL+    I A++V+          ++  Q EK    + ++       H
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN-------H 112
Query: 100 ENLVKLHGGCIDGPCRIL-VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
             LV LH  C     R+  V +Y+    L    +   +R+ K   +  R     I   L 
Sbjct: 113 PFLVGLHS-CFQTESRLFFVIEYVNGGDL----MFHMQRQRKLPEEHARFYSAEISLALN 167
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLGYLA 216
           Y+HE     +++RD+K  N+LLD   + K++D+G+ K  L P +TT   +   GT  Y+A
Sbjct: 168 YLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIA 221
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVD 249
           PE           D ++ GVL+ E+++GR+  D
Sbjct: 222 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 103/238 (43%), Gaps = 35/238 (14%)
Query: 32  FSYNQLKIATNGFRWSNKIGEGGFGSVYKG------RLQDGTIVAVKVLSVESKQGE-KE 84
           +  ++ +   +  +    +G G FG V +       +      VAVK+L   +   E + 
Sbjct: 17  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 76
Query: 85  FMSEVASMANVNVCHENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEEKRRAKFG 142
            MSE+  + ++   H N+V L G C    GP  ++V ++    +LS  L    KR     
Sbjct: 77  LMSELKILIHIGH-HLNVVNLLGACTKPGGPLMVIV-EFCKFGNLSTYL--RSKRNEFVP 132
Query: 143 WKARREII--------------MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKI 188
           +K   E +                + +G+ ++        +HRD+   NILL +    KI
Sbjct: 133 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKI 189
Query: 189 SDFGLSKLF---PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
            DFGL++     P+       R+   L ++APE       T +SDV+SFGVLL EI S
Sbjct: 190 CDFGLARDIYKDPDXVRKGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 101/200 (50%), Gaps = 15/200 (7%)
Query: 48  NKIGEGGFGSVYKGRLQDGT--IVAVKVLSVESKQGEKEF-MSEVASMANVNVCHENLVK 104
           ++IG+G FG VYKG + + T  +VA+K++ +E  + E E    E+  ++  +  +  + +
Sbjct: 25  DRIGKGSFGEVYKG-IDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY--ITR 81
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
             G  +      ++ +Y+   S +  LL        +     REI+    +GL Y+H E 
Sbjct: 82  YFGSYLKSTKLWIIMEYLGGGS-ALDLLKPGPLEETYIATILREIL----KGLDYLHSER 136
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
           +   +HRDIK +N+LL +  + K++DFG++     +T        GT  ++APE      
Sbjct: 137 K---IHRDIKAANVLLSEQGDVKLADFGVAGQL-TDTQIKRNXFVGTPFWMAPEVIKQSA 192
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
              K+D++S G+  +E+  G
Sbjct: 193 YDFKADIWSLGITAIELAKG 212

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 97/200 (48%), Gaps = 17/200 (8%)
Query: 49  KIGEGGFGSVYKG---RLQDGTIVAVKVLSVESKQGEKEF-MSEVASMANVNVCHENLVK 104
           KIG+G FG V+KG   R Q   +VA+K++ +E  + E E    E+  ++  +  +  + K
Sbjct: 29  KIGKGSFGEVFKGIDNRTQ--KVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY--VTK 84
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
            +G  +      ++ +Y+   S    L        +        I+  I +GL Y+H E 
Sbjct: 85  YYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA-----TILREILKGLDYLHSEK 139
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
           +   +HRDIK +N+LL ++   K++DFG++     +T        GT  ++APE      
Sbjct: 140 K---IHRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNXFVGTPFWMAPEVIKQSA 195
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
              K+D++S G+  +E+  G
Sbjct: 196 YDSKADIWSLGITAIELARG 215

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 97/201 (48%), Gaps = 17/201 (8%)
Query: 48  NKIGEGGFGSVYKG---RLQDGTIVAVKVLSVESKQGEKEF-MSEVASMANVNVCHENLV 103
            KIG+G FG V+KG   R Q   +VA+K++ +E  + E E    E+  ++  +  +  + 
Sbjct: 13  EKIGKGSFGEVFKGIDNRTQ--KVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY--VT 68
Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
           K +G  +      ++ +Y+   S    L        +        I+  I +GL Y+H E
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA-----TILREILKGLDYLHSE 123
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG 223
            +   +HRDIK +N+LL ++   K++DFG++     +T        GT  ++APE     
Sbjct: 124 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNXFVGTPFWMAPEVIKQS 179
Query: 224 RLTRKSDVYSFGVLLLEIVSG 244
               K+D++S G+  +E+  G
Sbjct: 180 AYDSKADIWSLGITAIELARG 200

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 90/199 (45%), Gaps = 17/199 (8%)
Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEF---MSEVASMANVNVCHENLVKL 105
           +G G FG V   + ++ G   A+K+L  +     KE    ++E   +  VN     LVKL
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPF--LVKL 106
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
                D     +V +Y P   +   L    +R  +F     R     I     Y+H    
Sbjct: 107 EFSFKDNSNLYMVMEYAPGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH---S 159
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL 225
             +++RD+K  N+++DQ    K++DFGL+K     T  +     GT  YLAPE  +S   
Sbjct: 160 LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXL----CGTPEYLAPEIILSKGY 215
Query: 226 TRKSDVYSFGVLLLEIVSG 244
            +  D ++ GVL+ E+ +G
Sbjct: 216 NKAVDWWALGVLIYEMAAG 234

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 25/222 (11%)
Query: 38  KIATNGFRWSNKIGEGGFGSVYKGRLQD-GTIVAVKVL---------SVESKQGEKEFMS 87
           ++  + F +   +G+G FG V   R+++ G + AVKVL          VE    EK  +S
Sbjct: 19  RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILS 78
Query: 88  EVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARR 147
              +       H  L +L   C   P R+       N      L+   ++  +F     R
Sbjct: 79  LARN-------HPFLTQLFC-CFQTPDRLFFVMEFVNGG---DLMFHIQKSRRFDEARAR 127
Query: 148 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 207
                I   L ++H++    +++RD+K  N+LLD   + K++DFG+ K    N    +T 
Sbjct: 128 FYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT- 183
Query: 208 VAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVD 249
             GT  Y+APE           D ++ GVLL E++ G    +
Sbjct: 184 FCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFE 225

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 26/218 (11%)
Query: 49  KIGEGGFGSVYKGRLQDG-TIVAVKVLSVESKQGEKEFMSEVASMANVNVC------HEN 101
           KIGEG +G+V+K + ++   IVA+K + ++           V S A   +C      H+N
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD------EGVPSSALREICLLKELKHKN 62
Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
           +V+LH          LV+++  +  L +     +        +  +  +  + +GL + H
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFC-DQDLKKYF---DSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI 221
                +V+HRD+K  N+L+++N   K++DFGL++ F       S  V  TL Y  P+   
Sbjct: 119 SR---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLF 174
Query: 222 SGRLTRKS-DVYSFGVLLLEIVSGRTAV----DFDVQL 254
             +L   S D++S G +  E+ +    +    D D QL
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQL 212

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 106/224 (47%), Gaps = 43/224 (19%)
Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG 108
           +G+G FG V K R   D    A+K +   +++     +SEV  +A++N  H+ +V+ +  
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVXLLASLN--HQYVVRYYAA 70
Query: 109 CID-------------GPCRILVYDYMPNNSLSQTLLGEE--KRRAKFGWKARREIIMGI 153
            ++                  +  +Y  N +L   +  E   ++R ++ W+  R+I+   
Sbjct: 71  WLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEY-WRLFRQIL--- 126
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--------------LFPE 199
              L+YIH +    ++HR++K  NI +D++ N KI DFGL+K                P 
Sbjct: 127 -EALSYIHSQ---GIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 200 NTTHISTRVAGTLGYLAPEYAI-SGRLTRKSDVYSFGVLLLEIV 242
           ++ ++++ + GT  Y+A E    +G    K D YS G++  E +
Sbjct: 183 SSDNLTSAI-GTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 50  IGEGGFGSVYKG------RLQDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHENL 102
           +G G FG V +       +      VAVK+L   +   E +  MSE+  + ++   H N+
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGH-HLNV 93
Query: 103 VKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
           V L G C    GP  ++V ++    +LS  L    KR     +K   +  + +   + Y 
Sbjct: 94  VNLLGACTKPGGPLMVIV-EFCKFGNLSTYL--RSKRNEFVPYKDLYKDFLTLEHLICYS 150
Query: 161 HEEIQ-------PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG-TL 212
            +  +          +HRD+   NILL +    KI DFGL++   ++  ++    A   L
Sbjct: 151 FQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 210
Query: 213 GYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
            ++APE       T +SDV+SFGVLL EI S
Sbjct: 211 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 104/236 (44%), Gaps = 31/236 (13%)
Query: 32  FSYNQLKIATNGFRWSNKIGEGGFGSVYKG------RLQDGTIVAVKVLSVESKQGE-KE 84
           +  ++ +   +  +    +G G FG V +       +      VAVK+L   +   E + 
Sbjct: 8   YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 67
Query: 85  FMSEVASMANVNVCHENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEEKRRAKFG 142
            MSE+  + ++   H N+V L G C    GP  +++ ++    +LS  L    KR     
Sbjct: 68  LMSELKILIHIGH-HLNVVNLLGACTKPGGPL-MVITEFCKFGNLSTYL--RSKRNEFVP 123
Query: 143 WKARREII--------------MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKI 188
           +K   E +                + +G+ ++        +HRD+   NILL +    KI
Sbjct: 124 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKI 180
Query: 189 SDFGLSKLFPENTTHISTRVAG-TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
            DFGL++   ++  ++    A   L ++APE       T +SDV+SFGVLL EI S
Sbjct: 181 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 104/236 (44%), Gaps = 31/236 (13%)
Query: 32  FSYNQLKIATNGFRWSNKIGEGGFGSVYKG------RLQDGTIVAVKVLSVESKQGE-KE 84
           +  ++ +   +  +    +G G FG V +       +      VAVK+L   +   E + 
Sbjct: 8   YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 67
Query: 85  FMSEVASMANVNVCHENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEEKRRAKFG 142
            MSE+  + ++   H N+V L G C    GP  +++ ++    +LS  L    KR     
Sbjct: 68  LMSELKILIHIGH-HLNVVNLLGACTKPGGPL-MVITEFCKFGNLSTYL--RSKRNEFVP 123
Query: 143 WKARREII--------------MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKI 188
           +K   E +                + +G+ ++        +HRD+   NILL +    KI
Sbjct: 124 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKI 180
Query: 189 SDFGLSKLFPENTTHISTRVAG-TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
            DFGL++   ++  ++    A   L ++APE       T +SDV+SFGVLL EI S
Sbjct: 181 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 27/214 (12%)
Query: 50  IGEGGFGSVYKG------RLQDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHENL 102
           +G G FG V +       +      VAVK+L   +   E +  MSE+  + ++   H N+
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIG-HHLNV 93
Query: 103 VKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG-------- 152
           V L G C    GP  ++V ++    +LS  L    KR     +K   +  +         
Sbjct: 94  VNLLGACTKPGGPLMVIV-EFCKFGNLSTYL--RSKRNEFVPYKDLYKDFLTLEHLIXYS 150
Query: 153 --IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG 210
             + +G+ ++        +HRD+   NILL +    KI DFGL++   ++  ++    A 
Sbjct: 151 FQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDAR 207
Query: 211 -TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
             L ++APE       T +SDV+SFGVLL EI S
Sbjct: 208 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 49  KIGEGGFGSVYK-GRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           ++G G FG V++      G   A K +    +  ++    E+ +M+ +   H  LV LH 
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR--HPTLVNLHD 221
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
              D    +++Y++M    L + +  E  + ++       E +  + +GL ++HE    +
Sbjct: 222 AFEDDNEMVMIYEFMSGGELFEKVADEHNKMSE---DEAVEYMRQVCKGLCHMHEN---N 275
Query: 168 VVHRDIKTSNILL--DQNFNPKISDFGLS-KLFPENTTHISTRVAGTLGYLAPEYAISGR 224
            VH D+K  NI+    ++   K+ DFGL+  L P+ +  ++T   GT  + APE A    
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGKP 332
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
           +   +D++S GVL   ++SG
Sbjct: 333 VGYYTDMWSVGVLSYILLSG 352

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 94/203 (46%), Gaps = 12/203 (5%)
Query: 50  IGEGGFGSVYKGRLQDGT-IVAVKVL--SVESKQGEKEFMSEVASMANVNVCHENLVKLH 106
           +G+GGF   ++    D   + A K++  S+  K  ++E MS   S+   ++ H+++V  H
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR-SLAHQHVVGFH 83
Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
           G   D     +V +     SL    L   KRR        R  +  I  G  Y+H     
Sbjct: 84  GFFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARYYLRQIVLGCQYLHRN--- 136
Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLT 226
            V+HRD+K  N+ L+++   KI DFGL+     +     T + GT  Y+APE       +
Sbjct: 137 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGHS 195
Query: 227 RKSDVYSFGVLLLEIVSGRTAVD 249
            + DV+S G ++  ++ G+   +
Sbjct: 196 FEVDVWSIGCIMYTLLVGKPPFE 218

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 94/213 (44%), Gaps = 16/213 (7%)
Query: 38  KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVA-SMANV 95
           K+  N F +   +G+G FG V   R +  G   A+K+L  E    + E    V  S    
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 96  NVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEE---KRRAKFGWKARREIIMG 152
           N  H  L  L            V +Y     L   L  E    + RA+F + A  EI+  
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGA--EIV-- 115
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL 212
               L Y+H      VV+RDIK  N++LD++ + KI+DFGL K    +   + T   GT 
Sbjct: 116 --SALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTP 169
Query: 213 GYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
            YLAPE        R  D +  GV++ E++ GR
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 94/203 (46%), Gaps = 12/203 (5%)
Query: 50  IGEGGFGSVYKGRLQDGT-IVAVKVL--SVESKQGEKEFMSEVASMANVNVCHENLVKLH 106
           +G+GGF   ++    D   + A K++  S+  K  ++E MS   S+   ++ H+++V  H
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR-SLAHQHVVGFH 87
Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
           G   D     +V +     SL    L   KRR        R  +  I  G  Y+H     
Sbjct: 88  GFFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARYYLRQIVLGCQYLHRN--- 140
Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLT 226
            V+HRD+K  N+ L+++   KI DFGL+     +     T + GT  Y+APE       +
Sbjct: 141 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGHS 199
Query: 227 RKSDVYSFGVLLLEIVSGRTAVD 249
            + DV+S G ++  ++ G+   +
Sbjct: 200 FEVDVWSIGCIMYTLLVGKPPFE 222

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 92/200 (46%), Gaps = 19/200 (9%)
Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V   + ++ G   A+K+L     V+ KQ E   ++E   +  VN     LVK
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPF--LVK 106
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L     D     +V +Y+P   +   L    +R  +F     R     I     Y+H   
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH--- 159
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              +++RD+K  N+L+DQ    +++DFG +K     T  +     GT  YLAPE  +S  
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSKG 215
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
             +  D ++ GVL+ E+ +G
Sbjct: 216 YNKAVDWWALGVLIYEMAAG 235

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 49  KIGEGGFGSVYK-GRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           ++G G FG V++      G   A K +    +  ++    E+ +M+ +   H  LV LH 
Sbjct: 58  ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR--HPTLVNLHD 115
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
              D    +++Y++M    L + +  E  + ++       E +  + +GL ++HE    +
Sbjct: 116 AFEDDNEMVMIYEFMSGGELFEKVADEHNKMSE---DEAVEYMRQVCKGLCHMHEN---N 169
Query: 168 VVHRDIKTSNILL--DQNFNPKISDFGLS-KLFPENTTHISTRVAGTLGYLAPEYAISGR 224
            VH D+K  NI+    ++   K+ DFGL+  L P+ +  ++T   GT  + APE A    
Sbjct: 170 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGKP 226
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
           +   +D++S GVL   ++SG
Sbjct: 227 VGYYTDMWSVGVLSYILLSG 246

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 94/203 (46%), Gaps = 12/203 (5%)
Query: 50  IGEGGFGSVYKGRLQDGT-IVAVKVL--SVESKQGEKEFMSEVASMANVNVCHENLVKLH 106
           +G+GGF   ++    D   + A K++  S+  K  ++E MS   S+   ++ H+++V  H
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR-SLAHQHVVGFH 83
Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
           G   D     +V +     SL    L   KRR        R  +  I  G  Y+H     
Sbjct: 84  GFFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARYYLRQIVLGCQYLHRN--- 136
Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLT 226
            V+HRD+K  N+ L+++   KI DFGL+     +     T + GT  Y+APE       +
Sbjct: 137 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGHS 195
Query: 227 RKSDVYSFGVLLLEIVSGRTAVD 249
            + DV+S G ++  ++ G+   +
Sbjct: 196 FEVDVWSIGCIMYTLLVGKPPFE 218

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 19/205 (9%)
Query: 50  IGEGGFGSVYKGRLQ-DGTIVAVKVLS-VESKQGEKEFMSEVASMANVNVCHENLVK--- 104
           IGEG +G V         T VA+K +S  E +   +  + E+  +      HEN++    
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFR--HENVIGIRD 108
Query: 105 -LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
            L    ++    + +   +    L + L  ++       +      +  I RGL YIH  
Sbjct: 109 ILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICY-----FLYQILRGLKYIHSA 163
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PE-NTTHISTRVAGTLGYLAPEYAI 221
              +V+HRD+K SN+L++   + KI DFGL+++  PE + T   T    T  Y APE  +
Sbjct: 164 ---NVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIML 220
Query: 222 SGR-LTRKSDVYSFGVLLLEIVSGR 245
           + +  T+  D++S G +L E++S R
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 94/213 (44%), Gaps = 16/213 (7%)
Query: 38  KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVA-SMANV 95
           K+  N F +   +G+G FG V   R +  G   A+K+L  E    + E    V  S    
Sbjct: 4   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 63
Query: 96  NVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEE---KRRAKFGWKARREIIMG 152
           N  H  L  L            V +Y     L   L  E    + RA+F + A  EI+  
Sbjct: 64  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGA--EIV-- 118
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL 212
               L Y+H      VV+RDIK  N++LD++ + KI+DFGL K    +   + T   GT 
Sbjct: 119 --SALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTP 172
Query: 213 GYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
            YLAPE        R  D +  GV++ E++ GR
Sbjct: 173 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 94/213 (44%), Gaps = 16/213 (7%)
Query: 38  KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVA-SMANV 95
           K+  N F +   +G+G FG V   R +  G   A+K+L  E    + E    V  S    
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 96  NVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEE---KRRAKFGWKARREIIMG 152
           N  H  L  L            V +Y     L   L  E    + RA+F + A  EI+  
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGA--EIV-- 115
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL 212
               L Y+H      VV+RDIK  N++LD++ + KI+DFGL K    +   + T   GT 
Sbjct: 116 --SALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTP 169
Query: 213 GYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
            YLAPE        R  D +  GV++ E++ GR
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 92/200 (46%), Gaps = 19/200 (9%)
Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V   + ++ G   A+K+L     V+ KQ E   ++E   +  VN     LVK
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPF--LVK 105
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L     D     +V +Y+P   +   L    +R  +F     R     I     Y+H   
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH--- 158
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              +++RD+K  N+L+DQ    +++DFG +K     T  +     GT  YLAPE  +S  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSKG 214
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
             +  D ++ GVL+ E+ +G
Sbjct: 215 YNKAVDWWALGVLIYEMAAG 234

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 92/200 (46%), Gaps = 19/200 (9%)
Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V   + ++ G   A+K+L     V+ KQ E   ++E   +  VN     LVK
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPF--LVK 105
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L     D     +V +Y+P   +   L    +R  +F     R     I     Y+H   
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH--- 158
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              +++RD+K  N+L+DQ    +++DFG +K     T  +     GT  YLAPE  +S  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSKG 214
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
             +  D ++ GVL+ E+ +G
Sbjct: 215 YNKAVDWWALGVLIYEMAAG 234

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 92/200 (46%), Gaps = 19/200 (9%)
Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V   + ++ G   A+K+L     V+ KQ E   ++E   +  VN     LVK
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPF--LVK 105
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L     D     +V +Y+P   +   L    +R  +F     R     I     Y+H   
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH--- 158
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              +++RD+K  N+L+DQ    +++DFG +K     T  +     GT  YLAPE  +S  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSKG 214
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
             +  D ++ GVL+ E+ +G
Sbjct: 215 YNKAVDWWALGVLIYEMAAG 234

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 92/200 (46%), Gaps = 19/200 (9%)
Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V   + ++ G   A+K+L     V+ KQ E   ++E   +  VN     LVK
Sbjct: 35  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPF--LVK 91
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L     D     +V +Y+P   +   L    +R  +F     R     I     Y+H   
Sbjct: 92  LEFSFKDNSNLYMVMEYVPGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH--- 144
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              +++RD+K  N+L+DQ    +++DFG +K     T      + GT  YLAPE  +S  
Sbjct: 145 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT----WTLCGTPEYLAPEIILSKG 200
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
             +  D ++ GVL+ E+ +G
Sbjct: 201 YNKAVDWWALGVLIYEMAAG 220

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 118/254 (46%), Gaps = 49/254 (19%)
Query: 19  TIGGEQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQD-GTIVAVKVLSVE 77
           TIGG++    IN                  ++G G  G V+K R +  G ++AVK +   
Sbjct: 14  TIGGQRYQAEINDLEN------------LGEMGSGTCGQVWKMRFRKTGHVIAVKQMR-- 59
Query: 78  SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNS---LSQTLLG- 133
            + G KE    +  + +++V    ++K H    D P  +  +     N+   ++  L+G 
Sbjct: 60  -RSGNKEENKRI--LMDLDV----VLKSH----DCPYIVQCFGTFITNTDVFIAMELMGT 108
Query: 134 --EEKRRAKFGWKARR---EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKI 188
             E+ ++   G    R   ++ + I + L Y+ E  +  V+HRD+K SNILLD+    K+
Sbjct: 109 CAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKL 166
Query: 189 SDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR-----KSDVYSFGVLLLEIVS 243
            DFG+S    ++      R AG   Y+APE       T+     ++DV+S G+ L+E+ +
Sbjct: 167 CDFGISGRLVDDKA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELAT 224
Query: 244 GR-----TAVDFDV 252
           G+        DF+V
Sbjct: 225 GQFPYKNCKTDFEV 238

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 91/200 (45%), Gaps = 19/200 (9%)
Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V   + ++ G   A+K+L     V+ KQ E   ++E   +  VN     LVK
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPF--LVK 105
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L     D     +V +Y P   +   L    +R  +F     R     I     Y+H   
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH--- 158
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              +++RD+K  N+++DQ    K++DFG +K     T  +     GT  YLAPE  +S  
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSKG 214
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
             +  D ++ GVL+ E+ +G
Sbjct: 215 YNKAVDWWALGVLIYEMAAG 234

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 92/200 (46%), Gaps = 19/200 (9%)
Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V   + ++ G   A+K+L     V+ KQ E   ++E   +  VN     LVK
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPF--LVK 106
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L     D     +V +Y+P   +   L    +R  +F     R     I     Y+H   
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH--- 159
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              +++RD+K  N+L+DQ    +++DFG +K     T      + GT  YLAPE  +S  
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT----WTLCGTPEYLAPEIILSKG 215
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
             +  D ++ GVL+ E+ +G
Sbjct: 216 YNKAVDWWALGVLIYEMAAG 235

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 120/246 (48%), Gaps = 20/246 (8%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLSV----ESKQG-EKEFMSEVASMANVNVCHENLV 103
           +GEG F +VYK R ++   IVA+K + +    E+K G  +  + E+  +  ++  H N++
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS--HPNII 75
Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
            L           LV+D+M  +     ++ ++          +  ++M + +GL Y+H  
Sbjct: 76  GLLDAFGHKSNISLVFDFMETD---LEVIIKDNSLVLTPSHIKAYMLMTL-QGLEYLH-- 129
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG 223
            Q  ++HRD+K +N+LLD+N   K++DFGL+K F         +V  T  Y APE     
Sbjct: 130 -QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV-TRWYRAPELLFGA 187
Query: 224 RLTRKS-DVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKE---LMNLVDPM 279
           R+     D+++ G +L E++     +  D  L +   + +  G    ++   + +L D +
Sbjct: 188 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 247
Query: 280 LYGNFP 285
            + +FP
Sbjct: 248 TFKSFP 253

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 88/200 (44%), Gaps = 18/200 (9%)
Query: 50  IGEGGFGSVY--KGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           +G G F  V+  K RL  G + A+K +       +    +E+A +  +   HEN+V L  
Sbjct: 17  LGSGAFSEVFLVKQRLT-GKLFALKCIKKSPAFRDSSLENEIAVLKKIK--HENIVTLED 73
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
                    LV   +    L   +L     R  +  K    +I  +   + Y+HE     
Sbjct: 74  IYESTTHYYLVMQLVSGGELFDRIL----ERGVYTEKDASLVIQQVLSAVKYLHEN---G 126
Query: 168 VVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
           +VHRD+K  N+L    ++N    I+DFGLSK+       I +   GT GY+APE      
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKM---EQNGIMSTACGTPGYVAPEVLAQKP 183
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
            ++  D +S GV+   ++ G
Sbjct: 184 YSKAVDCWSIGVITYILLCG 203

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 103/236 (43%), Gaps = 31/236 (13%)
Query: 32  FSYNQLKIATNGFRWSNKIGEGGFGSVYKG------RLQDGTIVAVKVLSVESKQGE-KE 84
           +  ++ +   +  +    +G G FG V +       +      VAVK+L   +   E + 
Sbjct: 8   YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 67
Query: 85  FMSEVASMANVNVCHENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEEKRRAKFG 142
            MSE+  + ++   H N+V L G C    GP  +++ ++    +LS  L    KR     
Sbjct: 68  LMSELKILIHIGH-HLNVVNLLGACTKPGGPL-MVITEFCKFGNLSTYL--RSKRNEFVP 123
Query: 143 WKARREII--------------MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKI 188
           +K   E +                + +G+ ++        +HRD+   NILL +    KI
Sbjct: 124 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKI 180
Query: 189 SDFGLSKLFPENTTHISTRVAG-TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
            DFGL++   ++   +    A   L ++APE       T +SDV+SFGVLL EI S
Sbjct: 181 CDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 92/200 (46%), Gaps = 19/200 (9%)
Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V   + ++ G   A+K+L     V+ KQ E   ++E   +  VN     LVK
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPF--LVK 106
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L     D     +V +Y+P   +   L    +R  +F     R     I     Y+H   
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHL----RRIGRFXEPHARFYAAQIVLTFEYLH--- 159
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              +++RD+K  N+L+DQ    +++DFG +K     T  +     GT  YLAPE  +S  
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSKG 215
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
             +  D ++ GVL+ E+ +G
Sbjct: 216 YNKAVDWWALGVLIYEMAAG 235

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 90/199 (45%), Gaps = 17/199 (8%)
Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEF---MSEVASMANVNVCHENLVKL 105
           +G G FG V   + ++ G   A+K+L  +     KE    ++E   +  VN     LVKL
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPF--LVKL 106
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
                D     +V +Y P   +   L    +R  +F     R     I     Y+H    
Sbjct: 107 EFSFKDNSNLYMVMEYAPGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH---S 159
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL 225
             +++RD+K  N+++DQ    +++DFGL+K     T  +     GT  YLAPE  +S   
Sbjct: 160 LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXL----CGTPEYLAPEIILSKGY 215
Query: 226 TRKSDVYSFGVLLLEIVSG 244
            +  D ++ GVL+ E+ +G
Sbjct: 216 NKAVDWWALGVLIYEMAAG 234

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 76
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     + AK      + +I  I
Sbjct: 77  ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQI 130
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI DFGL++    +T    T    T  
Sbjct: 131 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 183
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 217

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 92/200 (46%), Gaps = 19/200 (9%)
Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V   + ++ G   A+K+L     V+ KQ E   ++E   +  VN     LVK
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPF--LVK 105
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L     D     +V +Y+P   +   L    +R  +F     R     I     Y+H   
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHL----RRIGRFXEPHARFYAAQIVLTFEYLH--- 158
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              +++RD+K  N+L+DQ    +++DFG +K     T  +     GT  YLAPE  +S  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSKG 214
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
             +  D ++ GVL+ E+ +G
Sbjct: 215 YNKAVDWWALGVLIYEMAAG 234

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 109/229 (47%), Gaps = 48/229 (20%)
Query: 49  KIGEGGFGSVYKG-RLQDGTIVAVKVL------SVESKQGEKEFM--SEVASMANVNVCH 99
           K+G+G +G V+K    + G +VAVK +      S ++++  +E M  +E++        H
Sbjct: 16  KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG-------H 68
Query: 100 ENLVKLHGGCIDGPCR--ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
           EN+V L         R   LV+DYM      +T L    R        ++ ++  + + +
Sbjct: 69  ENIVNLLNVLRADNDRDVYLVFDYM------ETDLHAVIRANILEPVHKQYVVYQLIKVI 122
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--------------PENTTH 203
            Y+H      ++HRD+K SNILL+   + K++DFGLS+ F               ENT +
Sbjct: 123 KYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179
Query: 204 ------ISTRVAGTLGYLAPEYAI-SGRLTRKSDVYSFGVLLLEIVSGR 245
                 I T    T  Y APE  + S + T+  D++S G +L EI+ G+
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 92/200 (46%), Gaps = 19/200 (9%)
Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V   + ++ G   A+K+L     V+ KQ E   ++E   +  VN     LVK
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPF--LVK 105
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L     D     +V +Y+P   +   L    +R  +F     R     I     Y+H   
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHL----RRIGRFXEPHARFYAAQIVLTFEYLH--- 158
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              +++RD+K  N+L+DQ    +++DFG +K     T  +     GT  YLAPE  +S  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSKG 214
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
             +  D ++ GVL+ E+ +G
Sbjct: 215 YNKAVDWWALGVLIYEMAAG 234

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 21/212 (9%)
Query: 41  TNGFRWSNKIGEGGFGSVY--KGRLQDGTIVAVKVL---SVESKQGEKEFMSEVASMANV 95
           ++ ++   K+G G +G V   K +L  G   A+K++   SV +       + EVA +  +
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 61
Query: 96  NVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR 155
           +  H N++KL+    D     LV +      L   ++     R KF       I+  +  
Sbjct: 62  D--HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEII----LRQKFSEVDAAVIMKQVLS 115
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNP---KISDFGLSKLFPENTTHISTRVAGTL 212
           G  Y+H+    ++VHRD+K  N+LL+        KI DFGLS  F E    +  R+ GT 
Sbjct: 116 GTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF-EVGGKMKERL-GTA 170
Query: 213 GYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
            Y+APE  +  +   K DV+S GV+L  ++ G
Sbjct: 171 YYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 201

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 91/200 (45%), Gaps = 19/200 (9%)
Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V   + ++ G   A+K+L     V+ KQ E   ++E   +  VN     LVK
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPF--LVK 105
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L     D     +V +Y P   +   L    +R  +F     R     I     Y+H   
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHL----RRIGRFXEPHARFYAAQIVLTFEYLH--- 158
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              +++RD+K  N+++DQ    K++DFG +K     T  +     GT  YLAPE  +S  
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSKG 214
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
             +  D ++ GVL+ E+ +G
Sbjct: 215 YNKAVDWWALGVLIYEMAAG 234

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 21/212 (9%)
Query: 41  TNGFRWSNKIGEGGFGSVY--KGRLQDGTIVAVKVL---SVESKQGEKEFMSEVASMANV 95
           ++ ++   K+G G +G V   K +L  G   A+K++   SV +       + EVA +  +
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 78
Query: 96  NVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR 155
           +  H N++KL+    D     LV +      L   ++     R KF       I+  +  
Sbjct: 79  D--HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEII----LRQKFSEVDAAVIMKQVLS 132
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNP---KISDFGLSKLFPENTTHISTRVAGTL 212
           G  Y+H+    ++VHRD+K  N+LL+        KI DFGLS  F E    +  R+ GT 
Sbjct: 133 GTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF-EVGGKMKERL-GTA 187
Query: 213 GYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
            Y+APE  +  +   K DV+S GV+L  ++ G
Sbjct: 188 YYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 218

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 103/234 (44%), Gaps = 29/234 (12%)
Query: 32  FSYNQLKIATNGFRWSNKIGEGGFGSVYKG------RLQDGTIVAVKVLSVESKQGE-KE 84
           +  ++ +   +  +    +G G FG V +       +      VAVK+L   +   E + 
Sbjct: 19  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRA 78
Query: 85  FMSEVASMANVNVCHENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEEKRRAKFG 142
            MSE+  + ++   H N+V L G C    GP  ++V ++    +LS  L    KR     
Sbjct: 79  LMSELKILIHIG-HHLNVVNLLGACTKPGGPLMVIV-EFCKFGNLSTYL--RSKRNEFVP 134
Query: 143 WKAR---------REII---MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD 190
           +K             +I     + +G+ ++        +HRD+   NILL +    KI D
Sbjct: 135 YKPEDLYKDFLTLEHLIXYSFQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICD 191
Query: 191 FGLSKLFPENTTHISTRVAG-TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
           FGL++   ++   +    A   L ++APE       T +SDV+SFGVLL EI S
Sbjct: 192 FGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 12/203 (5%)
Query: 50  IGEGGFGSVYKGRLQDGT-IVAVKVL--SVESKQGEKEFMSEVASMANVNVCHENLVKLH 106
           +G+GGF   ++    D   + A K++  S+  K  ++E MS   S+   ++ H+++V  H
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR-SLAHQHVVGFH 81
Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
           G   D     +V +     SL    L   KRR        R  +  I  G  Y+H     
Sbjct: 82  GFFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARYYLRQIVLGCQYLHRN--- 134
Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLT 226
            V+HRD+K  N+ L+++   KI DFGL+    E        + GT  Y+APE       +
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDGERKKVLCGTPNYIAPEVLSKKGHS 193
Query: 227 RKSDVYSFGVLLLEIVSGRTAVD 249
            + DV+S G ++  ++ G+   +
Sbjct: 194 FEVDVWSIGCIMYTLLVGKPPFE 216

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 106/227 (46%), Gaps = 20/227 (8%)
Query: 25  ILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVY---KGRLQDGTIVAVKVLSVESKQG 81
           +L  +    + Q +   + + + + +G G F  V      R Q   +VA+K ++ E+ +G
Sbjct: 1   MLGAVEGPRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQ--KLVAIKCIAKEALEG 58
Query: 82  EKEFM-SEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAK 140
           ++  M +E+A +  +   H N+V L      G    L+   +    L   ++     +  
Sbjct: 59  KEGSMENEIAVLHKIK--HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV----EKGF 112
Query: 141 FGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL---LDQNFNPKISDFGLSKLF 197
           +  +    +I  +   + Y+H+     +VHRD+K  N+L   LD++    ISDFGLSK+ 
Sbjct: 113 YTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM- 168
Query: 198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
            E+   + +   GT GY+APE       ++  D +S GV+   ++ G
Sbjct: 169 -EDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 12/203 (5%)
Query: 50  IGEGGFGSVYKGRLQDGT-IVAVKVL--SVESKQGEKEFMSEVASMANVNVCHENLVKLH 106
           +G+GGF   ++    D   + A K++  S+  K  ++E MS   S+   ++ H+++V  H
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR-SLAHQHVVGFH 105
Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
           G   D     +V +     SL    L   KRR        R  +  I  G  Y+H     
Sbjct: 106 GFFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARYYLRQIVLGCQYLHRN--- 158
Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLT 226
            V+HRD+K  N+ L+++   KI DFGL+    E        + GT  Y+APE       +
Sbjct: 159 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDGERKKVLCGTPNYIAPEVLSKKGHS 217
Query: 227 RKSDVYSFGVLLLEIVSGRTAVD 249
            + DV+S G ++  ++ G+   +
Sbjct: 218 FEVDVWSIGCIMYTLLVGKPPFE 240

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 92/200 (46%), Gaps = 19/200 (9%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V   + ++ G   A+K+L     V+ KQ E   ++E   +  VN     LVK
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPF--LVK 105
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L     D     +V +Y+P   +   L    +R  +F     R     I     Y+H   
Sbjct: 106 LEYSFKDNSNLYMVMEYVPGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH--- 158
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              +++RD+K  N+L+DQ    +++DFG +K     T  +     GT  YLAPE  +S  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSKG 214
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
             +  D ++ GVL+ E+ +G
Sbjct: 215 YNKAVDWWALGVLIYEMAAG 234

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 89/212 (41%), Gaps = 14/212 (6%)
Query: 38  KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVA-SMANV 95
           K+  N F +   +G+G FG V   R +  G   A+K+L  E    + E    V  S    
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 96  NVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR 155
           N  H  L  L            V +Y     L   L     R   F  +  R     I  
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVS 116
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIST--RVAGTLG 213
            L Y+H      VV+RDIK  N++LD++ + KI+DFGL K   E  +  +T     GT  
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCGTPE 170
Query: 214 YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
           YLAPE        R  D +  GV++ E++ GR
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 92/200 (46%), Gaps = 19/200 (9%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V   + ++ G   A+K+L     V+ KQ E   ++E   +  VN     LVK
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPF--LVK 105
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L     D     +V +Y+P   +   L    +R  +F     R     I     Y+H   
Sbjct: 106 LEYSFKDNSNLYMVMEYVPGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH--- 158
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              +++RD+K  N+L+DQ    +++DFG +K     T  +     GT  YLAPE  +S  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSKG 214
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
             +  D ++ GVL+ E+ +G
Sbjct: 215 YNKAVDWWALGVLIYEMAAG 234

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 69/278 (24%), Positives = 121/278 (43%), Gaps = 27/278 (9%)
Query: 41  TNGFRWSNKIGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGEKEFMS-EVASMANVNVC 98
           ++ +    ++G+G F  V +      G   A K+++ + K   ++F   E  +     + 
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTK-KLSARDFQKLEREARICRKLQ 63
Query: 99  HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
           H N+V+LH    +     LV+D +    L + ++     R  +        I  I   +A
Sbjct: 64  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIA 119
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFN---PKISDFGLSKLFPENTTHISTRVAGTLGYL 215
           Y H      +VHR++K  N+LL         K++DFGL+     N +      AGT GYL
Sbjct: 120 YCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYL 174
Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVSGRTAV-DFD-------VQLGEYHLVDKAWGMY 267
           +PE       ++  D+++ GV+L  ++ G     D D       ++ G Y      W   
Sbjct: 175 SPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTV 234
Query: 268 NSKELMNLVDPMLYGNFPENE--AIRFLKVGLLCVQEK 303
            + E  +L+D ML  N P+    A + LKV  +C +E+
Sbjct: 235 -TPEAKSLIDSMLTVN-PKKRITADQALKVPWICNRER 270

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 12/203 (5%)
Query: 50  IGEGGFGSVYKGRLQDGT-IVAVKVL--SVESKQGEKEFMSEVASMANVNVCHENLVKLH 106
           +G+GGF   ++    D   + A K++  S+  K  ++E MS   S+   ++ H+++V  H
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR-SLAHQHVVGFH 107
Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
           G   D     +V +        ++LL   KRR        R  +  I  G  Y+H     
Sbjct: 108 GFFEDNDFVFVVLEL----CRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN--- 160
Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLT 226
            V+HRD+K  N+ L+++   KI DFGL+    E        + GT  Y+APE       +
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDGERKKVLCGTPNYIAPEVLSKKGHS 219
Query: 227 RKSDVYSFGVLLLEIVSGRTAVD 249
            + DV+S G ++  ++ G+   +
Sbjct: 220 FEVDVWSIGCIMYTLLVGKPPFE 242

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 93/215 (43%), Gaps = 20/215 (9%)
Query: 38  KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVA-SMANV 95
           K+  N F +   +G+G FG V   R +  G   A+K+L  E    + E    V  S    
Sbjct: 6   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 65
Query: 96  NVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEE---KRRAKFGWKARREIIMG 152
           N  H  L  L            V +Y     L   L  E    + RA+F      EI+  
Sbjct: 66  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF---YGAEIV-- 120
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIST--RVAG 210
               L Y+H      VV+RDIK  N++LD++ + KI+DFGL K   E  +  +T     G
Sbjct: 121 --SALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCG 172
Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
           T  YLAPE        R  D +  GV++ E++ GR
Sbjct: 173 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 92/200 (46%), Gaps = 19/200 (9%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V   + ++ G   A+K+L     V+ KQ E   ++E   +  VN     LVK
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPF--LVK 98
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L     D     +V +Y+P   +   L    +R  +F     R     I     Y+H   
Sbjct: 99  LEFSFKDNSNLYMVMEYVPGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH--- 151
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              +++RD+K  N+L+DQ    +++DFG +K     T  +     GT  YLAPE  +S  
Sbjct: 152 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSKG 207
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
             +  D ++ GVL+ E+ +G
Sbjct: 208 YNKAVDWWALGVLIYEMAAG 227

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 92/200 (46%), Gaps = 19/200 (9%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V   + ++ G   A+K+L     V+ KQ E   ++E   +  VN     LVK
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPF--LVK 105
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L     D     +V +Y+P   +   L    +R  +F     R     I     Y+H   
Sbjct: 106 LEYSFKDNSNLYMVMEYVPGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH--- 158
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              +++RD+K  N+L+DQ    +++DFG +K     T  +     GT  YLAPE  +S  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSKG 214
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
             +  D ++ GVL+ E+ +G
Sbjct: 215 YNKAVDWWALGVLIYEMAAG 234

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 95/215 (44%), Gaps = 20/215 (9%)
Query: 38  KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVA-SMANV 95
           K+  N F +   +G+G FG V   R +  G   A+K+L  E    + E    V  S    
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 96  NVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEE---KRRAKFGWKARREIIMG 152
           N  H  L  L            V +Y     L   L  E    + RA+F + A  EI+  
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGA--EIV-- 115
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIST--RVAG 210
               L Y+H      VV+RDIK  N++LD++ + KI+DFGL K   E  +  +T     G
Sbjct: 116 --SALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCG 167
Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
           T  YLAPE        R  D +  GV++ E++ GR
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 92/200 (46%), Gaps = 19/200 (9%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V   + ++ G   A+K+L     V+ KQ E   ++E   +  VN     LVK
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPF--LVK 106
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L     D     +V +Y+P   +   L    +R  +F     R     I     Y+H   
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH--- 159
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              +++RD+K  N+L+DQ    +++DFG +K     T  +     GT  YLAPE  +S  
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSKG 215
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
             +  D ++ GVL+ E+ +G
Sbjct: 216 YNKAVDWWALGVLIYEMAAG 235

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 92/200 (46%), Gaps = 19/200 (9%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V   + ++ G   A+K+L     V+ KQ E   ++E   +  VN     LVK
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPF--LVK 106
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L     D     +V +Y+P   +   L    +R  +F     R     I     Y+H   
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH--- 159
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              +++RD+K  N+L+DQ    +++DFG +K     T  +     GT  YLAPE  +S  
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSKG 215
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
             +  D ++ GVL+ E+ +G
Sbjct: 216 YNKAVDWWALGVLIYEMAAG 235

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 69/278 (24%), Positives = 121/278 (43%), Gaps = 27/278 (9%)
Query: 41  TNGFRWSNKIGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGEKEFMS-EVASMANVNVC 98
           ++ +    ++G+G F  V +      G   A K+++ + K   ++F   E  +     + 
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTK-KLSARDFQKLEREARICRKLQ 62
Query: 99  HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
           H N+V+LH    +     LV+D +    L + ++     R  +        I  I   +A
Sbjct: 63  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIA 118
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFN---PKISDFGLSKLFPENTTHISTRVAGTLGYL 215
           Y H      +VHR++K  N+LL         K++DFGL+     N +      AGT GYL
Sbjct: 119 YCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYL 173
Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVSGRTAV-DFD-------VQLGEYHLVDKAWGMY 267
           +PE       ++  D+++ GV+L  ++ G     D D       ++ G Y      W   
Sbjct: 174 SPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTV 233
Query: 268 NSKELMNLVDPMLYGNFPENE--AIRFLKVGLLCVQEK 303
            + E  +L+D ML  N P+    A + LKV  +C +E+
Sbjct: 234 -TPEAKSLIDSMLTVN-PKKRITADQALKVPWICNRER 269

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 92/200 (46%), Gaps = 19/200 (9%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V   + ++ G   A+K+L     V+ KQ E   ++E   +  VN     LVK
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPF--LVK 106
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L     D     +V +Y+P   +   L    +R  +F     R     I     Y+H   
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH--- 159
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              +++RD+K  N+L+DQ    +++DFG +K     T  +     GT  YLAPE  +S  
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSKG 215
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
             +  D ++ GVL+ E+ +G
Sbjct: 216 YNKAVDWWALGVLIYEMAAG 235

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 80
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 81  ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQI 134
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI DFGL++    +T    T    T  
Sbjct: 135 LRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLAR----HTDDEMTGYVATRW 187
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 95/215 (44%), Gaps = 20/215 (9%)
Query: 38  KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVA-SMANV 95
           K+  N F +   +G+G FG V   R +  G   A+K+L  E    + E    V  S    
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 96  NVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEE---KRRAKFGWKARREIIMG 152
           N  H  L  L            V +Y     L   L  E    + RA+F + A  EI+  
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGA--EIV-- 115
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIST--RVAG 210
               L Y+H      VV+RDIK  N++LD++ + KI+DFGL K   E  +  +T     G
Sbjct: 116 --SALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCG 167
Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
           T  YLAPE        R  D +  GV++ E++ GR
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 103/218 (47%), Gaps = 26/218 (11%)
Query: 49  KIGEGGFGSVYKGRLQDG-TIVAVKVLSVESKQGEKEFMSEVASMANVNVC------HEN 101
           KIGEG +G+V+K + ++   IVA+K + ++           V S A   +C      H+N
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD------EGVPSSALREICLLKELKHKN 62
Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
           +V+LH          LV+++  +  L +     +        +  +  +  + +GL + H
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFC-DQDLKKYF---DSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI 221
                +V+HRD+K  N+L+++N   K+++FGL++ F       S  V  TL Y  P+   
Sbjct: 119 SR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLF 174
Query: 222 SGRLTRKS-DVYSFGVLLLEIV-SGRTAV---DFDVQL 254
             +L   S D++S G +  E+  +GR      D D QL
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL 212

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 103/218 (47%), Gaps = 20/218 (9%)
Query: 34  YNQLKIATNGFRWSNKIGEGGFGSVY---KGRLQDGTIVAVKVLSVESKQGEKEFM-SEV 89
           + Q +   + + + + +G G F  V      R Q   +VA+K ++ E+ +G++  M +E+
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQ--KLVAIKCIAKEALEGKEGSMENEI 67
Query: 90  ASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREI 149
           A +  +   H N+V L      G    L+   +    L   ++     +  +  +    +
Sbjct: 68  AVLHKIK--HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV----EKGFYTERDASRL 121
Query: 150 IMGIGRGLAYIHEEIQPHVVHRDIKTSNIL---LDQNFNPKISDFGLSKLFPENTTHIST 206
           I  +   + Y+H+     +VHRD+K  N+L   LD++    ISDFGLSK+  E+   + +
Sbjct: 122 IFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLS 176
Query: 207 RVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
              GT GY+APE       ++  D +S GV+   ++ G
Sbjct: 177 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 80
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 81  ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI DFGL++    +T    T    T  
Sbjct: 135 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 187
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 188 YRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 100/225 (44%), Gaps = 27/225 (12%)
Query: 36  QLKIATNGFRWSNKIGEGGFGSVYKGRLQDGT-IVAVKVLSVES--KQGEKEFMSEVASM 92
           ++++    F     IG G FG V   ++++   I A+K+L+     K+ E     E   +
Sbjct: 68  EMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDV 127
Query: 93  ANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTL------LGEEKRRAKFGWKAR 146
             VN   + +  LH    D     LV DY     L   L      L E+  R   G    
Sbjct: 128 L-VNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIG---- 182
Query: 147 REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIST 206
            E+++ I      IH   Q H VHRDIK  N+LLD N + +++DFG      ++ T  S+
Sbjct: 183 -EMVLAIDS----IH---QLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSS 234
Query: 207 RVAGTLGYLAPEYAIS-----GRLTRKSDVYSFGVLLLEIVSGRT 246
              GT  Y++PE   +     G+   + D +S GV + E++ G T
Sbjct: 235 VAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGET 279

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 91/200 (45%), Gaps = 19/200 (9%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V   + ++ G   A+K+L     V+ KQ E   ++E   +  VN     LVK
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPF--LVK 106
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L     D     +V +Y P   +   L    +R  +F     R     I     Y+H   
Sbjct: 107 LEFSFKDNSNLYMVMEYAPGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH--- 159
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              +++RD+K  N+++DQ    K++DFG +K     T  +     GT  YLAPE  +S  
Sbjct: 160 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSKG 215
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
             +  D ++ GVL+ E+ +G
Sbjct: 216 YNKAVDWWALGVLIYEMAAG 235

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 92/200 (46%), Gaps = 19/200 (9%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V   + ++ G   A+K+L     V+ KQ E   ++E   +  VN     LVK
Sbjct: 70  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPF--LVK 126
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L     D     +V +Y+P   +   L    +R  +F     R     I     Y+H   
Sbjct: 127 LEFSFKDNSNLYMVMEYVPGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH--- 179
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              +++RD+K  N+L+DQ    +++DFG +K     T  +     GT  YLAPE  +S  
Sbjct: 180 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSKG 235
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
             +  D ++ GVL+ E+ +G
Sbjct: 236 YNKAVDWWALGVLIYEMAAG 255

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 100/225 (44%), Gaps = 27/225 (12%)
Query: 36  QLKIATNGFRWSNKIGEGGFGSVYKGRLQDGT-IVAVKVLSVES--KQGEKEFMSEVASM 92
           ++++    F     IG G FG V   ++++   I A+K+L+     K+ E     E   +
Sbjct: 84  EMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDV 143
Query: 93  ANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTL------LGEEKRRAKFGWKAR 146
             VN   + +  LH    D     LV DY     L   L      L E+  R   G    
Sbjct: 144 L-VNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIG---- 198
Query: 147 REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIST 206
            E+++ I      IH   Q H VHRDIK  N+LLD N + +++DFG      ++ T  S+
Sbjct: 199 -EMVLAIDS----IH---QLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSS 250
Query: 207 RVAGTLGYLAPEYAIS-----GRLTRKSDVYSFGVLLLEIVSGRT 246
              GT  Y++PE   +     G+   + D +S GV + E++ G T
Sbjct: 251 VAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGET 295

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 103/218 (47%), Gaps = 20/218 (9%)
Query: 34  YNQLKIATNGFRWSNKIGEGGFGSVY---KGRLQDGTIVAVKVLSVESKQGEKEFM-SEV 89
           + Q +   + + + + +G G F  V      R Q   +VA+K ++ E+ +G++  M +E+
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQ--KLVAIKCIAKEALEGKEGSMENEI 67
Query: 90  ASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREI 149
           A +  +   H N+V L      G    L+   +    L   ++     +  +  +    +
Sbjct: 68  AVLHKIK--HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV----EKGFYTERDASRL 121
Query: 150 IMGIGRGLAYIHEEIQPHVVHRDIKTSNIL---LDQNFNPKISDFGLSKLFPENTTHIST 206
           I  +   + Y+H+     +VHRD+K  N+L   LD++    ISDFGLSK+  E+   + +
Sbjct: 122 IFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLS 176
Query: 207 RVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
              GT GY+APE       ++  D +S GV+   ++ G
Sbjct: 177 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 90/200 (45%), Gaps = 19/200 (9%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V   + ++ G   A+K+L     V+ KQ E   ++E      VN     LVK
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT-LNEKRIQQAVNFPF--LVK 106
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L     D     +V +Y P   +   L    +R  +F     R     I     Y+H   
Sbjct: 107 LEFSFKDNSNLYMVLEYAPGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH--- 159
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              +++RD+K  N+L+DQ    K++DFG +K     T  +     GT  YLAPE  +S  
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXL----CGTPEYLAPEIILSKG 215
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
             +  D ++ GVL+ E+ +G
Sbjct: 216 YNKAVDWWALGVLIYEMAAG 235

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 92/200 (46%), Gaps = 19/200 (9%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V   + ++ G   A+K+L     V+ KQ E   ++E   +  VN     LVK
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPF--LVK 98
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L     D     +V +Y+P   +   L    +R  +F     R     I     Y+H   
Sbjct: 99  LEFSFKDNSNLYMVMEYVPGGEMFSHL----RRIGRFXEPHARFYAAQIVLTFEYLH--- 151
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              +++RD+K  N+L+DQ    +++DFG +K     T  +     GT  YLAPE  +S  
Sbjct: 152 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSKG 207
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
             +  D ++ GVL+ E+ +G
Sbjct: 208 YNKAVDWWALGVLIYEMAAG 227

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 80
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 81  ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQI 134
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI DFGL++    +T    T    T  
Sbjct: 135 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 187
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 19/200 (9%)
Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V   + ++ G   A+K+L     V+ KQ E   ++E   +  VN     LVK
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPF--LVK 105
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L     D     +V +Y P   +   L    +R  +F     R     I     Y+H   
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH--- 158
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              +++RD+K  N+++DQ    +++DFG +K     T  +     GT  YLAPE  +S  
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSKG 214
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
             +  D ++ GVL+ E+ +G
Sbjct: 215 YNKAVDWWALGVLIYEMAAG 234

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   IG G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 28  RYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 85
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 86  ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 139
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI DFGL++    +T    T    T  
Sbjct: 140 LRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLAR----HTDDEMTGYVATRW 192
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 193 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 226

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 19/200 (9%)
Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V   + ++ G   A+K+L     V+ KQ E   ++E   +  VN     L K
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPF--LTK 106
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L     D     +V +Y P   +   L    +R  +F     R     I     Y+H   
Sbjct: 107 LEFSFKDNSNLYMVMEYAPGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH--- 159
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              +++RD+K  N+++DQ    K++DFG +K     T  +     GT  YLAPE  +S  
Sbjct: 160 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSKG 215
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
             +  D ++ GVL+ E+ +G
Sbjct: 216 YNKAVDWWALGVLIYEMAAG 235

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 19/200 (9%)
Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V   + ++ G   A+K+L     V+ KQ E   ++E   +  VN     L K
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPF--LTK 106
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L     D     +V +Y P   +   L    +R  +F     R     I     Y+H   
Sbjct: 107 LEFSFKDNSNLYMVMEYAPGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH--- 159
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              +++RD+K  N+++DQ    K++DFG +K     T  +     GT  YLAPE  +S  
Sbjct: 160 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSKG 215
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
             +  D ++ GVL+ E+ +G
Sbjct: 216 YNKAVDWWALGVLIYEMAAG 235

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 87
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 88  ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 141
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI DFGL++    +T    T    T  
Sbjct: 142 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTADEMTGYVATRW 194
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 14/204 (6%)
Query: 50  IGEGGFGSVYK-GRLQDGTIVAVKVL--SVESKQGEKEFMS-EVASMANVNVCHENLVKL 105
           +G+GGF   Y+   +    + A KV+  S+  K  +KE MS E+A   +++  H  +V  
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPH--VVGF 107
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
           HG   D     +V +        ++LL   KRR        R  +    +G+ Y+H    
Sbjct: 108 HGFFEDDDFVYVVLEI----CRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNN-- 161
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL 225
             V+HRD+K  N+ L+ + + KI DFGL+     +     T + GT  Y+APE       
Sbjct: 162 -RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT-LCGTPNYIAPEVLCKKGH 219
Query: 226 TRKSDVYSFGVLLLEIVSGRTAVD 249
           + + D++S G +L  ++ G+   +
Sbjct: 220 SFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 120/277 (43%), Gaps = 27/277 (9%)
Query: 41  TNGFRWSNKIGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGEKEFMS-EVASMANVNVC 98
           ++ +    ++G+G F  V +      G   A K+++ + K   ++F   E  +     + 
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTK-KLSARDFQKLEREARICRKLQ 63
Query: 99  HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
           H N+V+LH    +     LV+D +    L + ++     R  +        I  I   +A
Sbjct: 64  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIA 119
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFN---PKISDFGLSKLFPENTTHISTRVAGTLGYL 215
           Y H      +VHR++K  N+LL         K++DFGL+     N +      AGT GYL
Sbjct: 120 YCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYL 174
Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVSGRTAV-DFD-------VQLGEYHLVDKAWGMY 267
           +PE       ++  D+++ GV+L  ++ G     D D       ++ G Y      W   
Sbjct: 175 SPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTV 234
Query: 268 NSKELMNLVDPMLYGNFPENE--AIRFLKVGLLCVQE 302
            + E  +L+D ML  N P+    A + LKV  +C +E
Sbjct: 235 -TPEAKSLIDSMLTVN-PKKRITADQALKVPWICNRE 269

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 14/204 (6%)
Query: 50  IGEGGFGSVYK-GRLQDGTIVAVKVL--SVESKQGEKEFMS-EVASMANVNVCHENLVKL 105
           +G+GGF   Y+   +    + A KV+  S+  K  +KE MS E+A   +++  H  +V  
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPH--VVGF 91
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
           HG   D     +V +     SL    L   KRR        R  +    +G+ Y+H    
Sbjct: 92  HGFFEDDDFVYVVLEICRRRSL----LELHKRRKAVTEPEARYFMRQTIQGVQYLHNN-- 145
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL 225
             V+HRD+K  N+ L+ + + KI DFGL+    E        + GT  Y+APE       
Sbjct: 146 -RVIHRDLKLGNLFLNDDMDVKIGDFGLATKI-EFDGERKKDLCGTPNYIAPEVLCKKGH 203
Query: 226 TRKSDVYSFGVLLLEIVSGRTAVD 249
           + + D++S G +L  ++ G+   +
Sbjct: 204 SFEVDIWSLGCILYTLLVGKPPFE 227

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 87
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 88  ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 141
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI DFGL++    +T    T    T  
Sbjct: 142 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTADEMTGYVATRW 194
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 87
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 88  ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 141
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI DFGL++    +T    T    T  
Sbjct: 142 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTADEMTGYVATRW 194
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 88/205 (42%), Gaps = 21/205 (10%)
Query: 49  KIGEGGFGSVYKGRLQDGTIVAVKVLSVE----SKQGEKEFMSEVASMANVNVCHENLVK 104
           +IG G F +VYKG L   T V V    ++    +K   + F  E   +  +   H N+V+
Sbjct: 33  EIGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQ--HPNIVR 89
Query: 105 LHGG---CIDGP-CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
            +      + G  C +LV +   + +L   L    KR      K  R     I +GL ++
Sbjct: 90  FYDSWESTVKGKKCIVLVTELXTSGTLKTYL----KRFKVXKIKVLRSWCRQILKGLQFL 145
Query: 161 HEEIQPHVVHRDIKTSNILLD-QNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEY 219
           H    P ++HRD+K  NI +     + KI D GL+ L        +  V GT  + APE 
Sbjct: 146 HTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAKAVIGTPEFXAPE- 200
Query: 220 AISGRLTRKSDVYSFGVLLLEIVSG 244
               +     DVY+FG   LE  + 
Sbjct: 201 XYEEKYDESVDVYAFGXCXLEXATS 225

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 14/204 (6%)
Query: 50  IGEGGFGSVYK-GRLQDGTIVAVKVL--SVESKQGEKEFMS-EVASMANVNVCHENLVKL 105
           +G+GGF   Y+   +    + A KV+  S+  K  +KE MS E+A   +++  H  +V  
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPH--VVGF 107
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
           HG   D     +V +        ++LL   KRR        R  +    +G+ Y+H    
Sbjct: 108 HGFFEDDDFVYVVLEI----CRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNN-- 161
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL 225
             V+HRD+K  N+ L+ + + KI DFGL+    E        + GT  Y+APE       
Sbjct: 162 -RVIHRDLKLGNLFLNDDMDVKIGDFGLATKI-EFDGERKKXLCGTPNYIAPEVLCKKGH 219
Query: 226 TRKSDVYSFGVLLLEIVSGRTAVD 249
           + + D++S G +L  ++ G+   +
Sbjct: 220 SFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 87/193 (45%), Gaps = 24/193 (12%)
Query: 66  GTIVAVKVLSVESKQGEKEFMSEV--ASMANVNVC-----HENLVKLHGGCIDGPCRILV 118
           G   AVK++ V +++   E + EV  A+    ++      H +++ L           LV
Sbjct: 119 GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178
Query: 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNI 178
           +D M    L   L      +     K  R I+  +   ++++H     ++VHRD+K  NI
Sbjct: 179 FDLMRKGELFDYL----TEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENI 231
Query: 179 LLDQNFNPKISDFGLS-KLFPENTTHISTRVAGTLGYLAPEYAISGR------LTRKSDV 231
           LLD N   ++SDFG S  L P         + GT GYLAPE              ++ D+
Sbjct: 232 LLDDNMQIRLSDFGFSCHLEPGEKLR---ELCGTPGYLAPEILKCSMDETHPGYGKEVDL 288
Query: 232 YSFGVLLLEIVSG 244
           ++ GV+L  +++G
Sbjct: 289 WACGVILFTLLAG 301

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 80
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 81  ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI DFGL++    +T    T    T  
Sbjct: 135 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 187
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 28  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 85
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 86  ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 139
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI DFGL++    +T    T    T  
Sbjct: 140 LRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLAR----HTDDEMTGYVATRW 192
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 193 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 226

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 82
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 83  ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 136
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI DFGL++    +T    T    T  
Sbjct: 137 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 189
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 190 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 223

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 80
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 81  ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI DFGL++    +T    T    T  
Sbjct: 135 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 187
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 82
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 83  ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 136
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI DFGL++    +T    T    T  
Sbjct: 137 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 189
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 190 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 223

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 28  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 85
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 86  ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 139
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI DFGL++    +T    T    T  
Sbjct: 140 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 192
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 193 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 226

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 34  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 91
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 92  ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 145
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI DFGL++    +T    T    T  
Sbjct: 146 LRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLAR----HTDDEMTGYVATRW 198
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 199 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 232

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 19/200 (9%)
Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V   + ++ G   A+K+L     V+ KQ E   ++E   +  VN     L K
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPF--LTK 106
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L     D     +V +Y P   +   L    +R  +F     R     I     Y+H   
Sbjct: 107 LEFSFKDNSNLYMVMEYAPGGEMFSHL----RRIGRFXEPHARFYAAQIVLTFEYLH--- 159
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              +++RD+K  N+++DQ    K++DFG +K     T  +     GT  YLAPE  +S  
Sbjct: 160 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSKG 215
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
             +  D ++ GVL+ E+ +G
Sbjct: 216 YNKAVDWWALGVLIYEMAAG 235

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 80
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 81  ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI DFGL++    +T    T    T  
Sbjct: 135 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 187
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 82
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 83  ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 136
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI DFGL++    +T    T    T  
Sbjct: 137 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 189
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 190 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 223

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 80
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 81  ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI DFGL++    +T    T    T  
Sbjct: 135 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 187
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 14/204 (6%)
Query: 50  IGEGGFGSVYK-GRLQDGTIVAVKVL--SVESKQGEKEFMS-EVASMANVNVCHENLVKL 105
           +G+GGF   Y+   +    + A KV+  S+  K  +KE MS E+A   +++  H  +V  
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPH--VVGF 107
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
           HG   D     +V +        ++LL   KRR        R  +    +G+ Y+H    
Sbjct: 108 HGFFEDDDFVYVVLEI----CRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNN-- 161
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL 225
             V+HRD+K  N+ L+ + + KI DFGL+    E        + GT  Y+APE       
Sbjct: 162 -RVIHRDLKLGNLFLNDDMDVKIGDFGLATKI-EFDGERKKDLCGTPNYIAPEVLCKKGH 219
Query: 226 TRKSDVYSFGVLLLEIVSGRTAVD 249
           + + D++S G +L  ++ G+   +
Sbjct: 220 SFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 28  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 85
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 86  ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 139
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI DFGL++    +T    T    T  
Sbjct: 140 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 192
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 193 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 226

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 22  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 79
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 80  ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 133
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI DFGL++    +T    T    T  
Sbjct: 134 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 186
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 187 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 220

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 53/94 (56%), Gaps = 8/94 (8%)
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI---STRVA 209
           + RG+ ++        +HRD+   NILL +N   KI DFGL++   +N  ++    TR+ 
Sbjct: 208 VARGMEFLSSR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 210 GTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
             L ++APE       + KSDV+S+GVLL EI S
Sbjct: 265 --LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 80
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 81  ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI DFGL++    +T    T    T  
Sbjct: 135 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 187
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 35  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMK--H 92
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 93  ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 146
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI DFGL++    +T    T    T  
Sbjct: 147 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 199
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 200 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 233

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 86
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 87  ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 140
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI DFGL++    +T    T    T  
Sbjct: 141 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 193
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 227

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 87
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 88  ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 141
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI DFGL++    +T    T    T  
Sbjct: 142 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 194
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 80
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 81  ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI DFGL++    +T    T    T  
Sbjct: 135 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGXVATRW 187
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 80
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 81  ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI DFGL++    +T    T    T  
Sbjct: 135 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 187
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 80
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 81  ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI DFGL++    +T    T    T  
Sbjct: 135 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 187
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 35  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 92
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 93  ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 146
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI DFGL++    +T    T    T  
Sbjct: 147 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 199
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 200 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 233

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 20  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 77
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 78  ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 131
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI DFGL++    +T    T    T  
Sbjct: 132 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 184
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 185 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 218

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 80
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 81  ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI DFGL++    +T    T    T  
Sbjct: 135 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 187
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 35  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 92
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 93  ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 146
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI DFGL++    +T    T    T  
Sbjct: 147 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 199
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 200 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 233

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 33/217 (15%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 80
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 81  ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG--- 210
            RGL YIH      ++HRD+K SN+ ++++   KI DFGL++       H    +AG   
Sbjct: 135 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMAGFVA 184
Query: 211 TLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           T  Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 33/217 (15%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 80
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 81  ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG--- 210
            RGL YIH      ++HRD+K SN+ ++++   KI DFGL++       H    +AG   
Sbjct: 135 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMAGFVA 184
Query: 211 TLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           T  Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 34  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 91
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 92  ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 145
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI DFGL++    +T    T    T  
Sbjct: 146 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 198
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 199 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 232

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 76
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 77  ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 130
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI DFGL++    +T    T    T  
Sbjct: 131 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 183
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 217

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 86
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 87  ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 140
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI DFGL++    +T    T    T  
Sbjct: 141 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 193
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 227

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 33  RYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 90
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 91  ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 144
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI DFGL++    +T    T    T  
Sbjct: 145 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 197
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 198 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 231

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 76
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 77  ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 130
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI DFGL++    +T    T    T  
Sbjct: 131 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 183
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 217

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 33/217 (15%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 76
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 77  ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 130
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG--- 210
            RGL YIH      ++HRD+K SN+ ++++   KI DFGL++       H    +AG   
Sbjct: 131 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMAGFVA 180
Query: 211 TLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           T  Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 217

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 46  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 103
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 104 ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 157
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI DFGL++    +T    T    T  
Sbjct: 158 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 210
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 211 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 244

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 43  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 100
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 101 ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 154
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI DFGL++    +T    T    T  
Sbjct: 155 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 207
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 208 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 241

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 21  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 78
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 79  ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 132
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI DFGL++    +T    T    T  
Sbjct: 133 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 185
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 186 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 219

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 42  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 99
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 100 ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 153
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI DFGL++    +T    T    T  
Sbjct: 154 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 206
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 207 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 240

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 86
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 87  ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 140
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI DFGL++    +T    T    T  
Sbjct: 141 LRGLKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLAR----HTDDEMTGYVATRW 193
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 227

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 86
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 87  ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 140
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI DFGL++    +T    T    T  
Sbjct: 141 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 193
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 227

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 20  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 77
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 78  ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 131
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI DFGL++    +T    T    T  
Sbjct: 132 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 184
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 185 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 218

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 43  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 100
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 101 ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 154
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI DFGL++    +T    T    T  
Sbjct: 155 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 207
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 208 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 241

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 112/236 (47%), Gaps = 26/236 (11%)
Query: 18  NTIGGEQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIV--AVKVLS 75
            T+G   I++ ++    N ++  T+G+     IG G + SV K  +   T +  AVK++ 
Sbjct: 2   QTVGVHSIVQQLHR---NSIQF-TDGYEVKEDIGVGSY-SVCKRCIHKATNMEFAVKIID 56
Query: 76  VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEE 135
            +SK+   E +  +         H N++ L     DG    +V + M    L   +L   
Sbjct: 57  -KSKRDPTEEIEILLRYGQ----HPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL--- 108
Query: 136 KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL-LDQNFNP---KISDF 191
            R+  F  +    ++  I + + Y+H +    VVHRD+K SNIL +D++ NP   +I DF
Sbjct: 109 -RQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDF 164
Query: 192 GLSK-LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT 246
           G +K L  EN   ++     T  ++APE           D++S GVLL  +++G T
Sbjct: 165 GFAKQLRAENGLLMTP--CYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYT 218

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 113/260 (43%), Gaps = 31/260 (11%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLH-- 106
           IG G FG VY+ +L D G +VA+K    +  QG+     E+  M  ++ C  N+V+L   
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIK----KVLQGKAFKNRELQIMRKLDHC--NIVRLRYF 81
Query: 107 ----GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKA--RREIIMGIGRGLAYI 160
               G   D     LV DY+P        +     RAK        +  +  + R LAYI
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYR---VARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLF---PENTTHISTRVAGTLGYLA 216
           H      + HRDIK  N+LLD +    K+ DFG +K       N ++I +R      Y A
Sbjct: 139 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRA 190
Query: 217 PEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNL 275
           PE        T   DV+S G +L E++ G+     D  + +   + K  G    +++  +
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250
Query: 276 VDPMLYGNFPENEAIRFLKV 295
                   FP+ +A  + KV
Sbjct: 251 NPNYTEFKFPQIKAHPWTKV 270

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 23/217 (10%)
Query: 38  KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMA 93
           ++  N F +   +G+G FG V   + +  G   A+K+L  E   +K      ++E   + 
Sbjct: 147 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 206
Query: 94  NVNVCHENLVKLHGGCIDGPCRILVYDYMPNN-----SLSQTLLGEEKRRAKFGWKARRE 148
           N        +K      D  C ++ Y    N       LS+  +  E R   +G     E
Sbjct: 207 NSRHPFLTALKYSFQTHDRLCFVMEY---ANGGELFFHLSRERVFSEDRARFYG----AE 259
Query: 149 IIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRV 208
           I+      L Y+H E   +VV+RD+K  N++LD++ + KI+DFGL K   ++   + T  
Sbjct: 260 IV----SALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-F 312
Query: 209 AGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
            GT  YLAPE        R  D +  GV++ E++ GR
Sbjct: 313 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 349

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 80
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 81  ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQI 134
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI DFGL +    +T    T    T  
Sbjct: 135 LRGLKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLCR----HTDDEMTGYVATRW 187
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 82
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 83  ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 136
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI DFGL++    +T    T    T  
Sbjct: 137 LRGLKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLAR----HTDDEMTGYVATRW 189
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 190 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 223

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 23/217 (10%)
Query: 38  KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMA 93
           ++  N F +   +G+G FG V   + +  G   A+K+L  E   +K      ++E   + 
Sbjct: 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 203
Query: 94  NVNVCHENLVKLHGGCIDGPCRILVYDYMPNN-----SLSQTLLGEEKRRAKFGWKARRE 148
           N        +K      D  C ++ Y    N       LS+  +  E R   +G     E
Sbjct: 204 NSRHPFLTALKYSFQTHDRLCFVMEY---ANGGELFFHLSRERVFSEDRARFYG----AE 256
Query: 149 IIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRV 208
           I+      L Y+H E   +VV+RD+K  N++LD++ + KI+DFGL K   ++   + T  
Sbjct: 257 IV----SALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-F 309
Query: 209 AGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
            GT  YLAPE        R  D +  GV++ E++ GR
Sbjct: 310 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 42  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 99
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 100 ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 153
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI DFGL++    +T    T    T  
Sbjct: 154 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 206
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 207 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 240

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 100/231 (43%), Gaps = 20/231 (8%)
Query: 36  QLKIATNGFRWSNKIGEGGFGSVYKGRLQDG-TIVAVKVLS---VESKQGEKEFMSEVAS 91
            L++    +     IG G FG V   R +    + A+K+LS   +  +     F  E   
Sbjct: 63  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 122
Query: 92  MANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
           MA  N     +V+L     D     +V +YMP   L   L+       K+      E+++
Sbjct: 123 MAFANSPW--VVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVL 179
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS-KLFPENTTHISTRVAG 210
                L  IH       +HRD+K  N+LLD++ + K++DFG   K+  E      T V G
Sbjct: 180 A----LDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-G 231
Query: 211 TLGYLAPEYAIS----GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEY 257
           T  Y++PE   S    G   R+ D +S GV L E++ G T    D  +G Y
Sbjct: 232 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY 282

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 92/200 (46%), Gaps = 19/200 (9%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V   + ++ G   A+K+L     V+ KQ E   ++E   +  VN     LVK
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPF--LVK 105
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L     D     +V +Y+    +   L    +R  +F     R     I     Y+H   
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH--- 158
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              +++RD+K  N+L+DQ    +++DFG +K     T  +    AGT  YLAPE  +S  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----AGTPEYLAPEIILSKG 214
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
             +  D ++ GVL+ E+ +G
Sbjct: 215 YNKAVDWWALGVLIYEMAAG 234

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 100/231 (43%), Gaps = 20/231 (8%)
Query: 36  QLKIATNGFRWSNKIGEGGFGSVYKGRLQDG-TIVAVKVLS---VESKQGEKEFMSEVAS 91
            L++    +     IG G FG V   R +    + A+K+LS   +  +     F  E   
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 127
Query: 92  MANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
           MA  N     +V+L     D     +V +YMP   L   L+       K+      E+++
Sbjct: 128 MAFANSPW--VVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVL 184
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS-KLFPENTTHISTRVAG 210
                L  IH       +HRD+K  N+LLD++ + K++DFG   K+  E      T V G
Sbjct: 185 A----LDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-G 236
Query: 211 TLGYLAPEYAIS----GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEY 257
           T  Y++PE   S    G   R+ D +S GV L E++ G T    D  +G Y
Sbjct: 237 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY 287

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 100/231 (43%), Gaps = 20/231 (8%)
Query: 36  QLKIATNGFRWSNKIGEGGFGSVYKGRLQDG-TIVAVKVLS---VESKQGEKEFMSEVAS 91
            L++    +     IG G FG V   R +    + A+K+LS   +  +     F  E   
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 127
Query: 92  MANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
           MA  N     +V+L     D     +V +YMP   L   L+       K+      E+++
Sbjct: 128 MAFANSPW--VVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVL 184
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS-KLFPENTTHISTRVAG 210
                L  IH       +HRD+K  N+LLD++ + K++DFG   K+  E      T V G
Sbjct: 185 A----LDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-G 236
Query: 211 TLGYLAPEYAIS----GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEY 257
           T  Y++PE   S    G   R+ D +S GV L E++ G T    D  +G Y
Sbjct: 237 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY 287

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 113/260 (43%), Gaps = 31/260 (11%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLH-- 106
           IG G FG VY+ +L D G +VA+K    +  QG+     E+  M  ++ C  N+V+L   
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIK----KVLQGKAFKNRELQIMRKLDHC--NIVRLRYF 81
Query: 107 ----GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKA--RREIIMGIGRGLAYI 160
               G   D     LV DY+P        +     RAK        +  +  + R LAYI
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYR---VARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLF---PENTTHISTRVAGTLGYLA 216
           H      + HRDIK  N+LLD +    K+ DFG +K       N ++I +R      Y A
Sbjct: 139 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRA 190
Query: 217 PEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNL 275
           PE        T   DV+S G +L E++ G+     D  + +   + K  G    +++  +
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250
Query: 276 VDPMLYGNFPENEAIRFLKV 295
                   FP+ +A  + KV
Sbjct: 251 NPNYTEFAFPQIKAHPWTKV 270

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 102/219 (46%), Gaps = 20/219 (9%)
Query: 34  YNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTI-VAVKVLSVESKQGEKEFMSEVASM 92
           Y Q  + ++G+     IG G +    +   +   +  AVKV+  +SK+   E +  +   
Sbjct: 19  YFQSMVFSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVID-KSKRDPSEEIEILLRY 77
Query: 93  ANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG 152
                 H N++ L     DG    LV + M    L   +L    R+  F  +    ++  
Sbjct: 78  GQ----HPNIITLKDVYDDGKHVYLVTELMRGGELLDKIL----RQKFFSEREASFVLHT 129
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNIL-LDQNFNP---KISDFGLSK-LFPENTTHISTR 207
           IG+ + Y+H +    VVHRD+K SNIL +D++ NP   +I DFG +K L  EN   ++  
Sbjct: 130 IGKTVEYLHSQ---GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTP- 185
Query: 208 VAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT 246
              T  ++APE           D++S G+LL  +++G T
Sbjct: 186 -CYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYT 223

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 16/202 (7%)
Query: 50  IGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCHENLVKLH 106
           +G G +GSV      + G  VA+K LS   +S+   K    E+  + ++   HEN++ L 
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ--HENVIGLL 89
Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
                       YD+       QT L ++    KF  +  + ++  + +GL YIH     
Sbjct: 90  DVFTPASSLRNFYDFYLVMPFMQTDL-QKIMGLKFSEEKIQYLVYQMLKGLKYIHSA--- 145
Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLAPEYAISG-R 224
            VVHRD+K  N+ ++++   KI DFGL++    E T ++ TR      Y APE  +S   
Sbjct: 146 GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVILSWMH 200
Query: 225 LTRKSDVYSFGVLLLEIVSGRT 246
             +  D++S G ++ E+++G+T
Sbjct: 201 YNQTVDIWSVGCIMAEMLTGKT 222

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 103/218 (47%), Gaps = 20/218 (9%)
Query: 34  YNQLKIATNGFRWSNKIGEGGFGSVY---KGRLQDGTIVAVKVLSVESKQGEKEFM-SEV 89
           + Q +   + + + + +G G F  V      R Q   +VA+K ++ ++ +G++  M +E+
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQ--KLVAIKCIAKKALEGKEGSMENEI 67
Query: 90  ASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREI 149
           A +  +   H N+V L      G    L+   +    L   ++     +  +  +    +
Sbjct: 68  AVLHKIK--HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV----EKGFYTERDASRL 121
Query: 150 IMGIGRGLAYIHEEIQPHVVHRDIKTSNIL---LDQNFNPKISDFGLSKLFPENTTHIST 206
           I  +   + Y+H+     +VHRD+K  N+L   LD++    ISDFGLSK+  E+   + +
Sbjct: 122 IFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLS 176
Query: 207 RVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
              GT GY+APE       ++  D +S GV+   ++ G
Sbjct: 177 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 118/268 (44%), Gaps = 47/268 (17%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVK-VLSVESKQGEKEFMS-EVASMANVNVCHENLVKLH 106
           IG G FG VY+ +L D G +VA+K VL       +K F + E+  M  ++ C  N+V+L 
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDHC--NIVRLR 158
Query: 107 ------GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREI--------IMG 152
                 G   D     LV DY+P             R A+   +A++ +        +  
Sbjct: 159 YFFYSSGEKKDEVYLNLVLDYVPETVY---------RVARHYSRAKQTLPVIYVKLYMYQ 209
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLF---PENTTHISTRV 208
           + R LAYIH      + HRDIK  N+LLD +    K+ DFG +K       N ++I +R 
Sbjct: 210 LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 266
Query: 209 AGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMY 267
                Y APE        T   DV+S G +L E++ G+     D  + +   + K  G  
Sbjct: 267 -----YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 321
Query: 268 NSKELMNLVDPMLYGNFPENEAIRFLKV 295
             +++  +        FP+ +A  + KV
Sbjct: 322 TREQIREMNPNYTEFKFPQIKAHPWTKV 349

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 72/297 (24%), Positives = 121/297 (40%), Gaps = 31/297 (10%)
Query: 41  TNGFRWSNKIGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCH 99
           T+ ++    IG+G F  V +  +L  G   A K+++ +          E  +     + H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
            N+V+LH    +     LV+D +    L + ++     R  +        I  I   + +
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLH 118
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFN---PKISDFGLSKLFPENTTHISTRVAGTLGYLA 216
            H   Q  VVHRD+K  N+LL         K++DFGL+ +  +         AGT GYL+
Sbjct: 119 CH---QMGVVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLS 174
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVSGRTAV-DFD-------VQLGEYHLVDKAWGMYN 268
           PE        +  D+++ GV+L  ++ G     D D       ++ G Y      W    
Sbjct: 175 PEVLRKEAYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTV- 233
Query: 269 SKELMNLVDPMLYGNFPEN-EAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNID 324
           + E  NL++ ML  N  +   A   LK   +C         Q ST   MM+ +  ++
Sbjct: 234 TPEAKNLINQMLTINPAKRITAHEALKHPWVC---------QRSTVASMMHRQETVE 281

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 118/268 (44%), Gaps = 47/268 (17%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVK-VLSVESKQGEKEFMS-EVASMANVNVCHENLVKLH 106
           IG G FG VY+ +L D G +VA+K VL       +K F + E+  M  ++ C  N+V+L 
Sbjct: 56  IGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDHC--NIVRLR 107
Query: 107 ------GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREI--------IMG 152
                 G   D     LV DY+P             R A+   +A++ +        +  
Sbjct: 108 YFFYSSGEKKDEVYLNLVLDYVPETVY---------RVARHYSRAKQTLPVIYVKLYMYQ 158
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLF---PENTTHISTRV 208
           + R LAYIH      + HRDIK  N+LLD +    K+ DFG +K       N ++I +R 
Sbjct: 159 LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 215
Query: 209 AGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMY 267
                Y APE        T   DV+S G +L E++ G+     D  + +   + K  G  
Sbjct: 216 -----YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 270
Query: 268 NSKELMNLVDPMLYGNFPENEAIRFLKV 295
             +++  +        FP+ +A  + KV
Sbjct: 271 TREQIREMNPNYTEFKFPQIKAHPWTKV 298

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 99/212 (46%), Gaps = 39/212 (18%)
Query: 49  KIGEGGFGSVYKGRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLH 106
           K+ E   G ++KGR Q   IV VKVL V   S +  ++F  E   +   +  H N++ + 
Sbjct: 17  KLNENHSGELWKGRWQGNDIV-VKVLKVRDWSTRKSRDFNEECPRLRIFS--HPNVLPVL 73
Query: 107 GGCIDGPCR--ILVYDYMPNNSLSQTL------LGEEKRRAKFGWKARREIIMGIGRGLA 158
           G C   P     L+  +MP  SL   L      + ++ +  KF         + + RG+A
Sbjct: 74  GACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFA--------LDMARGMA 125
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL---GYL 215
           ++H  ++P +    + + ++++D++   +IS   +           S +  G +    ++
Sbjct: 126 FLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVK---------FSFQSPGRMYAPAWV 175
Query: 216 APEYAISGRLT----RKSDVYSFGVLLLEIVS 243
           APE A+  +      R +D++SF VLL E+V+
Sbjct: 176 APE-ALQKKPEDTNRRSADMWSFAVLLWELVT 206

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 80
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 81  ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI D+GL++    +T    T    T  
Sbjct: 135 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDYGLAR----HTDDEMTGYVATRW 187
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 118/268 (44%), Gaps = 47/268 (17%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVK-VLSVESKQGEKEFMS-EVASMANVNVCHENLVKLH 106
           IG G FG VY+ +L D G +VA+K VL       +K F + E+  M  ++ C  N+V+L 
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDHC--NIVRLR 113
Query: 107 ------GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREI--------IMG 152
                 G   D     LV DY+P             R A+   +A++ +        +  
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPETVY---------RVARHYSRAKQTLPVIYVKLYMYQ 164
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLF---PENTTHISTRV 208
           + R LAYIH      + HRDIK  N+LLD +    K+ DFG +K       N ++I +R 
Sbjct: 165 LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 221
Query: 209 AGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMY 267
                Y APE        T   DV+S G +L E++ G+     D  + +   + K  G  
Sbjct: 222 -----YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 276
Query: 268 NSKELMNLVDPMLYGNFPENEAIRFLKV 295
             +++  +        FP+ +A  + KV
Sbjct: 277 TREQIREMNPNYTEFKFPQIKAHPWTKV 304

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 118/268 (44%), Gaps = 47/268 (17%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVK-VLSVESKQGEKEFMS-EVASMANVNVCHENLVKLH 106
           IG G FG VY+ +L D G +VA+K VL       +K F + E+  M  ++ C  N+V+L 
Sbjct: 64  IGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDHC--NIVRLR 115
Query: 107 ------GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREI--------IMG 152
                 G   D     LV DY+P             R A+   +A++ +        +  
Sbjct: 116 YFFYSSGEKKDEVYLNLVLDYVPETVY---------RVARHYSRAKQTLPVIYVKLYMYQ 166
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLF---PENTTHISTRV 208
           + R LAYIH      + HRDIK  N+LLD +    K+ DFG +K       N ++I +R 
Sbjct: 167 LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 223
Query: 209 AGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMY 267
                Y APE        T   DV+S G +L E++ G+     D  + +   + K  G  
Sbjct: 224 -----YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 278
Query: 268 NSKELMNLVDPMLYGNFPENEAIRFLKV 295
             +++  +        FP+ +A  + KV
Sbjct: 279 TREQIREMNPNYTEFKFPQIKAHPWTKV 306

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 40/215 (18%)
Query: 50  IGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK------QG---EKEFMSEVASMANVNVCH 99
           +G GGFG V+  +++  G + A K L+ +        QG   EK+ +++V S   V++ +
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 100 ENLVK---------LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 150
               K         ++GG I    R  +Y+   +N       G ++ RA F         
Sbjct: 253 AFETKTDLCLVMTIMNGGDI----RYHIYNVDEDNP------GFQEPRAIF-------YT 295
Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG 210
             I  GL ++H   Q ++++RD+K  N+LLD + N +ISD GL+       T  +   AG
Sbjct: 296 AQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAG 351
Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
           T G++APE  +        D ++ GV L E+++ R
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 19/200 (9%)
Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V   + ++ G   A+K+L     V+ KQ E   ++E   +  VN     LVK
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPF--LVK 105
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L     D     +V +Y+    +   L    +R  +F     R     I     Y+H   
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH--- 158
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              +++RD+K  N+L+DQ    +++DFG +K     T  +     GT  YLAPE  +S  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSKG 214
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
             +  D ++ GVL+ E+ +G
Sbjct: 215 YNKAVDWWALGVLIYEMAAG 234

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 118/268 (44%), Gaps = 47/268 (17%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVK-VLSVESKQGEKEFMS-EVASMANVNVCHENLVKLH 106
           IG G FG VY+ +L D G +VA+K VL       +K F + E+  M  ++ C  N+V+L 
Sbjct: 66  IGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDHC--NIVRLR 117
Query: 107 ------GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREI--------IMG 152
                 G   D     LV DY+P             R A+   +A++ +        +  
Sbjct: 118 YFFYSSGEKKDEVYLNLVLDYVPETVY---------RVARHYSRAKQTLPVIYVKLYMYQ 168
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLF---PENTTHISTRV 208
           + R LAYIH      + HRDIK  N+LLD +    K+ DFG +K       N ++I +R 
Sbjct: 169 LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 225
Query: 209 AGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMY 267
                Y APE        T   DV+S G +L E++ G+     D  + +   + K  G  
Sbjct: 226 -----YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 280
Query: 268 NSKELMNLVDPMLYGNFPENEAIRFLKV 295
             +++  +        FP+ +A  + KV
Sbjct: 281 TREQIREMNPNYTEFKFPQIKAHPWTKV 308

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 44  FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQG-EKEFMSEVASMANVNVCHEN 101
           F +   +G G F  V     +  G + AVK +  ++ +G E    +E+A +  +   HEN
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIK--HEN 81
Query: 102 LVKLHGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
           +V L     + P  + LV   +    L   ++     +  +  K    +I  +   + Y+
Sbjct: 82  IVALED-IYESPNHLYLVMQLVSGGELFDRIV----EKGFYTEKDASTLIRQVLDAVYYL 136
Query: 161 HEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
           H   +  +VHRD+K  N+L    D+     ISDFGLSK+  E    + +   GT GY+AP
Sbjct: 137 H---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM--EGKGDVMSTACGTPGYVAP 191
Query: 218 EYAISGRLTRKSDVYSFGVLLLEIVSG 244
           E       ++  D +S GV+   ++ G
Sbjct: 192 EVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 40/215 (18%)
Query: 50  IGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK------QG---EKEFMSEVASMANVNVCH 99
           +G GGFG V+  +++  G + A K L+ +        QG   EK+ +++V S   V++ +
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 100 ENLVK---------LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 150
               K         ++GG I    R  +Y+   +N       G ++ RA F         
Sbjct: 253 AFETKTDLCLVMTIMNGGDI----RYHIYNVDEDNP------GFQEPRAIF-------YT 295
Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG 210
             I  GL ++H   Q ++++RD+K  N+LLD + N +ISD GL+       T  +   AG
Sbjct: 296 AQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAG 351
Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
           T G++APE  +        D ++ GV L E+++ R
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 115/266 (43%), Gaps = 43/266 (16%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLH-- 106
           IG G FG VY+ +L D G +VA+K +  + +   +E       M  ++ C  N+V+L   
Sbjct: 33  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQI----MRKLDHC--NIVRLRYF 86
Query: 107 ----GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREI--------IMGIG 154
               G   D     LV DY+P             R A+   +A++ +        +  + 
Sbjct: 87  FYSSGEKKDEVYLNLVLDYVPETVY---------RVARHYSRAKQTLPVIYVKLYMYQLF 137
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLF---PENTTHISTRVAG 210
           R LAYIH      + HRDIK  N+LLD +    K+ DFG +K       N ++I +R   
Sbjct: 138 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 192
Query: 211 TLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNS 269
              Y APE        T   DV+S G +L E++ G+     D  + +   + K  G    
Sbjct: 193 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 249
Query: 270 KELMNLVDPMLYGNFPENEAIRFLKV 295
           +++  +        FP+ +A  + KV
Sbjct: 250 EQIREMNPNYTEFKFPQIKAHPWTKV 275

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 40/215 (18%)
Query: 50  IGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK------QG---EKEFMSEVASMANVNVCH 99
           +G GGFG V+  +++  G + A K L+ +        QG   EK+ +++V S   V++ +
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 100 ENLVK---------LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 150
               K         ++GG I    R  +Y+   +N       G ++ RA F         
Sbjct: 253 AFETKTDLCLVMTIMNGGDI----RYHIYNVDEDNP------GFQEPRAIF-------YT 295
Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG 210
             I  GL ++H   Q ++++RD+K  N+LLD + N +ISD GL+       T  +   AG
Sbjct: 296 AQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAG 351
Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
           T G++APE  +        D ++ GV L E+++ R
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 40/215 (18%)
Query: 50  IGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK------QG---EKEFMSEVASMANVNVCH 99
           +G GGFG V+  +++  G + A K L+ +        QG   EK+ +++V S   V++ +
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 100 ENLVK---------LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 150
               K         ++GG I    R  +Y+   +N       G ++ RA F         
Sbjct: 253 AFETKTDLCLVMTIMNGGDI----RYHIYNVDEDNP------GFQEPRAIF-------YT 295
Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG 210
             I  GL ++H   Q ++++RD+K  N+LLD + N +ISD GL+       T  +   AG
Sbjct: 296 AQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAG 351
Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
           T G++APE  +        D ++ GV L E+++ R
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 24/206 (11%)
Query: 50  IGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCHENLVKLH 106
           +G G +GSV      + G  VA+K LS   +S+   K    E+  + ++   HEN++ L 
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ--HENVIGLL 107
Query: 107 GGCIDGPCRILVYDY---MPNNSLS-QTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE 162
                       YD+   MP      Q ++G E    K  +     ++  + +GL YIH 
Sbjct: 108 DVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQY-----LVYQMLKGLKYIHS 162
Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLAPEYAI 221
                VVHRD+K  N+ ++++   KI DFGL++    E T ++ TR      Y APE  +
Sbjct: 163 A---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVIL 214
Query: 222 SG-RLTRKSDVYSFGVLLLEIVSGRT 246
           S     +  D++S G ++ E+++G+T
Sbjct: 215 SWMHYNQTVDIWSVGCIMAEMLTGKT 240

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 112/260 (43%), Gaps = 31/260 (11%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLH-- 106
           IG G FG VY+ +L D G +VA+K +  + +   +E       M  ++ C  N+V+L   
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQI----MRKLDHC--NIVRLRYF 94
Query: 107 ----GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKA--RREIIMGIGRGLAYI 160
               G   D     LV DY+P        +     RAK        +  +  + R LAYI
Sbjct: 95  FYSSGEKKDEVYLNLVLDYVPETVYR---VARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 151
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLF---PENTTHISTRVAGTLGYLA 216
           H      + HRDIK  N+LLD +    K+ DFG +K       N ++I +R      Y A
Sbjct: 152 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRA 203
Query: 217 PEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNL 275
           PE        T   DV+S G +L E++ G+     D  + +   + K  G    +++  +
Sbjct: 204 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 263
Query: 276 VDPMLYGNFPENEAIRFLKV 295
                   FP+ +A  + KV
Sbjct: 264 NPNYTEFKFPQIKAHPWTKV 283

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 114/260 (43%), Gaps = 31/260 (11%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLH-- 106
           IG G FG VY+ +L D G +VA+K    +  Q ++    E+  M  ++ C  N+V+L   
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHC--NIVRLRYF 81
Query: 107 ----GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKA--RREIIMGIGRGLAYI 160
               G   D     LV DY+P        +     RAK        +  +  + R LAYI
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYR---VARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLF---PENTTHISTRVAGTLGYLA 216
           H      + HRDIK  N+LLD +    K+ DFG +K       N ++I +R      Y A
Sbjct: 139 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRA 190
Query: 217 PEYAI-SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNL 275
           PE    +   T   DV+S G +L E++ G+     D  + +   + K  G    +++  +
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250
Query: 276 VDPMLYGNFPENEAIRFLKV 295
                   FP+ +A  + KV
Sbjct: 251 NPNYTEFKFPQIKAHPWTKV 270

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 33/217 (15%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 46  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 103
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 104 ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 157
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG--- 210
            RGL YIH      ++HRD+K SN+ ++++   KI DFGL++       H    + G   
Sbjct: 158 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMXGYVA 207
Query: 211 TLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           T  Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 208 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 244

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 89/202 (44%), Gaps = 35/202 (17%)
Query: 117 LVYDYMPNNSL---SQTLLGEEKRRAKF-GWKARREIIMGIGRGLAYIHEEIQPHVVHRD 172
           ++Y+YM N+S+    +     +K    F   +  + II  +    +YIH E   ++ HRD
Sbjct: 120 IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE--KNICHRD 177
Query: 173 IKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI--SGRLTRKSD 230
           +K SNIL+D+N   K+SDFG S+   +     S    GT  ++ PE+    S     K D
Sbjct: 178 VKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS---RGTYEFMPPEFFSNESSYNGAKVD 234
Query: 231 VYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPM-----LY---- 281
           ++S G+ L  +          + L E         ++N+    N+  P+     LY    
Sbjct: 235 IWSLGICLYVMFYNVVPFSLKISLVE---------LFNNIRTKNIEYPLDRNHFLYPLTN 285
Query: 282 ------GNFPENEAIRFLKVGL 297
                  NF  NE I FLK+ L
Sbjct: 286 KKSTCSNNFLSNEDIDFLKLFL 307

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 19/200 (9%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V   + ++ G   A+K+L     V+ KQ E   ++E   +  VN     LVK
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPF--LVK 105
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L     D     +V +Y+    +   L    +R  +F     R     I     Y+H   
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL----RRIGRFAEPHARFYAAQIVLTFEYLH--- 158
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              +++RD+K  N+L+DQ    +++DFG +K     T  +     GT  YLAPE  +S  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSKG 214
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
             +  D ++ GVL+ E+ +G
Sbjct: 215 YNKAVDWWALGVLIYEMAAG 234

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 75/307 (24%), Positives = 125/307 (40%), Gaps = 51/307 (16%)
Query: 41  TNGFRWSNKIGEGGFGSVYKGRLQDGT------IVAVKVLSVESKQG-EKEFMSEVASMA 93
           T+ ++   ++G+G F  V +   +  T      I+  K LS    Q  E+E         
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLERE--------- 80
Query: 94  NVNVC----HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREI 149
              +C    H N+V+LH    +     LV+D +    L + ++     R  +        
Sbjct: 81  -ARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVA----REYYSEADASHC 135
Query: 150 IMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN---PKISDFGLSKLFPENTTHIST 206
           I  I   + +IH   Q  +VHRD+K  N+LL         K++DFGL+ +  +       
Sbjct: 136 IHQILESVNHIH---QHDIVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGEQQAWF 191
Query: 207 RVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAV-DFD-------VQLGEYH 258
             AGT GYL+PE        +  D+++ GV+L  ++ G     D D       ++ G Y 
Sbjct: 192 GFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYD 251
Query: 259 LVDKAWGMYNSKELMNLVDPMLYGNFPEN-EAIRFLKVGLLCVQEKSKLRPQMSTAIKMM 317
                W    + E  NL++ ML  N  +   A + LK   +C         Q ST   MM
Sbjct: 252 FPSPEWDTV-TPEAKNLINQMLTINPAKRITADQALKHPWVC---------QRSTVASMM 301
Query: 318 NGETNID 324
           + +  ++
Sbjct: 302 HRQETVE 308

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 76/153 (49%), Gaps = 14/153 (9%)
Query: 99  HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
           H N++ L     DG    LV + M    L   +L    R+  F  +    ++  IG+ + 
Sbjct: 80  HPNIITLKDVYDDGKHVYLVTELMRGGELLDKIL----RQKFFSEREASFVLHTIGKTVE 135
Query: 159 YIHEEIQPHVVHRDIKTSNIL-LDQNFNP---KISDFGLSK-LFPENTTHISTRVAGTLG 213
           Y+H +    VVHRD+K SNIL +D++ NP   +I DFG +K L  EN   ++     T  
Sbjct: 136 YLHSQ---GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTP--CYTAN 190
Query: 214 YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT 246
           ++APE           D++S G+LL  +++G T
Sbjct: 191 FVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYT 223

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 94/218 (43%), Gaps = 26/218 (11%)
Query: 50  IGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGEKEFMSEVASMAN-VNVCHEN-LVKLH 106
           +G GGFGSVY G R+ D   VA+K         EK+ +S+   + N   V  E  L+K  
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIK-------HVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 107 GGCIDGPCRILVYDYMPNNSL--------SQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
                G  R+L +   P++ +         Q L      R     +  R     +   + 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
           + H      V+HRDIK  NIL+D N    K+ DFG   L  +    + T   GT  Y  P
Sbjct: 125 HCHNX---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPP 178
Query: 218 EYAISGRLT-RKSDVYSFGVLLLEIVSGRTAVDFDVQL 254
           E+    R   R + V+S G+LL ++V G    + D ++
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 216

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 13/212 (6%)
Query: 38  KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMA 93
           ++  N F +   +G+G FG V   + +  G   A+K+L  E   +K      ++E   + 
Sbjct: 5   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 64
Query: 94  NVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGI 153
           N        +K      D  C ++ Y      +    L     R   F     R     I
Sbjct: 65  NSRHPFLTALKYSFQTHDRLCFVMEY------ANGGELFFHLSRERVFSEDRARFYGAEI 118
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
              L Y+H E   +VV+RD+K  N++LD++ + KI+DFGL K   ++   +     GT  
Sbjct: 119 VSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKX-FCGTPE 175
Query: 214 YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
           YLAPE        R  D +  GV++ E++ GR
Sbjct: 176 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 13/212 (6%)
Query: 38  KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMA 93
           ++  N F +   +G+G FG V   + +  G   A+K+L  E   +K      ++E   + 
Sbjct: 4   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 63
Query: 94  NVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGI 153
           N        +K      D  C ++ Y      +    L     R   F     R     I
Sbjct: 64  NSRHPFLTALKYSFQTHDRLCFVMEY------ANGGELFFHLSRERVFSEDRARFYGAEI 117
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
              L Y+H E   +VV+RD+K  N++LD++ + KI+DFGL K   ++   +     GT  
Sbjct: 118 VSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKX-FCGTPE 174
Query: 214 YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
           YLAPE        R  D +  GV++ E++ GR
Sbjct: 175 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 13/212 (6%)
Query: 38  KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMA 93
           ++  N F +   +G+G FG V   + +  G   A+K+L  E   +K      ++E   + 
Sbjct: 6   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 65
Query: 94  NVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGI 153
           N        +K      D  C ++ Y      +    L     R   F     R     I
Sbjct: 66  NSRHPFLTALKYSFQTHDRLCFVMEY------ANGGELFFHLSRERVFSEDRARFYGAEI 119
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
              L Y+H E   +VV+RD+K  N++LD++ + KI+DFGL K   ++   +     GT  
Sbjct: 120 VSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKX-FCGTPE 176
Query: 214 YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
           YLAPE        R  D +  GV++ E++ GR
Sbjct: 177 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 26/218 (11%)
Query: 50  IGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGEKEFMSEVASMAN-VNVCHEN-LVKLH 106
           +G GGFGSVY G R+ D   VA+K +       EK+ +S+   + N   V  E  L+K  
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHV-------EKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 107 GGCIDGPCRILVYDYMPNNSL--------SQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
                G  R+L +   P++ +         Q L      R     +  R     +   + 
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 129
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
           + H      V+HRDIK  NIL+D N    K+ DFG   L  +    + T   GT  Y  P
Sbjct: 130 HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPP 183
Query: 218 EYAISGRLT-RKSDVYSFGVLLLEIVSGRTAVDFDVQL 254
           E+    R   R + V+S G+LL ++V G    + D ++
Sbjct: 184 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 221

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 19/200 (9%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V   + ++ G   A+K+L     V+ KQ E   ++E   +  VN     LVK
Sbjct: 50  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPF--LVK 106
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L     D     +V +Y+    +   L    +R  +F     R     I     Y+H   
Sbjct: 107 LEFSFKDNSNLYMVMEYVAGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH--- 159
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              +++RD+K  N+L+DQ    +++DFG +K     T  +     GT  YLAPE  +S  
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSKG 215
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
             +  D ++ GVL+ E+ +G
Sbjct: 216 YNKAVDWWALGVLIYEMAAG 235

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 100/213 (46%), Gaps = 34/213 (15%)
Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC----HENLV 103
           KIG+G FG V+K R  + G  VA+K + +E+   EKE    + ++  + +     HEN+V
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMEN---EKEGFP-ITALREIKILQLLKHENVV 80
Query: 104 KLHGGCIDGP-----CR---ILVYDYMPNNS---LSQTLLGEEKRRAKFGWKARREIIMG 152
            L   C         C+    LV+D+  ++    LS  L+       KF     + ++  
Sbjct: 81  NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV-------KFTLSEIKRVMQM 133
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG-- 210
           +  GL YIH      ++HRD+K +N+L+ ++   K++DFGL++ F         R     
Sbjct: 134 LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRV 190
Query: 211 -TLGYLAPEYAISGR-LTRKSDVYSFGVLLLEI 241
            TL Y  PE  +  R      D++  G ++ E+
Sbjct: 191 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 19/200 (9%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V   + ++ G   A+K+L     V+ KQ E   ++E   +  VN     LVK
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPF--LVK 105
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L     D     +V +Y+    +   L    +R  +F     R     I     Y+H   
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH--- 158
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              +++RD+K  N+L+DQ    +++DFG +K     T  +     GT  YLAPE  +S  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSKG 214
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
             +  D ++ GVL+ E+ +G
Sbjct: 215 YNKAVDWWALGVLIYEMAAG 234

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 75/328 (22%), Positives = 136/328 (41%), Gaps = 33/328 (10%)
Query: 41  TNGFRWSNKIGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCH 99
           T+ ++   ++G+G F  V +  ++  G   A K+++ +          E  +     + H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
            N+V+LH    +     LV+D +    L + ++     R  +        I  I   + +
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVA----REYYSEADASHCIQQILESVNH 118
Query: 160 IHEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLA 216
            H      +VHRD+K  N+LL    +    K++DFGL+ +  +         AGT GYL+
Sbjct: 119 CHLN---GIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLS 174
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVSGRTAV-DFD-------VQLGEYHLVDKAWGMYN 268
           PE        +  D+++ GV+L  ++ G     D D       ++ G Y      W    
Sbjct: 175 PEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTV- 233
Query: 269 SKELMNLVDPMLYGNFPEN-EAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNIDGXD 327
           + E  +L++ ML  N  +   A   LK   +C         Q ST   MM+ +  +D   
Sbjct: 234 TPEAKDLINKMLTINPAKRITASEALKHPWIC---------QRSTVASMMHRQETVDCLK 284
Query: 328 VEISQPGLIGDIMDVKVGQR--SSSKSM 353
              ++  L G I+   +  R  S++KS+
Sbjct: 285 KFNARRKLKGAILTTMLATRNFSAAKSL 312

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 19/200 (9%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V   + ++ G   A+K+L     V+ KQ E   ++E   +  VN     LVK
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPF--LVK 105
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L     D     +V +Y+    +   L    +R  +F     R     I     Y+H   
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH--- 158
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              +++RD+K  N+++DQ    +++DFG +K     T  +     GT  YLAPE  IS  
Sbjct: 159 SLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIIISKG 214
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
             +  D ++ GVL+ E+ +G
Sbjct: 215 YNKAVDWWALGVLIYEMAAG 234

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 19/200 (9%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V   + ++ G   A+K+L     V+ KQ E   ++E   +  VN     LVK
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPF--LVK 105
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L     D     +V +Y+    +   L    +R  +F     R     I     Y+H   
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH--- 158
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              +++RD+K  N+L+DQ    +++DFG +K     T  +     GT  YLAPE  +S  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSKG 214
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
             +  D ++ GVL+ E+ +G
Sbjct: 215 YNKAVDWWALGVLIYEMAAG 234

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 19/200 (9%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V   + ++ G   A+K+L     V+ KQ E   ++E   +  VN     LVK
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPF--LVK 105
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L     D     +V +Y+    +   L    +R  +F     R     I     Y+H   
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH--- 158
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              +++RD+K  N+L+DQ    +++DFG +K     T  +     GT  YLAPE  +S  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSKG 214
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
             +  D ++ GVL+ E+ +G
Sbjct: 215 YNKAVDWWALGVLIYEMAAG 234

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 26/218 (11%)
Query: 50  IGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGEKEFMSEVASMAN-VNVCHEN-LVKLH 106
           +G GGFGSVY G R+ D   VA+K +       EK+ +S+   + N   V  E  L+K  
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHV-------EKDRISDWGELPNGTRVPMEVVLLKKV 111
Query: 107 GGCIDGPCRILVYDYMPNNSL--------SQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
                G  R+L +   P++ +         Q L      R     +  R     +   + 
Sbjct: 112 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 171
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
           + H      V+HRDIK  NIL+D N    K+ DFG   L  +    + T   GT  Y  P
Sbjct: 172 HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPP 225
Query: 218 EYAISGRLT-RKSDVYSFGVLLLEIVSGRTAVDFDVQL 254
           E+    R   R + V+S G+LL ++V G    + D ++
Sbjct: 226 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 263

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 26/218 (11%)
Query: 50  IGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGEKEFMSEVASMAN-VNVCHEN-LVKLH 106
           +G GGFGSVY G R+ D   VA+K +       EK+ +S+   + N   V  E  L+K  
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHV-------EKDRISDWGELPNGTRVPMEVVLLKKV 68
Query: 107 GGCIDGPCRILVYDYMPNNSL--------SQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
                G  R+L +   P++ +         Q L      R     +  R     +   + 
Sbjct: 69  SSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVR 128
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
           + H      V+HRDIK  NIL+D N    K+ DFG   L  +    + T   GT  Y  P
Sbjct: 129 HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPP 182
Query: 218 EYAISGRLT-RKSDVYSFGVLLLEIVSGRTAVDFDVQL 254
           E+    R   R + V+S G+LL ++V G    + D ++
Sbjct: 183 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 220

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 19/200 (9%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V   + ++ G   A+K+L     V+ KQ E   ++E   +  VN     LVK
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPF--LVK 105
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L     D     +V +Y+    +   L    +R  +F     R     I     Y+H   
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH--- 158
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              +++RD+K  N+L+DQ    +++DFG +K     T  +     GT  YLAPE  +S  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSKG 214
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
             +  D ++ GVL+ E+ +G
Sbjct: 215 YNKAVDWWALGVLIYEMAAG 234

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 33/217 (15%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 43  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 100
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 101 ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 154
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG--- 210
            RGL YIH      ++HRD+K SN+ ++++   KI DFGL++       H    + G   
Sbjct: 155 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMXGXVA 204
Query: 211 TLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           T  Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 205 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 241

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 19/200 (9%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V   + ++ G   A+K+L     V+ KQ E   ++E   +  VN     LVK
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPF--LVK 105
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L     D     +V +Y+    +   L    +R  +F     R     I     Y+H   
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH--- 158
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              +++RD+K  N+L+DQ    +++DFG +K     T  +     GT  YLAPE  +S  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLX----GTPEYLAPEIILSKG 214
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
             +  D ++ GVL+ E+ +G
Sbjct: 215 YNKAVDWWALGVLIYEMAAG 234

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 26/218 (11%)
Query: 50  IGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGEKEFMSEVASMAN-VNVCHEN-LVKLH 106
           +G GGFGSVY G R+ D   VA+K +       EK+ +S+   + N   V  E  L+K  
Sbjct: 15  LGSGGFGSVYSGIRVSDNLPVAIKHV-------EKDRISDWGELPNGTRVPMEVVLLKKV 67
Query: 107 GGCIDGPCRILVYDYMPNNSL--------SQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
                G  R+L +   P++ +         Q L      R     +  R     +   + 
Sbjct: 68  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 127
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
           + H      V+HRDIK  NIL+D N    K+ DFG   L  +    + T   GT  Y  P
Sbjct: 128 HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPP 181
Query: 218 EYAISGRLT-RKSDVYSFGVLLLEIVSGRTAVDFDVQL 254
           E+    R   R + V+S G+LL ++V G    + D ++
Sbjct: 182 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 219

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 26/218 (11%)
Query: 50  IGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGEKEFMSEVASMAN-VNVCHEN-LVKLH 106
           +G GGFGSVY G R+ D   VA+K +       EK+ +S+   + N   V  E  L+K  
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHV-------EKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 107 GGCIDGPCRILVYDYMPNNSL--------SQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
                G  R+L +   P++ +         Q L      R     +  R     +   + 
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 144
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
           + H      V+HRDIK  NIL+D N    K+ DFG   L  +    + T   GT  Y  P
Sbjct: 145 HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPP 198
Query: 218 EYAISGRLT-RKSDVYSFGVLLLEIVSGRTAVDFDVQL 254
           E+    R   R + V+S G+LL ++V G    + D ++
Sbjct: 199 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 236

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 112/260 (43%), Gaps = 31/260 (11%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLH-- 106
           IG G FG VY+ +L D G +VA+K    +  QG+     E+  M  ++ C  N+V+L   
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIK----KVLQGKAFKNRELQIMRKLDHC--NIVRLRYF 81
Query: 107 ----GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKA--RREIIMGIGRGLAYI 160
               G   D     LV DY+P        +     RAK        +  +  + R LAYI
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPATVYR---VARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLF---PENTTHISTRVAGTLGYLA 216
           H      + HRDIK  N+LLD +    K+ DFG +K       N + I +R      Y A
Sbjct: 139 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRA 190
Query: 217 PEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNL 275
           PE        T   DV+S G +L E++ G+     D  + +   + K  G    +++  +
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250
Query: 276 VDPMLYGNFPENEAIRFLKV 295
                   FP+ +A  + KV
Sbjct: 251 NPNYTEFAFPQIKAHPWTKV 270

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 117/268 (43%), Gaps = 47/268 (17%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVK-VLSVESKQGEKEFMS-EVASMANVNVCHENLVKLH 106
           IG G FG VY+ +L D G +VA+K VL       +K F + E+  M  ++ C  N+V+L 
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDHC--NIVRLR 113
Query: 107 ------GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREI--------IMG 152
                 G   D     LV DY+P             R A+   +A++ +        +  
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPETVY---------RVARHYSRAKQTLPVIYVKLYMYQ 164
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLF---PENTTHISTRV 208
           + R LAYIH      + HRDIK  N+LLD +    K+ DFG +K       N + I +R 
Sbjct: 165 LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY 221
Query: 209 AGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMY 267
                Y APE        T   DV+S G +L E++ G+     D  + +   + K  G  
Sbjct: 222 -----YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 276
Query: 268 NSKELMNLVDPMLYGNFPENEAIRFLKV 295
             +++  +        FP+ +A  + KV
Sbjct: 277 TREQIREMNPNYTEFKFPQIKAHPWTKV 304

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 26/218 (11%)
Query: 50  IGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGEKEFMSEVASMAN-VNVCHEN-LVKLH 106
           +G GGFGSVY G R+ D   VA+K +       EK+ +S+   + N   V  E  L+K  
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHV-------EKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 107 GGCIDGPCRILVYDYMPNNSL--------SQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
                G  R+L +   P++ +         Q L      R     +  R     +   + 
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 129
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
           + H      V+HRDIK  NIL+D N    K+ DFG   L  +    + T   GT  Y  P
Sbjct: 130 HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPP 183
Query: 218 EYAISGRLT-RKSDVYSFGVLLLEIVSGRTAVDFDVQL 254
           E+    R   R + V+S G+LL ++V G    + D ++
Sbjct: 184 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 221

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 26/218 (11%)
Query: 50  IGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGEKEFMSEVASMAN-VNVCHEN-LVKLH 106
           +G GGFGSVY G R+ D   VA+K +       EK+ +S+   + N   V  E  L+K  
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHV-------EKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 107 GGCIDGPCRILVYDYMPNNSL--------SQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
                G  R+L +   P++ +         Q L      R     +  R     +   + 
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 129
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
           + H      V+HRDIK  NIL+D N    K+ DFG   L  +    + T   GT  Y  P
Sbjct: 130 HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPP 183
Query: 218 EYAISGRLT-RKSDVYSFGVLLLEIVSGRTAVDFDVQL 254
           E+    R   R + V+S G+LL ++V G    + D ++
Sbjct: 184 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 221

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 26/218 (11%)
Query: 50  IGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGEKEFMSEVASMAN-VNVCHEN-LVKLH 106
           +G GGFGSVY G R+ D   VA+K +       EK+ +S+   + N   V  E  L+K  
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHV-------EKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 107 GGCIDGPCRILVYDYMPNNSL--------SQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
                G  R+L +   P++ +         Q L      R     +  R     +   + 
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 157
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
           + H      V+HRDIK  NIL+D N    K+ DFG   L  +    + T   GT  Y  P
Sbjct: 158 HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPP 211
Query: 218 EYAISGRLT-RKSDVYSFGVLLLEIVSGRTAVDFDVQL 254
           E+    R   R + V+S G+LL ++V G    + D ++
Sbjct: 212 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 249

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 26/218 (11%)
Query: 50  IGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGEKEFMSEVASMAN-VNVCHEN-LVKLH 106
           +G GGFGSVY G R+ D   VA+K +       EK+ +S+   + N   V  E  L+K  
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHV-------EKDRISDWGELPNGTRVPMEVVLLKKV 68
Query: 107 GGCIDGPCRILVYDYMPNNSL--------SQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
                G  R+L +   P++ +         Q L      R     +  R     +   + 
Sbjct: 69  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 128
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
           + H      V+HRDIK  NIL+D N    K+ DFG   L  +    + T   GT  Y  P
Sbjct: 129 HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPP 182
Query: 218 EYAISGRLT-RKSDVYSFGVLLLEIVSGRTAVDFDVQL 254
           E+    R   R + V+S G+LL ++V G    + D ++
Sbjct: 183 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 220

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 26/218 (11%)
Query: 50  IGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGEKEFMSEVASMAN-VNVCHEN-LVKLH 106
           +G GGFGSVY G R+ D   VA+K +       EK+ +S+   + N   V  E  L+K  
Sbjct: 39  LGSGGFGSVYSGIRVSDNLPVAIKHV-------EKDRISDWGELPNGTRVPMEVVLLKKV 91
Query: 107 GGCIDGPCRILVYDYMPNNSL--------SQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
                G  R+L +   P++ +         Q L      R     +  R     +   + 
Sbjct: 92  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 151
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
           + H      V+HRDIK  NIL+D N    K+ DFG   L  +    + T   GT  Y  P
Sbjct: 152 HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPP 205
Query: 218 EYAISGRLT-RKSDVYSFGVLLLEIVSGRTAVDFDVQL 254
           E+    R   R + V+S G+LL ++V G    + D ++
Sbjct: 206 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 243

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 19/200 (9%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V   + ++ G   A+K+L     V+ KQ E   ++E   +  VN     LVK
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPF--LVK 105
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L     D     +V +Y+    +   L    +R  +F     R     I     Y+H   
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH--- 158
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              +++RD+K  N+L+DQ    +++DFG +K     T  +     GT  YLAPE  +S  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSKG 214
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
             +  D ++ GVL+ E+ +G
Sbjct: 215 YNKAVDWWALGVLIYEMAAG 234

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 26/218 (11%)
Query: 50  IGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGEKEFMSEVASMAN-VNVCHEN-LVKLH 106
           +G GGFGSVY G R+ D   VA+K +       EK+ +S+   + N   V  E  L+K  
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHV-------EKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 107 GGCIDGPCRILVYDYMPNNSL--------SQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
                G  R+L +   P++ +         Q L      R     +  R     +   + 
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 156
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
           + H      V+HRDIK  NIL+D N    K+ DFG   L  +    + T   GT  Y  P
Sbjct: 157 HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPP 210
Query: 218 EYAISGRLT-RKSDVYSFGVLLLEIVSGRTAVDFDVQL 254
           E+    R   R + V+S G+LL ++V G    + D ++
Sbjct: 211 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 248

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 26/218 (11%)
Query: 50  IGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGEKEFMSEVASMAN-VNVCHEN-LVKLH 106
           +G GGFGSVY G R+ D   VA+K +       EK+ +S+   + N   V  E  L+K  
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHV-------EKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 107 GGCIDGPCRILVYDYMPNNSL--------SQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
                G  R+L +   P++ +         Q L      R     +  R     +   + 
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 157
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
           + H      V+HRDIK  NIL+D N    K+ DFG   L  +    + T   GT  Y  P
Sbjct: 158 HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPP 211
Query: 218 EYAISGRLT-RKSDVYSFGVLLLEIVSGRTAVDFDVQL 254
           E+    R   R + V+S G+LL ++V G    + D ++
Sbjct: 212 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 249

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 26/218 (11%)
Query: 50  IGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGEKEFMSEVASMAN-VNVCHEN-LVKLH 106
           +G GGFGSVY G R+ D   VA+K +       EK+ +S+   + N   V  E  L+K  
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHV-------EKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 107 GGCIDGPCRILVYDYMPNNSL--------SQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
                G  R+L +   P++ +         Q L      R     +  R     +   + 
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 157
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
           + H      V+HRDIK  NIL+D N    K+ DFG   L  +    + T   GT  Y  P
Sbjct: 158 HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPP 211
Query: 218 EYAISGRLT-RKSDVYSFGVLLLEIVSGRTAVDFDVQL 254
           E+    R   R + V+S G+LL ++V G    + D ++
Sbjct: 212 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 249

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 26/218 (11%)
Query: 50  IGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGEKEFMSEVASMAN-VNVCHEN-LVKLH 106
           +G GGFGSVY G R+ D   VA+K +       EK+ +S+   + N   V  E  L+K  
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHV-------EKDRISDWGELPNGTRVPMEVVLLKKV 83
Query: 107 GGCIDGPCRILVYDYMPNNSL--------SQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
                G  R+L +   P++ +         Q L      R     +  R     +   + 
Sbjct: 84  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 143
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
           + H      V+HRDIK  NIL+D N    K+ DFG   L  +    + T   GT  Y  P
Sbjct: 144 HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPP 197
Query: 218 EYAISGRLT-RKSDVYSFGVLLLEIVSGRTAVDFDVQL 254
           E+    R   R + V+S G+LL ++V G    + D ++
Sbjct: 198 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 235

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 94/218 (43%), Gaps = 26/218 (11%)
Query: 50  IGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGEKEFMSEVASMAN-VNVCHEN-LVKLH 106
           +G GGFGSVY G R+ D   VA+K         EK+ +S+   + N   V  E  L+K  
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIK-------HVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 107 GGCIDGPCRILVYDYMPNNSL--------SQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
                G  R+L +   P++ +         Q L      R     +  R     +   + 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
           + H      V+HRDIK  NIL+D N    K+ DFG   L  +    + T   GT  Y  P
Sbjct: 125 HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPP 178
Query: 218 EYAISGRLT-RKSDVYSFGVLLLEIVSGRTAVDFDVQL 254
           E+    R   R + V+S G+LL ++V G    + D ++
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 216

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 26/218 (11%)
Query: 50  IGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGEKEFMSEVASMAN-VNVCHEN-LVKLH 106
           +G GGFGSVY G R+ D   VA+K +       EK+ +S+   + N   V  E  L+K  
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHV-------EKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 107 GGCIDGPCRILVYDYMPNNSL--------SQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
                G  R+L +   P++ +         Q L      R     +  R     +   + 
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 144
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
           + H      V+HRDIK  NIL+D N    K+ DFG   L  +    + T   GT  Y  P
Sbjct: 145 HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPP 198
Query: 218 EYAISGRLT-RKSDVYSFGVLLLEIVSGRTAVDFDVQL 254
           E+    R   R + V+S G+LL ++V G    + D ++
Sbjct: 199 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 236

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 21/207 (10%)
Query: 48  NKIGEGGFGSVYKGR-LQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCHENLVK 104
           + +G G +GSV     ++ G  +AVK LS   +S    K    E+  + ++   HEN++ 
Sbjct: 57  SPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMK--HENVI- 113
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGIGRGLAYI 160
              G +D        +   +  L   L+G +     +  K      + +I  I RGL YI
Sbjct: 114 ---GLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 170
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
           H      ++HRD+K SN+ ++++   KI DFGL++    +T    T    T  Y APE  
Sbjct: 171 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 223
Query: 221 ISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           ++        D++S G ++ E+++GRT
Sbjct: 224 LNWMHYNMTVDIWSVGCIMAELLTGRT 250

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 112/260 (43%), Gaps = 31/260 (11%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLH-- 106
           IG G FG VY+ +L D G +VA+K +  + +   +E       M  ++ C  N+V+L   
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQI----MRKLDHC--NIVRLRYF 100
Query: 107 ----GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKA--RREIIMGIGRGLAYI 160
               G   D     LV DY+P        +     RAK        +  +  + R LAYI
Sbjct: 101 FYSSGEKKDEVYLNLVLDYVPETVYR---VARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 157
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLF---PENTTHISTRVAGTLGYLA 216
           H      + HRDIK  N+LLD +    K+ DFG +K       N + I +R      Y A
Sbjct: 158 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRA 209
Query: 217 PEYAI-SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNL 275
           PE    +   T   DV+S G +L E++ G+     D  + +   + K  G    +++  +
Sbjct: 210 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 269
Query: 276 VDPMLYGNFPENEAIRFLKV 295
                   FP+ +A  + KV
Sbjct: 270 NPNYTEFKFPQIKAHPWTKV 289

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 100/213 (46%), Gaps = 34/213 (15%)
Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC----HENLV 103
           KIG+G FG V+K R  + G  VA+K + +E+   EKE    + ++  + +     HEN+V
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMEN---EKEGFP-ITALREIKILQLLKHENVV 80
Query: 104 KLHGGCIDGP-----CR---ILVYDYMPNNS---LSQTLLGEEKRRAKFGWKARREIIMG 152
            L   C         C+    LV+D+  ++    LS  L+       KF     + ++  
Sbjct: 81  NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV-------KFTLSEIKRVMQM 133
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG-- 210
           +  GL YIH      ++HRD+K +N+L+ ++   K++DFGL++ F         R     
Sbjct: 134 LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRV 190
Query: 211 -TLGYLAPEYAISGR-LTRKSDVYSFGVLLLEI 241
            TL Y  PE  +  R      D++  G ++ E+
Sbjct: 191 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 92/195 (47%), Gaps = 33/195 (16%)
Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC----HENLV 103
           KIG+G FG V+K R  + G  VA+K + +E+   EKE    + ++  + +     HEN+V
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKVLMEN---EKEGFP-ITALREIKILQLLKHENVV 79
Query: 104 KLHGGCIDGP-----CR---ILVYDYMPNNS---LSQTLLGEEKRRAKFGWKARREIIMG 152
            L   C         C+    LV+D+  ++    LS  L+       KF     + ++  
Sbjct: 80  NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV-------KFTLSEIKRVMQM 132
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG-- 210
           +  GL YIH      ++HRD+K +N+L+ ++   K++DFGL++ F         R     
Sbjct: 133 LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRV 189
Query: 211 -TLGYLAPEYAISGR 224
            TL Y  PE  +  R
Sbjct: 190 VTLWYRPPELLLGER 204

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 71/292 (24%), Positives = 124/292 (42%), Gaps = 78/292 (26%)
Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVL--SVESKQGEKEFMSEVASMANVN--------- 96
           ++G G +G V K R +  G I+AVK +  +V S++ ++  M    SM  V+         
Sbjct: 58  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 117
Query: 97  ---------VCHE----NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGW 143
                    +C E    +L K +   ID              ++ + +LG+         
Sbjct: 118 ALFREGDVWICMELMDTSLDKFYKQVIDK-----------GQTIPEDILGK--------- 157
Query: 144 KARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 203
                I + I + L ++H ++   V+HRD+K SN+L++     K+ DFG+S    ++   
Sbjct: 158 -----IAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVA- 209
Query: 204 ISTRVAGTLGYLAPEYAISGRLTR-----KSDVYSFGVLLLEIVSGRTAVDFDVQLGEYH 258
             T  AG   Y+APE  I+  L +     KSD++S G+ ++E+   R   D         
Sbjct: 210 -KTIDAGCKPYMAPE-RINPELNQKGYSVKSDIWSLGITMIELAILRFPYD--------- 258
Query: 259 LVDKAWG--MYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRP 308
               +WG      K+++    P L  +    E + F      C+++ SK RP
Sbjct: 259 ----SWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTS---QCLKKNSKERP 303

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 26/218 (11%)
Query: 50  IGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGEKEFMSEVASMAN-VNVCHEN-LVKLH 106
           +G GGFGSVY G R+ D   VA+K +       EK+ +S+   + N   V  E  L+K  
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHV-------EKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 107 GGCIDGPCRILVYDYMPNNSL--------SQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
                G  R+L +   P++ +         Q L      R     +  R     +   + 
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 163
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
           + H      V+HRDIK  NIL+D N    K+ DFG   L  +    + T   GT  Y  P
Sbjct: 164 HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPP 217
Query: 218 EYAISGRLT-RKSDVYSFGVLLLEIVSGRTAVDFDVQL 254
           E+    R   R + V+S G+LL ++V G    + D ++
Sbjct: 218 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 255

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 26/218 (11%)
Query: 50  IGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGEKEFMSEVASMAN-VNVCHEN-LVKLH 106
           +G GGFGSVY G R+ D   VA+K +       EK+ +S+   + N   V  E  L+K  
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHV-------EKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 107 GGCIDGPCRILVYDYMPNNSL--------SQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
                G  R+L +   P++ +         Q L      R     +  R     +   + 
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 156
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
           + H      V+HRDIK  NIL+D N    K+ DFG   L  +    + T   GT  Y  P
Sbjct: 157 HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPP 210
Query: 218 EYAISGRLT-RKSDVYSFGVLLLEIVSGRTAVDFDVQL 254
           E+    R   R + V+S G+LL ++V G    + D ++
Sbjct: 211 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 248

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 26/218 (11%)
Query: 50  IGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGEKEFMSEVASMAN-VNVCHEN-LVKLH 106
           +G GGFGSVY G R+ D   VA+K +       EK+ +S+   + N   V  E  L+K  
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHV-------EKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 107 GGCIDGPCRILVYDYMPNNSL--------SQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
                G  R+L +   P++ +         Q L      R     +  R     +   + 
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 156
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
           + H      V+HRDIK  NIL+D N    K+ DFG   L  +    + T   GT  Y  P
Sbjct: 157 HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPP 210
Query: 218 EYAISGRLT-RKSDVYSFGVLLLEIVSGRTAVDFDVQL 254
           E+    R   R + V+S G+LL ++V G    + D ++
Sbjct: 211 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 248

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 26/218 (11%)
Query: 50  IGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGEKEFMSEVASMAN-VNVCHEN-LVKLH 106
           +G GGFGSVY G R+ D   VA+K +       EK+ +S+   + N   V  E  L+K  
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHV-------EKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 107 GGCIDGPCRILVYDYMPNNSL--------SQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
                G  R+L +   P++ +         Q L      R     +  R     +   + 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
           + H      V+HRDIK  NIL+D N    K+ DFG   L  +    + T   GT  Y  P
Sbjct: 125 HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPP 178
Query: 218 EYAISGRLT-RKSDVYSFGVLLLEIVSGRTAVDFDVQL 254
           E+    R   R + V+S G+LL ++V G    + D ++
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 216

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 26/218 (11%)
Query: 50  IGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGEKEFMSEVASMAN-VNVCHEN-LVKLH 106
           +G GGFGSVY G R+ D   VA+K +       EK+ +S+   + N   V  E  L+K  
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHV-------EKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 107 GGCIDGPCRILVYDYMPNNSL--------SQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
                G  R+L +   P++ +         Q L      R     +  R     +   + 
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 157
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
           + H      V+HRDIK  NIL+D N    K+ DFG   L  +    + T   GT  Y  P
Sbjct: 158 HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPP 211
Query: 218 EYAISGRLT-RKSDVYSFGVLLLEIVSGRTAVDFDVQL 254
           E+    R   R + V+S G+LL ++V G    + D ++
Sbjct: 212 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 249

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 26/218 (11%)
Query: 50  IGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGEKEFMSEVASMAN-VNVCHEN-LVKLH 106
           +G GGFGSVY G R+ D   VA+K +       EK+ +S+   + N   V  E  L+K  
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHV-------EKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 107 GGCIDGPCRILVYDYMPNNSL--------SQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
                G  R+L +   P++ +         Q L      R     +  R     +   + 
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 156
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
           + H      V+HRDIK  NIL+D N    K+ DFG   L  +    + T   GT  Y  P
Sbjct: 157 HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPP 210
Query: 218 EYAISGRLT-RKSDVYSFGVLLLEIVSGRTAVDFDVQL 254
           E+    R   R + V+S G+LL ++V G    + D ++
Sbjct: 211 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 248

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 100/213 (46%), Gaps = 34/213 (15%)
Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC----HENLV 103
           KIG+G FG V+K R  + G  VA+K + +E+   EKE    + ++  + +     HEN+V
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMEN---EKEGFP-ITALREIKILQLLKHENVV 80
Query: 104 KLHGGCIDGP-----CR---ILVYDYMPNNS---LSQTLLGEEKRRAKFGWKARREIIMG 152
            L   C         C+    LV+D+  ++    LS  L+       KF     + ++  
Sbjct: 81  NLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLV-------KFTLSEIKRVMQM 133
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG-- 210
           +  GL YIH      ++HRD+K +N+L+ ++   K++DFGL++ F         R     
Sbjct: 134 LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRV 190
Query: 211 -TLGYLAPEYAISGR-LTRKSDVYSFGVLLLEI 241
            TL Y  PE  +  R      D++  G ++ E+
Sbjct: 191 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 26/218 (11%)
Query: 50  IGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGEKEFMSEVASMAN-VNVCHEN-LVKLH 106
           +G GGFGSVY G R+ D   VA+K +       EK+ +S+   + N   V  E  L+K  
Sbjct: 64  LGSGGFGSVYSGIRVSDNLPVAIKHV-------EKDRISDWGELPNGTRVPMEVVLLKKV 116
Query: 107 GGCIDGPCRILVYDYMPNNSL--------SQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
                G  R+L +   P++ +         Q L      R     +  R     +   + 
Sbjct: 117 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 176
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
           + H      V+HRDIK  NIL+D N    K+ DFG   L  +    + T   GT  Y  P
Sbjct: 177 HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPP 230
Query: 218 EYAISGRLT-RKSDVYSFGVLLLEIVSGRTAVDFDVQL 254
           E+    R   R + V+S G+LL ++V G    + D ++
Sbjct: 231 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 268

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 26/218 (11%)
Query: 50  IGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGEKEFMSEVASMAN-VNVCHEN-LVKLH 106
           +G GGFGSVY G R+ D   VA+K +       EK+ +S+   + N   V  E  L+K  
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHV-------EKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 107 GGCIDGPCRILVYDYMPNNSL--------SQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
                G  R+L +   P++ +         Q L      R     +  R     +   + 
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 144
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
           + H      V+HRDIK  NIL+D N    K+ DFG   L  +    + T   GT  Y  P
Sbjct: 145 HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPP 198
Query: 218 EYAISGRLT-RKSDVYSFGVLLLEIVSGRTAVDFDVQL 254
           E+    R   R + V+S G+LL ++V G    + D ++
Sbjct: 199 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 236

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 26/218 (11%)
Query: 50  IGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGEKEFMSEVASMAN-VNVCHEN-LVKLH 106
           +G GGFGSVY G R+ D   VA+K +       EK+ +S+   + N   V  E  L+K  
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHV-------EKDRISDWGELPNGTRVPMEVVLLKKV 83
Query: 107 GGCIDGPCRILVYDYMPNNSL--------SQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
                G  R+L +   P++ +         Q L      R     +  R     +   + 
Sbjct: 84  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 143
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
           + H      V+HRDIK  NIL+D N    K+ DFG   L  +    + T   GT  Y  P
Sbjct: 144 HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPP 197
Query: 218 EYAISGRLT-RKSDVYSFGVLLLEIVSGRTAVDFDVQL 254
           E+    R   R + V+S G+LL ++V G    + D ++
Sbjct: 198 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 235

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 19/200 (9%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V   + ++ G   A+K+L     V+ KQ E   ++E   +  VN     LVK
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPF--LVK 105
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L     D     +V +Y+    +   L    +R  +F     R     I     Y+H   
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL----RRIGRFXEPHARFYAAQIVLTFEYLH--- 158
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              +++RD+K  N+L+DQ    +++DFG +K     T  +     GT  YLAPE  +S  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSKG 214
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
             +  D ++ GVL+ E+ +G
Sbjct: 215 YNKAVDWWALGVLIYEMAAG 234

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 21/227 (9%)
Query: 23  EQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQD-GTIVAVKVLS----VE 77
           E  LK     S N  ++  + F     +G G FG V   + ++ G   A+K+L     V+
Sbjct: 45  EDFLKKWETPSQNTAQL--DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK 102
Query: 78  SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKR 137
            KQ E   ++E   +  VN     LVKL     D     +V +Y+    +   L    +R
Sbjct: 103 LKQIEHT-LNEKRILQAVNFPF--LVKLEFSFKDNSNLYMVMEYVAGGEMFSHL----RR 155
Query: 138 RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197
             +F     R     I     Y+H      +++RD+K  N+L+DQ    +++DFG +K  
Sbjct: 156 IGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-- 210
Query: 198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
                  +  + GT  YLAPE  +S    +  D ++ GVL+ E+ +G
Sbjct: 211 --RVKGATWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 94/218 (43%), Gaps = 26/218 (11%)
Query: 50  IGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGEKEFMSEVASMAN-VNVCHEN-LVKLH 106
           +G GGFGSVY G R+ D   VA+K         EK+ +S+   + N   V  E  L+K  
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIK-------HVEKDRISDWGELPNGTRVPMEVVLLKKV 111
Query: 107 GGCIDGPCRILVYDYMPNNSL--------SQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
                G  R+L +   P++ +         Q L      R     +  R     +   + 
Sbjct: 112 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 171
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
           + H      V+HRDIK  NIL+D N    K+ DFG   L  +    + T   GT  Y  P
Sbjct: 172 HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPP 225
Query: 218 EYAISGRLT-RKSDVYSFGVLLLEIVSGRTAVDFDVQL 254
           E+    R   R + V+S G+LL ++V G    + D ++
Sbjct: 226 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 263

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 19/200 (9%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V   + ++ G   A+K+L     V+ KQ E   ++E   +  VN     LVK
Sbjct: 44  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPF--LVK 100
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L     D     +V +Y+    +   L    +R  +F     R     I     Y+H   
Sbjct: 101 LEFSFKDNSNLYMVMEYVAGGEMFSHL----RRIGRFXEPHARFYAAQIVLTFEYLH--- 153
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              +++RD+K  N+L+DQ    +++DFG +K     T  +     GT  YLAPE  +S  
Sbjct: 154 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSKG 209
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
             +  D ++ GVL+ E+ +G
Sbjct: 210 YNKAVDWWALGVLIYEMAAG 229

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 19/200 (9%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V   + ++ G   A+K+L     V+ KQ E   ++E   +  VN     LVK
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPF--LVK 105
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L     D     +V +Y+    +   L    +R  +F     R     I     Y+H   
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL----RRIGRFXEPHARFYAAQIVLTFEYLH--- 158
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              +++RD+K  N+L+DQ    +++DFG +K     T  +     GT  YLAPE  +S  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSKG 214
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
             +  D ++ GVL+ E+ +G
Sbjct: 215 YNKAVDWWALGVLIYEMAAG 234

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 114/266 (42%), Gaps = 43/266 (16%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLH-- 106
           IG G FG VY+ +L D G +VA+K +  + +   +E       M  ++ C  N+V+L   
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQI----MRKLDHC--NIVRLRYF 93
Query: 107 ----GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREI--------IMGIG 154
               G   D     LV DY+P             R A+   +A++ +        +  + 
Sbjct: 94  FYSSGEKKDEVYLNLVLDYVPETVY---------RVARHYSRAKQTLPVIYVKLYMYQLF 144
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLF---PENTTHISTRVAG 210
           R LAYIH      + HRDIK  N+LLD +    K+ DFG +K       N + I +R   
Sbjct: 145 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-- 199
Query: 211 TLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNS 269
              Y APE        T   DV+S G +L E++ G+     D  + +   + K  G    
Sbjct: 200 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 256
Query: 270 KELMNLVDPMLYGNFPENEAIRFLKV 295
           +++  +        FP+ +A  + KV
Sbjct: 257 EQIREMNPNYTEFKFPQIKAHPWTKV 282

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 100/227 (44%), Gaps = 21/227 (9%)
Query: 23  EQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQD-GTIVAVKVLS----VE 77
           E  LK     S N  ++  + F     +G G FG V   + ++ G   A+K+L     V+
Sbjct: 45  EDFLKKWETPSQNTAQL--DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK 102
Query: 78  SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKR 137
            KQ E   ++E   +  VN     LVKL     D     +V +Y+    +   L    +R
Sbjct: 103 LKQIEHT-LNEKRILQAVNFPF--LVKLEFSFKDNSNLYMVMEYVAGGEMFSHL----RR 155
Query: 138 RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197
             +F     R     I     Y+H      +++RD+K  N+L+DQ    +++DFG +K  
Sbjct: 156 IGRFXEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 212
Query: 198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
              T  +     GT  YLAPE  +S    +  D ++ GVL+ E+ +G
Sbjct: 213 KGRTWXL----CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 19/200 (9%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V   + ++ G   A+K+L     V+ KQ E   ++E   +  VN     LVK
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPF--LVK 105
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L     D     +V +Y+    +   L    +R  +F     R     I     Y+H   
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL----RRIGRFXEPHARFYAAQIVLTFEYLH--- 158
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              +++RD+K  N+L+DQ    +++DFG +K     T  +     GT  YLAPE  +S  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSKG 214
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
             +  D ++ GVL+ E+ +G
Sbjct: 215 YNKAVDWWALGVLIYEMAAG 234

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 91/203 (44%), Gaps = 18/203 (8%)
Query: 50  IGEGGFGSVYKGRLQDGT-IVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKL 105
           IG+G FG V   +  D   + A+K ++ +    +   +    E+  M  +   H  LV L
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE--HPFLVNL 80
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
                D     +V D +    L   L    ++   F  +  +  I  +   L Y+  +  
Sbjct: 81  WYSFQDEEDMFMVVDLLLGGDLRYHL----QQNVHFKEETVKLFICELVMALDYLQNQ-- 134
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR- 224
             ++HRD+K  NILLD++ +  I+DF ++ + P  T    T +AGT  Y+APE   S + 
Sbjct: 135 -RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ--ITTMAGTKPYMAPEMFSSRKG 191
Query: 225 --LTRKSDVYSFGVLLLEIVSGR 245
              +   D +S GV   E++ GR
Sbjct: 192 AGYSFAVDWWSLGVTAYELLRGR 214

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 112/260 (43%), Gaps = 31/260 (11%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLH-- 106
           IG G FG VY+ +L D G +VA+K    +  Q ++    E+  M  ++ C  N+V+L   
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHC--NIVRLRYF 85
Query: 107 ----GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKA--RREIIMGIGRGLAYI 160
               G   D     LV DY+P        +     RAK        +  +  + R LAYI
Sbjct: 86  FYSSGEKKDEVYLNLVLDYVPETVYR---VARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 142
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLF---PENTTHISTRVAGTLGYLA 216
           H      + HRDIK  N+LLD +    K+ DFG +K       N + I +R      Y A
Sbjct: 143 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRA 194
Query: 217 PEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNL 275
           PE        T   DV+S G +L E++ G+     D  + +   + K  G    +++  +
Sbjct: 195 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 254
Query: 276 VDPMLYGNFPENEAIRFLKV 295
                   FP+ +A  + KV
Sbjct: 255 NPNYTEFKFPQIKAHPWTKV 274

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 55/103 (53%), Gaps = 7/103 (6%)
Query: 147 REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK---LFPENTTH 203
           R  +  + RGL Y+H      V+HRD+K SN+L+++N   KI DFG+++     P    +
Sbjct: 162 RYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQY 218
Query: 204 ISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGR 245
             T    T  Y APE  +S    T+  D++S G +  E+++ R
Sbjct: 219 FMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARR 261

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 112/260 (43%), Gaps = 31/260 (11%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLH-- 106
           IG G FG VY+ +L D G +VA+K +  + +   +E       M  ++ C  N+V+L   
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQI----MRKLDHC--NIVRLRYF 93
Query: 107 ----GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKA--RREIIMGIGRGLAYI 160
               G   D     LV DY+P        +     RAK        +  +  + R LAYI
Sbjct: 94  FYSSGEKKDEVYLNLVLDYVPETVYR---VARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 150
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLF---PENTTHISTRVAGTLGYLA 216
           H      + HRDIK  N+LLD +    K+ DFG +K       N + I +R      Y A
Sbjct: 151 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRA 202
Query: 217 PEYAI-SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNL 275
           PE    +   T   DV+S G +L E++ G+     D  + +   + K  G    +++  +
Sbjct: 203 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 262
Query: 276 VDPMLYGNFPENEAIRFLKV 295
                   FP+ +A  + KV
Sbjct: 263 NPNYTEFKFPQIKAHPWTKV 282

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 113/260 (43%), Gaps = 31/260 (11%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLH-- 106
           IG G FG VY+ +L D G +VA+K    +  Q ++    E+  M  ++ C  N+V+L   
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHC--NIVRLRYF 81
Query: 107 ----GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKA--RREIIMGIGRGLAYI 160
               G   D     LV DY+P        +     RAK        +  +  + R LAYI
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYR---VARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLF---PENTTHISTRVAGTLGYLA 216
           H      + HRDIK  N+LLD +    K+ DFG +K       N + I +R      Y A
Sbjct: 139 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRA 190
Query: 217 PEYAI-SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNL 275
           PE    +   T   DV+S G +L E++ G+     D  + +   + K  G    +++  +
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250
Query: 276 VDPMLYGNFPENEAIRFLKV 295
                   FP+ +A  + KV
Sbjct: 251 NPNYTEFKFPQIKAHPWTKV 270

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 113/260 (43%), Gaps = 31/260 (11%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLH-- 106
           IG G FG VY+ +L D G +VA+K    +  Q ++    E+  M  ++ C  N+V+L   
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHC--NIVRLRYF 81
Query: 107 ----GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKA--RREIIMGIGRGLAYI 160
               G   D     LV DY+P        +     RAK        +  +  + R LAYI
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYR---VARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLF---PENTTHISTRVAGTLGYLA 216
           H      + HRDIK  N+LLD +    K+ DFG +K       N + I +R      Y A
Sbjct: 139 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRA 190
Query: 217 PEYAI-SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNL 275
           PE    +   T   DV+S G +L E++ G+     D  + +   + K  G    +++  +
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250
Query: 276 VDPMLYGNFPENEAIRFLKV 295
                   FP+ +A  + KV
Sbjct: 251 NPNYTEFKFPQIKAHPWTKV 270

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/266 (22%), Positives = 112/266 (42%), Gaps = 40/266 (15%)
Query: 69  VAVKVLSVESKQGE-KEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNS- 126
           VA+K +++E  Q    E + E+ +M+  +  H N+V  +   +      LV   +   S 
Sbjct: 38  VAIKRINLEKCQTSMDELLKEIQAMSQCH--HPNIVSYYTSFVVKDELWLVMKLLSGGSV 95
Query: 127 ---LSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN 183
              +   +   E +           I+  +  GL Y+H+  Q   +HRD+K  NILL ++
Sbjct: 96  LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGED 152
Query: 184 FNPKISDFGLSKLFPE----NTTHISTRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVLL 238
            + +I+DFG+S             +     GT  ++APE     R    K+D++SFG+  
Sbjct: 153 GSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITA 212
Query: 239 LEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV----DPMLYGNFPENEAIR--- 291
           +E+ +G            YH        Y   +++ L      P L     + E ++   
Sbjct: 213 IELATGA---------APYH-------KYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYG 256
Query: 292 --FLKVGLLCVQEKSKLRPQMSTAIK 315
             F K+  LC+Q+  + RP  +  ++
Sbjct: 257 KSFRKMISLCLQKDPEKRPTAAELLR 282

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 112/260 (43%), Gaps = 31/260 (11%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLH-- 106
           IG G FG VY+ +L D G +VA+K +  + +   +E       M  ++ C  N+V+L   
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQI----MRKLDHC--NIVRLRYF 89
Query: 107 ----GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKA--RREIIMGIGRGLAYI 160
               G   D     LV DY+P        +     RAK        +  +  + R LAYI
Sbjct: 90  FYSSGEKKDEVYLNLVLDYVPETVYR---VARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 146
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLF---PENTTHISTRVAGTLGYLA 216
           H      + HRDIK  N+LLD +    K+ DFG +K       N + I +R      Y A
Sbjct: 147 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRA 198
Query: 217 PEYAI-SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNL 275
           PE    +   T   DV+S G +L E++ G+     D  + +   + K  G    +++  +
Sbjct: 199 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 258
Query: 276 VDPMLYGNFPENEAIRFLKV 295
                   FP+ +A  + KV
Sbjct: 259 NPNYTEFKFPQIKAHPWTKV 278

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/266 (22%), Positives = 112/266 (42%), Gaps = 40/266 (15%)
Query: 69  VAVKVLSVESKQGE-KEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNS- 126
           VA+K +++E  Q    E + E+ +M+  +  H N+V  +   +      LV   +   S 
Sbjct: 43  VAIKRINLEKCQTSMDELLKEIQAMSQCH--HPNIVSYYTSFVVKDELWLVMKLLSGGSV 100
Query: 127 ---LSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN 183
              +   +   E +           I+  +  GL Y+H+  Q   +HRD+K  NILL ++
Sbjct: 101 LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGED 157
Query: 184 FNPKISDFGLSKLFPE----NTTHISTRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVLL 238
            + +I+DFG+S             +     GT  ++APE     R    K+D++SFG+  
Sbjct: 158 GSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITA 217
Query: 239 LEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV----DPMLYGNFPENEAIR--- 291
           +E+ +G            YH        Y   +++ L      P L     + E ++   
Sbjct: 218 IELATGAAP---------YH-------KYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYG 261
Query: 292 --FLKVGLLCVQEKSKLRPQMSTAIK 315
             F K+  LC+Q+  + RP  +  ++
Sbjct: 262 KSFRKMISLCLQKDPEKRPTAAELLR 287

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 113/260 (43%), Gaps = 31/260 (11%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLH-- 106
           IG G FG VY+ +L D G +VA+K    +  Q ++    E+  M  ++ C  N+V+L   
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHC--NIVRLRYF 82
Query: 107 ----GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKA--RREIIMGIGRGLAYI 160
               G   D     LV DY+P        +     RAK        +  +  + R LAYI
Sbjct: 83  FYSSGEKKDEVYLNLVLDYVPETVYR---VARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 139
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLF---PENTTHISTRVAGTLGYLA 216
           H      + HRDIK  N+LLD +    K+ DFG +K       N + I +R      Y A
Sbjct: 140 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRA 191
Query: 217 PEYAI-SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNL 275
           PE    +   T   DV+S G +L E++ G+     D  + +   + K  G    +++  +
Sbjct: 192 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 251
Query: 276 VDPMLYGNFPENEAIRFLKV 295
                   FP+ +A  + KV
Sbjct: 252 NPNYTEFKFPQIKAHPWTKV 271

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 105/216 (48%), Gaps = 31/216 (14%)
Query: 44  FRWSNKIGEGGFGSV---YKGRLQDGTIVAVKVL--SVESKQGEKEFMSEVASMANVNVC 98
           +R    +G G +G+V     GR   G  VA+K L    +S+   K    E+  + ++   
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRT--GAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR-- 82
Query: 99  HENLVKLHGGCID--GPCRIL-----VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
           HEN++    G +D   P   L      Y  MP      T LG+  +  K G    + ++ 
Sbjct: 83  HENVI----GLLDVFTPDETLDDFTDFYLVMP---FMGTDLGKLMKHEKLGEDRIQFLVY 135
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT 211
            + +GL YIH      ++HRD+K  N+ ++++   KI DFGL++   +  + +   V  T
Sbjct: 136 QMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEMXGXVV-T 188
Query: 212 LGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
             Y APE  ++  R T+  D++S G ++ E+++G+T
Sbjct: 189 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 224

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 55/103 (53%), Gaps = 7/103 (6%)
Query: 147 REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK---LFPENTTH 203
           R  +  + RGL Y+H      V+HRD+K SN+L+++N   KI DFG+++     P    +
Sbjct: 161 RYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQY 217
Query: 204 ISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGR 245
             T    T  Y APE  +S    T+  D++S G +  E+++ R
Sbjct: 218 FMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARR 260

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 80
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 81  ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI DF L++    +T    T    T  
Sbjct: 135 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFYLAR----HTDDEMTGYVATRW 187
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 113/260 (43%), Gaps = 31/260 (11%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLH-- 106
           IG G FG VY+ +L D G +VA+K    +  Q ++    E+  M  ++ C  N+V+L   
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHC--NIVRLRYF 81
Query: 107 ----GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKA--RREIIMGIGRGLAYI 160
               G   D     LV DY+P        +     RAK        +  +  + R LAYI
Sbjct: 82  FYSSGEKKDVVYLNLVLDYVPETVYR---VARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLF---PENTTHISTRVAGTLGYLA 216
           H      + HRDIK  N+LLD +    K+ DFG +K       N + I +R      Y A
Sbjct: 139 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRA 190
Query: 217 PEYAI-SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNL 275
           PE    +   T   DV+S G +L E++ G+     D  + +   + K  G    +++  +
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250
Query: 276 VDPMLYGNFPENEAIRFLKV 295
                   FP+ +A  + KV
Sbjct: 251 NPNYTEFKFPQIKAHPWTKV 270

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 73/154 (47%), Gaps = 19/154 (12%)
Query: 99  HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
           H N+++L           LV+D M    L   L      +     K  R+I+  +   + 
Sbjct: 70  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRALLEVIC 125
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS-KLFPENTTHISTRVAGTLGYLAP 217
            +H   + ++VHRD+K  NILLD + N K++DFG S +L P         V GT  YLAP
Sbjct: 126 ALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---EVCGTPSYLAP 179
Query: 218 EYAISGRLT-------RKSDVYSFGVLLLEIVSG 244
           E  I   +        ++ D++S GV++  +++G
Sbjct: 180 E-IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 105/237 (44%), Gaps = 39/237 (16%)
Query: 39  IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLS---------------------- 75
           +  N +   ++IG+G +G V     + D T  A+KVLS                      
Sbjct: 10  VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPA 69
Query: 76  ----VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTL 131
               ++ +   ++   E+A +  ++  H N+VKL    +D P    +Y  M    ++Q  
Sbjct: 70  PGGCIQPRGPIEQVYQEIAILKKLD--HPNVVKL-VEVLDDPNEDHLY--MVFELVNQGP 124
Query: 132 LGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF 191
           + E            R     + +G+ Y+H +    ++HRDIK SN+L+ ++ + KI+DF
Sbjct: 125 VMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADF 181
Query: 192 GLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLT---RKSDVYSFGVLLLEIVSGR 245
           G+S  F  +   +S  V GT  ++APE     R     +  DV++ GV L   V G+
Sbjct: 182 GVSNEFKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 80
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 81  ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI  FGL++    +T    T    T  
Sbjct: 135 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILGFGLAR----HTDDEMTGYVATRW 187
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/231 (23%), Positives = 100/231 (43%), Gaps = 33/231 (14%)
Query: 33  SYNQLKIATNGFRWSNKIGEGGFGSV-YKGRLQDGTIVAVKVL---------SVESKQGE 82
           S N  ++    F +   +G+G FG V    R     + A+K+L          VE    E
Sbjct: 10  SNNLDRVKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVE 69
Query: 83  KE---FMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRA 139
           K     + +   +  ++ C + + +L+           V +Y+    L   +    ++  
Sbjct: 70  KRVLALLDKPPFLTQLHSCFQTVDRLY----------FVMEYVNGGDLMYHI----QQVG 115
Query: 140 KFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 199
           KF           I  GL ++H+     +++RD+K  N++LD   + KI+DFG+ K    
Sbjct: 116 KFKEPQAVFYAAEISIGLFFLHKR---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--EH 170
Query: 200 NTTHISTR-VAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVD 249
               ++TR   GT  Y+APE        +  D +++GVLL E+++G+   D
Sbjct: 171 MMDGVTTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 80
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 81  ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI D GL++    +T    T    T  
Sbjct: 135 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDAGLAR----HTDDEMTGYVATRW 187
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 91/200 (45%), Gaps = 19/200 (9%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V   + ++ G   A+K+L     V+ KQ E   ++E   +  VN     LVK
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPF--LVK 105
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L     D     +V +Y+    +   L    +R  +F     R     I     Y+H   
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH--- 158
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              +++RD+K  N+L+DQ    +++DFG +K     T  +     GT  YLAPE  +S  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSKG 214
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
             +  D ++ GVL+ ++ +G
Sbjct: 215 YNKAVDWWALGVLIYQMAAG 234

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 16/222 (7%)
Query: 49  KIGEGGFGSVYKGRLQD-GTIVAVKVL--SVESKQGEKEFMSEVASMANVNVCHENLVKL 105
           KIGEG +G V+K R +D G IVA+K    S +    +K  + E+  +  +   H NLV L
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK--HPNLVNL 67
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAK-FGWKARREIIMGIGRGLAYIHEEI 164
                      LV++Y        T+L E  R  +       + I     + + + H+  
Sbjct: 68  LEVFRRKRRLHLVFEYC-----DHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH- 121
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI-SG 223
             + +HRD+K  NIL+ ++   K+ DFG ++L    + +    VA T  Y +PE  +   
Sbjct: 122 --NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPELLVGDT 178
Query: 224 RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG 265
           +     DV++ G +  E++SG         + + +L+ K  G
Sbjct: 179 QYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLG 220

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 91/200 (45%), Gaps = 19/200 (9%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V   + ++ G   A+K+L     V+ KQ E   ++E   +  VN     LVK
Sbjct: 36  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPF--LVK 92
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L     D     +V +Y+    +   L    +R  +F     R     I     Y+H   
Sbjct: 93  LEFSFKDNSNLYMVMEYVAGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH--- 145
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              +++RD+K  N+L+D+    +++DFG +K     T  +     GT  YLAPE  +S  
Sbjct: 146 SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSKG 201
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
             +  D ++ GVL+ E+ +G
Sbjct: 202 YNKAVDWWALGVLIYEMAAG 221

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 73/154 (47%), Gaps = 19/154 (12%)
Query: 99  HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
           H N+++L           LV+D M    L   L      +     K  R+I+  +   + 
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRALLEVIC 138
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS-KLFPENTTHISTRVAGTLGYLAP 217
            +H   + ++VHRD+K  NILLD + N K++DFG S +L P         V GT  YLAP
Sbjct: 139 ALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---EVCGTPSYLAP 192
Query: 218 EYAISGRLT-------RKSDVYSFGVLLLEIVSG 244
           E  I   +        ++ D++S GV++  +++G
Sbjct: 193 E-IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 80
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 81  ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI D GL++    +T    T    T  
Sbjct: 135 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDRGLAR----HTDDEMTGYVATRW 187
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 73/154 (47%), Gaps = 19/154 (12%)
Query: 99  HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
           H N+++L           LV+D M    L   L      +     K  R+I+  +   + 
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRALLEVIC 138
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS-KLFPENTTHISTRVAGTLGYLAP 217
            +H   + ++VHRD+K  NILLD + N K++DFG S +L P         V GT  YLAP
Sbjct: 139 ALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---SVCGTPSYLAP 192
Query: 218 EYAISGRLT-------RKSDVYSFGVLLLEIVSG 244
           E  I   +        ++ D++S GV++  +++G
Sbjct: 193 E-IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 27/214 (12%)
Query: 45  RWSN--KIGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCH 99
           R+ N   +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--H 80
Query: 100 ENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGI 153
           EN++    G +D   P R L  +   +  L   L+G +     +  K      + +I  I
Sbjct: 81  ENVI----GLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
            RGL YIH      ++HRD+K SN+ ++++   KI D GL++    +T    T    T  
Sbjct: 135 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDGGLAR----HTDDEMTGYVATRW 187
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
           Y APE  ++     +  D++S G ++ E+++GRT
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 123/276 (44%), Gaps = 46/276 (16%)
Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVL--SVESKQGEKEFMSEVASMANVNVCHENLVKL 105
           ++G G +G V K R +  G I+AVK +  +V S++ ++  M    SM  V+      V  
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT--VTF 71
Query: 106 HGGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG-----IGRGLAY 159
           +G    +G   I +        L  T L +  ++     +   E I+G     I + L +
Sbjct: 72  YGALFREGDVWICM-------ELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEY 219
           +H ++   V+HRD+K SN+L++     K+ DFG+S    ++        AG   Y+APE 
Sbjct: 125 LHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID--AGCKPYMAPE- 179
Query: 220 AISGRLTR-----KSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG--MYNSKEL 272
            I+  L +     KSD++S G+ ++E+   R   D             +WG      K++
Sbjct: 180 RINPELNQKGYSVKSDIWSLGITMIELAILRFPYD-------------SWGTPFQQLKQV 226
Query: 273 MNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRP 308
           +    P L  +    E + F      C+++ SK RP
Sbjct: 227 VEEPSPQLPADKFSAEFVDFTS---QCLKKNSKERP 259

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 106/235 (45%), Gaps = 24/235 (10%)
Query: 18  NTIGGEQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGT--IVAVKVLS 75
            T+G   I++ ++    N ++  T+G+     IG G + SV K  +   T    AVK++ 
Sbjct: 2   QTVGVHSIVQQLHR---NSIQF-TDGYEVKEDIGVGSY-SVCKRCIHKATNXEFAVKIID 56
Query: 76  VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEE 135
            +SK+   E +  +         H N++ L     DG    +V +      L   +L   
Sbjct: 57  -KSKRDPTEEIEILLRYGQ----HPNIITLKDVYDDGKYVYVVTELXKGGELLDKIL--- 108
Query: 136 KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL-LDQNFNP---KISDF 191
            R+  F  +    ++  I + + Y+H +    VVHRD+K SNIL +D++ NP   +I DF
Sbjct: 109 -RQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDF 164
Query: 192 GLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT 246
           G +K        + T    T  ++APE           D++S GVLL   ++G T
Sbjct: 165 GFAKQLRAENGLLXTPCY-TANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYT 218

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 90/200 (45%), Gaps = 19/200 (9%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V   + ++ G   A+K+L     V+ KQ E   ++E   +  VN     LVK
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPF--LVK 105
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L     D     +V +Y+    +   L    +R  +F     R     I     Y+H   
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH--- 158
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              +++RD+K  N+L+DQ    +++DFG +K     T  +     GT  YLAP   +S  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPAIILSKG 214
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
             +  D ++ GVL+ E+ +G
Sbjct: 215 YNKAVDWWALGVLIYEMAAG 234

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 103/212 (48%), Gaps = 18/212 (8%)
Query: 40  ATNGFRWSNK---IGEGGFGSVYK-GRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANV 95
           A N F   +K   +G G FG V+K      G  +A K++     + ++E  +E++ M  +
Sbjct: 84  AVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL 143
Query: 96  NVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR 155
           +  H NL++L+         +LV +Y+    L   ++ E     +         +  I  
Sbjct: 144 D--HANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTIL---FMKQICE 198
Query: 156 GLAYIHEEIQPHVVHRDIKTSNIL-LDQNFNP-KISDFGLSKLF-PENTTHISTRVAGTL 212
           G+ ++H   Q +++H D+K  NIL ++++    KI DFGL++ + P     ++    GT 
Sbjct: 199 GIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF---GTP 252
Query: 213 GYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
            +LAPE      ++  +D++S GV+   ++SG
Sbjct: 253 EFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 68/297 (22%), Positives = 122/297 (41%), Gaps = 31/297 (10%)
Query: 41  TNGFRWSNKIGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCH 99
           T+ ++   ++G+G F  V +  ++  G   A K+++ +          E  +     + H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
            N+V+LH    +     LV+D +    L + ++     R  +        I  I   + +
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVA----REYYSEADASHCIQQILESVNH 118
Query: 160 IHEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLA 216
            H      +VHRD+K  N+LL    +    K++DFGL+ +  +         AGT GYL+
Sbjct: 119 CHLN---GIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLS 174
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVSGRTAV-DFD-------VQLGEYHLVDKAWGMYN 268
           PE        +  D+++ GV+L  ++ G     D D       ++ G Y      W    
Sbjct: 175 PEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTV- 233
Query: 269 SKELMNLVDPMLYGNFPEN-EAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNID 324
           + E  +L++ ML  N  +   A   LK   +C         Q ST   MM+ +  +D
Sbjct: 234 TPEAKDLINKMLTINPAKRITASEALKHPWIC---------QRSTVASMMHRQETVD 281

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 27/208 (12%)
Query: 50  IGEGGFGSV---YKGRLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G +GSV   Y  RL+    VAVK LS   +S    +    E+  + ++   HEN++ 
Sbjct: 36  VGSGAYGSVCSAYDARLRQK--VAVKKLSRPFQSLIHARRTYRELRLLKHLK--HENVI- 90
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGIGRGLAYI 160
              G +D        +      L  TL+G +     +      +  + ++  + RGL YI
Sbjct: 91  ---GLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYI 147
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEY 219
           H      ++HRD+K SN+ ++++   +I DFGL++   E  T +++TR      Y APE 
Sbjct: 148 H---SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR-----WYRAPEI 199
Query: 220 AISG-RLTRKSDVYSFGVLLLEIVSGRT 246
            ++     +  D++S G ++ E++ G+ 
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLQGKA 227

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 36/219 (16%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLH-- 106
           +G GG G V+     D    VA+K + +   Q  K  + E+  +  ++  H+N+VK+   
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLD--HDNIVKVFEI 76
Query: 107 ------------GGCIDGPCRILVYDYMPN---NSLSQTLLGEEKRRAKFGWKARREIIM 151
                       G   +     +V +YM     N L Q  L EE  R  F ++       
Sbjct: 77  LGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARL-FMYQ------- 128
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLD-QNFNPKISDFGLSKLFPENTTHISTRVAG 210
            + RGL YIH     +V+HRD+K +N+ ++ ++   KI DFGL+++   + +H      G
Sbjct: 129 -LLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184
Query: 211 --TLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRT 246
             T  Y +P   +S    T+  D+++ G +  E+++G+T
Sbjct: 185 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 27/208 (12%)
Query: 50  IGEGGFGSV---YKGRLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G +GSV   Y  RL+    VAVK LS   +S    +    E+  + ++   HEN++ 
Sbjct: 28  VGSGAYGSVCSAYDARLRQK--VAVKKLSRPFQSLIHARRTYRELRLLKHLK--HENVI- 82
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGIGRGLAYI 160
              G +D        +      L  TL+G +     +      +  + ++  + RGL YI
Sbjct: 83  ---GLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYI 139
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEY 219
           H      ++HRD+K SN+ ++++   +I DFGL++   E  T +++TR      Y APE 
Sbjct: 140 HSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYVATR-----WYRAPEI 191
Query: 220 AISG-RLTRKSDVYSFGVLLLEIVSGRT 246
            ++     +  D++S G ++ E++ G+ 
Sbjct: 192 MLNWMHYNQTVDIWSVGCIMAELLQGKA 219

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 90/200 (45%), Gaps = 19/200 (9%)
Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V   + ++ G   A+K+L     V+ KQ E   ++E   +  VN     LVK
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPF--LVK 105
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L     D     +V +Y+    +   L    +R  +F     R     I     Y+H   
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH--- 158
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              +++RD+K  N+L+DQ    +++DFG +K     T  +     GT   LAPE  +S  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEALAPEIILSKG 214
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
             +  D ++ GVL+ E+ +G
Sbjct: 215 YNKAVDWWALGVLIYEMAAG 234

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 108/246 (43%), Gaps = 31/246 (12%)
Query: 32  FSYNQLKIATNGFRWSNKIGEGGFGSV--YKGRLQDGTIVAVKVLSVESKQGEKEFMSEV 89
           F  + + I    + +  K+GEGGF  V   +G L DG   A+K +    +Q  +E   E 
Sbjct: 19  FQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDREEAQREA 77
Query: 90  ASMANVNVCHENLVKLHGGCI-DGPCRILVYDYMPNNSLSQTLLGE-EKRRAKFGWKARR 147
                 N  H N+++L   C+ +   +   +  +P      TL  E E+ + K  +    
Sbjct: 78  DMHRLFN--HPNILRLVAYCLRERGAKHEAWLLLPFFKRG-TLWNEIERLKDKGNFLTED 134
Query: 148 EII---MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 204
           +I+   +GI RGL  IH +      HRD+K +NILL     P + D G      +   H+
Sbjct: 135 QILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMN---QACIHV 188
Query: 205 S-TRVAGTL----------GYLAPE-YAISGR--LTRKSDVYSFGVLLLEIVSGRTAVDF 250
             +R A TL           Y APE +++     +  ++DV+S G +L  ++ G    D 
Sbjct: 189 EGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248
Query: 251 DVQLGE 256
             Q G+
Sbjct: 249 VFQKGD 254

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 27/208 (12%)
Query: 50  IGEGGFGSV---YKGRLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G +GSV   Y  RL+    VAVK LS   +S    +    E+  + ++   HEN++ 
Sbjct: 36  VGSGAYGSVCSAYDARLRQK--VAVKKLSRPFQSLIHARRTYRELRLLKHLK--HENVI- 90
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGIGRGLAYI 160
              G +D        +      L  TL+G +     +      +  + ++  + RGL YI
Sbjct: 91  ---GLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYI 147
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEY 219
           H      ++HRD+K SN+ ++++   +I DFGL++   E  T +++TR      Y APE 
Sbjct: 148 H---SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR-----WYRAPEI 199
Query: 220 AISG-RLTRKSDVYSFGVLLLEIVSGRT 246
            ++     +  D++S G ++ E++ G+ 
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLQGKA 227

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/77 (40%), Positives = 44/77 (57%), Gaps = 1/77 (1%)
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG-TLGYLAPEYAISGRLT 226
            +HRD+   NILL +    KI DFGL++   ++  ++    A   L ++APE       T
Sbjct: 219 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT 278
Query: 227 RKSDVYSFGVLLLEIVS 243
            +SDV+SFGVLL EI S
Sbjct: 279 IQSDVWSFGVLLWEIFS 295

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/77 (40%), Positives = 44/77 (57%), Gaps = 1/77 (1%)
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG-TLGYLAPEYAISGRLT 226
            +HRD+   NILL +    KI DFGL++   ++  ++    A   L ++APE       T
Sbjct: 221 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT 280
Query: 227 RKSDVYSFGVLLLEIVS 243
            +SDV+SFGVLL EI S
Sbjct: 281 IQSDVWSFGVLLWEIFS 297

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/77 (40%), Positives = 44/77 (57%), Gaps = 1/77 (1%)
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG-TLGYLAPEYAISGRLT 226
            +HRD+   NILL +    KI DFGL++   ++  ++    A   L ++APE       T
Sbjct: 212 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT 271
Query: 227 RKSDVYSFGVLLLEIVS 243
            +SDV+SFGVLL EI S
Sbjct: 272 IQSDVWSFGVLLWEIFS 288

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 48/88 (54%), Gaps = 10/88 (11%)
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS---------TRVAGTLGYLAPE 218
           V+HRD+K SN+L++ N + K+ DFGL+++  E+    S         T    T  Y APE
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPE 192
Query: 219 YAI-SGRLTRKSDVYSFGVLLLEIVSGR 245
             + S + +R  DV+S G +L E+   R
Sbjct: 193 VMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/77 (40%), Positives = 44/77 (57%), Gaps = 1/77 (1%)
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG-TLGYLAPEYAISGRLT 226
            +HRD+   NILL +    KI DFGL++   ++  ++    A   L ++APE       T
Sbjct: 214 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT 273
Query: 227 RKSDVYSFGVLLLEIVS 243
            +SDV+SFGVLL EI S
Sbjct: 274 IQSDVWSFGVLLWEIFS 290

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/84 (34%), Positives = 50/84 (59%), Gaps = 5/84 (5%)
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH-ISTR-VAGTLGYLAPEYAISGRL 225
           +++RD+K  N++LD   + KI+DFG+ K   EN    ++T+   GT  Y+APE       
Sbjct: 142 IIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTTKXFCGTPDYIAPEIIAYQPY 198
Query: 226 TRKSDVYSFGVLLLEIVSGRTAVD 249
            +  D ++FGVLL E+++G+   +
Sbjct: 199 GKSVDWWAFGVLLYEMLAGQAPFE 222

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 48/88 (54%), Gaps = 10/88 (11%)
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS---------TRVAGTLGYLAPE 218
           V+HRD+K SN+L++ N + K+ DFGL+++  E+    S         T    T  Y APE
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPE 192
Query: 219 YAI-SGRLTRKSDVYSFGVLLLEIVSGR 245
             + S + +R  DV+S G +L E+   R
Sbjct: 193 VMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/84 (34%), Positives = 50/84 (59%), Gaps = 5/84 (5%)
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH-ISTR-VAGTLGYLAPEYAISGRL 225
           +++RD+K  N++LD   + KI+DFG+ K   EN    ++T+   GT  Y+APE       
Sbjct: 463 IIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTTKXFCGTPDYIAPEIIAYQPY 519
Query: 226 TRKSDVYSFGVLLLEIVSGRTAVD 249
            +  D ++FGVLL E+++G+   +
Sbjct: 520 GKSVDWWAFGVLLYEMLAGQAPFE 543

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/272 (23%), Positives = 115/272 (42%), Gaps = 47/272 (17%)
Query: 47  SNKIGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKL 105
           S  +GEG +  V     LQ+G   AVK++  ++         EV ++      ++N+++L
Sbjct: 18  SELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQG-NKNILEL 76
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
                D     LV++ +   S+    L   +++  F  +    ++  +   L ++H +  
Sbjct: 77  IEFFEDDTRFYLVFEKLQGGSI----LAHIQKQKHFNEREASRVVRDVAAALDFLHTK-- 130
Query: 166 PHVVHRDIKTSNILLD--QNFNP-KISDFGLSKLFPEN------TTHISTRVAGTLGYLA 216
             + HRD+K  NIL +  +  +P KI DF L      N      TT   T   G+  Y+A
Sbjct: 131 -GIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMA 189
Query: 217 PEY--AISGRLT---RKSDVYSFGVLLLEIVSG-----------------------RTAV 248
           PE     + + T   ++ D++S GV+L  ++SG                       +  +
Sbjct: 190 PEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKL 249
Query: 249 DFDVQLGEYHLVDKAWGMYNSKELMNLVDPML 280
              +Q G+Y   DK W  + S E  +L+  +L
Sbjct: 250 FESIQEGKYEFPDKDWA-HISSEAKDLISKLL 280

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/262 (26%), Positives = 113/262 (43%), Gaps = 36/262 (13%)
Query: 50  IGEGGFGSVYKGRLQDGTIVAV-KVLSVESKQGEKEFMSEVASMANVNVCHENLVKL--- 105
           IG G FG V++ +L +   VA+ KVL       +K F +    +  + V H N+V L   
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAIKKVLQ------DKRFKNRELQIMRI-VKHPNVVDLKAF 100
Query: 106 ---HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII----MGIGRGLA 158
              +G   D     LV +Y+P     +T+    +  AK        +I      + R LA
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVP-----ETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLA 155
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLF---PENTTHISTRVAGTLGY 214
           YIH      + HRDIK  N+LLD      K+ DFG +K+      N + I +R      Y
Sbjct: 156 YIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRY-----Y 207
Query: 215 LAPEYAI-SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELM 273
            APE    +   T   D++S G ++ E++ G+     +  + +   + K  G  + +++ 
Sbjct: 208 RAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK 267
Query: 274 NLVDPMLYGNFPENEAIRFLKV 295
            +    +   FP+     F KV
Sbjct: 268 TMNPNYMEHKFPQIRPHPFSKV 289

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 98/222 (44%), Gaps = 39/222 (17%)
Query: 50  IGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKE-FMSEVASMANVNVCHENLVKLHG 107
           +G GGFG V++ + + D    A+K + + +++  +E  M EV ++A +   H  +V+   
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE--HPGIVRYFN 70
Query: 108 GCIDG-------PCRILVYDYMP-----NNSLSQTLLG----EEKRRAKFGWKARREIIM 151
             ++        P    VY Y+        +L   + G    EE+ R+         I +
Sbjct: 71  AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERS-----VCLHIFL 125
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL-----------SKLFPEN 200
            I   + ++H +    ++HRD+K SNI    +   K+ DFGL           + L P  
Sbjct: 126 QIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 201 TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIV 242
                T   GT  Y++PE       + K D++S G++L E++
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 95/205 (46%), Gaps = 20/205 (9%)
Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEF---MSEVASMANVNVCH 99
           F+  +++G G +G V+K R  +DG + AVK  S+   +G K+    ++EV S   V   H
Sbjct: 59  FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR-SMSPFRGPKDRARKLAEVGSHEKVGQ-H 116
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTL--LGEEKRRAKFGWKARREIIMGIGRGL 157
              V+L     +G    L  + +   SL Q     G     A+  W   R+ ++     L
Sbjct: 117 PCCVRLEQAWEEGGILYLQTE-LCGPSLQQHCEAWGASLPEAQV-WGYLRDTLLA----L 170
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
           A++H +    +VH D+K +NI L      K+ DFGL  L    T        G   Y+AP
Sbjct: 171 AHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGL--LVELGTAGAGEVQEGDPRYMAP 225
Query: 218 EYAISGRLTRKSDVYSFGVLLLEIV 242
           E  + G     +DV+S G+ +LE+ 
Sbjct: 226 EL-LQGSYGTAADVFSLGLTILEVA 249

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 106/225 (47%), Gaps = 32/225 (14%)
Query: 38  KIATNGFRWSNKIGEGGFGSVYKG-RLQDG-------TIVAVKVLSVESKQGEKEFMSEV 89
           KI      ++  +G+G F  ++KG R + G       T V +KVL    +   + F  E 
Sbjct: 4   KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFF-EA 62
Query: 90  ASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREI 149
           ASM +  + H++LV  +G C+ G   ILV +++   SL  T L + K      WK   E+
Sbjct: 63  ASMMS-KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLD-TYLKKNKNCINILWKL--EV 118
Query: 150 IMGIGRGLAYIHEEIQPHVVHRDIKTSNILL-----DQNFNP---KISDFGLS-KLFPEN 200
              +   + ++ E     ++H ++   NILL      +  NP   K+SD G+S  + P++
Sbjct: 119 AKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175
Query: 201 TTHISTRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSG 244
              +  R+     ++ PE   + + L   +D +SFG  L EI SG
Sbjct: 176 I--LQERIP----WVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 92/212 (43%), Gaps = 24/212 (11%)
Query: 41  TNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVN--- 96
           ++ +     IG G FG     R  Q   +VAVK +    ++GEK  + E      +N   
Sbjct: 18  SDRYELVKDIGAGNFGVARLMRDKQANELVAVKYI----ERGEK--IDENVKREIINHRS 71
Query: 97  VCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRG 156
           + H N+V+     +      +V +Y     L + +        +F     R     +  G
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA----GRFSEDEARFFFQQLISG 127
Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNP--KISDFGLSKLFPENTTHISTRVA-GTLG 213
           ++Y H      V HRD+K  N LLD +  P  KI+DFG SK    +  H   + A GT  
Sbjct: 128 VSYAHAM---QVAHRDLKLENTLLDGSPAPRLKIADFGYSK---ASVLHSQPKSAVGTPA 181
Query: 214 YLAPEYAISGRLTRK-SDVYSFGVLLLEIVSG 244
           Y+APE  +      K +DV+S GV L  ++ G
Sbjct: 182 YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 41  TNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHE 100
           ++ F   +++G G    VY+ + Q GT     +  ++    +K   +E+  +  + + H 
Sbjct: 52  SDFFEVESELGRGATSIVYRCK-QKGTQKPYALKVLKKTVDKKIVRTEIGVL--LRLSHP 108
Query: 101 NLVKLHGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
           N++KL     + P  I LV + +    L   ++     +  +  +   + +  I   +AY
Sbjct: 109 NIIKLKE-IFETPTEISLVLELVTGGELFDRIV----EKGYYSERDAADAVKQILEAVAY 163
Query: 160 IHEEIQPHVVHRDIKTSNILLDQ---NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLA 216
           +HE     +VHRD+K  N+L      +   KI+DFGLSK+  E+   + T V GT GY A
Sbjct: 164 LHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV-EHQVLMKT-VCGTPGYCA 218
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVSG 244
           PE         + D++S G++   ++ G
Sbjct: 219 PEILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 97/233 (41%), Gaps = 32/233 (13%)
Query: 44  FRWSNKIGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC---- 98
           +R    +G+GGFG+V+ G RL D   VA+KV+      G       V     V +     
Sbjct: 33  YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92
Query: 99  ----HENLVKLHGGCIDGPCRILVYDY-MPNNSLSQTL-----LGEEKRRAKFGWKARRE 148
               H  +++L          +LV +  +P   L   +     LGE   R  FG     +
Sbjct: 93  AGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFG-----Q 147
Query: 149 IIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD-QNFNPKISDFGLSKLFPENTTHISTR 207
           ++  I     + H      VVHRDIK  NIL+D +    K+ DFG   L  +      T 
Sbjct: 148 VVAAI----QHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY---TD 197
Query: 208 VAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHL 259
             GT  Y  PE+    +     + V+S G+LL ++V G    + D ++ E  L
Sbjct: 198 FDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAEL 250

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 103/248 (41%), Gaps = 21/248 (8%)
Query: 48  NKIGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLH 106
            ++G+G F  V +  ++  G   A K+++ +          E  +     + H N+V+LH
Sbjct: 28  EELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 87
Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
               +     L++D +    L + ++     R  +        I  I   + + H   Q 
Sbjct: 88  DSISEEGHHYLIFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCH---QM 140
Query: 167 HVVHRDIKTSNILLDQNFN---PKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG 223
            VVHRD+K  N+LL         K++DFGL+ +  E         AGT GYL+PE     
Sbjct: 141 GVVHRDLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAGTPGYLSPEVLRKD 199
Query: 224 RLTRKSDVYSFGVLLLEIVSGRTAV-DFD-------VQLGEYHLVDKAWGMYNSKELMNL 275
              +  D+++ GV+L  ++ G     D D       ++ G Y      W    + E  +L
Sbjct: 200 PYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTV-TPEAKDL 258
Query: 276 VDPMLYGN 283
           ++ ML  N
Sbjct: 259 INKMLTIN 266

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 91/209 (43%), Gaps = 18/209 (8%)
Query: 41  TNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMAN-VNVC 98
           ++ +     IG G FG     R  Q   +VAVK +    ++GEK   +    + N  ++ 
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYI----ERGEKIAANVKREIINHRSLR 73
Query: 99  HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
           H N+V+     +      +V +Y     L + +        +F     R     +  G++
Sbjct: 74  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVS 129
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNP--KISDFGLSKLFPENTTHISTRVAGTLGYLA 216
           Y H      V HRD+K  N LLD +  P  KI DFG SK    ++   ST   GT  Y+A
Sbjct: 130 YCHAM---QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIA 184
Query: 217 PEYAISGRLTRK-SDVYSFGVLLLEIVSG 244
           PE  +      K +DV+S GV L  ++ G
Sbjct: 185 PEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 91/211 (43%), Gaps = 22/211 (10%)
Query: 41  TNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVN--- 96
           ++ +     IG G FG     R  Q   +VAVK +    ++GEK  + E      +N   
Sbjct: 17  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYI----ERGEK--IDENVKREIINHRS 70
Query: 97  VCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRG 156
           + H N+V+     +      +V +Y     L + +        +F     R     +  G
Sbjct: 71  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA----GRFSEDEARFFFQQLISG 126
Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNP--KISDFGLSKLFPENTTHISTRVAGTLGY 214
           ++Y H      V HRD+K  N LLD +  P  KI DFG SK    ++   ST   GT  Y
Sbjct: 127 VSYCHAM---QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAY 181
Query: 215 LAPEYAISGRLTRK-SDVYSFGVLLLEIVSG 244
           +APE  +      K +DV+S GV L  ++ G
Sbjct: 182 IAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 212

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 47/88 (53%), Gaps = 10/88 (11%)
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS---------TRVAGTLGYLAPE 218
           V+HRD+K SN+L++ N + K+ DFGL+++  E+    S              T  Y APE
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPE 192
Query: 219 YAI-SGRLTRKSDVYSFGVLLLEIVSGR 245
             + S + +R  DV+S G +L E+   R
Sbjct: 193 VMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 105/225 (46%), Gaps = 32/225 (14%)
Query: 38  KIATNGFRWSNKIGEGGFGSVYKG-RLQDG-------TIVAVKVLSVESKQGEKEFMSEV 89
           KI      ++  +G+G F  ++KG R + G       T V +KVL    +   + F  E 
Sbjct: 4   KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFF-EA 62
Query: 90  ASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREI 149
           ASM +  + H++LV  +G C  G   ILV +++   SL  T L + K      WK   E+
Sbjct: 63  ASMMS-KLSHKHLVLNYGVCFCGDENILVQEFVKFGSLD-TYLKKNKNCINILWKL--EV 118
Query: 150 IMGIGRGLAYIHEEIQPHVVHRDIKTSNILL-----DQNFNP---KISDFGLS-KLFPEN 200
              +   + ++ E     ++H ++   NILL      +  NP   K+SD G+S  + P++
Sbjct: 119 AKQLAWAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175
Query: 201 TTHISTRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSG 244
              +  R+     ++ PE   + + L   +D +SFG  L EI SG
Sbjct: 176 I--LQERIP----WVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 78/282 (27%), Positives = 120/282 (42%), Gaps = 35/282 (12%)
Query: 35  NQLKIATNGFRWSNKIGEGGFGSVYKGRL-QDGTIVAVKVLSVES--KQGEKEFMSEVAS 91
            ++++  + F     IG G F  V   ++ Q G + A+K+++     K+GE     E   
Sbjct: 54  KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERD 113
Query: 92  MANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGE--EKRRAKFGWKARREI 149
           +  VN     + +LH    D     LV +Y     L  TLL +  E+  A+       EI
Sbjct: 114 VL-VNGDRRWITQLHFAFQDENYLYLVMEYYVGGDL-LTLLSKFGERIPAEMARFYLAEI 171
Query: 150 IMGIG--RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 207
           +M I     L Y         VHRDIK  NILLD+  + +++DFG       + T  S  
Sbjct: 172 VMAIDSVHRLGY---------VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV 222
Query: 208 VAGTLGYLAPE-------YAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLV 260
             GT  YL+PE          +G    + D ++ GV   E+  G+T    D     Y  +
Sbjct: 223 AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKI 282
Query: 261 DKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQE 302
                  + KE ++L  P++    PE EA  F++  LLC  E
Sbjct: 283 ------VHYKEHLSL--PLVDEGVPE-EARDFIQ-RLLCPPE 314

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 107/265 (40%), Gaps = 41/265 (15%)
Query: 41  TNGFRWSNKIGEGGFGSVYK------GRLQDGTIVAVKVLSVESKQG-EKEFMSEVASMA 93
           T  ++   ++G+G F  V +      G+     I+  K LS    Q  E+E         
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLERE--------- 60
Query: 94  NVNVC----HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREI 149
              +C    H N+V+LH    +     L++D +    L + ++     R  +        
Sbjct: 61  -ARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVA----REYYSEADASHC 115
Query: 150 IMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN---PKISDFGLSKLFPENTTHIST 206
           I  I   + + H   Q  VVHR++K  N+LL         K++DFGL+ +  E       
Sbjct: 116 IQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWF 171
Query: 207 RVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAV-DFD-------VQLGEYH 258
             AGT GYL+PE        +  D+++ GV+L  ++ G     D D       ++ G Y 
Sbjct: 172 GFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYD 231
Query: 259 LVDKAWGMYNSKELMNLVDPMLYGN 283
                W    + E  +L++ ML  N
Sbjct: 232 FPSPEWDTV-TPEAKDLINKMLTIN 255

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 37/141 (26%), Positives = 64/141 (45%), Gaps = 22/141 (15%)
Query: 141 FGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ---NFNPKISDFGLSKLF 197
           F  +   EI+  IG  + Y+H     ++ HRD+K  N+L      N   K++DFG +K  
Sbjct: 112 FTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-- 166
Query: 198 PENTTHIS-TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG------------ 244
            E T+H S T    T  Y+APE     +  +  D++S GV++  ++ G            
Sbjct: 167 -ETTSHNSLTEPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 225
Query: 245 RTAVDFDVQLGEYHLVDKAWG 265
              +   +++G+Y   +  W 
Sbjct: 226 SPGMKTRIRMGQYEFPNPEWS 246

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 92/209 (44%), Gaps = 33/209 (15%)
Query: 49  KIGEGGFGSVYKGRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLH 106
           K+ E   G ++KGR Q G  + VKVL V   S +  ++F  E   +   +  H N++ + 
Sbjct: 17  KLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS--HPNVLPVL 73
Query: 107 GGCIDGPCR--ILVYDYMPNNSLSQTL------LGEEKRRAKFGWKARREIIMGIGRGLA 158
           G C   P     L+  + P  SL   L      + ++ +  KF         +   RG A
Sbjct: 74  GACQSPPAPHPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFA--------LDXARGXA 125
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE 218
           ++H  ++P +    + + ++ +D++   +IS   +   F       S        ++APE
Sbjct: 126 FLHT-LEPLIPRHALNSRSVXIDEDXTARISXADVKFSF------QSPGRXYAPAWVAPE 178
Query: 219 YAISGRLT----RKSDVYSFGVLLLEIVS 243
            A+  +      R +D +SF VLL E+V+
Sbjct: 179 -ALQKKPEDTNRRSADXWSFAVLLWELVT 206

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 37/141 (26%), Positives = 64/141 (45%), Gaps = 22/141 (15%)
Query: 141 FGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ---NFNPKISDFGLSKLF 197
           F  +   EI+  IG  + Y+H     ++ HRD+K  N+L      N   K++DFG +K  
Sbjct: 158 FTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-- 212
Query: 198 PENTTHIS-TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG------------ 244
            E T+H S T    T  Y+APE     +  +  D++S GV++  ++ G            
Sbjct: 213 -ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 271
Query: 245 RTAVDFDVQLGEYHLVDKAWG 265
              +   +++G+Y   +  W 
Sbjct: 272 SPGMKTRIRMGQYEFPNPEWS 292

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 37/141 (26%), Positives = 64/141 (45%), Gaps = 22/141 (15%)
Query: 141 FGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ---NFNPKISDFGLSKLF 197
           F  +   EI+  IG  + Y+H     ++ HRD+K  N+L      N   K++DFG +K  
Sbjct: 128 FTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-- 182
Query: 198 PENTTHIS-TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG------------ 244
            E T+H S T    T  Y+APE     +  +  D++S GV++  ++ G            
Sbjct: 183 -ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 241
Query: 245 RTAVDFDVQLGEYHLVDKAWG 265
              +   +++G+Y   +  W 
Sbjct: 242 SPGMKTRIRMGQYEFPNPEWS 262

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 37/141 (26%), Positives = 64/141 (45%), Gaps = 22/141 (15%)
Query: 141 FGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ---NFNPKISDFGLSKLF 197
           F  +   EI+  IG  + Y+H     ++ HRD+K  N+L      N   K++DFG +K  
Sbjct: 120 FTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-- 174
Query: 198 PENTTHIS-TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG------------ 244
            E T+H S T    T  Y+APE     +  +  D++S GV++  ++ G            
Sbjct: 175 -ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 233
Query: 245 RTAVDFDVQLGEYHLVDKAWG 265
              +   +++G+Y   +  W 
Sbjct: 234 SPGMKTRIRMGQYEFPNPEWS 254

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 37/141 (26%), Positives = 64/141 (45%), Gaps = 22/141 (15%)
Query: 141 FGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ---NFNPKISDFGLSKLF 197
           F  +   EI+  IG  + Y+H     ++ HRD+K  N+L      N   K++DFG +K  
Sbjct: 164 FTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-- 218
Query: 198 PENTTHIS-TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG------------ 244
            E T+H S T    T  Y+APE     +  +  D++S GV++  ++ G            
Sbjct: 219 -ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 277
Query: 245 RTAVDFDVQLGEYHLVDKAWG 265
              +   +++G+Y   +  W 
Sbjct: 278 SPGMKTRIRMGQYEFPNPEWS 298

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 37/141 (26%), Positives = 64/141 (45%), Gaps = 22/141 (15%)
Query: 141 FGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ---NFNPKISDFGLSKLF 197
           F  +   EI+  IG  + Y+H     ++ HRD+K  N+L      N   K++DFG +K  
Sbjct: 119 FTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-- 173
Query: 198 PENTTHIS-TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG------------ 244
            E T+H S T    T  Y+APE     +  +  D++S GV++  ++ G            
Sbjct: 174 -ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 232
Query: 245 RTAVDFDVQLGEYHLVDKAWG 265
              +   +++G+Y   +  W 
Sbjct: 233 SPGMKTRIRMGQYEFPNPEWS 253

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/141 (26%), Positives = 64/141 (45%), Gaps = 22/141 (15%)
Query: 141 FGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ---NFNPKISDFGLSKLF 197
           F  +   EI+  IG  + Y+H     ++ HRD+K  N+L      N   K++DFG +K  
Sbjct: 112 FTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-- 166
Query: 198 PENTTHIS-TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG------------ 244
            E T+H S T    T  Y+APE     +  +  D++S GV++  ++ G            
Sbjct: 167 -ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 225
Query: 245 RTAVDFDVQLGEYHLVDKAWG 265
              +   +++G+Y   +  W 
Sbjct: 226 SPGMKTRIRMGQYEFPNPEWS 246

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/141 (26%), Positives = 64/141 (45%), Gaps = 22/141 (15%)
Query: 141 FGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ---NFNPKISDFGLSKLF 197
           F  +   EI+  IG  + Y+H     ++ HRD+K  N+L      N   K++DFG +K  
Sbjct: 113 FTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-- 167
Query: 198 PENTTHIS-TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG------------ 244
            E T+H S T    T  Y+APE     +  +  D++S GV++  ++ G            
Sbjct: 168 -ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 226
Query: 245 RTAVDFDVQLGEYHLVDKAWG 265
              +   +++G+Y   +  W 
Sbjct: 227 SPGMKTRIRMGQYEFPNPEWS 247

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/141 (26%), Positives = 64/141 (45%), Gaps = 22/141 (15%)
Query: 141 FGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ---NFNPKISDFGLSKLF 197
           F  +   EI+  IG  + Y+H     ++ HRD+K  N+L      N   K++DFG +K  
Sbjct: 118 FTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-- 172
Query: 198 PENTTHIS-TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG------------ 244
            E T+H S T    T  Y+APE     +  +  D++S GV++  ++ G            
Sbjct: 173 -ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 231
Query: 245 RTAVDFDVQLGEYHLVDKAWG 265
              +   +++G+Y   +  W 
Sbjct: 232 SPGMKTRIRMGQYEFPNPEWS 252

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/141 (26%), Positives = 64/141 (45%), Gaps = 22/141 (15%)
Query: 141 FGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ---NFNPKISDFGLSKLF 197
           F  +   EI+  IG  + Y+H     ++ HRD+K  N+L      N   K++DFG +K  
Sbjct: 114 FTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-- 168
Query: 198 PENTTHIS-TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG------------ 244
            E T+H S T    T  Y+APE     +  +  D++S GV++  ++ G            
Sbjct: 169 -ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 227
Query: 245 RTAVDFDVQLGEYHLVDKAWG 265
              +   +++G+Y   +  W 
Sbjct: 228 SPGMKTRIRMGQYEFPNPEWS 248

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/141 (26%), Positives = 64/141 (45%), Gaps = 22/141 (15%)
Query: 141 FGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ---NFNPKISDFGLSKLF 197
           F  +   EI+  IG  + Y+H     ++ HRD+K  N+L      N   K++DFG +K  
Sbjct: 114 FTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-- 168
Query: 198 PENTTHIS-TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG------------ 244
            E T+H S T    T  Y+APE     +  +  D++S GV++  ++ G            
Sbjct: 169 -ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 227
Query: 245 RTAVDFDVQLGEYHLVDKAWG 265
              +   +++G+Y   +  W 
Sbjct: 228 SPGMKTRIRMGQYEFPNPEWS 248

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 104/230 (45%), Gaps = 34/230 (14%)
Query: 26  LKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQD---GTIVAVKVLSVESKQGE 82
           LK ++     ++  AT+  R    +G G FG V+  R++D   G   AVK + +E  + E
Sbjct: 81  LKPVDYEYREEVHWATHQLR----LGRGSFGEVH--RMEDKQTGFQCAVKKVRLEVFRAE 134
Query: 83  KEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFG 142
           +        MA   +    +V L+G   +GP   +  + +   SL Q L+ E+      G
Sbjct: 135 E-------LMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ-LVKEQ------G 180
Query: 143 WKARREIIMGIGR---GLAYIHEEIQPHVVHRDIKTSNILLDQN-FNPKISDFGLS-KLF 197
                  +  +G+   GL Y+H      ++H D+K  N+LL  +  +  + DFG +  L 
Sbjct: 181 CLPEDRALYYLGQALEGLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQ 237
Query: 198 PE---NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
           P+    +      + GT  ++APE  +      K DV+S   ++L +++G
Sbjct: 238 PDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 73/154 (47%), Gaps = 17/154 (11%)
Query: 41  TNGFRWSNKIGEGGFGSVYK--GRLQDGTIVAVKVLSVESKQ------GEKEFMSEVASM 92
           T  F    KIG G FGSV+K   RL DG I A+K     SK+       E+  + EV + 
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRL-DGCIYAIK----RSKKPLAGSVDEQNALREVYAH 62
Query: 93  ANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG 152
           A +   H ++V+      +    ++  +Y    SL+  +    +  + F     +++++ 
Sbjct: 63  AVLGQ-HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQ 121
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP 186
           +GRGL YIH      +VH DIK SNI + +   P
Sbjct: 122 VGRGLRYIHSM---SLVHMDIKPSNIFISRTSIP 152

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 71/150 (47%), Gaps = 9/150 (6%)
Query: 41  TNGFRWSNKIGEGGFGSVYK--GRLQDGTIVAVK--VLSVESKQGEKEFMSEVASMANVN 96
           T  F    KIG G FGSV+K   RL DG I A+K     +     E+  + EV + A + 
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRL-DGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLG 68
Query: 97  VCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRG 156
             H ++V+      +    ++  +Y    SL+  +    +  + F     +++++ +GRG
Sbjct: 69  Q-HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNP 186
           L YIH      +VH DIK SNI + +   P
Sbjct: 128 LRYIHSM---SLVHMDIKPSNIFISRTSIP 154

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 73/154 (47%), Gaps = 17/154 (11%)
Query: 41  TNGFRWSNKIGEGGFGSVYK--GRLQDGTIVAVKVLSVESKQ------GEKEFMSEVASM 92
           T  F    KIG G FGSV+K   RL DG I A+K     SK+       E+  + EV + 
Sbjct: 6   TTEFHELEKIGSGEFGSVFKCVKRL-DGCIYAIK----RSKKPLAGSVDEQNALREVYAH 60
Query: 93  ANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG 152
           A +   H ++V+      +    ++  +Y    SL+  +    +  + F     +++++ 
Sbjct: 61  AVLGQ-HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQ 119
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP 186
           +GRGL YIH      +VH DIK SNI + +   P
Sbjct: 120 VGRGLRYIHSM---SLVHMDIKPSNIFISRTSIP 150

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 73/154 (47%), Gaps = 17/154 (11%)
Query: 41  TNGFRWSNKIGEGGFGSVYK--GRLQDGTIVAVKVLSVESKQ------GEKEFMSEVASM 92
           T  F    KIG G FGSV+K   RL DG I A+K     SK+       E+  + EV + 
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRL-DGCIYAIK----RSKKPLAGSVDEQNALREVYAH 62
Query: 93  ANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG 152
           A +   H ++V+      +    ++  +Y    SL+  +    +  + F     +++++ 
Sbjct: 63  AVLGQ-HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQ 121
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP 186
           +GRGL YIH      +VH DIK SNI + +   P
Sbjct: 122 VGRGLRYIHSM---SLVHMDIKPSNIFISRTSIP 152

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 103/230 (44%), Gaps = 34/230 (14%)
Query: 26  LKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQD---GTIVAVKVLSVESKQGE 82
           LK ++     ++  AT+  R    +G G FG V+  R++D   G   AVK + +E  + E
Sbjct: 62  LKPVDYEYREEVHWATHQLR----LGRGSFGEVH--RMEDKQTGFQCAVKKVRLEVFRAE 115
Query: 83  KEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFG 142
           +        MA   +    +V L+G   +GP   +  + +   SL Q L+ E+      G
Sbjct: 116 E-------LMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ-LVKEQ------G 161
Query: 143 WKARREIIMGIGR---GLAYIHEEIQPHVVHRDIKTSNILLDQN-FNPKISDFGLS-KLF 197
                  +  +G+   GL Y+H      ++H D+K  N+LL  +  +  + DFG +  L 
Sbjct: 162 CLPEDRALYYLGQALEGLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQ 218
Query: 198 PENTTH---ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
           P+           + GT  ++APE  +      K DV+S   ++L +++G
Sbjct: 219 PDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/180 (22%), Positives = 82/180 (45%), Gaps = 25/180 (13%)
Query: 114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDI 173
           C +++ + M    L   +  +E+    F  +   EI+  IG  + ++H     ++ HRD+
Sbjct: 100 CLLIIMECMEGGELFSRI--QERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDV 154
Query: 174 KTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSD 230
           K  N+L    +++   K++DFG +K   E T +       T  Y+APE     +  +  D
Sbjct: 155 KPENLLYTSKEKDAVLKLTDFGFAK---ETTQNALQTPCYTPYYVAPEVLGPEKYDKSCD 211
Query: 231 VYSFGVLLLEIVSG------------RTAVDFDVQLGEYHLVDKAWGMY--NSKELMNLV 276
           ++S GV++  ++ G               +   ++LG+Y   +  W     ++K+L+ L+
Sbjct: 212 MWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLL 271

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 90/211 (42%), Gaps = 22/211 (10%)
Query: 41  TNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVN--- 96
           ++ +     IG G FG     R  Q   +VAVK +    ++GEK  + E      +N   
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYI----ERGEK--IDENVKREIINHRS 71
Query: 97  VCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRG 156
           + H N+V+     +      +V +Y     L + +        +F     R     +  G
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA----GRFSEDEARFFFQQLISG 127
Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNP--KISDFGLSKLFPENTTHISTRVAGTLGY 214
           ++Y H      V HRD+K  N LLD +  P  KI  FG SK    ++   ST   GT  Y
Sbjct: 128 VSYCHAM---QVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKST--VGTPAY 182
Query: 215 LAPEYAISGRLTRK-SDVYSFGVLLLEIVSG 244
           +APE  +      K +DV+S GV L  ++ G
Sbjct: 183 IAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 76/168 (45%), Gaps = 28/168 (16%)
Query: 148 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 207
           +I + I + L ++H ++   V+HRD+K SN+L++     K  DFG+S    ++       
Sbjct: 140 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDID- 196
Query: 208 VAGTLGYLAPEYAISGRLTR-----KSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDK 262
            AG   Y APE  I+  L +     KSD++S G+  +E+   R   D             
Sbjct: 197 -AGCKPYXAPE-RINPELNQKGYSVKSDIWSLGITXIELAILRFPYD------------- 241
Query: 263 AWG--MYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRP 308
           +WG      K+++    P L  +    E + F      C+++ SK RP
Sbjct: 242 SWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTS---QCLKKNSKERP 286

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/180 (22%), Positives = 82/180 (45%), Gaps = 25/180 (13%)
Query: 114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDI 173
           C +++ + M    L   +  +E+    F  +   EI+  IG  + ++H     ++ HRD+
Sbjct: 81  CLLIIMECMEGGELFSRI--QERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDV 135
Query: 174 KTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSD 230
           K  N+L    +++   K++DFG +K   E T +       T  Y+APE     +  +  D
Sbjct: 136 KPENLLYTSKEKDAVLKLTDFGFAK---ETTQNALQTPCYTPYYVAPEVLGPEKYDKSCD 192
Query: 231 VYSFGVLLLEIVSG------------RTAVDFDVQLGEYHLVDKAWGMY--NSKELMNLV 276
           ++S GV++  ++ G               +   ++LG+Y   +  W     ++K+L+ L+
Sbjct: 193 MWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLL 252

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 24/212 (11%)
Query: 41  TNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVN--- 96
           ++ +     IG G FG     R  Q   +VAVK +    ++GEK  + E      +N   
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYI----ERGEK--IDENVKREIINHRS 71
Query: 97  VCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRG 156
           + H N+V+     +      +V +Y     L + +        +F     R     +  G
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA----GRFSEDEARFFFQQLISG 127
Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNP--KISDFGLSKLFPENTTHISTR-VAGTLG 213
           ++Y H      V HRD+K  N LLD +  P  KI  FG SK    +  H   +   GT  
Sbjct: 128 VSYCHAM---QVCHRDLKLENTLLDGSPAPRLKICAFGYSK---SSVLHSQPKDTVGTPA 181
Query: 214 YLAPEYAISGRLTRK-SDVYSFGVLLLEIVSG 244
           Y+APE  +      K +DV+S GV L  ++ G
Sbjct: 182 YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 100/216 (46%), Gaps = 26/216 (12%)
Query: 42  NGFRWSNKIGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHE 100
           N FR   KIG G FG +Y G  +Q    VA+K+ +V++K  +  + S++  +        
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIP 66
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
           N V+  G  ++G   +LV D +   SL + L     R  K   K    +   +   + ++
Sbjct: 67  N-VRWFG--VEGDYNVLVMDLL-GPSL-EDLFNFCSR--KLSLKTVLMLADQMINRVEFV 119
Query: 161 HEEIQPHVVHRDIKTSNILL------DQNFNPKISDFGLSKLFPENTT--HISTR----V 208
           H +     +HRDIK  N L+      +Q +   I DFGL+K + + +T  HI  R    +
Sbjct: 120 HSK---SFLHRDIKPDNFLMGLGRRANQVY---IIDFGLAKKYRDTSTHQHIPYRENKNL 173
Query: 209 AGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
            GT  Y +    +    +R+ D+ S G +L+  + G
Sbjct: 174 TGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRG 209

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 35/120 (29%), Positives = 59/120 (49%), Gaps = 4/120 (3%)
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR 227
           ++HRD+K SNI++  +   KI DFGL++    +T  + T    T  Y APE  +      
Sbjct: 145 IIHRDLKPSNIVVKSDCTLKILDFGLART--ASTNFMMTPYVVTRYYRAPEVILGMGYKE 202
Query: 228 KSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPEN 287
             D++S G ++ E+V G         + +++ V +  G   S E M  + P +  N+ EN
Sbjct: 203 NVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGT-PSAEFMAALQPTV-RNYVEN 260

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 89/208 (42%), Gaps = 16/208 (7%)
Query: 41  TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCH 99
           ++ + +   IG G FG     R +    +VAVK +   +   E     E+ +  ++   H
Sbjct: 19  SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN-VQREIINHRSLR--H 75
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
            N+V+     +      ++ +Y     L + +        +F     R     +  G++Y
Sbjct: 76  PNIVRFKEVILTPTHLAIIMEYASGGELYERICNA----GRFSEDEARFFFQQLLSGVSY 131
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNP--KISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
            H      + HRD+K  N LLD +  P  KI DFG SK    ++   ST   GT  Y+AP
Sbjct: 132 CHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAP 186
Query: 218 EYAISGRLTRK-SDVYSFGVLLLEIVSG 244
           E  +      K +DV+S GV L  ++ G
Sbjct: 187 EVLLRQEYDGKIADVWSCGVTLYVMLVG 214

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 99/212 (46%), Gaps = 23/212 (10%)
Query: 49  KIGEGGFGSVYKGRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLH 106
           +IG GG   V++   +   I A+K +++E    Q    + +E+A +  +    + +++L+
Sbjct: 35  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
              I      +V +   N  L+  L   +K+++   W+ R+     +   +  IH   Q 
Sbjct: 95  DYEITDQYIYMVME-CGNIDLNSWL---KKKKSIDPWE-RKSYWKNMLEAVHTIH---QH 146
Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGLS-KLFPENTTHISTRVAGTLGYLAPEYAISGRL 225
            +VH D+K +N L+      K+ DFG++ ++ P+ T+ +     GT+ Y+ PE       
Sbjct: 147 GIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 226 TRKS-----------DVYSFGVLLLEIVSGRT 246
           +R++           DV+S G +L  +  G+T
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKT 237

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 99/227 (43%), Gaps = 48/227 (21%)
Query: 50  IGEGGFGSV-YKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMA----NVNVCHENLVK 104
           +G G  G+V ++G  Q G  VAVK + ++          ++A M       +  H N+++
Sbjct: 23  LGYGSSGTVVFQGSFQ-GRPVAVKRMLID--------FCDIALMEIKLLTESDDHPNVIR 73
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARRE-----IIMGIGRGLAY 159
            +  C +   R L Y  +   +L+   L E K  +    K ++E     ++  I  G+A+
Sbjct: 74  YY--CSETTDRFL-YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 160 IHEEIQPHVVHRDIKTSNILLD-------------QNFNPKISDFGLSKLFPENTTHIST 206
           +H      ++HRD+K  NIL+              +N    ISDFGL K      +   T
Sbjct: 131 LHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 207 RV---AGTLGYLAPE-------YAISGRLTRKSDVYSFGVLLLEIVS 243
            +   +GT G+ APE            RLTR  D++S G +   I+S
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 49  KIGEGGFGSVYKGRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLH 106
           +IG GG   V++   +   I A+K +++E    Q    + +E+A +  +    + +++L+
Sbjct: 19  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 78
Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
              I      +V +   N  L+  L   +K+++   W+ R+     +   +  IH   Q 
Sbjct: 79  DYEITDQYIYMVME-CGNIDLNSWL---KKKKSIDPWE-RKSYWKNMLEAVHTIH---QH 130
Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGLS-KLFPENTTHISTRVAGTLGYLAPEYAISGRL 225
            +VH D+K +N L+      K+ DFG++ ++ P+ T+ +     GT+ Y+ PE       
Sbjct: 131 GIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 189
Query: 226 TRKS-----------DVYSFGVLLLEIVSGRTA 247
           +R++           DV+S G +L  +  G+T 
Sbjct: 190 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 222

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/128 (28%), Positives = 60/128 (46%), Gaps = 6/128 (4%)
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR 227
           ++HRD+K SNI++  +   KI DFGL++     T  + T    T  Y APE  +      
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLART--ACTNFMMTPYVVTRYYRAPEVILGMGYAA 204
Query: 228 KSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYG---NF 284
             D++S G ++ E+V G         + +++ V +  G   S E M  + P +     N 
Sbjct: 205 NVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGT-PSAEFMAALQPTVRNYVENR 263
Query: 285 PENEAIRF 292
           P+   I+F
Sbjct: 264 PKYPGIKF 271

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 91/203 (44%), Gaps = 13/203 (6%)
Query: 50  IGEGGFGSVYKG-RLQDGTIVAVKVLSV----ESKQGEKEFMSEVASMANVNVCHENLVK 104
           IG+G F  V +    + G   AVK++ V     S     E +   AS+ ++ + H ++V+
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM-LKHPHIVE 90
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L           +V+++M    L   ++        +        +  I   L Y H+  
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN- 149
Query: 165 QPHVVHRDIKTSNILL--DQNFNP-KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI 221
             +++HRD+K  N+LL   +N  P K+ DFG++    E+      RV GT  ++APE   
Sbjct: 150 --NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRV-GTPHFMAPEVVK 206
Query: 222 SGRLTRKSDVYSFGVLLLEIVSG 244
                +  DV+  GV+L  ++SG
Sbjct: 207 REPYGKPVDVWGCGVILFILLSG 229

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 26/77 (33%), Positives = 43/77 (55%), Gaps = 2/77 (2%)
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR 227
           ++HRD+K SNI++  +   KI DFGL++     T+ + T    T  Y APE  +      
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKE 204
Query: 228 KSDVYSFGVLLLEIVSG 244
             D++S GV++ E++ G
Sbjct: 205 NVDIWSVGVIMGEMIKG 221

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 26/77 (33%), Positives = 43/77 (55%), Gaps = 2/77 (2%)
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR 227
           ++HRD+K SNI++  +   KI DFGL++     T+ + T    T  Y APE  +      
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKE 204
Query: 228 KSDVYSFGVLLLEIVSG 244
             D++S GV++ E++ G
Sbjct: 205 NVDIWSVGVIMGEMIKG 221

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/89 (35%), Positives = 46/89 (51%), Gaps = 5/89 (5%)
Query: 168 VVHRDIKTSNILLDQNFNP-KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLT 226
           V+HRDIK  NIL+D N    K+ DFG   L  +    + T   GT  Y  PE+    R  
Sbjct: 178 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYH 234
Query: 227 -RKSDVYSFGVLLLEIVSGRTAVDFDVQL 254
            R + V+S G+LL ++V G    + D ++
Sbjct: 235 GRSAAVWSLGILLYDMVCGDIPFEHDEEI 263

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 52/108 (48%), Gaps = 10/108 (9%)
Query: 141 FGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ---NFNPKISDFGLSKLF 197
           F  +   EI   IG  + Y+H     ++ HRD+K  N+L      N   K++DFG +K  
Sbjct: 158 FTEREASEIXKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-- 212
Query: 198 PENTTHIS-TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
            E T+H S T    T  Y+APE     +  +  D +S GV+   ++ G
Sbjct: 213 -ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDXWSLGVIXYILLCG 259

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/274 (21%), Positives = 117/274 (42%), Gaps = 39/274 (14%)
Query: 49  KIGEGGFGSVYKGRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLH 106
           +IG GG   V++   +   I A+K +++E    Q    + +E+A +  +    + +++L+
Sbjct: 63  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
              I      +V +   N  L+  L   +K+++   W+ R+     +   +  IH   Q 
Sbjct: 123 DYEITDQYIYMVME-CGNIDLNSWL---KKKKSIDPWE-RKSYWKNMLEAVHTIH---QH 174
Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGLS-KLFPENTTHISTRVAGTLGYLAPEYAISGRL 225
            +VH D+K +N L+      K+ DFG++ ++ P+ T+ +     GT+ Y+ PE       
Sbjct: 175 GIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 233
Query: 226 TRKS-----------DVYSFGVLLLEIVSGRTAVDFDV-QLGEYHLVDKAWGMYNSKELM 273
           +R++           DV+S G +L  +  G+T     + Q+ + H +             
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI------------- 280
Query: 274 NLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLR 307
             +DP     FP+        V   C++   K R
Sbjct: 281 --IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQR 312

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 92/212 (43%), Gaps = 20/212 (9%)
Query: 40  ATNGFRWSNKIGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQG--EKEFMSEVASMANVN 96
           + + +R   K+GEG +G VYK         VA+K + +E ++       + EV+ +  + 
Sbjct: 32  SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQ 91
Query: 97  VCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRG 156
             H N+++L           L+++Y  N+     L     +      +  +  +  +  G
Sbjct: 92  --HRNIIELKSVIHHNHRLHLIFEYAEND-----LKKYMDKNPDVSMRVIKSFLYQLING 144
Query: 157 LAYIHEEIQPHVVHRDIKTSNILL---DQNFNP--KISDFGLSKLFPENTTHISTRVAGT 211
           + + H       +HRD+K  N+LL   D +  P  KI DFGL++ F       +  +  T
Sbjct: 145 VNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-T 200
Query: 212 LGYLAPEYAISGRLTRKS-DVYSFGVLLLEIV 242
           L Y  PE  +  R    S D++S   +  E++
Sbjct: 201 LWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 99/212 (46%), Gaps = 23/212 (10%)
Query: 49  KIGEGGFGSVYKGRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLH 106
           +IG GG   V++   +   I A+K +++E    Q    + +E+A +  +    + +++L+
Sbjct: 15  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 74
Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
              I      +V +   N  L+  L   +K+++   W+ R+     +   +  IH   Q 
Sbjct: 75  DYEITDQYIYMVME-CGNIDLNSWL---KKKKSIDPWE-RKSYWKNMLEAVHTIH---QH 126
Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGLS-KLFPENTTHISTRVAGTLGYLAPEYAISGRL 225
            +VH D+K +N L+      K+ DFG++ ++ P+ T+ +     GT+ Y+ PE       
Sbjct: 127 GIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 185
Query: 226 TRKS-----------DVYSFGVLLLEIVSGRT 246
           +R++           DV+S G +L  +  G+T
Sbjct: 186 SRENGKSKSKISPKSDVWSLGCILYYMTYGKT 217

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 99/212 (46%), Gaps = 23/212 (10%)
Query: 49  KIGEGGFGSVYKGRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLH 106
           +IG GG   V++   +   I A+K +++E    Q    + +E+A +  +    + +++L+
Sbjct: 16  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
              I      +V +   N  L+  L   +K+++   W+ R+     +   +  IH   Q 
Sbjct: 76  DYEITDQYIYMVME-CGNIDLNSWL---KKKKSIDPWE-RKSYWKNMLEAVHTIH---QH 127
Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGLS-KLFPENTTHISTRVAGTLGYLAPEYAISGRL 225
            +VH D+K +N L+      K+ DFG++ ++ P+ T+ +     GT+ Y+ PE       
Sbjct: 128 GIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 226 TRKS-----------DVYSFGVLLLEIVSGRT 246
           +R++           DV+S G +L  +  G+T
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKT 218

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 98/223 (43%), Gaps = 44/223 (19%)
Query: 50  IGEGGFGSV-YKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMA----NVNVCHENLVK 104
           +G G  G+V ++G  Q G  VAVK + ++          ++A M       +  H N+++
Sbjct: 41  LGYGSSGTVVFQGSFQ-GRPVAVKRMLID--------FCDIALMEIKLLTESDDHPNVIR 91
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARRE-----IIMGIGRGLAY 159
            +  C +   R L Y  +   +L+   L E K  +    K ++E     ++  I  G+A+
Sbjct: 92  YY--CSETTDRFL-YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 148
Query: 160 IHEEIQPHVVHRDIKTSNILLD-------------QNFNPKISDFGLSKLFPENTTHIST 206
           +H      ++HRD+K  NIL+              +N    ISDFGL K           
Sbjct: 149 LHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRX 205
Query: 207 RV---AGTLGYLAPEY---AISGRLTRKSDVYSFGVLLLEIVS 243
            +   +GT G+ APE    +   RLTR  D++S G +   I+S
Sbjct: 206 NLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILS 248

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/274 (21%), Positives = 117/274 (42%), Gaps = 39/274 (14%)
Query: 49  KIGEGGFGSVYKGRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLH 106
           +IG GG   V++   +   I A+K +++E    Q    + +E+A +  +    + +++L+
Sbjct: 63  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
              I      +V +   N  L+  L   +K+++   W+ R+     +   +  IH   Q 
Sbjct: 123 DYEITDQYIYMVME-CGNIDLNSWL---KKKKSIDPWE-RKSYWKNMLEAVHTIH---QH 174
Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGLS-KLFPENTTHISTRVAGTLGYLAPEYAISGRL 225
            +VH D+K +N L+      K+ DFG++ ++ P+ T+ +     GT+ Y+ PE       
Sbjct: 175 GIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 233
Query: 226 TRKS-----------DVYSFGVLLLEIVSGRTAVDFDV-QLGEYHLVDKAWGMYNSKELM 273
           +R++           DV+S G +L  +  G+T     + Q+ + H +             
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI------------- 280
Query: 274 NLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLR 307
             +DP     FP+        V   C++   K R
Sbjct: 281 --IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQR 312

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 98/223 (43%), Gaps = 44/223 (19%)
Query: 50  IGEGGFGSV-YKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMA----NVNVCHENLVK 104
           +G G  G+V ++G  Q G  VAVK + ++          ++A M       +  H N+++
Sbjct: 41  LGYGSSGTVVFQGSFQ-GRPVAVKRMLID--------FCDIALMEIKLLTESDDHPNVIR 91
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARRE-----IIMGIGRGLAY 159
            +  C +   R L Y  +   +L+   L E K  +    K ++E     ++  I  G+A+
Sbjct: 92  YY--CSETTDRFL-YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 148
Query: 160 IHEEIQPHVVHRDIKTSNILLD-------------QNFNPKISDFGLSKLFPENTTHIST 206
           +H      ++HRD+K  NIL+              +N    ISDFGL K           
Sbjct: 149 LHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRX 205
Query: 207 RV---AGTLGYLAPEY---AISGRLTRKSDVYSFGVLLLEIVS 243
            +   +GT G+ APE    +   RLTR  D++S G +   I+S
Sbjct: 206 NLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILS 248

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/273 (21%), Positives = 110/273 (40%), Gaps = 43/273 (15%)
Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENL 102
            R    + EGGF  VY+ + +  G   A+K L    ++  +  + EV  M  ++  H N+
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLS-GHPNI 88
Query: 103 VKLHGGCI-------DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR 155
           V+              G    L+   +    L +  L + + R         +I     R
Sbjct: 89  VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVE-FLKKMESRGPLSCDTVLKIFYQTCR 147
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL---FPENTTHISTRVA--- 209
            + ++H + +P ++HRD+K  N+LL      K+ DFG +     +P+ +     R     
Sbjct: 148 AVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 210 -----GTLGYLAPE----YAISGRLTRKSDVYSFGVLL---------------LEIVSGR 245
                 T  Y  PE    Y+ +  +  K D+++ G +L               L IV+G+
Sbjct: 207 EITRNTTPMYRTPEIIDLYS-NFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGK 265
Query: 246 TAV-DFDVQLGEYHLVDKAWGMYNSKELMNLVD 277
            ++   D Q   +H + +A    N +E +++ +
Sbjct: 266 YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAE 298

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 113/250 (45%), Gaps = 28/250 (11%)
Query: 44  FRWSNKIGEGGFGSVYKGRLQD-GTIVAVK--VLSVESKQGEKEFMSEVASMANVNVCHE 100
           F+     G+G FG+V  G+ +  G  VA+K  +     +  E + M ++A +      H 
Sbjct: 25  FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLH-----HP 79
Query: 101 NLVKLHG-----GCIDGPCRIL--VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGI 153
           N+V+L       G  D     L  V +Y+P+ +L +      +R+        +  +  +
Sbjct: 80  NIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQL 138
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQ-NFNPKISDFGLS-KLFPE--NTTHISTRVA 209
            R +  +H     +V HRDIK  N+L+++ +   K+ DFG + KL P   N  +I +R  
Sbjct: 139 IRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY- 196
Query: 210 GTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYN 268
               Y APE     +  T   D++S G +  E++ G      D   G+ H + +  G   
Sbjct: 197 ----YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGC-P 251
Query: 269 SKELMNLVDP 278
           S+E++  ++P
Sbjct: 252 SREVLRKLNP 261

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 94/205 (45%), Gaps = 26/205 (12%)
Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           ++G G FG V++ +  Q G   AVK + +E  + E     E+ + A ++     +V L+G
Sbjct: 65  RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLS--SPRIVPLYG 117
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR---GLAYIHEEI 164
              +GP   +  + +   SL Q +        + G       +  +G+   GL Y+H   
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLI-------KQMGCLPEDRALYYLGQALEGLEYLHTR- 169
Query: 165 QPHVVHRDIKTSNILLDQNFN-PKISDFGLS-KLFPE---NTTHISTRVAGTLGYLAPEY 219
              ++H D+K  N+LL  + +   + DFG +  L P+    +      + GT  ++APE 
Sbjct: 170 --RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 227
Query: 220 AISGRLTRKSDVYSFGVLLLEIVSG 244
            +      K D++S   ++L +++G
Sbjct: 228 VMGKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 25/77 (32%), Positives = 42/77 (54%), Gaps = 2/77 (2%)
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR 227
           ++HRD+K SNI++  +   KI DFGL++     T+ + T    T  Y APE  +      
Sbjct: 148 IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKE 205
Query: 228 KSDVYSFGVLLLEIVSG 244
             D++S G ++ E++ G
Sbjct: 206 NVDIWSVGCIMGEMIKG 222

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/124 (34%), Positives = 58/124 (46%), Gaps = 16/124 (12%)
Query: 138 RAKFGWKARREIIMGIGR----GLAYIHEEIQPHVVHRDIKTSNILLDQN--FNPKISDF 191
           R    +  R ++I  I R     L Y+H +    + HRDIK  N L   N  F  K+ DF
Sbjct: 158 RESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDF 214
Query: 192 GLSKLFPE---NTTHISTRVAGTLGYLAPEY--AISGRLTRKSDVYSFGVLLLEIVSGRT 246
           GLSK F +      +  T  AGT  ++APE     +     K D +S GVLL  ++ G  
Sbjct: 215 GLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMG-- 272
Query: 247 AVDF 250
           AV F
Sbjct: 273 AVPF 276

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 94/205 (45%), Gaps = 26/205 (12%)
Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           ++G G FG V++ +  Q G   AVK + +E  + E     E+ + A ++     +V L+G
Sbjct: 81  RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLS--SPRIVPLYG 133
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR---GLAYIHEEI 164
              +GP   +  + +   SL Q +        + G       +  +G+   GL Y+H   
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLI-------KQMGCLPEDRALYYLGQALEGLEYLHTR- 185
Query: 165 QPHVVHRDIKTSNILLDQNFN-PKISDFGLS-KLFPE---NTTHISTRVAGTLGYLAPEY 219
              ++H D+K  N+LL  + +   + DFG +  L P+    +      + GT  ++APE 
Sbjct: 186 --RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 243
Query: 220 AISGRLTRKSDVYSFGVLLLEIVSG 244
            +      K D++S   ++L +++G
Sbjct: 244 VMGKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 25/77 (32%), Positives = 42/77 (54%), Gaps = 2/77 (2%)
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR 227
           ++HRD+K SNI++  +   KI DFGL++     T+ + T    T  Y APE  +      
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKE 204
Query: 228 KSDVYSFGVLLLEIVSG 244
             D++S G ++ E++ G
Sbjct: 205 NVDIWSVGCIMGEMIKG 221

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 94/205 (45%), Gaps = 26/205 (12%)
Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           ++G G FG V++ +  Q G   AVK + +E  + E     E+ + A ++     +V L+G
Sbjct: 79  RLGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLS--SPRIVPLYG 131
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR---GLAYIHEEI 164
              +GP   +  + +   SL Q +        + G       +  +G+   GL Y+H   
Sbjct: 132 AVREGPWVNIFMELLEGGSLGQLI-------KQMGCLPEDRALYYLGQALEGLEYLHTR- 183
Query: 165 QPHVVHRDIKTSNILLDQNFN-PKISDFGLS-KLFPE---NTTHISTRVAGTLGYLAPEY 219
              ++H D+K  N+LL  + +   + DFG +  L P+    +      + GT  ++APE 
Sbjct: 184 --RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 241
Query: 220 AISGRLTRKSDVYSFGVLLLEIVSG 244
            +      K D++S   ++L +++G
Sbjct: 242 VMGKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 25/77 (32%), Positives = 42/77 (54%), Gaps = 2/77 (2%)
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR 227
           ++HRD+K SNI++  +   KI DFGL++     T+ + T    T  Y APE  +      
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKE 204
Query: 228 KSDVYSFGVLLLEIVSG 244
             D++S G ++ E++ G
Sbjct: 205 NVDIWSVGCIMGEMIKG 221

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 25/77 (32%), Positives = 42/77 (54%), Gaps = 2/77 (2%)
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR 227
           ++HRD+K SNI++  +   KI DFGL++     T+ + T    T  Y APE  +      
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKE 204
Query: 228 KSDVYSFGVLLLEIVSG 244
             D++S G ++ E++ G
Sbjct: 205 NVDIWSVGCIMGEMIKG 221

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 25/77 (32%), Positives = 42/77 (54%), Gaps = 2/77 (2%)
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR 227
           ++HRD+K SNI++  +   KI DFGL++     T+ + T    T  Y APE  +      
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKE 204
Query: 228 KSDVYSFGVLLLEIVSG 244
             D++S G ++ E++ G
Sbjct: 205 NVDIWSVGCIMGEMIKG 221

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 86/198 (43%), Gaps = 16/198 (8%)
Query: 47  SNKIGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGEK---EFMSEVASMANVNVCHENL 102
           S ++G G F  V +      G   A K L  + ++G+    E + E+A +     C   +
Sbjct: 34  SKELGRGKFAVVRQCISKSTGQEYAAKFLK-KRRRGQDCRAEILHEIAVLELAKSC-PRV 91
Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE 162
           + LH    +    IL+ +Y     +    L E           R  +I  I  G+ Y+H 
Sbjct: 92  INLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIR--LIKQILEGVYYLH- 148
Query: 163 EIQPHVVHRDIKTSNILLDQNF---NPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEY 219
             Q ++VH D+K  NILL   +   + KI DFG+S+            + GT  YLAPE 
Sbjct: 149 --QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE--LREIMGTPEYLAPEI 204
Query: 220 AISGRLTRKSDVYSFGVL 237
                +T  +D+++ G++
Sbjct: 205 LNYDPITTATDMWNIGII 222

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 25/77 (32%), Positives = 42/77 (54%), Gaps = 2/77 (2%)
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR 227
           ++HRD+K SNI++  +   KI DFGL++     T+ + T    T  Y APE  +      
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKE 204
Query: 228 KSDVYSFGVLLLEIVSG 244
             D++S G ++ E++ G
Sbjct: 205 NVDIWSVGCIMGEMIKG 221

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 25/77 (32%), Positives = 42/77 (54%), Gaps = 2/77 (2%)
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR 227
           ++HRD+K SNI++  +   KI DFGL++     T+ + T    T  Y APE  +      
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKE 204
Query: 228 KSDVYSFGVLLLEIVSG 244
             D++S G ++ E++ G
Sbjct: 205 NVDIWSVGCIMGEMIKG 221

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 25/77 (32%), Positives = 42/77 (54%), Gaps = 2/77 (2%)
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR 227
           ++HRD+K SNI++  +   KI DFGL++     T+ + T    T  Y APE  +      
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPEVVTRYYRAPEVILGMGYKE 204
Query: 228 KSDVYSFGVLLLEIVSG 244
             D++S G ++ E++ G
Sbjct: 205 NVDIWSVGCIMGEMIKG 221

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 56/244 (22%), Positives = 97/244 (39%), Gaps = 44/244 (18%)
Query: 34  YNQLKIATNGFRWSNKIGEGGFGSVY--KGRLQDGTIVAVKVLSVESKQGEKEFMSEVAS 91
           Y  +   +N F+  +KIGEG F SVY    +LQ G    + +  +          +E+  
Sbjct: 13  YEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQC 72
Query: 92  MANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
           +  V    +N++ +          ++   Y+ + S    L           ++  RE ++
Sbjct: 73  L-TVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDIL-------NSLSFQEVREYML 124
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSK--------------- 195
            + + L  IH   Q  +VHRD+K SN L ++      + DFGL++               
Sbjct: 125 NLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQS 181
Query: 196 -------------LFPENTTHISTRVAGTLGYLAPEYAI-SGRLTRKSDVYSFGVLLLEI 241
                        +       ++ R AGT G+ APE        T   D++S GV+ L +
Sbjct: 182 EAQQERCSQNKCSICLSRRQQVAPR-AGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSL 240
Query: 242 VSGR 245
           +SGR
Sbjct: 241 LSGR 244

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 58/274 (21%), Positives = 116/274 (42%), Gaps = 39/274 (14%)
Query: 49  KIGEGGFGSVYKGRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLH 106
           +IG GG   V++   +   I A+K +++E    Q    + +E+A +  +    + +++L+
Sbjct: 63  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
              I      +V +   N  L+  L   +K+++   W+ R+     +   +  IH   Q 
Sbjct: 123 DYEITDQYIYMVME-CGNIDLNSWL---KKKKSIDPWE-RKSYWKNMLEAVHTIH---QH 174
Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGLS-KLFPENTTHISTRVAGTLGYLAPEYAISGRL 225
            +VH D+K +N L+      K+ DFG++ ++ P+ T+ +     G + Y+ PE       
Sbjct: 175 GIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233
Query: 226 TRKS-----------DVYSFGVLLLEIVSGRTAVDFDV-QLGEYHLVDKAWGMYNSKELM 273
           +R++           DV+S G +L  +  G+T     + Q+ + H +             
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI------------- 280
Query: 274 NLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLR 307
             +DP     FP+        V   C++   K R
Sbjct: 281 --IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQR 312

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 8/88 (9%)
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR 227
           ++HRD+K SNI++  +   KI DFGL++     T+ + T    T  Y APE  +      
Sbjct: 185 IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKE 242
Query: 228 KSDVYSFGVLLLEIV------SGRTAVD 249
             D++S G ++ E+V       GR  +D
Sbjct: 243 NVDIWSVGCIMGEMVRHKILFPGRDYID 270

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 8/88 (9%)
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR 227
           ++HRD+K SNI++  +   KI DFGL++     T+ + T    T  Y APE  +      
Sbjct: 140 IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKE 197
Query: 228 KSDVYSFGVLLLEIV------SGRTAVD 249
             D++S G ++ E+V       GR  +D
Sbjct: 198 NVDIWSVGCIMGEMVRHKILFPGRDYID 225

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 8/88 (9%)
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR 227
           ++HRD+K SNI++  +   KI DFGL++     T+ + T    T  Y APE  +      
Sbjct: 148 IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKE 205
Query: 228 KSDVYSFGVLLLEIV------SGRTAVD 249
             D++S G ++ E+V       GR  +D
Sbjct: 206 NVDIWSVGCIMGEMVRHKILFPGRDYID 233

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 8/88 (9%)
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR 227
           ++HRD+K SNI++  +   KI DFGL++     T+ + T    T  Y APE  +      
Sbjct: 148 IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKE 205
Query: 228 KSDVYSFGVLLLEIV------SGRTAVD 249
             D++S G ++ E+V       GR  +D
Sbjct: 206 NVDIWSVGCIMGEMVRHKILFPGRDYID 233

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 20/208 (9%)
Query: 42  NGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHE 100
           N +R   KIG G FG +Y G  +  G  VA+K+  V++K  +    S++  M    V   
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGV--- 65
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
            +  +     +G   ++V + +   SL + L     R  KF  K    +   +   + YI
Sbjct: 66  GIPTIRWCGAEGDYNVMVMELL-GPSL-EDLFNFCSR--KFSLKTVLLLADQMISRIEYI 121
Query: 161 HEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTT--HISTR----VAGT 211
           H +   + +HRD+K  N L+    +     I DFGL+K + +  T  HI  R    + GT
Sbjct: 122 HSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 178
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLL 239
             Y +    +    +R+ D+ S G +L+
Sbjct: 179 ARYASINTHLGIEQSRRDDLESLGYVLM 206

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 8/88 (9%)
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR 227
           ++HRD+K SNI++  +   KI DFGL++     T+ + T    T  Y APE  +      
Sbjct: 185 IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKE 242
Query: 228 KSDVYSFGVLLLEIV------SGRTAVD 249
             D++S G ++ E+V       GR  +D
Sbjct: 243 NVDIWSVGCIMGEMVRHKILFPGRDYID 270

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 8/88 (9%)
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR 227
           ++HRD+K SNI++  +   KI DFGL++     T+ + T    T  Y APE  +      
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKE 204
Query: 228 KSDVYSFGVLLLEIV------SGRTAVD 249
             D++S G ++ E+V       GR  +D
Sbjct: 205 NVDIWSVGCIMGEMVRHKILFPGRDYID 232

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 8/88 (9%)
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR 227
           ++HRD+K SNI++  +   KI DFGL++     T+ + T    T  Y APE  +      
Sbjct: 141 IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKE 198
Query: 228 KSDVYSFGVLLLEIV------SGRTAVD 249
             D++S G ++ E+V       GR  +D
Sbjct: 199 NVDIWSVGCIMGEMVRHKILFPGRDYID 226

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 8/88 (9%)
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR 227
           ++HRD+K SNI++  +   KI DFGL++     T+ + T    T  Y APE  +      
Sbjct: 141 IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKE 198
Query: 228 KSDVYSFGVLLLEIV------SGRTAVD 249
             D++S G ++ E+V       GR  +D
Sbjct: 199 NVDIWSVGCIMGEMVRHKILFPGRDYID 226

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 8/88 (9%)
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR 227
           ++HRD+K SNI++  +   KI DFGL++     T+ + T    T  Y APE  +      
Sbjct: 146 IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKE 203
Query: 228 KSDVYSFGVLLLEIV------SGRTAVD 249
             D++S G ++ E+V       GR  +D
Sbjct: 204 NVDIWSVGCIMGEMVRHKILFPGRDYID 231

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 8/88 (9%)
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR 227
           ++HRD+K SNI++  +   KI DFGL++     T+ + T    T  Y APE  +      
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKE 204
Query: 228 KSDVYSFGVLLLEIV------SGRTAVD 249
             D++S G ++ E+V       GR  +D
Sbjct: 205 NVDIWSVGCIMGEMVRHKILFPGRDYID 232

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 8/88 (9%)
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR 227
           ++HRD+K SNI++  +   KI DFGL++     T+ + T    T  Y APE  +      
Sbjct: 147 IIHRDLKPSNIVVKSDXTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKE 204
Query: 228 KSDVYSFGVLLLEIV------SGRTAVD 249
             D++S G ++ E+V       GR  +D
Sbjct: 205 NVDIWSVGCIMGEMVRHKILFPGRDYID 232

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 8/88 (9%)
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR 227
           ++HRD+K SNI++  +   KI DFGL++     T+ + T    T  Y APE  +      
Sbjct: 140 IIHRDLKPSNIVVKSDXTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKE 197
Query: 228 KSDVYSFGVLLLEIV------SGRTAVD 249
             D++S G ++ E+V       GR  +D
Sbjct: 198 NVDIWSVGCIMGEMVRHKILFPGRDYID 225

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 8/88 (9%)
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR 227
           ++HRD+K SNI++  +   KI DFGL++     T+ + T    T  Y APE  +      
Sbjct: 147 IIHRDLKPSNIVVKSDXTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKE 204
Query: 228 KSDVYSFGVLLLEIV------SGRTAVD 249
             D++S G ++ E+V       GR  +D
Sbjct: 205 NVDIWSVGCIMGEMVRHKILFPGRDYID 232

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 8/88 (9%)
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR 227
           ++HRD+K SNI++  +   KI DFGL++     T+ + T    T  Y APE  +      
Sbjct: 147 IIHRDLKPSNIVVKSDXTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKE 204
Query: 228 KSDVYSFGVLLLEIV------SGRTAVD 249
             D++S G ++ E+V       GR  +D
Sbjct: 205 NVDIWSVGCIMGEMVRHKILFPGRDYID 232

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 20/208 (9%)
Query: 42  NGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHE 100
           N +R   KIG G FG +Y G  +  G  VA+K+  V++K  +    S++  M    V   
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGV--- 63
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
            +  +     +G   ++V + +   SL + L     R  KF  K    +   +   + YI
Sbjct: 64  GIPTIRWCGAEGDYNVMVMELL-GPSL-EDLFNFCSR--KFSLKTVLLLADQMISRIEYI 119
Query: 161 HEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTT--HISTR----VAGT 211
           H +   + +HRD+K  N L+    +     I DFGL+K + +  T  HI  R    + GT
Sbjct: 120 HSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLL 239
             Y +    +    +R+ D+ S G +L+
Sbjct: 177 ARYASINTHLGIEQSRRDDLESLGYVLM 204

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 8/88 (9%)
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR 227
           ++HRD+K SNI++  +   KI DFGL++     T+ + T    T  Y APE  +      
Sbjct: 147 IIHRDLKPSNIVVKSDXTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKE 204
Query: 228 KSDVYSFGVLLLEIV------SGRTAVD 249
             D++S G ++ E+V       GR  +D
Sbjct: 205 NVDIWSVGCIMGEMVRHKILFPGRDYID 232

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 27/77 (35%), Positives = 40/77 (51%), Gaps = 2/77 (2%)
Query: 169 VHRDIKTSNILLDQNFNPKISDFGL-SKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR 227
            HRD+K  NIL+  +    + DFG+ S    E  T +   V GTL Y APE       T 
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYXAPERFSESHATY 214
Query: 228 KSDVYSFGVLLLEIVSG 244
           ++D+Y+   +L E ++G
Sbjct: 215 RADIYALTCVLYECLTG 231

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 24/77 (31%), Positives = 41/77 (53%), Gaps = 2/77 (2%)
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR 227
           ++HRD+K SNI++  +   KI DFGL++     T+ +      T  Y APE  +      
Sbjct: 149 IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMVPFVVTRYYRAPEVILGMGYKE 206
Query: 228 KSDVYSFGVLLLEIVSG 244
             D++S G ++ E++ G
Sbjct: 207 NVDIWSVGCIMGEMIKG 223

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/107 (27%), Positives = 48/107 (44%), Gaps = 18/107 (16%)
Query: 149 IIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL------------ 196
           I + I   + ++H +    ++HRD+K SNI    +   K+ DFGL               
Sbjct: 169 IFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 225
Query: 197 -FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIV 242
             P   TH      GT  Y++PE       + K D++S G++L E++
Sbjct: 226 PMPAYATHXGQ--VGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 97/227 (42%), Gaps = 48/227 (21%)
Query: 50  IGEGGFGSV-YKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMA----NVNVCHENLVK 104
           +G G  G+V ++G  Q G  VAVK + ++          ++A M       +  H N+++
Sbjct: 23  LGYGSSGTVVFQGSFQ-GRPVAVKRMLID--------FCDIALMEIKLLTESDDHPNVIR 73
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARRE-----IIMGIGRGLAY 159
            +  C +   R L Y  +   +L+   L E K  +    K ++E     ++  I  G+A+
Sbjct: 74  YY--CSETTDRFL-YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 160 IHEEIQPHVVHRDIKTSNILLD-------------QNFNPKISDFGLSKLFPENTTHIST 206
           +H      ++HRD+K  NIL+              +N    ISDFGL K           
Sbjct: 131 LHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRX 187
Query: 207 RV---AGTLGYLAPE-------YAISGRLTRKSDVYSFGVLLLEIVS 243
            +   +GT G+ APE            RLTR  D++S G +   I+S
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 8/88 (9%)
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR 227
           ++HRD+K SNI++  +   KI DFGL++     T+ + T    T  Y APE  +      
Sbjct: 141 IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKE 198
Query: 228 KSDVYSFGVLLLEIVS------GRTAVD 249
             D++S G ++ E+V       GR  +D
Sbjct: 199 NVDLWSVGCIMGEMVCHKILFPGRDYID 226

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 8/88 (9%)
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR 227
           ++HRD+K SNI++  +   KI DFGL++     T+ + T    T  Y APE  +      
Sbjct: 152 IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKE 209
Query: 228 KSDVYSFGVLLLEIVS------GRTAVD 249
             D++S G ++ E+V       GR  +D
Sbjct: 210 NVDLWSVGCIMGEMVCHKILFPGRDYID 237

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 42  NGFRWSNKIGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHE 100
           N +R   KIG G FG +Y G  +  G  VA+K+  V++K  +    S+   M    V   
Sbjct: 9   NKYRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKHPQLHIESKFYKMMQGGVGIP 68
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
           + +K  G   +G   ++V + +   SL + L     R  KF  K    +   +   + YI
Sbjct: 69  S-IKWCGA--EGDYNVMVMELL-GPSL-EDLFNFCSR--KFSLKTVLLLADQMISRIEYI 121
Query: 161 HEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTT--HISTR----VAGT 211
           H +   + +HRD+K  N L+    +     I DFGL+K + +  T  HI  R    + GT
Sbjct: 122 HSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 178
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLL 239
             Y +    +    +R+ D+ S G +L+
Sbjct: 179 ARYASINTHLGIEQSRRDDLESLGYVLM 206

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 97/212 (45%), Gaps = 23/212 (10%)
Query: 49  KIGEGGFGSVYKGRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLH 106
           +IG GG   V++   +   I A+K +++E    Q    + +E+A +  +    + +++L+
Sbjct: 35  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
              I      +V +   N  L+  L   +K+++   W+ R+     +   +  IH   Q 
Sbjct: 95  DYEITDQYIYMVME-CGNIDLNSWL---KKKKSIDPWE-RKSYWKNMLEAVHTIH---QH 146
Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGLS-KLFPENTTHISTRVAGTLGYLAPEYAISGRL 225
            +VH D+K +N L+      K+ DFG++ ++ P+    +     GT+ Y+ PE       
Sbjct: 147 GIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 226 TRKS-----------DVYSFGVLLLEIVSGRT 246
           +R++           DV+S G +L  +  G+T
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKT 237

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 85/214 (39%), Gaps = 60/214 (28%)
Query: 130 TLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ--NFNP- 186
           ++L    +R  F       ++  +   L ++H +    + HRD+K  NIL +     +P 
Sbjct: 97  SILSHIHKRRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPV 153
Query: 187 KISDFGLSK-------LFPENTTHISTRVAGTLGYLAPEY--AISGRLT---RKSDVYSF 234
           KI DFGL           P +T  + T   G+  Y+APE   A S   +   ++ D++S 
Sbjct: 154 KICDFGLGSGIKLNGDCSPISTPELLTP-CGSAEYMAPEVVEAFSEEASIYDKRCDLWSL 212
Query: 235 GVLLLEIVS------GRTAVDF-----------------DVQLGEYHLVDKAWGMYN--S 269
           GV+L  ++S      GR   D                   +Q G+Y   DK W   +  +
Sbjct: 213 GVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAA 272
Query: 270 KELMN----------------LVDPMLYGNFPEN 287
           K+L++                L  P + G  PEN
Sbjct: 273 KDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPEN 306

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 90/210 (42%), Gaps = 19/210 (9%)
Query: 49  KIGEGGFGSVYKGRLQDGTIVAVKVL-SVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           K+G G +G VYK + +DG       L  +E          E+A +  +   H N++ L  
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELK--HPNVISLQK 85
Query: 108 GCIDGPCR--ILVYDYMPNNSLS----QTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
             +    R   L++DY  ++              K+  +      + ++  I  G+ Y+H
Sbjct: 86  VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 162 EEIQPHVVHRDIKTSNILL----DQNFNPKISDFGLSKLF--PENTTHISTRVAGTLGYL 215
                 V+HRD+K +NIL+     +    KI+D G ++LF  P         V  T  Y 
Sbjct: 146 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 202
Query: 216 APEYAISGR-LTRKSDVYSFGVLLLEIVSG 244
           APE  +  R  T+  D+++ G +  E+++ 
Sbjct: 203 APELLLGARHYTKAIDIWAIGCIFAELLTS 232

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 48  NKIGEGGFGSVYKGRLQD-GTIVAVKVL----SVESKQG--EKEFMSEVASMANVNVCHE 100
            ++G G F  V K R +  G   A K +    S  S++G   +E   EV+ +  V   H 
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV--LHH 75
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
           N++ LH    +    +L+ + +    L   L  +E    +      ++I+ G+     Y+
Sbjct: 76  NVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN----YL 131
Query: 161 HEEIQPHVVHRDIKTSNI-LLDQNF---NPKISDFGLSKLFPENTTHISTRVAGTLGYLA 216
           H +    + H D+K  NI LLD+N    + K+ DFGL+    +        + GT  ++A
Sbjct: 132 HTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTPEFVA 186
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVSG 244
           PE      L  ++D++S GV+   ++SG
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 22/207 (10%)
Query: 49  KIGEGGFGSVYKGRLQD-GTIVAVKVL----SVESKQG--EKEFMSEVASMANVNVCHEN 101
           ++G G F  V K R +  G   A K +    S  S++G   +E   EV+ +  V   H N
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV--LHHN 76
Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
           ++ LH    +    +L+ + +    L   L  +E    +      ++I+ G+     Y+H
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN----YLH 132
Query: 162 EEIQPHVVHRDIKTSNI-LLDQNF---NPKISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
            +    + H D+K  NI LLD+N    + K+ DFGL+    +        + GT  ++AP
Sbjct: 133 TK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTPEFVAP 187
Query: 218 EYAISGRLTRKSDVYSFGVLLLEIVSG 244
           E      L  ++D++S GV+   ++SG
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 106/225 (47%), Gaps = 30/225 (13%)
Query: 40  ATNGFRW--SNKIGEGGFGSVYKGRLQD-GTIVAVKVLS-VESKQGEKEFMSEVASMANV 95
           +T+   W  S+ +G+G   +V++GR +  G + A+KV + +   +     M E   +  +
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 96  NVCHENLVKLHGGCIDGPCR--ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM-- 151
           N  H+N+VKL     +   R  +L+ ++ P  SL   L  EE   A +G      +I+  
Sbjct: 65  N--HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVL--EEPSNA-YGLPESEFLIVLR 119
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILL----DQNFNPKISDFGLSKLFPENTTHISTR 207
            +  G+ ++ E     +VHR+IK  NI+     D     K++DFG ++   ++   +S  
Sbjct: 120 DVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS-- 174
Query: 208 VAGTLGYLAP---EYAISGRLTRKS-----DVYSFGVLLLEIVSG 244
           + GT  YL P   E A+  +  +K      D++S GV      +G
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	358
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-170
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-148
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-142
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-86
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	6e-71
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-60
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-58
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-57
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-57
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	8e-56
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-54
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-54
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-54
3q4u_A	301	Activin receptor type-1; structural genomics conso	5e-54
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-52
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-52
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-52
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-50
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-43
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-43
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-42
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-42
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-42
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-42
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	7e-42
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-41
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-40
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-40
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-40
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-40
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-40
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	5e-40
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	6e-40
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	6e-40
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	7e-40
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	8e-40
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-39
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-39
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-39
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	7e-39
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	7e-39
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	9e-39
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-38
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-38
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-38
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-38
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-38
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-38
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	6e-38
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	6e-38
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	8e-38
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-37
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-37
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-37
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-37
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-37
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-37
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-36
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-36
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-36
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-36
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	5e-36
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	5e-36
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	5e-36
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	9e-36
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	9e-36
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-35
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-35
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-35
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-35
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-35
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-35
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-35
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-35
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	6e-35
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-34
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-34
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-34
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-34
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-34
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-34
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	4e-34
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	5e-34
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	7e-34
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	9e-34
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	9e-34
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-33
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-33
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-33
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-33
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-33
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	8e-33
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	8e-33
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-32
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-32
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-32
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-32
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-32
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	4e-32
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	7e-32
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-31
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-31
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-31
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-30
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-30
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-30
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-30
3an0_A	340	Dual specificity mitogen-activated protein kinase;	7e-30
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	9e-30
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-29
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-29
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-29
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-29
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-29
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	5e-29
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	6e-29
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-28
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-28
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-28
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	5e-28
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	7e-28
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-27
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-27
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-27
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-27
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-27
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	5e-27
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	6e-27
2dyl_A	318	Dual specificity mitogen-activated protein kinase	7e-27
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	8e-27
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	8e-27
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	8e-27
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-26
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-26
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-26
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-26
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	5e-26
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	6e-26
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	7e-26
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	8e-26
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	8e-26
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-25
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-25
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-25
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-25
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-25
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	5e-25
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	5e-25
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	5e-25
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	6e-25
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	6e-25
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	7e-25
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-24
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-24
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-24
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-24
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-24
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-24
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-24
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	4e-24
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	4e-24
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-24
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	5e-24
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	6e-24
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	7e-24
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	8e-24
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	9e-24
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-23
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-23
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-23
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-23
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-23
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-23
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-23
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-23
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	6e-23
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-22
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-22
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-22
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-22
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-22
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-22
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-22
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	4e-22
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	6e-22
3bhy_A	283	Death-associated protein kinase 3; death associate	6e-22
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	8e-22
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-21
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-21
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-21
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	5e-21
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	5e-21
3uqc_A	286	Probable conserved transmembrane protein; structur	6e-21
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-20
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	4e-20
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	5e-20
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-19
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-19
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	6e-19
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	8e-19
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	8e-19
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	8e-19
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-18
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-18
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-18
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	5e-18
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	8e-18
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	9e-18
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	9e-17
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-16
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-16
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	6e-16
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	7e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	9e-15
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-14
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-14
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-08
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-14
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-14
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	3e-14
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-14
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	7e-14
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	8e-14
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-13
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-13
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	4e-13
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-12
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-12
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-12
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	7e-12
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-11
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-10
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	7e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	8e-05
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-08
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-06
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-05
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-05

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  475 bits (1224), Expect = e-170
 Identities = 122/305 (40%), Positives = 184/305 (60%), Gaps = 5/305 (1%)

Query: 23  EQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQG- 81
           E  L  +  FS  +L++A++ F   N +G GGFG VYKGRL DGT+VAVK L  E  QG 
Sbjct: 11  EVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG 70

Query: 82  EKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKF 141
           E +F +EV  ++     H NL++L G C+    R+LVY YM N S++  L    + +   
Sbjct: 71  ELQFQTEVEMISMAV--HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPL 128

Query: 142 GWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 201
            W  R+ I +G  RGLAY+H+   P ++HRD+K +NILLD+ F   + DFGL+KL     
Sbjct: 129 DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 188

Query: 202 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE--YHL 259
           TH++T V GT+G++APEY  +G+ + K+DV+ +GV+LLE+++G+ A D      +    L
Sbjct: 189 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 248

Query: 260 VDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNG 319
           +D   G+   K+L  LVD  L GN+ + E  + ++V LLC Q     RP+MS  ++M+ G
Sbjct: 249 LDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308

Query: 320 ETNID 324
           +   +
Sbjct: 309 DGLAE 313

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  420 bits (1083), Expect = e-148
 Identities = 119/320 (37%), Positives = 171/320 (53%), Gaps = 6/320 (1%)

Query: 6   SCFSFPSRVSAENTIGGEQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQD 65
           S +S  +    +       +           L+ ATN F     IG G FG VYKG L+D
Sbjct: 3   SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62

Query: 66  GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 125
           G  VA+K  + ES QG +EF +E+ +++     H +LV L G C +    IL+Y YM N 
Sbjct: 63  GAKVALKRRTPESSQGIEEFETEIETLSFCR--HPHLVSLIGFCDERNEMILIYKYMENG 120

Query: 126 SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN 185
           +L + L G +       W+ R EI +G  RGL Y+H      ++HRD+K+ NILLD+NF 
Sbjct: 121 NLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFV 177

Query: 186 PKISDFGLSKLFPE-NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
           PKI+DFG+SK   E + TH+ST V GTLGY+ PEY I GRLT KSDVYSFGV+L E++  
Sbjct: 178 PKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCA 237

Query: 245 RTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKS 304
           R+A+   +     +L + A   +N+ +L  +VDP L          +F    + C+   S
Sbjct: 238 RSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSS 297

Query: 305 KLRPQMSTAIKMMNGETNID 324
           + RP M   +  +     + 
Sbjct: 298 EDRPSMGDVLWKLEYALRLQ 317

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  405 bits (1043), Expect = e-142
 Identities = 110/306 (35%), Positives = 165/306 (53%), Gaps = 23/306 (7%)

Query: 28  NINAFSYNQLKIATNGFR------WSNKIGEGGFGSVYKGRLQDGTIVAVKVLS----VE 77
             ++FS+ +LK  TN F         NK+GEGGFG VYKG + + T VAVK L+    + 
Sbjct: 11  RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDIT 69

Query: 78  SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKR 137
           +++ +++F  E+  MA     HENLV+L G   DG    LVY YMPN SL   L   +  
Sbjct: 70  TEELKQQFDQEIKVMAKCQ--HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT 127

Query: 138 RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197
                W  R +I  G   G+ ++HE    H +HRDIK++NILLD+ F  KISDFGL++  
Sbjct: 128 -PPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARAS 183

Query: 198 PEN-TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE 256
            +   T +++R+ GT  Y+APE  + G +T KSD+YSFGV+LLEI++G  AVD       
Sbjct: 184 EKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEH--REP 240

Query: 257 YHLVDKAWGMYNSKE-LMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK 315
             L+D    + + ++ + + +D  +  +           V   C+ EK   RP +    +
Sbjct: 241 QLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299

Query: 316 MMNGET 321
           ++   T
Sbjct: 300 LLQEMT 305

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  262 bits (671), Expect = 4e-86
 Identities = 74/310 (23%), Positives = 124/310 (40%), Gaps = 32/310 (10%)

Query: 32  FSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVAS 91
                L   +   +       G FG V+K +L     VAVK+  ++ KQ   +   EV S
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSW-QNEYEVYS 71

Query: 92  MANVNVCHENLVKLHGGCIDGPC----RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARR 147
           +  +   HEN+++  G    G        L+  +    SLS  L     +     W    
Sbjct: 72  LPGMK--HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-----KANVVSWNELC 124

Query: 148 EIIMGIGRGLAYIHEEIQ-------PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 200
            I   + RGLAY+HE+I        P + HRDIK+ N+LL  N    I+DFGL+  F   
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG 184

Query: 201 TTHI-STRVAGTLGYLAPEYAISG-----RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254
            +   +    GT  Y+APE              + D+Y+ G++L E+ S  TA D  V  
Sbjct: 185 KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244

Query: 255 GEYHLVDKAWGMYNSKELMNLV-----DPMLYGNFPENEAIRFL-KVGLLCVQEKSKLRP 308
                 ++     + +++  +V      P+L   + ++  +  L +    C    ++ R 
Sbjct: 245 YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL 304

Query: 309 QMSTAIKMMN 318
                 + + 
Sbjct: 305 SAGCVGERIT 314

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  223 bits (571), Expect = 6e-71
 Identities = 75/321 (23%), Positives = 128/321 (39%), Gaps = 43/321 (13%)

Query: 32  FSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVAS 91
            + ++  +  +  +    IG G +G+VYKG L D   VAVKV S  ++Q    F++E   
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58

Query: 92  MANVNVCHENLVKLHGGCIDGPCRI-----LVYDYMPNNSLSQTLLGEEKRRAKFGWKAR 146
                + H+N+ +   G             LV +Y PN SL + L           W + 
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-----SLHTSDWVSS 113

Query: 147 REIIMGIGRGLAYIHEEI------QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 200
             +   + RGLAY+H E+      +P + HRD+ + N+L+  +    ISDFGLS     N
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173

Query: 201 T-------THISTRVAGTLGYLAPEYA-------ISGRLTRKSDVYSFGVLLLEIVSGRT 246
                    + +    GT+ Y+APE               ++ D+Y+ G++  EI    T
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233

Query: 247 AVDFDVQLGEYHLV--DKAWGMYNSKELMNLVD-----PMLYGNFPENEAIRFLKVGLL- 298
            +     + EY +    +       +++  LV      P     + EN          + 
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293

Query: 299 -CVQEKSKLRPQMSTAIKMMN 318
            C  + ++ R     A + M 
Sbjct: 294 DCWDQDAEARLTAQXAEERMA 314

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  196 bits (500), Expect = 1e-60
 Identities = 68/201 (33%), Positives = 107/201 (53%), Gaps = 8/201 (3%)

Query: 48  NKIGEGGFGSVYKGRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKL 105
            KIG G FG+V++     G+ VAVK+L  +    +   EF+ EVA M  +   H N+V  
Sbjct: 43  EKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLR--HPNIVLF 99

Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
            G     P   +V +Y+   SL + LL +   R +   + R  +   + +G+ Y+H    
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYR-LLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-N 157

Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL 225
           P +VHR++K+ N+L+D+ +  K+ DFGLS+    +T   S   AGT  ++APE       
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSR-LKASTFLSSKSAAGTPEWMAPEVLRDEPS 216

Query: 226 TRKSDVYSFGVLLLEIVSGRT 246
             KSDVYSFGV+L E+ + + 
Sbjct: 217 NEKSDVYSFGVILWELATLQQ 237

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  190 bits (485), Expect = 1e-58
 Identities = 70/214 (32%), Positives = 113/214 (52%), Gaps = 29/214 (13%)

Query: 48  NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGE-------KEFMSEVASMANVNVCH 99
            +IG+GGFG V+KGRL  D ++VA+K L +   +GE       +EF  EV  M+N+N  H
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN--H 82

Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
            N+VKL+G   + P   +V +++P   L   LL    +     W  +  +++ I  G+ Y
Sbjct: 83  PNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDIALGIEY 137

Query: 160 IHEEIQPHVVHRDIKTSNILLDQ-----NFNPKISDFGLSKLFPENTTHISTRVAGTLGY 214
           +  +  P +VHRD+++ NI L           K++DFGLS+     + H  + + G   +
Sbjct: 138 MQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGNFQW 192

Query: 215 LAPEYAISGRL---TRKSDVYSFGVLLLEIVSGR 245
           +APE  I       T K+D YSF ++L  I++G 
Sbjct: 193 MAPE-TIGAEEESYTEKADTYSFAMILYTILTGE 225

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  188 bits (480), Expect = 1e-57
 Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 13/200 (6%)

Query: 48  NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
             +G G FG V K + +    VA+K +  ES+   K F+ E+  ++ VN  H N+VKL+G
Sbjct: 14  EVVGRGAFGVVCKAKWR-AKDVAIKQIESESE--RKAFIVELRQLSRVN--HPNIVKLYG 68

Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
            C++  C  LV +Y    SL   +L   +    +         +   +G+AY+H      
Sbjct: 69  ACLNPVC--LVMEYAEGGSL-YNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 125

Query: 168 VVHRDIKTSNILLDQNFN-PKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLT 226
           ++HRD+K  N+LL       KI DFG +     +     T   G+  ++APE       +
Sbjct: 126 LIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPEVFEGSNYS 181

Query: 227 RKSDVYSFGVLLLEIVSGRT 246
            K DV+S+G++L E+++ R 
Sbjct: 182 EKCDVFSWGIILWEVITRRK 201

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  186 bits (475), Expect = 2e-57
 Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 23/211 (10%)

Query: 48  NKIGEGGFGSVYKGRLQDGTIVAVKVL----SVESKQGEKEFMSEVASMANVNVCHENLV 103
             IG GGFG VY+     G  VAVK        +  Q  +    E    A +   H N++
Sbjct: 13  EIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK--HPNII 69

Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
            L G C+  P   LV ++     L++ L        +          + I RG+ Y+H+E
Sbjct: 70  ALRGVCLKEPNLCLVMEFARGGPLNRVL-----SGKRIPPDILVNWAVQIARGMNYLHDE 124

Query: 164 IQPHVVHRDIKTSNILLDQNFNP--------KISDFGLSKLFPENTTHISTRVAGTLGYL 215
               ++HRD+K+SNIL+ Q            KI+DFGL++ +   T       AG   ++
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK---MSAAGAYAWM 181

Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVSGRT 246
           APE   +   ++ SDV+S+GVLL E+++G  
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEV 212

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  182 bits (464), Expect = 8e-56
 Identities = 53/227 (23%), Positives = 96/227 (42%), Gaps = 31/227 (13%)

Query: 27  KNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVE--SKQGEKE 84
             I+   + QL           K+ E   G ++KGR Q G  + VKVL V   S +  ++
Sbjct: 5   SGID---FKQLNF-------LTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRD 53

Query: 85  FMSEVASMANVNVCHENLVKLHGGCIDGPCRIL--VYDYMPNNSLSQTLLGEEKRRAKFG 142
           F  E   +   +  H N++ + G C   P      +  +MP  SL   L   E       
Sbjct: 54  FNEECPRLRIFS--HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLH--EGTNFVVD 109

Query: 143 WKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 202
                +  + + RG+A++H   +P +    + + ++++D++   +IS   +   F     
Sbjct: 110 QSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKFSF----- 163

Query: 203 HISTRVAGTLGYLAPEYAISGR----LTRKSDVYSFGVLLLEIVSGR 245
             S        ++APE A+  +      R +D++SF VLL E+V+  
Sbjct: 164 -QSPGRMYAPAWVAPE-ALQKKPEDTNRRSADMWSFAVLLWELVTRE 208

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  179 bits (457), Expect = 2e-54
 Identities = 64/204 (31%), Positives = 106/204 (51%), Gaps = 17/204 (8%)

Query: 48  NKIGEGGFGSVYKGRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKL 105
            +IG G FG+VYKG+   G  VAVK+L+V   + Q  + F +EV  +      H N++  
Sbjct: 30  QRIGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR--HVNILLF 85

Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
            G        I V  +   +SL   L        KF  K   +I     RG+ Y+H    
Sbjct: 86  MGYSTAPQLAI-VTQWCEGSSLYHHL---HASETKFEMKKLIDIARQTARGMDYLH---A 138

Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE-NTTHISTRVAGTLGYLAPE---YAI 221
             ++HRD+K++NI L ++   KI DFGL+      + +H   +++G++ ++APE      
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198

Query: 222 SGRLTRKSDVYSFGVLLLEIVSGR 245
           S   + +SDVY+FG++L E+++G+
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQ 222

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  180 bits (459), Expect = 3e-54
 Identities = 72/297 (24%), Positives = 119/297 (40%), Gaps = 38/297 (12%)

Query: 48  NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
            +IG+G +G V+ G+ + G  VAVKV        E  +  E      V + HEN++    
Sbjct: 43  KQIGKGRYGEVWMGKWR-GEKVAVKVFF---TTEEASWFRETEIYQTVLMRHENILGFIA 98

Query: 108 GCIDGPCRI----LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
             I G        L+ DY  N SL   L     +      K+  ++      GL ++H E
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSLYDYL-----KSTTLDAKSMLKLAYSSVSGLCHLHTE 153

Query: 164 I-----QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI---STRVAGTLGYL 215
           I     +P + HRD+K+ NIL+ +N    I+D GL+  F  +T  +        GT  Y+
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213

Query: 216 APEYAISGRL-------TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYN 268
            PE  +   L          +D+YSFG++L E+   R      V+  +    D      +
Sbjct: 214 PPE-VLDESLNRNHFQSYIMADMYSFGLILWEVAR-RCVSGGIVEEYQLPYHDLVPSDPS 271

Query: 269 SKELMNLVD-----PMLYGNFPENEAIRFLKVGLL--CVQEKSKLRPQMSTAIKMMN 318
            +++  +V      P     +  +E +R +   L+  C       R       K + 
Sbjct: 272 YEDMREIVCIKKLRPSFPNRWSSDECLRQMG-KLMTECWAHNPASRLTALRVKKTLA 327

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  179 bits (455), Expect = 5e-54
 Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 27/215 (12%)

Query: 48  NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
             +G+G +G V++G  Q G  VAVK+ S    + EK +  E      V + HEN++    
Sbjct: 14  ECVGKGRYGEVWRGSWQ-GENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIA 69

Query: 108 GCIDGPCRI----LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
             +          L+  Y    SL   L     +       +   I++ I  GLA++H E
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHIE 124

Query: 164 I-----QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI---STRVAGTLGYL 215
           I     +P + HRD+K+ NIL+ +N    I+D GL+ +  ++T  +   +    GT  Y+
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184

Query: 216 APE------YAISGRLTRKSDVYSFGVLLLEIVSG 244
           APE              ++ D+++FG++L E+   
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  174 bits (444), Expect = 3e-52
 Identities = 53/213 (24%), Positives = 89/213 (41%), Gaps = 26/213 (12%)

Query: 48  NKIGEGGFGSVYKGRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKL 105
             IG+G FG VY GR   G  VA++++ +E  ++   K F  EV +       HEN+V  
Sbjct: 39  ELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTR--HENVVLF 94

Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
            G C+  P   ++       +L   +      +        R+I   I +G+ Y+H    
Sbjct: 95  MGACMSPPHLAIITSLCKGRTLYSVVR---DAKIVLDVNKTRQIAQEIVKGMGYLH---A 148

Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKL----FPENTTHISTRVAGTLGYLAPE--- 218
             ++H+D+K+ N+  D N    I+DFGL  +                 G L +LAPE   
Sbjct: 149 KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIR 207

Query: 219 ------YAISGRLTRKSDVYSFGVLLLEIVSGR 245
                        ++ SDV++ G +  E+ +  
Sbjct: 208 QLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  174 bits (442), Expect = 4e-52
 Identities = 56/223 (25%), Positives = 98/223 (43%), Gaps = 27/223 (12%)

Query: 44  FRWS-----NKIGEGGFGSVYKGRL-QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNV 97
           FR S       +G+G FG   K    + G ++ +K L    ++ ++ F+ EV  M  +  
Sbjct: 7   FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLE- 65

Query: 98  CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
            H N++K  G          + +Y+   +L   +       +++ W  R      I  G+
Sbjct: 66  -HPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIK---SMDSQYPWSQRVSFAKDIASGM 121

Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH-------------I 204
           AY+H     +++HRD+ + N L+ +N N  ++DFGL++L  +  T               
Sbjct: 122 AYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKK 178

Query: 205 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTA 247
              V G   ++APE         K DV+SFG++L EI+    A
Sbjct: 179 RYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA 221

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  171 bits (435), Expect = 1e-50
 Identities = 59/216 (27%), Positives = 95/216 (43%), Gaps = 29/216 (13%)

Query: 48  NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
             IG+G FG V++G+ + G  VAVK+ S    + E+ +  E      V + HEN++    
Sbjct: 48  ESIGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIA 103

Query: 108 GCID----GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
                        LV DY  + SL   L      R     +   ++ +    GLA++H E
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHME 158

Query: 164 IQ-----PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI---STRVAGTLGYL 215
           I      P + HRD+K+ NIL+ +N    I+D GL+      T  I        GT  Y+
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218

Query: 216 APEYAISGRL-------TRKSDVYSFGVLLLEIVSG 244
           APE  +   +        +++D+Y+ G++  EI   
Sbjct: 219 APE-VLDDSINMKHFESFKRADIYAMGLVFWEIARR 253

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  151 bits (383), Expect = 2e-43
 Identities = 63/242 (26%), Positives = 111/242 (45%), Gaps = 17/242 (7%)

Query: 45  RWSNKIGEGGFGSVYKGRL-----QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCH 99
           ++  ++G+G FGSV   R        G +VAVK L   +++  ++F  E+  + ++   H
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ--H 70

Query: 100 ENLVKLHGGCIDGPCR--ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
           +N+VK  G C     R   L+ +Y+P  SL   L   +K + +       +    I +G+
Sbjct: 71  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGM 127

Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL--GYL 215
            Y+  +     +HRD+ T NIL++     KI DFGL+K+ P++      +  G     + 
Sbjct: 128 EYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY 184

Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNL 275
           APE     + +  SDV+SFGV+L E+ +               + +   G      L+ L
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244

Query: 276 VD 277
           + 
Sbjct: 245 LK 246

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  152 bits (385), Expect = 2e-43
 Identities = 63/239 (26%), Positives = 110/239 (46%), Gaps = 17/239 (7%)

Query: 48  NKIGEGGFGSVYKGRL-----QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENL 102
            ++G+G FGSV   R        G +VAVK L   +++  ++F  E+  + ++   H+N+
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ--HDNI 104

Query: 103 VKLHGGCIDGPCR--ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
           VK  G C     R   L+ +Y+P  SL   L   +K + +       +    I +G+ Y+
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYL 161

Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL--GYLAPE 218
             +     +HRD+ T NIL++     KI DFGL+K+ P++  +   +  G     + APE
Sbjct: 162 GTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPE 218

Query: 219 YAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD 277
                + +  SDV+SFGV+L E+ +               + +   G      L+ L+ 
Sbjct: 219 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  151 bits (383), Expect = 1e-42
 Identities = 55/201 (27%), Positives = 86/201 (42%), Gaps = 17/201 (8%)

Query: 49  KIGEGGFGSVYKGRLQDGTI-VAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLH 106
           +IG G FG V+ GRL+     VAVK          + +F+ E   +   +  H N+V+L 
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYS--HPNIVRLI 178

Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
           G C       +V + +        L       A+   K   +++     G+ Y+  +   
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFL---RTEGARLRVKTLLQMVGDAAAGMEYLESK--- 232

Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY----LAPEYAIS 222
             +HRD+   N L+ +    KISDFG+S+   +          G         APE    
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY---AASGGLRQVPVKWTAPEALNY 289

Query: 223 GRLTRKSDVYSFGVLLLEIVS 243
           GR + +SDV+SFG+LL E  S
Sbjct: 290 GRYSSESDVWSFGILLWETFS 310

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  149 bits (379), Expect = 1e-42
 Identities = 58/239 (24%), Positives = 106/239 (44%), Gaps = 35/239 (14%)

Query: 48  NKIGEGGFGSVYKGRLQDG-----TIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHEN 101
             +G G FG+VYKG            VA+K L    S +  KE + E   MA+V+  + +
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD--NPH 78

Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
           + +L G C+    ++ +   MP   L   +    + +   G +      + I +G+ Y+ 
Sbjct: 79  VCRLLGICLTSTVQL-ITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLE 134

Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT-LGYLAPEYA 220
           +     +VHRD+   N+L+    + KI+DFGL+KL                + ++A E  
Sbjct: 135 DR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191

Query: 221 ISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE--YHLVDKAWGMYNSKELMNLVD 277
           +    T +SDV+S+GV + E+++           G   Y       G+  S E+ ++++
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMT----------FGSKPY------DGIPAS-EISSILE 233

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  148 bits (375), Expect = 3e-42
 Identities = 62/241 (25%), Positives = 103/241 (42%), Gaps = 21/241 (8%)

Query: 48  NKIGEGGFGSVYKGRL-----QDGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHEN 101
             +GEG FG V   R        G  VAVK L  E       +   E+  + N+   HEN
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY--HEN 84

Query: 102 LVKLHGGCIDGPCR--ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
           +VK  G C +       L+ +++P+ SL + L    K + K   K + +  + I +G+ Y
Sbjct: 85  IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PKNKNKINLKQQLKYAVQICKGMDY 141

Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL--GYLAP 217
           +        VHRD+   N+L++     KI DFGL+K    +  + + +        + AP
Sbjct: 142 LGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAP 198

Query: 218 EYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV 276
           E  +  +    SDV+SFGV L E+++   +         +  +      M     L+N +
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKM-IGPTHGQMTV-TRLVNTL 256

Query: 277 D 277
            
Sbjct: 257 K 257

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  148 bits (375), Expect = 4e-42
 Identities = 69/241 (28%), Positives = 103/241 (42%), Gaps = 23/241 (9%)

Query: 48  NKIGEGGFGSVYKGRLQD-----GTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHEN 101
             +GEG FG V            G +VAVK L  +   Q    +  E+  +  +   HE+
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLY--HEH 94

Query: 102 LVKLHGGCIDGPCR--ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
           ++K  G C D       LV +Y+P  SL   L      R   G          I  G+AY
Sbjct: 95  IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-----PRHSIGLAQLLLFAQQICEGMAY 149

Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL--GYLAP 217
           +H +   H +HRD+   N+LLD +   KI DFGL+K  PE   +   R  G     + AP
Sbjct: 150 LHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 206

Query: 218 EYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV 276
           E     +    SDV+SFGV L E+++   ++     +  E   + +   M     L  L+
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ-GQMTV-LRLTELL 264

Query: 277 D 277
           +
Sbjct: 265 E 265

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  147 bits (374), Expect = 7e-42
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 17/208 (8%)

Query: 45  RWSNKIGEGGFGSVYKGRL-----QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCH 99
           ++ +++G+G FGSV   R        G +VAVK L       +++F  E+  +  ++   
Sbjct: 26  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH--S 83

Query: 100 ENLVKLHGGCIDGPCR--ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
           + +VK  G       +   LV +Y+P+  L   L   ++ RA+            I +G+
Sbjct: 84  DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL---QRHRARLDASRLLLYSSQICKGM 140

Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL--GYL 215
            Y+        VHRD+   NIL++   + KI+DFGL+KL P +  +   R  G     + 
Sbjct: 141 EYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 197

Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVS 243
           APE       +R+SDV+SFGV+L E+ +
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFT 225

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  145 bits (367), Expect = 4e-41
 Identities = 59/201 (29%), Positives = 100/201 (49%), Gaps = 15/201 (7%)

Query: 49  KIGEGGFGSVYKGRL--QDGTI-VAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLVK 104
           ++G G FGSV +G    +   I VA+KVL   +++ +  E M E   M  ++  +  +V+
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD--NPYIVR 74

Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L G C      + V +      L + L+    +R +       E++  +  G+ Y+ E+ 
Sbjct: 75  LIGVCQAEALML-VMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEK- 129

Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL--GYLAPEYAIS 222
             + VHRD+   N+LL      KISDFGLSK    + ++ + R AG     + APE    
Sbjct: 130 --NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 187

Query: 223 GRLTRKSDVYSFGVLLLEIVS 243
            + + +SDV+S+GV + E +S
Sbjct: 188 RKFSSRSDVWSYGVTMWEALS 208

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  143 bits (364), Expect = 1e-40
 Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 17/202 (8%)

Query: 49  KIGEGGFGSVYKGRLQDG---TIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLV 103
           ++G G FG+V KG  Q       VAVK+L  E      + E ++E   M  ++  +  +V
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD--NPYIV 81

Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
           ++ G C      + V +      L++ L    ++      K   E++  +  G+ Y+ E 
Sbjct: 82  RMIGICEAESWML-VMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEES 136

Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL--GYLAPEYAI 221
              + VHRD+   N+LL      KISDFGLSK    +  +   +  G     + APE   
Sbjct: 137 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 193

Query: 222 SGRLTRKSDVYSFGVLLLEIVS 243
             + + KSDV+SFGVL+ E  S
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFS 215

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  142 bits (361), Expect = 2e-40
 Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 16/203 (7%)

Query: 48  NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
            +IG G FG V+ G   +   VA+K +   +   E++F+ E   M  ++  H  LV+L+G
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLS--HPKLVQLYG 70

Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
            C++     LV ++M +  LS  L     +R  F  +    + + +  G+AY+ E     
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYL---RTQRGLFAAETLLGMCLDVCEGMAYLEEA---C 124

Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL---GYLAPEYAISGR 224
           V+HRD+   N L+ +N   K+SDFG+++   ++     T   GT     + +PE     R
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY---TSSTGTKFPVKWASPEVFSFSR 181

Query: 225 LTRKSDVYSFGVLLLEIVS-GRT 246
            + KSDV+SFGVL+ E+ S G+ 
Sbjct: 182 YSSKSDVWSFGVLMWEVFSEGKI 204

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  144 bits (364), Expect = 2e-40
 Identities = 57/243 (23%), Positives = 106/243 (43%), Gaps = 35/243 (14%)

Query: 44  FRWSNKIGEGGFGSVYKGRLQDG-----TIVAVKVLSVESKQGEK-EFMSEVASMANVNV 97
           F+    +G G FG+VYKG            VA+K L   +      E + E   MA+V+ 
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD- 75

Query: 98  CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
            + ++ +L G C+    ++ +   MP   L   +    + +   G +      + I +G+
Sbjct: 76  -NPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGM 130

Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT-LGYLA 216
            Y+ +     +VHRD+   N+L+    + KI+DFGL+KL                + ++A
Sbjct: 131 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187

Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE--YHLVDKAWGMYNSKELMN 274
            E  +    T +SDV+S+GV + E+++           G   Y       G+  S E+ +
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMT----------FGSKPY------DGIPAS-EISS 230

Query: 275 LVD 277
           +++
Sbjct: 231 ILE 233

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  142 bits (360), Expect = 3e-40
 Identities = 56/210 (26%), Positives = 90/210 (42%), Gaps = 19/210 (9%)

Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHE 100
            ++  +IG G F +VYKG   +    VA   L     +K   + F  E   +  +   H 
Sbjct: 28  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ--HP 85

Query: 101 NLVKLHGGCIDGPCR----ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRG 156
           N+V+ +             +LV + M + +L   L    KR      K  R     I +G
Sbjct: 86  NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKG 141

Query: 157 LAYIHEEIQPHVVHRDIKTSNILLD-QNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
           L ++H    P ++HRD+K  NI +     + KI D GL+ L   +       V GT  ++
Sbjct: 142 LQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFM 197

Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
           APE     +     DVY+FG+ +LE+ +  
Sbjct: 198 APEM-YEEKYDESVDVYAFGMCMLEMATSE 226

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  142 bits (360), Expect = 3e-40
 Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 18/204 (8%)

Query: 49  KIGEGGFGSVYKGRLQ----DGTIVAVKVL---SVESKQGEKEFMSEVASMANVNVCHEN 101
           K+G+G FG V +G           VAVK L    +   +   +F+ EV +M +++  H N
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD--HRN 82

Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
           L++L+G  +  P ++ V +  P  SL   L    K +  F         + +  G+ Y+ 
Sbjct: 83  LIRLYGVVLTPPMKM-VTELAPLGSLLDRLR---KHQGHFLLGTLSRYAVQVAEGMGYLE 138

Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY--LAPEY 219
            +     +HRD+   N+LL      KI DFGL +  P+N  H   +    + +   APE 
Sbjct: 139 SK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 195

Query: 220 AISGRLTRKSDVYSFGVLLLEIVS 243
             +   +  SD + FGV L E+ +
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFT 219

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  148 bits (374), Expect = 5e-40
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 15/201 (7%)

Query: 49  KIGEGGFGSVYKGRL--QDGTI-VAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVK 104
           ++G G FGSV +G    +   I VA+KVL     K   +E M E   M  ++  +  +V+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD--NPYIVR 400

Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L G C      + V +      L + L+    +R +       E++  +  G+ Y+ E+ 
Sbjct: 401 LIGVCQAEALML-VMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEK- 455

Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY--LAPEYAIS 222
             + VHR++   N+LL      KISDFGLSK    + ++ + R AG       APE    
Sbjct: 456 --NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 513

Query: 223 GRLTRKSDVYSFGVLLLEIVS 243
            + + +SDV+S+GV + E +S
Sbjct: 514 RKFSSRSDVWSYGVTMWEALS 534

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  142 bits (359), Expect = 6e-40
 Identities = 55/266 (20%), Positives = 102/266 (38%), Gaps = 44/266 (16%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
            +G+G FG V K R   D    A+K +    ++     +SEV  +A++N  H+ +V+ + 
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLN--HQYVVRYYA 69

Query: 108 GCIDGPCRI-------------LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIG 154
             ++    +             +  +Y  N +L   +                 +   I 
Sbjct: 70  AWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI---HSENLNQQRDEYWRLFRQIL 126

Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS--------- 205
             L+YIH +    ++HRD+K  NI +D++ N KI DFGL+K    +   +          
Sbjct: 127 EALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183

Query: 206 ----TRVAGTLGYLAPE-YAISGRLTRKSDVYSFGVLLLEIVSG------RTAVDFDVQL 254
               T   GT  Y+A E    +G    K D+YS G++  E++        R  +   ++ 
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRS 243

Query: 255 GEYHLVDKAWGMYNSKELMNLVDPML 280
                          K    ++  ++
Sbjct: 244 VSIEFPPDFDDNK-MKVEKKIIRLLI 268

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  142 bits (360), Expect = 6e-40
 Identities = 63/246 (25%), Positives = 107/246 (43%), Gaps = 23/246 (9%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKE---FMSEVASMANVNVCHENLVK 104
           KIG G F  VY+   L DG  VA+K + +      K     + E+  +  +N  H N++K
Sbjct: 39  KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN--HPNVIK 96

Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
            +   I+     +V +      LS+ +   +K++     +   +  + +   L ++H   
Sbjct: 97  YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR- 155

Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              V+HRDIK +N+ +      K+ D GL + F   TT   + V GT  Y++PE      
Sbjct: 156 --RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENG 212

Query: 225 LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYH-LVDK---------AWGMYNSKELMN 274
              KSD++S G LL E+ + ++   F       + L  K             Y S+EL  
Sbjct: 213 YNFKSDIWSLGCLLYEMAALQSP--FYGDKMNLYSLCKKIEQCDYPPLPSDHY-SEELRQ 269

Query: 275 LVDPML 280
           LV+  +
Sbjct: 270 LVNMCI 275

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  142 bits (360), Expect = 7e-40
 Identities = 57/239 (23%), Positives = 112/239 (46%), Gaps = 35/239 (14%)

Query: 48  NKIGEGGFGSVYKGRLQDG-----TIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHEN 101
             +G G FG+V+KG            V +KV+  +S +Q  +     + ++ +++  H +
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD--HAH 76

Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
           +V+L G C     ++ V  Y+P  SL   +    + R   G +      + I +G+ Y+ 
Sbjct: 77  IVRLLGLCPGSSLQL-VTQYLPLGSLLDHVR---QHRGALGPQLLLNWGVQIAKGMYYLE 132

Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT-LGYLAPEYA 220
           E     +VHR++   N+LL      +++DFG++ L P +   +    A T + ++A E  
Sbjct: 133 EH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI 189

Query: 221 ISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE--YHLVDKAWGMYNSKELMNLVD 277
             G+ T +SDV+S+GV + E+++           G   Y       G+  + E+ +L++
Sbjct: 190 HFGKYTHQSDVWSYGVTVWELMT----------FGAEPY------AGLRLA-EVPDLLE 231

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  142 bits (359), Expect = 8e-40
 Identities = 59/271 (21%), Positives = 101/271 (37%), Gaps = 35/271 (12%)

Query: 36  QLKIATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMAN 94
            + I    + +  K+GEGGF  V     L DG   A+K +    +Q  +E   E      
Sbjct: 23  MVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRL 82

Query: 95  VNVCHENLVKLHGGCIDGPCR----ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 150
            N  H N+++L   C+          L+  +    +L   +   + +           ++
Sbjct: 83  FN--HPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLL 140

Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVA- 209
           +GI RGL  IH        HRD+K +NILL     P + D G       +       +  
Sbjct: 141 LGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197

Query: 210 -------GTLGYLAPE------YAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE 256
                   T+ Y APE      + +   +  ++DV+S G +L  ++ G    D   Q G+
Sbjct: 198 QDWAAQRCTISYRAPELFSVQSHCV---IDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD 254

Query: 257 YHLVDKAWGMYN-------SKELMNLVDPML 280
             +        +       S  L  L++ M+
Sbjct: 255 -SVALAVQNQLSIPQSPRHSSALWQLLNSMM 284

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  140 bits (356), Expect = 1e-39
 Identities = 60/219 (27%), Positives = 103/219 (47%), Gaps = 15/219 (6%)

Query: 28  NINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMS 87
           +     Y   +I      +  ++G G FG V  G+ +    VA+K++   S   E EF+ 
Sbjct: 10  STAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIE 68

Query: 88  EVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARR 147
           E   M N++  HE LV+L+G C       ++ +YM N  L   L    + R +F  +   
Sbjct: 69  EAKVMMNLS--HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL---REMRHRFQTQQLL 123

Query: 148 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 207
           E+   +   + Y+  +     +HRD+   N L++     K+SDFGLS+   ++     T 
Sbjct: 124 EMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TS 177

Query: 208 VAGTL---GYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
             G+     +  PE  +  + + KSD+++FGVL+ EI S
Sbjct: 178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  140 bits (355), Expect = 3e-39
 Identities = 66/277 (23%), Positives = 106/277 (38%), Gaps = 22/277 (7%)

Query: 11  PSRVSAENTIGGEQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGR-LQDGTIV 69
           P RVS        + L++               F+  +++G G +G V+K R  +DG + 
Sbjct: 28  PRRVSFRG--EASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLY 85

Query: 70  AVKV--LSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSL 127
           AVK         +     ++EV S   V   H   V+L     +G    L  +     SL
Sbjct: 86  AVKRSMSPFRGPKDRARKLAEVGSHEKV-GQHPCCVRLEQAWEEGGILYLQTELC-GPSL 143

Query: 128 SQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPK 187
            Q     E   A          +      LA++H +    +VH D+K +NI L      K
Sbjct: 144 QQHC---EAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCK 197

Query: 188 ISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR-- 245
           + DFGL             +  G   Y+APE  + G     +DV+S G+ +LE+      
Sbjct: 198 LGDFGLLVEL-GTAGAGEVQE-GDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNMEL 254

Query: 246 --TAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPML 280
                 +  QL + +L  +      S EL +++  ML
Sbjct: 255 PHGGEGWQ-QLRQGYLPPEFTAGL-SSELRSVLVMML 289

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  139 bits (352), Expect = 3e-39
 Identities = 55/198 (27%), Positives = 92/198 (46%), Gaps = 15/198 (7%)

Query: 49  KIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG 108
           ++G G FG V  G+ +    VAVK++  E    E EF  E  +M  ++  H  LVK +G 
Sbjct: 15  ELGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLS--HPKLVKFYGV 71

Query: 109 CIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHV 168
           C       +V +Y+ N  L   L                E+   +  G+A++        
Sbjct: 72  CSKEYPIYIVTEYISNGCLLNYL---RSHGKGLEPSQLLEMCYDVCEGMAFLESH---QF 125

Query: 169 VHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL---GYLAPEYAISGRL 225
           +HRD+   N L+D++   K+SDFG+++   ++         GT     + APE     + 
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY---VSSVGTKFPVKWSAPEVFHYFKY 182

Query: 226 TRKSDVYSFGVLLLEIVS 243
           + KSDV++FG+L+ E+ S
Sbjct: 183 SSKSDVWAFGILMWEVFS 200

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  142 bits (361), Expect = 7e-39
 Identities = 65/203 (32%), Positives = 99/203 (48%), Gaps = 16/203 (7%)

Query: 48  NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
            K+G G FG V+       T VAVK +        + F++E   M  +   H+ LVKLH 
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQ--HDKLVKLHA 250

Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
                P  I + ++M   SL   L  +    +K       +    I  G+A+I +    +
Sbjct: 251 VVTKEPIYI-ITEFMAKGSLLDFL--KSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---N 304

Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG---YLAPEYAISGR 224
            +HRD++ +NIL+  +   KI+DFGL+++  +N     T   G      + APE    G 
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAINFGS 361

Query: 225 LTRKSDVYSFGVLLLEIVS-GRT 246
            T KSDV+SFG+LL+EIV+ GR 
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRI 384

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  140 bits (356), Expect = 7e-39
 Identities = 61/203 (30%), Positives = 100/203 (49%), Gaps = 15/203 (7%)

Query: 48  NKIGEGGFGSVYKGRLQ----DGTIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENL 102
             +G G FG V  GRL+        VA+K L V   + ++ +F+ E + M   +  H N+
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD--HPNI 108

Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE 162
           ++L G        ++V +YM N SL   L    K  A+F       ++ GI  G+ Y+ +
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSD 165

Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL--APEYA 220
                 VHRD+   NIL++ N   K+SDFGL ++  ++     T   G +     +PE  
Sbjct: 166 M---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222

Query: 221 ISGRLTRKSDVYSFGVLLLEIVS 243
              + T  SDV+S+G++L E++S
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMS 245

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  138 bits (350), Expect = 9e-39
 Identities = 59/203 (29%), Positives = 93/203 (45%), Gaps = 20/203 (9%)

Query: 49  KIGEGGFGSVYKGRLQDG----TIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLV 103
            +GEG FG VY+G   +       VAVK    + +   +++FMSE   M N++  H ++V
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD--HPHIV 76

Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
           KL G   + P  I + +  P   L   L   E+ +            + I + +AY+   
Sbjct: 77  KLIGIIEEEPTWI-IMELYPYGELGHYL---ERNKNSLKVLTLVLYSLQICKAMAYLESI 132

Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL---GYLAPEYA 220
              + VHRDI   NIL+      K+ DFGLS+   +       + + T     +++PE  
Sbjct: 133 ---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY---YKASVTRLPIKWMSPESI 186

Query: 221 ISGRLTRKSDVYSFGVLLLEIVS 243
              R T  SDV+ F V + EI+S
Sbjct: 187 NFRRFTTASDVWMFAVCMWEILS 209

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  139 bits (353), Expect = 1e-38
 Identities = 62/289 (21%), Positives = 118/289 (40%), Gaps = 45/289 (15%)

Query: 39  IATNGFRWS--NKIGEGGFGSVYKGRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMAN 94
           I+  G  +S   +IG GG   V++   +   I A+K +++E    Q    + +E+A +  
Sbjct: 4   ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 63

Query: 95  VNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIG 154
           +    + +++L+   I      +V +   N  L+  L    K++       R+     + 
Sbjct: 64  LQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL----KKKKSIDPWERKSYWKNML 118

Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR-VAGTLG 213
             +  IH+     +VH D+K +N L+      K+ DFG++     +TT +      GT+ 
Sbjct: 119 EAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVN 174

Query: 214 YLAPE-----------YAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDK 262
           Y+ PE                +++ KSDV+S G +L  +  G+T   F   + +      
Sbjct: 175 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--FQQIINQI----- 227

Query: 263 AWGMYNSKELMNLVDPMLYGNFPEN---EAIRFLKVGLLCVQEKSKLRP 308
                   +L  ++DP     FP+    +    LK    C++   K R 
Sbjct: 228 -------SKLHAIIDPNHEIEFPDIPEKDLQDVLK---CCLKRDPKQRI 266

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  139 bits (352), Expect = 1e-38
 Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 15/203 (7%)

Query: 48  NKIGEGGFGSVYKGRLQDG----TIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENL 102
             IG G  G V  GRL+        VA+K L     + ++ +F+SE + M   +  H N+
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD--HPNI 112

Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE 162
           ++L G    G   ++V +YM N SL   L        +F       ++ G+G G+ Y+ +
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFL---RTHDGQFTIMQLVGMLRGVGAGMRYLSD 169

Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL--APEYA 220
                 VHRD+   N+L+D N   K+SDFGLS++  ++     T   G +     APE  
Sbjct: 170 L---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAI 226

Query: 221 ISGRLTRKSDVYSFGVLLLEIVS 243
                +  SDV+SFGV++ E+++
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLA 249

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  138 bits (351), Expect = 1e-38
 Identities = 61/290 (21%), Positives = 118/290 (40%), Gaps = 45/290 (15%)

Query: 38  KIATNGFRWS--NKIGEGGFGSVYKGRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMA 93
            ++  G  +S   +IG GG   V++   +   I A+K +++E    Q    + +E+A + 
Sbjct: 22  SMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLN 81

Query: 94  NVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGI 153
            +    + +++L+   I      +V +   N  L+  L    K++       R+     +
Sbjct: 82  KLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL----KKKKSIDPWERKSYWKNM 136

Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR-VAGTL 212
              +  IH+     +VH D+K +N L+      K+ DFG++     +TT +      GT+
Sbjct: 137 LEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTV 192

Query: 213 GYLAPE-----------YAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVD 261
            Y+ PE                +++ KSDV+S G +L  +  G+T   F   + +     
Sbjct: 193 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--FQQIINQI---- 246

Query: 262 KAWGMYNSKELMNLVDPMLYGNFPEN---EAIRFLKVGLLCVQEKSKLRP 308
                    +L  ++DP     FP+    +    LK    C++   K R 
Sbjct: 247 --------SKLHAIIDPNHEIEFPDIPEKDLQDVLK---CCLKRDPKQRI 285

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  137 bits (348), Expect = 2e-38
 Identities = 58/236 (24%), Positives = 101/236 (42%), Gaps = 33/236 (13%)

Query: 49  KIGEGGFGSVYKGRLQDG----TIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLV 103
            IGEG FG V++G           VA+K     +    + +F+ E  +M   +  H ++V
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD--HPHIV 79

Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
           KL G   + P  I + +      L   L     R+      +       +   LAY+  +
Sbjct: 80  KLIGVITENPVWI-IMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLESK 135

Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG 223
                VHRDI   N+L+  N   K+ DFGLS+   ++T + +++    + ++APE     
Sbjct: 136 ---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 192

Query: 224 RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE--YHLVDKAWGMYNSKELMNLVD 277
           R T  SDV+ FGV + EI+            G   +       G+ N+ +++  ++
Sbjct: 193 RFTSASDVWMFGVCMWEILM----------HGVKPF------QGVKNN-DVIGRIE 231

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  138 bits (350), Expect = 2e-38
 Identities = 59/203 (29%), Positives = 102/203 (50%), Gaps = 16/203 (7%)

Query: 49  KIGEGGFGSVYKGRLQDGTI-----VAVKVLSVESKQGEK-EFMSEVASMANVNVCHENL 102
            IG G FG VYKG L+  +      VA+K L     + ++ +F+ E   M   +  H N+
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS--HHNI 108

Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE 162
           ++L G        +++ +YM N +L + L    ++  +F       ++ GI  G+ Y+  
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFL---REKDGEFSVLQLVGMLRGIAAGMKYLAN 165

Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY--LAPEYA 220
               + VHRD+   NIL++ N   K+SDFGLS++  ++     T   G +     APE  
Sbjct: 166 M---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 222

Query: 221 ISGRLTRKSDVYSFGVLLLEIVS 243
              + T  SDV+SFG+++ E+++
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMT 245

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  138 bits (350), Expect = 3e-38
 Identities = 57/241 (23%), Positives = 107/241 (44%), Gaps = 19/241 (7%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKL 105
           KIGEG FG     +  +DG    +K +++   S +  +E   EVA +AN+   H N+V+ 
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMK--HPNIVQY 88

Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
                +     +V DY     L + +    ++   F      +  + I   L ++H+   
Sbjct: 89  RESFEENGSLYIVMDYCEGGDLFKRI--NAQKGVLFQEDQILDWFVQICLALKHVHDR-- 144

Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL 225
             ++HRDIK+ NI L ++   ++ DFG++++           + GT  YL+PE   +   
Sbjct: 145 -KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICENKPY 202

Query: 226 TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYN------SKELMNLVDPM 279
             KSD+++ G +L E+ + + A +          +    G +       S +L +LV  +
Sbjct: 203 NNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS--GSFPPVSLHYSYDLRSLVSQL 260

Query: 280 L 280
            
Sbjct: 261 F 261

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  136 bits (344), Expect = 6e-38
 Identities = 64/249 (25%), Positives = 108/249 (43%), Gaps = 26/249 (10%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKL 105
            IG G +G   K R   DG I+  K L     ++  ++  +SEV  +  +   H N+V+ 
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK--HPNIVRY 70

Query: 106 HGGCIDGPCRIL--VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE- 162
           +   ID     L  V +Y     L+  +    K R     +    ++  +   L   H  
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130

Query: 163 -EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI 221
            +    V+HRD+K +N+ LD   N K+ DFGL+++   +T+   T V GT  Y++PE   
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMN 189

Query: 222 SGRLTRKSDVYSFGVLLLEIVSGRTAVDFD----------VQLGEYHLVDKAWGMYNSKE 271
                 KSD++S G LL E+ +      F           ++ G++  +   +    S E
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMPP--FTAFSQKELAGKIREGKFRRIPYRY----SDE 243

Query: 272 LMNLVDPML 280
           L  ++  ML
Sbjct: 244 LNEIITRML 252

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  136 bits (344), Expect = 6e-38
 Identities = 69/205 (33%), Positives = 99/205 (48%), Gaps = 20/205 (9%)

Query: 48  NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
            ++G G FG V+ G     T VAVK L   S      F++E   M  +   H+ LV+L+ 
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQ--HQRLVRLYA 75

Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
                P  I + +YM N SL   L  +     K       ++   I  G+A+I E    +
Sbjct: 76  VVTQEPIYI-ITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---N 129

Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL-----APEYAIS 222
            +HRD++ +NIL+    + KI+DFGL++L  +N     T   G          APE    
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAK--FPIKWTAPEAINY 184

Query: 223 GRLTRKSDVYSFGVLLLEIVS-GRT 246
           G  T KSDV+SFG+LL EIV+ GR 
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRI 209

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  139 bits (353), Expect = 8e-38
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 20/203 (9%)

Query: 48  NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQG--EKEFMSEVASMANVNVCHENLVKL 105
             IG+G FG V  G  + G  VAVK +    K     + F++E + M  +   H NLV+L
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCI----KNDATAQAFLAEASVMTQLR--HSNLVQL 251

Query: 106 HGGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
            G  + +     +V +YM   SL   L    + R+  G     +  + +   + Y+    
Sbjct: 252 LGVIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN- 308

Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
             + VHRD+   N+L+ ++   K+SDFGL+K    ++T  + ++   + + APE     +
Sbjct: 309 --NFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKK 362

Query: 225 LTRKSDVYSFGVLLLEIVS-GRT 246
            + KSDV+SFG+LL EI S GR 
Sbjct: 363 FSTKSDVWSFGILLWEIYSFGRV 385

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  140 bits (354), Expect = 1e-37
 Identities = 60/200 (30%), Positives = 100/200 (50%), Gaps = 15/200 (7%)

Query: 48  NKIGEGGFGSVYKGRLQDGTI-VAVKVLSVESKQG---EKEFMSEVASMANVNVCHENLV 103
           +K+G G +G VY+G  +  ++ VAVK L    K+     +EF+ E A M  +   H NLV
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIK--HPNLV 279

Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
           +L G C   P   ++ ++M   +L   L   E  R +        +   I   + Y+ ++
Sbjct: 280 QLLGVCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLEKK 337

Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG 223
              + +HR++   N L+ +N   K++DFGLS+L   +T          + + APE     
Sbjct: 338 ---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 394

Query: 224 RLTRKSDVYSFGVLLLEIVS 243
           + + KSDV++FGVLL EI +
Sbjct: 395 KFSIKSDVWAFGVLLWEIAT 414

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  138 bits (349), Expect = 1e-37
 Identities = 52/226 (23%), Positives = 98/226 (43%), Gaps = 27/226 (11%)

Query: 38  KIATNGFRWS--NKIGEGGFGSVYKGRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMA 93
            I+  G  +S   +IG GG   V++   +   I A+K +++E    Q    + +E+A + 
Sbjct: 50  CISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLN 109

Query: 94  NVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGI 153
            +    + +++L+   I      +V +   N  L+  L    K++       R+     +
Sbjct: 110 KLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL----KKKKSIDPWERKSYWKNM 164

Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR-VAGTL 212
              +  IH+     +VH D+K +N L+      K+ DFG++     +TT +      G +
Sbjct: 165 LEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAV 220

Query: 213 GYLAPEYAISGR------------LTRKSDVYSFGVLLLEIVSGRT 246
            Y+ PE AI               ++ KSDV+S G +L  +  G+T
Sbjct: 221 NYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 265

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  139 bits (352), Expect = 1e-37
 Identities = 64/196 (32%), Positives = 99/196 (50%), Gaps = 9/196 (4%)

Query: 48  NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
            K+G+G FG V+ G     T VA+K L        + F+ E   M  +   HE LV+L+ 
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLR--HEKLVQLYA 246

Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
              + P  I V +YM   SL   L  + +           ++   I  G+AY+      +
Sbjct: 247 VVSEEPIYI-VTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYVERM---N 300

Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR 227
            VHRD++ +NIL+ +N   K++DFGL++L  +N           + + APE A+ GR T 
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 360

Query: 228 KSDVYSFGVLLLEIVS 243
           KSDV+SFG+LL E+ +
Sbjct: 361 KSDVWSFGILLTELTT 376

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  141 bits (357), Expect = 2e-37
 Identities = 58/236 (24%), Positives = 102/236 (43%), Gaps = 33/236 (13%)

Query: 49  KIGEGGFGSVYKGRLQDG----TIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLV 103
            IGEG FG V++G           VA+K     +    + +F+ E  +M   +  H ++V
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD--HPHIV 454

Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
           KL G   + P  I + +      L   L   + R+      +       +   LAY+  +
Sbjct: 455 KLIGVITENPVWI-IMELCTLGELRSFL---QVRKFSLDLASLILYAYQLSTALAYLESK 510

Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG 223
                VHRDI   N+L+  N   K+ DFGLS+   ++T + +++    + ++APE     
Sbjct: 511 ---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 567

Query: 224 RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE--YHLVDKAWGMYNSKELMNLVD 277
           R T  SDV+ FGV + EI+            G   +       G+ N+ +++  ++
Sbjct: 568 RFTSASDVWMFGVCMWEILM----------HGVKPF------QGVKNN-DVIGRIE 606

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  140 bits (354), Expect = 2e-37
 Identities = 64/196 (32%), Positives = 99/196 (50%), Gaps = 9/196 (4%)

Query: 48  NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
            K+G+G FG V+ G     T VA+K L        + F+ E   M  +   HE LV+L+ 
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLR--HEKLVQLYA 329

Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
              + P  I V +YM   SL   L  + +           ++   I  G+AY+      +
Sbjct: 330 VVSEEPIYI-VTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYVERM---N 383

Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR 227
            VHRD++ +NIL+ +N   K++DFGL++L  +N           + + APE A+ GR T 
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 443

Query: 228 KSDVYSFGVLLLEIVS 243
           KSDV+SFG+LL E+ +
Sbjct: 444 KSDVWSFGILLTELTT 459

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  134 bits (340), Expect = 3e-37
 Identities = 62/206 (30%), Positives = 102/206 (49%), Gaps = 20/206 (9%)

Query: 48  NKIGEGGFGSVYKGRLQDGTI-VAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLH 106
           +K+G G +G VY+G  +  ++ VAVK L  ++ +  +EF+ E A M  +   H NLV+L 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK--HPNLVQLL 75

Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
           G C   P   ++ ++M   +L   L   E  R +        +   I   + Y+ ++   
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK--- 130

Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL-----APEYAI 221
           + +HRD+   N L+ +N   K++DFGLS+L   +T       A           APE   
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-----TAHAGAKFPIKWTAPESLA 185

Query: 222 SGRLTRKSDVYSFGVLLLEIVS-GRT 246
             + + KSDV++FGVLL EI + G +
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMS 211

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  133 bits (336), Expect = 1e-36
 Identities = 62/244 (25%), Positives = 101/244 (41%), Gaps = 42/244 (17%)

Query: 48  NKIGEGGFGSVYKGRLQDG----TIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENL 102
             IG G FG VY G L D        AVK L+  +  GE  +F++E   M + +  H N+
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS--HPNV 88

Query: 103 VKLHGGCIDG-PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
           + L G C+      ++V  YM +  L   +            K      + + +G+ Y+ 
Sbjct: 89  LSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKYLA 145

Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL------ 215
            +     VHRD+   N +LD+ F  K++DFGL++   +   +    V    G        
Sbjct: 146 SK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY---SVHNKTGAKLPVKWM 199

Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE--YHLVDKAWGMYNSKELM 273
           A E   + + T KSDV+SFGVLL E+++           G   Y        +    ++ 
Sbjct: 200 ALESLQTQKFTTKSDVWSFGVLLWELMT----------RGAPPY------PDVNT-FDIT 242

Query: 274 NLVD 277
             + 
Sbjct: 243 VYLL 246

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  133 bits (336), Expect = 3e-36
 Identities = 58/218 (26%), Positives = 94/218 (43%), Gaps = 31/218 (14%)

Query: 48  NKIGEGGFGSVYKGRLQDG------TIVAVKVLSVESKQGEKEFMSEVASMANVNVCHEN 101
            ++GEG FG V+     +        +VAVK L   S+   ++F  E   +  +   H++
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQ--HQH 104

Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARRE-----------II 150
           +V+  G C +G   ++V++YM +  L++ L                            + 
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164

Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG 210
             +  G+ Y+      H VHRD+ T N L+ Q    KI DFG+S+           RV G
Sbjct: 165 SQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY---YRV-G 217

Query: 211 TLGYL-----APEYAISGRLTRKSDVYSFGVLLLEIVS 243
               L      PE  +  + T +SDV+SFGV+L EI +
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  131 bits (333), Expect = 3e-36
 Identities = 62/203 (30%), Positives = 102/203 (50%), Gaps = 20/203 (9%)

Query: 48  NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQG--EKEFMSEVASMANVNVCHENLVKL 105
             IG+G FG V  G  + G  VAVK +    K     + F++E + M  +   H NLV+L
Sbjct: 27  QTIGKGEFGDVMLGDYR-GNKVAVKCI----KNDATAQAFLAEASVMTQLR--HSNLVQL 79

Query: 106 HGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
            G  ++    + +V +YM   SL   L    + R+  G     +  + +   + Y+    
Sbjct: 80  LGVIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN- 136

Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
             + VHRD+   N+L+ ++   K+SDFGL+K    ++T  + ++   + + APE     +
Sbjct: 137 --NFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKK 190

Query: 225 LTRKSDVYSFGVLLLEIVS-GRT 246
            + KSDV+SFG+LL EI S GR 
Sbjct: 191 FSTKSDVWSFGILLWEIYSFGRV 213

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  132 bits (333), Expect = 3e-36
 Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 17/205 (8%)

Query: 48  NKIGEGGFGSVYKGRLQDG----TIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENL 102
             IG+G FG VY G   D        A+K LS  ++  +   F+ E   M  +N  H N+
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN--HPNV 84

Query: 103 VKLHGGCIDG-PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
           + L G  +       ++  YM +  L Q +      +     K      + + RG+ Y+ 
Sbjct: 85  LALIGIMLPPEGLPHVLLPYMCHGDLLQFI---RSPQRNPTVKDLISFGLQVARGMEYLA 141

Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL---GYLAPE 218
           E+     VHRD+   N +LD++F  K++DFGL++   +   +   +         + A E
Sbjct: 142 EQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE 198

Query: 219 YAISGRLTRKSDVYSFGVLLLEIVS 243
              + R T KSDV+SFGVLL E+++
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLT 223

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  131 bits (332), Expect = 5e-36
 Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 13/201 (6%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGE---KEFMSEVASMANVNVCHENLVK 104
           K+G GG  +VY          VA+K + +  ++ E   K F  EV + + ++  H+N+V 
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS--HQNIVS 75

Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           +     +  C  LV +Y+   +LS+ +    +                I  G+ + H+  
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSEYI----ESHGPLSVDTAINFTNQILDGIKHAHDM- 130

Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              +VHRDIK  NIL+D N   KI DFG++K   E +   +  V GT+ Y +PE A    
Sbjct: 131 --RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEA 188

Query: 225 LTRKSDVYSFGVLLLEIVSGR 245
               +D+YS G++L E++ G 
Sbjct: 189 TDECTDIYSIGIVLYEMLVGE 209

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  131 bits (332), Expect = 5e-36
 Identities = 65/219 (29%), Positives = 98/219 (44%), Gaps = 32/219 (14%)

Query: 48  NKIGEGGFGSVYKGRL------QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHEN 101
            ++GEG FG V+          +D  +VAVK L   +    K+F  E   + N+   HE+
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQ--HEH 78

Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARRE------------I 149
           +VK +G C DG   I+V++YM +  L++ L               R+            I
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138

Query: 150 IMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVA 209
              I  G+ Y+  +   H VHRD+ T N L+  N   KI DFG+S+       +      
Sbjct: 139 ASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY----RV 191

Query: 210 GTLGYL-----APEYAISGRLTRKSDVYSFGVLLLEIVS 243
           G    L      PE  +  + T +SDV+SFGV+L EI +
Sbjct: 192 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  131 bits (332), Expect = 5e-36
 Identities = 52/263 (19%), Positives = 100/263 (38%), Gaps = 41/263 (15%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKE-FMSEVASMANVNVCHENLVKLH 106
            +G GGFG V++ +   D    A+K + + +++  +E  M EV ++A +   H  +V+  
Sbjct: 12  CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE--HPGIVRYF 69

Query: 107 GGCIDGPC---------RILVY---DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIG 154
              ++            ++ +Y         +L    +       +        I + I 
Sbjct: 70  NAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKD-WMNGRCTIEERERSVCLHIFLQIA 128

Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-----------PENTTH 203
             + ++H +    ++HRD+K SNI    +   K+ DFGL               P     
Sbjct: 129 EAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185

Query: 204 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIV------SGRTAVDFDVQLGEY 257
             T   GT  Y++PE       + K D++S G++L E++        R     DV+  ++
Sbjct: 186 RHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKF 245

Query: 258 HLVDKAWGMYNSKELMNLVDPML 280
                 +          +V  ML
Sbjct: 246 ---PPLFTQK-YPCEYVMVQDML 264

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  132 bits (333), Expect = 9e-36
 Identities = 47/223 (21%), Positives = 88/223 (39%), Gaps = 35/223 (15%)

Query: 49  KIGEGGFGSVYKGRLQDGTIVAVKVLS-----------------VESKQGEKEFMSEVAS 91
            + +G F  +     +D    A+K                    +  K    +F +E+  
Sbjct: 38  TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96

Query: 92  MANVNVCHENLVKLHGGCIDGPCRI-LVYDYMPN----NSLSQTLLGEEKRRAKFGWKAR 146
           + ++   +E  +   G  I     + ++Y+YM N           + ++        +  
Sbjct: 97  ITDIK--NEYCLTCEG-IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVI 153

Query: 147 REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIST 206
           + II  +    +YIH   + ++ HRD+K SNIL+D+N   K+SDFG S+   +     S 
Sbjct: 154 KCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS- 210

Query: 207 RVAGTLGYLAPEYAISGRLT---RKSDVYSFGVLLLEIVSGRT 246
              GT  ++ PE   S   +    K D++S G+ L  +     
Sbjct: 211 --RGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNVV 250

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  131 bits (332), Expect = 9e-36
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 27/214 (12%)

Query: 48  NKIGEGGFGSVYKGRLQDG------TIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHE 100
            ++G+G FG VY+G  +        T VA+K ++  +   E+ EF++E + M   N    
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN--CH 88

Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARR------EIIMGIG 154
           ++V+L G    G   +++ + M    L   L       A     A        ++   I 
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148

Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY 214
            G+AY++       VHRD+   N ++ ++F  KI DFG+++   E   +      G  G 
Sbjct: 149 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----RKGGKGL 201

Query: 215 L-----APEYAISGRLTRKSDVYSFGVLLLEIVS 243
           L     +PE    G  T  SDV+SFGV+L EI +
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  130 bits (329), Expect = 1e-35
 Identities = 61/214 (28%), Positives = 102/214 (47%), Gaps = 25/214 (11%)

Query: 44  FRWSNK--IGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHE 100
               ++  +G+G +G VY GR L +   +A+K +     +  +    E+A   ++   H+
Sbjct: 22  DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLK--HK 79

Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG-----IGR 155
           N+V+  G   +     +  + +P  SLS  L      R+K+G     E  +G     I  
Sbjct: 80  NIVQYLGSFSENGFIKIFMEQVPGGSLSALL------RSKWGPLKDNEQTIGFYTKQILE 133

Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQ-NFNPKISDFGLSKLFPENTTHISTRVAGTLGY 214
           GL Y+H+     +VHRDIK  N+L++  +   KISDFG SK          T   GTL Y
Sbjct: 134 GLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQY 189

Query: 215 LAPEYAISGRL---TRKSDVYSFGVLLLEIVSGR 245
           +APE  I        + +D++S G  ++E+ +G+
Sbjct: 190 MAPE-IIDKGPRGYGKAADIWSLGCTIIEMATGK 222

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  130 bits (328), Expect = 1e-35
 Identities = 61/253 (24%), Positives = 109/253 (43%), Gaps = 37/253 (14%)

Query: 48  NKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLH 106
             IG GGFG V+K +   DG    +K +   ++    +   EV ++A ++  H N+V  +
Sbjct: 17  ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLD--HVNIVHYN 70

Query: 107 GGCIDGPCRI----------------LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 150
           G                         +  ++    +L Q +  E++R  K       E+ 
Sbjct: 71  GCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI--EKRRGEKLDKVLALELF 128

Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG 210
             I +G+ YIH +    +++RD+K SNI L      KI DFGL     +N    +    G
Sbjct: 129 EQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL-KNDGKRTRSK-G 183

Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKA--WGMY 267
           TL Y++PE   S    ++ D+Y+ G++L E++    TA  F+     +  +       ++
Sbjct: 184 TLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA--FETS-KFFTDLRDGIISDIF 240

Query: 268 NSKELMNLVDPML 280
             K+   L+  +L
Sbjct: 241 -DKKEKTLLQKLL 252

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  130 bits (330), Expect = 2e-35
 Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 27/214 (12%)

Query: 48  NKIGEGGFGSVYKGRLQDG----TIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHEN 101
             +GEG FGSV +G L+        VAVK + ++  S++  +EF+SE A M + +  H N
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFS--HPN 97

Query: 102 LVKLHGGCIDG-----PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG--IG 154
           +++L G CI+      P  +++  +M    L   LL             +  +     I 
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157

Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY 214
            G+ Y+      + +HRD+   N +L  +    ++DFGLSK       +      G +  
Sbjct: 158 LGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY----RQGRIAK 210

Query: 215 L-----APEYAISGRLTRKSDVYSFGVLLLEIVS 243
           +     A E       T KSDV++FGV + EI +
Sbjct: 211 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  129 bits (327), Expect = 2e-35
 Identities = 50/213 (23%), Positives = 90/213 (42%), Gaps = 32/213 (15%)

Query: 49  KIGEGGFGSVYKGRLQD--------GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHE 100
            +G+G F  ++KG  ++         T V +KVL    +   + F    + M+ ++  H+
Sbjct: 15  SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS--HK 72

Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
           +LV  +G C+ G   ILV +++   SL   L   +K +       + E+   +   + ++
Sbjct: 73  HLVLNYGVCVCGDENILVQEFVKFGSLDTYL---KKNKNCINILWKLEVAKQLAAAMHFL 129

Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNP--------KISDFGLSKLFPENTTHISTRVAGTL 212
            E     ++H ++   NILL +  +         K+SD G+S         +  R+    
Sbjct: 130 EEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV-LPKDILQERIPWV- 184

Query: 213 GYLAPEYAIS--GRLTRKSDVYSFGVLLLEIVS 243
               PE  I     L   +D +SFG  L EI S
Sbjct: 185 ---PPE-CIENPKNLNLATDKWSFGTTLWEICS 213

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  129 bits (326), Expect = 2e-35
 Identities = 67/209 (32%), Positives = 104/209 (49%), Gaps = 20/209 (9%)

Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCH 99
           F     +G+G FG+VY  R  Q   I+A+KVL    +E    E +   EV   +++   H
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR--H 68

Query: 100 ENLVKLHGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
            N+++L+G       R+ L+ +Y P  ++ + L    ++ +KF  +     I  +   L+
Sbjct: 69  PNILRLYG-YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALS 123

Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE 218
           Y H +    V+HRDIK  N+LL      KI+DFG S   P +       + GTL YL PE
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--D-LCGTLDYLPPE 177

Query: 219 YAISGRL-TRKSDVYSFGVLLLEIVSGRT 246
             I GR+   K D++S GVL  E + G+ 
Sbjct: 178 -MIEGRMHDEKVDLWSLGVLCYEFLVGKP 205

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  131 bits (332), Expect = 2e-35
 Identities = 61/243 (25%), Positives = 100/243 (41%), Gaps = 40/243 (16%)

Query: 48  NKIGEGGFGSVYKGRLQDG----TIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENL 102
             IG G FG VY G L D        AVK L+  +  GE  +F++E   M + +  H N+
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS--HPNV 152

Query: 103 VKLHGGCIDG-PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
           + L G C+      ++V  YM +  L   +            K      + + +G+ ++ 
Sbjct: 153 LSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKFLA 209

Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL-----A 216
            +     VHRD+   N +LD+ F  K++DFGL++   +           T   L     A
Sbjct: 210 SK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH--NKTGAKLPVKWMA 264

Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE--YHLVDKAWGMYNSKELMN 274
            E   + + T KSDV+SFGVLL E+++           G   Y        +    ++  
Sbjct: 265 LESLQTQKFTTKSDVWSFGVLLWELMT----------RGAPPY------PDVNT-FDITV 307

Query: 275 LVD 277
            + 
Sbjct: 308 YLL 310

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  132 bits (334), Expect = 3e-35
 Identities = 59/287 (20%), Positives = 104/287 (36%), Gaps = 39/287 (13%)

Query: 12  SRVSAENTIGGEQI-LKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVA 70
           S  S E   G E+  +  +   S+    +          +G G  G++    + D   VA
Sbjct: 3   SSPSLEQDDGDEETSVVIVGKISFCPKDV----------LGHGAEGTIVYRGMFDNRDVA 52

Query: 71  VKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQT 130
           VK +     +       EV  +   +  H N+++      D   + +  +     +L + 
Sbjct: 53  VKRI---LPECFSFADREVQLLRESDE-HPNVIRYFCTEKDRQFQYIAIELCA-ATLQEY 107

Query: 131 LLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL-----DQNFN 185
           +   E++           ++     GLA++H     ++VHRD+K  NIL+          
Sbjct: 108 V---EQKDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIK 161

Query: 186 PKISDFGLSKLFPENTTHISTR--VAGTLGYLAPEY---AISGRLTRKSDVYSFGVLLLE 240
             ISDFGL K         S R  V GT G++APE          T   D++S G +   
Sbjct: 162 AMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYY 221

Query: 241 IVSG-------RTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPML 280
           ++S              ++ LG   L       +       L++ M+
Sbjct: 222 VISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMI 268

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  128 bits (325), Expect = 3e-35
 Identities = 61/203 (30%), Positives = 98/203 (48%), Gaps = 20/203 (9%)

Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCHENLVKL 105
           +G+G FG+VY  R  Q+  I+A+KVL    +E +  E +   E+   +++   H N++++
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR--HPNILRM 79

Query: 106 HGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           +        RI L+ ++ P   L + L    ++  +F  +     +  +   L Y HE  
Sbjct: 80  YN-YFHDRKRIYLMLEFAPRGELYKEL----QKHGRFDEQRSATFMEELADALHYCHER- 133

Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
              V+HRDIK  N+L+      KI+DFG S   P       T + GTL YL PE  I G+
Sbjct: 134 --KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR--T-MCGTLDYLPPE-MIEGK 187

Query: 225 L-TRKSDVYSFGVLLLEIVSGRT 246
               K D++  GVL  E + G  
Sbjct: 188 THDEKVDLWCAGVLCYEFLVGMP 210

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  129 bits (326), Expect = 6e-35
 Identities = 53/215 (24%), Positives = 91/215 (42%), Gaps = 28/215 (13%)

Query: 48  NKIGEGGFGSVYKGRLQDG----TIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHEN 101
             +G+G FGSV + +L+        VAVK+L  +  +    +EF+ E A M   +  H +
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD--HPH 86

Query: 102 LVKLHGGCIDG------PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG--I 153
           + KL G  +        P  +++  +M +  L   LL        F    +  +     I
Sbjct: 87  VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146

Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
             G+ Y+      + +HRD+   N +L ++    ++DFGLS+       +      G   
Sbjct: 147 ACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY----RQGCAS 199

Query: 214 YL-----APEYAISGRLTRKSDVYSFGVLLLEIVS 243
            L     A E       T  SDV++FGV + EI++
Sbjct: 200 KLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  128 bits (323), Expect = 2e-34
 Identities = 59/222 (26%), Positives = 89/222 (40%), Gaps = 35/222 (15%)

Query: 48  NKIGEGGFGSVYKGRLQD------GTIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHE 100
             +G G FG V +              VAVK+L   +   E    MSE+  + ++   H 
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG-HHL 91

Query: 101 NLVKLHGGC--IDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARRE---------- 148
           N+V L G C    GP  ++V ++    +LS  L  +      +                 
Sbjct: 92  NVVNLLGACTKPGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150

Query: 149 IIMG--IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIST 206
           I     + +G+ ++        +HRD+   NILL +    KI DFGL++   ++      
Sbjct: 151 ICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD----PD 203

Query: 207 RVAGTLGYL-----APEYAISGRLTRKSDVYSFGVLLLEIVS 243
            V      L     APE       T +SDV+SFGVLL EI S
Sbjct: 204 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  128 bits (324), Expect = 2e-34
 Identities = 50/203 (24%), Positives = 93/203 (45%), Gaps = 20/203 (9%)

Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G+GGF   ++        + A K++     ++  Q EK    E++   ++   H+++V 
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLA--HQHVVG 105

Query: 105 LHGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
            HG   +    + +V +     SL +      KRR        R  +  I  G  Y+H  
Sbjct: 106 FHG-FFEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEARYYLRQIVLGCQYLHRN 160

Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG 223
               V+HRD+K  N+ L+++   KI DFGL+     +       + GT  Y+APE  +S 
Sbjct: 161 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPE-VLSK 215

Query: 224 RL-TRKSDVYSFGVLLLEIVSGR 245
           +  + + DV+S G ++  ++ G+
Sbjct: 216 KGHSFEVDVWSIGCIMYTLLVGK 238

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  127 bits (321), Expect = 2e-34
 Identities = 61/256 (23%), Positives = 98/256 (38%), Gaps = 52/256 (20%)

Query: 48  NKIGEGGFGSVYKGRLQDG------TIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHE 100
            ++GE  FG VYKG L           VA+K L  +      +EF  E    A +   H 
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQ--HP 72

Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARRE------------ 148
           N+V L G         +++ Y  +  L + L+              R             
Sbjct: 73  NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132

Query: 149 IIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRV 208
           ++  I  G+ Y+      HVVH+D+ T N+L+    N KISD GL +       +     
Sbjct: 133 LVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYY----K 185

Query: 209 AGTLGYL-----APEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE--YHLVD 261
                 L     APE  + G+ +  SD++S+GV+L E+ S           G   Y    
Sbjct: 186 LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS----------YGLQPY---- 231

Query: 262 KAWGMYNSKELMNLVD 277
              G  N ++++ ++ 
Sbjct: 232 --CGYSN-QDVVEMIR 244

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  127 bits (321), Expect = 2e-34
 Identities = 50/203 (24%), Positives = 93/203 (45%), Gaps = 20/203 (9%)

Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G+GGF   ++        + A K++     ++  Q EK    E++   ++   H+++V 
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLA--HQHVVG 79

Query: 105 LHGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
            HG   +    + +V +     SL +      KRR        R  +  I  G  Y+H  
Sbjct: 80  FHG-FFEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEARYYLRQIVLGCQYLHRN 134

Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG 223
               V+HRD+K  N+ L+++   KI DFGL+     +       + GT  Y+APE  +S 
Sbjct: 135 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPE-VLSK 189

Query: 224 RL-TRKSDVYSFGVLLLEIVSGR 245
           +  + + DV+S G ++  ++ G+
Sbjct: 190 KGHSFEVDVWSIGCIMYTLLVGK 212

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  127 bits (321), Expect = 2e-34
 Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 19/207 (9%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGE---KEFMSEVASMANVNVCHENLVK 104
            +G GG   V+  R L+D   VAVKVL  +  +       F  E  + A +N  H  +V 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN--HPAIVA 76

Query: 105 LH-GGCIDGPCRILVY---DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
           ++  G  + P   L Y   +Y+   +L   +            K   E+I    + L + 
Sbjct: 77  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIV----HTEGPMTPKRAIEVIADACQALNFS 132

Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI--STRVAGTLGYLAPE 218
           H+     ++HRD+K +NI++      K+ DFG+++   ++   +  +  V GT  YL+PE
Sbjct: 133 HQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189

Query: 219 YAISGRLTRKSDVYSFGVLLLEIVSGR 245
            A    +  +SDVYS G +L E+++G 
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGE 216

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  127 bits (322), Expect = 2e-34
 Identities = 67/253 (26%), Positives = 102/253 (40%), Gaps = 51/253 (20%)

Query: 48  NKIGEGGFGSVYKGRLQDG---TIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLV 103
           + IGEG FG V K R++        A+K +   + + +  +F  E+  +  +   H N++
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG-HHPNII 89

Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTL----LGEEKRRAKFGWKARREIIM-------- 151
            L G C       L  +Y P+ +L   L    + E              +          
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT 211
            + RG+ Y+ ++     +HRD+   NIL+ +N+  KI+DFGLS+            V  T
Sbjct: 150 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKKT 199

Query: 212 LGYL-----APEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE--YHLVDKAW 264
           +G L     A E       T  SDV+S+GVLL EIVS          LG   Y       
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS----------LGGTPY------C 243

Query: 265 GMYNSKELMNLVD 277
           GM    EL   + 
Sbjct: 244 GMTC-AELYEKLP 255

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  127 bits (321), Expect = 4e-34
 Identities = 55/222 (24%), Positives = 93/222 (41%), Gaps = 34/222 (15%)

Query: 48  NKIGEGGFGSVYKGRLQD--------GTIVAVKVLSVESKQGEK-EFMSEVASMANVNVC 98
             +GEG FG V                  VAVK+L  ++ + +  + +SE+  M  +   
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-K 99

Query: 99  HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARRE---------- 148
           H+N++ L G C       ++ +Y    +L + L        ++ +   R           
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159

Query: 149 IIMG--IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIST 206
           +     + RG+ Y+  +     +HRD+   N+L+ +N   KI+DFGL++           
Sbjct: 160 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNI----DY 212

Query: 207 RVAGTLGYL-----APEYAISGRLTRKSDVYSFGVLLLEIVS 243
               T G L     APE       T +SDV+SFGVL+ EI +
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  129 bits (324), Expect = 5e-34
 Identities = 35/247 (14%), Positives = 69/247 (27%), Gaps = 39/247 (15%)

Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKE------------------------ 84
           +G+    +  +    + G    V V     +                             
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 85  ----FMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN--SLSQTLLGEEKRR 138
               F+     + +        V+L    +    R  +Y  M +N  +  + LL      
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 139 AKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198
                 AR ++ + + R LA +H      +VH  ++  +I+LDQ     ++ F       
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262

Query: 199 ENTTHISTRVAGTLGYLAPEYAIS-----GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253
            +      R        A             +T   D ++ G+ +  I         D  
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAA 322

Query: 254 LGEYHLV 260
           LG    +
Sbjct: 323 LGGSEWI 329

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  126 bits (319), Expect = 7e-34
 Identities = 60/214 (28%), Positives = 91/214 (42%), Gaps = 27/214 (12%)

Query: 48  NKIGEGGFGSVYKGRLQDG------TIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHE 100
             +G G FG VY+G++           VAVK L     + ++ +F+ E   ++  N  H+
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN--HQ 93

Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII---MGIGRGL 157
           N+V+  G  +    R ++ + M    L   L     R ++    A  +++     I  G 
Sbjct: 94  NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153

Query: 158 AYIHEEIQPHVVHRDIKTSNILLD---QNFNPKISDFGLSKLFPENTTHISTRVAGTLGY 214
            Y+ E    H +HRDI   N LL         KI DFG+++         S    G    
Sbjct: 154 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA----SYYRKGGCAM 206

Query: 215 L-----APEYAISGRLTRKSDVYSFGVLLLEIVS 243
           L      PE  + G  T K+D +SFGVLL EI S
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  124 bits (315), Expect = 9e-34
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 19/203 (9%)

Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCHENLVKL 105
           +G+G F  VY+   +  G  VA+K++    +      +   +EV     +   H ++++L
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK--HPSILEL 76

Query: 106 HGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFG-WKARREIIMGIGRGLAYIHEE 163
           +    +    + LV +   N  +++ L   + R   F   +AR   +  I  G+ Y+H  
Sbjct: 77  YN-YFEDSNYVYLVLEMCHNGEMNRYL---KNRVKPFSENEARH-FMHQIITGMLYLHSH 131

Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG 223
               ++HRD+  SN+LL +N N KI+DFGL+           T + GT  Y++PE   + 
Sbjct: 132 ---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPE-IATR 186

Query: 224 RL-TRKSDVYSFGVLLLEIVSGR 245
                +SDV+S G +   ++ GR
Sbjct: 187 SAHGLESDVWSLGCMFYTLLIGR 209

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  127 bits (320), Expect = 9e-34
 Identities = 59/214 (27%), Positives = 90/214 (42%), Gaps = 27/214 (12%)

Query: 48  NKIGEGGFGSVYKGRLQDG------TIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHE 100
             +G G FG VY+G++           VAVK L     + ++ +F+ E   ++  N  H+
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN--HQ 134

Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM---GIGRGL 157
           N+V+  G  +    R ++ + M    L   L     R ++    A  +++     I  G 
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194

Query: 158 AYIHEEIQPHVVHRDIKTSNILLD---QNFNPKISDFGLSKLFPENTTHISTRVAGTLGY 214
            Y+ E    H +HRDI   N LL         KI DFG+++              G    
Sbjct: 195 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA----GYYRKGGCAM 247

Query: 215 L-----APEYAISGRLTRKSDVYSFGVLLLEIVS 243
           L      PE  + G  T K+D +SFGVLL EI S
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  126 bits (318), Expect = 2e-33
 Identities = 56/225 (24%), Positives = 92/225 (40%), Gaps = 40/225 (17%)

Query: 48  NKIGEGGFGSVYKGRLQD--------GTIVAVKVLSVESKQGEK-EFMSEVASMANVNVC 98
             +GEG FG V                  VAVK+L  ++ + +  + +SE+  M  +   
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-K 145

Query: 99  HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG------ 152
           H+N++ L G C       ++ +Y    +L + L     RR      +     +       
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLR---ARRPPGMEYSYDINRVPEEQMTF 202

Query: 153 ---------IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 203
                    + RG+ Y+  +     +HRD+   N+L+ +N   KI+DFGL++        
Sbjct: 203 KDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNI--- 256

Query: 204 ISTRVAGTLGYL-----APEYAISGRLTRKSDVYSFGVLLLEIVS 243
                  T G L     APE       T +SDV+SFGVL+ EI +
Sbjct: 257 -DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  124 bits (314), Expect = 3e-33
 Identities = 63/260 (24%), Positives = 100/260 (38%), Gaps = 58/260 (22%)

Query: 48  NKIGEGGFGSVYKGRL------QDGTIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHE 100
             +G G FG V +              VAVK+L   +   E+   MSE+  ++ +   H 
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG-NHM 87

Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG-------- 152
           N+V L G C  G   +++ +Y     L   L    ++R  F        IM         
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLR---RKRDSFICSKTSPAIMEDDELALDL 144

Query: 153 ---------IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 203
                    + +G+A++  +   + +HRD+   NILL      KI DFGL++    +   
Sbjct: 145 EDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKND--- 198

Query: 204 ISTRVAGTLGYL-----APEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE-- 256
            S  V      L     APE   +   T +SDV+S+G+ L E+ S          LG   
Sbjct: 199 -SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS----------LGSSP 247

Query: 257 YHLVDKAWGMYNSKELMNLV 276
           Y       GM    +   ++
Sbjct: 248 YP------GMPVDSKFYKMI 261

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  125 bits (317), Expect = 4e-33
 Identities = 56/224 (25%), Positives = 92/224 (41%), Gaps = 38/224 (16%)

Query: 48  NKIGEGGFGSVYKGRLQD--------GTIVAVKVLSVESKQGEK-EFMSEVASMANVNVC 98
             +GEG FG V                T VAVK+L  ++ + +  + +SE+  M  +   
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG-K 133

Query: 99  HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG------ 152
           H+N++ L G C       ++ +Y    +L + L    +R     +               
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQ--ARRPPGLEYSYNPSHNPEEQLSSK 191

Query: 153 --------IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 204
                   + RG+ Y+  +     +HRD+   N+L+ ++   KI+DFGL++         
Sbjct: 192 DLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI---- 244

Query: 205 STRVAGTLGYL-----APEYAISGRLTRKSDVYSFGVLLLEIVS 243
                 T G L     APE       T +SDV+SFGVLL EI +
Sbjct: 245 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  124 bits (313), Expect = 4e-33
 Identities = 68/228 (29%), Positives = 98/228 (42%), Gaps = 41/228 (17%)

Query: 48  NKIGEGGFGSVYKGRLQDG------TIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHE 100
             +GEG FG V K            T VAVK+L   +   E  + +SE   +  VN  H 
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN--HP 86

Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSL------------SQTLLGEEKRRAKFGWKARRE 148
           +++KL+G C      +L+ +Y    SL                 G  +  +       R 
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146

Query: 149 IIMG--------IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 200
           + MG        I +G+ Y+ E     +VHRD+   NIL+ +    KISDFGLS+   E 
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203

Query: 201 TTHISTRVAGTLGYL-----APEYAISGRLTRKSDVYSFGVLLLEIVS 243
                + V  + G +     A E       T +SDV+SFGVLL EIV+
Sbjct: 204 ----DSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  125 bits (316), Expect = 4e-33
 Identities = 33/239 (13%), Positives = 69/239 (28%), Gaps = 50/239 (20%)

Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKE------------------------ 84
           +G+    +  +    + G    V V     +                             
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 85  ----FMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN--SLSQTLLGEEKRR 138
               F+     + +        V+L    +    R  +Y  M +N  +  + LL      
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 139 AKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198
                 AR ++ + + R LA +H      +VH  ++  +I+LDQ     ++ F       
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257

Query: 199 ENTTHISTRVAGTLGYLAPEYAIS-----------GRLTRKSDVYSFGVLLLEIVSGRT 246
                     + + G+  PE                 +T   D ++ G+++  I     
Sbjct: 258 ARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  123 bits (312), Expect = 8e-33
 Identities = 59/218 (27%), Positives = 95/218 (43%), Gaps = 30/218 (13%)

Query: 48  NKIGEGGFGSVYKGRLQD------GTIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHE 100
             +G G FG V +              VAVK+L   +   EK   MSE+  M+++   HE
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLG-QHE 110

Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKAR-------REIIM-- 151
           N+V L G C  G   +++ +Y     L   L  + +        A        R+++   
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170

Query: 152 -GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG 210
             + +G+A++  +   + +HRD+   N+LL      KI DFGL++    +    S  +  
Sbjct: 171 SQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND----SNYIVK 223

Query: 211 TLGYL-----APEYAISGRLTRKSDVYSFGVLLLEIVS 243
               L     APE       T +SDV+S+G+LL EI S
Sbjct: 224 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  124 bits (313), Expect = 8e-33
 Identities = 68/231 (29%), Positives = 96/231 (41%), Gaps = 47/231 (20%)

Query: 48  NKIGEGGFGSVYKGRLQDG------TIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHE 100
             IGEG FG V++ R          T+VAVK+L  E S   + +F  E A MA  +  + 
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD--NP 110

Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARRE------------ 148
           N+VKL G C  G    L+++YM    L++ L                             
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLR---SMSPHTVCSLSHSDLSTRARVSSPG 167

Query: 149 -----------IIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197
                      I   +  G+AY+ E      VHRD+ T N L+ +N   KI+DFGLS+  
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSR-- 222

Query: 198 PENTTHISTRVAGTLGYL-----APEYAISGRLTRKSDVYSFGVLLLEIVS 243
             N        A     +      PE     R T +SDV+++GV+L EI S
Sbjct: 223 --NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  123 bits (310), Expect = 2e-32
 Identities = 47/205 (22%), Positives = 91/205 (44%), Gaps = 22/205 (10%)

Query: 48  NKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLH 106
            ++G G FG V++ +  Q G   AVK + +E  +     + E+ + A ++     +V L+
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLS--SPRIVPLY 116

Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
           G   +GP   +  + +   SL Q +    K+            +     GL Y+H     
Sbjct: 117 GAVREGPWVNIFMELLEGGSLGQLI----KQMGCLPEDRALYYLGQALEGLEYLHTR--- 169

Query: 167 HVVHRDIKTSNILLDQNFNP-KISDFGLSKLFPENTTHISTR----VAGTLGYLAPEYAI 221
            ++H D+K  N+LL  + +   + DFG +     +    S      + GT  ++APE  +
Sbjct: 170 RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE-VV 228

Query: 222 SGR-LTRKSDVYSFGVLLLEIVSGR 245
            G+    K D++S   ++L +++G 
Sbjct: 229 MGKPCDAKVDIWSSCCMMLHMLNGC 253

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  122 bits (309), Expect = 2e-32
 Identities = 51/267 (19%), Positives = 98/267 (36%), Gaps = 50/267 (18%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
            + EGGF  VY+ + +  G   A+K L    ++  +  + EV  M  ++  H N+V+   
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSG-HPNIVQFCS 93

Query: 108 GCIDGP----------------CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
               G                 C+  + +++     S+  L  +     F      +   
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKGQLVEFL-KKMESRGPLSCDTVLKIF-----YQTC- 146

Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF---PENTTHISTRV 208
              R + ++H + +P ++HRD+K  N+LL      K+ DFG +      P+ +     R 
Sbjct: 147 ---RAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRA 202

Query: 209 A--------GTLGYLAPE-YAISGRL--TRKSDVYSFGVLLLEIVSGRTAVDFDVQL--- 254
                     T  Y  PE   +        K D+++ G +L  +   +   +   +L   
Sbjct: 203 LVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV 262

Query: 255 -GEYHLVDKAWGMYNSKELMNLVDPML 280
            G+Y +              +L+  ML
Sbjct: 263 NGKYSI--PPHDTQ-YTVFHSLIRAML 286

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  121 bits (305), Expect = 3e-32
 Identities = 56/261 (21%), Positives = 97/261 (37%), Gaps = 43/261 (16%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKV--LSVESKQGEKEFMSEVASMANVNVCHENLVKL 105
           KIG G FGSV+K     DG I A+K     +     E+  + EV + A +   H ++V+ 
Sbjct: 18  KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLG-QHSHVVRY 76

Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
                +    ++  +Y    SL+  +    +  + F     +++++ +GRGL YIH    
Sbjct: 77  FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM-- 134

Query: 166 PHVVHRDIKTSNILLDQNFNP-------------------KISDFGLSKLFPENTTHIST 206
             +VH DIK SNI + +   P                   KI D G              
Sbjct: 135 -SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE-- 191

Query: 207 RVAGTLGYLAPEYAISGRL--TRKSDVYSFGVLLLEIVSGRTAVDFDVQL-----GEYHL 259
              G   +LA E  +        K+D+++  + ++             Q      G    
Sbjct: 192 ---GDSRFLANE-VLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQGRLPR 247

Query: 260 VDKAWGMYNSKELMNLVDPML 280
           + +      S+E   L+  M+
Sbjct: 248 IPQVL----SQEFTELLKVMI 264

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  122 bits (307), Expect = 3e-32
 Identities = 49/226 (21%), Positives = 92/226 (40%), Gaps = 28/226 (12%)

Query: 38  KIATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKE-FMSEVASMANV 95
             + + +  S+ +G+G   +V++GR  + G + A+KV +  S     +  M E   +  +
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64

Query: 96  NVCHENLVKLHGGCIDGPCRILVY---DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG 152
           N  H+N+VKL     +           ++ P  SL   +L E              ++  
Sbjct: 65  N--HKNIVKLFA-IEEETTTRHKVLIMEFCPCGSLYT-VLEEPSNAYGLPESEFLIVLRD 120

Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILL----DQNFNPKISDFGLSKLFPENTTHISTRV 208
           +  G+ ++ E     +VHR+IK  NI+     D     K++DFG ++   ++     +  
Sbjct: 121 VVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY 176

Query: 209 AGTLGYLAPEYAISGRLTR---------KSDVYSFGVLLLEIVSGR 245
            GT  YL P+      + R           D++S GV      +G 
Sbjct: 177 -GTEEYLHPDM-YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  126 bits (318), Expect = 4e-32
 Identities = 46/206 (22%), Positives = 77/206 (37%), Gaps = 28/206 (13%)

Query: 49  KIGEGGFGSVYKG---RLQDGTIVAVKVLSVESKQGEKE-FMSEVASMANVNVCHENLVK 104
            I  GG G +Y      + +G  V +K L        +   M+E   +A V   H ++V+
Sbjct: 87  CIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVV--HPSIVQ 143

Query: 105 L-----HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
           +     H      P   +V +Y+   SL         +  K         ++ I   L+Y
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLK------RSKGQKLPVAEAIAYLLEILPALSY 197

Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEY 219
           +H      +V+ D+K  NI+L +    K+ D G               + GT G+ APE 
Sbjct: 198 LHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS----RINSFGY-LYGTPGFQAPEI 248

Query: 220 AISGRLTRKSDVYSFGVLLLEIVSGR 245
                 T  +D+Y+ G  L  +    
Sbjct: 249 V-RTGPTVATDIYTVGRTLAALTLDL 273

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  122 bits (307), Expect = 4e-32
 Identities = 64/262 (24%), Positives = 98/262 (37%), Gaps = 57/262 (21%)

Query: 48  NKIGEGGFGSVYKGRLQDG------TIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHE 100
             +G G FG V                VAVK+L  ++   E+   MSE+  M  +   HE
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG-SHE 109

Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSL-----------SQTLLGEEKRRAKFGWKARREI 149
           N+V L G C       L+++Y     L           S+  +  E ++     +    +
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169

Query: 150 IMG--------IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 201
                      + +G+ ++  +     VHRD+   N+L+      KI DFGL++    + 
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD- 225

Query: 202 THISTRVAGTLGYL-----APEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE 256
              S  V      L     APE    G  T KSDV+S+G+LL EI S          LG 
Sbjct: 226 ---SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS----------LGV 272

Query: 257 --YHLVDKAWGMYNSKELMNLV 276
             Y       G+        L+
Sbjct: 273 NPY------PGIPVDANFYKLI 288

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  125 bits (315), Expect = 7e-32
 Identities = 57/209 (27%), Positives = 86/209 (41%), Gaps = 21/209 (10%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKE-FMSEVASMANVNVCHENLVKLH 106
           ++G GGFG V +      G  VA+K    E     +E +  E+  M  +N  H N+V   
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN--HPNVVSAR 78

Query: 107 ------GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
                          +L  +Y     L +  L + +          R ++  I   L Y+
Sbjct: 79  EVPDGLQKLAPNDLPLLAMEYCEGGDLRK-YLNQFENCCGLKEGPIRTLLSDISSALRYL 137

Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNP---KISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
           HE     ++HRD+K  NI+L         KI D G +K   +     +  V GTL YLAP
Sbjct: 138 HEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFV-GTLQYLAP 192

Query: 218 EYAISGRL-TRKSDVYSFGVLLLEIVSGR 245
           E  +  +  T   D +SFG L  E ++G 
Sbjct: 193 E-LLEQKKYTVTVDYWSFGTLAFECITGF 220

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  121 bits (306), Expect = 2e-31
 Identities = 49/226 (21%), Positives = 92/226 (40%), Gaps = 28/226 (12%)

Query: 38  KIATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKE-FMSEVASMANV 95
             + + +  S+ +G+G   +V++GR  + G + A+KV +  S     +  M E   +  +
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64

Query: 96  NVCHENLVKLHGGCIDGPCRILVY---DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG 152
           N  H+N+VKL     +           ++ P  SL   +L E              ++  
Sbjct: 65  N--HKNIVKLFA-IEEETTTRHKVLIMEFCPCGSLYT-VLEEPSNAYGLPESEFLIVLRD 120

Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILL----DQNFNPKISDFGLSKLFPENTTHISTRV 208
           +  G+ ++ E     +VHR+IK  NI+     D     K++DFG ++   ++     +  
Sbjct: 121 VVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY 176

Query: 209 AGTLGYLAPEYAISGRLTR---------KSDVYSFGVLLLEIVSGR 245
            GT  YL P+      + R           D++S GV      +G 
Sbjct: 177 -GTEEYLHPDM-YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  119 bits (301), Expect = 2e-31
 Identities = 50/204 (24%), Positives = 82/204 (40%), Gaps = 17/204 (8%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGE---KEFMSEVASMANVNVCHENLVK 104
            +G GG G VY+        IVA+K++S               E  +   +     ++V 
Sbjct: 41  LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ--EPHVVP 98

Query: 105 LHG-GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
           +H  G IDG    +    +    L+  L    +R+          I+  IG  L   H  
Sbjct: 99  IHDFGEIDG-QLYVDMRLINGVDLAAML----RRQGPLAPPRAVAIVRQIGSALDAAHAA 153

Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT-THISTRVAGTLGYLAPEYAIS 222
                 HRD+K  NIL+  +    + DFG++    +   T +     GTL Y+APE    
Sbjct: 154 ---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYMAPERFSE 209

Query: 223 GRLTRKSDVYSFGVLLLEIVSGRT 246
              T ++D+Y+   +L E ++G  
Sbjct: 210 SHATYRADIYALTCVLYECLTGSP 233

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  120 bits (302), Expect = 3e-31
 Identities = 27/228 (11%), Positives = 59/228 (25%), Gaps = 39/228 (17%)

Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKE---FMSEVASMANVNVCHENLVKL 105
           +  G    V+  R ++     A+KV ++ ++    E         + A +        + 
Sbjct: 70  LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129

Query: 106 HGGCI---------------------DGPCRILVYDYMPNNSLSQTLLGEE-----KRRA 139
               +                     D          MP  S+   LL          R 
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189

Query: 140 KFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 199
             G  A   +   + R  A +  +    +VH      N+ +  +    + D         
Sbjct: 190 DEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT 246

Query: 200 NTTHISTRVAGTLGYLAPEYAISGRL--TRKSDVYSFGVLLLEIVSGR 245
                    +  + Y   E+  +     T   + +  G+ +  +    
Sbjct: 247 RG----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  118 bits (298), Expect = 1e-30
 Identities = 51/204 (25%), Positives = 98/204 (48%), Gaps = 13/204 (6%)

Query: 44  FRWSNKIGEGGFGSVYKGRL-QDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHEN 101
           F   +++G G  G V+K      G ++A K++ +E K     + + E+  +   N     
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN--SPY 92

Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
           +V  +G         +  ++M   SL Q L    K+  +   +   ++ + + +GL Y+ 
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLR 148

Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI 221
           E+    ++HRD+K SNIL++     K+ DFG+S    +    ++    GT  Y++PE   
Sbjct: 149 EKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFVGTRSYMSPERLQ 203

Query: 222 SGRLTRKSDVYSFGVLLLEIVSGR 245
               + +SD++S G+ L+E+  GR
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGR 227

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  117 bits (295), Expect = 1e-30
 Identities = 53/218 (24%), Positives = 98/218 (44%), Gaps = 18/218 (8%)

Query: 37  LKIATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGE-KEFMSEVA-SMA 93
           +++  +      ++G G +G V K R +  G I+AVK +       E K  + ++  SM 
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61

Query: 94  NVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGI 153
            V+      V  +G         +  + M + SL +       +          +I + I
Sbjct: 62  TVD--CPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSI 118

Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS-TRVAGTL 212
            + L ++H ++   V+HRD+K SN+L++     K+ DFG+S         ++    AG  
Sbjct: 119 VKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISG---YLVDDVAKDIDAGCK 173

Query: 213 GYLAPEYAISGRLTR-----KSDVYSFGVLLLEIVSGR 245
            Y+APE  I+  L +     KSD++S G+ ++E+   R
Sbjct: 174 PYMAPE-RINPELNQKGYSVKSDIWSLGITMIELAILR 210

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  117 bits (296), Expect = 2e-30
 Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 15/205 (7%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHENLVKLH 106
           +IG G +GSV K      G I+AVK +     + E K+ + ++  +   +     +V+ +
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDL-DVVMRSSDCPYIVQFY 87

Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
           G         +  + M  +                  +   +I +   + L ++ E +  
Sbjct: 88  GALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL-- 145

Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS-TRVAGTLGYLAPEYAISGRL 225
            ++HRDIK SNILLD++ N K+ DFG+S    +    I+ TR AG   Y+APE  I    
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSIAKTRDAGCRPYMAPE-RIDPSA 201

Query: 226 TR-----KSDVYSFGVLLLEIVSGR 245
           +R     +SDV+S G+ L E+ +GR
Sbjct: 202 SRQGYDVRSDVWSLGITLYELATGR 226

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  119 bits (300), Expect = 2e-30
 Identities = 54/268 (20%), Positives = 98/268 (36%), Gaps = 43/268 (16%)

Query: 48  NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
             +G G  G+V       G  VAVK +           + E+  +      H N+++ + 
Sbjct: 21  KILGYGSSGTVVFQGSFQGRPVAVKRML---IDFCDIALMEIKLLTES-DDHPNVIRYYC 76

Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGE---EKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
                    +  +   N +L   +  +   ++            ++  I  G+A++H   
Sbjct: 77  SETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL- 134

Query: 165 QPHVVHRDIKTSNILLD-------------QNFNPKISDFGLSKLFPENTTHISTR---V 208
              ++HRD+K  NIL+              +N    ISDFGL K      +   T     
Sbjct: 135 --KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192

Query: 209 AGTLGYLAPE-------YAISGRLTRKSDVYSFGVLLLEIVSG-------RTAVDFDVQL 254
           +GT G+ APE            RLTR  D++S G +   I+S        + + + ++  
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIR 252

Query: 255 GEYHLVDKAW--GMYNSKELMNLVDPML 280
           G + L +           E  +L+  M+
Sbjct: 253 GIFSLDEMKCLHDRSLIAEATDLISQMI 280

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  115 bits (290), Expect = 9e-30
 Identities = 62/256 (24%), Positives = 101/256 (39%), Gaps = 53/256 (20%)

Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMS------EVASMANVNVCHENL 102
           +G GGFGSVY G  + D   VA+K +  +      E  +      EV  +  V+     +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 103 VKLHGGCIDGPCRIL-----------VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
           ++L     + P   +           ++D++         L EE  R+ F      +++ 
Sbjct: 111 IRLLD-WFERPDSFVLILERPEPVQDLFDFITER----GALQEELARSFF-----WQVLE 160

Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN-FNPKISDFGLSKLFPENTTHISTRVAG 210
            +     + H      V+HRDIK  NIL+D N    K+ DFG   L  +          G
Sbjct: 161 AV----RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DG 210

Query: 211 TLGYLAPEYAISGRL--TRKSDVYSFGVLLLEIVSGRTAVDFD----VQLGEYHLVDKAW 264
           T  Y  PE+ I       R + V+S G+LL ++V G   + F+    +  G+        
Sbjct: 211 TRVYSPPEW-IRYHRYHGRSAAVWSLGILLYDMVCGD--IPFEHDEEIIRGQVFFRQ--- 264

Query: 265 GMYNSKELMNLVDPML 280
               S E  +L+   L
Sbjct: 265 --RVSSECQHLIRWCL 278

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  114 bits (287), Expect = 2e-29
 Identities = 64/258 (24%), Positives = 100/258 (38%), Gaps = 55/258 (21%)

Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVL------SVESKQGEKEFMSEVASMANVNVC--HE 100
           +G+GGFG+V+ G  L D   VA+KV+                   EVA +  V     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 101 NLVKLHGGCIDGPCRIL-----------VYDYMPNNSLSQTLLGEEKRRAKFGWKARREI 149
            +++L     +     +           ++DY+      +  LGE   R  F      ++
Sbjct: 99  GVIRLLD-WFETQEGFMLVLERPLPAQDLFDYI----TEKGPLGEGPSRCFF-----GQV 148

Query: 150 IMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD-QNFNPKISDFGLSKLFPENTTHISTRV 208
           +  I     + H      VVHRDIK  NIL+D +    K+ DFG   L  +         
Sbjct: 149 VAAI----QHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF--- 198

Query: 209 AGTLGYLAPEYAISGRL--TRKSDVYSFGVLLLEIVSGRTAVDFD----VQLGEYHLVDK 262
            GT  Y  PE+ IS        + V+S G+LL ++V G   + F+    +   E H    
Sbjct: 199 DGTRVYSPPEW-ISRHQYHALPATVWSLGILLYDMVCGD--IPFERDQEILEAELHFPA- 254

Query: 263 AWGMYNSKELMNLVDPML 280
               + S +   L+   L
Sbjct: 255 ----HVSPDCCALIRRCL 268

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  114 bits (287), Expect = 2e-29
 Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 24/208 (11%)

Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENL 102
                KIGEG  G V   R    G  VAVK++ +  +Q  +   +EV  M +    H N+
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ--HFNV 104

Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLS----QTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
           V+++   + G    ++ +++   +L+    Q  L EE+            +   + + LA
Sbjct: 105 VEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIAT---------VCEAVLQALA 155

Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR--VAGTLGYLA 216
           Y+H +    V+HRDIK+ +ILL  +   K+SDFG      + +  +  R  + GT  ++A
Sbjct: 156 YLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCA---QISKDVPKRKSLVGTPYWMA 209

Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVSG 244
           PE         + D++S G++++E+V G
Sbjct: 210 PEVISRSLYATEVDIWSLGIMVIEMVDG 237

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  113 bits (285), Expect = 3e-29
 Identities = 52/208 (25%), Positives = 99/208 (47%), Gaps = 24/208 (11%)

Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENL 102
           +    KIG+G  G+VY    +  G  VA++ ++++ +  ++  ++E+  M      + N+
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK--NPNI 79

Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLS----QTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
           V      + G    +V +Y+   SL+    +T + E +  A         +     + L 
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA---------VCRECLQALE 130

Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR--VAGTLGYLA 216
           ++H      V+HRDIK+ NILL  + + K++DFG      + T   S R  + GT  ++A
Sbjct: 131 FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA---QITPEQSKRSTMVGTPYWMA 184

Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVSG 244
           PE         K D++S G++ +E++ G
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  113 bits (284), Expect = 3e-29
 Identities = 66/279 (23%), Positives = 116/279 (41%), Gaps = 70/279 (25%)

Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLS---------------------VESKQGEKEFMS 87
           IG+G +G V       D T  A+KVLS                           +     
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 88  -----EVASMANVNVCHENLVKLHGGCIDGPCR---ILVYDYMPNNSL----SQTLLGEE 135
                E+A +  ++  H N+VKL    +D P      +V++ +    +    +   L E+
Sbjct: 81  EQVYQEIAILKKLD--HPNVVKLVE-VLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSED 137

Query: 136 KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK 195
           + R  F     +++I GI     Y+H +    ++HRDIK SN+L+ ++ + KI+DFG+S 
Sbjct: 138 QARFYF-----QDLIKGI----EYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSN 185

Query: 196 LFPENTTHISTRVAGTLGYLAPEYAISGRLT----RKSDVYSFGVLLLEIVSGRTAVDFD 251
            F  +   +S    GT  ++APE ++S        +  DV++ GV L   V G+    F 
Sbjct: 186 EFKGSDALLSN-TVGTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYCFVFGQ--CPFM 241

Query: 252 ----------VQLGEYHLVDKAWGMYNSKELMNLVDPML 280
                     ++       D+      +++L +L+  ML
Sbjct: 242 DERIMCLHSKIKSQALEFPDQPD---IAEDLKDLITRML 277

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  113 bits (285), Expect = 4e-29
 Identities = 56/307 (18%), Positives = 102/307 (33%), Gaps = 84/307 (27%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKE-FMSEVASMANVNVCHENLVKLH 106
            +G GGFG V++ +   D    A+K + + +++  +E  M EV ++A +   H  +V+  
Sbjct: 13  CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE--HPGIVRYF 70

Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGE---EKRRAKFGWKARRE--------------- 148
              ++ P      +        ++                K RR                
Sbjct: 71  NAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPS 130

Query: 149 -------IIMG-------------------------------IGRGLAYIHEEIQPHVVH 170
                  I M                                I   + ++H +    ++H
Sbjct: 131 SPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK---GLMH 187

Query: 171 RDIKTSNILLDQNFNPKISDFGLSK-----------LFPENTTHISTRVAGTLGYLAPEY 219
           RD+K SNI    +   K+ DFGL             L P       T   GT  Y++PE 
Sbjct: 188 RDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQ 247

Query: 220 AISGRLTRKSDVYSFGVLLLEIVSG------RTAVDFDVQLGEYHLVDKAWGMYNSKELM 273
                 + K D++S G++L E++        R  +  DV+  ++      +      +  
Sbjct: 248 IHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKF---PLLFTQK-YPQEH 303

Query: 274 NLVDPML 280
            +V  ML
Sbjct: 304 MMVQDML 310

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  112 bits (282), Expect = 5e-29
 Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 13/200 (6%)

Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLS-VESKQGEKEFMSEVASMANVNVCHEN 101
           F +  K+G G FG V+       G    +K ++   S+   ++  +E+  + +++  H N
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLD--HPN 81

Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
           ++K+     D     +V +      L + ++  + R          E++  +   LAY H
Sbjct: 82  IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141

Query: 162 EEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE 218
            +   HVVH+D+K  NIL      +   KI DFGL++LF  +     T  AGT  Y+APE
Sbjct: 142 SQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS--TNAAGTALYMAPE 196

Query: 219 YAISGRLTRKSDVYSFGVLL 238
                 +T K D++S GV++
Sbjct: 197 -VFKRDVTFKCDIWSAGVVM 215

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  115 bits (291), Expect = 6e-29
 Identities = 71/253 (28%), Positives = 110/253 (43%), Gaps = 38/253 (15%)

Query: 48  NKIGEGGFGSVYKGR-LQDGTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCHENLV 103
             +G+G FG V   +    G   AVKV+S   V+ K  ++  + EV  +  ++  H N++
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD--HPNIM 89

Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEE-----KRRAKFGWKARREIIMGIGRGLA 158
           KL+    D     LV +            G E       R +F       II  +  G+ 
Sbjct: 90  KLYEFFEDKGYFYLVGEVYT---------GGELFDEIISRKRFSEVDAARIIRQVLSGIT 140

Query: 159 YIHEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
           Y+H+     +VHRD+K  N+LL    ++ N +I DFGLS  F  +         GT  Y+
Sbjct: 141 YMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS--KKMKDKIGTAYYI 195

Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVSGR--------TAVDFDVQLGEYHLVDKAWGMY 267
           APE  + G    K DV+S GV+L  ++SG           +   V+ G+Y      W   
Sbjct: 196 APE-VLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKV 254

Query: 268 NSKELMNLVDPML 280
            S+   +L+  ML
Sbjct: 255 -SESAKDLIRKML 266

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  112 bits (281), Expect = 1e-28
 Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 21/207 (10%)

Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKE-FMSEVASMANVNVCHEN 101
           F    KIG+G FG V+KG   +   +VA+K++ +E  + E E    E+  ++  +     
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD--SPY 81

Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLS----QTLLGEEKRRAKFGWKARREIIMGIGRGL 157
           + K +G  +      ++ +Y+   S         L E +            I+  I +GL
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT---------ILREILKGL 132

Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
            Y+H E     +HRDIK +N+LL ++   K++DFG++    +     +T V GT  ++AP
Sbjct: 133 DYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAP 188

Query: 218 EYAISGRLTRKSDVYSFGVLLLEIVSG 244
           E         K+D++S G+  +E+  G
Sbjct: 189 EVIKQSAYDSKADIWSLGITAIELARG 215

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  112 bits (281), Expect = 2e-28
 Identities = 73/252 (28%), Positives = 113/252 (44%), Gaps = 46/252 (18%)

Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLH 106
           IG+G F  V   R +  G  VA+K++     +    ++   EV  M  +N  H N+VKL 
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILN--HPNIVKLF 80

Query: 107 GGCIDGPCRI-LVYDYMPNNSLSQTL-----LGEEKRRAKFGWKARREIIMGIGRGLAYI 160
              I+    + L+ +Y     +   L     + E++ R+KF     R+I+  +     Y 
Sbjct: 81  E-VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKF-----RQIVSAV----QYC 130

Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
           H++    +VHRD+K  N+LLD + N KI+DFG S  F      +     G   Y APE  
Sbjct: 131 HQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDAFC-GAPPYAAPE-L 184

Query: 221 ISGRL--TRKSDVYSFGVLLLEIVSGRTAVDFD----------VQLGEYHLVDKAWGMYN 268
             G+     + DV+S GV+L  +VSG   + FD          V  G+Y +       Y 
Sbjct: 185 FQGKKYDGPEVDVWSLGVILYTLVSGS--LPFDGQNLKELRERVLRGKYRIPF-----YM 237

Query: 269 SKELMNLVDPML 280
           S +  NL+   L
Sbjct: 238 STDCENLLKRFL 249

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  113 bits (285), Expect = 3e-28
 Identities = 66/247 (26%), Positives = 107/247 (43%), Gaps = 27/247 (10%)

Query: 48  NKIGEGGFGSVYKGR-LQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVK 104
            K+G G +G V   R        A+K++     S     + + EVA +  ++  H N++K
Sbjct: 43  KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD--HPNIMK 100

Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           L+    D     LV +      L   ++     R KF       II  +  G+ Y+H+  
Sbjct: 101 LYDFFEDKRNYYLVMECYKGGELFDEII----HRMKFNEVDAAVIIKQVLSGVTYLHKH- 155

Query: 165 QPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI 221
             ++VHRD+K  N+LL   +++   KI DFGLS +F            GT  Y+APE  +
Sbjct: 156 --NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ--KKMKERLGTAYYIAPE-VL 210

Query: 222 SGRLTRKSDVYSFGVLLLEIVSGRTAVDFD--------VQLGEYHLVDKAWGMYNSKELM 273
             +   K DV+S GV+L  +++G               V+ G+Y      W    S+   
Sbjct: 211 RKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNV-SEGAK 269

Query: 274 NLVDPML 280
           +L+  ML
Sbjct: 270 DLIKQML 276

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  111 bits (280), Expect = 5e-28
 Identities = 47/219 (21%), Positives = 74/219 (33%), Gaps = 28/219 (12%)

Query: 44  FRWSNKIGEG--GFGSVYKGR-LQDGTIVAVKVLSVESKQGE--KEFMSEVASMANVNVC 98
           +     IG+G     +V   R    G  V V+ +++E+   E       E+      N  
Sbjct: 27  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN-- 84

Query: 99  HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR--- 155
           H N+V      I      +V  +M   S    +         F        I  I +   
Sbjct: 85  HPNIVPYRATFIADNELWVVTSFMAYGSAKDLI------CTHFMDGMNELAIAYILQGVL 138

Query: 156 -GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS-KLFPE----NTTH-ISTRV 208
             L YIH       VHR +K S+IL+  +    +S    +  +          H      
Sbjct: 139 KALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195

Query: 209 AGTLGYLAPEYAISGRL--TRKSDVYSFGVLLLEIVSGR 245
              L +L+PE           KSD+YS G+   E+ +G 
Sbjct: 196 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  112 bits (283), Expect = 7e-28
 Identities = 70/257 (27%), Positives = 112/257 (43%), Gaps = 39/257 (15%)

Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCH 99
           +     +G+G FG V K +        AVKV++    ++K      + EV  +  ++  H
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST-ILREVELLKKLD--H 80

Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEE-----KRRAKFGWKARREIIMGIG 154
            N++KL     D     +V +            G E      +R +F       II  + 
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYT---------GGELFDEIIKRKRFSEHDAARIIKQVF 131

Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGT 211
            G+ Y+H+    ++VHRD+K  NILL   +++ + KI DFGLS  F +N         GT
Sbjct: 132 SGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRIGT 186

Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR--------TAVDFDVQLGEYHLVDKA 263
             Y+APE  + G    K DV+S GV+L  ++SG           +   V+ G+Y      
Sbjct: 187 AYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQ 245

Query: 264 WGMYNSKELMNLVDPML 280
           W    S +  +L+  ML
Sbjct: 246 WRTI-SDDAKDLIRKML 261

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  109 bits (275), Expect = 1e-27
 Identities = 61/216 (28%), Positives = 97/216 (44%), Gaps = 26/216 (12%)

Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC-HEN 101
           F     +G G +G VYKGR ++ G + A+KV+ V     E+E   E+  +       H N
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKY--SHHRN 82

Query: 102 LVKLHGGCIDGPCRI------LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR 155
           +   +G  I            LV ++    S++  +   +    K  W A   I   I R
Sbjct: 83  IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREILR 140

Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR--VAGTLG 213
           GL+++H+     V+HRDIK  N+LL +N   K+ DFG+S    +    +  R    GT  
Sbjct: 141 GLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRTVGRRNTFIGTPY 194

Query: 214 YLAPEYAISGRLTR-----KSDVYSFGVLLLEIVSG 244
           ++APE              KSD++S G+  +E+  G
Sbjct: 195 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  108 bits (273), Expect = 2e-27
 Identities = 51/213 (23%), Positives = 89/213 (41%), Gaps = 16/213 (7%)

Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKE-FMSEVASMANVNVCHEN 101
           +     IG G    V           VA+K +++E  Q   +  + E+ +M+  +  H N
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH--HPN 74

Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR----GL 157
           +V  +   +      LV   +   S+   +     +            I  I R    GL
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134

Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS-KLFPENTTHISTR---VAGTLG 213
            Y+H+      +HRD+K  NILL ++ + +I+DFG+S  L        +       GT  
Sbjct: 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191

Query: 214 YLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGR 245
           ++APE     R    K+D++SFG+  +E+ +G 
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  109 bits (274), Expect = 2e-27
 Identities = 57/257 (22%), Positives = 95/257 (36%), Gaps = 55/257 (21%)

Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVL--------SVESKQGEKEFMSEVASMANVNVCHE 100
           +G G FG V+     +    V VK +                 +   E+A ++ V   H 
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE--HA 89

Query: 101 NLVKLHGGCIDGPCRI-LV----------YDYMPNNSLSQTLLGEEKRRAKFGWKARREI 149
           N++K+     +      LV          + ++         L E      F     R++
Sbjct: 90  NIIKVLD-IFENQGFFQLVMEKHGSGLDLFAFI----DRHPRLDEPLASYIF-----RQL 139

Query: 150 IMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVA 209
           +  +     Y+  +    ++HRDIK  NI++ ++F  K+ DFG +           T   
Sbjct: 140 VSAV----GYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG-KLFYT-FC 190

Query: 210 GTLGYLAPEYAISGRLTR--KSDVYSFGVLLLEIVSGRTAVDFD----VQLGEYHLVDKA 263
           GT+ Y APE  + G   R  + +++S GV L  +V       F           H     
Sbjct: 191 GTIEYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEE--NPFCELEETVEAAIHPPY-- 245

Query: 264 WGMYNSKELMNLVDPML 280
                SKELM+LV  +L
Sbjct: 246 ---LVSKELMSLVSGLL 259

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  110 bits (275), Expect = 2e-27
 Identities = 48/310 (15%), Positives = 100/310 (32%), Gaps = 39/310 (12%)

Query: 36  QLKIATNGFRWSNKIGEGGFGSVYKGR------LQDGTIVAVKVLSVESKQGEKEFMSEV 89
           + ++ +      + +GEG F  VY+         ++     +K   V+      EF    
Sbjct: 59  EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLK---VQKPANPWEFYIGT 115

Query: 90  ASMANVN-VCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTL-LGEEKRRAKFGWKARR 147
             M  +        +K +   +     +LV +     +L   + L +             
Sbjct: 116 QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175

Query: 148 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL-----------DQNFNPKISDFGLS-- 194
              M +   +  +H+     ++H DIK  N +L           D +    + D G S  
Sbjct: 176 SFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID 232

Query: 195 -KLFPENTTHISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDV 252
            KLFP+ T   +     T G+   E  +S +    + D +     +  ++ G        
Sbjct: 233 MKLFPKGTIFTA--KCETSGFQCVE-MLSNKPWNYQIDYFGVAATVYCMLFGTYM--KVK 287

Query: 253 QLGEYHLVDKAWGMYNSKELMN-LVDPML----YGNFPENEAIRFLKVGLLCVQEKSKLR 307
             G     +  +      ++ N     ML      + P  + +R     +      +K+R
Sbjct: 288 NEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIR 347

Query: 308 PQMSTAIKMM 317
              +  I ++
Sbjct: 348 ALRNRLIVLL 357

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  108 bits (271), Expect = 3e-27
 Identities = 47/209 (22%), Positives = 101/209 (48%), Gaps = 19/209 (9%)

Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENL 102
           +    ++G+G FG VYK +  + G + A KV+  +S++  ++++ E+  +A  +  H  +
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCD--HPYI 78

Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE 162
           VKL G         ++ ++ P  ++   ++ E  R           +   +   L ++H 
Sbjct: 79  VKLLGAYYHDGKLWIMIEFCPGGAVD-AIMLELDRGLTEPQIQV--VCRQMLEALNFLHS 135

Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR--VAGTLGYLAPEYA 220
           +    ++HRD+K  N+L+    + +++DFG+S    +N   +  R    GT  ++APE  
Sbjct: 136 K---RIIHRDLKAGNVLMTLEGDIRLADFGVSA---KNLKTLQKRDSFIGTPYWMAPEVV 189

Query: 221 ISGRLTR-----KSDVYSFGVLLLEIVSG 244
           +   +       K+D++S G+ L+E+   
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEMAQI 218

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  110 bits (277), Expect = 5e-27
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 29/215 (13%)

Query: 48  NKIGEGGFGSVYKGR-LQDGTIVAVKVLS-------------VESKQGEKEFMSEVASMA 93
            K+G G +G V   +     +  A+KV+                 ++  +E  +E++ + 
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101

Query: 94  NVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGI 153
           +++  H N++KL     D     LV ++     L + ++     R KF       I+  I
Sbjct: 102 SLD--HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQII----NRHKFDECDAANIMKQI 155

Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAG 210
             G+ Y+H+    ++VHRDIK  NILL   +   N KI DFGLS  F ++  +      G
Sbjct: 156 LSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD--YKLRDRLG 210

Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
           T  Y+APE  +  +   K DV+S GV++  ++ G 
Sbjct: 211 TAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGY 244

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  106 bits (267), Expect = 6e-27
 Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 29/208 (13%)

Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMS-EVASMANVNVCHENLVKLHG 107
           +GEG +G V           VAVK++ ++      E +  E+     +N  HEN+VK +G
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN--HENVVKFYG 72

Query: 108 GCIDGPCRI-LVYDYMPNNSL-----SQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
                     L  +Y     L         + E   +  F      +++ G+     Y+H
Sbjct: 73  -HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF-----HQLMAGV----VYLH 122

Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT--HISTRVAGTLGYLAPEY 219
                 + HRDIK  N+LLD+  N KISDFGL+ +F  N     ++    GTL Y+APE 
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPE- 177

Query: 220 AISGRL--TRKSDVYSFGVLLLEIVSGR 245
            +  R       DV+S G++L  +++G 
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  107 bits (269), Expect = 7e-27
 Identities = 56/245 (22%), Positives = 103/245 (42%), Gaps = 30/245 (12%)

Query: 9   SFPSRVSAENTIGGEQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGR-LQDGT 67
               + +   TIGG++             +   N      ++G G  G V+K R  + G 
Sbjct: 4   GSSGKQTGYLTIGGQR------------YQAEINDLENLGEMGSGTCGQVWKMRFRKTGH 51

Query: 68  IVAVKVLSVESKQGE-KEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNS 126
           ++AVK +     + E K  + ++  +   +     +V+  G  I      +  + M    
Sbjct: 52  VIAVKQMRRSGNKEENKRILMDLDVVLK-SHDCPYIVQCFGTFITNTDVFIAMELM-GTC 109

Query: 127 LSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP 186
             +      + +     +   ++ + I + L Y+ E+    V+HRD+K SNILLD+    
Sbjct: 110 AEKLKK---RMQGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGQI 164

Query: 187 KISDFGLS-KLFPENTTHISTRVAGTLGYLAPE-----YAISGRLTRKSDVYSFGVLLLE 240
           K+ DFG+S +L          R AG   Y+APE              ++DV+S G+ L+E
Sbjct: 165 KLCDFGISGRLV---DDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVE 221

Query: 241 IVSGR 245
           + +G+
Sbjct: 222 LATGQ 226

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  106 bits (267), Expect = 8e-27
 Identities = 72/252 (28%), Positives = 113/252 (44%), Gaps = 39/252 (15%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCHENLVK 104
            +G+G FG V K +        AVKV++    ++K      + EV  +  ++  H N++K
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST-ILREVELLKKLD--HPNIMK 85

Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEE-----KRRAKFGWKARREIIMGIGRGLAY 159
           L     D     +V +            G E      +R +F       II  +  G+ Y
Sbjct: 86  LFEILEDSSSFYIVGELYT---------GGELFDEIIKRKRFSEHDAARIIKQVFSGITY 136

Query: 160 IHEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLA 216
           +H+    ++VHRD+K  NILL   +++ + KI DFGLS  F +NT        GT  Y+A
Sbjct: 137 MHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAYYIA 191

Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVSG------RTAVD-FD-VQLGEYHLVDKAWGMYN 268
           PE  + G    K DV+S GV+L  ++SG      +   D    V+ G+Y      W    
Sbjct: 192 PE-VLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTI- 249

Query: 269 SKELMNLVDPML 280
           S +  +L+  ML
Sbjct: 250 SDDAKDLIRKML 261

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  106 bits (267), Expect = 8e-27
 Identities = 53/249 (21%), Positives = 94/249 (37%), Gaps = 35/249 (14%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
            IG G +G V            A K +     +    F  E+  M +++  H N+++L+ 
Sbjct: 16  TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD--HPNIIRLYE 73

Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEE-----KRRAKFGWKARREIIMGIGRGLAYIHE 162
              D     LV +            G E       +  F       I+  +   +AY H+
Sbjct: 74  TFEDNTDIYLVMELCT---------GGELFERVVHKRVFRESDAARIMKDVLSAVAYCHK 124

Query: 163 EIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEY 219
               +V HRD+K  N L      +   K+ DFGL+  F            GT  Y++P+ 
Sbjct: 125 L---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--RTKVGTPYYVSPQ- 178

Query: 220 AISGRLTRKSDVYSFGVLLLEIVSG------RTAVD-FD-VQLGEYHLVDKAWGMYNSKE 271
            + G    + D +S GV++  ++ G       T  +    ++ G +   +K W    S +
Sbjct: 179 VLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNV-SPQ 237

Query: 272 LMNLVDPML 280
             +L+  +L
Sbjct: 238 AESLIRRLL 246

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  106 bits (268), Expect = 8e-27
 Identities = 50/210 (23%), Positives = 85/210 (40%), Gaps = 34/210 (16%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLS---------VESKQGEKEFMSEVASMANVNVC 98
            +G G    V +          AVK++           E ++  +  + EV  +  V+  
Sbjct: 24  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG- 82

Query: 99  HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGE--EK--RRAKFGWKARREIIMGIG 154
           H N+++L           LV+D M          GE  +    +     K  R+I+  + 
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKK--------GELFDYLTEKVTLSEKETRKIMRALL 134

Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY 214
             +  +H+    ++VHRD+K  NILLD + N K++DFG S         +     GT  Y
Sbjct: 135 EVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-LREVC-GTPSY 189

Query: 215 LAPE------YAISGRLTRKSDVYSFGVLL 238
           LAPE              ++ D++S GV++
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  106 bits (267), Expect = 1e-26
 Identities = 50/199 (25%), Positives = 81/199 (40%), Gaps = 26/199 (13%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
            +G G F  V+  +    G + A+K +       +    +E+A +  +   HEN+V L  
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIK--HENIVTLED 73

Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEE-----KRRAKFGWKARREIIMGIGRGLAYIHE 162
                    LV   +          G E       R  +  K    +I  +   + Y+HE
Sbjct: 74  IYESTTHYYLVMQLVS---------GGELFDRILERGVYTEKDASLVIQQVLSAVKYLHE 124

Query: 163 EIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEY 219
                +VHRD+K  N+L    ++N    I+DFGLSK+         +   GT GY+APE 
Sbjct: 125 N---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM---STACGTPGYVAPEV 178

Query: 220 AISGRLTRKSDVYSFGVLL 238
                 ++  D +S GV+ 
Sbjct: 179 LAQKPYSKAVDCWSIGVIT 197

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  106 bits (267), Expect = 1e-26
 Identities = 58/202 (28%), Positives = 98/202 (48%), Gaps = 12/202 (5%)

Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENL 102
           F    K+GEG +GSVYK    + G IVA+K + VES    +E + E++ M   +    ++
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCD--SPHV 86

Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE 162
           VK +G         +V +Y    S+S  ++    +       A   I+    +GL Y+H 
Sbjct: 87  VKYYGSYFKNTDLWIVMEYCGAGSVS-DIIRLRNKTLTEDEIAT--ILQSTLKGLEYLHF 143

Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS 222
                 +HRDIK  NILL+   + K++DFG++    +     +T + GT  ++APE    
Sbjct: 144 M---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQE 199

Query: 223 GRLTRKSDVYSFGVLLLEIVSG 244
                 +D++S G+  +E+  G
Sbjct: 200 IGYNCVADIWSLGITAIEMAEG 221

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  106 bits (267), Expect = 2e-26
 Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 29/208 (13%)

Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMS-EVASMANVNVCHENLVKLHG 107
           +GEG +G V           VAVK++ ++      E +  E+     +N  HEN+VK +G
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN--HENVVKFYG 72

Query: 108 GCIDGPCRI-LVYDYMPNNSL-----SQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
                     L  +Y     L         + E   +  F      +++ G+     Y+H
Sbjct: 73  -HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF-----HQLMAGV----VYLH 122

Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT--HISTRVAGTLGYLAPEY 219
                 + HRDIK  N+LLD+  N KISDFGL+ +F  N     ++    GTL Y+APE 
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPE- 177

Query: 220 AISGRL--TRKSDVYSFGVLLLEIVSGR 245
            +  R       DV+S G++L  +++G 
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  106 bits (266), Expect = 2e-26
 Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 24/212 (11%)

Query: 48  NKIGEGGFGSVYKGR-LQDGTIVAVKVLSVES-KQGEKEFMS----EVASMANVNVC-HE 100
            +IG G +G+VYK R    G  VA+K + V +   G          EVA +  +    H 
Sbjct: 15  AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHP 74

Query: 101 NLVKL----HGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR 155
           N+V+L         D   ++ LV++++  + L   L  ++        +  ++++    R
Sbjct: 75  NVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYL--DKAPPPGLPAETIKDLMRQFLR 131

Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PENTTHISTRVAGTLG 213
           GL ++H      +VHRD+K  NIL+      K++DFGL++++      T     V  TL 
Sbjct: 132 GLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP---VVV-TLW 184

Query: 214 YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
           Y APE  +        D++S G +  E+   +
Sbjct: 185 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  108 bits (271), Expect = 5e-26
 Identities = 68/221 (30%), Positives = 105/221 (47%), Gaps = 24/221 (10%)

Query: 36  QLKIATNGFRWSNKIGEGGFGSVYKGRLQD-GTIVAVKVLS---VESKQGEKEFMSEVAS 91
            + +  N F     IG GGFG VY  R  D G + A+K L    ++ KQGE   ++E   
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM 242

Query: 92  MANVN-VCHENLVKLHGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEK---RRAKFGWKAR 146
           ++ V+      +V +       P ++  + D M    L   L           +F + A 
Sbjct: 243 LSLVSTGDCPFIVCMSY-AFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAA- 299

Query: 147 REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIST 206
            EII+G    L ++H      VV+RD+K +NILLD++ + +ISD GL+  F +   H   
Sbjct: 300 -EIILG----LEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--A 349

Query: 207 RVAGTLGYLAPEYAISGRLTRKS-DVYSFGVLLLEIVSGRT 246
            V GT GY+APE    G     S D +S G +L +++ G +
Sbjct: 350 SV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  106 bits (266), Expect = 6e-26
 Identities = 62/260 (23%), Positives = 108/260 (41%), Gaps = 45/260 (17%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLS--------VESKQGEKEFMSEVASMANVNVCH 99
            +G G  G V      +    VA++++S                   +E+  +  +N  H
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN--H 199

Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGE--EK--RRAKFGWKARREIIMGIGR 155
             ++K+     D     +V + M          GE  +K     +      +     +  
Sbjct: 200 PCIIKIKN-FFDAEDYYIVLELMEG--------GELFDKVVGNKRLKEATCKLYFYQMLL 250

Query: 156 GLAYIHEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTL 212
            + Y+HE     ++HRD+K  N+LL   +++   KI+DFG SK+  E +  + T   GT 
Sbjct: 251 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLC-GTP 305

Query: 213 GYLAPE---YAISGRLTRKSDVYSFGVLLLEIVSG-------RTAVD-FD-VQLGEYHLV 260
            YLAPE      +    R  D +S GV+L   +SG       RT V   D +  G+Y+ +
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 365

Query: 261 DKAWGMYNSKELMNLVDPML 280
            + W    S++ ++LV  +L
Sbjct: 366 PEVWA-EVSEKALDLVKKLL 384

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  104 bits (262), Expect = 7e-26
 Identities = 55/269 (20%), Positives = 92/269 (34%), Gaps = 71/269 (26%)

Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +GEG +G V +    +     AVK+L          GE     E+  +  +   H+N+++
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR--HKNVIQ 70

Query: 105 LH-------------------GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKA 145
           L                     G  +      + D +P            +    F    
Sbjct: 71  LVDVLYNEEKQKMYMVMEYCVCGMQE------MLDSVPEKRFP-----VCQAHGYF---- 115

Query: 146 RREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT-HI 204
             ++I G+     Y+H      +VH+DIK  N+LL      KIS  G+++          
Sbjct: 116 -CQLIDGL----EYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDT 167

Query: 205 STRVAGTLGYLAPEYAISGRLT---RKSDVYSFGVLLLEIVSGRTAVDFD---------- 251
                G+  +  PE   +G  T    K D++S GV L  I +G     F+          
Sbjct: 168 CRTSQGSPAFQPPE-IANGLDTFSGFKVDIWSAGVTLYNITTGL--YPFEGDNIYKLFEN 224

Query: 252 VQLGEYHLVDKAWGMYNSKELMNLVDPML 280
           +  G Y +            L +L+  ML
Sbjct: 225 IGKGSYAIPG-----DCGPPLSDLLKGML 248

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  104 bits (262), Expect = 8e-26
 Identities = 53/194 (27%), Positives = 85/194 (43%), Gaps = 16/194 (8%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
            +GEG F    K    +     AVK++S   K+ E     E+ ++      H N+VKLH 
Sbjct: 18  PLGEGSFSICRKCVHKKSNQAFAVKIIS---KRMEANTQKEITALKLCE-GHPNIVKLHE 73

Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
              D     LV + +    L + +     ++  F       I+  +   ++++H+     
Sbjct: 74  VFHDQLHTFLVMELLNGGELFERIK----KKKHFSETEASYIMRKLVSAVSHMHDV---G 126

Query: 168 VVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
           VVHRD+K  N+L    + N   KI DFG ++L P +   + T    TL Y APE      
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELLNQNG 185

Query: 225 LTRKSDVYSFGVLL 238
                D++S GV+L
Sbjct: 186 YDESCDLWSLGVIL 199

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  105 bits (263), Expect = 8e-26
 Identities = 42/199 (21%), Positives = 79/199 (39%), Gaps = 15/199 (7%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKV-----LSVESKQGEKEFMSEVASMANVNVCHENL 102
            IG+G F  V +    + G   AVK+      +       ++   E +    +   H ++
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK--HPHI 88

Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE 162
           V+L           +V+++M    L   ++        +        +  I   L Y H+
Sbjct: 89  VELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148

Query: 163 EIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEY 219
               +++HRD+K   +LL   + +   K+  FG++    E+      RV GT  ++APE 
Sbjct: 149 N---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMAPEV 204

Query: 220 AISGRLTRKSDVYSFGVLL 238
                  +  DV+  GV+L
Sbjct: 205 VKREPYGKPVDVWGCGVIL 223

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  103 bits (259), Expect = 1e-25
 Identities = 70/253 (27%), Positives = 118/253 (46%), Gaps = 47/253 (18%)

Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCHENLVKL 105
           +G G FG V  G     G  VAVK+L+   + S     +   E+ ++      H +++KL
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR--HPHIIKL 76

Query: 106 HGGCIDGPCRI-LVYDYMPNNSLSQTL-----LGEEKRRAKFGWKARREIIMGIGRGLAY 159
           +   I  P    +V +Y+    L   +     + E + R  F     ++I+  +     Y
Sbjct: 77  YQ-VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLF-----QQILSAV----DY 126

Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEY 219
            H   +  VVHRD+K  N+LLD + N KI+DFGLS +  +    + T   G+  Y APE 
Sbjct: 127 CH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRT-SCGSPNYAAPE- 180

Query: 220 AISGRL--TRKSDVYSFGVLLLEIVSGRTAVDFD----------VQLGEYHLVDKAWGMY 267
            ISGRL    + D++S GV+L  ++ G   + FD          ++ G +++ +     Y
Sbjct: 181 VISGRLYAGPEVDIWSCGVILYALLCGT--LPFDDEHVPTLFKKIRGGVFYIPE-----Y 233

Query: 268 NSKELMNLVDPML 280
            ++ +  L+  ML
Sbjct: 234 LNRSVATLLMHML 246

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  106 bits (266), Expect = 2e-25
 Identities = 52/217 (23%), Positives = 97/217 (44%), Gaps = 20/217 (9%)

Query: 38  KIATNGFRWSNKIGEGGFGSVYKGRLQD-GTIVAVKVLS---VESKQGEKEFMSEVASMA 93
            +  + F     +G GGFG V+  +++  G + A K L+   ++ ++G +  M E   +A
Sbjct: 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA 240

Query: 94  NVNVCHENLVKLHGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARR----E 148
            V+     +V L     +    + LV   M    +   +   ++    F          +
Sbjct: 241 KVH--SRFIVSLAY-AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ 297

Query: 149 IIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRV 208
           I+ G    L ++H+    ++++RD+K  N+LLD + N +ISD GL+       T      
Sbjct: 298 IVSG----LEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA 350

Query: 209 AGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
            GT G++APE  +        D ++ GV L E+++ R
Sbjct: 351 -GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  103 bits (258), Expect = 2e-25
 Identities = 58/213 (27%), Positives = 108/213 (50%), Gaps = 37/213 (17%)

Query: 48  NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMS-----EVASMANVNVCHENL 102
            K+GEG +G VYK +   G IVA+K + +++   E E +      E++ +  ++  H N+
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRIRLDA---EDEGIPSTAIREISLLKELH--HPNI 81

Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE 162
           V L        C  LV+++M  + L + L   ++ +        +  +  + RG+A+ H+
Sbjct: 82  VSLIDVIHSERCLTLVFEFMEKD-LKKVL---DENKTGLQDSQIKIYLYQLLRGVAHCHQ 137

Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PENT-THISTRVAGTLGYLAPE- 218
                ++HRD+K  N+L++ +   K++DFGL++ F  P  + TH    V  TL Y AP+ 
Sbjct: 138 H---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH---EVV-TLWYRAPDV 190

Query: 219 ------YAISGRLTRKSDVYSFGVLLLEIVSGR 245
                 Y+ S       D++S G +  E+++G+
Sbjct: 191 LMGSKKYSTS------VDIWSIGCIFAEMITGK 217

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  103 bits (259), Expect = 3e-25
 Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 23/209 (11%)

Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGE---KEFMSEVASMANVNVCH 99
           F    +IG G FG+VY  R +++  +VA+K +S   KQ     ++ + EV  +  +   H
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR--H 113

Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
            N ++  G  +      LV +Y   ++    LL   K+  +    A   +  G  +GLAY
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYCLGSAS--DLLEVHKKPLQEVEIAA--VTHGALQGLAY 169

Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS-KLFPENTTHISTRVAGTLGYLAPE 218
           +H     +++HRD+K  NILL +    K+ DFG +  + P N+        GT  ++APE
Sbjct: 170 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS------FVGTPYWMAPE 220

Query: 219 YAISGRLTR---KSDVYSFGVLLLEIVSG 244
             ++    +   K DV+S G+  +E+   
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAER 249

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  102 bits (257), Expect = 3e-25
 Identities = 48/207 (23%), Positives = 90/207 (43%), Gaps = 24/207 (11%)

Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +GEG F +V   R        A+K+L     ++  +       E   M+ ++  H   VK
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLD--HPFFVK 94

Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKR----RAKFGWKARREIIMGIGRGLAYI 160
           L+    D         Y  N  L    + +         +F + A  EI+  +     Y+
Sbjct: 95  LYFTFQDDEKLYFGLSYAKNGEL-LKYIRKIGSFDETCTRF-YTA--EIVSALE----YL 146

Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR-VAGTLGYLAPEY 219
           H +    ++HRD+K  NILL+++ + +I+DFG +K+    +         GT  Y++PE 
Sbjct: 147 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 203

Query: 220 AISGRLTRKSDVYSFGVLLLEIVSGRT 246
                  + SD+++ G ++ ++V+G  
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLP 230

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  105 bits (263), Expect = 5e-25
 Identities = 78/274 (28%), Positives = 120/274 (43%), Gaps = 40/274 (14%)

Query: 38  KIATNGFRWSNKIGEGGFGSVYKGRLQD-GTIVAVKVLS---VESKQGEKEFMSEVASMA 93
            +  N FR    +G+GGFG V   +++  G + A K L    ++ ++GE   ++E   + 
Sbjct: 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILE 239

Query: 94  NVNVCHENLVKLHGGCIDGPCRI-LVYDYMPNNSL-------SQTLLGEEKRRAKFGWKA 145
            VN     +V L     +    + LV   M    L        Q    E   RA F + A
Sbjct: 240 KVN--SRFVVSLAY-AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA--RAVF-YAA 293

Query: 146 RREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS 205
             EI  G    L  +H E    +V+RD+K  NILLD + + +ISD GL+   PE  T I 
Sbjct: 294 --EICCG----LEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IK 343

Query: 206 TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG 265
            RV GT+GY+APE   + R T   D ++ G LL E+++G++   F  +  +    ++   
Sbjct: 344 GRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP--FQQR-KKKIKREE--- 396

Query: 266 MYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLC 299
           +           P  Y      +A       LLC
Sbjct: 397 VERLV----KEVPEEYSERFSPQARSLCS-QLLC 425

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  103 bits (258), Expect = 5e-25
 Identities = 51/180 (28%), Positives = 87/180 (48%), Gaps = 22/180 (12%)

Query: 48  NKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKE---FMS--EVASMANVNVCHEN 101
           + +GEG F +VYK R      IVA+K + +  +   K+     +  E+  +  ++  H N
Sbjct: 16  DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS--HPN 73

Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
           ++ L           LV+D+M  + L   +   +           +  ++   +GL Y+H
Sbjct: 74  IIGLLDAFGHKSNISLVFDFMETD-LEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLH 129

Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PENT-THISTRVAGTLGYLAPE 218
           +     ++HRD+K +N+LLD+N   K++DFGL+K F  P    TH   +V  T  Y APE
Sbjct: 130 QH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH---QVV-TRWYRAPE 182

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  102 bits (257), Expect = 5e-25
 Identities = 57/213 (26%), Positives = 103/213 (48%), Gaps = 28/213 (13%)

Query: 48  NKIGEGGFGSVYKGR--LQDGTIVAVKVLSVESKQGEKEFMS-----EVASMANVNVC-H 99
            +IGEG +G V+K R     G  VA+K + V++    +E M      EVA + ++    H
Sbjct: 17  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT---GEEGMPLSTIREVAVLRHLETFEH 73

Query: 100 ENLVKL----HGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIG 154
            N+V+L         D   ++ LV++++ +  L+  L  ++        +  ++++  + 
Sbjct: 74  PNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL--DKVPEPGVPTETIKDMMFQLL 130

Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PENTTHISTRVAGTL 212
           RGL ++H      VVHRD+K  NIL+  +   K++DFGL++++      T     V  TL
Sbjct: 131 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS---VVV-TL 183

Query: 213 GYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
            Y APE  +        D++S G +  E+   +
Sbjct: 184 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  102 bits (257), Expect = 6e-25
 Identities = 50/209 (23%), Positives = 82/209 (39%), Gaps = 33/209 (15%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLS--------VESKQGEKEFMSEVASMANVNVCH 99
            IG G    V +      G   AVK++          + ++  +    E   +  V   H
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAG-H 159

Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGE--EK--RRAKFGWKARREIIMGIGR 155
            +++ L           LV+D M          GE  +    +     K  R I+  +  
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRK--------GELFDYLTEKVALSEKETRSIMRSLLE 211

Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
            ++++H     ++VHRD+K  NILLD N   ++SDFG S         +     GT GYL
Sbjct: 212 AVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK-LRELC-GTPGYL 266

Query: 216 APE------YAISGRLTRKSDVYSFGVLL 238
           APE              ++ D+++ GV+L
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACGVIL 295

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  101 bits (255), Expect = 6e-25
 Identities = 61/260 (23%), Positives = 105/260 (40%), Gaps = 45/260 (17%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLS--------VESKQGEKEFMSEVASMANVNVCH 99
            +G G  G V      +    VA+K++S                   +E+  +  +N  H
Sbjct: 17  TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN--H 74

Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGE--EK--RRAKFGWKARREIIMGIGR 155
             ++K+     D     +V + M          GE  +K     +      +     +  
Sbjct: 75  PCIIKIKN-FFDAEDYYIVLELMEG--------GELFDKVVGNKRLKEATCKLYFYQMLL 125

Query: 156 GLAYIHEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTL 212
            + Y+HE     ++HRD+K  N+LL   +++   KI+DFG SK+  E +  + T   GT 
Sbjct: 126 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLC-GTP 180

Query: 213 GYLAPE---YAISGRLTRKSDVYSFGVLLLEIVSGRT---AVDFDVQL------GEYHLV 260
            YLAPE      +    R  D +S GV+L   +SG          V L      G+Y+ +
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 240

Query: 261 DKAWGMYNSKELMNLVDPML 280
            + W    S++ ++LV  +L
Sbjct: 241 PEVWA-EVSEKALDLVKKLL 259

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  103 bits (258), Expect = 7e-25
 Identities = 65/263 (24%), Positives = 111/263 (42%), Gaps = 44/263 (16%)

Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           IG+G FG V   +  D   + A+K ++    VE  +       E+  M  +   H  LV 
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVR-NVFKELQIMQGLE--HPFLVN 79

Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKR----RAKFGWKARREIIMGIGRGLAYI 160
           L     D     +V D +    L +  L +         K  +    E++M     L Y+
Sbjct: 80  LWYSFQDEEDMFMVVDLLLGGDL-RYHLQQNVHFKEETVKL-FIC--ELVMA----LDYL 131

Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
             +    ++HRD+K  NILLD++ +  I+DF ++ + P  T   +  +AGT  Y+APE  
Sbjct: 132 QNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPEMF 186

Query: 221 ISGRL---TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMN--L 275
            S +    +   D +S GV   E++ GR    + ++              +SKE+++   
Sbjct: 187 SSRKGAGYSFAVDWWSLGVTAYELLRGRRP--YHIRSST-----------SSKEIVHTFE 233

Query: 276 VDPMLYGNFPENEAIRFLKVGLL 298
              + Y +    E +  LK  LL
Sbjct: 234 TTVVTYPSAWSQEMVSLLK-KLL 255

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  101 bits (254), Expect = 1e-24
 Identities = 52/181 (28%), Positives = 89/181 (49%), Gaps = 23/181 (12%)

Query: 48  NKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMS----EVASMANVNVCHENL 102
            K+G G + +VYKG     G  VA+K + ++S++G     S    E++ M  +   HEN+
Sbjct: 11  EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG---TPSTAIREISLMKELK--HENI 65

Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTL--LGEEKRRAKFGWKARREIIMGIGRGLAYI 160
           V+L+          LV+++M N+ L + +                 +     + +GLA+ 
Sbjct: 66  VRLYDVIHTENKLTLVFEFMDND-LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124

Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PENT-THISTRVAGTLGYLAP 217
           HE     ++HRD+K  N+L+++    K+ DFGL++ F  P NT +     V  TL Y AP
Sbjct: 125 HEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS---EVV-TLWYRAP 177

Query: 218 E 218
           +
Sbjct: 178 D 178

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  100 bits (251), Expect = 1e-24
 Identities = 44/180 (24%), Positives = 87/180 (48%), Gaps = 25/180 (13%)

Query: 48  NKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMS-----EVASMANVNVCHEN 101
            KIGEG +G+V+K +  +   IVA+K + ++    + E +      E+  +  +   H+N
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDD---DDEGVPSSALREICLLKELK--HKN 62

Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
           +V+LH          LV+++   + L +     +        +  +  +  + +GL + H
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFCDQD-LKKYF---DSCNGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PENT-THISTRVAGTLGYLAPE 218
                +V+HRD+K  N+L+++N   K+++FGL++ F  P    +     V  TL Y  P+
Sbjct: 119 SR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA---EVV-TLWYRPPD 171

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  100 bits (251), Expect = 2e-24
 Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 37/213 (17%)

Query: 48  NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMS-----EVASMANVNVCHENL 102
            KIGEG +G VYK +   G   A+K + +E    E E +      E++ +  +   H N+
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEK---EDEGIPSTTIREISILKELK--HSNI 62

Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE 162
           VKL+         +LV++++  + L + L   +           +  ++ +  G+AY H+
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQD-LKKLL---DVCEGGLESVTAKSFLLQLLNGIAYCHD 118

Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PENT-THISTRVAGTLGYLAPE- 218
                V+HRD+K  N+L+++    KI+DFGL++ F  P    TH    +  TL Y AP+ 
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH---EIV-TLWYRAPDV 171

Query: 219 ------YAISGRLTRKSDVYSFGVLLLEIVSGR 245
                 Y+ +       D++S G +  E+V+G 
Sbjct: 172 LMGSKKYSTT------IDIWSVGCIFAEMVNGT 198

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  100 bits (252), Expect = 3e-24
 Identities = 73/323 (22%), Positives = 125/323 (38%), Gaps = 54/323 (16%)

Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG 108
           IG G FG     R      +VAVK +   +   E     E+ +  ++   H N+V+    
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN-VQREIINHRSLR--HPNIVRFKE- 83

Query: 109 CIDGPCRI-LVYDYMPNNSLSQTL-----LGEEKRRAKFGWKARREIIMGIGRGLAYIHE 162
            I  P  + ++ +Y     L + +       E++ R  F     ++++ G+    +Y H 
Sbjct: 84  VILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFF-----QQLLSGV----SYCHS 134

Query: 163 EIQPHVVHRDIKTSNILLDQNFNP--KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
                + HRD+K  N LLD +  P  KI DFG SK    + +   + V GT  Y+APE  
Sbjct: 135 M---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTV-GTPAYIAPE-V 188

Query: 221 ISGRL--TRKSDVYSFGVLLLEIVSGR-------TAVDF-----DVQLGEYHLVDKAWGM 266
           +  +    + +DV+S GV L  ++ G           D+      +   +Y + D     
Sbjct: 189 LLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIR-- 246

Query: 267 YNSKELMNLVDPMLYGNFPEN----EAIR----FLKVGLLCVQEKSKLRPQMSTAIKMMN 318
             S E  +L+  +   + P        I+    FLK     +  +S    Q     + M 
Sbjct: 247 -ISPECCHLISRIFVAD-PATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQ 304

Query: 319 GETNIDGXDVEISQPGLIGDIMD 341
               I     E + P +    +D
Sbjct: 305 SLDTIMQIISEATIPAVRNRCLD 327

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  100 bits (251), Expect = 3e-24
 Identities = 52/175 (29%), Positives = 82/175 (46%), Gaps = 15/175 (8%)

Query: 48  NKIGEGGFGSVYKGR-LQDGTIVAVK--VLSVESKQGEKEFMSEVASMANVNVCHENLVK 104
             +GEG +G V K R    G IVA+K  + S + K  +K  M E+  +  +   HENLV 
Sbjct: 31  GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR--HENLVN 88

Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGE-EKRRAKFGWKARREIIMGIGRGLAYIHEE 163
           L   C       LV++++       T+L + E       ++  ++ +  I  G+ + H  
Sbjct: 89  LLEVCKKKKRWYLVFEFV-----DHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH 143

Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE 218
              +++HRDIK  NIL+ Q+   K+ DFG ++            VA T  Y APE
Sbjct: 144 ---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRAPE 194

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =   99 bits (250), Expect = 4e-24
 Identities = 48/175 (27%), Positives = 81/175 (46%), Gaps = 15/175 (8%)

Query: 48  NKIGEGGFGSVYKGR-LQDGTIVAVK--VLSVESKQGEKEFMSEVASMANVNVCHENLVK 104
            KIGEG +G V+K R    G IVA+K  + S +    +K  + E+  +  +   H NLV 
Sbjct: 9   GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK--HPNLVN 66

Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGE-EKRRAKFGWKARREIIMGIGRGLAYIHEE 163
           L           LV++Y        T+L E ++ +        + I     + + + H+ 
Sbjct: 67  LLEVFRRKRRLHLVFEYC-----DHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH 121

Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE 218
              + +HRD+K  NIL+ ++   K+ DFG ++L    + +    VA T  Y +PE
Sbjct: 122 ---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPE 172

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  100 bits (250), Expect = 4e-24
 Identities = 71/257 (27%), Positives = 118/257 (45%), Gaps = 56/257 (21%)

Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +GEG FG V      +    VA+K +S     +S    +    E++ +  +   H +++K
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE-REISYLKLLR--HPHIIK 73

Query: 105 LHGGCIDGPCRI-LV--------YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR 155
           L+   I  P  I +V        +DY+    + +  + E++ R  F     ++II  I  
Sbjct: 74  LYD-VITTPTDIVMVIEYAGGELFDYI----VEKKRMTEDEGRRFF-----QQIICAI-- 121

Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
              Y H   +  +VHRD+K  N+LLD N N KI+DFGLS +  +    + T   G+  Y 
Sbjct: 122 --EYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-NFLKT-SCGSPNYA 174

Query: 216 APEYAISGRL--TRKSDVYSFGVLLLEIVSGRTAVDFD----------VQLGEYHLVDKA 263
           APE  I+G+L    + DV+S G++L  ++ GR  + FD          V    Y + D  
Sbjct: 175 APE-VINGKLYAGPEVDVWSCGIVLYVMLVGR--LPFDDEFIPNLFKKVNSCVYVMPD-- 229

Query: 264 WGMYNSKELMNLVDPML 280
              + S    +L+  M+
Sbjct: 230 ---FLSPGAQSLIRRMI 243

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 99.7 bits (249), Expect = 4e-24
 Identities = 48/205 (23%), Positives = 78/205 (38%), Gaps = 25/205 (12%)

Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG 108
           +GEG    V     L      AVK++  +          EV  +      H N+++L   
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQ-GHRNVLELIEF 79

Query: 109 CIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHV 168
             +     LV++ M   S+    L    +R  F       ++  +   L ++H      +
Sbjct: 80  FEEEDRFYLVFEKMRGGSI----LSHIHKRRHFNELEASVVVQDVASALDFLHN---KGI 132

Query: 169 VHRDIKTSNILL---DQNFNPKISDFGLSKLFPEN-------TTHISTRVAGTLGYLAPE 218
            HRD+K  NIL    +Q    KI DF L      N       T  + T   G+  Y+APE
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GSAEYMAPE 191

Query: 219 -----YAISGRLTRKSDVYSFGVLL 238
                   +    ++ D++S GV+L
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVIL 216

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =   99 bits (249), Expect = 5e-24
 Identities = 60/289 (20%), Positives = 97/289 (33%), Gaps = 63/289 (21%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKV-----LSVESKQGEKEFMSEVASMANVNVCHENL 102
            IG+G +G V      Q   I A+K+     +   + +  +   +EV  M  ++  H N+
Sbjct: 33  AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH--HPNI 90

Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKAR---------------- 146
            +L+    D     LV +      L   L                               
Sbjct: 91  ARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150

Query: 147 --------------------REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL--DQNF 184
                                 I+  I   L Y+H +    + HRDIK  N L   +++F
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSF 207

Query: 185 NPKISDFGLSKLFPENTTHISTR---VAGTLGYLAPE--YAISGRLTRKSDVYSFGVLLL 239
             K+ DFGLSK F +            AGT  ++APE     +     K D +S GVLL 
Sbjct: 208 EIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLH 267

Query: 240 EIVSGR-------TAVDFD-VQLGEYHLVDKAWGMYNSKELMNLVDPML 280
            ++ G         A     V   +    +  + +  S    +L+  +L
Sbjct: 268 LLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVL-SPLARDLLSNLL 315

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  101 bits (253), Expect = 6e-24
 Identities = 73/253 (28%), Positives = 120/253 (47%), Gaps = 47/253 (18%)

Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCHENLVKL 105
           +G G FG V  G+    G  VAVK+L+   + S     +   E+ ++      H +++KL
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR--HPHIIKL 81

Query: 106 HGGCIDGPCRI-LVYDYMPNNSLSQTL-----LGEEKRRAKFGWKARREIIMGIGRGLAY 159
           +   I  P  I +V +Y+    L   +     L E++ R  F     ++I+ G+     Y
Sbjct: 82  YQ-VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLF-----QQILSGV----DY 131

Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEY 219
            H   +  VVHRD+K  N+LLD + N KI+DFGLS +  +    + T   G+  Y APE 
Sbjct: 132 CH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTSC-GSPNYAAPE- 185

Query: 220 AISGRL--TRKSDVYSFGVLLLEIVSGRTAVDFD----------VQLGEYHLVDKAWGMY 267
            ISGRL    + D++S GV+L  ++ G   + FD          +  G ++        Y
Sbjct: 186 VISGRLYAGPEVDIWSSGVILYALLCGT--LPFDDDHVPTLFKKICDGIFYTPQ-----Y 238

Query: 268 NSKELMNLVDPML 280
            +  +++L+  ML
Sbjct: 239 LNPSVISLLKHML 251

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  100 bits (250), Expect = 7e-24
 Identities = 43/199 (21%), Positives = 76/199 (38%), Gaps = 25/199 (12%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           ++G G FG V++      G +   K ++      +    +E++ M  ++  H  L+ LH 
Sbjct: 58  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH--HPKLINLHD 115

Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEE------KRRAKFGWKARREIIMGIGRGLAYIH 161
              D    +L+ +++          G E          K         +     GL ++H
Sbjct: 116 AFEDKYEMVLILEFLS---------GGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH 166

Query: 162 EEIQPHVVHRDIKTSNILLDQNFNP--KISDFGLSKLFPENTTHISTRVAGTLGYLAPEY 219
           E     +VH DIK  NI+ +       KI DFGL+     +          T  + APE 
Sbjct: 167 EH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV--KVTTATAEFAAPEI 221

Query: 220 AISGRLTRKSDVYSFGVLL 238
                +   +D+++ GVL 
Sbjct: 222 VDREPVGFYTDMWAIGVLG 240

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  100 bits (251), Expect = 8e-24
 Identities = 70/225 (31%), Positives = 104/225 (46%), Gaps = 59/225 (26%)

Query: 49  KIGEGGFGSVYKGRLQD-GTIVAVK-VLSVESKQGEKEFMS-EVASMANVNVCHENLVKL 105
            IG G FG VY+ +L D G +VA+K VL       +K F + E+  M  ++  H N+V+L
Sbjct: 61  VIGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLD--HCNIVRL 112

Query: 106 H------GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG------- 152
                  G   D     LV DY+P     +T+     R A+   +A++ + +        
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVP-----ETV----YRVARHYSRAKQTLPVIYVKLYMY 163

Query: 153 -IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLF---PENTTHISTR 207
            + R LAYIH      + HRDIK  N+LLD +    K+ DFG +K       N ++I +R
Sbjct: 164 QLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 220

Query: 208 VAGTLGYLAPE-------YAISGRLTRKSDVYSFGVLLLEIVSGR 245
                 Y APE       Y      T   DV+S G +L E++ G+
Sbjct: 221 Y-----YRAPELIFGATDY------TSSIDVWSAGCVLAELLLGQ 254

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 98.4 bits (246), Expect = 9e-24
 Identities = 50/200 (25%), Positives = 86/200 (43%), Gaps = 25/200 (12%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKL 105
           ++G+G F  V +      G   A K+++ +  S +  ++   E      +   H N+V+L
Sbjct: 13  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ--HPNIVRL 70

Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGE--EK--RRAKFGWKARREIIMGIGRGLAYIH 161
           H    +     LV+D +          GE  E    R  +        I  I   +AY H
Sbjct: 71  HDSIQEESFHYLVFDLVTG--------GELFEDIVAREFYSEADASHCIQQILESIAYCH 122

Query: 162 EEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE 218
                 +VHR++K  N+LL    +    K++DFGL+    ++        AGT GYL+PE
Sbjct: 123 SN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGFAGTPGYLSPE 177

Query: 219 YAISGRLTRKSDVYSFGVLL 238
                  ++  D+++ GV+L
Sbjct: 178 VLKKDPYSKPVDIWACGVIL 197

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  101 bits (252), Expect = 1e-23
 Identities = 55/243 (22%), Positives = 105/243 (43%), Gaps = 22/243 (9%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           ++G G FG V++      G   A K +    +  ++    E+ +M+ +   H  LV LH 
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR--HPTLVNLHD 221

Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
              D    +++Y++M    L + +  E     K       E +  + +GL ++HE    +
Sbjct: 222 AFEDDNEMVMIYEFMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---N 275

Query: 168 VVHRDIKTSNILLDQNFNP--KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL 225
            VH D+K  NI+     +   K+ DFGL+       +       GT  + APE A    +
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV--KVTTGTAEFAAPEVAEGKPV 333

Query: 226 TRKSDVYSFGVLLLEIVSG------RTAVD-FD-VQLGEYHLVDKAWGMYNSKELMNLVD 277
              +D++S GVL   ++SG          +    V+  ++++ D A+    S++  + + 
Sbjct: 334 GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF-SGISEDGKDFIR 392

Query: 278 PML 280
            +L
Sbjct: 393 KLL 395

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 98.9 bits (247), Expect = 1e-23
 Identities = 47/202 (23%), Positives = 79/202 (39%), Gaps = 26/202 (12%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKL 105
           ++G G F  V +      G   A K L      +    E + E+A +         ++ L
Sbjct: 36  ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK-SCPRVINL 94

Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGE------EKRRAKFGWKARREIIMGIGRGLAY 159
           H    +    IL+ +Y           GE       +            +I  I  G+ Y
Sbjct: 95  HEVYENTSEIILILEYAAG--------GEIFSLCLPELAEMVSENDVIRLIKQILEGVYY 146

Query: 160 IHEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLA 216
           +H+    ++VH D+K  NILL       + KI DFG+S+        +   + GT  YLA
Sbjct: 147 LHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIM-GTPEYLA 201

Query: 217 PEYAISGRLTRKSDVYSFGVLL 238
           PE      +T  +D+++ G++ 
Sbjct: 202 PEILNYDPITTATDMWNIGIIA 223

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 98.5 bits (246), Expect = 2e-23
 Identities = 55/202 (27%), Positives = 87/202 (43%), Gaps = 28/202 (13%)

Query: 47  SNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKL 105
              IG G +    +          AVK++  +SK+   E   E+  +      H N++ L
Sbjct: 27  KEDIGVGSYSVCKRCIHKATNMEFAVKIID-KSKRDPTE---EIEILLRY-GQHPNIITL 81

Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
                DG    +V + M    L   +L    R+  F  +    ++  I + + Y+H +  
Sbjct: 82  KDVYDDGKYVYVVTELMKGGELLDKIL----RQKFFSEREASAVLFTITKTVEYLHAQ-- 135

Query: 166 PHVVHRDIKTSNILL-DQNFNP---KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI 221
             VVHRD+K SNIL  D++ NP   +I DFG +K        + T    T  ++APE   
Sbjct: 136 -GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANFVAPEV-- 191

Query: 222 SGRLTRKS-----DVYSFGVLL 238
              L R+      D++S GVLL
Sbjct: 192 ---LERQGYDAACDIWSLGVLL 210

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 98.1 bits (245), Expect = 2e-23
 Identities = 51/183 (27%), Positives = 90/183 (49%), Gaps = 24/183 (13%)

Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEF----MSEVASMANVNVC 98
           +   +K+GEG + +VYKG+      +VA+K + +E ++G        + EV+ + ++   
Sbjct: 4   YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG---APCTAIREVSLLKDLK-- 58

Query: 99  HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
           H N+V LH          LV++Y+  + L Q L   +           +  +  + RGLA
Sbjct: 59  HANIVTLHDIIHTEKSLTLVFEYLDKD-LKQYL---DDCGNIINMHNVKLFLFQLLRGLA 114

Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PENT-THISTRVAGTLGYL 215
           Y H   +  V+HRD+K  N+L+++    K++DFGL++    P  T  +    V  TL Y 
Sbjct: 115 YCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN---EVV-TLWYR 167

Query: 216 APE 218
            P+
Sbjct: 168 PPD 170

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 98.6 bits (246), Expect = 2e-23
 Identities = 46/199 (23%), Positives = 85/199 (42%), Gaps = 25/199 (12%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
            +G G FG V+K      G  +A K++     + ++E  +E++ M  ++  H NL++L+ 
Sbjct: 96  ILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLD--HANLIQLYD 153

Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEE------KRRAKFGWKARREIIMGIGRGLAYIH 161
                   +LV +Y+          G E                    +  I  G+ ++H
Sbjct: 154 AFESKNDIVLVMEYVD---------GGELFDRIIDESYNLTELDTILFMKQICEGIRHMH 204

Query: 162 EEIQPHVVHRDIKTSNILLDQNFNP--KISDFGLSKLFPENTTHISTRVAGTLGYLAPEY 219
           +    +++H D+K  NIL         KI DFGL++ +      +     GT  +LAPE 
Sbjct: 205 QM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-LKVNF-GTPEFLAPEV 259

Query: 220 AISGRLTRKSDVYSFGVLL 238
                ++  +D++S GV+ 
Sbjct: 260 VNYDFVSFPTDMWSVGVIA 278

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 98.9 bits (247), Expect = 2e-23
 Identities = 64/218 (29%), Positives = 98/218 (44%), Gaps = 46/218 (21%)

Query: 49  KIGEGGFGSVYKGRLQDGTIVAVK-VLSVESKQGEKEFMS-EVASMANVNVCHENLVKLH 106
            IG G FG V++ +L +   VA+K VL       +K F + E+  M  V   H N+V L 
Sbjct: 47  VIGNGSFGVVFQAKLVESDEVAIKKVLQ------DKRFKNRELQIMRIVK--HPNVVDLK 98

Query: 107 ------GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG-------- 152
                 G   D     LV +Y+P     +T+     R ++   K ++ + M         
Sbjct: 99  AFFYSNGDKKDEVFLNLVLEYVP-----ETV----YRASRHYAKLKQTMPMLLIKLYMYQ 149

Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLF---PENTTHISTRV 208
           + R LAYIH      + HRDIK  N+LLD      K+ DFG +K+      N ++I +R 
Sbjct: 150 LLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY 206

Query: 209 AGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGR 245
                Y APE        T   D++S G ++ E++ G+
Sbjct: 207 -----YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 99.1 bits (247), Expect = 3e-23
 Identities = 66/225 (29%), Positives = 102/225 (45%), Gaps = 25/225 (11%)

Query: 35  NQLKIATNGFRWSNKIGEGGFGSVYKGRLQD-GTIVAVKVLSVES--KQGEKE-FMSEVA 90
            Q+++    F     IG G FG V   +L++   + A+K+L+     K+ E   F  E  
Sbjct: 67  KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERD 126

Query: 91  SMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKR----RAKFGWKAR 146
            + N +   + +  LH    D     LV DY     L   L   E R     A+F + A 
Sbjct: 127 VLVNGD--SKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARF-YLA- 182

Query: 147 REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIST 206
            E+++ I      +H+    H VHRDIK  NIL+D N + +++DFG      E+ T  S+
Sbjct: 183 -EMVIAID----SVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSS 234

Query: 207 RVAGTLGYLAPE-----YAISGRLTRKSDVYSFGVLLLEIVSGRT 246
              GT  Y++PE         GR   + D +S GV + E++ G T
Sbjct: 235 VAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 98.9 bits (247), Expect = 4e-23
 Identities = 45/201 (22%), Positives = 81/201 (40%), Gaps = 26/201 (12%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKL 105
           ++G+G F  V +   +  G   A  +++ +  S +  ++   E      +   H N+V+L
Sbjct: 18  ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLK--HPNIVRL 75

Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEE-----KRRAKFGWKARREIIMGIGRGLAYI 160
           H    +     L++D +          G E       R  +        I  I   + + 
Sbjct: 76  HDSISEEGHHYLIFDLVT---------GGELFEDIVAREYYSEADASHCIQQILEAVLHC 126

Query: 161 HEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
           H+     VVHR++K  N+LL    +    K++DFGL+               GT GYL+P
Sbjct: 127 HQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSP 182

Query: 218 EYAISGRLTRKSDVYSFGVLL 238
           E        +  D+++ GV+L
Sbjct: 183 EVLRKDPYGKPVDLWACGVIL 203

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 97.4 bits (243), Expect = 6e-23
 Identities = 49/201 (24%), Positives = 85/201 (42%), Gaps = 27/201 (13%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKL 105
           ++G+G F  V +      G   A K+++ +  S +  ++   E      +   H N+V+L
Sbjct: 36  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ--HPNIVRL 93

Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEE-----KRRAKFGWKARREIIMGIGRGLAYI 160
           H    +     LV+D +          G E       R  +        I  I   +AY 
Sbjct: 94  HDSIQEESFHYLVFDLVT---------GGELFEDIVAREFYSEADASHCIQQILESIAYC 144

Query: 161 HEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
           H      +VHR++K  N+LL    +    K++DFGL+    ++        AGT GYL+P
Sbjct: 145 HSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGFAGTPGYLSP 199

Query: 218 EYAISGRLTRKSDVYSFGVLL 238
           E       ++  D+++ GV+L
Sbjct: 200 EVLKKDPYSKPVDIWACGVIL 220

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 96.2 bits (240), Expect = 1e-22
 Identities = 47/185 (25%), Positives = 80/185 (43%), Gaps = 31/185 (16%)

Query: 48  NKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMS-----EVASMANVNVCHEN 101
            K+GEG +G VYK         VA+K + +E    E+E +      EV+ +  +   H N
Sbjct: 40  TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH---EEEGVPGTAIREVSLLKELQ--HRN 94

Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
           +++L           L+++Y  N+ L + +     +      +  +  +  +  G+ + H
Sbjct: 95  IIELKSVIHHNHRLHLIFEYAEND-LKKYM----DKNPDVSMRVIKSFLYQLINGVNFCH 149

Query: 162 EEIQPHVVHRDIKTSNILLDQNFNP-----KISDFGLSKLF--PENT-THISTRVAGTLG 213
                  +HRD+K  N+LL  +        KI DFGL++ F  P    TH    +  TL 
Sbjct: 150 ---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH---EII-TLW 202

Query: 214 YLAPE 218
           Y  PE
Sbjct: 203 YRPPE 207

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 96.1 bits (240), Expect = 1e-22
 Identities = 62/228 (27%), Positives = 104/228 (45%), Gaps = 54/228 (23%)

Query: 48  NKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKE---FMS--EVASMANVNVCHEN 101
            KIG+G FG V+K R  + G  VA+K + +E+   EKE     +  E+  +  +   HEN
Sbjct: 23  AKIGQGTFGEVFKARHRKTGQKVALKKVLMEN---EKEGFPITALREIKILQLLK--HEN 77

Query: 102 LVKLHGGCIDGPCRI--------LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGI 153
           +V L   C               LV+D+  ++ L+  L        KF     + ++  +
Sbjct: 78  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHD-LAGLL---SNVLVKFTLSEIKRVMQML 133

Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PENT-----THIST 206
             GL YIH      ++HRD+K +N+L+ ++   K++DFGL++ F   +N+     T+   
Sbjct: 134 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN--- 187

Query: 207 RVAGTLGYLAPE-------Y--AISGRLTRKSDVYSFGVLLLEIVSGR 245
           RV  TL Y  PE       Y   I        D++  G ++ E+ +  
Sbjct: 188 RVV-TLWYRPPELLLGERDYGPPI--------DLWGAGCIMAEMWTRS 226

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 95.5 bits (238), Expect = 3e-22
 Identities = 49/199 (24%), Positives = 82/199 (41%), Gaps = 27/199 (13%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           ++G G    VY+ +        A+KVL       +K   +E+  +  ++  H N++KL  
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLK--KTVDKKIVRTEIGVLLRLS--HPNIIKLKE 115

Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEE-----KRRAKFGWKARREIIMGIGRGLAYIHE 162
                    LV + +          G E       +  +  +   + +  I   +AY+HE
Sbjct: 116 IFETPTEISLVLELVT---------GGELFDRIVEKGYYSERDAADAVKQILEAVAYLHE 166

Query: 163 EIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEY 219
                +VHRD+K  N+L      +   KI+DFGLSK+           V GT GY APE 
Sbjct: 167 N---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM--KTVCGTPGYCAPEI 221

Query: 220 AISGRLTRKSDVYSFGVLL 238
                   + D++S G++ 
Sbjct: 222 LRGCAYGPEVDMWSVGIIT 240

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 95.1 bits (237), Expect = 3e-22
 Identities = 44/204 (21%), Positives = 84/204 (41%), Gaps = 34/204 (16%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
            +G G  G V +    + G   A+K+L         +   EV      +    ++V +  
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLY---DS--PKARQEVDHHWQASG-GPHIVCILD 89

Query: 108 GCIDG----PCRILVYDYMPNNSLSQTLLGE------EKRRAKFGWKARREIIMGIGRGL 157
              +      C +++ + M          GE      E+    F  +   EI+  IG  +
Sbjct: 90  VYENMHHGKRCLLIIMECMEG--------GELFSRIQERGDQAFTEREAAEIMRDIGTAI 141

Query: 158 AYIHEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY 214
            ++H     ++ HRD+K  N+L    +++   K++DFG +K   +N   + T    T  Y
Sbjct: 142 QFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPC-YTPYY 195

Query: 215 LAPEYAISGRLTRKSDVYSFGVLL 238
           +APE     +  +  D++S GV++
Sbjct: 196 VAPEVLGPEKYDKSCDMWSLGVIM 219

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 94.6 bits (236), Expect = 3e-22
 Identities = 47/205 (22%), Positives = 81/205 (39%), Gaps = 30/205 (14%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSV------ESKQGEKEFMSEVASMANVNVCHEN 101
           ++G G F  V K R    G   A K +              +E   EV+ +  V   H N
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL--HHN 76

Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGE--EK--RRAKFGWKARREIIMGIGRGL 157
           ++ LH    +    +L+ + +          GE  +   ++     +     I  I  G+
Sbjct: 77  VITLHDVYENRTDVVLILELVSG--------GELFDFLAQKESLSEEEATSFIKQILDGV 128

Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNP----KISDFGLSKLFPENTTHISTRVAGTLG 213
            Y+H +    + H D+K  NI+L     P    K+ DFGL+    +        + GT  
Sbjct: 129 NYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTPE 183

Query: 214 YLAPEYAISGRLTRKSDVYSFGVLL 238
           ++APE      L  ++D++S GV+ 
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVIT 208

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 95.0 bits (237), Expect = 3e-22
 Identities = 53/246 (21%), Positives = 101/246 (41%), Gaps = 39/246 (15%)

Query: 21  GGEQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQD-GTIVAVK-VLSVES 78
            G  +  N  A +  + +   + F+     G+G FG+V  G+ +  G  VA+K V+    
Sbjct: 2   PGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR 61

Query: 79  -KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR--------ILVYDYMPNNSLSQ 129
            +  E + M ++A +      H N+V+L                   +V +Y+P      
Sbjct: 62  FRNRELQIMQDLAVLH-----HPNIVQLQS-YFYTLGERDRRDIYLNVVMEYVP-----D 110

Query: 130 TLLGEEKRRAKFGWKARREIIMG--------IGRGLAYIHEEIQPHVVHRDIKTSNILLD 181
           TL     R  +  ++ +              + R +  +H     +V HRDIK  N+L++
Sbjct: 111 TL----HRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVN 165

Query: 182 -QNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLL 239
             +   K+ DFG +K    +  +++  +  +  Y APE     +  T   D++S G +  
Sbjct: 166 EADGTLKLCDFGSAKKLSPSEPNVAY-IC-SRYYRAPELIFGNQHYTTAVDIWSVGCIFA 223

Query: 240 EIVSGR 245
           E++ G 
Sbjct: 224 EMMLGE 229

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 94.6 bits (236), Expect = 3e-22
 Identities = 32/199 (16%), Positives = 71/199 (35%), Gaps = 26/199 (13%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
            +G G FG V++            K + V     +     E++ +      H N++ LH 
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIAR--HRNILHLHE 68

Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEE------KRRAKFGWKARREIIMGIGRGLAYIH 161
                   +++++++          G +          +   +     +  +   L ++H
Sbjct: 69  SFESMEELVMIFEFIS---------GLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119

Query: 162 EEIQPHVVHRDIKTSNILLDQNFNP--KISDFGLSKLFPENTTHISTRVAGTLGYLAPEY 219
                ++ H DI+  NI+     +   KI +FG ++            +     Y APE 
Sbjct: 120 SH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAPEV 174

Query: 220 AISGRLTRKSDVYSFGVLL 238
                ++  +D++S G L+
Sbjct: 175 HQHDVVSTATDMWSLGTLV 193

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 95.5 bits (238), Expect = 4e-22
 Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 26/209 (12%)

Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           IG G FG V   R +    + A+K+LS    ++       F  E   MA  N     +V+
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF-FWEERDIMAFAN--SPWVVQ 133

Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEK---RRAKFGWKARREIIMGIGRGLAYIH 161
           L     D     +V +YMP   L   L+       + A+F + A  E+++ +      IH
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARF-YTA--EVVLALD----AIH 185

Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE--- 218
                  +HRD+K  N+LLD++ + K++DFG      +          GT  Y++PE   
Sbjct: 186 SM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 242

Query: 219 -YAISGRLTRKSDVYSFGVLLLEIVSGRT 246
                G   R+ D +S GV L E++ G T
Sbjct: 243 SQGGDGYYGRECDWWSVGVFLYEMLVGDT 271

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 93.9 bits (234), Expect = 6e-22
 Identities = 47/206 (22%), Positives = 78/206 (37%), Gaps = 32/206 (15%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVL------SVESKQGEKEFMSEVASMANVNVCHEN 101
           ++G G F  V K R    G   A K +      S       ++   EV+ +  +   H N
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ--HPN 75

Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEE-----KRRAKFGWKARREIIMGIGRG 156
           ++ LH    +    IL+ + +          G E       +     +   E +  I  G
Sbjct: 76  VITLHEVYENKTDVILILELVA---------GGELFDFLAEKESLTEEEATEFLKQILNG 126

Query: 157 LAYIHEEIQPHVVHRDIKTSNILL----DQNFNPKISDFGLSKLFPENTTHISTRVAGTL 212
           + Y+H      + H D+K  NI+L          KI DFGL+             + GT 
Sbjct: 127 VYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTP 181

Query: 213 GYLAPEYAISGRLTRKSDVYSFGVLL 238
            ++APE      L  ++D++S GV+ 
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVIT 207

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 93.0 bits (232), Expect = 6e-22
 Identities = 45/205 (21%), Positives = 79/205 (38%), Gaps = 30/205 (14%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVL------SVESKQGEKEFMSEVASMANVNVCHEN 101
           ++G G F  V K R    G   A K +      S       +E   EV  +  +   H N
Sbjct: 12  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR--HPN 69

Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGE--EK--RRAKFGWKARREIIMGIGRGL 157
           ++ LH    +    +L+ + +          GE  +    +         + +  I  G+
Sbjct: 70  IITLHDIFENKTDVVLILELVSG--------GELFDFLAEKESLTEDEATQFLKQILDGV 121

Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNP----KISDFGLSKLFPENTTHISTRVAGTLG 213
            Y+H +    + H D+K  NI+L     P    K+ DFG++             + GT  
Sbjct: 122 HYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTPE 176

Query: 214 YLAPEYAISGRLTRKSDVYSFGVLL 238
           ++APE      L  ++D++S GV+ 
Sbjct: 177 FVAPEIVNYEPLGLEADMWSIGVIT 201

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 94.0 bits (234), Expect = 8e-22
 Identities = 47/205 (22%), Positives = 81/205 (39%), Gaps = 30/205 (14%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSV------ESKQGEKEFMSEVASMANVNVCHEN 101
           ++G G F  V K R    G   A K +              +E   EV+ +  V   H N
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL--HPN 76

Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGE--EK--RRAKFGWKARREIIMGIGRGL 157
           ++ LH    +    +L+ + +          GE  +   ++     +     I  I  G+
Sbjct: 77  IITLHDVYENRTDVVLILELVSG--------GELFDFLAQKESLSEEEATSFIKQILDGV 128

Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNP----KISDFGLSKLFPENTTHISTRVAGTLG 213
            Y+H +    + H D+K  NI+L     P    K+ DFGL+    +        + GT  
Sbjct: 129 NYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTPE 183

Query: 214 YLAPEYAISGRLTRKSDVYSFGVLL 238
           ++APE      L  ++D++S GV+ 
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVIT 208

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 94.0 bits (234), Expect = 1e-21
 Identities = 57/212 (26%), Positives = 90/212 (42%), Gaps = 27/212 (12%)

Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCHENLVKL 105
           IG G F  V   +++  G + A+K+++   +  +     F  E   + N +     + +L
Sbjct: 69  IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD--RRWITQL 126

Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKR----RAKFGWKARREIIMGIGRGLAYIH 161
           H    D     LV +Y     L   L    +R     A+F + A  EI+M I      +H
Sbjct: 127 HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARF-YLA--EIVMAID----SVH 179

Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE--- 218
                  VHRDIK  NILLD+  + +++DFG       + T  S    GT  YL+PE   
Sbjct: 180 RL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQ 236

Query: 219 ----YAISGRLTRKSDVYSFGVLLLEIVSGRT 246
                  +G    + D ++ GV   E+  G+T
Sbjct: 237 AVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 94.1 bits (234), Expect = 1e-21
 Identities = 52/227 (22%), Positives = 92/227 (40%), Gaps = 51/227 (22%)

Query: 49  KIGEGGFGSVYKGRLQD---GTIVAVKVLSVE----SKQGEKEFMSEVASMANVNVCHEN 101
           K+G G +G VYK + +D       A+K +       S   E   + E+         H N
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELK--------HPN 79

Query: 102 LVKLHGGCID-GPCRI-LVYDYMPNNSLSQTL-----LGEEKRRAKFGWKARREIIMGIG 154
           ++ L    +     ++ L++DY  ++ L   +         K+  +      + ++  I 
Sbjct: 80  VISLQKVFLSHADRKVWLLFDYAEHD-LWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138

Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP----KISDFGLSKLF--PENT-THISTR 207
            G+ Y+H      V+HRD+K +NIL+          KI+D G ++LF  P      +   
Sbjct: 139 DGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 195

Query: 208 VAGTLGYLAPE-------Y--AISGRLTRKSDVYSFGVLLLEIVSGR 245
           V  T  Y APE       Y  AI        D+++ G +  E+++  
Sbjct: 196 VV-TFWYRAPELLLGARHYTKAI--------DIWAIGCIFAELLTSE 233

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 92.4 bits (230), Expect = 3e-21
 Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 27/206 (13%)

Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V   + ++ G   A+K+L     V+ KQ E   ++E   +  VN     LVK
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIE-HTLNEKRILQAVN--FPFLVK 105

Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKR----RAKFGWKARREIIMGIGRGLAYI 160
           L     D     +V +Y+    +  + L    R     A+F + A  +I++       Y+
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMF-SHLRRIGRFSEPHARF-YAA--QIVLT----FEYL 157

Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
           H      +++RD+K  N+L+DQ    +++DFG +K     T    T + GT   LAPE  
Sbjct: 158 HSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WT-LCGTPEALAPEII 210

Query: 221 ISGRLTRKSDVYSFGVLLLEIVSGRT 246
           +S    +  D ++ GVL+ E+ +G  
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 91.1 bits (227), Expect = 5e-21
 Identities = 66/206 (32%), Positives = 106/206 (51%), Gaps = 27/206 (13%)

Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
           +G G FG V+  R +  G   A+KVL     V  KQ E     E   ++ V   H  +++
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVE-HTNDERLMLSIVT--HPFIIR 70

Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKR----RAKFGWKARREIIMGIGRGLAYI 160
           + G   D     ++ DY+    L  +LL + +R     AKF + A  E+ +     L Y+
Sbjct: 71  MWGTFQDAQQIFMIMDYIEGGELF-SLLRKSQRFPNPVAKF-YAA--EVCLA----LEYL 122

Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
           H +    +++RD+K  NILLD+N + KI+DFG +K  P+ T    T + GT  Y+APE  
Sbjct: 123 HSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT---YT-LCGTPDYIAPEVV 175

Query: 221 ISGRLTRKSDVYSFGVLLLEIVSGRT 246
            +    +  D +SFG+L+ E+++G T
Sbjct: 176 STKPYNKSIDWWSFGILIYEMLAGYT 201

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 92.1 bits (229), Expect = 5e-21
 Identities = 43/204 (21%), Positives = 81/204 (39%), Gaps = 33/204 (16%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
            +G G  G V +    +     A+K+L    K        EV      +    ++V++  
Sbjct: 69  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRAS-QCPHIVRIVD 122

Query: 108 GCIDGPCRI----LVYDYMPNNSLSQTLLGE------EKRRAKFGWKARREIIMGIGRGL 157
              +         +V + +          GE      ++    F  +   EI+  IG  +
Sbjct: 123 VYENLYAGRKCLLIVMECLDG--------GELFSRIQDRGDQAFTEREASEIMKSIGEAI 174

Query: 158 AYIHEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY 214
            Y+H     ++ HRD+K  N+L      N   K++DFG +K    + + ++T    T  Y
Sbjct: 175 QYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPC-YTPYY 229

Query: 215 LAPEYAISGRLTRKSDVYSFGVLL 238
           +APE     +  +  D++S GV++
Sbjct: 230 VAPEVLGPEKYDKSCDMWSLGVIM 253

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 90.6 bits (225), Expect = 6e-21
 Identities = 20/204 (9%), Positives = 50/204 (24%), Gaps = 49/204 (24%)

Query: 49  KIGEGGFGSVYKGRLQD---GTIVAVKVLSVESKQGE---KEFMSEVASMANVNVCHENL 102
             G       ++    D      VA+  +  +    +   +E +S    ++ ++     +
Sbjct: 38  FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID--KPGV 93

Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGE-EKRRAKFGWKARREIIMGIGRGLAYIH 161
            ++          ++V +++   SL +          A          +  +       H
Sbjct: 94  ARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGA-------IRAMQSLAAAADAAH 146

Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI 221
                 V       S +         +S  G   L                  +      
Sbjct: 147 RA---GVALSIDHPSRVR--------VSIDGDVVL-------------AYPATMPDA--- 179

Query: 222 SGRLTRKSDVYSFGVLLLEIVSGR 245
                 + D+   G  L  ++  R
Sbjct: 180 ----NPQDDIRGIGASLYALLVNR 199

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 92.4 bits (229), Expect = 1e-20
 Identities = 66/267 (24%), Positives = 110/267 (41%), Gaps = 56/267 (20%)

Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLS---------VESKQGEKEFMSEVASMANVNVCH 99
           +G+G FG V     +    + AVK+L          VE    EK  ++            
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK-------P 401

Query: 100 ENLVKLHGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEK---RRAKFGWKARREIIMGIGR 155
             L +LH  C     R+  V +Y+    L   +    +     A F + A  EI +G   
Sbjct: 402 PFLTQLHS-CFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVF-YAA--EIAIG--- 454

Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLG 213
            L ++  +    +++RD+K  N++LD   + KI+DFG+ K  ++   TT   T   GT  
Sbjct: 455 -LFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT--KT-FCGTPD 507

Query: 214 YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELM 273
           Y+APE        +  D ++FGVLL E+++G+    F+ +              +  EL 
Sbjct: 508 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP--FEGE--------------DEDELF 551

Query: 274 N--LVDPMLYGNFPENEAIRFLKVGLL 298
              +   + Y      EA+   K GL+
Sbjct: 552 QSIMEHNVAYPKSMSKEAVAICK-GLM 577

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 89.7 bits (223), Expect = 4e-20
 Identities = 72/269 (26%), Positives = 112/269 (41%), Gaps = 51/269 (18%)

Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLS---------VESKQGEKEFMSEVASMANVNVCH 99
           IG G +  V   RL+    I A++V+          ++  Q EK    + ++       H
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN-------H 112

Query: 100 ENLVKLHGGCIDGPCRI-LVYDYMPNNSL-----SQTLLGEEKRRAKFGWKARREIIMGI 153
             LV LH  C     R+  V +Y+    L      Q  L EE   A+F + A  EI +  
Sbjct: 113 PFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE--HARF-YSA--EISLA- 165

Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGT 211
              L Y+HE     +++RD+K  N+LLD   + K++D+G+ K  L P +TT   T   GT
Sbjct: 166 ---LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS--T-FCGT 216

Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKE 271
             Y+APE           D ++ GVL+ E+++GR+   FD+     +             
Sbjct: 217 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP--FDIVGSSDNPDQN-----TEDY 269

Query: 272 LMN--LVDPMLYGNFPENEAIRFLKVGLL 298
           L    L   +        +A   LK   L
Sbjct: 270 LFQVILEKQIRIPRSLSVKAASVLK-SFL 297

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 88.8 bits (221), Expect = 5e-20
 Identities = 73/269 (27%), Positives = 112/269 (41%), Gaps = 51/269 (18%)

Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLS---------VESKQGEKEFMSEVASMANVNVCH 99
           IG G +  V   RL+    I A+KV+          ++  Q EK    + ++       H
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN-------H 69

Query: 100 ENLVKLHGGCIDGPCRI-LVYDYMPNNSL-----SQTLLGEEKRRAKFGWKARREIIMGI 153
             LV LH  C     R+  V +Y+    L      Q  L EE   A+F + A  EI +  
Sbjct: 70  PFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE--HARF-YSA--EISLA- 122

Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGT 211
              L Y+HE     +++RD+K  N+LLD   + K++D+G+ K  L P +TT   T   GT
Sbjct: 123 ---LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS--T-FCGT 173

Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKE 271
             Y+APE           D ++ GVL+ E+++GR+   FD+     +             
Sbjct: 174 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP--FDIVGSSDNPDQN-----TEDY 226

Query: 272 LMN--LVDPMLYGNFPENEAIRFLKVGLL 298
           L    L   +        +A   LK   L
Sbjct: 227 LFQVILEKQIRIPRSLSVKAASVLK-SFL 254

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 88.1 bits (219), Expect = 1e-19
 Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 37/212 (17%)

Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLS---------VESKQGEKEFMSEVASMANVNVCH 99
           +G+G FG V     +    + AVK+L          VE    EK  ++            
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK-------P 80

Query: 100 ENLVKLHGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEK---RRAKFGWKARREIIMGIGR 155
             L +LH  C     R+  V +Y+    L   +    +     A F + A  EI +G   
Sbjct: 81  PFLTQLHS-CFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVF-YAA--EIAIG--- 133

Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLG 213
            L ++  +    +++RD+K  N++LD   + KI+DFG+ K  ++   TT   T   GT  
Sbjct: 134 -LFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK--T-FCGTPD 186

Query: 214 YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
           Y+APE        +  D ++FGVLL E+++G+
Sbjct: 187 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 86.5 bits (215), Expect = 3e-19
 Identities = 71/267 (26%), Positives = 112/267 (41%), Gaps = 56/267 (20%)

Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLS---------VESKQGEKEFMSEVASMANVNVCH 99
           +G+G FG V+    +      A+K L          VE    EK  +S           H
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE-------H 77

Query: 100 ENLVKLHGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEK---RRAKFGWKARREIIMGIGR 155
             L  +          +  V +Y+    L   +    K    RA F + A  EII+G+  
Sbjct: 78  PFLTHMFC-TFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF-YAA--EIILGLQ- 132

Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLG 213
              ++H +    +V+RD+K  NILLD++ + KI+DFG+ K  +  +  T  +T   GT  
Sbjct: 133 ---FLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NT-FCGTPD 183

Query: 214 YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELM 273
           Y+APE  +  +     D +SFGVLL E++ G++   F  Q              + +EL 
Sbjct: 184 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP--FHGQ--------------DEEELF 227

Query: 274 N--LVDPMLYGNFPENEAIRFLKVGLL 298
           +   +D   Y  + E EA   L   L 
Sbjct: 228 HSIRMDNPFYPRWLEKEAKDLLV-KLF 253

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 85.7 bits (213), Expect = 6e-19
 Identities = 62/212 (29%), Positives = 99/212 (46%), Gaps = 37/212 (17%)

Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLS---------VESKQGEKEFMSEVASMANVNVCH 99
           +G+G FG V   R+++ G + AVKVL          VE    EK  +S   +       H
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN-------H 83

Query: 100 ENLVKLHGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEK---RRAKFGWKARREIIMGIGR 155
             L +L   C   P R+  V +++    L   +    +    RA+F + A  EII     
Sbjct: 84  PFLTQLFC-CFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAA--EIISA--- 136

Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLG 213
            L ++H++    +++RD+K  N+LLD   + K++DFG+ K  +    TT  +T   GT  
Sbjct: 137 -LMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT--AT-FCGTPD 189

Query: 214 YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
           Y+APE           D ++ GVLL E++ G 
Sbjct: 190 YIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 85.4 bits (212), Expect = 8e-19
 Identities = 63/212 (29%), Positives = 88/212 (41%), Gaps = 38/212 (17%)

Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLS---------VESKQGEKEFMSEVASMANVNVCH 99
           +G+G FG V   R +  G   A+K+L          V     E   +         N  H
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ--------NTRH 64

Query: 100 ENLVKLHGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEK---RRAKFGWKARREIIMGIGR 155
             L  L         R+  V +Y     L   L  E      RA+F + A  EI+     
Sbjct: 65  PFLTALKY-AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGA--EIVSA--- 117

Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLG 213
            L Y+H      VV+RDIK  N++LD++ + KI+DFGL K  +    T    T   GT  
Sbjct: 118 -LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KT-FCGTPE 170

Query: 214 YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
           YLAPE        R  D +  GV++ E++ GR
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 85.8 bits (213), Expect = 8e-19
 Identities = 77/267 (28%), Positives = 109/267 (40%), Gaps = 56/267 (20%)

Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLS---------VESKQGEKEFMSEVASMANVNVCH 99
           IG+G FG V   R +      AVKVL           +    E+  + +       NV H
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLK-------NVKH 98

Query: 100 ENLVKLHGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEK---RRAKFGWKARREIIMGIGR 155
             LV LH        ++  V DY+    L   L  E      RA+F + A  EI   +G 
Sbjct: 99  PFLVGLHF-SFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAA--EIASALG- 153

Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLG 213
              Y+H     ++V+RD+K  NILLD   +  ++DFGL K  +   +TT  ST   GT  
Sbjct: 154 ---YLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT--ST-FCGTPE 204

Query: 214 YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELM 273
           YLAPE        R  D +  G +L E++ G     F  +              N+ E+ 
Sbjct: 205 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP--FYSR--------------NTAEMY 248

Query: 274 N--LVDPMLYGNFPENEAIRFLKVGLL 298
           +  L  P+       N A   L+ GLL
Sbjct: 249 DNILNKPLQLKPNITNSARHLLE-GLL 274

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 86.3 bits (214), Expect = 8e-19
 Identities = 62/204 (30%), Positives = 94/204 (46%), Gaps = 21/204 (10%)

Query: 50  IGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEF---MSEVASMANVNVCHENLVKL 105
           +G+G FG V   + +  G   A+K+L  E    + E    ++E   + N    H  L  L
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR--HPFLTAL 213

Query: 106 HGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEK---RRAKFGWKARREIIMGIGRGLAYIH 161
                    R+  V +Y     L   L  E      RA+F + A  EI+      L Y+H
Sbjct: 214 KY-SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGA--EIVSA----LDYLH 265

Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI 221
            E    VV+RD+K  N++LD++ + KI+DFGL K   ++   + T   GT  YLAPE   
Sbjct: 266 SEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLE 322

Query: 222 SGRLTRKSDVYSFGVLLLEIVSGR 245
                R  D +  GV++ E++ GR
Sbjct: 323 DNDYGRAVDWWGLGVVMYEMMCGR 346

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 84.5 bits (208), Expect = 1e-18
 Identities = 48/284 (16%), Positives = 91/284 (32%), Gaps = 54/284 (19%)

Query: 27  KNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESK------- 79
           K    FS+    + T   +   KIGEG FG V++    D T VA+K++++E         
Sbjct: 8   KGPVPFSHC---LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSH 63

Query: 80  -QGEKEFMSEVASM-------ANVNVCHENLVKLHGGCI----DGPCRILVYDYMPNNSL 127
            +  +E + E+            V    E  + L+          P  +  +D+  +   
Sbjct: 64  QKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKG 123

Query: 128 SQ---------------------TLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
           S                       +  E+ R         + I+  +   LA     +  
Sbjct: 124 SANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL-- 181

Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLT 226
              HRD+   N+LL +    K+      K     +  +   +         +Y +S    
Sbjct: 182 RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSII--------DYTLSRLER 233

Query: 227 RKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSK 270
               V+    +  ++ +G     FD+        +  WG Y+  
Sbjct: 234 DGIVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPY 277

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 84.1 bits (209), Expect = 1e-18
 Identities = 70/264 (26%), Positives = 114/264 (43%), Gaps = 49/264 (18%)

Query: 50  IGEGGFGSVY----KGRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLV 103
           +G+G FG V+            + A+KVL   +   +       E   +  VN  H  +V
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN--HPFIV 89

Query: 104 KLHGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEKR----RAKFGWKARREIIMGIGRGLA 158
           KLH        ++ L+ D++    L  T L +E        KF + A  E+ +     L 
Sbjct: 90  KLHY-AFQTEGKLYLILDFLRGGDLF-TRLSKEVMFTEEDVKF-YLA--ELALA----LD 140

Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLGYLA 216
           ++H      +++RD+K  NILLD+  + K++DFGLSK  +  E   +  +   GT+ Y+A
Sbjct: 141 HLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY--S-FCGTVEYMA 194

Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMN-- 274
           PE       T+ +D +SFGVL+ E+++G     F  +              + KE M   
Sbjct: 195 PEVVNRRGHTQSADWWSFGVLMFEMLTGTLP--FQGK--------------DRKETMTMI 238

Query: 275 LVDPMLYGNFPENEAIRFLKVGLL 298
           L   +    F   EA   L+  L 
Sbjct: 239 LKAKLGMPQFLSPEAQSLLR-MLF 261

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 84.8 bits (210), Expect = 2e-18
 Identities = 45/240 (18%), Positives = 85/240 (35%), Gaps = 57/240 (23%)

Query: 49  KIGEGGFGSVYKGRLQD-GTIVAVK--------------------------VLSVESKQG 81
            +G G FG V +    + G   A+K                          ++      G
Sbjct: 14  TLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTG 73

Query: 82  EKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI------LVYDYMPNNSLSQTLLGEE 135
           ++E         +  +  +N    +                ++ +Y+P      TL    
Sbjct: 74  DEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-----DTL---- 124

Query: 136 KRRAKFGWKARREI--------IMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP- 186
            +  K   ++ R I        I  + R + +IH      + HRDIK  N+L++   N  
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTL 181

Query: 187 KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGR 245
           K+ DFG +K    +   ++  +  +  Y APE  +     T   D++S G +  E++ G+
Sbjct: 182 KLCDFGSAKKLIPSEPSVAY-IC-SRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 82.6 bits (205), Expect = 5e-18
 Identities = 67/265 (25%), Positives = 113/265 (42%), Gaps = 49/265 (18%)

Query: 50  IGEGGFGSVY---KGRLQD-GTIVAVKVL---SVESKQGEKEF-MSEVASMANVNVCHEN 101
           +G+GG+G V+   K    + G I A+KVL    +     +     +E   +  V   H  
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK--HPF 82

Query: 102 LVKLHGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEK---RRAKFGWKARREIIMGIGRGL 157
           +V L         ++ L+ +Y+    L   L  E       A F + A  EI M     L
Sbjct: 83  IVDLIY-AFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-YLA--EISMA----L 134

Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLGYL 215
            ++H++    +++RD+K  NI+L+   + K++DFGL K  +     TH  T   GT+ Y+
Sbjct: 135 GHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH--T-FCGTIEYM 188

Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMN- 274
           APE  +     R  D +S G L+ ++++G     F  +              N K+ ++ 
Sbjct: 189 APEILMRSGHNRAVDWWSLGALMYDMLTGAPP--FTGE--------------NRKKTIDK 232

Query: 275 -LVDPMLYGNFPENEAIRFLKVGLL 298
            L   +    +   EA   LK  LL
Sbjct: 233 ILKCKLNLPPYLTQEARDLLK-KLL 256

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 83.4 bits (206), Expect = 8e-18
 Identities = 60/265 (22%), Positives = 108/265 (40%), Gaps = 39/265 (14%)

Query: 2   KSIFSCFSFPSRVSAENTIGGEQILKNINAFSYNQLKIATNGF----RWSN--KIGEGGF 55
             I  C  F  +V          + K+     +  +++  + F    R+ N   IG G  
Sbjct: 16  VKIAFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQ 75

Query: 56  GSVYKGR-LQDGTIVAVKVLSV--ESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG 112
           G V           VA+K LS   +++   K    E+  M  VN  H+N++ L    +  
Sbjct: 76  GIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN--HKNIISLLN--VFT 131

Query: 113 PCR--------ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
           P +         LV + M  N L Q +      + +   +    ++  +  G+ ++H   
Sbjct: 132 PQKTLEEFQDVYLVMELMDAN-LCQVI------QMELDHERMSYLLYQMLCGIKHLHSA- 183

Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN---TTHISTRVAGTLGYLAPEYAI 221
              ++HRD+K SNI++  +   KI DFGL++    +   T ++ TR      Y APE  +
Sbjct: 184 --GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----YRAPEVIL 236

Query: 222 SGRLTRKSDVYSFGVLLLEIVSGRT 246
                   D++S G ++ E+V  + 
Sbjct: 237 GMGYKENVDIWSVGCIMGEMVRHKI 261

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 81.9 bits (203), Expect = 9e-18
 Identities = 47/207 (22%), Positives = 94/207 (45%), Gaps = 27/207 (13%)

Query: 48  NKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLH 106
            K+G G +  V++   + +   V VK+L    K   K+   E+  + N+     N++ L 
Sbjct: 42  RKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLR-GGPNIITLA 97

Query: 107 GGCIDGPCR--ILVYDYMPN---NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
               D   R   LV++++ N     L QTL   + R            +  I + L Y H
Sbjct: 98  DIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRF----------YMYEILKALDYCH 147

Query: 162 EEIQPHVVHRDIKTSNILLD-QNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
                 ++HRD+K  N+++D ++   ++ D+GL++ +     + + RVA +  +  PE  
Sbjct: 148 ---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVA-SRYFKGPELL 202

Query: 221 ISGRLTRKS-DVYSFGVLLLEIVSGRT 246
           +  ++   S D++S G +L  ++  + 
Sbjct: 203 VDYQMYDYSLDMWSLGCMLASMIFRKE 229

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 79.3 bits (196), Expect = 9e-17
 Identities = 51/211 (24%), Positives = 91/211 (43%), Gaps = 33/211 (15%)

Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLSV--ESKQGEKEFMSEVASMANVNVCHENLVKLH 106
           IG G  G V           VA+K LS   +++   K    E+  M  VN  H+N++ L 
Sbjct: 33  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN--HKNIIGLL 90

Query: 107 GGCIDGPCRI--------LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
              +  P +         +V + M  N L Q +      + +   +    ++  +  G+ 
Sbjct: 91  N--VFTPQKSLEEFQDVYIVMELMDAN-LCQVI------QMELDHERMSYLLYQMLCGIK 141

Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN---TTHISTRVAGTLGYL 215
           ++H      ++HRD+K SNI++  +   KI DFGL++    +   T ++ TR      Y 
Sbjct: 142 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----YR 193

Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVSGRT 246
           APE  +        D++S G ++ E++ G  
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMIKGGV 224

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 78.9 bits (195), Expect = 1e-16
 Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 40/217 (18%)

Query: 50  IGEGGFGSVY---KGRLQD-GTIVAVKVLS----------VESKQGEKEFMSEVASMANV 95
           +G G +G V+   K    D G + A+KVL            E  + E++ +  +      
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ---- 117

Query: 96  NVCHENLVKLHGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEKR----RAKFGWKARREII 150
                 LV LH        ++ L+ DY+    L  T L + +R      +  +    EI+
Sbjct: 118 ---SPFLVTLHY-AFQTETKLHLILDYINGGELF-THLSQRERFTEHEVQI-YVG--EIV 169

Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG 210
           +     L ++H+     +++RDIK  NILLD N +  ++DFGLSK F  + T  +    G
Sbjct: 170 LA----LEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCG 222

Query: 211 TLGYLAPEYAISGRL--TRKSDVYSFGVLLLEIVSGR 245
           T+ Y+AP+    G     +  D +S GVL+ E+++G 
Sbjct: 223 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 78.9 bits (195), Expect = 1e-16
 Identities = 48/225 (21%), Positives = 87/225 (38%), Gaps = 48/225 (21%)

Query: 49  KIGEGGFGSVYKGRLQDGTIVAVK--VLSVESKQGEKEFMS---------EVASMANVNV 97
            I  G +G+V  G   +G  VA+K    +V   +                E+  + + + 
Sbjct: 29  FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH- 87

Query: 98  CHENLVKLHGGCIDGPCRI-------LVYDYMPNN-----SLSQTLLGEEKRRAKFGWKA 145
            H N++ L    I             LV + M  +        + ++  +    ++    
Sbjct: 88  -HPNILGLRD--IFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQ--HIQY---- 138

Query: 146 RREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN---TT 202
               +  I  GL  +HE     VVHRD+   NILL  N +  I DF L++    +   T 
Sbjct: 139 ---FMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTH 192

Query: 203 HISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRT 246
           +++ R      Y APE  +     T+  D++S G ++ E+ + + 
Sbjct: 193 YVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 77.0 bits (190), Expect = 6e-16
 Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 38/215 (17%)

Query: 48  NKIGEGGFGSVYKGR-LQDGTIVAVKVLSV--ESKQGEKEFMSEVASMANVNVCHENLVK 104
             +G G +GSV      + G  VA+K LS   +S+   K    E+  + ++   HEN++ 
Sbjct: 30  THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ--HENVIG 87

Query: 105 LHGGCIDGPCRI--------LVYDYMP---NNSLSQTLLGEEKRRAKFGWKARREIIMGI 153
           L    +  P           LV  +M       +      E+ +           ++  +
Sbjct: 88  LLD--VFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQY----------LVYQM 135

Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTHISTRVAGTL 212
            +GL YIH      VVHRD+K  N+ ++++   KI DFGL++    E T ++ TR     
Sbjct: 136 LKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW---- 188

Query: 213 GYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRT 246
            Y APE  +S     +  D++S G ++ E+++G+T
Sbjct: 189 -YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKT 222

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 73.9 bits (182), Expect = 7e-15
 Identities = 55/210 (26%), Positives = 102/210 (48%), Gaps = 31/210 (14%)

Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLSV--ESKQGEKEFMSEVASMANVNVCHENLVKLH 106
           +G G +G+V      + G  VA+K L    +S+   K    E+  + ++   HEN++ L 
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR--HENVIGLL 90

Query: 107 GGCIDGPCRI--------LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
              +  P           LV  +M  + L + +     +  K G    + ++  + +GL 
Sbjct: 91  D--VFTPDETLDDFTDFYLVMPFMGTD-LGKLM-----KHEKLGEDRIQFLVYQMLKGLR 142

Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTHISTRVAGTLGYLAP 217
           YIH      ++HRD+K  N+ ++++   KI DFGL++    E T ++ TR      Y AP
Sbjct: 143 YIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW-----YRAP 194

Query: 218 EYAIS-GRLTRKSDVYSFGVLLLEIVSGRT 246
           E  ++  R T+  D++S G ++ E+++G+T
Sbjct: 195 EVILNWMRYTQTVDIWSVGCIMAEMITGKT 224

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 73.5 bits (181), Expect = 9e-15
 Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 45/221 (20%)

Query: 48  NKIGEGGFGSVYKGR-LQDGTIVAVKVLSV-ESKQGEKEFMSEVASMANVNVCHENLVKL 105
           + IGEG +G V       +   VA+K +S  E +   +  + E+  +      HEN++ +
Sbjct: 33  SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR--HENIIGI 90

Query: 106 HGGCIDGPCRI-------LVYDYMPNNSL-----SQTLLGEEKRRAKFGWKARREIIMGI 153
           +   I     I       +V D M  + L     +Q L         +        +  I
Sbjct: 91  ND--IIRAPTIEQMKDVYIVQDLMETD-LYKLLKTQHL---SNDHICY-------FLYQI 137

Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN-------TTHIST 206
            RGL YIH     +V+HRD+K SN+LL+   + KI DFGL+++   +       T +++T
Sbjct: 138 LRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194

Query: 207 RVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRT 246
           R      Y APE  ++    T+  D++S G +L E++S R 
Sbjct: 195 R-----WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 72.8 bits (179), Expect = 1e-14
 Identities = 53/227 (23%), Positives = 91/227 (40%), Gaps = 27/227 (11%)

Query: 33  SYNQLKIATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVAS 91
           S   L +  N FR   KIG G FG +  G+ L     VA+K   +E  +     +     
Sbjct: 1   SMGVLMVGPN-FRVGKKIGCGNFGELRLGKNLYTNEYVAIK---LEPMKSRAPQLHLEYR 56

Query: 92  MANVNVCHENLVKLHGGCIDGPCRILVYDYM-PNNSLSQTLLGEEKRRAKFGWKARREII 150
                   + + +++     G    +V + + P  SL   L     R   F  K    I 
Sbjct: 57  FYKQLGSGDGIPQVYYFGPCGKYNAMVLELLGP--SLED-LFDLCDR--TFSLKTVLMIA 111

Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPK-----ISDFGLSKLF--PENTTH 203
           + +   + Y+H +   ++++RD+K  N L+ +  N       I DF L+K +  PE   H
Sbjct: 112 IQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKH 168

Query: 204 ISTR----VAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGR 245
           I  R    + GT  Y        G+  +R+ D+ + G + +  + G 
Sbjct: 169 IPYREHKSLTGTARY-MSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 73.0 bits (179), Expect = 1e-14
 Identities = 32/92 (34%), Positives = 50/92 (54%), Gaps = 4/92 (4%)

Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT- 211
           + +G+ ++        +HRD+   NILL +    KI DFGL++   ++  ++    A   
Sbjct: 202 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258

Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
           L ++APE       T +SDV+SFGVLL EI S
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 34/157 (21%), Positives = 58/157 (36%), Gaps = 22/157 (14%)

Query: 48  NKIGEGGFGSVYKGRL------QDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHE 100
             +G G FG V +              VAVK+L   +   E +  MSE+  + ++   H 
Sbjct: 28  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG-HHL 86

Query: 101 NLVKLHGGCI--DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
           N+V L G C    GP  ++V ++    +LS  L              R E +    +G  
Sbjct: 87  NVVNLLGACTKPGGPLMVIV-EFCKFGNLSTYL-----------RSKRNEFVPYKTKGAR 134

Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK 195
           +   +     +  D+K     +  + +   S F   K
Sbjct: 135 FRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 72.3 bits (178), Expect = 2e-14
 Identities = 56/221 (25%), Positives = 101/221 (45%), Gaps = 38/221 (17%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKL-- 105
            +G GG G V+          VA+K + +   Q  K  + E+  +  ++  H+N+VK+  
Sbjct: 18  PLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLD--HDNIVKVFE 75

Query: 106 -----HGGCIDGPCRI-------LVYDYMP---NNSLSQTLLGEEKRRAKFGWKARREII 150
                     D    +       +V +YM     N L Q  L EE   A+         +
Sbjct: 76  ILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEE--HARL-------FM 126

Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLD-QNFNPKISDFGLSKLF---PENTTHIST 206
             + RGL YIH     +V+HRD+K +N+ ++ ++   KI DFGL+++      +  H+S 
Sbjct: 127 YQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSE 183

Query: 207 RVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGRT 246
            +  T  Y +P   +S    T+  D+++ G +  E+++G+T
Sbjct: 184 GLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 72.4 bits (178), Expect = 3e-14
 Identities = 47/222 (21%), Positives = 94/222 (42%), Gaps = 38/222 (17%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVL-SVES--KQGEKE-----FMSEVASMANVNVCH 99
           K+G G F +V+  + + + T VA+K++   +   +  E E      +++  +    ++  
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85

Query: 100 ENLVKL------HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRR--AKFGWKARREIIM 151
            +++KL       G         +V++      L + LL   K+           ++I  
Sbjct: 86  NHILKLLDHFNHKGPNGVHVV--MVFE-----VLGENLLALIKKYEHRGIPLIYVKQISK 138

Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLD------QNFNPKISDFGLSKLFPEN-TTHI 204
            +  GL Y+H      ++H DIK  N+L++           KI+D G +  + E+ T  I
Sbjct: 139 QLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 196

Query: 205 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT 246
            TR      Y +PE  +       +D++S   L+ E+++G  
Sbjct: 197 QTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 71.9 bits (177), Expect = 3e-14
 Identities = 52/226 (23%), Positives = 96/226 (42%), Gaps = 52/226 (23%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSV-ESKQGEKEFMSEVASMANVNVCHENLVKLH 106
            +GEG +G V        G IVA+K +   +        + E+  + +    HEN++ + 
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFK--HENIITIF 75

Query: 107 GGCIDGPCRI-------LVYDYMP---NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRG 156
              I  P          ++ + M    +  +S  +L ++    ++        I    R 
Sbjct: 76  N--IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDD--HIQY-------FIYQTLRA 124

Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN--------------TT 202
           +  +H     +V+HRD+K SN+L++ N + K+ DFGL+++  E+                
Sbjct: 125 VKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181

Query: 203 HISTRVAGTLGYLAPEYAI---SGRLTRKSDVYSFGVLLLEIVSGR 245
            ++TR      Y APE  +   S + +R  DV+S G +L E+   R
Sbjct: 182 FVATR-----WYRAPE--VMLTSAKYSRAMDVWSCGCILAELFLRR 220

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 71.6 bits (176), Expect = 4e-14
 Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 37/213 (17%)

Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLSV--ESKQGEKEFMSEVASMANVNVCHENLVKLH 106
           +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   HEN++ L 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--HENVIGLL 94

Query: 107 GGCIDGPCRI--------LVYDYMP---NNSLSQTLLGEEKRRAKFGWKARREIIMGIGR 155
              +  P R         LV   M    NN +    L ++    +F       +I  I R
Sbjct: 95  D--VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD--HVQF-------LIYQILR 143

Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTHISTRVAGTLGY 214
           GL YIH      ++HRD+K SN+ ++++   KI DFGL++    E T +++TR      Y
Sbjct: 144 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW-----Y 195

Query: 215 LAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRT 246
            APE  ++     +  D++S G ++ E+++GRT
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 70.9 bits (174), Expect = 7e-14
 Identities = 53/228 (23%), Positives = 84/228 (36%), Gaps = 35/228 (15%)

Query: 44  FRWSNKIGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQG-----EKEFMSEVASMANVNV 97
           +    KIG GGFG +Y           A  V+ VE ++      E +F   VA    +  
Sbjct: 39  WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKK 98

Query: 98  CHENLVKLHGG-----------CIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKAR 146
             E     + G                 R +V + +    L +       +   F     
Sbjct: 99  WIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKIS----GQNGTFKKSTV 153

Query: 147 REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKI--SDFGLSKLFPENTTHI 204
            ++ + +   L YIHE      VH DIK +N+LL      ++  +D+GLS  +  N  H 
Sbjct: 154 LQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210

Query: 205 ------STRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGR 245
                      GT+ +     A  G  L+R+SDV   G  +L  + G+
Sbjct: 211 QYQENPRKGHNGTIEF-TSLDAHKGVALSRRSDVEILGYCMLRWLCGK 257

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 70.0 bits (172), Expect = 8e-14
 Identities = 32/162 (19%), Positives = 60/162 (37%), Gaps = 33/162 (20%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLS-VESKQGEKEFMSEVASMANVNVCHENLVKLH 106
            +G G  G V +    +     A+K+L      + E E     +          ++V++ 
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQ-------CPHIVRIV 77

Query: 107 GGCIDGPCRI----LVYDYMPNNSLSQTLLGE------EKRRAKFGWKARREIIMGIGRG 156
               +         +V + +          GE      ++    F  +   EI+  IG  
Sbjct: 78  DVYENLYAGRKCLLIVMECLDG--------GELFSRIQDRGDQAFTEREASEIMKSIGEA 129

Query: 157 LAYIHEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSK 195
           + Y+H     ++ HRD+K  N+L      N   K++DFG +K
Sbjct: 130 IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 69.4 bits (170), Expect = 2e-13
 Identities = 38/264 (14%), Positives = 85/264 (32%), Gaps = 50/264 (18%)

Query: 18  NTIGGEQILKNINAFSYNQLKIATNGFRW--SNKIGEGGFGSVYKGR---------LQDG 66
             +  + +  ++ A     +    +G +W   +       G +Y+               
Sbjct: 16  ENLYFQSMTTSLEALPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQK 75

Query: 67  TIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG------------GCIDGPC 114
              ++K   +++K G           A   +      KL+             G      
Sbjct: 76  QKFSLK---LDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKY 132

Query: 115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIK 174
           R LV   +   SL Q+ L    +      ++  ++   +   L ++HE      VH ++ 
Sbjct: 133 RFLVLPSL-GRSL-QSALDVSPKH-VLSERSVLQVACRLLDALEFLHEN---EYVHGNVT 186

Query: 175 TSNILLDQNFNPKI--SDFGLSKLFPENTTHISTR------VAGTLGYLAPEYA-----I 221
             NI +D     ++  + +G +  +  +  H++          G       E+       
Sbjct: 187 AENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGD-----LEFISMDLHK 241

Query: 222 SGRLTRKSDVYSFGVLLLEIVSGR 245
               +R+SD+ S G  +L+ + G 
Sbjct: 242 GCGPSRRSDLQSLGYCMLKWLYGF 265

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 69.2 bits (169), Expect = 3e-13
 Identities = 51/276 (18%), Positives = 94/276 (34%), Gaps = 74/276 (26%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQG-----EKEFMSEVASMANVNVCHENL 102
           K+G G F +V+    +Q    VA+KV+            E   +  V +    +   E +
Sbjct: 44  KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103

Query: 103 VKLHGG-CIDGP-----CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRG 156
           V+L     I G      C  +V++ +  + L + ++    +         ++II  + +G
Sbjct: 104 VQLLDDFKISGVNGTHIC--MVFEVL-GHHLLKWIIKSNYQG--LPLPCVKKIIQQVLQG 158

Query: 157 LAYIHEEIQPHVVHRDIKTSNILL------------------------------------ 180
           L Y+H +    ++H DIK  NILL                                    
Sbjct: 159 LDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216

Query: 181 -------------DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR 227
                         +    KI+D G +    ++ T        T  Y + E  I      
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ----TRQYRSLEVLIGSGYNT 272

Query: 228 KSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKA 263
            +D++S   +  E+ +G     F+   GE +  D+ 
Sbjct: 273 PADIWSTACMAFELATGDYL--FEPHSGEEYTRDED 306

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 68.2 bits (167), Expect = 4e-13
 Identities = 52/217 (23%), Positives = 84/217 (38%), Gaps = 30/217 (13%)

Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQG----EKEFMSEVASMANVNVC 98
           +R   KIG G FG +Y G  +  G  VA+K+  V++K      E +    +     +   
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGI--- 67

Query: 99  HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
                 +     +G   ++V + +   SL            KF  K    +   +   + 
Sbjct: 68  ----PTIRWCGAEGDYNVMVMELL-GPSLEDLF---NFCSRKFSLKTVLLLADQMISRIE 119

Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPK---ISDFGLSKLF--PENTTHISTR----VA 209
           YIH +   + +HRD+K  N L+          I DFGL+K +       HI  R    + 
Sbjct: 120 YIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 176

Query: 210 GTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGR 245
           GT  Y A      G   +R+ D+ S G +L+    G 
Sbjct: 177 GTARY-ASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 66.2 bits (162), Expect = 1e-12
 Identities = 49/215 (22%), Positives = 90/215 (41%), Gaps = 24/215 (11%)

Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENL 102
           ++   +IGEG FG +++G  L +   VA+K    E ++ +   + +      +      +
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIK---FEPRRSDAPQLRDEYRTYKLLAGCTGI 68

Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE 162
             ++    +G   +LV D +   SL   L   +    KF  K        +   +  IHE
Sbjct: 69  PNVYYFGQEGLHNVLVIDLLG-PSLEDLL---DLCGRKFSVKTVAMAAKQMLARVQSIHE 124

Query: 163 EIQPHVVHRDIKTSNILLDQNFNPK-----ISDFGLSKLF--PENTTHISTR----VAGT 211
           +    +V+RDIK  N L+ +  +       + DFG+ K +  P    HI  R    ++GT
Sbjct: 125 K---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 181

Query: 212 LGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGR 245
             Y        GR  +R+ D+ + G + +  + G 
Sbjct: 182 ARY-MSINTHLGREQSRRDDLEALGHVFMYFLRGS 215

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 54/225 (24%), Positives = 89/225 (39%), Gaps = 31/225 (13%)

Query: 36  QLKIATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESK----QGEKEFMSEVA 90
           + ++  N FR   KIG G FG +Y G  +Q    VA+K+ +V++K      E +    + 
Sbjct: 2   EPRVG-NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQ 60

Query: 91  SMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 150
               +         +    ++G   +LV D +   SL            K   K    + 
Sbjct: 61  GGTGI-------PNVRWFGVEGDYNVLVMDLL-GPSLEDLF---NFCSRKLSLKTVLMLA 109

Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPK---ISDFGLSKLF--PENTTHIS 205
             +   + ++H +     +HRDIK  N L+          I DFGL+K +       HI 
Sbjct: 110 DQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166

Query: 206 TR----VAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGR 245
            R    + GT  Y A      G   +R+ D+ S G +L+  + G 
Sbjct: 167 YRENKNLTGTARY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 66.3 bits (162), Expect = 2e-12
 Identities = 48/236 (20%), Positives = 84/236 (35%), Gaps = 44/236 (18%)

Query: 42  NGFRWSNKIGEGGFGSVYKGRLQDGTIV------AVKVLSVESKQ--GEKEFMSEVASMA 93
             ++    IG+GGFG +Y   +     V       VKV   ++     E +F    A   
Sbjct: 35  AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94

Query: 94  NVNVCHENLVKLHGG-----------CIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFG 142
            +          + G                 R ++ D    + L Q +     +  +F 
Sbjct: 95  QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDL-QKIYEANAK--RFS 150

Query: 143 WKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKI--SDFGLSKLF--P 198
            K   ++ + I   L YIHE      VH DIK SN+LL+     ++   D+GL+  +   
Sbjct: 151 RKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPE 207

Query: 199 ENTTHISTR----VAGTLGYLAPEYA-IS---GR-LTRKSDVYSFGVLLLEIVSGR 245
                 +        GT      E+  I    G   +R+ D+   G  +++ ++G 
Sbjct: 208 GVHKAYAADPKRCHDGT-----IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 65.2 bits (159), Expect = 7e-12
 Identities = 43/194 (22%), Positives = 80/194 (41%), Gaps = 33/194 (17%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSV--ESKQGEKEFMSEVASMANVNVCHENLVKL 105
            IG G +G VY          VA+K ++   E     K  + E+  +  +    + +++L
Sbjct: 33  LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLK--SDYIIRL 90

Query: 106 HGGCIDGPCRI-------LVYDYMPNNSL-----SQTLLGEEKRRAKFGWKARREIIMGI 153
           +   +  P  +       +V +   ++ L     +   L EE    K        I+  +
Sbjct: 91  YD--LIIPDDLLKFDELYIVLEIADSD-LKKLFKTPIFLTEE--HIKT-------ILYNL 138

Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS-KLFPENTTHISTRVAGTL 212
             G  +IHE     ++HRD+K +N LL+Q+ + K+ DFGL+  +  E  T+I   +    
Sbjct: 139 LLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195

Query: 213 GYLAPEYAISGRLT 226
                   +  +LT
Sbjct: 196 EPGPHNKNLKKQLT 209

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 64.1 bits (156), Expect = 2e-11
 Identities = 38/189 (20%), Positives = 75/189 (39%), Gaps = 40/189 (21%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVK-VLSVESKQGE-KEFMSEVASMANVNVCHENLVKL 105
            IG G +G V +     +  +VA+K +L V     + K  + E+A +  +N  H+++VK+
Sbjct: 60  LIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLN--HDHVVKV 117

Query: 106 HGGCIDGPCRI-------LVYDYMP---------NNSLSQTLLGEEKRRAKFGWKARREI 149
               I  P  +       +V +               L++  +       K        +
Sbjct: 118 LD--IVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHI-------KT-------L 161

Query: 150 IMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVA 209
           +  +  G+ Y+H      ++HRD+K +N L++Q+ + K+ DFGL++         S    
Sbjct: 162 LYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPI 218

Query: 210 GTLGYLAPE 218
                    
Sbjct: 219 SPREDDMNL 227

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 60.1 bits (146), Expect = 3e-10
 Identities = 45/191 (23%), Positives = 81/191 (42%), Gaps = 29/191 (15%)

Query: 48  NKIGEGGFGSVYKGR-LQDGTIVAVKVLSV--ESKQGEKEFMSEVASMANVNVCHENLVK 104
            K+G+G +G V+K    + G +VAVK +    ++    +    E+  +  ++  HEN+V 
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELS-GHENIVN 73

Query: 105 LHGGCIDGPCRI----LVYDYMPNNSL-----SQTLLGEEKRRAKFGWKARREIIMGIGR 155
           L    +          LV+DYM  + L     +  L   E    ++       ++  + +
Sbjct: 74  LLN--VLRADNDRDVYLVFDYMETD-LHAVIRANIL---EPVHKQY-------VVYQLIK 120

Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
            + Y+H      ++HRD+K SNILL+   + K++DFGLS+ F       +          
Sbjct: 121 VIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177

Query: 216 APEYAISGRLT 226
                    LT
Sbjct: 178 ENFDDDQPILT 188

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 59.0 bits (143), Expect = 7e-10
 Identities = 52/215 (24%), Positives = 88/215 (40%), Gaps = 40/215 (18%)

Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVL-SVES--KQGEKEFMSEVASMANVNVCHENLVKL 105
           IG+G FG V K    +    VA+K++ + +   +Q  +E          + +    L  L
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE----------IRI----LEHL 150

Query: 106 HGGCIDGPCRIL-VYDY--------MPNNSLSQTL--LGEEKRRAKFGWKARREIIMGIG 154
                D    ++ + +         M    LS  L  L ++ +   F     R+    I 
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSIL 210

Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP--KISDFGLSKLFPEN-TTHISTRVAGT 211
           + L  +H+     ++H D+K  NILL Q      K+ DFG S    +   T+I +R    
Sbjct: 211 QCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF--- 264

Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT 246
             Y APE  +  R     D++S G +L E+++G  
Sbjct: 265 --YRAPEVILGARYGMPIDMWSLGCILAELLTGYP 297

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 58.7 bits (141), Expect = 2e-09
 Identities = 55/331 (16%), Positives = 100/331 (30%), Gaps = 117/331 (35%)

Query: 96  NVCHENLVKLHGGCIDGPCRILV---------------YDYMPNNSLSQTLLGEEKRR-- 138
           NV +           +  C+IL+                 ++  +  S TL  +E +   
Sbjct: 252 NVQNAKAWNA----FNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLL 307

Query: 139 AKF-GWKA---RREIIMGIGRGLAYIHEEIQPHVVHRD-------------IKTS-NILL 180
            K+   +     RE++    R L+ I E I+  +   D             I++S N+L 
Sbjct: 308 LKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLE 367

Query: 181 DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEY---AISGRLTRKSDV------ 231
              +           +FP +  HI T +   + +   +     +  +L + S V      
Sbjct: 368 PAEYRKMFDRLS---VFPPS-AHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKE 423

Query: 232 --YSFGVLLLEI---VSGRTAV-----------------DFDVQ---------LGEYHLV 260
              S   + LE+   +    A+                 D             +G +HL 
Sbjct: 424 STISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIG-HHL- 481

Query: 261 DKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE 320
            K         L      M++ +F      RFL         + K+R   STA       
Sbjct: 482 -KNIEHPERMTLF----RMVFLDF------RFL---------EQKIR-HDSTAWNASGSI 520

Query: 321 TNIDGXDVEI-------SQP---GLIGDIMD 341
            N     ++        + P    L+  I+D
Sbjct: 521 LN-TLQQLKFYKPYICDNDPKYERLVNAILD 550

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 43.7 bits (102), Expect = 8e-05
 Identities = 52/318 (16%), Positives = 88/318 (27%), Gaps = 111/318 (34%)

Query: 34  YNQLKIATNGFRWSNKI---GEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEV- 89
           Y +L+ A    R +  +   G  G G   K      T VA+ V      Q + +F  ++ 
Sbjct: 137 YLKLRQALLELRPAKNVLIDGVLGSG---K------TWVALDVCLSYKVQCKMDF--KIF 185

Query: 90  -ASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARRE 148
             ++ N N     L  L                       Q LL     +    W +R +
Sbjct: 186 WLNLKNCNSPETVLEML-----------------------QKLL----YQIDPNWTSRSD 218

Query: 149 IIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD-FGLS------------- 194
               I   +  I  E++  +  +  +   ++L    N K  + F LS             
Sbjct: 219 HSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVT 278

Query: 195 -KLFPENTTHIST--RVAG-----TLGYLA----------PEYAISGRLTRKSDVYSFGV 236
             L    TTHIS                L           P   ++              
Sbjct: 279 DFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNP----------- 327

Query: 237 LLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV-------DPM----LYGN-- 283
             L I+   +  D      +       W   N  +L  ++       +P     ++    
Sbjct: 328 RRLSII-AESIRDGLATW-DN------WKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLS 379

Query: 284 -FPENEAIRFLKVGLLCV 300
            FP +  I      LL +
Sbjct: 380 VFPPSAHI---PTILLSL 394

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 54.7 bits (132), Expect = 1e-08
 Identities = 45/217 (20%), Positives = 82/217 (37%), Gaps = 38/217 (17%)

Query: 48  NKIGEGGFGSVYKGR-LQDGTIVAVKVL-SVES--KQGEKEFMSEVASMANVNVCHENLV 103
           + IG+G FG V K     +   VA+K++ + ++   Q + E          V +    L 
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIE----------VRL----LE 105

Query: 104 KLHGGCIDGPCRIL-VYDY--------MPNNSLSQTL--LGEEKRRAKFGWKARREIIMG 152
            ++    +    I+ +  +        +    LS  L  L              R+    
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQ 165

Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP--KISDFGLSKLFPEN-TTHISTRVA 209
           +   L ++    +  ++H D+K  NILL        KI DFG S    +    +I +R  
Sbjct: 166 MCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF- 223

Query: 210 GTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT 246
               Y +PE  +        D++S G +L+E+ +G  
Sbjct: 224 ----YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEP 256

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 47.7 bits (114), Expect = 3e-06
 Identities = 47/246 (19%), Positives = 82/246 (33%), Gaps = 82/246 (33%)

Query: 49  KIGEGGFGSVYKG--RLQDGTIVAVKVL-SVES--KQGEKE--FMSEVASMANVNVCHEN 101
            +GEG FG V +     +  + VA+K++ +V    +    E   + ++      N     
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFL-- 83

Query: 102 LVKL-----HGG--CID----GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 150
            V +       G  CI     G      ++++  N+              +     R + 
Sbjct: 84  CVLMSDWFNFHGHMCIAFELLGKN---TFEFLKENNFQP-----------YPLPHVRHMA 129

Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP-------------------KISDF 191
             +   L ++HE     + H D+K  NIL   +                      +++DF
Sbjct: 130 YQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 186

Query: 192 GLSKLFPENTTH---ISTRVAGTLGYLAPE--------YAISGRLTRKSDVYSFGVLLLE 240
           G S  F ++  H   ++TR      Y  PE                   DV+S G +L E
Sbjct: 187 G-SATF-DHEHHTTIVATRH-----YRPPEVILELGWAQPC--------DVWSIGCILFE 231

Query: 241 IVSGRT 246
              G T
Sbjct: 232 YYRGFT 237

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 45.0 bits (107), Expect = 2e-05
 Identities = 52/249 (20%), Positives = 93/249 (37%), Gaps = 84/249 (33%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVL-SVES--KQGEKEFMSEVASMANVNVCHENLVK 104
           K+G+G FG V   + + +    AVKV+ +++   +  + E    +  + N ++ + N+VK
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE-ADILKKIQNDDINNNNIVK 100

Query: 105 L-----HGG--CID----GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGI 153
                 +    C+     GP    +Y+ +  N               F  +  +   + I
Sbjct: 101 YHGKFMYYDHMCLIFEPLGPS---LYEIITRN-----------NYNGFHIEDIKLYCIEI 146

Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP-------------------------KI 188
            + L Y+ +     + H D+K  NILLD  +                           K+
Sbjct: 147 LKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203

Query: 189 SDFGLSKLFPENTTH---ISTRVAGTLGYLAPE--------YAISGRLTRKSDVYSFGVL 237
            DFG    F ++  H   I+TR      Y APE         +         D++SFG +
Sbjct: 204 IDFG-CATF-KSDYHGSIINTRQ-----YRAPEVILNLGWDVSS--------DMWSFGCV 248

Query: 238 LLEIVSGRT 246
           L E+ +G  
Sbjct: 249 LAELYTGSL 257

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 43.8 bits (104), Expect = 4e-05
 Identities = 54/246 (21%), Positives = 86/246 (34%), Gaps = 82/246 (33%)

Query: 49  KIGEGGFGSVYKG--RLQDGTIVAVKVL-SVES--KQGEKEFMSEVASMANVN----VCH 99
            +GEG FG V +       G  VAVK++ +V+   +       SE+  + ++N       
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA----RSEIQVLEHLNTTDPNST 76

Query: 100 ENLVKLHGG-------CID----GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARRE 148
              V++          CI     G      YD++  N               F     R+
Sbjct: 77  FRCVQMLEWFEHHGHICIVFELLGLS---TYDFIKEN-----------GFLPFRLDHIRK 122

Query: 149 IIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP-------------------KIS 189
           +   I + + ++H      + H D+K  NIL  Q+                      K+ 
Sbjct: 123 MAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVV 179

Query: 190 DFGLSKLFPEN-TTHISTRVAGTLGYLAPE--------YAISGRLTRKSDVYSFGVLLLE 240
           DFG +    E+ +T +STR      Y APE                   DV+S G +L+E
Sbjct: 180 DFGSATYDDEHHSTLVSTRH-----YRAPEVILALGWSQPC--------DVWSIGCILIE 226

Query: 241 IVSGRT 246
              G T
Sbjct: 227 YYLGFT 232

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	358
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.92
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.88
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.79
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.71
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.43
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.23
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.12
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.97
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.77
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.58
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.56
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.44
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.42
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.41
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.31
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.13
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.09
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.0
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.82
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.75
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.73
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.68
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.64
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.61
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.51
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.41
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.22
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.18
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.11
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.92
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.09
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.8
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	93.87
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	93.25

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.4e-55  Score=400.18  Aligned_cols=250  Identities=22%  Similarity=0.354  Sum_probs=205.3

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      ++|++++.||+|+||.||+|++. +|+.||||++...  .......+.+|+.+++.++  ||||+++++++.+++..|+|
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~--HpnIV~~~~~~~~~~~~yiV  101 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMK--HPNIVQYRESFEENGSLYIV  101 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCC--CTTBCCEEEEEEETTEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCC--CCCCCcEEEEEEECCEEEEE
Confidence            68999999999999999999975 6999999999754  3445678899999999998  99999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      ||||+||+|.+++..  .....+++..++.++.||+.||+|||++   ||+||||||+|||++.+|.+||+|||+++...
T Consensus       102 mEy~~gg~L~~~i~~--~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  176 (350)
T 4b9d_A          102 MDYCEGGDLFKRINA--QKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLN  176 (350)
T ss_dssp             EECCTTCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCC
T ss_pred             EeCCCCCcHHHHHHH--cCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeec
Confidence            999999999999943  2345678999999999999999999999   99999999999999999999999999998653


Q ss_pred             CCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhcc
Q 018263          199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDP  278 (358)
Q Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (358)
                      .. .......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||...+.......+.               ..
T Consensus       177 ~~-~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~---------------~~  240 (350)
T 4b9d_A          177 ST-VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII---------------SG  240 (350)
T ss_dssp             HH-HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---------------HT
T ss_pred             CC-cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH---------------cC
Confidence            21 122344679999999999999999999999999999999999999998654322221111               10


Q ss_pred             ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          279 MLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       279 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                       .....+...+.++.+||.+||+.||.+|||+.|+++
T Consensus       241 -~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          241 -SFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -CCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             011233456678999999999999999999999976

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.4e-55  Score=395.34  Aligned_cols=263  Identities=26%  Similarity=0.422  Sum_probs=218.9

Q ss_pred             HhhcCCcccceecccCceEEEEEEEC------CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG  112 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~  112 (358)
                      +..++|++.++||+|+||.||+|++.      ++..||||++........+.+.+|+.++++++  ||||+++++++.++
T Consensus        10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~--HpnIV~l~g~~~~~   87 (299)
T 4asz_A           10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ--HEHIVKFYGVCVEG   87 (299)
T ss_dssp             CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCC--CTTBCCEEEEECSS
T ss_pred             cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCC--CCCCccEEEEEeeC
Confidence            34578999999999999999999863      47789999998777777788999999999998  99999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHhhhcc---------ccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCC
Q 018263          113 PCRILVYDYMPNNSLSQTLLGEE---------KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN  183 (358)
Q Consensus       113 ~~~~iv~e~~~~~~L~~~l~~~~---------~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~  183 (358)
                      +..++||||+++|+|.+++....         .....+++..+..++.||+.||+|||++   +|+||||||+||+++.+
T Consensus        88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~  164 (299)
T 4asz_A           88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN  164 (299)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCC
Confidence            99999999999999999996432         2235799999999999999999999999   99999999999999999


Q ss_pred             CceEEeecccccccCCCCcc-cccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhH
Q 018263          184 FNPKISDFGLSKLFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVD  261 (358)
Q Consensus       184 ~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~  261 (358)
                      +.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+| |+.||...+....     
T Consensus       165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~-----  239 (299)
T 4asz_A          165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV-----  239 (299)
T ss_dssp             GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-----
T ss_pred             CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-----
Confidence            99999999999865332222 2233568999999999999999999999999999999998 8999975433211     


Q ss_pred             hhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCC
Q 018263          262 KAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETN  322 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~  322 (358)
                                 ...+........|..++.++.+|+.+||+.||++|||+.+|.+.|+++..
T Consensus       240 -----------~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~  289 (299)
T 4asz_A          240 -----------IECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK  289 (299)
T ss_dssp             -----------HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----------HHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence                       11111222234455677889999999999999999999999999987653

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=8.1e-55  Score=397.06  Aligned_cols=249  Identities=21%  Similarity=0.326  Sum_probs=212.1

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEe
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD  120 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e  120 (358)
                      +.|++.++||+|+||.||+|+++ +|+.||||++........+.+.+|+.+++.++  ||||+++++++.+.+..|+|||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~--HpnIV~l~~~~~~~~~~~ivmE  151 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ--HENVVEMYNSYLVGDELWVVME  151 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCC--CTTBCCEEEEEEETTEEEEEEC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCC--CCCCCcEEEEEEECCEEEEEEe
Confidence            56999999999999999999976 69999999998766566677889999999998  9999999999999999999999


Q ss_pred             cCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCC
Q 018263          121 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN  200 (358)
Q Consensus       121 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~  200 (358)
                      |++||+|.+++.     ...+++..++.++.||+.||+|||++   ||+||||||+|||++.+|.+||+|||++......
T Consensus       152 y~~gg~L~~~l~-----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  223 (346)
T 4fih_A          152 FLEGGALTDIVT-----HTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE  223 (346)
T ss_dssp             CCTTEEHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred             CCCCCcHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCC
Confidence            999999999983     35699999999999999999999999   9999999999999999999999999999876433


Q ss_pred             CcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhcccc
Q 018263          201 TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPML  280 (358)
Q Consensus       201 ~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (358)
                      .. .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||...........+...            ..  .
T Consensus       224 ~~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~------------~~--~  288 (346)
T 4fih_A          224 VP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN------------LP--P  288 (346)
T ss_dssp             SC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS------------SC--C
T ss_pred             CC-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC------------CC--C
Confidence            22 234578999999999999999999999999999999999999999865433222222110            00  0


Q ss_pred             CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          281 YGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       281 ~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ....+...+.++.+||.+||+.||.+|||+.|+++
T Consensus       289 ~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          289 RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11122345678999999999999999999999986

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5.5e-55  Score=392.50  Aligned_cols=258  Identities=21%  Similarity=0.304  Sum_probs=215.9

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI  116 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~  116 (358)
                      .++|++.+.||+|+||.||+|++. +|+.||||++...   .......+.+|+++++.++  ||||+++++++.+.+..|
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~--HpnIv~l~~~~~~~~~~y  108 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD--HPFFVKLYFTFQDDEKLY  108 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC--CTTBCCEEEEEECSSEEE
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCC--CCCCCeEEEEEEeCCEEE
Confidence            467999999999999999999975 6999999999743   2345578899999999998  999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       117 iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      +||||++||+|.+++    ...+.+++..++.++.||+.||+|||++   ||+||||||+|||++.++.+||+|||++..
T Consensus       109 ivmEy~~gG~L~~~i----~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~  181 (311)
T 4aw0_A          109 FGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKV  181 (311)
T ss_dssp             EEECCCTTEEHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEecCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCcee
Confidence            999999999999999    4557899999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCC-cccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhh
Q 018263          197 FPENT-THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNL  275 (358)
Q Consensus       197 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                      ..... .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+..             
T Consensus       182 ~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~-------------  248 (311)
T 4aw0_A          182 LSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIK-------------  248 (311)
T ss_dssp             CCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------------
T ss_pred             cCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-------------
Confidence            64332 2334457899999999999999999999999999999999999999986543222211111             


Q ss_pred             hccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHH--HHhhcCCCCC
Q 018263          276 VDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAI--KMMNGETNID  324 (358)
Q Consensus       276 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil--~~L~~~~~~~  324 (358)
                        .  ...++...+.++.+||.+||+.||.+|||++|++  ..+.++.-+.
T Consensus       249 --~--~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~  295 (311)
T 4aw0_A          249 --L--EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE  295 (311)
T ss_dssp             --T--CCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGT
T ss_pred             --C--CCCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcC
Confidence              0  1123445567789999999999999999999863  2344444443

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.8e-54  Score=394.78  Aligned_cols=263  Identities=24%  Similarity=0.393  Sum_probs=214.3

Q ss_pred             HhhcCCcccceecccCceEEEEEEEC------CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG  112 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~  112 (358)
                      +..++|.+.++||+|+||.||+|++.      +++.||||++........+.+.+|++++++++  ||||+++++++.+.
T Consensus        38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~--HpnIV~l~g~~~~~  115 (329)
T 4aoj_A           38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQ--HQHIVRFFGVCTEG  115 (329)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCC--CTTBCCEEEEECSS
T ss_pred             cCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCC--CCCCCcEEEEEEEC
Confidence            34578889999999999999999864      47889999998777777788999999999998  99999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHhhhccc-----------cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEc
Q 018263          113 PCRILVYDYMPNNSLSQTLLGEEK-----------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD  181 (358)
Q Consensus       113 ~~~~iv~e~~~~~~L~~~l~~~~~-----------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~  181 (358)
                      +..++||||+++|+|.+++.....           ...++++..+..++.||+.||+|||++   +|+||||||+||+++
T Consensus       116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~  192 (329)
T 4aoj_A          116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVG  192 (329)
T ss_dssp             SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEEC
Confidence            999999999999999999965322           235699999999999999999999999   999999999999999


Q ss_pred             CCCceEEeecccccccCCCC-cccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhh
Q 018263          182 QNFNPKISDFGLSKLFPENT-THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHL  259 (358)
Q Consensus       182 ~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~  259 (358)
                      .++.+||+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||+| |+.||.......... 
T Consensus       193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~-  271 (329)
T 4aoj_A          193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID-  271 (329)
T ss_dssp             TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH-
T ss_pred             CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH-
Confidence            99999999999998654322 222334678999999999999999999999999999999999 899997544322111 


Q ss_pred             hHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCC
Q 018263          260 VDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETN  322 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~  322 (358)
                                     .+....+...|..++..+.+|+.+||+.||++|||+.||++.|+.+..
T Consensus       272 ---------------~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~  319 (329)
T 4aoj_A          272 ---------------CITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ  319 (329)
T ss_dssp             ---------------HHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ---------------HHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence                           111122234455677889999999999999999999999999998754

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.8e-54  Score=389.92  Aligned_cols=263  Identities=24%  Similarity=0.373  Sum_probs=217.1

Q ss_pred             hhcCCcccceecccCceEEEEEEEC------CCCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG  112 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~  112 (358)
                      ..+++++.++||+|+||.||+|++.      +++.||||.+... .....+.+.+|+.++.+++  ||||+++++++..+
T Consensus        24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~--HpNIV~l~g~~~~~  101 (308)
T 4gt4_A           24 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQ--HPNVVCLLGVVTKD  101 (308)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCC--CTTBCCEEEEECSS
T ss_pred             CHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCC--CCCCCCcceEEEEC
Confidence            3466788999999999999999863      4678999998654 3344578999999999998  99999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHhhhcc------------ccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEE
Q 018263          113 PCRILVYDYMPNNSLSQTLLGEE------------KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL  180 (358)
Q Consensus       113 ~~~~iv~e~~~~~~L~~~l~~~~------------~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv  180 (358)
                      +..++||||+++|+|.+++....            .....+++..+..++.||+.||+|||++   +|+||||||+||||
T Consensus       102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl  178 (308)
T 4gt4_A          102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLV  178 (308)
T ss_dssp             SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEE
Confidence            99999999999999999995432            1235689999999999999999999999   99999999999999


Q ss_pred             cCCCceEEeecccccccCCCC-cccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchh
Q 018263          181 DQNFNPKISDFGLSKLFPENT-THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYH  258 (358)
Q Consensus       181 ~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~  258 (358)
                      ++++.+||+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||+| |..||......+   
T Consensus       179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~---  255 (308)
T 4gt4_A          179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---  255 (308)
T ss_dssp             CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH---
T ss_pred             CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH---
Confidence            999999999999998653222 222344678999999999999999999999999999999998 899997543321   


Q ss_pred             hhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCC
Q 018263          259 LVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNI  323 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~  323 (358)
                                   +...+........+..++..+.+|+.+||+.||.+|||+.||++.|+...++
T Consensus       256 -------------~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~nl  307 (308)
T 4gt4_A          256 -------------VVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGNL  307 (308)
T ss_dssp             -------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC-
T ss_pred             -------------HHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccCC
Confidence                         1222222223345566778899999999999999999999999999976543

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=7.8e-54  Score=389.43  Aligned_cols=253  Identities=19%  Similarity=0.241  Sum_probs=208.7

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      .+.|++.++||+|+||.||+|+++ +|+.||||+++.....     .+|+.+++.++  ||||+++++++.+++..||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-----~~E~~il~~l~--HpnIV~l~~~~~~~~~~~ivm  129 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLS--SPRIVPLYGAVREGPWVNIFM  129 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-----THHHHTTTTCC--CTTBCCEEEEEEETTEEEEEE
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-----HHHHHHHHhCC--CCCCCcEEEEEEECCEEEEEE
Confidence            467889999999999999999976 6999999999754322     36899999998  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCC-ceEEeecccccccC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF-NPKISDFGLSKLFP  198 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~-~~~l~Dfg~~~~~~  198 (358)
                      ||++|++|.+++    ...+.+++..+..++.||+.||+|||++   ||+||||||+|||++.+| .+||+|||++....
T Consensus       130 Ey~~gg~L~~~l----~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~  202 (336)
T 4g3f_A          130 ELLEGGSLGQLI----KQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQ  202 (336)
T ss_dssp             CCCTTCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred             eccCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence            999999999999    4456799999999999999999999999   999999999999999887 69999999998764


Q ss_pred             CCCcc----cccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhh
Q 018263          199 ENTTH----ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMN  274 (358)
Q Consensus       199 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                      .....    .....+||+.|+|||++.+..++.++|||||||++|+|++|++||...........+....   .      
T Consensus       203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~---~------  273 (336)
T 4g3f_A          203 PDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEP---P------  273 (336)
T ss_dssp             -----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSC---C------
T ss_pred             CCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCC---C------
Confidence            32211    1223579999999999999999999999999999999999999998665444332221110   0      


Q ss_pred             hhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCC
Q 018263          275 LVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGET  321 (358)
Q Consensus       275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~  321 (358)
                           .....+...+..+.++|.+||+.||.+|||+.|+++.|....
T Consensus       274 -----~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l  315 (336)
T 4g3f_A          274 -----PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKAL  315 (336)
T ss_dssp             -----GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----CchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence                 001233456678999999999999999999999988776543

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.2e-53  Score=398.52  Aligned_cols=249  Identities=22%  Similarity=0.339  Sum_probs=212.2

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEe
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD  120 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e  120 (358)
                      +.|+++++||+|+||.||+|++. +|+.||||++........+.+.+|+.+++.++  ||||+++++++.+.+.+|||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~--HpnIV~l~~~~~~~~~~~iVmE  228 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ--HENVVEMYNSYLVGDELWVVME  228 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCC--CTTBCCEEEEEEETTEEEEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCC--CCCCCceEEEEEECCEEEEEEe
Confidence            57999999999999999999976 69999999998766666677889999999998  9999999999999999999999


Q ss_pred             cCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCC
Q 018263          121 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN  200 (358)
Q Consensus       121 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~  200 (358)
                      ||+||+|.+++.     ...+++..+..++.||+.||+|||++   ||+||||||+|||++.+|.+||+|||++......
T Consensus       229 y~~gG~L~~~i~-----~~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~  300 (423)
T 4fie_A          229 FLEGGALTDIVT-----HTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE  300 (423)
T ss_dssp             CCTTEEHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSS
T ss_pred             CCCCCcHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCC
Confidence            999999999983     35699999999999999999999999   9999999999999999999999999999876433


Q ss_pred             CcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhcccc
Q 018263          201 TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPML  280 (358)
Q Consensus       201 ~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (358)
                      .. .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||...........+...            ..+  
T Consensus       301 ~~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~------------~~~--  365 (423)
T 4fie_A          301 VP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN------------LPP--  365 (423)
T ss_dssp             CC-CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS------------CCC--
T ss_pred             Cc-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC------------CCC--
Confidence            22 234578999999999999999999999999999999999999999765433322222110            000  


Q ss_pred             CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          281 YGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       281 ~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ........+.++.+||.+||+.||.+|||+.|+++
T Consensus       366 ~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          366 RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             CCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11122345677999999999999999999999986

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.7e-53  Score=377.66  Aligned_cols=245  Identities=23%  Similarity=0.335  Sum_probs=194.0

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      ++|++.+.||+|+||.||+|++. +|+.||+|++...   .......+.+|+.+++.++  ||||+++++++.+.+..|+
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~~~~~~~~~~~~~i   90 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR--HPHIIKLYDVIKSKDEIIM   90 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCC--CTTBCCEEEEEECSSEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCC--CCCCCeEEEEEEECCEEEE
Confidence            58999999999999999999975 6999999998643   2344567899999999998  9999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      ||||+ +|+|.+.+    ...+.+++..++.++.||+.||+|||++   ||+||||||+||+++.++.+||+|||++...
T Consensus        91 vmEy~-~g~L~~~l----~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~  162 (275)
T 3hyh_A           91 VIEYA-GNELFDYI----VQRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM  162 (275)
T ss_dssp             EEECC-CEEHHHHH----HHSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC---
T ss_pred             EEeCC-CCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeec
Confidence            99999 67999998    4557899999999999999999999999   9999999999999999999999999999865


Q ss_pred             CCCCcccccccccccCccCccccccCCC-CccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhh
Q 018263          198 PENTTHISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV  276 (358)
Q Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                      ....  .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+.......   +.            
T Consensus       163 ~~~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~---i~------------  225 (275)
T 3hyh_A          163 TDGN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKN---IS------------  225 (275)
T ss_dssp             --------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HH------------
T ss_pred             CCCC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHH---HH------------
Confidence            4322  2344689999999999988776 5799999999999999999999975433211111   11            


Q ss_pred             ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          277 DPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       277 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ..  ...++...+.++.+||.+||+.||++|||+.|+++
T Consensus       226 ~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          226 NG--VYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             HT--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cC--CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            00  11233445677899999999999999999999987

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-53  Score=384.32  Aligned_cols=265  Identities=25%  Similarity=0.386  Sum_probs=210.1

Q ss_pred             HHHHhhcCCcccceecccCceEEEEEEECCCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC
Q 018263           36 QLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP  113 (358)
Q Consensus        36 ~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~  113 (358)
                      .|.+..+++++.++||+|+||.||+|++++  .||||+++..  .....+.+.+|+.++++++  ||||+++++++.. +
T Consensus        30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~--HpNIV~l~g~~~~-~  104 (307)
T 3omv_A           30 YWEIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTR--HVNILLFMGYMTK-D  104 (307)
T ss_dssp             CCBCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCC--CTTBCCEEEEECS-S
T ss_pred             CcEEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCC--CCCEeeEEEEEEC-C
Confidence            356778899999999999999999998753  5899998644  3445578999999999998  9999999998764 5


Q ss_pred             eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccc
Q 018263          114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL  193 (358)
Q Consensus       114 ~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~  193 (358)
                      ..++||||++||+|.+++..   ....+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       105 ~~~iVmEy~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGl  178 (307)
T 3omv_A          105 NLAIVTQWCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGL  178 (307)
T ss_dssp             SCEEEEECCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSS
T ss_pred             eEEEEEEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccC
Confidence            68999999999999999942   345799999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCC-cccccccccccCccCcccccc---CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccch
Q 018263          194 SKLFPENT-THISTRVAGTLGYLAPEYAIS---GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNS  269 (358)
Q Consensus       194 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~---~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      ++...... ........||+.|+|||++.+   ..++.++|||||||++|||++|+.||............  ....   
T Consensus       179 a~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~--~~~~---  253 (307)
T 3omv_A          179 ATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFM--VGRG---  253 (307)
T ss_dssp             CBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH--HHTT---
T ss_pred             ceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHH--HhcC---
Confidence            98654322 223345679999999999864   45899999999999999999999999754332211111  1000   


Q ss_pred             hhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCC
Q 018263          270 KELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETN  322 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~  322 (358)
                            .........+..++..+.+|+.+||+.||++|||+.||++.|+.++.
T Consensus       254 ------~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~  300 (307)
T 3omv_A          254 ------YASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH  300 (307)
T ss_dssp             ------CCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred             ------CCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence                  00001122344567789999999999999999999999999988764

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=9.2e-53  Score=376.05  Aligned_cols=245  Identities=24%  Similarity=0.379  Sum_probs=198.6

Q ss_pred             CcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEc----CCeeE
Q 018263           44 FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID----GPCRI  116 (358)
Q Consensus        44 y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~----~~~~~  116 (358)
                      |++.++||+|+||.||+|.+. ++..||+|.+...  .......+.+|+.+++.++  ||||+++++++.+    ....|
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~--HpnIV~~~~~~~~~~~~~~~~~  105 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ--HPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCC--CTTBCCEEEEEEEEETTEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCC--CCCCCcEEEEEeeccCCCcEEE
Confidence            367788999999999999976 6899999998644  3445577999999999998  9999999999865    34579


Q ss_pred             EEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCC--cEEcCCCCCcEEEcC-CCceEEeeccc
Q 018263          117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH--VVHRDIKTSNILLDQ-NFNPKISDFGL  193 (358)
Q Consensus       117 iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~--i~H~di~p~Nilv~~-~~~~~l~Dfg~  193 (358)
                      +||||++||+|.+++    ...+.+++..+..++.||+.||+|||++   +  |+||||||+|||++. ++.+||+|||+
T Consensus       106 lvmEy~~gg~L~~~l----~~~~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGl  178 (290)
T 3fpq_A          106 LVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL  178 (290)
T ss_dssp             EEEECCCSCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTG
T ss_pred             EEEeCCCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcC
Confidence            999999999999999    4456799999999999999999999998   7  999999999999974 78999999999


Q ss_pred             ccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHh
Q 018263          194 SKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELM  273 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      +.....   ......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||........  ....+..        
T Consensus       179 a~~~~~---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~--~~~~i~~--------  244 (290)
T 3fpq_A          179 ATLKRA---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRRVTS--------  244 (290)
T ss_dssp             GGGCCT---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHHHHTT--------
T ss_pred             CEeCCC---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH--HHHHHHc--------
Confidence            986432   22345689999999998765 699999999999999999999999975432211  1111110        


Q ss_pred             hhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          274 NLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                          ......++...+.++.+||.+||+.||++|||+.|+++
T Consensus       245 ----~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          245 ----GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             ----TCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ----CCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                00001112223456889999999999999999999986

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.1e-53  Score=383.83  Aligned_cols=244  Identities=23%  Similarity=0.313  Sum_probs=198.4

Q ss_pred             hhcCCcccceecccCceEEEEEEEC----CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ----DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP  113 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~----~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~  113 (358)
                      ++++|++++.||+|+||.||+|+..    +++.||+|++...  .......+.+|+.+++.++  ||||+++++++.+++
T Consensus        22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~--HpnIv~l~~~~~~~~   99 (304)
T 3ubd_A           22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN--HPFIVKLHYAFQTEG   99 (304)
T ss_dssp             CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCC--CTTEECEEEEEEETT
T ss_pred             CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCC--CCCCCeEEEEEEECC
Confidence            4578999999999999999999862    4789999998643  2223346778999999998  999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccc
Q 018263          114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL  193 (358)
Q Consensus       114 ~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~  193 (358)
                      ..|+||||++||+|.+++    .+.+.+++..++.++.||+.||+|||++   ||+||||||+|||++.+|.+||+|||+
T Consensus       100 ~~~ivmEy~~gg~L~~~l----~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGl  172 (304)
T 3ubd_A          100 KLYLILDFLRGGDLFTRL----SKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGL  172 (304)
T ss_dssp             EEEEEECCCTTCEEHHHH----HHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEE
T ss_pred             EEEEEEEcCCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEeccccc
Confidence            999999999999999999    4556899999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHh
Q 018263          194 SKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELM  273 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      ++...... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.            
T Consensus       173 a~~~~~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~------------  239 (304)
T 3ubd_A          173 SKESIDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL------------  239 (304)
T ss_dssp             EEC------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------------
T ss_pred             ceeccCCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHH------------
Confidence            98643322 22344689999999999999999999999999999999999999998654332221111            


Q ss_pred             hhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 018263          274 NLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQM  310 (358)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~  310 (358)
                         ..  ...++...+.++.+||.+||+.||.+|||+
T Consensus       240 ---~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~ta  271 (304)
T 3ubd_A          240 ---KA--KLGMPQFLSPEAQSLLRMLFKRNPANRLGA  271 (304)
T ss_dssp             ---HC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred             ---cC--CCCCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence               11  112344566789999999999999999995

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.1e-52  Score=385.96  Aligned_cols=271  Identities=23%  Similarity=0.341  Sum_probs=223.4

Q ss_pred             cCHHHHHHhhcCCcccceecccCceEEEEEEECC------CCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCcee
Q 018263           32 FSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQD------GTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVK  104 (358)
Q Consensus        32 ~~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~------~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~  104 (358)
                      +..+.+++..++|++.+.||+|+||.||+|.+..      ++.||+|.+.... ....+.+.+|+.++.++. .||||++
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~-hhpnIV~  132 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG-HHLNVVN  132 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC-CCTTBCC
T ss_pred             CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcC-CCCcEEE
Confidence            5667888999999999999999999999998642      3579999987543 344567899999999997 3599999


Q ss_pred             eeceEEcC-CeeEEEEecCCCCCHHHHhhhccc------------cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEc
Q 018263          105 LHGGCIDG-PCRILVYDYMPNNSLSQTLLGEEK------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHR  171 (358)
Q Consensus       105 ~~~~~~~~-~~~~iv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~  171 (358)
                      +++++... +..++|||||++|+|.++++....            ....+++..+..++.||+.||+|||++   +|+||
T Consensus       133 l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHR  209 (353)
T 4ase_A          133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR  209 (353)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred             EEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecC
Confidence            99998764 568999999999999999965322            134589999999999999999999999   99999


Q ss_pred             CCCCCcEEEcCCCceEEeecccccccCCCCc-ccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCC
Q 018263          172 DIKTSNILLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVD  249 (358)
Q Consensus       172 di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~  249 (358)
                      ||||+||+++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.
T Consensus       210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~  289 (353)
T 4ase_A          210 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  289 (353)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             ccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCC
Confidence            9999999999999999999999986643332 23344678999999999999999999999999999999998 899997


Q ss_pred             ccccccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCC
Q 018263          250 FDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGET  321 (358)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~  321 (358)
                      ......               .+...+....+...|...+.++.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus       290 ~~~~~~---------------~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll  346 (353)
T 4ase_A          290 GVKIDE---------------EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  346 (353)
T ss_dssp             TCCCSH---------------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCHHH---------------HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            543221               111222222333455566778999999999999999999999999998764

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.7e-51  Score=372.13  Aligned_cols=274  Identities=24%  Similarity=0.304  Sum_probs=203.7

Q ss_pred             hcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC----eeE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP----CRI  116 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~----~~~  116 (358)
                      .++|.+.++||+|+||.||+|++. |+.||||++.... ......+.|+..+..++  ||||+++++++..++    ..+
T Consensus         2 ar~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~--HpNIv~l~g~~~~~~~~~~~~~   77 (303)
T 3hmm_A            2 ARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE-ERSWFREAEIYQTVMLR--HENILGFIAADNKDNGTWTQLW   77 (303)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCC--CTTBCCEEEEEEEECSSSEEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc-hhhHHHHHHHHHHhcCC--CCCCCcEEEEEEecCCCceEEE
Confidence            357889999999999999999984 8999999986432 22223334555566666  999999999998654    579


Q ss_pred             EEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCcEEcCCCCCcEEEcCCCceEEeec
Q 018263          117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI-----QPHVVHRDIKTSNILLDQNFNPKISDF  191 (358)
Q Consensus       117 iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~-----~~~i~H~di~p~Nilv~~~~~~~l~Df  191 (358)
                      +||||+++|+|.+++.     ...+++..+.+++.|++.||+|||+++     ..+|+||||||+|||++.++.+||+||
T Consensus        78 lV~Ey~~~gsL~~~l~-----~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DF  152 (303)
T 3hmm_A           78 LVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  152 (303)
T ss_dssp             EEEECCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred             EEecCCCCCcHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeC
Confidence            9999999999999993     346899999999999999999999751     348999999999999999999999999


Q ss_pred             ccccccCCCCcc---cccccccccCccCccccccC------CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHh
Q 018263          192 GLSKLFPENTTH---ISTRVAGTLGYLAPEYAISG------RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDK  262 (358)
Q Consensus       192 g~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~------~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~  262 (358)
                      |+++........   ......||+.|+|||++.+.      .++.++|||||||++|||++|.+||........... ..
T Consensus       153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~-~~  231 (303)
T 3hmm_A          153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY-DL  231 (303)
T ss_dssp             TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT-TT
T ss_pred             CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccch-hc
Confidence            999865433322   12235799999999998754      367899999999999999999988765432211100 00


Q ss_pred             hhhccchhhHhh-hhccccCCCCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCC
Q 018263          263 AWGMYNSKELMN-LVDPMLYGNFP-----ENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNID  324 (358)
Q Consensus       263 ~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~  324 (358)
                      ............ ......++..+     ...+..+.+|+.+||+.||++||||.||++.|+++...+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~  299 (303)
T 3hmm_A          232 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  299 (303)
T ss_dssp             SCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             ccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence            000011111111 22333333333     246678999999999999999999999999999876443

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.6e-50  Score=364.37  Aligned_cols=247  Identities=20%  Similarity=0.345  Sum_probs=189.2

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC------
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP------  113 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~------  113 (358)
                      ++|++++.||+|+||.||+|+++ +|+.||||++.... ....+.+.+|+.+++.++  ||||+++++++...+      
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~--HpnIV~~~~~~~~~~~~~~~~   82 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE--HPGIVRYFNAWLEKNTTEKLQ   82 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCC--CTTBCCEEEEEEEEC------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCC--CCCCCeEEEEEEecCcccccc
Confidence            46999999999999999999976 69999999987553 344567899999999998  999999999987554      


Q ss_pred             ------eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceE
Q 018263          114 ------CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPK  187 (358)
Q Consensus       114 ------~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~  187 (358)
                            ..|+||||++|++|.+++.... .....++..++.++.||+.||+|||++   ||+||||||+||+++.++.+|
T Consensus        83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vK  158 (299)
T 4g31_A           83 PSSPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVK  158 (299)
T ss_dssp             ----CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred             ccCCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEE
Confidence                  3689999999999999994321 223345677899999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcc-----------cccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccc
Q 018263          188 ISDFGLSKLFPENTTH-----------ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE  256 (358)
Q Consensus       188 l~Dfg~~~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~  256 (358)
                      |+|||+++........           .....+||+.|+|||++.+..|+.++|||||||++|+|++   ||.....  .
T Consensus       159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~--~  233 (299)
T 4g31_A          159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME--R  233 (299)
T ss_dssp             ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH--H
T ss_pred             EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH--H
Confidence            9999999876432211           1233579999999999999999999999999999999996   7753211  1


Q ss_pred             hhhhHhhhhccchhhHhhhhccccCCCCCH---HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          257 YHLVDKAWGMYNSKELMNLVDPMLYGNFPE---NEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .......                ....+++   .......+||.+||+.||.+|||+.|+++
T Consensus       234 ~~~~~~~----------------~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          234 VRTLTDV----------------RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HHHHHHH----------------HTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHH----------------hcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1111111                1112222   33445778999999999999999999987

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.9e-50  Score=375.16  Aligned_cols=270  Identities=21%  Similarity=0.308  Sum_probs=213.7

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEc------
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID------  111 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~------  111 (358)
                      +++|++++.||+|+||.||+|++. +|+.||||++...  .....+.+.+|+.+++.++  ||||+++++++..      
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~~~~~  130 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFK--HDNIIAIKDILRPTVPYGE  130 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCC--CTTBCCEEEECCCSSCTTT
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcC--CCCcceEeeeeeccccccc
Confidence            368999999999999999999975 6999999999644  3344567889999999998  9999999998764      


Q ss_pred             CCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeec
Q 018263          112 GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF  191 (358)
Q Consensus       112 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Df  191 (358)
                      .+..|+||||++ |+|.+++    ...+.+++..++.++.||+.||.|||++   ||+||||||+||+++.++.+||+||
T Consensus       131 ~~~~~ivmE~~~-g~L~~~i----~~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DF  202 (398)
T 4b99_A          131 FKSVYVVLDLME-SDLHQII----HSSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDF  202 (398)
T ss_dssp             CCCEEEEEECCS-EEHHHHH----TSSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCC
T ss_pred             CCEEEEEEeCCC-CCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeec
Confidence            367899999995 6799998    4567899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCC---cccccccccccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhcc
Q 018263          192 GLSKLFPENT---THISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMY  267 (358)
Q Consensus       192 g~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~  267 (358)
                      |+++......   .......+||+.|+|||++.+. .++.++||||+||++|+|++|++||.+.+..+....+....+.+
T Consensus       203 Gla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p  282 (398)
T 4b99_A          203 GMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTP  282 (398)
T ss_dssp             TTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             ceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            9998653322   2233457899999999998875 56999999999999999999999999887766666655544433


Q ss_pred             chhhHhh--------hhccccCC-CC-----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhhcC
Q 018263          268 NSKELMN--------LVDPMLYG-NF-----PENEAIRFLKVGLLCVQEKSKLRPQMSTAIK--MMNGE  320 (358)
Q Consensus       268 ~~~~~~~--------~~~~~~~~-~~-----~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~--~L~~~  320 (358)
                      ....+..        .+...... ..     .+..+.++.+||.+||+.||.+|||+.|+++  .|...
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  351 (398)
T 4b99_A          283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY  351 (398)
T ss_dssp             CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred             ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence            3221111        11110000 00     0123567889999999999999999999986  45444

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=4.2e-49  Score=364.31  Aligned_cols=265  Identities=22%  Similarity=0.273  Sum_probs=202.0

Q ss_pred             HHhhcCCcccceecccCceEEEEEEEC----CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC
Q 018263           38 KIATNGFRWSNKIGEGGFGSVYKGRLQ----DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP  113 (358)
Q Consensus        38 ~~~~~~y~i~~~lg~g~~g~v~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~  113 (358)
                      ....++|++.++||+|+||.||+|+.+    +++.||+|.+....  ...++.+|++.++.+. .||||+++++++.+.+
T Consensus        17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~-~h~nIv~l~~~~~~~~   93 (361)
T 4f9c_A           17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAG-GQDNVMGVKYCFRKND   93 (361)
T ss_dssp             GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTC-SBTTBCCCSEEEEETT
T ss_pred             CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhc-CCCCCceEEEEEEECC
Confidence            345689999999999999999999853    47889999886433  3456788999998874 4999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCC-CceEEeecc
Q 018263          114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN-FNPKISDFG  192 (358)
Q Consensus       114 ~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~-~~~~l~Dfg  192 (358)
                      ..|+||||++|++|.+++       +.+++..++.++.||+.||+|||++   ||+||||||+||+++.+ +.+||+|||
T Consensus        94 ~~~lvmE~~~g~~L~~~~-------~~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFG  163 (361)
T 4f9c_A           94 HVVIAMPYLEHESFLDIL-------NSLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFG  163 (361)
T ss_dssp             EEEEEEECCCCCCHHHHH-------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEEEEEeCCCcccHHHHH-------cCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCC
Confidence            999999999999999998       2489999999999999999999999   99999999999999876 799999999


Q ss_pred             cccccCCCCc---------------------------ccccccccccCccCccccccC-CCCccCceecHHHHHHHHHhC
Q 018263          193 LSKLFPENTT---------------------------HISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSG  244 (358)
Q Consensus       193 ~~~~~~~~~~---------------------------~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg  244 (358)
                      +++.......                           ......+||+.|+|||++.+. .++.++||||+||++|+|++|
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G  243 (361)
T 4f9c_A          164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG  243 (361)
T ss_dssp             TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred             CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence            9976433211                           112235799999999998875 589999999999999999999


Q ss_pred             CCCCCccc-cccchhhhHhhhhccchhhH-------------------hhhhccc------------------cCCCCCH
Q 018263          245 RTAVDFDV-QLGEYHLVDKAWGMYNSKEL-------------------MNLVDPM------------------LYGNFPE  286 (358)
Q Consensus       245 ~~pf~~~~-~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~------------------~~~~~~~  286 (358)
                      +.||.... ..+....+....+.......                   .......                  .......
T Consensus       244 ~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~  323 (361)
T 4f9c_A          244 RYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWN  323 (361)
T ss_dssp             CSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CT
T ss_pred             CCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccc
Confidence            99996443 22222222222211111000                   0000000                  0001112


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          287 NEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       287 ~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ..+.++.+||.+||+.||.+|||++|+++
T Consensus       324 ~is~~a~DLl~~lL~~dP~~R~ta~eaL~  352 (361)
T 4f9c_A          324 EVPDEAYDLLDKLLDLNPASRITAEEALL  352 (361)
T ss_dssp             TCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             cCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            34567889999999999999999999985

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=3.2e-48  Score=354.92  Aligned_cols=298  Identities=40%  Similarity=0.742  Sum_probs=249.5

Q ss_pred             ccccccccCHHHHHHhhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCce
Q 018263           25 ILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLV  103 (358)
Q Consensus        25 ~~~~~~~~~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~  103 (358)
                      ....+..++..++.+..++|++.+.||+|+||.||+|+..+|+.||+|++.... ......+.+|+..++.+.  ||||+
T Consensus        13 ~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv   90 (326)
T 3uim_A           13 HLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAV--HRNLL   90 (326)
T ss_dssp             --CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCC--CTTBC
T ss_pred             ccCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhcc--CCCcc
Confidence            345678899999999999999999999999999999998889999999986543 222336889999999998  99999


Q ss_pred             eeeceEEcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCC
Q 018263          104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN  183 (358)
Q Consensus       104 ~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~  183 (358)
                      ++++++...+..++||||+++++|.+++.........+++..++.++.|++.||.|||+.+..|++|+||+|+||+++.+
T Consensus        91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~  170 (326)
T 3uim_A           91 RLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEE  170 (326)
T ss_dssp             CCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTT
T ss_pred             ceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCC
Confidence            99999999999999999999999999997655556679999999999999999999999766699999999999999999


Q ss_pred             CceEEeecccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccc--cchhhhH
Q 018263          184 FNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL--GEYHLVD  261 (358)
Q Consensus       184 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~--~~~~~~~  261 (358)
                      +.++|+|||++...............+++.|+|||++.+..++.++||||||+++|+|++|+.||......  .......
T Consensus       171 ~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  250 (326)
T 3uim_A          171 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD  250 (326)
T ss_dssp             CCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHH
T ss_pred             CCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHH
Confidence            99999999999876555554455567999999999998888999999999999999999999999643221  2222223


Q ss_pred             hhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCC
Q 018263          262 KAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNID  324 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~  324 (358)
                      .............+.+......++...+..+.+++.+||+.||.+|||+.+|++.|++....+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~  313 (326)
T 3uim_A          251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAE  313 (326)
T ss_dssp             HHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSS
T ss_pred             HHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhh
Confidence            333333444555666666777788899999999999999999999999999999999754433

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.8e-47  Score=349.35  Aligned_cols=285  Identities=41%  Similarity=0.642  Sum_probs=239.1

Q ss_pred             HHHHHhhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCe
Q 018263           35 NQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC  114 (358)
Q Consensus        35 ~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~  114 (358)
                      .++....++|++.+.||+|+||.||+|++++|+.||+|.+..........+.+|+..++.++  ||||+++++++...+.
T Consensus        32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~  109 (321)
T 2qkw_B           32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCR--HPHLVSLIGFCDERNE  109 (321)
T ss_dssp             SCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCC--CTTBCCEEEECCCTTC
T ss_pred             HHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCC--CCCEeeEEEEEcCCCe
Confidence            34444678999999999999999999998889999999987766667788999999999998  9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccc
Q 018263          115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS  194 (358)
Q Consensus       115 ~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~  194 (358)
                      .++||||+++++|.+++.........+++..++.++.||+.||.|||++   |++|+||+|+||+++.++.++|+|||++
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~  186 (321)
T 2qkw_B          110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGIS  186 (321)
T ss_dssp             CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred             EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecccc
Confidence            9999999999999999955444445689999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCC-cccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHh
Q 018263          195 KLFPENT-THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELM  273 (358)
Q Consensus       195 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      ....... ........+++.|+|||++.+..++.++||||||+++|+|++|+.||.........................
T Consensus       187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (321)
T 2qkw_B          187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE  266 (321)
T ss_dssp             EECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCC
T ss_pred             cccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHH
Confidence            7643222 222233568999999999998899999999999999999999999998766554444333322222333344


Q ss_pred             hhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCC
Q 018263          274 NLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNID  324 (358)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~  324 (358)
                      ..+++......+...+..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus       267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~  317 (321)
T 2qkw_B          267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ  317 (321)
T ss_dssp             SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence            555566666677889999999999999999999999999999999876554

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=8.2e-48  Score=375.07  Aligned_cols=249  Identities=25%  Similarity=0.325  Sum_probs=202.9

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHH---HHHhhhcccCCCCceeeeceEEcCC
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSE---VASMANVNVCHENLVKLHGGCIDGP  113 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e---~~~l~~l~~~h~~i~~~~~~~~~~~  113 (358)
                      .++|++++.||+|+||.||+|+.+ +|+.||||++...   .........+|   +..+..++  ||||++++++|.+.+
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~--HP~IV~l~~~f~~~~  265 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD--CPFIVCMSYAFHTPD  265 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSC--CTTBCCEEEEEECSS
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCC--CCCEeEEEEEEEECC
Confidence            468999999999999999999976 6999999998643   12223333344   45555556  999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccc
Q 018263          114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL  193 (358)
Q Consensus       114 ~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~  193 (358)
                      .+|+||||++||+|.+++    ...+.+++..++.++.||+.||+|||++   ||+||||||+|||++.+|.+||+|||+
T Consensus       266 ~lylVmEy~~GGdL~~~l----~~~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGl  338 (689)
T 3v5w_A          266 KLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGL  338 (689)
T ss_dssp             EEEEEECCCCSCBHHHHH----HHHCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEEecCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccce
Confidence            999999999999999999    4567899999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhH
Q 018263          194 SKLFPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKEL  272 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      +.......   ....+||+.|+|||++.+ ..|+.++|+|||||++|+|++|++||......+.......+..       
T Consensus       339 A~~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~-------  408 (689)
T 3v5w_A          339 ACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-------  408 (689)
T ss_dssp             CEECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH-------
T ss_pred             eeecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC-------
Confidence            98754322   234689999999999974 5799999999999999999999999976544333222221110       


Q ss_pred             hhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 018263          273 MNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQ-----MSTAIK  315 (358)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt-----~~eil~  315 (358)
                             ....++...+.++.+||.+||+.||.+|++     ++||++
T Consensus       409 -------~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          409 -------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             -------CCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             -------CCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence                   012344556778999999999999999998     566653

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.1e-47  Score=374.96  Aligned_cols=252  Identities=21%  Similarity=0.284  Sum_probs=212.2

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      .++|++.+.||+|+||.||+|.++ +|+.||+|++..........+.+|+.+++.++  ||||++++++|.+.+..|+||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~~~iv~  233 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR--HPTLVNLHDAFEDDNEMVMIY  233 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTC--CTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCC--CCCCCeEEEEEEECCEEEEEE
Confidence            368999999999999999999976 69999999998777677788999999999998  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCC--CceEEeeccccccc
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN--FNPKISDFGLSKLF  197 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~--~~~~l~Dfg~~~~~  197 (358)
                      ||++||+|.+++.   ...+.+++..+..++.||+.||+|||++   ||+||||||+||+++.+  +.+||+|||++..+
T Consensus       234 E~~~gg~L~~~i~---~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~  307 (573)
T 3uto_A          234 EFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  307 (573)
T ss_dssp             ECCCCCBHHHHHT---CTTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred             eecCCCcHHHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence            9999999999983   2346799999999999999999999999   99999999999999854  89999999999876


Q ss_pred             CCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhc
Q 018263          198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD  277 (358)
Q Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      ....  .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||...........+.....            
T Consensus       308 ~~~~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~------------  373 (573)
T 3uto_A          308 DPKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW------------  373 (573)
T ss_dssp             CTTS--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC------------
T ss_pred             cCCC--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCC------------
Confidence            4432  23446799999999999999999999999999999999999999986654332222211100            


Q ss_pred             cccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          278 PMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       278 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                       ..........+..+.+||.+||+.||.+|||+.|+++
T Consensus       374 -~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          374 -NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             -CCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             0001111234567889999999999999999999987

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.5e-46  Score=331.90  Aligned_cols=262  Identities=24%  Similarity=0.361  Sum_probs=218.4

Q ss_pred             HHhhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           38 KIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        38 ~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      .+..++|++.+.||+|+||.||+|.++++..||+|++.... .....+.+|+..+..++  ||||+++++++...+..++
T Consensus         4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~l   80 (268)
T 3sxs_A            4 ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLS--HPKLVKFYGVCSKEYPIYI   80 (268)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCC--CTTBCCEEEEECSSSSEEE
T ss_pred             EechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCC--CCCEeeEEEEEccCCceEE
Confidence            34578999999999999999999999888899999987443 34567889999999998  9999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      ||||+++++|.+++..   ....+++..++.++.|++.||+|||+.   |++|+||+|+||+++.++.++|+|||++...
T Consensus        81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~  154 (268)
T 3sxs_A           81 VTEYISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYV  154 (268)
T ss_dssp             EEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEEC
T ss_pred             EEEccCCCcHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceec
Confidence            9999999999999943   345689999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhHhhhh
Q 018263          198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV  276 (358)
Q Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                      ............++..|+|||++.+..++.++||||||+++|+|++ |..||...........                +
T Consensus       155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~----------------~  218 (268)
T 3sxs_A          155 LDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK----------------V  218 (268)
T ss_dssp             CTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH----------------H
T ss_pred             chhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHH----------------H
Confidence            5544444444556778999999998899999999999999999999 9999975433211111                1


Q ss_pred             ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCC
Q 018263          277 DPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNID  324 (358)
Q Consensus       277 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~  324 (358)
                      ........+...+..+.+++.+||+.+|.+|||+.++++.|+.+++..
T Consensus       219 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~  266 (268)
T 3sxs_A          219 SQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD  266 (268)
T ss_dssp             HTTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred             HcCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence            111112223334567999999999999999999999999999988654

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.2e-45  Score=333.74  Aligned_cols=251  Identities=21%  Similarity=0.342  Sum_probs=211.8

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      ..++|++.+.||+|+||.||+|.+. +|+.||+|++..........+.+|+..++.++  ||||+++++++...+..++|
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~~~~lv   95 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK--NPNIVNYLDSYLVGDELWVV   95 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCC--CTTBCCEEEEEEETTEEEEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCC--CCCCCeEeEEEEECCEEEEE
Confidence            3579999999999999999999964 69999999998776667778899999999998  99999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      |||+++++|.+++.     ...+++..++.++.|++.||+|||++   |++|+||+|+||+++.++.++|+|||++....
T Consensus        96 ~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (297)
T 3fxz_A           96 MEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  167 (297)
T ss_dssp             EECCTTCBHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EECCCCCCHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence            99999999999983     34689999999999999999999999   99999999999999999999999999988654


Q ss_pred             CCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhcc
Q 018263          199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDP  278 (358)
Q Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (358)
                      .... ......+++.|+|||++.+..++.++||||||+++|+|++|+.||...............              .
T Consensus       168 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--------------~  232 (297)
T 3fxz_A          168 PEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN--------------G  232 (297)
T ss_dssp             STTC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH--------------C
T ss_pred             Cccc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------C
Confidence            3332 233467999999999999999999999999999999999999999755432221111110              0


Q ss_pred             ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          279 MLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       279 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ......+...+..+.+++.+||+.||.+|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          233 TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             SCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            0111223445677899999999999999999999986

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=3.3e-46  Score=339.22  Aligned_cols=272  Identities=28%  Similarity=0.411  Sum_probs=210.4

Q ss_pred             cccCHHHHHHhhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccC--hhhHHHHHHHHHHhhhcccCCCCceeeec
Q 018263           30 NAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHG  107 (358)
Q Consensus        30 ~~~~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~~~h~~i~~~~~  107 (358)
                      ......++.+..++|++.+.||+|+||.||+|++ .|+.||+|++....  ......+.+|+..++.++  ||||+++++
T Consensus        25 ~~~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~  101 (309)
T 3p86_A           25 GAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLR--HPNIVLFMG  101 (309)
T ss_dssp             -------CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCC--CTTBCCEEE
T ss_pred             cCCCcccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCC--CCCEeeEEE
Confidence            3456666677789999999999999999999988 48889999986543  344567889999999998  999999999


Q ss_pred             eEEcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCC--cEEcCCCCCcEEEcCCCc
Q 018263          108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH--VVHRDIKTSNILLDQNFN  185 (358)
Q Consensus       108 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~--i~H~di~p~Nilv~~~~~  185 (358)
                      ++......++||||+++++|.+++.... ....+++..++.++.||+.||+|||+.   |  ++|+||||+||+++.++.
T Consensus       102 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~  177 (309)
T 3p86_A          102 AVTQPPNLSIVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYT  177 (309)
T ss_dssp             EECSTTCCEEEEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCC
T ss_pred             EEEECCceEEEEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCc
Confidence            9999999999999999999999994321 123489999999999999999999999   9  999999999999999999


Q ss_pred             eEEeecccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhh
Q 018263          186 PKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG  265 (358)
Q Consensus       186 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~  265 (358)
                      ++|+|||++....... .......+++.|+|||++.+..++.++||||||+++|+|++|+.||...........+     
T Consensus       178 ~kL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~-----  251 (309)
T 3p86_A          178 VKVCDFGLSRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV-----  251 (309)
T ss_dssp             EEECCCC------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH-----
T ss_pred             EEECCCCCCccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-----
Confidence            9999999997543222 2223457899999999999999999999999999999999999999754322111111     


Q ss_pred             ccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCC
Q 018263          266 MYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNID  324 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~  324 (358)
                                .........+...+..+.++|.+||+.+|.+|||+.++++.|+.+....
T Consensus       252 ----------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          252 ----------GFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             ----------HHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             ----------HhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence                      1111223344556678999999999999999999999999999887655

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.9e-46  Score=332.66  Aligned_cols=261  Identities=26%  Similarity=0.422  Sum_probs=218.1

Q ss_pred             HHHhhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeE
Q 018263           37 LKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI  116 (358)
Q Consensus        37 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~  116 (358)
                      +.+..++|++.+.||+|+||.||+|.+.+++.||+|++.... .....+.+|+..++.++  ||||+++++++...+..+
T Consensus         5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~   81 (269)
T 4hcu_A            5 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLS--HPKLVQLYGVCLEQAPIC   81 (269)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCC--CTTBCCEEEEECSSSSEE
T ss_pred             EEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCC--CCCEeeEEEEEecCCceE
Confidence            345678999999999999999999999888999999987443 34467889999999998  999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       117 iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      +||||+++++|.+++..   ....+++..++.++.|++.||+|||+.   |++|+||+|+||+++.++.++|+|||++..
T Consensus        82 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  155 (269)
T 4hcu_A           82 LVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRF  155 (269)
T ss_dssp             EEEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGG
T ss_pred             EEEEeCCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccc
Confidence            99999999999999832   345689999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhHhhh
Q 018263          197 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNL  275 (358)
Q Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                      .............++..|+|||++.+..++.++||||||+++|+|++ |..||.........                ..
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~----------------~~  219 (269)
T 4hcu_A          156 VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV----------------ED  219 (269)
T ss_dssp             BCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH----------------HH
T ss_pred             ccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHH----------------HH
Confidence            64433333344556778999999998999999999999999999999 99999754332111                11


Q ss_pred             hccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCC
Q 018263          276 VDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETN  322 (358)
Q Consensus       276 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~  322 (358)
                      +........+...+..+.+++.+||+.||.+|||+.++++.|+.+.+
T Consensus       220 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          220 ISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             HHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HhcCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence            11112223334456779999999999999999999999999987653

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=8.1e-46  Score=336.66  Aligned_cols=263  Identities=23%  Similarity=0.386  Sum_probs=216.8

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|.+..........+.+|+..++.++  ||||+++++++.+.+..++|
T Consensus         8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~~~~lv   85 (310)
T 3s95_A            8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLE--HPNVLKFIGVLYKDKRLNFI   85 (310)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCC--CTTBCCEEEEEEETTEEEEE
T ss_pred             ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCC--CcCcccEEEEEecCCeeEEE
Confidence            4679999999999999999999976 68999999987667777888999999999998  99999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      |||+++++|.+++..   ....+++..+..++.||+.||+|||++   |++|+||+|+||+++.++.++|+|||++....
T Consensus        86 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  159 (310)
T 3s95_A           86 TEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMV  159 (310)
T ss_dssp             EECCTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC
T ss_pred             EEecCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecc
Confidence            999999999999943   346789999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCccc-------------ccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhh
Q 018263          199 ENTTHI-------------STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG  265 (358)
Q Consensus       199 ~~~~~~-------------~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~  265 (358)
                      ......             .....||+.|+|||++.+..++.++||||||+++|+|++|..||............     
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~-----  234 (310)
T 3s95_A          160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL-----  234 (310)
T ss_dssp             --------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB-----
T ss_pred             cccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh-----
Confidence            322211             11457899999999999999999999999999999999999998754332211100     


Q ss_pred             ccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCC
Q 018263          266 MYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNID  324 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~  324 (358)
                           .........    .+...+..+.+++.+||+.||.+|||+.++++.|+.++...
T Consensus       235 -----~~~~~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~  284 (310)
T 3s95_A          235 -----NVRGFLDRY----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL  284 (310)
T ss_dssp             -----CHHHHHHHT----CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -----hhhcccccc----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence                 001111111    12334456889999999999999999999999999887543

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=3.8e-46  Score=334.27  Aligned_cols=266  Identities=25%  Similarity=0.401  Sum_probs=216.8

Q ss_pred             ccCHHHHHHhhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEE
Q 018263           31 AFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCI  110 (358)
Q Consensus        31 ~~~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~  110 (358)
                      ......+.+..++|++.+.||+|+||.||++.+.++..||+|++.... .....+.+|+..+..++  ||||+++++++.
T Consensus        13 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~   89 (283)
T 3gen_A           13 GLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLS--HEKLVQLYGVCT   89 (283)
T ss_dssp             ---CCTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCC--CTTBCCEEEEEC
T ss_pred             CCCCCCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCC--CCCEeeEEEEEe
Confidence            333445567789999999999999999999999988899999997443 34467889999999998  999999999999


Q ss_pred             cCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEee
Q 018263          111 DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD  190 (358)
Q Consensus       111 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~D  190 (358)
                      ..+..++||||+++++|.+++..   ....+++..++.++.|++.||.|||++   |++|+||+|+||+++.++.++|+|
T Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~D  163 (283)
T 3gen_A           90 KQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSD  163 (283)
T ss_dssp             SSSSEEEEECCCTTCBHHHHHHC---GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECS
T ss_pred             cCCCeEEEEeccCCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcc
Confidence            99999999999999999999942   245699999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccch
Q 018263          191 FGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNS  269 (358)
Q Consensus       191 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      ||++...............+++.|+|||++.+..++.++||||||+++|+|++ |+.||.........            
T Consensus       164 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~------------  231 (283)
T 3gen_A          164 FGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA------------  231 (283)
T ss_dssp             TTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH------------
T ss_pred             ccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHH------------
Confidence            99998764433333334556778999999998899999999999999999998 99999754322111            


Q ss_pred             hhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCC
Q 018263          270 KELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGET  321 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~  321 (358)
                          ..+........+...+..+.+++.+||+.+|.+|||+.++++.|..+.
T Consensus       232 ----~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~  279 (283)
T 3gen_A          232 ----EHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM  279 (283)
T ss_dssp             ----HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----HHHhcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence                111122222333444567999999999999999999999999998764

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=5.3e-45  Score=328.94  Aligned_cols=266  Identities=23%  Similarity=0.355  Sum_probs=211.8

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCee
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR  115 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~  115 (358)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|.+...   .....+.+.+|+..+..++  ||||+++++++...+..
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~--hp~iv~~~~~~~~~~~~   86 (294)
T 4eqm_A            9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS--HQNIVSMIDVDEEDDCY   86 (294)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC--BTTBCCEEEEEECSSEE
T ss_pred             hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCC--CCCCceEEEeeeeCCeE
Confidence            3579999999999999999999975 6899999998543   3344567889999999998  99999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccc
Q 018263          116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK  195 (358)
Q Consensus       116 ~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~  195 (358)
                      ++||||++|++|.+++    ...+.+++..++.++.||+.||+|||++   |++|+||||+||+++.++.++|+|||++.
T Consensus        87 ~lv~e~~~g~~L~~~l----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~  159 (294)
T 4eqm_A           87 YLVMEYIEGPTLSEYI----ESHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAK  159 (294)
T ss_dssp             EEEEECCCSCBHHHHH----HHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSST
T ss_pred             EEEEeCCCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcc
Confidence            9999999999999999    3456799999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhh
Q 018263          196 LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNL  275 (358)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                      ..............+++.|+|||++.+..++.++||||||+++|+|++|+.||...........  ......        
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~--~~~~~~--------  229 (294)
T 4eqm_A          160 ALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIK--HIQDSV--------  229 (294)
T ss_dssp             TC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHH--HHSSCC--------
T ss_pred             ccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH--HhhccC--------
Confidence            7654444444456789999999999999999999999999999999999999975543211100  000000        


Q ss_pred             hccccCCCCCHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHhhcCCCCCCC
Q 018263          276 VDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRP-QMSTAIKMMNGETNIDGX  326 (358)
Q Consensus       276 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp-t~~eil~~L~~~~~~~~~  326 (358)
                        +..........+..+.+++.+||+.||.+|| +++++.+.|+.+......
T Consensus       230 --~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~  279 (294)
T 4eqm_A          230 --PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRA  279 (294)
T ss_dssp             --CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSST
T ss_pred             --CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccC
Confidence              0000011233456799999999999999998 999999999988765533

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=3.4e-45  Score=335.09  Aligned_cols=248  Identities=26%  Similarity=0.331  Sum_probs=208.9

Q ss_pred             hhcCCcccceecccCceEEEEEEE-CCCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeE
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRL-QDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI  116 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~  116 (358)
                      ..++|++.+.||+|+||.||+|.+ .+|+.||+|++...  .......+.+|+..++.++  ||||+++++++...+..+
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~l~~~~~~~~~~~   90 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILN--HPNIVKLFEVIETEKTLY   90 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCC--CTTBCCEEEEEECSSEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCC--CCCEeeEEEEEEECCEEE
Confidence            356899999999999999999997 47999999998654  3445567889999999998  999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       117 iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      +||||+++++|.+++    ...+.+++..++.++.||+.||+|||++   |++||||||+||+++.++.++|+|||++..
T Consensus        91 lv~e~~~~~~L~~~l----~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  163 (328)
T 3fe3_A           91 LIMEYASGGEVFDYL----VAHGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNE  163 (328)
T ss_dssp             EEECCCTTCBHHHHH----HHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGG
T ss_pred             EEEECCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCcee
Confidence            999999999999999    3456799999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCcccccccccccCccCccccccCCCC-ccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhh
Q 018263          197 FPENTTHISTRVAGTLGYLAPEYAISGRLT-RKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNL  275 (358)
Q Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s-~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                      .....  ......||+.|+|||++.+..++ .++||||||+++|+|++|+.||...........+.              
T Consensus       164 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~--------------  227 (328)
T 3fe3_A          164 FTVGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL--------------  227 (328)
T ss_dssp             GSSSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--------------
T ss_pred             cCCCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--------------
Confidence            54322  23456799999999999887764 79999999999999999999997654322111110              


Q ss_pred             hccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          276 VDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       276 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                       ..  ....+...+..+.+|+.+||+.||.+|||++++++
T Consensus       228 -~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          228 -RG--KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             -HC--CCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             -hC--CCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence             00  11233345677899999999999999999999986

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.4e-45  Score=335.86  Aligned_cols=262  Identities=26%  Similarity=0.433  Sum_probs=214.5

Q ss_pred             HhhcCCcccceecccCceEEEEEEEC----CCCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQ----DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP  113 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~----~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~  113 (358)
                      +..++|++.+.||+|+||.||+|.+.    .+..||||++... .......+.+|+..++.++  ||||+++++++...+
T Consensus        46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~  123 (325)
T 3kul_A           46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD--HPNIIRLEGVVTRGR  123 (325)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCC--CTTBCCEEEEECGGG
T ss_pred             cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCC--CCCCCcEEEEEEeCC
Confidence            34678999999999999999999974    3456999999754 4445678899999999998  999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccc
Q 018263          114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL  193 (358)
Q Consensus       114 ~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~  193 (358)
                      ..++||||+++++|.+++..   ....+++..++.++.||+.||.|||+.   ||+|+||+|+||+++.++.++|+|||+
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~  197 (325)
T 3kul_A          124 LAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGL  197 (325)
T ss_dssp             CCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSS
T ss_pred             ccEEEeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCc
Confidence            99999999999999999832   345789999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcc--cccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchh
Q 018263          194 SKLFPENTTH--ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSK  270 (358)
Q Consensus       194 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      +.........  ......++..|+|||++.+..++.++||||||+++|+|++ |..||.......               
T Consensus       198 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---------------  262 (325)
T 3kul_A          198 SRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD---------------  262 (325)
T ss_dssp             CEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---------------
T ss_pred             ccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH---------------
Confidence            9876433221  2222345678999999998899999999999999999999 999996543221               


Q ss_pred             hHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCC
Q 018263          271 ELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNID  324 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~  324 (358)
                       ....+........+...+..+.+++.+||+.||.+|||+.+|++.|+.+....
T Consensus       263 -~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~  315 (325)
T 3kul_A          263 -VISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP  315 (325)
T ss_dssp             -HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred             -HHHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence             11111222223344556778999999999999999999999999999886543

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=7.7e-46  Score=334.37  Aligned_cols=276  Identities=23%  Similarity=0.374  Sum_probs=214.7

Q ss_pred             HhhcCCcccceecccCceEEEEEEE-----CCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEc--
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRL-----QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID--  111 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~--  111 (358)
                      +..++|++.+.||+|+||.||+|+.     .+++.||+|++..........+.+|+..++.++  ||||+++++++..  
T Consensus         7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~   84 (295)
T 3ugc_A            7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ--HDNIVKYKGVCYSAG   84 (295)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCC--CTTBCCEEEEECHHH
T ss_pred             CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCC--CCCEeeEEEEEecCC
Confidence            4568999999999999999999984     368899999998777777788999999999998  9999999999865  


Q ss_pred             CCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeec
Q 018263          112 GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF  191 (358)
Q Consensus       112 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Df  191 (358)
                      ....++||||+++++|.+++..   ....+++..++.++.||+.||+|||+.   |++|+||||+||+++.++.++|+||
T Consensus        85 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Df  158 (295)
T 3ugc_A           85 RRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDF  158 (295)
T ss_dssp             HTSCEEEEECCTTCBHHHHHHH---CGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCC
T ss_pred             CCceEEEEEeCCCCCHHHHHHh---cccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccC
Confidence            3568999999999999999943   234589999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCc--ccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccch
Q 018263          192 GLSKLFPENTT--HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNS  269 (358)
Q Consensus       192 g~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      |++........  .......++..|+|||++.+..++.++||||||+++|+|++|..|+.....................
T Consensus       159 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~  238 (295)
T 3ugc_A          159 GLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV  238 (295)
T ss_dssp             CSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHH
T ss_pred             cccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhH
Confidence            99987543322  1222345677799999999999999999999999999999999998643211000000000000001


Q ss_pred             hhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCC
Q 018263          270 KELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETN  322 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~  322 (358)
                      ......+........+...+..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~  291 (295)
T 3ugc_A          239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  291 (295)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence            12222233333344556677889999999999999999999999999998753

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.5e-45  Score=335.39  Aligned_cols=278  Identities=24%  Similarity=0.336  Sum_probs=217.0

Q ss_pred             HHHhhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC---
Q 018263           37 LKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP---  113 (358)
Q Consensus        37 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~---  113 (358)
                      +.+..++|++.+.||+|+||.||+|++. ++.||||++.... ........|+..+..++  ||||+++++++....   
T Consensus        19 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~   94 (322)
T 3soc_A           19 LYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMK--HENILQFIGAEKRGTSVD   94 (322)
T ss_dssp             EEETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCC--CTTBCCEEEEEEEECSSS
T ss_pred             cccchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCC--CCCchhhcceeccCCCCC
Confidence            3455789999999999999999999986 7899999986543 33445566888888887  999999999998754   


Q ss_pred             -eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcC-------CCCCcEEcCCCCCcEEEcCCCc
Q 018263          114 -CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE-------IQPHVVHRDIKTSNILLDQNFN  185 (358)
Q Consensus       114 -~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-------~~~~i~H~di~p~Nilv~~~~~  185 (358)
                       ..++||||+++++|.+++.     ...+++..++.++.||+.||+|||+.       ++.|++|+||||+||+++.++.
T Consensus        95 ~~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~  169 (322)
T 3soc_A           95 VDLWLITAFHEKGSLSDFLK-----ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT  169 (322)
T ss_dssp             EEEEEEEECCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCC
T ss_pred             ceEEEEEecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCe
Confidence             3699999999999999993     34589999999999999999999975       1338999999999999999999


Q ss_pred             eEEeecccccccCCCCcc-cccccccccCccCccccccC-----CCCccCceecHHHHHHHHHhCCCCCCccccccchhh
Q 018263          186 PKISDFGLSKLFPENTTH-ISTRVAGTLGYLAPEYAISG-----RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHL  259 (358)
Q Consensus       186 ~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-----~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~  259 (358)
                      +||+|||++......... ......+|+.|+|||++.+.     .++.++||||||+++|+|++|+.||...........
T Consensus       170 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~  249 (322)
T 3soc_A          170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF  249 (322)
T ss_dssp             EEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTT
T ss_pred             EEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccch
Confidence            999999999765433222 22335789999999998763     456789999999999999999999987655444433


Q ss_pred             hHhhhhccchhhHhhhhc-cccCCCCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCC
Q 018263          260 VDKAWGMYNSKELMNLVD-PMLYGNFP-----ENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNI  323 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~-~~~~~~~~-----~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~  323 (358)
                      ................+. ....+..+     ...+..+.+++.+||+.||.+|||+.++++.|+.++..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          250 EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             HHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            333322223333333222 22222222     24667799999999999999999999999999987654

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=9.2e-45  Score=337.76  Aligned_cols=264  Identities=23%  Similarity=0.358  Sum_probs=215.9

Q ss_pred             HhhcCCcccceecccCceEEEEEEEC--------CCCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceE
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQ--------DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGC  109 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~--------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~  109 (358)
                      +..++|++.+.||+|+||.||+|.+.        ++..||+|++... .......+.+|+..++.+. .||||+++++++
T Consensus        78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-~hpnIv~~~~~~  156 (370)
T 2psq_A           78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-KHKNIINLLGAC  156 (370)
T ss_dssp             CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSC-CCTTBCCEEEEE
T ss_pred             ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhc-CCCCEeeEEEEE
Confidence            44678999999999999999999852        3567999999754 3344567889999999993 299999999999


Q ss_pred             EcCCeeEEEEecCCCCCHHHHhhhccc------------cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCc
Q 018263          110 IDGPCRILVYDYMPNNSLSQTLLGEEK------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSN  177 (358)
Q Consensus       110 ~~~~~~~iv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~N  177 (358)
                      ...+..++||||+++++|.+++.....            ....+++..++.++.||+.||.|||++   ||+|+||||+|
T Consensus       157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~N  233 (370)
T 2psq_A          157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARN  233 (370)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGG
T ss_pred             ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccchhh
Confidence            999999999999999999999954321            124588999999999999999999999   99999999999


Q ss_pred             EEEcCCCceEEeecccccccCCCCc-ccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCcccccc
Q 018263          178 ILLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG  255 (358)
Q Consensus       178 ilv~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~  255 (358)
                      |+++.++.+||+|||++........ .......+++.|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus       234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~  313 (370)
T 2psq_A          234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  313 (370)
T ss_dssp             EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred             EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            9999999999999999986543322 22233456788999999999999999999999999999999 999997543221


Q ss_pred             chhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCC
Q 018263          256 EYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETN  322 (358)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~  322 (358)
                      .                ...+........+..++..+.+++.+||+.+|.+|||+.|+++.|+.+..
T Consensus       314 ~----------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~  364 (370)
T 2psq_A          314 L----------------FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  364 (370)
T ss_dssp             H----------------HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             H----------------HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            1                11122222233445567789999999999999999999999999998754

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.6e-44  Score=331.59  Aligned_cols=249  Identities=26%  Similarity=0.322  Sum_probs=208.8

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCee
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR  115 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~  115 (358)
                      ..++|++++.||+|+||.||+|+.+ +|+.||+|++...   .......+..|+..++.++  ||||+++++++...+..
T Consensus         3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~l~~~~~~~~~~   80 (337)
T 1o6l_A            3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR--HPFLTALKYAFQTHDRL   80 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC--CTTBCCEEEEEECSSEE
T ss_pred             ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCC--CCcCcceEEEEEeCCEE
Confidence            3578999999999999999999976 6999999999754   2344567888999999987  99999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccc
Q 018263          116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK  195 (358)
Q Consensus       116 ~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~  195 (358)
                      ++||||++|++|.+++    .....+++..++.++.||+.||.|||++   ||+||||||+||+++.+|.++|+|||++.
T Consensus        81 ~lv~E~~~gg~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~  153 (337)
T 1o6l_A           81 CFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK  153 (337)
T ss_dssp             EEEEECCTTCBHHHHH----HHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEeCCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchh
Confidence            9999999999999998    3456789999999999999999999999   99999999999999999999999999997


Q ss_pred             ccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhh
Q 018263          196 LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNL  275 (358)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                      ...... ......+||+.|+|||++.+..++.++|+||||+++|+|++|+.||...........+               
T Consensus       154 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i---------------  217 (337)
T 1o6l_A          154 EGISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI---------------  217 (337)
T ss_dssp             CSCCTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---------------
T ss_pred             hcccCC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHH---------------
Confidence            543222 2234467999999999999999999999999999999999999999754322111111               


Q ss_pred             hccccCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 018263          276 VDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRP-----QMSTAIK  315 (358)
Q Consensus       276 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp-----t~~eil~  315 (358)
                      ...  ...++...+..+.++|.+||+.||.+||     +++++++
T Consensus       218 ~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          218 LME--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             HHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             HcC--CCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence            100  1123445667899999999999999999     8998875

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3.2e-44  Score=332.62  Aligned_cols=252  Identities=21%  Similarity=0.295  Sum_probs=207.7

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChh------hHHHHHHHHHHhhhcccCCCCceeeeceEEcC
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQ------GEKEFMSEVASMANVNVCHENLVKLHGGCIDG  112 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~  112 (358)
                      ..++|++.+.||+|+||.||+|..+ +|+.||+|++......      ....+.+|+..++.+.  ||||+++++++.+.
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~--hpnIv~l~~~~~~~   87 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL--HPNIITLHDVYENR   87 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCC--CTTBCCEEEEEECS
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCC--CcCCCcEEEEEEeC
Confidence            3578999999999999999999976 6899999998754321      3567889999999998  99999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCC----ceEE
Q 018263          113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF----NPKI  188 (358)
Q Consensus       113 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~----~~~l  188 (358)
                      +..++||||++|++|.+++    .....+++..++.++.||+.||.|||+.   ||+|+||||+||+++.++    .++|
T Consensus        88 ~~~~lv~e~~~gg~L~~~l----~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl  160 (361)
T 2yab_A           88 TDVVLILELVSGGELFDFL----AQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKL  160 (361)
T ss_dssp             SEEEEEEECCCSCBHHHHH----TTCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEE
T ss_pred             CEEEEEEEcCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEE
Confidence            9999999999999999999    4456799999999999999999999999   999999999999998877    7999


Q ss_pred             eecccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccc
Q 018263          189 SDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYN  268 (358)
Q Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  268 (358)
                      +|||++.......  ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+......+.
T Consensus       161 ~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~  238 (361)
T 2yab_A          161 IDFGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFD  238 (361)
T ss_dssp             CCCSSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC
T ss_pred             EecCCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence            9999998754322  22346799999999999988999999999999999999999999976543222211111000000


Q ss_pred             hhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          269 SKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .             ......+..+.+||.+||+.||.+|||+.|+++
T Consensus       239 ~-------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          239 E-------------EFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             H-------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             c-------------hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            0             001123556889999999999999999999885

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1e-44  Score=329.66  Aligned_cols=265  Identities=21%  Similarity=0.333  Sum_probs=210.2

Q ss_pred             hcCCcccceecccCceEEEEEEECCCCEEEEEEeeccC--hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      .++|++++.||+|+||.||+|++.+|+.||+|++....  ......+.+|+..++.++  ||||+++++++...+..++|
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~~~~lv   97 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELH--HPNIVSLIDVIHSERCLTLV   97 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCC--CTTBCCEEEEECCSSCEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcC--CCCEeeeeeEEccCCEEEEE
Confidence            58999999999999999999999889999999986542  333467889999999998  99999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      |||+++ +|.+.+.   .....+++..++.++.||+.||.|||++   ||+|+||||+||+++.++.++|+|||++....
T Consensus        98 ~e~~~~-~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  170 (311)
T 3niz_A           98 FEFMEK-DLKKVLD---ENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFG  170 (311)
T ss_dssp             EECCSE-EHHHHHH---TCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred             EcCCCC-CHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence            999974 7877773   2345689999999999999999999999   99999999999999999999999999998754


Q ss_pred             CCCcccccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhc
Q 018263          199 ENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD  277 (358)
Q Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      .... ......+++.|+|||++.+ ..++.++||||||+++|+|++|+.||......+....+....+......+....+
T Consensus       171 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  249 (311)
T 3niz_A          171 IPVR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQE  249 (311)
T ss_dssp             SCCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTT
T ss_pred             CCcc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhc
Confidence            3222 2233568999999999876 5689999999999999999999999987776665555544433333222221111


Q ss_pred             ------cccC--C-----CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          278 ------PMLY--G-----NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       278 ------~~~~--~-----~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                            ....  .     ......+.++.+||.+||+.||.+|||+.|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             SHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             cchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                  0000  0     011123457889999999999999999999987

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.2e-45  Score=325.29  Aligned_cols=260  Identities=26%  Similarity=0.415  Sum_probs=216.0

Q ss_pred             HHhhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           38 KIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        38 ~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      .+..++|++.+.||+|++|.||++.+.++..|++|++.... .....+.+|+..++.++  ||||+++++++...+..++
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~l   80 (267)
T 3t9t_A            4 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLS--HPKLVQLYGVCLEQAPICL   80 (267)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCC--CTTBCCEEEEECSSSSCEE
T ss_pred             EEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCC--CCCEeeEEEEEccCCCeEE
Confidence            35678999999999999999999999888899999997543 34467889999999998  9999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      ||||+++++|.+++..   ....+++..++.++.|++.||.+||++   |++|+||+|+||+++.++.++|+|||++...
T Consensus        81 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~  154 (267)
T 3t9t_A           81 VTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFV  154 (267)
T ss_dssp             EECCCTTCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGB
T ss_pred             EEeCCCCCcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccc
Confidence            9999999999999942   345689999999999999999999999   9999999999999999999999999999865


Q ss_pred             CCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhHhhhh
Q 018263          198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV  276 (358)
Q Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                      ............++..|+|||++.+..++.++||||||+++|+|++ |+.||.........                ..+
T Consensus       155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~----------------~~i  218 (267)
T 3t9t_A          155 LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV----------------EDI  218 (267)
T ss_dssp             CCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH----------------HHH
T ss_pred             ccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHH----------------HHH
Confidence            4332223334556778999999998899999999999999999999 89999754322111                111


Q ss_pred             ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCC
Q 018263          277 DPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETN  322 (358)
Q Consensus       277 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~  322 (358)
                      ........+...+..+.+++.+||+.||.+|||+.++++.|+.+.+
T Consensus       219 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          219 STGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hcCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            1111222334456779999999999999999999999999987653

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=3.8e-45  Score=332.40  Aligned_cols=272  Identities=27%  Similarity=0.369  Sum_probs=219.5

Q ss_pred             ccccCHHHHHHhhcCCcccceecccCceEEEEEEE------CCCCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCC
Q 018263           29 INAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRL------QDGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHEN  101 (358)
Q Consensus        29 ~~~~~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~------~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~  101 (358)
                      ++......+.+..++|++.+.||+|+||.||+|.+      .++..||+|++... .......+.+|+..++.++  |||
T Consensus        10 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--hp~   87 (314)
T 2ivs_A           10 FKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN--HPH   87 (314)
T ss_dssp             ----CCTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCC--CTT
T ss_pred             eeccCCcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCC--CCc
Confidence            34444455666789999999999999999999985      24578999998754 3445577889999999998  999


Q ss_pred             ceeeeceEEcCCeeEEEEecCCCCCHHHHhhhccc--------------------cccCCCHHHHHHHHHHHHHHHHHHh
Q 018263          102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEK--------------------RRAKFGWKARREIIMGIGRGLAYIH  161 (358)
Q Consensus       102 i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~--------------------~~~~l~~~~~~~~~~qi~~aL~~LH  161 (358)
                      |+++++++...+..++||||+++++|.+++.....                    ....+++..++.++.||+.||.|||
T Consensus        88 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH  167 (314)
T 2ivs_A           88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA  167 (314)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH
T ss_pred             eeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH
Confidence            99999999999999999999999999999954322                    1234889999999999999999999


Q ss_pred             cCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCcc-cccccccccCccCccccccCCCCccCceecHHHHHHH
Q 018263          162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLE  240 (358)
Q Consensus       162 ~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~  240 (358)
                      ++   |++|+||+|+||+++.++.++|+|||++......... ......+++.|+|||++.+..++.++||||||+++|+
T Consensus       168 ~~---~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e  244 (314)
T 2ivs_A          168 EM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWE  244 (314)
T ss_dssp             HT---TEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHH
T ss_pred             HC---CCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHH
Confidence            99   9999999999999999999999999999865433222 2233456788999999998889999999999999999


Q ss_pred             HHh-CCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 018263          241 IVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNG  319 (358)
Q Consensus       241 llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~  319 (358)
                      |++ |..||.........                ..+........+...+..+.+++.+||+.||.+|||+.++++.|++
T Consensus       245 l~t~g~~p~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~  308 (314)
T 2ivs_A          245 IVTLGGNPYPGIPPERLF----------------NLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEK  308 (314)
T ss_dssp             HHTTSCCSSTTCCGGGHH----------------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHhCCCCCCCCCCHHHHH----------------HHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            999 99999755432211                1111222233444566789999999999999999999999999987


Q ss_pred             CC
Q 018263          320 ET  321 (358)
Q Consensus       320 ~~  321 (358)
                      +.
T Consensus       309 ~~  310 (314)
T 2ivs_A          309 MM  310 (314)
T ss_dssp             HH
T ss_pred             HH
Confidence            53

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=7.1e-45  Score=325.33  Aligned_cols=266  Identities=27%  Similarity=0.404  Sum_probs=217.9

Q ss_pred             cCHHHHHHhhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEc
Q 018263           32 FSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID  111 (358)
Q Consensus        32 ~~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~  111 (358)
                      |-.+++.+..++|++.+.||+|+||.||+|...++..|++|.+.... .....+.+|+..++.++  ||||+++++++..
T Consensus         3 ~~~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~   79 (279)
T 1qpc_A            3 WWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQ--HQRLVRLYAVVTQ   79 (279)
T ss_dssp             TTTCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCC--CTTBCCEEEEECS
T ss_pred             cchhhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCC--CcCcceEEEEEcC
Confidence            33445667789999999999999999999999888899999986443 34567889999999998  9999999998864


Q ss_pred             CCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeec
Q 018263          112 GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF  191 (358)
Q Consensus       112 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Df  191 (358)
                       +..++||||+++++|.+++..  .....+++..++.++.|++.||.|||++   |++|+||+|+||+++.++.++|+||
T Consensus        80 -~~~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Df  153 (279)
T 1qpc_A           80 -EPIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADF  153 (279)
T ss_dssp             -SSCEEEEECCTTCBHHHHTTS--HHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred             -CCcEEEEecCCCCCHHHHHhc--CCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCC
Confidence             568999999999999999932  1223689999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchh
Q 018263          192 GLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSK  270 (358)
Q Consensus       192 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      |++...............++..|+|||++.+..++.++||||||+++|+|++ |+.||.........             
T Consensus       154 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~-------------  220 (279)
T 1qpc_A          154 GLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI-------------  220 (279)
T ss_dssp             TTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-------------
T ss_pred             cccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHH-------------
Confidence            9998765444333344556788999999988889999999999999999999 99999754322111             


Q ss_pred             hHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCC
Q 018263          271 ELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETN  322 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~  322 (358)
                         ..+........+...+..+.+++.+||+.+|.+|||+.++++.|+.+..
T Consensus       221 ---~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  269 (279)
T 1qpc_A          221 ---QNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (279)
T ss_dssp             ---HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---HHHhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence               1111111222334556789999999999999999999999999988653

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=3.8e-45  Score=328.47  Aligned_cols=262  Identities=26%  Similarity=0.377  Sum_probs=221.3

Q ss_pred             HHHHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCe
Q 018263           36 QLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC  114 (358)
Q Consensus        36 ~~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~  114 (358)
                      .+.+..++|++.+.||+|+||.||+|.+. ++..|++|++... ......+.+|+..++.++  ||||+++++++...+.
T Consensus         7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~   83 (288)
T 3kfa_A            7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIK--HPNLVQLLGVCTREPP   83 (288)
T ss_dssp             TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCC--CTTBCCEEEEECSSSS
T ss_pred             cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCC--CCCEeeEEEEEccCCC
Confidence            44567889999999999999999999976 4888999998643 345577889999999998  9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccc
Q 018263          115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS  194 (358)
Q Consensus       115 ~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~  194 (358)
                      .++||||+++++|.+++..  .....+++..++.++.||+.||.|||+.   |++|+||+|+||+++.++.++|+|||.+
T Consensus        84 ~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~  158 (288)
T 3kfa_A           84 FYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLS  158 (288)
T ss_dssp             EEEEEECCTTEEHHHHHHH--CCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGG
T ss_pred             EEEEEEcCCCCcHHHHHHh--cccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccc
Confidence            9999999999999999943  2346689999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhHh
Q 018263          195 KLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELM  273 (358)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      ...............++..|+|||++.+..++.++||||||+++|+|++ |..||........                .
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~----------------~  222 (288)
T 3kfa_A          159 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV----------------Y  222 (288)
T ss_dssp             GTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH----------------H
T ss_pred             eeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH----------------H
Confidence            8766555444455667789999999998999999999999999999999 9999975433221                1


Q ss_pred             hhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCC
Q 018263          274 NLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGET  321 (358)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~  321 (358)
                      ..+........+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus       223 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~  270 (288)
T 3kfa_A          223 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  270 (288)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence            122222233344556678999999999999999999999999998754

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.8e-44  Score=329.85  Aligned_cols=252  Identities=25%  Similarity=0.355  Sum_probs=204.6

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+..++.++  ||||+++++++...+..++|
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~~~~~lv   83 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN--HENVVKFYGHRREGNIQYLF   83 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCC--CTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCC--CCCCCeEEEEEecCCeEEEE
Confidence            478999999999999999999976 78999999986543 233466889999999998  99999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      |||+++++|.+++    .....+++..++.++.||+.||+|||++   |++|+||||+||+++.++.++|+|||++....
T Consensus        84 ~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  156 (323)
T 3tki_A           84 LEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR  156 (323)
T ss_dssp             EECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred             EEcCCCCcHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceec
Confidence            9999999999998    4556799999999999999999999999   99999999999999999999999999997653


Q ss_pred             CCC-cccccccccccCccCccccccCCC-CccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhh
Q 018263          199 ENT-THISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV  276 (358)
Q Consensus       199 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~-s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                      ... ........|++.|+|||++.+..+ +.++||||||+++|+|++|+.||...........              ...
T Consensus       157 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~--------------~~~  222 (323)
T 3tki_A          157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--------------DWK  222 (323)
T ss_dssp             ETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHH--------------HHH
T ss_pred             cCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHH--------------HHh
Confidence            222 222334678999999999987765 7899999999999999999999975543221111              111


Q ss_pred             ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          277 DPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       277 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ............+..+.+|+.+||+.||.+|||+.|+++
T Consensus       223 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          223 EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            111111112345567889999999999999999999976

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-44  Score=338.88  Aligned_cols=270  Identities=23%  Similarity=0.363  Sum_probs=220.8

Q ss_pred             HHHHhhcCCcccceecccCceEEEEEEEC--------CCCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeee
Q 018263           36 QLKIATNGFRWSNKIGEGGFGSVYKGRLQ--------DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLH  106 (358)
Q Consensus        36 ~~~~~~~~y~i~~~lg~g~~g~v~~~~~~--------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~  106 (358)
                      .+.+..++|++.+.||+|+||.||+|++.        .+..||+|++... .......+.+|+..++.+. .||||++++
T Consensus        63 ~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-~hpnIv~~~  141 (382)
T 3tt0_A           63 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG-KHKNIINLL  141 (382)
T ss_dssp             TTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC-CCTTBCCEE
T ss_pred             ccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhc-CCchhhhhe
Confidence            34566789999999999999999999852        2457999998755 3344577889999999993 399999999


Q ss_pred             ceEEcCCeeEEEEecCCCCCHHHHhhhccc------------cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCC
Q 018263          107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEK------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIK  174 (358)
Q Consensus       107 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~  174 (358)
                      +++...+..++||||+++++|.+++.....            ....+++..++.++.||+.||.|||+.   |++|+|||
T Consensus       142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlk  218 (382)
T 3tt0_A          142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLA  218 (382)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCC
T ss_pred             eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCC
Confidence            999999999999999999999999954321            124589999999999999999999999   99999999


Q ss_pred             CCcEEEcCCCceEEeecccccccCCCCc-ccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccc
Q 018263          175 TSNILLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV  252 (358)
Q Consensus       175 p~Nilv~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~  252 (358)
                      |+||+++.++.++|+|||++........ .......++..|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus       219 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~  298 (382)
T 3tt0_A          219 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP  298 (382)
T ss_dssp             GGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             cceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999986543322 22333557789999999999999999999999999999999 999997543


Q ss_pred             cccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCCC
Q 018263          253 QLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNIDG  325 (358)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~~  325 (358)
                      ..                +....+........+...+..+.+++.+||+.+|.+|||+.+|++.|+++.....
T Consensus       299 ~~----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  355 (382)
T 3tt0_A          299 VE----------------ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS  355 (382)
T ss_dssp             HH----------------HHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred             HH----------------HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence            21                1222222222333445566789999999999999999999999999999876553

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.4e-44  Score=334.07  Aligned_cols=251  Identities=21%  Similarity=0.311  Sum_probs=203.2

Q ss_pred             HhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCe
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC  114 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~  114 (358)
                      +..++|++.+.||+|+||.||+|+.+ +|+.||+|++...   .......+..|..++..+. .||||+++++++...+.
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~-~hp~Iv~l~~~~~~~~~   98 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQLFCCFQTPDR   98 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTT-TCTTBCCEEEEEECSSE
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCE
Confidence            45689999999999999999999976 5899999999754   2334566778888888774 49999999999999999


Q ss_pred             eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccc
Q 018263          115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS  194 (358)
Q Consensus       115 ~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~  194 (358)
                      .|+||||++|++|.+++    .....+++..++.++.||+.||+|||++   ||+||||||+||+++.++.++|+|||++
T Consensus        99 ~~lv~E~~~gg~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a  171 (353)
T 3txo_A           99 LFFVMEFVNGGDLMFHI----QKSRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMC  171 (353)
T ss_dssp             EEEEEECCCSCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEeCCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccce
Confidence            99999999999999999    4456799999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhh
Q 018263          195 KLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMN  274 (358)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                      ...... .......+||+.|+|||++.+..++.++|+||||+++|+|++|+.||...........+.             
T Consensus       172 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~-------------  237 (353)
T 3txo_A          172 KEGICN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL-------------  237 (353)
T ss_dssp             BCSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------------
T ss_pred             eecccC-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHH-------------
Confidence            753222 222344679999999999998889999999999999999999999998654332221111             


Q ss_pred             hhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCH------HHHHH
Q 018263          275 LVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQM------STAIK  315 (358)
Q Consensus       275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~------~eil~  315 (358)
                        ..  ...++...+..+.++|.+||+.||.+||++      +++++
T Consensus       238 --~~--~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          238 --ND--EVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             --HC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             --cC--CCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence              11  112344456778999999999999999998      66654

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=7.9e-45  Score=347.17  Aligned_cols=268  Identities=26%  Similarity=0.402  Sum_probs=221.6

Q ss_pred             cCHHHHHHhhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEc
Q 018263           32 FSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID  111 (358)
Q Consensus        32 ~~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~  111 (358)
                      +....+.+..++|++.+.||+|+||.||+|.++++..||||.+.... ...+.+.+|+..++.++  ||||+++++++. 
T Consensus       178 ~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~--h~~iv~l~~~~~-  253 (454)
T 1qcf_A          178 WEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQ--HDKLVKLHAVVT-  253 (454)
T ss_dssp             CCTTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCC--CTTBCCEEEEEC-
T ss_pred             ccccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCC--CCCEeeEEEEEe-
Confidence            44556777889999999999999999999999888999999997543 45678999999999998  999999999986 


Q ss_pred             CCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeec
Q 018263          112 GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF  191 (358)
Q Consensus       112 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Df  191 (358)
                      ....++||||+++++|.+++...  ....+++..+..++.||+.||+|||++   +++||||+|+||+++.++.+||+||
T Consensus       254 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DF  328 (454)
T 1qcf_A          254 KEPIYIITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADF  328 (454)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECST
T ss_pred             CCccEEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeC
Confidence            56789999999999999999432  234688999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchh
Q 018263          192 GLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSK  270 (358)
Q Consensus       192 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      |++...............++..|+|||++.+..++.++||||||+++|+|++ |+.||.........             
T Consensus       329 G~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~-------------  395 (454)
T 1qcf_A          329 GLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI-------------  395 (454)
T ss_dssp             TGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-------------
T ss_pred             CCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHH-------------
Confidence            9998754322222233446778999999998899999999999999999999 99999754322111             


Q ss_pred             hHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCC
Q 018263          271 ELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNID  324 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~  324 (358)
                         ..+....+...+..++..+.+++.+||+.||.+|||+.+|++.|+.+....
T Consensus       396 ---~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~  446 (454)
T 1qcf_A          396 ---RALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT  446 (454)
T ss_dssp             ---HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred             ---HHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence               111111222334456778999999999999999999999999999987654

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=5.8e-45  Score=340.05  Aligned_cols=263  Identities=25%  Similarity=0.358  Sum_probs=216.4

Q ss_pred             HHHHHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC
Q 018263           35 NQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG  112 (358)
Q Consensus        35 ~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~  112 (358)
                      ..+.+..++|++.+.||+|+||.||+|.+. +++.||+|.+.... ......+.+|+..++.++  ||||+++++++...
T Consensus       107 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~  184 (377)
T 3cbl_A          107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYS--HPNIVRLIGVCTQK  184 (377)
T ss_dssp             CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCC--CTTBCCEEEEECSS
T ss_pred             cccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCC--CCCEEEEEEEEecC
Confidence            345667789999999999999999999986 68999999987542 334456888999999998  99999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecc
Q 018263          113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG  192 (358)
Q Consensus       113 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg  192 (358)
                      +..++||||+++++|.+++..   ....+++..+..++.||+.||+|||++   |++|+||+|+||+++.++.+||+|||
T Consensus       185 ~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG  258 (377)
T 3cbl_A          185 QPIYIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFG  258 (377)
T ss_dssp             SSCEEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGG
T ss_pred             CCcEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCC
Confidence            999999999999999999942   334689999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccc-cccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchh
Q 018263          193 LSKLFPENTTHIS-TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSK  270 (358)
Q Consensus       193 ~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      ++........... ....++..|+|||.+.+..++.++||||||+++|+|++ |..||......                
T Consensus       259 ~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~----------------  322 (377)
T 3cbl_A          259 MSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ----------------  322 (377)
T ss_dssp             GCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH----------------
T ss_pred             CceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----------------
Confidence            9986433221111 11235678999999998899999999999999999998 99999754321                


Q ss_pred             hHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCC
Q 018263          271 ELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGET  321 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~  321 (358)
                      .....+....+...+...+..+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus       323 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~  373 (377)
T 3cbl_A          323 QTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR  373 (377)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence            111222222223344556678999999999999999999999999998764

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3.7e-44  Score=322.94  Aligned_cols=264  Identities=19%  Similarity=0.294  Sum_probs=205.7

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC--hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++....  ......+.+|+..++.++  ||||+++++++.+.+..++|
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv   79 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK--HKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCC--CTTBCCEEEEEEETTEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCC--CCCEeeEEeEEEeCCEEEEE
Confidence            68999999999999999999976 68999999987543  334567889999999998  99999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      |||+++ +|.+.+.   ...+.+++..++.++.||+.||+|||++   |++|+||||+||+++.++.++|+|||++....
T Consensus        80 ~e~~~~-~l~~~~~---~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~  152 (292)
T 3o0g_A           80 FEFCDQ-DLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFG  152 (292)
T ss_dssp             EECCSE-EHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EecCCC-CHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecC
Confidence            999975 5555552   3456799999999999999999999999   99999999999999999999999999998754


Q ss_pred             CCCcccccccccccCccCccccccCC-CCccCceecHHHHHHHHHhCCCCC-CccccccchhhhHhhhhccchhhHhhhh
Q 018263          199 ENTTHISTRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAV-DFDVQLGEYHLVDKAWGMYNSKELMNLV  276 (358)
Q Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~s~~sDiwslG~il~~lltg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                      .... ......+|..|+|||++.+.. ++.++||||||+++|+|++|..|| ...........+....+.+....+....
T Consensus       153 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  231 (292)
T 3o0g_A          153 IPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             SCCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             Cccc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhc
Confidence            3222 223456899999999988765 799999999999999999988875 3333332223332222222222111111


Q ss_pred             cc------------ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          277 DP------------MLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       277 ~~------------~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ..            ..........+..+.+|+.+||+.||.+|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            10            0001122345677899999999999999999999986

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=7.1e-45  Score=336.99  Aligned_cols=273  Identities=22%  Similarity=0.346  Sum_probs=220.6

Q ss_pred             cccCHHHHHHhhcCCcccceecccCceEEEEEEE------CCCCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCc
Q 018263           30 NAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRL------QDGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENL  102 (358)
Q Consensus        30 ~~~~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~------~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i  102 (358)
                      ..+....+.+..++|++.+.||+|+||.||+|++      .+++.||+|++... .......+.+|+..+..+. .||||
T Consensus        10 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-~hpni   88 (359)
T 3vhe_A           10 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG-HHLNV   88 (359)
T ss_dssp             SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC-CCTTB
T ss_pred             CCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhc-CCcce
Confidence            4566778888999999999999999999999973      24678999999754 3344567899999999994 39999


Q ss_pred             eeeeceEEcCCe-eEEEEecCCCCCHHHHhhhcccc--------------------------------------------
Q 018263          103 VKLHGGCIDGPC-RILVYDYMPNNSLSQTLLGEEKR--------------------------------------------  137 (358)
Q Consensus       103 ~~~~~~~~~~~~-~~iv~e~~~~~~L~~~l~~~~~~--------------------------------------------  137 (358)
                      +++++++...+. .++||||+++++|.+++......                                            
T Consensus        89 v~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (359)
T 3vhe_A           89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV  168 (359)
T ss_dssp             CCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------
T ss_pred             eeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccc
Confidence            999999887654 89999999999999999644221                                            


Q ss_pred             ------------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          138 ------------------RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       138 ------------------~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                                        ...+++..++.++.||+.||+|||++   ||+|+||||+||+++.++.++|+|||++.....
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  245 (359)
T 3vhe_A          169 EEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYK  245 (359)
T ss_dssp             ---------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTS
T ss_pred             cccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecc
Confidence                              12289999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCc-ccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhHhhhhc
Q 018263          200 NTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD  277 (358)
Q Consensus       200 ~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      ... .......+|..|+|||++.+..++.++||||||+++|+|++ |..||.........               ...+.
T Consensus       246 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---------------~~~~~  310 (359)
T 3vhe_A          246 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF---------------CRRLK  310 (359)
T ss_dssp             CTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH---------------HHHHH
T ss_pred             cccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH---------------HHHHH
Confidence            222 23334567889999999999999999999999999999998 99999755432211               11111


Q ss_pred             cccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCC
Q 018263          278 PMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGET  321 (358)
Q Consensus       278 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~  321 (358)
                      .......+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus       311 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  354 (359)
T 3vhe_A          311 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  354 (359)
T ss_dssp             HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence            11222334445667999999999999999999999999998764

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=6.1e-43  Score=317.09  Aligned_cols=285  Identities=38%  Similarity=0.602  Sum_probs=229.6

Q ss_pred             cccccCHHHHHHhhcCCccc------ceecccCceEEEEEEECCCCEEEEEEeecc----ChhhHHHHHHHHHHhhhccc
Q 018263           28 NINAFSYNQLKIATNGFRWS------NKIGEGGFGSVYKGRLQDGTIVAVKVLSVE----SKQGEKEFMSEVASMANVNV   97 (358)
Q Consensus        28 ~~~~~~~~~~~~~~~~y~i~------~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~~   97 (358)
                      .+..|...++....++|...      +.||+|+||.||+|.. +++.|++|++...    .......+.+|+..++.++ 
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-   88 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ-   88 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC-
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC-
Confidence            36778888888888777666      8999999999999987 4889999998643    2345678889999999998 


Q ss_pred             CCCCceeeeceEEcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCc
Q 018263           98 CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSN  177 (358)
Q Consensus        98 ~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~N  177 (358)
                       ||||+++++++...+..++||||+++++|.+++... .....+++..++.++.||+.||.|||+.   |++|+||+|+|
T Consensus        89 -h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~N  163 (307)
T 2nru_A           89 -HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSAN  163 (307)
T ss_dssp             -CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTG-GGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGG
T ss_pred             -CCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHH
Confidence             999999999999999999999999999999998543 2345689999999999999999999999   99999999999


Q ss_pred             EEEcCCCceEEeecccccccCCCCcc-cccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccc
Q 018263          178 ILLDQNFNPKISDFGLSKLFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE  256 (358)
Q Consensus       178 ilv~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~  256 (358)
                      |+++.++.++|+|||++......... ......+++.|+|||.+.+ .++.++||||||+++|+|++|..||........
T Consensus       164 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~  242 (307)
T 2nru_A          164 ILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL  242 (307)
T ss_dssp             EEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB
T ss_pred             EEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH
Confidence            99999999999999999865432222 2233568999999998765 578999999999999999999999986654433


Q ss_pred             hhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCC
Q 018263          257 YHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETN  322 (358)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~  322 (358)
                      ...+..... .....+...++..+ ...+...+..+.+++.+||+.+|.+|||+.++++.|+++..
T Consensus       243 ~~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          243 LLDIKEEIE-DEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             TTHHHHHHH-TTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             HHHHHHHhh-hhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            322221111 01122333344333 34567888999999999999999999999999999998754

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.1e-44  Score=331.77  Aligned_cols=276  Identities=24%  Similarity=0.332  Sum_probs=220.5

Q ss_pred             hhcCCcccceecccCceEEEEEEE-----CCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEE--cC
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRL-----QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCI--DG  112 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~--~~  112 (358)
                      ..++|++.+.||+|+||.||+|++     .+++.||+|++..........+.+|+..++.++  ||||+++++++.  ..
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~   98 (327)
T 3lxl_A           21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH--SDFIVKYRGVSYGPGR   98 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCC--CTTBCCEEEEEECSSS
T ss_pred             chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcC--CCceeEEEEEEecCCC
Confidence            357999999999999999999984     368899999998777777788999999999997  999999999887  45


Q ss_pred             CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecc
Q 018263          113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG  192 (358)
Q Consensus       113 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg  192 (358)
                      ...++||||+++++|.+++..   ....+++..++.++.||+.||+|||+.   |++|+||+|+||+++.++.++|+|||
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg  172 (327)
T 3lxl_A           99 QSLRLVMEYLPSGCLRDFLQR---HRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFG  172 (327)
T ss_dssp             CEEEEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGG
T ss_pred             ceEEEEEeecCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccc
Confidence            668999999999999999943   235689999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcc--cccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchh
Q 018263          193 LSKLFPENTTH--ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSK  270 (358)
Q Consensus       193 ~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      ++.........  ......++..|+|||++.+..++.++||||||+++|+|++|..||.......... ...........
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~-~~~~~~~~~~~  251 (327)
T 3lxl_A          173 LAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM-MGCERDVPALS  251 (327)
T ss_dssp             GCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH-CC----CCHHH
T ss_pred             cceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhh-cccccccccHH
Confidence            99876433321  2233557788999999998889999999999999999999999987543211000 00000111112


Q ss_pred             hHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCC
Q 018263          271 ELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNID  324 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~  324 (358)
                      .....+........+...+..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  305 (327)
T 3lxl_A          252 RLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS  305 (327)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred             HHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            333334444444556677788999999999999999999999999999987655

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5e-44  Score=326.50  Aligned_cols=251  Identities=16%  Similarity=0.234  Sum_probs=206.8

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      .++|++.+.||+|+||.||+|.+. +++.||+|.+... ......+.+|+..++.++  ||||+++++++.+.+..++||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~~~~~lv~   80 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIAR--HRNILHLHESFESMEELVMIF   80 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSC--CTTBCCEEEEEEETTEEEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCC--CCCCCeEeEEEecCCEEEEEE
Confidence            578999999999999999999976 5889999998744 344567889999999998  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcC--CCceEEeeccccccc
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ--NFNPKISDFGLSKLF  197 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~--~~~~~l~Dfg~~~~~  197 (358)
                      ||++|++|.+.+.   .....+++..++.++.||+.||.|||++   |++|+||||+||+++.  ++.++|+|||++...
T Consensus        81 e~~~g~~L~~~l~---~~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~  154 (321)
T 1tki_A           81 EFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             CCCCCCBHHHHHT---SSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             EeCCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence            9999999999983   2335789999999999999999999999   9999999999999987  789999999999876


Q ss_pred             CCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhc
Q 018263          198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD  277 (358)
Q Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      ....  ......+++.|+|||++.+..++.++||||||+++|+|++|..||...........+......+....      
T Consensus       155 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~------  226 (321)
T 1tki_A          155 KPGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA------  226 (321)
T ss_dssp             CTTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH------
T ss_pred             CCCC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhh------
Confidence            4332  23345689999999999888889999999999999999999999976543222211111100000000      


Q ss_pred             cccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          278 PMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       278 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                             ....+..+.+++.+||+.||.+|||+.|+++
T Consensus       227 -------~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          227 -------FKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             -------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -------hccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                   0123567899999999999999999999987

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.6e-44  Score=320.20  Aligned_cols=253  Identities=29%  Similarity=0.443  Sum_probs=200.2

Q ss_pred             HhhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccCh----hhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCe
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESK----QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC  114 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~  114 (358)
                      +..++|++.+.||+|+||.||+|.+. ++.||+|++.....    .....+.+|+..++.++  ||||+++++++...+.
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~   80 (271)
T 3dtc_A            4 IDFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK--HPNIIALRGVCLKEPN   80 (271)
T ss_dssp             CCTTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCC--CTTBCCEEEEECCC--
T ss_pred             cchhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcC--CCCEeeEEEEEecCCc
Confidence            34679999999999999999999986 88999999865432    23467889999999998  9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCC---cEEcCCCCCcEEEcC--------C
Q 018263          115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH---VVHRDIKTSNILLDQ--------N  183 (358)
Q Consensus       115 ~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~---i~H~di~p~Nilv~~--------~  183 (358)
                      .++||||+++++|.+++     ....+++..++.++.|++.||.|||++   |   ++|+||+|+||+++.        +
T Consensus        81 ~~lv~e~~~~~~L~~~~-----~~~~~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~~~~~~~  152 (271)
T 3dtc_A           81 LCLVMEFARGGPLNRVL-----SGKRIPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVENGDLSN  152 (271)
T ss_dssp             CEEEEECCTTEEHHHHH-----TSSCCCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCSSSCCSS
T ss_pred             eEEEEEcCCCCCHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccccccccC
Confidence            99999999999999998     345789999999999999999999999   8   999999999999986        7


Q ss_pred             CceEEeecccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhh
Q 018263          184 FNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKA  263 (358)
Q Consensus       184 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~  263 (358)
                      +.++|+|||++........   ....+++.|+|||.+.+..++.++||||||+++|+|++|+.||........       
T Consensus       153 ~~~kl~Dfg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------  222 (271)
T 3dtc_A          153 KILKITDFGLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV-------  222 (271)
T ss_dssp             CCEEECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH-------
T ss_pred             cceEEccCCcccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------
Confidence            7899999999976543222   235689999999999998999999999999999999999999975432111       


Q ss_pred             hhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 018263          264 WGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE  320 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~  320 (358)
                              .............+...+..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus       223 --------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          223 --------AYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             --------HHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             --------HHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                    1111112222334455667899999999999999999999999999864

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-44  Score=333.17  Aligned_cols=268  Identities=29%  Similarity=0.414  Sum_probs=216.6

Q ss_pred             HHHHhhcCCcccceecccCceEEEEEEEC------CCCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeece
Q 018263           36 QLKIATNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGG  108 (358)
Q Consensus        36 ~~~~~~~~y~i~~~lg~g~~g~v~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~  108 (358)
                      .+.+..++|++.+.||+|+||.||+|++.      +++.||+|++... .......+.+|+..++.++  ||||++++++
T Consensus        41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~  118 (343)
T 1luf_A           41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD--NPNIVKLLGV  118 (343)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCC--CTTBCCEEEE
T ss_pred             eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCC--CCCEEEEEEE
Confidence            44556789999999999999999999974      3478999999754 3344577899999999998  9999999999


Q ss_pred             EEcCCeeEEEEecCCCCCHHHHhhhcccc--------------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 018263          109 CIDGPCRILVYDYMPNNSLSQTLLGEEKR--------------------RAKFGWKARREIIMGIGRGLAYIHEEIQPHV  168 (358)
Q Consensus       109 ~~~~~~~~iv~e~~~~~~L~~~l~~~~~~--------------------~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i  168 (358)
                      +...+..++||||+++++|.+++......                    ...+++..++.++.||+.||.|||++   |+
T Consensus       119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~i  195 (343)
T 1luf_A          119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF  195 (343)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred             EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            99999999999999999999999543211                    26789999999999999999999999   99


Q ss_pred             EEcCCCCCcEEEcCCCceEEeecccccccCCCCc-ccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCC
Q 018263          169 VHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRT  246 (358)
Q Consensus       169 ~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~  246 (358)
                      +|+||+|+||+++.++.++|+|||++........ .......++..|+|||++.+..++.++||||||+++|+|++ |..
T Consensus       196 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~  275 (343)
T 1luf_A          196 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ  275 (343)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence            9999999999999999999999999876432221 12233567889999999998899999999999999999999 999


Q ss_pred             CCCccccccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCC
Q 018263          247 AVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNID  324 (358)
Q Consensus       247 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~  324 (358)
                      ||.........                ..+........+...+..+.+++.+||+.||.+|||+.++++.|+++....
T Consensus       276 p~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~  337 (343)
T 1luf_A          276 PYYGMAHEEVI----------------YYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA  337 (343)
T ss_dssp             TTTTSCHHHHH----------------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred             cCCCCChHHHH----------------HHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence            99754321111                111111112234456678999999999999999999999999999987644

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3e-44  Score=323.00  Aligned_cols=264  Identities=24%  Similarity=0.358  Sum_probs=205.0

Q ss_pred             cCCcccceecccCceEEEEEEECCCCEEEEEEeeccCh--hhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESK--QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      ++|++.+.||+|+||.||+|++.+|+.||+|.+.....  .....+.+|+..++.++  ||||+++++++...+..++||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~   79 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELK--HSNIVKLYDVIHTKKRLVLVF   79 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCC--CTTBCCEEEEEECSSCEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcC--CCCEeeeeeEEccCCeEEEEE
Confidence            68999999999999999999998899999999865432  23467889999999998  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      ||+++ +|.+++.   ...+.+++..++.++.||+.||+|||++   |++|+||||+||+++.++.++|+|||++.....
T Consensus        80 e~~~~-~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  152 (288)
T 1ob3_A           80 EHLDQ-DLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGI  152 (288)
T ss_dssp             ECCSE-EHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred             EecCC-CHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCc
Confidence            99965 8888883   2346789999999999999999999999   999999999999999999999999999976543


Q ss_pred             CCcccccccccccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhh--
Q 018263          200 NTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV--  276 (358)
Q Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  276 (358)
                      ... ......+++.|+|||++.+. .++.++||||||+++|+|++|+.||......+....+....+......+....  
T Consensus       153 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T 1ob3_A          153 PVR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL  231 (288)
T ss_dssp             ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred             ccc-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcc
Confidence            222 22335689999999998764 58999999999999999999999998665443333332222222111111110  


Q ss_pred             ---cccc-------CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          277 ---DPML-------YGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       277 ---~~~~-------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                         ++..       ........+..+.+++.+||+.||.+|||+.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence               0000       00112235667899999999999999999999985

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=8.9e-45  Score=325.19  Aligned_cols=260  Identities=23%  Similarity=0.297  Sum_probs=201.5

Q ss_pred             HHHhhcCCcccceecccCceEEEEEEECC----CCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEc
Q 018263           37 LKIATNGFRWSNKIGEGGFGSVYKGRLQD----GTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID  111 (358)
Q Consensus        37 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~  111 (358)
                      +.+..++|++.+.||+|+||.||+|.+..    +..|++|..... .......+.+|+..++.++  ||||+++++++. 
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~-   86 (281)
T 1mp8_A           10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD--HPHIVKLIGVIT-   86 (281)
T ss_dssp             CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCC--CTTBCCEEEEEC-
T ss_pred             eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCC--CCccceEEEEEc-
Confidence            45567899999999999999999998642    457999998653 3445567889999999998  999999999984 


Q ss_pred             CCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeec
Q 018263          112 GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF  191 (358)
Q Consensus       112 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Df  191 (358)
                      .+..++||||+++++|.+++..   ....+++..++.++.|++.||.|||+.   |++|+||||+||+++.++.++|+||
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df  160 (281)
T 1mp8_A           87 ENPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDF  160 (281)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-
T ss_pred             cCccEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcc
Confidence            5678999999999999999942   334689999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchh
Q 018263          192 GLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSK  270 (358)
Q Consensus       192 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      |++...............+++.|+|||++.+..++.++||||||+++|+|++ |..||...........+          
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i----------  230 (281)
T 1mp8_A          161 GLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI----------  230 (281)
T ss_dssp             ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH----------
T ss_pred             ccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHH----------
Confidence            9998764433333334456778999999998899999999999999999996 99999755432211111          


Q ss_pred             hHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCC
Q 018263          271 ELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGET  321 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~  321 (358)
                            ........+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus       231 ------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  275 (281)
T 1mp8_A          231 ------ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  275 (281)
T ss_dssp             ------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------HcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                  111112234456678999999999999999999999999998764

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-43  Score=324.86  Aligned_cols=251  Identities=21%  Similarity=0.284  Sum_probs=206.9

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccCh------hhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK------QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP  113 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~  113 (358)
                      .++|++.+.||+|+||.||+|... +|+.||+|++.....      .....+.+|+..++.++  ||||+++++++....
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~   87 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ--HPNVITLHEVYENKT   87 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCC--CTTBCCEEEEEECSS
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCC--CCCCCcEEEEEEeCC
Confidence            467999999999999999999976 689999999875432      24677889999999998  999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCC----ceEEe
Q 018263          114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF----NPKIS  189 (358)
Q Consensus       114 ~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~----~~~l~  189 (358)
                      ..++||||+++++|.+++    .....+++..++.++.||+.||.|||++   |++|+||+|+||+++.++    .++|+
T Consensus        88 ~~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~  160 (326)
T 2y0a_A           88 DVILILELVAGGELFDFL----AEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKII  160 (326)
T ss_dssp             EEEEEEECCCSCBHHHHH----TTSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEEC
T ss_pred             EEEEEEEcCCCCCHHHHH----HhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEE
Confidence            999999999999999999    3456799999999999999999999999   999999999999998887    79999


Q ss_pred             ecccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccch
Q 018263          190 DFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNS  269 (358)
Q Consensus       190 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      |||++.......  ......+|+.|+|||++.+..++.++||||||+++|+|++|..||...........+.........
T Consensus       161 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~  238 (326)
T 2y0a_A          161 DFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED  238 (326)
T ss_dssp             CCTTCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCH
T ss_pred             ECCCCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCc
Confidence            999998754322  223456899999999998889999999999999999999999999755432222111110000000


Q ss_pred             hhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          270 KELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                                   ......+..+.++|.+||+.||.+|||+.++++
T Consensus       239 -------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          239 -------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             -------------HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -------------cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                         001123456889999999999999999999987

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.1e-44  Score=343.92  Aligned_cols=266  Identities=27%  Similarity=0.417  Sum_probs=214.8

Q ss_pred             HHHHHHhhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC
Q 018263           34 YNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP  113 (358)
Q Consensus        34 ~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~  113 (358)
                      ...+.+..++|++.+.||+|+||.||+|.++.+..||||++.... .....+.+|+..++.++  ||||+++++++.. +
T Consensus       176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~-~  251 (452)
T 1fmk_A          176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLR--HEKLVQLYAVVSE-E  251 (452)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCC--CTTBCCEEEEECS-S
T ss_pred             ccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCC--CCCEeeEEEEEcC-C
Confidence            455667788999999999999999999999888889999997543 34567899999999998  9999999999876 6


Q ss_pred             eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccc
Q 018263          114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL  193 (358)
Q Consensus       114 ~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~  193 (358)
                      ..++||||+++++|.+++..  .....+++..+..++.||+.||+|||++   +++|+||+|+||+++.++.+||+|||+
T Consensus       252 ~~~iv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~  326 (452)
T 1fmk_A          252 PIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGL  326 (452)
T ss_dssp             SCEEEECCCTTCBHHHHHSH--HHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred             ceEEEehhhcCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCcc
Confidence            78999999999999999942  2335689999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhH
Q 018263          194 SKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKEL  272 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      +...............++..|+|||++.+..++.++||||||+++|+|++ |+.||........                
T Consensus       327 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~----------------  390 (452)
T 1fmk_A          327 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV----------------  390 (452)
T ss_dssp             TC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH----------------
T ss_pred             ceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHH----------------
Confidence            98754333323333456788999999998999999999999999999999 9999975432211                


Q ss_pred             hhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCC
Q 018263          273 MNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNID  324 (358)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~  324 (358)
                      ...+....+...+..++..+.+++.+||+.||.+|||+.+|++.|+.+....
T Consensus       391 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~  442 (452)
T 1fmk_A          391 LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  442 (452)
T ss_dssp             HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             HHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence            1111122223344556778999999999999999999999999999987654

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=5.5e-44  Score=331.49  Aligned_cols=256  Identities=22%  Similarity=0.303  Sum_probs=208.6

Q ss_pred             HHHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC
Q 018263           37 LKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP  113 (358)
Q Consensus        37 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~  113 (358)
                      .....++|++.+.||+|+||.||+|.++ +|+.||+|++...  .......+.+|+.+++.++  ||||+++++++.+.+
T Consensus        24 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~--hpnIv~~~~~~~~~~  101 (362)
T 2bdw_A           24 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ--HPNIVRLHDSIQEES  101 (362)
T ss_dssp             CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCC--CTTBCCEEEEEECSS
T ss_pred             CCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCC--CCCCCeEEEEEEeCC
Confidence            3345678999999999999999999976 6899999999754  3344567889999999998  999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCC---ceEEee
Q 018263          114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF---NPKISD  190 (358)
Q Consensus       114 ~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~---~~~l~D  190 (358)
                      ..++||||++|++|.+.+    .....+++..++.++.||+.||.|||++   ||+|+||||+||+++.++   .++|+|
T Consensus       102 ~~~lv~e~~~gg~L~~~l----~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~D  174 (362)
T 2bdw_A          102 FHYLVFDLVTGGELFEDI----VAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLAD  174 (362)
T ss_dssp             EEEEEECCCCSCBHHHHH----TTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECC
T ss_pred             EEEEEEecCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEee
Confidence            999999999999999998    3456789999999999999999999999   999999999999997654   599999


Q ss_pred             cccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchh
Q 018263          191 FGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSK  270 (358)
Q Consensus       191 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      ||++.......  ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+......+   
T Consensus       175 fG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~---  249 (362)
T 2bdw_A          175 FGLAIEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY---  249 (362)
T ss_dssp             CTTCBCCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC---
T ss_pred             cCcceEecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC---
Confidence            99998754322  2234679999999999998899999999999999999999999997654322111111100000   


Q ss_pred             hHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 018263          271 ELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKM  316 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~  316 (358)
                                ........+..+.++|.+||+.||.+|||+.++++.
T Consensus       250 ----------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          250 ----------PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             ----------CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ----------CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                      000112345678999999999999999999998753

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.9e-43  Score=322.73  Aligned_cols=247  Identities=22%  Similarity=0.333  Sum_probs=207.1

Q ss_pred             CcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecC
Q 018263           44 FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM  122 (358)
Q Consensus        44 y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~  122 (358)
                      |...+.||+|+||.||+|+.. +|+.||||++..........+.+|+..++.++  ||||+++++++...+..++||||+
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~  124 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ--HFNVVEMYKSYLVGEELWVLMEFL  124 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCC--CTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCC--CCCcceEEEEEEECCEEEEEEecC
Confidence            777889999999999999986 79999999998776667778899999999998  999999999999999999999999


Q ss_pred             CCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCc
Q 018263          123 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT  202 (358)
Q Consensus       123 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~  202 (358)
                      ++++|.+++     ....+++..+..++.||+.||.|||+.   |++|+||+|+||+++.++.++|+|||++........
T Consensus       125 ~~~~L~~~l-----~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  196 (321)
T 2c30_A          125 QGGALTDIV-----SQVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP  196 (321)
T ss_dssp             CSCBHHHHH-----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred             CCCCHHHHH-----HhcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc
Confidence            999999998     234689999999999999999999999   999999999999999999999999999886543322


Q ss_pred             ccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccCC
Q 018263          203 HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYG  282 (358)
Q Consensus       203 ~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (358)
                       ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...........   ..         ....+.  .
T Consensus       197 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~---~~---------~~~~~~--~  261 (321)
T 2c30_A          197 -KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR---LR---------DSPPPK--L  261 (321)
T ss_dssp             -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH---HH---------HSSCCC--C
T ss_pred             -ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---Hh---------cCCCCC--c
Confidence             22345789999999999988999999999999999999999999975433221111   10         000000  0


Q ss_pred             CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          283 NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       283 ~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ......+..+.+++.+||+.||.+|||+.++++
T Consensus       262 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          262 KNSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            112234567899999999999999999999987

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.2e-44  Score=335.48  Aligned_cols=261  Identities=26%  Similarity=0.436  Sum_probs=203.7

Q ss_pred             HhhcCCcccceecccCceEEEEEEEC----CCCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQ----DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP  113 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~----~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~  113 (358)
                      +..++|++.+.||+|+||.||+|+..    ++..||||.+... .......+.+|+..+..++  ||||+++++++...+
T Consensus        42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~  119 (373)
T 2qol_A           42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD--HPNIIRLEGVVTKSK  119 (373)
T ss_dssp             CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCC--CTTBCCEEEEECSSS
T ss_pred             cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCC--CCCCCeEEEEEeeCC
Confidence            34578999999999999999999864    5778999998754 3445578899999999998  999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccc
Q 018263          114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL  193 (358)
Q Consensus       114 ~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~  193 (358)
                      ..++||||+++++|.+++..   ....+++..++.++.||+.||+|||++   |++|+||||+||+++.++.+||+|||+
T Consensus       120 ~~~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~  193 (373)
T 2qol_A          120 PVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGL  193 (373)
T ss_dssp             SCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--
T ss_pred             ceEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcc
Confidence            99999999999999999942   345689999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCccc--ccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchh
Q 018263          194 SKLFPENTTHI--STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSK  270 (358)
Q Consensus       194 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      +..........  .....++..|+|||++.+..++.++||||||+++|+|++ |+.||.......               
T Consensus       194 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~---------------  258 (373)
T 2qol_A          194 GRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD---------------  258 (373)
T ss_dssp             --------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH---------------
T ss_pred             ccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---------------
Confidence            98754332211  112335678999999999999999999999999999998 999996543211               


Q ss_pred             hHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCC
Q 018263          271 ELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNI  323 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~  323 (358)
                       ....+........+...+..+.+++.+||+.+|.+||++.+|++.|+.+...
T Consensus       259 -~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          259 -VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             -HHHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             -HHHHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence             1111222222233445667899999999999999999999999999887543

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.1e-43  Score=328.27  Aligned_cols=252  Identities=19%  Similarity=0.269  Sum_probs=206.9

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC-----hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-----KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP  113 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~  113 (358)
                      ..++|++.+.||+|+||.||+|.+. +|+.||+|++....     ......+.+|+.+++.++  ||||+++++++...+
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~~   99 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK--HPHIVELLETYSSDG   99 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCC--CTTBCCEEEEEEETT
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCC--CCCCCcEEEEEEeCC
Confidence            4578999999999999999999975 68999999986432     224577889999999998  999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCc---eEEee
Q 018263          114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN---PKISD  190 (358)
Q Consensus       114 ~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~---~~l~D  190 (358)
                      ..++||||++|++|.+.+.........+++..++.++.||+.||.|||++   ||+|+||||+||+++.++.   ++|+|
T Consensus       100 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~D  176 (351)
T 3c0i_A          100 MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGG  176 (351)
T ss_dssp             EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECC
T ss_pred             EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEec
Confidence            99999999999999988855444455689999999999999999999999   9999999999999986655   99999


Q ss_pred             cccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchh
Q 018263          191 FGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSK  270 (358)
Q Consensus       191 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      ||++........ ......+|+.|+|||++.+..++.++||||||+++|+|++|..||.....    .....+.      
T Consensus       177 fg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~i~------  245 (351)
T 3c0i_A          177 FGVAIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLFEGII------  245 (351)
T ss_dssp             CTTCEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHHHHHH------
T ss_pred             CcceeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHHHHHH------
Confidence            999987654322 23345799999999999988999999999999999999999999975421    1111110      


Q ss_pred             hHhhhhccccCCCCC----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          271 ELMNLVDPMLYGNFP----ENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                            ....  ..+    ...+..+.+||.+||+.||.+|||+.++++
T Consensus       246 ------~~~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          246 ------KGKY--KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             ------HTCC--CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ------cCCC--CCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                  0000  001    123567899999999999999999999985

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=9.2e-44  Score=337.92  Aligned_cols=253  Identities=20%  Similarity=0.255  Sum_probs=207.2

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC--hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeE
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI  116 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~  116 (358)
                      ..++|++.+.||+|+||.||+|.+. +|+.||+|++....  ......+.+|+.+++.++  ||||+++++++.+.+..+
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~--hpnIv~l~~~~~~~~~~~   86 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLK--HPNIVRLHDSISEEGHHY   86 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCC--BTTBCCEEEEEECSSEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCC--CcCCCeEEEEEEECCEEE
Confidence            4678999999999999999999875 68999999987543  334567889999999998  999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEc---CCCceEEeeccc
Q 018263          117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD---QNFNPKISDFGL  193 (358)
Q Consensus       117 iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~---~~~~~~l~Dfg~  193 (358)
                      +||||++|++|.+.+    .....+++..+..++.||+.||.|||++   ||+||||||+||+++   .++.++|+|||+
T Consensus        87 lv~E~~~gg~L~~~i----~~~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~  159 (444)
T 3soa_A           87 LIFDLVTGGELFEDI----VAREYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGL  159 (444)
T ss_dssp             EEECCCBCCBHHHHH----HHCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred             EEEEeCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCce
Confidence            999999999999998    3456799999999999999999999999   999999999999998   567899999999


Q ss_pred             ccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHh
Q 018263          194 SKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELM  273 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      +........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+.....        
T Consensus       160 a~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~--------  230 (444)
T 3soa_A          160 AIEVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAY--------  230 (444)
T ss_dssp             CBCCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC--------
T ss_pred             eEEecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC--------
Confidence            986543322 22346799999999999988999999999999999999999999976543222222111100        


Q ss_pred             hhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          274 NLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                           ..........+..+.+||.+||+.||.+|||+.|+++
T Consensus       231 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          231 -----DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             -----CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -----CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                 0001111234567899999999999999999999987

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=9.2e-44  Score=324.19  Aligned_cols=245  Identities=24%  Similarity=0.374  Sum_probs=207.0

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI  116 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~  116 (358)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|++....   ......+.+|...++.+.  ||||+++++++.+....+
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~Iv~~~~~~~~~~~~~   82 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT--HPFIIRMWGTFQDAQQIF   82 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC--BTTBCCEEEEEECSSEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCC--CCCCceEeEEEEeCCEEE
Confidence            578999999999999999999976 69999999987542   234567788999999987  999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       117 iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      +||||++|++|.+++    .....+++..++.++.||+.||.|||++   ||+||||||+||+++.+|.++|+|||++..
T Consensus        83 lv~e~~~gg~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~  155 (318)
T 1fot_A           83 MIMDYIEGGELFSLL----RKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKY  155 (318)
T ss_dssp             EEECCCCSCBHHHHH----HHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             EEEeCCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCccee
Confidence            999999999999999    3456789999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhh
Q 018263          197 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV  276 (358)
Q Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                      ....    .....||+.|+|||++.+..++.++|+||||+++|+|++|+.||........+..               ++
T Consensus       156 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---------------i~  216 (318)
T 1fot_A          156 VPDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK---------------IL  216 (318)
T ss_dssp             CSSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH---------------HH
T ss_pred             cCCc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH---------------HH
Confidence            5332    2345789999999999999999999999999999999999999975433221111               11


Q ss_pred             ccccCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 018263          277 DPMLYGNFPENEAIRFLKVGLLCVQEKSKLRP-----QMSTAIK  315 (358)
Q Consensus       277 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp-----t~~eil~  315 (358)
                      ..  ...++...+..+.+++.+||+.||.+||     +++++++
T Consensus       217 ~~--~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          217 NA--ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             HC--CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             hC--CCCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence            11  1123445567899999999999999999     8888873

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=4.9e-44  Score=328.17  Aligned_cols=246  Identities=22%  Similarity=0.321  Sum_probs=204.9

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI  116 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~  116 (358)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++....   ......+.+|+..++.++  ||||+++++++...+..+
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~l~~~~~~~~~~~   85 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR--HPHIIKLYDVITTPTDIV   85 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCC--CTTBCCEEEEEECSSEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCC--CCCCCeEEEEEEeCCEEE
Confidence            478999999999999999999974 78999999986432   223457889999999998  999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       117 iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      +||||+ +++|.+.+    ...+.+++..++.++.||+.||.|||+.   |++|+||||+||+++.++.++|+|||++..
T Consensus        86 lv~E~~-~g~l~~~l----~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~  157 (336)
T 3h4j_B           86 MVIEYA-GGELFDYI----VEKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNI  157 (336)
T ss_dssp             EEECCC-CEEHHHHH----HHHCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBT
T ss_pred             EEEECC-CCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEecccee
Confidence            999999 78898888    3456799999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCcccccccccccCccCccccccCCC-CccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhh
Q 018263          197 FPENTTHISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNL  275 (358)
Q Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                      .....  .....+|++.|+|||++.+..+ +.++||||||+++|+|++|+.||...........+               
T Consensus       158 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i---------------  220 (336)
T 3h4j_B          158 MTDGN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV---------------  220 (336)
T ss_dssp             TTTSB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC---------------
T ss_pred             ccCCc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH---------------
Confidence            54322  2344579999999999988775 78999999999999999999999754332211111               


Q ss_pred             hccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          276 VDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       276 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                       .. .....+...+..+.+|+.+||+.||.+|||+.|+++
T Consensus       221 -~~-~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          221 -NS-CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             -CS-SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             -Hc-CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence             00 011233445677899999999999999999999975

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=8.3e-44  Score=331.88  Aligned_cols=251  Identities=23%  Similarity=0.340  Sum_probs=208.5

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCee
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR  115 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~  115 (358)
                      ..++|++.+.||+|+||.||+|... +++.||+|++...   .......+.+|+.+++.++  ||||+++++++......
T Consensus        13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~--hp~Iv~l~~~~~~~~~~   90 (384)
T 4fr4_A           13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE--HPFLVNLWYSFQDEEDM   90 (384)
T ss_dssp             CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC--CTTBCCEEEEEECSSEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCC--CCCCCcEEEEEEeCCEE
Confidence            4578999999999999999999976 5889999998643   2334567889999999998  99999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccc
Q 018263          116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK  195 (358)
Q Consensus       116 ~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~  195 (358)
                      ++||||++|++|.+++    .....+++..++.++.||+.||.|||++   ||+||||||+||+++.++.++|+|||++.
T Consensus        91 ~lv~e~~~gg~L~~~l----~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~  163 (384)
T 4fr4_A           91 FMVVDLLLGGDLRYHL----QQNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAA  163 (384)
T ss_dssp             EEEECCCTTEEHHHHH----HTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEecCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceee
Confidence            9999999999999999    4456799999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCcccccccccccCccCcccccc---CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhH
Q 018263          196 LFPENTTHISTRVAGTLGYLAPEYAIS---GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKEL  272 (358)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      .....  .......||+.|+|||++.+   ..++.++||||||+++|+|++|+.||.................       
T Consensus       164 ~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~-------  234 (384)
T 4fr4_A          164 MLPRE--TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET-------  234 (384)
T ss_dssp             ECCTT--CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH-------
T ss_pred             eccCC--CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh-------
Confidence            75432  22345679999999999874   4589999999999999999999999976544332222211110       


Q ss_pred             hhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCC-HHHHHH
Q 018263          273 MNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQ-MSTAIK  315 (358)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt-~~eil~  315 (358)
                             ....++...+..+.+||.+||+.||.+||+ ++++++
T Consensus       235 -------~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          235 -------TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             -------CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             -------cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence                   112234456678999999999999999998 666654

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.6e-44  Score=328.56  Aligned_cols=267  Identities=22%  Similarity=0.352  Sum_probs=201.3

Q ss_pred             HHHHHhhcCCcccceecccCceEEEEEEECC-C---CEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeece
Q 018263           35 NQLKIATNGFRWSNKIGEGGFGSVYKGRLQD-G---TIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGG  108 (358)
Q Consensus        35 ~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~-~---~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~  108 (358)
                      .++.+..++|++.+.||+|+||.||+|.+.. +   ..||+|++...  .......+.+|+..++.++  ||||++++++
T Consensus        16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~   93 (323)
T 3qup_A           16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD--HPHVAKLVGV   93 (323)
T ss_dssp             CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCC--CTTBCCCCEE
T ss_pred             hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCC--CCceehhhce
Confidence            3455667899999999999999999998653 3   27999998754  3445678899999999997  9999999999


Q ss_pred             EEcCCee------EEEEecCCCCCHHHHhhhccc--cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEE
Q 018263          109 CIDGPCR------ILVYDYMPNNSLSQTLLGEEK--RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL  180 (358)
Q Consensus       109 ~~~~~~~------~iv~e~~~~~~L~~~l~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv  180 (358)
                      +......      ++||||+++++|.+++.....  ....+++..++.++.||+.||.|||++   |++|+||||+||++
T Consensus        94 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli  170 (323)
T 3qup_A           94 SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCML  170 (323)
T ss_dssp             EECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             eeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEE
Confidence            9877655      999999999999999954322  223689999999999999999999999   99999999999999


Q ss_pred             cCCCceEEeecccccccCCCCc-ccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchh
Q 018263          181 DQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYH  258 (358)
Q Consensus       181 ~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~  258 (358)
                      +.++.++|+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||..........
T Consensus       171 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~  250 (323)
T 3qup_A          171 AEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN  250 (323)
T ss_dssp             CTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH
T ss_pred             cCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHH
Confidence            9999999999999986543222 12223456778999999999999999999999999999999 999997654332211


Q ss_pred             hhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCC
Q 018263          259 LVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETN  322 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~  322 (358)
                      .+                ........+...+..+.+++.+||+.||.+|||+.++++.|+++..
T Consensus       251 ~~----------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~  298 (323)
T 3qup_A          251 YL----------------IGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG  298 (323)
T ss_dssp             HH----------------HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HH----------------hcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            11                1111222334556779999999999999999999999999998754

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.7e-43  Score=321.30  Aligned_cols=274  Identities=21%  Similarity=0.287  Sum_probs=207.7

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC--hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      .++|++.+.||+|++|.||+|.+. +|+.||+|++....  ......+.+|+..++.++  ||||+++++++...+..++
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~l   79 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK--HPNLVNLLEVFRRKRRLHL   79 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCC--CTTBCCEEEEEEETTEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCC--CCCccchhheeecCCeEEE
Confidence            468999999999999999999986 58999999885443  333567888999999998  9999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      ||||+++++|.+++    .....+++..++.++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++...
T Consensus        80 v~e~~~~~~l~~~~----~~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  152 (311)
T 4agu_A           80 VFEYCDHTVLHELD----RYQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLL  152 (311)
T ss_dssp             EEECCSEEHHHHHH----HTSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEeCCCchHHHHH----hhhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhc
Confidence            99999999999887    4456789999999999999999999999   9999999999999999999999999999875


Q ss_pred             CCCCcccccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhh
Q 018263          198 PENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV  276 (358)
Q Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                      ..... ......++..|+|||++.+ ..++.++||||||+++|+|++|..||......+....+....+...........
T Consensus       153 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (311)
T 4agu_A          153 TGPSD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFS  231 (311)
T ss_dssp             C-------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHH
T ss_pred             cCccc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccc
Confidence            43222 2234568899999999876 568999999999999999999999998766554444333332222111111100


Q ss_pred             ccc-----cCC---CC------CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhhcCCCCC
Q 018263          277 DPM-----LYG---NF------PENEAIRFLKVGLLCVQEKSKLRPQMSTAIK--MMNGETNID  324 (358)
Q Consensus       277 ~~~-----~~~---~~------~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~--~L~~~~~~~  324 (358)
                      ...     ...   ..      ....+..+.+++.+||+.||.+|||++++++  .++++.+..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  295 (311)
T 4agu_A          232 TNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE  295 (311)
T ss_dssp             TCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC---
T ss_pred             cccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHH
Confidence            000     000   00      0234566899999999999999999999986  344444443

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=6.5e-44  Score=317.28  Aligned_cols=255  Identities=22%  Similarity=0.361  Sum_probs=210.5

Q ss_pred             HhhcCCcccceecccCceEEEEEEECCCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC--Ce
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG--PC  114 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~--~~  114 (358)
                      +..++|++.+.||+|+||.||+|++. ++.||+|++...  .......+.+|+..++.++  ||||+++++++...  ..
T Consensus         7 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~   83 (271)
T 3kmu_A            7 IDFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS--HPNVLPVLGACQSPPAPH   83 (271)
T ss_dssp             CCGGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCS--CTTEECEEEEECTTTSSS
T ss_pred             CCHHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcC--CCchhheEEEEccCCCCC
Confidence            45689999999999999999999986 888999998754  3444567889999999997  99999999999887  77


Q ss_pred             eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCC--cEEcCCCCCcEEEcCCCceEEeecc
Q 018263          115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH--VVHRDIKTSNILLDQNFNPKISDFG  192 (358)
Q Consensus       115 ~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~--i~H~di~p~Nilv~~~~~~~l~Dfg  192 (358)
                      .++||||+++++|.+++..  .....+++..++.++.||+.||.|||+.   +  ++|+||+|+||+++.++.++++|||
T Consensus        84 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~  158 (271)
T 3kmu_A           84 PTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMAD  158 (271)
T ss_dssp             CEEEEECCTTCBHHHHHHS--CSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGG
T ss_pred             eEeeecccCCCcHHHHHhh--cccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEecc
Confidence            8999999999999999943  2233689999999999999999999999   8  9999999999999999999999998


Q ss_pred             cccccCCCCcccccccccccCccCccccccCCCCc---cCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccch
Q 018263          193 LSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR---KSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNS  269 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~---~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      +......      ....+++.|+|||++.+..++.   ++||||||+++|+|++|+.||........             
T Consensus       159 ~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-------------  219 (271)
T 3kmu_A          159 VKFSFQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI-------------  219 (271)
T ss_dssp             SCCTTSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH-------------
T ss_pred             ceeeecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH-------------
Confidence            8764322      2245789999999988765544   79999999999999999999975432211             


Q ss_pred             hhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCC
Q 018263          270 KELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETN  322 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~  322 (358)
                        .............+...+..+.+++.+||+.||.+|||+.++++.|+.+.+
T Consensus       220 --~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          220 --GMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             --HHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             --HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence              111222222334455567789999999999999999999999999998764

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3.8e-44  Score=330.11  Aligned_cols=253  Identities=23%  Similarity=0.312  Sum_probs=205.6

Q ss_pred             HHHHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceEEc
Q 018263           36 QLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCID  111 (358)
Q Consensus        36 ~~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~  111 (358)
                      ...+..++|++.+.||+|+||.||+|+.+ +|+.||+|++....   ......+..|...+..+. .||||+++++++.+
T Consensus        11 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~-~hp~iv~l~~~~~~   89 (345)
T 1xjd_A           11 QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW-EHPFLTHMFCTFQT   89 (345)
T ss_dssp             -----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHT-TCTTBCCEEEEEEC
T ss_pred             cCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcC-CCCCCCcEEEEEEe
Confidence            34566789999999999999999999986 68999999997542   334456777888887762 39999999999999


Q ss_pred             CCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeec
Q 018263          112 GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF  191 (358)
Q Consensus       112 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Df  191 (358)
                      .+..++||||++|++|.+++    .....+++..++.++.||+.||.|||++   ||+||||||+||+++.+|.++|+||
T Consensus        90 ~~~~~lv~E~~~gg~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DF  162 (345)
T 1xjd_A           90 KENLFFVMEYLNGGDLMYHI----QSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADF  162 (345)
T ss_dssp             SSEEEEEEECCTTCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred             CCEEEEEEeCCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEC
Confidence            99999999999999999999    3456799999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhh
Q 018263          192 GLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKE  271 (358)
Q Consensus       192 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      |++....... ......+||+.|+|||++.+..++.++|+||||+++|+|++|+.||...........+.          
T Consensus       163 G~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~----------  231 (345)
T 1xjd_A          163 GMCKENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR----------  231 (345)
T ss_dssp             TTCBCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----------
T ss_pred             hhhhhcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH----------
Confidence            9997543222 22345679999999999999899999999999999999999999997554322111110          


Q ss_pred             HhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 018263          272 LMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMS-TAI  314 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~-eil  314 (358)
                           ..  ...++...+..+.++|.+||+.||.+||++. +++
T Consensus       232 -----~~--~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          232 -----MD--NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             -----HC--CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             -----hC--CCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence                 00  1223344567899999999999999999997 554

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=6.6e-44  Score=324.88  Aligned_cols=268  Identities=22%  Similarity=0.275  Sum_probs=213.6

Q ss_pred             HHhhcCCcccceecccCceEEEEEEE-CCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEE----cC
Q 018263           38 KIATNGFRWSNKIGEGGFGSVYKGRL-QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCI----DG  112 (358)
Q Consensus        38 ~~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~----~~  112 (358)
                      .+..++|++.+.||+|+||.||++.. .+|+.||+|++..........+.+|+..++.++  ||||+++++++.    ..
T Consensus        25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~  102 (317)
T 2buj_A           25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFN--HPNILRLVAYCLRERGAK  102 (317)
T ss_dssp             EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCC--CTTBCCCCEEEEEEETTE
T ss_pred             EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcC--CCCeeeEEEEEEeccCCC
Confidence            45678999999999999999999997 479999999987777777788999999999998  999999999987    34


Q ss_pred             CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecc
Q 018263          113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG  192 (358)
Q Consensus       113 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg  192 (358)
                      ...++||||+++++|.+++.........+++..++.++.||+.||.|||+.   |++|+||+|+||+++.++.++|+|||
T Consensus       103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg  179 (317)
T 2buj_A          103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLG  179 (317)
T ss_dssp             EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCS
T ss_pred             ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecC
Confidence            478999999999999999965544567899999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcc--------cccccccccCccCccccccCC---CCccCceecHHHHHHHHHhCCCCCCccccccchhhhH
Q 018263          193 LSKLFPENTTH--------ISTRVAGTLGYLAPEYAISGR---LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVD  261 (358)
Q Consensus       193 ~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~---~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~  261 (358)
                      .+.........        ......+++.|+|||++.+..   ++.++||||||+++|+|++|+.||..........   
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~---  256 (317)
T 2buj_A          180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV---  256 (317)
T ss_dssp             SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCH---
T ss_pred             cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchh---
Confidence            88754321110        011244689999999887543   6889999999999999999999996432111110   


Q ss_pred             hhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCC
Q 018263          262 KAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNID  324 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~  324 (358)
                                 ...+........+...+..+.+++.+||+.||.+|||+.++++.|+.++...
T Consensus       257 -----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~  308 (317)
T 2buj_A          257 -----------ALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA  308 (317)
T ss_dssp             -----------HHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred             -----------hHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence                       0001111111222345667999999999999999999999999999987544

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=8.2e-44  Score=321.69  Aligned_cols=258  Identities=24%  Similarity=0.346  Sum_probs=201.3

Q ss_pred             hhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEc----CCee
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID----GPCR  115 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~----~~~~  115 (358)
                      ..++|++.+.||+|+||.||+|++ +++.||+|++...   ....+..|.+.+......||||+++++++..    ....
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            468999999999999999999998 5899999998643   3344556666666643349999999998654    3457


Q ss_pred             EEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCcEEcCCCCCcEEEcCCCceE
Q 018263          116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH--------EEIQPHVVHRDIKTSNILLDQNFNPK  187 (358)
Q Consensus       116 ~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--------~~~~~~i~H~di~p~Nilv~~~~~~~  187 (358)
                      ++||||+++++|.+++     ....+++..++.++.||+.||+|||        +.   +++|+||||+||+++.++.+|
T Consensus        82 ~lv~e~~~~g~L~~~l-----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~k  153 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCC  153 (301)
T ss_dssp             EEEECCCTTCBHHHHH-----TTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEE
T ss_pred             EEehhhccCCCHHHHH-----hhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEE
Confidence            8999999999999999     3456899999999999999999999        88   999999999999999999999


Q ss_pred             EeecccccccCCCCccc---ccccccccCccCccccccC------CCCccCceecHHHHHHHHHhC----------CCCC
Q 018263          188 ISDFGLSKLFPENTTHI---STRVAGTLGYLAPEYAISG------RLTRKSDVYSFGVLLLEIVSG----------RTAV  248 (358)
Q Consensus       188 l~Dfg~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~------~~s~~sDiwslG~il~~lltg----------~~pf  248 (358)
                      |+|||++..........   .....+|+.|+|||++.+.      .++.++||||||+++|+|++|          ..||
T Consensus       154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf  233 (301)
T 3q4u_A          154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF  233 (301)
T ss_dssp             ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence            99999997653332221   2234789999999998876      455799999999999999999          7777


Q ss_pred             Cccccccch-hhhHhhhhccchhhHhhhhccccCCC-----CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 018263          249 DFDVQLGEY-HLVDKAWGMYNSKELMNLVDPMLYGN-----FPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE  320 (358)
Q Consensus       249 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~  320 (358)
                      ......... ......           .........     .+...+..+.+++.+||+.||.+|||+.+|++.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          234 YDVVPNDPSFEDMRKV-----------VCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TTTSCSSCCHHHHHHH-----------HTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccCCCCcchhhhhHH-----------HhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            543322111 111110           001111111     2235778899999999999999999999999999875

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2e-44  Score=338.93  Aligned_cols=258  Identities=24%  Similarity=0.291  Sum_probs=210.4

Q ss_pred             HHHHHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceEE
Q 018263           35 NQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCI  110 (358)
Q Consensus        35 ~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~  110 (358)
                      .++.+..++|++.+.||+|+||.||+|+.+ +++.||+|++....   ......+.+|..++..++  ||||+++++++.
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~--hp~Iv~l~~~~~  139 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN--SPWVVQLFYAFQ  139 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCC--CTTBCCEEEEEE
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCC--CCCCCeEEEEEE
Confidence            345556789999999999999999999976 58999999986421   222345778999999987  999999999999


Q ss_pred             cCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEee
Q 018263          111 DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD  190 (358)
Q Consensus       111 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~D  190 (358)
                      +....|+||||++|++|.+++.     ...+++..++.++.||+.||+|||++   ||+||||||+||+++.++.+||+|
T Consensus       140 ~~~~~~lV~E~~~gg~L~~~l~-----~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~D  211 (410)
T 3v8s_A          140 DDRYLYMVMEYMPGGDLVNLMS-----NYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLAD  211 (410)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred             ECCEEEEEEeCCCCCcHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEec
Confidence            9999999999999999999983     34689999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccCccCccccccCC----CCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhc
Q 018263          191 FGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR----LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGM  266 (358)
Q Consensus       191 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~  266 (358)
                      ||++..............+||+.|+|||++.+..    ++.++|+||||+++|+|++|+.||...+....+..+..... 
T Consensus       212 FG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~-  290 (410)
T 3v8s_A          212 FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN-  290 (410)
T ss_dssp             CTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH-
T ss_pred             cceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccc-
Confidence            9999876554444445678999999999998655    78999999999999999999999986554332222211100 


Q ss_pred             cchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCC--CCCHHHHHH
Q 018263          267 YNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKL--RPQMSTAIK  315 (358)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~--Rpt~~eil~  315 (358)
                             .     ..-......+..+.+||.+||+.+|.+  ||+++||++
T Consensus       291 -------~-----~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          291 -------S-----LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             -------H-----CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             -------c-----ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence                   0     000011234567899999999999988  999999986

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.1e-43  Score=319.01  Aligned_cols=254  Identities=32%  Similarity=0.523  Sum_probs=207.0

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhh-------HHHHHHHHHHhhhcccCCCCceeeeceEEc
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQG-------EKEFMSEVASMANVNVCHENLVKLHGGCID  111 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~-------~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~  111 (358)
                      ..++|++.+.||+|+||.||+|++. +++.||+|++.......       ...+.+|+..++.++  ||||+++++++..
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~   94 (287)
T 4f0f_A           17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN--HPNIVKLYGLMHN   94 (287)
T ss_dssp             CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCC--CTTBCCEEEEETT
T ss_pred             hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCC--CCCchhhheeecC
Confidence            3589999999999999999999975 78999999986543221       167889999999998  9999999999876


Q ss_pred             CCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCC--cEEcCCCCCcEEEcCCCc----
Q 018263          112 GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH--VVHRDIKTSNILLDQNFN----  185 (358)
Q Consensus       112 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~--i~H~di~p~Nilv~~~~~----  185 (358)
                      ..  ++||||+++++|.+.+.   .....+++..++.++.|++.||+|||+.   |  ++|+||+|+||+++.++.    
T Consensus        95 ~~--~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~  166 (287)
T 4f0f_A           95 PP--RMVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPV  166 (287)
T ss_dssp             TT--EEEEECCTTCBHHHHHH---CTTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSC
T ss_pred             CC--eEEEEecCCCCHHHHHh---cccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCce
Confidence            65  69999999999998883   2445789999999999999999999999   9  999999999999988776    


Q ss_pred             -eEEeecccccccCCCCcccccccccccCccCccccc--cCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHh
Q 018263          186 -PKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI--SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDK  262 (358)
Q Consensus       186 -~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~  262 (358)
                       ++|+|||++.....    ......+++.|+|||++.  +..++.++||||||+++|+|++|+.||..........    
T Consensus       167 ~~kl~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~----  238 (287)
T 4f0f_A          167 CAKVADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF----  238 (287)
T ss_dssp             CEEECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH----
T ss_pred             eEEeCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH----
Confidence             99999999975332    233456899999999884  4567899999999999999999999997543321110    


Q ss_pred             hhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 018263          263 AWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE  320 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~  320 (358)
                               .............+...+..+.+++.+||+.||.+|||+.++++.|+++
T Consensus       239 ---------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          239 ---------INMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             ---------HHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             ---------HHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence                     1111122223344556677899999999999999999999999999864

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=4.9e-44  Score=344.99  Aligned_cols=264  Identities=25%  Similarity=0.385  Sum_probs=221.5

Q ss_pred             HHHHHhhcCCcccceecccCceEEEEEEECC-CCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC
Q 018263           35 NQLKIATNGFRWSNKIGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP  113 (358)
Q Consensus        35 ~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~  113 (358)
                      ..+.+..++|++.+.||+|+||.||+|.++. +..||||.+.... .....+.+|+..++.++  ||||+++++++....
T Consensus       213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~  289 (495)
T 1opk_A          213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIK--HPNLVQLLGVCTREP  289 (495)
T ss_dssp             SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCC--CTTBCCEEEEECSSS
T ss_pred             cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcC--CCCEeeEEEEEecCC
Confidence            3455667889999999999999999999874 8899999987543 34677899999999998  999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccc
Q 018263          114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL  193 (358)
Q Consensus       114 ~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~  193 (358)
                      ..++||||+++++|.+++...  ....+++..++.++.||+.||+|||++   +|+||||+|+||+++.++.+||+|||+
T Consensus       290 ~~~lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~  364 (495)
T 1opk_A          290 PFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGL  364 (495)
T ss_dssp             SCEEEEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTC
T ss_pred             cEEEEEEccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeeccc
Confidence            999999999999999999432  345689999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhH
Q 018263          194 SKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKEL  272 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      +...............++..|+|||++.+..++.++||||||+++|+|++ |..||.......                .
T Consensus       365 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~----------------~  428 (495)
T 1opk_A          365 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------V  428 (495)
T ss_dssp             EECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----------------H
T ss_pred             ceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH----------------H
Confidence            98765443333334556778999999998899999999999999999999 999997543321                1


Q ss_pred             hhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCC
Q 018263          273 MNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETN  322 (358)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~  322 (358)
                      ...+....+...+..++..+.+||.+||+.||.+|||+.+|++.|+.+..
T Consensus       429 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          429 YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             HHHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence            12222222334455667789999999999999999999999999998754

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=4.7e-44  Score=325.08  Aligned_cols=267  Identities=21%  Similarity=0.382  Sum_probs=216.9

Q ss_pred             HHHhhcCCcccceecccCceEEEEEEE------CCCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceE
Q 018263           37 LKIATNGFRWSNKIGEGGFGSVYKGRL------QDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGC  109 (358)
Q Consensus        37 ~~~~~~~y~i~~~lg~g~~g~v~~~~~------~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~  109 (358)
                      +.+..++|++.+.||+|+||.||+|++      .+++.||+|++.... ......+.+|+..+..+. .||||+++++++
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-~h~~i~~~~~~~   96 (313)
T 1t46_A           18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG-NHMNIVNLLGAC   96 (313)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE
T ss_pred             cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcc-cCCCeeeEEEEE
Confidence            456678999999999999999999985      247789999997553 344577889999999992 299999999999


Q ss_pred             EcCCeeEEEEecCCCCCHHHHhhhccc--------------cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCC
Q 018263          110 IDGPCRILVYDYMPNNSLSQTLLGEEK--------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKT  175 (358)
Q Consensus       110 ~~~~~~~iv~e~~~~~~L~~~l~~~~~--------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p  175 (358)
                      ...+..++||||+++++|.+++.....              ....+++..++.++.||+.||.|||++   |++|+||+|
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp  173 (313)
T 1t46_A           97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAA  173 (313)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred             ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCcc
Confidence            999999999999999999999954321              123589999999999999999999999   999999999


Q ss_pred             CcEEEcCCCceEEeecccccccCCCCcc-cccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCcccc
Q 018263          176 SNILLDQNFNPKISDFGLSKLFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ  253 (358)
Q Consensus       176 ~Nilv~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~  253 (358)
                      +||+++.++.++|+|||++......... ......++..|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus       174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  253 (313)
T 1t46_A          174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (313)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             ceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence            9999999999999999999876543322 2233456788999999999999999999999999999999 9999975443


Q ss_pred             ccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCC
Q 018263          254 LGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETN  322 (358)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~  322 (358)
                      ....               ...+........+...+..+.+++.+||+.||.+|||+.++++.|+++..
T Consensus       254 ~~~~---------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  307 (313)
T 1t46_A          254 DSKF---------------YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (313)
T ss_dssp             SHHH---------------HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhHH---------------HHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence            2211               11111112222334456789999999999999999999999999987653

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1e-44  Score=337.13  Aligned_cols=265  Identities=25%  Similarity=0.368  Sum_probs=214.3

Q ss_pred             HhhcCCcccceecccCceEEEEEEEC------CCCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEc
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID  111 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~  111 (358)
                      +..++|++.+.||+|+||.||+|.+.      ++..||||++... .......+.+|+..++.++  ||||+++++++..
T Consensus        68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~  145 (367)
T 3l9p_A           68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN--HQNIVRCIGVSLQ  145 (367)
T ss_dssp             CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCC--CTTBCCEEEEECS
T ss_pred             cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCC--CCCCCeEEEEEec
Confidence            34578999999999999999999843      4678999998644 3445567889999999998  9999999999999


Q ss_pred             CCeeEEEEecCCCCCHHHHhhhccc---cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCC---c
Q 018263          112 GPCRILVYDYMPNNSLSQTLLGEEK---RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF---N  185 (358)
Q Consensus       112 ~~~~~iv~e~~~~~~L~~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~---~  185 (358)
                      ....++||||+++++|.+++.....   ....+++..++.++.||+.||+|||++   ||+||||||+||+++.++   .
T Consensus       146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~  222 (367)
T 3l9p_A          146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRV  222 (367)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCC
T ss_pred             CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCce
Confidence            9999999999999999999954332   224689999999999999999999999   999999999999998554   4


Q ss_pred             eEEeecccccccCCC-CcccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhh
Q 018263          186 PKISDFGLSKLFPEN-TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKA  263 (358)
Q Consensus       186 ~~l~Dfg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~  263 (358)
                      ++|+|||++...... .........+|+.|+|||++.+..++.++||||||+++|+|++ |..||.......        
T Consensus       223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~--------  294 (367)
T 3l9p_A          223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE--------  294 (367)
T ss_dssp             EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--------
T ss_pred             EEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--------
Confidence            999999999753211 1122233567889999999999999999999999999999998 999997553321        


Q ss_pred             hhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCC
Q 018263          264 WGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNID  324 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~  324 (358)
                              ....+........+...+..+.+++.+||+.+|.+|||+.+|++.|+.+....
T Consensus       295 --------~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~  347 (367)
T 3l9p_A          295 --------VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  347 (367)
T ss_dssp             --------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             --------HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence                    11112222223334455677999999999999999999999999998876443

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.6e-43  Score=324.08  Aligned_cols=250  Identities=22%  Similarity=0.334  Sum_probs=198.2

Q ss_pred             HhhcCCcccceecccCceEEEEEEE----CCCCEEEEEEeeccC----hhhHHHHHHHHHHhhhcccCCCCceeeeceEE
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRL----QDGTIVAVKVLSVES----KQGEKEFMSEVASMANVNVCHENLVKLHGGCI  110 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~----~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~  110 (358)
                      +..++|++.+.||+|+||.||+|+.    .+|+.||+|++....    ......+.+|+..++.++  ||||+++++++.
T Consensus        14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~   91 (327)
T 3a62_A           14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK--HPFIVDLIYAFQ   91 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCC--CTTBCCEEEEEE
T ss_pred             CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCC--CCCccceeEEEE
Confidence            3468999999999999999999987    478999999986542    234456778999999998  999999999999


Q ss_pred             cCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEee
Q 018263          111 DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD  190 (358)
Q Consensus       111 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~D  190 (358)
                      ..+..++||||++|++|.+++    .....+++..++.++.||+.||.|||++   ||+|+||||+||+++.++.++|+|
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~D  164 (327)
T 3a62_A           92 TGGKLYLILEYLSGGELFMQL----EREGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTD  164 (327)
T ss_dssp             CSSCEEEEEECCTTEEHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECC
T ss_pred             cCCEEEEEEeCCCCCcHHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEe
Confidence            999999999999999999999    3456789999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchh
Q 018263          191 FGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSK  270 (358)
Q Consensus       191 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      ||++....... .......|++.|+|||++.+..++.++||||||+++|+|++|+.||...........+          
T Consensus       165 fg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i----------  233 (327)
T 3a62_A          165 FGLCKESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKI----------  233 (327)
T ss_dssp             CSCC-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH----------
T ss_pred             CCcccccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHH----------
Confidence            99987543222 1223457899999999999889999999999999999999999999755432211111          


Q ss_pred             hHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 018263          271 ELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRP-----QMSTAIK  315 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp-----t~~eil~  315 (358)
                           ...  ...++...+..+.+++.+||+.||.+||     ++.++++
T Consensus       234 -----~~~--~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          234 -----LKC--KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             -----HHT--CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             -----HhC--CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence                 111  1123344567799999999999999999     6777765

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=5.5e-44  Score=328.02  Aligned_cols=270  Identities=22%  Similarity=0.358  Sum_probs=216.9

Q ss_pred             HHHHHhhcCCcccceecccCceEEEEEEEC--------CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceee
Q 018263           35 NQLKIATNGFRWSNKIGEGGFGSVYKGRLQ--------DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKL  105 (358)
Q Consensus        35 ~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~--------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~  105 (358)
                      +.+.+..++|++.+.||+|+||.||+|.+.        ++..||+|++.... ......+.+|+..++.+. .||||+++
T Consensus        28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-~hp~iv~~  106 (334)
T 2pvf_A           28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-KHKNIINL  106 (334)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHC-CCTTBCCE
T ss_pred             ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhh-cCCCEeeE
Confidence            334566799999999999999999999863        46789999997543 344567889999999983 39999999


Q ss_pred             eceEEcCCeeEEEEecCCCCCHHHHhhhccc------------cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCC
Q 018263          106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEK------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDI  173 (358)
Q Consensus       106 ~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di  173 (358)
                      ++++...+..++||||+++++|.+++.....            ....+++..++.++.||+.||.|||++   |++|+||
T Consensus       107 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dl  183 (334)
T 2pvf_A          107 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDL  183 (334)
T ss_dssp             EEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred             EEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCC
Confidence            9999999999999999999999999954321            123488999999999999999999999   9999999


Q ss_pred             CCCcEEEcCCCceEEeecccccccCCCCc-ccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCcc
Q 018263          174 KTSNILLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFD  251 (358)
Q Consensus       174 ~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~  251 (358)
                      +|+||+++.++.++|+|||++........ .......+++.|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus       184 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~  263 (334)
T 2pvf_A          184 AARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI  263 (334)
T ss_dssp             SGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence            99999999999999999999987544332 12223456788999999988889999999999999999999 99999754


Q ss_pred             ccccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCC
Q 018263          252 VQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNID  324 (358)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~  324 (358)
                      .....                ...+........+...+..+.+++.+||+.+|.+|||+.++++.|+++....
T Consensus       264 ~~~~~----------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~  320 (334)
T 2pvf_A          264 PVEEL----------------FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT  320 (334)
T ss_dssp             CHHHH----------------HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CHHHH----------------HHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence            32211                1111111122334456678999999999999999999999999999886544

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=7.6e-44  Score=330.33  Aligned_cols=286  Identities=22%  Similarity=0.256  Sum_probs=218.5

Q ss_pred             CCCcccccccccccCHHHHHHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhccc
Q 018263           19 TIGGEQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNV   97 (358)
Q Consensus        19 ~~~~~~~~~~~~~~~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~   97 (358)
                      +....|-..++..++...-.+..++|++.+.||+|+||.||+|++. +++.||+|++.. ..........|+..++.+..
T Consensus        12 ~~~~~~~~~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~   90 (360)
T 3llt_A           12 ENLYFQGDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQN   90 (360)
T ss_dssp             --------CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCC
T ss_pred             cceeeecCccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcc
Confidence            3344455577888888888888999999999999999999999975 689999999863 33444566678888877742


Q ss_pred             ---CCCCceeeeceEEcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCC
Q 018263           98 ---CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIK  174 (358)
Q Consensus        98 ---~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~  174 (358)
                         .||||+++++++...+..++||||+ +++|.+++...  ....+++..++.++.||+.||+|||++   ||+|+|||
T Consensus        91 ~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlk  164 (360)
T 3llt_A           91 DDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLK  164 (360)
T ss_dssp             CSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCS
T ss_pred             cCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCC
Confidence               3999999999999999999999999 99999999432  334589999999999999999999999   99999999


Q ss_pred             CCcEEEcC-------------------------CCceEEeecccccccCCCCcccccccccccCccCccccccCCCCccC
Q 018263          175 TSNILLDQ-------------------------NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKS  229 (358)
Q Consensus       175 p~Nilv~~-------------------------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~s  229 (358)
                      |+||+++.                         ++.++|+|||++......    .....+|+.|+|||++.+..++.++
T Consensus       165 p~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~  240 (360)
T 3llt_A          165 PENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSS  240 (360)
T ss_dssp             GGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTH
T ss_pred             cccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCcc
Confidence            99999975                         788999999999864332    2345689999999999999999999


Q ss_pred             ceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccc-------------cCCCC------------
Q 018263          230 DVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPM-------------LYGNF------------  284 (358)
Q Consensus       230 DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~------------  284 (358)
                      ||||||+++|+|++|+.||...........+...................             .....            
T Consensus       241 DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~  320 (360)
T 3llt_A          241 DMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKC  320 (360)
T ss_dssp             HHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTC
T ss_pred             chHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhc
Confidence            99999999999999999998765544444333332222211111110000             00000            


Q ss_pred             ----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          285 ----PENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       285 ----~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                          +......+.+|+.+||+.||.+|||+.|+++
T Consensus       321 ~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          321 LPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             CCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ccccccchHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence                0011256789999999999999999999975

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.3e-43  Score=331.74  Aligned_cols=256  Identities=23%  Similarity=0.314  Sum_probs=202.7

Q ss_pred             HHHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC
Q 018263           37 LKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG  112 (358)
Q Consensus        37 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~  112 (358)
                      ..+..++|++++.||+|+||.||+|+.+ +++.||+|++....   ......+..|..++..+. .||||+++++++...
T Consensus        47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~-~hp~Iv~l~~~~~~~  125 (396)
T 4dc2_A           47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS-NHPFLVGLHSCFQTE  125 (396)
T ss_dssp             --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHT-TCTTBCCEEEEEECS
T ss_pred             cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcC-CCCCcCeeEEEEEEC
Confidence            3455689999999999999999999976 58899999997542   223345778888887763 399999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecc
Q 018263          113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG  192 (358)
Q Consensus       113 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg  192 (358)
                      +..++||||++|++|..++    .....+++..++.++.||+.||.|||++   ||+||||||+||+++.++.+||+|||
T Consensus       126 ~~~~lV~E~~~gg~L~~~l----~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG  198 (396)
T 4dc2_A          126 SRLFFVIEYVNGGDLMFHM----QRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYG  198 (396)
T ss_dssp             SEEEEEEECCTTCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEEcCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecc
Confidence            9999999999999999998    3456799999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhH
Q 018263          193 LSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKEL  272 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      ++...... .......+||+.|+|||++.+..++.++|+||||+++|+|++|+.||............       .....
T Consensus       199 la~~~~~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~-------~~~~~  270 (396)
T 4dc2_A          199 MCKEGLRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN-------TEDYL  270 (396)
T ss_dssp             TCBCCCCT-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------C-------CHHHH
T ss_pred             eeeecccC-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchh-------hHHHH
Confidence            99753222 22234567999999999999999999999999999999999999999644321111000       00000


Q ss_pred             hh-hhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 018263          273 MN-LVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQM  310 (358)
Q Consensus       273 ~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~  310 (358)
                      .. +...  ...++...+..+.+||.+||+.||.+||++
T Consensus       271 ~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          271 FQVILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             HHHHHHC--CCCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             HHHHhcc--ccCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence            11 1111  123445567789999999999999999996

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-44  Score=330.34  Aligned_cols=268  Identities=23%  Similarity=0.356  Sum_probs=214.6

Q ss_pred             HHHHhhcCCcccceecccCceEEEEEEE------CCCCEEEEEEeecc-ChhhHHHHHHHHHHhhhc-ccCCCCceeeec
Q 018263           36 QLKIATNGFRWSNKIGEGGFGSVYKGRL------QDGTIVAVKVLSVE-SKQGEKEFMSEVASMANV-NVCHENLVKLHG  107 (358)
Q Consensus        36 ~~~~~~~~y~i~~~lg~g~~g~v~~~~~------~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~~~h~~i~~~~~  107 (358)
                      .+.+..++|++.+.||+|+||.||+|.+      .++..||+|++... .......+.+|+..+..+ .  ||||+++++
T Consensus        39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~--hp~iv~~~~  116 (344)
T 1rjb_A           39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS--HENIVNLLG  116 (344)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCC--CTTBCCEEE
T ss_pred             CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcC--CCCeeeEEE
Confidence            4566779999999999999999999986      24668999998754 233446788999999999 5  999999999


Q ss_pred             eEEcCCeeEEEEecCCCCCHHHHhhhcccc-------------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 018263          108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKR-------------------RAKFGWKARREIIMGIGRGLAYIHEEIQPHV  168 (358)
Q Consensus       108 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~-------------------~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i  168 (358)
                      ++...+..++||||+++++|.+++......                   ...+++..++.++.||+.||.|||+.   |+
T Consensus       117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  193 (344)
T 1rjb_A          117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SC  193 (344)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence            999999999999999999999999543211                   13479999999999999999999999   99


Q ss_pred             EEcCCCCCcEEEcCCCceEEeecccccccCCCCc-ccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCC
Q 018263          169 VHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRT  246 (358)
Q Consensus       169 ~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~  246 (358)
                      +|+||+|+||+++.++.++|+|||++........ .......+++.|+|||++.+..++.++||||||+++|+|++ |..
T Consensus       194 vH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~  273 (344)
T 1rjb_A          194 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN  273 (344)
T ss_dssp             EETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred             ccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCC
Confidence            9999999999999999999999999986533222 22233557788999999999999999999999999999998 999


Q ss_pred             CCCccccccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCC
Q 018263          247 AVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNI  323 (358)
Q Consensus       247 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~  323 (358)
                      ||........               ....+........+...+..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus       274 p~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  335 (344)
T 1rjb_A          274 PYPGIPVDAN---------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD  335 (344)
T ss_dssp             SSTTCCCSHH---------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             CcccCCcHHH---------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence            9975543221               1111222222333445567899999999999999999999999999987654

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.9e-43  Score=319.07  Aligned_cols=274  Identities=19%  Similarity=0.237  Sum_probs=215.0

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC--ee
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP--CR  115 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~--~~  115 (358)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+..++.++  ||||+++++++....  ..
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~~   84 (319)
T 4euu_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN--HKNIVKLFAIEEETTTRHK   84 (319)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCC--CTTBCCEEEEEECTTTCCE
T ss_pred             CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcC--CCCcceEEEEeecCCCceE
Confidence            3578999999999999999999976 58999999987543 344567789999999998  999999999988665  77


Q ss_pred             EEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEE----cCCCceEEeec
Q 018263          116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL----DQNFNPKISDF  191 (358)
Q Consensus       116 ~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv----~~~~~~~l~Df  191 (358)
                      ++||||+++++|.+++.... ....+++..++.++.||+.||+|||+.   |++|+||||+||++    +.++.++|+||
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Df  160 (319)
T 4euu_A           85 VLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDF  160 (319)
T ss_dssp             EEEEECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCC
T ss_pred             EEEEeCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccC
Confidence            99999999999999995432 223489999999999999999999999   99999999999999    77888999999


Q ss_pred             ccccccCCCCcccccccccccCccCccccc--------cCCCCccCceecHHHHHHHHHhCCCCCCccccccc-hhhhHh
Q 018263          192 GLSKLFPENTTHISTRVAGTLGYLAPEYAI--------SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE-YHLVDK  262 (358)
Q Consensus       192 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~-~~~~~~  262 (358)
                      |++........  .....++..|+|||++.        +..++.++||||||+++|+|++|+.||........ ......
T Consensus       161 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  238 (319)
T 4euu_A          161 GAARELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK  238 (319)
T ss_dssp             TTCEECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHH
T ss_pred             CCceecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHH
Confidence            99987644332  23456899999999886        46789999999999999999999999975433222 222222


Q ss_pred             hhhccchhhHhhhh-----------ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCC
Q 018263          263 AWGMYNSKELMNLV-----------DPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGET  321 (358)
Q Consensus       263 ~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~  321 (358)
                      +........+..+.           .-......+...+..+.+++.+||+.||.+|||+.|+++......
T Consensus       239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             HHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             HhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence            21111110000000           001112456788899999999999999999999999999887554

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.3e-43  Score=327.31  Aligned_cols=245  Identities=24%  Similarity=0.320  Sum_probs=206.8

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI  116 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~  116 (358)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|++....   ......+.+|+..++.+.  ||||+++++++.+....+
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~~~~  117 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN--FPFLVKLEFSFKDNSNLY  117 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC--CTTBCCEEEEEECSSEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCC--CCCCCeEEEEEEcCCEEE
Confidence            478999999999999999999976 69999999986432   234567888999999997  999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       117 iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      +||||++|++|.+++    ...+.+++..++.++.||+.||.|||++   ||+||||||+||+++.++.++|+|||++..
T Consensus       118 lv~e~~~gg~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~  190 (350)
T 1rdq_E          118 MVMEYVAGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKR  190 (350)
T ss_dssp             EEEECCTTCBHHHHH----HHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEcCCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEccccccee
Confidence            999999999999999    3446799999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhh
Q 018263          197 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV  276 (358)
Q Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                      ....    .....||+.|+|||++.+..++.++|+||||+++|+|++|..||........+..+               .
T Consensus       191 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i---------------~  251 (350)
T 1rdq_E          191 VKGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI---------------V  251 (350)
T ss_dssp             CSSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---------------H
T ss_pred             ccCC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHH---------------H
Confidence            5332    23457899999999999989999999999999999999999999755332211111               1


Q ss_pred             ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 018263          277 DPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQ-----MSTAIK  315 (358)
Q Consensus       277 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt-----~~eil~  315 (358)
                      ..  ...++...+..+.++|.+||+.||.+||+     +++|++
T Consensus       252 ~~--~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          252 SG--KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             HC--CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             cC--CCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence            11  11234455678999999999999999998     777764

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-43  Score=329.78  Aligned_cols=252  Identities=20%  Similarity=0.269  Sum_probs=209.3

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      .++|++.+.||+|+||.||+|... +|+.||+|++..........+.+|+.++..++  ||||+++++++......++||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~--hpnIv~~~~~~~~~~~~~lv~  127 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH--HPKLINLHDAFEDKYEMVLIL  127 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCC--STTBCCEEEEEECSSEEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCC--CcCCCeEEEEEEeCCEEEEEE
Confidence            468999999999999999999976 68999999998766666678899999999998  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcC--CCceEEeeccccccc
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ--NFNPKISDFGLSKLF  197 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~--~~~~~l~Dfg~~~~~  197 (358)
                      ||+++++|.+++.   .....+++..++.++.||+.||.|||++   ||+|+||||+||+++.  ++.++|+|||++...
T Consensus       128 E~~~gg~L~~~l~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~  201 (387)
T 1kob_A          128 EFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL  201 (387)
T ss_dssp             ECCCCCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred             EcCCCCcHHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceec
Confidence            9999999999983   2334689999999999999999999999   9999999999999974  567999999999876


Q ss_pred             CCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhc
Q 018263          198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD  277 (358)
Q Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      .....  .....+|+.|+|||++.+..++.++||||||+++|+|++|..||...........+...             .
T Consensus       202 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~-------------~  266 (387)
T 1kob_A          202 NPDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC-------------D  266 (387)
T ss_dssp             CTTSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC-------------C
T ss_pred             CCCcc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------C
Confidence            43322  23356899999999999889999999999999999999999999865432221111100             0


Q ss_pred             cccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          278 PMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       278 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ...........+..+.++|.+||+.||.+|||+.++++
T Consensus       267 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          267 WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence            00111122345667999999999999999999999987

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=3.1e-44  Score=324.72  Aligned_cols=272  Identities=25%  Similarity=0.372  Sum_probs=213.4

Q ss_pred             hhcCCcccceecccCceEEEEEEE-----CCCCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC-
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRL-----QDGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG-  112 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~-----~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~-  112 (358)
                      ..++|++.+.||+|+||.||+|++     .+++.||+|++... .......+.+|+..++.++  ||||+++++++... 
T Consensus        19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~   96 (302)
T 4e5w_A           19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY--HENIVKYKGICTEDG   96 (302)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCC--CTTBCCEEEEEEC--
T ss_pred             hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCC--CCCeeeeeeEEecCC
Confidence            356799999999999999999983     36889999998754 3344577889999999998  99999999999876 


Q ss_pred             -CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeec
Q 018263          113 -PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF  191 (358)
Q Consensus       113 -~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Df  191 (358)
                       ...++||||+++++|.+++..   ....+++..++.++.||+.||+|||++   |++|+||+|+||+++.++.++|+||
T Consensus        97 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Df  170 (302)
T 4e5w_A           97 GNGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDF  170 (302)
T ss_dssp             -CCEEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCC
T ss_pred             CceEEEEEEeCCCCcHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcc
Confidence             668999999999999999842   345689999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCc--ccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccch
Q 018263          192 GLSKLFPENTT--HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNS  269 (358)
Q Consensus       192 g~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      |++........  .......++..|+|||++.+..++.++||||||+++|+|++|..|+........ ............
T Consensus       171 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~  249 (302)
T 4e5w_A          171 GLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFL-KMIGPTHGQMTV  249 (302)
T ss_dssp             TTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCGGGHH
T ss_pred             cccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHh-hccCCcccccCH
Confidence            99987654332  223345678889999999998999999999999999999999998653211000 000000001111


Q ss_pred             hhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 018263          270 KELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE  320 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~  320 (358)
                      ......+........+...+..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  300 (302)
T 4e5w_A          250 TRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL  300 (302)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence            222223333333445566778899999999999999999999999999865

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.6e-43  Score=328.36  Aligned_cols=253  Identities=21%  Similarity=0.281  Sum_probs=196.5

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      ..++|++++.||+|+||.||+++.. +++.||+|++.... .....+.+|+..++.++  ||||+++++++...+..++|
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~lv   94 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLR--HPNIVRFKEVILTPTHLAII   94 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCC--CTTBCCEEEEEECSSEEEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCC--CCCCCcEEEEEeeCCEEEEE
Confidence            4679999999999999999999986 79999999987433 33456789999999998  99999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCc--eEEeecccccc
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN--PKISDFGLSKL  196 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~--~~l~Dfg~~~~  196 (358)
                      |||+++++|.+++    ...+.+++..++.++.||+.||.|||++   ||+||||||+||+++.++.  ++|+|||++..
T Consensus        95 ~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~  167 (361)
T 3uc3_A           95 MEYASGGELYERI----CNAGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKS  167 (361)
T ss_dssp             EECCCSCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred             EEeCCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence            9999999999998    3456799999999999999999999999   9999999999999987765  99999999874


Q ss_pred             cCCCCcccccccccccCccCccccccCCCCcc-CceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhh
Q 018263          197 FPENTTHISTRVAGTLGYLAPEYAISGRLTRK-SDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNL  275 (358)
Q Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~-sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                      ....  .......||+.|+|||++.+..++.+ +||||||+++|+|++|+.||..............           .+
T Consensus       168 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~-----------~~  234 (361)
T 3uc3_A          168 SVLH--SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQ-----------RI  234 (361)
T ss_dssp             ---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHH-----------HH
T ss_pred             cccc--CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHH-----------HH
Confidence            3221  12234568999999999988877655 8999999999999999999986554333222111           11


Q ss_pred             hccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          276 VDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       276 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .............+..+.+||.+||+.||.+|||+.++++
T Consensus       235 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          235 LSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             HTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence            1111111111134567899999999999999999999986

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.3e-43  Score=319.84  Aligned_cols=267  Identities=19%  Similarity=0.215  Sum_probs=213.8

Q ss_pred             HhhcCCcccceecccCceEEEEEEE-CCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRL-QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      +..++|++.+.||+|++|.||+|.+ .+|+.||+|++....  ....+.+|+..+..+. .|++++.+++++......++
T Consensus         7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~-~~~~i~~~~~~~~~~~~~~l   83 (298)
T 1csn_A            7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLA-GCTGIPNVYYFGQEGLHNVL   83 (298)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTT-TCTTCCCEEEEEEETTEEEE
T ss_pred             ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHh-cCCCCCeEEeecCCCceeEE
Confidence            3467899999999999999999996 468999999986433  2345778888888884 49999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCc-----eEEeecc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN-----PKISDFG  192 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~-----~~l~Dfg  192 (358)
                      ||||+ +++|.+++..   ....+++..++.++.||+.||+|||++   |++|+||+|+||+++.++.     ++|+|||
T Consensus        84 v~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg  156 (298)
T 1csn_A           84 VIDLL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFG  156 (298)
T ss_dssp             EEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred             EEEec-CCCHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence            99999 9999999942   234689999999999999999999999   9999999999999987766     9999999


Q ss_pred             cccccCCCCc------ccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhc
Q 018263          193 LSKLFPENTT------HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGM  266 (358)
Q Consensus       193 ~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~  266 (358)
                      ++........      .......+|+.|+|||++.+..++.++||||||+++|+|++|+.||..............+...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  236 (298)
T 1csn_A          157 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK  236 (298)
T ss_dssp             TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred             cccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh
Confidence            9987643322      1233467899999999999989999999999999999999999999875443333222222111


Q ss_pred             cchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCC
Q 018263          267 YNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNID  324 (358)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~  324 (358)
                      ........+         ....+..+.+++.+||+.||.+|||+.+|++.|+++....
T Consensus       237 ~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~  285 (298)
T 1csn_A          237 KQSTPLREL---------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  285 (298)
T ss_dssp             HHHSCHHHH---------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             ccCccHHHH---------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence            000101110         1124567999999999999999999999999999887544

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.5e-43  Score=322.85  Aligned_cols=264  Identities=23%  Similarity=0.355  Sum_probs=194.9

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      .++|++++.||+|+||.||+|.+. +|+.||+|++.... ......+.+|+..++.++  ||||+++++++...+..++|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~~~~lv   81 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK--HENIVRLYDVIHTENKLTLV   81 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCC--BTTBCCEEEEECCTTEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcC--CCCcceEEEEEEECCeEEEE
Confidence            578999999999999999999975 68999999987543 233467889999999998  99999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccc--cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          119 YDYMPNNSLSQTLLGEEK--RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      |||++ ++|.+++.....  ....+++..++.++.||+.||.|||++   ||+|+||||+||+++.++.++|+|||++..
T Consensus        82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~  157 (317)
T 2pmi_A           82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARA  157 (317)
T ss_dssp             EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred             EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCcccee
Confidence            99997 589998854321  224589999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCcccccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHh--
Q 018263          197 FPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELM--  273 (358)
Q Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--  273 (358)
                      ...... ......+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||...........+....+......+.  
T Consensus       158 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (317)
T 2pmi_A          158 FGIPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV  236 (317)
T ss_dssp             TTSCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGG
T ss_pred             cCCCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhh
Confidence            543222 2234568999999999876 468999999999999999999999998765544443333322221111111  


Q ss_pred             -------------------hhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          274 -------------------NLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       274 -------------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                                         ..+.+..    +...+..+.+++.+||+.||.+|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          237 TKLPKYNPNIQQRPPRDLRQVLQPHT----KEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GGCTTCCTTCCCCCCCCSHHHHGGGC----SSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhcccccccccchhHHHhhcccc----cccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence                               1111111    1124557999999999999999999999985

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.8e-43  Score=321.46  Aligned_cols=247  Identities=23%  Similarity=0.286  Sum_probs=194.6

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC--hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeE
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI  116 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~  116 (358)
                      ..++|++.++||+|+||.||+|++. +|+.||||++....  .........|+..+..+. .||||+++++++...+..+
T Consensus        55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~-~h~~iv~l~~~~~~~~~~~  133 (311)
T 3p1a_A           55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVG-QHPCCVRLEQAWEEGGILY  133 (311)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEE
T ss_pred             hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhc-CCCcEEEEEEEEEeCCEEE
Confidence            3478999999999999999999986 79999999976432  333344555555555552 3999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       117 iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      +||||+ +++|.+.+..   ....+++..++.++.||+.||+|||+.   +|+|+||||+||+++.++.+||+|||++..
T Consensus       134 lv~e~~-~~~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~  206 (311)
T 3p1a_A          134 LQTELC-GPSLQQHCEA---WGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVE  206 (311)
T ss_dssp             EEEECC-CCBHHHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEE
T ss_pred             EEEecc-CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeee
Confidence            999999 6789888843   345699999999999999999999999   999999999999999999999999999887


Q ss_pred             cCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhh
Q 018263          197 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV  276 (358)
Q Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                      ......  .....||+.|+|||++.+ .++.++||||||+++|+|++|..|+.....                  ...+.
T Consensus       207 ~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~------------------~~~~~  265 (311)
T 3p1a_A          207 LGTAGA--GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG------------------WQQLR  265 (311)
T ss_dssp             CC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH------------------HHHHT
T ss_pred             cccCCC--CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH------------------HHHHh
Confidence            543222  233568999999998876 789999999999999999999776653211                  11111


Q ss_pred             ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          277 DPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       277 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .......++...+..+.+++.+||+.||.+|||+.|+++
T Consensus       266 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          266 QGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             TTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            111111111234567999999999999999999999986

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=4.1e-44  Score=339.31  Aligned_cols=263  Identities=23%  Similarity=0.290  Sum_probs=213.0

Q ss_pred             CHHHHHHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeece
Q 018263           33 SYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGG  108 (358)
Q Consensus        33 ~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~  108 (358)
                      ...++.+..++|++.+.||+|+||.||+|+.+ +++.||+|++....   ......+.+|..++..+.  ||||++++++
T Consensus        65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~--hp~Iv~l~~~  142 (437)
T 4aw2_A           65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD--SKWITTLHYA  142 (437)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSC--TTTBCCEEEE
T ss_pred             hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCC--CCCEEEEEEE
Confidence            44556667789999999999999999999986 58899999986432   222234778999999887  9999999999


Q ss_pred             EEcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEE
Q 018263          109 CIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKI  188 (358)
Q Consensus       109 ~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l  188 (358)
                      +.+.+..++||||++|++|.+++..   ....+++..++.++.||+.||.|||++   ||+||||||+||+++.++.+||
T Consensus       143 ~~~~~~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL  216 (437)
T 4aw2_A          143 FQDDNNLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRL  216 (437)
T ss_dssp             EECSSEEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEE
T ss_pred             EeeCCEEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEE
Confidence            9999999999999999999999932   246799999999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccCccCccccc-----cCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhh
Q 018263          189 SDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI-----SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKA  263 (358)
Q Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~  263 (358)
                      +|||++..............+||+.|+|||++.     +..++.++||||||+++|+|++|+.||...+....+..+...
T Consensus       217 ~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~  296 (437)
T 4aw2_A          217 ADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH  296 (437)
T ss_dssp             CCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH
T ss_pred             cchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhc
Confidence            999999876554444444568999999999987     456899999999999999999999999865543332222111


Q ss_pred             hhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCC--CCCHHHHHH
Q 018263          264 WGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKL--RPQMSTAIK  315 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~--Rpt~~eil~  315 (358)
                      ..            ....+......+..+.+||.+||+.+|++  ||+++|+++
T Consensus       297 ~~------------~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          297 KE------------RFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             HH------------HCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             cc------------cccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            00            00011111235667899999999998888  999999986

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-43  Score=326.80  Aligned_cols=254  Identities=22%  Similarity=0.359  Sum_probs=203.4

Q ss_pred             HhhcCCcccceecccCceEEEEEEECCCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeE
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI  116 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~  116 (358)
                      +..++|++.+.||+|+||.||++...+++.||+|++...  .......+.+|+..+..+...||||+++++++...+..+
T Consensus         6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~   85 (343)
T 3dbq_A            6 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY   85 (343)
T ss_dssp             SSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             eecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence            456789999999999999999999988999999998754  334446788999999999833499999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       117 iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      +|||+ .+++|.+++    .....+++..+..++.||+.||.|||+.   ||+||||||+||+++ ++.++|+|||++..
T Consensus        86 lv~e~-~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~  156 (343)
T 3dbq_A           86 MVMEC-GNIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQ  156 (343)
T ss_dssp             EEECC-CSEEHHHHH----HHSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred             EEEeC-CCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccc
Confidence            99995 588999999    3456789999999999999999999999   999999999999997 56899999999987


Q ss_pred             cCCCCcc-cccccccccCccCcccccc-----------CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhh
Q 018263          197 FPENTTH-ISTRVAGTLGYLAPEYAIS-----------GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAW  264 (358)
Q Consensus       197 ~~~~~~~-~~~~~~~~~~y~aPE~~~~-----------~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~  264 (358)
                      ....... ......||+.|+|||++.+           ..++.++||||||+++|+|++|+.||......          
T Consensus       157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----------  226 (343)
T 3dbq_A          157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ----------  226 (343)
T ss_dssp             C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH----------
T ss_pred             cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH----------
Confidence            6433222 2234679999999999865           66889999999999999999999999643211          


Q ss_pred             hccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          265 GMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                          .......+++.....++...+..+.+++.+||+.||.+|||+.++++
T Consensus       227 ----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~  273 (343)
T 3dbq_A          227 ----ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  273 (343)
T ss_dssp             ----HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ----HHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence                11222333333334445555667899999999999999999999975

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=7.1e-44  Score=320.96  Aligned_cols=264  Identities=25%  Similarity=0.352  Sum_probs=210.9

Q ss_pred             cCHHHHHHhhcCCcccc-eecccCceEEEEEEE---CCCCEEEEEEeeccC--hhhHHHHHHHHHHhhhcccCCCCceee
Q 018263           32 FSYNQLKIATNGFRWSN-KIGEGGFGSVYKGRL---QDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKL  105 (358)
Q Consensus        32 ~~~~~~~~~~~~y~i~~-~lg~g~~g~v~~~~~---~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~~~h~~i~~~  105 (358)
                      ....++.+..++|++.+ .||+|+||.||+|.+   .+++.|++|++....  ......+.+|+..++.++  ||||+++
T Consensus         6 i~~~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~   83 (291)
T 1xbb_A            6 IRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD--NPYIVRM   83 (291)
T ss_dssp             -----CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCC--CTTBCCE
T ss_pred             cCcceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCC--CCCEEEE
Confidence            34455666788999998 999999999999964   247889999987543  333577889999999998  9999999


Q ss_pred             eceEEcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCc
Q 018263          106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN  185 (358)
Q Consensus       106 ~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~  185 (358)
                      ++++ ..+..++||||+++++|.+++.    ....+++..++.++.||+.||.|||+.   |++|+||+|+||+++.++.
T Consensus        84 ~~~~-~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~  155 (291)
T 1xbb_A           84 IGIC-EAESWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHY  155 (291)
T ss_dssp             EEEE-ESSSEEEEEECCTTEEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTE
T ss_pred             EEEE-CCCCcEEEEEeCCCCCHHHHHH----hCcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCc
Confidence            9999 5667899999999999999993    445689999999999999999999999   9999999999999999999


Q ss_pred             eEEeecccccccCCCCccc--ccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHh
Q 018263          186 PKISDFGLSKLFPENTTHI--STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDK  262 (358)
Q Consensus       186 ~~l~Dfg~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~  262 (358)
                      ++|+|||++..........  .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||.......       
T Consensus       156 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------  228 (291)
T 1xbb_A          156 AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------  228 (291)
T ss_dssp             EEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------
T ss_pred             EEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------
Confidence            9999999998764433221  122345688999999988889999999999999999999 999997543221       


Q ss_pred             hhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCC
Q 018263          263 AWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGET  321 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~  321 (358)
                               ....+........+...+..+.+++.+||+.||.+||++.++++.|+++.
T Consensus       229 ---------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  278 (291)
T 1xbb_A          229 ---------VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  278 (291)
T ss_dssp             ---------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             ---------HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                     11112222223344556778999999999999999999999999998754

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=8.5e-44  Score=324.61  Aligned_cols=271  Identities=27%  Similarity=0.407  Sum_probs=215.5

Q ss_pred             hcCC-cccceecccCceEEEEEEEC-----CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEc--
Q 018263           41 TNGF-RWSNKIGEGGFGSVYKGRLQ-----DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCID--  111 (358)
Q Consensus        41 ~~~y-~i~~~lg~g~~g~v~~~~~~-----~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~--  111 (358)
                      .++| ++++.||+|+||.||++.+.     +++.||+|++.... ......+.+|+..++.++  ||||+++++++..  
T Consensus        29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~  106 (318)
T 3lxp_A           29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLY--HEHIIKYKGCCEDAG  106 (318)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCC--CTTBCCEEEEEEETT
T ss_pred             cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCC--CcchhhEEEEEecCC
Confidence            3455 99999999999999988642     68899999997553 344577899999999998  9999999999987  


Q ss_pred             CCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeec
Q 018263          112 GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF  191 (358)
Q Consensus       112 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Df  191 (358)
                      ....++||||+++++|.+++.     ...+++..++.++.||+.||.|||+.   |++|+||+|+||+++.++.++|+||
T Consensus       107 ~~~~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Df  178 (318)
T 3lxp_A          107 AASLQLVMEYVPLGSLRDYLP-----RHSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDF  178 (318)
T ss_dssp             TTEEEEEECCCTTCBHHHHGG-----GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCG
T ss_pred             CceEEEEEecccCCcHHHHHh-----hCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCc
Confidence            467899999999999999993     33489999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCc--ccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccch
Q 018263          192 GLSKLFPENTT--HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNS  269 (358)
Q Consensus       192 g~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      |++........  .......++..|+|||++.+..++.++||||||+++|+|++|..||........ ............
T Consensus       179 g~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~  257 (318)
T 3lxp_A          179 GLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIAQGQMTV  257 (318)
T ss_dssp             GGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCHHHHH
T ss_pred             cccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhcccccchhH
Confidence            99987654332  122335577889999999998999999999999999999999999874322100 000000011112


Q ss_pred             hhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCC
Q 018263          270 KELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETN  322 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~  322 (358)
                      ......+........+...+..+.+++.+||+.||.+|||+.++++.|+.+.+
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~  310 (318)
T 3lxp_A          258 LRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE  310 (318)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence            23333444444455566677889999999999999999999999999998754

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=5.2e-44  Score=320.14  Aligned_cols=261  Identities=24%  Similarity=0.315  Sum_probs=209.0

Q ss_pred             HHHhhcCCcccceecccCceEEEEEEECC----CCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEc
Q 018263           37 LKIATNGFRWSNKIGEGGFGSVYKGRLQD----GTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID  111 (358)
Q Consensus        37 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~  111 (358)
                      +.+..++|++.+.||+|+||.||+|.+..    +..|++|.+... .......+.+|+..++.++  ||||+++++++..
T Consensus         7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~   84 (281)
T 3cc6_A            7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD--HPHIVKLIGIIEE   84 (281)
T ss_dssp             CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHC--CTTBCCEEEEECS
T ss_pred             ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCC--CCCcceEEEEEcC
Confidence            34567899999999999999999998542    346999998755 3445677889999999998  9999999999865


Q ss_pred             CCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeec
Q 018263          112 GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF  191 (358)
Q Consensus       112 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Df  191 (358)
                      . ..++||||+++++|.+++..   ....+++..++.++.||+.||.|||++   |++|+||+|+||+++.++.++|+||
T Consensus        85 ~-~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df  157 (281)
T 3cc6_A           85 E-PTWIIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDF  157 (281)
T ss_dssp             S-SCEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCC
T ss_pred             C-CCEEEEecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCcc
Confidence            4 56899999999999999942   345689999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchh
Q 018263          192 GLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSK  270 (358)
Q Consensus       192 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      |++...............++..|+|||++.+..++.++||||||+++|+|++ |+.||...........+          
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~----------  227 (281)
T 3cc6_A          158 GLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL----------  227 (281)
T ss_dssp             CGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHH----------
T ss_pred             CCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHH----------
Confidence            9998765433333344557788999999988899999999999999999998 99999754332221111          


Q ss_pred             hHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCC
Q 018263          271 ELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETN  322 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~  322 (358)
                            ........+...+..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       228 ------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  273 (281)
T 3cc6_A          228 ------EKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ  273 (281)
T ss_dssp             ------HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------hcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence                  1111122233456679999999999999999999999999987643

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2e-43  Score=323.33  Aligned_cols=251  Identities=20%  Similarity=0.336  Sum_probs=199.5

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC-----
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP-----  113 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~-----  113 (358)
                      .++|++.+.||+|+||.||+|++. +|+.||||++.... ......+.+|+..++.++  ||||+++++++....     
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~~~   82 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE--HPGIVRYFNAWLETPPEKWQ   82 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCC--CTTBCCEEEEEEECCSCHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCC--CCCEeeEEEEEEEeccchhh
Confidence            468999999999999999999986 79999999997543 345578899999999998  999999999886543     


Q ss_pred             ----------------------------------------------------eeEEEEecCCCCCHHHHhhhccccccCC
Q 018263          114 ----------------------------------------------------CRILVYDYMPNNSLSQTLLGEEKRRAKF  141 (358)
Q Consensus       114 ----------------------------------------------------~~~iv~e~~~~~~L~~~l~~~~~~~~~l  141 (358)
                                                                          ..++||||+++++|.+++.... .....
T Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~  161 (332)
T 3qd2_B           83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDR  161 (332)
T ss_dssp             HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGS
T ss_pred             hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-Cccch
Confidence                                                                3799999999999999995432 23445


Q ss_pred             CHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCc-----------cccccccc
Q 018263          142 GWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT-----------HISTRVAG  210 (358)
Q Consensus       142 ~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~-----------~~~~~~~~  210 (358)
                      ++..++.++.||+.||+|||++   |++|+||||+||+++.++.++|+|||++........           .......+
T Consensus       162 ~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g  238 (332)
T 3qd2_B          162 EHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG  238 (332)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred             hhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence            6778999999999999999999   999999999999999999999999999987654321           12233569


Q ss_pred             ccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHH
Q 018263          211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAI  290 (358)
Q Consensus       211 ~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (358)
                      |+.|+|||++.+..++.++||||||+++|+|++|..|+....     .....             ......+........
T Consensus       239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~-----~~~~~-------------~~~~~~~~~~~~~~~  300 (332)
T 3qd2_B          239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV-----RIITD-------------VRNLKFPLLFTQKYP  300 (332)
T ss_dssp             CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH-----HHHHH-------------HHTTCCCHHHHHHCH
T ss_pred             CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH-----HHHHH-------------hhccCCCcccccCCh
Confidence            999999999999999999999999999999999877643111     00000             001011111234456


Q ss_pred             HHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          291 RFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       291 ~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .+.+++.+||+.||.+|||+.++++
T Consensus       301 ~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          301 QEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             hHHHHHHHHccCCCCcCCCHHHHhh
Confidence            7889999999999999999999986

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.6e-43  Score=323.06  Aligned_cols=263  Identities=18%  Similarity=0.211  Sum_probs=210.5

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      ..++|++.+.||+|+||.||+|+.. +|+.||||++.....  ...+..|+..++.+. .||||+++++++......++|
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~-~h~~i~~~~~~~~~~~~~~lv   83 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLG-SGDGIPQVYYFGPCGKYNAMV   83 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHC-SCTTSCCEEEEEEETTEEEEE
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhh-CCCCCCEEEEEEecCCccEEE
Confidence            4678999999999999999999974 689999999865432  235778999999993 399999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCc-----eEEeeccc
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN-----PKISDFGL  193 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~-----~~l~Dfg~  193 (358)
                      |||+ +++|.+++..   ....+++..++.++.||+.||+|||+.   ||+|+||||+||+++.++.     ++|+|||+
T Consensus        84 ~e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~  156 (330)
T 2izr_A           84 LELL-GPSLEDLFDL---CDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFAL  156 (330)
T ss_dssp             EECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTT
T ss_pred             EEeC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEccc
Confidence            9999 9999999943   246799999999999999999999999   9999999999999998887     99999999


Q ss_pred             ccccCCCCcc------cccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhcc
Q 018263          194 SKLFPENTTH------ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMY  267 (358)
Q Consensus       194 ~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~  267 (358)
                      +.........      ......||+.|+|||++.+..++.++||||||+++|+|++|+.||..............+....
T Consensus       157 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~  236 (330)
T 2izr_A          157 AKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTK  236 (330)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHH
T ss_pred             ceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhh
Confidence            9865432221      1234679999999999999999999999999999999999999998754433332222221100


Q ss_pred             chhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCC
Q 018263          268 NSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETN  322 (358)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~  322 (358)
                      .......     ..    ...+ .+.+++.+||+.+|.+||++.+|++.|+.+..
T Consensus       237 ~~~~~~~-----~~----~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~  281 (330)
T 2izr_A          237 RATPIEV-----LC----ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFD  281 (330)
T ss_dssp             HHSCHHH-----HT----TTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             ccCCHHH-----Hh----ccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence            0000000     00    1123 79999999999999999999999999986643

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=4.7e-43  Score=323.11  Aligned_cols=252  Identities=23%  Similarity=0.317  Sum_probs=202.6

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI  116 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~  116 (358)
                      .++|++.+.||+|+||.||+|+.+ +++.||+|++...   .......+..|..++..+. .||||+++++++...+..+
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~-~hp~iv~l~~~~~~~~~~~   86 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS-NHPFLVGLHSCFQTESRLF   86 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTT-TCTTBCCEEEEEECSSEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcC-CCCccCeEEEEEEeCCEEE
Confidence            578999999999999999999976 5889999999754   3334566778999888873 3999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       117 iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      +||||++|++|.+++    .....+++..++.++.||+.||.|||++   ||+||||||+||+++.++.++|+|||++..
T Consensus        87 lv~e~~~gg~L~~~l----~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~  159 (345)
T 3a8x_A           87 FVIEYVNGGDLMFHM----QRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE  159 (345)
T ss_dssp             EEECCCCSCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBC
T ss_pred             EEEeCCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccccc
Confidence            999999999999998    3446799999999999999999999999   999999999999999999999999999985


Q ss_pred             cCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHh-hh
Q 018263          197 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELM-NL  275 (358)
Q Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~  275 (358)
                      ..... ......+||+.|+|||++.+..++.++|+||||+++|+|++|+.||............       ...... .+
T Consensus       160 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~-------~~~~~~~~i  231 (345)
T 3a8x_A          160 GLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN-------TEDYLFQVI  231 (345)
T ss_dssp             SCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC--------------CHHHHHHHH
T ss_pred             ccCCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccc-------cHHHHHHHH
Confidence            43222 2234467999999999999989999999999999999999999999643221110000       000000 11


Q ss_pred             hccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 018263          276 VDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQM  310 (358)
Q Consensus       276 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~  310 (358)
                      ...  ...++...+..+.++|.+||+.||.+||++
T Consensus       232 ~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          232 LEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             HHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             HcC--CCCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence            111  122444566789999999999999999996

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.9e-43  Score=331.05  Aligned_cols=267  Identities=24%  Similarity=0.340  Sum_probs=201.7

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC--e
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP--C  114 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~--~  114 (358)
                      ..++|++.+.||+|+||.||+|.+. +|+.||+|++...  .......+.+|+..+..+. .||||+++++++...+  .
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~-~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELS-GHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTT-TCTTBCCEEEEEECTTSSC
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhcc-CCCCCCeeeeEEecCCCCE
Confidence            4689999999999999999999975 6899999998533  4455567788999999886 5999999999997544  6


Q ss_pred             eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccc
Q 018263          115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS  194 (358)
Q Consensus       115 ~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~  194 (358)
                      .|+||||++ ++|...+.     ...+++..+..++.||+.||+|||+.   ||+||||||+||+++.++.+||+|||++
T Consensus        86 ~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a  156 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIR-----ANILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLS  156 (388)
T ss_dssp             EEEEEECCS-EEHHHHHH-----HTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEecccC-cCHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccc
Confidence            899999996 58988883     35789999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCC--------------------CcccccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCCCCCCcccc
Q 018263          195 KLFPEN--------------------TTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ  253 (358)
Q Consensus       195 ~~~~~~--------------------~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~~pf~~~~~  253 (358)
                      ......                    .........+|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  236 (388)
T 3oz6_A          157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST  236 (388)
T ss_dssp             EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            765321                    1112234679999999999886 6789999999999999999999999988776


Q ss_pred             ccchhhhHhhhhccchhhHhhhhccc------------------cCC------------CCCHHHHHHHHHHHhhccCCC
Q 018263          254 LGEYHLVDKAWGMYNSKELMNLVDPM------------------LYG------------NFPENEAIRFLKVGLLCVQEK  303 (358)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~------------~~~~~~~~~l~~li~~~l~~~  303 (358)
                      ......+....+.+....+..+..+.                  ...            ......+..+.+|+.+||+.|
T Consensus       237 ~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~d  316 (388)
T 3oz6_A          237 MNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFN  316 (388)
T ss_dssp             HHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSS
T ss_pred             HHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccC
Confidence            65555554444433333222111100                  000            001123567899999999999


Q ss_pred             CCCCCCHHHHHHH
Q 018263          304 SKLRPQMSTAIKM  316 (358)
Q Consensus       304 P~~Rpt~~eil~~  316 (358)
                      |.+|||+.|+++-
T Consensus       317 P~~R~t~~e~l~H  329 (388)
T 3oz6_A          317 PNKRISANDALKH  329 (388)
T ss_dssp             GGGSCCHHHHTTS
T ss_pred             cccCCCHHHHhCC
Confidence            9999999999864

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2.1e-43  Score=326.07  Aligned_cols=252  Identities=20%  Similarity=0.290  Sum_probs=205.8

Q ss_pred             HHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC
Q 018263           38 KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP  113 (358)
Q Consensus        38 ~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~  113 (358)
                      .+..++|++.+.||+|+||.||+|+.+ +|+.||+|++...   .......+..|...+..+. .||+|+++++++...+
T Consensus        16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~-~hp~iv~l~~~~~~~~   94 (353)
T 2i0e_A           16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG-KPPFLTQLHSCFQTMD   94 (353)
T ss_dssp             ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTT-CCTTBCCEEEEEECSS
T ss_pred             CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcC-CCCEEeeEEEEEEcCC
Confidence            345689999999999999999999986 4889999998754   2334566778888888773 4999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccc
Q 018263          114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL  193 (358)
Q Consensus       114 ~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~  193 (358)
                      ..|+||||++|++|.+++    ...+.+++..++.++.||+.||.|||++   ||+||||||+||+++.+|.++|+|||+
T Consensus        95 ~~~lv~E~~~gg~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~  167 (353)
T 2i0e_A           95 RLYFVMEYVNGGDLMYHI----QQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGM  167 (353)
T ss_dssp             EEEEEEECCCSCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEEeCCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCc
Confidence            999999999999999999    3446799999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHh
Q 018263          194 SKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELM  273 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      +....... ......+||+.|+|||++.+..++.++|+||||+++|+|++|+.||........+..+             
T Consensus       168 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i-------------  233 (353)
T 2i0e_A          168 CKENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI-------------  233 (353)
T ss_dssp             CBCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------------
T ss_pred             ccccccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHH-------------
Confidence            98533222 2234467999999999999999999999999999999999999999755432211111             


Q ss_pred             hhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 018263          274 NLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQ-----MSTAIK  315 (358)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt-----~~eil~  315 (358)
                        ...  ...++...+..+.++|.+||+.||.+||+     ++++++
T Consensus       234 --~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          234 --MEH--NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             --HHC--CCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             --HhC--CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence              111  11234456678999999999999999996     455553

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=5.1e-44  Score=321.33  Aligned_cols=259  Identities=22%  Similarity=0.344  Sum_probs=206.0

Q ss_pred             hhcCCcccceecccCceEEEEEEECC-C-------CEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEc
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQD-G-------TIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID  111 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~~-~-------~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~  111 (358)
                      ..++|++.+.||+|+||.||+|.+.. +       ..|++|++..........+.+|+..++.++  ||||+++++++..
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~   83 (289)
T 4fvq_A            6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS--HKHLVLNYGVCVC   83 (289)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSC--CTTBCCEEEEECC
T ss_pred             chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCC--CCCEeEEEEEEEe
Confidence            46789999999999999999998652 3       469999997777777788999999999998  9999999999999


Q ss_pred             CCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCc------
Q 018263          112 GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN------  185 (358)
Q Consensus       112 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~------  185 (358)
                      .+..++||||+++++|.+++..   ....+++..++.++.||+.||.|||++   |++|+||||+||+++.++.      
T Consensus        84 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~  157 (289)
T 4fvq_A           84 GDENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNP  157 (289)
T ss_dssp             TTCCEEEEECCTTCBHHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBC
T ss_pred             CCCCEEEEECCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCccccccc
Confidence            9999999999999999999943   334489999999999999999999999   9999999999999998887      


Q ss_pred             --eEEeecccccccCCCCcccccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCCCC-CCccccccchhhhH
Q 018263          186 --PKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTA-VDFDVQLGEYHLVD  261 (358)
Q Consensus       186 --~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~~p-f~~~~~~~~~~~~~  261 (358)
                        ++|+|||++.....     .....++..|+|||++.+ ..++.++||||||+++|+|++|..| |............ 
T Consensus       158 ~~~kl~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~-  231 (289)
T 4fvq_A          158 PFIKLSDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY-  231 (289)
T ss_dssp             CEEEECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH-
T ss_pred             ceeeeccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh-
Confidence              99999999875422     123457889999999987 6789999999999999999996544 4322211100000 


Q ss_pred             hhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCCCCCCC
Q 018263          262 KAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNIDGXDVE  329 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~~~~~~  329 (358)
                                     ..  ....+...+..+.+++.+||+.||.+|||+.++++.|+++....+....
T Consensus       232 ---------------~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~~~  282 (289)
T 4fvq_A          232 ---------------ED--RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRG  282 (289)
T ss_dssp             ---------------HT--TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--------
T ss_pred             ---------------hc--cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCCCC
Confidence                           00  1111222345688999999999999999999999999999887655443

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=5e-43  Score=317.98  Aligned_cols=269  Identities=23%  Similarity=0.302  Sum_probs=202.4

Q ss_pred             HhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccCh-----hhHHHHHHHHHHhhhcc-cCCCCceeeeceEEc
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK-----QGEKEFMSEVASMANVN-VCHENLVKLHGGCID  111 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~-~~h~~i~~~~~~~~~  111 (358)
                      +..++|++.+.||+|+||.||+|++. +|+.||+|++.....     .......+|+..++.+. ..||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            34689999999999999999999964 689999999864321     11234555666555542 139999999999987


Q ss_pred             CC-----eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCce
Q 018263          112 GP-----CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP  186 (358)
Q Consensus       112 ~~-----~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~  186 (358)
                      ..     ..+++|||+. ++|.+++...  ....+++..++.++.||+.||+|||++   |++|+||||+||+++.++.+
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~  159 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVD-QDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTV  159 (308)
T ss_dssp             CCSSSEEEEEEEEECCC-CBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCE
T ss_pred             cCCCCceeEEEEehhhh-cCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCE
Confidence            65     4789999996 5999998432  234489999999999999999999999   99999999999999999999


Q ss_pred             EEeecccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhc
Q 018263          187 KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGM  266 (358)
Q Consensus       187 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~  266 (358)
                      +|+|||++.......  ......+|+.|+|||++.+..++.++||||||+++|+|++|+.||...........+....+.
T Consensus       160 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  237 (308)
T 3g33_A          160 KLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL  237 (308)
T ss_dssp             EECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             EEeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            999999998654322  234467899999999999999999999999999999999999999876655444443333222


Q ss_pred             cchhhHhhhhc---cccCC-------CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          267 YNSKELMNLVD---PMLYG-------NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       267 ~~~~~~~~~~~---~~~~~-------~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .....+.....   .....       ......+..+.++|.+||+.||.+|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            22221111000   00000       001134567899999999999999999999986

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.9e-43  Score=318.00  Aligned_cols=250  Identities=23%  Similarity=0.298  Sum_probs=197.9

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccCh--------------------------hhHHHHHHHHHHh
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK--------------------------QGEKEFMSEVASM   92 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~--------------------------~~~~~~~~e~~~l   92 (358)
                      ..++|++.+.||+|+||.||+|++. +++.||+|++.....                          .....+.+|+..+
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   90 (298)
T 2zv2_A           11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL   90 (298)
T ss_dssp             EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred             eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence            3579999999999999999999975 688999999864421                          1235678899999


Q ss_pred             hhcccCCCCceeeeceEEc--CCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEE
Q 018263           93 ANVNVCHENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVH  170 (358)
Q Consensus        93 ~~l~~~h~~i~~~~~~~~~--~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H  170 (358)
                      +.++  ||||+++++++..  ....++||||+++++|.+++     ....+++..++.++.||+.||+|||++   |++|
T Consensus        91 ~~l~--h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH  160 (298)
T 2zv2_A           91 KKLD--HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-----TLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIH  160 (298)
T ss_dssp             HTCC--CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-----CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred             HhCC--CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---Ceec
Confidence            9998  9999999999986  56789999999999998875     345799999999999999999999999   9999


Q ss_pred             cCCCCCcEEEcCCCceEEeecccccccCCCCcccccccccccCccCccccccCC---CCccCceecHHHHHHHHHhCCCC
Q 018263          171 RDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR---LTRKSDVYSFGVLLLEIVSGRTA  247 (358)
Q Consensus       171 ~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~s~~sDiwslG~il~~lltg~~p  247 (358)
                      +||||+||+++.++.++|+|||++........ ......+++.|+|||++.+..   ++.++||||||+++|+|++|+.|
T Consensus       161 ~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p  239 (298)
T 2zv2_A          161 RDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP  239 (298)
T ss_dssp             CCCCGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCS
T ss_pred             cCCCHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence            99999999999999999999999987543322 223457899999999987654   37789999999999999999999


Q ss_pred             CCccccccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          248 VDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       248 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      |........   ...+.            ............+..+.++|.+||+.||.+|||+.|+++
T Consensus       240 f~~~~~~~~---~~~~~------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          240 FMDERIMCL---HSKIK------------SQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SCCSSHHHH---HHHHH------------HCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCCccHHHH---HHHHh------------cccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            975432111   11110            000001111234567999999999999999999999874

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.6e-43  Score=320.14  Aligned_cols=268  Identities=19%  Similarity=0.203  Sum_probs=202.4

Q ss_pred             HHHHHHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceE
Q 018263           34 YNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGC  109 (358)
Q Consensus        34 ~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~  109 (358)
                      ........++|++.+.||+|+||.||+|.+. +++.||+|++....   ......+.+|+..+..++  ||||+++++++
T Consensus        26 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~--hp~iv~~~~~~  103 (309)
T 2h34_A           26 ESREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ--EPHVVPIHDFG  103 (309)
T ss_dssp             --------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCC--CTTBCCEEEEE
T ss_pred             ccCCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcC--CCCeeEEEEEE
Confidence            3344555689999999999999999999976 68899999986542   233477889999999998  99999999999


Q ss_pred             EcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEe
Q 018263          110 IDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKIS  189 (358)
Q Consensus       110 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~  189 (358)
                      ...+..+++|||+++++|.+++.    ....+++..++.++.||+.||.|||+.   |++|+||+|+||+++.++.++|+
T Consensus       104 ~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~  176 (309)
T 2h34_A          104 EIDGQLYVDMRLINGVDLAAMLR----RQGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLV  176 (309)
T ss_dssp             EETTEEEEEEECCCCEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred             eeCCeEEEEEEecCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEe
Confidence            99999999999999999999993    446789999999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccch
Q 018263          190 DFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNS  269 (358)
Q Consensus       190 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      |||++...............++..|+|||++.+..++.++||||||+++|+|++|+.||.......   .......... 
T Consensus       177 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~-  252 (309)
T 2h34_A          177 DFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV---MGAHINQAIP-  252 (309)
T ss_dssp             SCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH---HHHHHHSCCC-
T ss_pred             cCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH---HHHHhccCCC-
Confidence            999998654433333344668999999999998899999999999999999999999997543221   1000000000 


Q ss_pred             hhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHhhcCCCCC
Q 018263          270 KELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRP-QMSTAIKMMNGETNID  324 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp-t~~eil~~L~~~~~~~  324 (358)
                                .....+...+..+.+++.+||+.||.+|| +++++++.|+......
T Consensus       253 ----------~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          253 ----------RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             ----------CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             ----------CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence                      00112234455789999999999999999 9999999999876554

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=6.3e-43  Score=312.36  Aligned_cols=247  Identities=21%  Similarity=0.275  Sum_probs=206.6

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      ..++|++.+.||+|+||.||+|.+. ++..|++|.+..........+.+|+..++.++  ||||+++++++......++|
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv   84 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD--HPNIIRLYETFEDNTDIYLV   84 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCC--CTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCC--CCCEeeEEEEEecCCeEEEE
Confidence            4578999999999999999999976 57789999998766666788999999999998  99999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEE---cCCCceEEeeccccc
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSK  195 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv---~~~~~~~l~Dfg~~~  195 (358)
                      |||+++++|.+.+    .....+++..++.++.|++.||.|||++   |++|+||+|+||++   +.++.++|+|||++.
T Consensus        85 ~e~~~~~~L~~~~----~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~  157 (277)
T 3f3z_A           85 MELCTGGELFERV----VHKRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA  157 (277)
T ss_dssp             EECCCSCBHHHHH----HHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EeccCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccce
Confidence            9999999999998    3456789999999999999999999999   99999999999999   788899999999998


Q ss_pred             ccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhh
Q 018263          196 LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNL  275 (358)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                      ......  ......+++.|+|||++.+ .++.++||||||+++|+|++|+.||...........+....           
T Consensus       158 ~~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-----------  223 (277)
T 3f3z_A          158 RFKPGK--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGT-----------  223 (277)
T ss_dssp             ECCTTS--CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----------
T ss_pred             eccCcc--chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC-----------
Confidence            754332  2334568999999998765 48999999999999999999999997544322111111100           


Q ss_pred             hccccCCCCCH----HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          276 VDPMLYGNFPE----NEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       276 ~~~~~~~~~~~----~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                            ...+.    ..+..+.+++.+||+.||.+|||+.++++
T Consensus       224 ------~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          224 ------FTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             ------CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ------CCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                  01111    23567899999999999999999999975

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.2e-43  Score=323.84  Aligned_cols=272  Identities=24%  Similarity=0.372  Sum_probs=219.9

Q ss_pred             cccCHHHHHHhhcCCcccceecccCceEEEEEEEC------CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCc
Q 018263           30 NAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENL  102 (358)
Q Consensus        30 ~~~~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i  102 (358)
                      ..+..+++.+..++|++.+.||+|+||.||+|.+.      +++.||+|.+.... ......+.+|+..++.+.  ||||
T Consensus        13 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i   90 (322)
T 1p4o_A           13 DVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN--CHHV   90 (322)
T ss_dssp             SCCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCC--CTTB
T ss_pred             cccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcC--CCCE
Confidence            44556667788899999999999999999999854      37789999987543 344567889999999998  9999


Q ss_pred             eeeeceEEcCCeeEEEEecCCCCCHHHHhhhcccc------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCC
Q 018263          103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKR------RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTS  176 (358)
Q Consensus       103 ~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~------~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~  176 (358)
                      +++++++...+..++||||+++++|.+++......      ...+++..++.++.||+.||.|||++   |++|+||+|+
T Consensus        91 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~  167 (322)
T 1p4o_A           91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAAR  167 (322)
T ss_dssp             CCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGG
T ss_pred             eeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccc
Confidence            99999999999999999999999999999543211      24578999999999999999999999   9999999999


Q ss_pred             cEEEcCCCceEEeecccccccCCCCc-ccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccc
Q 018263          177 NILLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQL  254 (358)
Q Consensus       177 Nilv~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~  254 (358)
                      ||+++.++.++|+|||++........ .......+++.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus       168 NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  247 (322)
T 1p4o_A          168 NCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE  247 (322)
T ss_dssp             GEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH
T ss_pred             eEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH
Confidence            99999999999999999975432221 12223456788999999998899999999999999999999 89998754321


Q ss_pred             cchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCC
Q 018263          255 GEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETN  322 (358)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~  322 (358)
                      ...                ..+........+...+..+.+++.+||+.||.+|||+.++++.|+++..
T Consensus       248 ~~~----------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          248 QVL----------------RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HHH----------------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHH----------------HHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            111                1111111122334556779999999999999999999999999998754

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.3e-43  Score=330.65  Aligned_cols=284  Identities=19%  Similarity=0.204  Sum_probs=212.4

Q ss_pred             ccCHHHHHHhhcCCcccceeccc--CceEEEEEEEC-CCCEEEEEEeeccC--hhhHHHHHHHHHHhhhcccCCCCceee
Q 018263           31 AFSYNQLKIATNGFRWSNKIGEG--GFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKL  105 (358)
Q Consensus        31 ~~~~~~~~~~~~~y~i~~~lg~g--~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~~~h~~i~~~  105 (358)
                      .-+...+....++|++.+.||+|  +||.||+|++. +|+.||+|++....  ......+.+|+..++.++  ||||+++
T Consensus        14 ~~~~s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~   91 (389)
T 3gni_B           14 FQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN--HPNIVPY   91 (389)
T ss_dssp             CC--CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCC--CTTBCCE
T ss_pred             hhhhhcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCC--CCCCCcE
Confidence            33444455567899999999999  99999999986 69999999997553  444577888999999998  9999999


Q ss_pred             eceEEcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCc
Q 018263          106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN  185 (358)
Q Consensus       106 ~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~  185 (358)
                      ++++...+..++||||+++++|.+++...  ....+++..++.++.||+.||+|||++   ||+||||||+||+++.++.
T Consensus        92 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~  166 (389)
T 3gni_B           92 RATFIADNELWVVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGK  166 (389)
T ss_dssp             EEEEEETTEEEEEEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCC
T ss_pred             eEEEEECCEEEEEEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCC
Confidence            99999999999999999999999999432  335689999999999999999999999   9999999999999999999


Q ss_pred             eEEeecccccccCCCC------cccccccccccCccCcccccc--CCCCccCceecHHHHHHHHHhCCCCCCccccccch
Q 018263          186 PKISDFGLSKLFPENT------THISTRVAGTLGYLAPEYAIS--GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEY  257 (358)
Q Consensus       186 ~~l~Dfg~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~--~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~  257 (358)
                      ++|+|||.+.......      ........++..|+|||++.+  ..++.++|||||||++|+|++|+.||.........
T Consensus       167 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~  246 (389)
T 3gni_B          167 VYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML  246 (389)
T ss_dssp             EEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH
T ss_pred             EEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence            9999999876432111      111122468889999999987  57899999999999999999999999765443322


Q ss_pred             hhhHhh-hhcc------chhh-------------Hhhhh---------ccccCCCCCHHHHHHHHHHHhhccCCCCCCCC
Q 018263          258 HLVDKA-WGMY------NSKE-------------LMNLV---------DPMLYGNFPENEAIRFLKVGLLCVQEKSKLRP  308 (358)
Q Consensus       258 ~~~~~~-~~~~------~~~~-------------~~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp  308 (358)
                      ...... ....      ....             ....+         ........+...+..+.+||.+||+.||.+||
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp  326 (389)
T 3gni_B          247 LEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARP  326 (389)
T ss_dssp             HHC--------------------------------------------------------CCHHHHHHHHHHTCSCTTTSC
T ss_pred             HHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCC
Confidence            111000 0000      0000             00000         00000112334566799999999999999999


Q ss_pred             CHHHHHHH--hhcCC
Q 018263          309 QMSTAIKM--MNGET  321 (358)
Q Consensus       309 t~~eil~~--L~~~~  321 (358)
                      |+.|+++-  ++++.
T Consensus       327 ta~ell~hp~f~~~~  341 (389)
T 3gni_B          327 SASTLLNHSFFKQIK  341 (389)
T ss_dssp             CHHHHTTSGGGGGC-
T ss_pred             CHHHHhcCHHHHHHh
Confidence            99999853  55544

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.2e-43  Score=324.97  Aligned_cols=257  Identities=25%  Similarity=0.390  Sum_probs=205.1

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCC----EEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCe
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGT----IVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC  114 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~----~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~  114 (358)
                      .++|++.+.||+|+||.||+|++. +++    +|++|.+... .......+.+|+..++.++  ||||+++++++.... 
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~-   90 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD--NPHVCRLLGICLTST-   90 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCC--BTTBCCEEEEEESSS-
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCC--CCCEeEEEEEEecCC-
Confidence            578999999999999999999864 344    3588877533 3345678899999999998  999999999998765 


Q ss_pred             eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccc
Q 018263          115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS  194 (358)
Q Consensus       115 ~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~  194 (358)
                      .+++++++++++|.+++..   ....+++..++.++.||+.||.|||++   |++|+||||+||+++.++.++|+|||++
T Consensus        91 ~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a  164 (327)
T 3poz_A           91 VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA  164 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred             eEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcce
Confidence            7789999999999999843   346789999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcc-cccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhH
Q 018263          195 KLFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKEL  272 (358)
Q Consensus       195 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      ......... ......++..|+|||++.+..++.++||||||+++|+|++ |+.||.......                .
T Consensus       165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----------------~  228 (327)
T 3poz_A          165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------------I  228 (327)
T ss_dssp             HHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----------------H
T ss_pred             eEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH----------------H
Confidence            865433322 2223456789999999999999999999999999999999 999997543322                1


Q ss_pred             hhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCC
Q 018263          273 MNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETN  322 (358)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~  322 (358)
                      ...+........+...+..+.+++.+||+.+|.+|||+.++++.|+.+..
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          229 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             HHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            22222222233445566789999999999999999999999999987653

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=8.4e-43  Score=312.57  Aligned_cols=252  Identities=22%  Similarity=0.304  Sum_probs=207.1

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeE
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI  116 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~  116 (358)
                      ..++|++.+.||+|+||.||+|.+. +|+.||+|++...  .......+.+|+..++.++  ||||+++++++...+..+
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~   81 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ--HPNIVRLHDSIQEESFHY   81 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCC--CTTBCCEEEEEECSSEEE
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcC--CCCcCeEEEEEEcCCEEE
Confidence            4689999999999999999999976 5899999998754  3344567889999999998  999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCc---eEEeeccc
Q 018263          117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN---PKISDFGL  193 (358)
Q Consensus       117 iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~---~~l~Dfg~  193 (358)
                      +||||+++++|.+.+    .....+++..++.++.|++.||.|||++   |++|+||+|+||+++.++.   ++|+|||+
T Consensus        82 ~v~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~  154 (284)
T 3kk8_A           82 LVFDLVTGGELFEDI----VAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGL  154 (284)
T ss_dssp             EEECCCCSCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEecCCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeecee
Confidence            999999999999988    3456789999999999999999999999   9999999999999976655   99999999


Q ss_pred             ccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHh
Q 018263          194 SKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELM  273 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      +........  .....+++.|+|||++.+..++.++||||||+++|+|++|+.||...........+.....        
T Consensus       155 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~--------  224 (284)
T 3kk8_A          155 AIEVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY--------  224 (284)
T ss_dssp             CEECCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--------
T ss_pred             eEEcccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccc--------
Confidence            987543322  2345689999999999998999999999999999999999999975543222111111000        


Q ss_pred             hhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          274 NLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                           ..........+..+.+++.+||+.||.+|||+.++++
T Consensus       225 -----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          225 -----DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             -----CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -----cCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                 0001111234567899999999999999999999987

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.1e-43  Score=318.51  Aligned_cols=259  Identities=25%  Similarity=0.374  Sum_probs=201.5

Q ss_pred             hhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      ..++|++.+.||+|+||.||++++. ++.||+|.+..  ....+.+.+|+..++.++  ||||+++++++.+  ..++||
T Consensus         6 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~--~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~--~~~lv~   78 (307)
T 2eva_A            6 DYKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES--ESERKAFIVELRQLSRVN--HPNIVKLYGACLN--PVCLVM   78 (307)
T ss_dssp             CGGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS--TTHHHHHHHHHHHHHHCC--CTTBCCEEEBCTT--TTEEEE
T ss_pred             CHhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC--hhHHHHHHHHHHHHhcCC--CCCcCeEEEEEcC--CcEEEE
Confidence            4678999999999999999999986 78899999863  345567889999999998  9999999998774  478999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCc-eEEeecccccccC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN-PKISDFGLSKLFP  198 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~-~~l~Dfg~~~~~~  198 (358)
                      ||+++++|.+++... .....+++..++.++.|++.||+|||+.+..|++|+||||+||+++.++. ++|+|||++....
T Consensus        79 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~  157 (307)
T 2eva_A           79 EYAEGGSLYNVLHGA-EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ  157 (307)
T ss_dssp             ECCTTCBHHHHHHCS-SSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred             EcCCCCCHHHHHhcc-CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence            999999999999432 12235789999999999999999999921129999999999999998886 7999999997543


Q ss_pred             CCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhcc
Q 018263          199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDP  278 (358)
Q Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (358)
                      ..    .....++..|+|||++.+..++.++||||||+++|+|++|+.||........ .....             ...
T Consensus       158 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~-------------~~~  219 (307)
T 2eva_A          158 TH----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF-RIMWA-------------VHN  219 (307)
T ss_dssp             -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH-HHHHH-------------HHT
T ss_pred             cc----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH-HHHHH-------------Hhc
Confidence            22    2234589999999999988999999999999999999999999974332110 01000             011


Q ss_pred             ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCC
Q 018263          279 MLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNID  324 (358)
Q Consensus       279 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~  324 (358)
                      ......+...+..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus       220 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  265 (307)
T 2eva_A          220 GTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF  265 (307)
T ss_dssp             TCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred             CCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence            1112233345667899999999999999999999999999876443

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.7e-43  Score=336.14  Aligned_cols=256  Identities=26%  Similarity=0.383  Sum_probs=211.9

Q ss_pred             HHHhhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC-ee
Q 018263           37 LKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP-CR  115 (358)
Q Consensus        37 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~-~~  115 (358)
                      +.+..++|++.+.||+|+||.||++.+. |+.||||++....  ....+.+|+..++.++  ||||+++++++.... ..
T Consensus       188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~  262 (450)
T 1k9a_A          188 WALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLR--HSNLVQLLGVIVEEKGGL  262 (450)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCC--CTTBCCEEEEEECTTSCE
T ss_pred             cccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhcc--CCCEEEEEEEEEcCCCce
Confidence            4456789999999999999999999986 7899999987543  4567889999999998  999999999987665 78


Q ss_pred             EEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccc
Q 018263          116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK  195 (358)
Q Consensus       116 ~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~  195 (358)
                      ++||||+++++|.+++...  ....+++..++.++.||+.||+|||++   +++||||+|+||+++.++.+||+|||++.
T Consensus       263 ~iv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~  337 (450)
T 1k9a_A          263 YIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK  337 (450)
T ss_dssp             EEEEECCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcc
Confidence            9999999999999999432  233478999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhHhh
Q 018263          196 LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMN  274 (358)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                      .....    .....++..|+|||++.+..++.++||||||+++|+|++ |+.||..........                
T Consensus       338 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~----------------  397 (450)
T 1k9a_A          338 EASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP----------------  397 (450)
T ss_dssp             ECC----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHH----------------
T ss_pred             ccccc----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----------------
Confidence            54321    122356789999999999999999999999999999998 999997544322111                


Q ss_pred             hhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCC
Q 018263          275 LVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETN  322 (358)
Q Consensus       275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~  322 (358)
                      .+....+...+..++..+.++|.+||+.||.+|||+.++++.|+.+..
T Consensus       398 ~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~  445 (450)
T 1k9a_A          398 RVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT  445 (450)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence            111222233455667789999999999999999999999999998754

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.5e-43  Score=329.29  Aligned_cols=252  Identities=22%  Similarity=0.349  Sum_probs=201.8

Q ss_pred             hcCCcccceecccCceEEEEEEECCCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      ..+|++.+.||+|+||.||+|...+++.||||++...  .......+.+|+..+..+...||||+++++++...+..++|
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            4569999999999999999999888999999998754  34455778899999999974469999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      || +.+++|.+++.    ....+++..++.++.||+.||.|||+.   ||+||||||+||+++ ++.+||+|||++....
T Consensus       135 ~E-~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~  205 (390)
T 2zmd_A          135 ME-CGNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  205 (390)
T ss_dssp             EE-CCSEEHHHHHH----HCSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred             Ee-cCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence            99 55889999993    445789999999999999999999999   999999999999996 5789999999998764


Q ss_pred             CCCcc-cccccccccCccCcccccc-----------CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhc
Q 018263          199 ENTTH-ISTRVAGTLGYLAPEYAIS-----------GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGM  266 (358)
Q Consensus       199 ~~~~~-~~~~~~~~~~y~aPE~~~~-----------~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~  266 (358)
                      ..... ......||+.|+|||++.+           ..++.++||||||+++|+|++|+.||......            
T Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~------------  273 (390)
T 2zmd_A          206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------------  273 (390)
T ss_dssp             --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------------
T ss_pred             CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH------------
Confidence            33221 2334679999999999865           36888999999999999999999999643211            


Q ss_pred             cchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          267 YNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                        ...+..+++......++...+..+.+||.+||+.||.+|||+.++++
T Consensus       274 --~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          274 --ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             --HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             --HHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence              01122223332233333344567899999999999999999999985

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.5e-43  Score=322.28  Aligned_cols=271  Identities=23%  Similarity=0.350  Sum_probs=218.2

Q ss_pred             cCHHHHHHhhcCCcccceecccCceEEEEEEE------CCCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCcee
Q 018263           32 FSYNQLKIATNGFRWSNKIGEGGFGSVYKGRL------QDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVK  104 (358)
Q Consensus        32 ~~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~------~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~  104 (358)
                      +....+.+..++|++.+.||+|+||.||+|.+      .+++.||+|++.... ......+.+|+..+..+. .||||++
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-~hp~iv~   95 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG-HHLNVVN   95 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC-CCTTBCC
T ss_pred             ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcc-cCCCeee
Confidence            56677788889999999999999999999984      246889999987543 334567889999999984 3999999


Q ss_pred             eeceEEcCC-eeEEEEecCCCCCHHHHhhhcccc------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEc
Q 018263          105 LHGGCIDGP-CRILVYDYMPNNSLSQTLLGEEKR------------RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHR  171 (358)
Q Consensus       105 ~~~~~~~~~-~~~iv~e~~~~~~L~~~l~~~~~~------------~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~  171 (358)
                      +++++...+ ..++||||+++++|.+++......            ...+++..++.++.||+.||.|||+.   |++|+
T Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~  172 (316)
T 2xir_A           96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR  172 (316)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred             EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Ccccc
Confidence            999988755 489999999999999999543221            22388999999999999999999999   99999


Q ss_pred             CCCCCcEEEcCCCceEEeecccccccCCCCc-ccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCC
Q 018263          172 DIKTSNILLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVD  249 (358)
Q Consensus       172 di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~  249 (358)
                      ||+|+||+++.++.++|+|||++........ .......++..|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus       173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~  252 (316)
T 2xir_A          173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  252 (316)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence            9999999999999999999999986543322 22334567889999999999999999999999999999998 999997


Q ss_pred             ccccccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCC
Q 018263          250 FDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGET  321 (358)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~  321 (358)
                      ........               ...+........+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus       253 ~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  309 (316)
T 2xir_A          253 GVKIDEEF---------------CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  309 (316)
T ss_dssp             TCCCSHHH---------------HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccchhHHH---------------HHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            54432211               1111111112233445667999999999999999999999999998765

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=4.5e-43  Score=321.10  Aligned_cols=263  Identities=19%  Similarity=0.265  Sum_probs=209.8

Q ss_pred             cCHHHHHHhhcCCccc-ceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeec
Q 018263           32 FSYNQLKIATNGFRWS-NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHG  107 (358)
Q Consensus        32 ~~~~~~~~~~~~y~i~-~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~  107 (358)
                      ..........++|.+. +.||+|+||.||+|... +++.||+|++...  .......+.+|+..+..+. .||||+++++
T Consensus        18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~~iv~~~~   96 (327)
T 3lm5_A           18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK-SCPRVINLHE   96 (327)
T ss_dssp             CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTT-TCTTBCCEEE
T ss_pred             hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhcc-CCCCEEEEEE
Confidence            3344455667889988 88999999999999976 6999999998754  2334677889999999986 4799999999


Q ss_pred             eEEcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcC---CC
Q 018263          108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ---NF  184 (358)
Q Consensus       108 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~---~~  184 (358)
                      ++...+..++||||+++++|.+++..  .....+++..++.++.||+.||+|||++   |++|+||+|+||+++.   ++
T Consensus        97 ~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~  171 (327)
T 3lm5_A           97 VYENTSEIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLG  171 (327)
T ss_dssp             EEECSSEEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBC
T ss_pred             EEEeCCeEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCC
Confidence            99999999999999999999999832  2346789999999999999999999999   9999999999999987   78


Q ss_pred             ceEEeecccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhh
Q 018263          185 NPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAW  264 (358)
Q Consensus       185 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~  264 (358)
                      .++|+|||++........  .....+++.|+|||++.+..++.++||||||+++|+|++|+.||...........+... 
T Consensus       172 ~~kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-  248 (327)
T 3lm5_A          172 DIKIVDFGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV-  248 (327)
T ss_dssp             CEEECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-
T ss_pred             cEEEeeCccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhc-
Confidence            999999999987543222  23456899999999999899999999999999999999999999765433222211111 


Q ss_pred             hccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          265 GMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                                  ............+..+.++|.+||+.||.+|||++++++
T Consensus       249 ------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          249 ------------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             ------------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ------------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence                        011111222345667899999999999999999999975

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-43  Score=315.60  Aligned_cols=261  Identities=26%  Similarity=0.370  Sum_probs=214.2

Q ss_pred             HhhcCCcccc-eecccCceEEEEEEEC---CCCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC
Q 018263           39 IATNGFRWSN-KIGEGGFGSVYKGRLQ---DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP  113 (358)
Q Consensus        39 ~~~~~y~i~~-~lg~g~~g~v~~~~~~---~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~  113 (358)
                      +..++|.+.+ .||+|+||.||+|.+.   ++..||+|++... .......+.+|+..++.++  ||||+++++++ ..+
T Consensus         6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~-~~~   82 (287)
T 1u59_A            6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD--NPYIVRLIGVC-QAE   82 (287)
T ss_dssp             CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCC--CTTBCCEEEEE-ESS
T ss_pred             ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCC--CCCEeEEEEEe-cCC
Confidence            3467888887 9999999999999853   5788999999764 3445677889999999997  99999999999 455


Q ss_pred             eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccc
Q 018263          114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL  193 (358)
Q Consensus       114 ~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~  193 (358)
                      ..++||||+++++|.+++.   .....+++..++.++.||+.||.|||+.   |++|+||+|+||+++.++.++|+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~  156 (287)
T 1u59_A           83 ALMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGL  156 (287)
T ss_dssp             SEEEEEECCTTEEHHHHHT---TCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTT
T ss_pred             CcEEEEEeCCCCCHHHHHH---hCCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccc
Confidence            6899999999999999983   2445689999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCccc--ccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchh
Q 018263          194 SKLFPENTTHI--STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSK  270 (358)
Q Consensus       194 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      +..........  .....++..|+|||++.+..++.++||||||+++|+|++ |+.||.......               
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---------------  221 (287)
T 1u59_A          157 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---------------  221 (287)
T ss_dssp             CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---------------
T ss_pred             eeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---------------
Confidence            98764333221  223446788999999988889999999999999999998 999997543221               


Q ss_pred             hHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCC
Q 018263          271 ELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNID  324 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~  324 (358)
                       ....+........+...+..+.+++.+||+.+|.+||++.++++.|+++....
T Consensus       222 -~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  274 (287)
T 1u59_A          222 -VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  274 (287)
T ss_dssp             -HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -HHHHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence             11111122223345566778999999999999999999999999999876443

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=4.8e-43  Score=313.56  Aligned_cols=247  Identities=28%  Similarity=0.438  Sum_probs=204.1

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCee
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR  115 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~  115 (358)
                      ..++|++.+.||+|++|.||+|.+. ++..||+|++....   ......+.+|+..++.++  ||||+++++++......
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~   84 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR--HPNILRLYGYFHDATRV   84 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCC--CTTBCCEEEEEECSSEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCC--CCCCcchhheEecCCEE
Confidence            3578999999999999999999876 57899999986432   233567889999999998  99999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccc
Q 018263          116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK  195 (358)
Q Consensus       116 ~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~  195 (358)
                      ++||||+++++|.+.+    .....+++..++.++.||+.||.|||+.   |++|+||+|+||+++.++.++|+|||++.
T Consensus        85 ~lv~e~~~~~~l~~~l----~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~  157 (279)
T 3fdn_A           85 YLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV  157 (279)
T ss_dssp             EEEECCCTTEEHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEES
T ss_pred             EEEEecCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccc
Confidence            9999999999999998    3446789999999999999999999999   99999999999999999999999999886


Q ss_pred             ccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhh
Q 018263          196 LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNL  275 (358)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                      .....   ......++..|+|||.+.+..++.++||||||+++|+|++|..||...........+..             
T Consensus       158 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------------  221 (279)
T 3fdn_A          158 HAPSS---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR-------------  221 (279)
T ss_dssp             CC-----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH-------------
T ss_pred             cCCcc---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHh-------------
Confidence            54322   22345689999999999998999999999999999999999999975433221111110             


Q ss_pred             hccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          276 VDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       276 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                          ....++...+..+.+++.+||+.||.+|||+.|+++
T Consensus       222 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          222 ----VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             ----TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ----CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                111233445667899999999999999999999986

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=5.9e-44  Score=319.29  Aligned_cols=264  Identities=25%  Similarity=0.384  Sum_probs=205.5

Q ss_pred             ccccCHHHHHHhhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeece
Q 018263           29 INAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG  108 (358)
Q Consensus        29 ~~~~~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~  108 (358)
                      ..++....+.+..++|++.+.||+|++|.||++... |+.||+|++....  ..+.+.+|+..++.++  ||||++++++
T Consensus         8 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~--h~~iv~~~~~   82 (278)
T 1byg_A            8 QDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLR--HSNLVQLLGV   82 (278)
T ss_dssp             -------CCBCCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCC--CTTBCCEEEE
T ss_pred             hhhhhhccccCChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCC--CCCEeeEEEE
Confidence            334444455667899999999999999999999885 8899999986433  4567889999999998  9999999998


Q ss_pred             EEcC-CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceE
Q 018263          109 CIDG-PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPK  187 (358)
Q Consensus       109 ~~~~-~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~  187 (358)
                      +... +..++||||+++++|.+++...  ....+++..++.++.|++.||.|||++   |++|+||+|+||+++.++.++
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~  157 (278)
T 1byg_A           83 IVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAK  157 (278)
T ss_dssp             ECCC--CCEEEECCCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEE
T ss_pred             EEcCCCceEEEEecCCCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEE
Confidence            7654 4789999999999999999432  223478999999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhc
Q 018263          188 ISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGM  266 (358)
Q Consensus       188 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~  266 (358)
                      |+|||++.......    ....++..|+|||++.+..++.++||||||+++|+|++ |+.||........          
T Consensus       158 l~Dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~----------  223 (278)
T 1byg_A          158 VSDFGLTKEASSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV----------  223 (278)
T ss_dssp             ECCCCC----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH----------
T ss_pred             Eeeccccccccccc----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH----------
Confidence            99999987643221    22356788999999998899999999999999999998 9999975432211          


Q ss_pred             cchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCC
Q 018263          267 YNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETN  322 (358)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~  322 (358)
                            ...+........+...+..+.+++.+||+.||.+|||+.++++.|+.++.
T Consensus       224 ------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~  273 (278)
T 1byg_A          224 ------VPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  273 (278)
T ss_dssp             ------HHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------HHHHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence                  11111122233444566789999999999999999999999999998754

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=9.3e-44  Score=346.10  Aligned_cols=267  Identities=27%  Similarity=0.416  Sum_probs=219.9

Q ss_pred             CHHHHHHhhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC
Q 018263           33 SYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG  112 (358)
Q Consensus        33 ~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~  112 (358)
                      ....+.+..++|++.+.||+|+||.||+|.++.+..||||++.... .....+.+|+.+++.++  ||||+++++++.. 
T Consensus       258 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~-  333 (535)
T 2h8h_A          258 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLR--HEKLVQLYAVVSE-  333 (535)
T ss_dssp             STTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCC--CTTBCCEEEEECS-
T ss_pred             CccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCC--CCCEeeEEEEEee-
Confidence            3455667789999999999999999999999888889999997543 34567899999999998  9999999999876 


Q ss_pred             CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecc
Q 018263          113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG  192 (358)
Q Consensus       113 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg  192 (358)
                      ...++||||+++++|.+++..  .....+++..++.++.||+.||+|||++   +|+|+||+|+||+++.++.+||+|||
T Consensus       334 ~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG  408 (535)
T 2h8h_A          334 EPIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFG  408 (535)
T ss_dssp             SSCEEEECCCTTEEHHHHHSH--HHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTT
T ss_pred             ccceEeeehhcCCcHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccc
Confidence            678999999999999999943  2335689999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhh
Q 018263          193 LSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKE  271 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      ++...............++..|+|||++.+..++.++||||||+++|+|++ |+.||........               
T Consensus       409 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~---------------  473 (535)
T 2h8h_A          409 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---------------  473 (535)
T ss_dssp             STTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHH---------------
T ss_pred             cceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---------------
Confidence            998654322222233456778999999998899999999999999999999 9999975432211               


Q ss_pred             HhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCC
Q 018263          272 LMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNID  324 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~  324 (358)
                       ...+....+...+..++..+.+||.+||+.||.+|||+.+|++.|+.+....
T Consensus       474 -~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  525 (535)
T 2h8h_A          474 -LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  525 (535)
T ss_dssp             -HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred             -HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence             1111122222334456778999999999999999999999999999887554

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-43  Score=324.80  Aligned_cols=270  Identities=23%  Similarity=0.378  Sum_probs=214.6

Q ss_pred             hhcCCcccceecccCceEEEEEEE-----CCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC-
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRL-----QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP-  113 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~-  113 (358)
                      ..++|++.+.||+|+||.||+|+.     .+++.||+|++..........+.+|+..++.++  ||||+++++++...+ 
T Consensus        39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~  116 (326)
T 2w1i_A           39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ--HDNIVKYKGVCYSAGR  116 (326)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCC--CTTBCCEEEEECC---
T ss_pred             CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCC--CCCeeeEEEEEEecCC
Confidence            457899999999999999999983     368899999998766667788999999999998  999999999887654 


Q ss_pred             -eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecc
Q 018263          114 -CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG  192 (358)
Q Consensus       114 -~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg  192 (358)
                       ..++||||+++++|.+++..   ....+++..++.++.||+.||.+||+.   |++|+||+|+||+++.++.++|+|||
T Consensus       117 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg  190 (326)
T 2w1i_A          117 RNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFG  190 (326)
T ss_dssp             -CCEEEECCCTTCBHHHHHHH---STTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCT
T ss_pred             CceEEEEECCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCc
Confidence             68999999999999999943   235689999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcc--cccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhh----c
Q 018263          193 LSKLFPENTTH--ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG----M  266 (358)
Q Consensus       193 ~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~----~  266 (358)
                      ++.........  ......++..|+|||++.+..++.++||||||+++|+|++|..||......    .......    .
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~----~~~~~~~~~~~~  266 (326)
T 2w1i_A          191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGNDKQGQ  266 (326)
T ss_dssp             TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH----HHHHHCTTCCTH
T ss_pred             chhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH----HHHhhccccchh
Confidence            99876443321  122345667899999998888999999999999999999999998643110    0000000    0


Q ss_pred             cchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCC
Q 018263          267 YNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGET  321 (358)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~  321 (358)
                      .........+........+...+..+.++|.+||+.||.+|||+.+|++.|+++.
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~  321 (326)
T 2w1i_A          267 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  321 (326)
T ss_dssp             HHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            0011122223322233345566778999999999999999999999999998764

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3.4e-43  Score=319.30  Aligned_cols=266  Identities=23%  Similarity=0.342  Sum_probs=205.8

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCee
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR  115 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~  115 (358)
                      ..++|++.+.||+|+||.||+|... +|+.||+|++...   .......+.+|+..++.++  ||||+++++++...+..
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~  107 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN--HPNVIKYYASFIEDNEL  107 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCC--CTTBCCEEEEEEETTEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCC--CCCEeeEEEEEEcCCcE
Confidence            3468999999999999999999974 6899999998753   3445677889999999998  99999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccc
Q 018263          116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK  195 (358)
Q Consensus       116 ~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~  195 (358)
                      ++||||+++++|.+++.........+++..++.++.||+.||.|||+.   |++|+||+|+||+++.++.++|+|||++.
T Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~  184 (310)
T 2wqm_A          108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGR  184 (310)
T ss_dssp             EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC----
T ss_pred             EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEecccee
Confidence            999999999999999965544567799999999999999999999999   99999999999999999999999999987


Q ss_pred             ccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhh
Q 018263          196 LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNL  275 (358)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                      ....... ......++..|+|||++.+..++.++||||||+++|+|++|+.||...... ........            
T Consensus       185 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~------------  250 (310)
T 2wqm_A          185 FFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKI------------  250 (310)
T ss_dssp             ---------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC-HHHHHHHH------------
T ss_pred             eecCCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh-HHHHHHHh------------
Confidence            6543222 223356889999999999889999999999999999999999999754321 11111111            


Q ss_pred             hccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCC
Q 018263          276 VDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNID  324 (358)
Q Consensus       276 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~  324 (358)
                      .............+..+.+++.+||+.||.+|||+.+|++.|+++.+..
T Consensus       251 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~  299 (310)
T 2wqm_A          251 EQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT  299 (310)
T ss_dssp             HTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             hcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence            0011111112345667999999999999999999999999999987665

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.3e-42  Score=332.27  Aligned_cols=261  Identities=21%  Similarity=0.250  Sum_probs=203.5

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC-----
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG-----  112 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~-----  112 (358)
                      .++|++++.||+|+||.||+|.+. +|+.||||++...  .......+.+|+..++.++  ||||+++++++...     
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~l~~~~~~~~~~~~  138 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN--HKNIISLLNVFTPQKTLEE  138 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCC--CTTBCCCSEEECSCCSTTT
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCC--CCCCCcEEEEEccCCcccc
Confidence            478999999999999999999876 6899999999754  4455677889999999998  99999999999755     


Q ss_pred             -CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeec
Q 018263          113 -PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF  191 (358)
Q Consensus       113 -~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Df  191 (358)
                       ...|+||||+++ +|.+.+.      ..+++..++.++.||+.||+|||+.   ||+||||||+||+++.++.+||+||
T Consensus       139 ~~~~~lv~E~~~~-~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DF  208 (464)
T 3ttj_A          139 FQDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  208 (464)
T ss_dssp             CCEEEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             CCeEEEEEeCCCC-CHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEE
Confidence             356999999965 5666662      2488999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhh
Q 018263          192 GLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKE  271 (358)
Q Consensus       192 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      |++......  .......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+....+.+....
T Consensus       209 G~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~  286 (464)
T 3ttj_A          209 GLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF  286 (464)
T ss_dssp             CCC-----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             EeeeecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            999865432  223446789999999999999999999999999999999999999988776655555544433332221


Q ss_pred             Hhh-------hhccc---------------cCCC---CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          272 LMN-------LVDPM---------------LYGN---FPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       272 ~~~-------~~~~~---------------~~~~---~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      +..       .+...               ....   .....+..+.+|+.+||+.||.+|||+.|+++
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             HTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            111       11100               0000   01123677999999999999999999999986

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.1e-43  Score=315.69  Aligned_cols=260  Identities=22%  Similarity=0.315  Sum_probs=210.7

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEE--cCCe
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCI--DGPC  114 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~--~~~~  114 (358)
                      ..++|++.+.||+|+||.||++... +|+.|++|.+...  .......+.+|+..++.++  ||||+++++++.  ....
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~   81 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK--HPNIVRYYDRIIDRTNTT   81 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCC--CTTBCCEEEEEEEGGGTE
T ss_pred             chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcC--CCCCCeEEEEEecCCCce
Confidence            3578999999999999999999976 6899999998754  3445577889999999998  999999999875  4668


Q ss_pred             eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----cEEcCCCCCcEEEcCCCceEEe
Q 018263          115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH-----VVHRDIKTSNILLDQNFNPKIS  189 (358)
Q Consensus       115 ~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~-----i~H~di~p~Nilv~~~~~~~l~  189 (358)
                      .++||||+++++|.+++.........+++..++.++.||+.||.|||+.   +     ++|+||+|+||+++.++.++|+
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~  158 (279)
T 2w5a_A           82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLG  158 (279)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEEC
T ss_pred             EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEe
Confidence            8999999999999999965544556699999999999999999999999   8     9999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccch
Q 018263          190 DFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNS  269 (358)
Q Consensus       190 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      |||.+........ ......++..|+|||++.+..++.++||||||+++|+|++|+.||........   ..        
T Consensus       159 dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~--------  226 (279)
T 2w5a_A          159 DFGLARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL---AG--------  226 (279)
T ss_dssp             CCCHHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH--------
T ss_pred             cCchheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHH---HH--------
Confidence            9999986543222 12235688999999999988999999999999999999999999975432111   11        


Q ss_pred             hhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCC
Q 018263          270 KELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGET  321 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~  321 (358)
                           .+........+...+..+.+++.+||+.||.+|||+.++++.+....
T Consensus       227 -----~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~  273 (279)
T 2w5a_A          227 -----KIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE  273 (279)
T ss_dssp             -----HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred             -----HHhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence                 11111112334456678999999999999999999999998765443

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=4.4e-43  Score=319.28  Aligned_cols=265  Identities=19%  Similarity=0.245  Sum_probs=201.1

Q ss_pred             hcCCccc-ceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           41 TNGFRWS-NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        41 ~~~y~i~-~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      .++|++. +.||+|+||.||+|.+. +++.||+|++..........+.+|+..+.++. .||||+++++++...+..++|
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~-~h~~i~~~~~~~~~~~~~~lv   89 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQ-GHRNVLELIEFFEEEDRFYLV   89 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEeeCCEEEEE
Confidence            5789985 78999999999999965 69999999998766666778899999998853 499999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCc---eEEeeccccc
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN---PKISDFGLSK  195 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~---~~l~Dfg~~~  195 (358)
                      |||+++++|.+++.    ....+++..++.++.||+.||+|||++   |++|+||+|+||+++.++.   ++|+|||++.
T Consensus        90 ~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~  162 (316)
T 2ac3_A           90 FEKMRGGSILSHIH----KRRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGS  162 (316)
T ss_dssp             EECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred             EEcCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence            99999999999993    446789999999999999999999999   9999999999999988776   9999999987


Q ss_pred             ccCCCCc------ccccccccccCccCcccccc-----CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhh
Q 018263          196 LFPENTT------HISTRVAGTLGYLAPEYAIS-----GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAW  264 (358)
Q Consensus       196 ~~~~~~~------~~~~~~~~~~~y~aPE~~~~-----~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~  264 (358)
                      .......      .......++..|+|||++.+     ..++.++||||||+++|+|++|+.||......+.........
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  242 (316)
T 2ac3_A          163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC  242 (316)
T ss_dssp             -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CC
T ss_pred             ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccc
Confidence            5432111      11223458999999999875     458899999999999999999999997654322110000000


Q ss_pred             hccchhhHhhhhccccCCCCCH----HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          265 GMYNSKELMNLVDPMLYGNFPE----NEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .. ........+.... ..++.    ..+..+.+++.+||+.||.+|||+.|+++
T Consensus       243 ~~-~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          243 PA-CQNMLFESIQEGK-YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HH-HHHHHHHHHHHCC-CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hh-HHHHHHHHHhccC-cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            00 0000001011000 11221    24567899999999999999999999987

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2e-43  Score=321.24  Aligned_cols=269  Identities=25%  Similarity=0.359  Sum_probs=206.8

Q ss_pred             cCHHHHHHhhcCCcccceecccCceEEEEEEEC----CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceee
Q 018263           32 FSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ----DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKL  105 (358)
Q Consensus        32 ~~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~----~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~  105 (358)
                      ....++.+..++|++.+.||+|+||.||+|...    ++..||+|.+...  .......+.+|+..++.++  ||||+++
T Consensus        24 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~  101 (313)
T 3brb_A           24 NKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFS--HPNVIRL  101 (313)
T ss_dssp             CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCC--CTTBCCC
T ss_pred             hhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCC--CCCeeee
Confidence            344566677899999999999999999999854    3558999998754  3344567889999999998  9999999


Q ss_pred             eceEEcCCe-----eEEEEecCCCCCHHHHhhhcc--ccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcE
Q 018263          106 HGGCIDGPC-----RILVYDYMPNNSLSQTLLGEE--KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNI  178 (358)
Q Consensus       106 ~~~~~~~~~-----~~iv~e~~~~~~L~~~l~~~~--~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Ni  178 (358)
                      ++++.....     .++||||+++++|.+++....  .....+++..++.++.||+.||.|||++   |++|+||+|+||
T Consensus       102 ~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NI  178 (313)
T 3brb_A          102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNC  178 (313)
T ss_dssp             CEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGE
T ss_pred             eEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceE
Confidence            999887553     499999999999999985432  2346799999999999999999999999   999999999999


Q ss_pred             EEcCCCceEEeecccccccCCCCc-ccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccc
Q 018263          179 LLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGE  256 (358)
Q Consensus       179 lv~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~  256 (358)
                      +++.++.++|+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||........
T Consensus       179 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  258 (313)
T 3brb_A          179 MLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM  258 (313)
T ss_dssp             EECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred             EEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH
Confidence            999999999999999986543221 12223456788999999999899999999999999999999 8899875543221


Q ss_pred             hhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCC
Q 018263          257 YHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGET  321 (358)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~  321 (358)
                      ...                +........+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus       259 ~~~----------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~  307 (313)
T 3brb_A          259 YDY----------------LLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL  307 (313)
T ss_dssp             HHH----------------HHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHH----------------HHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            111                1111122233445677999999999999999999999999998764

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.2e-42  Score=317.48  Aligned_cols=252  Identities=21%  Similarity=0.291  Sum_probs=206.9

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChh------hHHHHHHHHHHhhhcccCCCCceeeeceEEcC
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQ------GEKEFMSEVASMANVNVCHENLVKLHGGCIDG  112 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~  112 (358)
                      ..++|++.+.||+|+||.||+|.+. +|+.||+|++......      ....+.+|+..++.+.  ||||+++++++...
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~   87 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL--HHNVITLHDVYENR   87 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCC--CTTBCCEEEEEECS
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCC--CCCcceEEEEEecC
Confidence            3578999999999999999999976 6899999998754321      3677899999999998  99999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCC----ceEE
Q 018263          113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF----NPKI  188 (358)
Q Consensus       113 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~----~~~l  188 (358)
                      +..++||||+++++|.+++    .....+++..++.++.||+.||.|||+.   |++|+||+|+||+++.++    .++|
T Consensus        88 ~~~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl  160 (321)
T 2a2a_A           88 TDVVLILELVSGGELFDFL----AQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKL  160 (321)
T ss_dssp             SEEEEEECCCCSCBHHHHH----HTCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEE
T ss_pred             CEEEEEEEcCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEE
Confidence            9999999999999999999    3456789999999999999999999999   999999999999999887    7999


Q ss_pred             eecccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccc
Q 018263          189 SDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYN  268 (358)
Q Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  268 (358)
                      +|||++........  .....+++.|+|||++.+..++.++||||||+++|+|++|..||...........+......  
T Consensus       161 ~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~--  236 (321)
T 2a2a_A          161 IDFGLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYD--  236 (321)
T ss_dssp             CCCTTCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC--
T ss_pred             ccCccceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccc--
Confidence            99999987543222  23456899999999999889999999999999999999999999755432211111100000  


Q ss_pred             hhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          269 SKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                                 .........+..+.++|.+||+.||.+|||+.++++
T Consensus       237 -----------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          237 -----------FDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             -----------CCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             -----------cChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                       000001123456899999999999999999999987

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.1e-43  Score=328.41  Aligned_cols=258  Identities=27%  Similarity=0.325  Sum_probs=201.3

Q ss_pred             HhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHH-hhhcccCCCCceeeeceEEcCC
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVAS-MANVNVCHENLVKLHGGCIDGP  113 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~-l~~l~~~h~~i~~~~~~~~~~~  113 (358)
                      ...++|++.+.||+|+||.||+|+.+ +++.||+|++....   ......+..|... ++.++  ||||+++++++...+
T Consensus        35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~--hp~Iv~l~~~~~~~~  112 (373)
T 2r5t_A           35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK--HPFLVGLHFSFQTAD  112 (373)
T ss_dssp             CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCC--CTTBCCEEEEEECSS
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCC--CCCCCCEEEEEEeCC
Confidence            34678999999999999999999976 58899999997543   2233455566665 34555  999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccc
Q 018263          114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL  193 (358)
Q Consensus       114 ~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~  193 (358)
                      ..|+||||++|++|.+++    .....+++..++.++.||+.||+|||++   ||+||||||+||+++.+|.++|+|||+
T Consensus       113 ~~~lv~E~~~gg~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~  185 (373)
T 2r5t_A          113 KLYFVLDYINGGELFYHL----QRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGL  185 (373)
T ss_dssp             EEEEEEECCCSCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCB
T ss_pred             EEEEEEeCCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcc
Confidence            999999999999999999    3456789999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHh
Q 018263          194 SKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELM  273 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      +....... ......+||+.|+|||++.+..++.++|+||||+++|+|++|..||........+..+             
T Consensus       186 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i-------------  251 (373)
T 2r5t_A          186 CKENIEHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI-------------  251 (373)
T ss_dssp             CGGGBCCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHH-------------
T ss_pred             ccccccCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-------------
Confidence            97532222 2234467999999999999999999999999999999999999999755432211111             


Q ss_pred             hhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCC
Q 018263          274 NLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNI  323 (358)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~  323 (358)
                        +..  ...++...+..+.+||.+||+.||.+||++.+.++.+.++.-.
T Consensus       252 --~~~--~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f  297 (373)
T 2r5t_A          252 --LNK--PLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFF  297 (373)
T ss_dssp             --HHS--CCCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGG
T ss_pred             --Hhc--ccCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccc
Confidence              111  1123344566799999999999999999987655555555433

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=4.1e-43  Score=315.70  Aligned_cols=263  Identities=27%  Similarity=0.424  Sum_probs=199.1

Q ss_pred             HHhhcCCcccceecccCceEEEEEEECCCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCee
Q 018263           38 KIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR  115 (358)
Q Consensus        38 ~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~  115 (358)
                      .+..++|++.+.||+|+||.||+|++..  .|++|++...  .......+.+|+..++.++  ||||++++++. .....
T Consensus        20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~-~~~~~   94 (289)
T 3og7_A           20 EIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR--HVNILLFMGYS-TAPQL   94 (289)
T ss_dssp             BCCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCC--CTTBCCEEEEE-CSSSC
T ss_pred             ccCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCC--CCcEEEEEeec-cCCcc
Confidence            4557899999999999999999998753  5999998654  3445577889999999998  99999999954 55668


Q ss_pred             EEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccc
Q 018263          116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK  195 (358)
Q Consensus       116 ~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~  195 (358)
                      ++||||+++++|.+++.   .....+++..++.++.||+.||.|||+.   |++|+||+|+||+++.++.++|+|||++.
T Consensus        95 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~  168 (289)
T 3og7_A           95 AIVTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLAT  168 (289)
T ss_dssp             EEEEECCCEEEHHHHHT---TC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC---
T ss_pred             EEEEEecCCCcHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecc
Confidence            99999999999999983   2346689999999999999999999999   99999999999999999999999999997


Q ss_pred             ccCCC-CcccccccccccCccCccccc---cCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhh
Q 018263          196 LFPEN-TTHISTRVAGTLGYLAPEYAI---SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKE  271 (358)
Q Consensus       196 ~~~~~-~~~~~~~~~~~~~y~aPE~~~---~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      ..... .........+++.|+|||++.   +..++.++||||||+++|+|++|+.||...............  ..    
T Consensus       169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--~~----  242 (289)
T 3og7_A          169 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR--GS----  242 (289)
T ss_dssp             ---------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHH--TS----
T ss_pred             ccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcc--cc----
Confidence            64321 122233456899999999886   567888999999999999999999999754332211111000  00    


Q ss_pred             HhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCC
Q 018263          272 LMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETN  322 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~  322 (358)
                          . ..........++..+.+++.+||+.+|.+|||+.++++.|+.+..
T Consensus       243 ----~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          243 ----L-SPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             ----C-CCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             ----c-CcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence                0 000111233456789999999999999999999999999998753

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=3.7e-43  Score=321.56  Aligned_cols=267  Identities=27%  Similarity=0.372  Sum_probs=211.1

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEE--EEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCee
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIV--AVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR  115 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v--aiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~  115 (358)
                      ..++|++.+.||+|+||.||+|++. ++..+  ++|.+... .......+.+|+..++.+. .||||+++++++...+..
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~-~hp~iv~~~~~~~~~~~~  101 (327)
T 1fvr_A           23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG-HHPNIINLLGACEHRGYL  101 (327)
T ss_dssp             CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCC-CCTTBCCEEEEEEETTEE
T ss_pred             cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhcc-CCCchhhhceeeeeCCce
Confidence            3578999999999999999999865 46544  88988643 3334567889999999993 399999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhhcc------------ccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCC
Q 018263          116 ILVYDYMPNNSLSQTLLGEE------------KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN  183 (358)
Q Consensus       116 ~iv~e~~~~~~L~~~l~~~~------------~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~  183 (358)
                      ++||||+++++|.+++....            .....+++..++.++.||+.||.|||++   |++|+||+|+||+++.+
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~  178 (327)
T 1fvr_A          102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN  178 (327)
T ss_dssp             EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGG
T ss_pred             EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCC
Confidence            99999999999999995432            2235789999999999999999999999   99999999999999999


Q ss_pred             CceEEeecccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHh
Q 018263          184 FNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDK  262 (358)
Q Consensus       184 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~  262 (358)
                      +.++|+|||++.....  ........++..|+|||++.+..++.++||||||+++|+|++ |..||........      
T Consensus       179 ~~~kL~Dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~------  250 (327)
T 1fvr_A          179 YVAKIADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL------  250 (327)
T ss_dssp             GCEEECCTTCEESSCE--ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------
T ss_pred             CeEEEcccCcCccccc--cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH------
Confidence            9999999999874321  111223456788999999988889999999999999999998 9999975432211      


Q ss_pred             hhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCCCCCC
Q 018263          263 AWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNIDGXDV  328 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~~~~~  328 (358)
                                ...+........+...+..+.+++.+||+.+|.+|||+.++++.|+.+........
T Consensus       251 ----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~  306 (327)
T 1fvr_A          251 ----------YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV  306 (327)
T ss_dssp             ----------HHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSB
T ss_pred             ----------HHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCcc
Confidence                      11111112223344556789999999999999999999999999998776554333

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.3e-43  Score=331.89  Aligned_cols=261  Identities=21%  Similarity=0.247  Sum_probs=209.1

Q ss_pred             HHHHHHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceE
Q 018263           34 YNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGC  109 (358)
Q Consensus        34 ~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~  109 (358)
                      ..++.+..++|++.+.||+|+||.||+|+.+ +|+.||+|++....   ......+.+|..++..+.  ||||+++++++
T Consensus        53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~--hp~Iv~l~~~~  130 (412)
T 2vd5_A           53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD--RRWITQLHFAF  130 (412)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSC--TTTBCCEEEEE
T ss_pred             hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcC--CCCeeeEEEEE
Confidence            4455566789999999999999999999986 69999999986432   223345778999999887  99999999999


Q ss_pred             EcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEe
Q 018263          110 IDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKIS  189 (358)
Q Consensus       110 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~  189 (358)
                      .+.+..|+||||++|++|.+++..   ....+++..++.++.||+.||+|||++   ||+||||||+||+++.++.+||+
T Consensus       131 ~~~~~~~lVmE~~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~  204 (412)
T 2vd5_A          131 QDENYLYLVMEYYVGGDLLTLLSK---FGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLA  204 (412)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHH---HSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred             eeCCEEEEEEcCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEe
Confidence            999999999999999999999932   234789999999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccCccCccccc-------cCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHh
Q 018263          190 DFGLSKLFPENTTHISTRVAGTLGYLAPEYAI-------SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDK  262 (358)
Q Consensus       190 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~  262 (358)
                      |||++..............+||+.|+|||++.       +..++.++|+||||+++|+|++|+.||........+..+..
T Consensus       205 DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  284 (412)
T 2vd5_A          205 DFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVH  284 (412)
T ss_dssp             CCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred             echhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence            99999876544433334467999999999987       35689999999999999999999999986544322222211


Q ss_pred             hhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCC---CCHHHHHH
Q 018263          263 AWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLR---PQMSTAIK  315 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R---pt~~eil~  315 (358)
                      ..         .   ....+..+...+..+.+||.+||+ +|.+|   |+++|+++
T Consensus       285 ~~---------~---~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          285 YK---------E---HLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             HH---------H---HCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             cc---------c---CcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            00         0   000111123456679999999999 99998   58988865

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.1e-42  Score=310.54  Aligned_cols=253  Identities=25%  Similarity=0.351  Sum_probs=206.5

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      ..++|++.+.||+|++|.||+|... +++.|++|++.... ......+.+|+..++.++  ||||+++++++...+..++
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~l   82 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN--HENVVKFYGHRREGNIQYL   82 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCC--CTTBCCEEEEEEETTEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcC--CCCceeeeeEEEcCCEEEE
Confidence            3578999999999999999999976 68999999987543 344577889999999998  9999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      ||||+++++|.+++    .....+++..++.++.||+.||.|||+.   |++|+||+|+||+++.++.++|+|||.+...
T Consensus        83 v~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  155 (276)
T 2yex_A           83 FLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVF  155 (276)
T ss_dssp             EEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEecCCCcHHHHH----hhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCcccc
Confidence            99999999999998    4456789999999999999999999999   9999999999999999999999999999765


Q ss_pred             CCCC-cccccccccccCccCccccccCCC-CccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhh
Q 018263          198 PENT-THISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNL  275 (358)
Q Consensus       198 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~-s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                      .... ........++..|+|||++.+..+ +.++||||||+++|+|++|+.||...........              .+
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~--------------~~  221 (276)
T 2yex_A          156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--------------DW  221 (276)
T ss_dssp             EETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHH--------------HH
T ss_pred             CCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHH--------------Hh
Confidence            3222 122334568999999999887665 7899999999999999999999976543221110              00


Q ss_pred             hccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          276 VDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       276 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .............+..+.+++.+||+.||.+|||+.++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          222 KEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             HTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence            0000011112334567889999999999999999999976

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=8.4e-43  Score=333.55  Aligned_cols=247  Identities=24%  Similarity=0.370  Sum_probs=207.6

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI  116 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~  116 (358)
                      .++|++.+.||+|+||.||+|++. +|+.||+|++....   ......+.+|+..++.++  ||||+++++++...+..+
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~--HpnIv~l~~~~~~~~~~~   92 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR--HPHIIKLYQVISTPSDIF   92 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCC--CTTBCCEEEEEECSSEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCC--CCCCCcEEEEEEECCEEE
Confidence            478999999999999999999976 79999999996542   234567889999999998  999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       117 iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      +||||++|++|.+++    ...+.+++..++.++.||+.||.|||++   ||+||||||+||+++.++.++|+|||++..
T Consensus        93 lv~E~~~gg~L~~~l----~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~  165 (476)
T 2y94_A           93 MVMEYVSGGELFDYI----CKNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNM  165 (476)
T ss_dssp             EEEECCSSEEHHHHT----TSSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             EEEeCCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhh
Confidence            999999999999999    4456799999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCcccccccccccCccCccccccCCC-CccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhh
Q 018263          197 FPENTTHISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNL  275 (358)
Q Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                      .....  .....+|++.|+|||++.+..+ +.++||||||+++|+|++|+.||...........+               
T Consensus       166 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i---------------  228 (476)
T 2y94_A          166 MSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKI---------------  228 (476)
T ss_dssp             CCTTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHH---------------
T ss_pred             ccccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHH---------------
Confidence            54322  2334679999999999988765 68999999999999999999999755432111111               


Q ss_pred             hccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          276 VDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       276 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .+..  ...+...+..+.+||.+||+.||.+|||+.++++
T Consensus       229 ~~~~--~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          229 CDGI--FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             HTTC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hcCC--cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence            1110  1123334567899999999999999999999987

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=8.7e-43  Score=321.98  Aligned_cols=252  Identities=21%  Similarity=0.299  Sum_probs=191.7

Q ss_pred             HhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      ...++|++.+.||+|+||.||+|++. +++.||+|++....  ..+.+.+|+..+..+.  ||||+++++++...+..++
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~l  125 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLS--HPNIIKLKEIFETPTEISL  125 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCC--CTTBCCEEEEEECSSEEEE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCC--CCCCcceeeeEecCCeEEE
Confidence            34578999999999999999999986 58899999987543  3456778999999998  9999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcC---CCceEEeecccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ---NFNPKISDFGLS  194 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~---~~~~~l~Dfg~~  194 (358)
                      ||||+++++|.+++    ...+.+++..++.++.||+.||.|||+.   |++|+||+|+||+++.   ++.++|+|||++
T Consensus       126 v~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a  198 (349)
T 2w4o_A          126 VLELVTGGELFDRI----VEKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLS  198 (349)
T ss_dssp             EECCCCSCBHHHHH----TTCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC--
T ss_pred             EEEeCCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccc
Confidence            99999999999998    3456789999999999999999999999   9999999999999975   889999999999


Q ss_pred             cccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhh
Q 018263          195 KLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMN  274 (358)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                      .......  ......+++.|+|||++.+..++.++||||||+++|+|++|..||........  ....+...        
T Consensus       199 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~~i~~~--------  266 (349)
T 2w4o_A          199 KIVEHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--MFRRILNC--------  266 (349)
T ss_dssp             ----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--HHHHHHTT--------
T ss_pred             cccCccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--HHHHHHhC--------
Confidence            8653321  22345689999999999998999999999999999999999999975432211  11111000        


Q ss_pred             hhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          275 LVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                        ............+..+.+||.+||+.||.+|||+.++++
T Consensus       267 --~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          267 --EYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             --CCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --CCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              000111122345667999999999999999999999987

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.9e-43  Score=324.08  Aligned_cols=266  Identities=23%  Similarity=0.385  Sum_probs=214.9

Q ss_pred             HHHHhhcCCcccceecccCceEEEEEEECC------CCEEEEEEeeccC-hhhHHHHHHHHHHhhhc-ccCCCCceeeec
Q 018263           36 QLKIATNGFRWSNKIGEGGFGSVYKGRLQD------GTIVAVKVLSVES-KQGEKEFMSEVASMANV-NVCHENLVKLHG  107 (358)
Q Consensus        36 ~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~------~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~~~h~~i~~~~~  107 (358)
                      .+.+..++|++.+.||+|+||.||+|.+..      +..|++|.+.... ......+.+|+..++.+ .  ||||+++++
T Consensus        40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~--h~~iv~~~~  117 (333)
T 2i1m_A           40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ--HENIVNLLG  117 (333)
T ss_dssp             GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCC--CTTBCCEEE
T ss_pred             cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcC--CCCeeeEEE
Confidence            456678999999999999999999999642      2479999987543 34556788999999999 6  999999999


Q ss_pred             eEEcCCeeEEEEecCCCCCHHHHhhhccc----------cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCc
Q 018263          108 GCIDGPCRILVYDYMPNNSLSQTLLGEEK----------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSN  177 (358)
Q Consensus       108 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~----------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~N  177 (358)
                      ++...+..++||||+++++|.+++.....          ....+++..++.++.||+.||.|||+.   |++|+||+|+|
T Consensus       118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~N  194 (333)
T 2i1m_A          118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARN  194 (333)
T ss_dssp             EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccce
Confidence            99999999999999999999999954321          134689999999999999999999999   99999999999


Q ss_pred             EEEcCCCceEEeecccccccCCCCc-ccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCcccccc
Q 018263          178 ILLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG  255 (358)
Q Consensus       178 ilv~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~  255 (358)
                      |+++.++.++|+|||++........ .......++..|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus       195 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~  274 (333)
T 2i1m_A          195 VLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS  274 (333)
T ss_dssp             CEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH
T ss_pred             EEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH
Confidence            9999999999999999986533222 12233456788999999999899999999999999999998 999997543322


Q ss_pred             chhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCC
Q 018263          256 EYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGET  321 (358)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~  321 (358)
                      ..               ...+........+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus       275 ~~---------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  325 (333)
T 2i1m_A          275 KF---------------YKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA  325 (333)
T ss_dssp             HH---------------HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HH---------------HHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence            11               1111111222233344667999999999999999999999999998653

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.4e-43  Score=322.10  Aligned_cols=263  Identities=23%  Similarity=0.197  Sum_probs=205.8

Q ss_pred             CHHHHHHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc-----ChhhHHHHHHHHHHhhhcccCCCCceeee
Q 018263           33 SYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE-----SKQGEKEFMSEVASMANVNVCHENLVKLH  106 (358)
Q Consensus        33 ~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~~~h~~i~~~~  106 (358)
                      ...++....++|++.+.||+|+||.||+|.+. +++.||+|++...     .......+.+|+..++.++  ||||++++
T Consensus        17 q~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~   94 (345)
T 3hko_A           17 QGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH--HPNIARLY   94 (345)
T ss_dssp             CCBCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCC--CTTBCCEE
T ss_pred             cCchhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCC--CCCcceee
Confidence            34455667899999999999999999999975 6889999998643     2345578889999999998  99999999


Q ss_pred             ceEEcCCeeEEEEecCCCCCHHHHhhhccc------------------------------------cccCCCHHHHHHHH
Q 018263          107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEK------------------------------------RRAKFGWKARREII  150 (358)
Q Consensus       107 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~------------------------------------~~~~l~~~~~~~~~  150 (358)
                      +++...+..++||||+++++|.+++.....                                    ....+++..++.++
T Consensus        95 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  174 (345)
T 3hko_A           95 EVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIM  174 (345)
T ss_dssp             EEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHH
T ss_pred             hhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHH
Confidence            999999999999999999999999842111                                    12234678899999


Q ss_pred             HHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCC--ceEEeecccccccCCC---CcccccccccccCccCcccccc--C
Q 018263          151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF--NPKISDFGLSKLFPEN---TTHISTRVAGTLGYLAPEYAIS--G  223 (358)
Q Consensus       151 ~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~--~~~l~Dfg~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~--~  223 (358)
                      .||+.||+|||++   |++|+||+|+||+++.++  .++|+|||++......   .........+++.|+|||++.+  .
T Consensus       175 ~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  251 (345)
T 3hko_A          175 RQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNE  251 (345)
T ss_dssp             HHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSS
T ss_pred             HHHHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCC
Confidence            9999999999999   999999999999998776  8999999999864321   1122344678999999999875  6


Q ss_pred             CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccCC--CCCHHHHHHHHHHHhhccC
Q 018263          224 RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYG--NFPENEAIRFLKVGLLCVQ  301 (358)
Q Consensus       224 ~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~  301 (358)
                      .++.++||||||+++|+|++|+.||...........+.               ......  ......+..+.++|.+||+
T Consensus       252 ~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~li~~~l~  316 (345)
T 3hko_A          252 SYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVL---------------NKKLCFENPNYNVLSPLARDLLSNLLN  316 (345)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---------------HCCCCTTSGGGGGSCHHHHHHHHHHSC
T ss_pred             CCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHH---------------hcccccCCcccccCCHHHHHHHHHHcC
Confidence            78899999999999999999999997554322221111               111100  0111245678999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 018263          302 EKSKLRPQMSTAIK  315 (358)
Q Consensus       302 ~~P~~Rpt~~eil~  315 (358)
                      .||.+|||+.++++
T Consensus       317 ~~p~~Rps~~~~l~  330 (345)
T 3hko_A          317 RNVDERFDAMRALQ  330 (345)
T ss_dssp             SCTTTSCCHHHHHH
T ss_pred             CChhHCCCHHHHhc
Confidence            99999999999987

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-42  Score=316.59  Aligned_cols=271  Identities=25%  Similarity=0.355  Sum_probs=205.8

Q ss_pred             HHHHHHhhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC-
Q 018263           34 YNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG-  112 (358)
Q Consensus        34 ~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~-  112 (358)
                      ...-....++|++.+.||+|+||.||+|+.. ++.||+|++....   ......|.+.+......||||+++++++... 
T Consensus        29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~  104 (337)
T 3mdy_A           29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGT  104 (337)
T ss_dssp             HHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred             cccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence            3344455689999999999999999999986 8999999986432   2334455555555533499999999999877 


Q ss_pred             ---CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCcEEcCCCCCcEEEcCCC
Q 018263          113 ---PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI-----QPHVVHRDIKTSNILLDQNF  184 (358)
Q Consensus       113 ---~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~-----~~~i~H~di~p~Nilv~~~~  184 (358)
                         ...++||||+++++|.+++.     ...+++..++.++.|++.||+|||+..     ..|++|+||||+||+++.++
T Consensus       105 ~~~~~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~  179 (337)
T 3mdy_A          105 GSWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG  179 (337)
T ss_dssp             GGGCEEEEEECCCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred             CCCCceEEEEeccCCCcHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC
Confidence               78899999999999999993     346899999999999999999999641     23899999999999999999


Q ss_pred             ceEEeecccccccCCCCccc---ccccccccCccCccccccCCCCcc------CceecHHHHHHHHHhC----------C
Q 018263          185 NPKISDFGLSKLFPENTTHI---STRVAGTLGYLAPEYAISGRLTRK------SDVYSFGVLLLEIVSG----------R  245 (358)
Q Consensus       185 ~~~l~Dfg~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~s~~------sDiwslG~il~~lltg----------~  245 (358)
                      .+||+|||++..........   .....||+.|+|||++.+...+..      +||||||+++|+|++|          +
T Consensus       180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~  259 (337)
T 3mdy_A          180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ  259 (337)
T ss_dssp             CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence            99999999997654332221   123578999999999987766655      9999999999999999          4


Q ss_pred             CCCCccccccchhhhHhhhhccchhhHhh-hhccccCCCCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 018263          246 TAVDFDVQLGEYHLVDKAWGMYNSKELMN-LVDPMLYGNFP-----ENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNG  319 (358)
Q Consensus       246 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~  319 (358)
                      .||.........           ...... ..........+     ..++..+.+++.+||+.||.+|||+.+|++.|++
T Consensus       260 ~p~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  328 (337)
T 3mdy_A          260 LPYHDLVPSDPS-----------YEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK  328 (337)
T ss_dssp             CTTTTTSCSSCC-----------HHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             ccHhhhcCCCCc-----------hhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHH
Confidence            555432221111           011111 11112222233     2678889999999999999999999999999998


Q ss_pred             CCCCC
Q 018263          320 ETNID  324 (358)
Q Consensus       320 ~~~~~  324 (358)
                      +.+..
T Consensus       329 l~~~~  333 (337)
T 3mdy_A          329 MSESQ  333 (337)
T ss_dssp             HHHTT
T ss_pred             HHhhc
Confidence            87654

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=4.2e-43  Score=323.66  Aligned_cols=266  Identities=19%  Similarity=0.235  Sum_probs=200.5

Q ss_pred             hhcCCcccceecccCceEEEEEEEC----CCCEEEEEEeeccChh-----------hHHHHHHHHHHhhhcccCCCCcee
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ----DGTIVAVKVLSVESKQ-----------GEKEFMSEVASMANVNVCHENLVK  104 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~----~~~~vaiK~~~~~~~~-----------~~~~~~~e~~~l~~l~~~h~~i~~  104 (358)
                      ..++|++.+.||+|+||.||+|.+.    ++..||+|+.......           ....+.+|+..+..+.  ||||++
T Consensus        35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~--h~ni~~  112 (345)
T 2v62_A           35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLD--YLGIPL  112 (345)
T ss_dssp             TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCS--CCCCCC
T ss_pred             cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhcccc--ccCcce
Confidence            3578999999999999999999975    5788999998754321           1123556777788877  999999


Q ss_pred             eeceEEc----CCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEE
Q 018263          105 LHGGCID----GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL  180 (358)
Q Consensus       105 ~~~~~~~----~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv  180 (358)
                      +++++..    ....++||||+ +++|.+++    ...+.+++..++.++.||+.||+|||+.   |++|+||||+||++
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l----~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll  184 (345)
T 2v62_A          113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKIS----GQNGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLL  184 (345)
T ss_dssp             EEEEEEEESSSCEEEEEEEECE-EEEHHHHC----BGGGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred             eecccccccCCCcEEEEEEecc-CCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEE
Confidence            9999987    77889999999 99999999    3344899999999999999999999999   99999999999999


Q ss_pred             cCCC--ceEEeecccccccCCCCc------ccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccc
Q 018263          181 DQNF--NPKISDFGLSKLFPENTT------HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV  252 (358)
Q Consensus       181 ~~~~--~~~l~Dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~  252 (358)
                      +.++  .++|+|||++........      .......++..|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus       185 ~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~  264 (345)
T 2v62_A          185 GYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNL  264 (345)
T ss_dssp             ESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGT
T ss_pred             ccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence            8877  999999999976532211      11234578999999999999899999999999999999999999996432


Q ss_pred             cccchhhh-HhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCC
Q 018263          253 QLGEYHLV-DKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETN  322 (358)
Q Consensus       253 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~  322 (358)
                      ........ .................       ....+..+.+++.+||+.||.+|||+.+|++.|+....
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          265 KDPVAVQTAKTNLLDELPQSVLKWAP-------SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             TCHHHHHHHHHHHHHTTTHHHHHHSC-------TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             cccHHHHHHHHhhcccccHHHHhhcc-------ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            22111111 00000000111111000       11345679999999999999999999999999998764

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.8e-43  Score=324.42  Aligned_cols=267  Identities=22%  Similarity=0.299  Sum_probs=207.1

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC----
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP----  113 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~----  113 (358)
                      .++|++.+.||+|+||.||+|.+. +|+.||||.+...  .....+.+.+|+..++.++  ||||+++++++....    
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~l~~~~~~~~~~~~  101 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR--HENVIGLLDVFTPDETLDD  101 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC--BTTBCCCSEEECSCSSTTT
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCC--CcCCCCceeeEecCCcccc
Confidence            578999999999999999999975 6999999998543  3444567889999999998  999999999998653    


Q ss_pred             --eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeec
Q 018263          114 --CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF  191 (358)
Q Consensus       114 --~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Df  191 (358)
                        ..++||||+ +++|.+++.     ...+++..+..++.||+.||.|||+.   |++|+||||+||+++.++.+||+||
T Consensus       102 ~~~~~lv~e~~-~~~L~~~~~-----~~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Df  172 (367)
T 1cm8_A          102 FTDFYLVMPFM-GTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDF  172 (367)
T ss_dssp             CCCCEEEEECC-SEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred             CceEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEee
Confidence              459999999 889999983     35689999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchh
Q 018263          192 GLSKLFPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSK  270 (358)
Q Consensus       192 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      |++......    .....+|..|+|||++.+ ..++.++|||||||++|+|++|+.||......+....+....+.+...
T Consensus       173 g~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~  248 (367)
T 1cm8_A          173 GLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE  248 (367)
T ss_dssp             TTCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             ecccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence            999875332    234568999999999887 679999999999999999999999998776655554444333333222


Q ss_pred             hHhh--------hhccc---cC---CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhhcCCC
Q 018263          271 ELMN--------LVDPM---LY---GNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK--MMNGETN  322 (358)
Q Consensus       271 ~~~~--------~~~~~---~~---~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~--~L~~~~~  322 (358)
                      ....        .+...   ..   .......+..+.+|+.+||+.||.+|||+.++++  .++....
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~  316 (367)
T 1cm8_A          249 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD  316 (367)
T ss_dssp             HHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred             HHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence            1111        11100   00   1122345677999999999999999999999988  4655543

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3.4e-43  Score=335.26  Aligned_cols=250  Identities=25%  Similarity=0.312  Sum_probs=198.9

Q ss_pred             HhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCe
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC  114 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~  114 (358)
                      +..++|++.+.||+|+||.||+|+.. +|+.||+|++...   .......+..|+..++.+.  ||||+++++++...+.
T Consensus       145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~l~~~~~~~~~  222 (446)
T 4ejn_A          145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR--HPFLTALKYSFQTHDR  222 (446)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCS--CTTSCCEEEEEEETTE
T ss_pred             CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCC--CCeEeeEEEEEeeCCE
Confidence            34578999999999999999999975 6899999998753   2334456778899999887  9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcEEcCCCCCcEEEcCCCceEEeeccc
Q 018263          115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNILLDQNFNPKISDFGL  193 (358)
Q Consensus       115 ~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~  193 (358)
                      .++||||+++++|.+++    .....+++..+..++.||+.||+|||+ .   ||+||||||+||+++.++.++|+|||+
T Consensus       223 ~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~  295 (446)
T 4ejn_A          223 LCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGL  295 (446)
T ss_dssp             EEEEECCCSSCBHHHHH----HHHSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCC
T ss_pred             EEEEEeeCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCC
Confidence            99999999999999998    445679999999999999999999998 8   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHh
Q 018263          194 SKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELM  273 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      +....... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+.            
T Consensus       296 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~------------  362 (446)
T 4ejn_A          296 CKEGIKDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL------------  362 (446)
T ss_dssp             CCTTCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------------
T ss_pred             ceeccCCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHH------------
Confidence            97543222 22344679999999999999999999999999999999999999997544322111110            


Q ss_pred             hhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 018263          274 NLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRP-----QMSTAIK  315 (358)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp-----t~~eil~  315 (358)
                         ..  ...++...+..+.+||.+||+.||.+||     +++|+++
T Consensus       363 ---~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          363 ---ME--EIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             ---HC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ---hC--CCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence               00  1123444567799999999999999999     9999985

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.1e-42  Score=312.44  Aligned_cols=253  Identities=23%  Similarity=0.323  Sum_probs=201.8

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      .++|++.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+..++.++  ||||+++++++......++|
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~~~~lv   98 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLD--HPNIIKIFEVFEDYHNMYIV   98 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCC--CTTBCCEEEEEECSSEEEEE
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCC--CchHHhHHHheecCCeEEEE
Confidence            478999999999999999999975 68899999987553 345678889999999998  99999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEE---cCCCceEEeeccccc
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSK  195 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv---~~~~~~~l~Dfg~~~  195 (358)
                      |||+++++|.+.+.........+++..++.++.||+.||.|||+.   |++|+||+|+||++   +.++.++|+|||++.
T Consensus        99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~  175 (285)
T 3is5_A           99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAE  175 (285)
T ss_dssp             ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred             EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence            999999999999965545567899999999999999999999999   99999999999999   456789999999997


Q ss_pred             ccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhh
Q 018263          196 LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNL  275 (358)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                      ......  ......+++.|+|||++. ..++.++||||||+++|+|++|+.||..............             
T Consensus       176 ~~~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~-------------  239 (285)
T 3is5_A          176 LFKSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY-------------  239 (285)
T ss_dssp             C------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------------
T ss_pred             ecCCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhcc-------------
Confidence            654322  223456899999999875 5688999999999999999999999975432211111100             


Q ss_pred             hccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          276 VDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       276 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ..... .......+..+.+++.+||+.||.+|||+.|+++
T Consensus       240 ~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          240 KEPNY-AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             CCCCC-CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             CCccc-ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00000 0000113457889999999999999999999985

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2e-43  Score=323.10  Aligned_cols=257  Identities=24%  Similarity=0.390  Sum_probs=204.7

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCE----EEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCe
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTI----VAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC  114 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~----vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~  114 (358)
                      .++|++.+.||+|+||.||+|.+. +++.    |++|.+.... ......+.+|+..+..++  ||||+++++++. .+.
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~-~~~   88 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD--HAHIVRLLGLCP-GSS   88 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCC--CTTBCCEEEEEC-BSS
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCC--CCCcCeEEEEEc-CCc
Confidence            578999999999999999999965 4444    7777764332 223345678889999987  999999999886 456


Q ss_pred             eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccc
Q 018263          115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS  194 (358)
Q Consensus       115 ~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~  194 (358)
                      .++||||+++++|.+++..   ....+++..++.++.||+.||.|||+.   |++|+||||+||+++.++.++|+|||++
T Consensus        89 ~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a  162 (325)
T 3kex_A           89 LQLVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVA  162 (325)
T ss_dssp             EEEEEECCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGG
T ss_pred             cEEEEEeCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcc
Confidence            8899999999999999842   345789999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcc-cccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhH
Q 018263          195 KLFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKEL  272 (358)
Q Consensus       195 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      ......... ......++..|+|||++.+..++.++||||||+++|+|++ |..||.........               
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~---------------  227 (325)
T 3kex_A          163 DLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP---------------  227 (325)
T ss_dssp             GGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHH---------------
T ss_pred             cccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHH---------------
Confidence            876443322 2234567789999999999999999999999999999999 99999754432211               


Q ss_pred             hhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCC
Q 018263          273 MNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETN  322 (358)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~  322 (358)
                       ..+........+...+..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       228 -~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          228 -DLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             -HHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             -HHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence             1111212222333345568899999999999999999999999988753

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=8.5e-43  Score=312.63  Aligned_cols=248  Identities=23%  Similarity=0.331  Sum_probs=202.9

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeE
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI  116 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~  116 (358)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++...  .......+.+|+..+..+. .||||+++++++...+..+
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~-~h~~iv~~~~~~~~~~~~~   87 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLG-QHSHVVRYFSAWAEDDHML   87 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSC-SCTTBCCEEEEEEETTEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeeecCCeEE
Confidence            3578999999999999999999986 7999999998754  3345567888888888883 3999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCC-------------
Q 018263          117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN-------------  183 (358)
Q Consensus       117 iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~-------------  183 (358)
                      +||||+++++|.+++.........+++..++.++.||+.||.|||++   |++|+||+|+||+++.+             
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~  164 (289)
T 1x8b_A           88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDED  164 (289)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC---------------
T ss_pred             EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccc
Confidence            99999999999999965544447799999999999999999999999   99999999999999844             


Q ss_pred             ------CceEEeecccccccCCCCcccccccccccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCCCccccccc
Q 018263          184 ------FNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE  256 (358)
Q Consensus       184 ------~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~  256 (358)
                            ..++|+|||.+.......     ...++..|+|||++.+. .++.++||||||+++|+|++|.+++.....   
T Consensus       165 ~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---  236 (289)
T 1x8b_A          165 DWASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---  236 (289)
T ss_dssp             -----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---
T ss_pred             cccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---
Confidence                  479999999998754322     23588999999998765 567899999999999999999987643211   


Q ss_pred             hhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          257 YHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                                     ...+. .......+...+..+.+++.+||+.||.+|||+.++++
T Consensus       237 ---------------~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          237 ---------------WHEIR-QGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             ---------------HHHHH-TTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---------------HHHHH-cCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence                           11111 11112334445677999999999999999999999975

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=7.5e-44  Score=326.81  Aligned_cols=269  Identities=18%  Similarity=0.251  Sum_probs=199.4

Q ss_pred             ccCHHHHHHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceE
Q 018263           31 AFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGC  109 (358)
Q Consensus        31 ~~~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~  109 (358)
                      ++....+.+...+|++.+.||+|+||.||+|++. +++.||+|++..........+.+|+..+..+. .||||+++++++
T Consensus        17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-~h~~iv~~~~~~   95 (337)
T 3ll6_A           17 DFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLS-GHPNIVQFCSAA   95 (337)
T ss_dssp             SSTTCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHT-TSTTBCCEEEEE
T ss_pred             HhhcceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhc-cCCChhhccccc
Confidence            4444555667789999999999999999999975 68999999987777677778889999999985 499999999998


Q ss_pred             E--------cCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCC--cEEcCCCCCcEE
Q 018263          110 I--------DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH--VVHRDIKTSNIL  179 (358)
Q Consensus       110 ~--------~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~--i~H~di~p~Nil  179 (358)
                      .        .....+++|||++ ++|.+++... .....+++..++.++.||+.||.|||+.   |  ++|+||||+||+
T Consensus        96 ~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl  170 (337)
T 3ll6_A           96 SIGKEESDTGQAEFLLLTELCK-GQLVEFLKKM-ESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLL  170 (337)
T ss_dssp             EECTTTSTTSSEEEEEEEECCS-EEHHHHHHHH-HTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCE
T ss_pred             cccccccccCCceEEEEEEecC-CCHHHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEE
Confidence            4        3445789999995 7898888442 2345699999999999999999999999   8  999999999999


Q ss_pred             EcCCCceEEeecccccccCCCCccc-----------ccccccccCccCcccc---ccCCCCccCceecHHHHHHHHHhCC
Q 018263          180 LDQNFNPKISDFGLSKLFPENTTHI-----------STRVAGTLGYLAPEYA---ISGRLTRKSDVYSFGVLLLEIVSGR  245 (358)
Q Consensus       180 v~~~~~~~l~Dfg~~~~~~~~~~~~-----------~~~~~~~~~y~aPE~~---~~~~~s~~sDiwslG~il~~lltg~  245 (358)
                      ++.++.++|+|||++..........           .....+++.|+|||++   .+..++.++||||||+++|+|++|+
T Consensus       171 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~  250 (337)
T 3ll6_A          171 LSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ  250 (337)
T ss_dssp             ECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSS
T ss_pred             ECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCC
Confidence            9999999999999998754322211           1134588999999988   4667899999999999999999999


Q ss_pred             CCCCccccccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCC
Q 018263          246 TAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNID  324 (358)
Q Consensus       246 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~  324 (358)
                      .||........                   +............+..+.+++.+||+.||.+|||+.|+++.|+.+....
T Consensus       251 ~p~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~  310 (337)
T 3ll6_A          251 HPFEDGAKLRI-------------------VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR  310 (337)
T ss_dssp             CCC-------------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             CCCcchhHHHh-------------------hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence            99974332110                   0111111111222345789999999999999999999999999887654

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=3.1e-43  Score=322.45  Aligned_cols=267  Identities=20%  Similarity=0.310  Sum_probs=199.6

Q ss_pred             HHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccCh--hhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCe
Q 018263           38 KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK--QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC  114 (358)
Q Consensus        38 ~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~  114 (358)
                      ....++|++.+.||+|+||.||+|.+. +++.||+|++.....  .....+.+|+..++.++  ||||+++++++.....
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~  107 (329)
T 3gbz_A           30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQ--HRNIIELKSVIHHNHR  107 (329)
T ss_dssp             --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCC--CTTBCCEEEEEEETTE
T ss_pred             ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcC--CCCcceEEEEEecCCE
Confidence            445679999999999999999999865 689999999865432  23456778999999998  9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEc-----CCCceEEe
Q 018263          115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD-----QNFNPKIS  189 (358)
Q Consensus       115 ~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~-----~~~~~~l~  189 (358)
                      .++||||++ ++|.+++    .....+++..++.++.||+.||.|||++   ||+|+||||+||+++     .++.++|+
T Consensus       108 ~~lv~e~~~-~~L~~~~----~~~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~  179 (329)
T 3gbz_A          108 LHLIFEYAE-NDLKKYM----DKNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIG  179 (329)
T ss_dssp             EEEEEECCS-EEHHHHH----HHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEEC
T ss_pred             EEEEEecCC-CCHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEEC
Confidence            999999997 5999998    3455699999999999999999999999   999999999999994     55569999


Q ss_pred             ecccccccCCCCcccccccccccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccc
Q 018263          190 DFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYN  268 (358)
Q Consensus       190 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  268 (358)
                      |||++........ ......++..|+|||++.+. .++.++||||||+++|+|++|+.||...........+....+.+.
T Consensus       180 Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  258 (329)
T 3gbz_A          180 DFGLARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPD  258 (329)
T ss_dssp             CTTHHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             cCCCccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCc
Confidence            9999986543222 22335679999999998874 489999999999999999999999987655444433333222222


Q ss_pred             hhhHhhhhc------c--ccCC-----CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          269 SKELMNLVD------P--MLYG-----NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       269 ~~~~~~~~~------~--~~~~-----~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ...+.....      .  ....     ..+...+..+.+||.+||+.||.+|||+.|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            111111000      0  0000     001124567899999999999999999999986

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.6e-43  Score=320.02  Aligned_cols=263  Identities=25%  Similarity=0.422  Sum_probs=207.7

Q ss_pred             HHhhcCCcccceecccCceEEEEEEECC-----CCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEc
Q 018263           38 KIATNGFRWSNKIGEGGFGSVYKGRLQD-----GTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID  111 (358)
Q Consensus        38 ~~~~~~y~i~~~lg~g~~g~v~~~~~~~-----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~  111 (358)
                      .+..++|++.+.||+|+||.||+|....     +..||+|.+... .......+.+|+..+..++  ||||+++++++..
T Consensus        40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~  117 (333)
T 1mqb_A           40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS--HHNIIRLEGVISK  117 (333)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCC--CTTBCCEEEEECS
T ss_pred             cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCC--CCCCCcEEEEEec
Confidence            3456789999999999999999998642     245999998754 3345567889999999998  9999999999999


Q ss_pred             CCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeec
Q 018263          112 GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF  191 (358)
Q Consensus       112 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Df  191 (358)
                      .+..++||||+++++|.+++..   ....+++..++.++.||+.||.|||++   |++|+||+|+||+++.++.++|+||
T Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Df  191 (333)
T 1mqb_A          118 YKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDF  191 (333)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred             CCCcEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCC
Confidence            9999999999999999999842   346789999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcc--cccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccc
Q 018263          192 GLSKLFPENTTH--ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYN  268 (358)
Q Consensus       192 g~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~  268 (358)
                      |++.........  ......++..|+|||++.+..++.++||||||+++|+|++ |+.||........            
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~------------  259 (333)
T 1mqb_A          192 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV------------  259 (333)
T ss_dssp             CC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------------
T ss_pred             CcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHH------------
Confidence            999875432221  1122345678999999998899999999999999999999 9999964432111            


Q ss_pred             hhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCC
Q 018263          269 SKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNID  324 (358)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~  324 (358)
                          ...+........+...+..+.+++.+||+.+|.+||++.++++.|+.+....
T Consensus       260 ----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  311 (333)
T 1mqb_A          260 ----MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  311 (333)
T ss_dssp             ----HHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             ----HHHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence                1111111122233456678999999999999999999999999999876433

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.3e-43  Score=321.22  Aligned_cols=258  Identities=25%  Similarity=0.375  Sum_probs=204.6

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCE----EEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCe
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTI----VAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC  114 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~----vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~  114 (358)
                      .++|++.+.||+|+||.||+|.+. +++.    |++|.+... .......+.+|+..++.++  ||||+++++++.... 
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~-   90 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD--NPHVCRLLGICLTST-   90 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCC--BTTBCCCCEEEESSS-
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCC--CCCeeEEEEEEecCC-
Confidence            578999999999999999999964 4544    577766433 3456678899999999998  999999999998765 


Q ss_pred             eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccc
Q 018263          115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS  194 (358)
Q Consensus       115 ~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~  194 (358)
                      .+++++++++++|.+++..   ....+++..++.++.||+.||.|||++   |++|+||||+||+++.++.++|+|||++
T Consensus        91 ~~~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a  164 (327)
T 3lzb_A           91 VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA  164 (327)
T ss_dssp             EEEEECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred             ceEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcce
Confidence            7889999999999999843   345689999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCc-ccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhH
Q 018263          195 KLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKEL  272 (358)
Q Consensus       195 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      ........ .......++..|+|||++.+..++.++||||||+++|+|++ |..||.......                .
T Consensus       165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~----------------~  228 (327)
T 3lzb_A          165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------------I  228 (327)
T ss_dssp             ---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----------------H
T ss_pred             eEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH----------------H
Confidence            87543222 22223456778999999999999999999999999999999 999997554322                1


Q ss_pred             hhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCC
Q 018263          273 MNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNI  323 (358)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~  323 (358)
                      ...+........+...+..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus       229 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          229 SSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             HHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            122222222333445667899999999999999999999999999987643

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.7e-43  Score=323.48  Aligned_cols=272  Identities=22%  Similarity=0.339  Sum_probs=206.0

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhh-HHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQG-EKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++....... ...+.+|+..++.++  ||||+++++++...+..++||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~   79 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLK--HANIVTLHDIIHTEKSLTLVF   79 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCC--CTTBCCEEEEEECSSCEEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcC--CCCCCeeeeEEeeCCEEEEEe
Confidence            68999999999999999999976 68999999986543221 123456899999998  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      ||++ ++|.+++..   ....+++..++.++.||+.||.|||+.   |++|+||+|+||+++.++.++|+|||++.....
T Consensus        80 e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  152 (324)
T 3mtl_A           80 EYLD-KDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSI  152 (324)
T ss_dssp             ECCS-EEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred             cccc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence            9996 588888832   345689999999999999999999999   999999999999999999999999999976533


Q ss_pred             CCcccccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhcc
Q 018263          200 NTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDP  278 (358)
Q Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (358)
                      ... ......++..|+|||++.+ ..++.++||||||+++|+|++|+.||......+....+....+.+....+......
T Consensus       153 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  231 (324)
T 3mtl_A          153 PTK-TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN  231 (324)
T ss_dssp             -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred             Ccc-ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence            222 2233567999999999876 56899999999999999999999999877665555444444333332222221111


Q ss_pred             ---------ccCC----CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhhcCCCC
Q 018263          279 ---------MLYG----NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK--MMNGETNI  323 (358)
Q Consensus       279 ---------~~~~----~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~--~L~~~~~~  323 (358)
                               ....    ......+..+.+|+.+||+.||.+|||+.|+++  .+.+..+.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  291 (324)
T 3mtl_A          232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER  291 (324)
T ss_dssp             HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred             hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence                     0000    001134567899999999999999999999987  55555443

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=9.8e-43  Score=315.45  Aligned_cols=258  Identities=22%  Similarity=0.360  Sum_probs=208.3

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      ..++|++.+.||+|+||.||+|+.. +|+.||+|++..........+.+|+..++.++  ||||+++++++...+..++|
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv   84 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIK--HENIVTLEDIYESTTHYYLV   84 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCC--CTTBCCEEEEEECSSEEEEE
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCC--CCCeeehhhhcccCCEEEEE
Confidence            4578999999999999999999976 69999999998665555667889999999998  99999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEE---cCCCceEEeeccccc
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSK  195 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv---~~~~~~~l~Dfg~~~  195 (358)
                      |||+++++|.+.+    ...+.+++..++.++.||+.||.|||+.   |++|+||+|+||++   +.++.++|+|||++.
T Consensus        85 ~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~  157 (304)
T 2jam_A           85 MQLVSGGELFDRI----LERGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSK  157 (304)
T ss_dssp             ECCCCSCBHHHHH----HHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred             EEcCCCccHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence            9999999999998    3446789999999999999999999999   99999999999999   788899999999987


Q ss_pred             ccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhh
Q 018263          196 LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNL  275 (358)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                      .....   ......+++.|+|||++.+..++.++||||||+++|+|++|..||...........+....           
T Consensus       158 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~-----------  223 (304)
T 2jam_A          158 MEQNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGY-----------  223 (304)
T ss_dssp             CCCCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCC-----------
T ss_pred             ecCCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-----------
Confidence            54322   2233568999999999998899999999999999999999999997543321111111000           


Q ss_pred             hccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhhcCCC
Q 018263          276 VDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK--MMNGETN  322 (358)
Q Consensus       276 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~--~L~~~~~  322 (358)
                        ...........+..+.+++.+||+.||.+|||+.++++  .+.+...
T Consensus       224 --~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  270 (304)
T 2jam_A          224 --YEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTA  270 (304)
T ss_dssp             --CCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSCS
T ss_pred             --CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCCc
Confidence              00111122345667999999999999999999999986  4555443

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=3.7e-43  Score=319.34  Aligned_cols=261  Identities=23%  Similarity=0.290  Sum_probs=198.8

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCe-
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC-  114 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~-  114 (358)
                      ..++|++.+.||+|+||.||+|++. +++.||+|++....   ......+.+|+..+..++  ||||+++++++..... 
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~~~   87 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN--HPAIVAVYDTGEAETPA   87 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCC--CTTBCCEEEEEEEEETT
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCC--CCCcceEEEeeeccCCC
Confidence            3579999999999999999999974 68999999997542   334467888999999987  9999999999876543 


Q ss_pred             ---eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeec
Q 018263          115 ---RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF  191 (358)
Q Consensus       115 ---~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Df  191 (358)
                         .++||||++|++|.+++    ...+.+++..++.++.||+.||+|||++   |++|+||||+||+++.++.++|+||
T Consensus        88 ~~~~~lv~e~~~g~~L~~~l----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Df  160 (311)
T 3ork_A           88 GPLPYIVMEYVDGVTLRDIV----HTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDF  160 (311)
T ss_dssp             EEEEEEEEECCCEEEHHHHH----HHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCC
T ss_pred             CcccEEEEecCCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeec
Confidence               39999999999999999    3456799999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCc--ccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccch
Q 018263          192 GLSKLFPENTT--HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNS  269 (358)
Q Consensus       192 g~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      |++........  .......|++.|+|||++.+..++.++||||||+++|+|++|+.||.............  ......
T Consensus       161 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~--~~~~~~  238 (311)
T 3ork_A          161 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV--REDPIP  238 (311)
T ss_dssp             SCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH--HCCCCC
T ss_pred             cCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh--cCCCCC
Confidence            99986543222  22233568999999999999999999999999999999999999997554322111110  000000


Q ss_pred             hhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCH-HHHHHHhhcCCC
Q 018263          270 KELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQM-STAIKMMNGETN  322 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~-~eil~~L~~~~~  322 (358)
                      .           .......+..+.+++.+||+.||.+||++ +++.+.|.....
T Consensus       239 ~-----------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  281 (311)
T 3ork_A          239 P-----------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  281 (311)
T ss_dssp             H-----------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred             c-----------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence            0           00011245678999999999999999964 455566665543

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=4.5e-43  Score=325.75  Aligned_cols=271  Identities=19%  Similarity=0.250  Sum_probs=206.7

Q ss_pred             HhhcCCcccceecccCceEEEEEEECC------CCEEEEEEeeccChhhH-----------HHHHHHHHHhhhcccCCCC
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQD------GTIVAVKVLSVESKQGE-----------KEFMSEVASMANVNVCHEN  101 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~~------~~~vaiK~~~~~~~~~~-----------~~~~~e~~~l~~l~~~h~~  101 (358)
                      +..++|++.+.||+|+||.||+|.+..      ++.||+|++........           .....++..+..+.  |||
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~--h~~  109 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLK--YLG  109 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCS--CCC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhcc--CCC
Confidence            346799999999999999999998754      47899999875432211           12233444555665  999


Q ss_pred             ceeeeceEEcC----CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCc
Q 018263          102 LVKLHGGCIDG----PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSN  177 (358)
Q Consensus       102 i~~~~~~~~~~----~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~N  177 (358)
                      |+++++++...    ...++||||+ |++|.+++..   ....+++..++.++.||+.||+|||++   ||+||||||+|
T Consensus       110 iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~N  182 (364)
T 3op5_A          110 VPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASN  182 (364)
T ss_dssp             SCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGG
T ss_pred             CCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHH
Confidence            99999998764    4579999999 9999999942   346799999999999999999999999   99999999999


Q ss_pred             EEEc--CCCceEEeecccccccCCCCcc------cccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCC
Q 018263          178 ILLD--QNFNPKISDFGLSKLFPENTTH------ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVD  249 (358)
Q Consensus       178 ilv~--~~~~~~l~Dfg~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~  249 (358)
                      |+++  .++.++|+|||++.........      ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.
T Consensus       183 ill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~  262 (364)
T 3op5_A          183 LLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWE  262 (364)
T ss_dssp             EEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred             EEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            9999  8899999999999765322111      1123459999999999999899999999999999999999999998


Q ss_pred             ccccccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCC
Q 018263          250 FDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNID  324 (358)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~  324 (358)
                      ...............   .......+++..+.   ....+..+.+++..||+.+|.+||++.+|++.|+.+....
T Consensus       263 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~  331 (364)
T 3op5_A          263 DNLKDPKYVRDSKIR---YRENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI  331 (364)
T ss_dssp             GGTTCHHHHHHHHHH---HHHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             ccccCHHHHHHHHHH---hhhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence            644332222111111   12223333333321   1233567899999999999999999999999998776443

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.3e-42  Score=324.91  Aligned_cols=267  Identities=19%  Similarity=0.281  Sum_probs=208.1

Q ss_pred             HHHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC---
Q 018263           37 LKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG---  112 (358)
Q Consensus        37 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~---  112 (358)
                      +....++|++.+.||+|+||.||+|.+. +|+.||+|++......    ..+|+.+++.++  ||||+++++++...   
T Consensus         2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~--hpnIv~l~~~~~~~~~~   75 (383)
T 3eb0_A            2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLD--HVNIIKLVDYFYTTGDE   75 (383)
T ss_dssp             ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCC--CTTBCCEEEEEEEC---
T ss_pred             CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcC--CCCccchhheeeecCcc
Confidence            3456789999999999999999999874 7999999998654322    236899999998  99999999998543   


Q ss_pred             -----------------------------------CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHH
Q 018263          113 -----------------------------------PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL  157 (358)
Q Consensus       113 -----------------------------------~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL  157 (358)
                                                         ...++||||++ ++|.+.+.........+++..++.++.||+.||
T Consensus        76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL  154 (383)
T 3eb0_A           76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV  154 (383)
T ss_dssp             ----------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence                                               34789999997 588888865445667899999999999999999


Q ss_pred             HHHhcCCCCCcEEcCCCCCcEEEc-CCCceEEeecccccccCCCCcccccccccccCccCccccccC-CCCccCceecHH
Q 018263          158 AYIHEEIQPHVVHRDIKTSNILLD-QNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFG  235 (358)
Q Consensus       158 ~~LH~~~~~~i~H~di~p~Nilv~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG  235 (358)
                      +|||++   ||+|+||||+||+++ .++.++|+|||++........  .....++..|+|||++.+. .++.++||||+|
T Consensus       155 ~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG  229 (383)
T 3eb0_A          155 GFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIG  229 (383)
T ss_dssp             HHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHH
T ss_pred             HHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHH
Confidence            999999   999999999999997 688999999999986543322  2345678999999988765 489999999999


Q ss_pred             HHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccc------------cCCCCCHHHHHHHHHHHhhccCCC
Q 018263          236 VLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPM------------LYGNFPENEAIRFLKVGLLCVQEK  303 (358)
Q Consensus       236 ~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~l~~li~~~l~~~  303 (358)
                      |++|+|++|+.||......+....+....+.+....+...-...            ....++...+..+.+|+.+||+.|
T Consensus       230 ~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  309 (383)
T 3eb0_A          230 CVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE  309 (383)
T ss_dssp             HHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred             HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence            99999999999998876665555554444444333332211100            001123345667999999999999


Q ss_pred             CCCCCCHHHHHH
Q 018263          304 SKLRPQMSTAIK  315 (358)
Q Consensus       304 P~~Rpt~~eil~  315 (358)
                      |.+|||+.|+++
T Consensus       310 P~~R~t~~e~l~  321 (383)
T 3eb0_A          310 PDLRINPYEAMA  321 (383)
T ss_dssp             GGGSCCHHHHHT
T ss_pred             hhhCCCHHHHhc
Confidence            999999999974

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=8.3e-43  Score=319.80  Aligned_cols=265  Identities=23%  Similarity=0.359  Sum_probs=204.7

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC--hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      .++|++.+.||+|+||.||+|++. +|+.||+|++....  ......+.+|+..++.++  ||||+++++++...+..++
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~l  101 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR--HENLVNLLEVCKKKKRWYL  101 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCC--CTTBCCEEEEEEETTEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCC--CCCEeeEEEEeecCCEEEE
Confidence            478999999999999999999976 58999999986443  334566788999999998  9999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      ||||+++++|.++.    .....+++..++.++.||+.||.|||+.   |++|+||+|+||+++.++.++|+|||++...
T Consensus       102 v~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  174 (331)
T 4aaa_A          102 VFEFVDHTILDDLE----LFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL  174 (331)
T ss_dssp             EEECCSEEHHHHHH----HSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             EEecCCcchHHHHH----hhccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceee
Confidence            99999998888886    3456799999999999999999999999   9999999999999999999999999999765


Q ss_pred             CCCCcccccccccccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHh---
Q 018263          198 PENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELM---  273 (358)
Q Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---  273 (358)
                      ..... ......++..|+|||++.+. .++.++||||||+++|+|++|+.||...........+....+........   
T Consensus       175 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (331)
T 4aaa_A          175 AAPGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFN  253 (331)
T ss_dssp             ----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHH
T ss_pred             cCCcc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhh
Confidence            43222 22345689999999998775 78999999999999999999999998765544333332222111111100   


Q ss_pred             ------hhhccccCCCCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          274 ------NLVDPMLYGNFP-----ENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       274 ------~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                            ....+......+     ...+..+.+|+.+||+.||.+|||+.|+++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             HCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             hccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                  000011111111     134667999999999999999999999875

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.6e-42  Score=322.82  Aligned_cols=251  Identities=21%  Similarity=0.274  Sum_probs=200.4

Q ss_pred             cCCcc--cceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           42 NGFRW--SNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        42 ~~y~i--~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      +.|.+  .+.||+|+||.||+|... +|+.||+|++..........+.+|+..++.++  ||||+++++++...+..++|
T Consensus        87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~~~~~lv  164 (373)
T 2x4f_A           87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLD--HANLIQLYDAFESKNDIVLV  164 (373)
T ss_dssp             GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCC--CTTBCCEEEEEECSSEEEEE
T ss_pred             cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCC--CCCCCeEEEEEEECCEEEEE
Confidence            34444  567999999999999975 69999999998776667778999999999998  99999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEE--cCCCceEEeecccccc
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL--DQNFNPKISDFGLSKL  196 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv--~~~~~~~l~Dfg~~~~  196 (358)
                      |||+++++|.+.+..   ....+++..++.++.||+.||.|||+.   ||+|+||||+||++  +.++.++|+|||++..
T Consensus       165 ~E~~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~  238 (373)
T 2x4f_A          165 MEYVDGGELFDRIID---ESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARR  238 (373)
T ss_dssp             EECCTTCEEHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEE
T ss_pred             EeCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCcee
Confidence            999999999998842   345689999999999999999999999   99999999999999  5677899999999987


Q ss_pred             cCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhh
Q 018263          197 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV  276 (358)
Q Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                      ......  .....+|+.|+|||++.+..++.++||||||+++|+|++|..||...........+....  +.        
T Consensus       239 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~--~~--------  306 (373)
T 2x4f_A          239 YKPREK--LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACR--WD--------  306 (373)
T ss_dssp             CCTTCB--CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC--CC--------
T ss_pred             cCCccc--cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--CC--------
Confidence            643322  233568999999999988889999999999999999999999997654332221111100  00        


Q ss_pred             ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          277 DPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       277 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                         .........+..+.+||.+||+.||.+|||+.|+++
T Consensus       307 ---~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          307 ---LEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             ---SCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ---CChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence               000011234567899999999999999999999987

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=7e-43  Score=334.21  Aligned_cols=265  Identities=17%  Similarity=0.258  Sum_probs=190.6

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC-----
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG-----  112 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~-----  112 (358)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++...  .....+.+.+|+.+++.++  ||||+++++++...     
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~~  129 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLN--HDHVVKVLDIVIPKDVEKF  129 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCC--CTTBCCEEEECCCSCTTTC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCC--CCCCCceEEEEecCCcccC
Confidence            478999999999999999999876 6899999998643  3445578889999999998  99999999998543     


Q ss_pred             CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecc
Q 018263          113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG  192 (358)
Q Consensus       113 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg  192 (358)
                      ...|+|||++ +++|.+++    .....+++..++.++.||+.||.|||+.   ||+||||||+||+++.++.+||+|||
T Consensus       130 ~~~~lv~e~~-~~~L~~~~----~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFG  201 (458)
T 3rp9_A          130 DELYVVLEIA-DSDFKKLF----RTPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFG  201 (458)
T ss_dssp             CCEEEEECCC-SEEHHHHH----HSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred             ceEEEEEecc-ccchhhhc----ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccc
Confidence            5689999998 57899988    4556799999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCc--------------------------ccccccccccCccCccccc-cCCCCccCceecHHHHHHHHHh--
Q 018263          193 LSKLFPENTT--------------------------HISTRVAGTLGYLAPEYAI-SGRLTRKSDVYSFGVLLLEIVS--  243 (358)
Q Consensus       193 ~~~~~~~~~~--------------------------~~~~~~~~~~~y~aPE~~~-~~~~s~~sDiwslG~il~~llt--  243 (358)
                      ++........                          .......+|+.|+|||++. +..++.++|||||||++|+|++  
T Consensus       202 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~  281 (458)
T 3rp9_A          202 LARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI  281 (458)
T ss_dssp             TCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred             cchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhc
Confidence            9987542211                          1223457899999999764 5679999999999999999999  


Q ss_pred             ---------CCCCCCcccc--------------------ccchhhhHhhhhccchhhHhh--------hhccccCC----
Q 018263          244 ---------GRTAVDFDVQ--------------------LGEYHLVDKAWGMYNSKELMN--------LVDPMLYG----  282 (358)
Q Consensus       244 ---------g~~pf~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~----  282 (358)
                               |+++|.+...                    .+....+....+.+....+..        .+......    
T Consensus       282 ~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  361 (458)
T 3rp9_A          282 KENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTD  361 (458)
T ss_dssp             TTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCC
T ss_pred             cccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCC
Confidence                     6666655431                    111122222222222221111        11110000    


Q ss_pred             --CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          283 --NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       283 --~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                        ...+..+..+.+||.+||+.||.+|||++|+++
T Consensus       362 ~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~  396 (458)
T 3rp9_A          362 LAERFPASSADAIHLLKRMLVFNPNKRITINECLA  396 (458)
T ss_dssp             GGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence              011234677899999999999999999999987

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=4e-43  Score=321.11  Aligned_cols=253  Identities=23%  Similarity=0.289  Sum_probs=182.0

Q ss_pred             cCCccc---ceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           42 NGFRWS---NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        42 ~~y~i~---~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      ++|.+.   +.||+|+||.||+|.+. +++.||+|++...   ......+|+..++.+. .||||+++++++.+....++
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~-~h~niv~~~~~~~~~~~~~l   83 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCE-GHPNIVKLHEVFHDQLHTFL   83 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTT-TCTTBCCEEEEEECSSEEEE
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhc-CCCCeeEEEEEEEcCCEEEE
Confidence            345554   78999999999999976 6899999998643   4456778999988886 59999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCC---ceEEeecccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF---NPKISDFGLS  194 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~---~~~l~Dfg~~  194 (358)
                      ||||+++++|.+++    .....+++..++.++.||+.||.|||++   |++|+||+|+||+++.++   .++|+|||++
T Consensus        84 v~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a  156 (325)
T 3kn6_A           84 VMELLNGGELFERI----KKKKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFA  156 (325)
T ss_dssp             EECCCCSCBHHHHH----HHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTC
T ss_pred             EEEccCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccc
Confidence            99999999999999    3456799999999999999999999999   999999999999997765   7999999999


Q ss_pred             cccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhh
Q 018263          195 KLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMN  274 (358)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                      ........ ......+|+.|+|||++.+..++.++||||||+++|+|++|+.||.............         +...
T Consensus       157 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~---------~~~~  226 (325)
T 3kn6_A          157 RLKPPDNQ-PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAV---------EIMK  226 (325)
T ss_dssp             EECCC-----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHH---------HHHH
T ss_pred             eecCCCCC-cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHH---------HHHH
Confidence            86543322 2234568999999999999999999999999999999999999997654321111110         0011


Q ss_pred             hhccccCCCC---CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          275 LVDPMLYGNF---PENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       275 ~~~~~~~~~~---~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .+........   ....+..+.+||.+||+.||.+|||+.++++
T Consensus       227 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          227 KIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             HHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             HHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            1111000000   1234667999999999999999999999873

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.8e-42  Score=309.53  Aligned_cols=249  Identities=25%  Similarity=0.381  Sum_probs=185.9

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI  116 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~  116 (358)
                      .++|++.+.||+|+||.||+|++. +|+.||+|++....   ......+.+|+..+..++  ||||+++++++...+..+
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~   87 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK--HPSILELYNYFEDSNYVY   87 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBC--CTTBCCEEEEEECSSEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCC--CCCeEeEEEEEccCCeEE
Confidence            478999999999999999999974 79999999986442   223467889999999998  999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       117 iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      +||||+++++|.+++..   ....+++..++.++.|++.||.|||++   |++|+||+|+||+++.++.++|+|||++..
T Consensus        88 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~  161 (278)
T 3cok_A           88 LVLEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQ  161 (278)
T ss_dssp             EEEECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceee
Confidence            99999999999999832   336789999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhh
Q 018263          197 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV  276 (358)
Q Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                      ...... ......+++.|+|||++.+..++.++||||||+++|+|++|+.||............               .
T Consensus       162 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---------------~  225 (278)
T 3cok_A          162 LKMPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV---------------V  225 (278)
T ss_dssp             CC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C---------------C
T ss_pred             ccCCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH---------------h
Confidence            543222 122356889999999998888999999999999999999999999755432211110               0


Q ss_pred             ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          277 DPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       277 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ..  ....+...+..+.+++.+||+.||.+|||+.++++
T Consensus       226 ~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          226 LA--DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             SS--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hc--ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            00  01123345667899999999999999999999986

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.1e-42  Score=320.20  Aligned_cols=253  Identities=21%  Similarity=0.297  Sum_probs=201.7

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      ..++|++.+.||+|+||.||+|.++ +|+.||+|++......    ..+|++.+..+. .||||+++++++.+....++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~-~hp~iv~~~~~~~~~~~~~lv   94 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYG-QHPNIITLKDVYDDGKYVYVV   94 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHT-TSTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhc-CCCCcCeEEEEEEcCCEEEEE
Confidence            4678999999999999999999976 6889999999754332    235777777763 499999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCC----CceEEeecccc
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN----FNPKISDFGLS  194 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~----~~~~l~Dfg~~  194 (358)
                      |||++|++|.+.+    ...+.+++..++.++.||+.||+|||++   ||+||||||+||++.++    +.++|+|||++
T Consensus        95 ~E~~~gg~L~~~i----~~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a  167 (342)
T 2qr7_A           95 TELMKGGELLDKI----LRQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFA  167 (342)
T ss_dssp             ECCCCSCBHHHHH----HTCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred             EeCCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence            9999999999998    3456799999999999999999999999   99999999999998543    34999999999


Q ss_pred             cccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhh
Q 018263          195 KLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMN  274 (358)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                      ........ ......+|+.|+|||++.+..++.++||||||+++|+|++|..||..............+...        
T Consensus       168 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~--------  238 (342)
T 2qr7_A          168 KQLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG--------  238 (342)
T ss_dssp             EECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHC--------
T ss_pred             ccCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccC--------
Confidence            86543322 223457899999999998888999999999999999999999999754322222222211100        


Q ss_pred             hhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          275 LVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                        ............+..+.+||.+||+.||.+|||+.++++
T Consensus       239 --~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          239 --KFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             --CCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             --CcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence              000111222345677999999999999999999999875

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=3.4e-42  Score=310.25  Aligned_cols=266  Identities=21%  Similarity=0.266  Sum_probs=204.9

Q ss_pred             hhcCCcccceecccCceEEEEEEE-CCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeec-eEEcCCeeEE
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRL-QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG-GCIDGPCRIL  117 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~-~~~~~~~~~i  117 (358)
                      ..++|++.+.||+|+||.||+|++ .+++.||+|++......  ..+..|+..+..+.  |++++..+. ++......++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~--~~~~i~~~~~~~~~~~~~~l   82 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQ--GGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHT--TSTTCCCEEEEEEETTEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhc--CCCCCCeeeeecCCCCceEE
Confidence            458999999999999999999997 46899999987544322  34678889999887  666555554 4567788899


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEE---cCCCceEEeecccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLS  194 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv---~~~~~~~l~Dfg~~  194 (358)
                      ||||+ +++|.+++..   ....+++..++.++.||+.||.|||++   |++|+||||+||++   +.++.++|+|||++
T Consensus        83 v~e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a  155 (296)
T 4hgt_A           83 VMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA  155 (296)
T ss_dssp             EEECC-CCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTC
T ss_pred             EEEcc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccc
Confidence            99999 9999999832   345689999999999999999999999   99999999999999   78899999999999


Q ss_pred             cccCCCCc------ccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccc
Q 018263          195 KLFPENTT------HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYN  268 (358)
Q Consensus       195 ~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  268 (358)
                      ........      .......+++.|+|||++.+..++.++||||||+++|+|++|+.||....................
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  235 (296)
T 4hgt_A          156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM  235 (296)
T ss_dssp             EECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred             eeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc
Confidence            87543322      122346789999999999999999999999999999999999999986554433333322211100


Q ss_pred             hhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCCC
Q 018263          269 SKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNIDG  325 (358)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~~  325 (358)
                      ......     .    ....+..+.+++.+||+.+|.+|||+.++++.|+++....+
T Consensus       236 ~~~~~~-----~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~  283 (296)
T 4hgt_A          236 STPIEV-----L----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             HSCHHH-----H----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             cchhhh-----h----hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence            000000     0    01234679999999999999999999999999998775543

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=4.3e-42  Score=309.70  Aligned_cols=266  Identities=21%  Similarity=0.273  Sum_probs=208.9

Q ss_pred             hcCCcccceecccCceEEEEEEE-CCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeec-eEEcCCeeEEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRL-QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG-GCIDGPCRILV  118 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~-~~~~~~~~~iv  118 (358)
                      .++|++.+.||+|+||.||+|++ .+|+.||+|++......  ..+.+|+..+..+.  |++++..+. +.......++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~--~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQ--GGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHT--TSTTCCCEEEEEEETTEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhh--cCCCCCccccccCCCCceEEE
Confidence            57999999999999999999997 47999999998654332  35778999999988  776555554 44677788999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEE---cCCCceEEeeccccc
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSK  195 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv---~~~~~~~l~Dfg~~~  195 (358)
                      |||+ +++|.+++..   ....+++..++.++.||+.||+|||++   |++|+||+|+||++   +.++.++|+|||++.
T Consensus        84 ~e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~  156 (296)
T 3uzp_A           84 MELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             EECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             EEec-CCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence            9999 9999999942   345799999999999999999999999   99999999999999   488899999999998


Q ss_pred             ccCCCCcc------cccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccch
Q 018263          196 LFPENTTH------ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNS  269 (358)
Q Consensus       196 ~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      ........      ......++..|+|||++.+..++.++||||||+++|+|++|+.||..............+......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  236 (296)
T 3uzp_A          157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS  236 (296)
T ss_dssp             ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC
Confidence            75433221      123467899999999999989999999999999999999999999865443333222222110000


Q ss_pred             hhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCCCC
Q 018263          270 KELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNIDGX  326 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~~~  326 (358)
                      .....     .    ....+..+.+++.+||+.||.+|||+.+|++.|+.+....+.
T Consensus       237 ~~~~~-----~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~  284 (296)
T 3uzp_A          237 TPIEV-----L----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF  284 (296)
T ss_dssp             SCHHH-----H----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             CchHH-----H----HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence            00000     0    122346799999999999999999999999999988765543

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.3e-42  Score=311.42  Aligned_cols=248  Identities=25%  Similarity=0.365  Sum_probs=207.4

Q ss_pred             HhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCe
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC  114 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~  114 (358)
                      ...++|++.+.||+|++|.||+|... +++.|++|++....   ......+.+|+..+..++  ||||+++++++...+.
T Consensus        11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~   88 (284)
T 2vgo_A           11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR--HPNILRMYNYFHDRKR   88 (284)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC--CTTBCCEEEEEECSSE
T ss_pred             hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCC--CCCEeeEEEEEEcCCE
Confidence            34578999999999999999999976 57889999986432   233567889999999998  9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccc
Q 018263          115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS  194 (358)
Q Consensus       115 ~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~  194 (358)
                      .++||||+++++|.+++.    ....+++..++.++.||+.||.|||++   |++|+||+|+||+++.++.++|+|||++
T Consensus        89 ~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~  161 (284)
T 2vgo_A           89 IYLMLEFAPRGELYKELQ----KHGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWS  161 (284)
T ss_dssp             EEEEECCCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEEeCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEeccccc
Confidence            999999999999999993    345789999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhh
Q 018263          195 KLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMN  274 (358)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                      .......   .....++..|+|||++.+..++.++||||||+++|+|++|..||...........               
T Consensus       162 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---------------  223 (284)
T 2vgo_A          162 VHAPSLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRR---------------  223 (284)
T ss_dssp             EECSSSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH---------------
T ss_pred             ccCcccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHH---------------
Confidence            7643322   2345689999999999998999999999999999999999999975432211111               


Q ss_pred             hhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          275 LVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      +...  ...++...+..+.++|.+||+.||.+|||+.++++
T Consensus       224 ~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          224 IVNV--DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             HHTT--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             Hhcc--ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence            1110  11233445667899999999999999999999986

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-42  Score=312.29  Aligned_cols=258  Identities=25%  Similarity=0.325  Sum_probs=206.0

Q ss_pred             CCcccceecccCceEEEEEEEC-C---CCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCee-E
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQ-D---GTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR-I  116 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~-~---~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~-~  116 (358)
                      .|.+.+.||+|+||.||+|.+. +   +..|++|.+... .......+.+|+..++.++  ||||+++++++...+.. +
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~~   99 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN--HPNVLALIGIMLPPEGLPH   99 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCC--CTTBCCCCEEECCSSSCCE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCC--CCCeeeEEEEEecCCCCcE
Confidence            5666799999999999999853 2   337999998654 3345577889999999998  99999999999876665 9


Q ss_pred             EEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       117 iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      ++|||+.+++|.+++..   ....+++..++.++.|++.||+|||+.   |++|+||||+||+++.++.++|+|||++..
T Consensus       100 ~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~  173 (298)
T 3pls_A          100 VLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARD  173 (298)
T ss_dssp             EEECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCT
T ss_pred             EEEecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccc
Confidence            99999999999999932   346688999999999999999999999   999999999999999999999999999976


Q ss_pred             cCCCC---cccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCC-CccccccchhhhHhhhhccchhhH
Q 018263          197 FPENT---THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAV-DFDVQLGEYHLVDKAWGMYNSKEL  272 (358)
Q Consensus       197 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      .....   ........++..|.|||.+.+..++.++||||||+++|+|++|..|+ .......                .
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~----------------~  237 (298)
T 3pls_A          174 ILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD----------------L  237 (298)
T ss_dssp             TTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG----------------H
T ss_pred             ccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH----------------H
Confidence            53322   11223356788999999999989999999999999999999965554 4322211                1


Q ss_pred             hhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCC
Q 018263          273 MNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNID  324 (358)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~  324 (358)
                      ...+........+...+..+.+++.+||+.||.+|||+.++++.|+++....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l  289 (298)
T 3pls_A          238 THFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL  289 (298)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             HHHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence            1111122222334445677999999999999999999999999999876544

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-42  Score=320.37  Aligned_cols=269  Identities=22%  Similarity=0.322  Sum_probs=202.8

Q ss_pred             HHHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChh-----hHHHHHHHHHHhhhcccCCCCceeeeceEE
Q 018263           37 LKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQ-----GEKEFMSEVASMANVNVCHENLVKLHGGCI  110 (358)
Q Consensus        37 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~-----~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~  110 (358)
                      +....++|++.+.||+|+||.||+|.+. +|+.||+|++......     ....+.+|+..++.++  ||||+++++++.
T Consensus         5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~   82 (346)
T 1ua2_A            5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS--HPNIIGLLDAFG   82 (346)
T ss_dssp             --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC--CTTBCCEEEEEC
T ss_pred             hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCC--CCCCCeEEEEEe
Confidence            3445689999999999999999999975 6899999998653221     1246778999999998  999999999999


Q ss_pred             cCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEee
Q 018263          111 DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD  190 (358)
Q Consensus       111 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~D  190 (358)
                      +.+..++||||+++ +|.+.+.   .....+++..++.++.|++.||.|||++   |++|+||+|+||+++.++.++|+|
T Consensus        83 ~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~D  155 (346)
T 1ua2_A           83 HKSNISLVFDFMET-DLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLAD  155 (346)
T ss_dssp             CTTCCEEEEECCSE-EHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred             eCCceEEEEEcCCC-CHHHHHH---hcCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEe
Confidence            99999999999975 8888873   2345688999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccch
Q 018263          191 FGLSKLFPENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNS  269 (358)
Q Consensus       191 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      ||++........ ......+|+.|+|||++.+. .++.++||||||+++|+|++|.+||...........+....+.+..
T Consensus       156 fg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~  234 (346)
T 1ua2_A          156 FGLAKSFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTE  234 (346)
T ss_dssp             CGGGSTTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCT
T ss_pred             cccceeccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence            999987543322 23345689999999998764 5889999999999999999999999876654444333332222222


Q ss_pred             hhHhhhhc---ccc---CCCCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          270 KELMNLVD---PML---YGNFP-----ENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       270 ~~~~~~~~---~~~---~~~~~-----~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ..+.....   ...   ....+     ...+..+.+||.+||+.||.+|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  291 (346)
T 1ua2_A          235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  291 (346)
T ss_dssp             TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence            21111110   000   00111     234567999999999999999999999987

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3.2e-42  Score=308.61  Aligned_cols=252  Identities=19%  Similarity=0.280  Sum_probs=203.7

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccCh------hhHHHHHHHHHHhhhcccCCCCceeeeceEEcC
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK------QGEKEFMSEVASMANVNVCHENLVKLHGGCIDG  112 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~  112 (358)
                      ..++|++.+.||+|+||.||+|... +|+.||+|++.....      .....+.+|+..++.++  ||||+++++++...
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~   80 (283)
T 3bhy_A            3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR--HPNIITLHDIFENK   80 (283)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC--CTTBCCEEEEEECS
T ss_pred             hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCC--CCCeeehhheecCC
Confidence            3578999999999999999999986 689999999865421      23678899999999998  99999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCC----ceEE
Q 018263          113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF----NPKI  188 (358)
Q Consensus       113 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~----~~~l  188 (358)
                      ...++||||+++++|.+++    .....+++..++.++.||+.||.|||++   |++|+||+|+||+++.++    .++|
T Consensus        81 ~~~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl  153 (283)
T 3bhy_A           81 TDVVLILELVSGGELFDFL----AEKESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKL  153 (283)
T ss_dssp             SEEEEEEECCCSCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEE
T ss_pred             CeEEEEEeecCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEE
Confidence            9999999999999999999    3456789999999999999999999999   999999999999998877    7999


Q ss_pred             eecccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccc
Q 018263          189 SDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYN  268 (358)
Q Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  268 (358)
                      +|||.+........  .....+++.|+|||++.+..++.++||||||+++|+|++|..||...........+......  
T Consensus       154 ~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--  229 (283)
T 3bhy_A          154 IDFGIAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYD--  229 (283)
T ss_dssp             CCCTTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC--
T ss_pred             EecccceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccC--
Confidence            99999987543222  23356889999999998889999999999999999999999999765432211111100000  


Q ss_pred             hhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          269 SKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                                 .........+..+.+++.+||+.||.+|||+.++++
T Consensus       230 -----------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          230 -----------FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             -----------CCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -----------CcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence                       000000123456899999999999999999999987

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=3.5e-42  Score=311.60  Aligned_cols=249  Identities=22%  Similarity=0.384  Sum_probs=208.1

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+..+..+.  ||||+++++++......++|
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv   98 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD--SPYVTKYYGSYLKDTKLWII   98 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCC--CTTBCCEEEEEEETTEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCC--CCCEeEEEEEEecCCeEEEE
Confidence            467999999999999999999875 68999999987553 345678889999999997  99999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      |||+++++|.+++     ....+++..++.++.||+.||.|||+.   |++|+||+|+||+++.++.++|+|||++....
T Consensus        99 ~e~~~~~~L~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~  170 (303)
T 3a7i_A           99 MEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT  170 (303)
T ss_dssp             EECCTTEEHHHHH-----TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECB
T ss_pred             EEeCCCCcHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecC
Confidence            9999999999998     335789999999999999999999999   99999999999999999999999999997654


Q ss_pred             CCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhcc
Q 018263          199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDP  278 (358)
Q Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (358)
                      .... ......++..|+|||++.+..++.++||||||+++|+|++|+.||...........                +..
T Consensus       171 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----------------~~~  233 (303)
T 3a7i_A          171 DTQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL----------------IPK  233 (303)
T ss_dssp             TTBC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----------------HHH
T ss_pred             cccc-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHH----------------hhc
Confidence            3222 22345688999999999988999999999999999999999999975432211111                111


Q ss_pred             ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 018263          279 MLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKM  316 (358)
Q Consensus       279 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~  316 (358)
                      ......+...+..+.+++.+||+.||.+|||+.++++.
T Consensus       234 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          234 NNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             SCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             CCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            11122334456679999999999999999999999863

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.8e-42  Score=312.72  Aligned_cols=259  Identities=26%  Similarity=0.373  Sum_probs=205.2

Q ss_pred             hhcCCcccceecccCceEEEEEEECC----CCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceE-EcCC
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQD----GTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGC-IDGP  113 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~-~~~~  113 (358)
                      ...+|++.+.||+|+||.||+|.+..    +..|++|.+... .......+.+|+..++.++  ||||+++++++ ...+
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~  100 (298)
T 3f66_A           23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS--HPNVLSLLGICLRSEG  100 (298)
T ss_dssp             GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCC--CTTBCCCCEEECCSSS
T ss_pred             cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCC--CCCEeeeeeEEEcCCC
Confidence            34689999999999999999998542    335899988653 3445577889999999998  99999999985 4566


Q ss_pred             eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccc
Q 018263          114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL  193 (358)
Q Consensus       114 ~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~  193 (358)
                      ..++||||+++++|.+++.   .....+++..++.++.|++.||.|||++   |++|+||+|+||+++.++.++|+|||+
T Consensus       101 ~~~~v~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~  174 (298)
T 3f66_A          101 SPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGL  174 (298)
T ss_dssp             CCEEEEECCTTCBHHHHHH---CTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGG
T ss_pred             ceEEEEeCCCCCCHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccc
Confidence            7899999999999999993   2345688999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCc---ccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccch
Q 018263          194 SKLFPENTT---HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNS  269 (358)
Q Consensus       194 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      +........   .......+++.|+|||.+.+..++.++||||||+++|+|++ |.+||............         
T Consensus       175 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~---------  245 (298)
T 3f66_A          175 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL---------  245 (298)
T ss_dssp             GCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH---------
T ss_pred             cccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH---------
Confidence            986543221   12223456788999999999999999999999999999999 55666544322211111         


Q ss_pred             hhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCC
Q 018263          270 KELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETN  322 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~  322 (358)
                             ........+...+..+.+++.+||+.+|.+|||+.++++.|+++..
T Consensus       246 -------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  291 (298)
T 3f66_A          246 -------LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  291 (298)
T ss_dssp             -------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------hcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                   1111122233445679999999999999999999999999998754

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.2e-42  Score=322.44  Aligned_cols=263  Identities=21%  Similarity=0.313  Sum_probs=206.5

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++... .......+.+|+..++.++  ||||+++++++...+..++|
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv  109 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN--SPYIVGFYGAFYSDGEISIC  109 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCC--CTTBCCEEEEEEETTEEEEE
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCC--CCCEEEEeEEEEECCEEEEE
Confidence            578999999999999999999976 6899999998765 3445577889999999997  99999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      |||+++++|.+++    .....+++..+..++.|++.||.|||+ .   |++|+||+|+||+++.++.++|+|||++...
T Consensus       110 ~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  182 (360)
T 3eqc_A          110 MEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  182 (360)
T ss_dssp             ECCCTTCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred             EECCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEcCCccHHHEEECCCCCEEEEECCCCccc
Confidence            9999999999999    344578999999999999999999998 5   8999999999999999999999999998653


Q ss_pred             CCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhh-------------
Q 018263          198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAW-------------  264 (358)
Q Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~-------------  264 (358)
                      ..   .......+++.|+|||++.+..++.++||||||+++|+|++|+.||................             
T Consensus       183 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (360)
T 3eqc_A          183 ID---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT  259 (360)
T ss_dssp             HH---HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------
T ss_pred             cc---ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCccc
Confidence            21   12233568999999999999999999999999999999999999997644322111100000             


Q ss_pred             -------------hccchhh-HhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          265 -------------GMYNSKE-LMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       265 -------------~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                                   ......+ ...+.............+..+.+|+.+||+.||.+|||+.++++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          260 PGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             --------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                         0000000 01111111111122235667999999999999999999999975

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.9e-42  Score=317.21  Aligned_cols=267  Identities=24%  Similarity=0.323  Sum_probs=210.4

Q ss_pred             HHHHHhhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC-
Q 018263           35 NQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP-  113 (358)
Q Consensus        35 ~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~-  113 (358)
                      ..-....++|++.+.||+|+||.||+|++. |+.||+|++...   ....+..|.+.+..+...||||+++++++.... 
T Consensus        35 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~  110 (342)
T 1b6c_B           35 LVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNG  110 (342)
T ss_dssp             HHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred             eecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence            334556789999999999999999999985 899999998643   345667788888774445999999999998876 


Q ss_pred             ---eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCcEEcCCCCCcEEEcC
Q 018263          114 ---CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH--------EEIQPHVVHRDIKTSNILLDQ  182 (358)
Q Consensus       114 ---~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--------~~~~~~i~H~di~p~Nilv~~  182 (358)
                         ..++||||+++++|.+++.     ...+++..++.++.|++.||.|||        +.   +++|+||||+||+++.
T Consensus       111 ~~~~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~  182 (342)
T 1b6c_B          111 TWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKK  182 (342)
T ss_dssp             SCCCEEEEECCCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECT
T ss_pred             ccceeEEEEeecCCCcHHHHHh-----ccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECC
Confidence               7899999999999999993     346899999999999999999999        88   9999999999999999


Q ss_pred             CCceEEeecccccccCCCCcc---cccccccccCccCccccccC------CCCccCceecHHHHHHHHHhC---------
Q 018263          183 NFNPKISDFGLSKLFPENTTH---ISTRVAGTLGYLAPEYAISG------RLTRKSDVYSFGVLLLEIVSG---------  244 (358)
Q Consensus       183 ~~~~~l~Dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~------~~s~~sDiwslG~il~~lltg---------  244 (358)
                      ++.++|+|||++.........   ......+++.|+|||++.+.      .++.++||||||+++|+|++|         
T Consensus       183 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~  262 (342)
T 1b6c_B          183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED  262 (342)
T ss_dssp             TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred             CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccc
Confidence            999999999999765433321   22345689999999998765      234689999999999999999         


Q ss_pred             -CCCCCccccccchhhhHhhhhccchhhHhh-hhccccCCCCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 018263          245 -RTAVDFDVQLGEYHLVDKAWGMYNSKELMN-LVDPMLYGNFP-----ENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMM  317 (358)
Q Consensus       245 -~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L  317 (358)
                       ..||.........           ...+.. +.........+     ...+..+.+++.+||+.||.+|||+.+|++.|
T Consensus       263 ~~~p~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L  331 (342)
T 1b6c_B          263 YQLPYYDLVPSDPS-----------VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL  331 (342)
T ss_dssp             CCCTTTTTSCSSCC-----------HHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred             cccCccccCcCccc-----------HHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence             6677543322111           011111 11222222222     36778899999999999999999999999999


Q ss_pred             hcCCCCC
Q 018263          318 NGETNID  324 (358)
Q Consensus       318 ~~~~~~~  324 (358)
                      +++....
T Consensus       332 ~~i~~~~  338 (342)
T 1b6c_B          332 SQLSQQE  338 (342)
T ss_dssp             HHHHHTT
T ss_pred             HHHHHHh
Confidence            9876544

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1e-42  Score=311.78  Aligned_cols=251  Identities=25%  Similarity=0.382  Sum_probs=206.6

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEc-------
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID-------  111 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~-------  111 (358)
                      ...+|++.+.||+|+||.||+|.+. +|+.||+|.+.....    .+.+|+..++.++  ||||+++++++..       
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~~~   82 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLD--HVNIVHYNGCWDGFDYDPET   82 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSG----GGHHHHHHHHHCC--CTTBCCEEEEEEEEEEC---
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccH----HHHHHHHHHHhCC--CCCEEEEeeeEeccccCccc
Confidence            4678999999999999999999986 799999999975442    4568999999998  9999999998764       


Q ss_pred             ---------CCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcC
Q 018263          112 ---------GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ  182 (358)
Q Consensus       112 ---------~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~  182 (358)
                               ....++||||+++++|.+++...  ....+++..++.++.||+.||.|||++   |++|+||+|+||+++.
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~  157 (284)
T 2a19_B           83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVD  157 (284)
T ss_dssp             ------CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEE
T ss_pred             ccccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcC
Confidence                     44579999999999999999432  346789999999999999999999999   9999999999999999


Q ss_pred             CCceEEeecccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHh
Q 018263          183 NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDK  262 (358)
Q Consensus       183 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~  262 (358)
                      ++.++|+|||++........  .....+++.|+|||++.+..++.++||||||+++|+|++|..|+.....         
T Consensus       158 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---------  226 (284)
T 2a19_B          158 TKQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK---------  226 (284)
T ss_dssp             TTEEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH---------
T ss_pred             CCCEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH---------
Confidence            99999999999987543322  2335689999999999998999999999999999999999988742110         


Q ss_pred             hhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCC
Q 018263          263 AWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNID  324 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~  324 (358)
                              ....+...    ..+...+..+.+++.+||+.||.+|||+.++++.|+.++...
T Consensus       227 --------~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~  276 (284)
T 2a19_B          227 --------FFTDLRDG----IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP  276 (284)
T ss_dssp             --------HHHHHHTT----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred             --------HHHHhhcc----cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence                    01111111    122334556889999999999999999999999999887544

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.2e-42  Score=330.03  Aligned_cols=271  Identities=18%  Similarity=0.250  Sum_probs=203.9

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC-----
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG-----  112 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~-----  112 (358)
                      .++|++.+.||+|+||.||+|.+. +++.||||++...  .....+.+.+|+..++.++  ||||+++++++...     
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~~  102 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLK--SDYIIRLYDLIIPDDLLKF  102 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCC--CTTBCCEEEECCCSCTTTC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcC--CCCcceEEEEEecCCCCcC
Confidence            579999999999999999999976 5889999998653  3445578889999999998  99999999998766     


Q ss_pred             CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecc
Q 018263          113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG  192 (358)
Q Consensus       113 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg  192 (358)
                      ...|+||||++ ++|.+++    .....+++..++.++.||+.||.|||+.   ||+||||||+||+++.++.+||+|||
T Consensus       103 ~~~~lv~e~~~-~~L~~~~----~~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFG  174 (432)
T 3n9x_A          103 DELYIVLEIAD-SDLKKLF----KTPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFG  174 (432)
T ss_dssp             CCEEEEEECCS-EEHHHHH----HSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             CeEEEEEecCC-cCHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCC
Confidence            56899999995 6999998    4456799999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCc---------------------ccccccccccCccCcccc-ccCCCCccCceecHHHHHHHHHhCCCCCC-
Q 018263          193 LSKLFPENTT---------------------HISTRVAGTLGYLAPEYA-ISGRLTRKSDVYSFGVLLLEIVSGRTAVD-  249 (358)
Q Consensus       193 ~~~~~~~~~~---------------------~~~~~~~~~~~y~aPE~~-~~~~~s~~sDiwslG~il~~lltg~~pf~-  249 (358)
                      ++........                     .......+|+.|+|||++ .+..++.++|||||||++|+|++|..||. 
T Consensus       175 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~  254 (432)
T 3n9x_A          175 LARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN  254 (432)
T ss_dssp             TCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCS
T ss_pred             CcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccc
Confidence            9987643221                     123456789999999986 45679999999999999999998655543 


Q ss_pred             ----------cccc-----------------ccchhhhHhhhhccchhhH--------hhhhccccCC-CCC-----HHH
Q 018263          250 ----------FDVQ-----------------LGEYHLVDKAWGMYNSKEL--------MNLVDPMLYG-NFP-----ENE  288 (358)
Q Consensus       250 ----------~~~~-----------------~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~-~~~-----~~~  288 (358)
                                +...                 .++...+....+.+....+        ...+...... ..+     +..
T Consensus       255 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (432)
T 3n9x_A          255 DPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSI  334 (432)
T ss_dssp             SGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTS
T ss_pred             ccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCC
Confidence                      2211                 1111122222222222211        1111111110 000     234


Q ss_pred             HHHHHHHHhhccCCCCCCCCCHHHHHH--HhhcCC
Q 018263          289 AIRFLKVGLLCVQEKSKLRPQMSTAIK--MMNGET  321 (358)
Q Consensus       289 ~~~l~~li~~~l~~~P~~Rpt~~eil~--~L~~~~  321 (358)
                      +..+.+|+.+||+.||.+|||++|+++  .|.+..
T Consensus       335 s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  369 (432)
T 3n9x_A          335 SDDGINLLESMLKFNPNKRITIDQALDHPYLKDVR  369 (432)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred             CHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence            667899999999999999999999987  455543

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.4e-43  Score=322.83  Aligned_cols=256  Identities=23%  Similarity=0.335  Sum_probs=206.0

Q ss_pred             hhcCCcccceecccCceEEEEEEE----CCCCEEEEEEeeccC----hhhHHHHHHHHHHhhhcccCCCCceeeeceEEc
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRL----QDGTIVAVKVLSVES----KQGEKEFMSEVASMANVNVCHENLVKLHGGCID  111 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~----~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~  111 (358)
                      ..++|++.+.||+|+||.||+|+.    .+++.||||++....    ......+..|+..+..+. .||||+++++++..
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~h~~iv~~~~~~~~  130 (355)
T 1vzo_A           52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR-QSPFLVTLHYAFQT  130 (355)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHH-TCTTBCCEEEEEEE
T ss_pred             cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHcc-CCCceeEEEEEEee
Confidence            357899999999999999999997    368999999986432    223345667888888884 49999999999999


Q ss_pred             CCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeec
Q 018263          112 GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF  191 (358)
Q Consensus       112 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Df  191 (358)
                      .+..++||||+++++|.+++.    ....+++..++.++.||+.||.|||++   ||+|+||||+||+++.++.++|+||
T Consensus       131 ~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Df  203 (355)
T 1vzo_A          131 ETKLHLILDYINGGELFTHLS----QRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDF  203 (355)
T ss_dssp             TTEEEEEECCCCSCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCS
T ss_pred             CceEEEEeecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeC
Confidence            999999999999999999993    445789999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccCccCcccccc--CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccch
Q 018263          192 GLSKLFPENTTHISTRVAGTLGYLAPEYAIS--GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNS  269 (358)
Q Consensus       192 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      |++...............+|+.|+|||++.+  ..++.++||||||+++|+|++|+.||...........+...      
T Consensus       204 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~------  277 (355)
T 1vzo_A          204 GLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR------  277 (355)
T ss_dssp             SEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH------
T ss_pred             CCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHH------
Confidence            9998654433334445679999999999885  34788999999999999999999999765433222211110      


Q ss_pred             hhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 018263          270 KELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRP-----QMSTAIKM  316 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp-----t~~eil~~  316 (358)
                           ...  ....++...+..+.+||.+||+.||.+||     ++.++++.
T Consensus       278 -----~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          278 -----ILK--SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             -----HHH--CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             -----Hhc--cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence                 000  11223445567789999999999999999     89998864

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=3.5e-42  Score=310.26  Aligned_cols=249  Identities=21%  Similarity=0.336  Sum_probs=207.9

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCee
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR  115 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~  115 (358)
                      ..++|++.+.||+|+||.||+|.+. +++.|++|++...   .......+.+|+..++.+.  ||||+++++++...+..
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~   90 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA--HQHVVGFHGFFEDNDFV   90 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC--CTTBCCEEEEEECSSEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCC--CCCEeeeeeeeccCCEE
Confidence            3578999999999999999999976 5889999998654   3345567888999999997  99999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccc
Q 018263          116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK  195 (358)
Q Consensus       116 ~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~  195 (358)
                      ++||||+++++|.+++    .....+++..++.++.||+.||.|||++   |++|+||+|+||+++.++.++|+|||++.
T Consensus        91 ~lv~e~~~~~~L~~~~----~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  163 (294)
T 2rku_A           91 FVVLELCRRRSLLELH----KRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLAT  163 (294)
T ss_dssp             EEEEECCTTCBHHHHH----HHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEecCCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCce
Confidence            9999999999999988    3456789999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhh
Q 018263          196 LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNL  275 (358)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                      ....... ......++..|+|||++.+..++.++||||||+++|+|++|+.||...........+               
T Consensus       164 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~---------------  227 (294)
T 2rku_A          164 KVEYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI---------------  227 (294)
T ss_dssp             ECCSTTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH---------------
T ss_pred             ecccCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---------------
Confidence            7543222 223356899999999998888999999999999999999999999754322111111               


Q ss_pred             hccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          276 VDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       276 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ...  ....+...+..+.+++.+||+.||.+|||+.++++
T Consensus       228 ~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          228 KKN--EYSIPKHINPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             HTT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             hhc--cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence            000  01223345567899999999999999999999986

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.9e-42  Score=323.90  Aligned_cols=276  Identities=19%  Similarity=0.231  Sum_probs=215.7

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC--ee
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP--CR  115 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~--~~  115 (358)
                      ..++|++.+.||+|+||.||+|++. +|+.||+|++.... ......+.+|++.++.++  ||||+++++++...+  ..
T Consensus         7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~~~~~~   84 (396)
T 4eut_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN--HKNIVKLFAIEEETTTRHK   84 (396)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCC--CTTBCCEEEEEECTTTCCE
T ss_pred             CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcC--CCCCCeEEEeeccCCCCee
Confidence            3578999999999999999999976 58999999987543 334567789999999998  999999999998765  67


Q ss_pred             EEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEE----cCCCceEEeec
Q 018263          116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL----DQNFNPKISDF  191 (358)
Q Consensus       116 ~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv----~~~~~~~l~Df  191 (358)
                      ++||||+++++|.+++.... ....+++..++.++.||+.||+|||++   ||+|+||||+||++    +.++.+||+||
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DF  160 (396)
T 4eut_A           85 VLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDF  160 (396)
T ss_dssp             EEEECCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCG
T ss_pred             EEEEecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecC
Confidence            99999999999999994332 223489999999999999999999999   99999999999999    77788999999


Q ss_pred             ccccccCCCCcccccccccccCccCcccccc--------CCCCccCceecHHHHHHHHHhCCCCCCcccccc-chhhhHh
Q 018263          192 GLSKLFPENTTHISTRVAGTLGYLAPEYAIS--------GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG-EYHLVDK  262 (358)
Q Consensus       192 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~-~~~~~~~  262 (358)
                      |++.......  ......++..|+|||++.+        ..++.++||||||+++|+|++|+.||....... .......
T Consensus       161 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~  238 (396)
T 4eut_A          161 GAARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK  238 (396)
T ss_dssp             GGCEECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHH
T ss_pred             CCceEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHH
Confidence            9998754322  2234568999999998865        567889999999999999999999997543322 2222222


Q ss_pred             hhhccchhhHhhhh-----------ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCC
Q 018263          263 AWGMYNSKELMNLV-----------DPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNI  323 (358)
Q Consensus       263 ~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~  323 (358)
                      +........+....           ........+...+..+.+++.+||+.||.+|||+.++++.++.+...
T Consensus       239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            22111111000000           00111234578889999999999999999999999999999887543

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=5.9e-42  Score=308.18  Aligned_cols=248  Identities=24%  Similarity=0.359  Sum_probs=200.0

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEc----CC
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID----GP  113 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~----~~  113 (358)
                      ...|++.+.||+|+||.||+|.+. ++..|++|.+...  .......+.+|+..++.++  ||||+++++++..    ..
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~~  102 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ--HPNIVRFYDSWESTVKGKK  102 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCC--CTTBCCEEEEEEEESSSCE
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCC--CCCeeeeeeeeccccCCCc
Confidence            456899999999999999999975 6888999998754  3445677889999999998  9999999998875    35


Q ss_pred             eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCC--cEEcCCCCCcEEEc-CCCceEEee
Q 018263          114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH--VVHRDIKTSNILLD-QNFNPKISD  190 (358)
Q Consensus       114 ~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~--i~H~di~p~Nilv~-~~~~~~l~D  190 (358)
                      ..++||||+++++|.+++    .....+++..++.++.||+.||.|||+.   +  ++|+||+|+||+++ .++.++|+|
T Consensus       103 ~~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~D  175 (290)
T 1t4h_A          103 CIVLVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGD  175 (290)
T ss_dssp             EEEEEEECCCSCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECC
T ss_pred             eEEEEEEecCCCCHHHHH----HHccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEee
Confidence            589999999999999999    3446789999999999999999999999   8  99999999999997 788999999


Q ss_pred             cccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchh
Q 018263          191 FGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSK  270 (358)
Q Consensus       191 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      ||++.......   .....+++.|+|||++. ..++.++||||||+++|+|++|+.||.........  .....      
T Consensus       176 fg~~~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~~~~------  243 (290)
T 1t4h_A          176 LGLATLKRASF---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--YRRVT------  243 (290)
T ss_dssp             TTGGGGCCTTS---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH--HHHHT------
T ss_pred             CCCcccccccc---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH--HHHHh------
Confidence            99997643322   23456899999999776 45899999999999999999999999754322111  11110      


Q ss_pred             hHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          271 ELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                            ........+...+..+.+++.+||+.||.+|||+.++++
T Consensus       244 ------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          244 ------SGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             ------TTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ------ccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                  000011112223456899999999999999999999986

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=4.6e-42  Score=330.87  Aligned_cols=251  Identities=25%  Similarity=0.341  Sum_probs=204.7

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeE
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI  116 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~  116 (358)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++...  .......+.+|+.+++.++  ||||+++++++......+
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~   97 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD--HPNIMKLFEILEDSSSFY   97 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCC--CTTBCCEEEEEECSSEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCC--CCCcCeEEEEEEcCCEEE
Confidence            4578999999999999999999976 6899999998643  2345677889999999998  999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEc---CCCceEEeeccc
Q 018263          117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD---QNFNPKISDFGL  193 (358)
Q Consensus       117 iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~---~~~~~~l~Dfg~  193 (358)
                      +||||+++++|.+.+    .....+++..++.++.||+.||.|||++   ||+|+||||+||+++   .++.++|+|||+
T Consensus        98 lv~e~~~~~~L~~~~----~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~  170 (486)
T 3mwu_A           98 IVGELYTGGELFDEI----IKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGL  170 (486)
T ss_dssp             EEECCCCSCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSC
T ss_pred             EEEEcCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCc
Confidence            999999999999988    3446799999999999999999999999   999999999999995   456799999999


Q ss_pred             ccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHh
Q 018263          194 SKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELM  273 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      +.......  ......||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+........     
T Consensus       171 a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-----  242 (486)
T 3mwu_A          171 STCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD-----  242 (486)
T ss_dssp             TTTBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSC-----
T ss_pred             CeECCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-----
Confidence            98654332  2334578999999998865 589999999999999999999999976543322222111100000     


Q ss_pred             hhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          274 NLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                              .......+..+.++|.+||+.||.+|||+.++++
T Consensus       243 --------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          243 --------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             --------SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             --------CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                    0011234567899999999999999999999987

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.2e-42  Score=333.74  Aligned_cols=252  Identities=26%  Similarity=0.341  Sum_probs=200.9

Q ss_pred             HhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC--hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCee
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR  115 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~  115 (358)
                      ...++|++++.||+|+||.||+|+++ ++..||+|++....  ......+.+|+..++.++  ||||+++++++......
T Consensus        34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~  111 (494)
T 3lij_A           34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD--HPNIMKLYDFFEDKRNY  111 (494)
T ss_dssp             CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCC--CTTBCCEEEEEECSSEE
T ss_pred             chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCC--CCCCCeEEEEEEeCCEE
Confidence            34568999999999999999999976 68899999987542  334567889999999998  99999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCC---CceEEeecc
Q 018263          116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN---FNPKISDFG  192 (358)
Q Consensus       116 ~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~---~~~~l~Dfg  192 (358)
                      ++||||+++++|.+.+    .....+++..++.++.||+.||.|||++   ||+||||||+||+++..   +.++|+|||
T Consensus       112 ~lv~e~~~~g~L~~~~----~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG  184 (494)
T 3lij_A          112 YLVMECYKGGELFDEI----IHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFG  184 (494)
T ss_dssp             EEEEECCCSCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEecCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECC
Confidence            9999999999999988    3456799999999999999999999999   99999999999999764   459999999


Q ss_pred             cccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhH
Q 018263          193 LSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKEL  272 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      ++.......  ......||+.|+|||++. ..++.++||||||+++|+|++|..||...........+......+...  
T Consensus       185 ~a~~~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~--  259 (494)
T 3lij_A          185 LSAVFENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSP--  259 (494)
T ss_dssp             TCEECBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSG--
T ss_pred             CCeECCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCch--
Confidence            998754322  233467999999999875 568999999999999999999999998654432222221110000000  


Q ss_pred             hhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          273 MNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                                 .....+..+.++|.+||+.+|.+|||+.++++
T Consensus       260 -----------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          260 -----------EWKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             -----------GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -----------hcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence                       01234567899999999999999999999874

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.8e-42  Score=334.80  Aligned_cols=255  Identities=27%  Similarity=0.351  Sum_probs=210.2

Q ss_pred             HhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCe
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC  114 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~  114 (358)
                      +..++|++.+.||+|+||.||+|+.. +|+.||+|++...   .......+.+|+.++..++  ||||+++++++.+.+.
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~--hp~Iv~l~~~~~~~~~  258 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN--SRFVVSLAYAYETKDA  258 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC--CTTBCCEEEEEECSSE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcC--CCCEeeEEEEEeeCCE
Confidence            34578999999999999999999976 6999999998643   2334567888999999998  9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccc
Q 018263          115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS  194 (358)
Q Consensus       115 ~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~  194 (358)
                      .++||||++|++|.+++...  ....+++..++.++.||+.||.|||++   ||+||||||+||+++.+|.++|+|||++
T Consensus       259 l~lVmEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla  333 (576)
T 2acx_A          259 LCLVLTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLA  333 (576)
T ss_dssp             EEEEECCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEEcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccc
Confidence            99999999999999998432  234589999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhh
Q 018263          195 KLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMN  274 (358)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                      ........  .....||+.|+|||++.+..++.++|+||||+++|+|++|+.||...........+.            .
T Consensus       334 ~~~~~~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~------------~  399 (576)
T 2acx_A          334 VHVPEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE------------R  399 (576)
T ss_dssp             EECCTTCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHH------------H
T ss_pred             eecccCcc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHH------------H
Confidence            87543322  234579999999999998889999999999999999999999998654322211111            1


Q ss_pred             hhccccCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 018263          275 LVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRP-----QMSTAIK  315 (358)
Q Consensus       275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp-----t~~eil~  315 (358)
                      .+.. ....++...+..+.+||.+||+.||.+||     ++.|+++
T Consensus       400 ~i~~-~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          400 LVKE-VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             HHHH-CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             Hhhc-ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence            1110 11233455667899999999999999999     6788864

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.1e-41  Score=316.38  Aligned_cols=254  Identities=23%  Similarity=0.342  Sum_probs=203.8

Q ss_pred             HhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccCh--------hhHHHHHHHHHHhhhcccCCCCceeeeceE
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK--------QGEKEFMSEVASMANVNVCHENLVKLHGGC  109 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~  109 (358)
                      ...++|++.+.||+|++|.||+|.+. +|+.||||++.....        .....+.+|+..+..+. .||||+++++++
T Consensus        91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~hp~iv~~~~~~  169 (365)
T 2y7j_A           91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA-GHPHIITLIDSY  169 (365)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHT-TCTTBCCEEEEE
T ss_pred             hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhc-CCCCEeEEEEEE
Confidence            34478999999999999999999986 799999999865431        22456778999999883 399999999999


Q ss_pred             EcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEe
Q 018263          110 IDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKIS  189 (358)
Q Consensus       110 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~  189 (358)
                      ...+..++||||++|++|.+++    .....+++..+..++.||+.||.|||+.   |++|+||+|+||+++.++.++|+
T Consensus       170 ~~~~~~~lv~e~~~g~~L~~~l----~~~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~  242 (365)
T 2y7j_A          170 ESSSFMFLVFDLMRKGELFDYL----TEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLS  242 (365)
T ss_dssp             EBSSEEEEEECCCTTCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred             eeCCEEEEEEEeCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEE
Confidence            9999999999999999999999    3456799999999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccCccCcccccc------CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhh
Q 018263          190 DFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS------GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKA  263 (358)
Q Consensus       190 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~  263 (358)
                      |||++.......  ......|++.|+|||++.+      ..++.++||||||+++|+|++|..||...........+...
T Consensus       243 DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~  320 (365)
T 2y7j_A          243 DFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEG  320 (365)
T ss_dssp             CCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred             ecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC
Confidence            999998754322  2234678999999998864      35788999999999999999999999754322111111110


Q ss_pred             hhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          264 WGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ...+....+             ...+..+.+++.+||+.||.+|||+.++++
T Consensus       321 ~~~~~~~~~-------------~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          321 QYQFSSPEW-------------DDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             CCCCCHHHH-------------SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCCCCccc-------------ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            000000000             123456899999999999999999999986

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.3e-42  Score=319.31  Aligned_cols=266  Identities=23%  Similarity=0.319  Sum_probs=205.1

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC--hhhHHHHHHHHHHhhhcccCCCCceeeeceEEc------
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCID------  111 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~------  111 (358)
                      .++|++.+.||+|+||.||+|++. +|+.||+|++....  ......+.+|+..++.++  ||||+++++++..      
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~~   93 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK--HENVVNLIEICRTKASPYN   93 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCC--CTTBCCEEEEEEEC-----
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhcc--CCCcccHhheeeccccccc
Confidence            478999999999999999999974 79999999986543  233456778999999998  9999999999886      


Q ss_pred             --CCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEe
Q 018263          112 --GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKIS  189 (358)
Q Consensus       112 --~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~  189 (358)
                        .+..++||||+++ +|.+.+.   .....+++..++.++.||+.||+|||++   |++|+||||+||+++.++.++|+
T Consensus        94 ~~~~~~~lv~e~~~~-~l~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~  166 (351)
T 3mi9_A           94 RCKGSIYLVFDFCEH-DLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLA  166 (351)
T ss_dssp             ---CEEEEEEECCSE-EHHHHHH---CTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred             cCCceEEEEEeccCC-CHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEc
Confidence              4468999999965 7777763   3345689999999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCC---cccccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhh
Q 018263          190 DFGLSKLFPENT---THISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG  265 (358)
Q Consensus       190 Dfg~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~  265 (358)
                      |||++.......   ........+|+.|+|||++.+ ..++.++||||||+++|+|++|..||...........+....+
T Consensus       167 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  246 (351)
T 3mi9_A          167 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG  246 (351)
T ss_dssp             CCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             cchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            999998654222   222234568999999998876 4589999999999999999999999987665544444443332


Q ss_pred             ccchhhHhhhhc-----c---ccCCCCC--HH-----HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          266 MYNSKELMNLVD-----P---MLYGNFP--EN-----EAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       266 ~~~~~~~~~~~~-----~---~~~~~~~--~~-----~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ......+...-.     .   .......  ..     .+..+.+||.+||+.||.+|||+.|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            222211111100     0   0000000  01     1346889999999999999999999987

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=3.2e-42  Score=320.06  Aligned_cols=265  Identities=24%  Similarity=0.314  Sum_probs=210.3

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC-----
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG-----  112 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~-----  112 (358)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++... .......+.+|+..+..++  ||||+++++++...     
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~  102 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR--HENIIGINDIIRAPTIEQM  102 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCC--CTTBCCCCEEECCSSTTTC
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcC--CCCCccceeEEecCCcccc
Confidence            3579999999999999999999976 6889999998743 3344577889999999998  99999999998765     


Q ss_pred             CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecc
Q 018263          113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG  192 (358)
Q Consensus       113 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg  192 (358)
                      ...++|||+++ ++|.+++     ....+++..++.++.||+.||+|||++   |++|+||||+||+++.++.++|+|||
T Consensus       103 ~~~~iv~e~~~-~~L~~~l-----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg  173 (364)
T 3qyz_A          103 KDVYIVQDLME-TDLYKLL-----KTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFG  173 (364)
T ss_dssp             CCEEEEEECCS-EEHHHHH-----HHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             ceEEEEEcccC-cCHHHHH-----HhCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCc
Confidence            36899999996 5899988     235689999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcc--cccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccch
Q 018263          193 LSKLFPENTTH--ISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNS  269 (358)
Q Consensus       193 ~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      ++.........  ......+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||......+....+....+.+..
T Consensus       174 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  253 (364)
T 3qyz_A          174 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ  253 (364)
T ss_dssp             TCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCH
T ss_pred             ceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            99865432221  1234578999999998764 45899999999999999999999999877766655555444433333


Q ss_pred             hhHhhhhc--------cccC-CCC-----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          270 KELMNLVD--------PMLY-GNF-----PENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       270 ~~~~~~~~--------~~~~-~~~-----~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ..+....+        .... ...     ....+..+.+|+.+||+.||.+|||+.++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            32222111        0000 001     1234567899999999999999999999986

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3.7e-42  Score=316.05  Aligned_cols=248  Identities=21%  Similarity=0.339  Sum_probs=207.6

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI  116 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~  116 (358)
                      .++|++.+.||+|+||.||++.+. +++.|++|++...   .......+.+|+..++.+.  ||||+++++++.+.+..+
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~  117 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA--HQHVVGFHGFFEDNDFVF  117 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC--CTTBCCEEEEEECSSEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCC--CCCCCeEEEEEecCCeEE
Confidence            578999999999999999999976 5889999998654   3345677889999999998  999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       117 iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      +||||+++++|.+++    .....+++..++.++.||+.||.|||++   |++|+||+|+||+++.++.++|+|||++..
T Consensus       118 lv~e~~~~~~L~~~~----~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  190 (335)
T 2owb_A          118 VVLELCRRRSLLELH----KRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATK  190 (335)
T ss_dssp             EEECCCTTCBHHHHH----HHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEecCCCCCHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCcee
Confidence            999999999999998    3456789999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhh
Q 018263          197 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV  276 (358)
Q Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                      ...... ......++..|+|||++.+..++.++||||||+++|+|++|+.||...........+.               
T Consensus       191 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---------------  254 (335)
T 2owb_A          191 VEYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK---------------  254 (335)
T ss_dssp             CCSTTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH---------------
T ss_pred             cccCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHh---------------
Confidence            543222 2234568999999999998889999999999999999999999997543221111110               


Q ss_pred             ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          277 DPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       277 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ..  ....+...+..+.+++.+||+.||.+|||+.++++
T Consensus       255 ~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          255 KN--EYSIPKHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             HT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             cC--CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00  01123344567889999999999999999999986

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=5.5e-42  Score=331.75  Aligned_cols=250  Identities=23%  Similarity=0.324  Sum_probs=207.9

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI  116 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~  116 (358)
                      .++|++.+.||+|+||.||+|+.+ +|+.||+|++....   ......+..|+.+++.++  ||||+++++++......|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~--hp~Iv~l~~~~~~~~~l~  261 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH--SRFIVSLAYAFETKTDLC  261 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC--CTTBCCEEEEEECSSEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcC--CCCEeeEEEEEeeCCEEE
Confidence            478999999999999999999986 69999999996432   234467888999999998  999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       117 iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      +||||++|++|.+++.........+++..++.++.||+.||.|||++   ||+||||||+||+++.+|.+||+|||++..
T Consensus       262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~  338 (543)
T 3c4z_A          262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVE  338 (543)
T ss_dssp             EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeee
Confidence            99999999999999965444456799999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchh-hhHhhhhccchhhHhhh
Q 018263          197 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYH-LVDKAWGMYNSKELMNL  275 (358)
Q Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~  275 (358)
                      ...... ......||+.|+|||++.+..++.++|+|||||++|+|++|+.||.......... ....+            
T Consensus       339 ~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i------------  405 (543)
T 3c4z_A          339 LKAGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV------------  405 (543)
T ss_dssp             CCTTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHH------------
T ss_pred             ccCCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHH------------
Confidence            543322 2234579999999999999999999999999999999999999998654322111 11111            


Q ss_pred             hccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 018263          276 VDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQM  310 (358)
Q Consensus       276 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~  310 (358)
                      ...  ...++...+..+.++|.+||+.||.+||++
T Consensus       406 ~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          406 LEQ--AVTYPDKFSPASKDFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             HHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred             hhc--ccCCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence            111  122345567789999999999999999975

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.9e-42  Score=316.88  Aligned_cols=264  Identities=25%  Similarity=0.373  Sum_probs=209.5

Q ss_pred             HhhcCCcccceecccCceEEEEEEE------CCCCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEc
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRL------QDGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID  111 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~------~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~  111 (358)
                      +..++|++.+.||+|+||.||+|++      .++..||+|.+... .......+.+|+..++.+.  ||||+++++++..
T Consensus        27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~  104 (327)
T 2yfx_A           27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN--HQNIVRCIGVSLQ  104 (327)
T ss_dssp             CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCC--CTTBCCEEEEECS
T ss_pred             CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCC--CCCCCeEEEEEcC
Confidence            4578999999999999999999983      25778999998644 3455567889999999997  9999999999999


Q ss_pred             CCeeEEEEecCCCCCHHHHhhhccc---cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcC---CCc
Q 018263          112 GPCRILVYDYMPNNSLSQTLLGEEK---RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ---NFN  185 (358)
Q Consensus       112 ~~~~~iv~e~~~~~~L~~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~---~~~  185 (358)
                      ....++||||+++++|.+++.....   ....+++..++.++.||+.||.|||+.   |++|+||+|+||+++.   +..
T Consensus       105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~  181 (327)
T 2yfx_A          105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRV  181 (327)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCC
T ss_pred             CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcce
Confidence            9999999999999999999954332   124589999999999999999999999   9999999999999984   446


Q ss_pred             eEEeecccccccCCCC-cccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhh
Q 018263          186 PKISDFGLSKLFPENT-THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKA  263 (358)
Q Consensus       186 ~~l~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~  263 (358)
                      ++|+|||++....... ........++..|+|||++.+..++.++||||||+++|+|++ |..||........       
T Consensus       182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-------  254 (327)
T 2yfx_A          182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV-------  254 (327)
T ss_dssp             EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-------
T ss_pred             EEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHH-------
Confidence            9999999987542222 122233567889999999998899999999999999999998 9999975432211       


Q ss_pred             hhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCC
Q 018263          264 WGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNI  323 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~  323 (358)
                               ...+........+...+..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus       255 ---------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  305 (327)
T 2yfx_A          255 ---------LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  305 (327)
T ss_dssp             ---------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             ---------HHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence                     111111112233445567899999999999999999999999999887643

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.7e-42  Score=318.18  Aligned_cols=242  Identities=20%  Similarity=0.272  Sum_probs=202.2

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccCh--------hhHHHHHHHHHHhhhcccCCCCceeeeceEEc
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK--------QGEKEFMSEVASMANVNVCHENLVKLHGGCID  111 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~  111 (358)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++.....        .....+.+|+..++.++  ||||+++++++..
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~Iv~~~~~~~~  100 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE--HANIIKVLDIFEN  100 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCC--CTTBCCEEEEEEC
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCC--CCCEeeEEEEEee
Confidence            579999999999999999999965 688999999875421        13345667999999998  9999999999999


Q ss_pred             CCeeEEEEecCCCC-CHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEee
Q 018263          112 GPCRILVYDYMPNN-SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD  190 (358)
Q Consensus       112 ~~~~~iv~e~~~~~-~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~D  190 (358)
                      .+..++||||+.++ +|.+++    .....+++..++.++.||+.||.|||++   |++|+||||+||+++.++.++|+|
T Consensus       101 ~~~~~lv~e~~~~g~~l~~~~----~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~D  173 (335)
T 3dls_A          101 QGFFQLVMEKHGSGLDLFAFI----DRHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLID  173 (335)
T ss_dssp             SSEEEEEEECCTTSCBHHHHH----HTCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECC
T ss_pred             CCEEEEEEEeCCCCccHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEee
Confidence            99999999998666 999998    4456799999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccCccCccccccCCC-CccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccch
Q 018263          191 FGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNS  269 (358)
Q Consensus       191 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      ||++........  .....+|+.|+|||++.+..+ +.++||||||+++|+|++|..||......               
T Consensus       174 fg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------------  236 (335)
T 3dls_A          174 FGSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------------  236 (335)
T ss_dssp             CTTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------------
T ss_pred             cccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------------
Confidence            999987543322  234568999999999988776 78999999999999999999999642110               


Q ss_pred             hhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 018263          270 KELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKM  316 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~  316 (358)
                            ....  ...+...+..+.+++.+||+.||.+|||+.++++-
T Consensus       237 ------~~~~--~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          237 ------VEAA--IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             ------TTTC--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             ------Hhhc--cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                  0000  01122245678999999999999999999999873

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=5.8e-42  Score=305.86  Aligned_cols=248  Identities=24%  Similarity=0.340  Sum_probs=198.3

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCee
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR  115 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~  115 (358)
                      ..++|++.+.||+|++|.||+|.+. +|+.|++|++....   ......+.+|+..++.++  ||||+++++++...+..
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~   86 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR--HPHIIKLYQVISTPTDF   86 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC--CTTBCCEEEEEECSSEE
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCC--CCCEeEEEEEEecCCeE
Confidence            4579999999999999999999986 79999999986542   234567889999999998  99999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccc
Q 018263          116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK  195 (358)
Q Consensus       116 ~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~  195 (358)
                      ++||||+++++|.+++.    ....+++..++.++.||+.||.|||++   |++|+||+|+||+++.++.++|+|||++.
T Consensus        87 ~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~  159 (276)
T 2h6d_A           87 FMVMEYVSGGELFDYIC----KHGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSN  159 (276)
T ss_dssp             EEEEECCCSCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGG
T ss_pred             EEEEeccCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeeccccc
Confidence            99999999999999993    445689999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCcccccccccccCccCccccccCCC-CccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhh
Q 018263          196 LFPENTTHISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMN  274 (358)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                      ......  ......+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||..........   .+.          
T Consensus       160 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~---~~~----------  224 (276)
T 2h6d_A          160 MMSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFK---KIR----------  224 (276)
T ss_dssp             CCCC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHH----------
T ss_pred             ccCCCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH---Hhh----------
Confidence            754322  2233568899999999887765 689999999999999999999997543211111   110          


Q ss_pred             hhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          275 LVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                         .. ....+...+..+.+++.+||+.||.+|||+.++++
T Consensus       225 ---~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          225 ---GG-VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             ---HC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---cC-cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence               00 01123334567899999999999999999999987

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=8.6e-42  Score=320.82  Aligned_cols=252  Identities=18%  Similarity=0.220  Sum_probs=191.0

Q ss_pred             hcCCccc-ceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEc----CCe
Q 018263           41 TNGFRWS-NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID----GPC  114 (358)
Q Consensus        41 ~~~y~i~-~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~----~~~  114 (358)
                      .++|.+. +.||.|+||.||++.+. +|+.||||++...     ..+.+|+..+..+. .||||+++++++..    ...
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~-~hp~iv~l~~~~~~~~~~~~~  133 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKC  133 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHT-TSTTBCCEEEEEEEEETTEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhc-CCCCcceEeEEEeecccCCcE
Confidence            4567776 68999999999999976 6899999998632     34557777765443 49999999999875    567


Q ss_pred             eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcC---CCceEEeec
Q 018263          115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ---NFNPKISDF  191 (358)
Q Consensus       115 ~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~---~~~~~l~Df  191 (358)
                      .++||||++|++|.+++..  .....+++..++.++.||+.||.|||+.   ||+||||||+||+++.   ++.+||+||
T Consensus       134 ~~lv~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DF  208 (400)
T 1nxk_A          134 LLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF  208 (400)
T ss_dssp             EEEEEECCCSEEHHHHHHC--C---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred             EEEEEEeCCCCcHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEec
Confidence            8999999999999999943  2234689999999999999999999999   9999999999999987   788999999


Q ss_pred             ccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchh-hhHhhhhccchh
Q 018263          192 GLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYH-LVDKAWGMYNSK  270 (358)
Q Consensus       192 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~-~~~~~~~~~~~~  270 (358)
                      |++.......  ......+|+.|+|||++.+..++.++||||||+++|+|++|+.||.......... ....+..     
T Consensus       209 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~-----  281 (400)
T 1nxk_A          209 GFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM-----  281 (400)
T ss_dssp             TTCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH-----
T ss_pred             ccccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc-----
Confidence            9998653322  2234678999999999988899999999999999999999999997654332111 1111100     


Q ss_pred             hHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          271 ELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                           -............+..+.+||.+||+.||.+|||+.++++
T Consensus       282 -----~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  321 (400)
T 1nxk_A          282 -----GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  321 (400)
T ss_dssp             -----TCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -----CcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                 0000000111235667899999999999999999999987

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=6.2e-42  Score=331.40  Aligned_cols=252  Identities=25%  Similarity=0.351  Sum_probs=203.2

Q ss_pred             HhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccCh-------------hhHHHHHHHHHHhhhcccCCCCcee
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK-------------QGEKEFMSEVASMANVNVCHENLVK  104 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~-------------~~~~~~~~e~~~l~~l~~~h~~i~~  104 (358)
                      ...++|++++.||+|+||.||+|... +++.||+|++.....             .....+.+|+.+++.++  ||||++
T Consensus        33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~  110 (504)
T 3q5i_A           33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD--HPNIIK  110 (504)
T ss_dssp             CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC--CTTBCC
T ss_pred             CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC--CCCCCe
Confidence            35689999999999999999999976 588999999865321             33567889999999998  999999


Q ss_pred             eeceEEcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCC
Q 018263          105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF  184 (358)
Q Consensus       105 ~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~  184 (358)
                      +++++......++||||++|++|.+.+    .....+++..++.++.||+.||.|||++   ||+|+||||+||+++.++
T Consensus       111 ~~~~~~~~~~~~lv~e~~~gg~L~~~l----~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~  183 (504)
T 3q5i_A          111 LFDVFEDKKYFYLVTEFYEGGELFEQI----INRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKN  183 (504)
T ss_dssp             EEEEEECSSEEEEEEECCTTCBHHHHH----HHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTT
T ss_pred             EEEEEEcCCEEEEEEecCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCC
Confidence            999999999999999999999999998    3456799999999999999999999999   999999999999998776


Q ss_pred             ---ceEEeecccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhH
Q 018263          185 ---NPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVD  261 (358)
Q Consensus       185 ---~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~  261 (358)
                         .++|+|||++.......  ......||+.|+|||++. ..++.++||||||+++|+|++|..||...........+.
T Consensus       184 ~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  260 (504)
T 3q5i_A          184 SLLNIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE  260 (504)
T ss_dssp             CCSSEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CCccEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence               69999999998764332  233457999999999876 468999999999999999999999998654332222221


Q ss_pred             hhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          262 KAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .....+....+             ...+..+.+||.+||+.||.+|||+.++++
T Consensus       261 ~~~~~~~~~~~-------------~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          261 KGKYYFDFNDW-------------KNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             HCCCCCCHHHH-------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cCCCCCCcccc-------------CCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            11000000000             123567899999999999999999999975

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.9e-42  Score=316.59  Aligned_cols=282  Identities=26%  Similarity=0.377  Sum_probs=202.9

Q ss_pred             HHhhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEE-----cC
Q 018263           38 KIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCI-----DG  112 (358)
Q Consensus        38 ~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~-----~~  112 (358)
                      .+..++|++.+.||+|+||.||+|+. +++.||+|++...... ......++..+..+.  ||||+++++.+.     ..
T Consensus         9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~-~~~~e~~~~~~~~~~--h~~i~~~~~~~~~~~~~~~   84 (336)
T 3g2f_A            9 SLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ-NFINEKNIYRVPLME--HDNIARFIVGDERVTADGR   84 (336)
T ss_dssp             CCCTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHH-HHHHHHHHHTSTTCC--CTTBCCEEEEEEEECTTSC
T ss_pred             CcChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccchh-hHHHHHHHHHHHhcc--CcchhhheecccccccCCC
Confidence            34568999999999999999999987 5899999998744322 122223444444455  999999997543     23


Q ss_pred             CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCC------CCCcEEcCCCCCcEEEcCCCce
Q 018263          113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI------QPHVVHRDIKTSNILLDQNFNP  186 (358)
Q Consensus       113 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~------~~~i~H~di~p~Nilv~~~~~~  186 (358)
                      ...++||||+++++|.+++.     ....++..++.++.||+.||.|||+..      ..||+|+||||+||+++.++.+
T Consensus        85 ~~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~  159 (336)
T 3g2f_A           85 MEYLLVMEYYPNGSLXKYLS-----LHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC  159 (336)
T ss_dssp             EEEEEEECCCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred             ceEEEEEecCCCCcHHHHHh-----hcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcE
Confidence            35689999999999999993     334588999999999999999999752      2289999999999999999999


Q ss_pred             EEeecccccccCCCC-------cccccccccccCccCcccccc-------CCCCccCceecHHHHHHHHHhCCCCCCccc
Q 018263          187 KISDFGLSKLFPENT-------THISTRVAGTLGYLAPEYAIS-------GRLTRKSDVYSFGVLLLEIVSGRTAVDFDV  252 (358)
Q Consensus       187 ~l~Dfg~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~-------~~~s~~sDiwslG~il~~lltg~~pf~~~~  252 (358)
                      ||+|||++.......       ........||+.|+|||++.+       ..++.++||||||+++|+|++|..||....
T Consensus       160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~  239 (336)
T 3g2f_A          160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE  239 (336)
T ss_dssp             EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred             EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence            999999998654321       112223568999999999876       356678999999999999999987775443


Q ss_pred             cccchhhh-H-hhhhccchhhHhhhh-ccccCCCCC------HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCC
Q 018263          253 QLGEYHLV-D-KAWGMYNSKELMNLV-DPMLYGNFP------ENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNI  323 (358)
Q Consensus       253 ~~~~~~~~-~-~~~~~~~~~~~~~~~-~~~~~~~~~------~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~  323 (358)
                      ........ . ..............+ ....+..++      ...+..+.++|.+||+.||.+|||+.|+++.|+.+...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~  319 (336)
T 3g2f_A          240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI  319 (336)
T ss_dssp             CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             chhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence            32222111 1 111111111112111 111222222      34777899999999999999999999999999998755


Q ss_pred             CCCCC
Q 018263          324 DGXDV  328 (358)
Q Consensus       324 ~~~~~  328 (358)
                      .....
T Consensus       320 ~~~~~  324 (336)
T 3g2f_A          320 WERNK  324 (336)
T ss_dssp             CCC--
T ss_pred             HHhcc
Confidence            54433

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=4.4e-42  Score=317.04  Aligned_cols=245  Identities=24%  Similarity=0.359  Sum_probs=200.6

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      ++|++.+.||+|+||.||+|+.. +|+.||||++....   ......+.+|+..++.++  ||||+++++++...+..++
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~l  131 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR--HPNTIQYRGCYLREHTAWL  131 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCC--CTTBCCEEEEEEETTEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCC--CCCEeeEEEEEEECCeEEE
Confidence            56999999999999999999974 78999999987542   233467889999999998  9999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      ||||+. ++|.+.+.   .....+++..++.++.|++.||.|||++   |++|+||||+||+++.++.++|+|||++...
T Consensus       132 v~e~~~-g~l~~~l~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~  204 (348)
T 1u5q_A          132 VMEYCL-GSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM  204 (348)
T ss_dssp             EEECCS-EEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred             EEecCC-CCHHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceec
Confidence            999996 57888773   2346789999999999999999999999   9999999999999999999999999999765


Q ss_pred             CCCCcccccccccccCccCccccc---cCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhh
Q 018263          198 PENTTHISTRVAGTLGYLAPEYAI---SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMN  274 (358)
Q Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                      ...     ....+++.|+|||++.   +..++.++||||||+++|+|++|+.||...........+              
T Consensus       205 ~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~--------------  265 (348)
T 1u5q_A          205 APA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--------------  265 (348)
T ss_dssp             SSB-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--------------
T ss_pred             CCC-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--------------
Confidence            322     2356899999999885   467899999999999999999999999754322211111              


Q ss_pred             hhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          275 LVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                       .........+...+..+.++|.+||+.||.+|||+.++++
T Consensus       266 -~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          266 -AQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             -HHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -HhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence             1111111112334567889999999999999999999976

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.3e-42  Score=320.61  Aligned_cols=272  Identities=20%  Similarity=0.236  Sum_probs=205.5

Q ss_pred             CHHHHHHhhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccC-----------hhhHHHHHHHHHHhhhcccCCCC
Q 018263           33 SYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVES-----------KQGEKEFMSEVASMANVNVCHEN  101 (358)
Q Consensus        33 ~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~-----------~~~~~~~~~e~~~l~~l~~~h~~  101 (358)
                      ....+....++|++.+.||+|+||.||+|.+.+|+.||+|++....           ....+.+.+|+..++.++  |||
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~   90 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH--HPN   90 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCC--CTT
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCC--CcC
Confidence            3556777889999999999999999999998889999999985432           122377889999999998  999


Q ss_pred             ceeeeceEEc-----CCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCC
Q 018263          102 LVKLHGGCID-----GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTS  176 (358)
Q Consensus       102 i~~~~~~~~~-----~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~  176 (358)
                      |+++++++..     ....++||||++ ++|.+.+.   .....+++..++.++.||+.||.|||++   |++|+||+|+
T Consensus        91 iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~  163 (362)
T 3pg1_A           91 ILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIH---DQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPG  163 (362)
T ss_dssp             BCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHH---CTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGG
T ss_pred             ccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChH
Confidence            9999999854     336799999996 67888873   3445789999999999999999999999   9999999999


Q ss_pred             cEEEcCCCceEEeecccccccCCCCcccccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCCCCCCcccccc
Q 018263          177 NILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG  255 (358)
Q Consensus       177 Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~  255 (358)
                      ||+++.++.++|+|||++.......  ......+++.|+|||++.+ ..++.++||||||+++|+|++|+.||.......
T Consensus       164 NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~  241 (362)
T 3pg1_A          164 NILLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN  241 (362)
T ss_dssp             GEEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             HEEEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence            9999999999999999997543222  2234568899999998876 678999999999999999999999998765544


Q ss_pred             chhhhHhhhhccchhh--------HhhhhccccCCC-------CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          256 EYHLVDKAWGMYNSKE--------LMNLVDPMLYGN-------FPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       256 ~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ....+....+.+....        ....+.......       .....+..+.+|+.+||+.||.+|||+.++++
T Consensus       242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          242 QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            4433333222222111        111111111110       11233567899999999999999999999986

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.6e-42  Score=311.68  Aligned_cols=261  Identities=26%  Similarity=0.406  Sum_probs=201.2

Q ss_pred             hhcCCcccceecccCceEEEEEEEC--CCC--EEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ--DGT--IVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG  112 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~--~~~--~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~  112 (358)
                      ..++|++.+.||+|+||.||+|++.  +++  .|++|++...   .......+.+|+..++.++  ||||+++++++...
T Consensus        16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~   93 (291)
T 1u46_A           16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD--HRNLIRLYGVVLTP   93 (291)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC--CTTBCCEEEEECSS
T ss_pred             chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCC--CCCcccEEEEEccC
Confidence            4679999999999999999999853  333  6899998654   3345578889999999998  99999999999876


Q ss_pred             CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecc
Q 018263          113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG  192 (358)
Q Consensus       113 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg  192 (358)
                      . .++|+||+++++|.+++..   ....+++..++.++.||+.||.|||++   |++|+||+|+||+++.++.++|+|||
T Consensus        94 ~-~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg  166 (291)
T 1u46_A           94 P-MKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFG  166 (291)
T ss_dssp             S-CEEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCT
T ss_pred             C-ceeeEecccCCCHHHHHHh---ccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccc
Confidence            5 8899999999999999843   245689999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcc--cccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccch
Q 018263          193 LSKLFPENTTH--ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNS  269 (358)
Q Consensus       193 ~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      ++.........  ......++..|+|||++.+..++.++||||||+++|+|++ |+.||..........           
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~-----------  235 (291)
T 1u46_A          167 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH-----------  235 (291)
T ss_dssp             TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH-----------
T ss_pred             ccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHH-----------
Confidence            99876433321  1223456778999999988889999999999999999999 999997543221111           


Q ss_pred             hhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCC
Q 018263          270 KELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNID  324 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~  324 (358)
                          .+.........+...+..+.+++.+||+.||.+|||+.++++.|++++...
T Consensus       236 ----~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  286 (291)
T 1u46_A          236 ----KIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD  286 (291)
T ss_dssp             ----HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             ----HHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence                111111112233456678999999999999999999999999999887644

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.9e-42  Score=311.10  Aligned_cols=257  Identities=23%  Similarity=0.308  Sum_probs=191.2

Q ss_pred             HHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC-hhhH-HHHHHHHHHhhhcccCCCCceeeeceEEcCCe
Q 018263           38 KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGE-KEFMSEVASMANVNVCHENLVKLHGGCIDGPC  114 (358)
Q Consensus        38 ~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~-~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~  114 (358)
                      .+..++|++.+.||+|+||.||+|.+. +|+.||+|++.... .... ..+.++...++.+.  ||||+++++++...+.
T Consensus         3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~--h~~iv~~~~~~~~~~~   80 (290)
T 3fme_A            3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVD--CPFTVTFYGALFREGD   80 (290)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCC--CTTBCCEEEEEECSSS
T ss_pred             cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCC--CCeEEEEeeeeeccCC
Confidence            345789999999999999999999975 68999999986542 2222 33334444466666  9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccc
Q 018263          115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS  194 (358)
Q Consensus       115 ~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~  194 (358)
                      .++||||++ ++|.+++.........+++..++.++.||+.||+|||++.  |++|+||+|+||+++.++.++|+|||++
T Consensus        81 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  157 (290)
T 3fme_A           81 VWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGIS  157 (290)
T ss_dssp             EEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC---
T ss_pred             EEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCc
Confidence            999999996 5888888554456678999999999999999999999831  9999999999999999999999999999


Q ss_pred             cccCCCCcccccccccccCccCcccc----ccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchh
Q 018263          195 KLFPENTTHISTRVAGTLGYLAPEYA----ISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSK  270 (358)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      ........  .....+++.|+|||++    .+..++.++||||||+++|+|++|+.||.......              .
T Consensus       158 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------------~  221 (290)
T 3fme_A          158 GYLVDDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF--------------Q  221 (290)
T ss_dssp             --------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH--------------H
T ss_pred             cccccccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH--------------H
Confidence            76543222  2234689999999996    45678999999999999999999999997432110              1


Q ss_pred             hHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          271 ELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .....+............+..+.+++.+||+.||.+|||+.++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          222 QLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             HHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            111111111112222345667999999999999999999999976

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3.1e-42  Score=332.01  Aligned_cols=252  Identities=26%  Similarity=0.341  Sum_probs=207.6

Q ss_pred             HhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCe
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC  114 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~  114 (358)
                      +..++|++.+.||+|+||.||+|+.. +|+.||+|++...   .......+.+|+..++.++  ||||+++++++...+.
T Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~  100 (484)
T 3nyv_A           23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD--HPNIMKLYEFFEDKGY  100 (484)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCC--CTTBCCEEEEEECSSE
T ss_pred             cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCC--CCCCCcEEEEEEeCCE
Confidence            44678999999999999999999976 7999999998644   2445678899999999998  9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEE---cCCCceEEeec
Q 018263          115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL---DQNFNPKISDF  191 (358)
Q Consensus       115 ~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv---~~~~~~~l~Df  191 (358)
                      .++||||+.+++|.+.+    .....+++..++.++.||+.||.|||++   ||+|+||||+||++   +.++.++|+||
T Consensus       101 ~~lv~e~~~~~~L~~~~----~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Df  173 (484)
T 3nyv_A          101 FYLVGEVYTGGELFDEI----ISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDF  173 (484)
T ss_dssp             EEEEECCCCSCBHHHHH----HTCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCT
T ss_pred             EEEEEecCCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEee
Confidence            99999999999999998    3456799999999999999999999999   99999999999999   56789999999


Q ss_pred             ccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhh
Q 018263          192 GLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKE  271 (358)
Q Consensus       192 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      |++.......  ......||+.|+|||++.+ .++.++||||||+++|+|++|.+||...........+......+.   
T Consensus       174 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~---  247 (484)
T 3nyv_A          174 GLSTHFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFE---  247 (484)
T ss_dssp             THHHHBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC---
T ss_pred             eeeEEccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC---
Confidence            9998654332  2234568999999998866 689999999999999999999999986543322222111100000   


Q ss_pred             HhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          272 LMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                                .......+..+.+||.+||+.+|.+|||+.++++
T Consensus       248 ----------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          248 ----------LPQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             ----------SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence                      0011234567899999999999999999999985

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=6.7e-42  Score=324.46  Aligned_cols=265  Identities=21%  Similarity=0.265  Sum_probs=206.2

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcc----cCCCCceeeeceEEcCCe
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVN----VCHENLVKLHGGCIDGPC  114 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~----~~h~~i~~~~~~~~~~~~  114 (358)
                      ...+|++.+.||+|+||.||+|.+. +++.||||++... ......+.+|+.++..+.    ..|+||+.+++.+...+.
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  173 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH  173 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence            3568999999999999999999876 5899999999643 334456667777777663    137899999999999999


Q ss_pred             eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCc--eEEeecc
Q 018263          115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN--PKISDFG  192 (358)
Q Consensus       115 ~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~--~~l~Dfg  192 (358)
                      .++||||+. ++|.+++...  ....+++..++.++.||+.||+|||+.   ||+||||||+||+++.++.  ++|+|||
T Consensus       174 ~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG  247 (429)
T 3kvw_A          174 ICMTFELLS-MNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFG  247 (429)
T ss_dssp             EEEEECCCC-CBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred             EEEEEeccC-CCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecc
Confidence            999999995 6899988432  334589999999999999999999999   9999999999999999887  9999999


Q ss_pred             cccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhH
Q 018263          193 LSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKEL  272 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      ++......    .....+|+.|+|||++.+..++.++|||||||++|+|++|.+||......+....+....+.+...-.
T Consensus       248 ~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~  323 (429)
T 3kvw_A          248 SSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL  323 (429)
T ss_dssp             TCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             cceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence            99764322    23356899999999999999999999999999999999999999877665544444333322221111


Q ss_pred             ------hhhhccccC----------------------------C--------CCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 018263          273 ------MNLVDPMLY----------------------------G--------NFPENEAIRFLKVGLLCVQEKSKLRPQM  310 (358)
Q Consensus       273 ------~~~~~~~~~----------------------------~--------~~~~~~~~~l~~li~~~l~~~P~~Rpt~  310 (358)
                            ..+++....                            .        ..+...+..+.+||.+||+.||.+|||+
T Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta  403 (429)
T 3kvw_A          324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTP  403 (429)
T ss_dssp             HTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             HhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCH
Confidence                  001100000                            0        0011125678999999999999999999


Q ss_pred             HHHHH
Q 018263          311 STAIK  315 (358)
Q Consensus       311 ~eil~  315 (358)
                      .|+++
T Consensus       404 ~e~L~  408 (429)
T 3kvw_A          404 GQALR  408 (429)
T ss_dssp             HHHHT
T ss_pred             HHHhC
Confidence            99986

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=4.9e-42  Score=322.03  Aligned_cols=269  Identities=21%  Similarity=0.274  Sum_probs=208.4

Q ss_pred             hcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCe------
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC------  114 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~------  114 (358)
                      ..+|++.+.||+|+||.||+|++..+..||+|.+......    ..+|+.+++.++  ||||+++++++...+.      
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~--h~niv~l~~~~~~~~~~~~~~~  112 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVK--HPNVVDLKAFFYSNGDKKDEVF  112 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCC--CTTBCCEEEEEEEESSSSSCEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCC--CCCcceEEEEEEecCCCCCceE
Confidence            4579999999999999999999877777898887543322    226889999998  9999999999865443      


Q ss_pred             eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEc-CCCceEEeeccc
Q 018263          115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD-QNFNPKISDFGL  193 (358)
Q Consensus       115 ~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~-~~~~~~l~Dfg~  193 (358)
                      .++||||+++ ++...+.........+++..++.++.||+.||+|||++   ||+||||||+||+++ .++.+||+|||+
T Consensus       113 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~  188 (394)
T 4e7w_A          113 LNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGS  188 (394)
T ss_dssp             EEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence            7899999965 45555543334567899999999999999999999999   999999999999999 799999999999


Q ss_pred             ccccCCCCcccccccccccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhH
Q 018263          194 SKLFPENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKEL  272 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      +........  .....+++.|+|||++.+. .++.++|||||||++|+|++|+.||......+....+....+.+....+
T Consensus       189 a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~  266 (394)
T 4e7w_A          189 AKILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI  266 (394)
T ss_dssp             CEECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             cccccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            986533222  2345689999999998765 5899999999999999999999999887666555555554444444333


Q ss_pred             hhhhccccCC------------CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--hhcCC
Q 018263          273 MNLVDPMLYG------------NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKM--MNGET  321 (358)
Q Consensus       273 ~~~~~~~~~~------------~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~--L~~~~  321 (358)
                      ...-......            .++...+..+.+|+.+||+.||.+|||+.|+++-  ++++.
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  329 (394)
T 4e7w_A          267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR  329 (394)
T ss_dssp             HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred             HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence            3221111100            1122355689999999999999999999999873  55544

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.7e-42  Score=313.80  Aligned_cols=263  Identities=22%  Similarity=0.357  Sum_probs=205.4

Q ss_pred             cccCHHHHHHhhcCCcccceecccCceEEEEEEECCCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeec
Q 018263           30 NAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHG  107 (358)
Q Consensus        30 ~~~~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~  107 (358)
                      .++....+.+..++|++.+.||+|+||.||++.+.+++.||+|++...  .......+.+|+..+..+...||||+++++
T Consensus        16 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~   95 (313)
T 3cek_A           16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD   95 (313)
T ss_dssp             ----CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred             CCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEE
Confidence            344445556678899999999999999999999988999999998754  344557788999999999744699999999


Q ss_pred             eEEcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceE
Q 018263          108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPK  187 (358)
Q Consensus       108 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~  187 (358)
                      ++...+..+++|| +.+++|.+++    .....+++..++.++.||+.||.|||++   |++|+||+|+||++++ +.++
T Consensus        96 ~~~~~~~~~lv~e-~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~k  166 (313)
T 3cek_A           96 YEITDQYIYMVME-CGNIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLK  166 (313)
T ss_dssp             EEECSSEEEEEEC-CCSEEHHHHH----HHCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEE
T ss_pred             EeecCCEEEEEEe-cCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEE
Confidence            9999999999999 5588999999    3456789999999999999999999999   9999999999999965 7999


Q ss_pred             EeecccccccCCCCcc-cccccccccCccCcccccc-----------CCCCccCceecHHHHHHHHHhCCCCCCcccccc
Q 018263          188 ISDFGLSKLFPENTTH-ISTRVAGTLGYLAPEYAIS-----------GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG  255 (358)
Q Consensus       188 l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-----------~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~  255 (358)
                      |+|||++......... ......+++.|+|||++.+           ..++.++||||||+++|+|++|+.||...... 
T Consensus       167 L~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-  245 (313)
T 3cek_A          167 LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-  245 (313)
T ss_dssp             ECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-
T ss_pred             EeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-
Confidence            9999999865432221 2233568999999999865           46788999999999999999999999643211 


Q ss_pred             chhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          256 EYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                                   .......++......++...+..+.+++.+||+.||.+|||+.++++
T Consensus       246 -------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          246 -------------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             -------------HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -------------HHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence                         11122223333333344444667999999999999999999999986

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.2e-41  Score=316.95  Aligned_cols=261  Identities=21%  Similarity=0.259  Sum_probs=196.9

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC----
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP----  113 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~----  113 (358)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++...  .......+.+|+..++.++  ||||+++++++....    
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~~  101 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN--HKNIIGLLNVFTPQKSLEE  101 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCC--CTTBCCEEEEECSCCSTTT
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcC--CCCccceEEeecccccccc
Confidence            479999999999999999999875 6889999998753  3445567889999999998  999999999998665    


Q ss_pred             --eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeec
Q 018263          114 --CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF  191 (358)
Q Consensus       114 --~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Df  191 (358)
                        ..++||||++ ++|.+.+.      ..+++..+..++.||+.||.|||++   |++|+||||+||+++.++.++|+||
T Consensus       102 ~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df  171 (371)
T 2xrw_A          102 FQDVYIVMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  171 (371)
T ss_dssp             CCEEEEEEECCS-EEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCC
T ss_pred             ccceEEEEEcCC-CCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEe
Confidence              6799999996 57888772      3488999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchh-
Q 018263          192 GLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSK-  270 (358)
Q Consensus       192 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~-  270 (358)
                      |++.......  ......++..|+|||++.+..++.++||||||+++|+|++|+.||...........+....+..... 
T Consensus       172 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  249 (371)
T 2xrw_A          172 GLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF  249 (371)
T ss_dssp             CC------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHH
T ss_pred             eccccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            9998653321  2234578999999999999899999999999999999999999998765443333222211111110 


Q ss_pred             ---------------------hHhhhhccccCCC---CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          271 ---------------------ELMNLVDPMLYGN---FPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       271 ---------------------~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                                           .+.........+.   .....+..+.+|+.+||+.||.+|||+.|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          250 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             HTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence                                 0111111111010   11234678999999999999999999999986

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.5e-42  Score=322.30  Aligned_cols=260  Identities=25%  Similarity=0.317  Sum_probs=192.6

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC-----
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG-----  112 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~-----  112 (358)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++...  .......+.+|+..++.++  ||||+++++++...     
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~~~~~~  105 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--HENVIGLLDVFTPARSLEE  105 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC--CTTBCCCSEEECSCSSGGG
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCC--CCCCCcEEEEEecCCcccc
Confidence            589999999999999999999865 6899999998643  3445577889999999998  99999999998754     


Q ss_pred             -CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeec
Q 018263          113 -PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF  191 (358)
Q Consensus       113 -~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Df  191 (358)
                       ...++++|++ +++|.+++     ....+++..++.++.||+.||.|||+.   |++|+||||+||+++.++.++|+||
T Consensus       106 ~~~~~lv~e~~-~~~L~~~~-----~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DF  176 (367)
T 2fst_X          106 FNDVYLVTHLM-GADLNNIV-----KCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDF  176 (367)
T ss_dssp             CCCCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-
T ss_pred             CCeEEEEeccc-CCCHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeec
Confidence             5679999999 78999988     235799999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchh
Q 018263          192 GLSKLFPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSK  270 (358)
Q Consensus       192 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      |++......    .....+|..|+|||++.+ ..++.++|||||||++|+|++|+.||......+....+....+.+...
T Consensus       177 G~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~  252 (367)
T 2fst_X          177 GLARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE  252 (367)
T ss_dssp             ------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred             ccccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            999864322    234578999999999887 678999999999999999999999998776655555444443333222


Q ss_pred             hH--------hhhhccccCC-CCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          271 EL--------MNLVDPMLYG-NFP-----ENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       271 ~~--------~~~~~~~~~~-~~~-----~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .+        ...+...... ..+     ...+..+.+|+.+||+.||.+|||+.++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             HHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence            11        1111111110 000     123567899999999999999999999986

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.1e-42  Score=338.06  Aligned_cols=257  Identities=26%  Similarity=0.372  Sum_probs=206.7

Q ss_pred             hcCCcccc-eecccCceEEEEEEEC---CCCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCee
Q 018263           41 TNGFRWSN-KIGEGGFGSVYKGRLQ---DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR  115 (358)
Q Consensus        41 ~~~y~i~~-~lg~g~~g~v~~~~~~---~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~  115 (358)
                      .+++.+.+ .||+|+||.||+|.+.   ++..||||++... .......+.+|+.+++.++  ||||+++++++.. +..
T Consensus       334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~--hpniv~l~~~~~~-~~~  410 (613)
T 2ozo_A          334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD--NPYIVRLIGVCQA-EAL  410 (613)
T ss_dssp             TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCC--CTTBCCEEEEEES-SSE
T ss_pred             ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCC--CCCEeeEEEEecc-CCe
Confidence            34455555 7999999999999864   4667999999754 3345678999999999998  9999999999976 568


Q ss_pred             EEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccc
Q 018263          116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK  195 (358)
Q Consensus       116 ~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~  195 (358)
                      ++||||+++++|.+++.   .....+++..+..++.||+.||+|||++   +|+|+||||+||+++.++.+||+|||++.
T Consensus       411 ~lv~E~~~~g~L~~~l~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~  484 (613)
T 2ozo_A          411 MLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSK  484 (613)
T ss_dssp             EEEEECCTTCBHHHHHT---TCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTT
T ss_pred             EEEEEeCCCCcHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcc
Confidence            99999999999999983   2356689999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCccc--ccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhH
Q 018263          196 LFPENTTHI--STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKEL  272 (358)
Q Consensus       196 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      .........  .....++..|+|||++.+..++.++||||||+++|+|++ |+.||.......                .
T Consensus       485 ~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~----------------~  548 (613)
T 2ozo_A          485 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE----------------V  548 (613)
T ss_dssp             TCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH----------------H
T ss_pred             cccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH----------------H
Confidence            764332211  122345678999999999999999999999999999998 999997544322                1


Q ss_pred             hhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCC
Q 018263          273 MNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETN  322 (358)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~  322 (358)
                      ...+....+...+..++..+.++|.+||+.+|.+||++.+|++.|+.+..
T Consensus       549 ~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~  598 (613)
T 2ozo_A          549 MAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  598 (613)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence            12222222334455677889999999999999999999999999998653

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1e-42  Score=324.95  Aligned_cols=245  Identities=16%  Similarity=0.139  Sum_probs=189.7

Q ss_pred             hcCCcccceecccCceEEEEEEE-CCCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcc-cCCCCceeee-------ce
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRL-QDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVN-VCHENLVKLH-------GG  108 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~-~~h~~i~~~~-------~~  108 (358)
                      .++|++.+.||+|+||.||+|++ .+|+.||||++...   .....+.+.+|+.+++.+. ..||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46799999999999999999996 46999999998743   3445678889995544442 1399999998       55


Q ss_pred             EEcCC-----------------eeEEEEecCCCCCHHHHhhhccc---cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 018263          109 CIDGP-----------------CRILVYDYMPNNSLSQTLLGEEK---RRAKFGWKARREIIMGIGRGLAYIHEEIQPHV  168 (358)
Q Consensus       109 ~~~~~-----------------~~~iv~e~~~~~~L~~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i  168 (358)
                      +...+                 ..+++|||+ +++|.+++.....   ....+++..++.++.||+.||+|||++   ||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            55543                 278999999 6799999953211   112233588889999999999999999   99


Q ss_pred             EEcCCCCCcEEEcCCCceEEeecccccccCCCCcccccccccccCccCccccccC-----------CCCccCceecHHHH
Q 018263          169 VHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG-----------RLTRKSDVYSFGVL  237 (358)
Q Consensus       169 ~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~s~~sDiwslG~i  237 (358)
                      +|+||||+||+++.++.+||+|||++.....    ......| +.|+|||++.+.           .++.++||||||++
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i  302 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV  302 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence            9999999999999999999999999986322    2234557 999999999887           89999999999999


Q ss_pred             HHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          238 LLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       238 l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      +|+|++|+.||...........+...                     ....+..+.++|.+||+.||.+|||+.++++
T Consensus       303 l~elltg~~Pf~~~~~~~~~~~~~~~---------------------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          303 IYWIWCADLPITKDAALGGSEWIFRS---------------------CKNIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHHSSCCC------CCSGGGGSS---------------------CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHHCCCCCcccccccchhhhhhh---------------------ccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            99999999999755433222111100                     0123456899999999999999999999985

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.2e-41  Score=320.00  Aligned_cols=250  Identities=22%  Similarity=0.299  Sum_probs=193.0

Q ss_pred             HhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC--------hhhHHHHHHHHHHhhhcccCCCCceeeeceE
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--------KQGEKEFMSEVASMANVNVCHENLVKLHGGC  109 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~  109 (358)
                      ...++|++.+.||+|+||.||+|.+. +++.||+|++....        ......+.+|+..++.++  ||||+++++++
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~l~~~~  209 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN--HPCIIKIKNFF  209 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCC--CTTBCCCCEEE
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCC--CCCEeeEEEEE
Confidence            44689999999999999999999875 58999999986532        112235788999999998  99999999997


Q ss_pred             EcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCC---ce
Q 018263          110 IDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF---NP  186 (358)
Q Consensus       110 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~---~~  186 (358)
                      .. ...++||||+++++|.+.+    .....+++..++.++.||+.||+|||++   ||+|+||||+||+++.++   .+
T Consensus       210 ~~-~~~~lv~e~~~~g~L~~~l----~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~  281 (419)
T 3i6u_A          210 DA-EDYYIVLELMEGGELFDKV----VGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLI  281 (419)
T ss_dssp             ES-SEEEEEEECCTTCBGGGGT----SSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCE
T ss_pred             ec-CceEEEEEcCCCCcHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceE
Confidence            64 4579999999999999998    4556799999999999999999999999   999999999999997544   49


Q ss_pred             EEeecccccccCCCCcccccccccccCccCcccccc---CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhh
Q 018263          187 KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS---GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKA  263 (358)
Q Consensus       187 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~  263 (358)
                      ||+|||++.......  ......||+.|+|||++.+   ..++.++||||||+++|+|++|+.||............  +
T Consensus       282 kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~--i  357 (419)
T 3i6u_A          282 KITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ--I  357 (419)
T ss_dssp             EECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHH--H
T ss_pred             EEeecccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHH--H
Confidence            999999998754322  2334678999999999863   56788999999999999999999999754332221111  0


Q ss_pred             hhccchhhHhhhhccccCCCCC---HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          264 WGMYNSKELMNLVDPMLYGNFP---ENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .             .......+   ...+..+.+++.+||+.||.+|||+.++++
T Consensus       358 ~-------------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          358 T-------------SGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             H-------------TTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             h-------------cCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            0             00000000   123567899999999999999999999986

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=8.4e-42  Score=322.98  Aligned_cols=269  Identities=23%  Similarity=0.284  Sum_probs=207.5

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC------C
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG------P  113 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~------~  113 (358)
                      ..+|++.+.||+|+||.||+|++. +|+.||||++.....    ...+|+++++.++  ||||+++++++...      .
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~--hpniv~l~~~~~~~~~~~~~~  126 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLD--HCNIVRLRYFFYSSGEKKDEV  126 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCC--CTTBCCEEEEEEEEETTTTEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcC--CCCccceeeEEeccCCCCcce
Confidence            347999999999999999999986 599999999864322    2236899999998  99999999988542      2


Q ss_pred             eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCC-CceEEeecc
Q 018263          114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN-FNPKISDFG  192 (358)
Q Consensus       114 ~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~-~~~~l~Dfg  192 (358)
                      ..++||||+++ +|.+.+.........+++..++.++.||+.||.|||++   ||+||||||+||+++.+ +.+||+|||
T Consensus       127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG  202 (420)
T 1j1b_A          127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFG  202 (420)
T ss_dssp             EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccch
Confidence            36799999964 67777754445567899999999999999999999999   99999999999999955 568999999


Q ss_pred             cccccCCCCcccccccccccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhh
Q 018263          193 LSKLFPENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKE  271 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      ++........  .....++..|+|||++.+. .++.++|||||||++|+|++|+.||......+....+....+.+..+.
T Consensus       203 ~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~  280 (420)
T 1j1b_A          203 SAKQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ  280 (420)
T ss_dssp             TCEECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             hhhhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            9986543222  2345689999999998765 789999999999999999999999987765555544444444443333


Q ss_pred             HhhhhccccCC------------CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhhcCC
Q 018263          272 LMNLVDPMLYG------------NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK--MMNGET  321 (358)
Q Consensus       272 ~~~~~~~~~~~------------~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~--~L~~~~  321 (358)
                      +...-.....-            .++...+..+.+||.+||+.||.+|||+.|+++  .++.+.
T Consensus       281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~  344 (420)
T 1j1b_A          281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  344 (420)
T ss_dssp             HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence            33221110000            012334678999999999999999999999985  454443

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3.4e-41  Score=309.24  Aligned_cols=265  Identities=20%  Similarity=0.275  Sum_probs=207.1

Q ss_pred             hhcCCcccceecccCceEEEEEEE-C-CCCEEEEEEeeccChhhHHHHHHHHHHhhhccc----CCCCceeeeceEEcCC
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRL-Q-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNV----CHENLVKLHGGCIDGP  113 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~-~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~----~h~~i~~~~~~~~~~~  113 (358)
                      ..++|++.+.||+|+||.||+|.+ . +++.||+|++... ......+.+|+..++.+..    .|++++++++++...+
T Consensus        12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~   90 (339)
T 1z57_A           12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG   90 (339)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred             ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence            357999999999999999999987 3 6889999998643 3445677788888888761    1345999999999999


Q ss_pred             eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcC-----------
Q 018263          114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ-----------  182 (358)
Q Consensus       114 ~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~-----------  182 (358)
                      ..++||||+ +++|.+++...  ....+++..++.++.||+.||+|||++   |++|+||||+||+++.           
T Consensus        91 ~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~  164 (339)
T 1z57_A           91 HICIVFELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKI  164 (339)
T ss_dssp             EEEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC---
T ss_pred             cEEEEEcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcc
Confidence            999999999 88999998432  234688999999999999999999999   9999999999999987           


Q ss_pred             --------CCceEEeecccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccc
Q 018263          183 --------NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL  254 (358)
Q Consensus       183 --------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~  254 (358)
                              ++.++|+|||++......    .....+|..|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus       165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  240 (339)
T 1z57_A          165 KRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK  240 (339)
T ss_dssp             -CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred             ccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence                    668999999999864322    23356899999999999989999999999999999999999999876554


Q ss_pred             cchhhhHhhhhccchhhHhhh--------------------------hccc-cCCCCCHHHHHHHHHHHhhccCCCCCCC
Q 018263          255 GEYHLVDKAWGMYNSKELMNL--------------------------VDPM-LYGNFPENEAIRFLKVGLLCVQEKSKLR  307 (358)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~-~~~~~~~~~~~~l~~li~~~l~~~P~~R  307 (358)
                      .....+....+.....-....                          ..+. .....+...+..+.+++.+||+.||.+|
T Consensus       241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  320 (339)
T 1z57_A          241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR  320 (339)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence            433333332221111100000                          0000 0012234667889999999999999999


Q ss_pred             CCHHHHHH
Q 018263          308 PQMSTAIK  315 (358)
Q Consensus       308 pt~~eil~  315 (358)
                      ||+.|+++
T Consensus       321 pt~~ell~  328 (339)
T 1z57_A          321 ITLREALK  328 (339)
T ss_dssp             CCHHHHTT
T ss_pred             cCHHHHhc
Confidence            99999974

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.1e-41  Score=315.55  Aligned_cols=279  Identities=20%  Similarity=0.276  Sum_probs=202.6

Q ss_pred             HHHHHHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC
Q 018263           34 YNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG  112 (358)
Q Consensus        34 ~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~  112 (358)
                      ........++|++.+.||+|+||.||+|++. +|+.||||++.... .......+++..+..++  ||||+++++++...
T Consensus        15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~--h~niv~~~~~~~~~   91 (360)
T 3e3p_A           15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLH--HPNIVQLQSYFYTL   91 (360)
T ss_dssp             SHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHC--CTTBCCEEEEEEEE
T ss_pred             hhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcC--CCCcccHHHhhhcc
Confidence            3456677899999999999999999999975 68999999886432 23334567777788877  99999999998764


Q ss_pred             Ce-------eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHh--cCCCCCcEEcCCCCCcEEEcC-
Q 018263          113 PC-------RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH--EEIQPHVVHRDIKTSNILLDQ-  182 (358)
Q Consensus       113 ~~-------~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--~~~~~~i~H~di~p~Nilv~~-  182 (358)
                      ..       .++||||+++ +|...+.........+++..++.++.|++.||.|||  +.   ||+|+||||+||+++. 
T Consensus        92 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~  167 (360)
T 3e3p_A           92 GERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEA  167 (360)
T ss_dssp             CSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETT
T ss_pred             ccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCC
Confidence            43       7899999965 666655433345677899999999999999999999  88   9999999999999996 


Q ss_pred             CCceEEeecccccccCCCCcccccccccccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhH
Q 018263          183 NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVD  261 (358)
Q Consensus       183 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~  261 (358)
                      ++.++|+|||++........  .....+++.|+|||++.+. .++.++||||||+++|+|++|+.||...........+.
T Consensus       168 ~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~  245 (360)
T 3e3p_A          168 DGTLKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIV  245 (360)
T ss_dssp             TTEEEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CCcEEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHH
Confidence            89999999999987543322  2345689999999998765 48999999999999999999999998766554444443


Q ss_pred             hhhhccchhhHhhhhccc---------------cCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhhcCC
Q 018263          262 KAWGMYNSKELMNLVDPM---------------LYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK--MMNGET  321 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~--~L~~~~  321 (358)
                      ...+......+..+....               .........+..+.+|+.+||+.||.+|||+.|+++  .+++..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  322 (360)
T 3e3p_A          246 RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH  322 (360)
T ss_dssp             HHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred             HHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence            333222222211111000               001122235678999999999999999999999986  355544

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.1e-42  Score=314.26  Aligned_cols=264  Identities=24%  Similarity=0.368  Sum_probs=201.5

Q ss_pred             ccccCHHHHHHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeec
Q 018263           29 INAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG  107 (358)
Q Consensus        29 ~~~~~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~  107 (358)
                      +.++....+....++|++.+.||+|+||.||+|++. +|+.||+|++.... .....+.+|+..++.+. .||||+++++
T Consensus        11 ~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~-~h~~i~~~~~   88 (326)
T 2x7f_A           11 LDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYS-HHRNIATYYG   88 (326)
T ss_dssp             -----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHC-CSTTBCCEEE
T ss_pred             chhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhcc-CCCCeeeeee
Confidence            444555555666889999999999999999999975 68999999987543 34467888999999883 3999999999


Q ss_pred             eEEc------CCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEc
Q 018263          108 GCID------GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD  181 (358)
Q Consensus       108 ~~~~------~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~  181 (358)
                      ++..      .+..++||||+++++|.+++...  ....+++..++.++.||+.||.|||+.   |++|+||+|+||+++
T Consensus        89 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~  163 (326)
T 2x7f_A           89 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLT  163 (326)
T ss_dssp             EEEECC--CCCCEEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEC
T ss_pred             EEeeccCccccceEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEc
Confidence            9987      46789999999999999999432  346789999999999999999999999   999999999999999


Q ss_pred             CCCceEEeecccccccCCCCcccccccccccCccCccccc-----cCCCCccCceecHHHHHHHHHhCCCCCCccccccc
Q 018263          182 QNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI-----SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE  256 (358)
Q Consensus       182 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~  256 (358)
                      .++.++|+|||++........ ......++..|+|||++.     +..++.++||||||+++|+|++|..||........
T Consensus       164 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~  242 (326)
T 2x7f_A          164 ENAEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA  242 (326)
T ss_dssp             TTCCEEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred             CCCCEEEeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH
Confidence            999999999999876533221 123356899999999986     45688999999999999999999999965432211


Q ss_pred             hhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          257 YHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ...+.               ........+...+..+.++|.+||+.||.+|||+.++++
T Consensus       243 ~~~~~---------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          243 LFLIP---------------RNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HHHHH---------------HSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHhh---------------cCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            11110               000011112234567899999999999999999999987

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.5e-41  Score=315.70  Aligned_cols=260  Identities=13%  Similarity=0.107  Sum_probs=204.7

Q ss_pred             HHHHhhcCCcccceecccCceEEEEEE------ECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcc-cCCCCceeeece
Q 018263           36 QLKIATNGFRWSNKIGEGGFGSVYKGR------LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVN-VCHENLVKLHGG  108 (358)
Q Consensus        36 ~~~~~~~~y~i~~~lg~g~~g~v~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-~~h~~i~~~~~~  108 (358)
                      .+.+..++|++.+.||+|+||.||+|.      ..+++.||+|++......   .+..|...+..+. ..|+|++.+++.
T Consensus        59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~e~~~~~~l~~~~~~~iv~~~~~  135 (365)
T 3e7e_A           59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW---EFYIGTQLMERLKPSMQHMFMKFYSA  135 (365)
T ss_dssp             EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHH---HHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred             eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChh---HHHHHHHHHHHhhhhhhhhhhhhhee
Confidence            344556889999999999999999994      346889999998754433   4455555555543 128999999999


Q ss_pred             EEcCCeeEEEEecCCCCCHHHHhhhccc-cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcC-----
Q 018263          109 CIDGPCRILVYDYMPNNSLSQTLLGEEK-RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ-----  182 (358)
Q Consensus       109 ~~~~~~~~iv~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~-----  182 (358)
                      +...+..++||||+++++|.+++..... ....+++..++.++.||+.||+|||+.   ||+||||||+||+++.     
T Consensus       136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~  212 (365)
T 3e7e_A          136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQ  212 (365)
T ss_dssp             EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC
T ss_pred             eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCc
Confidence            9999999999999999999999954332 356799999999999999999999999   9999999999999998     


Q ss_pred             ------CCceEEeecccccccC-CCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCcccccc
Q 018263          183 ------NFNPKISDFGLSKLFP-ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG  255 (358)
Q Consensus       183 ------~~~~~l~Dfg~~~~~~-~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~  255 (358)
                            ++.+||+|||++..+. ...........||..|+|||++.+..++.++||||||+++|+|++|+.||.......
T Consensus       213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~  292 (365)
T 3e7e_A          213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE  292 (365)
T ss_dssp             ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred             cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence                  8999999999997543 122233445679999999999999999999999999999999999999996443211


Q ss_pred             chhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCC-CCHHHHHHHhhcCCC
Q 018263          256 EYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLR-PQMSTAIKMMNGETN  322 (358)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R-pt~~eil~~L~~~~~  322 (358)
                      ..                  +...+...   .....+.+++..||+.+|.+| |++.++.+.|+...+
T Consensus       293 ~~------------------~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~  339 (365)
T 3e7e_A          293 CK------------------PEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ  339 (365)
T ss_dssp             EE------------------ECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred             ee------------------echhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence            00                  01111111   124567789999999999999 678888888876543

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=3.8e-41  Score=308.39  Aligned_cols=259  Identities=17%  Similarity=0.258  Sum_probs=201.6

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEc--CCeeEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID--GPCRIL  117 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~--~~~~~i  117 (358)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++...   ....+.+|+..++.+. .||||+++++++..  ....++
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~-~~~~i~~~~~~~~~~~~~~~~l  110 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLR-GGPNIITLADIVKDPVSRTPAL  110 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHT-TSTTBCCEEEEEECTTTCCEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcC-CCCCEEEeeeeeccCCCCceEE
Confidence            478999999999999999999864 6899999998643   3457889999999986 59999999999987  667899


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCC-ceEEeecccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF-NPKISDFGLSKL  196 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~-~~~l~Dfg~~~~  196 (358)
                      ||||+++++|.+++.       .+++..++.++.||+.||+|||++   |++|+||||+||+++.++ .++|+|||++..
T Consensus       111 v~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~  180 (330)
T 3nsz_A          111 VFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF  180 (330)
T ss_dssp             EEECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceE
Confidence            999999999999882       378999999999999999999999   999999999999999776 899999999986


Q ss_pred             cCCCCcccccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCCCCCCccccc-cchhhhHhhhhcc-------
Q 018263          197 FPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL-GEYHLVDKAWGMY-------  267 (358)
Q Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~~pf~~~~~~-~~~~~~~~~~~~~-------  267 (358)
                      ......  .....++..|+|||++.+ ..++.++||||||+++|+|++|+.||...... ..........+..       
T Consensus       181 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~  258 (330)
T 3nsz_A          181 YHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID  258 (330)
T ss_dssp             CCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred             cCCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHH
Confidence            543322  234568899999999877 67899999999999999999999999543221 1111111111000       


Q ss_pred             -----chhhHhhhhcc--------ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          268 -----NSKELMNLVDP--------MLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       268 -----~~~~~~~~~~~--------~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                           .......+...        ......+...+..+.+||.+||+.||.+|||+.|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                 00011111111        1111222235678999999999999999999999987

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2.7e-41  Score=304.33  Aligned_cols=253  Identities=24%  Similarity=0.322  Sum_probs=201.3

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEe
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD  120 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e  120 (358)
                      ++|.....||+|+||.||+|.+. +++.|++|.+..........+.+|+..++.++  ||||+++++++...+..++|||
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e   99 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLK--HKNIVQYLGSFSENGFIKIFME   99 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCC--CTTBCCEEEEEEETTEEEEEEE
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCC--CCCEeeEeeEEEeCCcEEEEEE
Confidence            44555569999999999999975 68899999998766666778999999999998  9999999999999999999999


Q ss_pred             cCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcC-CCceEEeecccccccCC
Q 018263          121 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ-NFNPKISDFGLSKLFPE  199 (358)
Q Consensus       121 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~-~~~~~l~Dfg~~~~~~~  199 (358)
                      |+++++|.+++... .....+++..++.++.||+.||.|||+.   |++|+||+|+||+++. ++.++|+|||++.....
T Consensus       100 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~  175 (295)
T 2clq_A          100 QVPGGSLSALLRSK-WGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG  175 (295)
T ss_dssp             CCSEEEHHHHHHHT-TCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred             eCCCCCHHHHHHhh-ccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence            99999999999432 1234567999999999999999999999   9999999999999987 88999999999986543


Q ss_pred             CCcccccccccccCccCccccccCC--CCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhc
Q 018263          200 NTTHISTRVAGTLGYLAPEYAISGR--LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD  277 (358)
Q Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~~~~--~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      ... ......++..|+|||++.+..  ++.++||||||+++|+|++|+.||...........              ....
T Consensus       176 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--------------~~~~  240 (295)
T 2clq_A          176 INP-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF--------------KVGM  240 (295)
T ss_dssp             ------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHH--------------HHHH
T ss_pred             CCC-cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHH--------------hhcc
Confidence            221 223456889999999987653  78999999999999999999999964322111000              0000


Q ss_pred             cccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          278 PMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       278 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .......+...+..+.+++.+||+.||.+|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          241 FKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             HCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11122344556678999999999999999999999985

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=8.4e-42  Score=340.14  Aligned_cols=246  Identities=21%  Similarity=0.297  Sum_probs=204.8

Q ss_pred             HhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCe
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC  114 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~  114 (358)
                      +..++|++++.||+|+||.||+|+.+ +++.||||++...   .......+..|..++..+. .||+|+.+++++.+.+.
T Consensus       338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~-~~~~i~~l~~~~~~~~~  416 (674)
T 3pfq_A          338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG-KPPFLTQLHSCFQTMDR  416 (674)
T ss_dssp             --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTT-CCTTBCCEEEECBCSSE
T ss_pred             ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhcc-CCCeEEEEEEEEEeCCE
Confidence            44578999999999999999999976 5889999998743   2334456778888888774 49999999999999999


Q ss_pred             eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccc
Q 018263          115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS  194 (358)
Q Consensus       115 ~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~  194 (358)
                      .|+||||++|++|.+++    ...+.+++..++.++.||+.||+|||++   ||+||||||+||+++.++.+||+|||++
T Consensus       417 ~~lV~E~~~gg~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla  489 (674)
T 3pfq_A          417 LYFVMEYVNGGDLMYHI----QQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC  489 (674)
T ss_dssp             EEEEEECCCSCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTC
T ss_pred             EEEEEeCcCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeeccee
Confidence            99999999999999999    3446799999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhh
Q 018263          195 KLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMN  274 (358)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                      ....... .......||+.|+|||++.+..++.++|+||||+++|+|++|+.||...+....+..+              
T Consensus       490 ~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i--------------  554 (674)
T 3pfq_A          490 KENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI--------------  554 (674)
T ss_dssp             EECCCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------------
T ss_pred             eccccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHH--------------
Confidence            8643222 2234567999999999999999999999999999999999999999865432221111              


Q ss_pred             hhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 018263          275 LVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQM  310 (358)
Q Consensus       275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~  310 (358)
                       +..  ...++...+.++.+||.+||+.||.+||++
T Consensus       555 -~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~  587 (674)
T 3pfq_A          555 -MEH--NVAYPKSMSKEAVAICKGLMTKHPGKRLGC  587 (674)
T ss_dssp             -HSS--CCCCCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred             -HhC--CCCCCccCCHHHHHHHHHHccCCHHHCCCC
Confidence             111  123445567789999999999999999997

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.5e-41  Score=310.49  Aligned_cols=275  Identities=23%  Similarity=0.342  Sum_probs=206.9

Q ss_pred             hhcCCcccceecccCceEEEEEEE--CCCCEEEEEEeeccChh--hHHHHHHHHHHhhhcc-cCCCCceeeeceEE----
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRL--QDGTIVAVKVLSVESKQ--GEKEFMSEVASMANVN-VCHENLVKLHGGCI----  110 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~--~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~-~~h~~i~~~~~~~~----  110 (358)
                      ..++|++.+.||+|+||.||+|.+  .+|+.||+|++......  ....+.+|+..++.+. ..||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            458999999999999999999997  36889999998654321  2234556666666551 13999999999987    


Q ss_pred             -cCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEe
Q 018263          111 -DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKIS  189 (358)
Q Consensus       111 -~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~  189 (358)
                       .....++||||++ ++|.+++...  ....+++..++.++.||+.||.|||+.   |++|+||+|+||+++.++.++|+
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~  162 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA  162 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence             5567899999997 6999998432  234589999999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccch
Q 018263          190 DFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNS  269 (358)
Q Consensus       190 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      |||++......  .......++..|+|||++.+..++.++||||||+++|+|++|+.||...........+....+....
T Consensus       163 Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  240 (326)
T 1blx_A          163 DFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE  240 (326)
T ss_dssp             SCCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred             cCcccccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCc
Confidence            99999765322  2233456899999999999889999999999999999999999999876544433333222222211


Q ss_pred             hhHhhhhc----------cccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhhcCCC
Q 018263          270 KELMNLVD----------PMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK--MMNGETN  322 (358)
Q Consensus       270 ~~~~~~~~----------~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~--~L~~~~~  322 (358)
                      ..+.....          ......+....+..+.+++.+||+.||.+|||+.++++  .+..+..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  305 (326)
T 1blx_A          241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  305 (326)
T ss_dssp             GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence            11111000          00001122345667899999999999999999999984  4554443

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.7e-41  Score=304.89  Aligned_cols=254  Identities=22%  Similarity=0.275  Sum_probs=205.2

Q ss_pred             HhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC---------hhhHHHHHHHHHHhhhcccCCCCceeeece
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---------KQGEKEFMSEVASMANVNVCHENLVKLHGG  108 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---------~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~  108 (358)
                      ...++|++.+.||+|++|.||+|.+. +|+.||+|++....         ......+.+|+..++++. .||||++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~h~~i~~~~~~   92 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS-GHPNIIQLKDT   92 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHT-TCTTBCCEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhc-CCCCEeeeeee
Confidence            34689999999999999999999976 68999999987543         123456778999999884 49999999999


Q ss_pred             EEcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEE
Q 018263          109 CIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKI  188 (358)
Q Consensus       109 ~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l  188 (358)
                      +...+..++||||+++++|.+++    .....+++..++.++.||+.||.|||++   |++|+||+|+||+++.++.++|
T Consensus        93 ~~~~~~~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl  165 (298)
T 1phk_A           93 YETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKL  165 (298)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred             eccCCeEEEEEeccCCCcHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEE
Confidence            99999999999999999999999    3456789999999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccCccCccccc------cCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHh
Q 018263          189 SDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI------SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDK  262 (358)
Q Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~  262 (358)
                      +|||++.......  ......++..|+|||++.      ...++.++||||||+++|+|++|..||...........+..
T Consensus       166 ~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~  243 (298)
T 1phk_A          166 TDFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS  243 (298)
T ss_dssp             CCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             ecccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhc
Confidence            9999998754322  223456889999999885      34678899999999999999999999975432211111100


Q ss_pred             hhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          263 AWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ..             ...........+..+.+++.+||+.||.+|||+.++++
T Consensus       244 ~~-------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          244 GN-------------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             TC-------------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             CC-------------cccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            00             00001111345667999999999999999999999985

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.4e-42  Score=319.84  Aligned_cols=259  Identities=25%  Similarity=0.359  Sum_probs=198.0

Q ss_pred             cCCcccceecccCceEEEEEEEC--C--CCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEE-cCCee
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ--D--GTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCI-DGPCR  115 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~--~--~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~-~~~~~  115 (358)
                      ..|++.+.||+|+||.||+|.+.  +  +..|++|.+... .......+.+|+..++.++  ||||+++++++. ..+..
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~--hpnIv~~~~~~~~~~~~~  166 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS--HPNVLSLLGICLRSEGSP  166 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCC--CTTBCCCCEEECCCSSCC
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCC--CCCcceEEEEEEcCCCCe
Confidence            35778899999999999999853  2  236899988643 3445678899999999998  999999999865 45678


Q ss_pred             EEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccc
Q 018263          116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK  195 (358)
Q Consensus       116 ~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~  195 (358)
                      ++||||+++++|.+++.   .....+++..++.++.||+.||.|||++   |++|+||||+||+++.++.+||+|||++.
T Consensus       167 ~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~  240 (373)
T 3c1x_A          167 LVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR  240 (373)
T ss_dssp             EEEEECCTTCBHHHHHH---CTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred             EEEEECCCCCCHHHHHh---hcccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccc
Confidence            99999999999999993   2345678999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCcc---cccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhh
Q 018263          196 LFPENTTH---ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKE  271 (358)
Q Consensus       196 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      ........   ......++..|+|||++.+..++.++||||||+++|+|++ |.+||...........+.          
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~----------  310 (373)
T 3c1x_A          241 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL----------  310 (373)
T ss_dssp             -----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHH----------
T ss_pred             cccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHH----------
Confidence            65332211   1223456778999999999999999999999999999999 677876544322211111          


Q ss_pred             HhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCC
Q 018263          272 LMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNID  324 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~  324 (358)
                            .......+...+..+.+++.+||+.+|.+|||+.++++.|+.+....
T Consensus       311 ------~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~  357 (373)
T 3c1x_A          311 ------QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  357 (373)
T ss_dssp             ------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             ------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence                  11111223445667999999999999999999999999999876443

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.4e-42  Score=313.88  Aligned_cols=268  Identities=21%  Similarity=0.329  Sum_probs=189.8

Q ss_pred             HHHHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC
Q 018263           36 QLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP  113 (358)
Q Consensus        36 ~~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~  113 (358)
                      .+.+..++|++.+.||+|++|.||+|.+. +++.||+|.+.... ......+.+|+..+..++  ||||+++++++...+
T Consensus         9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~   86 (303)
T 2vwi_A            9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH--HPNIVSYYTSFVVKD   86 (303)
T ss_dssp             ----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCC--CTTBCCEEEEEESSS
T ss_pred             ccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcC--CCCEeeEEEEEeecC
Confidence            35667899999999999999999999864 68999999986542 334567788999999987  999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHhhhcc----ccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEe
Q 018263          114 CRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKIS  189 (358)
Q Consensus       114 ~~~iv~e~~~~~~L~~~l~~~~----~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~  189 (358)
                      ..++||||+++++|.+++....    .....+++..++.++.||+.||.|||+.   |++|+||+|+||+++.++.++|+
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~  163 (303)
T 2vwi_A           87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIA  163 (303)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEEC
T ss_pred             CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEE
Confidence            9999999999999999985321    1345689999999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCc----ccccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhh
Q 018263          190 DFGLSKLFPENTT----HISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAW  264 (358)
Q Consensus       190 Dfg~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~  264 (358)
                      |||++........    .......+++.|+|||++.+ ..++.++||||||+++|+|++|+.||............... 
T Consensus       164 dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-  242 (303)
T 2vwi_A          164 DFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN-  242 (303)
T ss_dssp             CCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTS-
T ss_pred             eccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhcc-
Confidence            9999876543211    11233568999999998875 56899999999999999999999999765433222111100 


Q ss_pred             hccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          265 GMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                       ...     ...............+..+.+++.+||+.||.+|||+.++++
T Consensus       243 -~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          243 -DPP-----SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             -SCC-----CTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             -CCC-----ccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence             000     000000111122234567899999999999999999999986

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=7.3e-41  Score=303.02  Aligned_cols=260  Identities=19%  Similarity=0.237  Sum_probs=203.6

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC----hhhHHHHHHHHHHhhhcccCCCCceeeeceEE--cC
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES----KQGEKEFMSEVASMANVNVCHENLVKLHGGCI--DG  112 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~--~~  112 (358)
                      ..++|++.+.||+|+||.||+|.+. +++.|++|++....    ......+.+|+..++.++  ||||+++++++.  ..
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~   80 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR--HKNVIQLVDVLYNEEK   80 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCC--CTTBCCEEEEEECC--
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcC--CCCeeEEEEEEEcCCC
Confidence            3579999999999999999999975 68899999986542    344678899999999998  999999999984  45


Q ss_pred             CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecc
Q 018263          113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG  192 (358)
Q Consensus       113 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg  192 (358)
                      ...++||||++++ |.+.+...  ....+++..++.++.||+.||.|||++   |++|+||+|+||+++.++.++|+|||
T Consensus        81 ~~~~lv~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg  154 (305)
T 2wtk_C           81 QKMYMVMEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALG  154 (305)
T ss_dssp             -CEEEEEECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CeEEEEehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccc
Confidence            6789999999766 77777432  346789999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCC-cccccccccccCccCccccccCC--CCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccch
Q 018263          193 LSKLFPENT-THISTRVAGTLGYLAPEYAISGR--LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNS  269 (358)
Q Consensus       193 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~--~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      .+....... ........++..|+|||++.+..  ++.++||||||+++|+|++|+.||...........+.        
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~--------  226 (305)
T 2wtk_C          155 VAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIG--------  226 (305)
T ss_dssp             TCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH--------
T ss_pred             cccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHh--------
Confidence            998654322 22233456899999999887644  4779999999999999999999997543221111110        


Q ss_pred             hhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhhcCCCCC
Q 018263          270 KELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK--MMNGETNID  324 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~--~L~~~~~~~  324 (358)
                             ..  ....+...+..+.+++.+||+.||.+|||+.++++  .+.+.....
T Consensus       227 -------~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~  274 (305)
T 2wtk_C          227 -------KG--SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPA  274 (305)
T ss_dssp             -------HC--CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-
T ss_pred             -------cC--CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCc
Confidence                   00  01223345667899999999999999999999995  466555443

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=8.4e-42  Score=310.91  Aligned_cols=264  Identities=20%  Similarity=0.296  Sum_probs=200.4

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEE---------
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCI---------  110 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~---------  110 (358)
                      .++|++.+.||+|++|.||+|.+. +|+.||+|.+..........+.+|+..++.++  ||||+++++++.         
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~~~~   87 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLD--HDNIVKVFEILGPSGSQLTDD   87 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCC--CTTBCCEEEEECTTSCBCCC-
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcC--CCCeeEEEEeccccccccccc
Confidence            579999999999999999999986 48999999998777677788999999999998  999999998874         


Q ss_pred             -----cCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEc-CCC
Q 018263          111 -----DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD-QNF  184 (358)
Q Consensus       111 -----~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~-~~~  184 (358)
                           .....++||||++ ++|.+++     ..+.+++..++.++.||+.||+|||++   |++|+||+|+||+++ .++
T Consensus        88 ~~~~~~~~~~~lv~e~~~-~~L~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~  158 (320)
T 2i6l_A           88 VGSLTELNSVYIVQEYME-TDLANVL-----EQGPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDL  158 (320)
T ss_dssp             ---CCSCSEEEEEEECCS-EEHHHHH-----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTT
T ss_pred             cccccccCceeEEeeccC-CCHHHHh-----hcCCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCC
Confidence                 3467899999997 5999998     345689999999999999999999999   999999999999997 567


Q ss_pred             ceEEeecccccccCCCCc--ccccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhH
Q 018263          185 NPKISDFGLSKLFPENTT--HISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVD  261 (358)
Q Consensus       185 ~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~  261 (358)
                      .++|+|||++........  .......++..|+|||++.+ ..++.++||||||+++|+|++|+.||...........+.
T Consensus       159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  238 (320)
T 2i6l_A          159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL  238 (320)
T ss_dssp             EEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             eEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            899999999986543211  12233457889999998875 678999999999999999999999998765443333332


Q ss_pred             hhhhccchhhHhhhhccc--------cCCC-----CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          262 KAWGMYNSKELMNLVDPM--------LYGN-----FPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~--------~~~~-----~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .............+....        ....     .....+..+.+++.+||+.||.+|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            222222222211111100        0000     11234667999999999999999999999986

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=4.9e-42  Score=339.65  Aligned_cols=247  Identities=27%  Similarity=0.384  Sum_probs=201.6

Q ss_pred             ceecccCceEEEEEEEC---CCCEEEEEEeeccC--hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecC
Q 018263           48 NKIGEGGFGSVYKGRLQ---DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM  122 (358)
Q Consensus        48 ~~lg~g~~g~v~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~  122 (358)
                      +.||+|+||.||+|.+.   .++.||||++....  ......+.+|+.++..++  ||||+++++++.. ...++||||+
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~--hpnIv~l~~~~~~-~~~~lv~E~~  451 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD--NPYIVRMIGICEA-ESWMLVMEMA  451 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCC--CTTBCCEEEEEES-SSEEEEEECC
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCC--CCCEeeEEEEEec-CCEEEEEEcc
Confidence            37999999999999653   46789999997543  344678999999999998  9999999999875 4588999999


Q ss_pred             CCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCc
Q 018263          123 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT  202 (358)
Q Consensus       123 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~  202 (358)
                      ++++|.+++    .....+++..++.++.||+.||+|||++   ||+||||||+||+++.++.+||+|||++........
T Consensus       452 ~~g~L~~~l----~~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~  524 (635)
T 4fl3_A          452 ELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN  524 (635)
T ss_dssp             TTEEHHHHH----HHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---
T ss_pred             CCCCHHHHH----hhCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc
Confidence            999999999    3456789999999999999999999999   999999999999999999999999999987643322


Q ss_pred             --ccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhHhhhhccc
Q 018263          203 --HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPM  279 (358)
Q Consensus       203 --~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (358)
                        .......++..|+|||++.+..++.++||||||+++|+|++ |+.||......                +....+...
T Consensus       525 ~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~----------------~~~~~i~~~  588 (635)
T 4fl3_A          525 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS----------------EVTAMLEKG  588 (635)
T ss_dssp             ----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----------------HHHHHHHTT
T ss_pred             ccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH----------------HHHHHHHcC
Confidence              12223446788999999999999999999999999999998 99999754332                122222233


Q ss_pred             cCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 018263          280 LYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE  320 (358)
Q Consensus       280 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~  320 (358)
                      .....+..++..+.++|.+||+.||.+|||+.+|++.|+.+
T Consensus       589 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  629 (635)
T 4fl3_A          589 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  629 (635)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            33344556778899999999999999999999999999864

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.2e-41  Score=306.72  Aligned_cols=251  Identities=25%  Similarity=0.386  Sum_probs=201.1

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      ..++|++.+.||+|+||.||+|.+. +|+.||+|.+....  ....+.+|+..++.+.  ||||+++++++...+..++|
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv  102 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCD--SPHVVKYYGSYFKNTDLWIV  102 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCC--CTTBCCEEEEEEETTEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCC--CCCCccEEEEEEeCCEEEEE
Confidence            4579999999999999999999976 58999999987543  3456888999999997  99999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      |||+++++|.+++.   .....+++..++.++.||+.||.|||+.   |++|+||+|+||+++.++.++|+|||.+....
T Consensus       103 ~e~~~~~~L~~~~~---~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  176 (314)
T 3com_A          103 MEYCGAGSVSDIIR---LRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLT  176 (314)
T ss_dssp             EECCTTEEHHHHHH---HHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred             eecCCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence            99999999999983   2356789999999999999999999999   99999999999999999999999999997654


Q ss_pred             CCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhcc
Q 018263          199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDP  278 (358)
Q Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (358)
                      .... ......++..|+|||++.+..++.++||||||+++|+|++|+.||..............              ..
T Consensus       177 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------------~~  241 (314)
T 3com_A          177 DTMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPT--------------NP  241 (314)
T ss_dssp             TTBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH--------------SC
T ss_pred             hhcc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc--------------CC
Confidence            3222 22345688999999999988999999999999999999999999975432211111100              00


Q ss_pred             ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          279 MLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       279 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ......+...+..+.+++.+||+.||.+|||+.++++
T Consensus       242 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          242 PPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             CCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            0001122334567999999999999999999999976

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.5e-42  Score=319.30  Aligned_cols=264  Identities=14%  Similarity=0.157  Sum_probs=204.4

Q ss_pred             hcCCcccceecccCceEEEEEEECC---------CCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCcee-------
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQD---------GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVK-------  104 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~-------  104 (358)
                      .++|++.+.||+|+||.||+|++..         ++.||+|++...     ..+.+|+..++.++  ||||++       
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~--h~niv~~~~~~~~  113 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAA--KPLQVNKWKKLYS  113 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHC--CHHHHHHHHHHTT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhc--ccchhhhhhhhcc
Confidence            5799999999999999999999763         789999998743     35778999999988  999887       


Q ss_pred             --------eeceEEc-CCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCC
Q 018263          105 --------LHGGCID-GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKT  175 (358)
Q Consensus       105 --------~~~~~~~-~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p  175 (358)
                              +++++.. ....++||||+ +++|.+++...  ....+++..++.++.||+.||.|||++   |++|+||+|
T Consensus       114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp  187 (352)
T 2jii_A          114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTA  187 (352)
T ss_dssp             CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCG
T ss_pred             CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCH
Confidence                    4556655 67889999999 99999999432  246799999999999999999999999   999999999


Q ss_pred             CcEEEcCCC--ceEEeecccccccCCCCcc------cccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCC
Q 018263          176 SNILLDQNF--NPKISDFGLSKLFPENTTH------ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTA  247 (358)
Q Consensus       176 ~Nilv~~~~--~~~l~Dfg~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~p  247 (358)
                      +||+++.++  .++|+|||++.........      ......+++.|+|||++.+..++.++||||||+++|+|++|+.|
T Consensus       188 ~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p  267 (352)
T 2jii_A          188 ENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP  267 (352)
T ss_dssp             GGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred             HHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            999999998  8999999999765422211      11335789999999999998999999999999999999999999


Q ss_pred             CCccccccchhhhHhhhhccchhhHhhhhccccCC-CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCC
Q 018263          248 VDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYG-NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNID  324 (358)
Q Consensus       248 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~  324 (358)
                      |.........  +....     ............. ......+..+.+++.+||+.||.+|||+.++++.|+++....
T Consensus       268 f~~~~~~~~~--~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~  338 (352)
T 2jii_A          268 WTNCLPNTED--IMKQK-----QKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL  338 (352)
T ss_dssp             TGGGTTCHHH--HHHHH-----HHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             cccCCcCHHH--HHHHH-----HhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence            9865421111  00000     0000000000000 001123567999999999999999999999999999887554

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=7.2e-42  Score=309.22  Aligned_cols=253  Identities=19%  Similarity=0.354  Sum_probs=200.5

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      ..++|++.+.||+|+||.||+|.+. +++.|++|++..........+.+|+..+..+.  ||||+++++++...+..++|
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv   94 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCD--HPYIVKLLGAYYHDGKLWIM   94 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCC--CTTBCCEEEEEECC-CEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCC--CCCEeeeeeeeeeCCeEEEE
Confidence            3579999999999999999999986 58999999997766667788899999999997  99999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      |||+++++|.+++..   ....+++..++.++.||+.||.|||+.   |++|+||+|+||+++.++.++|+|||++....
T Consensus        95 ~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  168 (302)
T 2j7t_A           95 IEFCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL  168 (302)
T ss_dssp             EECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHH
T ss_pred             EEeCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccc
Confidence            999999999998832   345689999999999999999999999   99999999999999999999999999875321


Q ss_pred             CCCcccccccccccCccCccccc-----cCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHh
Q 018263          199 ENTTHISTRVAGTLGYLAPEYAI-----SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELM  273 (358)
Q Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~-----~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      .. ........++..|+|||++.     +..++.++||||||+++|+|++|..||...............          
T Consensus       169 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----------  237 (302)
T 2j7t_A          169 KT-LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS----------  237 (302)
T ss_dssp             HH-HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS----------
T ss_pred             cc-ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhcc----------
Confidence            11 11122346889999999884     567889999999999999999999999754332111111000          


Q ss_pred             hhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          274 NLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                          .......+...+..+.+++.+||+.||.+|||+.++++
T Consensus       238 ----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          238 ----DPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             ----CCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             ----CCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                00001123345667999999999999999999999875

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=4.2e-41  Score=322.34  Aligned_cols=263  Identities=21%  Similarity=0.285  Sum_probs=209.4

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      ..++|++.+.||+|+||.||+|.+. +++.||||++......  ..+..|+.++..+. .++++..+..++......++|
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~-~~~~i~~i~~~~~~~~~~~lv   81 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQ-GGTGIPNVRWFGVEGDYNVLV   81 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTT-TSTTCCCEEEEEEETTEEEEE
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhc-CCCCCCeEEEEEeeCCEEEEE
Confidence            3579999999999999999999974 6999999998654332  34678889999887 346677777777888889999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEE---cCCCceEEeeccccc
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSK  195 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv---~~~~~~~l~Dfg~~~  195 (358)
                      |||+ +++|.+++..   ....+++..++.++.||+.||.|||++   ||+|+||||+||+|   +.++.++|+|||++.
T Consensus        82 me~~-g~sL~~ll~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~  154 (483)
T 3sv0_A           82 MDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (483)
T ss_dssp             EECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             EECC-CCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence            9999 9999999942   345799999999999999999999999   99999999999999   688899999999998


Q ss_pred             ccCCCCcc------cccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccch
Q 018263          196 LFPENTTH------ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNS  269 (358)
Q Consensus       196 ~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      ........      ......|+..|+|||++.+..++.++||||||+++|+|++|+.||..............+......
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (483)
T 3sv0_A          155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA  234 (483)
T ss_dssp             ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH
T ss_pred             eccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc
Confidence            75433221      122467999999999999999999999999999999999999999875544333333322211111


Q ss_pred             hhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCC
Q 018263          270 KELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGET  321 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~  321 (358)
                      .....+.         ..++..+.+++.+||+.+|.+||++.+|++.|+.+.
T Consensus       235 ~~~~~l~---------~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~  277 (483)
T 3sv0_A          235 TSIEALC---------RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF  277 (483)
T ss_dssp             SCHHHHH---------TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred             ccHHHHh---------cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence            1111111         123457899999999999999999999999998873

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=6.6e-42  Score=315.71  Aligned_cols=266  Identities=20%  Similarity=0.285  Sum_probs=205.8

Q ss_pred             hhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhh-----------------HHHHHHHHHHhhhcccCCCCc
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQG-----------------EKEFMSEVASMANVNVCHENL  102 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~-----------------~~~~~~e~~~l~~l~~~h~~i  102 (358)
                      ..++|++.+.||+|+||.||+|.. +|+.||+|++.......                 ...+.+|+..+..++  ||||
T Consensus        29 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i  105 (348)
T 2pml_X           29 YINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK--NEYC  105 (348)
T ss_dssp             EETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC--CTTB
T ss_pred             ccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC--CCCc
Confidence            357999999999999999999999 89999999987542211                 178889999999998  9999


Q ss_pred             eeeeceEEcCCeeEEEEecCCCCCHHHHhhh----ccccccCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcEEcCCCCCc
Q 018263          103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLG----EEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSN  177 (358)
Q Consensus       103 ~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~----~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~~~~i~H~di~p~N  177 (358)
                      +++++++...+..++||||+++++|.+++..    .......+++..++.++.||+.||.|||+ .   |++|+||+|+|
T Consensus       106 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~N  182 (348)
T 2pml_X          106 LTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSN  182 (348)
T ss_dssp             CCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGG
T ss_pred             ceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHh
Confidence            9999999999999999999999999998311    11225779999999999999999999999 8   99999999999


Q ss_pred             EEEcCCCceEEeecccccccCCCCcccccccccccCccCccccccC-CCCc-cCceecHHHHHHHHHhCCCCCCcccccc
Q 018263          178 ILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG-RLTR-KSDVYSFGVLLLEIVSGRTAVDFDVQLG  255 (358)
Q Consensus       178 ilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~-~sDiwslG~il~~lltg~~pf~~~~~~~  255 (358)
                      |+++.++.++|+|||.+......   ......++..|+|||++.+. .++. ++||||||+++|+|++|..||.......
T Consensus       183 il~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  259 (348)
T 2pml_X          183 ILMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV  259 (348)
T ss_dssp             EEECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred             EEEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence            99999999999999999865332   23446789999999999877 6666 9999999999999999999998654421


Q ss_pred             -chhhhHhhhhccchhhHhhhhccc---cCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          256 -EYHLVDKAWGMYNSKELMNLVDPM---LYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       256 -~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                       ....+........ ........+.   .........+..+.+++.+||+.||.+|||+.++++
T Consensus       260 ~~~~~i~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          260 ELFNNIRTKNIEYP-LDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HHHHHHTSCCCCCC-CSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhccCcCCc-cchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence             1111100000000 0000000000   000111345667999999999999999999999987

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=6.6e-41  Score=305.93  Aligned_cols=252  Identities=22%  Similarity=0.313  Sum_probs=197.1

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC--------hhhHHHHHHHHHHhhhcccCCCCceeeeceEE
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--------KQGEKEFMSEVASMANVNVCHENLVKLHGGCI  110 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~  110 (358)
                      ..++|++.+.||+|+||.||+|.+. +++.||||++....        ......+.+|+..++.+.  ||||+++++++.
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~   85 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN--HPCIIKIKNFFD   85 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCC--CTTBCCEEEEEE
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCC--CCCCceEeeEEc
Confidence            4578999999999999999999976 58899999986432        122345788999999998  999999999987


Q ss_pred             cCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCc---eE
Q 018263          111 DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN---PK  187 (358)
Q Consensus       111 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~---~~  187 (358)
                      ... .++||||+++++|.+.+    .....+++..++.++.||+.||.|||++   |++|+||+|+||+++.++.   ++
T Consensus        86 ~~~-~~lv~e~~~~~~L~~~~----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~k  157 (322)
T 2ycf_A           86 AED-YYIVLELMEGGELFDKV----VGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIK  157 (322)
T ss_dssp             SSS-EEEEEECCTTEETHHHH----STTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEE
T ss_pred             CCc-eEEEEecCCCCcHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEE
Confidence            665 89999999999999998    4456789999999999999999999999   9999999999999987665   99


Q ss_pred             EeecccccccCCCCcccccccccccCccCccccc---cCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhh
Q 018263          188 ISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI---SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAW  264 (358)
Q Consensus       188 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~  264 (358)
                      |+|||++.......  ......+++.|+|||++.   +..++.++||||||+++|+|++|..||............... 
T Consensus       158 l~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-  234 (322)
T 2ycf_A          158 ITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS-  234 (322)
T ss_dssp             ECCCTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHH-
T ss_pred             EccCccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHh-
Confidence            99999998754322  223456899999999874   456889999999999999999999999754432221111000 


Q ss_pred             hccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          265 GMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      +...           .........+..+.+++.+||+.||.+|||+.++++
T Consensus       235 ~~~~-----------~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          235 GKYN-----------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             TCCC-----------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             Cccc-----------cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            0000           000000123567899999999999999999999884

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=8.9e-41  Score=308.72  Aligned_cols=271  Identities=20%  Similarity=0.268  Sum_probs=207.3

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC-----C
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG-----P  113 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~-----~  113 (358)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++... .......+.+|+..++.++  ||||+++++++...     .
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~~~   87 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFK--HENIITIFNIQRPDSFENFN   87 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCC--CTTBCCEEEECCCSCSTTCC
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCc--CCCcCCeeeeecccccCccc
Confidence            579999999999999999999976 6899999998643 3344567889999999998  99999999987654     6


Q ss_pred             eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccc
Q 018263          114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL  193 (358)
Q Consensus       114 ~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~  193 (358)
                      ..++||||+. ++|.+++.     ...+++..++.++.||+.||+|||++   |++|+||+|+||+++.++.++|+|||+
T Consensus        88 ~~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  158 (353)
T 2b9h_A           88 EVYIIQELMQ-TDLHRVIS-----TQMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGL  158 (353)
T ss_dssp             CEEEEECCCS-EEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEeccC-ccHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccc
Confidence            7899999996 68999883     35689999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcc---------cccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhh
Q 018263          194 SKLFPENTTH---------ISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKA  263 (358)
Q Consensus       194 ~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~  263 (358)
                      +.........         ......++..|+|||++.+ ..++.++||||||+++|+|++|+.||...........+...
T Consensus       159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  238 (353)
T 2b9h_A          159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGI  238 (353)
T ss_dssp             CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             ccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Confidence            9875432211         1223468999999998764 67899999999999999999999999876544333332222


Q ss_pred             hhccch---------hhHhhhhccccC-CC-----CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhhcCCC
Q 018263          264 WGMYNS---------KELMNLVDPMLY-GN-----FPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK--MMNGETN  322 (358)
Q Consensus       264 ~~~~~~---------~~~~~~~~~~~~-~~-----~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~--~L~~~~~  322 (358)
                      .+.+..         ....+.+..... ..     .....+..+.+++.+||+.||.+|||+.++++  .+.....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  314 (353)
T 2b9h_A          239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD  314 (353)
T ss_dssp             HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence            221111         111111111100 00     01234567899999999999999999999987  5655543

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3e-41  Score=314.28  Aligned_cols=259  Identities=23%  Similarity=0.314  Sum_probs=201.9

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCee--
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR--  115 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~--  115 (358)
                      .++|++.+.||+|+||.||+|.+. +|+.||+|++...  .......+.+|+..++.++  ||||+++++++...+..  
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~  118 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ--HENVIGLLDVFTPASSLRN  118 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCC--CTTBCCCSEEECSCSSSTT
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcC--CCCchhhhhheeccCCccc
Confidence            579999999999999999999976 6899999998754  3344577889999999998  99999999999877655  


Q ss_pred             ----EEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeec
Q 018263          116 ----ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF  191 (358)
Q Consensus       116 ----~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Df  191 (358)
                          ++||||+. ++|.+.+      ...+++..++.++.||+.||+|||+.   |++|+||+|+||+++.++.++|+||
T Consensus       119 ~~~~~lv~e~~~-~~l~~~~------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Df  188 (371)
T 4exu_A          119 FYDFYLVMPFMQ-TDLQKIM------GMEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDF  188 (371)
T ss_dssp             CCCCEEEEECCC-EEHHHHT------TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECST
T ss_pred             ceeEEEEEcccc-ccHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEec
Confidence                99999996 6788777      23489999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchh
Q 018263          192 GLSKLFPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSK  270 (358)
Q Consensus       192 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      |++......    .....+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||......+....+....+.+...
T Consensus       189 g~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  264 (371)
T 4exu_A          189 GLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE  264 (371)
T ss_dssp             TCC------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             CcccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHH
Confidence            999864322    234568999999999887 678999999999999999999999998765444433333222222111


Q ss_pred             h--------HhhhhccccCC---C---CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          271 E--------LMNLVDPMLYG---N---FPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       271 ~--------~~~~~~~~~~~---~---~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .        ...........   .   .....+..+.+||.+||+.||.+|||+.++++
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          265 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             HHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence            1        11111111000   0   11234667999999999999999999999986

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=4.3e-42  Score=313.07  Aligned_cols=267  Identities=22%  Similarity=0.344  Sum_probs=204.9

Q ss_pred             cCHHHHHHhhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccC--hhhHHHHHHHHHHhhhcccCCCCceeeeceE
Q 018263           32 FSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGC  109 (358)
Q Consensus        32 ~~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~  109 (358)
                      .....+.+..++|++.+.||+|+||.||+|.++.  .|++|++....  ....+.+.+|+..++.++  ||||+++++++
T Consensus        23 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~   98 (319)
T 2y4i_B           23 IFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTR--HENVVLFMGAC   98 (319)
T ss_dssp             CCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCC--CTTBCCCCEEE
T ss_pred             cccccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCC--CCCEeEEEEEE
Confidence            3445566678999999999999999999999863  48999986542  223345678899999988  99999999999


Q ss_pred             EcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEe
Q 018263          110 IDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKIS  189 (358)
Q Consensus       110 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~  189 (358)
                      ......+++|||+++++|.+++..   ....+++..++.++.||+.||.|||+.   |++|+||+|+||+++ ++.++|+
T Consensus        99 ~~~~~~~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~  171 (319)
T 2y4i_B           99 MSPPHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVIT  171 (319)
T ss_dssp             ECSSCEEEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEEC
T ss_pred             ecCCceEEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEe
Confidence            999999999999999999999932   334689999999999999999999999   999999999999998 6799999


Q ss_pred             ecccccccCCCC----cccccccccccCccCcccccc---------CCCCccCceecHHHHHHHHHhCCCCCCccccccc
Q 018263          190 DFGLSKLFPENT----THISTRVAGTLGYLAPEYAIS---------GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE  256 (358)
Q Consensus       190 Dfg~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~---------~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~  256 (358)
                      |||++.......    ........++..|+|||++.+         ..++.++||||||+++|+|++|+.||........
T Consensus       172 Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~  251 (319)
T 2y4i_B          172 DFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI  251 (319)
T ss_dssp             CCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH
T ss_pred             ecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            999987543211    112223458899999998864         3478899999999999999999999975432211


Q ss_pred             hhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCC
Q 018263          257 YHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNID  324 (358)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~  324 (358)
                      ...+               .........+...+..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus       252 ~~~~---------------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~  304 (319)
T 2y4i_B          252 IWQM---------------GTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN  304 (319)
T ss_dssp             HHHH---------------HTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred             HHHh---------------ccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence            1111               0000001111123456899999999999999999999999999998765

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=6.3e-41  Score=301.06  Aligned_cols=253  Identities=25%  Similarity=0.338  Sum_probs=203.8

Q ss_pred             HHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCe
Q 018263           38 KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC  114 (358)
Q Consensus        38 ~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~  114 (358)
                      ....++|++.+.||+|++|.||+|+.. +++.|++|++...  .......+.+|+..++.++  ||||+++++++...+.
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~   95 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD--HPNIMKLFEILEDSSS   95 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCC--CTTBCCEEEEEECSSE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcc--CCCccEEEEEEeCCCe
Confidence            345689999999999999999999986 6899999998654  2345678889999999997  9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCC---CceEEeec
Q 018263          115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN---FNPKISDF  191 (358)
Q Consensus       115 ~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~---~~~~l~Df  191 (358)
                      .++|+||+++++|.+.+.    ....+++..++.++.||+.||.+||++   |++|+||+|+||+++.+   +.++|+||
T Consensus        96 ~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Df  168 (287)
T 2wei_A           96 FYIVGELYTGGELFDEII----KRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDF  168 (287)
T ss_dssp             EEEEECCCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECST
T ss_pred             EEEEEEccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEecc
Confidence            999999999999999883    445789999999999999999999999   99999999999999654   46999999


Q ss_pred             ccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhh
Q 018263          192 GLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKE  271 (358)
Q Consensus       192 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      |++........  .....++..|+|||.+.+ .++.++||||||+++|+|++|..||...........+...   ...  
T Consensus       169 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---~~~--  240 (287)
T 2wei_A          169 GLSTCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG---KYA--  240 (287)
T ss_dssp             TGGGTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC---CCC--
T ss_pred             CcceeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC---CCC--
Confidence            99986543322  223457889999998765 4889999999999999999999999765432111111100   000  


Q ss_pred             HhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          272 LMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                              .........+..+.+++.+||+.||.+|||+.++++
T Consensus       241 --------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          241 --------FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             --------CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence                    000001234567899999999999999999999987

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.5e-40  Score=309.26  Aligned_cols=269  Identities=19%  Similarity=0.240  Sum_probs=204.9

Q ss_pred             HHHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCC-----CceeeeceEE
Q 018263           37 LKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHE-----NLVKLHGGCI  110 (358)
Q Consensus        37 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~-----~i~~~~~~~~  110 (358)
                      -....++|++.+.||+|+||.||+|.+. +++.||||++... ......+..|+..+..+. .|+     +++.+++.+.
T Consensus        49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~-~~~~~~~~~iv~~~~~~~  126 (382)
T 2vx3_A           49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMN-KHDTEMKYYIVHLKRHFM  126 (382)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHH-HCSSGGGGGBCCEEEEEE
T ss_pred             CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHH-hcccccceeEEEeeeeec
Confidence            3444689999999999999999999976 6889999998743 334456667777777664 244     5999999999


Q ss_pred             cCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEc--CCCceEE
Q 018263          111 DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD--QNFNPKI  188 (358)
Q Consensus       111 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~--~~~~~~l  188 (358)
                      ..+..++||||++ ++|.+++...  ....+++..++.++.||+.||.|||+. ..||+||||||+||+++  .++.+||
T Consensus       127 ~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL  202 (382)
T 2vx3_A          127 FRNHLCLVFEMLS-YNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKI  202 (382)
T ss_dssp             ETTEEEEEEECCC-CBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEE
T ss_pred             cCCceEEEEecCC-CCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEE
Confidence            9999999999995 5999998432  234589999999999999999999952 22999999999999994  4778999


Q ss_pred             eecccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccc
Q 018263          189 SDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYN  268 (358)
Q Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  268 (358)
                      +|||++......    .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||...........+....+.+.
T Consensus       203 ~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~  278 (382)
T 2vx3_A          203 VDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPP  278 (382)
T ss_dssp             CCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred             EeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            999999875432    2345689999999999999999999999999999999999999987665444433332222211


Q ss_pred             hhh------Hhhhhcccc-----------------------------------------CCCCCHHHHHHHHHHHhhccC
Q 018263          269 SKE------LMNLVDPML-----------------------------------------YGNFPENEAIRFLKVGLLCVQ  301 (358)
Q Consensus       269 ~~~------~~~~~~~~~-----------------------------------------~~~~~~~~~~~l~~li~~~l~  301 (358)
                      ...      ....+....                                         ...........+.+||.+||+
T Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~  358 (382)
T 2vx3_A          279 AHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLD  358 (382)
T ss_dssp             HHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTC
T ss_pred             HHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcC
Confidence            110      011111000                                         001123445689999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 018263          302 EKSKLRPQMSTAIK  315 (358)
Q Consensus       302 ~~P~~Rpt~~eil~  315 (358)
                      .||.+|||+.|+++
T Consensus       359 ~dP~~Rpta~e~L~  372 (382)
T 2vx3_A          359 YDPKTRIQPYYALQ  372 (382)
T ss_dssp             SCTTTSCCHHHHTT
T ss_pred             CChhhCCCHHHHhc
Confidence            99999999999976

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.9e-41  Score=336.60  Aligned_cols=263  Identities=23%  Similarity=0.292  Sum_probs=210.5

Q ss_pred             HHHHHHhhcCCcccceecccCceEEEEEEEC----CCCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeece
Q 018263           34 YNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ----DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGG  108 (358)
Q Consensus        34 ~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~----~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~  108 (358)
                      ..++.+..++|++.+.||+|+||.||+|.+.    .+..|++|..... .......+.+|+..++.++  ||||++++++
T Consensus       382 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--HpnIv~l~~~  459 (656)
T 2j0j_A          382 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD--HPHIVKLIGV  459 (656)
T ss_dssp             GGGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCC--CTTBCCEEEE
T ss_pred             ccccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCC--CCCCCeEEEE
Confidence            3455666789999999999999999999864    2557999998654 3444577889999999998  9999999999


Q ss_pred             EEcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEE
Q 018263          109 CIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKI  188 (358)
Q Consensus       109 ~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l  188 (358)
                      +. .+..++||||+++++|.+++..   ....+++..++.++.||+.||.|||++   |++||||||+||+++.++.++|
T Consensus       460 ~~-~~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL  532 (656)
T 2j0j_A          460 IT-ENPVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKL  532 (656)
T ss_dssp             EC-SSSCEEEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEE
T ss_pred             Ee-cCceEEEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEE
Confidence            85 4568999999999999999942   344689999999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhcc
Q 018263          189 SDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMY  267 (358)
Q Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~  267 (358)
                      +|||++...............+++.|+|||++.+..++.++||||||+++|+|++ |..||......+....        
T Consensus       533 ~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~--------  604 (656)
T 2j0j_A          533 GDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR--------  604 (656)
T ss_dssp             CCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH--------
T ss_pred             EecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH--------
Confidence            9999998765443333334556789999999998899999999999999999997 9999975433221111        


Q ss_pred             chhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCC
Q 018263          268 NSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGET  321 (358)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~  321 (358)
                              +........+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus       605 --------i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il  650 (656)
T 2j0j_A          605 --------IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  650 (656)
T ss_dssp             --------HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --------HHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence                    1111122334456678999999999999999999999999998763

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1e-40  Score=308.58  Aligned_cols=259  Identities=23%  Similarity=0.312  Sum_probs=201.8

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCe---
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC---  114 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~---  114 (358)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++...  .......+.+|+..++.++  ||||+++++++.....   
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~~  100 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ--HENVIGLLDVFTPASSLRN  100 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCC--CTTBCCCSEEECSCSSGGG
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcC--CCCcccHhheEeccccccc
Confidence            578999999999999999999975 6899999998653  3344567889999999998  9999999999987654   


Q ss_pred             ---eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeec
Q 018263          115 ---RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF  191 (358)
Q Consensus       115 ---~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Df  191 (358)
                         .++||||++ ++|.+.+      ...+++..++.++.||+.||.|||++   |++|+||+|+||+++.++.++|+||
T Consensus       101 ~~~~~lv~e~~~-~~l~~~~------~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Df  170 (353)
T 3coi_A          101 FYDFYLVMPFMQ-TDLQKIM------GLKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDF  170 (353)
T ss_dssp             CCCCEEEEECCS-EEGGGTT------TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECST
T ss_pred             ceeEEEEecccc-CCHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeec
Confidence               499999996 5888776      12489999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchh
Q 018263          192 GLSKLFPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSK  270 (358)
Q Consensus       192 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      |++......    .....++..|+|||++.+ ..++.++||||||+++|+|++|+.||......+....+....+.....
T Consensus       171 g~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  246 (353)
T 3coi_A          171 GLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE  246 (353)
T ss_dssp             TCTTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHH
T ss_pred             ccccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            999764322    233568999999999877 678999999999999999999999998765443333332222221111


Q ss_pred             hH--------hhhhcc---ccC---CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          271 EL--------MNLVDP---MLY---GNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       271 ~~--------~~~~~~---~~~---~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ..        ...+..   ...   .......+..+.++|.+||+.||.+|||+.++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          247 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            11        111110   001   1122355778999999999999999999999985

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.8e-40  Score=305.18  Aligned_cols=262  Identities=19%  Similarity=0.274  Sum_probs=203.9

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CC-CEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCC------ceeeeceEEcC
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DG-TIVAVKVLSVESKQGEKEFMSEVASMANVNVCHEN------LVKLHGGCIDG  112 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~-~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~------i~~~~~~~~~~  112 (358)
                      .++|++.+.||+|+||.||+|.+. ++ +.||+|++... ......+..|+..++.+.  |++      ++.+.+++...
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~--~~~~~~~~~~~~~~~~~~~~   94 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIK--EKDKENKFLCVLMSDWFNFH   94 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHH--HHCTTSCSCBCCEEEEEEET
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHh--hcCCCCceeEEEeeeeeeeC
Confidence            589999999999999999999975 34 68999998643 344567778888888886  444      89999999999


Q ss_pred             CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEE------------
Q 018263          113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL------------  180 (358)
Q Consensus       113 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv------------  180 (358)
                      +..++||||+ +++|.+.+..  .....+++..++.++.||+.||+|||++   ||+|+||||+||++            
T Consensus        95 ~~~~lv~e~~-~~~l~~~l~~--~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~  168 (355)
T 2eu9_A           95 GHMCIAFELL-GKNTFEFLKE--NNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEH  168 (355)
T ss_dssp             TEEEEEEECC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC
T ss_pred             CeEEEEEecc-CCChHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccc
Confidence            9999999999 6677777733  2335689999999999999999999999   99999999999999            


Q ss_pred             -------cCCCceEEeecccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCcccc
Q 018263          181 -------DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ  253 (358)
Q Consensus       181 -------~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~  253 (358)
                             +.++.++|+|||++......    .....+|..|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus       169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  244 (355)
T 2eu9_A          169 KSCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN  244 (355)
T ss_dssp             -CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ccccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence                   66789999999999864322    2345689999999999998999999999999999999999999987655


Q ss_pred             ccchhhhHhhhhccchhhHhh--------------------------hhccc-cCCCCCHHHHHHHHHHHhhccCCCCCC
Q 018263          254 LGEYHLVDKAWGMYNSKELMN--------------------------LVDPM-LYGNFPENEAIRFLKVGLLCVQEKSKL  306 (358)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~-~~~~~~~~~~~~l~~li~~~l~~~P~~  306 (358)
                      ......+....+.....-...                          ...+. .........+..+.+|+.+||+.||.+
T Consensus       245 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  324 (355)
T 2eu9_A          245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ  324 (355)
T ss_dssp             HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence            443333333322211110000                          00000 001123456778999999999999999


Q ss_pred             CCCHHHHHH
Q 018263          307 RPQMSTAIK  315 (358)
Q Consensus       307 Rpt~~eil~  315 (358)
                      |||+.++++
T Consensus       325 Rpt~~e~l~  333 (355)
T 2eu9_A          325 RITLAEALL  333 (355)
T ss_dssp             SCCHHHHTT
T ss_pred             CcCHHHHhc
Confidence            999999974

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.3e-41  Score=315.04  Aligned_cols=256  Identities=9%  Similarity=-0.018  Sum_probs=182.5

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccCh---hhHHHHHHHHHHhhhcccCCCCceeee-------ceE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK---QGEKEFMSEVASMANVNVCHENLVKLH-------GGC  109 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~~~h~~i~~~~-------~~~  109 (358)
                      ..+|++.+.||+|+||.||+|.+. +|+.||+|++.....   .....+.+|+..+..+...||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            346999999999999999999976 789999999986532   344566777554444432499988755       344


Q ss_pred             EcC-----------------CeeEEEEecCCCCCHHHHhhhccccccCCCHHHH------HHHHHHHHHHHHHHhcCCCC
Q 018263          110 IDG-----------------PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKAR------REIIMGIGRGLAYIHEEIQP  166 (358)
Q Consensus       110 ~~~-----------------~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~------~~~~~qi~~aL~~LH~~~~~  166 (358)
                      ...                 ...++||||++ ++|.+++...   ...+++..+      ..++.||+.||+|||++   
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---  213 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSK---  213 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---
Confidence            332                 33799999997 8999999543   233455555      67789999999999999   


Q ss_pred             CcEEcCCCCCcEEEcCCCceEEeecccccccCCCCcccccccccccCccCcccccc--CCCCccCceecHHHHHHHHHhC
Q 018263          167 HVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS--GRLTRKSDVYSFGVLLLEIVSG  244 (358)
Q Consensus       167 ~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~s~~sDiwslG~il~~lltg  244 (358)
                      ||+||||||+||+++.++.+||+|||++.......    ....+++.|+|||++.+  ..++.++||||||+++|+|++|
T Consensus       214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg  289 (371)
T 3q60_A          214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL  289 (371)
T ss_dssp             TEEETTCSGGGEEECTTSCEEECCGGGEEETTCEE----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred             CCccCcCCHHHEEECCCCCEEEEecceeeecCCCc----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence            99999999999999999999999999998653211    13456699999999987  6799999999999999999999


Q ss_pred             CCCCCccccccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          245 RTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       245 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      +.||............        ....................+..+.+||.+||+.||.+|||+.++++
T Consensus       290 ~~Pf~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          290 FLPFGLVTPGIKGSWK--------RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             SCSTTBCCTTCTTCCC--------BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCCCcCcccccchh--------hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            9999866432111000        00000000001111111245677999999999999999999999874

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.6e-40  Score=307.78  Aligned_cols=272  Identities=19%  Similarity=0.251  Sum_probs=204.5

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhccc---------CCCCceeeeceE
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNV---------CHENLVKLHGGC  109 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~---------~h~~i~~~~~~~  109 (358)
                      ..++|++.+.||+|+||.||+|++. +++.||+|++.. .......+.+|+..++.+..         .||||+++++++
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~   95 (373)
T 1q8y_A           17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   95 (373)
T ss_dssp             TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence            3579999999999999999999974 689999999863 33445667788888877652         278999999998


Q ss_pred             EcCC----eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEc----
Q 018263          110 IDGP----CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD----  181 (358)
Q Consensus       110 ~~~~----~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~----  181 (358)
                      ...+    ..+++||++ +++|.+++...  ....+++..++.++.||+.||+|||+++  ||+|+||||+||+++    
T Consensus        96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~  170 (373)
T 1q8y_A           96 NHKGPNGVHVVMVFEVL-GENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDS  170 (373)
T ss_dssp             EEEETTEEEEEEEECCC-CEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEET
T ss_pred             hccCCCCceEEEEEecC-CCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCC
Confidence            8654    789999999 89999998432  3455899999999999999999999832  899999999999994    


Q ss_pred             --CCCceEEeecccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccc---
Q 018263          182 --QNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE---  256 (358)
Q Consensus       182 --~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~---  256 (358)
                        ..+.++|+|||++......    .....+|+.|+|||++.+..++.++||||||+++|+|++|+.||........   
T Consensus       171 ~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  246 (373)
T 1q8y_A          171 PENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  246 (373)
T ss_dssp             TTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             CcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence              4447999999999865332    2335689999999999999999999999999999999999999986542211   


Q ss_pred             ---hhhhHhhhhccchhhH---------------------------hhhhccccCCCCCHHHHHHHHHHHhhccCCCCCC
Q 018263          257 ---YHLVDKAWGMYNSKEL---------------------------MNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKL  306 (358)
Q Consensus       257 ---~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~  306 (358)
                         ...+....+.......                           ...+.  ....++...+..+.+||.+||+.||.+
T Consensus       247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~  324 (373)
T 1q8y_A          247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT--EKYKFSKDEAKEISDFLSPMLQLDPRK  324 (373)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHH--HTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred             HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhh--hcccCCcchHHHHHHHHHHHhccCccc
Confidence               1111111111110000                           00000  012356788899999999999999999


Q ss_pred             CCCHHHHHH--HhhcCCCC
Q 018263          307 RPQMSTAIK--MMNGETNI  323 (358)
Q Consensus       307 Rpt~~eil~--~L~~~~~~  323 (358)
                      |||+.|+++  .+.+....
T Consensus       325 Rpt~~ell~hp~f~~~~~~  343 (373)
T 1q8y_A          325 RADAGGLVNHPWLKDTLGM  343 (373)
T ss_dssp             CBCHHHHHTCGGGTTCTTC
T ss_pred             cCCHHHHhhChhhhcccCc
Confidence            999999987  55554433

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.1e-40  Score=310.72  Aligned_cols=265  Identities=20%  Similarity=0.275  Sum_probs=204.1

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhccc------CCCCceeeeceEE---
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNV------CHENLVKLHGGCI---  110 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~------~h~~i~~~~~~~~---  110 (358)
                      .++|++.+.||+|+||.||+|++. +++.||+|++.. .......+.+|+..++.+..      .|+||+++++.+.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS-AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec-CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            579999999999999999999875 688999999863 34455678889998888852      2788999999988   


Q ss_pred             -cCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCC-----
Q 018263          111 -DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF-----  184 (358)
Q Consensus       111 -~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~-----  184 (358)
                       .....++||||+ +++|.+.+..  .....+++..++.++.||+.||.|||+++  ||+||||||+||+++.++     
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~  189 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIK--SNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRR  189 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhh
Confidence             566789999999 6667666632  23356899999999999999999999842  899999999999998775     


Q ss_pred             --------------------------------------------ceEEeecccccccCCCCcccccccccccCccCcccc
Q 018263          185 --------------------------------------------NPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA  220 (358)
Q Consensus       185 --------------------------------------------~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~  220 (358)
                                                                  .++|+|||++......    .....+|..|+|||++
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~  265 (397)
T 1wak_A          190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVL  265 (397)
T ss_dssp             HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHH
T ss_pred             hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhh
Confidence                                                        7999999999865332    2335689999999999


Q ss_pred             ccCCCCccCceecHHHHHHHHHhCCCCCCccccccch------hhhHhhhhccchhhHh------hhhcc----------
Q 018263          221 ISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEY------HLVDKAWGMYNSKELM------NLVDP----------  278 (358)
Q Consensus       221 ~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~------~~~~~~~~~~~~~~~~------~~~~~----------  278 (358)
                      .+..++.++|||||||++|+|++|+.||.........      ..+....+......+.      .....          
T Consensus       266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (397)
T 1wak_A          266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL  345 (397)
T ss_dssp             HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred             cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence            9999999999999999999999999999765433221      1111111111110000      00000          


Q ss_pred             ---------ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          279 ---------MLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       279 ---------~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                               ......+...+..+.+||.+||+.||.+|||+.|+++
T Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                     0011345778889999999999999999999999985

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.8e-41  Score=319.43  Aligned_cols=266  Identities=20%  Similarity=0.325  Sum_probs=185.6

Q ss_pred             cCCcc-cceecccCceEEEEEEEC---CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEc--CCee
Q 018263           42 NGFRW-SNKIGEGGFGSVYKGRLQ---DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID--GPCR  115 (358)
Q Consensus        42 ~~y~i-~~~lg~g~~g~v~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~--~~~~  115 (358)
                      +.|++ .++||+|+||.||+|+.+   +++.||+|++....  ....+.+|+.+++.++  ||||+++++++..  ....
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~~   95 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELK--HPNVISLQKVFLSHADRKV   95 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCC--CTTBCCCCEEEEETTTTEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcC--CCCeeeEeeEEecCCCCeE
Confidence            45776 457999999999999965   57899999986432  2346778999999998  9999999999954  6788


Q ss_pred             EEEEecCCCCCHHHHhhhccc-----cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEE----cCCCce
Q 018263          116 ILVYDYMPNNSLSQTLLGEEK-----RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL----DQNFNP  186 (358)
Q Consensus       116 ~iv~e~~~~~~L~~~l~~~~~-----~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv----~~~~~~  186 (358)
                      ++||||++ ++|.+++.....     ....+++..++.++.||+.||+|||++   ||+||||||+||++    +.++.+
T Consensus        96 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~  171 (405)
T 3rgf_A           96 WLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRV  171 (405)
T ss_dssp             EEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCE
T ss_pred             EEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcE
Confidence            99999995 578887743321     223589999999999999999999999   99999999999999    678899


Q ss_pred             EEeecccccccCCCCc--ccccccccccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCCCccccc---------
Q 018263          187 KISDFGLSKLFPENTT--HISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL---------  254 (358)
Q Consensus       187 ~l~Dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf~~~~~~---------  254 (358)
                      +|+|||++........  .......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||......         
T Consensus       172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~  251 (405)
T 3rgf_A          172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH  251 (405)
T ss_dssp             EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred             EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence            9999999987543221  223346789999999998874 5899999999999999999999999765432         


Q ss_pred             cchhhhHhhhhccchhhHhhh------------hccccCCCCC---------HHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 018263          255 GEYHLVDKAWGMYNSKELMNL------------VDPMLYGNFP---------ENEAIRFLKVGLLCVQEKSKLRPQMSTA  313 (358)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~---------~~~~~~l~~li~~~l~~~P~~Rpt~~ei  313 (358)
                      +....+....+.+....+..+            +.........         ...+..+.+||.+||+.||.+|||+.|+
T Consensus       252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~  331 (405)
T 3rgf_A          252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA  331 (405)
T ss_dssp             HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence            111111111222211111111            0000000000         0114568899999999999999999999


Q ss_pred             HH
Q 018263          314 IK  315 (358)
Q Consensus       314 l~  315 (358)
                      ++
T Consensus       332 L~  333 (405)
T 3rgf_A          332 MQ  333 (405)
T ss_dssp             HT
T ss_pred             hc
Confidence            87

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.3e-40  Score=298.95  Aligned_cols=252  Identities=25%  Similarity=0.374  Sum_probs=194.7

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEc-------
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID-------  111 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~-------  111 (358)
                      ..++|++.+.||+|+||.||+|+.. +|+.||+|++.. .......+.+|+..++.++  ||||+++++++..       
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~~~   80 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLN--HQYVVRYYAAWLERRNFVKP   80 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCC--CTTBCCEEEEEEECCCCCC-
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcC--chHHHHHHHHHHhhcchhhh
Confidence            3578999999999999999999975 799999999864 3345577889999999998  9999999998765       


Q ss_pred             ------CCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCc
Q 018263          112 ------GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN  185 (358)
Q Consensus       112 ------~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~  185 (358)
                            .+..++||||+++++|.+++..   ....+++..++.++.||+.||+|||++   |++|+||+|+||+++.++.
T Consensus        81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~  154 (303)
T 1zy4_A           81 MTAVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRN  154 (303)
T ss_dssp             -----CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSC
T ss_pred             hcccccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCC
Confidence                  4567999999999999999943   345678899999999999999999999   9999999999999999999


Q ss_pred             eEEeecccccccCCCC-------------cccccccccccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCCCcc
Q 018263          186 PKISDFGLSKLFPENT-------------THISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFD  251 (358)
Q Consensus       186 ~~l~Dfg~~~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf~~~  251 (358)
                      ++|+|||++.......             ........++..|+|||++.+. .++.++||||||+++|+|++   ||...
T Consensus       155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~  231 (303)
T 1zy4_A          155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG  231 (303)
T ss_dssp             EEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred             EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc
Confidence            9999999997653221             1122345688999999998764 68999999999999999998   44321


Q ss_pred             ccccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          252 VQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ...  .......         . .........++...+..+.+++.+||+.||.+|||+.++++
T Consensus       232 ~~~--~~~~~~~---------~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          232 MER--VNILKKL---------R-SVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             HHH--HHHHHHH---------H-STTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhH--HHHHHhc---------c-ccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            110  0011000         0 01111223344556677899999999999999999999986

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.7e-40  Score=303.05  Aligned_cols=249  Identities=23%  Similarity=0.321  Sum_probs=201.3

Q ss_pred             HHHHHHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChh------hHHHHHHHHHHhhhcccCCCCceeee
Q 018263           34 YNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQ------GEKEFMSEVASMANVNVCHENLVKLH  106 (358)
Q Consensus        34 ~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~~~h~~i~~~~  106 (358)
                      ........++|++.+.||+|+||.||+|.+. +++.||+|++......      ....+..|+..++.+...|+||++++
T Consensus        35 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~  114 (320)
T 3a99_A           35 GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL  114 (320)
T ss_dssp             -----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred             ccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEE
Confidence            3444556789999999999999999999865 6899999998654221      22456678888888874579999999


Q ss_pred             ceEEcCCeeEEEEecCCC-CCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEc-CCC
Q 018263          107 GGCIDGPCRILVYDYMPN-NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD-QNF  184 (358)
Q Consensus       107 ~~~~~~~~~~iv~e~~~~-~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~-~~~  184 (358)
                      +++...+..++|+|++.+ ++|.+++    .....+++..++.++.||+.||.|||+.   |++|+||+|+||+++ +++
T Consensus       115 ~~~~~~~~~~lv~e~~~~~~~L~~~l----~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~  187 (320)
T 3a99_A          115 DWFERPDSFVLILERPEPVQDLFDFI----TERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRG  187 (320)
T ss_dssp             EEEECSSEEEEEEECCSSEEEHHHHH----HHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTT
T ss_pred             EEEecCCcEEEEEEcCCCCccHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCC
Confidence            999999999999999975 8999998    3456789999999999999999999999   999999999999999 788


Q ss_pred             ceEEeecccccccCCCCcccccccccccCccCccccccCCC-CccCceecHHHHHHHHHhCCCCCCccccccchhhhHhh
Q 018263          185 NPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKA  263 (358)
Q Consensus       185 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~  263 (358)
                      .++|+|||++.......   .....++..|+|||++.+..+ +.++||||||+++|+|++|+.||......        .
T Consensus       188 ~~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--------~  256 (320)
T 3a99_A          188 ELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--------I  256 (320)
T ss_dssp             EEEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH--------H
T ss_pred             CEEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh--------h
Confidence            99999999998754322   233568999999999887665 68899999999999999999999643210        0


Q ss_pred             hhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          264 WGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .             .  ...++...+..+.+++.+||+.||.+|||+.++++
T Consensus       257 ~-------------~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          257 R-------------G--QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             H-------------C--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             c-------------c--cccccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0             0  00112234567899999999999999999999986

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-40  Score=301.38  Aligned_cols=247  Identities=25%  Similarity=0.382  Sum_probs=191.2

Q ss_pred             HHHHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccCh------hhHHHHHHHHHHhhhccc--CCCCceeee
Q 018263           36 QLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK------QGEKEFMSEVASMANVNV--CHENLVKLH  106 (358)
Q Consensus        36 ~~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~~--~h~~i~~~~  106 (358)
                      +.....++|++.+.||+|+||.||+|.+. +++.||+|++.....      .....+..|+..+..+..  .||||++++
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            34556789999999999999999999874 688999999865432      122345568888887721  299999999


Q ss_pred             ceEEcCCeeEEEEec-CCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEc-CCC
Q 018263          107 GGCIDGPCRILVYDY-MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD-QNF  184 (358)
Q Consensus       107 ~~~~~~~~~~iv~e~-~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~-~~~  184 (358)
                      +++...+..++|+|+ +.+++|.+++.    ....+++..++.++.||+.||.|||+.   |++|+||+|+||+++ .++
T Consensus       105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~  177 (312)
T 2iwi_A          105 DWFETQEGFMLVLERPLPAQDLFDYIT----EKGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRG  177 (312)
T ss_dssp             EEC-----CEEEEECCSSEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTT
T ss_pred             EEEecCCeEEEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCC
Confidence            999999999999999 78999999993    455789999999999999999999999   999999999999999 889


Q ss_pred             ceEEeecccccccCCCCcccccccccccCccCccccccCCC-CccCceecHHHHHHHHHhCCCCCCccccccchhhhHhh
Q 018263          185 NPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKA  263 (358)
Q Consensus       185 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~  263 (358)
                      .++|+|||++.......   .....++..|+|||++.+..+ +.++||||||+++|+|++|+.||.....          
T Consensus       178 ~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----------  244 (312)
T 2iwi_A          178 CAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE----------  244 (312)
T ss_dssp             EEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----------
T ss_pred             eEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH----------
Confidence            99999999998754322   234568999999999887665 4589999999999999999999964311          


Q ss_pred             hhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          264 WGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                              ...   .  ...++...+..+.++|.+||+.||.+|||+.++++
T Consensus       245 --------~~~---~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          245 --------ILE---A--ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             --------HHH---T--CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             --------Hhh---h--ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                    000   0  01123345667899999999999999999999997

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=4.2e-40  Score=302.49  Aligned_cols=257  Identities=18%  Similarity=0.245  Sum_probs=174.3

Q ss_pred             hhcCCcccc-eecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEc----CC
Q 018263           40 ATNGFRWSN-KIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID----GP  113 (358)
Q Consensus        40 ~~~~y~i~~-~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~----~~  113 (358)
                      ..++|.+.+ .||+|+||.||+|.+. +|+.||+|++.... ...   .+....++.+.  ||||+++++++..    ..
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~---~e~~~~~~~~~--h~~i~~~~~~~~~~~~~~~   99 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-KAR---QEVDHHWQASG--GPHIVCILDVYENMHHGKR   99 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-HHH---HHHHHHHHHTT--STTBCCEEEEEEEEETTEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-HHH---HHHHHHHHhcC--CCChHHHHHHHhhccCCCc
Confidence            367899966 5999999999999987 69999999986432 111   12222344444  9999999999876    45


Q ss_pred             eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcC---CCceEEee
Q 018263          114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ---NFNPKISD  190 (358)
Q Consensus       114 ~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~---~~~~~l~D  190 (358)
                      ..++||||+++++|.+++..  .....+++..++.++.||+.||.|||++   |++|+||+|+||+++.   ++.++|+|
T Consensus       100 ~~~lv~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~D  174 (336)
T 3fhr_A          100 CLLIIMECMEGGELFSRIQE--RGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTD  174 (336)
T ss_dssp             EEEEEEECCTTEEHHHHHHT--C-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred             eEEEEEeccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEec
Confidence            58999999999999999943  2335799999999999999999999999   9999999999999976   44599999


Q ss_pred             cccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchh
Q 018263          191 FGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSK  270 (358)
Q Consensus       191 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      ||++......   ......+++.|+|||++.+..++.++||||||+++|+|++|..||...............       
T Consensus       175 fg~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-------  244 (336)
T 3fhr_A          175 FGFAKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRR-------  244 (336)
T ss_dssp             CTTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------
T ss_pred             cccceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHh-------
Confidence            9999865322   223456799999999998888999999999999999999999999754432211000000       


Q ss_pred             hHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 018263          271 ELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK--MMNG  319 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~--~L~~  319 (358)
                        ................+..+.+++.+||+.||.+|||+.++++  .+.+
T Consensus       245 --~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  293 (336)
T 3fhr_A          245 --IRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ  293 (336)
T ss_dssp             --------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             --hhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence              0000000011111345667999999999999999999999997  4444

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.6e-39  Score=297.41  Aligned_cols=260  Identities=24%  Similarity=0.342  Sum_probs=180.8

Q ss_pred             HHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC-hhhHHHHHHHHH-HhhhcccCCCCceeeeceEEcCCe
Q 018263           38 KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVA-SMANVNVCHENLVKLHGGCIDGPC  114 (358)
Q Consensus        38 ~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~-~l~~l~~~h~~i~~~~~~~~~~~~  114 (358)
                      .+..++|++.+.||+|+||.||+|... +|+.||+|++.... ......+..|+. .++.+.  ||||+++++++...+.
T Consensus        18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~--h~niv~~~~~~~~~~~   95 (327)
T 3aln_A           18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSD--CPYIVQFYGALFREGD   95 (327)
T ss_dssp             CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCC--CTTBCCEEEEEECSSE
T ss_pred             ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCC--CCcEeeeeeEEEeCCc
Confidence            345689999999999999999999985 68999999997543 333445555655 555555  9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHhhhcc-ccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccc
Q 018263          115 RILVYDYMPNNSLSQTLLGEE-KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL  193 (358)
Q Consensus       115 ~~iv~e~~~~~~L~~~l~~~~-~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~  193 (358)
                      .++||||+++ +|.+++.... .....+++..++.++.|++.||.|||+..  |++|+||+|+||+++.++.++|+|||+
T Consensus        96 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~  172 (327)
T 3aln_A           96 CWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGI  172 (327)
T ss_dssp             EEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSS
T ss_pred             eEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCC
Confidence            9999999975 7888774321 13567899999999999999999999842  999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccCccCcccc----ccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccch
Q 018263          194 SKLFPENTTHISTRVAGTLGYLAPEYA----ISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNS  269 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      +........  .....++..|+|||++    .+..++.++||||||+++|+|++|+.||........  .....    ..
T Consensus       173 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~----~~  244 (327)
T 3aln_A          173 SGQLVDSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD--QLTQV----VK  244 (327)
T ss_dssp             SCC--------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CCC----CC
T ss_pred             ceecccccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH--HHHHH----hc
Confidence            976543222  2234688999999998    456789999999999999999999999975322100  00000    00


Q ss_pred             hhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          270 KELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .     ..+.+........+..+.+++.+||+.||.+|||+.++++
T Consensus       245 ~-----~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          245 G-----DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             S-----CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             C-----CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            0     0001111112235667999999999999999999999975

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.8e-39  Score=307.02  Aligned_cols=254  Identities=20%  Similarity=0.260  Sum_probs=187.5

Q ss_pred             cCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEec
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY  121 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~  121 (358)
                      +.|.+.+.||+|+||+||.+...+|+.||||++....   ...+..|+..+..+. .||||+++++++...+..++||||
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~-~HpnIv~~~~~~~~~~~~~lv~E~   90 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESD-DHPNVIRYYCSETTDRFLYIALEL   90 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHT-TSTTBCCEEEEEECSSEEEEEECC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhcc-CCCCcCeEEEEEecCCeEEEEEec
Confidence            4566678899999999987777789999999986532   345678888888762 399999999999999999999999


Q ss_pred             CCCCCHHHHhhhccccccC---CCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCC-------------Cc
Q 018263          122 MPNNSLSQTLLGEEKRRAK---FGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN-------------FN  185 (358)
Q Consensus       122 ~~~~~L~~~l~~~~~~~~~---l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~-------------~~  185 (358)
                      ++ ++|.+++.........   .++..++.++.||+.||+|||++   ||+|+||||+||+++.+             +.
T Consensus        91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~  166 (434)
T 2rio_A           91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLR  166 (434)
T ss_dssp             CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred             CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceE
Confidence            95 6999999543221111   13345678999999999999999   99999999999999754             47


Q ss_pred             eEEeecccccccCCCCcc---cccccccccCccCcccccc-------CCCCccCceecHHHHHHHHHh-CCCCCCccccc
Q 018263          186 PKISDFGLSKLFPENTTH---ISTRVAGTLGYLAPEYAIS-------GRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQL  254 (358)
Q Consensus       186 ~~l~Dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-------~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~  254 (358)
                      ++|+|||++.........   ......||+.|+|||++.+       ..++.++|||||||++|+|++ |..||......
T Consensus       167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~  246 (434)
T 2rio_A          167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR  246 (434)
T ss_dssp             EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred             EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence            999999999876543221   1224579999999999875       568899999999999999999 99999644221


Q ss_pred             cchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          255 GEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      . ....   ......        +......+...+..+.++|.+||+.||.+|||+.++++
T Consensus       247 ~-~~i~---~~~~~~--------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          247 E-SNII---RGIFSL--------DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             H-HHHH---HTCCCC--------CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             H-HHHh---cCCCCc--------ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            1 0000   000000        01111224567889999999999999999999999985

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=3e-39  Score=294.05  Aligned_cols=254  Identities=23%  Similarity=0.361  Sum_probs=180.5

Q ss_pred             HHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccCh-hhHHH-HHHHHHHhhhcccCCCCceeeeceEEcCCe
Q 018263           38 KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK-QGEKE-FMSEVASMANVNVCHENLVKLHGGCIDGPC  114 (358)
Q Consensus        38 ~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~-~~~~~-~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~  114 (358)
                      ....++|++.+.||+|+||.||+|.+. +|+.||+|++..... ..... +.++...++.+.  ||||+++++++...+.
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~--h~~i~~~~~~~~~~~~   98 (318)
T 2dyl_A           21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHD--CPYIVQCFGTFITNTD   98 (318)
T ss_dssp             ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTT--CTTBCCEEEEEECSSE
T ss_pred             hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcC--CCceeeEEEEEecCCc
Confidence            344678999999999999999999986 689999999975432 22233 334444566665  9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcEEcCCCCCcEEEcCCCceEEeeccc
Q 018263          115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNILLDQNFNPKISDFGL  193 (358)
Q Consensus       115 ~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~  193 (358)
                      .++||||+ ++.+..+..   .....+++..++.++.||+.||.|||+ .   |++|+||+|+||+++.++.++|+|||+
T Consensus        99 ~~lv~e~~-~~~~~~l~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~  171 (318)
T 2dyl_A           99 VFIAMELM-GTCAEKLKK---RMQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGI  171 (318)
T ss_dssp             EEEEECCC-SEEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEecc-CCcHHHHHH---HhccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCC
Confidence            99999999 555555552   235678999999999999999999998 7   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccCccCccccc-----cCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccc
Q 018263          194 SKLFPENTTHISTRVAGTLGYLAPEYAI-----SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYN  268 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  268 (358)
                      +.......  ......+++.|+|||++.     +..++.++||||||+++|+|++|+.||......  ..........  
T Consensus       172 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~--  245 (318)
T 2dyl_A          172 SGRLVDDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD--FEVLTKVLQE--  245 (318)
T ss_dssp             C----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHHHHHHHS--
T ss_pred             chhccCCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc--HHHHHHHhcc--
Confidence            97653322  223356899999999984     456888999999999999999999999753221  1111111000  


Q ss_pred             hhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          269 SKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                             ..+..  ......+..+.+++.+||+.||.+|||+.++++
T Consensus       246 -------~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          246 -------EPPLL--PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             -------CCCCC--CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             -------CCCCC--CccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence                   00000  011134567899999999999999999999975

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.8e-39  Score=304.24  Aligned_cols=254  Identities=21%  Similarity=0.261  Sum_probs=188.9

Q ss_pred             HHHhhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeE
Q 018263           37 LKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI  116 (358)
Q Consensus        37 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~  116 (358)
                      +.+...+|.+.+.||+|+||+|+.....+|+.||||++......   .+.+|+..++.+. .||||+++++++.+....+
T Consensus        19 ~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~-~HpnIv~l~~~~~~~~~~~   94 (432)
T 3p23_A           19 VIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESD-EHPNVIRYFCTEKDRQFQY   94 (432)
T ss_dssp             EEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSC-CCTTBCCEEEEEEETTEEE
T ss_pred             EEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhcc-CCCCcCeEEEEEecCCEEE
Confidence            34445689999999999999977666667999999998654322   2457888888883 3999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcC-----CCceEEeec
Q 018263          117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ-----NFNPKISDF  191 (358)
Q Consensus       117 iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~-----~~~~~l~Df  191 (358)
                      +||||++ ++|.+++..   .....++..++.++.||+.||.|||++   ||+||||||+||+++.     ...++|+||
T Consensus        95 lv~E~~~-g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DF  167 (432)
T 3p23_A           95 IAIELCA-ATLQEYVEQ---KDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDF  167 (432)
T ss_dssp             EEEECCS-EEHHHHHHS---SSCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCT
T ss_pred             EEEECCC-CCHHHHHHh---cCCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecc
Confidence            9999995 699999843   223455556788999999999999999   9999999999999953     235789999


Q ss_pred             ccccccCCCCc--ccccccccccCccCccccc---cCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhh
Q 018263          192 GLSKLFPENTT--HISTRVAGTLGYLAPEYAI---SGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWG  265 (358)
Q Consensus       192 g~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~---~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~  265 (358)
                      |++........  .......||+.|+|||++.   +..++.++|||||||++|+|++ |..||........    .....
T Consensus       168 G~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~----~~~~~  243 (432)
T 3p23_A          168 GLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA----NILLG  243 (432)
T ss_dssp             TEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH----HHHTT
T ss_pred             cceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH----HHHhc
Confidence            99987543221  2233467999999999987   4567889999999999999999 9999864322110    00000


Q ss_pred             ccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          266 MYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ..          ...........+..+.+||.+||+.||.+|||+.++++
T Consensus       244 ~~----------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          244 AC----------SLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             CC----------CCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cC----------CccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            00          00001122355667889999999999999999999983

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.7e-38  Score=285.17  Aligned_cols=235  Identities=11%  Similarity=0.075  Sum_probs=186.2

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCee
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR  115 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~  115 (358)
                      ..++|++.+.||+|+||.||+|++. +++.||+|++....   ......+.+|+..+..+.  ||||+++++++...+..
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--hp~iv~~~~~~~~~~~~  106 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID--KPGVARVLDVVHTRAGG  106 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCC--CTTBCCEEEEEEETTEE
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCC--CCCcceeeEEEEECCcE
Confidence            4578999999999999999999986 58999999997553   334477889999999987  99999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccc
Q 018263          116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK  195 (358)
Q Consensus       116 ~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~  195 (358)
                      |+||||++|++|.+++..     + .....+..++.||+.||.|||++   ||+|+||||+||+++.++.++|++++   
T Consensus       107 ~lv~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~---  174 (286)
T 3uqc_A          107 LVVAEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA---  174 (286)
T ss_dssp             EEEEECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC---
T ss_pred             EEEEEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc---
Confidence            999999999999999832     2 34567888999999999999999   99999999999999999999997432   


Q ss_pred             ccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhh-hhccchhhHhh
Q 018263          196 LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKA-WGMYNSKELMN  274 (358)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~  274 (358)
                                        |.+       .++.++||||||+++|+|++|+.||............... ......  .. 
T Consensus       175 ------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~-  226 (286)
T 3uqc_A          175 ------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIE--PA-  226 (286)
T ss_dssp             ------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCC--HH-
T ss_pred             ------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCC--hh-
Confidence                              233       3688999999999999999999999876543322111000 000000  00 


Q ss_pred             hhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCCC
Q 018263          275 LVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNIDG  325 (358)
Q Consensus       275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~~  325 (358)
                              ......+..+.+++.+||+.||.+| |+.++++.|+.+.....
T Consensus       227 --------~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~  268 (286)
T 3uqc_A          227 --------DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD  268 (286)
T ss_dssp             --------HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred             --------hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence                    0112345568999999999999999 99999999999876653

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=5.4e-39  Score=315.02  Aligned_cols=274  Identities=23%  Similarity=0.295  Sum_probs=203.1

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEc------C
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID------G  112 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~------~  112 (358)
                      .++|++.+.||+|+||.||+|.+. +|+.||+|++... .......+.+|+..+..++  ||||+++++++..      .
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~--HpnIV~l~~v~~~~~~~~~~   90 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN--HPNVVSAREVPDGLQKLAPN   90 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCC--BTTBCCEEECCTTTCCCCTT
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCC--CCCCCceeeeecccccccCC
Confidence            479999999999999999999875 6899999998654 4445677889999999998  9999999998765      6


Q ss_pred             CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCc---eEEe
Q 018263          113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN---PKIS  189 (358)
Q Consensus       113 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~---~~l~  189 (358)
                      +..++||||++|++|.+++... .....+++..++.++.||+.||+|||+.   |++|+||+|+||+++.++.   ++|+
T Consensus        91 ~~~~LVmEy~~ggsL~~~L~~~-~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~  166 (676)
T 3qa8_A           91 DLPLLAMEYCEGGDLRKYLNQF-ENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKII  166 (676)
T ss_dssp             SSCCCEEECCSSCBHHHHHHSS-SCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred             CeEEEEEEeCCCCCHHHHHHhc-ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEc
Confidence            6789999999999999999543 2234689999999999999999999999   9999999999999997765   8999


Q ss_pred             ecccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhh--h-hc
Q 018263          190 DFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKA--W-GM  266 (358)
Q Consensus       190 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~--~-~~  266 (358)
                      |||.+........  .....++..|+|||++.+..++.++||||||+++|+|++|..||...............  . ..
T Consensus       167 DFG~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~  244 (676)
T 3qa8_A          167 DLGYAKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHI  244 (676)
T ss_dssp             SCCCCCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------C
T ss_pred             ccccccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhh
Confidence            9999987643322  23467899999999999999999999999999999999999999754221100000000  0 00


Q ss_pred             cchhhHh---hhhc-cccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHH-----HHHHhhcCCC
Q 018263          267 YNSKELM---NLVD-PMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMST-----AIKMMNGETN  322 (358)
Q Consensus       267 ~~~~~~~---~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~e-----il~~L~~~~~  322 (358)
                      .......   .+.. ...........+..+.+++.+||+.||.+|||+.+     +.+.++.+..
T Consensus       245 ~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~  309 (676)
T 3qa8_A          245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS  309 (676)
T ss_dssp             CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred             hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence            0000000   0000 00112344567889999999999999999999977     4455554443

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=5.2e-38  Score=314.21  Aligned_cols=240  Identities=20%  Similarity=0.240  Sum_probs=194.5

Q ss_pred             hhcCCcccceecccCceEEEEEEEC--CCCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCe--
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ--DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC--  114 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~--~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~--  114 (358)
                      ..++|++.+.||+|+||.||++.+.  +|+.||||++... .......+..|+..+..++  ||||+++++++...+.  
T Consensus        78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~~~~  155 (681)
T 2pzi_A           78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVV--HPSIVQIFNFVEHTDRHG  155 (681)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCC--CTTBCCEEEEEEEECTTS
T ss_pred             eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcC--CCCcCeEeeeEeecCCCC
Confidence            3589999999999999999999975  5899999998644 3345567889999999998  9999999999987665  


Q ss_pred             ---eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeec
Q 018263          115 ---RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF  191 (358)
Q Consensus       115 ---~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Df  191 (358)
                         .|+||||++|++|.+.+.      ..+++..++.++.||+.||.|||++   ||+|+||||+||+++.+ .+||+||
T Consensus       156 ~~~~~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DF  225 (681)
T 2pzi_A          156 DPVGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDL  225 (681)
T ss_dssp             CEEEEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCC
T ss_pred             CceeEEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEec
Confidence               799999999999998772      2689999999999999999999999   99999999999999986 8999999


Q ss_pred             ccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhh
Q 018263          192 GLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKE  271 (358)
Q Consensus       192 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      |++......     ....||+.|+|||++.+.. +.++||||||+++|+|++|..||.........              
T Consensus       226 G~a~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~--------------  285 (681)
T 2pzi_A          226 GAVSRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLP--------------  285 (681)
T ss_dssp             TTCEETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCC--------------
T ss_pred             ccchhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccccc--------------
Confidence            999875432     3456899999999887654 88999999999999999999988643211100              


Q ss_pred             HhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCC-HHHHHHHhhcC
Q 018263          272 LMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQ-MSTAIKMMNGE  320 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt-~~eil~~L~~~  320 (358)
                               ........+..+.++|.+||+.||.+||+ ++++.+.|.+.
T Consensus       286 ---------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          286 ---------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             ---------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             ---------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence                     00011123457889999999999999995 66666666543

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.2e-37  Score=279.67  Aligned_cols=228  Identities=18%  Similarity=0.265  Sum_probs=176.8

Q ss_pred             hcCCccc-ceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEc----CCe
Q 018263           41 TNGFRWS-NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID----GPC  114 (358)
Q Consensus        41 ~~~y~i~-~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~----~~~  114 (358)
                      .++|.+. +.||+|+||.||+|.+. +++.||+|++...     ....+|+..+..+. .||||+++++++..    ...
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~-~h~~i~~~~~~~~~~~~~~~~   89 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKC   89 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHT-TSTTBCCEEEEEEEEETTEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhc-cCCCchhHHhhhhhhcCCCce
Confidence            4677777 77999999999999975 6899999998632     34557777774443 49999999999886    677


Q ss_pred             eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcC---CCceEEeec
Q 018263          115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ---NFNPKISDF  191 (358)
Q Consensus       115 ~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~---~~~~~l~Df  191 (358)
                      .++||||+++++|.+++..  .....+++..++.++.||+.||.|||+.   |++|+||+|+||+++.   ++.++|+||
T Consensus        90 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Df  164 (299)
T 3m2w_A           90 LLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF  164 (299)
T ss_dssp             EEEEECCCCSCBHHHHHHH--CTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             EEEEEeecCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecc
Confidence            8999999999999999943  2234689999999999999999999999   9999999999999998   788999999


Q ss_pred             ccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhh
Q 018263          192 GLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKE  271 (358)
Q Consensus       192 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      |++....                       +..++.++||||||+++|+|++|+.||.............          
T Consensus       165 g~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~----------  211 (299)
T 3m2w_A          165 GFAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK----------  211 (299)
T ss_dssp             TTCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSC----------
T ss_pred             ccccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHH----------
Confidence            9886432                       2346778999999999999999999997543221110000          


Q ss_pred             HhhhhccccCCCCC----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          272 LMNLVDPMLYGNFP----ENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       272 ~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                        ..+... ....+    ...+..+.+++.+||+.||.+|||+.|+++
T Consensus       212 --~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          212 --TRIRMG-QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             --CSSCTT-CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             --HHHhhc-cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence              000000 00111    124567999999999999999999999987

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.6e-37  Score=293.13  Aligned_cols=241  Identities=17%  Similarity=0.129  Sum_probs=179.8

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccCh---hhHHHHHHHHHHhhhcccCC-CCcee---------ee-
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK---QGEKEFMSEVASMANVNVCH-ENLVK---------LH-  106 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~~~h-~~i~~---------~~-  106 (358)
                      ..|++.+.||+|+||.||+|.+. +|+.||||++.....   ...+.+.+|+..+..+.  | +|...         .. 
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~--~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR--GIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGST--TCCSHHHHHHHTCBCCCCE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhc--cCCCHHHHHHhcccccchh
Confidence            35778899999999999999965 699999999874322   23467888999888886  4 22111         11 


Q ss_pred             -----------ceEEc-----CCeeEEEEecCCCCCHHHHhhhc---cccccCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 018263          107 -----------GGCID-----GPCRILVYDYMPNNSLSQTLLGE---EKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH  167 (358)
Q Consensus       107 -----------~~~~~-----~~~~~iv~e~~~~~~L~~~l~~~---~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~  167 (358)
                                 ..+..     ....+++|+.+ +++|.+++...   ......+++..+..++.||+.||+|||++   |
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~  231 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---G  231 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence                       11111     22356777766 78999888422   22345678889999999999999999999   9


Q ss_pred             cEEcCCCCCcEEEcCCCceEEeecccccccCCCCcccccccccccCccCcccc----------ccCCCCccCceecHHHH
Q 018263          168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA----------ISGRLTRKSDVYSFGVL  237 (358)
Q Consensus       168 i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~s~~sDiwslG~i  237 (358)
                      |+||||||+||+++.++.+||+|||++......    .....| +.|+|||++          .+..++.++||||||++
T Consensus       232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi  306 (413)
T 3dzo_A          232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA  306 (413)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred             cccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence            999999999999999999999999998764322    334567 999999998          45568889999999999


Q ss_pred             HHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 018263          238 LLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAI  314 (358)
Q Consensus       238 l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil  314 (358)
                      +|+|++|+.||...........+               +..  ..    ..+..+.+||.+||+.||.+|||+.+++
T Consensus       307 l~elltg~~Pf~~~~~~~~~~~~---------------~~~--~~----~~~~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          307 IYWIWCADLPNTDDAALGGSEWI---------------FRS--CK----NIPQPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             HHHHHHSSCCCCTTGGGSCSGGG---------------GSS--CC----CCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             HHHHHHCCCCCCCcchhhhHHHH---------------Hhh--cc----cCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            99999999999765432221111               110  01    2246699999999999999999976664

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.5e-37  Score=283.98  Aligned_cols=241  Identities=16%  Similarity=0.156  Sum_probs=183.6

Q ss_pred             HhhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccC--------hhhHHHHHHHHHHhhhccc-------CCCCce
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVES--------KQGEKEFMSEVASMANVNV-------CHENLV  103 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~~-------~h~~i~  103 (358)
                      +..++|++.+.||+|+||.||+|++ +|+.||||++....        ......+.+|+.+++.++.       .||||+
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv   95 (336)
T 2vuw_A           17 LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI   95 (336)
T ss_dssp             SCHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred             cccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence            4467899999999999999999998 68999999997542        2233667788887777641       255555


Q ss_pred             eeec-----------------eEEc-------------CCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHH
Q 018263          104 KLHG-----------------GCID-------------GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGI  153 (358)
Q Consensus       104 ~~~~-----------------~~~~-------------~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi  153 (358)
                      ++.+                 ++..             .+..++||||++++++.+.+.     ...+++..++.++.||
T Consensus        96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi  170 (336)
T 2vuw_A           96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQL  170 (336)
T ss_dssp             CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHH
T ss_pred             hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHH
Confidence            5554                 4443             678999999999997777662     2568999999999999


Q ss_pred             HHHHHHHh-cCCCCCcEEcCCCCCcEEEcCCC--------------------ceEEeecccccccCCCCccccccccccc
Q 018263          154 GRGLAYIH-EEIQPHVVHRDIKTSNILLDQNF--------------------NPKISDFGLSKLFPENTTHISTRVAGTL  212 (358)
Q Consensus       154 ~~aL~~LH-~~~~~~i~H~di~p~Nilv~~~~--------------------~~~l~Dfg~~~~~~~~~~~~~~~~~~~~  212 (358)
                      +.||+||| ++   ||+||||||+||+++.++                    .+||+|||++.....      ....||+
T Consensus       171 ~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------~~~~gt~  241 (336)
T 2vuw_A          171 TASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------GIVVFCD  241 (336)
T ss_dssp             HHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------TEEECCC
T ss_pred             HHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------CcEEEee
Confidence            99999999 89   999999999999999887                    899999999986532      1346899


Q ss_pred             CccCccccccCCCCccCceecHHHH-HHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhc-----cccCCCCCH
Q 018263          213 GYLAPEYAISGRLTRKSDVYSFGVL-LLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD-----PMLYGNFPE  286 (358)
Q Consensus       213 ~y~aPE~~~~~~~s~~sDiwslG~i-l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~  286 (358)
                      .|+|||++.+.. +.++|||||+++ .++++.|..||......              ......+..     .........
T Consensus       242 ~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~  306 (336)
T 2vuw_A          242 VSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWL--------------HYLTDKMLKQMTFKTKCNTPAMK  306 (336)
T ss_dssp             CTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHH--------------HHHHHHHHHTCCCSSCCCSHHHH
T ss_pred             cccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhh--------------hHHHHhhhhhhccCcccchhhhh
Confidence            999999988766 889999998777 77888899998521100              000001110     001111234


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 018263          287 NEAIRFLKVGLLCVQEKSKLRPQMSTAI  314 (358)
Q Consensus       287 ~~~~~l~~li~~~l~~~P~~Rpt~~eil  314 (358)
                      ..+..+.+||.+||+.|     |+.|++
T Consensus       307 ~~s~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          307 QIKRKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred             hcCHHHHHHHHHHhccC-----CHHHHH
Confidence            67889999999999976     999988

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=5.7e-30  Score=249.93  Aligned_cols=185  Identities=16%  Similarity=0.152  Sum_probs=129.6

Q ss_pred             cccCceEEEEEEE-CCCCEEEEEEeecc----------ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           51 GEGGFGSVYKGRL-QDGTIVAVKVLSVE----------SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        51 g~g~~g~v~~~~~-~~~~~vaiK~~~~~----------~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      ..|+.|.+..++. -.|+.|++|++...          .....+++.+|++.|+++. .|+||+++++++++++..||||
T Consensus       243 ~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~-~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          243 YAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPP-AGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCC-TTCCCCCEEEEEECSSEEEEEE
T ss_pred             ccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEECCEEEEEE
Confidence            3444444444332 24788999998643          1233467889999999995 4999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      ||++|++|.+.+    ...+++++.   .++.||+.||+|+|++   ||+||||||+|||++.+|.+||+|||+++....
T Consensus       322 Eyv~G~~L~d~i----~~~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          322 EKLPGRLLSDML----AAGEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             ECCCSEEHHHHH----HTTCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred             ecCCCCcHHHHH----HhCCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence            999999999999    445667665   4789999999999999   999999999999999999999999999987543


Q ss_pred             CCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCC
Q 018263          200 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAV  248 (358)
Q Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf  248 (358)
                      ... .....+||+.|+|||++.+ .+..++|+|++|++++.+.++..++
T Consensus       392 ~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          392 DCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             --C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred             CCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence            332 2344679999999998865 4567899999999988876655443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.92  E-value=1.4e-25  Score=217.74  Aligned_cols=184  Identities=18%  Similarity=0.159  Sum_probs=142.9

Q ss_pred             cccceecccCceEEEEEEECCCCEEEEEEeeccC--------hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeE
Q 018263           45 RWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVES--------KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI  116 (358)
Q Consensus        45 ~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~  116 (358)
                      ...+.||+|+||.||++.. .+..+++|......        ....+.+.+|++.++.++  ||||+++..++......+
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~--h~nIv~~~~~~~~~~~~~  415 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVK--DFGIPAPYIFDVDLDNKR  415 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGG--GGTCCCCCEEEEETTTTE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcC--CCCcCceEEEEEeCCccE
Confidence            3456899999999999955 47788888864321        112355789999999998  999996666666777789


Q ss_pred             EEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       117 iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      +||||++|++|.+++..            +..++.|++.+|.|||++   ||+||||||+||+++.  .+||+|||+++.
T Consensus       416 lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~  478 (540)
T 3en9_A          416 IMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKI  478 (540)
T ss_dssp             EEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEE
T ss_pred             EEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEE
Confidence            99999999999999932            568999999999999999   9999999999999999  999999999997


Q ss_pred             cCCCCccc------ccccccccCccCcccccc--CCCCccCceecHHHHHHHHHhCCCCC
Q 018263          197 FPENTTHI------STRVAGTLGYLAPEYAIS--GRLTRKSDVYSFGVLLLEIVSGRTAV  248 (358)
Q Consensus       197 ~~~~~~~~------~~~~~~~~~y~aPE~~~~--~~~s~~sDiwslG~il~~lltg~~pf  248 (358)
                      ........      .....||+.|+|||++.+  ..|+...|+|+..+-..+-..++.+|
T Consensus       479 ~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          479 SNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             CCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            64432211      234679999999999886  56788899999988888877777665

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.88  E-value=4.2e-23  Score=184.27  Aligned_cols=150  Identities=15%  Similarity=0.052  Sum_probs=118.4

Q ss_pred             HHHhhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccCh------------------hhHHHHHHHHHHhhhcccC
Q 018263           37 LKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESK------------------QGEKEFMSEVASMANVNVC   98 (358)
Q Consensus        37 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~------------------~~~~~~~~e~~~l~~l~~~   98 (358)
                      +......|.+.+.||+|++|.||+|.+.+|+.||+|++.....                  .....+.+|+..++.+.  
T Consensus        85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--  162 (282)
T 1zar_A           85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--  162 (282)
T ss_dssp             HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred             HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence            3334566777799999999999999997799999999864321                  23567889999999987  


Q ss_pred             CCCceeeeceEEcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcE
Q 018263           99 HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNI  178 (358)
Q Consensus        99 h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Ni  178 (358)
                      |.   ++.+.+.. +..++||||++|++|.+ +.    .      .....++.||+.||.+||+.   |++|+||||+||
T Consensus       163 ~~---~v~~~~~~-~~~~lvmE~~~g~~L~~-l~----~------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NI  224 (282)
T 1zar_A          163 GL---AVPKVYAW-EGNAVLMELIDAKELYR-VR----V------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNV  224 (282)
T ss_dssp             TS---SSCCEEEE-ETTEEEEECCCCEEGGG-CC----C------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSE
T ss_pred             CC---CcCeEEec-cceEEEEEecCCCcHHH-cc----h------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHE
Confidence            44   44444433 55699999999999988 51    1      22446999999999999999   999999999999


Q ss_pred             EEcCCCceEEeecccccccCCCCcccccccccccCccCccccc
Q 018263          179 LLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI  221 (358)
Q Consensus       179 lv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  221 (358)
                      +++ ++.++|+|||++..              +..+.|||++.
T Consensus       225 Ll~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~  252 (282)
T 1zar_A          225 LVS-EEGIWIIDFPQSVE--------------VGEEGWREILE  252 (282)
T ss_dssp             EEE-TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred             EEE-CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence            999 99999999999964              23467888764

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.79  E-value=2.4e-19  Score=157.95  Aligned_cols=137  Identities=15%  Similarity=0.137  Sum_probs=105.8

Q ss_pred             CCcccceecccCceEEEEEEE-CCCCE--EEEEEeeccCh------------------------hhHHHHHHHHHHhhhc
Q 018263           43 GFRWSNKIGEGGFGSVYKGRL-QDGTI--VAVKVLSVESK------------------------QGEKEFMSEVASMANV   95 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~-~~~~~--vaiK~~~~~~~------------------------~~~~~~~~e~~~l~~l   95 (358)
                      -|.+.+.||+|+||.||+|.+ .+|+.  ||||++.....                        .....+..|+..+..+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            367889999999999999998 67888  99998753311                        1123678899999988


Q ss_pred             ccCCCCc--eeeeceEEcCCeeEEEEecCCC-C----CHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHh-cCCCCC
Q 018263           96 NVCHENL--VKLHGGCIDGPCRILVYDYMPN-N----SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH-EEIQPH  167 (358)
Q Consensus        96 ~~~h~~i--~~~~~~~~~~~~~~iv~e~~~~-~----~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH-~~~~~~  167 (358)
                      .  |+++  +.+++.    ...++||||+.+ +    +|.+....       .++..+..++.|++.+|.+|| +.   |
T Consensus       128 ~--~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---g  191 (258)
T 1zth_A          128 K--EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---E  191 (258)
T ss_dssp             H--HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---C
T ss_pred             H--hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---C
Confidence            7  6543  333332    356899999942 3    66666421       234567889999999999999 98   9


Q ss_pred             cEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          168 VVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       168 i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      ++|+||||+||+++.  .++|+|||++...
T Consensus       192 ivHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          192 LVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            999999999999998  8999999999753

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.71  E-value=6.8e-18  Score=155.05  Aligned_cols=137  Identities=14%  Similarity=0.155  Sum_probs=98.8

Q ss_pred             cCCcccceecccCceEEEEEEECCCCEEEEEEeeccC--------------hh--------hHHHHHHHHHHhhhcccCC
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVES--------------KQ--------GEKEFMSEVASMANVNVCH   99 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~--------------~~--------~~~~~~~e~~~l~~l~~~h   99 (358)
                      .=|++...||.|++|.||+|...+|+.||||+++...              ..        .......|...+..+.  +
T Consensus        95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~--~  172 (397)
T 4gyi_A           95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY--E  172 (397)
T ss_dssp             SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH--H
T ss_pred             CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH--h
Confidence            3499999999999999999999999999999975320              00        0112234555555553  2


Q ss_pred             CCc--eeeeceEEcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCc
Q 018263          100 ENL--VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSN  177 (358)
Q Consensus       100 ~~i--~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~N  177 (358)
                      .++  ..+++.    ...++||||++|.+|..+..          ......++.||+.+|.+||+.   |++||||||.|
T Consensus       173 ~gv~vp~p~~~----~~~~LVME~i~G~~L~~l~~----------~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~N  235 (397)
T 4gyi_A          173 EGFPVPEPIAQ----SRHTIVMSLVDALPMRQVSS----------VPDPASLYADLIALILRLAKH---GLIHGDFNEFN  235 (397)
T ss_dssp             TTCSCCCEEEE----ETTEEEEECCSCEEGGGCCC----------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTS
T ss_pred             cCCCCCeeeec----cCceEEEEecCCccHhhhcc----------cHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHH
Confidence            222  222221    12479999999888766541          122356789999999999999   99999999999


Q ss_pred             EEEcCCC----------ceEEeeccccccc
Q 018263          178 ILLDQNF----------NPKISDFGLSKLF  197 (358)
Q Consensus       178 ilv~~~~----------~~~l~Dfg~~~~~  197 (358)
                      ||+++++          .+.|+||+.+...
T Consensus       236 ILl~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          236 ILIREEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             EEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             EEEeCCCCcccccccccceEEEEeCCcccC
Confidence            9998876          3899999987654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.43  E-value=6e-13  Score=117.01  Aligned_cols=145  Identities=15%  Similarity=0.034  Sum_probs=112.6

Q ss_pred             hhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      ....|++...++.|+.+.||++... +..+++|+...........+..|+..++.+.. +..+.+++++....+..|+||
T Consensus        12 ~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~-~~~vP~v~~~~~~~~~~~lv~   89 (263)
T 3tm0_A           12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEG-KLPVPKVLHFERHDGWSNLLM   89 (263)
T ss_dssp             HHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTT-TSCCCCEEEEEEETTEEEEEE
T ss_pred             HhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhc-CCCCCeEEEEEecCCceEEEE
Confidence            3467999999998889999999865 67899999865322223457789999988863 677888999988888999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI-----------------------------------  164 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~-----------------------------------  164 (358)
                      ||++|.+|.+.+.         +......++.+++.+|..||+..                                   
T Consensus        90 e~i~G~~l~~~~~---------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T 3tm0_A           90 SEADGVLCSEEYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             ECCSSEEHHHHCC---------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred             EecCCeehhhccC---------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence            9999999887641         11223467889999999999810                                   


Q ss_pred             ---------------------CCCcEEcCCCCCcEEEcCCCceEEeeccccc
Q 018263          165 ---------------------QPHVVHRDIKTSNILLDQNFNPKISDFGLSK  195 (358)
Q Consensus       165 ---------------------~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~  195 (358)
                                           ...++|+|+++.||++++++.+.|+||+.+.
T Consensus       161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                 0268999999999999876556799998775

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.23  E-value=1.9e-11  Score=106.94  Aligned_cols=139  Identities=15%  Similarity=0.153  Sum_probs=98.3

Q ss_pred             cCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCC-CceeeeceEEcCCeeEEEEe
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHE-NLVKLHGGCIDGPCRILVYD  120 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~-~i~~~~~~~~~~~~~~iv~e  120 (358)
                      ..|.+....+.|..+.||++...+|..+++|+....   ....+..|+..++.+.. +. .+.+++.+....+..++|||
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~-~~~~vP~~~~~~~~~~~~~~v~e   95 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLAT-TGVPCAAVLDVVTEAGRDWLLLG   95 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHT-TTCCBCCEEEEEECSSCEEEEEE
T ss_pred             CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHh-CCCCCCeEEEeccCCCCCEEEEE
Confidence            345544333455669999998777888999997543   22356678888888762 32 25668888888788899999


Q ss_pred             cCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCC------------------------------------
Q 018263          121 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI------------------------------------  164 (358)
Q Consensus       121 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~------------------------------------  164 (358)
                      |++|.+|.  ..    .   .+   ...++.+++..|..||+..                                    
T Consensus        96 ~i~G~~l~--~~----~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (264)
T 1nd4_A           96 EVPGQDLL--SS----H---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ  163 (264)
T ss_dssp             CCSSEETT--TS----C---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred             ecCCcccC--cC----c---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence            99998874  21    0   11   1256677778888888641                                    


Q ss_pred             -------------------CCCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          165 -------------------QPHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       165 -------------------~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                                         ..+++|+|++|.||++++++.+.|+||+.+..
T Consensus       164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                               01299999999999998775567999998753

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.12  E-value=1.9e-10  Score=105.81  Aligned_cols=146  Identities=14%  Similarity=0.144  Sum_probs=107.2

Q ss_pred             CcccceecccCceEEEEEEECCCCEEEEEEee--ccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC---CeeEE
Q 018263           44 FRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLS--VES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG---PCRIL  117 (358)
Q Consensus        44 y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~--~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~---~~~~i  117 (358)
                      ..-++.++.|.++.||++...+ ..+++|+..  ... ......+.+|+..++.+...+..+++++..+.+.   +..++
T Consensus        40 ~~~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~  118 (359)
T 3dxp_A           40 PLSVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY  118 (359)
T ss_dssp             CCEEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred             CceEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence            3446788999999999998764 678888875  221 1223467788888888874455678888887766   45799


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCC---------------------------------
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI---------------------------------  164 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---------------------------------  164 (358)
                      ||||++|..+.+..      ...++......++.+++.+|+.||+..                                 
T Consensus       119 vme~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (359)
T 3dxp_A          119 IMEFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE  192 (359)
T ss_dssp             EEECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred             EEEecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence            99999988775432      123677888899999999999999720                                 


Q ss_pred             ----------------------CCCcEEcCCCCCcEEEcCCCc--eEEeecccccc
Q 018263          165 ----------------------QPHVVHRDIKTSNILLDQNFN--PKISDFGLSKL  196 (358)
Q Consensus       165 ----------------------~~~i~H~di~p~Nilv~~~~~--~~l~Dfg~~~~  196 (358)
                                            ...++|+|+++.||+++.++.  +.|+||+.+..
T Consensus       193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                  137999999999999987653  58999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.97  E-value=3e-10  Score=102.01  Aligned_cols=188  Identities=16%  Similarity=0.170  Sum_probs=119.3

Q ss_pred             cceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCC--ceeeeceEEcCC---eeEEEEec
Q 018263           47 SNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHEN--LVKLHGGCIDGP---CRILVYDY  121 (358)
Q Consensus        47 ~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~--i~~~~~~~~~~~---~~~iv~e~  121 (358)
                      ++.++.|....||++.    ..+++|+...  ......+..|...++.+.. +..  +..++.......   ..|+||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~-~~~v~vP~~~~~~~~~~~~~~~~~vm~~   97 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHN-KLPLPIPEVVFTGMPSETYQMSFAGFTK   97 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTT-SSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHh-cCCCCCCceEeecCCCCCCCcceEEEcc
Confidence            4568999999999874    4588898643  2345678888888877741 222  334443333322   34789999


Q ss_pred             CCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 018263          122 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE--------------------------------------  163 (358)
Q Consensus       122 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~--------------------------------------  163 (358)
                      ++|.+|.+...      ..++......++.+++..|..||+.                                      
T Consensus        98 i~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (304)
T 3sg8_A           98 IKGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK  171 (304)
T ss_dssp             CCCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred             cCCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence            99988876431      3466777788888888888888861                                      


Q ss_pred             -----------------CCCCcEEcCCCCCcEEEcC--CCceEEeecccccccCCCCcccccccccccCccCccccc---
Q 018263          164 -----------------IQPHVVHRDIKTSNILLDQ--NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI---  221 (358)
Q Consensus       164 -----------------~~~~i~H~di~p~Nilv~~--~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---  221 (358)
                                       ....++|+|+++.||++++  .+.+.++||+.+..-.. ...... ......-..|+...   
T Consensus       172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~-~~Dl~~-~~~~~~~~~~~~~~~~l  249 (304)
T 3sg8_A          172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDP-DNDFIS-LMEDDEEYGMEFVSKIL  249 (304)
T ss_dssp             HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECT-THHHHT-TCCTTTSCCHHHHHHHH
T ss_pred             HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCCh-HHHHHH-HHhhccccCHHHHHHHH
Confidence                             0135799999999999998  45578999998765211 110000 00000001222111   


Q ss_pred             -cC-CC---------CccCceecHHHHHHHHHhCCCCCC
Q 018263          222 -SG-RL---------TRKSDVYSFGVLLLEIVSGRTAVD  249 (358)
Q Consensus       222 -~~-~~---------s~~sDiwslG~il~~lltg~~pf~  249 (358)
                       .. ..         ..-.++|+++.++|.+.+|..+|.
T Consensus       250 ~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          250 NHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             HHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence             00 00         112578999999999999988764

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.58  E-value=7e-07  Score=78.27  Aligned_cols=141  Identities=16%  Similarity=0.171  Sum_probs=99.5

Q ss_pred             CCcccceecccCce-EEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEe
Q 018263           43 GFRWSNKIGEGGFG-SVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD  120 (358)
Q Consensus        43 ~y~i~~~lg~g~~g-~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e  120 (358)
                      .|+. +.+..|..+ .||+.... ++..+++|+....   ....+..|...++.+.. +--+.+++.+..+.+..++|||
T Consensus        26 g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~-~vPVP~v~~~~~~~~~~~lvme  100 (272)
T 4gkh_A           26 GYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTA-FMPLPTIKHFIRTPDDAWLLTT  100 (272)
T ss_dssp             TCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTT-TSCCCCEEEEEEETTEEEEEEE
T ss_pred             CCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhcc-CCCcCeEEEEEEECCeEEEEEE
Confidence            4443 344445554 68988765 4677999986532   34457788888888752 3336778888888899999999


Q ss_pred             cCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 018263          121 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE-------------------------------------  163 (358)
Q Consensus       121 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-------------------------------------  163 (358)
                      +++|.++.+.....        ......+..++...|..||+.                                     
T Consensus       101 ~l~G~~~~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (272)
T 4gkh_A          101 AIPGKTAFQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERN  172 (272)
T ss_dssp             CCCSEEHHHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGT
T ss_pred             eeCCccccccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccccc
Confidence            99998887765211        122335666777777888753                                     


Q ss_pred             ------------------CCCCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          164 ------------------IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       164 ------------------~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                                        ....++|+|+++.||++++++.+-|+||+.+..
T Consensus       173 ~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          173 GWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             TCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             chHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                              011479999999999999876677999987753

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.56  E-value=8.3e-07  Score=79.50  Aligned_cols=138  Identities=16%  Similarity=0.175  Sum_probs=92.0

Q ss_pred             cceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCC-CceeeeceEE-cCCeeEEEEecCCC
Q 018263           47 SNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHE-NLVKLHGGCI-DGPCRILVYDYMPN  124 (358)
Q Consensus        47 ~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~-~i~~~~~~~~-~~~~~~iv~e~~~~  124 (358)
                      ++.++.|....||++    |..+++|+..  .......+..|...+..+....+ .+.+++.+.. ..+..+++|++++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            456788888899988    5668889853  33445678889999998862112 2455555553 45567899999999


Q ss_pred             CCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 018263          125 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE-----------------------------------------  163 (358)
Q Consensus       125 ~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-----------------------------------------  163 (358)
                      .++.+...      ..++......++.++...|..||+.                                         
T Consensus        98 ~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A           98 QILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             EECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             eECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            88876321      1223444444555555555555542                                         


Q ss_pred             ----------------CCCCcEEcCCCCCcEEEcC---CCce-EEeecccccc
Q 018263          164 ----------------IQPHVVHRDIKTSNILLDQ---NFNP-KISDFGLSKL  196 (358)
Q Consensus       164 ----------------~~~~i~H~di~p~Nilv~~---~~~~-~l~Dfg~~~~  196 (358)
                                      ....++|+|+++.||+++.   ++.+ .|+||+.+..
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                            1225699999999999987   4554 7999987764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.41  E-value=4.8e-07  Score=82.73  Aligned_cols=83  Identities=7%  Similarity=-0.007  Sum_probs=53.7

Q ss_pred             ccee-cccCceEEEEEEEC-------CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccC-CCCceeeeceEEcC--
Q 018263           47 SNKI-GEGGFGSVYKGRLQ-------DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVC-HENLVKLHGGCIDG--  112 (358)
Q Consensus        47 ~~~l-g~g~~g~v~~~~~~-------~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~-h~~i~~~~~~~~~~--  112 (358)
                      .+.| +.|....+|++...       ++..+++|+.....   ......+..|+..++.+... .-.+.+++.+..+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            4667 78888999998754       26678999865322   00123456777777776521 23456667666554  


Q ss_pred             -CeeEEEEecCCCCCHHH
Q 018263          113 -PCRILVYDYMPNNSLSQ  129 (358)
Q Consensus       113 -~~~~iv~e~~~~~~L~~  129 (358)
                       +..++|||+++|.++.+
T Consensus       105 ~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             TSSCEEEEECCCCBCCCB
T ss_pred             cCCceEEEEecCCCChhh
Confidence             35689999999876653

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.31  E-value=2.7e-06  Score=77.08  Aligned_cols=31  Identities=29%  Similarity=0.424  Sum_probs=27.5

Q ss_pred             CCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       166 ~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      ..+||+|+++.||+++.++.+.++||+.+..
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            3899999999999998778899999987753

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.13  E-value=8.5e-06  Score=75.59  Aligned_cols=78  Identities=13%  Similarity=0.103  Sum_probs=48.7

Q ss_pred             ccceecccCceEEEEEEEC-CCCEEEEEEeeccCh-------hhHHHHHHHHHHhhhcccCCCC-ceeeeceEEcCCeeE
Q 018263           46 WSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK-------QGEKEFMSEVASMANVNVCHEN-LVKLHGGCIDGPCRI  116 (358)
Q Consensus        46 i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~-------~~~~~~~~e~~~l~~l~~~h~~-i~~~~~~~~~~~~~~  116 (358)
                      -.+.+|.|..+.||++... +++.|++|.......       .....+..|.+.++.+....+. +.+++.+  +....+
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~  111 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV  111 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence            3568999999999999754 467899998653211       1223456677777776422233 3344433  344568


Q ss_pred             EEEecCCCC
Q 018263          117 LVYDYMPNN  125 (358)
Q Consensus       117 iv~e~~~~~  125 (358)
                      +|||++++.
T Consensus       112 lvmE~l~g~  120 (397)
T 2olc_A          112 TVMEDLSHL  120 (397)
T ss_dssp             EEECCCTTS
T ss_pred             EEEEeCCCc
Confidence            999999764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=98.09  E-value=2.5e-05  Score=69.07  Aligned_cols=83  Identities=18%  Similarity=0.207  Sum_probs=58.0

Q ss_pred             hhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCC-CceeeeceEEcCCeeEEE
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHE-NLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~-~i~~~~~~~~~~~~~~iv  118 (358)
                      .+....-++.+|.|..+.||+++..+|+.|++|+...........+..|...|+.+....+ -+.+++..  .  ..++|
T Consensus        13 ~G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv   88 (288)
T 3f7w_A           13 TGREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLA   88 (288)
T ss_dssp             HCCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEE
T ss_pred             cCCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEE
Confidence            3456666788999999999999999999999998764433333456778888887742222 23444443  2  24689


Q ss_pred             EecCCCCC
Q 018263          119 YDYMPNNS  126 (358)
Q Consensus       119 ~e~~~~~~  126 (358)
                      |||+++..
T Consensus        89 ~e~l~~~~   96 (288)
T 3f7w_A           89 MEWVDERP   96 (288)
T ss_dssp             EECCCCCC
T ss_pred             EEeecccC
Confidence            99998764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.00  E-value=5.1e-05  Score=67.87  Aligned_cols=77  Identities=14%  Similarity=0.081  Sum_probs=59.4

Q ss_pred             cceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccC-CCCceeeeceEEcCCeeEEEEecCCCC
Q 018263           47 SNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC-HENLVKLHGGCIDGPCRILVYDYMPNN  125 (358)
Q Consensus        47 ~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~-h~~i~~~~~~~~~~~~~~iv~e~~~~~  125 (358)
                      .+.|+.|....+|++... +..+++|+....   ....+..|...++.+... ...+++++.+....+..++||||++|.
T Consensus        41 ~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~  116 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS  116 (312)
T ss_dssp             EEEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred             eEEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence            467899999999999874 677899987632   345677888888887532 356777888877778899999999987


Q ss_pred             CH
Q 018263          126 SL  127 (358)
Q Consensus       126 ~L  127 (358)
                      .+
T Consensus       117 ~~  118 (312)
T 3jr1_A          117 KN  118 (312)
T ss_dssp             CC
T ss_pred             CC
Confidence            64

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.82  E-value=8.4e-05  Score=69.42  Aligned_cols=75  Identities=9%  Similarity=0.076  Sum_probs=45.5

Q ss_pred             ccceecccCceEEEEEEECCCCEEEEEEeecc-----Ch----hhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeE
Q 018263           46 WSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVE-----SK----QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI  116 (358)
Q Consensus        46 i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~-----~~----~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~  116 (358)
                      -++.||.|..+.||++.. ++..+++|.....     ..    .....+..|+..+.... ....+.+++.+.  ....+
T Consensus        38 ~i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~-~~~~vP~v~~~~--~~~~~  113 (420)
T 2pyw_A           38 VIKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNL-SPDHVPEVYHFD--RTMAL  113 (420)
T ss_dssp             EEEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHH-SGGGSCCEEEEE--TTTTE
T ss_pred             EEEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhh-CCCCCCeEEEEC--CCccE
Confidence            356789999999999965 4678999953221     11    12333444444333211 123455566554  56678


Q ss_pred             EEEecC-CC
Q 018263          117 LVYDYM-PN  124 (358)
Q Consensus       117 iv~e~~-~~  124 (358)
                      +|||++ +|
T Consensus       114 lv~e~l~~g  122 (420)
T 2pyw_A          114 IGMRYLEPP  122 (420)
T ss_dssp             EEECCCCTT
T ss_pred             EEEeecCCc
Confidence            999999 77

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.75  E-value=6.4e-05  Score=62.66  Aligned_cols=102  Identities=12%  Similarity=0.046  Sum_probs=67.4

Q ss_pred             CCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCccc
Q 018263          125 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI  204 (358)
Q Consensus       125 ~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~  204 (358)
                      .+|.+++.   ....+++++++|.++.|.+.+|..+-...  .-...=+.|..|++..+|.|.+.+- ...         
T Consensus        33 vSL~eIL~---~~~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~~-~s~---------   97 (229)
T 2yle_A           33 LSLEEILR---LYNQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAPA-ADD---------   97 (229)
T ss_dssp             EEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECCC-------------
T ss_pred             ccHHHHHH---HcCCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceecccc-ccc---------
Confidence            47999983   46789999999999999999988873210  2223445679999999999887641 110         


Q ss_pred             ccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCC
Q 018263          205 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT  246 (358)
Q Consensus       205 ~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~  246 (358)
                          .....+.|||... ...+.+.-|||||+++|.-+--..
T Consensus        98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL  134 (229)
T 2yle_A           98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL  134 (229)
T ss_dssp             -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred             ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence                1223467888653 345677889999999999987433

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.73  E-value=8.5e-05  Score=67.00  Aligned_cols=31  Identities=32%  Similarity=0.376  Sum_probs=27.0

Q ss_pred             CCcEEcCCCCCcEEEcCC----CceEEeecccccc
Q 018263          166 PHVVHRDIKTSNILLDQN----FNPKISDFGLSKL  196 (358)
Q Consensus       166 ~~i~H~di~p~Nilv~~~----~~~~l~Dfg~~~~  196 (358)
                      ..++|||+++.||+++.+    +.+.++||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            389999999999999874    6789999998865

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.68  E-value=0.0015  Score=58.27  Aligned_cols=162  Identities=10%  Similarity=0.101  Sum_probs=83.3

Q ss_pred             cCHHHHHHhhcCCcc-----cceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccC---CCCce
Q 018263           32 FSYNQLKIATNGFRW-----SNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC---HENLV  103 (358)
Q Consensus        32 ~~~~~~~~~~~~y~i-----~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~---h~~i~  103 (358)
                      ++...+.-...+|.+     ++.|+.|....+|++...+| .+++|+.....  ....+..|...+..+...   -|.++
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~   83 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL   83 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence            444555555555655     24566687889999987656 58889886421  112344555555555421   23333


Q ss_pred             eeec---eEEcCCeeEEEEecCCCCCHHH-----------H---hhhcccc---c--cCCC---HHHHHH----------
Q 018263          104 KLHG---GCIDGPCRILVYDYMPNNSLSQ-----------T---LLGEEKR---R--AKFG---WKARRE----------  148 (358)
Q Consensus       104 ~~~~---~~~~~~~~~iv~e~~~~~~L~~-----------~---l~~~~~~---~--~~l~---~~~~~~----------  148 (358)
                      ...+   +....+..+++++|++|..+..           .   ++.....   .  ....   +.....          
T Consensus        84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~  163 (322)
T 2ppq_A           84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  163 (322)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence            2211   1223456789999998865321           0   1100000   0  0001   111000          


Q ss_pred             --HHHHHHHHHHHHhcC----CCCCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          149 --IIMGIGRGLAYIHEE----IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       149 --~~~qi~~aL~~LH~~----~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                        +...+...+..++..    ...+++|+|+++.||++++++.+.++||+.+..
T Consensus       164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence              001133344444421    123899999999999998875557999987753

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.64  E-value=0.00069  Score=60.71  Aligned_cols=96  Identities=9%  Similarity=-0.034  Sum_probs=56.0

Q ss_pred             ccccCHHHHHHhhcCCcc-----cceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCce
Q 018263           29 INAFSYNQLKIATNGFRW-----SNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLV  103 (358)
Q Consensus        29 ~~~~~~~~~~~~~~~y~i-----~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~  103 (358)
                      +...+...+.-..+.|.+     +..++ |....||++...+|+.+++|+.... ......+..|...+..+....-.++
T Consensus         8 ~~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~-~~~~~~~~~E~~~~~~L~~~g~~vp   85 (328)
T 1zyl_A            8 FQTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVA   85 (328)
T ss_dssp             CCCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBC
T ss_pred             CCCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCC-CCCHHHHHHHHHHHHHHHHcCCeec
Confidence            334444444444444433     23566 7788999988777778999998632 1233455667776666642211233


Q ss_pred             eeece-----EEcCCeeEEEEecCCCCC
Q 018263          104 KLHGG-----CIDGPCRILVYDYMPNNS  126 (358)
Q Consensus       104 ~~~~~-----~~~~~~~~iv~e~~~~~~  126 (358)
                      +++..     ....+..++++++++|.+
T Consensus        86 ~~~~~~g~~~~~~~g~~~~l~~~i~G~~  113 (328)
T 1zyl_A           86 APVAFNGQTLLNHQGFYFAVFPSVGGRQ  113 (328)
T ss_dssp             CCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred             ceeecCCcEEEEECCEEEEEEEecCCCC
Confidence            33332     223456688999998754

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.61  E-value=9.3e-05  Score=65.77  Aligned_cols=73  Identities=10%  Similarity=0.071  Sum_probs=43.3

Q ss_pred             cceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecC-CCC
Q 018263           47 SNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM-PNN  125 (358)
Q Consensus        47 ~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~-~~~  125 (358)
                      ++.|+.|....+|++     ..+++|+....... ......|+..++.+.. +.-..+++..  .....+++++|+ +|.
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~-~g~~P~~~~~--~~~~~~~v~e~i~~g~   93 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAK-AGVSPEVLHV--DPATGVMVTRYIAGAQ   93 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHH-TTSSCCEEEE--CTTTCCEEEECCTTCE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHH-cCCCCceEEE--ECCCCEEEEeecCCCc
Confidence            788888999999999     45888987642111 1122356666665541 2111445443  333457899999 665


Q ss_pred             CHH
Q 018263          126 SLS  128 (358)
Q Consensus       126 ~L~  128 (358)
                      ++.
T Consensus        94 ~l~   96 (301)
T 3dxq_A           94 TMS   96 (301)
T ss_dssp             ECC
T ss_pred             cCC
Confidence            543

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.51  E-value=0.00032  Score=64.42  Aligned_cols=144  Identities=17%  Similarity=0.162  Sum_probs=82.3

Q ss_pred             cceecccCceEEEEEEEC--------CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           47 SNKIGEGGFGSVYKGRLQ--------DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        47 ~~~lg~g~~g~v~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      ++.|..|-...+|++...        ++..|++|+.... ........+|...++.+.. +.-..++++.+.+    .+|
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~-~gv~P~ll~~~~~----g~v  128 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAE-RSLGPQLYGVFPE----GRL  128 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHH-TTSSCCEEEEETT----EEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHh-cCCCCeEEEEcCC----ccE
Confidence            456777888899999864        2578999997432 1233455578888877752 3233556665543    289


Q ss_pred             EecCCCCCHHHHh-----------------hhccc-cccCC--CHHHHHHHHHHHHH-------------------HHHH
Q 018263          119 YDYMPNNSLSQTL-----------------LGEEK-RRAKF--GWKARREIIMGIGR-------------------GLAY  159 (358)
Q Consensus       119 ~e~~~~~~L~~~l-----------------~~~~~-~~~~l--~~~~~~~~~~qi~~-------------------aL~~  159 (358)
                      |||++|.+|...-                 +.... .....  -+..+.+|..++-.                   .+..
T Consensus       129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  208 (379)
T 3feg_A          129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN  208 (379)
T ss_dssp             EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred             EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence            9999986553210                 00000 01111  13455556554422                   1222


Q ss_pred             Hh----cC-CCCCcEEcCCCCCcEEEcCC----CceEEeecccccc
Q 018263          160 IH----EE-IQPHVVHRDIKTSNILLDQN----FNPKISDFGLSKL  196 (358)
Q Consensus       160 LH----~~-~~~~i~H~di~p~Nilv~~~----~~~~l~Dfg~~~~  196 (358)
                      |.    .. ....++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            22    11 12378999999999999876    7899999987753

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.41  E-value=0.00039  Score=65.09  Aligned_cols=74  Identities=19%  Similarity=0.195  Sum_probs=48.0

Q ss_pred             cceecccCceEEEEEEECC--------CCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           47 SNKIGEGGFGSVYKGRLQD--------GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        47 ~~~lg~g~~g~v~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      ++.|+.|....+|++...+        +..|++|+.....  ....+..|...+..+.. +.-..++++.+.+    .+|
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~-~g~~P~l~~~~~~----g~v  150 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSE-RHLGPKLYGIFSG----GRL  150 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHH-TTSSSCEEEEETT----EEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHh-CCCCCcEEEEeCC----CEE
Confidence            4677888889999998653        5789999984321  11344468887777752 2223556655432    389


Q ss_pred             EecCCCCCH
Q 018263          119 YDYMPNNSL  127 (358)
Q Consensus       119 ~e~~~~~~L  127 (358)
                      ++|++|.+|
T Consensus       151 ~e~l~G~~l  159 (429)
T 1nw1_A          151 EEYIPSRPL  159 (429)
T ss_dssp             ECCCCEEEC
T ss_pred             EEEeCCccc
Confidence            999987443

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.22  E-value=0.00046  Score=63.12  Aligned_cols=75  Identities=12%  Similarity=0.113  Sum_probs=43.1

Q ss_pred             cceecccCceEEEEEEECC---------CCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           47 SNKIGEGGFGSVYKGRLQD---------GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        47 ~~~lg~g~~g~v~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      ++.++.|....+|++...+         +..|++|+....... ......|...++.+.. +.-..+++..+  .  .++
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~-~g~~P~~~~~~--~--~~~  111 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSK-YKIAPQLLNTF--N--GGR  111 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHH-TTSSCCEEEEE--T--TEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHh-cCCCCceEEec--C--CcE
Confidence            4567778888999998753         268999987543211 1123466666766652 22244555443  2  368


Q ss_pred             EEecCCCCCH
Q 018263          118 VYDYMPNNSL  127 (358)
Q Consensus       118 v~e~~~~~~L  127 (358)
                      ||+|++|.++
T Consensus       112 v~e~i~G~~l  121 (369)
T 3c5i_A          112 IEEWLYGDPL  121 (369)
T ss_dssp             EEECCCSEEC
T ss_pred             EEEEecCCcC
Confidence            9999987543

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.18  E-value=0.00099  Score=62.76  Aligned_cols=75  Identities=9%  Similarity=-0.066  Sum_probs=45.8

Q ss_pred             cceecccCceEEEEEEECC-CCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecCCCC
Q 018263           47 SNKIGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN  125 (358)
Q Consensus        47 ~~~lg~g~~g~v~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~~~~  125 (358)
                      ++.|+.|-...+|++...+ +..|++|+........ ..-..|+..+..+.. +.-..++++.+.  +  .+|++|++|.
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~-~gl~P~ll~~~~--~--G~v~e~I~G~  186 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYN-KNIAKKIYVFFT--N--GRIEEFMDGY  186 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTT-SSSBCCEEEEET--T--EEEEECCCSE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHh-cCCCCCEEEEeC--C--eEEEEeeCCc
Confidence            4567778889999998764 5789999875322111 112467777777752 222355666652  2  3599999875


Q ss_pred             CH
Q 018263          126 SL  127 (358)
Q Consensus       126 ~L  127 (358)
                      +|
T Consensus       187 ~l  188 (458)
T 2qg7_A          187 AL  188 (458)
T ss_dssp             EC
T ss_pred             cC
Confidence            44

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.11  E-value=0.0024  Score=57.63  Aligned_cols=31  Identities=26%  Similarity=0.327  Sum_probs=27.3

Q ss_pred             CCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       166 ~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      ..++|+|+.+.||+++.++.+.++||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            3799999999999999888899999987654

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.09  E-value=0.018  Score=53.53  Aligned_cols=75  Identities=5%  Similarity=0.030  Sum_probs=46.1

Q ss_pred             cceecccCceEEEEEEECC--------CCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           47 SNKIGEGGFGSVYKGRLQD--------GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        47 ~~~lg~g~~g~v~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      ++.+..|-...+|++...+        +..|++|+....... ..+..+|...++.+.. +.-..++++.+  .  .+.|
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~-~gi~P~l~~~~--~--~~~I  148 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSN-INIAPNIIADF--P--EGRI  148 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHH-TTSSCCEEEEE--T--TEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHh-cCCCCCEEEEc--C--CCEE
Confidence            4567777788999998753        578999997543211 1122456666666641 22234555433  2  3689


Q ss_pred             EecCCCCCH
Q 018263          119 YDYMPNNSL  127 (358)
Q Consensus       119 ~e~~~~~~L  127 (358)
                      ++|++|.+|
T Consensus       149 ~efI~G~~l  157 (424)
T 3mes_A          149 EEFIDGEPL  157 (424)
T ss_dssp             EECCCSEEC
T ss_pred             EEEeCCccC
Confidence            999998654

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.80  E-value=0.025  Score=52.20  Aligned_cols=30  Identities=30%  Similarity=0.416  Sum_probs=25.2

Q ss_pred             CcEEcCCCCCcEEE------cCCCceEEeecccccc
Q 018263          167 HVVHRDIKTSNILL------DQNFNPKISDFGLSKL  196 (358)
Q Consensus       167 ~i~H~di~p~Nilv------~~~~~~~l~Dfg~~~~  196 (358)
                      .+||+|+.+.||++      ++++.+.++||..+..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            46899999999999      4567799999987754

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=93.87  E-value=0.23  Score=41.28  Aligned_cols=115  Identities=9%  Similarity=0.059  Sum_probs=77.8

Q ss_pred             CCCCceeeeceEEcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHH-HHhcCCCCCcEEcCCCCC
Q 018263           98 CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA-YIHEEIQPHVVHRDIKTS  176 (358)
Q Consensus        98 ~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~-~LH~~~~~~i~H~di~p~  176 (358)
                      .||++  -..+-...+...+.++.-+++.=...+       ...+....++++.+|+.... +++.     -+|--++|+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~  113 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE  113 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence            48888  555557777777777755343322333       45678999999999988777 5654     489999999


Q ss_pred             cEEEcCCCceEEeecccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCC
Q 018263          177 NILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVD  249 (358)
Q Consensus       177 Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~  249 (358)
                      |++++.++.+++.-.|.-..+                  +|..+     ++..=.-.+=+++..++.++..|.
T Consensus       114 NL~f~~~~~p~i~hRGi~~~l------------------pP~e~-----~ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          114 NLMFNRALEPFFLHVGVKESL------------------PPDEW-----DDERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             GEEECTTCCEEESCCEETTTB------------------SSCSC-----CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             eEEEeCCCcEEEEEcCCcccC------------------CCCCC-----CHHHHHHHHHHHHHHHHcCCCCHH
Confidence            999999999999877765432                  22211     111112355678888888888775

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=93.25  E-value=0.2  Score=41.55  Aligned_cols=118  Identities=9%  Similarity=0.058  Sum_probs=79.2

Q ss_pred             ccCCCCceeeeceEEcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCC
Q 018263           96 NVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKT  175 (358)
Q Consensus        96 ~~~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p  175 (358)
                      ...+|++++. .+-...+...+.++.-+.  ...+-     .-...+....++++.+|+....++++.     +|--++|
T Consensus        41 ~~~~~~Fl~~-~I~e~eD~v~~~y~~~~~--~~~f~-----~ik~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P  107 (215)
T 4ann_A           41 EQHSPYFIDA-ELTELRDSFQIHYDINDN--HTPFD-----NIKSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAP  107 (215)
T ss_dssp             GSCCTTBCCE-EEEECSSEEEEEECCCTT--SEEGG-----GGGGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSG
T ss_pred             hccCCcccce-EEEEcccEEEEEEEcCcc--cCCHH-----HHHhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEec
Confidence            3358888876 456666666666654432  22221     234567899999999999988666654     8999999


Q ss_pred             CcEEEcCCCceEEeecccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCC
Q 018263          176 SNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVD  249 (358)
Q Consensus       176 ~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~  249 (358)
                      +|++++.++.++++-.|+...+                  +|..     .++..=.-.+=+++..+++++..|.
T Consensus       108 ~NL~f~~~~~p~i~~RGik~~l------------------~P~~-----~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          108 DELFFTRDGLPIAKTRGLQNVV------------------DPLP-----VSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             GGEEECTTSCEEESCCEETTTB------------------SCCC-----CCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             ceEEEcCCCCEEEEEccCccCC------------------CCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999999999999877664432                  1110     0111112356678889999988885

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	358
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-68
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	4e-68
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	8e-68
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	7e-66
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-65
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-65
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-64
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-64
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-61
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	6e-61
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	7e-60
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	7e-60
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-59
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	9e-59
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-58
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-58
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-58
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-58
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	6e-58
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-57
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	4e-57
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	5e-57
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	6e-57
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	8e-57
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-55
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-54
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-54
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-53
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	8e-53
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	5e-52
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-51
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-50
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	5e-50
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	6e-50
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	9e-50
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-48
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-47
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	5e-46
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	7e-46
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-45
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	6e-45
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	9e-45
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	9e-45
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-44
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	5e-44
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	6e-44
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	9e-44
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	5e-43
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	5e-43
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	4e-42
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-41
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-41
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-40
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	5e-39
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-38
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-38
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	4e-38
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	5e-35
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-34
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-32
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-31
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-28
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-23

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (543), Expect = 2e-68
 Identities = 67/274 (24%), Positives = 125/274 (45%), Gaps = 24/274 (8%)

Query: 44  FRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLV 103
             +  +IG G FG V+ G   +   VA+K +  E    E++F+ E   M  ++  H  LV
Sbjct: 7   LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLS--HPKLV 63

Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
           +L+G C++     LV+++M +  LS        +R  F  +    + + +  G+AY+ E 
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDY---LRTQRGLFAAETLLGMCLDVCEGMAYLEE- 119

Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG 223
               V+HRD+   N L+ +N   K+SDFG+++   ++    ST     + + +PE     
Sbjct: 120 --ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 177

Query: 224 RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGN 283
           R + KSDV+SFGVL+ E+ S                    +   ++ E++  +       
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIP---------------YENRSNSEVVEDISTGFRLY 222

Query: 284 FPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMM 317
            P   +    ++   C +E+ + RP  S  ++ +
Sbjct: 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQL 256

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (543), Expect = 4e-68
 Identities = 71/279 (25%), Positives = 121/279 (43%), Gaps = 24/279 (8%)

Query: 39  IATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC 98
           +     +   ++G G FG V+ G     T VAVK L  +       F++E   M  +   
Sbjct: 10  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQ-- 66

Query: 99  HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
           H+ LV+L+      P   ++ +YM N SL   L  +     K       ++   I  G+A
Sbjct: 67  HQRLVRLYAVVTQEP-IYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMA 123

Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE 218
           +I E    + +HRD++ +NIL+    + KI+DFGL++L  +N           + + APE
Sbjct: 124 FIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 180

Query: 219 YAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDP 278
               G  T KSDV+SFG+LL EIV+                    +    + E++  ++ 
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRI---------------PYPGMTNPEVIQNLER 225

Query: 279 MLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMM 317
                 P+N      ++  LC +E+ + RP       ++
Sbjct: 226 GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (541), Expect = 8e-68
 Identities = 69/285 (24%), Positives = 124/285 (43%), Gaps = 28/285 (9%)

Query: 39  IATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVN 96
           I         +IG G FG+VYKG+      VAVK+L+V   + Q  + F +EV  +    
Sbjct: 5   IPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62

Query: 97  VCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRG 156
             H N++   G     P   +V  +   +SL   L        KF      +I     +G
Sbjct: 63  --HVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHL---HIIETKFEMIKLIDIARQTAQG 116

Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE-NTTHISTRVAGTLGYL 215
           + Y+H      ++HRD+K++NI L ++   KI DFGL+ +    + +H   +++G++ ++
Sbjct: 117 MDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173

Query: 216 APEYA---ISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKEL 272
           APE          + +SDVY+FG++L E+++G+            +  D+   M     L
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIFMVGRGYL 227

Query: 273 MNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMM 317
              +          N      ++   C+++K   RP     +  +
Sbjct: 228 SPDLSK-----VRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 267

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (529), Expect = 7e-66
 Identities = 70/286 (24%), Positives = 123/286 (43%), Gaps = 24/286 (8%)

Query: 32  FSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVAS 91
            + +  +I     R   K+G+G FG V+ G     T VA+K L        + F+ E   
Sbjct: 7   LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQV 65

Query: 92  MANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
           M  +   HE LV+L+    + P   +V +YM   SL      + +           ++  
Sbjct: 66  MKKLR--HEKLVQLYAVVSEEPI-YIVTEYMSKGSL--LDFLKGETGKYLRLPQLVDMAA 120

Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT 211
            I  G+AY+    + + VHRD++ +NIL+ +N   K++DFGL++L  +N           
Sbjct: 121 QIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 177

Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKE 271
           + + APE A+ GR T KSDV+SFG+LL E+ +                    +    ++E
Sbjct: 178 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP---------------YPGMVNRE 222

Query: 272 LMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMM 317
           +++ V+       P         +   C +++ + RP        +
Sbjct: 223 VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (525), Expect = 1e-65
 Identities = 65/274 (23%), Positives = 115/274 (41%), Gaps = 24/274 (8%)

Query: 44  FRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLV 103
             +  ++G G FG V  G+ +    VA+K++  E    E EF+ E   M N++  HE LV
Sbjct: 6   LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLS--HEKLV 62

Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
           +L+G C       ++ +YM N  L   L    + R +F  +   E+   +   + Y+   
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDVCEAMEYLE-- 117

Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG 223
                +HRD+   N L++     K+SDFGLS+   ++    S      + +  PE  +  
Sbjct: 118 -SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 176

Query: 224 RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGN 283
           + + KSD+++FGVL+ EI S                    +  + + E    +   L   
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLG---------------KMPYERFTNSETAEHIAQGLRLY 221

Query: 284 FPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMM 317
            P   + +   +   C  EK+  RP     +  +
Sbjct: 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  207 bits (527), Expect = 1e-65
 Identities = 69/286 (24%), Positives = 123/286 (43%), Gaps = 24/286 (8%)

Query: 33  SYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVAS 91
           +Y++ ++        +K+G G +G VY+G  +     VAVK L  ++ + E EF+ E A 
Sbjct: 8   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 66

Query: 92  MANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
           M  +   H NLV+L G C   P   ++ ++M   +L   L   E  R +        +  
Sbjct: 67  MKEIK--HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMAT 122

Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT 211
            I   + Y+    + + +HRD+   N L+ +N   K++DFGLS+L   +T          
Sbjct: 123 QISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 179

Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKE 271
           + + APE     + + KSDV++FGVLL EI +   +                +   +  +
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP---------------YPGIDLSQ 224

Query: 272 LMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMM 317
           +  L++       PE    +  ++   C Q     RP  +   +  
Sbjct: 225 VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  204 bits (519), Expect = 3e-64
 Identities = 68/308 (22%), Positives = 132/308 (42%), Gaps = 41/308 (13%)

Query: 29  INAFSYNQLKIATNGFRWS---------NKIGEGGFGSVYKGRL----QDGTIVAVKVLS 75
           I+ F++     A   F              IG G FG V  G L    +    VA+K L 
Sbjct: 4   IDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK 63

Query: 76  VE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGE 134
              +++  ++F+SE + M   +  H N++ L G        +++ ++M N SL       
Sbjct: 64  SGYTEKQRRDFLSEASIMGQFD--HPNVIHLEGVVTKSTPVMIITEFMENGSLDSF---L 118

Query: 135 EKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 194
            +   +F       ++ GI  G+ Y+      + VHRD+   NIL++ N   K+SDFGLS
Sbjct: 119 RQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLS 175

Query: 195 KLFPENTTHISTRVA----GTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDF 250
           +   ++T+  +   A      + + APE     + T  SDV+S+G+++ E++S       
Sbjct: 176 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG----- 230

Query: 251 DVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQM 310
                     ++ +    +++++N ++       P +      ++ L C Q+    RP+ 
Sbjct: 231 ----------ERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKF 280

Query: 311 STAIKMMN 318
              +  ++
Sbjct: 281 GQIVNTLD 288

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (521), Expect = 3e-64
 Identities = 51/212 (24%), Positives = 101/212 (47%), Gaps = 13/212 (6%)

Query: 37  LKIATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQG-EKEFMSEVASMAN 94
           +++  + F   +++G G  G V+K      G ++A K++ +E K     + + E+  +  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 95  VNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIG 154
            N     +V  +G         +  ++M   SL Q L    K+  +   +   ++ + + 
Sbjct: 61  CN--SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVI 114

Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY 214
           +GL Y+ E  +  ++HRD+K SNIL++     K+ DFG+S    ++         GT  Y
Sbjct: 115 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSY 169

Query: 215 LAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT 246
           ++PE       + +SD++S G+ L+E+  GR 
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRY 201

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 2e-61
 Identities = 65/290 (22%), Positives = 133/290 (45%), Gaps = 31/290 (10%)

Query: 38  KIATNGFRWSNKIGEGGFGSVYKGRLQDGT-----IVAVKVLSVESKQGEK-EFMSEVAS 91
           +I  +       IG G FG VYKG L+  +      VA+K L     + ++ +F+ E   
Sbjct: 3   EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62

Query: 92  MANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
           M   +  H N+++L G        +++ +YM N +L +      ++  +F       ++ 
Sbjct: 63  MGQFS--HHNIIRLEGVISKYKPMMIITEYMENGALDKF---LREKDGEFSVLQLVGMLR 117

Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN--TTHISTRVA 209
           GI  G+ Y+      + VHRD+   NIL++ N   K+SDFGLS++  ++   T+ ++   
Sbjct: 118 GIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK 174

Query: 210 GTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNS 269
             + + APE     + T  SDV+SFG+++ E+++      ++                ++
Sbjct: 175 IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE---------------LSN 219

Query: 270 KELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNG 319
            E+M  ++       P +      ++ + C Q++   RP+ +  + +++ 
Sbjct: 220 HEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 6e-61
 Identities = 69/293 (23%), Positives = 115/293 (39%), Gaps = 32/293 (10%)

Query: 49  KIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG 108
            IG+G FG V++G+   G  VAVK+ S    + E+ +  E      V + HEN++     
Sbjct: 10  SIGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAA 65

Query: 109 CIDG----PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
                       LV DY  + SL   L      R     +   ++ +    GLA++H EI
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHMEI 120

Query: 165 -----QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS---TRVAGTLGYLA 216
                +P + HRD+K+ NIL+ +N    I+D GL+      T  I        GT  Y+A
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180

Query: 217 PEYAIS------GRLTRKSDVYSFGVLLLEIVSGR----TAVDFDVQLGEYHLVDKAWGM 266
           PE              +++D+Y+ G++  EI           D+ +   +    D +   
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240

Query: 267 YNSKELMNLVDPMLYGNFPENEAIRFL-KVGLLCVQEKSKLRPQMSTAIKMMN 318
                    + P +   +   EA+R + K+   C       R       K ++
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  193 bits (490), Expect = 7e-60
 Identities = 78/313 (24%), Positives = 126/313 (40%), Gaps = 48/313 (15%)

Query: 33  SYNQLKIATNGFRWSNKIGEGGFGSVYKGRL------QDGTIVAVKVLSVE-SKQGEKEF 85
               L+   N   +   IGEG FG V++ R       +  T+VAVK+L  E S   + +F
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 86  MSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKR-------- 137
             E A MA  +  + N+VKL G C  G    L+++YM    L++ L              
Sbjct: 64  QREAALMAEFD--NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 121

Query: 138 ------------RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN 185
                               +  I   +  G+AY+ E      VHRD+ T N L+ +N  
Sbjct: 122 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMV 178

Query: 186 PKISDFGLSK-LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
            KI+DFGLS+ ++  +        A  + ++ PE     R T +SDV+++GV+L EI S 
Sbjct: 179 VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 238

Query: 245 RTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKS 304
                +                   +E++  V        PEN  +    +  LC  +  
Sbjct: 239 GLQPYYG---------------MAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLP 283

Query: 305 KLRPQMSTAIKMM 317
             RP   +  +++
Sbjct: 284 ADRPSFCSIHRIL 296

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 7e-60
 Identities = 67/290 (23%), Positives = 121/290 (41%), Gaps = 31/290 (10%)

Query: 36  QLKIATNGFRWSN-KIGEGGFGSVYKGRLQ---DGTIVAVKVLSVESKQGE-KEFMSEVA 90
           +L +  +    ++ ++G G FGSV +G  +       VA+KVL   +++ + +E M E  
Sbjct: 2   KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61

Query: 91  SMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 150
            M  ++  +  +V+L G        +LV +      L + L+G   +R +       E++
Sbjct: 62  IMHQLD--NPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELL 115

Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR--V 208
             +  G+ Y+    + + VHRD+   N+LL      KISDFGLSK    + ++ + R   
Sbjct: 116 HQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 172

Query: 209 AGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYN 268
              L + APE     + + +SDV+S+GV + E +S                    +    
Sbjct: 173 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK---------------PYKKMK 217

Query: 269 SKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN 318
             E+M  ++       P         +   C   K + RP   T  + M 
Sbjct: 218 GPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 4e-59
 Identities = 64/278 (23%), Positives = 111/278 (39%), Gaps = 32/278 (11%)

Query: 48  NKIGEGGFGSVYKGRLQD---GTIVAVKVLSVESKQGE--KEFMSEVASMANVNVCHENL 102
            ++G G FG+V KG  Q       VAVK+L  E+       E ++E   M  ++  +  +
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD--NPYI 70

Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE 162
           V++ G   +    +LV +      L++ L    ++      K   E++  +  G+ Y+  
Sbjct: 71  VRMIG-ICEAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLE- 124

Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR--VAGTLGYLAPEYA 220
             + + VHRD+   N+LL      KISDFGLSK    +  +   +      + + APE  
Sbjct: 125 --ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182

Query: 221 ISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPML 280
              + + KSDV+SFGVL+ E  S                  K +      E+  +++   
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQ---------------KPYRGMKGSEVTAMLEKGE 227

Query: 281 YGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN 318
               P         +  LC     + RP  +     + 
Sbjct: 228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 9e-59
 Identities = 63/323 (19%), Positives = 121/323 (37%), Gaps = 41/323 (12%)

Query: 21  GGEQILKNINAFSYN-QLKIATNGFRWSNKIGEGGFGSVYKGRL------QDGTIVAVKV 73
           G   +  +     Y+ + +   N   +   +G G FG V +              VAVK+
Sbjct: 1   GNNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKM 60

Query: 74  LSVESKQGEKE-FMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLL 132
           L   +   E+E  MSE+  ++ +   H N+V L G C  G   +++ +Y     L   L 
Sbjct: 61  LKPSAHLTEREALMSELKVLSYLG-NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLR 119

Query: 133 GE--------------EKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNI 178
            +              E        +        + +G+A++  +   + +HRD+   NI
Sbjct: 120 RKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNI 176

Query: 179 LLDQNFNPKISDFGLSKLFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVL 237
           LL      KI DFGL++    ++ + +       + ++APE   +   T +SDV+S+G+ 
Sbjct: 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIF 236

Query: 238 LLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGL 297
           L E+ S  ++                 GM    +   ++        PE+       +  
Sbjct: 237 LWELFSLGSSPY--------------PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMK 282

Query: 298 LCVQEKSKLRPQMSTAIKMMNGE 320
            C       RP     ++++  +
Sbjct: 283 TCWDADPLKRPTFKQIVQLIEKQ 305

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 1e-58
 Identities = 65/275 (23%), Positives = 113/275 (41%), Gaps = 30/275 (10%)

Query: 44  FRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLV 103
            +    IG+G FG V  G    G  VAVK +   +    + F++E + M  +   H NLV
Sbjct: 9   LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLR--HSNLV 63

Query: 104 KLHGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE 162
           +L G  ++    + +V +YM   SL   L    + R+  G     +  + +   + Y+  
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLE- 120

Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS 222
               + VHRD+   N+L+ ++   K+SDFGL+K                + + APE    
Sbjct: 121 --GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT----GKLPVKWTAPEALRE 174

Query: 223 GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYG 282
            + + KSDV+SFG+LL EI S                    +     K+++  V+     
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRV---------------PYPRIPLKDVVPRVEKGYKM 219

Query: 283 NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMM 317
           + P+       +V   C    + +RP      + +
Sbjct: 220 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQL 254

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 2e-58
 Identities = 62/280 (22%), Positives = 109/280 (38%), Gaps = 33/280 (11%)

Query: 44  FRWSNKIGEGGFGSVYKGRL-QDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHE 100
            ++  +IG G F +VYKG   +    VA   L     +K   + F  E   +  +   H 
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ--HP 68

Query: 101 NLVKLHGGCID----GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRG 156
           N+V+ +           C +LV + M + +L   L    KR      K  R     I +G
Sbjct: 69  NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKG 124

Query: 157 LAYIHEEIQPHVVHRDIKTSNILL-DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
           L ++H    P ++HRD+K  NI +     + KI D GL+ L   +       V GT  ++
Sbjct: 125 LQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA---KAVIGTPEFM 180

Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNL 275
           APE     +     DVY+FG+ +LE+ +            + +           + + + 
Sbjct: 181 APEM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY-----------RRVTSG 228

Query: 276 VDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK 315
           V P  +      E    ++    C+++    R  +   + 
Sbjct: 229 VKPASFDKVAIPEVKEIIE---GCIRQNKDERYSIKDLLN 265

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (477), Expect = 3e-58
 Identities = 63/279 (22%), Positives = 112/279 (40%), Gaps = 26/279 (9%)

Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHE 100
           +     IG G +G   K R   DG I+  K L   S  +  ++  +SEV  +  +   H 
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK--HP 63

Query: 101 NLVKLHGGCIDGPCRIL--VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
           N+V+ +   ID     L  V +Y     L+  +    K R     +    ++  +   L 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 159 YIHE--EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLA 216
             H   +    V+HRD+K +N+ LD   N K+ DFGL+++   +T+  +    GT  Y++
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF-AKAFVGTPYYMS 182

Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV 276
           PE         KSD++S G LL E+ +                    +  ++ KEL   +
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMP----------------PFTAFSQKELAGKI 226

Query: 277 DPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK 315
               +   P   +    ++    +  K   RP +   ++
Sbjct: 227 REGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  188 bits (479), Expect = 4e-58
 Identities = 61/279 (21%), Positives = 113/279 (40%), Gaps = 36/279 (12%)

Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGE---KEFMSEVASMANVNVCH 99
           F    +IG G FG+VY  R +++  +VA+K +S   KQ     ++ + EV  +  +   H
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR--H 74

Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
            N ++  G  +      LV +Y   ++           +          +  G  +GLAY
Sbjct: 75  PNTIQYRGCYLREHTAWLVMEYCLGSASDLLE----VHKKPLQEVEIAAVTHGALQGLAY 130

Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEY 219
           +H     +++HRD+K  NILL +    K+ DFG + +     + +     GT  ++APE 
Sbjct: 131 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEV 182

Query: 220 AIS---GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV 276
            ++   G+   K DV+S G+  +E+   +  +     +   + +                
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI------------AQNE 230

Query: 277 DPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK 315
            P L           F+     C+Q+  + RP     +K
Sbjct: 231 SPALQSGHWSEYFRNFVD---SCLQKIPQDRPTSEVLLK 266

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 6e-58
 Identities = 71/283 (25%), Positives = 121/283 (42%), Gaps = 32/283 (11%)

Query: 45  RWSNKIGEGGFGSVYKGRLQD----GTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCH 99
            ++  IG G FG VY G L D        AVK L+  +  GE  +F++E   M + +  H
Sbjct: 30  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS--H 87

Query: 100 ENLVKLHGGCIDGP-CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
            N++ L G C+      ++V  YM +  L                K      + + +G+ 
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF---IRNETHNPTVKDLIGFGLQVAKGMK 144

Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN---TTHISTRVAGTLGYL 215
           ++        VHRD+   N +LD+ F  K++DFGL++   +    + H  T     + ++
Sbjct: 145 FLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201

Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNL 275
           A E   + + T KSDV+SFGVLL E+++       DV               N+ ++   
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV---------------NTFDITVY 246

Query: 276 VDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN 318
           +        PE       +V L C   K+++RP  S  +  ++
Sbjct: 247 LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 2e-57
 Identities = 70/293 (23%), Positives = 111/293 (37%), Gaps = 37/293 (12%)

Query: 42  NGFRWSNKIGEGGFGSVYKGRLQDG---TIVAVKVLS-VESKQGEKEFMSEVASMANVNV 97
           N  ++ + IGEG FG V K R++        A+K +    SK   ++F  E+  +  +  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG- 68

Query: 98  CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGE------------EKRRAKFGWKA 145
            H N++ L G C       L  +Y P+ +L   L                   +    + 
Sbjct: 69  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128

Query: 146 RREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS 205
                  + RG+ Y+    Q   +HRD+   NIL+ +N+  KI+DFGLS+          
Sbjct: 129 LLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK-- 183

Query: 206 TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG 265
           T     + ++A E       T  SDV+S+GVLL EIVS                    + 
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT---------------PYC 228

Query: 266 MYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN 318
                EL   +        P N       +   C +EK   RP  +  +  +N
Sbjct: 229 GMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 4e-57
 Identities = 65/282 (23%), Positives = 120/282 (42%), Gaps = 31/282 (10%)

Query: 44  FRWSNKIGEGGFGSVYKGRLQD-----GTIVAVKVLS-VESKQGEKEFMSEVASMANVNV 97
           F+    +G G FG+VYKG            VA+K L    S +  KE + E   MA+V+ 
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD- 69

Query: 98  CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
            + ++ +L G C+    + L+   MP   L   L    + +   G +      + I +G+
Sbjct: 70  -NPHVCRLLGICLTSTVQ-LITQLMPFGCL---LDYVREHKDNIGSQYLLNWCVQIAKGM 124

Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLA 216
            Y+       +VHRD+   N+L+    + KI+DFGL+KL   E   + +      + ++A
Sbjct: 125 NYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181

Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV 276
            E  +    T +SDV+S+GV + E+++  +               K +    + E+ +++
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGS---------------KPYDGIPASEISSIL 226

Query: 277 DPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN 318
           +       P    I    + + C    +  RP+    I   +
Sbjct: 227 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 5e-57
 Identities = 68/328 (20%), Positives = 114/328 (34%), Gaps = 46/328 (14%)

Query: 21  GGEQILKNINAFSYNQL-KIATNGFRWSNKIGEGGFGSVYKGRLQD------GTIVAVKV 73
             E    +   + Y+   +       +   +G G FG V                VAVK+
Sbjct: 15  DNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKM 74

Query: 74  LSVESKQGEKE-FMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTL- 131
           L  ++   E+E  MSE+  M  +   HEN+V L G C       L+++Y     L   L 
Sbjct: 75  LKEKADSSEREALMSELKMMTQLG-SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLR 133

Query: 132 ------------------LGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDI 173
                             L EE+      ++        + +G+ ++        VHRD+
Sbjct: 134 SKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDL 190

Query: 174 KTSNILLDQNFNPKISDFGLSKLFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVY 232
              N+L+      KI DFGL++    ++ + +       + ++APE    G  T KSDV+
Sbjct: 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVW 250

Query: 233 SFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRF 292
           S+G+LL EI S                     G+        L+      + P       
Sbjct: 251 SYGILLWEIFSLGVNPY--------------PGIPVDANFYKLIQNGFKMDQPFYATEEI 296

Query: 293 LKVGLLCVQEKSKLRPQMSTAIKMMNGE 320
             +   C    S+ RP        +  +
Sbjct: 297 YIIMQSCWAFDSRKRPSFPNLTSFLGCQ 324

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 6e-57
 Identities = 51/270 (18%), Positives = 110/270 (40%), Gaps = 30/270 (11%)

Query: 23  EQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQG 81
           E + +++N           + +    ++G+G FG VYK +  +   + A KV+  +S++ 
Sbjct: 2   EHVTRDLNP---------EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE 52

Query: 82  EKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKF 141
            +++M E+  +A+ +  H N+VKL           ++ ++    ++   +    +     
Sbjct: 53  LEDYMVEIDILASCD--HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVM---LELERPL 107

Query: 142 GWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 201
                + +       L Y+H+     ++HRD+K  NIL   + + K++DFG+S       
Sbjct: 108 TESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164

Query: 202 THISTRVAGTLGYLAPEYAIS-----GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE 256
               + + GT  ++APE  +           K+DV+S G+ L+E+            +  
Sbjct: 165 QRRDSFI-GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV 223

Query: 257 YHLVDKAWGMYN------SKELMNLVDPML 280
              + K+           S    + +   L
Sbjct: 224 LLKIAKSEPPTLAQPSRWSSNFKDFLKKCL 253

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 8e-57
 Identities = 67/244 (27%), Positives = 112/244 (45%), Gaps = 19/244 (7%)

Query: 44  FRWSNKIGEGGFGSVYKGRL-QDGTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCH 99
           F     +G+G FG+VY  R  Q   I+A+KVL    +E    E +   EV   +++   H
Sbjct: 8   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR--H 65

Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
            N+++L+G   D     L+ +Y P  ++ + L    ++ +KF  +     I  +   L+Y
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSY 121

Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEY 219
            H +    V+HRDIK  N+LL      KI+DFG S   P +       + GTL YL PE 
Sbjct: 122 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEM 175

Query: 220 AISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYN---SKELMNLV 276
                   K D++S GVL  E + G+   + +     Y  + +    +    ++   +L+
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 235

Query: 277 DPML 280
             +L
Sbjct: 236 SRLL 239

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 1e-55
 Identities = 61/247 (24%), Positives = 103/247 (41%), Gaps = 19/247 (7%)

Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHEN 101
           +     +GEG +G V           VAVK++ ++ +    +    E+     +N  HEN
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN--HEN 64

Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
           +VK +G   +G  + L  +Y     L   +    +          +     +  G+ Y+H
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLH 120

Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLAPEYA 220
                 + HRDIK  N+LLD+  N KISDFGL+ +F   N   +  ++ GTL Y+APE  
Sbjct: 121 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177

Query: 221 ISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYN------SKELM 273
                     DV+S G++L  +++G    D      + +   K    Y           +
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 237

Query: 274 NLVDPML 280
            L+  +L
Sbjct: 238 ALLHKIL 244

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 1e-54
 Identities = 66/283 (23%), Positives = 108/283 (38%), Gaps = 32/283 (11%)

Query: 44  FRWSNKIGEGGFGSVYKGRL----QDGTIVAVKVLS---VESKQGEKEFMSEVASMANVN 96
            R   K+G+G FG V +G           VAVK L    +   +   +F+ EV +M +++
Sbjct: 10  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69

Query: 97  VCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRG 156
             H NL++L+G  +  P ++ V +  P  SL        K +  F         + +  G
Sbjct: 70  --HRNLIRLYGVVLTPPMKM-VTELAPLGSLLDR---LRKHQGHFLLGTLSRYAVQVAEG 123

Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH--ISTRVAGTLGY 214
           + Y+        +HRD+   N+LL      KI DFGL +  P+N  H  +         +
Sbjct: 124 MGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180

Query: 215 LAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMN 274
            APE   +   +  SD + FGV L E+ +                     G+  S+ L  
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI--------------GLNGSQILHK 226

Query: 275 LVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMM 317
           +         PE+       V + C   K + RP        +
Sbjct: 227 IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 1e-54
 Identities = 49/199 (24%), Positives = 92/199 (46%), Gaps = 12/199 (6%)

Query: 48  NKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLH 106
            KIG+G  G+VY    +  G  VA++ ++++ +  ++  ++E+  M      + N+V   
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK--NPNIVNYL 83

Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
              + G    +V +Y+   SL+  +                 +     + L ++H     
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHSN--- 135

Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLT 226
            V+HRDIK+ NILL  + + K++DFG         +  ST V GT  ++APE        
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 194

Query: 227 RKSDVYSFGVLLLEIVSGR 245
            K D++S G++ +E++ G 
Sbjct: 195 PKVDIWSLGIMAIEMIEGE 213

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  177 bits (449), Expect = 3e-53
 Identities = 55/250 (22%), Positives = 108/250 (43%), Gaps = 22/250 (8%)

Query: 42  NGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHE 100
           + +    ++G G FG V++      G   A K +    +  ++    E+ +M+ +   H 
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR--HP 83

Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
            LV LH    D    +++Y++M    L + +        K       E +  + +GL ++
Sbjct: 84  TLVNLHDAFEDDNEMVMIYEFMSGGELFEKV---ADEHNKMSEDEAVEYMRQVCKGLCHM 140

Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNP--KISDFGLSKLFPENTTHISTRVAGTLGYLAPE 218
           HE    + VH D+K  NI+     +   K+ DFGL+       +   T   GT  + APE
Sbjct: 141 HEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPE 195

Query: 219 YAISGRLTRKSDVYSFGVLLLEIVSGRT--------AVDFDVQLGEYHLVDKAWGMYNSK 270
            A    +   +D++S GVL   ++SG +            +V+  ++++ D A+    S+
Sbjct: 196 VAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI-SE 254

Query: 271 ELMNLVDPML 280
           +  + +  +L
Sbjct: 255 DGKDFIRKLL 264

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 8e-53
 Identities = 59/280 (21%), Positives = 106/280 (37%), Gaps = 29/280 (10%)

Query: 44  FRWSNKIGEGGFGSVYKGRL----QDGTIVAVKVLSVESKQGEKE-FMSEVASMANVNVC 98
                 IGEG FG V++G           VA+K     +    +E F+ E  +M   +  
Sbjct: 9   IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD-- 66

Query: 99  HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
           H ++VKL G   +     ++ +      L       + R+      +       +   LA
Sbjct: 67  HPHIVKLIGVITEN-PVWIIMELCTLGELRSF---LQVRKYSLDLASLILYAYQLSTALA 122

Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE 218
           Y+        VHRDI   N+L+  N   K+ DFGLS+   ++T + +++    + ++APE
Sbjct: 123 YLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179

Query: 219 YAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDP 278
                R T  SDV+ FGV + EI+                   K +    + +++  ++ 
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGV---------------KPFQGVKNNDVIGRIEN 224

Query: 279 MLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN 318
                 P N       +   C       RP+ +     ++
Sbjct: 225 GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 264

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 5e-52
 Identities = 67/296 (22%), Positives = 127/296 (42%), Gaps = 34/296 (11%)

Query: 39  IATNGFRWSNKIGEGGFGSVYKGRL------QDGTIVAVKVLSVESKQGEK-EFMSEVAS 91
           +A      S ++G+G FG VY+G        +  T VA+K ++  +   E+ EF++E + 
Sbjct: 17  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 76

Query: 92  MANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTL------LGEEKRRAKFGWKA 145
           M   N    ++V+L G    G   +++ + M    L   L      +      A      
Sbjct: 77  MKEFN--CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134

Query: 146 RREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE-NTTHI 204
             ++   I  G+AY++       VHRD+   N ++ ++F  KI DFG+++   E +    
Sbjct: 135 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 191

Query: 205 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAW 264
             +    + +++PE    G  T  SDV+SFGV+L EI +                 ++ +
Sbjct: 192 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA---------------EQPY 236

Query: 265 GMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE 320
              ++++++  V      + P+N      ++  +C Q   K+RP     I  +  E
Sbjct: 237 QGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 1e-51
 Identities = 62/302 (20%), Positives = 112/302 (37%), Gaps = 41/302 (13%)

Query: 39  IATNGFRWSNKIGEGGFGSVYKGRL--------QDGTIVAVKVLSVE-SKQGEKEFMSEV 89
           +  +       +GEG FG V                T VAVK+L  + +++   + +SE+
Sbjct: 10  LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM 69

Query: 90  ASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTL------------LGEEKR 137
             M  +   H+N++ L G C       ++ +Y    +L + L                  
Sbjct: 70  EMMKMIG-KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128

Query: 138 RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197
             +   K        + RG+ Y+        +HRD+   N+L+ ++   KI+DFGL++  
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDI 185

Query: 198 PENTTHISTRV-AGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE 256
                +  T      + ++APE       T +SDV+SFGVLL EI +   +         
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS--------- 236

Query: 257 YHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKM 316
                  +     +EL  L+      + P N       +   C       RP     ++ 
Sbjct: 237 ------PYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

Query: 317 MN 318
           ++
Sbjct: 291 LD 292

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (427), Expect = 1e-50
 Identities = 57/251 (22%), Positives = 106/251 (42%), Gaps = 17/251 (6%)

Query: 38  KIATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLS---VESKQGEKEFMSEVASMA 93
           K     F++   +GEG F +V   R L      A+K+L    +  +        E   M+
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63

Query: 94  NVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGI 153
            ++  H   VKL+    D         Y  N  L + +    ++   F     R     I
Sbjct: 64  RLD--HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEI 117

Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTL 212
              L Y+H      ++HRD+K  NILL+++ + +I+DFG +K+  PE+    +    GT 
Sbjct: 118 VSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 174

Query: 213 GYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYN---S 269
            Y++PE        + SD+++ G ++ ++V+G        +   +  + K    +     
Sbjct: 175 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFF 234

Query: 270 KELMNLVDPML 280
            +  +LV+ +L
Sbjct: 235 PKARDLVEKLL 245

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  169 bits (429), Expect = 5e-50
 Identities = 69/251 (27%), Positives = 108/251 (43%), Gaps = 22/251 (8%)

Query: 42  NGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLS---VESKQGEKEFMSEVASMANVNV 97
           N F     IG GGFG VY  R    G + A+K L    ++ KQGE   ++E   ++ V+ 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 98  C-HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRG 156
                +V +            + D M    L   L     +   F     R     I  G
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEIILG 119

Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLA 216
           L ++H      VV+RD+K +NILLD++ + +ISD GL+  F +   H S    GT GY+A
Sbjct: 120 LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMA 173

Query: 217 PEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYN------S 269
           PE    G      +D +S G +L +++ G +         ++ +      M        S
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS 233

Query: 270 KELMNLVDPML 280
            EL +L++ +L
Sbjct: 234 PELRSLLEGLL 244

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  168 bits (427), Expect = 6e-50
 Identities = 50/242 (20%), Positives = 94/242 (38%), Gaps = 20/242 (8%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           ++G G FG V++      G +   K ++      +    +E++ M  ++  H  L+ LH 
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH--HPKLINLHD 93

Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
              D    +L+ +++    L   +        K         +     GL ++HE     
Sbjct: 94  AFEDKYEMVLILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHEH---S 147

Query: 168 VVHRDIKTSNILLDQNFNP--KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL 225
           +VH DIK  NI+ +       KI DFGL+     +     T    T  + APE      +
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVDREPV 205

Query: 226 TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYN-------SKELMNLVDP 278
              +D+++ GVL   ++SG +    +  L     V +    ++       S E  + +  
Sbjct: 206 GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKN 265

Query: 279 ML 280
           +L
Sbjct: 266 LL 267

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 9e-50
 Identities = 64/301 (21%), Positives = 113/301 (37%), Gaps = 39/301 (12%)

Query: 39  IATNGFRWSNKIGEGGFGSVYKGR------LQDGTIVAVKVLSVESKQGE-KEFMSEVAS 91
              +  +    +G G FG V +              VAVK+L   +   E +  MSE+  
Sbjct: 10  FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 69

Query: 92  MANVNVCHENLVKLHGGCI-DGPCRILVYDYMPNNSLSQTL------------LGEEKRR 138
           + ++   H N+V L G C   G   +++ ++    +LS  L              E+  +
Sbjct: 70  LIHIG-HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 128

Query: 139 AKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198
                +        + +G+ ++        +HRD+   NILL +    KI DFGL++   
Sbjct: 129 DFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIY 185

Query: 199 ENTTHI-STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEY 257
           ++  ++        L ++APE       T +SDV+SFGVLL EI S   +          
Sbjct: 186 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-------- 237

Query: 258 HLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMM 317
                  G+   +E    +        P+       +  L C   +   RP  S  ++ +
Sbjct: 238 ------PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 291

Query: 318 N 318
            
Sbjct: 292 G 292

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  163 bits (413), Expect = 1e-48
 Identities = 61/261 (23%), Positives = 102/261 (39%), Gaps = 35/261 (13%)

Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSV---------ESKQGEKEFMSEVASMA 93
           +     +G G    V +          AVK++ V         E ++  +  + EV  + 
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 94  NVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGI 153
            V+  H N+++L           LV+D M    L   L      +     K  R+I+  +
Sbjct: 65  KVS-GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRAL 119

Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
              +  +H+    ++VHRD+K  NILLD + N K++DFG S             V GT  
Sbjct: 120 LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTPS 174

Query: 214 YLAPEYAISGRL------TRKSDVYSFGVLLLEIVSGRT--------AVDFDVQLGEYHL 259
           YLAPE              ++ D++S GV++  +++G           +   +  G Y  
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 234

Query: 260 VDKAWGMYNSKELMNLVDPML 280
               W  Y S  + +LV   L
Sbjct: 235 GSPEWDDY-SDTVKDLVSRFL 254

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  160 bits (405), Expect = 4e-47
 Identities = 49/257 (19%), Positives = 99/257 (38%), Gaps = 19/257 (7%)

Query: 34  YNQLKIATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQG-EKEFMSEVAS 91
           + Q +   + + + + +G G F  V      +   +VA+K ++ ++ +G E    +E+A 
Sbjct: 1   WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60

Query: 92  MANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
           +  +   H N+V L      G    L+   +    L   +      +  +  +    +I 
Sbjct: 61  LHKIK--HPNIVALDDIYESGGHLYLIMQLVSGGELFDRI----VEKGFYTERDASRLIF 114

Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT 211
            +   + Y+H+    H   +        LD++    ISDFGLSK+    +    +   GT
Sbjct: 115 QVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL--STACGT 172

Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT--------AVDFDVQLGEYHLVDKA 263
            GY+APE       ++  D +S GV+   ++ G           +   +   EY      
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPY 232

Query: 264 WGMYNSKELMNLVDPML 280
           W    S    + +  ++
Sbjct: 233 WDDI-SDSAKDFIRHLM 248

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 5e-46
 Identities = 42/243 (17%), Positives = 93/243 (38%), Gaps = 23/243 (9%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
            +G G FG V++            K + V+    +     E++ +      H N++ LH 
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIAR--HRNILHLHE 68

Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
                   +++++++    + + +        +   +     +  +   L ++H     +
Sbjct: 69  SFESMEELVMIFEFISGLDIFERI---NTSAFELNEREIVSYVHQVCEALQFLHS---HN 122

Query: 168 VVHRDIKTSNILLDQNFNP--KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL 225
           + H DI+  NI+     +   KI +FG ++                  Y APE      +
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVHQHDVV 180

Query: 226 TRKSDVYSFGVLLLEIVSGRT--------AVDFDVQLGEYHLVDKAWGMYNSKELMNLVD 277
           +  +D++S G L+  ++SG           +  ++   EY   ++A+    S E M+ VD
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEI-SIEAMDFVD 239

Query: 278 PML 280
            +L
Sbjct: 240 RLL 242

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  157 bits (397), Expect = 7e-46
 Identities = 59/244 (24%), Positives = 111/244 (45%), Gaps = 20/244 (8%)

Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCH 99
           F+    +G G FG V+  R   +G   A+KVL    V   +  +    E   ++ V   H
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT--H 63

Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
             ++++ G   D     ++ DY+    L        ++  +F     +     +   L Y
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFS----LLRKSQRFPNPVAKFYAAEVCLALEY 119

Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEY 219
           +H      +++RD+K  NILLD+N + KI+DFG +K  P+ T      + GT  Y+APE 
Sbjct: 120 LHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPEV 172

Query: 220 AISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYN---SKELMNLV 276
             +    +  D +SFG+L+ E+++G T       +  Y  +  A   +    ++++ +L+
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLL 232

Query: 277 DPML 280
             ++
Sbjct: 233 SRLI 236

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 1e-45
 Identities = 58/255 (22%), Positives = 110/255 (43%), Gaps = 17/255 (6%)

Query: 48  NKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKE-----FMSEVASMANVNVCHEN 101
           + +GEG F +VYK R      IVA+K + +  +   K+      + E+  +  ++  H N
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS--HPN 61

Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
           ++ L           LV+D+M  +         +           +  ++   +GL Y+H
Sbjct: 62  IIGLLDAFGHKSNISLVFDFMETDLEVII----KDNSLVLTPSHIKAYMLMTLQGLEYLH 117

Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI 221
           +     ++HRD+K +N+LLD+N   K++DFGL+K F       + +V  T  Y APE   
Sbjct: 118 Q---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLF 173

Query: 222 SGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPML 280
             R+     D+++ G +L E++     +  D  L +   + +  G    ++  ++     
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233

Query: 281 YGNFPENEAIRFLKV 295
           Y  F     I    +
Sbjct: 234 YVTFKSFPGIPLHHI 248

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  154 bits (389), Expect = 6e-45
 Identities = 58/294 (19%), Positives = 108/294 (36%), Gaps = 32/294 (10%)

Query: 36  QLKIATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMAN 94
           +L++  N +R   KIG G FG +Y G  +  G  VA+K+  V++K    +   E      
Sbjct: 2   ELRVG-NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKM 58

Query: 95  VNVCHENLVKLHGGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGI 153
           +       +     C  +G   ++V + +  +              KF  K    +   +
Sbjct: 59  MQ--GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFN----FCSRKFSLKTVLLLADQM 112

Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNIL---LDQNFNPKISDFGLSKLFPENTTHI------ 204
              + YIH +   + +HRD+K  N L     +     I DFGL+K + +  TH       
Sbjct: 113 ISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRE 169

Query: 205 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAW 264
           +  + GT  Y +    +    +R+ D+ S G +L+    G           +    ++  
Sbjct: 170 NKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS 229

Query: 265 GMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN 318
                   M+    +L   +P  E   +L     C   +   +P  S   ++  
Sbjct: 230 EKK-----MSTPIEVLCKGYPS-EFATYLN---FCRSLRFDDKPDYSYLRQLFR 274

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 9e-45
 Identities = 58/244 (23%), Positives = 98/244 (40%), Gaps = 16/244 (6%)

Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKE---FMSEVASMANVNVCH 99
           F     +G+G FG V+     +     A+K L  +    + +    M E   ++     H
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEH 62

Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
             L  +            V +Y+    L   +    +   KF           I  GL +
Sbjct: 63  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI----QSCHKFDLSRATFYAAEIILGLQF 118

Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEY 219
           +H      +V+RD+K  NILLD++ + KI+DFG+ K         +T   GT  Y+APE 
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEI 174

Query: 220 AISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYN---SKELMNLV 276
            +  +     D +SFGVLL E++ G++      +   +H +      Y     KE  +L+
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLL 234

Query: 277 DPML 280
             + 
Sbjct: 235 VKLF 238

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (386), Expect = 9e-45
 Identities = 58/241 (24%), Positives = 93/241 (38%), Gaps = 21/241 (8%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKE------FMSEVASMANVNVCHEN 101
            +G GGFGSVY G  + D   VA+K +  +      E         EV  +  V+     
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
           +++L          +L+ +           +     R     +  R     +   + + H
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHCH 127

Query: 162 EEIQPHVVHRDIKTSNILLDQN-FNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
                 V+HRDIK  NIL+D N    K+ DFG   L  +      T   GT  Y  PE+ 
Sbjct: 128 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRVYSPPEWI 181

Query: 221 ISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPM 279
              R   R + V+S G+LL ++V G    + D ++    +  +      S E  +L+   
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR---VSSECQHLIRWC 238

Query: 280 L 280
           L
Sbjct: 239 L 239

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  151 bits (383), Expect = 3e-44
 Identities = 55/251 (21%), Positives = 106/251 (42%), Gaps = 12/251 (4%)

Query: 48  NKIGEGGFGSVYKGRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKL 105
            KIGEG +G VYK +   G   A+K + +E   +      + E++ +  +   H N+VKL
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELK--HSNIVKL 65

Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
           +         +LV++++  +                     +  ++ +  G+AY H+   
Sbjct: 66  YDVIHTKKRLVLVFEHLDQDLKKLLD----VCEGGLESVTAKSFLLQLLNGIAYCHD--- 118

Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL 225
             V+HRD+K  N+L+++    KI+DFGL++ F       +  +             S + 
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178

Query: 226 TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYG-NF 284
           +   D++S G +  E+V+G        +  +   + +  G  NSK   N+ +   Y  NF
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238

Query: 285 PENEAIRFLKV 295
              E + +   
Sbjct: 239 TVYEPLPWESF 249

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 5e-44
 Identities = 57/256 (22%), Positives = 106/256 (41%), Gaps = 12/256 (4%)

Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVL--SVESKQGEKEFMSEVASMANVNVCHE 100
           F+   KIGEG +G VYK R    G +VA+K +    E++      + E++ +  +N  H 
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN--HP 61

Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
           N+VKL           LV++++  +        +            +  +  + +GLA+ 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKK---FMDASALTGIPLPLIKSYLFQLLQGLAFC 118

Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
           H      V+HRD+K  N+L++     K++DFGL++ F       +  V            
Sbjct: 119 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175

Query: 221 ISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD-PM 279
                +   D++S G +  E+V+ R     D ++ +   + +  G  +      +   P 
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235

Query: 280 LYGNFPENEAIRFLKV 295
              +FP+     F KV
Sbjct: 236 YKPSFPKWARQDFSKV 251

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 6e-44
 Identities = 60/296 (20%), Positives = 113/296 (38%), Gaps = 28/296 (9%)

Query: 40  ATNGFRWSNKIGEGGFGSVYKGR--LQDGTIVAVKVLSVESKQG--EKEFMSEVASMANV 95
           A   +    +IGEG +G V+K R     G  VA+K + V++ +       + EVA + ++
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 96  NVC-HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLG--EEKRRAKFGWKARREIIMG 152
               H N+V+L   C            +    + Q L    ++        +  ++++  
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL 212
           + RGL ++H      VVHRD+K  NIL+  +   K++DFGL++++        T V  TL
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTL 179

Query: 213 GYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKEL 272
            Y APE  +        D++S G +  E+   +        + +   +    G+   ++ 
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239

Query: 273 MNLVDPMLYGNFPEN-------------EAIRFLKVGLLCVQEKSKLRPQMSTAIK 315
              V         ++                  L     C+      R    +A+ 
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLL---KCLTFNPAKRISAYSALS 292

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  150 bits (379), Expect = 9e-44
 Identities = 55/215 (25%), Positives = 98/215 (45%), Gaps = 19/215 (8%)

Query: 41  TNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGE---KEFMSEVASMANVN 96
           ++ +     +G GG   V+  R L+    VAVKVL  +  +       F  E  + A +N
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 97  VCHENLVKLHGGCID----GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG 152
             H  +V ++         GP   +V +Y+   +L   +            K   E+I  
Sbjct: 66  --HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV----HTEGPMTPKRAIEVIAD 119

Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI--STRVAG 210
             + L + H+     ++HRD+K +NI++      K+ DFG+++   ++   +  +  V G
Sbjct: 120 ACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 176

Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
           T  YL+PE A    +  +SDVYS G +L E+++G 
Sbjct: 177 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 211

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 5e-43
 Identities = 58/246 (23%), Positives = 106/246 (43%), Gaps = 11/246 (4%)

Query: 41  TNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVC 98
              +   + IGEG +G V       +   VA+K +S    Q   +  + E+  +      
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-- 64

Query: 99  HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
           HEN++ ++          +   Y+  + +   L    K +           +  I RGL 
Sbjct: 65  HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLK 123

Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS--TRVAGTLGYLA 216
           YIH     +V+HRD+K SN+LL+   + KI DFGL+++   +  H    T    T  Y A
Sbjct: 124 YIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 180

Query: 217 PEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNL 275
           PE  ++ +  T+  D++S G +L E++S R        L + + +    G  + ++L  +
Sbjct: 181 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240

Query: 276 VDPMLY 281
           ++    
Sbjct: 241 INLKAR 246

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  148 bits (375), Expect = 5e-43
 Identities = 48/282 (17%), Positives = 99/282 (35%), Gaps = 31/282 (10%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           +IGEG FG +++G  L +   VA+K     S     +   E  +   +  C   +  ++ 
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCT-GIPNVYY 68

Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
              +G   +LV D +  +         +    KF  K        +   +  IH   +  
Sbjct: 69  FGQEGLHNVLVIDLLGPSLEDL----LDLCGRKFSVKTVAMAAKQMLARVQSIH---EKS 121

Query: 168 VVHRDIKTSNILLDQNFNP-----KISDFGLSKLFPENTTHI------STRVAGTLGYLA 216
           +V+RDIK  N L+ +  +       + DFG+ K + +  T           ++GT  Y++
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181

Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV 276
               +    +R+ D+ + G + +  + G                ++       ++  +  
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI-----GEKKQSTP 236

Query: 277 DPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN 318
              L   FPE E  +++              P       + +
Sbjct: 237 LRELCAGFPE-EFYKYMH---YARNLAFDATPDYDYLQGLFS 274

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 4e-42
 Identities = 61/260 (23%), Positives = 107/260 (41%), Gaps = 19/260 (7%)

Query: 44  FRWSNKIGEGGFGSVYKGRL-QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENL 102
           +  +  IG G FG VY+ +L   G +VA+K +     Q ++    E+  M  ++  H N+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLD--HCNI 75

Query: 103 VKLHGGCI------DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRG 156
           V+L           D     LV DY+P     +      + +        +  +  + R 
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVY-RVARHYSRAKQTLPVIYVKLYMYQLFRS 134

Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQN-FNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
           LAYIH      + HRDIK  N+LLD +    K+ DFG +K       ++ + +       
Sbjct: 135 LAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-SYICSRYYRA 190

Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNL 275
                 +   T   DV+S G +L E++ G+     D  + +   + K  G    +++  +
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250

Query: 276 VDPMLYGNFPENEAIRFLKV 295
                   FP+ +A  + KV
Sbjct: 251 NPNYTEFKFPQIKAHPWTKV 270

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 2e-41
 Identities = 66/250 (26%), Positives = 101/250 (40%), Gaps = 17/250 (6%)

Query: 38  KIATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLS---VESKQGEKEFMSEVASMA 93
           K+  N F +   +G+G FG V   R    G   A+K+L    + +K      ++E   + 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60

Query: 94  NVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGI 153
           N    H  L  L            V +Y     L   L     R   F  +  R     I
Sbjct: 61  NTR--HPFLTALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEI 114

Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
              L Y+H      VV+RDIK  N++LD++ + KI+DFGL K    +   + T   GT  
Sbjct: 115 VSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPE 170

Query: 214 YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT---AVDFDVQLGEYHLVDKAWGMYNSK 270
           YLAPE        R  D +  GV++ E++ GR      D +       + +  +    S 
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSP 230

Query: 271 ELMNLVDPML 280
           E  +L+  +L
Sbjct: 231 EAKSLLAGLL 240

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 4e-41
 Identities = 53/251 (21%), Positives = 94/251 (37%), Gaps = 31/251 (12%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGE------KEFMSEVASMANVNVCHEN 101
           ++G G F  V K R    G   A K +     +        ++   EV+ +  +   H N
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ--HPN 74

Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
           ++ LH    +    IL+ + +    L          +     +   E +  I  G+ Y+H
Sbjct: 75  VITLHEVYENKTDVILILELVAGGELFDF----LAEKESLTEEEATEFLKQILNGVYYLH 130

Query: 162 EEIQPHVVHRDIKTSNILLDQNFNP----KISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
                 + H D+K  NI+L     P    KI DFGL+             + GT  ++AP
Sbjct: 131 S---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAP 185

Query: 218 EYAISGRLTRKSDVYSFGVLLLEIVSGRT--------AVDFDVQLGEYHLVDKAWGMYNS 269
           E      L  ++D++S GV+   ++SG +            +V    Y   D+ +    S
Sbjct: 186 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT-S 244

Query: 270 KELMNLVDPML 280
               + +  +L
Sbjct: 245 ALAKDFIRRLL 255

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 3e-40
 Identities = 58/257 (22%), Positives = 110/257 (42%), Gaps = 24/257 (9%)

Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQG--EKEFMSEVASMANVNVCHE 100
           +    KIG+G FG V+K R  + G  VA+K + +E+++       + E+  +  +   HE
Sbjct: 12  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK--HE 69

Query: 101 NLVKLHGGCIDGPCRI--------LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG 152
           N+V L   C               LV+D+  ++              KF     + ++  
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS----NVLVKFTLSEIKRVMQM 125

Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT---HISTRVA 209
           +  GL YIH      ++HRD+K +N+L+ ++   K++DFGL++ F        +  T   
Sbjct: 126 LLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182

Query: 210 GTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYN 268
            TL Y  PE  +  R      D++  G ++ E+ +    +  + +  +  L+ +  G   
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242

Query: 269 SKELMNLVDPMLYGNFP 285
            +   N+ +  LY    
Sbjct: 243 PEVWPNVDNYELYEKLE 259

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  139 bits (352), Expect = 5e-39
 Identities = 64/265 (24%), Positives = 109/265 (41%), Gaps = 22/265 (8%)

Query: 23  EQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQG 81
           E  LK     S N  ++  + F     +G G FG V   +  + G   A+K+L  +    
Sbjct: 24  EDFLKKWETPSQNTAQL--DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK 81

Query: 82  EKE---FMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRR 138
            K+    ++E   +  VN     LVKL     D     +V +Y+    +   L    +R 
Sbjct: 82  LKQIEHTLNEKRILQAVN--FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL----RRI 135

Query: 139 AKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198
            +F     R     I     Y+H      +++RD+K  N+L+DQ    +++DFG +K   
Sbjct: 136 GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192

Query: 199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYH 258
             T  +     GT   LAPE  +S    +  D ++ GVL+ E+ +G      D  +  Y 
Sbjct: 193 GRTWTLC----GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248

Query: 259 LVDKAWGMYN---SKELMNLVDPML 280
            +      +    S +L +L+  +L
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLRNLL 273

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 1e-38
 Identities = 47/255 (18%), Positives = 105/255 (41%), Gaps = 13/255 (5%)

Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHE 100
           +    KIGEG +G+V+K +  +   IVA+K + ++   +      + E+  +  +   H+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK--HK 61

Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
           N+V+LH          LV+++   +         +        +  +  +  + +GL + 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYF----DSCNGDLDPEIVKSFLFQLLKGLGFC 117

Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
           H     +V+HRD+K  N+L+++N   K+++FGL++ F       S  V            
Sbjct: 118 H---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174

Query: 221 ISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE-YHLVDKAWGMYNSKELMNLVDPM 279
            +   +   D++S G +  E+ +    +     + +    + +  G    ++  ++    
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234

Query: 280 LYGNFPENEAIRFLK 294
            Y  +P   A   L 
Sbjct: 235 DYKPYPMYPATTSLV 249

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 2e-38
 Identities = 49/251 (19%), Positives = 102/251 (40%), Gaps = 34/251 (13%)

Query: 50  IGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG 108
           +G G  G V +    +     A+K+L     Q   +   EV      +    ++V++   
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRAS-QCPHIVRIVDV 73

Query: 109 CID----GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
             +      C ++V + +    L   +  +++    F  +   EI+  IG  + Y+H   
Sbjct: 74  YENLYAGRKCLLIVMECLDGGELFSRI--QDRGDQAFTEREASEIMKSIGEAIQYLHSI- 130

Query: 165 QPHVVHRDIKTSNILLDQNFNP---KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI 221
             ++ HRD+K  N+L          K++DFG +K    + +  +     T  Y+APE   
Sbjct: 131 --NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLG 186

Query: 222 SGRLTRKSDVYSFGVLLLEIVSGRT------------AVDFDVQLGEYHLVDKAWGMYNS 269
             +  +  D++S GV++  ++ G               +   +++G+Y   +  W    S
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV-S 245

Query: 270 KELMNLVDPML 280
           +E+  L+  +L
Sbjct: 246 EEVKMLIRNLL 256

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 4e-38
 Identities = 57/258 (22%), Positives = 104/258 (40%), Gaps = 14/258 (5%)

Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVL--SVESKQGEKEFMSEVASMANVNVCHE 100
           +R    +G G +G+V      + G  VA+K L    +S+   K    E+  + ++   HE
Sbjct: 20  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR--HE 77

Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
           N++ L              D+        T LG+  +  K G    + ++  + +GL YI
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137

Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
           H      ++HRD+K  N+ ++++   KI DFGL++      T     V            
Sbjct: 138 HA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT---GYVVTRWYRAPEVIL 191

Query: 221 ISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPML 280
              R T+  D++S G ++ E+++G+T       L +   + K  G   ++ +  L     
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251

Query: 281 YG---NFPENEAIRFLKV 295
                  PE E   F  +
Sbjct: 252 KNYMKGLPELEKKDFASI 269

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 5e-35
 Identities = 65/272 (23%), Positives = 114/272 (41%), Gaps = 26/272 (9%)

Query: 26  LKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRL----QDGTIVAVKVLS----VE 77
           L+  N  + +  K+    F     +G G +G V+  R       G + A+KVL     V+
Sbjct: 9   LRTAN-LTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ 67

Query: 78  SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKR 137
             +  +   +E   + ++      LV LH          L+ DY+    L   L     +
Sbjct: 68  KAKTTEHTRTERQVLEHIR-QSPFLVTLHYAFQTETKLHLILDYINGGELFTHL----SQ 122

Query: 138 RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197
           R +F     +  +  I   L ++H+     +++RDIK  NILLD N +  ++DFGLSK F
Sbjct: 123 RERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179

Query: 198 PENTTHISTRVAGTLGYLAPEYAISGR--LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255
             + T  +    GT+ Y+AP+    G     +  D +S GVL+ E+++G +    D +  
Sbjct: 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 239

Query: 256 EYHLVDKAWGMYN-------SKELMNLVDPML 280
               + +             S    +L+  +L
Sbjct: 240 SQAEISRRILKSEPPYPQEMSALAKDLIQRLL 271

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  126 bits (318), Expect = 2e-34
 Identities = 41/223 (18%), Positives = 90/223 (40%), Gaps = 24/223 (10%)

Query: 32  FSYNQLKIATNG---FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMS 87
           + Y    +       ++   K+G G +  V++   + +   V VK+L    K   K+   
Sbjct: 22  WDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKR 78

Query: 88  EVASMANVNVCHENLVKLHGGCIDGPCR--ILVYDYMPNNSLSQTLLGEEKRRAKFGWKA 145
           E+  + N+     N++ L     D   R   LV++++ N    Q                
Sbjct: 79  EIKILENLR-GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ-------LYQTLTDYD 130

Query: 146 RREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD-QNFNPKISDFGLSKLFPENTTHI 204
            R  +  I + L Y H      ++HRD+K  N+++D ++   ++ D+GL++ +     + 
Sbjct: 131 IRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY- 186

Query: 205 STRVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGRT 246
                 +  +  PE  +  ++     D++S G +L  ++  + 
Sbjct: 187 -NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 228

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 2e-32
 Identities = 59/247 (23%), Positives = 103/247 (41%), Gaps = 13/247 (5%)

Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCHE 100
           ++  + +G G +GSV      + G  VAVK LS   +S    K    E+  + ++   HE
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--HE 77

Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
           N++ L              D      L    L    +  K      + +I  I RGL YI
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 137

Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
           H      ++HRD+K SN+ ++++   KI DFGL++   +  T        T  Y APE  
Sbjct: 138 HS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPEIM 190

Query: 221 ISGR-LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPM 279
           ++     +  D++S G ++ E+++GRT       + +  L+ +  G   ++ L  +    
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250

Query: 280 LYGNFPE 286
                  
Sbjct: 251 ARNYIQS 257

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (298), Expect = 3e-31
 Identities = 55/263 (20%), Positives = 104/263 (39%), Gaps = 25/263 (9%)

Query: 44  FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCHE 100
           ++    IG G  G V           VA+K LS   +++   K    E+  M  VN  H+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN--HK 76

Query: 101 NLVKLHGGCI------DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIG 154
           N++ L           +     LV + M  N         +  + +   +    ++  + 
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLC-------QVIQMELDHERMSYLLYQML 129

Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY 214
            G+ ++H      ++HRD+K SNI++  +   KI DFGL++    +     T    T  Y
Sbjct: 130 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRYY 184

Query: 215 LAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMN 274
            APE  +        D++S G ++ E+V  +        + +++ V +  G    + +  
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244

Query: 275 LVDPM--LYGNFPENEAIRFLKV 295
           L   +     N P+   + F K+
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKL 267

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  112 bits (280), Expect = 1e-28
 Identities = 46/232 (19%), Positives = 94/232 (40%), Gaps = 28/232 (12%)

Query: 49  KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
           K+G G F +V+  + + + T VA+K++    K   +    E+  +  VN    +  K   
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVN--DADNTKEDS 76

Query: 108 GCIDGPCRIL-VYDYMPNNSLSQTLLGEE-----------KRRAKFGWKARREIIMGIGR 155
              +   ++L  +++   N +   ++ E                       ++I   +  
Sbjct: 77  MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136

Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNP------KISDFGLSKLFPENTTHISTRVA 209
           GL Y+H   +  ++H DIK  N+L++   +P      KI+D G +  + E+ T+      
Sbjct: 137 GLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN----SI 190

Query: 210 GTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVD 261
            T  Y +PE  +       +D++S   L+ E+++G    + D         D
Sbjct: 191 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 92.9 bits (230), Expect = 4e-23
 Identities = 37/205 (18%), Positives = 65/205 (31%), Gaps = 31/205 (15%)

Query: 48  NKIGEGGFGSVYKGRLQDGTIVAVKVLSVES----------KQGEKEFMSEVASMANVNV 97
             +GEG   +V+    +      VK   V              G+  F      + +   
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLA--IRSARN 63

Query: 98  CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
               L KL G  +       VY +  N  L +  L + K   +   +   E++  I   +
Sbjct: 64  EFRALQKLQGLAV-----PKVYAWEGNAVLME--LIDAKELYRVRVENPDEVLDMILEEV 116

Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PENTTHISTRVAGTLGYL 215
           A  +      +VH D+   N+L+       I DF  S           +   V   + Y 
Sbjct: 117 AKFY---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYF 172

Query: 216 APEYAISGRLTRKSDVYSFGVLLLE 240
           +  Y        + D+ S    +L+
Sbjct: 173 SRTYRT------EKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	358
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.88
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.89
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.39
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.88
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.54
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.48
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.33

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-53  Score=378.88  Aligned_cols=249  Identities=21%  Similarity=0.344  Sum_probs=211.5

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEe
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD  120 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e  120 (358)
                      ++|++.+.||+|+||.||+|.+. +|+.||||++........+.+.+|+.+++.++  ||||+++++++.+.+..|+|||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~--HpnIv~~~~~~~~~~~~~ivmE   97 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK--NPNIVNYLDSYLVGDELWVVME   97 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCC--CTTBCCEEEEEEETTEEEEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCC--CCCEeeEeEEEEECCEEEEEEE
Confidence            58999999999999999999975 69999999998766666778999999999998  9999999999999999999999


Q ss_pred             cCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCC
Q 018263          121 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN  200 (358)
Q Consensus       121 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~  200 (358)
                      |++|++|.+++     ....+++..++.++.||+.||+|||++   ||+||||||+||+++.++.+||+|||++......
T Consensus        98 y~~gg~L~~~~-----~~~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~  169 (293)
T d1yhwa1          98 YLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (293)
T ss_dssp             CCTTCBHHHHH-----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             ecCCCcHHHHh-----hccCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccc
Confidence            99999999987     234699999999999999999999999   9999999999999999999999999999876433


Q ss_pred             CcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhcccc
Q 018263          201 TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPML  280 (358)
Q Consensus       201 ~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (358)
                      .. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+...              ...
T Consensus       170 ~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~--------------~~~  234 (293)
T d1yhwa1         170 QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN--------------GTP  234 (293)
T ss_dssp             TC-CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH--------------CSC
T ss_pred             cc-cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhC--------------CCC
Confidence            22 234467999999999999999999999999999999999999999755432222111110              001


Q ss_pred             CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          281 YGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       281 ~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ....+...+..+.+||.+||+.||.+|||+.|+++
T Consensus       235 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11233455678999999999999999999999975

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-54  Score=379.59  Aligned_cols=258  Identities=26%  Similarity=0.434  Sum_probs=206.3

Q ss_pred             HhhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      +++++|++.+.||+|+||.||+|++.+++.||||++.. .....+.+.+|+..+++++  ||||+++++++...+..++|
T Consensus         2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~-~~~~~~~~~~E~~~l~~l~--HpnIv~~~g~~~~~~~~~lv   78 (263)
T d1sm2a_           2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLS--HPKLVQLYGVCLEQAPICLV   78 (263)
T ss_dssp             BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCS-SSSCHHHHHHHHHHHHHCC--CTTBCCEEEEECSSSSCEEE
T ss_pred             CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECC-CcCcHHHHHHHHHHHHhcC--CCCcccccceeccCCceEEE
Confidence            35689999999999999999999998888999999874 3445578999999999998  99999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      |||+++++|.+++.   .....+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus        79 ~E~~~~g~L~~~l~---~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~  152 (263)
T d1sm2a_          79 FEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVL  152 (263)
T ss_dssp             EECCTTCBHHHHHH---TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC------
T ss_pred             EEecCCCcHHHHhh---ccccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheecc
Confidence            99999999999983   2346688999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhC-CCCCCccccccchhhhHhhhhccchhhHhhhhc
Q 018263          199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG-RTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD  277 (358)
Q Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      ...........||..|+|||++.+..++.++||||||+++|+|+++ .+||......                +....+.
T Consensus       153 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~----------------~~~~~i~  216 (263)
T d1sm2a_         153 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS----------------EVVEDIS  216 (263)
T ss_dssp             ------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH----------------HHHHHHH
T ss_pred             CCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH----------------HHHHHHH
Confidence            5444444456789999999999999999999999999999999995 5555433221                1111122


Q ss_pred             cccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCC
Q 018263          278 PMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGET  321 (358)
Q Consensus       278 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~  321 (358)
                      ...+...+...+..+.+++.+||+.||++|||+++|++.|+++.
T Consensus       217 ~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~  260 (263)
T d1sm2a_         217 TGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA  260 (263)
T ss_dssp             HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence            22233344556678999999999999999999999999999864

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-53  Score=377.70  Aligned_cols=252  Identities=25%  Similarity=0.349  Sum_probs=206.3

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      .++|++++.||+|+||.||+|+++ +|+.||||++.... ....+.+.+|+.++++++  ||||+++++++.+++..|+|
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~--HpnIv~~~~~~~~~~~~~iv   81 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN--HENVVKFYGHRREGNIQYLF   81 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCC--CTTBCCEEEEEEETTEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCC--CCCEeeEeeeeccCceeEEE
Confidence            468999999999999999999975 69999999987543 234467889999999998  99999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      |||++|++|.+++    .....+++..++.++.||+.||+|||++   ||+||||||+||+++.++.+||+|||++....
T Consensus        82 mEy~~gg~L~~~l----~~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~  154 (271)
T d1nvra_          82 LEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR  154 (271)
T ss_dssp             EECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECE
T ss_pred             EeccCCCcHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeec
Confidence            9999999999999    4556799999999999999999999999   99999999999999999999999999998754


Q ss_pred             CCC-cccccccccccCccCccccccCCC-CccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhh
Q 018263          199 ENT-THISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV  276 (358)
Q Consensus       199 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~-s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                      ... ........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||............              ..
T Consensus       155 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~--------------~~  220 (271)
T d1nvra_         155 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD--------------WK  220 (271)
T ss_dssp             ETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH--------------HH
T ss_pred             cCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH--------------Hh
Confidence            332 223345679999999999988775 67899999999999999999999755432221111              11


Q ss_pred             ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          277 DPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       277 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ............+..+.+|+.+||+.||.+|||++|+++
T Consensus       221 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         221 EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            111111122344567889999999999999999999865

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-53  Score=374.50  Aligned_cols=245  Identities=28%  Similarity=0.434  Sum_probs=209.7

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      ++|++.+.||+|+||.||+|+++ +|+.||+|++...   .......+.+|+..++.++  ||||+++++++.+++..++
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~--hpnIv~~~~~~~~~~~~~i   83 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR--HPNILRLYGYFHDATRVYL   83 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC--CTTBCCEEEEEECSSEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcC--CCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999986 6899999998643   3345677889999999998  9999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      ||||+++++|.+++    ...+.+++..+..++.||+.||+|||++   ||+||||||+||+++.++.+||+|||++...
T Consensus        84 vmEy~~~g~L~~~l----~~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~  156 (263)
T d2j4za1          84 ILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA  156 (263)
T ss_dssp             EEECCTTCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCC
T ss_pred             EEeecCCCcHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeec
Confidence            99999999999999    4556799999999999999999999999   9999999999999999999999999999865


Q ss_pred             CCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhc
Q 018263          198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD  277 (358)
Q Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      ....   .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.               .
T Consensus       157 ~~~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~---------------~  218 (263)
T d2j4za1         157 PSSR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS---------------R  218 (263)
T ss_dssp             CCCC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH---------------T
T ss_pred             CCCc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHH---------------c
Confidence            4322   234679999999999999999999999999999999999999997554322221111               0


Q ss_pred             cccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          278 PMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       278 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .  ...++...+.++.+|+.+||+.||.+|||++|+++
T Consensus       219 ~--~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         219 V--EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             T--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             C--CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            0  11234456678999999999999999999999986

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.5e-54  Score=382.52  Aligned_cols=264  Identities=25%  Similarity=0.383  Sum_probs=223.6

Q ss_pred             HHHHhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCe
Q 018263           36 QLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC  114 (358)
Q Consensus        36 ~~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~  114 (358)
                      .+++..++|++.+.||+|+||.||+|.++ +|+.||||++... ....+.+.+|+..+++++  ||||+++++++.+.+.
T Consensus        11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~--HpnIv~~~~~~~~~~~   87 (287)
T d1opja_          11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIK--HPNLVQLLGVCTREPP   87 (287)
T ss_dssp             TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCC--CTTBCCEEEEECSSSS
T ss_pred             ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCC--CCCEecCCccEeeCCe
Confidence            35577889999999999999999999976 5889999998644 344567899999999998  9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccc
Q 018263          115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS  194 (358)
Q Consensus       115 ~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~  194 (358)
                      .++||||+++|+|.+++..  .....+++..+..++.||+.||+|||++   ||+||||||+||+++.++.+||+|||++
T Consensus        88 ~~iv~E~~~~g~l~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a  162 (287)
T d1opja_          88 FYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLS  162 (287)
T ss_dssp             CEEEEECCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCT
T ss_pred             eEEEeecccCcchHHHhhh--ccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccce
Confidence            9999999999999999843  3456789999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhh
Q 018263          195 KLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMN  274 (358)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                      +..............++..|+|||++.+..++.++||||||+++|+|++|..||.....               ......
T Consensus       163 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~---------------~~~~~~  227 (287)
T d1opja_         163 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID---------------LSQVYE  227 (287)
T ss_dssp             TTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC---------------HHHHHH
T ss_pred             eecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch---------------HHHHHH
Confidence            87665555444556688999999999999999999999999999999997776643322               112222


Q ss_pred             hhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCC
Q 018263          275 LVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETN  322 (358)
Q Consensus       275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~  322 (358)
                      .+........+...+..+.+|+.+||+.||.+|||+.+|++.|+.+..
T Consensus       228 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         228 LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             HHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            233333445556677889999999999999999999999999988754

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-53  Score=377.21  Aligned_cols=256  Identities=23%  Similarity=0.335  Sum_probs=200.2

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEc--CCee
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID--GPCR  115 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~--~~~~  115 (358)
                      .++|++++.||+|+||.||+|+++ +|+.||+|.+...  .....+.+.+|+++++.++  ||||+++++++.+  .+..
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~--HpnIv~~~~~~~~~~~~~~   80 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK--HPNIVRYYDRIIDRTNTTL   80 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCC--CTTBCCEEEEEEC----CE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCC--CCCEeeEEEEEEeCCCCEE
Confidence            478999999999999999999975 6899999998654  3444567889999999998  9999999999865  4568


Q ss_pred             EEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCC--CCCcEEcCCCCCcEEEcCCCceEEeeccc
Q 018263          116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI--QPHVVHRDIKTSNILLDQNFNPKISDFGL  193 (358)
Q Consensus       116 ~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--~~~i~H~di~p~Nilv~~~~~~~l~Dfg~  193 (358)
                      |+||||+++|+|.+++.........+++..++.++.||+.||.|||+++  ..+|+||||||+||+++.++.+||+|||+
T Consensus        81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~  160 (269)
T d2java1          81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL  160 (269)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred             EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence            9999999999999999665556678999999999999999999999971  01399999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHh
Q 018263          194 SKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELM  273 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      +........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......              
T Consensus       161 a~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~--------------  225 (269)
T d2java1         161 ARILNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK--------------  225 (269)
T ss_dssp             HHHC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH--------------
T ss_pred             eeecccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHH--------------
Confidence            987643322 23446799999999999999999999999999999999999999975433211111              


Q ss_pred             hhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          274 NLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                        +........+...+.++.+|+.+||+.||.+|||+.|+++
T Consensus       226 --i~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         226 --IREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             --HHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --HHcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence              1111112334456678999999999999999999999975

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-53  Score=376.94  Aligned_cols=262  Identities=27%  Similarity=0.405  Sum_probs=217.2

Q ss_pred             HHHHHHhhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC
Q 018263           34 YNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP  113 (358)
Q Consensus        34 ~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~  113 (358)
                      .+++++..++|++.+.||+|+||.||+|.+++++.||||++... ....+.+.+|+..+++++  ||||+++++++.. +
T Consensus         5 ~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~--HpnIv~~~g~~~~-~   80 (272)
T d1qpca_           5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQ--HQRLVRLYAVVTQ-E   80 (272)
T ss_dssp             TCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCC--CTTBCCEEEEECS-S
T ss_pred             CCCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCC--CCCEeEEEeeecc-C
Confidence            34566778899999999999999999999988889999998743 344567999999999998  9999999998754 5


Q ss_pred             eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccc
Q 018263          114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL  193 (358)
Q Consensus       114 ~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~  193 (358)
                      ..++||||+++|+|.+++..  .....+++..+..++.||+.||.|||++   +|+||||||+||+|++++.+||+|||+
T Consensus        81 ~~~iv~Ey~~~g~L~~~~~~--~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGl  155 (272)
T d1qpca_          81 PIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGL  155 (272)
T ss_dssp             SCEEEEECCTTCBHHHHTTS--HHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             CeEEEEEeCCCCcHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccc
Confidence            67999999999999998833  3345689999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCC-CccccccchhhhHhhhhccchhhH
Q 018263          194 SKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAV-DFDVQLGEYHLVDKAWGMYNSKEL  272 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      ++..............+++.|+|||++.+..++.++||||||+++|+|++|..|+ ......                +.
T Consensus       156 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~----------------~~  219 (272)
T d1qpca_         156 ARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP----------------EV  219 (272)
T ss_dssp             CEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----------------HH
T ss_pred             eEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH----------------HH
Confidence            9877555444445567889999999999889999999999999999999965554 332211                11


Q ss_pred             hhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 018263          273 MNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE  320 (358)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~  320 (358)
                      ...+....+...+...+..+.+|+.+||+.||++|||+.+|++.|+..
T Consensus       220 ~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         220 IQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence            112222233334455677899999999999999999999999998753

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-52  Score=368.42  Aligned_cols=256  Identities=25%  Similarity=0.401  Sum_probs=218.9

Q ss_pred             hhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      ++++|++.++||+|+||.||+|++++++.||||+++... .....+.+|+..++.++  ||||+++++++.+++..++||
T Consensus         2 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~--HpnIv~~~g~~~~~~~~~iv~   78 (258)
T d1k2pa_           2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLS--HEKLVQLYGVCTKQRPIFIIT   78 (258)
T ss_dssp             CCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCC--CTTBCCEEEEECCSSSEEEEE
T ss_pred             ChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcC--CCceeeEEEEEeeCCceEEEE
Confidence            568999999999999999999999888899999987543 34568999999999998  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      ||+++|+|.+++.   .....+++..++.++.||+.||.|||++   ||+||||+|+||+++.++.+||+|||++.....
T Consensus        79 Ey~~~g~l~~~~~---~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  152 (258)
T d1k2pa_          79 EYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  152 (258)
T ss_dssp             ECCTTEEHHHHHH---SGGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSS
T ss_pred             EccCCCcHHHhhh---ccccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccC
Confidence            9999999999973   3456788999999999999999999999   999999999999999999999999999987655


Q ss_pred             CCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhHhhhhcc
Q 018263          200 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDP  278 (358)
Q Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (358)
                      ..........+|..|+|||++.+..++.++||||||+++|+|++ |+.||........                ...+..
T Consensus       153 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~----------------~~~i~~  216 (258)
T d1k2pa_         153 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET----------------AEHIAQ  216 (258)
T ss_dssp             SSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH----------------HHHHHT
T ss_pred             CCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH----------------HHHHHh
Confidence            44444445678999999999999999999999999999999998 8999975543221                111222


Q ss_pred             ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 018263          279 MLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE  320 (358)
Q Consensus       279 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~  320 (358)
                      ..+...+...+..+.+||.+||+.||++|||+++|++.|..+
T Consensus       217 ~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         217 GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             CCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence            223344556667899999999999999999999999998653

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-52  Score=373.94  Aligned_cols=248  Identities=21%  Similarity=0.328  Sum_probs=207.3

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI  116 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~  116 (358)
                      +++|++.+.||+|+||.||+|++. +|+.||||++...   .......+.+|+++++.++  ||||+++++++.+.+..|
T Consensus         7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~--HpnIv~l~~~~~~~~~~~   84 (288)
T d1uu3a_           7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD--HPFFVKLYFTFQDDEKLY   84 (288)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC--STTBCCEEEEEECSSEEE
T ss_pred             CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcC--CCCeeEEEEEEEECCEEE
Confidence            478999999999999999999975 6999999998643   2344567899999999998  999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       117 iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      +||||++|++|.+++    ...+.+++..++.++.||+.||+|||++   ||+||||||+||+++.++.++|+|||++..
T Consensus        85 ivmEy~~gg~L~~~~----~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~  157 (288)
T d1uu3a_          85 FGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKV  157 (288)
T ss_dssp             EEECCCTTEEHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEccCCCCHHHhh----hccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEeccccccee
Confidence            999999999999998    4567899999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCC-cccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhh
Q 018263          197 FPENT-THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNL  275 (358)
Q Consensus       197 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                      ..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+               
T Consensus       158 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i---------------  222 (288)
T d1uu3a_         158 LSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI---------------  222 (288)
T ss_dssp             CC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---------------
T ss_pred             cccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHH---------------
Confidence            64332 22334467999999999999999999999999999999999999999865432211111               


Q ss_pred             hccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 018263          276 VDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAI  314 (358)
Q Consensus       276 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil  314 (358)
                      ...  ...++...+.++.+||.+||+.||.+|||++|++
T Consensus       223 ~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~  259 (288)
T d1uu3a_         223 IKL--EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEME  259 (288)
T ss_dssp             HTT--CCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred             HcC--CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence            110  1123445567799999999999999999999874

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-52  Score=372.56  Aligned_cols=251  Identities=21%  Similarity=0.332  Sum_probs=209.1

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEe
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD  120 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e  120 (358)
                      +.|++++.||+|+||.||+|++. +|+.||+|++........+.+.+|++.++.++  ||||+++++++.+.+..++|||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~--HpnIv~l~~~~~~~~~~~lvmE   89 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD--HPNIVKLLDAFYYENNLWILIE   89 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCC--CTTBCCEEEEEEETTEEEEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCC--CCCCCeEEEEEeeCCeEEEEEe
Confidence            57999999999999999999975 68999999998766666778899999999998  9999999999999999999999


Q ss_pred             cCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCC
Q 018263          121 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN  200 (358)
Q Consensus       121 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~  200 (358)
                      |+++++|.+++.   ...+.+++..+..++.||+.||.|||++   ||+||||||+||+++.++.+||+|||++......
T Consensus        90 y~~~g~L~~~~~---~~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~  163 (288)
T d2jfla1          90 FCAGGAVDAVML---ELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT  163 (288)
T ss_dssp             CCTTEEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred             cCCCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCC
Confidence            999999999873   2346799999999999999999999999   9999999999999999999999999998753221


Q ss_pred             CcccccccccccCccCccccc-----cCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhh
Q 018263          201 TTHISTRVAGTLGYLAPEYAI-----SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNL  275 (358)
Q Consensus       201 ~~~~~~~~~~~~~y~aPE~~~-----~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                       ........||+.|+|||++.     +..++.++|||||||++|+|++|+.||...........+...            
T Consensus       164 -~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~------------  230 (288)
T d2jfla1         164 -IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS------------  230 (288)
T ss_dssp             -HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS------------
T ss_pred             -cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC------------
Confidence             11223467999999999984     456889999999999999999999999765443322211110            


Q ss_pred             hccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          276 VDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       276 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                        .......+...+.++.+||.+||+.||.+|||+.|+++
T Consensus       231 --~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         231 --EPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             --CCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --CCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              00011223456678999999999999999999999976

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-52  Score=372.51  Aligned_cols=263  Identities=26%  Similarity=0.414  Sum_probs=207.4

Q ss_pred             HHHhhcCCcccceecccCceEEEEEEECCCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCe
Q 018263           37 LKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC  114 (358)
Q Consensus        37 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~  114 (358)
                      +++..++|++.+.||+|+||.||+|+++.  .||||++...  .....+.+.+|+..+++++  ||||+++++++.. +.
T Consensus         3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~--HpnIv~~~~~~~~-~~   77 (276)
T d1uwha_           3 WEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR--HVNILLFMGYSTA-PQ   77 (276)
T ss_dssp             CBCCTTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCC--CTTBCCEEEEECS-SS
T ss_pred             cccccccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCC--CCCEeeeeEEEec-cE
Confidence            45667899999999999999999998753  5999998644  3455678999999999998  9999999998754 56


Q ss_pred             eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccc
Q 018263          115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS  194 (358)
Q Consensus       115 ~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~  194 (358)
                      .++||||+++++|.+++..   ....+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||++
T Consensus        78 ~~lv~Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla  151 (276)
T d1uwha_          78 LAIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLA  151 (276)
T ss_dssp             CEEEEECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCS
T ss_pred             EEEEEecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccce
Confidence            8999999999999999842   345689999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCc-ccccccccccCccCcccccc---CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchh
Q 018263          195 KLFPENTT-HISTRVAGTLGYLAPEYAIS---GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSK  270 (358)
Q Consensus       195 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      ........ .......||+.|+|||++.+   ..++.++||||||+++|+|++|+.||............  ........
T Consensus       152 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~--~~~~~~~p  229 (276)
T d1uwha_         152 TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM--VGRGYLSP  229 (276)
T ss_dssp             CC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH--HHHTSCCC
T ss_pred             eeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHH--HhcCCCCC
Confidence            87543222 23344679999999999864   35789999999999999999999999754432221111  10000000


Q ss_pred             hHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCC
Q 018263          271 ELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGET  321 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~  321 (358)
                               .....+..++..+.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus       230 ---------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~  271 (276)
T d1uwha_         230 ---------DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA  271 (276)
T ss_dssp             ---------CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---------cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence                     011223445678999999999999999999999999998765

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-52  Score=370.84  Aligned_cols=267  Identities=27%  Similarity=0.406  Sum_probs=213.2

Q ss_pred             HHHHHHhhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC
Q 018263           34 YNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP  113 (358)
Q Consensus        34 ~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~  113 (358)
                      .+++.+..++|++.+.||+|+||.||+|++++++.||||++... ....+.+.+|+..++.++  ||||+++++++. .+
T Consensus         9 ~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~--h~nIv~~~g~~~-~~   84 (285)
T d1fmka3           9 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLR--HEKLVQLYAVVS-EE   84 (285)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCC--CTTBCCEEEEEC-SS
T ss_pred             CcceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcc--cCCEeEEEEEEe-cC
Confidence            34444667899999999999999999999988888999999744 344567999999999998  999999999985 45


Q ss_pred             eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccc
Q 018263          114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL  193 (358)
Q Consensus       114 ~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~  193 (358)
                      ..++||||+++|+|..++..  ...+.+++..+..++.||+.||+|||++   ||+||||||+||+|+.++.+||+|||+
T Consensus        85 ~~~lv~Ey~~~g~l~~~~~~--~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGl  159 (285)
T d1fmka3          85 PIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGL  159 (285)
T ss_dssp             SCEEEECCCTTCBHHHHHSH--HHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred             CeEEEEEecCCCchhhhhhh--cccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccch
Confidence            68999999999999999843  2345689999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHh
Q 018263          194 SKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELM  273 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      ++..............+|+.|+|||++.+..++.++||||||+++|+|++|..|+.....               ..+..
T Consensus       160 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~---------------~~~~~  224 (285)
T d1fmka3         160 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV---------------NREVL  224 (285)
T ss_dssp             TC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC---------------HHHHH
T ss_pred             hhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC---------------HHHHH
Confidence            987654444444556789999999999999999999999999999999997666543221               11112


Q ss_pred             hhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCC
Q 018263          274 NLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNID  324 (358)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~  324 (358)
                      ..+....+...+...+..+.++|.+||+.||++|||+++|++.|+..-...
T Consensus       225 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         225 DQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             HHHHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence            222223334455666778999999999999999999999999998866543

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-52  Score=378.11  Aligned_cols=265  Identities=21%  Similarity=0.318  Sum_probs=208.4

Q ss_pred             HhhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeE
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI  116 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~  116 (358)
                      +..++|++++.||+|+||.||+|++. +|+.||+|+++.. .......+.+|+.+++.++  ||||+++++++.+.+..+
T Consensus         3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~~~~   80 (322)
T d1s9ja_           3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN--SPYIVGFYGAFYSDGEIS   80 (322)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCC--CTTBCCEEEEEECSSEEE
T ss_pred             CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCC--CCCCCcEEEEEEECCEEE
Confidence            45689999999999999999999975 6899999998755 3344567889999999998  999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcEEcCCCCCcEEEcCCCceEEeeccccc
Q 018263          117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK  195 (358)
Q Consensus       117 iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~  195 (358)
                      +||||++|++|.+++    .+.+.+++..++.++.||+.||.|||+ +   ||+||||||+||+++.++.+||+|||++.
T Consensus        81 iVmEy~~gg~L~~~l----~~~~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~  153 (322)
T d1s9ja_          81 ICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSG  153 (322)
T ss_dssp             EEEECCTTEEHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCH
T ss_pred             EEEEcCCCCcHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCcc
Confidence            999999999999999    345679999999999999999999996 6   89999999999999999999999999998


Q ss_pred             ccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhh-Hhhhhcc-------
Q 018263          196 LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLV-DKAWGMY-------  267 (358)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~-~~~~~~~-------  267 (358)
                      ....   .......||+.|+|||++.+..++.++||||+||++|+|++|+.||............ ....+..       
T Consensus       154 ~~~~---~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (322)
T d1s9ja_         154 QLID---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP  230 (322)
T ss_dssp             HHHH---HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------
T ss_pred             ccCC---CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccc
Confidence            6422   2223468999999999999999999999999999999999999999765432111000 0000000       


Q ss_pred             ------------------ch-hhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          268 ------------------NS-KELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       268 ------------------~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                                        .. ...................+.++.+|+.+||+.||.+|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             ---------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                              00 0000011110001111224567899999999999999999999987

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.7e-52  Score=371.95  Aligned_cols=259  Identities=26%  Similarity=0.444  Sum_probs=204.4

Q ss_pred             HhhcCCcccceecccCceEEEEEEEC-CC---CEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DG---TIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP  113 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~---~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~  113 (358)
                      +..++|++.+.||+|+||.||+|+++ ++   ..||||.+... .....+.+.+|+..+++++  ||||+++++++...+
T Consensus        23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--HpnIv~l~g~~~~~~  100 (299)
T d1jpaa_          23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD--HPNVIHLEGVVTKST  100 (299)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC--CTTBCCEEEEECSSS
T ss_pred             hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC--CCCCccEEEEEeeCC
Confidence            34578999999999999999999975 23   35888887654 4445578999999999998  999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccc
Q 018263          114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL  193 (358)
Q Consensus       114 ~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~  193 (358)
                      ..++||||+++++|.+++.   ...+.+++..+..++.||+.||.|||++   +++||||||+||+|+.++.+||+|||+
T Consensus       101 ~~~iv~Ey~~~g~L~~~~~---~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGl  174 (299)
T d1jpaa_         101 PVMIITEFMENGSLDSFLR---QNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGL  174 (299)
T ss_dssp             SCEEEEECCTTEEHHHHHH---TTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--
T ss_pred             EEEEEEEecCCCcceeeec---cccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCccc
Confidence            9999999999999999883   3345789999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcc----cccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccc
Q 018263          194 SKLFPENTTH----ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYN  268 (358)
Q Consensus       194 ~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~  268 (358)
                      ++........    ......+|+.|+|||.+.+..++.++|||||||++|+|++ |+.||.......             
T Consensus       175 a~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~-------------  241 (299)
T d1jpaa_         175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD-------------  241 (299)
T ss_dssp             ---------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------------
T ss_pred             ceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH-------------
Confidence            9876433221    1222457889999999999999999999999999999998 899997543321             


Q ss_pred             hhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCC
Q 018263          269 SKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGET  321 (358)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~  321 (358)
                         ....+....+...+...+..+.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus       242 ---~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l  291 (299)
T d1jpaa_         242 ---VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI  291 (299)
T ss_dssp             ---HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             ---HHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence               11122222233445567778999999999999999999999999998764

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3.6e-51  Score=374.37  Aligned_cols=252  Identities=21%  Similarity=0.289  Sum_probs=211.3

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      .++|++.+.||+|+||.||+|++. +|+.||||++........+.+.+|+.+++.++  ||||+++++++.+.+..|+||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~--HpnIv~~~~~~~~~~~~~ivm  102 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR--HPTLVNLHDAFEDDNEMVMIY  102 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTC--CTTBCCEEEEEEETTEEEEEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCC--CCCCCcEEEEEEECCEEEEEE
Confidence            468999999999999999999975 69999999998776667788999999999998  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEc--CCCceEEeeccccccc
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD--QNFNPKISDFGLSKLF  197 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~--~~~~~~l~Dfg~~~~~  197 (358)
                      ||++|++|.+++.   ...+.+++..++.++.||+.||.|||++   ||+||||||+||+++  .++.+||+|||++...
T Consensus       103 E~~~gg~L~~~l~---~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~  176 (350)
T d1koaa2         103 EFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  176 (350)
T ss_dssp             CCCCSCBHHHHHT---CTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred             EcCCCCCHHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence            9999999999983   2345799999999999999999999999   999999999999995  4678999999999876


Q ss_pred             CCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhc
Q 018263          198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD  277 (358)
Q Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      .....  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+....             
T Consensus       177 ~~~~~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~-------------  241 (350)
T d1koaa2         177 DPKQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCD-------------  241 (350)
T ss_dssp             CTTSC--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-------------
T ss_pred             ccccc--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------
Confidence            44332  334679999999999999999999999999999999999999997654332222111110             


Q ss_pred             cccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          278 PMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       278 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ...........+..+.+||.+||+.||.+|||+.|+++
T Consensus       242 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         242 WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             CCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00001111234567899999999999999999999998

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.2e-51  Score=371.27  Aligned_cols=255  Identities=20%  Similarity=0.329  Sum_probs=195.6

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      .++|++.+.||+|+||.||+|+++ +|+.||||++.... ......+.+|+.+++.++  ||||+++++++.+++..|+|
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~~~~lv   85 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK--HPNIVALDDIYESGGHLYLI   85 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCC--CTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCC--CCCCCcEEEEEEECCEEEEE
Confidence            467999999999999999999976 68999999987543 334466788999999998  99999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEc---CCCceEEeeccccc
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD---QNFNPKISDFGLSK  195 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~---~~~~~~l~Dfg~~~  195 (358)
                      |||++|++|.+++    ...+.+++..+..++.||+.||+|||++   ||+||||||+||++.   +++.+||+|||++.
T Consensus        86 mE~~~gg~L~~~l----~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~  158 (307)
T d1a06a_          86 MQLVSGGELFDRI----VEKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSK  158 (307)
T ss_dssp             ECCCCSCBHHHHH----HTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred             EeccCCCcHHHhh----hcccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeE
Confidence            9999999999999    4566799999999999999999999999   999999999999994   57889999999998


Q ss_pred             ccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhh
Q 018263          196 LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNL  275 (358)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                      ......  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+...            
T Consensus       159 ~~~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~------------  224 (307)
T d1a06a_         159 MEDPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA------------  224 (307)
T ss_dssp             ----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTT------------
T ss_pred             EccCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhcc------------
Confidence            653322  233467999999999999999999999999999999999999999754432211111100            


Q ss_pred             hccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 018263          276 VDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK--MMNG  319 (358)
Q Consensus       276 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~--~L~~  319 (358)
                       ............+.++.+||.+||+.||.+|||+.|+++  .+.+
T Consensus       225 -~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         225 -EYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG  269 (307)
T ss_dssp             -CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             -CCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence             011111223445678999999999999999999999987  3544

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-51  Score=361.27  Aligned_cols=245  Identities=24%  Similarity=0.382  Sum_probs=197.9

Q ss_pred             CcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEc----CCeeE
Q 018263           44 FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID----GPCRI  116 (358)
Q Consensus        44 y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~----~~~~~  116 (358)
                      |++.++||+|+||.||+|++. +++.||+|.+...  .....+.+.+|+++++.++  ||||+++++++..    ....+
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~--HpnIv~~~~~~~~~~~~~~~~~   88 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ--HPNIVRFYDSWESTVKGKKCIV   88 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCC--CTTBCCEEEEEEEESSSCEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCC--CCCeeeEEEEEeeccccCCEEE
Confidence            367789999999999999976 6889999998654  3445567889999999998  9999999999865    34579


Q ss_pred             EEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCC--cEEcCCCCCcEEEc-CCCceEEeeccc
Q 018263          117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH--VVHRDIKTSNILLD-QNFNPKISDFGL  193 (358)
Q Consensus       117 iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~--i~H~di~p~Nilv~-~~~~~~l~Dfg~  193 (358)
                      +||||+++++|.+++    .....+++..++.++.||+.||+|||++   +  |+||||||+||+++ .++.+||+|||+
T Consensus        89 ivmE~~~~g~L~~~l----~~~~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGl  161 (270)
T d1t4ha_          89 LVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL  161 (270)
T ss_dssp             EEEECCCSCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred             EEEeCCCCCcHHHHH----hccccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCc
Confidence            999999999999999    3456799999999999999999999998   7  99999999999996 578999999999


Q ss_pred             ccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHh
Q 018263          194 SKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELM  273 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      +......   ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||........  ....+..        
T Consensus       162 a~~~~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~--~~~~i~~--------  227 (270)
T d1t4ha_         162 ATLKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRRVTS--------  227 (270)
T ss_dssp             GGGCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHHHHTT--------
T ss_pred             ceeccCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH--HHHHHHc--------
Confidence            9864322   2345679999999998765 699999999999999999999999974432211  1111110        


Q ss_pred             hhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          274 NLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                          ......++...+.++.+||.+||+.||++|||+.|+++
T Consensus       228 ----~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         228 ----GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             ----TCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ----CCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence                00011122234456889999999999999999999986

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=4.7e-51  Score=373.86  Aligned_cols=257  Identities=20%  Similarity=0.288  Sum_probs=214.4

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      .++|++++.||+|+||.||+|++. +|+.||||++..........+.+|+.+++.++  ||||+++++++.+++..|+||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~--HpnIv~~~~~~~~~~~~~ivm  105 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH--HPKLINLHDAFEDKYEMVLIL  105 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCC--STTBCCEEEEEECSSEEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCC--CCCCCcEEEEEEECCEEEEEE
Confidence            357999999999999999999975 69999999998776666778889999999998  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEc--CCCceEEeeccccccc
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD--QNFNPKISDFGLSKLF  197 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~--~~~~~~l~Dfg~~~~~  197 (358)
                      ||++|++|.+.+.   .....+++..++.++.||+.||.|||++   ||+||||||+|||++  .++.+||+|||++...
T Consensus       106 E~~~gg~L~~~~~---~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~  179 (352)
T d1koba_         106 EFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL  179 (352)
T ss_dssp             ECCCCCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred             EcCCCChHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceec
Confidence            9999999998872   2345699999999999999999999999   999999999999997  6789999999999876


Q ss_pred             CCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhc
Q 018263          198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD  277 (358)
Q Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      ....  ......+++.|+|||++.+..++.++|||||||++|+|++|+.||...........+...             .
T Consensus       180 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~-------------~  244 (352)
T d1koba_         180 NPDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC-------------D  244 (352)
T ss_dssp             CTTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC-------------C
T ss_pred             CCCC--ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------C
Confidence            5432  234467899999999999999999999999999999999999999765433222211110             0


Q ss_pred             cccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhhcC
Q 018263          278 PMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK--MMNGE  320 (358)
Q Consensus       278 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~--~L~~~  320 (358)
                      ...........+..+.+||.+||+.||.+|||+.|+++  .+++.
T Consensus       245 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         245 WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence            11112223345677899999999999999999999987  35443

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-51  Score=363.58  Aligned_cols=257  Identities=26%  Similarity=0.376  Sum_probs=212.5

Q ss_pred             hhcCCcccc-eecccCceEEEEEEEC---CCCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCe
Q 018263           40 ATNGFRWSN-KIGEGGFGSVYKGRLQ---DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC  114 (358)
Q Consensus        40 ~~~~y~i~~-~lg~g~~g~v~~~~~~---~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~  114 (358)
                      ..++|.+.+ +||+|+||.||+|.++   ++..||||++... .....+.+.+|+..+++++  ||||+++++++.. +.
T Consensus         6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~--HpnIv~l~g~~~~-~~   82 (285)
T d1u59a_           6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD--NPYIVRLIGVCQA-EA   82 (285)
T ss_dssp             CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCC--CTTBCCEEEEEES-SS
T ss_pred             cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCC--CCCEeeEeeeecc-Ce
Confidence            456788888 4999999999999864   3557999998654 3445678999999999998  9999999999875 46


Q ss_pred             eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccc
Q 018263          115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS  194 (358)
Q Consensus       115 ~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~  194 (358)
                      .++||||+++|+|.+++.   ..+..+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||++
T Consensus        83 ~~lvmE~~~~g~L~~~l~---~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla  156 (285)
T d1u59a_          83 LMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLS  156 (285)
T ss_dssp             EEEEEECCTTEEHHHHHT---TCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred             EEEEEEeCCCCcHHHHhh---ccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhh
Confidence            899999999999999873   3456799999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcc--cccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhh
Q 018263          195 KLFPENTTH--ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKE  271 (358)
Q Consensus       195 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      .........  ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.......                
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~----------------  220 (285)
T d1u59a_         157 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE----------------  220 (285)
T ss_dssp             EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH----------------
T ss_pred             hcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH----------------
Confidence            876543322  2223568899999999999999999999999999999998 899997543221                


Q ss_pred             HhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCC
Q 018263          272 LMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGET  321 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~  321 (358)
                      ....+....+...+...+.++.+||.+||+.||++|||+.+|++.|+...
T Consensus       221 ~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~  270 (285)
T d1u59a_         221 VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  270 (285)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            12222223334455667788999999999999999999999999987654

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-51  Score=373.70  Aligned_cols=263  Identities=23%  Similarity=0.366  Sum_probs=212.2

Q ss_pred             HHHhhcCCcccceecccCceEEEEEEECC------CCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceE
Q 018263           37 LKIATNGFRWSNKIGEGGFGSVYKGRLQD------GTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGC  109 (358)
Q Consensus        37 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~~------~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~  109 (358)
                      +.+..++|++.+.||+|+||.||+|++..      ...||+|.+... .......+.+|+..+.++. .||||+++++++
T Consensus        32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-~HpnIv~l~~~~  110 (325)
T d1rjba_          32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG-SHENIVNLLGAC  110 (325)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHC-CCTTBCCEEEEE
T ss_pred             ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhc-CCCcEeEEEEEE
Confidence            44667899999999999999999998642      236899988643 3344467889999999883 399999999999


Q ss_pred             EcCCeeEEEEecCCCCCHHHHhhhccc-------------------cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEE
Q 018263          110 IDGPCRILVYDYMPNNSLSQTLLGEEK-------------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVH  170 (358)
Q Consensus       110 ~~~~~~~iv~e~~~~~~L~~~l~~~~~-------------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H  170 (358)
                      .+.+..++||||+++|+|.+++.....                   ....+++..++.++.||+.||+|||++   +|+|
T Consensus       111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiH  187 (325)
T d1rjba_         111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVH  187 (325)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred             eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceee
Confidence            999999999999999999999954321                   124589999999999999999999999   9999


Q ss_pred             cCCCCCcEEEcCCCceEEeecccccccCCCCc-ccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCC
Q 018263          171 RDIKTSNILLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAV  248 (358)
Q Consensus       171 ~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf  248 (358)
                      |||||+||+++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||
T Consensus       188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf  267 (325)
T d1rjba_         188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY  267 (325)
T ss_dssp             TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             ccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCC
Confidence            99999999999999999999999986543332 22334668999999999999999999999999999999997 89999


Q ss_pred             CccccccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 018263          249 DFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMN  318 (358)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~  318 (358)
                      ........               +..++....+...+...+..+.+||.+||+.||++|||++||++.|.
T Consensus       268 ~~~~~~~~---------------~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         268 PGIPVDAN---------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             TTCCCSHH---------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCHHHH---------------HHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            75443221               22222233334455566778999999999999999999999999985

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.7e-51  Score=366.14  Aligned_cols=245  Identities=23%  Similarity=0.349  Sum_probs=203.5

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      +.|+++++||+|+||.||+|++. +|+.||||++....   ....+.+.+|+.++++++  ||||+++++++.+++..++
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~~~~~~~~~~~~~i   92 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR--HPNTIQYRGCYLREHTAWL   92 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCC--CTTBCCEEEEEEETTEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCC--CCCEeeEEEEEEECCEEEE
Confidence            35999999999999999999975 68899999987543   334467889999999998  9999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      ||||+++++|..++    ...+.+++..++.++.||+.||.|||++   ||+||||||+||+++.++.+||+|||++...
T Consensus        93 v~E~~~~g~l~~~~----~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~  165 (309)
T d1u5ra_          93 VMEYCLGSASDLLE----VHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM  165 (309)
T ss_dssp             EEECCSEEHHHHHH----HHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred             EEEecCCCchHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeeccccccc
Confidence            99999999887766    3456799999999999999999999999   9999999999999999999999999999864


Q ss_pred             CCCCcccccccccccCccCcccccc---CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhh
Q 018263          198 PENTTHISTRVAGTLGYLAPEYAIS---GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMN  274 (358)
Q Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~~---~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                      ..     .....||+.|+|||++.+   ..++.++|||||||++|+|++|+.||...........+              
T Consensus       166 ~~-----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i--------------  226 (309)
T d1u5ra_         166 AP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--------------  226 (309)
T ss_dssp             SS-----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--------------
T ss_pred             CC-----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHH--------------
Confidence            32     234579999999999864   45889999999999999999999999754332211111              


Q ss_pred             hhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          275 LVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                       .........+...+..+.+||.+||+.||.+|||+.|+++
T Consensus       227 -~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         227 -AQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             -HHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -HhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence             1111111122345667999999999999999999999986

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-51  Score=363.59  Aligned_cols=261  Identities=25%  Similarity=0.450  Sum_probs=208.1

Q ss_pred             HhhcCCcccceecccCceEEEEEEECCC-----CEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC
Q 018263           39 IATNGFRWSNKIGEGGFGSVYKGRLQDG-----TIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG  112 (358)
Q Consensus        39 ~~~~~y~i~~~lg~g~~g~v~~~~~~~~-----~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~  112 (358)
                      +.++.|++.+.||+|+||.||+|.++.+     ..||||.+... .......+.+|+.++.+++  ||||+++++++...
T Consensus         4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~--H~nIv~~~g~~~~~   81 (283)
T d1mqba_           4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS--HHNIIRLEGVISKY   81 (283)
T ss_dssp             CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCC--CTTBCCEEEEECSS
T ss_pred             CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcC--CCCEeeeeEEEecC
Confidence            4567899999999999999999986532     36999998654 3344567889999999998  99999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecc
Q 018263          113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG  192 (358)
Q Consensus       113 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg  192 (358)
                      +..++||||+.++++.+.+.   .....+++..+..++.||+.||+|||++   +|+||||||+||+|+.++.+||+|||
T Consensus        82 ~~~~~v~e~~~~~~l~~~~~---~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG  155 (283)
T d1mqba_          82 KPMMIITEYMENGALDKFLR---EKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFG  155 (283)
T ss_dssp             SSEEEEEECCTTEEHHHHHH---HTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred             CceEEEEEecccCcchhhhh---cccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccc
Confidence            99999999999999998873   3446799999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCc--ccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchh
Q 018263          193 LSKLFPENTT--HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSK  270 (358)
Q Consensus       193 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      +++.......  .......||+.|+|||++.+..++.++||||||+++|+|++|..|+.....               ..
T Consensus       156 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~---------------~~  220 (283)
T d1mqba_         156 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS---------------NH  220 (283)
T ss_dssp             C-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---------------HH
T ss_pred             hhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC---------------HH
Confidence            9987543222  122235688999999999999999999999999999999997666543221               11


Q ss_pred             hHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCC
Q 018263          271 ELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETN  322 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~  322 (358)
                      +....+....+...+...+..+.+||.+||+.||++|||+.||++.|+++..
T Consensus       221 ~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         221 EVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             HHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence            2222233334445556677889999999999999999999999999987654

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-50  Score=360.94  Aligned_cols=251  Identities=21%  Similarity=0.273  Sum_probs=207.7

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC------hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES------KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP  113 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~------~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~  113 (358)
                      .++|++.+.||+|+||.||+|+++ +|+.||||++....      ....+.+.+|+.+++.++  ||||+++++++.+.+
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~--HpnIv~~~~~~~~~~   86 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ--HPNVITLHEVYENKT   86 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC--CTTBCCEEEEEECSS
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCC--CCCCCcEEEEEEECC
Confidence            478999999999999999999975 69999999986432      224578899999999998  999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCC----ceEEe
Q 018263          114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF----NPKIS  189 (358)
Q Consensus       114 ~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~----~~~l~  189 (358)
                      ..++||||++|++|.+++    ...+.+++..++.++.||+.||+|||++   +|+||||||+||+++.++    .+|++
T Consensus        87 ~~~iv~E~~~gg~L~~~i----~~~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~  159 (293)
T d1jksa_          87 DVILILELVAGGELFDFL----AEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKII  159 (293)
T ss_dssp             EEEEEEECCCSCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEEC
T ss_pred             EEEEEEEcCCCccccchh----ccccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEec
Confidence            999999999999999999    4456799999999999999999999999   999999999999998776    49999


Q ss_pred             ecccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccch
Q 018263          190 DFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNS  269 (358)
Q Consensus       190 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      |||++.......  ......+++.|+|||++.+..++.++|||||||++|+|++|+.||...........+......   
T Consensus       160 DfG~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~---  234 (293)
T d1jksa_         160 DFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE---  234 (293)
T ss_dssp             CCTTCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCC---
T ss_pred             chhhhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC---
Confidence            999998754332  233457899999999999989999999999999999999999999865433222211111000   


Q ss_pred             hhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          270 KELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                                .....+...+..+.+||.+||+.||.+|||++|+++
T Consensus       235 ----------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         235 ----------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             ----------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ----------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                      000011234567889999999999999999999986

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-50  Score=366.50  Aligned_cols=249  Identities=26%  Similarity=0.312  Sum_probs=211.2

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCee
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR  115 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~  115 (358)
                      .-++|++++.||+|+||.||+|+.+ +|+.||||++...   .......+.+|+.+++.++  ||||+++++++.+.+..
T Consensus         3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~--hp~Iv~l~~~~~~~~~~   80 (337)
T d1o6la_           3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR--HPFLTALKYAFQTHDRL   80 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC--CTTBCCEEEEEECSSEE
T ss_pred             chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCC--CCCEEEEEeeecccccc
Confidence            3568999999999999999999975 7999999999743   2345577889999999998  99999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccc
Q 018263          116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK  195 (358)
Q Consensus       116 ~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~  195 (358)
                      |+||||++||+|.+++    ...+.+++..++.++.||+.||+|||++   ||+||||||+||+++.+|.+||+|||++.
T Consensus        81 ~iv~ey~~gg~L~~~~----~~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~  153 (337)
T d1o6la_          81 CFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK  153 (337)
T ss_dssp             EEEEECCTTCBHHHHH----HHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             ccceeccCCCchhhhh----hcccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccc
Confidence            9999999999999998    4567799999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhh
Q 018263          196 LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNL  275 (358)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                      ....... .....+||+.|+|||++.+..++.++|||||||++|+|++|++||...+.......+..             
T Consensus       154 ~~~~~~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~-------------  219 (337)
T d1o6la_         154 EGISDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-------------  219 (337)
T ss_dssp             CSCCTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------------
T ss_pred             ccccCCc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhc-------------
Confidence            6543222 23446799999999999999999999999999999999999999986553222111110             


Q ss_pred             hccccCCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 018263          276 VDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQ-----MSTAIK  315 (358)
Q Consensus       276 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt-----~~eil~  315 (358)
                          ....++...+.++.+||.+||+.||.+||+     ++|+++
T Consensus       220 ----~~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         220 ----EEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ----CCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ----CCCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence                012344556778899999999999999995     778775

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-50  Score=358.63  Aligned_cols=246  Identities=27%  Similarity=0.384  Sum_probs=201.8

Q ss_pred             ceecccCceEEEEEEEC---CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecC
Q 018263           48 NKIGEGGFGSVYKGRLQ---DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM  122 (358)
Q Consensus        48 ~~lg~g~~g~v~~~~~~---~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~  122 (358)
                      ++||+|+||.||+|.++   .++.||||++...  +....+.+.+|+.++++++  ||||+++++++..+ ..++||||+
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~--HpnIv~~~g~~~~~-~~~lvmE~~   89 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD--NPYIVRMIGICEAE-SWMLVMEMA   89 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCC--CTTBCCEEEEEESS-SEEEEEECC
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCC--CCCCceEEEEeccC-CEEEEEEcC
Confidence            46999999999999854   3568999998643  3334567999999999998  99999999998654 578999999


Q ss_pred             CCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCCCc
Q 018263          123 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT  202 (358)
Q Consensus       123 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~  202 (358)
                      ++|+|.+++    .....+++..+..++.||+.||+|||++   +|+||||||+||+++.++.++|+|||+++.......
T Consensus        90 ~~g~L~~~l----~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~  162 (277)
T d1xbba_          90 ELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN  162 (277)
T ss_dssp             TTEEHHHHH----HHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred             CCCcHHHHH----hhccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence            999999998    4556799999999999999999999999   999999999999999999999999999987643332


Q ss_pred             c--cccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhHhhhhccc
Q 018263          203 H--ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDPM  279 (358)
Q Consensus       203 ~--~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (358)
                      .  ......||+.|+|||++.+..++.++||||||+++|+|++ |+.||......                +....+...
T Consensus       163 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~----------------~~~~~i~~~  226 (277)
T d1xbba_         163 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS----------------EVTAMLEKG  226 (277)
T ss_dssp             EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----------------HHHHHHHTT
T ss_pred             ccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH----------------HHHHHHHcC
Confidence            2  2233568899999999999999999999999999999998 89999754321                122222222


Q ss_pred             cCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 018263          280 LYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNG  319 (358)
Q Consensus       280 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~  319 (358)
                      .+...+...+..+.+|+.+||+.||.+|||+.+|++.|+.
T Consensus       227 ~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         227 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence            3344556677889999999999999999999999998875

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-51  Score=361.65  Aligned_cols=259  Identities=24%  Similarity=0.300  Sum_probs=203.1

Q ss_pred             HHhhcCCcccceecccCceEEEEEEECC----CCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC
Q 018263           38 KIATNGFRWSNKIGEGGFGSVYKGRLQD----GTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG  112 (358)
Q Consensus        38 ~~~~~~y~i~~~lg~g~~g~v~~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~  112 (358)
                      ++..++|++.+.||+|+||.||+|++..    +..||||.+... .......+.+|+..++.++  ||||+++++++. .
T Consensus         3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~--HpnIv~l~~~~~-~   79 (273)
T d1mp8a_           3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD--HPHIVKLIGVIT-E   79 (273)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCC--CTTBCCEEEEEC-S
T ss_pred             CcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCC--CCCEeeEEEEEe-c
Confidence            3557899999999999999999998642    356888888643 3445577999999999998  999999999986 4


Q ss_pred             CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecc
Q 018263          113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG  192 (358)
Q Consensus       113 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg  192 (358)
                      +..++||||+++++|.+++.   .....+++..++.++.||+.||.|||++   +++||||||+||+++.++.+||+|||
T Consensus        80 ~~~~iv~E~~~~g~l~~~~~---~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG  153 (273)
T d1mp8a_          80 NPVWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFG  153 (273)
T ss_dssp             SSCEEEEECCTTEEHHHHHH---HTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC--
T ss_pred             CeEEEEEEeccCCcHHhhhh---ccCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccch
Confidence            67899999999999999873   3456789999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhh
Q 018263          193 LSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKE  271 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      ++...............+|+.|+|||++.+..++.++||||||+++|+|++ |.+||...........+           
T Consensus       154 ~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i-----------  222 (273)
T d1mp8a_         154 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-----------  222 (273)
T ss_dssp             -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-----------
T ss_pred             hheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHH-----------
Confidence            998765444444455678899999999999999999999999999999998 89999765443222111           


Q ss_pred             HhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCC
Q 018263          272 LMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGET  321 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~  321 (358)
                           ........+...+..+.+||.+||+.||.+|||+.||++.|+.+.
T Consensus       223 -----~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~  267 (273)
T d1mp8a_         223 -----ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  267 (273)
T ss_dssp             -----HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----HcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence                 111222345566778999999999999999999999999998753

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=7e-50  Score=361.17  Aligned_cols=245  Identities=24%  Similarity=0.377  Sum_probs=208.5

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI  116 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~  116 (358)
                      .++|++++.||+|+||.||+|+++ +|+.||||++...   .....+.+.+|+.+++.++  ||||+++++++.+.+..|
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~--HpnIv~~~~~~~~~~~~~   80 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT--HPFIIRMWGTFQDAQQIF   80 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC--BTTBCCEEEEEECSSEEE
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhcc--CcChhheeeeEeeCCeee
Confidence            367999999999999999999975 6999999998643   2344577889999999998  999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       117 iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      +||||++|++|..++    .....+++..++.++.||+.||+|||++   ||+||||||+||+++.+|.+||+|||++..
T Consensus        81 ivmE~~~gg~l~~~~----~~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~  153 (316)
T d1fota_          81 MIMDYIEGGELFSLL----RKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKY  153 (316)
T ss_dssp             EEECCCCSCBHHHHH----HHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             eEeeecCCccccccc----cccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceE
Confidence            999999999999998    5667788999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhh
Q 018263          197 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV  276 (358)
Q Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                      ....    .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+               .
T Consensus       154 ~~~~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i---------------~  214 (316)
T d1fota_         154 VPDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI---------------L  214 (316)
T ss_dssp             CSSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH---------------H
T ss_pred             eccc----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHH---------------H
Confidence            5432    23467999999999999999999999999999999999999999755432211111               1


Q ss_pred             ccccCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 018263          277 DPMLYGNFPENEAIRFLKVGLLCVQEKSKLRP-----QMSTAIK  315 (358)
Q Consensus       277 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp-----t~~eil~  315 (358)
                      ..  ...++...+.++.+++.+||+.||.+|+     |++++++
T Consensus       215 ~~--~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         215 NA--ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             HC--CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             cC--CCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence            11  1123445567799999999999999996     8999876

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3.7e-50  Score=357.31  Aligned_cols=259  Identities=22%  Similarity=0.299  Sum_probs=204.2

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC---
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP---  113 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~---  113 (358)
                      .++|++.+.||+|+||.||+|++. +|+.||||++...   +......+.+|+..++.++  ||||+++++++...+   
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~--hpniv~~~~~~~~~~~~~   83 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN--HPAIVAVYDTGEAETPAG   83 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCC--CTTBCCEEEEEEEECSSS
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcC--CCCCCcccceeeeccCCC
Confidence            578999999999999999999975 7999999999654   2344567889999999998  999999999988654   


Q ss_pred             -eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecc
Q 018263          114 -CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG  192 (358)
Q Consensus       114 -~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg  192 (358)
                       ..|+||||++|++|.+.+    ...+.+++..++.++.||+.||+|||++   ||+||||||+||+++.++..+++|||
T Consensus        84 ~~~~lvmE~~~g~~L~~~~----~~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~  156 (277)
T d1o6ya_          84 PLPYIVMEYVDGVTLRDIV----HTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFG  156 (277)
T ss_dssp             EEEEEEEECCCEEEHHHHH----HHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCT
T ss_pred             ceEEEEEECCCCCEehhhh----cccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhh
Confidence             378999999999999988    4556799999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCC--cccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchh
Q 018263          193 LSKLFPENT--THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSK  270 (358)
Q Consensus       193 ~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      .+.......  ........||+.|+|||++.+..++.++|||||||++|+|++|++||..............  ..    
T Consensus       157 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~--~~----  230 (277)
T d1o6ya_         157 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR--ED----  230 (277)
T ss_dssp             TCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH--CC----
T ss_pred             hhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHh--cC----
Confidence            887543222  2233346799999999999999999999999999999999999999976543222111100  00    


Q ss_pred             hHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHhhcCC
Q 018263          271 ELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRP-QMSTAIKMMNGET  321 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp-t~~eil~~L~~~~  321 (358)
                             +..........+..+.++|.+||+.||.+|| |++++++.|.++.
T Consensus       231 -------~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         231 -------PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             -------CCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             -------CCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence                   0000111223456799999999999999999 8999999988764

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-50  Score=356.04  Aligned_cols=254  Identities=26%  Similarity=0.404  Sum_probs=205.4

Q ss_pred             HHhhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEc-CCeeE
Q 018263           38 KIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID-GPCRI  116 (358)
Q Consensus        38 ~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~-~~~~~  116 (358)
                      .+..++|++.+.||+|+||.||+|+++ |+.||||+++.+  ...+.+.+|+..+++++  ||||+++++++.+ .+..+
T Consensus         3 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~--HpnIv~~~g~~~~~~~~~~   77 (262)
T d1byga_           3 ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLR--HSNLVQLLGVIVEEKGGLY   77 (262)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCC--CTTBCCEEEEECCC--CCE
T ss_pred             ccCHHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCC--CCCEeeEEEEEEecCCcEE
Confidence            345678999999999999999999996 788999998643  34567899999999998  9999999998865 45689


Q ss_pred             EEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       117 iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      +||||+++|+|.+++..  .....+++..+..++.||+.||+|||++   +++||||+|+||+++.++.++++|||++..
T Consensus        78 lv~ey~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~  152 (262)
T d1byga_          78 IVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKE  152 (262)
T ss_dssp             EEECCCTTEEHHHHHHH--HHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred             EEEeccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeeccccccee
Confidence            99999999999999943  2334589999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhHhhh
Q 018263          197 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELMNL  275 (358)
Q Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                      ....    .....++..|+|||++.+..++.++||||||+++|+|++ |++||......                ++...
T Consensus       153 ~~~~----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~----------------~~~~~  212 (262)
T d1byga_         153 ASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----------------DVVPR  212 (262)
T ss_dssp             -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG----------------GHHHH
T ss_pred             cCCC----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH----------------HHHHH
Confidence            4322    223457889999999999999999999999999999998 68887644322                22222


Q ss_pred             hccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCC
Q 018263          276 VDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGET  321 (358)
Q Consensus       276 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~  321 (358)
                      +....+..++...+..+.+||.+||+.||.+|||+.++++.|+.++
T Consensus       213 i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~  258 (262)
T d1byga_         213 VEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  258 (262)
T ss_dssp             HTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            3333445556667788999999999999999999999999998765

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.8e-49  Score=351.88  Aligned_cols=252  Identities=22%  Similarity=0.294  Sum_probs=208.1

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC---------hhhHHHHHHHHHHhhhcccCCCCceeeeceEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---------KQGEKEFMSEVASMANVNVCHENLVKLHGGCI  110 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---------~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~  110 (358)
                      .++|++.+.||+|+||+||+|++. +|+.||||++....         ....+.+.+|+..++++. .||||+++++++.
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~hpnIv~~~~~~~   80 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS-GHPNIIQLKDTYE   80 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHT-TCTTBCCEEEEEE
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhc-CCCCeEEEEeecc
Confidence            479999999999999999999975 68999999986542         122346788999999986 4999999999999


Q ss_pred             cCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEee
Q 018263          111 DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD  190 (358)
Q Consensus       111 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~D  190 (358)
                      +++..|+||||+++++|.+++    ..++.+++..++.++.||+.||+|||++   ||+||||||+||+++.++.+||+|
T Consensus        81 ~~~~~~ivmE~~~~g~L~~~l----~~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~D  153 (277)
T d1phka_          81 TNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTD  153 (277)
T ss_dssp             CSSEEEEEEECCTTCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred             cCcceEEEEEcCCCchHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEcc
Confidence            999999999999999999999    4566899999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccCccCcccccc------CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhh
Q 018263          191 FGLSKLFPENTTHISTRVAGTLGYLAPEYAIS------GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAW  264 (358)
Q Consensus       191 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~  264 (358)
                      ||++.......  ......||..|.|||++.+      ..++.++||||+||++|+|++|+.||...........+... 
T Consensus       154 FG~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~-  230 (277)
T d1phka_         154 FGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG-  230 (277)
T ss_dssp             CTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-
T ss_pred             chheeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhC-
Confidence            99998765432  2344679999999999863      34688999999999999999999999865433222111110 


Q ss_pred             hccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          265 GMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                                  ............++.+.+|+.+||+.||++|||++|+++
T Consensus       231 ------------~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         231 ------------NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             ------------CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ------------CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                        000111222356678999999999999999999999875

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-49  Score=357.76  Aligned_cols=271  Identities=22%  Similarity=0.327  Sum_probs=209.6

Q ss_pred             cCHHHHHHhhcCCcccceecccCceEEEEEEEC------CCCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCcee
Q 018263           32 FSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVK  104 (358)
Q Consensus        32 ~~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~  104 (358)
                      +..+.+.+..++|++.+.||+|+||.||+|.+.      +++.||||++... .......+..|...+.++. .|+||+.
T Consensus         3 ~~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~-~h~~iv~   81 (299)
T d1ywna1           3 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG-HHLNVVN   81 (299)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHC-CCTTBCC
T ss_pred             CCCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhc-CCCeEEE
Confidence            566777788899999999999999999999853      3468999998654 3344566777888887775 4899999


Q ss_pred             eeceEEcC-CeeEEEEecCCCCCHHHHhhhccc------------cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEc
Q 018263          105 LHGGCIDG-PCRILVYDYMPNNSLSQTLLGEEK------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHR  171 (358)
Q Consensus       105 ~~~~~~~~-~~~~iv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~  171 (358)
                      +++++... ...++||||+++|+|.+++.....            ....+++..+..++.||+.||+|||++   +|+||
T Consensus        82 ~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHr  158 (299)
T d1ywna1          82 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR  158 (299)
T ss_dssp             EEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred             eeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCC
Confidence            99987654 468999999999999999964322            234589999999999999999999999   99999


Q ss_pred             CCCCCcEEEcCCCceEEeecccccccCCCCc-ccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCC-CCCC
Q 018263          172 DIKTSNILLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR-TAVD  249 (358)
Q Consensus       172 di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~-~pf~  249 (358)
                      ||||+||+++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|+|++|. +||.
T Consensus       159 DlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~  238 (299)
T d1ywna1         159 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  238 (299)
T ss_dssp             CCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             cCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCC
Confidence            9999999999999999999999986543332 2333467999999999999999999999999999999999874 5776


Q ss_pred             ccccccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCC
Q 018263          250 FDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGET  321 (358)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~  321 (358)
                      .......               +...+....+...+...+.++.+++.+||+.||++|||+.||++.|+++.
T Consensus       239 ~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il  295 (299)
T d1ywna1         239 GVKIDEE---------------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  295 (299)
T ss_dssp             TCCCSHH---------------HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCHHHH---------------HHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            4432211               11222222233444556678999999999999999999999999998763

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.1e-49  Score=362.89  Aligned_cols=244  Identities=23%  Similarity=0.315  Sum_probs=207.7

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~i  117 (358)
                      ++|++++.||+|+||.||+|+++ +|+.||||++...   .......+.+|+.+++.++  ||||+++++++......++
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~--hpnIv~~~~~~~~~~~~~~  118 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN--FPFLVKLEFSFKDNSNLYM  118 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC--CTTBCCEEEEEECSSEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcC--CCcEeeccccccccccccc
Confidence            58999999999999999999975 6999999998643   2334567889999999998  9999999999999999999


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF  197 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~  197 (358)
                      ||||+.|++|...+    ...+.+++..++.++.||+.||.|||++   ||+||||||+||+++.+|.+||+|||++...
T Consensus       119 v~e~~~~g~l~~~l----~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~  191 (350)
T d1rdqe_         119 VMEYVAGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV  191 (350)
T ss_dssp             EEECCTTCBHHHHH----HHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             ccccccccchhhhH----hhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeec
Confidence            99999999999999    4456799999999999999999999999   9999999999999999999999999999875


Q ss_pred             CCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhc
Q 018263          198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD  277 (358)
Q Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      ...    .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+   .            .
T Consensus       192 ~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i---~------------~  252 (350)
T d1rdqe_         192 KGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI---V------------S  252 (350)
T ss_dssp             SSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---H------------H
T ss_pred             ccc----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHH---h------------c
Confidence            432    23467999999999999999999999999999999999999999755432211111   1            0


Q ss_pred             cccCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 018263          278 PMLYGNFPENEAIRFLKVGLLCVQEKSKLRP-----QMSTAIK  315 (358)
Q Consensus       278 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp-----t~~eil~  315 (358)
                      .  ....+...+.++.+||.+||+.||.+|+     |++++++
T Consensus       253 ~--~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         253 G--KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             C--CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             C--CCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence            0  1123345667899999999999999994     8999886

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-49  Score=354.90  Aligned_cols=264  Identities=22%  Similarity=0.298  Sum_probs=205.6

Q ss_pred             ccceecccCceEEEEEEEC-CCCEEEEEEeeccChh-----hHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           46 WSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQ-----GEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        46 i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~-----~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      .++.||+|+||+||+|+++ +|+.||||++......     ....+.+|+.+++.++  ||||+++++++..++..++||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~~~~~~~~~~~~~ivm   79 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS--HPNIIGLLDAFGHKSNISLVF   79 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC--CTTBCCEEEEECCTTCCEEEE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCC--CCCEeEEEeeeccCCceeehh
Confidence            4678999999999999975 6999999998654322     1246889999999998  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      ||+.++++..+.    .....+++..++.++.||+.||+|||++   ||+||||||+||+++.++.+||+|||++.....
T Consensus        80 E~~~~~~~~~~~----~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~  152 (299)
T d1ua2a_          80 DFMETDLEVIIK----DNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS  152 (299)
T ss_dssp             ECCSEEHHHHHT----TCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred             hhhcchHHhhhh----hcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCC
Confidence            999888777666    4567799999999999999999999999   999999999999999999999999999987544


Q ss_pred             CCcccccccccccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhcc
Q 018263          200 NTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVDP  278 (358)
Q Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (358)
                      .... .....+|+.|+|||++.+. .++.++|||||||++|+|++|.+||......+....+....+.+....+......
T Consensus       153 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~  231 (299)
T d1ua2a_         153 PNRA-YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL  231 (299)
T ss_dssp             CCCC-CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred             Cccc-ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhcc
Confidence            3322 2345789999999988754 6799999999999999999999999877665555444443333222221111110


Q ss_pred             cc------CCCCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 018263          279 ML------YGNFP-----ENEAIRFLKVGLLCVQEKSKLRPQMSTAIK--MMNG  319 (358)
Q Consensus       279 ~~------~~~~~-----~~~~~~l~~li~~~l~~~P~~Rpt~~eil~--~L~~  319 (358)
                      ..      ....+     ...+.++.+|+.+||+.||++|||++|+++  .|+.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~  285 (299)
T d1ua2a_         232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN  285 (299)
T ss_dssp             TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred             chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence            00      00111     123567999999999999999999999986  4543

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-49  Score=357.78  Aligned_cols=265  Identities=29%  Similarity=0.411  Sum_probs=215.2

Q ss_pred             HHHhhcCCcccceecccCceEEEEEEEC------CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceE
Q 018263           37 LKIATNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGC  109 (358)
Q Consensus        37 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~  109 (358)
                      +....++|++.+.||+|+||.||+|+++      +++.||||++.... ....+.+.+|+.+++.++  ||||+++++++
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~--h~niv~~~~~~   85 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD--NPNIVKLLGVC   85 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCC--CTTBCCEEEEE
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcC--CCCcccceeee
Confidence            3345678999999999999999999864      35789999987543 334577999999999998  99999999999


Q ss_pred             EcCCeeEEEEecCCCCCHHHHhhhccc--------------------cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcE
Q 018263          110 IDGPCRILVYDYMPNNSLSQTLLGEEK--------------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVV  169 (358)
Q Consensus       110 ~~~~~~~iv~e~~~~~~L~~~l~~~~~--------------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~  169 (358)
                      ...+..+++|||+++++|.+++.....                    ....+++..+..++.||+.||+|||++   +++
T Consensus        86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iv  162 (301)
T d1lufa_          86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV  162 (301)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeE
Confidence            999999999999999999999854221                    123588999999999999999999999   999


Q ss_pred             EcCCCCCcEEEcCCCceEEeecccccccCCCCc-ccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCC-CC
Q 018263          170 HRDIKTSNILLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR-TA  247 (358)
Q Consensus       170 H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~-~p  247 (358)
                      ||||||+||+++.++.+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++|. +|
T Consensus       163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p  242 (301)
T d1lufa_         163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP  242 (301)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence            999999999999999999999999976533222 2233456889999999999999999999999999999999985 56


Q ss_pred             CCccccccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCC
Q 018263          248 VDFDVQLGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETN  322 (358)
Q Consensus       248 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~  322 (358)
                      |........                ...+........+...+.++.+|+.+||+.+|++||||.||++.|+++.+
T Consensus       243 ~~~~~~~e~----------------~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~  301 (301)
T d1lufa_         243 YYGMAHEEV----------------IYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  301 (301)
T ss_dssp             TTTSCHHHH----------------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             CCCCCHHHH----------------HHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            764432211                11122222233455667789999999999999999999999999998764

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-50  Score=354.02  Aligned_cols=258  Identities=25%  Similarity=0.389  Sum_probs=202.4

Q ss_pred             hhcCCcccceecccCceEEEEEEEC--CC--CEEEEEEeecc---ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ--DG--TIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG  112 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~--~~--~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~  112 (358)
                      ..++|++.+.||+|+||.||+|+..  ++  ..||||++...   .....+.+.+|+.+++.++  ||||+++++++.++
T Consensus         6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~--H~nIv~~~g~~~~~   83 (273)
T d1u46a_           6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD--HRNLIRLYGVVLTP   83 (273)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC--CTTBCCEEEEECSS
T ss_pred             chHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCC--CCCEEEEEEEEeec
Confidence            4578999999999999999999853  22  36899988643   3344568899999999998  99999999999764


Q ss_pred             CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecc
Q 018263          113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG  192 (358)
Q Consensus       113 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg  192 (358)
                       ..++||||++++++.+.+.   .....+++..+..++.||+.||.|||++   +|+||||||+||+++.++.+||+|||
T Consensus        84 -~~~lv~e~~~~~~l~~~~~---~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfG  156 (273)
T d1u46a_          84 -PMKMVTELAPLGSLLDRLR---KHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFG  156 (273)
T ss_dssp             -SCEEEEECCTTCBHHHHHH---HHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCT
T ss_pred             -chheeeeeecCcchhhhhh---cccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccch
Confidence             6789999999999999874   2445699999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcc--cccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccch
Q 018263          193 LSKLFPENTTH--ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNS  269 (358)
Q Consensus       193 ~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      ++.........  ......++..|+|||++.+..++.++||||||+++|||++ |++||...+.....            
T Consensus       157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~------------  224 (273)
T d1u46a_         157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL------------  224 (273)
T ss_dssp             TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH------------
T ss_pred             hhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHH------------
Confidence            99976543332  2233567889999999999999999999999999999998 89999754332211            


Q ss_pred             hhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCC
Q 018263          270 KELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGET  321 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~  321 (358)
                         ..+.....+...+...+..+.+||.+||+.||++|||+.+|++.|++.+
T Consensus       225 ---~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~~  273 (273)
T d1u46a_         225 ---HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ  273 (273)
T ss_dssp             ---HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             ---HHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcC
Confidence               1122222333444556678999999999999999999999999998653

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=6.7e-49  Score=361.35  Aligned_cols=249  Identities=25%  Similarity=0.328  Sum_probs=202.2

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC---hhhHHHHHHH---HHHhhhcccCCCCceeeeceEEcCC
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSE---VASMANVNVCHENLVKLHGGCIDGP  113 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e---~~~l~~l~~~h~~i~~~~~~~~~~~  113 (358)
                      .++|++.+.||+|+||.||+|++. +|+.||||++....   ......+.+|   +..++.++  ||||+++++++...+
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~--hpnIv~l~~~~~~~~   80 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD--CPFIVCMSYAFHTPD   80 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSC--CTTBCCEEEEEECSS
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCC--CCcEEEEEEEEEECC
Confidence            468999999999999999999976 69999999986431   2223333344   55666666  999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccc
Q 018263          114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL  193 (358)
Q Consensus       114 ~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~  193 (358)
                      ..|+||||++|++|.+++    .....+++..++.++.||+.||.|||++   ||+||||||+||+++.+|.+||+|||+
T Consensus        81 ~~~ivmE~~~gg~L~~~l----~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGl  153 (364)
T d1omwa3          81 KLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGL  153 (364)
T ss_dssp             EEEEEECCCCSCBHHHHH----HHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTT
T ss_pred             EEEEEEEecCCCcHHHHH----HhcccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeece
Confidence            999999999999999999    4556789999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhH
Q 018263          194 SKLFPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKEL  272 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      +.......   .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||................        
T Consensus       154 a~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~--------  222 (364)
T d1omwa3         154 ACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--------  222 (364)
T ss_dssp             CEECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSS--------
T ss_pred             eeecCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--------
Confidence            98754332   234579999999999874 568999999999999999999999998654433222211110        


Q ss_pred             hhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 018263          273 MNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQ-----MSTAIK  315 (358)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt-----~~eil~  315 (358)
                            ......+...+..+.+||.+||+.||.+|||     ++|+++
T Consensus       223 ------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         223 ------TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             ------SCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             ------cCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence                  1112233456677999999999999999999     678764

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-49  Score=355.96  Aligned_cols=251  Identities=16%  Similarity=0.233  Sum_probs=206.4

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      .++|++.+.||+|+||.||+|.++ +|+.||+|++.... .....+.+|+++++.++  ||||+++++++.+++..|+||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~--HpnIv~~~~~~~~~~~~~lvm   80 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIAR--HRNILHLHESFESMEELVMIF   80 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSC--CTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCC--CCCCCeEEEEEEECCEEEEEE
Confidence            478999999999999999999976 68899999997543 34456889999999998  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcC--CCceEEeeccccccc
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ--NFNPKISDFGLSKLF  197 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~--~~~~~l~Dfg~~~~~  197 (358)
                      ||++|++|.+++.   .....+++..++.++.||+.||.|||++   ||+||||||+||+++.  ...++|+|||++...
T Consensus        81 E~~~gg~L~~~i~---~~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~  154 (321)
T d1tkia_          81 EFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             CCCCCCBHHHHHT---SSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             ecCCCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcc
Confidence            9999999999993   2334799999999999999999999999   9999999999999985  447999999999875


Q ss_pred             CCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhc
Q 018263          198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD  277 (358)
Q Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      ....  ......+++.|+|||.+.+..++.++|||||||++|+|++|..||...........+......+...       
T Consensus       155 ~~~~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~-------  225 (321)
T d1tkia_         155 KPGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEE-------  225 (321)
T ss_dssp             CTTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHH-------
T ss_pred             ccCC--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChh-------
Confidence            4322  2334568999999999999999999999999999999999999998665432222221110000000       


Q ss_pred             cccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          278 PMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       278 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                            .....+.++.+||.+||+.||.+|||+.|+++
T Consensus       226 ------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         226 ------AFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             ------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ------hccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  00123556889999999999999999999987

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-49  Score=357.99  Aligned_cols=247  Identities=22%  Similarity=0.315  Sum_probs=204.4

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc---ChhhHHHHHHHHHHhh-hcccCCCCceeeeceEEcCCeeE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMA-NVNVCHENLVKLHGGCIDGPCRI  116 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~-~l~~~h~~i~~~~~~~~~~~~~~  116 (358)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++...   .......+..|...+. .++  ||||+++++++.+++..|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~--hp~Iv~~~~~~~~~~~~y   79 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE--HPFLTHMFCTFQTKENLF   79 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTT--CTTBCCEEEEEECSSEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCC--CCcEEEEEEEEccCCcee
Confidence            68999999999999999999976 6999999999643   2233445556666554 556  999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       117 iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      +||||+++|+|.+++    .....+++..++.++.||+.||+|||++   +++||||||+||+++.++.+||+|||++..
T Consensus        80 ivmEy~~~g~L~~~i----~~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~  152 (320)
T d1xjda_          80 FVMEYLNGGDLMYHI----QSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKE  152 (320)
T ss_dssp             EEEECCTTCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEeecCCCcHHHHh----hccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhh
Confidence            999999999999999    4556789999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhh
Q 018263          197 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLV  276 (358)
Q Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                      ..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+..              
T Consensus       153 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~--------------  217 (320)
T d1xjda_         153 NMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM--------------  217 (320)
T ss_dssp             CCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------------
T ss_pred             ccccc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHc--------------
Confidence            54332 233446799999999999999999999999999999999999999986543221111100              


Q ss_pred             ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHH-HHHH
Q 018263          277 DPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMS-TAIK  315 (358)
Q Consensus       277 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~-eil~  315 (358)
                         ....++...+..+.+||.+||+.||.+|||+. ++++
T Consensus       218 ---~~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         218 ---DNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             ---CCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ---CCCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence               01233445667799999999999999999996 6753

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-49  Score=356.46  Aligned_cols=265  Identities=23%  Similarity=0.359  Sum_probs=212.6

Q ss_pred             HHHhhcCCcccceecccCceEEEEEEECC--------CCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeec
Q 018263           37 LKIATNGFRWSNKIGEGGFGSVYKGRLQD--------GTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHG  107 (358)
Q Consensus        37 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~~--------~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~  107 (358)
                      +.+..++|++.+.||+|+||.||+|+...        +..||||++.... ......+.+|...+.++. .||||+++++
T Consensus         8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~-~HpnIv~~~~   86 (299)
T d1fgka_           8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG-KHKNIINLLG   86 (299)
T ss_dssp             TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHC-CCTTBCCEEE
T ss_pred             CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhc-CCCeEEeccc
Confidence            44677899999999999999999998532        3479999987553 344577888888888873 3999999999


Q ss_pred             eEEcCCeeEEEEecCCCCCHHHHhhhccc------------cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCC
Q 018263          108 GCIDGPCRILVYDYMPNNSLSQTLLGEEK------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKT  175 (358)
Q Consensus       108 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p  175 (358)
                      ++.+++..++||||+++|+|.+++.....            ....+++..+..++.||+.||+|||+.   +++||||||
T Consensus        87 ~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp  163 (299)
T d1fgka_          87 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAA  163 (299)
T ss_dssp             EECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred             ccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecc
Confidence            99999999999999999999999954321            235689999999999999999999999   999999999


Q ss_pred             CcEEEcCCCceEEeecccccccCCCCc-ccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCcccc
Q 018263          176 SNILLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ  253 (358)
Q Consensus       176 ~Nilv~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~  253 (358)
                      +||+++.++.+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |++||.....
T Consensus       164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~  243 (299)
T d1fgka_         164 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  243 (299)
T ss_dssp             GGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             cceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence            999999999999999999986543322 22334678899999999999999999999999999999998 6888865432


Q ss_pred             ccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCC
Q 018263          254 LGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGET  321 (358)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~  321 (358)
                      ..                ....+........+...+..+.+||.+||+.||.+|||+.||++.|+++.
T Consensus       244 ~~----------------~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         244 EE----------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             HH----------------HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HH----------------HHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence            21                12222233334455566778999999999999999999999999998764

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-49  Score=355.07  Aligned_cols=254  Identities=25%  Similarity=0.395  Sum_probs=204.9

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCC----EEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCee
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGT----IVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR  115 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~----~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~  115 (358)
                      ++|++++.||+|+||.||+|.+. +|+    +||+|.+... .....+.+.+|+..+++++  ||||+++++++.++ ..
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--HpnIv~l~g~~~~~-~~   85 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD--NPHVCRLLGICLTS-TV   85 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCC--CTTBCCEEEEEESS-SE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCC--CCCEeeEEEEEecC-Ce
Confidence            57999999999999999999865 344    5888887543 3445678999999999998  99999999999875 46


Q ss_pred             EEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeeccccc
Q 018263          116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK  195 (358)
Q Consensus       116 ~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~  195 (358)
                      +++++++.+++|.+.+.   .....+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||++.
T Consensus        86 ~~v~e~~~~~~l~~~~~---~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~  159 (317)
T d1xkka_          86 QLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK  159 (317)
T ss_dssp             EEEEECCTTCBHHHHHH---HTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred             eEEEEeccCCccccccc---ccccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccce
Confidence            77889999999999873   3456789999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCcc-cccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCccccccchhhhHhhhhccchhhHh
Q 018263          196 LFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKAWGMYNSKELM  273 (358)
Q Consensus       196 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      ........ ......||+.|+|||++.+..++.++||||||+++|+|++ |..||.......                +.
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~----------------~~  223 (317)
T d1xkka_         160 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------------IS  223 (317)
T ss_dssp             HTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG----------------HH
T ss_pred             ecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH----------------HH
Confidence            76443332 2233568999999999999999999999999999999998 788887543322                12


Q ss_pred             hhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 018263          274 NLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE  320 (358)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~  320 (358)
                      ..+....+...+...+..+.+|+.+||+.||.+|||+.+|++.|+.+
T Consensus       224 ~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~  270 (317)
T d1xkka_         224 SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  270 (317)
T ss_dssp             HHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence            22222233344556777899999999999999999999999988765

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.2e-48  Score=349.34  Aligned_cols=264  Identities=23%  Similarity=0.339  Sum_probs=208.3

Q ss_pred             cCCcccceecccCceEEEEEEECCCCEEEEEEeeccC--hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      ++|+++++||+|+||+||+|++++|+.||||++....  ....+.+.+|+.++++++  ||||+++++++.+.+..++++
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~--hpnIv~~~~~~~~~~~~~i~~   79 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELK--HSNIVKLYDVIHTKKRLVLVF   79 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCC--CTTBCCEEEEEECSSCEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCC--CCcEEeeeeecccCCceeEEE
Confidence            6899999999999999999999999999999996543  333578889999999998  999999999999999999999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCC
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE  199 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~  199 (358)
                      +++.++.+..+.    ...+.+++..++.++.||+.||+|||+.   +|+||||||+||+++.++.+|++|||.+.....
T Consensus        80 e~~~~~~~~~~~----~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~  152 (286)
T d1ob3a_          80 EHLDQDLKKLLD----VCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGI  152 (286)
T ss_dssp             ECCSEEHHHHHH----TSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred             EeehhhhHHHHH----hhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceeccc
Confidence            999777666665    4567899999999999999999999999   999999999999999999999999999987543


Q ss_pred             CCcccccccccccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhc-
Q 018263          200 NTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD-  277 (358)
Q Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  277 (358)
                      ... ......+++.|.|||.+.+. .++.++||||||+++|+|++|+.||......+....+....+.+....+..... 
T Consensus       153 ~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  231 (286)
T d1ob3a_         153 PVR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL  231 (286)
T ss_dssp             ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred             Ccc-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhh
Confidence            322 22334688999999998754 578999999999999999999999987655444443333322222221111111 


Q ss_pred             -----------cccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          278 -----------PMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       278 -----------~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                                 +..........+..+.+|+.+||+.||++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                       00001122334567899999999999999999999984

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-49  Score=353.45  Aligned_cols=263  Identities=27%  Similarity=0.378  Sum_probs=210.6

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCC--EEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCee
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGT--IVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR  115 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~--~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~  115 (358)
                      +-++|++.+.||+|+||.||+|+++ +|.  .||||.+... .....+.+.+|+..++++. .||||+++++++...+..
T Consensus         8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-~HpnIv~~~~~~~~~~~~   86 (309)
T d1fvra_           8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG-HHPNIINLLGACEHRGYL   86 (309)
T ss_dssp             CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCC-CCTTBCCEEEEEEETTEE
T ss_pred             CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhcc-CCCCEeeEEEEEecCCee
Confidence            3489999999999999999999875 444  4677777533 3445567899999999983 399999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhhcc------------ccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCC
Q 018263          116 ILVYDYMPNNSLSQTLLGEE------------KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN  183 (358)
Q Consensus       116 ~iv~e~~~~~~L~~~l~~~~------------~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~  183 (358)
                      ++||||+++|+|.+++....            .....+++..+..++.||+.||.|||++   +++||||||+||+++.+
T Consensus        87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~  163 (309)
T d1fvra_          87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN  163 (309)
T ss_dssp             EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGG
T ss_pred             EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCC
Confidence            99999999999999995431            2346799999999999999999999999   99999999999999999


Q ss_pred             CceEEeecccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCC-CCCCccccccchhhhHh
Q 018263          184 FNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR-TAVDFDVQLGEYHLVDK  262 (358)
Q Consensus       184 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~-~pf~~~~~~~~~~~~~~  262 (358)
                      +.+||+|||++.......  ......+|..|+|||.+.+..++.++||||||+++|+|++|. +||......        
T Consensus       164 ~~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~--------  233 (309)
T d1fvra_         164 YVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--------  233 (309)
T ss_dssp             GCEEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------
T ss_pred             CceEEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH--------
Confidence            999999999997643222  223356889999999999999999999999999999999976 466543221        


Q ss_pred             hhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCCC
Q 018263          263 AWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNID  324 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~~  324 (358)
                              ++...+....+...+...+..+.+||.+||+.||++|||++||++.|+++....
T Consensus       234 --------~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~  287 (309)
T d1fvra_         234 --------ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  287 (309)
T ss_dssp             --------HHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             --------HHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence                    112222222334455567788999999999999999999999999999876544

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-48  Score=352.99  Aligned_cols=265  Identities=22%  Similarity=0.380  Sum_probs=217.9

Q ss_pred             HHHhhcCCcccceecccCceEEEEEEE------CCCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceE
Q 018263           37 LKIATNGFRWSNKIGEGGFGSVYKGRL------QDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGC  109 (358)
Q Consensus        37 ~~~~~~~y~i~~~lg~g~~g~v~~~~~------~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~  109 (358)
                      +.+..++|++.+.||+|+||.||+|++      .+++.||||++.... ......+.+|+..++.+. .||||+++++++
T Consensus        18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~-~HpnIv~~~g~~   96 (311)
T d1t46a_          18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG-NHMNIVNLLGAC   96 (311)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE
T ss_pred             ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhcc-CCCCEEEEEEEE
Confidence            446678999999999999999999985      246789999997543 345567889999999984 499999999999


Q ss_pred             EcCCeeEEEEecCCCCCHHHHhhhccc--------------cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCC
Q 018263          110 IDGPCRILVYDYMPNNSLSQTLLGEEK--------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKT  175 (358)
Q Consensus       110 ~~~~~~~iv~e~~~~~~L~~~l~~~~~--------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p  175 (358)
                      ......+++|||+++++|.+++.....              ....+++..+..++.||+.||+|||++   +++||||||
T Consensus        97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp  173 (311)
T d1t46a_          97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAA  173 (311)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred             eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccc
Confidence            999999999999999999999954321              234689999999999999999999999   999999999


Q ss_pred             CcEEEcCCCceEEeecccccccCCCCc-ccccccccccCccCccccccCCCCccCceecHHHHHHHHHh-CCCCCCcccc
Q 018263          176 SNILLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ  253 (358)
Q Consensus       176 ~Nilv~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~llt-g~~pf~~~~~  253 (358)
                      +||+++.++.++++|||.+........ .......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||.....
T Consensus       174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~  253 (311)
T d1t46a_         174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (311)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987654332 33344678999999999999999999999999999999999 5555544332


Q ss_pred             ccchhhhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 018263          254 LGEYHLVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE  320 (358)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~  320 (358)
                      .               ..+..+++...+...+...+..+.+||.+||+.||.+|||+.+|++.|++.
T Consensus       254 ~---------------~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~  305 (311)
T d1t46a_         254 D---------------SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             S---------------HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             H---------------HHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            2               122233333344445556677899999999999999999999999999864

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-48  Score=347.63  Aligned_cols=265  Identities=23%  Similarity=0.339  Sum_probs=204.2

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC--hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      ++|++++.||+|+||.||+|++. +|+.||||++....  ......+.+|+.+++.++  ||||+++++++.+.+..|+|
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~--Hp~Iv~~~~~~~~~~~~~iv   79 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN--HPNIVKLLDVIHTENKLYLV   79 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCC--CTTBCCEEEEEEETTEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCC--CCcEEEeccccccccceeEE
Confidence            68999999999999999999975 69999999986543  223567889999999998  99999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      |||+.+ .+.+.+.  ......+++..++.++.||+.||+|||++   ||+||||||+||+++.++.+||+|||.+....
T Consensus        80 ~e~~~~-~~~~~~~--~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~  153 (298)
T d1gz8a_          80 FEFLHQ-DLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG  153 (298)
T ss_dssp             EECCSE-EHHHHHH--HTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHC
T ss_pred             EeecCC-chhhhhh--hhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceecc
Confidence            999965 4444442  23456799999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCcccccccccccCccCccccccCC-CCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhc
Q 018263          199 ENTTHISTRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD  277 (358)
Q Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      .... ......+|+.|+|||++.... ++.++||||||+++|+|++|+.||...+..+....+....+.+....+.....
T Consensus       154 ~~~~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  232 (298)
T d1gz8a_         154 VPVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS  232 (298)
T ss_dssp             CCSB-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             CCcc-cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence            4332 233457999999999877655 57899999999999999999999987654443333222222111111111000


Q ss_pred             -cccCCC-----------CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          278 -PMLYGN-----------FPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       278 -~~~~~~-----------~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                       +.....           .....+.++.+|+.+||+.||.+|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~  282 (298)
T d1gz8a_         233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA  282 (298)
T ss_dssp             STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence             000000           01133467889999999999999999999987

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-48  Score=352.09  Aligned_cols=253  Identities=18%  Similarity=0.222  Sum_probs=197.7

Q ss_pred             hcCCcccc-eecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEc----CCe
Q 018263           41 TNGFRWSN-KIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID----GPC  114 (358)
Q Consensus        41 ~~~y~i~~-~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~----~~~  114 (358)
                      .++|.+.. .||+|+||.||+|++. +|+.||||++...     ..+.+|+..+.++. .||||++++++|.+    ...
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~-~hpnIv~l~~~~~~~~~~~~~   83 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKC   83 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHT-TSTTBCCEEEEEEEEETTEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhc-CCCCCCeEEEEEeecccCCCE
Confidence            46898876 5999999999999974 6999999998632     34567888765542 39999999999875    466


Q ss_pred             eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcC---CCceEEeec
Q 018263          115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ---NFNPKISDF  191 (358)
Q Consensus       115 ~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~---~~~~~l~Df  191 (358)
                      .|+|||||+||+|.+++..  .....+++..++.++.||+.||+|||++   ||+||||||+||+++.   ++.+||+||
T Consensus        84 ~~ivmEy~~gg~L~~~i~~--~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DF  158 (335)
T d2ozaa1          84 LLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF  158 (335)
T ss_dssp             EEEEEECCCSEEHHHHHHS--CSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred             EEEEEECCCCCcHHHHHHh--cCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccccc
Confidence            8999999999999999942  2235699999999999999999999999   9999999999999975   557999999


Q ss_pred             ccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhh
Q 018263          192 GLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKE  271 (358)
Q Consensus       192 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      |++........  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||................   ... 
T Consensus       159 G~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i---~~~-  232 (335)
T d2ozaa1         159 GFAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI---RMG-  232 (335)
T ss_dssp             TTCEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CC---CSC-
T ss_pred             ceeeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHH---hcC-
Confidence            99987544332  344679999999999999999999999999999999999999997654332221110000   000 


Q ss_pred             HhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          272 LMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                           ............+.++.+||.+||+.||++|||+.|+++
T Consensus       233 -----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         233 -----QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             -----SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -----CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                 000000111345678999999999999999999999987

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-48  Score=351.22  Aligned_cols=268  Identities=25%  Similarity=0.362  Sum_probs=219.0

Q ss_pred             HHHHHHhhcCCcccceecccCceEEEEEEEC------CCCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeee
Q 018263           34 YNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLH  106 (358)
Q Consensus        34 ~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~  106 (358)
                      .+++++..++|++.++||+|+||.||+|.++      +++.||||++... .......+.+|+.++++++  ||||++++
T Consensus        12 ~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~--h~nIv~~~   89 (308)
T d1p4oa_          12 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN--CHHVVRLL   89 (308)
T ss_dssp             CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCC--CTTBCCEE
T ss_pred             ccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcC--CCCEeeee
Confidence            3457788899999999999999999999863      3578999998754 3444567889999999998  99999999


Q ss_pred             ceEEcCCeeEEEEecCCCCCHHHHhhhccc------cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEE
Q 018263          107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEK------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL  180 (358)
Q Consensus       107 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv  180 (358)
                      +++......++||||+++|+|.+++.....      ....+++..+..++.|++.||.|||++   +|+||||||+||++
T Consensus        90 ~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLl  166 (308)
T d1p4oa_          90 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMV  166 (308)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEE
T ss_pred             eEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceee
Confidence            999999999999999999999999854321      224578999999999999999999999   99999999999999


Q ss_pred             cCCCceEEeecccccccCCCCc-ccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCC-CCCCccccccchh
Q 018263          181 DQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR-TAVDFDVQLGEYH  258 (358)
Q Consensus       181 ~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~-~pf~~~~~~~~~~  258 (358)
                      +.++.+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++|. +||......... 
T Consensus       167 d~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~-  245 (308)
T d1p4oa_         167 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL-  245 (308)
T ss_dssp             CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH-
T ss_pred             cCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHH-
Confidence            9999999999999986533222 2223356899999999999999999999999999999999984 677544322111 


Q ss_pred             hhHhhhhccchhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCC
Q 018263          259 LVDKAWGMYNSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETN  322 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~  322 (358)
                                     ..+........+...+..+.+++.+||+.+|++|||+++|++.|++..+
T Consensus       246 ---------------~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         246 ---------------RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             ---------------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             ---------------HHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence                           1111222233445566789999999999999999999999999988744

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-48  Score=345.91  Aligned_cols=272  Identities=24%  Similarity=0.281  Sum_probs=201.5

Q ss_pred             hcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC----eeE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP----CRI  116 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~----~~~  116 (358)
                      ..+|.+.+.||+|+||.||+|+. +|+.||||++..... .....+.|+..+..++  ||||+++++++...+    ..+
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~--HpnIv~~~~~~~~~~~~~~~~~   77 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLR--HENILGFIAADNKDNGTWTQLW   77 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCC--CTTBCCEEEEEEEECSSSEEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCC--CCcCcceEEEEEeCCCcceEEE
Confidence            46788999999999999999997 488999999864322 2222233444445555  999999999998654    578


Q ss_pred             EEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCcEEcCCCCCcEEEcCCCceEEeec
Q 018263          117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI-----QPHVVHRDIKTSNILLDQNFNPKISDF  191 (358)
Q Consensus       117 iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~-----~~~i~H~di~p~Nilv~~~~~~~l~Df  191 (358)
                      +||||+++++|.+++.     +..+++..++.++.|++.||+|+|+..     ..||+||||||+||+|+.++.+||+||
T Consensus        78 lv~Ey~~~g~L~~~l~-----~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF  152 (303)
T d1vjya_          78 LVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  152 (303)
T ss_dssp             EEEECCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred             EEEecccCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence            9999999999999993     346899999999999999999999620     239999999999999999999999999


Q ss_pred             ccccccCCCCcc---cccccccccCccCccccccCC------CCccCceecHHHHHHHHHhCCCCCCccccccchhhhHh
Q 018263          192 GLSKLFPENTTH---ISTRVAGTLGYLAPEYAISGR------LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDK  262 (358)
Q Consensus       192 g~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~------~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~  262 (358)
                      |++.........   ......||+.|+|||++.+..      ++.++|||||||++|+|++|..||............ .
T Consensus       153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~-~  231 (303)
T d1vjya_         153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD-L  231 (303)
T ss_dssp             TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT-T
T ss_pred             CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh-c
Confidence            999876433321   223467999999999887543      567899999999999999999888654332211111 0


Q ss_pred             hhhccchhh-HhhhhccccCCCCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCC
Q 018263          263 AWGMYNSKE-LMNLVDPMLYGNFP-----ENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETN  322 (358)
Q Consensus       263 ~~~~~~~~~-~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~  322 (358)
                      ......... .....+...++..+     ......+.+|+.+||+.||.+|||+.||++.|+++..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  297 (303)
T d1vjya_         232 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             SCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            000111111 11223333333332     2456679999999999999999999999999987754

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-48  Score=344.84  Aligned_cols=242  Identities=24%  Similarity=0.335  Sum_probs=199.4

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccCh------hhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK------QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP  113 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~  113 (358)
                      .++|++.+.||+|+||.||+|++. +|+.||||++.....      .....+.+|+.++++++..||||+++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            468999999999999999999975 689999999864321      1223466899999988766999999999999999


Q ss_pred             eeEEEEecCCC-CCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcC-CCceEEeec
Q 018263          114 CRILVYDYMPN-NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ-NFNPKISDF  191 (358)
Q Consensus       114 ~~~iv~e~~~~-~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~-~~~~~l~Df  191 (358)
                      ..++||||+.+ +++.+++    .....+++..++.++.||+.||+|||++   ||+||||||+||+++. ++.+||+||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~----~~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DF  155 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFI----TERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF  155 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHH----HHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             eEEEEEEeccCcchHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcc
Confidence            99999999976 5777777    4556799999999999999999999999   9999999999999985 578999999


Q ss_pred             ccccccCCCCcccccccccccCccCccccccCCC-CccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchh
Q 018263          192 GLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSK  270 (358)
Q Consensus       192 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      |++......   ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.....      +.  .      
T Consensus       156 G~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~--~------  218 (273)
T d1xwsa_         156 GSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------II--R------  218 (273)
T ss_dssp             TTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HH--H------
T ss_pred             ccceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------Hh--h------
Confidence            999865332   2344679999999999987665 6789999999999999999999974321      00  0      


Q ss_pred             hHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          271 ELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                             .  ...++...+.++.+||.+||+.||.+|||++|+++
T Consensus       219 -------~--~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         219 -------G--QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             -------C--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -------c--ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence                   0  01122334567899999999999999999999986

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-48  Score=347.72  Aligned_cols=267  Identities=22%  Similarity=0.334  Sum_probs=203.9

Q ss_pred             hcCCcccceecccCceEEEEEEEC-C-CCEEEEEEeeccC--hhhHHHHHHHHHHhhhcc-cCCCCceeeeceEEc----
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-D-GTIVAVKVLSVES--KQGEKEFMSEVASMANVN-VCHENLVKLHGGCID----  111 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~-~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~-~~h~~i~~~~~~~~~----  111 (358)
                      .++|+++++||+|+||.||+|++. + ++.||||++....  ......+.+|+..++.+. ..||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            579999999999999999999974 4 6679999986542  222334556777666652 139999999999853    


Q ss_pred             -CCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEee
Q 018263          112 -GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD  190 (358)
Q Consensus       112 -~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~D  190 (358)
                       ....+++||+++++.+....   ......+++..++.++.||+.||+|||++   +|+||||||+||+++.++.++|+|
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~---~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d  159 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLD---KVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD  159 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHH---HSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred             cCceEEEEEEeccCCchhhhh---hccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence             34679999999877665443   23556789999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchh
Q 018263          191 FGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSK  270 (358)
Q Consensus       191 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      ||++.....  ........||+.|+|||++.+..++.++||||+||++|+|++|++||...+..+....+....+.+...
T Consensus       160 fg~~~~~~~--~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  237 (305)
T d1blxa_         160 FGLARIYSF--QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE  237 (305)
T ss_dssp             CCSCCCCCG--GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             hhhhhhhcc--cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchh
Confidence            999876432  233445779999999999999999999999999999999999999998776555444443333222222


Q ss_pred             hHhhhhc----------cccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          271 ELMNLVD----------PMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       271 ~~~~~~~----------~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .+.....          ......+....+..+.+|+.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            1111000          00011122345567889999999999999999999976

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-47  Score=340.91  Aligned_cols=254  Identities=27%  Similarity=0.390  Sum_probs=204.3

Q ss_pred             cceecccCceEEEEEEECC----CCEEEEEEeecc-ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEc-CCeeEEEEe
Q 018263           47 SNKIGEGGFGSVYKGRLQD----GTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID-GPCRILVYD  120 (358)
Q Consensus        47 ~~~lg~g~~g~v~~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~-~~~~~iv~e  120 (358)
                      .++||+|+||+||+|++..    ...||||.++.. +....+++.+|++.+.+++  ||||+++++++.. ++..++|||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~--HpnIv~~~g~~~~~~~~~~lv~E  109 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS--HPNVLSLLGICLRSEGSPLVVLP  109 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCC--CTTBCCCCEEEEETTTEEEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC--CCCEeEEeEEEEecCCceEEEEE
Confidence            5689999999999998643    235899998643 5556678999999999998  9999999999765 568899999


Q ss_pred             cCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccCCC
Q 018263          121 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN  200 (358)
Q Consensus       121 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~~~  200 (358)
                      |+++++|.+++.   .....+++..+..++.|++.||.|||+.   +|+||||||+||++++++.+||+|||++......
T Consensus       110 ~~~~g~l~~~~~---~~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~  183 (311)
T d1r0pa_         110 YMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  183 (311)
T ss_dssp             CCTTCBHHHHHH---CTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred             EeecCchhhhhc---cccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence            999999999983   3445677889999999999999999999   9999999999999999999999999999875433


Q ss_pred             Cc---ccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHhhhhc
Q 018263          201 TT---HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELMNLVD  277 (358)
Q Consensus       201 ~~---~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      ..   .......+|..|+|||.+.+..++.++||||||+++|+|++|..||........  ..             ..+.
T Consensus       184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~--~~-------------~~i~  248 (311)
T d1r0pa_         184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--IT-------------VYLL  248 (311)
T ss_dssp             TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CH-------------HHHH
T ss_pred             ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH--HH-------------HHHH
Confidence            22   222335688999999999999999999999999999999998888764332111  11             1111


Q ss_pred             cccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCCCC
Q 018263          278 PMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGETNI  323 (358)
Q Consensus       278 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~~~  323 (358)
                      ...+...+...+..+.+||.+||+.||++|||+.||++.|+++...
T Consensus       249 ~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         249 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             cCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            1112233445567799999999999999999999999999998754

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-46  Score=340.06  Aligned_cols=266  Identities=22%  Similarity=0.293  Sum_probs=203.8

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEc------
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID------  111 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~------  111 (358)
                      .++|+++++||+|+||+||+|++. +|+.||||++...  .......+.+|+.++++++  |||++++++++..      
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~--h~nii~~~~~~~~~~~~~~   86 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK--HENVVNLIEICRTKASPYN   86 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCC--CTTBCCEEEEEEC------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhc--CCCccceEeeeeccccccc
Confidence            589999999999999999999975 7999999998644  3344567889999999998  9999999998754      


Q ss_pred             --CCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEe
Q 018263          112 --GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKIS  189 (358)
Q Consensus       112 --~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~  189 (358)
                        .+..+++||++.++.+....    .....+++..++.++.||+.||.|||++   ||+||||||+||+++.++.++++
T Consensus        87 ~~~~~~~iv~e~~~~~~~~~~~----~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~  159 (318)
T d3blha1          87 RCKGSIYLVFDFCEHDLAGLLS----NVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLA  159 (318)
T ss_dssp             ----CEEEEEECCCEEHHHHHT----CTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEEC
T ss_pred             ccCceEEEEEeccCCCccchhh----hcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEee
Confidence              34679999999777665554    4566789999999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCc---ccccccccccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhh
Q 018263          190 DFGLSKLFPENTT---HISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWG  265 (358)
Q Consensus       190 Dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~  265 (358)
                      |||++........   .......+|+.|+|||++.+. .++.++||||+||++|+|++|+.||...........+....+
T Consensus       160 dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~  239 (318)
T d3blha1         160 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG  239 (318)
T ss_dssp             CCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             ecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcC
Confidence            9999976543222   122235789999999998765 689999999999999999999999987665554444444433


Q ss_pred             ccchhhHhhhhcc--------ccCCCCCH-------HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          266 MYNSKELMNLVDP--------MLYGNFPE-------NEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       266 ~~~~~~~~~~~~~--------~~~~~~~~-------~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      .+...........        ......+.       .....+.+|+.+||+.||++|||++|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             CCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            3322211111111        01111111       12346778999999999999999999985

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-46  Score=342.51  Aligned_cols=266  Identities=23%  Similarity=0.305  Sum_probs=203.9

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC----
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP----  113 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~----  113 (358)
                      .++|+++++||+|+||+||+|.+. +|+.||||++...  .....+.+.+|+.+++.++  ||||+++++++...+    
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~--hpniv~l~~~~~~~~~~~~   94 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR--HENVIGLLDVFTPDETLDD   94 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC--BTTBCCCSEEECSCSSTTT
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcC--CCCeeEEEEEeccCccccc
Confidence            579999999999999999999975 6999999998643  3344567889999999998  999999999998654    


Q ss_pred             --eeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeec
Q 018263          114 --CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF  191 (358)
Q Consensus       114 --~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Df  191 (358)
                        ..|+||||+ +.+|..++     +...+++..++.++.||+.||+|||++   ||+||||||+||+++.++.++++||
T Consensus        95 ~~~~~lv~e~~-~~~l~~~~-----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Df  165 (346)
T d1cm8a_          95 FTDFYLVMPFM-GTDLGKLM-----KHEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDF  165 (346)
T ss_dssp             CCCCEEEEECC-SEEHHHHH-----HHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred             cceEEEEEecc-cccHHHHH-----HhccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccc
Confidence              469999999 67787776     345799999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchh
Q 018263          192 GLSKLFPENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSK  270 (358)
Q Consensus       192 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      |++......    .....+|+.|+|||++.+. .++.++||||+||++|+|++|+.||...+............+.+...
T Consensus       166 g~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  241 (346)
T d1cm8a_         166 GLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE  241 (346)
T ss_dssp             TTCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             cceeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHH
Confidence            999875332    2346789999999998764 57899999999999999999999998766544443333322222111


Q ss_pred             hH-----------hhhhccccC---CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhhcCC
Q 018263          271 EL-----------MNLVDPMLY---GNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK--MMNGET  321 (358)
Q Consensus       271 ~~-----------~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~--~L~~~~  321 (358)
                      ..           ...+.....   .......+..+.+||.+||+.||.+|||+.|+++  .|+.+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         242 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             HHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence            10           000111100   0112234567889999999999999999999997  365544

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-46  Score=342.27  Aligned_cols=268  Identities=23%  Similarity=0.286  Sum_probs=206.5

Q ss_pred             CCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC------Cee
Q 018263           43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG------PCR  115 (358)
Q Consensus        43 ~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~------~~~  115 (358)
                      +|+.++.||+|+||+||+|++. +|+.||||++......    ..+|+++++.++  ||||+++++++...      ...
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~--h~niv~~~~~~~~~~~~~~~~~~   94 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLD--HCNIVRLRYFFYSSGEKKDEVYL   94 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCC--CTTBCCEEEEEEEC--CCSCCEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcC--CCCCCcEEEEEEecCccCCceEE
Confidence            7889999999999999999986 6999999998754322    236899999998  99999999998643      347


Q ss_pred             EEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCC-ceEEeecccc
Q 018263          116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF-NPKISDFGLS  194 (358)
Q Consensus       116 ~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~-~~~l~Dfg~~  194 (358)
                      ++||||++++ +.+.+.........+++..++.++.||+.||+|||++   ||+||||||+||+++.++ .+||+|||++
T Consensus        95 ~lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a  170 (350)
T d1q5ka_          95 NLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA  170 (350)
T ss_dssp             EEEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred             EEEEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccch
Confidence            8999999655 4444433334567899999999999999999999999   999999999999999775 8999999999


Q ss_pred             cccCCCCcccccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhhHh
Q 018263          195 KLFPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKELM  273 (358)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      .......  ......++..|.|||.+.+ ..++.++||||+||++|+|++|+.||......+....+....+......+.
T Consensus       171 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~  248 (350)
T d1q5ka_         171 KQLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR  248 (350)
T ss_dssp             EECCTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             hhccCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhh
Confidence            8754332  2334578999999998875 468999999999999999999999998776655554444433333333222


Q ss_pred             hhhccccCC------------CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhhcCCC
Q 018263          274 NLVDPMLYG------------NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK--MMNGETN  322 (358)
Q Consensus       274 ~~~~~~~~~------------~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~--~L~~~~~  322 (358)
                      .........            ......+.++.+|+.+||+.||.+|||+.|+++  .|+.+.+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  311 (350)
T d1q5ka_         249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  311 (350)
T ss_dssp             HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence            222111111            112235667899999999999999999999996  4555544

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-46  Score=341.91  Aligned_cols=272  Identities=22%  Similarity=0.275  Sum_probs=204.0

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccC-hhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCC----e
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP----C  114 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~----~  114 (358)
                      +++|++++.||+|+||+||+|++. +|+.||||++.... ....+.+.+|+++++.++  ||||+++++++....    .
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~--hp~iv~~~~~~~~~~~~~~~   84 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR--HENIIGINDIIRAPTIEQMK   84 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCC--CTTBCCCCEEECCSSTTTCC
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcC--CCCCCcEEEEEeeccccccc
Confidence            468999999999999999999875 79999999986543 344567889999999998  999999999987543    2


Q ss_pred             eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccc
Q 018263          115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS  194 (358)
Q Consensus       115 ~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~  194 (358)
                      .+++++++.+++|.+++.     ...+++..++.++.||+.||+|||++   ||+||||||+||+++.++.+||+|||++
T Consensus        85 ~~~l~~~~~~g~L~~~l~-----~~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a  156 (345)
T d1pmea_          85 DVYLVTHLMGADLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLA  156 (345)
T ss_dssp             CEEEEEECCCEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEeecCCchhhhhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCce
Confidence            344455566999999983     34689999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCc--ccccccccccCccCcccccc-CCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchhh
Q 018263          195 KLFPENTT--HISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSKE  271 (358)
Q Consensus       195 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      ........  .......+++.|+|||++.. ..++.++||||+||++|+|++|+.||......+...........+....
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  236 (345)
T d1pmea_         157 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED  236 (345)
T ss_dssp             EECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             eeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhh
Confidence            86533222  22344678999999999854 5678999999999999999999999987665444433333222221111


Q ss_pred             Hh--------hhhccccC-CCC-----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--hhcCCC
Q 018263          272 LM--------NLVDPMLY-GNF-----PENEAIRFLKVGLLCVQEKSKLRPQMSTAIKM--MNGETN  322 (358)
Q Consensus       272 ~~--------~~~~~~~~-~~~-----~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~--L~~~~~  322 (358)
                      ..        ........ ...     ....+..+.+|+.+||+.||.+|||+.|+++-  |+...+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~  303 (345)
T d1pmea_         237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD  303 (345)
T ss_dssp             HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence            10        00000000 000     11234578899999999999999999999973  554443

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-45  Score=330.89  Aligned_cols=264  Identities=18%  Similarity=0.274  Sum_probs=208.6

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      ++|+++++||+|+||+||+|++. +|+.||||+++..  .......+.+|+.+++.++  ||||+++++++.+....+++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~--h~niv~~~~~~~~~~~~~iv   79 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK--HKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCC--CTTBCCEEEEEECSSEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcC--cCCEEeeccccccccceeEE
Confidence            68999999999999999999975 7899999998654  3345678899999999998  99999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecccccccC
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP  198 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~~~  198 (358)
                      ++++.+++|..++    ...+.+++..++.++.|++.||+|||++   ||+||||||+||+++.++.++|+|||.+....
T Consensus        80 ~~~~~~~~l~~~~----~~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~  152 (292)
T d1unla_          80 FEFCDQDLKKYFD----SCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFG  152 (292)
T ss_dssp             EECCSEEHHHHHH----HTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             eeecccccccccc----ccccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhccc
Confidence            9999998888877    4567789999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCcccccccccccCccCccccccCC-CCccCceecHHHHHHHHHhCCCCCCccc-cccchhhhHhhhhccchhhHhhhh
Q 018263          199 ENTTHISTRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAVDFDV-QLGEYHLVDKAWGMYNSKELMNLV  276 (358)
Q Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~s~~sDiwslG~il~~lltg~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                      .... ......++..|.|||++.+.. ++.++|||||||++|+|++|+.||.... ..+....+...........+....
T Consensus       153 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (292)
T d1unla_         153 IPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             SCCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             CCCc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhh
Confidence            4332 223345778899999887654 6899999999999999999999874332 222233332222222211111111


Q ss_pred             cc------------ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          277 DP------------MLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       277 ~~------------~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                      ..            ..........+..+.+|+.+||+.||.+||||+|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00            0111222345667899999999999999999999986

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-46  Score=337.96  Aligned_cols=260  Identities=23%  Similarity=0.321  Sum_probs=212.2

Q ss_pred             hcCCcccceecccCceEEEEEEEC----CCCEEEEEEeecc----ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ----DGTIVAVKVLSVE----SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG  112 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~----~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~  112 (358)
                      .++|++++.||+|+||+||+|+..    +|+.||||++...    .....+.+.+|+..+++++ .||||+++++++.+.
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~-h~pnIv~~~~~~~~~  101 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR-QSPFLVTLHYAFQTE  101 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHH-TCTTBCCEEEEEEET
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhcc-CCCeEEEeeeeeccC
Confidence            477999999999999999999852    4889999998543    2233456778999999997 248999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecc
Q 018263          113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG  192 (358)
Q Consensus       113 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg  192 (358)
                      ...+++|||+.+++|.+.+    ...+.+++..++.++.||+.||+|+|++   +++||||||+||+++.++.++|+|||
T Consensus       102 ~~~~~v~e~~~~~~L~~~i----~~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG  174 (322)
T d1vzoa_         102 TKLHLILDYINGGELFTHL----SQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFG  174 (322)
T ss_dssp             TEEEEEECCCCSCBHHHHH----HHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred             CceeeeeecccccHHHHHH----HhcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeecc
Confidence            9999999999999999999    4556788999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccCccCccccccC--CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchh
Q 018263          193 LSKLFPENTTHISTRVAGTLGYLAPEYAISG--RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSK  270 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      ++..+............+++.|+|||.+.+.  .++.++|||||||++|+|++|+.||...........+.....     
T Consensus       175 ~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~-----  249 (322)
T d1vzoa_         175 LSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL-----  249 (322)
T ss_dssp             EEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH-----
T ss_pred             chhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc-----
Confidence            9987655555555567899999999998754  468899999999999999999999987765544433322210     


Q ss_pred             hHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH--HhhcCC
Q 018263          271 ELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRP-----QMSTAIK--MMNGET  321 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp-----t~~eil~--~L~~~~  321 (358)
                              .....++...+..+.+|+.+||+.||.+||     |++|+++  .++++.
T Consensus       250 --------~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~  299 (322)
T d1vzoa_         250 --------KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN  299 (322)
T ss_dssp             --------HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred             --------cCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence                    001223445678899999999999999999     4788875  454443

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.2e-45  Score=328.22  Aligned_cols=261  Identities=21%  Similarity=0.270  Sum_probs=199.9

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY  119 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~  119 (358)
                      +++|++.+.||+|+||.||+|++. +|+.||||++.....  ...+..|+++++.+. .|++++.+..++...+..++||
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~-~~~~i~~~~~~~~~~~~~~ivm   82 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQ-GGVGIPTIRWCGAEGDYNVMVM   82 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHST-TSTTCCCEEEEEEETTEEEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHcc-CCCcccEEEEEEecCCEEEEEE
Confidence            468999999999999999999975 689999999875432  235678999999987 2444666667778888899999


Q ss_pred             ecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEc---CCCceEEeecccccc
Q 018263          120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD---QNFNPKISDFGLSKL  196 (358)
Q Consensus       120 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~---~~~~~~l~Dfg~~~~  196 (358)
                      ||+ +++|.+.+.   .....+++..+..++.|++.||+|||++   ||+||||||+||+++   .+..++++|||++..
T Consensus        83 e~~-~~~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~  155 (299)
T d1ckia_          83 ELL-GPSLEDLFN---FCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  155 (299)
T ss_dssp             ECC-CCBHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred             EEc-CCchhhhhh---hccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCccee
Confidence            999 566666652   3456799999999999999999999999   999999999999985   455799999999987


Q ss_pred             cCCCCc------ccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchh
Q 018263          197 FPENTT------HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSK  270 (358)
Q Consensus       197 ~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      ......      .......||+.|+|||++.+..++.++|||||||++|+|++|+.||......................
T Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~  235 (299)
T d1ckia_         156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  235 (299)
T ss_dssp             CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS
T ss_pred             ccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC
Confidence            643222      12334679999999999999999999999999999999999999998665544333332221100000


Q ss_pred             hHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 018263          271 ELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGE  320 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~  320 (358)
                      ....         .....+..+.+++.+||+.+|++||++.++.+.|+..
T Consensus       236 ~~~~---------~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         236 PIEV---------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             CHHH---------HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             ChhH---------hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            0000         1123456789999999999999999999998888765

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-45  Score=336.04  Aligned_cols=261  Identities=22%  Similarity=0.250  Sum_probs=194.6

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEc------
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID------  111 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~------  111 (358)
                      .++|+++++||+|+||+||+|.+. +|+.||||++...  .......+.+|+.+++.++  ||||++++++|..      
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~~~~~f~~~~~~~~   93 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN--HKNIISLLNVFTPQKTLEE   93 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCC--CTTBCCCSEEECSCCSTTT
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcC--CCCeeEEEEEEeccccccc
Confidence            378999999999999999999976 6999999999754  3444567889999999998  9999999999964      


Q ss_pred             CCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeec
Q 018263          112 GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF  191 (358)
Q Consensus       112 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Df  191 (358)
                      .+..|+||||+.++ +.+.+      ...+++..++.++.||+.||.|||++   ||+||||||+||+++.++.++++||
T Consensus        94 ~~~~~iv~Ey~~~~-l~~~~------~~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df  163 (355)
T d2b1pa1          94 FQDVYLVMELMDAN-LCQVI------QMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  163 (355)
T ss_dssp             CCEEEEEEECCSEE-HHHHH------TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred             CceeEEEEeccchH-HHHhh------hcCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeech
Confidence            46789999999655 44444      23589999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccch--
Q 018263          192 GLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNS--  269 (358)
Q Consensus       192 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~--  269 (358)
                      |++......  .......+|+.|+|||++.+..++.++||||+||++++|++|+.||...+.......+.........  
T Consensus       164 ~~~~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~  241 (355)
T d2b1pa1         164 GLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF  241 (355)
T ss_dssp             CC-----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             hhhhccccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHH
Confidence            998865432  2334467899999999999999999999999999999999999999866543333222211111100  


Q ss_pred             --------------------hhHhhhhccccCC---CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          270 --------------------KELMNLVDPMLYG---NFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       270 --------------------~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                                          .............   ......+.++.+|+.+||+.||++||||+|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                                0111111111111   112346778999999999999999999999984

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=7e-45  Score=330.98  Aligned_cols=259  Identities=17%  Similarity=0.254  Sum_probs=199.6

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEc--CCeeEE
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID--GPCRIL  117 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~--~~~~~i  117 (358)
                      .++|+++++||+|+||+||+|++. +|+.||||++...   ..+.+.+|+++++.+. .||||+++++++..  ....++
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~-~hpnIv~~~~~~~~~~~~~~~~  109 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLR-GGPNIITLADIVKDPVSRTPAL  109 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHT-TSTTBCCEEEEEECTTTCSEEE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhcc-CCCCCcEEEEEEEecCCCceeE
Confidence            468999999999999999999975 6999999998643   3457889999999985 49999999999984  456899


Q ss_pred             EEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCC-ceEEeecccccc
Q 018263          118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF-NPKISDFGLSKL  196 (358)
Q Consensus       118 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~-~~~l~Dfg~~~~  196 (358)
                      ||||+++++|....       +.+++..++.++.||+.||+|||++   ||+||||||+||+++.++ .++|+|||++..
T Consensus       110 v~e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~  179 (328)
T d3bqca1         110 VFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF  179 (328)
T ss_dssp             EEECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred             EEeecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeeccccccee
Confidence            99999999887664       3589999999999999999999999   999999999999998654 689999999986


Q ss_pred             cCCCCcccccccccccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCCCcccccc-chhhhHhhhhccc------
Q 018263          197 FPENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG-EYHLVDKAWGMYN------  268 (358)
Q Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf~~~~~~~-~~~~~~~~~~~~~------  268 (358)
                      .....  ......+|+.|+|||.+.+. .++.++||||+||++|+|++|+.||....... ....+....+...      
T Consensus       180 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~  257 (328)
T d3bqca1         180 YHPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID  257 (328)
T ss_dssp             CCTTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred             ccCCC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhh
Confidence            54332  23345689999999998765 57999999999999999999999997544321 1111111111100      


Q ss_pred             ------hhhHhhhhc--------cccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 018263          269 ------SKELMNLVD--------PMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIK  315 (358)
Q Consensus       269 ------~~~~~~~~~--------~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~  315 (358)
                            .........        ...........+.++.+||.+||+.||.+|||++|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  000111110        11111122345667899999999999999999999986

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.2e-44  Score=323.97  Aligned_cols=263  Identities=19%  Similarity=0.222  Sum_probs=208.3

Q ss_pred             hhcCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        40 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      .+++|++.+.||+|+||.||+|++. +|+.||||++.....  ...+.+|++.++.+. .|+|++.+++++......++|
T Consensus         3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~-~~~~i~~~~~~~~~~~~~~~v   79 (293)
T d1csna_           3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLA-GCTGIPNVYYFGQEGLHNVLV   79 (293)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTT-TCTTCCCEEEEEEETTEEEEE
T ss_pred             CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhc-CCCCCCEEEEEeecCCccEEE
Confidence            4689999999999999999999976 689999999864432  234667888888887 468999999999999999999


Q ss_pred             EecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcC-----CCceEEeeccc
Q 018263          119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ-----NFNPKISDFGL  193 (358)
Q Consensus       119 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~-----~~~~~l~Dfg~  193 (358)
                      |||+ +++|.+++..   ....+++..+..++.|++.||+|||++   ||+||||||+||+++.     ++.++|+|||+
T Consensus        80 me~~-~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~  152 (293)
T d1csna_          80 IDLL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM  152 (293)
T ss_dssp             EECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred             EEec-CCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccce
Confidence            9999 7899998832   345689999999999999999999999   9999999999999964     57899999999


Q ss_pred             ccccCCCCc------ccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhcc
Q 018263          194 SKLFPENTT------HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMY  267 (358)
Q Consensus       194 ~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~  267 (358)
                      +........      .......||+.|+|||++.+..++.++||||||+++|+|++|..||..............+....
T Consensus       153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~  232 (293)
T d1csna_         153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK  232 (293)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred             eEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhcc
Confidence            987543221      12234679999999999999999999999999999999999999998665544433332221111


Q ss_pred             chhhHhhhhccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCC
Q 018263          268 NSKELMNLVDPMLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMSTAIKMMNGET  321 (358)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~L~~~~  321 (358)
                      ......++     .    ...+.++.+++..|++.+|++||+++.+.+.|+.+.
T Consensus       233 ~~~~~~~l-----~----~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~  277 (293)
T d1csna_         233 QSTPLREL-----C----AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL  277 (293)
T ss_dssp             HHSCHHHH-----T----TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             CCCChHHh-----c----CCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            11111111     1    123456889999999999999999998888777653

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-45  Score=335.24  Aligned_cols=268  Identities=22%  Similarity=0.282  Sum_probs=204.2

Q ss_pred             hcCCcccceecccCceEEEEEEEC-CCCEEEEEEeecc--ChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcC-----
Q 018263           41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG-----  112 (358)
Q Consensus        41 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~-----  112 (358)
                      +++|+++++||+|+||+||+|++. +|+.||||++...  .....+.+.+|+.+++.++  |||++++++++...     
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~--h~~iv~~~~~~~~~~~~~~   94 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--HENVIGLLDVFTPARSLEE   94 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCC--CTTBCCCSEEECSCSSTTT
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcC--CCCeeeEEEEEeecccccc
Confidence            679999999999999999999975 7999999998754  3344567889999999998  99999999998643     


Q ss_pred             CeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCceEEeecc
Q 018263          113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG  192 (358)
Q Consensus       113 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~~~l~Dfg  192 (358)
                      ...+++++++.|++|.+++     ..+.+++..++.++.||+.||+|||++   ||+||||||+||+++.++.++++|||
T Consensus        95 ~~~~~i~~~~~gg~L~~~~-----~~~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg  166 (348)
T d2gfsa1          95 FNDVYLVTHLMGADLNNIV-----KCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG  166 (348)
T ss_dssp             CCCCEEEEECCSEEHHHHH-----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC-
T ss_pred             CceEEEEEeecCCchhhhc-----ccccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccc
Confidence            2345666777899999998     335699999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccCccCccccccC-CCCccCceecHHHHHHHHHhCCCCCCccccccchhhhHhhhhccchh-
Q 018263          193 LSKLFPENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKAWGMYNSK-  270 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~-  270 (358)
                      .+....    .......|+..|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+.......... 
T Consensus       167 ~a~~~~----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~  242 (348)
T d2gfsa1         167 LARHTD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL  242 (348)
T ss_dssp             ---CCT----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             hhcccC----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence            987532    233446788999999987765 46889999999999999999999998766544444333322221111 


Q ss_pred             -------hHhhhhccccCC-CC-----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhhcCCC
Q 018263          271 -------ELMNLVDPMLYG-NF-----PENEAIRFLKVGLLCVQEKSKLRPQMSTAIK--MMNGETN  322 (358)
Q Consensus       271 -------~~~~~~~~~~~~-~~-----~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~--~L~~~~~  322 (358)
                             ............ ..     ....+..+.+||.+||+.||.+|||+.|+++  .|.+...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~  309 (348)
T d2gfsa1         243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  309 (348)
T ss_dssp             HTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             hhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence                   111111111100 00     0124567889999999999999999999997  5665543

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.2e-38  Score=293.61  Aligned_cols=265  Identities=20%  Similarity=0.218  Sum_probs=191.6

Q ss_pred             cCCcccceecccCceEEEEEEEC-CCCEEEEEEeeccChhhHHHHHHHHHHhhhcc---------cCCCCceeeeceEEc
Q 018263           42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVN---------VCHENLVKLHGGCID  111 (358)
Q Consensus        42 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---------~~h~~i~~~~~~~~~  111 (358)
                      .+|+++++||+|+||+||+|++. +|+.||||+++... .....+.+|+..++.+.         ..|+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            46999999999999999999975 79999999997443 33456677888777764         126889999988764


Q ss_pred             --CCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcEEcCCCCCcEEEcCCCc---
Q 018263          112 --GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNILLDQNFN---  185 (358)
Q Consensus       112 --~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~~~~i~H~di~p~Nilv~~~~~---  185 (358)
                        ....++++.++..+....... .......+++..++.++.||+.||+|||+ .   ||+||||||+||+++.++.   
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~  167 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALI-KKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPEN  167 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHH-HHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTT
T ss_pred             ccccceeeeeeeccccccccccc-ccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccc
Confidence              345666776665443333221 22455678999999999999999999998 7   9999999999999976553   


Q ss_pred             ---eEEeecccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHHHHHHhCCCCCCccccccch-----
Q 018263          186 ---PKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEY-----  257 (358)
Q Consensus       186 ---~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~lltg~~pf~~~~~~~~~-----  257 (358)
                         ++++|||.+.....    ......+++.|+|||++.+..++.++|+||+||++++|++|+.||.........     
T Consensus       168 ~~~~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~  243 (362)
T d1q8ya_         168 LIQIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  243 (362)
T ss_dssp             EEEEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             cceeeEeeccccccccc----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence               89999999876432    223457899999999999999999999999999999999999999755432111     


Q ss_pred             -hhhHhhhhccchhhHhh------hhc---------c----------ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHH
Q 018263          258 -HLVDKAWGMYNSKELMN------LVD---------P----------MLYGNFPENEAIRFLKVGLLCVQEKSKLRPQMS  311 (358)
Q Consensus       258 -~~~~~~~~~~~~~~~~~------~~~---------~----------~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~  311 (358)
                       .......+.........      ..+         .          ..........+..+.+|+.+||+.||.+|||++
T Consensus       244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~  323 (362)
T d1q8ya_         244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  323 (362)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence             11111111111110000      000         0          011234567888999999999999999999999


Q ss_pred             HHHH
Q 018263          312 TAIK  315 (358)
Q Consensus       312 eil~  315 (358)
                      |+++
T Consensus       324 e~L~  327 (362)
T d1q8ya_         324 GLVN  327 (362)
T ss_dssp             HHHT
T ss_pred             HHhc
Confidence            9987

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.88  E-value=1e-23  Score=175.50  Aligned_cols=170  Identities=15%  Similarity=0.073  Sum_probs=119.8

Q ss_pred             CcccceecccCceEEEEEEECCCCEEEEEEeeccC------------------hhhHHHHHHHHHHhhhcccCCCCceee
Q 018263           44 FRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVES------------------KQGEKEFMSEVASMANVNVCHENLVKL  105 (358)
Q Consensus        44 y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~------------------~~~~~~~~~e~~~l~~l~~~h~~i~~~  105 (358)
                      +.+.++||+|+||.||+|.+.+|+.||||+++...                  .........|+..+..+.  |.+++..
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~v~~~   79 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--GLAVPKV   79 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--TSSSCCE
T ss_pred             chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc--CCCcceE
Confidence            45678999999999999999889999999875321                  111234456777888877  8888887


Q ss_pred             eceEEcCCeeEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCcEEEcCCCc
Q 018263          106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN  185 (358)
Q Consensus       106 ~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~~~i~H~di~p~Nilv~~~~~  185 (358)
                      ++...    .+++||++++..+.+           ++...+..++.|++.+|++||++   ||+|+||||+||+++++ .
T Consensus        80 ~~~~~----~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~  140 (191)
T d1zara2          80 YAWEG----NAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-G  140 (191)
T ss_dssp             EEEET----TEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-E
T ss_pred             EEecC----CEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-C
Confidence            76532    379999998754332           34455678999999999999999   99999999999999976 5


Q ss_pred             eEEeecccccccCCCCcccccccccccCccCccccccCCCCccCceecHHHHH
Q 018263          186 PKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLL  238 (358)
Q Consensus       186 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il  238 (358)
                      ++|+|||.+.....+........  +.. .-.+ +....|+.++|+||+.--+
T Consensus       141 ~~liDFG~a~~~~~~~~~~~l~r--d~~-~~~~-~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         141 IWIIDFPQSVEVGEEGWREILER--DVR-NIIT-YFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             EEECCCTTCEETTSTTHHHHHHH--HHH-HHHH-HHHHHHCCCCCHHHHHHHH
T ss_pred             EEEEECCCcccCCCCCcHHHHHH--HHH-HHHH-HHcCCCCCcccHHHHHHHH
Confidence            89999999976543322110000  000 0001 1245678899999975443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.89  E-value=5e-09  Score=89.57  Aligned_cols=151  Identities=16%  Similarity=0.047  Sum_probs=104.6

Q ss_pred             HHHHHhhcCCcccceecccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCe
Q 018263           35 NQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC  114 (358)
Q Consensus        35 ~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~  114 (358)
                      +++....+.|++++..+.+..+.||++... ++.+++|+...........+..|...+..+. .+--+.+++.+...++.
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~-~~vpvP~vl~~~~~~~~   84 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLE-GKLPVPKVLHFERHDGW   84 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHT-TTSCCCCEEEEEEETTE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHh-ccCCCCcEEEEEecCCc
Confidence            456666788888887665556789988754 6667888876554444445667777777664 23335677778888888


Q ss_pred             eEEEEecCCCCCHHHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcC-------------------------------
Q 018263          115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE-------------------------------  163 (358)
Q Consensus       115 ~~iv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-------------------------------  163 (358)
                      .++||++++|.++.+....         ......++.+++..++.||+.                               
T Consensus        85 ~~lv~~~l~G~~~~~~~~~---------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (263)
T d1j7la_          85 SNLLMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC  155 (263)
T ss_dssp             EEEEEECCSSEEHHHHTTT---------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred             eEEEEEecccccccccccc---------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhh
Confidence            9999999999887665521         111223455566666666643                               


Q ss_pred             -------------------------CCCCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          164 -------------------------IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       164 -------------------------~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                                               ....++|+|+.|.||++++++.+.|+||+.+..
T Consensus       156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             hcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                     022479999999999999876667999987753

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.39  E-value=4.8e-07  Score=76.43  Aligned_cols=132  Identities=15%  Similarity=0.114  Sum_probs=86.5

Q ss_pred             eecccCc-eEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEEEecCCCCCH
Q 018263           49 KIGEGGF-GSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSL  127 (358)
Q Consensus        49 ~lg~g~~-g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L  127 (358)
                      .+..|.. +.||++...++..+++|........   .+..|...++.+....--+.+++.+..+.+..++||++++|.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            4445543 6789999888888999987544322   35566666666653333466778888888889999999988665


Q ss_pred             HHHhhhccccccCCCHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 018263          128 SQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE--------------------------------------------  163 (358)
Q Consensus       128 ~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~--------------------------------------------  163 (358)
                      .+..         ....   ..+.++...|..||+.                                            
T Consensus        94 ~~~~---------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (255)
T d1nd4a_          94 LSSH---------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL  161 (255)
T ss_dssp             TTSC---------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred             cccc---------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHH
Confidence            4321         1111   1122344444444431                                            


Q ss_pred             -----------CCCCcEEcCCCCCcEEEcCCCceEEeeccccc
Q 018263          164 -----------IQPHVVHRDIKTSNILLDQNFNPKISDFGLSK  195 (358)
Q Consensus       164 -----------~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~  195 (358)
                                 ....++|+|+.|.||+++++..+.|+||+.+.
T Consensus       162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                       02247999999999999987667799998775

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.88  E-value=2.8e-05  Score=69.78  Aligned_cols=78  Identities=12%  Similarity=0.084  Sum_probs=47.4

Q ss_pred             cceecccCceEEEEEEEC-CCCEEEEEEeeccC-------hhhHHHHHHHHHHhhhcccCCC-CceeeeceEEcCCeeEE
Q 018263           47 SNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-------KQGEKEFMSEVASMANVNVCHE-NLVKLHGGCIDGPCRIL  117 (358)
Q Consensus        47 ~~~lg~g~~g~v~~~~~~-~~~~vaiK~~~~~~-------~~~~~~~~~e~~~l~~l~~~h~-~i~~~~~~~~~~~~~~i  117 (358)
                      .+.||.|....||++... +++.+++|.-....       .....+...|.+.+..+....| .+++++.+  +....++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            457899999999999865 46789999754311       1112234456666666542233 34445443  4556789


Q ss_pred             EEecCCCCC
Q 018263          118 VYDYMPNNS  126 (358)
Q Consensus       118 v~e~~~~~~  126 (358)
                      +||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997654

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.54  E-value=0.00091  Score=57.51  Aligned_cols=162  Identities=13%  Similarity=0.019  Sum_probs=83.3

Q ss_pred             cCHHHHHHhhcCCccccee-----cccCceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccC---CCCce
Q 018263           32 FSYNQLKIATNGFRWSNKI-----GEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC---HENLV  103 (358)
Q Consensus        32 ~~~~~~~~~~~~y~i~~~l-----g~g~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~---h~~i~  103 (358)
                      .+..++.-..++|.+.+..     ..|---+.|+++..+|+ |++|+.....  ....+..++..+..+...   .|..+
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence            4556677777888875543     34555778999987665 8999975321  122334455555555322   33333


Q ss_pred             eeec---eEEcCCeeEEEEecCCCCCHHHHh--------------hhc-c----------------------ccccCCCH
Q 018263          104 KLHG---GCIDGPCRILVYDYMPNNSLSQTL--------------LGE-E----------------------KRRAKFGW  143 (358)
Q Consensus       104 ~~~~---~~~~~~~~~iv~e~~~~~~L~~~l--------------~~~-~----------------------~~~~~l~~  143 (358)
                      ...+   +.......+.++.+..|......-              ... .                      ........
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence            2211   223345566777776654321100              000 0                      00000011


Q ss_pred             HHHHHHHHHHHHHHHHHhcC-CCCCcEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          144 KARREIIMGIGRGLAYIHEE-IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       144 ~~~~~~~~qi~~aL~~LH~~-~~~~i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      ......+..+...+...+.. ...|+||+|+.++||+++++...-++||+.+..
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence            11112222222333333221 134899999999999999887778999998853

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.48  E-value=0.00061  Score=59.08  Aligned_cols=139  Identities=14%  Similarity=0.044  Sum_probs=77.8

Q ss_pred             ceEEEEEEECCCCEEEEEEeeccChhhHHHHHHHHHHhhhcccC---CCCceeee--ceEEcCCeeEEEEecCCCCCHH-
Q 018263           55 FGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC---HENLVKLH--GGCIDGPCRILVYDYMPNNSLS-  128 (358)
Q Consensus        55 ~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~---h~~i~~~~--~~~~~~~~~~iv~e~~~~~~L~-  128 (358)
                      --.||++...+|..|++|+... .......+..|...+..+...   .+..+..-  ..+......+.++++.+|..+. 
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp-~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~  113 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRP-ERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA  113 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECT-TTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred             cceeEEEEcCCCCEEEEEEeCC-CCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence            3589999999999999999864 334455677777777666411   11111211  2344566778999998764321 


Q ss_pred             ----HHh---------hh----cc-cccc-------------------CCCHH---HHHHHHHHHHHHHHHHh-cCCCCC
Q 018263          129 ----QTL---------LG----EE-KRRA-------------------KFGWK---ARREIIMGIGRGLAYIH-EEIQPH  167 (358)
Q Consensus       129 ----~~l---------~~----~~-~~~~-------------------~l~~~---~~~~~~~qi~~aL~~LH-~~~~~~  167 (358)
                          .+.         +.    .. ..+.                   .++..   .....+.+++..+...- +....+
T Consensus       114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~  193 (325)
T d1zyla1         114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL  193 (325)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred             CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence                100         00    00 0001                   11111   22222333333332221 111348


Q ss_pred             cEEcCCCCCcEEEcCCCceEEeecccccc
Q 018263          168 VVHRDIKTSNILLDQNFNPKISDFGLSKL  196 (358)
Q Consensus       168 i~H~di~p~Nilv~~~~~~~l~Dfg~~~~  196 (358)
                      ++|+|+.+.||+++++  ..++||+-+..
T Consensus       194 liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         194 RLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             eecCCCCcccEEEeCC--ceEEechhccc
Confidence            8999999999999754  45889988764

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.33  E-value=0.00029  Score=62.92  Aligned_cols=74  Identities=19%  Similarity=0.195  Sum_probs=49.7

Q ss_pred             cceecccCceEEEEEEECC--------CCEEEEEEeeccChhhHHHHHHHHHHhhhcccCCCCceeeeceEEcCCeeEEE
Q 018263           47 SNKIGEGGFGSVYKGRLQD--------GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV  118 (358)
Q Consensus        47 ~~~lg~g~~g~v~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~~~h~~i~~~~~~~~~~~~~~iv  118 (358)
                      +++|+.|-.-.+|++...+        .+.|++++.....  ......+|..+++.+.. +.-..++++++.+    ++|
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~~idr~~E~~i~~~ls~-~gl~Pkll~~~~~----g~I  119 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSE-RHLGPKLYGIFSG----GRL  119 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHH-TTSSSCEEEEETT----EEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc--hhhHHHHHHHHHHHHHh-CCCCCeEEEEcCC----ceE
Confidence            5678888889999998653        3568888876322  23345578888877752 4334567776643    588


Q ss_pred             EecCCCCCH
Q 018263          119 YDYMPNNSL  127 (358)
Q Consensus       119 ~e~~~~~~L  127 (358)
                      ++|++|.++
T Consensus       120 ~efi~g~~l  128 (395)
T d1nw1a_         120 EEYIPSRPL  128 (395)
T ss_dssp             ECCCCEEEC
T ss_pred             EEEeccccC
Confidence            999987543